PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jeffries, EP; Di Filippo, M; Galbiati, F				Jeffries, Elizabeth P.; Di Filippo, Michela; Galbiati, Ferruccio			Failure to reabsorb the primary cilium induces cellular senescence	FASEB JOURNAL			English	Article						caveolae; caveolin-1; aurora kinase A; alisertib; mitotic spindle	PREMATURE SENESCENCE; BREAST-CANCER; AURORA KINASE; CAVEOLIN-1; FIBROBLASTS; INHIBITION; GROWTH; CYCLE; TUMORIGENESIS; ACTIVATION	Aurora kinase A (AURKA) is necessary for proper primary cilium disassembly before mitosis. We found that depletion of caveolin-1 expression promotes primary cilia formation through the proteasomal-dependent degradation of aurora kinase A and induces premature senescence in human fibroblasts. Down-regulation of intraflagellar transport-88, a protein essential for ciliogenesis, inhibits premature senescence induced by the depletion of caveolin-1. In support of these findings, we showed that alisertib, a pharmacological inhibitor of AURKA, causes primary cilia formation and cellular senescence by irreversibly arresting cell growth. Suppression of primary cilia formation limits cellular senescence induced by alisertib. The primary cilium must be disassembled to free its centriole to form the centrosome, a necessary structure for mitotic spindle assembly and cell division. We showed that the use of the centriole to form primary cilia blocks centrosome formation and mitotic spindle assembly and prevents the completion of mitosis in cells in which cellular senescence is caused by the inhibition of AURKA. We also found that AURKA is down-regulated and primary cilia formation is enhanced when cellular senescence is promoted by other senescence-inducing stimuli, such as oxidative stress and UV light. Thus, we propose that impaired AURKA function induces premature senescence by preventing reabsorption of the primary cilium, which inhibits centrosome and mitotic spindle formation and consequently prevents the completion of mitosis. Our study causally links the inability of the cell to disassemble the primary cilium, a microtubule-based cellular organelle, to the development of premature senescence, a functionally and pathologically relevant cellular state.	[Jeffries, Elizabeth P.; Di Filippo, Michela; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), Univ Pittsburgh, 200 Lothrop St,Biomed Sci Tower,Room E1154, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Galbiati, Ferruccio/AAF-3527-2020		U.S. National Institutes of Health (NIH) National Cancer Institute [R01-CA205165]; NIH National Heart, Lung, and Blood Institute [R01-HL124747]; NATIONAL CANCER INSTITUTE [R01CA205165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124747] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant R01-CA205165 from the U.S. National Institutes of Health (NIH) National Cancer Institute (to F.G.), and Grant R01-HL124747 from the NIH National Heart, Lung, and Blood Institute (to F.G.). The authors declare no conflicts of interest.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Breslin L, 2014, CELL CYCLE, V13, P2773, DOI 10.4161/15384101.2015.945868; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718; Carroll B, 2017, J CELL BIOL, V216, P1949, DOI 10.1083/jcb.201610113; Cirak Y, 2015, J BUON, V20, P1414; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Ferchichi I, 2013, DIS MARKERS, V34, P63, DOI [10.3233/DMA-120947, 10.1155/2013/871929]; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Goto H, 2013, CELL MOL LIFE SCI, V70, P3893, DOI 10.1007/s00018-013-1302-8; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027410; Korobeynikov V, 2017, BIOCHEM SOC T, V45, P37, DOI 10.1042/BST20160142; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Mercier I, 2008, CANCER BIOL THER, V7, P1212, DOI 10.4161/cbt.7.8.6220; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Park C, 2006, INT J MOL MED, V17, P715; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Seeger-Nukpezah Tamina, 2013, Drug Discov Today Dis Mech, V10, pe135; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Segal SS, 1999, AM J PHYSIOL-HEART C, V277, pH1167; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Tang AQ, 2017, ONCOTARGET, V8, P23937, DOI 10.18632/oncotarget.14893; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856	49	11	11	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4866	4882		10.1096/fj.201801382R	http://dx.doi.org/10.1096/fj.201801382R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596512	Bronze, Green Published			2022-12-26	WOS:000462888500019
J	Bar-Meir, M; Friedlander, Y; Calderon-Margalit, R; Hochner, H				Bar-Meir, Maskit; Friedlander, Yechiel; Calderon-Margalit, Ronit; Hochner, Hagit			Mode of delivery and offspring adiposity in late adolescence: The modifying role of maternal pre-pregnancy body size	PLOS ONE			English	Article							CESAREAN-SECTION; UNITED-STATES; MASS INDEX; OBESITY; MICROBIOTA; OVERWEIGHT; CHILDHOOD; RISK	Objective To study the association between mode of delivery and offspring BMI in late adolescence in a large cohort that predated the obesity epidemic, and assess the role of maternal pre-pregnancy BMI (ppBMI) in this association. Study design We conducted a historical prospective study in the setting of the Jerusalem Perinatal Study (JPS), a population-based cohort that includes all 17,003 births to residents of West Jerusalem, between 1974 and 1976. Offspring's BMI at age 17 was obtained upon army recruitment and was available for 11,001 of cohort participants. The associations were examined using logistic regressions, adjusting for socio-demographic characteristics and for proxies for indication for C-Section birth. Analyses were then stratified by quartiles of ppBMI. Results C-Section was associated with offspring overweight/obesity, with adjusted OR of 1.44 (95% CI: 1.14-1.82). Significant interaction of ppBMI with mode of delivery was observed, such that the associations of C-Section with overweight/obesity were limited to the upper quartile of ppBMI (adjusted OR = 1.70, 95% CI: 1.18-2.43). Restricting the analyses to singleton first births and excluding pregnancies complicated with toxemia and gestational diabetes yielded similar findings. Conclusions C-Section was positively associated with being overweight/obese at age 17. Importantly, ppBMI modified this association, with a significant association between C-Section and overweight/obesity evident only among offspring born to mothers in the highest ppBMI quartile. In light of the growing rates of obesity in women of reproductive age, these results should be	[Bar-Meir, Maskit] Shaare Zedek Med Ctr, Infect Dis, Jerusalem, Israel; [Bar-Meir, Maskit] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Friedlander, Yechiel; Calderon-Margalit, Ronit; Hochner, Hagit] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Bar-Meir, M (corresponding author), Shaare Zedek Med Ctr, Infect Dis, Jerusalem, Israel.; Bar-Meir, M (corresponding author), Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.; Hochner, H (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth, Jerusalem, Israel.	mbarmeir@gmail.com; hagit.hochner@mail.huji.ac.il		Bar-Meir, Maskit/0000-0003-1616-2111				Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Darmasseelane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087896; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Flemming K, 2013, ARCH DIS CHILD, V98, P526, DOI 10.1136/archdischild-2012-303459; Fyfe EM, 2011, OBSTET GYNECOL, V117, P1315, DOI 10.1097/AOG.0b013e318217922a; Hall KD, 2018, OBESITY, V26, P11, DOI 10.1002/oby.22073; Harlap S, 2007, PAEDIATR PERINAT EP, V21, P256, DOI 10.1111/j.1365-3016.2007.00799.x; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195; Li HT, 2012, AM J CLIN NUTR, V96, P215, DOI 10.3945/ajcn.112.038760; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pei ZC, 2014, J PEDIATR-US, V164, P1068, DOI 10.1016/j.jpeds.2013.12.044; TAFFEL SM, 1985, AM J PUBLIC HEALTH, V75, P190, DOI 10.2105/AJPH.75.2.190; Tun HM, 2018, JAMA PEDIATR, V172, P368, DOI 10.1001/jamapediatrics.2017.5535; Yuan C, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2385	18	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209581	10.1371/journal.pone.0209581	http://dx.doi.org/10.1371/journal.pone.0209581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605457	gold, Green Published, Green Submitted			2022-12-26	WOS:000454759900017
J	Pk, MMU; Islam, MS; Pervin, R; Dutta, S; Talukder, RI; Rahman, M				Pk, Md. Moyen Uddin; Islam, Mohammad Sayful; Pervin, Rumana; Dutta, Subhajit; Talukder, Rabiul Islam; Rahman, Matiar			Optimization of extraction of antioxidant polysaccharide from Pleurotus ostreatus (Jacq.) P. Kumm and its cytotoxic activity against murine lymphoid cancer cell line	PLOS ONE			English	Article							IN-VITRO; ANTITUMOR-ACTIVITY; ANGELICA-SINENSIS; FRUITING BODIES; PURIFICATION; MUSHROOM; CAPACITY; VIVO	The purpose of this study was to optimize the extraction method for polysaccharide from the fruiting bodies of Pleurotus ostreatus (Jacq.) P. Kumm and to assess the antioxidant and cytotoxic potentials of polysaccharide. In this investigation, polysaccharides from Pleurotus ostreatus (Jacq.) P. Kumm were extricated by utilizing the hot water. One-single factor and response surface methodology was established to optimize the extraction conditions for polysaccharide from Pleurotus ostreatus (Jacq.) P. Kumm. Examination of antioxidant activity of Pleurotus ostreatus polysaccharide (POP) was directed by utilizing 2, 2-diphenyl-1-picrylhydrazyl (DPPH) and 2, 2-azino-bis-3-ethyl-benzothiazoline-6-sulfonic acid (ABTS) techniques. Cytotoxicity of POP was evaluated using an MTT assay. The experimental data were fitted to a quadratic equation utilizing multiple regression investigations, and the ideal conditions were as per the following: water/crude material proportion, 26.04 mL/g; an extraction time of 62.08 minutes; and an extraction temperature 70.5 degrees C. Under such conditions, the polysaccharide yield was 5.32 +/- 0.12% with the anticipated yield. POP showed good scavenging activity against DPPH radical (p< 0.001, EC50 = 1036.38 mu g/mL, R-2 = 0.8313) and ABTS radicals (p<0.001, EC50 = 824.37 mu g/mL, R-2 = 0.8223), with a dose (p<0.001)and- time (p<0.001) dependent cytotoxic potential on Ehrlich ascites carcinoma cell line in vitro. This demonstrated that polysaccharides (POP) had certain cancer prevention agent exercises. In this manner, these examinations give reference to additionally research and reasonable improvement of Pleurotus ostreatus (Jacq.) P. Kumm polysaccharide and POP may prove a useful therapeutic agent, due to its robust antioxidant and cytotoxic activity.	[Pk, Md. Moyen Uddin] Univ Rajshahi, Inst Biol Sci, Rajshahi, Bangladesh; [Pk, Md. Moyen Uddin; Pervin, Rumana; Rahman, Matiar] Univ Rajshahi, Dept Biochem & Mol Biol, Rajshahi, Bangladesh; [Pk, Md. Moyen Uddin] Independent Univ Bangladesh, Sch Sci, Dhaka, Bangladesh; [Pk, Md. Moyen Uddin] Primeasia Univ, Dept Biochem, Dhaka, Bangladesh; [Islam, Mohammad Sayful] Mawlana Bhashani Sci & Technol Univ, Dept Pharm, Tangail, Bangladesh; [Dutta, Subhajit] Banaras Hindu Univ, Sch Sci, Varanasi, Uttar Pradesh, India; [Talukder, Rabiul Islam] Popular Diagnost Ctr Ltd, Dept Clin Biochem, Dhaka, Bangladesh	University of Rajshahi; University of Rajshahi; Independent University Bangladesh (IUB); Mawlana Bhashani Science & Technology University; Banaras Hindu University (BHU)	Pk, MMU (corresponding author), Univ Rajshahi, Inst Biol Sci, Rajshahi, Bangladesh.; Pk, MMU (corresponding author), Univ Rajshahi, Dept Biochem & Mol Biol, Rajshahi, Bangladesh.; Pk, MMU (corresponding author), Independent Univ Bangladesh, Sch Sci, Dhaka, Bangladesh.; Pk, MMU (corresponding author), Primeasia Univ, Dept Biochem, Dhaka, Bangladesh.	biomoyen@gmail.com	Dutta, Subhajit/AAX-2293-2020; Moyen, Moyen Uddin PK/A-4551-2018	Moyen, Moyen Uddin PK/0000-0001-9026-8518; Dutta, Subhajit/0000-0003-2390-7492	Popular Diagnostic Centre Ltd.	Popular Diagnostic Centre Ltd.	The authors received no specific funding for this work. RIT is employed by Popular Diagnostic Centre Ltd. Popular Diagnostic Centre Ltd. provided support in the form of salary for author RIT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alam Nuhu, 2011, Mycobiology, V39, P45, DOI 10.4489/MYCO.2011.39.1.045; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chai YY, 2016, CARBOHYD POLYM, V149, P121, DOI 10.1016/j.carbpol.2016.04.090; Chen Y, 2008, FOOD CHEM, V107, P231, DOI 10.1016/j.foodchem.2007.08.021; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fernandes A, 2015, FOOD CHEM, V169, P396, DOI 10.1016/j.foodchem.2014.08.027; Gonzalez-Centeno MR, 2015, ULTRASON SONOCHEM, V22, P506, DOI 10.1016/j.ultsonch.2014.05.027; Gupta S, 2010, PARASITOL INT, V59, P192, DOI 10.1016/j.parint.2010.01.004; Jain SK, 2006, FREE RADICAL BIO MED, V41, P1187, DOI 10.1016/j.freeradbiomed.2006.07.017; Jayakumar T, 2006, FOOD CHEM TOXICOL, V44, P1989, DOI 10.1016/j.fct.2006.06.025; Jin ZQ, 2018, MYCOBIOLOGY, V46, P24, DOI 10.1080/12298093.2018.1454014; Jing YQ, 2016, INT J BIOL MACROMOL, V91, P188, DOI 10.1016/j.ijbiomac.2016.05.069; Johnson MH, 2011, J AGR FOOD CHEM, V59, P8923, DOI 10.1021/jf201720z; Kang MC, 2014, CARBOHYD POLYM, V99, P365, DOI 10.1016/j.carbpol.2013.07.091; Ke CL, 2009, CARBOHYD POLYM, V75, P677, DOI 10.1016/j.carbpol.2008.09.008; Le K, 2007, FOOD CHEM, V105, P353, DOI 10.1016/j.foodchem.2006.11.063; Li PY, 2011, J SERB CHEM SOC, V76, P709, DOI 10.2298/JSC100818063L; Luo AX, 2010, CARBOHYD POLYM, V79, P1014, DOI 10.1016/j.carbpol.2009.10.033; Ma LS, 2012, CARBOHYD POLYM, V89, P371, DOI 10.1016/j.carbpol.2012.03.016; Maran JP, 2013, IND CROP PROD, V42, P159, DOI 10.1016/j.indcrop.2012.05.011; Miao SS, 2013, INT J BIOL MACROMOL, V60, P235, DOI 10.1016/j.ijbiomac.2013.05.033; Palacios I, 2012, CARBOHYD RES, V358, P72, DOI 10.1016/j.carres.2012.06.016; Pk M. M. U., 2018, Tropical Journal of Natural Product Research, V2, P314, DOI 10.26538/tjnpr/v2i7.3; Qiao DL, 2009, CARBOHYD POLYM, V76, P422, DOI 10.1016/j.carbpol.2008.11.004; Shang HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183001; Sharma K, 2015, J FOOD DRUG ANAL, V23, P243, DOI 10.1016/j.jfda.2014.10.005; Tian LM, 2011, CARBOHYD POLYM, V83, P537, DOI 10.1016/j.carbpol.2010.08.023; Tian SY, 2017, J FOOD DRUG ANAL, V25, P766, DOI 10.1016/j.jfda.2016.08.012; Xu FF, 2016, CARBOHYD POLYM, V151, P364, DOI 10.1016/j.carbpol.2016.05.091; Yang SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115638; Yu F, 2013, CARBOHYD POLYM, V94, P114, DOI 10.1016/j.carbpol.2013.01.050; Zhao T, 2014, CARBOHYD POLYM, V105, P26, DOI 10.1016/j.carbpol.2014.01.059	33	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209371	10.1371/journal.pone.0209371	http://dx.doi.org/10.1371/journal.pone.0209371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605465	gold, Green Published, Green Submitted			2022-12-26	WOS:000454759900015
J	Sagar, PS; Zhang, J; Luciuk, M; Mannix, C; Wong, ATY; Rangan, GK				Sagar, Priyanka S.; Zhang, Jennifer; Luciuk, Magda; Mannix, Carly; Wong, Annette T. Y.; Rangan, Gopala K.			Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; PLASMA OSMOLALITY; CYST GROWTH; VASOPRESSIN; TOLVAPTAN; COPEPTIN; URINE; MODEL	Polycystic kidney disease (PKD) is the most common inherited cause of kidney failure and currently has limited treatment options. Increasing water intake reduces renal cyst growth in the pck rat (a genetic ortholog of autosomal recessive PKD) but it is not clear if this beneficial effect is present in other models of PKD. In this study, we tested the hypothesis that high water intake (HWI) reduces the progression of cystic renal disease in Lewis polycystic kidney (LPK) rats (a genetic ortholog of human nephronophthisis-9). Groups of female and male LPK (n = 8-10 per group) and Lewis (n = 4 per group) rats received water ad libitum supplemented with or without 5% glucose [ to simulate HWI or normal water intake (NWI) respectively] from postnatal weeks 3 to 16. Water intake increased similar to 1.3-fold in the LPK + HWI group compared to LPK+NWI rats between weeks 3 to 10 but the differences were not significant at later timepoints. In LPK rats, HWI reduced the increases in the kidney to body weight ratio by 54% at week 10 and by 42% at week 16 compared to NWI (both p<0.01). The reduction in kidney enlargement was accompanied by decreases in the percentage renal cyst area, percentage renal interstitial collagen and proteinuria (all p<0.05). At week 16, HWI reduced systolic blood pressure and the heart to body to weight ratio by 16% and 21% respectively in males LPK rats (both p<0.01). In conclusion, a modest increase in water intake during the early phase of disease was sufficient to attenuate renal cystic disease in LPK rats, with secondary benefits on hypertension and cardiovascular disease. These data provide further preclinical evidence that increased water intake is a potential intervention in cystic renal diseases.	[Sagar, Priyanka S.; Zhang, Jennifer; Luciuk, Magda; Mannix, Carly; Wong, Annette T. Y.; Rangan, Gopala K.] Univ Sydney, Westmead Inst Med Res, Ctr Transplant & Renal Res, Sydney, NSW, Australia; [Sagar, Priyanka S.; Zhang, Jennifer; Luciuk, Magda; Mannix, Carly; Wong, Annette T. Y.; Rangan, Gopala K.] Western Sydney Local Hlth Dist, Westmead Hosp, Dept Renal Med, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Sagar, PS (corresponding author), Univ Sydney, Westmead Inst Med Res, Ctr Transplant & Renal Res, Sydney, NSW, Australia.; Sagar, PS (corresponding author), Western Sydney Local Hlth Dist, Westmead Hosp, Dept Renal Med, Sydney, NSW, Australia.	priyanka.sagar@sydney.edu.au		Zhang, Jennifer/0000-0003-3269-3801; Luciuk, Magdalena/0000-0003-1637-9919; Sagar, Priyanka/0000-0001-6874-4303	National Health and Research Medical Council [632674, 1138533]	National Health and Research Medical Council	This study was supported by a grant from the National Health and Research Medical Council (Grant numbers 632674 and 1138533, Recipient G.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2014, J PHARMACOL EXP THER, V349, P258, DOI 10.1124/jpet.114.213256; Casteleijn NF, 2015, AM J NEPHROL, V41, P248, DOI 10.1159/000382081; Council NHaMR, 2013, AUSTR COD CAR US AN; Czernichow P, 2003, DIAGNOSTICS ENDOCRIN, P212; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.021; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Grantham JJ, 2008, J AM SOC NEPHROL, V19, P1, DOI 10.1681/ASN.2007101100; Hopp K, 2015, AM J PHYSIOL-RENAL, V308, pF261, DOI 10.1152/ajprenal.00345.2014; Kalliokoski O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058460; Konig J, 2017, CLIN J AM SOC NEPHRO, V12, P1974, DOI 10.2215/CJN.01280217; Kurien BT, 2004, LAB ANIM-UK, V38, P333, DOI 10.1258/0023677041958945; McCooke JK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-393; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Phillips JK, 2007, KIDNEY BLOOD PRESS R, V30, P129, DOI 10.1159/000101828; Ponte B, 2015, J AM SOC NEPHROL, V26, P1415, DOI 10.1681/ASN.2014030260; Qian Q, 2001, KIDNEY INT, V59, P2005, DOI 10.1046/j.1523-1755.2001.00716.x; Rangan GK, 2016, INTERN MED J, V46, P883, DOI 10.1111/imj.13143; Reed BY, 2011, KIDNEY INT, V79, P128, DOI 10.1038/ki.2010.355; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Schwensen KG, 2011, NEPHRON EXP NEPHROL, V117, pE93, DOI 10.1159/000320149; Scott LV, 1998, LIFE SCI, V62, P1985, DOI 10.1016/S0024-3205(98)00027-7; Ta Michelle H T, 2016, World J Nephrol, V5, P339, DOI 10.5527/wjn.v5.i4.339; Ta MHT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164193; Ta MHT, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0193-3; TERWEL D, 1994, EUR J ENDOCRINOL, V131, P86, DOI 10.1530/eje.0.1310086; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Underwood CF, 2018, ANN NUTR METAB, V72, P33, DOI 10.1159/000488125; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Warner G, 2016, J AM SOC NEPHROL, V27, P1437, DOI 10.1681/ASN.2015020132; Wuthrich RP, 2015, POLYCYSTIC KIDNEY DISEASE, P95; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Zhao D, 2017, INT J BIOL SCI, V13, P276, DOI 10.7150/ijbs.17617; Zittema D, 2012, CLIN J AM SOC NEPHRO, V7, P906, DOI 10.2215/CJN.11311111	35	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209186	10.1371/journal.pone.0209186	http://dx.doi.org/10.1371/journal.pone.0209186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601830	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200046
J	Kakizaki, M; Yamamoto, Y; Yabutaid, S; Kurosaki, N; Kagawa, T; Kotani, A				Kakizaki, Masatoshi; Yamamoto, Yuichiro; Yabutaid, Suemi; Kurosaki, Natsumi; Kagawa, Tatehiro; Kotani, Ai			The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; RNA; CELLS; SERUM; DNA; HBV; EXPRESSION; MONOCYTES; ANTIGEN; MARKER	Hepatitis B virus (HBV) generates large amounts of complete and incomplete viral particles. Except for the virion, which acts as infectious particles, the function of those particles remains elusive. Extracellular vesicles (EVs) have been revealed to have biological functions. The EVs which size are less than 100 nm in diameter, were collected from HBV infected-patients. These vesicles contain, complete and incomplete virions, and exosomes, which have been recently shown to be critical as intercellular communicators. Here, the effects of the exosome, the complete, and the incomplete particles on the target cells were investigated. These particles are endocytosed by monocyte/macrophages and function primarily to upregulate PD-L1. The functions and composition of the EVs were affected by nucleotide reverse transcriptase inhibitors (NRTIs), suggesting that the EVs are involved in the pathogenesis of HBV hepatitis and clinical course of those patients treated by NRTIs.	[Kakizaki, Masatoshi; Yamamoto, Yuichiro; Yabutaid, Suemi; Kotani, Ai] Tokai Univ, Inst Med Sci, Div Hematol Malignancy, Isehara, Kanagawa, Japan; [Kakizaki, Masatoshi; Kagawa, Tatehiro] Tokai Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Isehara, Kanagawa, Japan; [Yabutaid, Suemi; Kurosaki, Natsumi; Kotani, Ai] Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University	Kotani, A (corresponding author), Tokai Univ, Inst Med Sci, Div Hematol Malignancy, Isehara, Kanagawa, Japan.; Kotani, A (corresponding author), Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Kanagawa, Japan.	aikotani@k-lab.jp	Kagawa, Tatehiro/AAF-7300-2020	Kagawa, Tatehiro/0000-0002-3442-1423; Kakizaki, Masatoshi/0000-0002-9388-8402	2018 Tokai University School of Medicine Research Aid; JSPS KAKENHI [JP18K15131]; Research Program on Hepatitis from Japan Agency for Medical Research and Development [16fk0210114h0001]	2018 Tokai University School of Medicine Research Aid; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Program on Hepatitis from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by 2018 Tokai University School of Medicine Research Aid (M, K., http://www.tsc.u-tokai.ac.jp/pubhome/ikenkyu/03youshiki/21kenkyu_joseikin/kenkyu_joseikin.htm), by JSPS KAKENHI Grant (JP18K15131, M. K.,https://www.jsps.go.jp/j-grantsinaid/), and by the Research Program on Hepatitis from Japan Agency for Medical Research and Development (16fk0210114h0001; A.K., https://www.amed.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Support Center for Medical Research and Education, Tokai University, for technical assistance. This study was supported by 2018 Tokai University School of Medicine Research Aid (M, K.), by JSPS KAKENHI Grant (JP18K15131, M.K.), and by the Research Program on Hepatitis from Japan Agency for Medical Research and Development (16fk0210114h0001; A.K.).	Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; BLUMBERG BS, 1977, SCIENCE, V197, P17, DOI 10.1126/science.325649; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Clark DN, 2015, ANTIVIR RES, V123, P132, DOI 10.1016/j.antiviral.2015.09.011; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Gerelsaikhan T, 1996, J VIROL, V70, P4269, DOI 10.1128/JVI.70.7.4269-4274.1996; Higuchi H, 2018, BLOOD, V131, P2552, DOI 10.1182/blood-2017-07-794529; Hu JM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021386; Huang YW, 2015, HEPATOL SURG NUTR, V4, P197, DOI 10.3978/j.issn.2304-3881.2014.11.08; Huang ZY, 2017, VIRAL IMMUNOL, V30, P224, DOI 10.1089/vim.2016.0122; Kouwaki T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00335; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lampertico P, 2016, ALIMENT PHARM THER, V44, P16, DOI 10.1111/apt.13659; Legut Mateusz, 2022, NAT REV MOL CELL BIO, V603, P728, DOI [10.1038/s41586-022-04494-7, DOI 10.1038/NRM.2017.27, 10.1038/onc.2017.117]; Liu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003856; Luckenbaugh L, 2015, J VIRAL HEPATITIS, V22, P561, DOI 10.1111/jvh.12361; Ning XJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002255; Perlman D, 2003, J VIROL, V77, P2287, DOI 10.1128/JVI.77.3.2287-2294.2003; Rokuhara A, 2006, J GASTROENTEROL, V41, P785, DOI 10.1007/s00535-006-1856-4; Said EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158265; Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171; Sanada T, 2017, CELL MOL GASTROENTER, V3, P272, DOI 10.1016/j.jcmgh.2016.10.003; Seeger C, 1997, TRENDS MICROBIOL, V5, P447, DOI 10.1016/S0966-842X(97)01141-4; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Tang CM, 2014, WORLD J GASTROENTERO, V20, P6262, DOI 10.3748/wjg.v20.i20.6262; van Bommel F, 2015, HEPATOLOGY, V61, P66, DOI 10.1002/hep.27381; Wang J, 2016, J HEPATOL, V65, P700, DOI 10.1016/j.jhep.2016.05.029; Wang YJ, 2016, VIRUS RES, V213, P205, DOI 10.1016/j.virusres.2015.12.014; Yang HC, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.64; Zheng JJ, 2014, CELL MOL IMMUNOL, V11, P294, DOI 10.1038/cmi.2013.70	32	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0205886	10.1371/journal.pone.0205886	http://dx.doi.org/10.1371/journal.pone.0205886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596665	gold, Green Submitted, Green Published			2022-12-26	WOS:000454627200006
J	Qu, YM; Pan, Y; Niu, HK; He, YH; Li, MQ; Li, L; Liu, JW; Li, B				Qu, Yangming; Pan, Yang; Niu, Huikun; He, Yinghua; Li, Meiqi; Li, Lu; Liu, Jianwei; Li, Bo			Short-term effects of fine particulate matter on non-accidental and circulatory diseases mortality: A time series study among the elder in Changchun	PLOS ONE			English	Article							EXPOSURE MEASUREMENT ERROR; HEART-RATE-VARIABILITY; AIR-POLLUTION; HEALTH; PM2.5; PARTICLES; CITIES; EPIDEMIOLOGY; ASSOCIATION; MODIFIERS	Background and objectives Fine particulate matter (PM2.5, particulate matter with an aerodynamic diameter less than or equal to 2.5 mu m) has multiple adverse effects on human health, especially on the respiratory and circulatory system. The purpose of this study was to evaluate the short-term effect of PM2.5 on the mortality risk of non-accidental and circulatory diseases, and to explore the potential effect modification by sex, education and death location. Methods We collected daily mortality counts of Changchun (China) residents, daily meteorology and air pollution data, from January 1, 2014, to January 1, 2017. We focused on the elderly (>= 65 years old) population who died from non-accidental causes and circulatory diseases, and stratified them by sex, education, and death location. A generalized additive Poisson regression model (GAM) was used to analyse the impact of air pollutants on mortality. We fit single pollutant models to examine PM2.5 effects with different lag structures of single-day (distributed lag:lag0-lag3) and multi-day (moving average lag:lag01-lag03). To test the sensitivity of the model, a multi-pollutant model was established when the PM2.5 effect was strongest. Results In the single pollutant models, an increment of PM2.5 by 10 mu g/m(3) at lag0-3 was associated with a 0.385% (95% CI: 0.069% to 0.702%) increase in daily non-accidental mortality and a 0.442% (95% CI: 0.038% to 0.848%) increase in daily circulatory disease mortality. NO2 (lag1) and O-3 (lag0, lag1, lag2, lag01, lag02, lag03) were associated with daily non-accidental death and NO2 (lag1, lag3, lag03) and O-3 (lag0, lag1, lag01, lag02, lag03) were associated with daily circulatory disease mortality. In the co-pollutant models, the risk estimates for PM2.5 changed slightly. The excess mortality risk of non-accidental and circulatory diseases was higher for women, people with low education, and died outside hospital. Conclusions We found that short-term exposure to PM2.5 increased the mortality risk of non-accidental and circulatory diseases among the elderly in Changchun. Women, people with low education and died outside hospital are more susceptible to PM2.5. NO2 and O-3 were also associated with an increase in mortality from non-accidental and circulatory diseases and the O-3 is a high effect.	[Qu, Yangming; Niu, Huikun; Li, Meiqi; Li, Lu; Li, Bo] Jilin Univ, Sch Publ Hlth, Minist Educ, Key Lab Zoonosis Res, Changchun, Jilin, Peoples R China; [Pan, Yang; He, Yinghua; Liu, Jianwei] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China	Jilin University	Li, B (corresponding author), Jilin Univ, Sch Publ Hlth, Minist Educ, Key Lab Zoonosis Res, Changchun, Jilin, Peoples R China.	li_bo@jlu.edu.cn	Li, Bo/AAA-8968-2020; niu, hui/GQP-6490-2022	Li, Bo/0000-0002-7294-6888; Qu, Yangming/0000-0001-9131-5152	China's central government; Key scientific research project of Jilin Provincial Health and Family Planning Commission [2015Z03]	China's central government; Key scientific research project of Jilin Provincial Health and Family Planning Commission	China's central government subsidizes projects to monitor the impact of local air pollution on people's health; Key scientific research project of Jilin Provincial Health and Family Planning Commission in 2015 (2015Z03).	[Anonymous], 2017, HEART FAIL REV, DOI DOI 10.1007/s10741-017-9606-7; Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236; Atkinson RW, 2015, J EXPO SCI ENV EPID, V25, P208, DOI 10.1038/jes.2014.63; Baxter LK, 2013, J EXPO SCI ENV EPID, V23, P457, DOI 10.1038/jes.2012.114; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chen RJ, 2017, AM J RESP CRIT CARE, V196, P73, DOI [10.1164/rccm.201609-1862OC, 10.1164/rccm.201612-2427OC, 10.1164/rccm.201609-1862oc]; Chen RJ, 2011, SCI TOTAL ENVIRON, V409, P4923, DOI 10.1016/j.scitotenv.2011.08.029; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Cox LA, 2013, REGUL TOXICOL PHARM, V66, P336, DOI 10.1016/j.yrtph.2013.05.006; Devlin RB, 2003, EUR RESPIR J, V21, p76S, DOI 10.1183/09031936.03.00402403; Electric heating versus oil heating in the service territory of Long Island Lighting Company, 1973, ELECT HEATING VERSUS; Franklin M, 2007, J EXPO SCI ENV EPID, V17, P279, DOI 10.1038/sj.jes.7500530; Gong H, 2004, INHAL TOXICOL, V16, P335, DOI 10.1080/08958370490439470; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Janssen NAH, 2013, SCI TOTAL ENVIRON, V463, P20, DOI 10.1016/j.scitotenv.2013.05.062; Jindal SK, 2007, INDIAN J MED RES, V126, P409; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kim CS, 1998, J APPL PHYSIOL, V84, P1834, DOI 10.1152/jappl.1998.84.6.1834; Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005; Kloog I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088578; Kloog I, 2013, EPIDEMIOLOGY, V24, P555, DOI 10.1097/EDE.0b013e318294beaa; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Li P, 2015, ENVIRON SCI POLLUT R, V22, P358, DOI 10.1007/s11356-014-3301-1; Li T, 2018, ENVIRON INT, V111, P52, DOI 10.1016/j.envint.2017.10.023; Liang HQ, 2018, SCI TOTAL ENVIRON, V615, P558, DOI 10.1016/j.scitotenv.2017.09.266; Niu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083782; Pellizzari ED, 1999, J EXPO ANAL ENV EPID, V9, P49, DOI 10.1038/sj.jea.7500025; Petronella SA, 2003, NURS CLIN N AM, V38, P725, DOI 10.1016/S0029-6465(03)00099-9; Ren M, 2017, CONCENTRATION RESPON, V2017, DOI 10.1155/2017/5806185; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Rotko T, 2001, J EXPO ANAL ENV EPID, V11, P216, DOI 10.1038/sj.jea.7500162; Samoli E, 2013, ENVIRON HEALTH PERSP, V121, P932, DOI 10.1289/ehp.1206124; Schwartz J, 2007, J EXPO SCI ENV EPID, V17, pS2, DOI 10.1038/sj.jes.7500619; SEXTON K, 1993, TOXICOL IND HEALTH, V9, P843, DOI 10.1177/074823379300900509; Song YS, 2016, J CLEAN PROD, V112, P1312, DOI 10.1016/j.jclepro.2015.05.006; Sorensen M, 2003, ENVIRON HEALTH PERSP, V111, P161, DOI 10.1289/ehp.5646; Wang Y, 2017, EPIDEMIOLOGY, V28, P207, DOI 10.1097/EDE.0000000000000614; Wilkinson RG, 1997, LANCET, V350, P516, DOI 10.1016/S0140-6736(05)63105-4; Yang CX, 2012, INT ARCH OCC ENV HEA, V85, P579, DOI 10.1007/s00420-011-0707-7; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116; Zuo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023116	44	12	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209793	10.1371/journal.pone.0209793	http://dx.doi.org/10.1371/journal.pone.0209793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596713	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200086
J	Buffa, G; Dahan, S; Sinclair, I; St-Pierre, M; Roofigari, N; Mutran, D; Rondeau, JJ; Dancause, KN				Buffa, Giavana; Dahan, Salome; Sinclair, Isabelle; St-Pierre, Myriane; Roofigari, Noushin; Mutran, Dima; Rondeau, Jean-Jacques; Dancause, Kelsey Needham			Prenatal stress and child development: A scoping review of research in low- and middle-income countries	PLOS ONE			English	Review							SPONTANEOUS PRETERM BIRTH; COMMON MENTAL-DISORDERS; MATERNAL STRESS; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; PSYCHIATRIC-DISORDERS; PSYCHOSOCIAL STRESS; CORTISOL-LEVELS; LIFE EVENTS; PREGNANCY	Introduction Past research has shown relationships between stress during pregnancy, and related psychosocial health measures such as anxiety and depressive symptoms, with infant, child, and adult outcomes. However, most research is from high-income countries. We conducted a scoping review to identify research studies on prenatal stress and outcomes of the pregnancy or offspring in low-and middle-income countries (LMICs), and to synthesize the stress measures and outcomes assessed, the findings observed, and directions for future research. Methods We searched PubMed, Scopus, and PsycINFO for English-language abstracts published from Jan 1960-Jan 2017. Search terms were related to stress and psychosocial health; pregnancy; infant or child development; and LMICs. Results 48 articles were identified. Sixty percent of studies were in upper-middle, 25% in lower-middle, and 15% in low income countries. Most studies used questionnaires, either existing or tailor-made, to assess stress. Eight assessed cortisol. Most studies (n = 31) assessed infant outcomes at birth, particularly gestational age or preterm birth (n = 22, 12 showing significant relationships), and birthweight (n = 21, 14 showing significant relationships). Five studies analyzed outcomes later in infancy such as temperament and motor development, all showing significant results; and nine in childhood such as behavioral development, asthma, and physical growth, with eight showing significant results. Conclusions Results highlight the importance of prenatal stress on infant and child outcomes in LMICs. Methods used in high-income countries are successfully employed in LMICs, but tailored tools remain necessary. Careful assessment of covariates is needed to foster analyses of interactive effects and pathways. Studies including longer-term follow-up should be prioritized.	[Buffa, Giavana] Ross Univ, Sch Med, Portsmouth, Dominica; [Dahan, Salome] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Sinclair, Isabelle; St-Pierre, Myriane; Dancause, Kelsey Needham] Univ Quebec Montreal, Dept Sci Act Phys, Montreal, PQ, Canada; [Roofigari, Noushin] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Mutran, Dima] Ecole Hautes Etud Commerciales, Dept Sci Gest, Montreal, PQ, Canada; [Rondeau, Jean-Jacques] Univ Quebec Montrel UQAM, Bibliotheque Sci, Montreal, PQ, Canada	University of Haifa; University of Quebec; University of Quebec Montreal; Laval University; Universite de Montreal; HEC Montreal; University of Quebec; University of Quebec Montreal	Dancause, KN (corresponding author), Univ Quebec Montreal, Dept Sci Act Phys, Montreal, PQ, Canada.	kelseydancause@gmail.com		Dancause, Kelsey/0000-0002-8677-9953	Fonds de recherche du Quebec -Sante	Fonds de recherche du Quebec -Sante(Fonds de la Recherche en Sante du Quebec)	Kelsey Dancause was supported by a salary award from Fonds de recherche du Quebec -Sante while working on this manuscript: http://www.frqs.gouv.qc.ca/partenariat/nos-projets-derecherche/projet? id= 3zjix07l1442500387658.	Abeysena C, 2010, J OBSTET GYNAECOL RE, V36, P260, DOI 10.1111/j.1447-0756.2009.01160.x; ABRAMSON JH, 1961, ARCH DIS CHILD, V36, P42, DOI 10.1136/adc.36.185.42; Amiri FN, 2010, IRAN RED CRESCENT ME, V12, P650; [Anonymous], J INDIAN ACAD APPL P; Arffin F, 2012, ARCH GYNECOL OBSTET, V286, P1187, DOI 10.1007/s00404-012-2417-0; Arteaga-Guerra John J, 2010, Rev. salud pública, V12, P276; Baig SA, 2013, J PAK MED ASSOC, V63, P414; Barrios YV, 2014, INT J WOMENS HEALTH, V6, P249, DOI 10.2147/IJWH.S54269; Basgul SS, 2011, TURKISH J PEDIATR, V53, P666; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Bhat A, 2015, INFANT BEHAV DEV, V39, P35, DOI 10.1016/j.infbeh.2014.12.002; Bindt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080711; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; CeronMireles P, 1996, AM J PUBLIC HEALTH, V86, P825, DOI 10.2105/AJPH.86.6.825; Chen D, 2000, OCCUP ENVIRON MED, V57, P661, DOI 10.1136/oem.57.10.661; CHERSICH M, 2016, GLOBALIZATION HEALTH, V12; Chersich M, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0189-1; Christian P, 2016, MATERN CHILD NUTR, V12, P64, DOI 10.1111/mcn.12138; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Fan F, 2016, J HUM HYPERTENS, V30, P171, DOI 10.1038/jhh.2015.64; Frith AL, 2015, MATERN CHILD NUTR, V11, P537, DOI 10.1111/mcn.12047; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Hanlon C, 2010, ARCH WOMEN MENT HLTH, V13, P385, DOI 10.1007/s00737-010-0149-3; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Hocher B, 2007, J PHYSIOL-LONDON, V579, P287, DOI 10.1113/jphysiol.2007.127738; Isaksson J, 2015, J PSYCHIATR RES, V71, P97, DOI 10.1016/j.jpsychires.2015.09.016; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Karamoozian M, 2015, IRAN J NEONATOL, V6, P14; Kertes DA, 2016, CHILD DEV, V87, P61, DOI 10.1111/cdev.12487; King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026; Kingston D, 2011, EFFECTS PRENATAL POS; Kingston D, 2014, MATERN CHILD HLTH J, V18, P1728, DOI 10.1007/s10995-013-1418-3; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Koen N, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.28720; Lazinski M, 2008, ARCH WOMEN MENT HLTH, V11, P363, DOI 10.1007/s00737-008-0035-4; Meghea CI, 2014, CENT EUR J PUBL HEAL, V22, P153, DOI 10.21101/cejph.a3947; Mirabzadeh A, 2013, IRAN RED CRESCENT ME, V15, P507, DOI 10.5812/ircmj.11271; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Monk C, 2012, DEV PSYCHOPATHOL, V24, P1361, DOI 10.1017/S0954579412000764; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; Nasreen HE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-515; Nations United, 2017, WORLD MORT REP; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Pires TD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-215; Premji S, 2014, MATERN CHILD HLTH J, V18, P2393, DOI 10.1007/s10995-014-1479-y; Qiao Y, 2012, J OBSTET GYNAECOL, V32, P237, DOI 10.3109/01443615.2011.647736; Qu XL, 2016, CLIN EXP OBSTET GYN, V43, P103; Ramchandani PG, 2010, J AM ACAD CHILD PSY, V49, P239, DOI 10.1016/j.jaac.2009.11.013; Rondo PHC, 2013, EUR J CLIN NUTR, V67, P348, DOI 10.1038/ejcn.2013.28; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Rosa MJ, 2016, ANN ALLERGY ASTHMA I; Ross J, 2011, ARCH DIS CHILD-FETAL, V96, pF59, DOI 10.1136/adc.2010.183327; ROTHBERG AD, 1991, S AFR MED J, V79, P35; Ruwanpathirana T, 2014, INDIAN J PEDIATR, V81, P1000, DOI 10.1007/s12098-014-1382-y; Sanchez SE, 2013, J REPROD MED, V58, P25; Sandman CA, 2012, NEUROENDOCRINOLOGY, V95, P7, DOI DOI 10.1159/000327017; Sandman Curt A, 2011, Int J Pept, V2011, P837596, DOI 10.1155/2011/837596; Sanguanklin N, 2014, JOGNN-J OBST GYN NEO, V43, P435, DOI 10.1111/1552-6909.12466; Santos IS, 2014, J AFFECT DISORDERS, V164, P112, DOI 10.1016/j.jad.2014.04.033; Sasaluxnanon Chadapim, 2005, Journal of the Medical Association of Thailand, V88, P1514; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Shaikh K, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-88; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stewart CP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0793-8; Tran TD, 2014, J AFFECT DISORDERS, V160, P104, DOI 10.1016/j.jad.2013.12.034; UNICEF, 2004, LOW BIRTHWEIGHT COUN; Valladares E, 2009, ACTA OBSTET GYN SCAN, V88, P818, DOI 10.1080/00016340903015321; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Wado YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096304; WHO, 2018, MAT MORT; WHO (World Health Organization), 2017, NEW PERSPECTIVES ON; WHO (World Health Organization), 2008, MATERNAL MENTAL HEAL; World Bank, WORLD BANK COUNTRY A; World Health Organization, 2005, CHRON DIS LOW MIDDL; Zhang YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052780; Zhu P, 2014, DEV MED CHILD NEUROL, V56, P283, DOI 10.1111/dmcn.12378; Zhu P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.023	79	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0207235	10.1371/journal.pone.0207235	http://dx.doi.org/10.1371/journal.pone.0207235			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0GV	30592715	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000454621900003
J	Papic, N; Lepej, SZ; Gorenec, L; Grgic, I; Gasparov, S; Kanizaj, TF; Vince, A				Papic, Neven; Lepej, Snjezana Zidovec; Gorenec, Lana; Grgic, Ivana; Gasparov, Slavko; Kanizaj, Tajana Filipec; Vince, Adriana			The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C	PLOS ONE			English	Article							RNA-SEQUENCING ANALYSIS; VIRUS; EXPRESSION; PLEXINS; CANCER; GENES; CELLS	Semaphorins are a diverse family of immunoregulators recently recognized to play a major role in various phases of immune responses. Their role in chronic viral hepatitis C (CHC) and contribution to the progression of liver disease is unknown. The aim of this study was to analyse the association of secreted semaphorins with the severity of liver disease in patients with CHC. Serum concentrations of semaphorins were measured in 114 treatment-naive CHC patients and 36 healthy controls. Serum concentrations of SEMA3A, SEMA3C, SEMA5A, SEMA6B and SEMA6D were significantly increased in patients with CHC compared to controls. While serum concentrations of SEMA3C and SEMA6D significantly increased with fibrosis stage in both HCV-g1 and HCV-g3 infections, the concentration of SEMA5A inversely correlated with fibrosis stage in both HCV genotypes. ROC analysis showed that serum concentrations of SEMA3C (>4.0ng/mL, AUC 0.88) and SEMA6D (>4.5, AUC 0.82) had higher AUC than widely used APRI (AUC 0.71) and FIB-4 (AUC 0.74) scores. Serum concentrations of SEMA3C and SEMA6D significantly decreased after DAA and PEG IFN-alpha/ribavirin therapy, while the serum concentration of SEMA5A significantly increased after DAAs therapy. Immunohistochemistry confirmed the expression of SEMA3C and SEMA5A in hepatocytes, endothelial cells and lymphocytes of cirrhotic livers from CHC patients but not in controls. In conclusion, we provide the first evidence that SEMA3C, SEMA5A and SEMA6D can be considered as markers of liver injury in CHC.	[Papic, Neven; Vince, Adriana] Univ Hosp Infect Dis Zagreb, Dept Viral Hepatitis, Zagreb, Croatia; [Papic, Neven; Gasparov, Slavko; Kanizaj, Tajana Filipec; Vince, Adriana] Univ Zagreb, Sch Med, Zagreb, Croatia; [Lepej, Snjezana Zidovec; Gorenec, Lana; Grgic, Ivana] Univ Hosp Infect Dis, Dept Immunol & Mol Diagnost, Zagreb, Croatia; [Gasparov, Slavko] Univ Hosp Merkur, Dept Pathol & Cytol, Zagreb, Croatia; [Kanizaj, Tajana Filipec] Univ Hosp Merkur, Dept Gastroenterol, Zagreb, Croatia	University of Zagreb	Papic, N (corresponding author), Univ Hosp Infect Dis Zagreb, Dept Viral Hepatitis, Zagreb, Croatia.; Papic, N (corresponding author), Univ Zagreb, Sch Med, Zagreb, Croatia.	npapic@bfm.hr	Vince, Adriana/ABE-1754-2021; Kanizaj, Tajana Filipec/AAQ-6438-2020	Kanizaj, Tajana Filipec/0000-0002-9828-8916	Croatian Science Foundation [IP-11-2013]; grant "Strengthening the capacity of CerVirVac for research in virus immunology and vaccinology" [KK.01.1.1.01.0006]; European Regional Development Fund	Croatian Science Foundation; grant "Strengthening the capacity of CerVirVac for research in virus immunology and vaccinology"; European Regional Development Fund(European Commission)	This publication was in part supported by the Croatian Science Foundation project titled "Infectomics Study of Human Liver Non-parenchymal Cells in Chronic hepatitis C" (principal investigator Professor Adriana Vince, project number IP-11-2013) as well as by the the grant "Strengthening the capacity of CerVirVac for research in virus immunology and vaccinology", KK.01.1.1.01.0006, awarded to the Scientific Centre of Excellence for Virus Immunology and Vaccines and co-financed by the European Regional Development Fund.	Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Folkers ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014697; Gamil M, 2018, J MED VIROL, V90, P1080, DOI 10.1002/jmv.25026; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Kurelac I, 2012, J INTERF CYTOK RES, V32, P386, DOI 10.1089/jir.2012.0006; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lu YJ, 2016, ONCOL LETT, V12, P3967, DOI 10.3892/ol.2016.5208; Maaroufi A, 2017, J VIRAL HEPATITIS, V24, P8, DOI 10.1111/jvh.12762; Mejhert N, 2013, DIABETOLOGIA, V56, P1792, DOI 10.1007/s00125-013-2931-z; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nishide M, 2018, NAT REV RHEUMATOL, V14, P19, DOI 10.1038/nrrheum.2017.201; Papic N, 2013, J HEPATOL, V58, pS146, DOI 10.1016/S0168-8278(13)60355-4; Papic N, 2012, VIRUSES-BASEL, V4, P581, DOI 10.3390/v4040581; Larrubia JR, 2014, WORLD J GASTROENTERO, V20, P3418, DOI 10.3748/wjg.v20.i13.3418; Roney K, 2013, PROTEIN CELL, V4, P17, DOI 10.1007/s13238-012-2108-4; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tang MW, 2018, RHEUMATOLOGY, V57, P909, DOI 10.1093/rheumatology/kex511; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Vadasz Z, 2014, CLIN REV ALLERG IMMU, V47, P17, DOI 10.1007/s12016-013-8360-4; Vince A, 2018, INFECT DIS REP, V10, P24, DOI 10.4081/idr.2018.7651; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733	27	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209481	10.1371/journal.pone.0209481	http://dx.doi.org/10.1371/journal.pone.0209481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592759	Green Accepted, Green Published, gold			2022-12-26	WOS:000454621900027
J	Ranjan, R				Ranjan, Ram			Protecting endemic species from African Catfish invasion when community behavioral responses get in the way	PLOS ONE			English	Article							CLARIAS-GARIEPINUS; WATER-QUALITY; CONSERVATION; ECONOMICS; HARVEST; EAT	Exotic invasive fish species, when introduced into pristine natural environments, threaten the survival of many endemic species. Management challenges associated with controlling their further spread and protecting endemic species can be exacerbated when the same exotic fish species also provide gastronomical benefits to humans. Local human populations can switch their consumption preferences toward the exotic fish species, leading to an increase in their spread rate and control costs. Using the example of the African Catfish invasion in a freshwater lake, we develop a bioeconomic model of its optimal control, which also incorporates the behavioral challenges arising from a gastronomical preference for the exotic fish species. In particular, the cost of catfish control increases with its consumption demand, which, through altering the inter-species dynamics, threatens the survival of endemic fish species. The manager has at his disposal the market and non-market values of the endemic fish species to invest toward their preservation efforts. The non-market value of the endemic species is further modeled as endogenous to the community's preference switching. Results suggest that a late detection of the exotic fish species in freshwater bodies can increase their control costs enough to make their eradication challenging, especially when the manager faces financial resource constraints. The presence of behavioral effects adds to this challenge-directly, through increasing the control costs, and indirectly, through lowering the non-market value of the endemic fish species.	[Ranjan, Ram] Macquarie Univ, Dept Environm Sci, Fac Sci & Engn, Sydney, NSW, Australia	Macquarie University	Ranjan, R (corresponding author), Macquarie Univ, Dept Environm Sci, Fac Sci & Engn, Sydney, NSW, Australia.	ram.ranjan@mq.edu.au		ranjan, ram/0000-0002-8756-9392				[Anonymous], 2015, EC TIMES; Booth AJ, 2010, AFR ZOOL, V45, P299, DOI 10.3377/004.045.0208; Buhle ER, 2005, ECOL ECON, V52, P355, DOI 10.1016/j.ecolecon.2004.07.018; Chirwa ER, RUFORUM WORKING DOCU, P869; Clark C. W., 1985, BIOECONOMIC MODELING; CLARK CW, 1979, SIAM REV, V21, P81, DOI 10.1137/1021006; CRAWLEY MJ, 1986, PHILOS T ROY SOC B, V314, P711, DOI 10.1098/rstb.1986.0082; Eiswerth ME, 2002, ENVIRON RESOUR ECON, V23, P319, DOI 10.1023/A:1021275607224; Falk-Petersen J, 2013, MAR RESOUR ECON, V28, P65, DOI 10.5950/0738-1360-28.1.65; Finnoff D, 2010, ANNU REV RESOUR ECON, V2, P77, DOI 10.1146/annurev.resource.050708.144212; Fruh D, 2012, ECOL EVOL, V2, P2843, DOI 10.1002/ece3.382; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Higgins SI, 1997, ECOL ECON, V22, P141, DOI 10.1016/S0921-8009(97)00574-0; Khedkar GD, 2013, SEQUENCING ANAL, V27, P569; Kovacic DA, 2006, ECOL ENG, V28, P258, DOI 10.1016/j.ecoleng.2006.08.002; Krishnakumar K., 2011, Journal of Threatened Taxa, V3, P1737; Kumar P, 2005, AGR EC RES REV, P167; Lanzoni M, 2018, EUR ZOOL J, V85, P1, DOI 10.1080/24750263.2017.1415384; Lew DK, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00096; Lotka AJ, 1920, J AM CHEM SOC, V42, P1595, DOI 10.1021/ja01453a010; Lyons JA, 2013, ECOL ECON, V93, P278, DOI 10.1016/j.ecolecon.2013.06.004; Marten AL, 2001, ECOLOGICAL EC, V70, P2050; Mason CF, BIOL FRESHWATER POLL; Meuser E, 2009, CONSERV BIOL, V23, P1041, DOI 10.1111/j.1523-1739.2009.01257.x; Milardi M, 2018, SCI TOTAL ENVIRON, V624, P1325, DOI 10.1016/j.scitotenv.2017.12.237; MORGAN GR, 1995, MAR POLICY, V19, P379, DOI 10.1016/0308-597X(95)00005-Q; Nunes PALD, 2004, ENVIRON RESOUR ECON, V28, P517, DOI 10.1023/B:EARE.0000036777.83060.b6; Nunez MA, 2012, CONSERV LETT, V5, P334, DOI 10.1111/j.1755-263X.2012.00250.x; OPIYO MA, 2017, J AQUAC ENG FISH RES, V3, P75, DOI DOI 10.3153/JAEFR17010; Pasko S, 2014, MANAG BIOL INVASION, V5, P263, DOI 10.3391/mbi.2014.5.3.10; Pathak AK, 2010, ACTA ICHTHYOL PISCAT, P11; Pathak H, 2012, ENV ANAL TOXICOLOGY, V2, P5, DOI [10.4172/2161-0525, DOI 10.4172/2161-0525]; Pinder AC, 2015, ENDANGER SPECIES RES, V28, P11, DOI 10.3354/esr00673; Radhakrishnan K.V., 2010, Journal of Threatened Taxa, V2, P1192; REED WJ, 1992, B MATH BIOL, V54, P185, DOI 10.1016/S0092-8240(05)80022-9; Robins C. R., 1991, AM FISH SOC SPEC PUB, V21, P243; Shogren JF, 1999, CONSERV BIOL, V13, P1257, DOI 10.1046/j.1523-1739.1999.98414.x; Singh AK., 2014, J AQUAT BIOL FISH, V2, P32; Snyder M., 2017, SCI AM; Sugunan V. V., 2002, FISHING CHIMES, V22, P50; Vermonden K, 2010, DIVERS DISTRIB, V16, P1009, DOI 10.1111/j.1472-4642.2010.00702.x; Volterra V., 1926, ANIMAL ECOLOGY, P409; Wilson RS, 2016, CONSERV BIOL, V30, P42, DOI 10.1111/cobi.12632	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209009	10.1371/journal.pone.0209009	http://dx.doi.org/10.1371/journal.pone.0209009			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7KM	30589878	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200014
J	Baisley, K; Chimbindi, N; Mthiyane, N; Floyd, S; McGrath, N; Pillay, D; Seeley, J; Zuma, T; Dreyer, J; Gareta, D; Smit, T; Mutevedzi, T; Fenty, J; Herbst, K; Birdthistle, I; Shahmanesh, M				Baisley, Kathy; Chimbindi, Natsayi; Mthiyane, Nondumiso; Floyd, Sian; McGrath, Nuala; Pillay, Deenan; Seeley, Janet; Zuma, Thembelihle; Dreyer, Jaco; Gareta, Dickman; Smit, Theresa; Mutevedzi, Tinofa; Fenty, Justin; Herbst, Kobus; Birdthistle, Isolde; Shahmanesh, Maryam			High HIV incidence and low uptake of HIV prevention services: The context of risk for young male adults prior to DREAMS in rural KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; MEN	Background Young men are less likely than young women to engage with HIV prevention and care, and their HIV-related mortality is higher. We describe HIV incidence and uptake of HIV services in men 20-29 years(y) in rural KwaZulu-Natal, South Africa, before the roll-out of DREAMS. Methods We used data from a population-based demographic and HIV surveillance cohort. HIV incidence was estimated from anonymised testing in an annual serosurvey. Service uptake was assessed in 2011 and 2015, through two self-reported outcomes: 1) HIV testing in the past 12 months(m); 2) voluntary medical male circumcision(VMMC). Logistic regression was used to estimate odds ratios(OR) and 95% confidence intervals(CI) for factors associated with each outcome. Results HIV incidence in 2011-2015 was 2.6/100 person-years (95% CI = 2.0-3.4) and 4.2 (95% CI = 3.1-5.6) among men 20-24y and 25-29y, respectively, with no significant change from 2006-2010. N = 1311 and N = 1221 young men participated in the 2011 and 2015 surveys, respectively. In both years, <50% reported testing for HIV in the past 12m. In 2011, only 5% reported VMMC, but coverage in 2015 increased to 40% and 20% in men 20-24y and 25-29y, respectively. HIV testing was positively associated with higher education and mobility. Testing uptake was higher in men reporting >1 partner in the past 12m, or condom use at last sex, but lower in those reporting a casual partner (adjusted (a) OR = 0.53, 95%CI = 0.37-0.75). VMMC uptake was associated with survey year and higher education. Men aged 25-29y and those who were employed (aOR = 0.66; 95%CI = 0.49-0.89) were less likely to report VMMC. Conclusions HIV incidence in men 20-29y was very high, and pre-exposure prophylaxis (PrEP) should be considered in this population. Uptake of services was low. VMMC coverage increased dramatically from 2011 to 2015, especially among younger men, suggesting a demand for this service. Interventions designed with and for young men are urgently needed.	[Baisley, Kathy; Floyd, Sian] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Baisley, Kathy; Chimbindi, Natsayi; Mthiyane, Nondumiso; Pillay, Deenan; Zuma, Thembelihle; Dreyer, Jaco; Gareta, Dickman; Smit, Theresa; Mutevedzi, Tinofa; Herbst, Kobus; Shahmanesh, Maryam] Africa Hlth Res Inst, Kwa Zulu, South Africa; [McGrath, Nuala; Seeley, Janet] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Africa Hlth Res Inst, Kwa Zulu, South Africa; [McGrath, Nuala] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [McGrath, Nuala] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [McGrath, Nuala] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Pillay, Deenan] UCL, Div Infect & Immun, London, England; [Seeley, Janet] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Fenty, Justin; Birdthistle, Isolde] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Shahmanesh, Maryam] UCL, Inst Global Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Africa Health Research Institute; Africa Health Research Institute; University of Kwazulu Natal; University of Southampton; University of Southampton; University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Baisley, K (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.; Baisley, K (corresponding author), Africa Hlth Res Inst, Kwa Zulu, South Africa.	kathy.baisley@lshtm.ac.uk	Herbst, Abraham J/E-4848-2010	Herbst, Abraham J/0000-0002-5436-9386; Shahmanesh, Maryam/0000-0001-7129-8535; Seeley, Janet/0000-0002-0583-5272; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust [082384/Z/07/Z]; People Programme (Marie Curie Actions) of the European Union's seventh Framework Programme FP7/2007-2013 under REA [612216]; Bill and Melinda Gates Foundation; MRC UK; DFID (MRC) [G0700837]	Wellcome Trust(Wellcome TrustEuropean Commission); People Programme (Marie Curie Actions) of the European Union's seventh Framework Programme FP7/2007-2013 under REA; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFID (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Africa Health Research Institute is supported by a grant from the Wellcome Trust (082384/Z/07/Z). The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's seventh Framework Programme FP7/2007-2013 under REA grant agreement no. 612216. The DREAMS IE Baseline Report received funding from the Bill and Melinda Gates Foundation. KB receives support from the MRC UK and DFID (MRC grant number G0700837).	Arnesen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177168; Asaolu IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164052; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Fleming PJ, 2016, CULT HEALTH SEX, V18, P1251, DOI 10.1080/13691058.2016.1183045; George G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179854; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Hudelson C, 2015, AIDS CARE, V27, P805, DOI 10.1080/09540121.2015.1011073; Humphries H, 2015, CULT HEALTH SEX, V17, P920, DOI 10.1080/13691058.2014.992045; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; Kaufman MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149892; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156909; Larmarange J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123345; Leichliter JS, 2011, SAHARA J-J SOC ASP H, V8, P82, DOI 10.1080/17290376.2011.9724989; McGrath N, 2016, 21 INT AIDS C AIDS 2; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Naidoo K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184124; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Plazy M, 2014, TROP MED INT HEALTH, V19, P680, DOI 10.1111/tmi.12301; Saul, OVERVIEW PAPER DREAM; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Shisana O, 2014, S AFRICAN NATL HIV P; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; UNAIDS W, 2016, FRAM VOL MED MAL CIR; van Rooyen H, 2013, AIDS BEHAV, V17, P2946, DOI 10.1007/s10461-012-0368-x; Vandormael A, 2018, 25 C RETR OPP INF CR; Varga C A, 2001, Afr J Reprod Health, V5, P175, DOI 10.2307/3583334; Winskell K, 2011, SOC SCI MED, V72, P953, DOI 10.1016/j.socscimed.2011.01.014	34	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208689	10.1371/journal.pone.0208689	http://dx.doi.org/10.1371/journal.pone.0208689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586376	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000454416400031
J	Enos, M; Sitienei, J; Ong'ang'o, J; Mungai, B; Kamene, M; Wambugu, J; Kipruto, H; Manduku, V; Mburu, J; Nyaboke, D; Ngari, F; Omesa, E; Omale, N; Mwirigi, N; Okallo, G; Njoroge, J; Githiomi, M; Mwangi, M; Kirathe, D; Kiplimo, R; Ndombi, A; Odeny, L; Mailu, E; Kandie, T; Maina, M; Kasera, K; Mulama, B; Mugi, B; Weyenga, H				Enos, Masini; Sitienei, Joseph; Ong'ang'o, Jane; Mungai, Brenda; Kamene, Maureen; Wambugu, Jesse; Kipruto, Hillary; Manduku, Veronica; Mburu, Josephine; Nyaboke, Drusilla; Ngari, Faith; Omesa, Eunice; Omale, Newton; Mwirigi, Nkirote; Okallo, Geoffrey; Njoroge, Janice; Githiomi, Martin; Mwangi, Mike; Kirathe, Dickson; Kiplimo, Richard; Ndombi, Amos; Odeny, Lazarus; Mailu, Eunice; Kandie, Timothy; Maina, Maurice; Kasera, Kadondi; Mulama, Beatrice; Mugi, Beatrice; Weyenga, Herman			Kenya tuberculosis prevalence survey 2016: Challenges and opportunities of ending TB in Kenya	PLOS ONE			English	Article								Background We aimed to determine the prevalence of pulmonary TB amongst the adult population (>= 15 years) in 2016 in Kenya. Method A nationwide cross-sectional survey where participants first underwent TB symptom screening and chest x-ray. Subsequently, participants who reported cough >2weeks and/or had a chest x-ray suggestive of TB, submitted sputum specimen for laboratory examination by smear microscopy, culture and Xpert MTB/RIF. Result The survey identified 305 prevalent TB cases translating to a prevalence of 558 [95%CI 455-662] per 100,000 adult population. The highest disease burden was reported among people aged 25-34 years (716 [95% CI 526-906]), males (809 [(95% CI 656-962]) and those who live in urban areas (760 [95% CI 539-981]). Compared to the reported TB notification rate for Kenya in 2016, the prevalence to notification ratio was 2.5:1. The gap between the survey prevalence and notification rates was highest among males, age groups 25-34, and the older age group of 65 years and above. Only 48% of the of the survey prevalent cases reported cough >2weeks. In addition, only 59% of the identified cases had the four cardinal symptoms for TB (cough. 2 weeks, fever, night sweat and weight loss. However, 88.2% had an abnormal chest x-ray suggestive of TB. The use of Xpert MTB/RIF identified 77.7% of the cases compared to smear microscopy's 46%. Twenty-one percent of the survey participants with respiratory symptoms reported to have sought prior health care at private clinics and chemists. Among the survey prevalent cases who reported TB related symptoms, 64.9% had not sought any health care prior to the survey. Conclusion This survey established that TB prevalence in Kenya is higher than had been estimated, and about half of the those who fall ill with the disease each year are missed.	[Enos, Masini; Sitienei, Joseph; Kamene, Maureen; Mburu, Josephine; Nyaboke, Drusilla; Ngari, Faith; Omesa, Eunice; Omale, Newton; Mwirigi, Nkirote; Okallo, Geoffrey; Githiomi, Martin; Mwangi, Mike; Kirathe, Dickson; Kiplimo, Richard; Ndombi, Amos; Mailu, Eunice; Kasera, Kadondi] Minist Hlth, Nairobi, Kenya; [Ong'ang'o, Jane; Manduku, Veronica; Odeny, Lazarus] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Mungai, Brenda; Njoroge, Janice; Kandie, Timothy] Ctr Hlth Solut, Nairobi, Kenya; [Wambugu, Jesse] Africa Holog, Nairobi, Kenya; [Kipruto, Hillary] World Hlth Org, Kenya Country Off, Nairobi, Kenya; [Maina, Maurice] US Agcy Int Dev, Nairobi, Kenya; [Mulama, Beatrice; Mugi, Beatrice] Kenyatta Natl Hosp, Nairobi, Kenya; [Weyenga, Herman] US Ctr Dis Control & Prevent, Nairobi, Kenya	Kenya Medical Research Institute; World Health Organization; United States Agency for International Development (USAID); Kenyatta National Hospital	Enos, M (corresponding author), Minist Hlth, Nairobi, Kenya.	emasini32@gmail.com	Kipruto, Hillary/ABB-7126-2021; Odeny, Lazarus/CAF-6591-2022	Enos, Masini/0000-0001-7522-5528; Omesa, Eunice/0000-0002-0087-3333	Global Fund for AIDS, Tuberculosis and Malaria; United States Agency for International Development through the Tuberculosis Accelerated Response and Care activity; Kenya Medical Research Institute; EXPAND-TB Project; Ministry of Health of the Government of Kenya; Kenya National Tuberculosis Leprosy and Lung Disease Program	Global Fund for AIDS, Tuberculosis and Malaria(United States Agency for International Development (USAID)); United States Agency for International Development through the Tuberculosis Accelerated Response and Care activity(United States Agency for International Development (USAID)); Kenya Medical Research Institute; EXPAND-TB Project; Ministry of Health of the Government of Kenya; Kenya National Tuberculosis Leprosy and Lung Disease Program	The Kenya Tuberculosis Prevalence Survey 2016 was funded by the Global Fund for AIDS, Tuberculosis and Malaria, United States Agency for International Development through the Tuberculosis Accelerated Response and Care activity, Kenya Medical Research Institute and EXPAND-TB Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Ministry of Health of the Government of Kenya and the Kenya National Tuberculosis Leprosy and Lung Disease Program for overall coordination and funding for the survey. In addition, we acknowledge the leadership of Dr Jackson Kioko and Dr. Nicholas Muraguri as Chairs of the survey advisory committee.; We are grateful for the financial and logistical support from the Global Fund for AIDS, Tuberculosis and Malaria, United States Agency for International Development through the Tuberculosis Accelerated Response and Care activity, Kenya Medical Research Institute and EXPAND-TB Project.	Anderson L, 2017, EPIDEMIOLOGICAL REV; [Anonymous], 2012, GLOB TUB REP 2012; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Federal Republic of Nigeria, 2012, 1 NAT TUB PREV SURV; Government of the Republic of Zambia. Ministry of Health, 2016, NAT TUB PREV SURV 20; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Kenya National Bureau of Statistics, 2018, BAS REP WELL BEING K; Kenya National Bureau of Statistiscs, 2018, KEN EC SURV 2018; Masini E, 2017, J INFECT DIS, V216, pS714, DOI 10.1093/infdis/jix381; Ministry of health and Social welfare The united Republic of Tanzania, 2013, UN REP TANZ 1 NAT TU; Ministry of Health Republic of Kenya, 2009, ANN REP 2009; Ministry of Health Republic of Kenya, 2018, 1 KEN TUB PAT COST S; Ministry of Health Republic of Kenya, 2018, LUNG DIS PROGR STRAT; Ministry of Health Republic of Kenya, 2018, PUBL PRIV MIX TB PRE; Ministry of Health Republic of Kenya, 2018, ACC PROGR UN HLTH CO; Ministry of Health Republic of Kenya. National Tuberculosis, 2018, NAT TUB LEPR LUNG DI; Ministry of Health Republic of Uganda, 2017, UG NAT TUB PREV SURV; ROELSGAARD E, 1961, B WORLD HEALTH ORGAN, V25, P851; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Tollefson D, 2016, INT J TUBERC LUNG D, V20, P1334, DOI 10.5588/ijtld.16.0156; UNAIDS, 2016, GET FAST TRACK LIFE; United for lung health, 2018, FOR INT RESP SOC FIR; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Vijay S., 2003, Indian Journal of Tuberculosis, V50, P185; Wells WA, 2017, INT J TUBERC LUNG D, V21, P1101, DOI 10.5588/ijtld.17.0271; WHO, 2017, GLOB TUB REP 2017; WHO, 2015, IMPLEMENTING END TB; World Bank. The World Bank, 2013, WORLD BANK REP 2013, DOI [10.1596/978-0-8213-9937-8, DOI 10.1596/978-0-8213-9937-8]; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World Health Organization, 2018, GLOB TUB REP 2018	31	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209098	10.1371/journal.pone.0209098	http://dx.doi.org/10.1371/journal.pone.0209098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586448	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400051
J	Kuzmic, M; Richaud, M; Cuq, P; Frelon, S; Galas, S				Kuzmic, Mira; Richaud, Myriam; Cuq, Pierre; Frelon, Sandrine; Galas, Simon			Carbonylation accumulation of the Hypsibius exemplaris anhydrobiote reveals age-associated marks	PLOS ONE			English	Article							TARDIGRADE RAMAZZOTTIUS-VARIEORNATUS; DESICCATION TOLERANCE; RADIATION TOLERANCE; RICHTERSIUS-CORONIFER; PROTEIN CARBONYLATION; DNA-DAMAGE; NEW-MODEL; LIFE; INDUCTION; TREHALOSE	Together with nematodes and rotifers, tardigrade belong to micrometazoans that can cope with environmental extremes such as UV and solar radiations, dehydration, supercooling or overheating. Tardigrade can resist the harshest conditions by turning to cryptobiosis, an anhydrobiotic state that results from almost complete dehydration and is characterized by an ametabolic status. Although reports have challenged the molecular basis of the mechanisms underlying genomic injury resistance, little is yet known regarding the possible involvement of other tardigrade macromolecules in injury during a stress experience. In this report, we show that the tardigrade Hypsibius exemplaris can accumulate molecular damages by means of in situ detection of carbonyls. Furthermore, we demonstrate that living tardigrade can accumulate carbonylation. Finally, we reveal that anhydrobiotic tardigrade can be constitutively affected by carbonylation that marks aging in other metazoans.	[Kuzmic, Mira; Frelon, Sandrine] SRTE, ENV, PSE, IRSN,Lab Ecotoxicol Radionucleides, St Paul Les Durance, France; [Richaud, Myriam; Cuq, Pierre; Galas, Simon] Univ Montpellier, IBMM, CNRS, ENSCM, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Galas, S (corresponding author), Univ Montpellier, IBMM, CNRS, ENSCM, Montpellier, France.	simon.galas@umontpellier.fr	Richaud, Myriam/N-3469-2019; Galas, Simon/X-1312-2019	Richaud, Myriam/0000-0002-7720-8569; Galas, Simon/0000-0002-1717-1266; FRELON, Sandrine/0000-0003-1583-1037; CUQ, Pierre/0000-0002-5440-9165	AAP-Defi Origines 2018 funding program of the CNRS [265880-Giga18]	AAP-Defi Origines 2018 funding program of the CNRS	Part of this work was funded by the grant No 265880-Giga18 of the AAP-Defi Origines 2018 funding program of the CNRS (http://www.cnrs.fr/mi/spip.php?article1345) for SG.	Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; Arakawa K, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.63; Baraibar MA, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/919832; Baumann H., 1992, ZOOLOGISCHE JAHRBUAN, P501; Beltran-Pardo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133658; Beltran-Pardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072098; Boothby TC, 2017, MOL CELL, V65, P975, DOI 10.1016/j.molcel.2017.02.018; Boothby TC, 2016, P NATL ACAD SCI USA, V113, pE5364, DOI 10.1073/pnas.1613046113; Boothby TC, 2015, P NATL ACAD SCI USA, V112, P15976, DOI 10.1073/pnas.1510461112; Bosshard F, 2010, ENVIRON MICROBIOL, V12, P2931, DOI 10.1111/j.1462-2920.2010.02268.x; CROWE J H, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P37; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Degma P, 2016, ACTUAL CHECKLIST TAR; Degma P, 2007, ZOOTAXA, P41, DOI 10.11646/zootaxa.1579.1.2; Doyere PLN, 1842, ANN SCI NAT ZOOL B E, V2e, P5; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gasiorek P, 2018, ZOOTAXA, V4415, P45, DOI 10.11646/zootaxa.4415.1.2; Goudeau J, 2010, AGING CELL, V9, P991, DOI 10.1111/j.1474-9726.2010.00625.x; Guidetti R, 2005, ZOOTAXA, P1, DOI 10.11646/zootaxa.845.1.1; Guidetti R, 2011, ZOOLOGY, V114, P123, DOI 10.1016/j.zool.2010.11.005; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horikawa DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064793; Horikawa DD, 2012, ASTROBIOLOGY, V12, P283, DOI 10.1089/ast.2011.0669; Horikawa DD, 2004, ZOOL SCI, V21, P813, DOI 10.2108/zsj.21.813; Jonsson I, 2013, J LIMNOL, V72, P73, DOI 10.4081/jlimnol.2013.s1.e9; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Kinchin I., 1995, J MAR BIOL ASSOC UK, V75, P262; Koutsovoulos G, 2016, P NATL ACAD SCI USA, V113, P5053, DOI 10.1073/pnas.1600338113; Kuzmic M, 2016, FREE RADICAL BIO MED, V101, P465, DOI 10.1016/j.freeradbiomed.2016.11.004; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; MARCUS ERNST, 1929, BRONN S KL U ORDN DES TIER REICHS, V5, P1; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; Ono F, 2012, J PHYS CONF SER, V377, DOI 10.1088/1742-6596/377/1/012053; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; POSSANZINI M, 1987, CHROMATOGRAPHIA, V23, P829, DOI 10.1007/BF02311408; Ramlov H, 2001, ZOOL ANZ, V240, P517, DOI 10.1078/0044-5231-00062; Schill RO, 2008, J ZOOL, V276, P103, DOI 10.1111/j.1469-7998.2008.00474.x; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305; Westh P., 1988, BERICHT BER GR NLAND, P227; Widel M, 2014, FREE RADICAL BIO MED, V68, P278, DOI 10.1016/j.freeradbiomed.2013.12.021; WOMERSLEY C, 1981, COMP BIOCHEM PHYS B, V70, P669, DOI 10.1016/0305-0491(81)90001-8; WRIGHT JC, 1989, J EXP BIOL, V142, P267; Yoshida Y, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002266	55	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208617	10.1371/journal.pone.0208617	http://dx.doi.org/10.1371/journal.pone.0208617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586374	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400028
J	Lee, E; Choi, EK; Han, KD; Lee, H; Choe, WS; Lee, SR; Cha, MJ; Lim, WH; Kim, YJ; Oh, S				Lee, Euijae; Choi, Eue-Keun; Han, Kyung-Do; Lee, HyunJung; Choe, Won-Seok; Lee, So-Ryoung; Cha, Myung-Jin; Lim, Woo-Hyun; Kim, Yong-Jin; Oh, Seil			Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study	PLOS ONE			English	Article							ANTAGONIST ORAL ANTICOAGULANTS; CARDIOVASCULAR-DISEASE; FOLLOW-UP; CHA(2)DS(2)-VASC SCORE; GENERAL-POPULATION; ISCHEMIC-STROKE; RISK-FACTOR; WOMEN; ASIA; MEN	Background Patients with atrial fibrillation are known to have a high risk of mortality. There is a paucity of population-based studies about the impact of atrial fibrillation on the mortality risk stratified by age, sex, and detailed causes of death. Methods A total of 15,411 patients with atrial fibrillation from the Korean National Health Insurance Service-National Sample Cohort were enrolled, and causes of death were identified according to codes of the 10th revision of the International Classification of Diseases. Results From 2002 to 2013, a total of 4,479 (29%) deaths were confirmed, and the crude mortality rate for all-cause death was 63.3 per 1,000 patient-years. Patients with atrial fibrillation had a 3.7-fold increased risk of all-cause death compared with the general population. The standardized mortality ratio for all-cause death was the highest in young patients and decreased with increasing age (standardized mortality ratio 21.93, 95% confidence interval 7.60-26.26 in patients aged <20 years; standardized mortality ratio 2.77, 95% confidence interval 2.63-2.91 in patients aged >= 80 years). Women with atrial fibrillation exhibited a greater excess mortality risk than men (standardized mortality ratio 3.81, 95% confidence interval 3.65-3.98 in women; standardized mortality ratio 3.35, 95% confidence interval 3.21-3.48 in men). Cardiovascular disease was the leading cause of death (38.5%), and cerebral infarction was the most common specific disease. Patients with atrial fibrillation had an about 5 times increased risk of death due to cardiovascular disease compared with the general population. Conclusions Patients with atrial fibrillation had a 4 times increased risk of mortality compared with the general population. However, the impact of atrial fibrillation on mortality decreased with age and in men. Cerebral infarction was the most common cause of death, and more attention should be paid to reducing the risk of stroke.	[Lee, Euijae; Choi, Eue-Keun; Lee, HyunJung; Cha, Myung-Jin; Kim, Yong-Jin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea; [Choe, Won-Seok] Sejong Gen Hosp, Dept Internal Med, Bucheon, South Korea; [Lee, So-Ryoung] SoonChunHyang Univ Hosp Seoul, Dept Internal Med, Seoul, South Korea; [Lim, Woo-Hyun] Seoul Natl Univ, Dept Internal Med, Seoul Metropolitan Govt Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Sejong General Hospital; Soonchunhyang University; Soonchunhyang University Hospital; Seoul National University (SNU)	Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	choiek17@snu.ac.kr	Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014	Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Lim, Woo-Hyun/0000-0001-9298-8500	SNUH Research Fund [0620160680]; National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [2014R1A1A2A16055218]; Ministry of Trade, Industry & Energy (MOTIE, Korea) [10052668]	SNUH Research Fund; National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology; Ministry of Trade, Industry & Energy (MOTIE, Korea)	This study was supported by grant no. 0620160680 from the SNUH Research Fund; a grant from the National Research Foundation (NRF) of Korea, funded by the Ministry of Education, Science and Technology (2014R1A1A2A16055218); and Technology Innovation Program (10052668, development of wearable self-powered energy source and low-power wireless communication system for a pacemaker) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi GS, 2013, THROMB RES, V132, P185, DOI 10.1016/j.thromres.2013.07.017; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; [Anonymous], 1970, Circulation, V41, pI162; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bosch Ralph F, 2013, Herzschrittmacherther Elektrophysiol, V24, P176, DOI 10.1007/s00399-013-0283-5; Bouchardy J, 2009, CIRCULATION, V120, P1679, DOI 10.1161/CIRCULATIONAHA.109.866319; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Fauchier L, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000290; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Friberg L, 2007, EUR HEART J, V28, P2346, DOI 10.1093/eurheartj/ehm308; Gadsboll K, 2017, EUR HEART J, V38, P899, DOI 10.1093/eurheartj/ehw658; Hamaguchi S, 2009, CIRC J, V73, P2084, DOI 10.1253/circj.CJ-09-0316; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Healey JS, 2016, LANCET, V388, P1161, DOI 10.1016/S0140-6736(16)30968-0; Huisman MV, 2016, EUROPACE, V18, P1308, DOI 10.1093/europace/euw073; Itskovich I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012340; Jose PO, 2014, J AM COLL CARDIOL, V64, P2486, DOI 10.1016/j.jacc.2014.08.048; Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kodama S, 2011, J AM COLL CARDIOL, V57, P427, DOI 10.1016/j.jacc.2010.08.641; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lee H, 2017, LIVER INT, V37, P1660, DOI 10.1111/liv.13459; Lee H, 2017, INT J CARDIOL, V240, P221, DOI 10.1016/j.ijcard.2017.03.103; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189495; Lee SR, 2017, INT J CARDIOL, V236, P226, DOI 10.1016/j.ijcard.2017.02.039; Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296; Lip GYH, 2015, INT J CARDIOL, V180, P246, DOI 10.1016/j.ijcard.2014.11.182; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Odutayo A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4482; Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236; Ohsawa M, 2007, CIRC J, V71, P814, DOI 10.1253/circj.71.814; Pokorney SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002197; Potpara T, 2010, SRP ARK CELOK LEK, V138, P177, DOI 10.2298/SARH1004177P; Redpath CJ, 2015, CURR OPIN CARDIOL, V30, P17, DOI 10.1097/HCO.0000000000000130; Renoux C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001402; Ruigomez Ana, 2005, BMC Cardiovasc Disord, V5, P20, DOI 10.1186/1471-2261-5-20; Song SO, 2016, DIABETES METAB J, V40, P35, DOI 10.4093/dmj.2016.40.1.35; Steinberg JS, 2004, CIRCULATION, V109, P1973, DOI 10.1161/01.CIR.0000118472.77237.FA; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Wattigney WA, 2002, AM J EPIDEMIOL, V155, P819, DOI 10.1093/aje/155.9.819; Xiong QM, 2015, INT J CARDIOL, V201, P195, DOI 10.1016/j.ijcard.2015.08.076	48	64	65	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209687	10.1371/journal.pone.0209687	http://dx.doi.org/10.1371/journal.pone.0209687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586468	Green Submitted, gold, Green Published			2022-12-26	WOS:000454416400084
J	Takata, H; Madung, M; Katoh, K; Fukui, K				Takata, Hideaki; Madung, Marliza; Katoh, Kaoru; Fukui, Kiichi			Cdk1-dependent phosphorylation of KIF4A at S1186 triggers lateral chromosome compaction during early mitosis	PLOS ONE			English	Article							CONDENSIN-II; MITOTIC CHROMOSOMES; PROTEOME ANALYSIS; TOPOISOMERASE-II; CHROMOKINESIN; SPINDLE; ASSOCIATION; SCAFFOLD; BINDING; ROLES	Chromosome organization during cell division is achieved through the timely association of proteins with chromatin and is regulated by protein phosphorylation. Kinesin family member 4A (KIF4A) plays an important role in the chromosome organization through the formation of the chromosome scaffold structure. However, the relationship between the function of KIF4A and its phosphorylation remains unclear. Here, we demonstrate that Cdk1-dependent phosphorylation of KIF4A at S1186 is required for chromosome binding and chromosome scaffold formation. The KIF4A mutant, which is not phosphorylated at S1186, was found to localize to the nucleus during interphase but did not accumulate in the chromosome scaffold after nuclear envelope breakdown. In addition, defects in KIF4A phosphorylation were found to disrupt the interaction of KIF4A with the condensin I complex. As a result, the morphology of the chromosomes was observed to be laterally decondensed, without condensin I in the chromosome scaffold. Additionally, a defect in chromosome segregation, chromosome bridge formation, was often observed. Although both KIF4A and condensin I disappeared from the chromosomes, the chromosomal localization of condensin II was not affected. Collectively, our novel results revealed that Cdk1-dependent KIF4A phosphorylation at S1186 is a trigger for chromosomal organization during early mitosis.	[Takata, Hideaki; Katoh, Kaoru] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ikeda, Osaka, Japan; [Madung, Marliza; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Osaka University	Takata, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ikeda, Osaka, Japan.	h.takata@aist.go.jp	Katoh, Kaoru/M-7526-2018	Katoh, Kaoru/0000-0001-6590-413X	JSPS KAKENHI [JP16H06212, JP25840073, A25252064]; MEXT LEADER; MEXT [17H06417, 17H06413]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT LEADER; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by funding from JSPS KAKENHI Grants JP16H06212, JP25840073, and MEXT LEADER to HT, a Grant-in-Aid from MEXT 17H06417 and 17H06413 to KK and JSPS KAKENHI Grant A25252064 to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; Bastos RN, 2014, J CELL BIOL, V207, P683, DOI 10.1083/jcb.201409129; Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; Dong ZX, 2018, J MOL CELL BIOL, V10, P358, DOI 10.1093/jmcb/mjy033; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; Gibcus JH, 2018, SCIENCE, V359, P652, DOI 10.1126/science.aao6135; Green LC, 2012, J CELL SCI, V125, P1591, DOI 10.1242/jcs.097790; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Kagami Y, 2014, J CELL BIOL, V205, P781, DOI 10.1083/jcb.201308172; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Li QR, 2018, J MOL CELL BIOL, V10, P2, DOI 10.1093/jmcb/mjx029; Maeshima K, 2018, CURR BIOL, V28, P444, DOI 10.1016/j.cub.2017.12.035; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Murphy LA, 2008, BIOCHEM BIOPH RES CO, V377, P1007, DOI 10.1016/j.bbrc.2008.10.114; Ohta S, 2016, J PROTEOME RES, V15, P3331, DOI 10.1021/acs.jproteome.6b00512; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Phengchat R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38281; Poonperm R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183298; Poonperm R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11916; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Takahashi M, 2016, GENE DEV, V30, P1931, DOI 10.1101/gad.282855.116; Takahashi M, 2016, BIOMED RES-TOKYO, V37, P161, DOI 10.2220/biomedres.37.161; Takata H, 2007, GENES CELLS, V12, P269, DOI 10.1111/j.1365-2443.2007.01051.x; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; WANG SZ, 1995, J CELL BIOL, V128, P761, DOI 10.1083/jcb.128.5.761; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Zhong A, 2016, GENE, V589, P43, DOI 10.1016/j.gene.2016.05.026; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209614	10.1371/journal.pone.0209614	http://dx.doi.org/10.1371/journal.pone.0209614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576375	gold, Green Submitted, Green Published			2022-12-26	WOS:000454149400064
J	De Marchi, U; Galindo, AN; Thevenet, J; Hermant, A; Bermont, F; Lassueur, S; Domingo, JS; Kussmann, M; Dayon, L; Wiederkehr, A				De Marchi, Umberto; Galindo, Antonio Nunez; Thevenet, Jonathan; Hermant, Aurelie; Bermont, Flavien; Lassueur, Steve; Domingo, Jaime Santo; Kussmann, Martin; Dayon, Loic; Wiederkehr, Andreas			Mitochondrial lysine deacetylation promotes energy metabolism and calcium signaling in insulin-secreting cells	FASEB JOURNAL			English	Article						SIRT3; mitochondria; pancreatic; beta-cells; type 2 diabetes	SIRT3; PROTEIN; ACETYLATION; CA2+; PHOSPHORYLATION; DEFICIENCY; INDICATORS; PROTEOMICS; GLUCOSE	In pancreatic beta-cells, mitochondria generate signals that promote insulin granule exocytosis. Here we study how lysine acetylation of mitochondrial proteins mechanistically affects metabolism-secretion coupling in insulin-secreting cells. Using mass spectrometry-based proteomics, we identified lysine acetylation sites in rat insulinoma cell line clone 1E cells. In cells lacking the mitochondrial lysine deacetylase sirtuin-3 (SIRT3), several matrix proteins are hyperacetylated. Disruption of the SIRT3 gene has a deleterious effect on mitochondrial energy metabolism and Ca2+ signaling. Under resting conditions, SIRT3 deficient cells are overactivated, which elevates the respiratory rate and enhances calcium signaling and basal insulin secretion. In response to glucose, the SIRT3 knockout cells are unable to mount a sustained cytosolic ATP response. Calcium signaling is strongly reduced and the respiratory response as well as insulin secretion are blunted. We propose mitochondrial protein lysine acetylation as a control mechanism in beta-cell energy metabolism and Ca2+ signaling.	[De Marchi, Umberto; Thevenet, Jonathan; Hermant, Aurelie; Bermont, Flavien; Lassueur, Steve; Domingo, Jaime Santo; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, Lausanne, Switzerland; [Galindo, Antonio Nunez; Dayon, Loic] Nestle Inst Hlth Sci, Prote, Lausanne, Switzerland; [Kussmann, Martin] Univ Auckland, Liggins Inst, Auckland, New Zealand	Nestle SA; Nestle SA; University of Auckland	Wiederkehr, A (corresponding author), Quartier Innovat, Nestle Inst Hlth Sci, Batiment G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com	Domingo, Jaime Santo/AAA-4995-2020; Kussmann, Martin/AAB-7453-2022; Domingo, Jaime Santo/AAE-1100-2021; Dayon, Loïc/J-2499-2019	Domingo, Jaime Santo/0000-0001-5501-0482; Kussmann, Martin/0000-0002-0966-2313; Dayon, Loïc/0000-0002-8499-270X; De Marchi, Umberto/0000-0002-6011-5446	Nestle Institute of Health Sciences SA	Nestle Institute of Health Sciences SA(Nestle SA)	The authors thank Prof. A. Miyawaki (Riken Brain Science Institute, Wako, Japan) for the YC3.6cyto probe to measure cytosolic Ca<SUP>2+</SUP> signals. This research was fully funded by Nestle Institute of Health Sciences SA. The authors declare no conflicts of interest.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Akhmedov D, 2012, BBA-MOL CELL RES, V1823, P1815, DOI 10.1016/j.bbamcr.2012.07.005; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Ciregia F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13908-w; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Marchi U, 2017, J CELL SCI, V130, P1929, DOI 10.1242/jcs.200741; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kim M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124744; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Mielke C, 2014, BIOCHEMISTRY-US, V53, P3817, DOI 10.1021/bi401651e; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002; Xu YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39517; Yang H, 2015, EMBO J, V34, P1110, DOI 10.15252/embj.201591041; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	39	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4660	4674		10.1096/fj.201801424R	http://dx.doi.org/10.1096/fj.201801424R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30589571				2022-12-26	WOS:000462888500003
J	Verschuren, EHJ; Hoenderop, JGJ; Peters, DJM; Arjona, FJ; Bindels, RJM				Verschuren, Eric H. J.; Hoenderop, Joost G. J.; Peters, Dorien J. M.; Arjona, Francisco J.; Bindels, Rene J. M.			Tubular flow activates magnesium transport in the distal convoluted tubule	FASEB JOURNAL			English	Article						DCT; primary cilia; mechanosensation; ion channels; fluid shear stress	COLLECTING DUCT; SHEAR-STRESS; FUNCTIONAL-CHARACTERIZATION; MATHEMATICAL-MODEL; TRPM6; CHANNEL; NA; REABSORPTION; EXPRESSION; FUROSEMIDE	Magnesium (Mg2+) is an important cofactor of many enzymes crucial for life; therefore, maintaining a Mg2+ balance in the body is essential. In the kidney, the distal convoluted tubule (DCT) determines the final urinary Mg2+ excretion. The nephron is subjected to variable urinary flow, but little is known about the influence of flow on Mg2+ transport. Primary cilia, which are mechanosensory organelles that sense changes in flow, are expressed on tubular epithelial cells. This study aimed to elucidate whether urinary flow facilitates DCT Mg2+ transport. To this end, mouse DCT15 cells, with and without primary cilia, were exposed to physiologic fluid flow generating 0.3, 0.6, and 1.2 dyn/cm(2) fluid shear stress (FSS). FSS stimulated Mg2+ uptake significantly. Net Mg2+ uptake (i.e., the difference between static and FSS) followed a single component saturable first-order transport function and was independent of FSS magnitude and primary cilia. FSS did not affect the expression of magnesiotropic genes, including Cnnm2, Kcna1, Proegf, Trpm6, and Trpm7. Transient receptor potential cation channel subfamily melastatin (TRPM) member 7 (Trmp7) inhibition by 2-aminoethyl diphenyl borinate or knockout of TRPM6 did not alter net Mg2+ uptake, suggesting that TRPM6/TRPM7 homo/heterodimeric channels are not involved in FSS-activated Mg2+ transport. In summary, FSS generated by physiologic fluid flow is a new factor activating Mg2+ transport in DCT independent of primary cilia.	[Verschuren, Eric H. J.; Hoenderop, Joost G. J.; Arjona, Francisco J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Peters, Dorien J. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bindels, RJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol,NCMLS, POB 9101, NL-6500 HB Nijmegen, Netherlands.	rene.bindels@radboudumc.nl	Verschuren, Eric/AAG-9346-2020; Verschuren, Eric H.J./AAX-6774-2020; Peters, Dorien/AFH-8507-2022; Verschuren, Eric/G-4259-2016; Bindels, René JM/B-9824-2013; Arjona, Francisco/P-6059-2015	Verschuren, Eric/0000-0003-4046-4849; Peters, Dorien/0000-0001-6974-7143; Bindels, René JM/0000-0003-1167-1339; Arjona, Francisco/0000-0002-2479-0735	Dutch Kidney Foundation [15OP03]; Netherlands Organization for Scientific Research Grant NWO [VICI 016.130.668]	Dutch Kidney Foundation; Netherlands Organization for Scientific Research Grant NWO(Netherlands Organization for Scientific Research (NWO))	The authors thank Sami G. Mohammed (Radboud University Medical Center) for advice on the microfluidic cell culture experiments and Paul van der Ven (General Instruments, Radboud University) for help with the mass spectrometry analysis. This work was supported by Dutch Kidney Foundation Grant 15OP03 (to R.J.M.B. and D.J.M.P.), and by Netherlands Organization for Scientific Research Grant NWO VICI 016.130.668 (to J.G.J.H.). The authors declare no conflicts of interest.	Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Arjona F. J., 2018, PFLUGERS ARCH; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Arjona FJ, 2011, ENDOCRINOLOGY, V152, P5065, DOI 10.1210/en.2011-1166; BARTOLI E, 1973, J CLIN INVEST, V52, P843, DOI 10.1172/JCI107248; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2012, CLIN KIDNEY J, V5, P15, DOI 10.1093/ndtplus/sfr164; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Ernandez T, 2018, AM J PHYSIOL-RENAL, V314, pF763, DOI 10.1152/ajprenal.00200.2017; Essig M, 2003, J AM SOC NEPHROL, V14, pS33, DOI 10.1097/01.ASN.0000067650.43083.DF; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Galarreta CI, 2014, AM J PATHOL, V184, P1957, DOI 10.1016/j.ajpath.2014.03.007; Gilmer GG, 2018, AM J PHYSIOL-RENAL, V315, pF1398, DOI 10.1152/ajprenal.00219.2018; Glasdam SM, 2016, ADV CLIN CHEM, V73, P169, DOI 10.1016/bs.acc.2015.10.002; Glaudemans B, 2010, KIDNEY INT, V77, P17, DOI 10.1038/ki.2009.358; Glaudemans B, 2009, J CLIN INVEST, V119, P936, DOI 10.1172/JCI36948; GREEN R, 1981, KIDNEY INT, V20, P580, DOI 10.1038/ki.1981.180; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Houillier P, 2014, ANNU REV PHYSIOL, V76, P411, DOI 10.1146/annurev-physiol-021113-170336; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Ko B, 2012, AM J PHYSIOL-RENAL, V303, pF700, DOI 10.1152/ajprenal.00139.2012; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lu H, 2015, DEV BIOL, V397, P225, DOI 10.1016/j.ydbio.2014.11.009; Mohammed SG, 2018, FASEB J, V32, P3653, DOI 10.1096/fj.201701228R; Mohammed SG, 2017, FASEB J, V31, P1796, DOI 10.1096/fj.201600687RRR; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Mount DB, 2014, CLIN J AM SOC NEPHRO, V9, P1974, DOI 10.2215/CJN.04480413; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Palmer LG, 2015, CLIN J AM SOC NEPHRO, V10, P676, DOI 10.2215/CJN.12391213; Pandit MM, 2012, AM J PHYSIOL-RENAL, V302, pF1325, DOI 10.1152/ajprenal.00034.2012; Pham PCT, 2014, INT J NEPHROL RENOV, V7, P219, DOI 10.2147/IJNRD.S42054; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/00041552-200309000-00006; Raghavan V, 2016, AM J PHYSIOL-RENAL, V310, pF1, DOI 10.1152/ajprenal.00373.2015; Raghavan V, 2015, CURR OPIN NEPHROL HY, V24, P359, DOI 10.1097/MNH.0000000000000135; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saez F, 2018, AM J PHYSIOL-RENAL, V314, pF934, DOI 10.1152/ajprenal.00631.2017; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; SCHRIER RW, 1973, KIDNEY INT, V3, P30, DOI 10.1038/ki.1973.5; Steinhausen M., 1976, MICROCIRCULATION TUB; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; van Angelen AA, 2012, CLIN KIDNEY J, V5, P535, DOI 10.1093/ckj/sfs140; Verschuren EHJ, 2018, AM J PHYSIOL-RENAL, V315, pF537, DOI 10.1152/ajprenal.00622.2017; Wang T, 2006, CURR OPIN NEPHROL HY, V15, P530, DOI 10.1097/01.mnh.0000242180.46362.c4; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Weinstein AM, 2007, AM J PHYSIOL-RENAL, V292, pF1164, DOI 10.1152/ajprenal.00392.2006; Weinstein AM, 2002, AM J PHYSIOL-RENAL, V283, pF1237, DOI 10.1152/ajprenal.00162.2002; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Xi Q, 2009, PFLUG ARCH EUR J PHY, V458, P89, DOI 10.1007/s00424-008-0601-7; Zierler S, 2011, J BIOL CHEM, V286, P39328, DOI 10.1074/jbc.M111.264341	54	4	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5034	5044		10.1096/fj.201802094R	http://dx.doi.org/10.1096/fj.201802094R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596515	Bronze			2022-12-26	WOS:000462888500032
J	Chou, AC; Aslanian, A; Sun, HY; Hunter, T				Chou, Annie C.; Aslanian, Aaron; Sun, Huaiyu; Hunter, Tony			An internal ribosome entry site in the coding region of tyrosyl-DNA phosphodiesterase 2 drives alternative translation start	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic translation initiation; translation; translation initiation; translation regulation; translation control; alternative translation initiation start; DNA repair; internal ribosomal entry site (IRES); phosphodiesterase; tyrosyl-DNA phosphodiesterase 2 (TDP2)	GENE-EXPRESSION; CANCER DEVELOPMENT; TTRAP; PROTEINS; APOPTOSIS; REPAIR	Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a multifunctional protein that has been implicated in a myriad of cellular pathways. Although most well-known for its phosphodiesterase activity removing stalled topoisomerase 2 from DNA, TDP2 has also been shown to interact with both survival and apoptotic mitogen-activated protein kinase (MAPK) signaling cascades. Moreover, it facilitates enterovirus replication and has been genetically linked to neurological disorders ranging from Parkinson's disease to dyslexia. To accurately evaluate TDP2 as a therapeutic target, we need to understand how TDP2 performs such a wide diversity of functions. Here, we use cancer cell lines modified with CRISPR/Cas9 or stably-expressed TDP2-targeted shRNA and transfection of various TDP2 mutants to show that its expression is regulated at the translational level via an internal ribosome entry site (IRES) that initiates translation at codon 54, the second in-frame methionine of the TDP2 coding sequence. We observed that this IRES drives expression of a shorter, N-terminally truncated isoform of TDP2, Delta N-TDP2, which omits a nuclear localization sequence. Additionally, we noted that Delta N-TDP2 retains phosphodiesterase activity and is protective against etoposide-induced cell death, but co-immunoprecipitates with fewer high-molecular-weight ubiquitinated peptide species, suggesting partial loss-of-function of TDP2's ubiquitin-association domain. In summary, our findings suggest the existence of an IRES in the 5 ' coding sequence of TDP2 that translationally regulates expression of an N-terminally truncated, cytoplasmic isoform of TDP2. These results shed light on the regulation of this multifunctional protein and may inform the design of therapies targeting TDP2 and associated pathways.	[Chou, Annie C.] Univ Calif San Diego, Grad Program Biomed Sci, La Jolla, CA 92093 USA; [Chou, Annie C.; Aslanian, Aaron; Sun, Huaiyu; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Aslanian, Aaron] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA	University of California System; University of California San Diego; Salk Institute; Illumina	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu			National Institutes of Health NCICCSG [P30 014195]; National Institutes of Health NCI CCSG [P30 014195]; National Institutes of Health NINDS Neuroscience Core Grant [NS072031]; Waitt Foundation; NATIONAL CANCER INSTITUTE [T32CA009523, R01CA082683, P30CA014195, R01CA080100] Funding Source: NIH RePORTER	National Institutes of Health NCICCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI CCSG; National Institutes of Health NINDS Neuroscience Core Grant; Waitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We have received numerous reagents from many groups without which this project would not have been possible, including Juan Carlos Izpisua Belmonte, px458 plasmid; Clodagh O'Shea, U2OS and A549 cell lines; Reuben Shaw, H1299, H460, H358, and A549 cell lines; Dwayne Stupack (UCSD), OVCAR3, HCT116, and HT29 cell lines; Richard Lloyd (Baylor College of Medicine, Houston, TX), pRL-FFL and pRL-HCV-FFL plasmids; and Felipe Cortes Ledesma (Cabimer Centro Andaluz de Biologia Molecular y SSMedicina Regenerativa, Sevilla, Spain) TDP2<SUP>fl/fl</SUP> and TDP2<SUP>Delta ex1-3/Delta ex1-3</SUP> MEFs. We thank the staff of the Flow Cytometry Core Facility, especially Carolyn O'Connor and Conor Fitzpatrick of the Salk Institute which was funded by National Institutes of Health NCICCSG Grant P30 014195, the Functional Genomics Core Facility, especially James Nguyen of the Salk Institute which was funded by National Institutes of Health NCICCSG Grant P30 014195, and the Waitt Advanced Biophotonics Core Facility of the Salk Institute which was funded by National Institutes of Health NCI CCSG Grant P30 014195, National Institutes of Health NINDS Neuroscience Core Grant NS072031, and the Waitt Foundation.	Adhikari S, 2011, ANAL BIOCHEM, V416, P112, DOI 10.1016/j.ab.2011.05.008; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bian K, 2016, ONCOTARGET, V7, P6665, DOI 10.18632/oncotarget.6682; Conidi A, 2011, CYTOKINE GROWTH F R, V22, P287, DOI 10.1016/j.cytogfr.2011.11.006; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379; Gomez-Herreros F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003226; Huang SYN, 2018, EMBO REP, V19, DOI 10.15252/embr.201642139; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Li C, 2011, ONCOGENE, V30, P3802, DOI 10.1038/onc.2011.94; Li CY, 2011, CELL CYCLE, V10, P3274, DOI 10.4161/cc.10.19.17763; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Muthalagu N, 2014, CELL REP, V8, P1347, DOI 10.1016/j.celrep.2014.07.057; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao T, 2016, NUCLEIC ACIDS RES, V44, P10201, DOI 10.1093/nar/gkw719; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P16041, DOI 10.1073/pnas.1214267109; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Sharathchandra A, 2014, WIRES RNA, V5, P131, DOI 10.1002/wrna.1202; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Varady G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025548; Virgen-Slane R, 2012, P NATL ACAD SCI USA, V109, P14634, DOI 10.1073/pnas.1208096109; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Xiong W, 2016, BIOCHEM BIOPH RES CO, V473, P1019, DOI 10.1016/j.bbrc.2016.04.009; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou CH, 2013, BMB REP, V46, P113, DOI 10.5483/BMBRep.2013.46.2.150; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	6	6	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2665	2677		10.1074/jbc.RA118.006269	http://dx.doi.org/10.1074/jbc.RA118.006269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593505	Green Published, hybrid			2022-12-26	WOS:000459601600009
J	Hong, HL; Koon, AC; Chen, ZS; Wei, YM; An, Y; Li, W; Lau, MHY; Lau, KF; Ngo, JCK; Wong, CH; Au-Yeung, HY; Zimmerman, SC; Chan, HYE				Hong, Huiling; Koon, Alex Chun; Chen, Zhefan Stephen; Wei, Yuming; An, Ying; Li, Wen; Lau, Matthew Ho Yan; Lau, Kwok-Fai; Ngo, Jacky Chi Ki; Wong, Chun-Ho; Au-Yeung, Ho Yu; Zimmerman, Steven C.; Chan, Ho Yin Edwin			AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; autophagy; Drosophila; neurodegeneration; trinucleotide repeat disease; neurodegenerative disease; Huntington disease; cytotoxic protein; neuronal inclusion; neurotoxicity	ENDOPLASMIC-RETICULUM STRESS; PEPTIDYLIC INHIBITOR; MUTANT HUNTINGTIN; NUCLEOLAR STRESS; RNA TOXICITY; CELL-DEATH; ER STRESS; AUTOPHAGY; NEURODEGENERATION; AGGREGATION	Polyglutamine (polyQ) diseases are a group of dominantly inherited neurodegenerative disorders caused by the expansion of an unstable CAG repeat in the coding region of the affected genes. Hallmarks of polyQ diseases include the accumulation of misfolded protein aggregates, leading to neuronal degeneration and cell death. PolyQ diseases are currently incurable, highlighting the urgent need for approaches that inhibit the formation of disaggregate cytotoxic polyQ protein inclusions. Here, we screened for bisamidine-based inhibitors that can inhibit neuronal polyQ protein inclusions. We demonstrated that one inhibitor, AQAMAN, prevents polyQ protein aggregation and promotes de-aggregation of self-assembled polyQ proteins in several models of polyQ diseases. Using immunocytochemistry, we found that AQAMAN significantly reduces polyQ protein aggregation and specifically suppresses polyQ protein-induced cell death. Using a recombinant and purified polyQ protein (thioredoxin-Huntingtin-Q46), we further demonstrated that AQAMAN interferes with polyQ self-assembly, preventing polyQ aggregation, and dissociates preformed polyQ aggregates in a cell-free system. Remarkably, AQAMAN feeding of Drosophila expressing expanded polyQ disease protein suppresses polyQ-induced neurodegeneration in vivo. In addition, using inhibitors and activators of the autophagy pathway, we demonstrated that AQAMAN's cytoprotective effect against polyQ toxicity is autophagy-dependent. In summary, we have identified AQAMAN as a potential therapeutic for combating polyQ protein toxicity in polyQ diseases. Our findings further highlight the importance of the autophagy pathway in clearing harmful polyQ proteins.	[Hong, Huiling; Koon, Alex Chun; Chen, Zhefan Stephen; Wei, Yuming; An, Ying; Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Lab Drosophila Res, Shatin, Hong Kong, Peoples R China; [Hong, Huiling; Koon, Alex Chun; Chen, Zhefan Stephen; Wei, Yuming; An, Ying; Li, Wen; Lau, Kwok-Fai; Ngo, Jacky Chi Ki; Wong, Chun-Ho; Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Shatin, Hong Kong, Peoples R China; [Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Gerald Choa Neurosci Ctr, Shatin, Hong Kong, Peoples R China; [Lau, Matthew Ho Yan; Au-Yeung, Ho Yu] Univ Hong Kong, Dept Chem, Pok Fu Lam Rd, Hong Kong, Peoples R China; [Zimmerman, Steven C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; University of Illinois System; University of Illinois Urbana-Champaign	Chan, HYE (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	hyechan@cuhk.edu.hk	Chan, Edwin/A-9478-2011; Chen, Zhefan Stephen/L-9888-2019; An, Ying/GQP-4457-2022; HONG, HUILING/AAT-9954-2020; Ngo, Jacky C/O-8093-2017	Chan, Edwin/0000-0003-4307-474X; Chen, Zhefan Stephen/0000-0002-9276-0378; Ngo, Jacky C/0000-0002-6004-7041; Lau, Kwok-Fai/0000-0002-0193-1152; Koon, Alex/0000-0002-4274-7052	CUHK Vice-Chancellor's One-Off Discretionary Fund [VCF2014011, EC/2017/012]; CUHK Lui Che Woo Institute of Innovative Medicine [8303404]; CUHK Gerald Choa Neuroscience Centre [7105306]; Croucher Foundation; Hong Kong Postgraduate Fellowship (HKPF); Hong Kong Spinocerebellar Ataxia Association [6903291]; National Institutes of Health [RO1 AR069645]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069645] Funding Source: NIH RePORTER	CUHK Vice-Chancellor's One-Off Discretionary Fund; CUHK Lui Che Woo Institute of Innovative Medicine; CUHK Gerald Choa Neuroscience Centre; Croucher Foundation; Hong Kong Postgraduate Fellowship (HKPF); Hong Kong Spinocerebellar Ataxia Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the CUHK Vice-Chancellor's One-Off Discretionary Fund VCF2014011 and EC/2017/012, CUHK Lui Che Woo Institute of Innovative Medicine Grant 8303404, CUHK Gerald Choa Neuroscience Centre Grant 7105306, the Croucher Foundation, the Hong Kong Postgraduate Fellowship (HKPF), donations from the Hong Kong Spinocerebellar Ataxia Association 6903291, and National Institutes of Health Grant RO1 AR069645. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BAILLY C, 1994, MOL PHARMACOL, V46, P313; Banez-Coronel M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002481; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Cai Y, 2016, AUTOPHAGY, V12, P225, DOI 10.1080/15548627.2015.1121360; Chan WM, 2011, HUM MOL GENET, V20, P1738, DOI 10.1093/hmg/ddr049; Chen ZS, 2018, EMBO REP, V19, DOI 10.15252/embr.201745409; Darrow MC, 2015, J BIOL CHEM, V290, P17451, DOI 10.1074/jbc.M115.655373; Ding Y, 2016, NEUROSCIENCE, V327, P20, DOI 10.1016/j.neuroscience.2016.03.064; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; El-Ami T, 2014, AGING CELL, V13, P165, DOI 10.1111/acel.12171; Fardghassemi Y, 2017, DIS MODEL MECH, V10, P1465, DOI 10.1242/dmm.029736; Garcia-Huerta P, 2016, BRAIN RES, V1649, P173, DOI 10.1016/j.brainres.2016.02.052; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hsieh CH, 2016, DRUG DES DEV THER, V10, P2947, DOI 10.2147/DDDT.S111903; Jiang YW, 2016, BRAIN RES, V1648, P650, DOI 10.1016/j.brainres.2016.03.034; Kim M, 2013, PRION, V7, P221, DOI 10.4161/pri.23807; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Lajoie P, 2011, J CELL SCI, V124, P3332, DOI 10.1242/jcs.087510; Lee SJ, 2011, NEUROSCI RES, V70, P339, DOI 10.1016/j.neures.2011.05.008; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056026; Nguyen L, 2014, CHEMMEDCHEM, V9, P2455, DOI 10.1002/cmdc.201402095; Liu HB, 2014, J CHEM INF MODEL, V54, P1050, DOI 10.1021/ci500004h; McMillan D. Randy, 1994, Current Opinion in Biotechnology, V5, P540, DOI 10.1016/0958-1669(94)90071-X; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pedersen JT, 2013, ANAL CHEM, V85, P4215, DOI 10.1021/ac400023c; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rusmini P, 2016, J MOL NEUROSCI, V58, P348, DOI 10.1007/s12031-015-0675-6; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Shekhar S, 2017, HUM MOL GENET, V26, P420, DOI 10.1093/hmg/ddw398; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; Singh V, 2018, MOL PHARMACEUT, V15, P3356, DOI 10.1021/acs.molpharmaceut.8b00380; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tanious FA, 2001, EUR J BIOCHEM, V268, P3455, DOI 10.1046/j.1432-1327.2001.02242.x; Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109; Tsoi H, 2011, HUM MOL GENET, V20, P3787, DOI 10.1093/hmg/ddr297; Vidal RL, 2012, AUTOPHAGY, V8, P970, DOI 10.4161/auto.20139; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wong CH, 2014, J AM CHEM SOC, V136, P6355, DOI 10.1021/ja5012146; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Zhang Q, 2018, RNA, V24, P486, DOI 10.1261/rna.062703.117; Zhang Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11695-y; Zhang Q, 2016, DIS MODEL MECH, V9, P321, DOI 10.1242/dmm.022350; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	63	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2757	2770		10.1074/jbc.RA118.006307	http://dx.doi.org/10.1074/jbc.RA118.006307			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593503	hybrid, Green Published			2022-12-26	WOS:000459601600016
J	Matsumoto, Y; Mori, Y; Kageyama, S; Arihara, K; Sato, H; Nagata, K; Shimada, Y; Nojima, Y; Iguchi, K; Sugiyama, T				Matsumoto, Yoshihiro; Mori, Yasuo; Kageyama, Shinji; Arihara, Kazuo; Sato, Hidemaro; Nagata, Kijun; Shimada, Yasushi; Nojima, Yohichi; Iguchi, Koichiro; Sugiyama, Toshikazu			Changes in QTc interval in long-term hemodialysis patients	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; PROLONGATION; MORTALITY; HYPOGLYCEMIA; POPULATION; DISPERSION; CALCIUM; HEART; RISK	Background Cardiovascular diseases, including sudden cardiac death (SCD), are the leading cause of death in hemodialysis (HD) patients. A prolonged QT interval on the electrocardiogram (ECG) is a risk factor for SCD in HD patients. This study investigated whether the heart ratecorrected QT (QTc) interval becomes prolonged along with dialysis vintage. Methods A total of 102 HD patients were retrospectively studied. Their ECG data were analyzed at 1, 4, and 7 years after HD initiation. The control group comprised 68 age-matched individuals who had normal renal function and two available ECG reports at an interval of more than 4 years. QTc was measured according to the Bazett formula. The association between QTc interval and dialysis vintage was studied. Additionally, clinically relevant variables related to QTc duration at 1 year after HD initiation were assessed. Results Average QTc interval at 4 and 7 years after HD initiation was significantly longer than that at 1 year after HD initiation (443, 445, and 437 ms) (p0.05). On the other hand, QTc interval in the control group was 425 ms in the first year and 426 ms after an average of 6 years. They had no significant differences, although they were much shorter than that in HD patients. Multivariate regression analysis of baseline variables revealed that the corrected calcium levels (p = 0.041) and diabetes (p = 0.043) were independently associated with longer QTc interval. Conclusions The QTc interval at 1 year after HD initiation was longer than in the control subjects and was prolonged over several years of HD treatment. Providing clinical management with a focus on QTc interval may be helpful for reducing the incidence of SCD in HD patients.	[Matsumoto, Yoshihiro; Shimada, Yasushi; Nojima, Yohichi; Iguchi, Koichiro] Shizuoka City Hosp, Dept Nephrol & Hemodialysis, Shizuoka, Japan; [Mori, Yasuo] Shibukawa Clin, Shizuoka, Japan; [Kageyama, Shinji] Kageyama Clin, Shizuoka, Japan; [Arihara, Kazuo] Ohtemachi Clin, Shizuoka, Japan; [Sato, Hidemaro; Nagata, Kijun] Sawada Hosp, Gifu, Japan; [Sugiyama, Toshikazu] Sugiyama Clin, Shizuoka, Japan		Matsumoto, Y (corresponding author), Shizuoka City Hosp, Dept Nephrol & Hemodialysis, Shizuoka, Japan.	matsumoto16@aol.com						Alabd MA, 2011, NEPHRON EXTRA, V1, P1, DOI 10.1159/000328930; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Burke JH, 1997, AM J CARDIOL, V79, P178, DOI 10.1016/S0002-9149(96)00707-2; Claes KJ, 2012, AM J NEPHROL, V35, P24, DOI 10.1159/000334597; Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094; Genovesi S, 2003, J HYPERTENS, V21, P1921, DOI 10.1097/00004872-200310000-00020; Genovesi S, 2008, EUROPACE, V10, P771, DOI 10.1093/europace/eun028; Genovesi S, 2013, EUROPACE, V15, P1025, DOI 10.1093/europace/eus412; Genovesi S, 2009, NEPHROL DIAL TRANSPL, V24, P2529, DOI 10.1093/ndt/gfp104; Gill G, 2009, DIABETOLOGIA, V52, P42, DOI 10.1007/s00125-008-1177-7; Gopalakrishnan M, 2015, AM J CARDIOL, V116, P1586, DOI 10.1016/j.amjcard.2015.08.024; Gray B, 2013, JACC-HEART FAIL, V1, P149, DOI 10.1016/j.jchf.2013.01.004; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Gruden G, 2012, DIABETES CARE, V35, P125, DOI 10.2337/dc11-1739; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Jackson MA, 2000, CLIN NEPHROL, V54, P30; Nie Y, 2016, PLOS ONE, V11; Patel SI, 2018, ACTA CARDIOL, V7, P1; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pun PH, 2012, BLOOD PURIFICAT, V33, P183, DOI 10.1159/000334154; Pun PH, 2011, KIDNEY INT, V79, P218, DOI 10.1038/ki.2010.315; Rossing P, 2001, DIABETIC MED, V18, P199, DOI 10.1046/j.1464-5491.2001.00446.x; Severi S, 2008, NEPHROL DIAL TRANSPL, V23, P1378, DOI 10.1093/ndt/gfm765; Sherif KA, 2014, CLIN CARDIOL, V37, P417, DOI 10.1002/clc.22277; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Suzuki R, 1998, CLIN NEPHROL, V49, P240; Thomson BKA, 2013, NEPHRON CLIN PRACT, V123, P74, DOI 10.1159/000351382; Vrtovec B, 2013, AM J CARDIOL, V111, P886, DOI 10.1016/j.amjcard.2012.11.041; Wong MCG, 2015, J AM COLL CARDIOL, V65, P1263, DOI 10.1016/j.jacc.2014.12.049	30	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209297	10.1371/journal.pone.0209297	http://dx.doi.org/10.1371/journal.pone.0209297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605455	Green Submitted, Green Published, gold			2022-12-26	WOS:000454759900014
J	Chen, FJ; Zhou, X; Lao, QB; Wang, SL; Jin, GZ; Chen, CQ; Zhu, QM				Chen, Fajin; Zhou, Xin; Lao, Qibin; Wang, Shuangling; Jin, Guangzhe; Chen, Chunqing; Zhu, Qingmei			Dual isotopic evidence for nitrate sources and active biological transformation in the Northern South China Sea in summer	PLOS ONE			English	Article							PEARL RIVER ESTUARY; SEASONAL DYNAMICS; NITROGEN-FIXATION; MIXING MODEL; N-2 FIXATION; FRACTIONATION; KUROSHIO; CONSTRAINTS; UNCERTAINTY; NUTRIENTS	Nitrate (NO3-) concentrations and their dual isotopic compositions (delta N-15-NO3- and delta O-18-NO3- ) were measured to constrain N sources and their cyclic processes in summer using samples from the water column of the northern South China Sea (NSCS). Our data revealed that higher NO3- concentrations and delta N-15-NO3- values were observed in the upper waters of the coastal areas near the Pearl River Estuary (PRE). The Bayesian stable isotope mixing model was used to calculated the proportion of nitrate sources, the results indicated that the nitrate in the upper waters of the coastal areas near PRE were mainly influenced by manure and sewage (63%), atmospheric deposition (19%), soil organic nitrogen (12%) and reduced N fertilizer (6%). For the upper waters of the outer areas, low NO3- concentrations and delta N-15-NO3- values, but high delta O-18-NO3- values, reflected that NO3- was mainly influenced by Kuroshio water intrusion (60%), atmospheric deposition (32%) and nitrogen fixation/nitrification (8%). Complex processes were found in bottom waters. Nitrification and phytoplankton assimilation may be responsible for the higher nitrate concentrations and delta N-15-NO3- values. Our study, therefore, utilizes the nitrate dual isotope to help illustrate the spatial variations in nitrate sources and complex nitrogen cycles in the NSCS.	[Chen, Fajin; Zhou, Xin; Lao, Qibin; Wang, Shuangling; Jin, Guangzhe; Chen, Chunqing; Zhu, Qingmei] Guangdong Ocean Univ, Guangdong Prov Key Lab Coastal Ocean Variat & Dis, Zhanjiang, Peoples R China; [Chen, Fajin; Zhou, Xin; Lao, Qibin; Wang, Shuangling; Jin, Guangzhe; Chen, Chunqing; Zhu, Qingmei] Guangdong Ocean Univ, Coll Ocean & Meteorol, Zhanjiang, Peoples R China; [Lao, Qibin] State Ocean Adm, Marine Environm Monitoring Ctr Beihai, Beihai, Peoples R China	Guangdong Ocean University; Guangdong Ocean University; State Oceanic Administration	Wang, SL (corresponding author), Guangdong Ocean Univ, Guangdong Prov Key Lab Coastal Ocean Variat & Dis, Zhanjiang, Peoples R China.; Wang, SL (corresponding author), Guangdong Ocean Univ, Coll Ocean & Meteorol, Zhanjiang, Peoples R China.	wishling@126.com		Jin, Guangzhe/0000-0002-2629-3337; Chen, Fajin/0000-0002-5775-911X	National Natural Science Foundation of China [41476066, 41466010, 41676008]; Guangdong Natural Science Foundation of China [2016A030312004]; International Science and Technology Cooperation Project [GASI-IPOVAI-04]; National Key Research and Development Plan [2016YFC1401403]; Project of Enhancing School with Innovation of Guangdong Ocean University [GDOU2014050201, GDOU2013050215, GDOU2013050315, GDOU2013050201]; Fund of Key Laboratory of Global Change and Marine-Atmospheric Chemistry, SOA [GCMAC1503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); International Science and Technology Cooperation Project; National Key Research and Development Plan; Project of Enhancing School with Innovation of Guangdong Ocean University; Fund of Key Laboratory of Global Change and Marine-Atmospheric Chemistry, SOA	This work was supported by the National Natural Science Foundation of China (41476066, 41466010, 41676008), Guangdong Natural Science Foundation of China (2016A030312004), International Science and Technology Cooperation Project (GASI-IPOVAI-04), National Key Research and Development Plan (2016YFC1401403), the Project of Enhancing School with Innovation of Guangdong Ocean University (GDOU2014050201, GDOU2013050215, GDOU2013050315, GDOU2013050201), and the Fund of Key Laboratory of Global Change and Marine-Atmospheric Chemistry, SOA, (GCMAC1503) to FC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger A, 1987, GEOCHIMICA COSMOCHIM, V51, P655; Cai WJ, 2004, CONT SHELF RES, V24, P1301, DOI 10.1016/j.csr.2004.04.005; Casciotti KL, 2010, LIMNOL OCEANOGR, V55, P753, DOI 10.4319/lo.2009.55.2.0753; Centurioni LR, 2004, J PHYS OCEANOGR, V2013, P2564; Chen CTA, 2001, MAR CHEM, V75, P281, DOI 10.1016/S0304-4203(01)00041-X; Chen FJ, 2013, ACTA OCEANOL SIN, V32, P11, DOI 10.1007/s13131-013-0294-4; Chen FJ, 2009, BIOGEOCHEMISTRY, V94, P163, DOI 10.1007/s10533-009-9316-x; Chen YLL, 2008, LIMNOL OCEANOGR, V53, P1705, DOI 10.4319/lo.2008.53.5.1705; Chen YLL, 2014, DEEP-SEA RES PT I, V85, P56, DOI 10.1016/j.dsr.2013.11.006; Dahnke K, 2008, LIMNOL OCEANOGR, V53, P1504, DOI 10.4319/lo.2008.53.4.1504; Dai M, 2008, BIOGEOSCIENCES, V5, P1227, DOI 10.5194/bg-5-1227-2008; Du C, 2013, BIOGEOSCIENCES, V10, P6419, DOI 10.5194/bg-10-6419-2013; Fang YT, 2010, ATMOSPHERIC CHEM PHY, V10, P1313; Granger J, 2004, LIMNOL OCEANOGR, V49, P1763, DOI 10.4319/lo.2004.49.5.1763; Granger J, 2008, LIMNOL OCEANOGR, V53, P2533, DOI 10.4319/lo.2008.53.6.2533; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Guo L, 2017, GEOPHYS RES LETT, V44, P11565, DOI 10.1002/2017GL075336; Hu J, 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Huang XP, 2003, MAR POLLUT BULL, V47, P30, DOI 10.1016/S0025-326X(02)00474-5; Kendall C, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P519; Kendall C., 1998, ISOTOPE TRACERS CATC, DOI [10.1016/c2009-0-10239-8, DOI 10.1016/C2009-0-10239-8, 10.1016/C2009-0-10239-8]; Liu KK, 1996, MAR CHEM, V54, P273, DOI 10.1016/0304-4203(96)00034-5; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; McIlvin MR, 2005, ANAL CHEM, V77, P5589, DOI 10.1021/ac050528s; Middelburg JJ, 2001, ESTUAR COAST SHELF S, V53, P385, DOI 10.1006/ecss.2001.0805; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Rafter PA, 2016, LIMNOL OCEANOGR, V61, P14, DOI 10.1002/lno.10152; Savarino J, 2007, ATMOS CHEM PHYS, V7, P1925, DOI 10.5194/acp-7-1925-2007; Shiozaki T, 2014, GEOPHYS RES LETT, V41, P2907, DOI 10.1002/2014GL059835; Sigman DM, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000384; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Strickland JDH, 1969, PRACTICAL HDB SEAWAT; van Breemen N, 2002, NATURE, V415, P381, DOI 10.1038/415381a; Wang WT, 2018, J GEOPHYS RES-OCEANS, V123, P2116, DOI 10.1002/2017JC013538; Wankel SD, 2006, LIMNOL OCEANOGR, V51, P1654, DOI 10.4319/lo.2006.51.4.1654; Wankel SD, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002723; Xiao HW, 2015, ATMOS ENVIRON, V109, P70, DOI 10.1016/j.atmosenv.2015.03.006; Xue DM, 2012, ENVIRON POLLUT, V161, P43, DOI 10.1016/j.envpol.2011.09.033; Xue DM, 2009, WATER RES, V43, P1159, DOI 10.1016/j.watres.2008.12.048; Yan XL, 2017, GEOPHYS RES LETT, V44, P12289, DOI 10.1002/2017GL075951; Yang JYT, 2014, BIOGEOSCIENCES, V11, P1833, DOI 10.5194/bg-11-1833-2014; Yang Z, 2018, ESTUAR COAST SHELF S, V207, P109, DOI 10.1016/j.ecss.2018.02.019; Ye F, 2016, J GEOPHYS RES-OCEANS, V121, P8689, DOI 10.1002/2016JC012066; Ye F, 2015, J GEOPHYS RES-BIOGEO, V120, P661, DOI 10.1002/2014JG002842; Zhang M, 2018, SCI TOTAL ENVIRON, V639, P1175, DOI 10.1016/j.scitotenv.2018.05.239	46	12	12	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209287	10.1371/journal.pone.0209287	http://dx.doi.org/10.1371/journal.pone.0209287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601849	Green Published, gold, Green Submitted			2022-12-26	WOS:000454683200054
J	Branavan, U; Muneeswaran, K; Wijesundera, S; Jayakody, S; Chandrasekharan, V; Wijeyaratne, C				Branavan, Umayal; Muneeswaran, Kajan; Wijesundera, Sulochana; Jayakody, Surangi; Chandrasekharan, Vishvanath; Wijeyaratne, Chandrika			Identification of selected genetic polymorphisms in polycystic ovary syndrome in Sri Lankan women using low cost genotyping techniques	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; STIMULATING-HORMONE RECEPTOR; GENOME-WIDE ASSOCIATION; LUTEINIZING-HORMONE; FTO GENE; INSULIN-RESISTANCE; CHINESE WOMEN; SYNDROME PCOS; FAT MASS; EXON 17	Background Polycystic ovary syndrome (PCOS), the commonest endocrine disorder affecting young women, appears to be a multigenic trait with contributing genes being unclear. Hence, analysis of polymorphisms in multiple candidate genes is required. Currently available genotyping methods are expensive, time-consuming with limited analytical sensitivity. Aim (i) Develop and validate high resolution melting (HRM) assay and allele-specific real-time quantitative PCR (AS-qPCR) for genotyping selected SNPs associated with PCOS. (ii) Identify selected SNPs and their association with a Sri Lankan cohort of well-characterized PCOS. Methods DNA was extracted from women with well-characterized PCOS from adolescence (n = 55) and ethnically matched controls (n = 110). FTO (Fat mass and obesity associated gene; rs9939609), FSHB (Follicle stimulating hormone beta subunit; rs6169), FSHR (Follicle stimulating hormone receptor; rs6165/rs6166), and INSR (Insulin receptor; rs1799817) genes were genotyped using HRM assay. GnRH1 (Gonadotropin releasing hormone; rs6185), LHB (Luteinizing hormone beta subunit; rs1800447/rs34349826) and LHCGR (Luteinizing hormone/choriogonadotropin receptor; rs2293275) genes were genotyped using AS-qPCR method. Genotyping results were validated using Sanger sequencing. Results A significant association was observed within FTO gene polymorphism (rs9939609) and PCOS. Genotype frequency of FTO gene (rs9939609)-cases versus controls were TT-36.4% vs.65.4% (p< 0.05), AT-23.6% vs. 20.9%, AA-40% vs. 13.6% (p< 0.05). Genotype frequencies of the SNPs GnRH1 (rs6185), FSHB (rs6169), FSHR (rs6165 & rs6166), LHB (rs1800447 & rs34349826), LHCGR (rs2293275) and INSR (rs1799817) were not significantly different between cases and controls (p> 0.05). Only the mutant alleles were observed for LHB rs1800447 and rs34349826 SNPs in both groups. The HRM and AS-qPCR assay results had 100% concordance with sequencing results. Conclusions FTO gene rs9939609 polymorphism is significantly more prevalent among Sri Lankan PCOS subjects while the other selected SNPs of HPG axis genes and INSR gene showed no association. HRM and AS-qPCR assays provide a reliable, fast and user-friendly genotyping method facilitating wider implication in clinical practice.	[Branavan, Umayal; Wijeyaratne, Chandrika] Univ Colombo, Dept Obstet & Gynecol, Fac Med, Colombo, Sri Lanka; [Muneeswaran, Kajan; Chandrasekharan, Vishvanath] Univ Colombo, Dept Chem, Fac Sci, Colombo, Sri Lanka; [Muneeswaran, Kajan] Univ Colombo, Dept Psychiat, Fac Med, Colombo, Sri Lanka; [Wijesundera, Sulochana] Univ Colombo, Dept Biochem & Mol Biol, Fac Med, Colombo, Sri Lanka; [Jayakody, Surangi] Univ Sri Jayawardanapura, Dept Community Med, Fac Med Sci, Nugegoda, Sri Lanka	University of Colombo; University of Colombo; University of Colombo; University of Colombo; University Sri Jayewardenepura	Wijeyaratne, C (corresponding author), Univ Colombo, Dept Obstet & Gynecol, Fac Med, Colombo, Sri Lanka.	mandika59@hotmail.com	Muneeswaran, Kajan/S-6485-2019	Muneeswaran, Kajan/0000-0001-6997-4709	National Research Council, Sri Lanka [15-149]	National Research Council, Sri Lanka	This study was supported by grant no 15-149, funder - National Research Council, Sri Lanka, http://www.nrc.gov.lk/, to Prof. CN Wijeyaratne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahbadia GN, 2011, MIDDLE EAST FERTIL S, V16, P19, DOI 10.1016/j.mefs.2010.10.002; AlTuma FJ., 2015, IJPPR HUMAN, V5, P62; BALASURIYA S, 1988, Ceylon Medical Journal, V33, P105; Barber TM, 2008, DIABETOLOGIA, V51, P1153, DOI 10.1007/s00125-008-1028-6; Bassiouny YA, 2014, GYNECOL ENDOCRINOL, V30, P428, DOI 10.3109/09513590.2014.895982; Borgbo T, 2014, J ASSIST REPROD GEN, V31, P1427, DOI 10.1007/s10815-014-0329-6; Boteju WM, 2014, SRI LANKA J DIABETES, V4, P3, DOI DOI 10.4038/SJDEM.V4I1.7240; Brower MA, 2015, J CLIN ENDOCR METAB, V100, pE182, DOI 10.1210/jc.2014-2689; Capalbo A, 2012, CLIN ENDOCRINOL, V77, P113, DOI 10.1111/j.1365-2265.2012.04372.x; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen L, 2017, EXP THER MED, V14, P4896, DOI 10.3892/etm.2017.5113; Cui LL, 2015, HUM REPROD, V30, P732, DOI 10.1093/humrep/deu361; Dhas DBB, 2015, INDIAN J MED RES, V142, P555, DOI 10.4103/0971-5916.171282; Diamanti-Kandarakis Evanthia, 2006, Hormones (Athens), V5, P17; Dolfin E, 2011, J ASSIST REPROD GEN, V28, P925, DOI 10.1007/s10815-011-9619-4; Du J, 2010, MOL GENET METAB, V100, P292, DOI 10.1016/j.ymgme.2010.03.018; Dunaif A, 2016, J CLIN ENDOCR METAB, V101, P759, DOI 10.1210/jc.2015-3780; Escobar-Morreale HF, 2005, ENDOCR REV, V26, P251, DOI 10.1210/er.2004-0004; Fu LY, 2013, J ASSIST REPROD GEN, V30, P717, DOI 10.1007/s10815-013-9979-z; FURUI K, 1994, J CLIN ENDOCR METAB, V78, P107, DOI 10.1210/jc.78.1.107; Gangopadhyay S, 2016, BIOCHEM GENET, V54, P158, DOI 10.1007/s10528-015-9708-7; Gu BH, 2010, INT J MOL MED, V26, P107, DOI 10.3892/ijmm_00000441; Ha LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126505; HAAVISTO AM, 1995, J CLIN ENDOCR METAB, V80, P1257, DOI 10.1210/jc.80.4.1257; Jakubowski Lucjusz, 2005, Endokrynol Pol, V56, P285; Kajan M., 2018, HIGH RESOLUTION MELT, DOI [10.13140/RG.2.2.24229.40166, DOI 10.13140/RG.2.2.24229.40166]; Lee EJ, 2006, FERTIL STERIL, V86, P380, DOI 10.1016/j.fertnstert.2005.12.073; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066250; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Mohamed-Hussein ZA, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-18; Mohiyiddeen L, 2012, GYNECOL ENDOCRINOL, V28, P375, DOI 10.3109/09513590.2011.633649; Mukherjee S, 2009, EUR J ENDOCRINOL, V160, P855, DOI 10.1530/EJE-08-0932; Nilsson C, 1997, FERTIL STERIL, V67, P998, DOI 10.1016/S0015-0282(97)81430-6; Osman H. G., 2014, Australian Journal of Basic and Applied Sciences, V8, P98; Batista MCP, 2014, GENE, V550, P68, DOI 10.1016/j.gene.2014.08.017; Ramos RB, 2015, GENE, V560, P25, DOI 10.1016/j.gene.2015.01.012; Rojas Joselyn, 2014, Int J Reprod Med, V2014, P719050, DOI 10.1155/2014/719050; Schlesselman JJ, 1982, CASE CONTROL STUDIES, V354; Shim U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136609; Slomka M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112316; Stewart A., 2011, INT STANDARDS ANTHRO; Tan S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-12; Tian Y, 2016, J CLIN ENDOCR METAB, V101, P2178, DOI 10.1210/jc.2015-3776; Tong Y, 2001, HORM METAB RES, V33, P221, DOI 10.1055/s-2001-14941; Tong Y, 2000, FERTIL STERIL, V74, P1233, DOI 10.1016/S0015-0282(00)01616-2; Unsal T, 2009, J ASSIST REPROD GEN, V26, P205, DOI 10.1007/s10815-009-9308-8; Valkenburg O, 2009, HUM REPROD, V24, P2014, DOI 10.1093/humrep/dep113; Wang ZY, 2013, REPROD BIOMED ONLINE, V27, P316, DOI 10.1016/j.rbmo.2013.05.007; Wehr E, 2010, METABOLISM, V59, P575, DOI 10.1016/j.metabol.2009.08.023; Wijeyaratne CN, 2011, HUM REPROD, V26, P202, DOI 10.1093/humrep/deq310; Xu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140695; Yan Q, 2009, ENDOCRINE, V36, P377, DOI 10.1007/s12020-009-9257-0; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377	54	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209830	10.1371/journal.pone.0209830	http://dx.doi.org/10.1371/journal.pone.0209830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596735	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200095
J	Fortin, M; Vitet, C; Souty-Grosset, C; Richard, FJ				Fortin, Margot; Vitet, Camille; Souty-Grosset, Catherine; Richard, Freddie-Jeanne			How do familiarity and relatedness influence mate choice in Armadillidium vulgare?	PLOS ONE			English	Article							POSTCOPULATORY INBREEDING AVOIDANCE; INDUCED SEX REVERSAL; KIN RECOGNITION; SPERM COMPETITION; MOLECULAR EVIDENCE; INCEST AVOIDANCE; WILD POPULATION; FIELD CRICKET; NO EVIDENCE; BULB MITE	Mate choice is an important process in sexual selection and usually prevents inbreeding depression in populations. In the terrestrial isopod Armadillidium vulgare, the close physical proximity between individuals may increase the risk of reproducing with siblings. Moreover, individuals of this species can be infected with the feminizing bacteria of Wolbachia, which influence male mate choice. However, little is known about the kinship or familiarity assessment of the selected partner that occurs when a male can choose between females with or without Wolbachia. To investigate the potential mechanisms leading to mate choice and the potential impact of the parasite, we performed behavioral choice tests on males where they could choose between sibling vs. nonsibling females, familiar vs. unfamiliar females, and sibling familiar vs. unfamiliar nonsibling females. To investigate the costs of inbreeding, we compared the reproductive success of both sibling and nonsibling mates. Our results revealed that male copulation attempts were higher for familiar females and for nonsibling females when both females were Wolbachia-infected, but the duration was longer when both females were Wolbachia-free. When males mated with a sibling female, their fecundity was severely decreased, consistent with inbreeding depression. Overall, we observed copulations with all types of females and demonstrated discrimination capacities and potential preferences. We highlight the complexity of the tradeoff between kinship, familiarity and parasite transmission assessment for mate choice.	[Fortin, Margot; Vitet, Camille; Souty-Grosset, Catherine; Richard, Freddie-Jeanne] Univ Poitiers, Lab Ecol & Biol Interact, Team Ecol, Evolut,Symbiose, Poitiers, France	Universite de Poitiers	Richard, FJ (corresponding author), Univ Poitiers, Lab Ecol & Biol Interact, Team Ecol, Evolut,Symbiose, Poitiers, France.	Freddie.jeanne.richard@univ-poitiers.fr		Richard, Freddie-Jeanne/0000-0002-2796-1181	2015-2020 State-Region Planning Contracts (CPER); European Regional Development Fund (FEDER); European Commission through the programme Erasmus Mundus Master Course - international Master in Applied Ecology (EMMC - IMAE) [FPA 2023 - 0224/532524-1-FR-2012-1-ERA MUNDUS-EMMC]; Center National de la Recherche Scientifique; Universite de Poitiers; Region Nouvelle-Aquitaine	2015-2020 State-Region Planning Contracts (CPER); European Regional Development Fund (FEDER)(European Commission); European Commission through the programme Erasmus Mundus Master Course - international Master in Applied Ecology (EMMC - IMAE); Center National de la Recherche Scientifique; Universite de Poitiers; Region Nouvelle-Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by the 2015-2020 State-Region Planning Contracts (CPER), the European Regional Development Fund (FEDER); by the European Commission through the programme Erasmus Mundus Master Course - international Master in Applied Ecology (EMMC - IMAE) (FPA 2023 - 0224/532524-1-FR-2012-1-ERA MUNDUS-EMMC) - Coordination F-J Richard, Unviersite de Poitiers, France; and intramural funds from the Center National de la Recherche Scientifique and the Universite de Poitiers. The doctoral studies of Margot Fortin were funded by the Region Nouvelle-Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Honkola O, 2011, EVOLUTION, V65, P2699, DOI 10.1111/j.1558-5646.2011.01317.x; Allee WC, 1926, J EXP ZOOL, V45, P255, DOI 10.1002/jez.1400450108; Andersson Malte, 1994; Baldo L, 2007, CURR MICROBIOL, V55, P367, DOI 10.1007/s00284-007-9009-4; BARNARD CJ, 1988, ANIM BEHAV, V36, P1078, DOI 10.1016/S0003-3472(88)80067-8; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; Beauche F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057737; Beltran-Bech S, 2014, ANIM BEHAV, V90, P159, DOI 10.1016/j.anbehav.2014.01.026; BLAUSTEIN AR, 1983, AM NAT, V121, P749, DOI 10.1086/284101; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Broly P, 2013, INSECT SOC, V60, P419, DOI 10.1007/s00040-013-0313-7; BURLEY N, 1990, ANIM BEHAV, V39, P775, DOI 10.1016/S0003-3472(05)80389-6; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clarke FM, 1999, P ROY SOC B-BIOL SCI, V266, P1995, DOI 10.1098/rspb.1999.0877; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Durand S, 2015, ETHOLOGY, V121, P1122, DOI 10.1111/eth.12429; Fortin M, 2018, ECOL EVOL, V8, P3341, DOI 10.1002/ece3.3858; Frommen JG, 2006, BIOL LETTERS, V2, P232, DOI 10.1098/rsbl.2005.0432; Hoglund J, 2002, P ROY SOC B-BIOL SCI, V269, P711, DOI 10.1098/rspb.2001.1937; HOLMES WG, 1983, AM SCI, V71, P46; Huang MH, 2012, ACYRTHOSIPHON PISUM, V12, P39; JUCHAULT P, 1992, HEREDITY, V69, P382, DOI 10.1038/hdy.1992.138; JUCHAULT P, 1989, CRUSTACEANA, V56, P83, DOI 10.1163/156854089X00824; Keane B, 1996, BEHAV ECOL, V7, P480, DOI 10.1093/beheco/7.4.480; KELLER L, 1993, BEHAV ECOL SOCIOBIOL, V33, P191, DOI 10.1007/BF00216600; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Konior M, 2005, HEREDITY, V94, P577, DOI 10.1038/sj.hdy.6800649; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Le Clec'h W, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1076; Lebigre C, 2010, MOL ECOL, V19, P1929, DOI 10.1111/j.1365-294X.2010.04614.x; Lefebvre F, 1999, INVERTEBR REPROD DEV, V35, P55, DOI 10.1080/07924259.1999.9652367; Lefebvre F, 2010, INVERTEBR REPROD DEV, V54, P177, DOI 10.1080/07924259.2010.9652331; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Lihoreau M, 2010, ANIM BEHAV, V80, P303, DOI 10.1016/j.anbehav.2010.05.011; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Liu XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094389; Loyau A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051293; MARTIN G, 1973, CR ACAD SCI D NAT, V276, P2313; Mateo JM, 2010, ANIM BEHAV, V80, P929, DOI 10.1016/j.anbehav.2010.08.019; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; McKee AA, 2014, J INSECT BEHAV, V27, P613, DOI 10.1007/s10905-014-9453-5; Mead F., 1973, THESIS; Metzger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013505; Moreau J, 2002, J CRUSTACEAN BIOL, V22, P353, DOI 10.1651/0278-0372(2002)022[0353:TSOCCD]2.0.CO;2; Moreau J, 2002, ANIM BEHAV, V64, P569, DOI 10.1006/anbe.2002.4000; Moreau J, 2000, OIKOS, V91, P477, DOI 10.1034/j.1600-0706.2000.910308.x; Moreau J, 2001, J EVOLUTION BIOL, V14, P388, DOI 10.1046/j.1420-9101.2001.00292.x; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Pitcher TE, 2008, GENETICA, V134, P137, DOI 10.1007/s10709-008-9246-x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Radwan J, 2003, HEREDITY, V90, P371, DOI 10.1038/sj.hdy.6800254; Reynolds SM, 2014, BEHAV ECOL, V25, P1005, DOI 10.1093/beheco/aru065; Richard FJ, 2013, INSECT SOC, V60, P275, DOI 10.1007/s00040-013-0306-6; Richard FJ, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00143; Rigaud T, 2004, P ROY SOC B-BIOL SCI, V271, P1941, DOI 10.1098/rspb.2004.2804; Roff DA, 1998, HEREDITY, V81, P28, DOI 10.1046/j.1365-2540.1998.00363.x; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Saxena S, 2016, CAN J ZOOL, V94, P361, DOI 10.1139/cjz-2015-0174; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; Sironi M, 1995, MOL BIOCHEM PARASIT, V74, P223, DOI 10.1016/0166-6851(95)02494-8; Slate J, 2000, P ROY SOC B-BIOL SCI, V267, P1657, DOI 10.1098/rspb.2000.1192; STEEL CGH, 1980, BIOL BULL, V159, P206, DOI 10.2307/1541019; Stockley P, 1999, P ROY SOC B-BIOL SCI, V266, P1663, DOI 10.1098/rspb.1999.0829; Szulkin M, 2008, P R SOC B, V275, P703, DOI 10.1098/rspb.2007.0989; TAKEDA N, 1980, EXPERIENTIA, V36, P1296, DOI 10.1007/BF01969598; Team RDC, 2019, R LANG ENV STAT COMP; Temple N, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0129-6; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tuni C, 2013, J EVOLUTION BIOL, V26, P1261, DOI 10.1111/jeb.12118; Vayssade C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097733; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zhang B, 2014, J INSECT PHYSIOL, V70, P15, DOI 10.1016/j.jinsphys.2014.08.006	80	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209893	10.1371/journal.pone.0209893	http://dx.doi.org/10.1371/journal.pone.0209893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596784	Green Submitted, gold, Green Published			2022-12-26	WOS:000454627200101
J	Lee, JY; Kwon, S; Kim, WS; Hahn, SJ; Park, J; Paik, NJ				Lee, Ji-Young; Kwon, SuYeon; Kim, Won-Seok; Hahn, Soo Jung; Park, Jihong; Paik, Nam-Jong			Feasibility, reliability, and validity of using accelerometers to measure physical activities of patients with stroke during inpatient rehabilitation	PLOS ONE			English	Article							1ST 6 MONTHS; ENERGY-EXPENDITURE; AEROBIC EXERCISE; WALKING	Promoting physical activities is important for medical and functional recovery after stroke. Therefore, an accurate and convenient measurement of physical activities is necessary to provide feedback on functional status and effects of rehabilitative interventions. We assessed the feasibility, reliability, and validity of wearing accelerometers to monitor physical activities of stroke patients by estimating energy expenditure. This was a prospective observational quantitative study conducted in an inpatient rehabilitation unit. Twenty-four patients with subacute stroke were enrolled. They wore accelerometers on wrists and ankles for three consecutive weekdays. The feasibility was evaluated by daily wear-time. The test-retest reliability was determined by intra-class correlation coefficient. The validity was evaluated by comparing accelerometeric data to behavior mappings using Mann-Whitney U test, Spearman's rho correlation coefficient (r) and Bland-Altman plots. Average wearing time for four accelerometers was 20.99 +/- 3.28 hours per day. The 3-day accelerometer recording showed excellent test-retest reliability. For sedentary activities, wrist accelerometers showed higher correlation with direct observation than ankle accelerometers. For light to moderate activities, ankle accelerometers showed higher correlation with direct observation than wrist accelerometers. Overall, combined models of accelerometers showed higher correlation with direct observation than separate ones. Wearing accelerometers for 24 h may be useful for measuring physical activities in subjects with subacute stroke in an inpatient rehabilitation unit.	[Lee, Ji-Young; Kwon, SuYeon; Kim, Won-Seok; Hahn, Soo Jung; Park, Jihong; Paik, Nam-Jong] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Rehabil Med, Seongnam Si, Gyeonggi Do, South Korea	Seoul National University (SNU)	Paik, NJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Rehabil Med, Seongnam Si, Gyeonggi Do, South Korea.	njpaik@snu.ac.kr	Paik, Nam-Jong/D-5798-2012; , 김원석/AAJ-2334-2020	Paik, Nam-Jong/0000-0002-5193-8678; , 김원석/0000-0002-1199-5707	Ministry of Science, ICT and Future Planning, Republic of Korea; Microsoft Research under ICT/SW Creative research program [NIPA-2014-(H0510-14-1014)]; Seoul National University Bundang Hospital Research Fund [14-2014 - 035]	Ministry of Science, ICT and Future Planning, Republic of Korea; Microsoft Research under ICT/SW Creative research program; Seoul National University Bundang Hospital Research Fund	This research received grant from the Ministry of Science, ICT and Future Planning, Republic of Korea and Microsoft Research under ICT/SW Creative research program [NIPA-2014-(H0510-14-1014)] supervised by National ICT Industry Promotion Agency, and from the Seoul National University Bundang Hospital Research Fund (14-2014 - 035).; This research was supported by the Ministry of Science, ICT and Future Planning, Republic of Korea and Microsoft Research under ICT/SW Creative research program [NIPA-2014-(H0510-14-1014)] supervised by National ICT Industry Promotion Agency.	Ainsworth BE, 2009, BRIT J SPORT MED, V43, P6, DOI 10.1136/bjsm.2008.052449; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Biasin L, 2014, PHYS THER, V94, P1796, DOI 10.2522/ptj.20130404; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Dannecker KL, 2013, MED SCI SPORT EXER, V45, P2105, DOI 10.1249/MSS.0b013e318299d2eb; Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Haeuber E, 2004, ARCH PHYS MED REHAB, V85, P1997, DOI 10.1016/j.apmr.2003.11.035; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Heil DP, 2012, MED SCI SPORT EXER, V44, pS50, DOI 10.1249/MSS.0b013e3182399dcc; Hills Andrew P, 2014, Front Nutr, V1, P5, DOI 10.3389/fnut.2014.00005; Kamada M, 2016, GAIT POSTURE, V44, P23, DOI 10.1016/j.gaitpost.2015.11.005; Kramer S, 2016, ARCH PHYS MED REHAB, V97, P619, DOI 10.1016/j.apmr.2015.11.007; Kramer SF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/460482; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P56; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Mahendran N, 2016, GAIT POSTURE, V49, P271, DOI 10.1016/j.gaitpost.2016.06.038; Mang CS, 2013, PHYS THER, V93, P1707, DOI 10.2522/ptj.20130053; Mansfield A, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/9476541; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Montoye AHK, 2017, MEAS PHYS EDUC EXERC, V21, P223, DOI 10.1080/1091367X.2017.1337638; Mooney RA, 2016, EXP BRAIN RES, V234, P3669, DOI 10.1007/s00221-016-4767-5; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Noorkoiv M, 2014, J NEUROENG REHABIL, V11, P144; Noorkoiv M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-144; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Prajapati SK, 2011, NEUROREHAB NEURAL RE, V25, P6, DOI 10.1177/1545968310374189; Sallis JF, 2010, J PUBLIC HEALTH MAN, V16, P404, DOI 10.1097/PHH.0b013e3181d52804; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; Vanroy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098735; Veerbeek JM, 2011, STROKE, V42, P3311, DOI 10.1161/STROKEAHA.111.623819; West T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/438679; West T, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/813765; Williams K, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-28	39	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209607	10.1371/journal.pone.0209607	http://dx.doi.org/10.1371/journal.pone.0209607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596694	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200066
J	Moore, HE; Haydel, KF; Banda, JA; Fiterau, M; Desai, M; Robinson, TN				Moore, Hyatt E.; Haydel, K. Farish; Banda, Jorge A.; Fiterau, Madalina; Desai, Manisha; Robinson, Thomas N.			Potential corner case cautions regarding publicly available implementations of the National Cancer Institute's nonwear/wear classification algorithm for accelerometer data	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; UNITED-STATES; CALIBRATION; TIME; IDENTIFICATION; VALIDATION	The National Cancer Institute's (NCI) wear time classification algorithm uses a rule based on the occurrence of physical activity data counts-a cumulative measure of movement, influenced by both magnitude and duration of acceleration-to differentiate between when a physical activity monitoring (PAM) device (ActiGraph accelerometer) is being worn by a participant (wear) from when it is not (nonwear). It was applied to PAM data generated from the 2003-2004 National Health and Nutrition Examination Survey (NHANES 2003-2004). We discuss two corner case conditions that can produce unexpected, and perhaps unintended results when the algorithm is applied. We show, using simulated data of two special cases, how this algorithm classifies a 24-hour period with only 72 total counts as 100% wear in one case, and classifies a 24-hour period with 96,000 counts as 0.1% wear in another. The prevalence of like scenarios in the NHANES 2003-2004 PAM dataset is presented with corresponding summary statistics for varying degrees of the algorithm's nonwear classification threshold (T). The number of participants with valid days, defined as 10 or more hours classified as wear time in a 24-hour day, increased while the mean counts-per-minute (CPM) decreased as the threshold for excluding non-wear was reduced from the allowed 4,000 counts in an hour. The number of participants with four or more valid days increased 2.29% (n = 113) and mean CPM dropped 2.45% (9.5 CPM) when adjusting the nonwear classification threshold to 50 counts an hour. Applying the most liberal criteria, only excluding hours as nonwear which contained 1 count or less, resulted in a 397 more participants (7.83% increase) and 26.5 fewer CPM (6.98% decrease) in NHANES 2003-2004 participants with four or more valid days. The algorithm should be used with caution due to the potential influence of these corner cases.	[Moore, Hyatt E.; Desai, Manisha] Stanford Univ, Quantitat Sci Unit, Stanford, CA 94305 USA; [Moore, Hyatt E.; Haydel, K. Farish; Robinson, Thomas N.] Stanford Univ, Dept Pediat, Div Gen Pediat, Stanford Solut Sci Lab, Stanford, CA 94305 USA; [Moore, Hyatt E.; Haydel, K. Farish; Robinson, Thomas N.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Banda, Jorge A.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Fiterau, Madalina] Stanford Univ, Mobilize Ctr, Stanford, CA 94305 USA; [Fiterau, Madalina] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; Stanford University	Moore, HE (corresponding author), Stanford Univ, Quantitat Sci Unit, Stanford, CA 94305 USA.; Moore, HE (corresponding author), Stanford Univ, Dept Pediat, Div Gen Pediat, Stanford Solut Sci Lab, Stanford, CA 94305 USA.; Moore, HE (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	hyatt4@stanford.edu		Moore, Hyatt/0000-0001-7866-2280	Stanford Child Health Research Institute; Department of Pediatrics at Stanford University; Li Ka Shing Foundation Stanford-Oxford Big Data for Human Health seed grant program; National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence [U54EB020405]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020405] Funding Source: NIH RePORTER	Stanford Child Health Research Institute; Department of Pediatrics at Stanford University; Li Ka Shing Foundation Stanford-Oxford Big Data for Human Health seed grant program; National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research reported in this publication was supported in part grants from the Stanford Child Health Research Institute, the Department of Pediatrics at Stanford University, and the Li Ka Shing Foundation Stanford-Oxford Big Data for Human Health seed grant program. The content is solely the responsibility of the authors and does not necessarily represent the official views of Stanford University or the Li Ka Shing Foundation. The Mobilize Center is a National Institutes of Health Big Data to Knowledge (BD2K) Center of Excellence supported through Grant U54EB020405.	ActiGraph LLC, 2015, ACT WHIT PAP WHAT IS; ACtiGraph LLC, 2016, WHAT AR COUNTS; ActiGraph LLC. Troiano, 2007, WEAR TIM VAL PAR; Barreira TV, 2015, MED SCI SPORT EXER, V47, P937, DOI 10.1249/MSS.0000000000000486; Butte NF, 2014, MED SCI SPORT EXER, V46, P1216, DOI 10.1249/MSS.0000000000000209; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Domelen DRV, ACCELEROMETRY FUNCTI; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; National Cancer Institute, 2004, SAS PROGRAMS FOR ANA; National Center for Health Statistics, 2006, 2003 2004 DAT DOC CO; National Center for Health Statistics. Centers for Disease Control and Prevention, 2004, NAT HLTH NUTR EX SUR; (NCHS) CfDCaPCNCfHS, 2004, NAT HLTH NUTR EX SUR; NHANES, 1998, DAT REL ACC POL; Oliver M, 2011, RES Q EXERCISE SPORT, V82, P779, DOI 10.1080/02701367.2011.10599814; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; Pulsford RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021822; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Song J, 2010, ARTHRIT CARE RES, V62, P1724, DOI 10.1002/acr.20305; Statistics NCfH, NHANES 1999 2004 PRO; Statistics NCfH, 2005, 2003 2004 PUBL DAT G; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2007, MED SCI SPORT EXER, V39, P1501, DOI 10.1097/mss.0b013e318150d42e; Trost SG, 2012, OBESITY, V20, P2317, DOI 10.1038/oby.2011.364; Winkler EAH, 2012, BRIT J SPORT MED, V46, P436, DOI 10.1136/bjsm.2010.079699	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210006	10.1371/journal.pone.0210006	http://dx.doi.org/10.1371/journal.pone.0210006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596771	Green Submitted, gold, Green Published			2022-12-26	WOS:000454627200124
J	Zhao, YD; Guo, LL; Fang, BH; Liu, BT				Zhao, Yongda; Guo, Li-Li; Fang, Binghu; Liu, Baotao			Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model	PLOS ONE			English	Article							LUNG-TISSUE CONCENTRATIONS; RESISTANT MUTANTS; DOSAGE REGIMEN; PHARMACOKINETICS; TRIAMILIDE; SELECTION; HEALTHY; PHARMACODYNAMICS; SUSCEPTIBILITY; ANTIBIOTICS	The objective of the study was to develop an ex-vivo PK/PD model of intramuscular (IM) administration of tulathromycin and to test its efficacy against Haemophilus parasuis (H. parasuis) infection in intraperitoneal-inoculated neutropenic guinea pigs. The pharmacokinetics (PKs) of tulathromycin at doses of 1 and 10 mg/kg in H. parasuis-infected neutropenic guinea pig were studied by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). In vitro minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), mutant prevention concentration (MPC), post-antibiotic effect (PAE) and dynamic time-kill curve experiments were carried out using H. parasuis strain 13R. Tulathromycin exhibited concentration-dependent activity and PAE persisted long after administration of the antibiotic. The ratio of the 24-h area under the concentration-time curve (AUC) to MIC in serum (AUC(24h)/MICserum) was recognized as an important PK/PD parameter that positively correlated with the in vitro antibacterial effectiveness of tulathromycin (R-2 = 0.9961 or R-2 = 1). For the 1 and 10 mg/kg treatments with tulathromycin, the values of AUC(24h)/MIC for H. parasuis bacteriostatic action, bactericidal action and virtual bacterial eradication were respectively 22.73, 34.5 and 88.03 h for the 1 mg/kg treatment and respectively 24.94, 30.94 and 49.92 h for the 10 mg/kg treatment. In addition, we demonstrated that doses of 7.2-8.0 mg/kg of tulathromycin resulted in high eradication rates (99.99%). Using a previously published conversion factor of 0.296, we were able to estimate an approximate dose, 2.1-2.4 mg/kg, that should also obtain high eradication rates in the target animal, pigs. This study can help optimize tulathromycin efficacy against H. parasuis infections in swine farming.	[Zhao, Yongda; Liu, Baotao] Qingdao Agr Univ, Coll Vet Med, Qingdao, Shandong, Peoples R China; [Zhao, Yongda; Fang, Binghu] South China Agr Univ, Coll Vet Med, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China; [Guo, Li-Li] Qingdao Yebio Biol Engn Co Ltd, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University; South China Agricultural University	Liu, BT (corresponding author), Qingdao Agr Univ, Coll Vet Med, Qingdao, Shandong, Peoples R China.; Fang, BH (corresponding author), South China Agr Univ, Coll Vet Med, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China.	bhfang_prof@126.com; liubaotao-1986@163.com		Fang, Binghu/0000-0001-6558-4447	Research of Novel Broad-spectrum Antibacterial Agent of Tulathromycin Raw Materials and its Preparation [2015B090901059]; National Natural Science Foundation of China [31502122]; Scientific and Technological Projects of Qingdao [16-5-1-49-jch]	Research of Novel Broad-spectrum Antibacterial Agent of Tulathromycin Raw Materials and its Preparation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Projects of Qingdao	This work was supported by the Research of Novel Broad-spectrum Antibacterial Agent of Tulathromycin Raw Materials and its Preparation (Grant No. 2015B090901059 to B.F.), National Natural Science Foundation of China (Grant No. 31502122 to B.L.) and the Scientific and Technological Projects of Qingdao (Grant No. 16-5-1-49-jch to B.L.). Author L.L.G. is employed by Qingdao Yebio Biological Engineering Co., Ltd. Qingdao Yebio Biological Engineering Co., Ltd. provided support in the form of salary for author L.L.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abo-El-Sooud K, 2012, VET WORLD, V5, P424, DOI 10.5455/vetworld.2012.424-428; Ahmad I, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5465678; Amer AMM, 2012, SMALL RUMINANT RES, V108, P137, DOI 10.1016/j.smallrumres.2012.07.003; Andes D, 2004, CLIN LAB MED, V24, P477, DOI 10.1016/j.cll.2004.03.009; Benchaoui HA, 2004, J VET PHARMACOL THER, V27, P203, DOI 10.1111/j.1365-2885.2004.00586.x; Bladek T, 2015, FOOD ADDIT CONTAM A, V32, P1823, DOI 10.1080/19440049.2015.1078915; Brockmeier SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103787; Brockmeier SL, 2013, CLIN VACCINE IMMUNOL, V20, P1466, DOI 10.1128/CVI.00168-13; Clinical and Laboratory Standards Institute (CLSI), 2013, CLSI DOCUMENT VET01; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Duszynska W, 2012, ANAESTH INTENSIVE TH, V44, P158; Evans NA, 2006, TIERAERZTL UMSCHAU, V61, pA1; FDA, 2005, DRAXXIN INJECTABLE S; Galer D, 2004, J AGR FOOD CHEM, V52, P2179, DOI 10.1021/jf0351624; Godinho KS, 2008, VET MICROBIOL, V129, P426, DOI 10.1016/j.vetmic.2007.11.033; Godinho KS, 2005, VET THER, V6, P113; Huang J., 2004, CHIN J CLIN PHARM TH, V09, P1069; Huang XH, 2012, J INTEGR AGR, V11, P465, DOI 10.1016/S2095-3119(12)60032-X; MOROZUMI T, 1982, NATL I ANIM HEALTH Q, V22, P23; Morselt Maria, 2004, Tijdschr Diergeneeskd, V129, P306; Nedbalcova K, 2013, ACTA VET BRNO, V82, P3, DOI 10.2754/avb201382010003; Nielsen EI, 2013, PHARMACOL REV, V65, P1053, DOI 10.1124/pr.111.005769; Nowakowski MA, 2004, VET THER, V5, P60; Olofsson SK, 2006, J ANTIMICROB CHEMOTH, V57, P1116, DOI 10.1093/jac/dkl135; Owens RC, 2007, DIAGN MICR INFEC DIS, V57, p77S, DOI 10.1016/j.diagmicrobio.2006.12.012; PENNINGTON JE, 1979, J INFECT DIS, V140, P881, DOI 10.1093/infdis/140.6.881; Pruller S, 2017, J CLIN MICROBIOL, V55, P264, DOI 10.1128/JCM.01403-16; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P659; Reese C, 2004, P 23 WORLD BUIATR C; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; SPIVEY JM, 1992, CLIN PHARMACY, V11, P865; Toutain PL, 2017, J VET PHARMACOL THER, V40, P16, DOI 10.1111/jvp.12333; Toutain PL, 2012, J VET PHARMACOL THER, V35, P23; Toutain PL, 2007, J ANTIMICROB CHEMOTH, V60, P1185, DOI 10.1093/jac/dkm360; Toutain PL, 2003, VET J, V165, P98, DOI 10.1016/S1090-0233(02)00271-X; Toutain PL, 2002, RES VET SCI, V73, P105, DOI 10.1016/S0034-5288(02)00039-5; Venner M, 2007, VET J, V174, P418, DOI 10.1016/j.tvjl.2006.08.016; Vilalta C, 2014, J VET PHARMACOL THER, V37, P542, DOI 10.1111/jvp.12134; Villarino N, 2012, ANTIMICROB AGENTS CH, V56, P4078, DOI 10.1128/AAC.00218-12; Villarino N, 2013, VET J, V198, P352, DOI 10.1016/j.tvjl.2013.07.032; Xiao X, 2015, ANTIMICROB AGENTS CH, V59, P3754, DOI 10.1128/AAC.00200-15; Young G, 2011, RES VET SCI, V90, P477, DOI 10.1016/j.rvsc.2010.06.025; Zhao X, 2008, J ANTIMICROB CHEMOTH, V62, P434, DOI 10.1093/jac/dkn229; Zhao XL, 2001, CLIN INFECT DIS, V33, pS147, DOI 10.1086/321841; Zhou QY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00392; Zhou YF, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00684	47	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209177	10.1371/journal.pone.0209177	http://dx.doi.org/10.1371/journal.pone.0209177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596709	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200032
J	Machekano, R; Tiam, A; Kassaye, S; Tukei, V; Gill, M; Mohai, F; Nchepe, M; Mokone, M; Barasa, J; Mohale, S; Letsie, M; Guay, L				Machekano, Rhoderick; Tiam, Appolinaire; Kassaye, Seble; Tukei, Vincent; Gill, Michelle; Mohai, Florence; Nchepe, Masepeli; Mokone, Majoalane; Barasa, Janet; Mohale, Sesomo; Letsie, Mosilinyane; Guay, Laura			HIV incidence among pregnant and postpartum women in a high prevalence setting	PLOS ONE			English	Article							INFECTION; AGE	In sub-Saharan Africa, most women who test HIV negative at the first antenatal care encounter are rarely tested again during pregnancy and postpartum, yet data suggests that pregnancy is associated with increased risk of HIV acquisition compared to non-pregnant women. We describe HIV incidence during pregnancy and postpartum in Lesotho, a high prevalence setting, and factors associated with HIV seroconversion. We enrolled a cohort of HIV negative women presenting at health facilities for antenatal care and followed them through delivery up to 24 months postpartum. Women were repeatedly tested for HIV according to the Lesotho Ministry of Health routine rapid HIV testing guidelines and responded to risk behavior questionnaire every three months. We estimated HIV incidence and associated 95% confidence intervals. We used mixed effects Cox regression models to identify independent factors associated with seroconversion accounting for repeated assessment. The estimated overall HIV incidence rate was 1.58 (95% CI: 1.05-2.28) per 100 person-years. The estimated HIV incidence rate during pregnancy (2.61 per 100 person-years, 95% CI: 1.12-5.14) was almost double the estimated HIV incidence during postpartum (1.36 per 100 person-years, 95% CI: 0.83-2.10). Women's age (14-24 years compared to 25-45 years), multiple sexual partnerships, urethral discharge and no condoms nor pre-exposure prophylaxis were independently associated with HIV infection. There is an increased need for counseling and support of HIV-uninfected pregnant and breastfeeding women to stay HIV-negative, including provision of pre-exposure prophylaxis during this high-risk period, particularly among adolescent and young women.	[Machekano, Rhoderick; Tiam, Appolinaire; Gill, Michelle; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC 20036 USA; [Tiam, Appolinaire] Univ Bergen, Bergen, Norway; [Kassaye, Seble] Georgetown Univ, Washington, DC USA; [Tukei, Vincent; Mohai, Florence; Mokone, Majoalane; Barasa, Janet; Mohale, Sesomo] Elizabeth Glaser Pediat AIDS Fdn, Maseru, Lesotho; [Nchepe, Masepeli; Letsie, Mosilinyane] Minist Hlth, Maseru, Lesotho; [Guay, Laura] George Washington Univ, Washington, DC USA	University of Bergen; Georgetown University; George Washington University	Machekano, R (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Washington, DC 20036 USA.	rmachekano@pedaids.org	Tukei, Vincent/GNH-5270-2022	Tukei, Vincent Joseph/0000-0002-9525-2600	United States Agency for International Development (USAID); USAID [AID-674-A-16-00005]; Lesotho Ministry of Health; Christian Health Association of Lesotho	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); USAID(United States Agency for International Development (USAID)); Lesotho Ministry of Health; Christian Health Association of Lesotho	This work was funded by the United States Agency for International Development (USAID) and the generous support of the American people through USAID Cooperative Agreement No. AID-674-A-16-00005 (AT).; We thank the study participants, research study team, the Lesotho Ministry of Health and the Christian Health Association of Lesotho for their support of the study and during the preparation of this manuscript.	Chetty T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1421-6; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Dinh TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125525; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Egbe TO, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/7397695; Fatti G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181691; Government of Lesotho, 2016, NAT HIV TEST SERV GU; Kinuthia J, 2017, JAIDS-J ACQ IMM DEF, V74, P142, DOI 10.1097/QAI.0000000000001225; Kinuthia J, 2015, AIDS, V29, P2025, DOI 10.1097/QAD.0000000000000793; LEROY V, 1994, AIDS, V8, P983, DOI 10.1097/00002030-199407000-00017; Ministry of Health Government of Lesotho, 2016, NAT GUID US ANT VIR; Ministry of Health/Lesotho, 2013, NAT GUID PREV MOTH C; Ministry of Health/Lesotho International ICF, 2016, LES DEM HLTH SURV 20; Mofenson LM, 2018, J INFECT DIS, V218, P1, DOI 10.1093/infdis/jiy118; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Pintye J, 2017, CLIN INFECT DIS, V64, P751, DOI 10.1093/cid/ciw850; Rogers AJ, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25036; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Thomson KA, 2018, J INFECT DIS, V218, P16, DOI 10.1093/infdis/jiy113; Tiam A, 2017, MEASURING PMTCT PROG; UNAIDS, 2016, COUNTR FACTSH LES 20; Unaids, PUTT HIV PREV AD GIR; Wettstein C, 2012, AIDS, P26; World Health Organization, CONS GUID HIV TEST S; Wu H, 2017, J CLIN VIROL, V93, P85, DOI 10.1016/j.jcv.2017.02.005	25	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209782	10.1371/journal.pone.0209782	http://dx.doi.org/10.1371/journal.pone.0209782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592749	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900041
J	Pietribiasi, M; Waniewski, J; Wojcik-Zaluska, A; Zaluska, W; Lindholm, B				Pietribiasi, Mauro; Waniewski, Jacek; Wojcik-Zaluska, Alicja; Zaluska, Wojciech; Lindholm, Bengt			Model of fluid and solute shifts during hemodialysis with active transport of sodium and potassium	PLOS ONE			English	Article							SKELETAL-MUSCLE; TRANSCAPILLARY EXCHANGE; VOLUME CHANGES; KINETICS; PERMEABILITY; DIALYSIS; REMOVAL; WATER; MICROVASCULATURE; ULTRAFILTRATION	Background Mathematical models are useful tools to predict fluid shifts between body compartments in patients undergoing hemodialysis (HD). The ability of a model to accurately describe the transport of water between cells and interstitium (J(v,ISIC)), and the consequent changes in intracellular volume (ICV), is important for a complete assessment of fluid distribution and plasma refilling. In this study, we propose a model describing transport of fluid in the three main body compartments (intracellular, interstitial and vascular), complemented by transport mechanisms for proteins and small solutes. Methods The model was applied to data from 23 patients who underwent standard HD. The substances described in the baseline model were: water, proteins, Na, K, and urea. Small solutes were described with two-compartment kinetics between intracellular and extracellular compartments. Solute transport across the cell membrane took place via passive diffusion and, for Na and K, through the ATPase pump, characterized by the maximum transport rate, Jp(MAX). From the data we estimated Jp(MAX) and two other parameters linked to transcapillary transport of fluid and protein: the capillary filtration coefficient Lp and its large pores fraction a LP. In an Expanded model one more generic solute was included to evaluate the impact of the number of substances appearing in the equation describing J(v,ISIC). Results In the baseline model, median values (interquartile range) of estimated parameters were: Lp: 11.63 (7.9, 14.2) mL/min/mmHg, alpha(LP): 0.056 (0.050, 0.058), and Jp(MAX): 5.52 (3.75, 7.54) mmol/min. These values were significantly different from those obtained by the Expanded model: Lp: 8.14 (6.29, 10.01) mL/min/mmHg, alpha(LP): 0.046 (0.038, 0.052), and Jp(MAX): 16.7 11.9, 25.2) mmol/min. The relative RMSE (root mean squared error) averaged between all simulated quantities compared to data was 3.9 (3.1, 5.6) %. Conclusions The model was able to accurately reproduce most of the changes observed in HD by tuning only three parameters. While the drop in ICV was overestimated by the model, the difference between simulations and data was less than the measurement error. The biggest change in the estimated parameters in the Expanded model was a marked increase of Jp(MAX) indicating that this parameter is highly sensitive to the number of species modeled, and that the value of Jp(MAX) should be interpreted only in relation to this factor.	[Pietribiasi, Mauro; Waniewski, Jacek] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Wojcik-Zaluska, Alicja] Med Univ Lublin, Dept Rehabil & Physiotherapy, Lublin, Poland; [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland; [Lindholm, Bengt] Karolinska Inst, Renal Med & Baxter Novum, Stockholm, Sweden	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin; Karolinska Institutet	Pietribiasi, M (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	mpietribiasi@ibib.waw.pl		Wojcik-Zaluska, Alicja/0000-0001-7971-0141; Zaluska, Wojciech/0000-0001-6043-3236; Jacek, Waniewski/0000-0002-2705-504X; Pietribiasi, Mauro/0000-0001-8224-783X	National Science Center (Poland) [UMO-2014/15/N/ST7/05316]; National Science Centre [N N518 289840]	National Science Center (Poland)(National Science Centre, Poland); National Science Centre(National Science Centre, Poland)	This work was supported by grant no. UMO-2014/15/N/ST7/05316 issued by the National Science Center (Poland, http://www.ncn.gov.pl/).M.P.is the beneficiary of the grant. The data were originally collected for the study "Evaluation of disturbances of calcium-phosphate management in patients on dialysis" supported by the National Science Centre, grant no N N518 289840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Baxter Novum provided support in the form of salaries for author BL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agar BU, 2015, HEMODIAL INT, V19, P23, DOI 10.1111/hdi.12195; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Bolasco P, 2008, J NEPHROL, V21, P384; Casagrande G, 2016, INT J ARTIF ORGANS, V39, P220, DOI 10.5301/ijao.5000504; Ciandrini A, 2009, ARTIF ORGANS, V33, P835, DOI 10.1111/j.1525-1594.2009.00806.x; Clausen T, 2013, J GEN PHYSIOL, V142, P327, DOI 10.1085/jgp.201310980; Coli L, 2000, BLOOD PURIFICAT, V18, P37, DOI 10.1159/000014406; Dahlmann A, 2015, KIDNEY INT, V87, P434, DOI 10.1038/ki.2014.269; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; de los Reyes AA, 2016, J THEOR BIOL, V390, P146, DOI 10.1016/j.jtbi.2015.11.012; Debowska M, 2015, NEPHROL DIAL TRANSPL, V30, P129, DOI 10.1093/ndt/gfu266; Ebah LM, 2013, KIDNEY INT, V84, P980, DOI 10.1038/ki.2013.208; El-Kateb S, 2016, NUTR CLIN PRACT, V31, P375, DOI 10.1177/0884533615621549; Ellmerer M, 2000, AM J PHYSIOL-ENDOC M, V278, pE352, DOI 10.1152/ajpendo.2000.278.2.E352; Eloot S, 2012, NEPHROL DIAL TRANSPL, V27, P4021, DOI 10.1093/ndt/gfs367; Flythe JE, 2017, J AM SOC NEPHROL, V28, P2260, DOI 10.1681/ASN.2017050491; Galach M, 2013, NEPHROL DIAL TRANSPL, V28, P447, DOI 10.1093/ndt/gfs592; Granger HJ, 1984, DYNAMICS CONTROL TRA, pp189; Guyton A, 2011, GUYTON AND HALL TEXT; Guyton A, 2000, MED PHYSL, P264; Gyenge CC, 1999, AM J PHYSIOL-HEART C, V277, pH1215, DOI 10.1152/ajpheart.1999.277.3.H1215; Iimura O, 1996, NEPHRON, V74, P19, DOI 10.1159/000189276; JAFFRIN MY, 1995, ARTIF ORGANS, V19, P1162, DOI 10.1111/j.1525-1594.1995.tb02277.x; KEDEM O, 1989, BIOCHIM BIOPHYS ACTA, V1000, P411, DOI 10.1016/S0006-3002(89)80036-8; Kellen MR, 2003, AM J PHYSIOL-HEART C, V285, pH1303, DOI 10.1152/ajpheart.00933.2001; Kellen MR, 2003, AM J PHYSIOL-HEART C, V285, pH1317, DOI 10.1152/ajpheart.00587.2002; Kennedy J., 1995, P ICNN 95 INT C NEUR, V194, P2; Kotyk A, 1970, CELL MEMBRANE TRANSP, P62; Landis E.M., 1963, HDB PHYSL SECTION 2, P961; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Mann H, 2000, KIDNEY INT, V58, pS79, DOI 10.1016/S0085-2538(15)47404-6; Margaris KN, 2012, J R SOC INTERFACE, V9, P601, DOI 10.1098/rsif.2011.0751; MASON EA, 1980, J MEMBRANE SCI, V6, P283, DOI 10.1016/S0376-7388(00)82170-5; PEDRINI LA, 1991, KIDNEY INT, V40, P525, DOI 10.1038/ki.1991.241; Pietribiasi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159748; Pietribiasi M, 2015, ASAIO J, V61, P350, DOI 10.1097/MAT.0000000000000206; POPOVICH RP, 1975, T AM SOC ART INT ORG, V21, P108; Purssell RA, 2001, ANN EMERG MED, V38, P653, DOI 10.1067/mem.2001.119455; Raimann JG, 2014, KIDNEY INT, V85, P898, DOI 10.1038/ki.2013.358; Ravagli E, 2016, INT J ARTIF ORGANS, V39, P471, DOI 10.5301/ijao.5000528; Reed RK, 2010, CARDIOVASC RES, V87, P211, DOI 10.1093/cvr/cvq143; Rippe B, 1993, Perit Dial Int, V13 Suppl 2, pS35; RIPPE B, 1978, ACTA PHYSIOL SCAND, V104, P318, DOI 10.1111/j.1748-1716.1978.tb06284.x; RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163; Rippe B, 2015, THE THREE PORE MODEL; ROSE AM, 1994, CLIN CHEM, V40, P1674; Rose B. D., 1989, CLIN PHYSL ACID BASE; Sargent GA, 1989, REPLACEMENT OF RENAL, P53; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Seoane F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/656323; Stachowska-Pietka J, 2012, AM J PHYSIOL-RENAL, V302, pF1331, DOI 10.1152/ajprenal.00301.2011; Titze J, 2009, SEMIN DIALYSIS, V22, P253, DOI 10.1111/j.1525-139X.2009.00569.x; Ursino M, 2006, INT J ARTIF ORGANS, V29, P1031, DOI 10.1177/039139880602901103; Ursino M, 1997, ARTIF ORGANS, V21, P873; Ursino M, 2000, ANN BIOMED ENG, V28, P204, DOI 10.1114/1.245; WANIEWSKI J, 1994, J MEMBRANE SCI, V95, P179, DOI 10.1016/0376-7388(94)00110-3; WATSON PD, 1995, AM J PHYSIOL-HEART C, V268, pH184, DOI 10.1152/ajpheart.1995.268.1.H184; Yashiro M, 2016, THER APHER DIAL, V20, P492, DOI 10.1111/1744-9987.12414; Yashiro M, 2013, INT J ARTIF ORGANS, V36, P7, DOI 10.5301/ijao.5000167; Yi CS, 2003, J THEOR BIOL, V220, P83, DOI 10.1006/jtbi.2003.3154; Zoccali C, 2017, J AM SOC NEPHROL, V28, P2491, DOI 10.1681/ASN.2016121341	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209553	10.1371/journal.pone.0209553	http://dx.doi.org/10.1371/journal.pone.0209553			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592754	gold, Green Published, Green Submitted			2022-12-26	WOS:000454621900031
J	Wong, K; Ozeki, K; Kwong, A; Patel, BN; Kwo, P				Wong, Katherine; Ozeki, Katharine; Kwong, Allison; Patel, Bhavik N.; Kwo, Paul			The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer	PLOS ONE			English	Article							PORTAL-VEIN THROMBOSIS; CARCINOMA; CT	Background and aims Transjugular intrahepatic portosystemic shunt (TIPS) may be placed to treat complications of portal hypertension by creating a conduit between the hepatic and portal vein. The diagnosis of hepatocellular carcinoma (HCC) is typically made by multiphasic imaging studies demonstrating arterial enhancement with washout on arterial, portal venous, and delayed phase imaging. The aim of our study was to determine how the presence of TIPS would affect the imaging diagnosis of HCC. Methods This was a single-center electronic database review of all patients who underwent multiphasic imaging with MRI or CT scan for HCC screening between January 2000 and July 2017 and who were subsequently diagnosed with HCC. Data collected included patient demographics, liver disease characteristics including CPT score, MELD-Na, AFP, type of imaging, tumor stage, and lab values at the time of HCC diagnosis. The diagnosis of HCC was made using LI-RADS criteria on contrast-enhanced CT or MR imaging and confirmed by chart abstraction as documented by the treating clinician. Demographic and imaging characteristics for HCC patients with and without TIPS were compared. Results A total of 279 patients met eligibility criteria for the study, 37 (13.2%) of whom had TIPS placed prior to diagnosis of HCC. There was no significant difference in demographics or liver disease characteristics between patients with and without TIPS. Compared to cirrhotic patients with no TIPS prior to HCC diagnosis, patients with TIPS had significantly more scans with a longer duration of surveillance until HCC diagnosis. However, LI-RADS criteria and stage of HCC at diagnosis were not significantly different between both groups. There were no differences in outcomes including liver transplant and survival. Conclusion The presence of TIPS does not lead to a delayed diagnosis of HCC. It is associated, however, with greater duration of time from first scan to diagnosis of HCC.	[Wong, Katherine; Kwong, Allison; Kwo, Paul] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Ozeki, Katharine; Patel, Bhavik N.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Kwo, P (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.	pkwo@stanford.edu		Kwong, Allison/0000-0002-3874-6612				[Anonymous], 2017, MMWR Morb Mortal Wkly Rep, V66, P1031, DOI 10.15585/mmwr.mm6638a9; [Anonymous], 2011, ANN ACAD MED SINGAPO, V40, P454; Boyer TD, 2010, HEPATOLOGY, V51, P306, DOI 10.1002/hep.23383; El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; George V, LI RADS WEB APPL FRE; Iannaccone R, 2005, RADIOLOGY, V234, P460, DOI 10.1148/radiol.2342031202; Marrero JA, 2005, LIVER TRANSPLANT, V11, P281, DOI 10.1002/lt.20357; Mitchell DG, 2015, HEPATOLOGY, V61, P1056, DOI 10.1002/hep.27304; Monzawa S, 2007, AM J ROENTGENOL, V188, P147, DOI 10.2214/AJR.05.0512; Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388; Roberts LR, 2018, HEPATOLOGY, V67, P401, DOI 10.1002/hep.29487; Thian YL, 2011, ANN ACAD MED SINGAP, V40, P454; Umar NK, 2015, DIGEST DIS SCI, V60, P2196, DOI 10.1007/s10620-015-3587-y; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670	15	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0208233	10.1371/journal.pone.0208233	http://dx.doi.org/10.1371/journal.pone.0208233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592722	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900007
J	Nieuwenhuis, BPS; Aanen, DK				Nieuwenhuis, Bart P. S.; Aanen, Duur K.			Nuclear arms races: Experimental evolution for mating success in the mushroom-forming fungus Schizophyllum commune	PLOS ONE			English	Article							SEXUAL SELECTION; NATURAL-POPULATIONS; POLLEN COMPETITION; SPERM COMPETITION; SIZE; PHEROMONES; POLYANDRY; DIVERSITY; INSIGHTS; FITNESS	When many gametes compete to fertilize a limited number of compatible gametes, sexual selection will favour traits that increase competitive success during mating. In animals and plants, sperm and pollen competition have yielded many interesting adaptations for improved mating success. In fungi, similar processes have not been shown directly yet. We test the hypothesis that sexual selection can increase competitive fitness during mating, using experimental evolution in the mushroom-forming fungus Schizophyllum commune (Basidiomycota). Mating in mushroom fungi occurs by donation of nuclei to a mycelium. These fertilizing 'male' nuclei migrate through the receiving 'female' mycelium. In our setup, an evolving population of nuclei was serially mated with a non-evolving female mycelium for 20 sexual generations. From the twelve tested evolved lines, four had increased and one had decreased fitness relative to an unevolved competitor. Even though only two of those five remained significant after correcting for multiple comparisons, for all five lines we found a correlation between the efficiency with which the female mycelium is accessed and fitness, providing additional circumstantial evidence for fitness change in those five lines. In two lines, fitness change was also accompanied by increased spore production. The one line with net reduced competitive fitness had increased spore production, but reduced fertilisation efficiency. We did not find trade-offs between male reproductive success and other fitness components. We compare these findings with examples of sperm and pollen competition and show that many similarities between these systems and nuclear competition in mushrooms exist.	[Nieuwenhuis, Bart P. S.] Ludwig Maximilians Univ Munchen, Fac Biol 2, Div Evolutionary Biol, Planegg Martinsried, Germany; [Nieuwenhuis, Bart P. S.; Aanen, Duur K.] Wageningen Univ, Genet Lab, Wageningen, Netherlands	University of Munich; Wageningen University & Research	Nieuwenhuis, BPS (corresponding author), Ludwig Maximilians Univ Munchen, Fac Biol 2, Div Evolutionary Biol, Planegg Martinsried, Germany.; Nieuwenhuis, BPS (corresponding author), Wageningen Univ, Genet Lab, Wageningen, Netherlands.	nieuwenhuis@bio.lmu.de		Nieuwenhuis, Bart/0000-0001-8159-4784; Aanen, Duur/0000-0002-5702-1617	Netherlands Science Organisation; Netherlands Science Organisation (ALW-NWO) [816.01.017]; Netherlands Science Organisation (VICI); Netherlands Science Organisation [NWO 86514007]	Netherlands Science Organisation(Netherlands Organization for Scientific Research (NWO)); Netherlands Science Organisation (ALW-NWO); Netherlands Science Organisation (VICI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Science Organisation(Netherlands Organization for Scientific Research (NWO))	BPSN and DKA were financed by the Netherlands Science Organisation (http://www.nwo.nl).; We acknowledge James Anderson, Arjan de Visser and Bas Zwaan for useful comments on the setup of the experiment. Bertha Koopmanschap is acknowledged for help with the qPCR assays, Luis Lugones and Karin Scholtmeijer for constructing and donating the resistant H4-8 strains, and for technical advice. We thank six anonymous reviewers for their useful comments and suggestions on previous versions of this manuscript. BPSN and DKA were financed by the Netherlands Science Organisation (ALW-NWO open competition 816.01.017; VICI; NWO 86514007).	Aanen DK, 2004, P ROY SOC B-BIOL SCI, V271, P1235, DOI 10.1098/rspb.2004.2693; Aanen DK, 2009, SCIENCE, V326, P1103, DOI 10.1126/science.1173462; Anderson James B., 2007, P333; Andersson Malte, 1994; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Branco S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04380-9; Buss L., 1987, EVOLUTION INDIVIDUAL; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Clark TA, 2004, GENETICS, V167, P1663, DOI 10.1534/genetics.104.027235; DONS JJM, 1979, BIOCHIM BIOPHYS ACTA, V563, P100, DOI 10.1016/0005-2787(79)90011-X; Dorken ME, 2009, CURR BIOL, V19, P514, DOI 10.1016/j.cub.2009.01.067; ELLINGBOE AH, 1964, AM J BOT, V51, P133, DOI 10.2307/2440096; Erdmann S, 2012, EUKARYOT CELL, V11, P571, DOI 10.1128/EC.05214-11; Evans JP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2047; Fowler TJ, 1999, MOL BIOL CELL, V10, P2559, DOI 10.1091/mbc.10.8.2559; Gage MJG, 2012, P NATL ACAD SCI USA, V109, P4341, DOI 10.1073/pnas.1201827109; Gage MJG, 2003, CURR BIOL, V13, P754, DOI 10.1016/S0960-9822(03)00282-3; Gladfelter A, 2009, NAT REV MICROBIOL, V7, P875, DOI 10.1038/nrmicro2249; Hiscox J, 2010, FUNGAL ECOL, V3, P347, DOI 10.1016/j.funeco.2010.02.003; Immler S, 2011, P NATL ACAD SCI USA, V108, P5325, DOI 10.1073/pnas.1009059108; JACKSON CL, 1990, MOL CELL BIOL, V10, P2202, DOI 10.1128/MCB.10.5.2202; James TY, 2015, FUNGAL BIOL REV, V29, P167, DOI 10.1016/j.fbr.2015.10.002; James TY, 2001, MOL ECOL, V10, P471, DOI 10.1046/j.1365-294x.2001.01224.x; Jennions MD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0312; Jennions Michael D., 2010, P343; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Kim H, 2006, EUKARYOT CELL, V5, P544, DOI 10.1128/EC.5.3.544-554.2006; Kues U, 2015, FUNGAL BIOL REV, V29, P126, DOI 10.1016/j.fbr.2015.11.001; Kues U, 2009, MYCOTA, V15, P79; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Lankinen A, 2007, AM NAT, V170, P854, DOI 10.1086/522839; Lankinen A, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv008; Lankinen A, 2011, AM J BOT, V98, P1191, DOI 10.3732/ajb.1000510; Lankinen A, 2009, ANN BOT-LONDON, V103, P941, DOI 10.1093/aob/mcp014; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lessells CM, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P43, DOI 10.1016/B978-0-12-372568-4.00002-1; Levitan DR, 2018, AM NAT, V191, P88, DOI 10.1086/694780; McCallum B, 2016, AM J BOT, V103, P460, DOI 10.3732/ajb.1500211; Nieuwenhuis BPS, 2013, HEREDITY, V111, P445, DOI 10.1038/hdy.2013.67; Nieuwenhuis BPS, 2012, J EVOLUTION BIOL, V25, P2397, DOI 10.1111/jeb.12017; Nieuwenhuis BPS, 2013, FUNGAL GENET BIOL, V56, P25, DOI 10.1016/j.fgb.2013.04.009; Nieuwenhuis BPS, 2011, P ROY SOC B-BIOL SCI, V278, P152, DOI 10.1098/rspb.2010.1110; Ohm Robin A, 2010, Nat Biotechnol, V28, P957, DOI 10.1038/nbt.1643; PAPAZIAN HP, 1950, BOT GAZ, V112, P143, DOI 10.1086/335643; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; PARKER GA, 1978, J THEOR BIOL, V73, P1, DOI 10.1016/0022-5193(78)90177-7; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Petit E, 2012, EVOLUTION, V66, P3519, DOI 10.1111/j.1558-5646.2012.01703.x; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; R Core Team, 2021, R LANGUAGE ENV STAT; Rademaker MCJ, 1998, J EVOLUTION BIOL, V11, P623, DOI 10.1007/s000360050110; RAPER J. R., 1966, Genetics of sexuality in higher fungi.; Rasband W., 1997, BETHESDA; RAYNER ADM, 1991, MYCOLOGIA, V83, P48, DOI 10.2307/3759832; Rayner ADM, 1984, ECOLOGY PHYSL FUNGAL, P509; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Rogers DW, 2009, P ROY SOC B-BIOL SCI, V276, P543, DOI 10.1098/rspb.2008.1146; ROSS IK, 1976, MYCOLOGIA, V68, P418, DOI 10.2307/3759012; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samils N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0862; Scharer L, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017673; Scharer L, 2011, P NATL ACAD SCI USA, V108, P1490, DOI 10.1073/pnas.1013892108; Schoustra SE, 2006, J EVOLUTION BIOL, V19, P1115, DOI 10.1111/j.1420-9101.2006.01102.x; Selosse MA, 2017, TRENDS MICROBIOL, V25, P784, DOI 10.1016/j.tim.2017.05.010; Simmons LW, 2012, REPRODUCTION, V144, P519, DOI 10.1530/REP-12-0285; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; SNIDER PJ, 1958, AM J BOT, V45, P538, DOI 10.2307/2439577; SNOW AA, 1991, NATURE, V352, P796, DOI 10.1038/352796a0; Snow AA, 1992, ANGIOSPERM POLLEN OV, P388, DOI [10.1007/978-1-4612-2958-2_63, DOI 10.1007/978-1-4612-2958-2_63]; Sun S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002527; Togashi T, 2009, POPUL ECOL, V51, P83, DOI 10.1007/s10144-008-0102-8; Turnell BR, 2015, EVOLUTION, V69, P2094, DOI 10.1111/evo.12721; van Peer AF, 2009, APPL ENVIRON MICROB, V75, P1243, DOI 10.1128/AEM.02162-08; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; VOORHEES DA, 1986, MYCOLOGIA, V78, P762, DOI 10.2307/3807520; Vreeburg S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0533; Wosten H.A.B., 2006, GROWTH DIFFERENTIATI, P393, DOI DOI 10.1007/3-540-28135-5_19	80	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209671	10.1371/journal.pone.0209671	http://dx.doi.org/10.1371/journal.pone.0209671			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589876	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200044
J	Shang, C; Wang, XN; Chaloupka, FJ				Shang, Ce; Wang, Xuening; Chaloupka, Frank J.			The association between excise tax structures and the price variability of alcoholic beverages in the United States	PLOS ONE			English	Article							CONSUMPTION; DRINKING; METAANALYSIS; DISPARITIES; RISK; US	Recent tobacco taxation research suggests that excise tax structure plays an important role in the effectiveness of increasing taxes in reducing consumption. However, evidence on excise tax structures of alcoholic beverages is scarce. We linked price variability measures for beer, wine, and liquor in the US derived using Economist Intelligence Unit city data from 2003 to 2016 with state-level excise tax structures from the Alcohol Policy Information System. Ordinary least squares (OLS) regressions were performed to assess the associations between excise tax structures and price variability, for beer, wine, and liquor (spirits), respectively. Results suggest that, compared with a specific excise beer tax structure based on volumes, a mixed structure with both specific and ad valorem components was associated with 38% (p <= 0.01) greater beer price variability. In addition, a mixed excise tax structure for liquor was associated with 60-77% (p <= 0.01) greater liquor price variability. However, these associations do not imply a causal link between tax structures and price variability. In summary, a mixed excise tax structure is associated with greater variability in beer and liquor prices, an indicator for tax avoidance opportunities. Future research is needed to identify the causal impact of tax structures on price variability.	[Shang, Ce; Chaloupka, Frank J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma Tobacco Res Ctr,Stephenson Canc Ctr, Oklahoma City, OK 73190 USA; [Wang, Xuening; Chaloupka, Frank J.] Univ Illinois, Dept Econ, Chicago, IL 60680 USA; [Chaloupka, Frank J.] Univ Illinois, Sch Publ Hlth, Div Hlth Policy & Adm, Chicago, IL USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shang, C (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma Tobacco Res Ctr,Stephenson Canc Ctr, Oklahoma City, OK 73190 USA.	Ce-Shang@ouhsc.edu			National Institute on Alcohol Abuse and Alcoholism [K99AA024810]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA024810, K99AA024810] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study is funded by K99AA024810, National Institute on Alcohol Abuse and Alcoholism.	An RP, 2011, J MENT HEALTH POLICY, V14, P13; [Anonymous], 2012, IMPROVING MEASUREMEN; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; Chaloupka FJIV, 2010, NATL BUREAU EC RES W, V16287, DOI [10.3386/w16287, DOI 10.3386/W16287]; Chaloupka FJ, 2014, NICOTINE TOB RES, V16, pS3, DOI 10.1093/ntr/ntt121; Chaloupka FJ, 2011, TOB CONTROL, V20, P235, DOI 10.1136/tc.2010.039982; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Elder RW, 2010, AM J PREV MED, V38, P217, DOI 10.1016/j.amepre.2009.11.005; Grossman M., 1994, J RES ADOLESC, V4, P347, DOI [10.1207/s15327795jra0402_9, DOI 10.1146/ANNUREVCLINPSY-032816-045128]; Lange JE, 2002, ADDICTION, V97, P1195, DOI 10.1046/j.1360-0443.2002.00182.x; Meier PS, 2010, ADDICTION, V105, P383, DOI 10.1111/j.1360-0443.2009.02721.x; Mosher JF, 2017, J STUD ALCOHOL DRUGS, V78, P241, DOI 10.15288/jsad.2017.78.241; Mulia N, 2009, ALCOHOL CLIN EXP RES, V33, P654, DOI 10.1111/j.1530-0277.2008.00880.x; Naimi TS, 2018, J STUD ALCOHOL DRUGS, V79, P43, DOI 10.15288/jsad.2018.79.43; Nelson JP, 2014, HEALTH ECON, V23, P1260, DOI 10.1002/hec.2974; Pesko MF, 2013, NICOTINE TOB RES, V15, P1858, DOI 10.1093/ntr/ntt068; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Saffer H., 1994, E ECON J, V20, P33; Scozzafava G., 2015, RECENT PATENTS FOOD, V8, P31; Shang C, 2019, TOB CONTROL, V28, pS31, DOI 10.1136/tobaccocontrol-2017-054160; Shang C, 2015, TOB CONTROL, V24, P88, DOI 10.1136/tobaccocontrol-2014-051771; Shang C, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-050966; Shrestha V, 2016, ECON INQ, V54, P1946, DOI 10.1111/ecin.12343; Siegel M, 2013, ADDICTION, V108, P339, DOI 10.1111/j.1360-0443.2012.04069.x; Stahre M, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130293; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Witbrodt J, 2014, ALCOHOL CLIN EXP RES, V38, P1662, DOI 10.1111/acer.12398; Xu X, 2011, ALCOHOL RES HEALTH, V34, P236; Xuan ZM, 2015, PEDIATRICS, V136, P18, DOI 10.1542/peds.2015-0537; Xuan ZM, 2015, ADDICTION, V110, P441, DOI 10.1111/add.12818	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208509	10.1371/journal.pone.0208509	http://dx.doi.org/10.1371/journal.pone.0208509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7KM	30589849	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200005
J	Wang, P; Sun, FF; Yu, Q; Wu, GF				Wang, Peng; Sun, Fangfang; Yu, Qing; Wu, Guofeng			Three-dimensional analysis of the relationship between the structure of maxillary central incisor and the preparation of dental all-ceramic	PLOS ONE			English	Article							PORCELAIN LAMINATE VENEERS; TOOTH PREPARATION; THICKNESS; SURVIVAL; STRENGTH; CROWNS; CEMENT	The purpose of this study is to investigate the interrelationship between tooth preparation and dental structure of Chinese maxillary central incisors and provide scientific guidance for clinical all-ceramic restoration. Forty-five specimens of maxillary central incisors were fabricated by 3D printer based on data of Micro CT scanning. Subsequently, every three specimens from the same natural tooth were randomly divided into three groups (n = 15): porcelain veneer, all ceramic crown, and the blank control group. All the specimen teeth were prepared according to routine clinical criteria, reconstructed into 3D models and then measured in software. The results showed that the mean quantity of reduction (volume fraction) was (28.35 +/- 4.37)% and (56.93 +/- 3.47)% for porcelain veneer and all-ceramic crown, respectively. The bonding areas of different all-ceramic restorations were (128.85 +/- 11.73) mm(2) and (97.15 +/- 9.98) mm(2) for all-ceramic crown and porcelain veneer respectively. In porcelain veneer group, the area of enamel adhesive was (54.80 +/- 12.70) mm(2), and the area of dentin was (42.35 +/- 9.62) mm(2). As the results of the one-sample t test, the mean distances from medullary angle to incisal edge or adjacent surface have significant differences with the test value which was set as 0.5 (P<.05). The reduction of the tooth for porcelain veneer is less than that of ceramic crown and the cementation of porcelain veneer is mostly dependent on the conservation of the enamel during preparation. The region from mesial adjacent surface to mesiopulpal angle is prone to have the problem of medullary perforation.	[Wang, Peng; Sun, Fangfang; Yu, Qing; Wu, Guofeng] Nanjing Univ, Med Sch, Nanjing Stomatol Hosp, Dept Prosthodont, Nanjing, Jiangsu, Peoples R China	Nanjing University	Wu, GF (corresponding author), Nanjing Univ, Med Sch, Nanjing Stomatol Hosp, Dept Prosthodont, Nanjing, Jiangsu, Peoples R China.	wgffmmu@sina.com		Wang, Peng/0000-0003-1347-7281				Lemos CAA, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/3163096; Ayad MF, 2009, J PROSTHET DENT, V102, P354, DOI 10.1016/S0022-3913(09)60192-X; Camps J, 2000, DENT MATER, V16, P432, DOI 10.1016/S0109-5641(00)00041-5; Chaiyabutr Y, 2008, OPER DENT, V33, P556, DOI 10.2341/07-141; Cherukara GP, 2005, J PROSTHET DENT, V94, P414, DOI 10.1016/j.prosdent.2005.08.016; Davis GR, 2012, J DENT, V40, P571, DOI 10.1016/j.jdent.2012.03.006; Edelhoff D, 2002, J PROSTHET DENT, V87, P503, DOI 10.1067/mpr.2002.124094; Farias-Neto A, 2015, CASE REP DENT, V2015, DOI 10.1155/2015/452765; Faus-Matoses Vicente, 2017, J Clin Exp Dent, V9, pe1379, DOI 10.4317/jced.54359; Fradeani M, 2005, INT J PERIODONT REST, V25, P9; Friedman MJ, 2012, J ESTHET RESTOR DENT, V24, P266, DOI 10.1111/j.1708-8240.2012.00518.x; Grenade C, 2011, J PROSTHET DENT, V105, P249, DOI 10.1016/S0022-3913(11)60040-1; Gresnigt MMM, 2013, CLIN ORAL INVEST, V17, P823, DOI 10.1007/s00784-012-0790-5; Gumrukcu Z, 2018, MED BIOL ENG COMPUT, V56, P979, DOI 10.1007/s11517-017-1737-4; Levin R P, 1989, J Esthet Dent, V1, P45; Ma JL, 2013, ACTA ODONTOL SCAND, V71, P1032, DOI 10.3109/00016357.2012.698306; Murray PE, 2003, INT ENDOD J, V36, P33, DOI 10.1046/j.0143-2885.2003.00609.x; Nawafleh NA, 2017, J ADV PROSTHODONT, V9, P416, DOI 10.4047/jap.2017.9.6.416; Pahlevan Ayoub, 2014, J Dent (Tehran), V11, P428; Prajapati Paranjay, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-010295; Radz Gary M, 2011, Dent Clin North Am, V55, P353, DOI 10.1016/j.cden.2011.01.006; Shadman Niloofar, 2015, Dent Res J (Isfahan), V12, P562; Shafiei F, 2017, INT J ESTHET DENT, V12, P60; SHEETS CG, 1990, J PROSTHET DENT, V64, P406, DOI 10.1016/0022-3913(90)90035-B; Sorensen JA, 1996, J PROSTHET DENT, V76, P374, DOI 10.1016/S0022-3913(96)90541-7; Wang P, 2014, J PROSTHET DENT, V112, P1553, DOI 10.1016/j.prosdent.2014.06.007	26	3	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209791	10.1371/journal.pone.0209791	http://dx.doi.org/10.1371/journal.pone.0209791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589894	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200053
J	Yim, AYFL; de Bruyn, JR; Duijvis, NW; Sharp, C; Ferrero, E; de Jonge, WJ; Wildenberg, ME; Mannens, MMAM; Buskens, CJ; D'Haens, GR; Henneman, P; te Velde, AA				Yim, Andrew Y. F. Li; de Bruyn, Jessica R.; Duijvis, Nicolette W.; Sharp, Catriona; Ferrero, Enrico; de Jonge, Wouter J.; Wildenberg, Manon E.; Mannens, Marcel M. A. M.; Buskens, Christianne J.; D'Haens, Geert R.; Henneman, Peter; te Velde, Anje A.			A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EPITHELIUM-DERIVED FACTOR; PROTEIN-KINASE-A; TRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS; METHYLATION CHANGES; GENE-EXPRESSION; MEIOTIC ARREST; FACTOR-I; FIBROSIS	Background The chronic remitting and relapsing intestinal inflammation characteristic of Crohn's disease frequently leads to fibrosis and subsequent stenosis of the inflamed region. Approximately a third of all Crohn's disease patients require resection at some stage in their disease course. As the pathogenesis of Crohn's disease associated fibrosis is largely unknown, a strong necessity exists to better understand the pathophysiology thereof. Methods In this study, we investigated changes of the DNA methylome and transcriptome of ileum-derived fibroblasts associated to the occurrence of Crohn's disease associated fibrosis. Eighteen samples were included in a DNA methylation array and twenty-one samples were used for RNA sequencing. Results Most differentially methylated regions and differentially expressed genes were observed when comparing stenotic with non-inflamed samples. By contrast, few differences were observed when comparing Crohn's disease with non-Crohn's disease, or inflamed with non-inflamed tissue. Integrative methylation and gene expression analyses revealed dysregulation of genes associated to the PRKACA and E2F1 network, which is involved in cell cycle progression, angiogenesis, epithelial to mesenchymal transition, and bile metabolism. Conclusion Our research provides evidence that the methylome and the transcriptome are systematically dysregulated in stenosis-associated fibroblasts.	[Yim, Andrew Y. F. Li; Mannens, Marcel M. A. M.; Henneman, Peter] Univ Amsterdam, Amsterdam UMC, Dept Clin Genet, Genome Diagnost Lab, Amsterdam, Netherlands; [Yim, Andrew Y. F. Li; Sharp, Catriona] GlaxoSmithKline, Epigenet Discovery Performance Unit, Stevenage, Herts, England; [de Bruyn, Jessica R.; Duijvis, Nicolette W.; de Jonge, Wouter J.; Wildenberg, Manon E.; te Velde, Anje A.] Univ Amsterdam, Amsterdam UMC, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [de Bruyn, Jessica R.; D'Haens, Geert R.] Univ Amsterdam, Amsterdam UMC, Dept Gastroenterol, Amsterdam, Netherlands; [Buskens, Christianne J.] Univ Amsterdam, Amsterdam UMC, Dept Surg, Amsterdam, Netherlands; [Ferrero, Enrico] GlaxoSmithKline, Target Sci, Computat Biol, Stevenage, Herts, England; [Ferrero, Enrico] Novartis Inst Biomed Res, Autoimmun Transplantat & Inflammat Bioinformat, Basel, Switzerland	University of Amsterdam; GlaxoSmithKline; University of Amsterdam; University of Amsterdam; University of Amsterdam; GlaxoSmithKline; Novartis	te Velde, AA (corresponding author), Univ Amsterdam, Amsterdam UMC, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.	a.a.tevelde@amc.nl	Yim, Andrew Li/AAF-2340-2020	Wildenberg, Manon Elisabeth/0000-0003-0671-818X; Ferrero, Enrico/0000-0002-8362-100X; Li Yim, Andrew Yung Fong/0000-0002-0754-0953	European Commission [SEP-210163258]; European Crohn's and Colitis Organisation	European Commission(European CommissionEuropean Commission Joint Research Centre); European Crohn's and Colitis Organisation	This work was supported by the European Commission, Horizon 2020 Framework Programme (SEP-210163258 to WJJ) and the European Crohn's and Colitis Organisation (project: 'DNA methylation profiles in IBD fibroblasts' to AAV and PH). WJJ was a co-owner of Gut Research BV at the time of writing this manuscript. GlaxoSmithKline provided support in the form of salaries for authors AYFLY and CS and GlaxoSmithKline and Novartis provided support in the form of salaries for author EF. GlaxoSmithKline, Novartis and Gut Research BV had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews S, FASTQC QUALITY CONTR; Arvaniti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26235; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Berthon AS, 2015, FRONT CELL DEV BIOL, V3, P1, DOI [10.3389/FCELL.2015.00001, DOI 10.3389/FCELL.2015.00001]; Blaauboer ME, 2014, MATRIX BIOL, V34, P170, DOI 10.1016/j.matbio.2013.11.002; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang CW, 2015, INTEST RES, V13, P19, DOI 10.5217/ir.2015.13.1.19; Chaussepied M, 2005, CELL CYCLE, V4, P392, DOI 10.4161/cc.4.3.1556; Chen ZX, 2013, INT J MED SCI, V10, P1868, DOI 10.7150/ijms.6868; Chiang John Y L, 2017, Liver Res, V1, P3, DOI 10.1016/j.livres.2017.05.001; Cooke J, 2012, INFLAMM BOWEL DIS, V18, P2128, DOI 10.1002/ibd.22942; Cosin-Roger J, 2016, MUCOSAL IMMUNOL, V9, P986, DOI 10.1038/mi.2015.123; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; de Bruyn JR, 2018, J CROHNS COLITIS, V12, P849, DOI 10.1093/ecco-jcc/jjy036; Delgado I, 2011, AM J PHYSIOL-GASTR L, V301, pG20, DOI 10.1152/ajpgi.00481.2010; Dhir M, 2008, J GASTROINTEST SURG, V12, P1745, DOI 10.1007/s11605-008-0633-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; Elpek GO, 2015, WORLD J HEPATOL, V7, P377, DOI 10.4254/wjh.v7.i3.377; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Fortin JP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0503-2; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Harris RA, 2014, EPIGENETICS-US, V9, P1131, DOI 10.4161/epi.29446; Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hughes TA, 2005, EXP CELL RES, V303, P32, DOI 10.1016/j.yexcr.2004.09.014; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Januszyk Michael, 2015, Microarrays (Basel), V4, P540, DOI 10.3390/microarrays4040540; Jenke AC, 2012, CURR OPIN GASTROEN, V28, P577, DOI 10.1097/MOG.0b013e328357336b; Jimenez SK, 2004, CARDIOVASC RES, V62, P548, DOI 10.1016/j.cardiores.2004.01.032; Johnson LA, 2013, INFLAMM BOWEL DIS, V19, P891, DOI 10.1097/MIB.0b013e3182813297; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kanai M, 2009, GENE, V438, P49, DOI 10.1016/j.gene.2009.03.004; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karatzas PS, 2014, ANN GASTROENTEROL, V27, P125; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kastenhuber ER, 2017, P NATL ACAD SCI USA, DOI [10.1073/PNAS, DOI 10.1073/PNAS]; Kerami Z, 2014, J CROHNS COLITIS, V8, P1208, DOI 10.1016/j.crohns.2014.02.009; Kovo M, 2006, REPRODUCTION, V132, P33, DOI 10.1530/rep.1.00824; Lee JC, 2017, NAT GENET, V49, P262, DOI 10.1038/ng.3755; Leeb SN, 2003, GASTROENTEROLOGY, V125, P1341, DOI 10.1016/j.gastro.2003.07.004; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JP, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.353; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu CT, 1996, P NATL ACAD SCI USA, V93, P11831, DOI 10.1073/pnas.93.21.11831; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McDermott E, 2016, J CROHNS COLITIS, V10, P77, DOI 10.1093/ecco-jcc/jjv176; MUNDSCHAU LJ, 1994, J BIOL CHEM, V269, P16137; Neumann E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3010; Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912; O'Reilly S, 2017, MOL ASPECTS MED, V54, P89, DOI 10.1016/j.mam.2016.10.001; Oda K, 2016, RESP RES RESP RES, V17, P1, DOI [10.1186/S12931-015-0319-Y, DOI 10.1186/S12931-015-0319-Y]; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Peters TJ, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-6; Polytarchou C, 2014, CURR OPIN GASTROEN, V30, P339, DOI 10.1097/MOG.0000000000000081; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rieder F, 2014, J CROHNS COLITIS, V8, P1166, DOI 10.1016/j.crohns.2014.03.009; Rieder F, 2013, DIGEST DIS, V31, P186, DOI 10.1159/000353364; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sadler T, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0193-6; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931; Schultze JL, 2016, EUR J IMMUNOL, V46, P1838, DOI 10.1002/eji.201646545; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Shimbori C, 2016, J PATHOL, V240, P197, DOI 10.1002/path.4768; Simon JM, 2016, EUR J IMMUNOL, V46, P1912, DOI 10.1002/eji.201546237; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stylianou E, 2013, CURR OPIN GASTROEN, V29, P370, DOI 10.1097/MOG.0b013e328360bd12; Swiss VA, 2010, GLIA, V58, P377, DOI 10.1002/glia.20933; Tarling EJ, 2017, J CLIN INVEST, V127, P3741, DOI 10.1172/JCI94029; Tashiro E, 2003, ONCOGENE, V22, P5630, DOI 10.1038/sj.onc.1206636; van Iterson M, 2014, BIOINFORMATICS, V30, P3435, DOI 10.1093/bioinformatics/btu566; Vitek L, 2015, INFLAMM BOWEL DIS, V21, P476, DOI 10.1097/MIB.0000000000000193; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu MH, 2009, AM J PATHOL, V175, P1041, DOI 10.2353/ajpath.2009.090241; Wu Z, 2011, ONCOGENE, V30, P3979, DOI 10.1038/onc.2011.129; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yeo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027231; Yim AYFL, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0230-5; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yu W, 2012, INFLAMMATION, V35, P889, DOI 10.1007/s10753-011-9390-9; Yu W, 2010, DIGEST DIS SCI, V55, P3171, DOI 10.1007/s10620-010-1138-0; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121; Zhou WD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw967	100	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209656	10.1371/journal.pone.0209656	http://dx.doi.org/10.1371/journal.pone.0209656			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589872	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200040
J	Jackson, M; Owens, MS; Cornwell, JC; Kellogg, ML				Jackson, Melanie; Owens, Michael S.; Cornwell, Jeffrey C.; Kellogg, M. Lisa			Comparison of methods for determining biogeochemical fluxes from a restored oyster reef	PLOS ONE			English	Article							CHESAPEAKE BAY; DENITRIFICATION; NITRIFICATION; REMOVAL; NITRATE; WATER; EUTROPHICATION; BIODEPOSITION; ECOSYSTEMS; HYPOXIA	Oyster reef restoration can significantly increase benthic denitrification rates. Methods applied to measure nutrient fluxes and denitrification from oyster reefs in previous studies include incubations of sediment cores collected adjacent to oyster clumps, benthic chambers filled with intact reef segments that have undergone in situ equilibration and ex situ incubation, and cores with single oysters. However, fluxes of nutrients vary by orders of magnitude among oyster reefs and methods. This study compares two methods of measuring nutrient and metabolic fluxes on restored oyster reefs: incubations including intact segments of oyster reef and incubations containing oyster clumps without underlying sediments. Fluxes of oxygen (O-2), dissolved inorganic carbon (DIC), ammonium (NH4+), combined nitrate and nitrite (NO2/3-), di-nitrogen (N-2), and soluble reactive phosphorus (SRP) were determined in June and August in Harris Creek, a tributary of the Chesapeake Bay, Maryland, USA. Regression of fluxes measured from clumps alone against those measured from intact reef segments showed significant positive relationships for O-2, DIC, NH4+, and SRP (R-2 = 0.920, 0.61, 0.26, and 0.52, respectively). Regression of clump fluxes against the oyster tissue biomass indicates significant positive relationships for O-2 and NH4+, marginally significant and positive relationships for DIC and N-2, and no significant relationship for NO2/3- or SRP. Although these results demonstrate that the incubation of oyster clumps without underlying sediments does not accurately represent biogeochemical fluxes measured from the whole oyster and sediment community, this work supports the need to understand the balance between the metabolism of oysters and local sediments to correctly estimate biogeochemical rates.	[Jackson, Melanie; Owens, Michael S.; Cornwell, Jeffrey C.] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA; [Kellogg, M. Lisa] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	University System of Maryland; University of Maryland Center for Environmental Science; William & Mary; Virginia Institute of Marine Science	Jackson, M (corresponding author), Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA.	mjackson@umces.edu	Cornwell, Jeffrey/R-5506-2016	Cornwell, Jeffrey/0000-0001-7111-2489	National Science Foundation [1427019]; National Oceanic and Atmospheric Administration [NA14NMF4570275]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	MJ, MSO, and JCC were supported by the National Science Foundation (grant number 1427019; https://www.nsf.gov/awardsearch/showAward?AWD_ID=1427019.Further support for JCC, MO, and MLK from the National Oceanic and Atmospheric Administration (grant number NA14NMF4570275; https://chesapeakebay.noaa.gov/monitoring-and-research/noaa-chesapeakebay-office-funded-research).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfken A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185071; Bahr L. M., 1974, THESIS; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; BOUCHER G, 1988, MAR ECOL PROG SER, V44, P229, DOI 10.3354/meps044229; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Burkholder JM, 2011, SHELLFISH AQUACULTURE AND THE ENVIRONMENT, P155; Caffrey JM, 2016, MAR POLLUT BULL, V112, P86, DOI 10.1016/j.marpolbul.2016.08.038; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Cornwell JC, 2016, OYSTER BMP EXPERT PA, P1; Cornwell Jeffrey C., 1999, Aquatic Ecology, V33, P41, DOI 10.1023/A:1009921414151; DAME RF, 1984, J EXP MAR BIOL ECOL, V83, P239, DOI 10.1016/S0022-0981(84)80003-9; DAME RF, 1992, J EXP MAR BIOL ECOL, V164, P147, DOI 10.1016/0022-0981(92)90171-6; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Green DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048410; Grizzle RE, 2008, ESTUAR COAST, V31, P1208, DOI 10.1007/s12237-008-9098-8; Hagy JD, 2004, ESTUARIES, V27, P634, DOI 10.1007/BF02907650; Hardison AK, 2015, GEOCHIM COSMOCHIM AC, V164, P146, DOI 10.1016/j.gca.2015.04.049; Henriksen K, NITROGEN CYCLING COA; Hoellein TJ, 2015, BIOGEOCHEMISTRY, V122, P113, DOI 10.1007/s10533-014-0034-7; Holyoke RR, 2008, THESIS; Humphries AT, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00074; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Newell RIE, 2005, NATO SCI S SS IV EAR, V47, P93; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Nizzoli D, 2007, ESTUAR COAST SHELF S, V75, P125, DOI 10.1016/j.ecss.2007.03.035; NOAA (National Oceanic and Atmospheric Administration), 2016, AN MON DAT HARR CREE; Paerl HW, 2018, ENVIRON SCI TECHNOL, V52, P5519, DOI 10.1021/acs.est.7b05950; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Piehler MF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00082.1; R Development Core Team, 2015, R LANG ENV STAT COMP; RISGAARDPEDERSEN N, 1994, LIMNOL OCEANOGR, V39, P573, DOI 10.4319/lo.1994.39.3.0573; Rodney WS, 2006, J EXP MAR BIOL ECOL, V335, P39, DOI 10.1016/j.jembe.2006.02.017; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Smyth AR, 2018, ESTUAR COAST, V41, P1147, DOI 10.1007/s12237-017-0344-9; Smyth AR, 2015, J APPL ECOL, V52, P716, DOI 10.1111/1365-2664.12435; Smyth AR, 2013, MAR ECOL PROG SER, V493, P23, DOI 10.3354/meps10516; Tiedje J. M., 1998, BIOL ANAEROBIC MICRO, P179; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Welsh DT, 2004, MAR BIOL, V144, P1029, DOI 10.1007/s00227-003-1252-z; Westbrook PT, 2016, THESIS; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161	46	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209799	10.1371/journal.pone.0209799	http://dx.doi.org/10.1371/journal.pone.0209799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586465	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400095
J	Liao, CW; Fuh, LJ; Shen, YW; Huang, HL; Kuo, CW; Tsai, MT; Hsu, JT				Liao, Che-Wei; Fuh, Lih-Jyh; Shen, Yen-Wen; Huang, Heng-Li; Kuo, Chih-Wei; Tsai, Ming-Tzu; Hsu, Jui-Ting			Self-assembled micro-computed tomography for dental education	PLOS ONE			English	Article							CT; RECONSTRUCTION; ROOT	This study used available or purchased equipment and an image reconstruction system developed by the college of dentistry to establish a basic self-assembled micro-computed tomography (micro-CT) system. Such a system would be suitable for teaching dental radiology to dental students. Specifically, it could help students to understand the principles governing dental cone-beam computed tomography (CBCT) and provide graduate students with a system for scanning small samples (e.g., individual teeth) during the early stages of research. The self-assembled micro-CT system was constructed using a portable dental Xray tube, an intraoral digital X-ray detector, a high-precision rotation stage, related bracket accessories, and a notebook computer. Reconstructed images and three-dimensional models of the maxillary right third molar were produced using the self-assembled micro-CT system and an advanced commercially available micro-CT system (Skyscan 2211). Subsequently, the reconstructed images and 3D models produced using the two systems were compared by two senior dentists to determine whether considerable visual differences could be observed. Finally, the signal-to-noise ratio (SNR) was used for quantitative analysis and to compare the systems. Although the self-assembled micro-CT system produced image boundaries that were not as sharp as those of Skyscan 2211, the images were nonetheless remarkably similar. In addition, the two micro-CT systems produced 3D models that were almost identical in appearance and root canal shape. Quantitative analysis revealed that Skyscan 2211 had produced a SNR that was superior to that of the self-assembled micro-CT system, with the difference ranging from 36.77% to 136.22%; enamel, which has a higher density, exhibited lower SNR differences, whereas dentin, which has a lower density, exhibited higher SNR differences. The self-assembled micro-CT system with a resolution of 36 mu m was created using a portable dental X-ray tube and an intraoral digital X-ray detector. Although the scanning time was relatively long (similar to 30 min to scan images of a tooth), the images were adequate in the preliminary stage of experiments. More importantly, students were afforded the opportunity to observe the process of assembling and disassembling each component of a micro-CT scanner and thereby achieve a more comprehensive understanding of the principles governing micro-CT and dental CBCT.	[Liao, Che-Wei] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Fuh, Lih-Jyh; Shen, Yen-Wen; Huang, Heng-Li; Hsu, Jui-Ting] China Med Univ, Sch Dent, Coll Dent, Taichung, Taiwan; [Fuh, Lih-Jyh; Shen, Yen-Wen] China Med Univ & Hosp, Dept Dent, Taichung, Taiwan; [Huang, Heng-Li; Hsu, Jui-Ting] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Kuo, Chih-Wei] Natl Chung Shan Inst Sci & Technol, Mat & Electroopt Res Div, Taoyuan, Taiwan; [Tsai, Ming-Tzu] Hungkuang Univ, Dept Biomed Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Hungkuang University	Hsu, JT (corresponding author), China Med Univ, Sch Dent, Coll Dent, Taichung, Taiwan.; Hsu, JT (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	jthsu@mail.cmu.edu.tw	Fuh, Lih-Jyh/D-1484-2012; Tsai, Ming-Tzu/GSM-9284-2022; Hsu, Jui-Ting/I-8224-2012	Fuh, Lih-Jyh/0000-0003-3008-8165; Hsu, Jui-Ting/0000-0002-5533-2059	National Chung-Shan Institute of Science and Technology [NCSIST-442-V101(107)]; China Medical University, Taiwan [CMU106-S-07]	National Chung-Shan Institute of Science and Technology; China Medical University, Taiwan(China Medical University)	This study was partly supported by the National Chung-Shan Institute of Science and Technology [NCSIST-442-V101(107)] and China Medical University, Taiwan (CMU106-S-07) to JTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen YJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1530-4; de Oliveira Jr JM, 2009, AIP C P; du Plessis A, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix027; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; Hsiao-Mei Fu, 2006, Biomedical Engineering, Applications Basis Communications, V18, P270; Hsu PY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154367; Huang HL, 2013, CLIN ORAL INVEST, V17, P535, DOI 10.1007/s00784-012-0725-1; Johnson RH, 1998, PHYS MED BIOL, V43, P929, DOI 10.1088/0031-9155/43/4/020; Keles A, 2017, J ENDODONT, V43, P481, DOI 10.1016/j.joen.2016.10.045; Li J, 2013, J ENDODONT, V39, P265, DOI 10.1016/j.joen.2012.10.003; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Phan CM, 2006, RADIOLOGY, V239, P488, DOI 10.1148/radiol.2392050574; Vaquero JJ, 2008, IEEE T NUCL SCI, V55, P898, DOI 10.1109/TNS.2008.922814; Vaquero Lopez JJ, 2006, DESIGN DEV HIGH PERF; Wolkowski B, 2015, J SYNCHROTRON RADIAT, V22, P1130, DOI 10.1107/S1600577515008437; Zhou H, 2010, INT J RADIAT ONCOL, V78, P297, DOI 10.1016/j.ijrobp.2009.11.008; Zhu S, 2009, J BIOMEDICAL IMAGING, V2009, P16	18	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209698	10.1371/journal.pone.0209698	http://dx.doi.org/10.1371/journal.pone.0209698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586444	gold, Green Submitted, Green Published			2022-12-26	WOS:000454416400086
J	Marcos, FCC; Silveira, NM; Marchiori, PER; Machado, EC; Souza, GM; Landell, MGA; Ribeiro, RV				Marcos, Fernanda C. C.; Silveira, Neidiquele M.; Marchiori, Paulo E. R.; Machado, Eduardo C.; Souza, Gustavo M.; Landell, Marcos G. A.; Ribeiro, Rafael V.			Drought tolerance of sugarcane propagules is improved when origin material faces water deficit	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; STRESS TOLERANCE; RESPONSES; PLANTS; ACCLIMATION; PHOTOSYNTHESIS; PEROXIDASE; RESISTANCE; MEMORY	Drought stress can imprint marks in plants after a previous exposure, leading to plant acclimation and a permissive state that facilitates a more effective response to subsequent stress events. Such stress imprints would benefit plants obtained through vegetative propagation (propagules). Herein, our hypothesis was that the propagules obtained from plants previously exposed to water deficit would perform better under water deficit as compared to those obtained from plants that did not face stressful conditions. Sugarcane plants were grown under well-hydrated conditions or subjected to three cycles of water deficit by water withholding. Then, the propagules were subjected to water deficit. Leaf gas exchange was reduced under water deficit and the propagules from plants that experienced water deficit presented a faster recovery of CO2 assimilation and higher instantaneous carboxylation efficiency after rehydration as compared to the propagules from plants that never faced water deficit. The propagules from plants that faced water deficit also showed the highest leaf proline concentration under water deficit as well as higher leaf H2O2 concentration and leaf ascorbate peroxidase activity regardless of water regime. Under well-watered conditions, the propagules from plants that faced stressful conditions presented higher root H2O2 concentration and higher activity of catalase in roots as compared to the ones from plants that did not experience water shortage. Such physiological changes were associated with improvements in leaf area and shoot and root dry matter accumulation in propagules obtained from stressed plants. Our results suggest that root H2O2 concentration is a chemical signal associated with improved sugarcane performance under water deficit. Taken together, our findings bring a new perspective to the sugarcane production systems, in which plant acclimation can be explored for improving drought tolerance in rainfed areas.	[Marcos, Fernanda C. C.; Ribeiro, Rafael V.] Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, Lab Crop Physiol, Campinas, SP, Brazil; [Silveira, Neidiquele M.; Machado, Eduardo C.] Agron Inst IAC, Lab Plant Physiol Coaracy M Franco, Ctr Res & Dev Ecophysiol & Biophys, Campinas, SP, Brazil; [Marchiori, Paulo E. R.] Fed Univ Lavras UFLA, Dept Biol, Lavras, MG, Brazil; [Souza, Gustavo M.] Fed Univ Pelotas UFPel, Inst Biol, Dept Bot, Pelotas, RS, Brazil; [Landell, Marcos G. A.] IAC, Sugarcane Res Ctr, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Universidade Federal de Lavras; Universidade Federal de Pelotas; Instituto Agronomico de Campinas (IAC)	Ribeiro, RV (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Plant Biol, Lab Crop Physiol, Campinas, SP, Brazil.	rvr@unicamp.br	Ribeiro, Rafael V/C-5521-2012; Machado, Eduardo C/A-2026-2013; Marchiori, Paulo Eduardo/AAM-1920-2020; Ribeiro, Rafael Vasconcelos/L-1929-2013; Marchiori, Paulo Eduardo R/C-6658-2015; Silveira, Neidiquele/AAF-8046-2019; Souza, Gustavo Maia/M-2661-2013	Marchiori, Paulo Eduardo/0000-0001-9767-9336; Marchiori, Paulo Eduardo R/0000-0001-9767-9336; Silveira, Neidiquele/0000-0003-2663-918X; Souza, Gustavo Maia/0000-0001-6754-4860; Ribeiro, Rafael/0000-0002-1148-6777	National Council for Scientific and Technological Development (CNPq, Brazil) [303732/2015-6, 303695/2015-3, 305221/2014-0]; Coordination for the Improvement of Higher Education Personnel [001]; FAPESP [2012/19167-0]; Sao Paulo Research Foundation (FAPESP, BIOEN Program, Brazil) [2008/57495-3]	National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP, BIOEN Program, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors acknowledge the studentships and fellowships granted by the National Council for Scientific and Technological Development (CNPq, Brazil; www.cnpq.br, Grants no. 303732/2015-6;303695/2015-3; 305221/2014-0; ECM, GMS and RVR), the Coordination for the Improvement of Higher Education Personnel (www.capes.gov.br; Grant 001; FCCM and PERM) and FAPESP (Grant no. 2012/19167-0; NMS and RVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This research was financed by the Sao Paulo Research Foundation (FAPESP, BIOEN Program, Brazil; www.fapesp.br; Grant no. 2008/57495-3, ECM and RVR).	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; BIELESKI RL, 1966, ANAL BIOCHEM, V17, P278, DOI 10.1016/0003-2697(66)90206-5; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Bresta P, 2018, FUNCT PLANT BIOL, V45, P1181, DOI [10.1071/FP17283, 10.1071/fp17283]; Brestic M., 2013, MOL STRESS PHYSL PLA, P87, DOI DOI 10.1007/978-81-322-0807-5_4; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Dias FL, 1975, SUMMA PHYTOPATHOL, V1, P231; DING Y, 2012, NAT COMMUN, V3; DODD RS, 2016, FRONT ECOL EVOL, V4; Dos Santos H.G., 2013, SISTEMA BRASILEIRO C, V3a; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EDWARDS GE, 1993, PHOTOSYNTH RES, V37, P89, DOI 10.1007/BF02187468; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Galle A, 2011, J EXP BOT, V62, P5207, DOI 10.1093/jxb/err233; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; HAVIR EA, 1987, PLANT PHYSIOL, V84, P450, DOI 10.1104/pp.84.2.450; Hu T, 2016, PHYSIOL PLANTARUM, V156, P54, DOI 10.1111/ppl.12342; Izanloo A, 2008, J EXP BOT, V59, P3327, DOI 10.1093/jxb/ern199; Latzel V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01354; Marcos FCC, 2018, J PLANT PHYSIOL, V223, P9, DOI 10.1016/j.jplph.2018.02.001; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Peng H, 2009, PROG NAT SCI-MATER, V19, P1037, DOI 10.1016/j.pnsc.2008.10.014; Rena A. B., 1976, Revista Ceres, V23, P288; Ribeiro RV, 2013, EXP AGR, V49, P212, DOI 10.1017/S0014479712001263; Sales CRG, 2015, PHOTOSYNTHETICA, V53, P547, DOI 10.1007/s11099-015-0146-x; Sales CRG, 2013, PLANT PHYSIOL BIOCH, V73, P326, DOI 10.1016/j.plaphy.2013.10.012; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Thellier M, 2013, PLANT BIOLOGY, V15, P1, DOI 10.1111/j.1438-8677.2012.00674.x; VANHANDEL E, 1968, ANAL BIOCHEM, V22, P280, DOI 10.1016/0003-2697(68)90317-5; Amaral Lourdes Isabel Velho do, 2007, Hoehnea, V34, P425; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Walter J, 2013, ENVIRON EXP BOT, V94, P3, DOI 10.1016/j.envexpbot.2012.02.009; WEATHERLEY P. E., 1950, NEW PHYTOL, V49, P81, DOI 10.1111/j.1469-8137.1950.tb05146.x; Yordanov I, 2000, PHOTOSYNTHETICA, V38, P171, DOI 10.1023/A:1007201411474	38	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0206716	10.1371/journal.pone.0206716	http://dx.doi.org/10.1371/journal.pone.0206716			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586361	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400005
J	Renema, W				Renema, Willem			Morphological diversity in the foraminiferal genus Marginopora	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BENTHIC FORAMINIFERA; EVOLUTION; ECOLOGY	Benthic foraminifera, and certainly symbiont-bearing (large) benthic foraminifera are generally considered to have large geographic ranges in combination with significant ecomorphological variation. With the advance of molecular phylogenetic approaches, supported or preceded by detailed morphological studies, it was demonstrated that this view needs to be reevaluated. In this paper I evaluate the morphology of five Marginopora populations from around the Coral Sea by microCT-scanning. I argue that ecomorphological and ontogenetic variation is smaller than geographic variation in morphology. This forms the basis for the description of three new species, M. santoensis nov. spec., M. charlottensis nov. spec., M. orpheusensis nov. spec. Quantitative morphological variation between M. rossi, M. orpheusensis nov. spec. and M. charlottensis nov. spec. is overlapping, but each species has unique morphological characters supporting recognition as new species. Support to distinguish the deep living (M. rossi, M. charlottensis nov. spec., M. orpheusensis nov. spec.) and shallow living (M. vertebralis) Marginopora populations as separate species is strong, but not enough molecular phylogenetic data are available to test the three new deep-living species on the Great Barrier Reef hypothesis. However, detailed understanding of ecophenotypic variation in M. santoensis nov. spec. supports the conclusion that it is unlikely that ecophenotypic variation can explain the morphological variation between the three species. I argue that the number of species in this genus is underestimated, and that there are at least five species in the Coral Sea area alone.	[Renema, Willem] Nat Biodivers Ctr, Leiden, Netherlands	Naturalis Biodiversity Center	Renema, W (corresponding author), Nat Biodivers Ctr, Leiden, Netherlands.	Willem.renema@naturalis.nl	Renema, Willem/E-2851-2016	Renema, Willem/0000-0002-1627-5995				Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Beavington-Penney SJ, 2004, EARTH-SCI REV, V67, P219, DOI 10.1016/j.earscirev.2004.02.005; BENZIE JAH, 1991, J FORAMIN RES, V21, P222, DOI 10.2113/gsjfr.21.3.222; Davies P, 1994, AUSTR GEOLOGIST, V92, P21; de Blainville HMD, 1830, MANUEL ACTINOLOGIE Z; dOrbigny A., 1826, ANN SCI NATURELLES, V7, P245; Ehrenberg C.G., 1839, ABHANDLUNGEN KONIGLI, P59; Garcia-Cuetos L, 2005, PROTIST, V156, P399, DOI 10.1016/j.protis.2005.08.003; GUDMUNDSSON G, 1994, MICROPALEONTOLOGY, V40, P101, DOI 10.2307/1485772; Gupta BKS, 1999, SYSTEMATICS MODERN F, P7; HALLOCK P, 1986, J FORAMIN RES, V16, P224, DOI 10.2113/gsjfr.16.3.224; Holzmann M, 2003, J FORAMIN RES, V33, P277, DOI 10.2113/0330277; Holzmann M, 2001, MAR MICROPALEONTOL, V43, P57, DOI 10.1016/S0377-8398(01)00021-4; HOTTINGER L., 2006, ILLUSTRATED GLOSSARY; Langer MR, 2001, MICROPALEONTOLOGY, V46, P105; Lee JJ, 2004, MICROPALEONTOLOGY, V50, P357, DOI 10.2113/50.4.357; Lee JJ, 2016, J FORAMIN RES, V46, P201, DOI 10.2113/gsjfr.46.2.201; Loeblich AR., 1987, FORAMINIFERAL GENERA; Ludt WB, 2015, J BIOGEOGR, V42, P25, DOI 10.1111/jbi.12416; Lukoschek V, 2016, MOL ECOL, V25, P3065, DOI 10.1111/mec.13649; Momigliano P, 2013, MAR ECOL PROG SER, V491, P33, DOI 10.3354/meps10465; Morard R, 2016, SYST BIOL; Pawlowski J, 2003, MAR MICROPALEONTOL, V100, P1; Pawlowski J, 2008, BIODIVERS CONSERV, V17, P317, DOI 10.1007/s10531-007-9253-8; Renema W, 2005, LETHAIA, V38, P137, DOI 10.1080/00241160510013259; Renema W, 2006, CORAL REEFS, V25, P351, DOI 10.1007/s00338-006-0119-4; ROSS CA, 1972, J PROTOZOOL, V19, P181, DOI 10.1111/j.1550-7408.1972.tb03433.x; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208158	10.1371/journal.pone.0208158	http://dx.doi.org/10.1371/journal.pone.0208158			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586401	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400011
J	Gu, LL; Ye, P; Li, HL; Wang, Y; Xu, YQ; Tian, QH; Lei, GX; Zhao, C; Gao, Z; Zhao, WF; Tan, SH				Gu, Lili; Ye, Pei; Li, Hengli; Wang, Yue; Xu, Yaqiong; Tian, Qinghua; Lei, Gaoxin; Zhao, Cheng; Gao, Zhan; Zhao, Wenfeng; Tan, Shuhua			Lunasin attenuates oxidant-induced endothelial injury and inhibits atherosclerotic plaque progression in ApoE(-/-) mice by up-regulating heme oxygenase-1 via PI3K/Akt/Nrf2/ARE pathway	FASEB JOURNAL			English	Article						atherosclerosis; endothelium; oxidative stress	OXIDATIVE STRESS; PEPTIDE LUNASIN; DYSFUNCTION; MECHANISMS; APOPTOSIS	Oxidative stress-induced vascular endothelial cell (VEC) injury is a major mechanism in the initiation and development of atherosclerosis. Lunasin, a soybean-derived 43-aa peptide, has been previously shown to possess potent antioxidant and anti-inflammatory activities other than its established anticancer activities. This study investigated the effects of lunasin on protecting VECs from oxidative damage and inhibiting atherosclerotic plaque progression in apolipoprotein E-deficient (ApoE(-/-)) mice and explored its underlying mechanism. Biochemical and histologic analyses were performed by using EA.hy926 human VECs and a high-fat diet (HFD) ApoE(-/-) mouse atherosclerosis model. Our data indicated that lunasin attenuated H2O2-induced, mitochondria-dependent endothelial apoptosis via down-regulating Bax and up-regulating Bcl-2, inhibiting the mitochondrial depolarization, and reducing the release of cytochrome c, as well as decreasing the activation of caspase-9 and caspase-3 invitro and invivo. Mechanic studies showed that lunasin significantly up-regulated heme oxygenase-1 via the PI3K/Akt/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway, and reduced H2O2-induced ROS production in VECs, thereby attenuating oxidant-induced endothelial injury and inhibiting atherosclerotic plaque progression in ApoE(-/-) mice. In conclusion, our in vitro and in vivo data suggest that lunasin protects VECs from oxidative damage by enhancing heme oxygenase-1 expression via activation of the PI3K/Akt/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway and inhibiting mitochondria-dependent apoptosis, thereby effectively attenuating atherosclerosis in HFD-fed ApoE(-/-) mice. Lunasin may act as a potential therapeutic agent for the prevention and treatment of atherosclerosis.	[Gu, Lili; Ye, Pei; Li, Hengli; Wang, Yue; Xu, Yaqiong; Tian, Qinghua; Lei, Gaoxin; Zhao, Cheng; Gao, Zhan; Zhao, Wenfeng; Tan, Shuhua] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, 211 Mailbox,24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University	Tan, SH (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, 211 Mailbox,24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China.	tanshuhua163@163.com		Tan, shuhua/0000-0002-4992-8876	National Fund for Major Projects of China [2009ZX09103-653, 2013ZX09301303-006, 2018ZX09301035]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Fund for Fostering Talents of Basic Science (NFFTBS) [3050040016]; China Pharmaceutical University Double First-Class project [CPU2018GY15]	National Fund for Major Projects of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Fund for Fostering Talents of Basic Science (NFFTBS); China Pharmaceutical University Double First-Class project	This work was supported by the National Fund for Major Projects of China (2009ZX09103-653; 2013ZX09301303-006; 2018ZX09301035), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National Fund for Fostering Talents of Basic Science (NFFTBS, 3050040016), and China Pharmaceutical University Double First-Class project (CPU2018GY15). The authors declare no conflicts of interest.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Ayer A, 2016, PHYSIOL REV, V96, P1449, DOI 10.1152/physrev.00003.2016; Azuma K, 2003, BIOCHEM BIOPH RES CO, V309, P384, DOI 10.1016/j.bbrc.2003.08.013; Bachschmid MM, 2013, ANN MED, V45, P17, DOI 10.3109/07853890.2011.645498; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Calay D, 2014, ANTIOXID REDOX SIGN, V20, P1789, DOI 10.1089/ars.2013.5659; Chen B, 2015, J ENDOCRINOL, V225, pR83, DOI 10.1530/JOE-14-0662; Daiber A, 2017, BRIT J PHARMACOL, V174, P1591, DOI 10.1111/bph.13517; Davis K., 2016, INT J CANC THER, V4, P1, DOI 10.14319/ijcto.42.18; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Fernandez-Tome S, 2014, FOOD RES INT, V62, P793, DOI 10.1016/j.foodres.2014.04.054; Goettsch C, 2011, BASIC RES CARDIOL, V106, P551, DOI 10.1007/s00395-011-0170-3; Hashimoto Y, 2003, EUR J CANCER, V39, P2239, DOI 10.1016/S0959-8049(03)00599-9; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; Hernandez-Ledesma B, 2009, PEPTIDES, V30, P426, DOI 10.1016/j.peptides.2008.11.002; Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005; Jensen HA, 2016, EXPERT REV CARDIOVAS, V14, P1021, DOI 10.1080/14779072.2016.1207527; Jeong JB, 2010, CANCER LETT, V293, P58, DOI 10.1016/j.canlet.2009.12.019; Garcia-Nebot MJ, 2014, FOOD CHEM TOXICOL, V65, P155, DOI 10.1016/j.fct.2013.12.021; Kattoor AJ, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0678-6; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Petrovic A, 2011, BIOTECH HISTOCHEM, V86, P429, DOI 10.3109/10520295.2010.528026; Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927; Schwendeman A, 2015, J LIPID RES, V56, P1727, DOI 10.1194/jlr.M060285; Shen HM, 2008, BRAIN RES BULL, V77, P274, DOI 10.1016/j.brainresbull.2008.08.002; Siasos G, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.06.21; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tian QH, 2017, PREP BIOCHEM BIOTECH, V47, P619, DOI 10.1080/10826068.2017.1286600; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Zhou CC, 2011, J LIPID RES, V52, P1483, DOI 10.1194/jlr.M014092	43	25	27	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4836	4850		10.1096/fj.201802251R	http://dx.doi.org/10.1096/fj.201802251R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601695	Bronze			2022-12-26	WOS:000462888500017
J	Tak, U; Vlach, J; Garza-Garcia, A; William, D; Danilchanka, O; de Carvalho, LPS; Saad, JS; Niederweis, M				Tak, Uday; Vlach, Jiri; Garza-Garcia, Acely; William, Doreen; Danilchanka, Olga; de Carvalho, Luiz Pedro Sorio; Saad, Jamil S.; Niederweis, Michael			The tuberculosis necrotizing toxin is an NAD(+) and NADP(+) glycohydrolase with distinct enzymatic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; tuberculosis; enzyme kinetics; enzyme mechanism; host-pathogen interaction	TRANSITION-STATE STRUCTURE; BACTERIAL PROTEIN TOXINS; PROGRESS CURVE ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; ADP-RIBOSYLATION; CELL-DEATH; MACROPHAGE; BINDING; HYDROLYSIS; MECHANISMS	Upon host infection, Mycobacterium tuberculosis secretes the tuberculosis necrotizing toxin (TNT) into the cytosol of infected macrophages, leading to host cell death by necroptosis. TNT hydrolyzes NAD(+) in the absence of any exogenous cofactor, thus classifying it as a -NAD(+) glycohydrolase. However, TNT lacks sequence similarity with other NAD(+) hydrolyzing enzymes and lacks the essential motifs involved in NAD(+) binding and hydrolysis by these enzymes. In this study, we used NMR to examine the enzymatic activity of TNT and found that TNT hydrolyzes NADP(+) as fast as NAD(+) but does not cleave the corresponding reduced dinucleotides. This activity of TNT was not inhibited by ADP-ribose or nicotinamide, indicating low affinity of TNT for these reaction products. A selection assay for nontoxic TNT variants in Escherichia coli identified four of six residues in the predicted NAD(+)-binding pocket and four glycine residues that form a cradle directly below the NAD(+)-binding site, a conserved feature in the TNT protein family. Site-directed mutagenesis of residues near the predicted NAD(+)-binding site revealed that Phe(727), Arg(757), and Arg(780) are essential for NAD(+) hydrolysis by TNT. These results identify the NAD(+)-binding site of TNT. Our findings also show that TNT is an NAD(+) glycohydrolase with properties distinct from those of other bacterial glycohydrolases. Because many of these residues are conserved within the TNT family, our findings provide insights into understanding the function of the >300 TNT homologs.	[Tak, Uday; Vlach, Jiri; William, Doreen; Danilchanka, Olga; Saad, Jamil S.; Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, BBRB 609,845 19th St S, Birmingham, AL 35205 USA; [Garza-Garcia, Acely; de Carvalho, Luiz Pedro Sorio] Francis Crick Inst, London NW1 1AT, England; [Vlach, Jiri] Univ Georgia, Athens, GA 30602 USA; [William, Doreen] Univ Rostock, D-18055 Rostock, Germany; [Danilchanka, Olga] Merck Exploratory Sci Ctr, Cambridge, MA 02141 USA	University of Alabama System; University of Alabama Birmingham; Francis Crick Institute; University System of Georgia; University of Georgia; University of Rostock	Niederweis, M (corresponding author), Univ Alabama Birmingham, Dept Microbiol, BBRB 609,845 19th St S, Birmingham, AL 35205 USA.	mnieder@uab.edu	William, Doreen/AHA-1288-2022	Vlach, Jiri/0000-0002-0874-2055; Saad, Jamil/0000-0001-9503-6484; Niederweis, Michael/0000-0003-4068-8092; Garza-Garcia, Acely/0000-0003-0307-0138; Tak, Uday/0000-0001-7907-3840	NCI, National Institutes of Health [P30 CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121354] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the comprehensive cancer center at the University of Alabama at Birmingham (funded by NCI, National Institutes of Health Grant P30 CA013148) for supporting the High-Field NMR facility.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; Berti PJ, 1997, J AM CHEM SOC, V119, P12079, DOI 10.1021/ja971317a; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Braun V, 2013, FEMS MICROBIOL LETT, V345, P13, DOI 10.1111/1574-6968.12180; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Cakir-Kiefer I, 2001, BIOCHEM J, V358, P399, DOI 10.1042/bj3580399; CAPARON M, 1988, REV INFECT DIS, V10, pS377; Danilchanka O, 2014, P NATL ACAD SCI USA, V111, P6750, DOI 10.1073/pnas.1400136111; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; DUGGLEBY RG, 1995, METHOD ENZYMOL, V249, P61; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Exnowitz F, 2012, BBA-PROTEINS PROTEOM, V1824, P443, DOI 10.1016/j.bbapap.2011.10.011; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; GALLOWAY TS, 1987, BIOCHEM J, V244, P225, DOI 10.1042/bj2440225; Ghosh J, 2010, J BIOL CHEM, V285, P5683, DOI 10.1074/jbc.M109.070300; GOPINATHAN KP, 1964, BIOCHEM J, V91, P277, DOI 10.1042/bj0910277; Goudar CT, 2012, MICROB ECOL, V63, P898, DOI 10.1007/s00248-011-9996-3; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Lebrun I, 2009, MINI-REV MED CHEM, V9, P820, DOI 10.2174/138955709788452603; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Meijers R, 2001, J BIOL CHEM, V276, P9316, DOI 10.1074/jbc.M010870200; Mozola CC, 2015, MOL MICROBIOL, V97, P1036, DOI 10.1111/mmi.13085; MULLERSTEFFNER HM, 1992, J BIOL CHEM, V267, P9606; Nambi S, 2015, CELL HOST MICROBE, V17, P829, DOI 10.1016/j.chom.2015.05.008; OPPENHEIMER NJ, 1994, MOL CELL BIOCHEM, V138, P245, DOI 10.1007/BF00928468; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pajuelo D, 2018, CELL REP, V24, P429, DOI 10.1016/j.celrep.2018.06.042; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Parikh SL, 2004, BIOCHEMISTRY-US, V43, P1204, DOI 10.1021/bi035907z; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Queval CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02284; Rajararna MVS, 2014, SEMIN IMMUNOL, V26, P471, DOI 10.1016/j.smim.2014.09.010; Riese MJ, 2002, J BIOL CHEM, V277, P12082, DOI 10.1074/jbc.M109039200; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Steinhauer K, 2010, APPL ENVIRON MICROB, V76, P546, DOI 10.1128/AEM.01660-09; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun J, 2015, NAT STRUCT MOL BIOL, V22, P672, DOI 10.1038/nsmb.3064; Tang JY, 2018, J BIOL CHEM, V293, P1504, DOI 10.1074/jbc.RA117.000178; VANDENBERG JI, 1986, ANAL BIOCHEM, V155, P38, DOI 10.1016/0003-2697(86)90221-6; VanderVen BC, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0025-2016; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	54	19	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3024	3036		10.1074/jbc.RA118.005832	http://dx.doi.org/10.1074/jbc.RA118.005832			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593509	Green Published, hybrid			2022-12-26	WOS:000464980100005
J	Mansouri, A; Abbes, C; Ben Mouhoub, R; Ben Hassine, S; Landoulsi, A				Mansouri, Ahlem; Abbes, Chiraz; Ben Mouhoub, Ramla; Ben Hassine, Sihem; Landoulsi, Ahmed			Enhancement of mixture pollutant biodegradation efficiency using a bacterial consortium under static magnetic field	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; GROWTH; DEGRADATION; DENITRIFICATION; ADSORBENTS; EXTRACTION; MEMBRANE; REMOVAL; PYRENE; SOILS	One of the main challenges of bioremediation is to define efficient protocols with low environmental impact and high removal rates, such as static magnetic field (SMF). The aim of this study was to evaluate the effect of SMF exposure on the biodegradation rate of a mixture of pollutants using three bacterial strains which were isolated and identified from the Bizerte lagoon: Pseudomonas stutzeri LBR (KC157911), Cupriavidus metallidurans LBJ (KU659610) and Rhodococcus equi LBB (KU743870). To recognize the improvement role of SMF, the culture was submitted to a pre-treatment with SMF with an induction equal to 200 mT for 5 hours, after that the degradation experiment was followed with individual strains and with a consortium. Results showed an increase by 20% in the growth of the exposed bacterial population compared to controls, and 98% of biodegradation of DDT and 90% for BaP after 30 days of follow-up. This encouraging data opens new perspectives for a bioremediation bioprocess using SMF.	[Mansouri, Ahlem; Abbes, Chiraz; Ben Mouhoub, Ramla; Landoulsi, Ahmed] Univ Carthage, Biochem & Mol Biol Lab, Fac Sci, Risks Related Environm Stress Struggle & Prevent, Bizerte, Zarzouna, Tunisia; [Ben Hassine, Sihem] Univ Carthage, Fac Sci Bizerte, Analyt Environm Chem Lab, Zarzouna, Tunisia	Universite de Carthage; Universite de Carthage	Mansouri, A (corresponding author), Univ Carthage, Biochem & Mol Biol Lab, Fac Sci, Risks Related Environm Stress Struggle & Prevent, Bizerte, Zarzouna, Tunisia.	Mansouri.ahlem87@gmail.com		abbes, chiraz/0000-0001-8150-163X; Landoulsi, Ahmed/0000-0002-5101-7641	Tunisian Ministry of Higher Education and Scientific Research [547]	Tunisian Ministry of Higher Education and Scientific Research	This work was supported by the Tunisian Ministry of Higher Education and Scientific Research, Grant 547.	Bajaj A, 2014, BIORESOURCE TECHNOL, V167, P398, DOI 10.1016/j.biortech.2014.06.007; Ben Garali A, 2010, ARAB J GEOSCI, V3, P295, DOI 10.1007/s12517-009-0082-9; Ben Said O, 2008, J APPL MICROBIOL, V104, P987, DOI 10.1111/j.1365-2672.2007.03621.x; Bouchez-Naitali M, 2001, MICROBIOL-SGM, V147, P2537, DOI 10.1099/00221287-147-9-2537; Filipic J, 2012, BIORESOURCE TECHNOL, V120, P225, DOI 10.1016/j.biortech.2012.06.023; Fojt L, 2007, BIOELECTROCHEMISTRY, V70, P91, DOI 10.1016/j.bioelechem.2006.03.023; Gu H.B., 2018, ENG SCI, V1, P46, DOI DOI 10.30919/ESPUB.ES.180308; Gu HB, 2018, POLYMER, V143, P324, DOI 10.1016/j.polymer.2018.04.008; Hajdu R, 2012, ENVIRON CHEM, V9, P389, DOI 10.1071/EN12015; Huang JN, 2017, IND ENG CHEM RES, V56, P10689, DOI 10.1021/acs.iecr.7b02835; Hunt RW, 2009, INT J MOL SCI, V10, P4515, DOI 10.3390/ijms10104515; Jirku V, 2006, MODERN MULTIDISCIPLI, P561, DOI 10.1002/9783527611904.ch99/summary; Jones MD, 2014, ENVIRON ENG SCI, V31, P689, DOI 10.1089/ees.2014.0275; Kang HJ, 2018, SEP PURIF TECHNOL, V201, P193, DOI 10.1016/j.seppur.2018.03.002; Kriklavova L, 2014, BIORESOURCE TECHNOL, V167, P510, DOI 10.1016/j.biortech.2014.06.060; Manoli E, 2000, CHEMOSPHERE, V41, P1845, DOI 10.1016/S0045-6535(00)00134-X; Mansouri A, 2017, MICROB PATHOGENESIS, V113, P40, DOI 10.1016/j.micpath.2017.10.008; Mansouri A, 2017, APPL BIOCHEM BIOTECH, V181, P309, DOI 10.1007/s12010-016-2214-5; Mihoub M, 2012, INT J FOOD MICROBIOL, V157, P259, DOI 10.1016/j.ijfoodmicro.2012.05.017; Miyakoshi J, 2005, PROG BIOPHYS MOL BIO, V87, P213, DOI 10.1016/j.pbiomolbio.2004.08.008; Moscoso F, 2015, INT J ENVIRON SCI TE, V12, P1243, DOI 10.1007/s13762-014-0498-y; Niu C, 2013, BIORESOURCE TECHNOL, V150, P156, DOI 10.1016/j.biortech.2013.08.139; Olaniran AO, 2013, INT J MOL SCI, V14, P10197, DOI 10.3390/ijms140510197; Potenza L, 2004, MUTAT RES-GEN TOX EN, V561, P53, DOI 10.1016/j.mrgentox.2004.03.009; Song M, 2015, APPL ENVIRON MICROB, V81, P7368, DOI 10.1128/AEM.01983-15; Song XH, 2011, MAR POLLUT BULL, V62, P2122, DOI 10.1016/j.marpolbul.2011.07.013; Takagai Y, 2001, ANALYST, V126, P551, DOI 10.1039/b102079j; Thavamani P, 2012, BIODEGRADATION, V23, P823, DOI 10.1007/s10532-012-9572-7; Thavamani P, 2011, ENVIRON INT, V37, P184, DOI 10.1016/j.envint.2010.08.017; Trabelsi S, 2005, MAR POLLUT BULL, V50, P344, DOI 10.1016/j.marpolbul.2004.11.031; WALTER U, 1991, APPL MICROBIOL BIOT, V34, P671, DOI 10.1007/BF00167921; Wei HG, 2018, ADV COMPOS HYBRID MA, V1, P127, DOI 10.1007/s42114-017-0003-4; Ye DY, 1996, ENVIRON SCI TECHNOL, V30, P136, DOI 10.1021/es9501878; Yoshida M., 2004, STUDY ENV POLLUTION, P31; Yu GQ, 2018, ADV COMPOS HYBRID MA, V1, P56, DOI 10.1007/s42114-017-0004-3; Zaidi NS, 2014, SEP PURIF REV, V43, P206, DOI 10.1080/15422119.2013.794148; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zhang L, 2017, J ELECTROCHEM SOC, V164, pF610, DOI 10.1149/2.1101706jes; Zhou QX, 2006, J CHROMATOGR A, V1125, P152, DOI 10.1016/j.chroma.2006.05.047	39	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0208431	10.1371/journal.pone.0208431	http://dx.doi.org/10.1371/journal.pone.0208431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608939	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800011
J	Yoshino, T; Miyazaki, J; Kojima, T; Kandori, S; Shiga, M; Kawahara, T; Kimura, T; Naka, T; Kiyohara, H; Watanabe, M; Yamasaki, S; Akaza, H; Yano, I; Nishiyama, H				Yoshino, Takayuki; Miyazaki, Jun; Kojima, Takahiro; Kandori, Shuya; Shiga, Masanobu; Kawahara, Takashi; Kimura, Tomokazu; Naka, Takashi; Kiyohara, Hideyasu; Watanabe, Miyuki; Yamasaki, Sho; Akaza, Hideyuki; Yano, Ikuya; Nishiyama, Hiroyuki			Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model	PLOS ONE			English	Article							CELL-WALL SKELETON; CORD FACTOR; TREHALOSE 6,6'-DIMYCOLATE; ANTIGEN PRESENTATION; BCG INTERNALIZATION; T-CELLS; TUBERCULOSIS; IMMUNOTHERAPY; CARCINOMA; THERAPY	Intravesical therapy using Mycobacterium bovis bacillus Calmette-Guerin (BCG) is the most established cancer immunotherapy for bladder cancer. However, its underlying mechanisms are unknown. Mycolic acid (MA), the most abundant lipid of the BCG cell wall, is suspected to be one of the essential active components of this immunogenicity. Here, we developed cationic liposomes incorporating three subclasses (alpha, keto, and methoxy) of MA purified separately from BCG, using the dendron-bearing lipid D22. The cationic liposomes using D22 were efficiently taken up by the murine bladder cancer cell line MB49 in vitro, but the non-cationic liposomes were not. Lip-kMA, a cationic liposome containing keto-MA, presented strong antitumor activity in two murine syngeneic graft models using the murine bladder cancer cell lines MB49 and MBT-2 in comparison to both Lip-aMA and Lip-mMA, which contained alpha-MA and methoxy-MA, respectively. Interestingly, Lip-kMA(D12), which was made of D12 instead of D22, did not exhibit antitumor activity in the murine syngeneic graft model using MB49 cells, although it was successfully taken up by MB49 cells in vitro. Histologically, compared to the number of infiltrating CD4 lymphocytes, the number of CD8 lymphocytes was higher in the tumors treated with Lip-kMA. Antitumor effects of Lip-kMA were not observed in nude mice, whereas weak but significant effects were observed in beige mice with natural killer activity deficiency. Thus, a cationized liposome containing keto-MA derived from BCG induced in vivo antitumor immunity. These findings will provide new insights into lipid immunogenicity and the underlying mechanisms of BCG immunotherapy.	[Yoshino, Takayuki; Kojima, Takahiro; Kandori, Shuya; Shiga, Masanobu; Kawahara, Takashi; Kimura, Tomokazu; Nishiyama, Hiroyuki] Univ Tsukuba, Fac Med, Dept Urol, Ibaraki, Japan; [Miyazaki, Jun] Int Univ Hlth & Welf, Dept Urol, Chiba, Japan; [Naka, Takashi] Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Dept Food & Nutr, Nara, Japan; [Kiyohara, Hideyasu] Japan BCG Lab, Kiyose, Japan; [Watanabe, Miyuki; Yamasaki, Sho] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Osaka, Japan; [Watanabe, Miyuki; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka, Fukuoka, Japan; [Yamasaki, Sho] Osaka Univ, Immunol Frontier Res Ctr, Dept Mol Immunol, Osaka, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba, Japan; [Akaza, Hideyuki] Univ Tokyo, Strateg Invest Comprehens Canc Network, Tokyo, Japan; [Yano, Ikuya] Osaka City Univ, Osaka, Japan	University of Tsukuba; International University of Health & Welfare; Osaka University; Kyushu University; Osaka University; Chiba University; University of Tokyo; Osaka Metropolitan University	Miyazaki, J (corresponding author), Int Univ Hlth & Welf, Dept Urol, Chiba, Japan.	jmiyazaki@iuhw.ac.jp	Miyazaki, Jun/HFZ-7703-2022; Kandori, Shuya/V-4257-2019	Kandori, Shuya/0000-0003-4621-8470	JSPS KAKENHI [24659710, 26462397, 17K11124, 26293349]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grants, nos. 24659710, 26462397, 17K11124 and 26293349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZUMA I, 1974, JNCI-J NATL CANCER I, V52, P95, DOI 10.1093/jnci/52.1.95; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDINGER B, 1993, APPL ENVIRON MICROB, V59, P3973, DOI 10.1128/AEM.59.11.3973-3977.1993; Bevers RFM, 1998, EUR CYTOKINE NETW, V9, P181; Brandau S, 2001, INT J CANCER, V92, P697, DOI 10.1002/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Coon BG, 2012, INT J CANCER, V131, P591, DOI 10.1002/ijc.26413; DEREIJKE TM, 1993, UROL RES, V21, P349, DOI 10.1007/BF00296835; Dkhar HK, 2014, J IMMUNOL, V193, P295, DOI 10.4049/jimmunol.1400092; Fujita Y, 2005, MICROBIOL-SGM, V151, P3403, DOI 10.1099/mic.0.28158-0; Groenewald W, 2014, CHEM PHYS LIPIDS, V180, P15, DOI 10.1016/j.chemphyslip.2013.12.004; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Higuchi T, 2009, CANCER IMMUNOL IMMUN, V58, P1245, DOI 10.1007/s00262-008-0643-x; Ikeda N, 2002, INT J UROL, V9, P29, DOI 10.1046/j.1442-2042.2002.00415.x; Ishikawa E, 2017, TRENDS IMMUNOL, V38, P66, DOI 10.1016/j.it.2016.10.009; Ito T, 2017, INT IMMUNOL, V29, P411, DOI 10.1093/intimm/dxx051; Iwashita S, 2012, J BIOMATER APPL, V27, P445, DOI 10.1177/0885328211411955; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Kawai K, 2013, CANCER SCI, V104, P22, DOI 10.1111/cas.12075; Korf J, 2005, EUR J IMMUNOL, V35, P890, DOI 10.1002/eji.200425332; Koya MP, 2006, J UROLOGY, V175, P2004, DOI 10.1016/S0022-5347(06)00264-3; Maksymowych WP, 2000, MICROBES INFECT, V2, P199, DOI 10.1016/S1286-4579(00)00268-9; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Minnikin DE, 2015, PATHOPHYSIOLOGICAL I; Miyazaki J, 2006, BJU INT, V97, P860, DOI 10.1111/j.1464-410X.2006.06026.x; Miyazaki J, 2013, JPN J CLIN ONCOL, V43, P827, DOI 10.1093/jjco/hyt086; Miyazaki J, 2011, ANTICANCER RES, V31, P2065; MORALES A, 1976, J UROLOGY, V116, P180, DOI 10.1016/S0022-5347(17)58737-6; Nakamura T, 2014, J CONTROL RELEASE, V176, P44, DOI 10.1016/j.jconrel.2013.12.027; Naoe M, 2007, INT J UROL, V14, P532, DOI 10.1111/j.1442-2042.2006.01697.x; Ozeki Y, 1997, INFECT IMMUN, V65, P1793, DOI 10.1128/IAI.65.5.1793-1799.1997; Poggi MM, 2000, UROL ONCOL, V5, P234, DOI 10.1016/S1078-1439(00)00074-0; PRYOR K, 1995, BRIT J CANCER, V71, P801, DOI 10.1038/bjc.1995.155; RATLIFF TL, 1987, J UROLOGY, V137, P155, DOI 10.1016/S0022-5347(17)43909-7; RATLIFF TL, 1993, J UROLOGY, V150, P1018, DOI 10.1016/S0022-5347(17)35678-1; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; RIBI E, 1976, ANN NY ACAD SCI, V277, P228, DOI 10.1111/j.1749-6632.1976.tb41700.x; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Siracusano S, 2007, EUR UROL, V51, P1589, DOI 10.1016/j.eururo.2006.11.045; Sonoda T, 2007, ONCOL REP, V17, P1469; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Suttmann H, 2006, CANCER RES, V66, P8250, DOI 10.1158/0008-5472.CAN-06-1416; Uenishi Y, 2008, J MICROBIOL METH, V72, P149, DOI 10.1016/j.mimet.2007.11.016; Van Rhijn I, 2017, EUR J IMMUNOL, V47, P1525, DOI 10.1002/eji.201747062; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005; Villeneuve M, 2007, BBA-BIOMEMBRANES, V1768, P1717, DOI 10.1016/j.bbamem.2007.04.003; Villeneuve M, 2013, MICROBIOL-SGM, V159, P2405, DOI 10.1099/mic.0.068866-0; Villeneuve M, 2010, CHEM PHYS LIPIDS, V163, P569, DOI 10.1016/j.chemphyslip.2010.04.010; Wang J, 2004, J IMMUNOL, V173, P4590, DOI 10.4049/jimmunol.173.7.4590; Yamada H, 2000, JPN J CANCER RES, V91, P534, DOI 10.1111/j.1349-7006.2000.tb00978.x; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001; Zhang GJ, 2000, J UROLOGY, V163, P1553, DOI 10.1016/S0022-5347(05)67678-1	55	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209196	10.1371/journal.pone.0209196	http://dx.doi.org/10.1371/journal.pone.0209196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608942	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800016
J	Liu, XH; Wan, SN; Shen, P; Qiu, YT; Sah, MK; Abdelrehem, A; Chen, MJ; Zhang, SY; Yang, C				Liu, Xiaohan; Wan, Shaonan; Shen, Pei; Qiu, Yating; Sah, Manoj Kumar; Abdelrehem, Ahmed; Chen, Minjie; Zhang, Shanyong; Yang, Chi			Diagnostic accuracy of synovial chondromatosis of the temporomandibular joint on magnetic resonance imaging	PLOS ONE			English	Article							LOOSE BODIES; OSTEOCHONDROMATOSIS; APPEARANCE; SURGERY	The purpose of this study was to evaluate the diagnostic accuracy of magnetic resonance imaging (MRI) for synovial chondromatosis (SC) of the temporomandibular joint (TMJ). In this study, 1415 patients (2109 joints) with temporomandibular joint disorders were collected between January 2012 and January 2017. All patients had a preoperative MRI examination and were treated by either arthroscopy or open surgery. On reviewing all MRI images, the number of "positive", "suspicious", and "negative" cases was collected afterwards, then the number of reported SC cases in operative data was recorded. The SPSS software was used to process all collected data. The kappa coefficient and ROC curve (AUC-index) with sensitivity and specificity were calculated to evaluate the consistency between MRI and arthroscopy/open surgery. Compared to 156 joints with SC detected by arthroscopy and open surgery, the results of MRI examination showed "positive" in 117 joints, and "negative" in 1938 joints. The number of "true positive", and "true negative" cases was 95, and 1897 respectively. The AUC-index was 0.86 (0.82-0.90) with a kappa coefficient of 0.74 (P < 0.05). In conclusion, the incidence of synovial chondromatosis diagnosed on MRI was in accordance with the arthroscopic and open surgery. Therefore, being a relatively non-invasive tool, MRI could be recommended as an effective diagnostic modality for SC.	[Liu, Xiaohan] Shanghai Jiao Tong Univ, Coll Stomatol, Sch Med, Shanghai, Peoples R China; [Liu, Xiaohan; Wan, Shaonan; Shen, Pei; Qiu, Yating; Sah, Manoj Kumar; Chen, Minjie; Zhang, Shanyong; Yang, Chi] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Dept Oral Surg, Sch Med, Shanghai, Peoples R China; [Abdelrehem, Ahmed] Alexandria Univ, Fac Dent, Dept Craniomaxillofacial & Plast Surg, Alexandria, Egypt; [Chen, Minjie; Zhang, Shanyong; Yang, Chi] Natl Clin Res Ctr Stomatol, Inst Stomatol, Shanghai Key Lab Stomatol & Shanghai Res, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Egyptian Knowledge Bank (EKB); Alexandria University	Chen, MJ; Zhang, SY; Yang, C (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Dept Oral Surg, Sch Med, Shanghai, Peoples R China.; Chen, MJ; Zhang, SY; Yang, C (corresponding author), Natl Clin Res Ctr Stomatol, Inst Stomatol, Shanghai Key Lab Stomatol & Shanghai Res, Shanghai, Peoples R China.	chenminjie00@126.com; zhangshanyong@126.com; yangchi63@hotmail.com	Sah, Manoj/P-3702-2019	Sah, Manoj/0000-0001-5023-1358	Youth Program of National Natural Science Foundation of China [81601915]; Science and Technology Commission of Shanghai [16411960900]; New Frontier Technology Joint Research Project of Shanghai [SHDC12017101]; Shanghai Summit & Plateau Disciplines, and the Municipality Science Research Project [JYLJ003]	Youth Program of National Natural Science Foundation of China; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); New Frontier Technology Joint Research Project of Shanghai; Shanghai Summit & Plateau Disciplines, and the Municipality Science Research Project	This study was supported by the Youth Program of National Natural Science Foundation of China (grant 81601915 awarded to Pei Shen), Science and Technology Commission of Shanghai Funding/Supporting (16411960900), The New Frontier Technology Joint Research Project of Shanghai (grant SHDC12017101 awarded to Dr. Chi Yang) and Shanghai Summit & Plateau Disciplines, and the Municipality Science Research Project (grant JYLJ003 awarded to Dr. Chi Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekian L, 2005, J ORAL MAXIL SURG, V63, P941, DOI 10.1016/j.joms.2005.03.009; AXHAUSEN G, 1952, Fortschr Kieferorthop, V13, P24, DOI 10.1007/BF02173195; Butt SH, 2005, SKELETAL RADIOL, V34, P707, DOI 10.1007/s00256-005-0946-3; Cai XY, 2012, J ORAL MAXIL SURG, V70, P2106, DOI 10.1016/j.joms.2011.09.043; CARLS FR, 1995, J CRANIO MAXILL SURG, V23, P215, DOI 10.1016/S1010-5182(05)80210-0; Chen MJ, 2015, J CRANIO MAXILL SURG, V43, P349, DOI 10.1016/j.jcms.2015.01.011; DOLAN EA, 1989, J ORAL MAXIL SURG, V47, P411, DOI 10.1016/0278-2391(89)90348-0; Durr HR, 2017, ORTHOPADE, V46, P498, DOI 10.1007/s00132-017-3427-1; DUNN EJ, 1974, J BONE JOINT SURG AM, VA 56, P811, DOI 10.2106/00004623-197456040-00017; Fujita S, 2004, BRIT J ORAL MAX SURG, V42, P259, DOI 10.1016/j.bjoms.2004.01.011; Holmlund AB, 2003, INT J ORAL MAX SURG, V32, P143, DOI 10.1054/ijom.2002.0300; Hopyan S, 2005, J PATHOL, V206, P143, DOI 10.1002/path.1761; Ikeda R, 2016, AM J ORTHOD DENTOFAC, V149, P39, DOI 10.1016/j.ajodo.2015.06.021; Kim HG, 2002, J OROFAC PAIN, V16, P148; Kim SH, 2002, KOREAN J RADIOL, V3, P254, DOI 10.3348/kjr.2002.3.4.254; KRAMER J, 1993, J COMPUT ASSIST TOMO, V17, P772, DOI 10.1097/00004728-199309000-00020; Leibur E, 2010, J CRANIO MAXILL SURG, V38, P615, DOI 10.1016/j.jcms.2010.02.003; MCCAIN JP, 1989, INT J ORAL MAX SURG, V18, P233, DOI 10.1016/S0901-5027(89)80060-8; MILGRAM JW, 1977, CLIN ORTHOP RELAT R, P282; Murphey MD, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275075116; SANTLER G, 1993, J CRANIO MAXILL SURG, V21, P284, DOI 10.1016/S1010-5182(05)80348-8; Sembronio S, 2008, BRIT J ORAL MAX SURG, V46, P582, DOI 10.1016/j.bjoms.2008.01.009; Shen P, 2014, J CRANIO MAXILL SURG, V42, P874, DOI 10.1016/j.jcms.2014.01.001; Sumida K, 2016, ACTA RADIOL OPEN, V5, DOI 10.1177/2058460115617352; Wilkes C H, 1990, Northwest Dent, V69, P25; WILKES CH, 1991, ARCH OTOLARYNGOL, V117, P64; Wong WC, 2001, CLIN RADIOL, V56, P773, DOI 10.1053/crad.2000.0462; Yura S, 2015, J CLIN DIAGN RES, V9, DOI 10.7860/JCDR/2015/12302.6260	28	16	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209739	10.1371/journal.pone.0209739	http://dx.doi.org/10.1371/journal.pone.0209739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605460	Green Submitted, Green Published, gold			2022-12-26	WOS:000454759900020
J	Delmas, GE; Lew, SE; Zanutto, BS				Delmas, Guillermo E.; Lew, Sergio E.; Silvano Zanutto, B.			High mutual cooperation rates in rats learning reciprocal altruism: The role of payoff matrix	PLOS ONE			English	Article							PRISONERS-DILEMMA; INCENTIVE THEORY; MODELS; EVOLUTION; FOOD; GAME	Cooperation is one of the most studied paradigms for the understanding of social interactions. Reciprocal altruism - a special type of cooperation that is taught by means of the iterated prisoner dilemma game (iPD)-has been shown to emerge in different species with different success rates. When playing iPD against a reciprocal opponent, the larger theoretical long-term reward is delivered when both players cooperate mutually. In this work, we trained rats in iPD against an opponent playing a Tit for Tat strategy, using a payoff matrix with positive and negative reinforcements, that is food and timeout respectively. We showed for the first time, that experimental rats were able to learn reciprocal altruism with a high average cooperation rate, where the most probable state was mutual cooperation (85%). Although when subjects defected, the most probable behavior was to go back to mutual cooperation. When we modified the matrix by increasing temptation rewards (T) or by increasing cooperation rewards (R), the cooperation rate decreased. In conclusion, we observe that an iPD matrix with large positive reward improves less cooperation than one with small rewards, shown that satisfying the relationship among iPD reinforcement was not enough to achieve high mutual cooperation behavior. Therefore, using positive and negative reinforcements and an appropriate contrast between rewards, rats have cognitive capacity to learn reciprocal altruism. This finding allows to infer that the learning of reciprocal altruism has early appeared in evolution.	[Delmas, Guillermo E.; Lew, Sergio E.; Silvano Zanutto, B.] Univ Buenos, Inst Ingn Biomed, Fac Ingn, Buenos Aires, DF, Argentina; [Silvano Zanutto, B.] IBYME CONICET, Lab Biol Comportamiento, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Delmas, GE (corresponding author), Univ Buenos, Inst Ingn Biomed, Fac Ingn, Buenos Aires, DF, Argentina.	gdelmas@fi.uba.ar	Lew, Sergio/AAE-7122-2022	Lew, Sergio/0000-0001-7700-6687	Dinamica e interaccion de circuitos neuronales involucrados en el aprendizaje de reglas: aplicacion a maquinas inteligentes [PICT-2016-2145, PICT 2012-1519]; Dinamica de la modulacion de circuitos neuronales corticales involucrados en el aprendizaje [PIP 112 201101 01054]; Dinamica de circuitos neuronales durante el aprendizaje por condicionamiento: aplicacion a maquinas inteligentes [GC UBACYT 200 20 100 100 978]	Dinamica e interaccion de circuitos neuronales involucrados en el aprendizaje de reglas: aplicacion a maquinas inteligentes; Dinamica de la modulacion de circuitos neuronales corticales involucrados en el aprendizaje; Dinamica de circuitos neuronales durante el aprendizaje por condicionamiento: aplicacion a maquinas inteligentes	This work was supported by PICT-20162145 and 2013-2015 PICT 2012-1519 Dinamica e interaccion de circuitos neuronales involucrados en el aprendizaje de reglas: aplicacion a maquinas inteligentes; 2012-2014 PIP 112 201101 01054 Dinamica de la modulacion de circuitos neuronales corticales involucrados en el aprendizaje; and 2011-2014 GC UBACYT 200 20 100 100 978 Dinamica de circuitos neuronales durante el aprendizaje por condicionamiento: aplicacion a maquinas inteligentes.; Supported by PICT 2012-1519 and PICT-2016-2145. We wish to thank Lic. Melanie Marino.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baker F, 2002, BEHAV PROCESS, V57, P211, DOI 10.1016/S0376-6357(02)00015-3; Cabrera F, 2013, BEHAV PROCESS, V92, P36, DOI 10.1016/j.beproc.2012.10.003; CAPALDI EJ, 1988, J EXP PSYCHOL ANIM B, V14, P3, DOI 10.1037/0097-7403.14.1.3; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; De Waal FBM, 2000, ANIM BEHAV, V60, P253, DOI 10.1006/anbe.2000.1471; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dolivo V, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0959; FLOOD M, 1983, BEHAV SCI, V28, P65, DOI 10.1002/bs.3830280108; GARDNER RM, 1984, PSYCHOL REP, V55, P687, DOI 10.2466/pr0.1984.55.3.687; GREEN L, 1995, J EXP ANAL BEHAV, V64, P1, DOI 10.1901/jeab.1995.64-1; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; Kefi S, 2007, ANIM BEHAV, V74, pE1, DOI 10.1016/j.anbehav.2006.11.025; KILLEEN PR, 1982, J EXP ANAL BEHAV, V38, P217, DOI 10.1901/jeab.1982.38-217; KILLEEN PR, 1985, J EXP ANAL BEHAV, V43, P407, DOI 10.1901/jeab.1985.43-407; Kummerli R, 2007, P R SOC B, V274, P2965, DOI 10.1098/rspb.2007.0793; Mazur J. E., 2015, LEARNING BEHAV; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Morgenstern O., 1944, GAME THEORY EC BEHAV; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Schneeberger K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-41; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; St-Pierre A, 2009, P ROY SOC B-BIOL SCI, V276, P4223, DOI 10.1098/rspb.2009.1156; Stephens DW, 2001, BEHAV ECOL, V12, P330, DOI 10.1093/beheco/12.3.330; Stephens DW, 2006, BEHAV PROCESS, V71, P29, DOI 10.1016/j.beproc.2005.09.003; Stephens DW, 2002, SCIENCE, V298, P2216, DOI 10.1126/science.1078498; Stevens JR, 2004, BEHAV ECOL, V15, P255, DOI 10.1093/beheco/arh006; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Viana DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008483; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; WILKINSON GS, 1988, ETHOL SOCIOBIOL, V9, P85, DOI 10.1016/0162-3095(88)90015-5; Wood RI, 2016, ANIM BEHAV, V114, P27, DOI 10.1016/j.anbehav.2016.01.010	37	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0204837	10.1371/journal.pone.0204837	http://dx.doi.org/10.1371/journal.pone.0204837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601809	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200002
J	Mahardja, B; Hobbs, JA; Ikemiyagi, N; Benjamin, A; Finger, AJ				Mahardja, Brian; Hobbs, James A.; Ikemiyagi, Naoaki; Benjamin, Alyssa; Finger, Amanda J.			Role of freshwater floodplain-tidal slough complex in the persistence of the endangered delta smelt	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; JUVENILE CHINOOK SALMON; POPULATION-DYNAMICS; PELAGIC FISHES; RIVER; CALIFORNIA; OSMERIDAE; LINKAGES; PATTERNS; DROUGHT	Seasonal floodplain wetland is one of the most variable and diverse habitats found in coastal ecosystems, yet it is also one of the most highly altered by humans. The Yolo Bypass, the primary floodplain of the Sacramento River in California's Central Valley, USA, has been shown to provide various benefits to native fishes when inundated. However, the Yolo Bypass exists as a tidal dead-end slough during dry periods and its value to native fishes has been less studied in this state. During the recent drought (2012-2016), we found higher abundance of the endangered Delta Smelt (Hypomesus transpacificus), than the previous 14 years of fish monitoring within the Yolo Bypass. Meanwhile, Delta Smelt abundance elsewhere in the estuary was at record lows during this time. To determine the value of the Yolo Bypass as a nursery habitat for Delta Smelt, we compared growth, hatch dates, and diets of juvenile Delta Smelt collected within the Yolo Bypass with fish collected among other putative nursery habitats in the San Francisco Estuary between 2010 and 2016. Our results indicated that when compared to other areas of the estuary, fish in the Yolo Bypass spawned earlier, and offspring experienced both higher quality feeding conditions and growth rates. The occurrence of healthy juvenile Delta Smelt in the Yolo Bypass suggested that the region may have acted as a refuge for the species during the drought years of 2012-2016. However, our results also demonstrated that no single region provided the best rearing habitat for juvenile Delta Smelt. It will likely require a mosaic of habitats that incorporates floodplaintidal sloughs in order to promote the resilience of this declining estuarine fish species.	[Mahardja, Brian; Ikemiyagi, Naoaki] Calif Dept Water Resources, Div Environm Serv, West Sacramento, CA 95605 USA; [Hobbs, James A.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Benjamin, Alyssa; Finger, Amanda J.] Univ Calif Davis, Dept Anim Sci, Genom Variat Lab, Davis, CA 95616 USA; [Mahardja, Brian] US Fish & Wildlife Serv, Delta Juvenile Fish Monitoring Program, Lodi, CA 95240 USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of the Interior; US Fish & Wildlife Service	Mahardja, B (corresponding author), Calif Dept Water Resources, Div Environm Serv, West Sacramento, CA 95605 USA.; Mahardja, B (corresponding author), US Fish & Wildlife Serv, Delta Juvenile Fish Monitoring Program, Lodi, CA 95240 USA.	brian_mahardja@fws.gov		Mahardja, Brian/0000-0003-0695-3745; Benjamin, Alyssa/0000-0002-1621-2898	California Department of Water Resources [4600011145, 4600011066]; California Department of Fish and Wildlife [D1583004]; Proposition 1 Grant from California Department of Fish and Wildlife [P1696005]; Interagency Ecological Program (IEP)	California Department of Water Resources; California Department of Fish and Wildlife; Proposition 1 Grant from California Department of Fish and Wildlife; Interagency Ecological Program (IEP)	Funding to JAH was provided by the California Department of Water Resources Contract #4600011145, the California Department of Fish and Wildlife Contract #D1583004 and Proposition 1 Grant from California Department of Fish and Wildlife Contract #P1696005. Funding to AB and AJF was provided by the California Department of Water Resources Contract #4600011066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted under the auspices of the Interagency Ecological Program (IEP) for the San Francisco Estuary. We thank past and present staff members of the YBFMP for their help with the field collection, including (but not limited to) Jared Frantzich, Jeremy Agundes, Mary Jade Farruggia, and Pascale Goertler. We also thank the California Department of Fish and Wildlife for providing additional fish collection for the study. We are grateful to Brian Healey and Mackenzie Gilliam for their help with otolith preparation and aging. Gut content (diet) identification was conducted by the University of Washington Wetland Ecosystem Team in collaboration with the California Department of Water Resources under California Department of Water Resources Contract #4600010863. Special thanks to Brian Schreier and J. Louise Conrad for facilitating the study and for their general support. Larry Brown, Felipe La Luz, Lauren Damon, Melinda Baerwald, Flora Luo, Ted Sommer, Denise Barnard, Brendan Ebner, and one anonymous reviewer provided helpful comments that improved the manuscript. Funding to JH was provided by the California Department of Water Resources Contract #4600011145, the California Department of Fish and Wildlife Contract #D1583004 and Proposition 1 Grant from California Department of Fish and Wildlife Contract #P1696005. Funding to AB and AJF was provided by the California Department of Water Resources Contract #4600011066. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of their respective organizations.	Arthington AH, 2015, AQUAT CONSERV, V25, P336, DOI 10.1002/aqc.2489; Atwater BF, 1979, SAN FRANCISCO BAY UR, P31; Baskerville-Bridges B, 2004, AM FISH S S, V39, P219; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BAYLEY P B, 1991, Regulated Rivers Research and Management, V6, P75, DOI 10.1002/rrr.3450060203; Benjamin A, 2018, CONSERV GENET, V19, P701, DOI 10.1007/s10592-018-1048-9; Bennett W.A., 2005, SAN FRANCISCO ESTUAR, V3, P2, DOI [DOI 10.15447/SFEWS.2005V3ISS2ART1, 10.15447/sfews.2005v3iss2art1]; Bernal B, 2012, GLOBAL CHANGE BIOL, V18, P1636, DOI 10.1111/j.1365-2486.2011.02619.x; Brown LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146724; Chipps Steven R., 2007, P473; Cloern J.E., 2016, SAN FRANC ESTUARY WA, V14, P1, DOI [10.15447/sfews.2016v14iss3art1, DOI 10.15447/SFEWS.2016V14ISS3ART1]; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Culliton TJ, 1990, 2 REPORT COASTAL TRE; Davis B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049107; Diffenbaugh NS, 2015, P NATL ACAD SCI USA, V112, P3931, DOI 10.1073/pnas.1422385112; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Fisch KM, 2014, CONSERV GENET, V15, P489, DOI 10.1007/s10592-013-0555-y; Frantzich Jared, 2018, San Francisco Estuary & Watershed Science, V16, P3; Geach C, 2017, 9 IEP CAL DEP WAT RE, P259; Goertler PAL, 2018, ECOL FRESHW FISH, V27, P580, DOI 10.1111/eff.12372; Hammock BG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173497; Hammock BG, 2015, SCI TOTAL ENVIRON, V532, P316, DOI 10.1016/j.scitotenv.2015.06.018; Hartman R, 91 CAL DEP WAT RES, P1; Hasenbein M, 2013, INTEGR COMP BIOL, V53, P620, DOI 10.1093/icb/ict082; Herbold B, 2014, SAN FRANC ESTUARY WA, V12, P1, DOI 10.15447/sfews.2014v12iss1art1; Hobbs J., 2017, SAN FRANC ESTUARY WA, V15, DOI 10.15447/sfews.2017v15iss2art2; Hobbs JA, 2006, J FISH BIOL, V69, P907, DOI 10.1111/j.1095-8649.2006.01176.x; Hobbs JA, 2007, FISH B-NOAA, V105, P30; Holland AF, 2004, J EXP MAR BIOL ECOL, V298, P151, DOI 10.1016/S0022-0981(03)00357-5; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ikemiyagi N, 2013, INTERAG ECOL PROGRAM, V28, P16; Jeffries KM, 2016, J EXP BIOL, V219, P1705, DOI 10.1242/jeb.134528; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Khanna S, 2012, BIOL INVASIONS, V14, P717, DOI 10.1007/s10530-011-0112-x; Kimmerer WJ, 2018, T AM FISH SOC, V147, P223, DOI 10.1002/tafs.10015; King AJ, 2003, CAN J FISH AQUAT SCI, V60, P773, DOI 10.1139/F03-057; Kingsford RT, 2000, AUSTRAL ECOL, V25, P109, DOI 10.1111/j.1442-9993.2000.tb00012.x; Komoroske LM, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou008; LaCava M, 2015, N AM J AQUACULT, V77, P255, DOI 10.1080/15222055.2015.1007192; Latour RJ, 2016, ESTUAR COAST, V39, P233, DOI 10.1007/s12237-015-9968-9; Lehman PW, 2010, AQUAT ECOL, V44, P359, DOI 10.1007/s10452-009-9295-y; Mahardja B, 2014, INTERAG ECOL PROGRAM, V29, P32; Mahardja B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170683; Mahardja Brian, 2016, San Francisco Estuary & Watershed Science, V14, P2; Morgan-King TL, 2013, ESTUAR COAST, V36, P300, DOI 10.1007/s12237-012-9574-z; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle Peter B., 2016, San Francisco Estuary & Watershed Science, V14, P6; Nobriga Matthew L., 2008, San Francisco Estuary & Watershed Science, V6, P1; Opperman JJ, 2010, J AM WATER RESOUR AS, V46, P211, DOI 10.1111/j.1752-1688.2010.00426.x; Peterson MS, 2003, REV FISH SCI, V11, P291, DOI 10.1080/10641260390255844; Polansky L, 2018, ESTUAR COAST, V41, P572, DOI 10.1007/s12237-017-0277-3; R Core Team, 2021, R LANGUAGE ENV STAT; Rose KA, 2013, T AM FISH SOC, V142, P1238, DOI 10.1080/00028487.2013.799518; Rose KA, 2013, T AM FISH SOC, V142, P1260, DOI 10.1080/00028487.2013.799519; Schemel LE, 2004, HYDROBIOLOGIA, V513, P129, DOI 10.1023/B:hydr.0000018178.85404.1c; Schreier B., 2015, INTERAGENCY ECOLOGIC, V28, P13; Schreier B, 2018, INTERAGENCY ECOLOGIC, DOI DOI 10.6073/PASTA/OAB359BEC75752C116862115E1768EBO; Schreier BM, 2016, T AM FISH SOC, V145, P723, DOI 10.1080/00028487.2016.1152299; Selwood KE, 2015, GLOBAL ECOL BIOGEOGR, V24, P838, DOI 10.1111/geb.12305; Sheaves M, 2015, ESTUAR COAST, V38, P401, DOI 10.1007/s12237-014-9846-x; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Slater S. B., 2014, SAN FRANCISCO ESTUAR, V12; Sommer T, 1997, T AM FISH SOC, V126, P961, DOI 10.1577/1548-8659(1997)126<0961:ROSITS>2.3.CO;2; Sommer T, 2011, SAN FRANCISCO ESTUAR, V9, P2; Sommer T, 2013, SAN FRANCISCO ESTUAR, V11, P2; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Sommer TR, 2001, CAN J FISH AQUAT SCI, V58, P325, DOI 10.1139/cjfas-58-2-325; Storm-Suke A, 2007, RAPID COMMUN MASS SP, V21, P503, DOI 10.1002/rcm.2850; Swanson C, 2000, OECOLOGIA, V123, P384, DOI 10.1007/s004420051025; Takata L, 2017, ENVIRON BIOL FISH, V100, P1105, DOI 10.1007/s10641-017-0631-0; Thomson JR, 2010, ECOL APPL, V20, P1431, DOI 10.1890/09-0998.1; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Whipple AA, SACRAMENTO SAN JOAQU; White J, 2016, INTERAGENCY ECOLOGIC, V30, P3; Williams AP, 2015, GEOPHYS RES LETT, V42, P6819, DOI 10.1002/2015GL064924	76	4	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208084	10.1371/journal.pone.0208084	http://dx.doi.org/10.1371/journal.pone.0208084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601817	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200007
J	Raghavan, RK; Peterson, AT; Cobos, ME; Ganta, R; Foley, D				Raghavan, Ram K.; Peterson, A. Townsend; Cobos, Marlon E.; Ganta, Roman; Foley, Des			Current and Future Distribution of the Lone Star Tick, Amblyomma americanum (L.) (Acari: Ixodidae) in North America	PLOS ONE			English	Article							ECOLOGICAL NICHE MODELS; CLIMATE-CHANGE; GEOGRAPHIC-DISTRIBUTION; SPECIES DISTRIBUTIONS; SAMPLING BIAS; BORNE; COMPLEXITY; MAXENT; EPIDEMIOLOGY; DETERMINANTS	Acarological surveys in areas outside the currently believed leading edge of the distribution of lone star ticks (Amblyomma americanum), coupled with recent reports of their identification in previously uninvaded areas in the public health literature, suggest that this species is more broadly distributed in North America than currently understood. Therefore, we evaluated the potential geographic extent under present and future conditions using ecological niche modeling approach based on museum records available for this species at the Walter Reed Biosystematics Unit (WRBU). The median prediction of a best fitting model indicated that lone star ticks are currently likely to be present in broader regions across the Eastern Seaboard as well as in the Upper Midwest, where this species could be expanding its range. Further northward and westward expansion of these ticks can be expected as a result of ongoing climate change, under both low- and high-emissions scenarios.	[Raghavan, Ram K.; Ganta, Roman] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Peterson, A. Townsend; Cobos, Marlon E.] Univ Kansas, Coll Liberal Arts & Sci, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Foley, Des] Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA	Kansas State University; University of Kansas; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	rkraghavan@vet.k-state.edu	Cobos, Marlon E./I-1647-2019	Cobos, Marlon E./0000-0002-2611-1767; Raghavan, Ram/0000-0002-2657-3398	NIAID NIH HHS [R01 AI070908] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Alkishe AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189092; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; BISHOPP FC, 1945, J PARASITOL, V31, P1, DOI 10.2307/3273061; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135; CDC, 2018, MAP EST AMBL AM TICK; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Dahlgren FS, 2016, AM J TROP MED HYG, V94, P35, DOI 10.4269/ajtmh.15-0580; Dantas-Torres F, 2015, INT J PARASITOL-PAR, V4, P452, DOI 10.1016/j.ijppaw.2015.07.001; Escobar LE, 2014, GEOSPATIAL HEALTH, V9, P221, DOI 10.4081/gh.2014.19; Estrada-Peria A, 2009, FRONT BIOSCI; Fick Stephen E, 2017, INT J CLIMATOL; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Hahn MB, 2017, J MED ENTOMOL, V54, P247, DOI [10.1093/jme/tjw145, 10.1093/jme/tjx096]; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Levin ML, 2018, VECTOR-BORNE ZOONOT, V18, P579, DOI 10.1089/vbz.2018.2284; Lindgren E, 2001, LANCET, V358, P16, DOI 10.1016/S0140-6736(00)05250-8; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Michigan Department of Health and Human Services, MICH 5 MOT COMM TICK; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Minnesota Department of Health, TICK BROCH 2108; Mixson TR, 2006, J MED ENTOMOL, V43, P1261, DOI 10.1603/0022-2585(2006)43[1261:POEBAR]2.0.CO;2; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Osorio-Olvera L, PEERJ; Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2017, J MED ENTOMOL, V54, P1103, DOI 10.1093/jme/tjx097; Peterson AT, 2017, J MED ENTOMOL, V54, P1080, DOI 10.1093/jme/tjx095; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prevention CfDCa, 2018, SO TIC ASS RASH ILLN; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Raghavan RK, 2016, VECTOR-BORNE ZOONOT, V16, P569, DOI 10.1089/vbz.2016.1975; Raghavan RK, 2016, VECTOR-BORNE ZOONOT, V16, P205, DOI 10.1089/vbz.2015.1837; Raghavan RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100850; Raghavan RK, 2014, VECTOR-BORNE ZOONOT, V14, P486, DOI 10.1089/vbz.2013.1496; Raghavan RK, 2013, VECTOR-BORNE ZOONOT, V13, P449, DOI 10.1089/vbz.2012.1234; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Savage HM, 2018, J MED ENTOMOL, V55, P1613, DOI 10.1093/jme/tjy103; Savage HM, 2018, J MED ENTOMOL, V55, P701, DOI 10.1093/jme/tjx251; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Springer YP, 2015, AM J TROP MED HYG, V93, P875, DOI 10.4269/ajtmh.15-0330; Springer YP, 2014, J MED ENTOMOL, V51, P342, DOI 10.1603/ME13115; Steinke JW, 2015, J ALLERGY CLIN IMMUN, V135, P589, DOI 10.1016/j.jaci.2014.12.1947; Ticks Commonly Encountered in California, 2018, TICKS COMM ENC CAL; University of Wisconsin-Madison, 2021, AMBL AM LON STAR TIC; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1	60	90	91	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209082	10.1371/journal.pone.0209082	http://dx.doi.org/10.1371/journal.pone.0209082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601855	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200036
J	Cayir, A; Barrow, TM; Wang, H; Liu, HB; Li, CP; Ding, N; Li, Y; Kang, CM; Guo, LQ; Li, PH; Byun, HM				Cayir, Akin; Barrow, Timothy M.; Wang, Hao; Liu, Hongbin; Li, Changping; Ding, Ning; Li, Yan; Kang, Choong-Min; Guo, Liqiong; Li, Peng-hui; Byun, Hyang-Min			Occupational noise exposure is associated with hypertension in China: Results from project ELEFANT	PLOS ONE			English	Article							DNA METHYLATION; BLOOD-PRESSURE; POLLUTION; WORKERS; DISEASE; BRAIN; RISK	Objectives We investigated the association between occupational noise exposure and the risk of elevated blood pressure and hypertension by stage in young adults. Methods We utilized 124,286 young adults (18-40 years) from the Project ELEFANT study. We categorized occupational noise exposure as high (75 dBA noise exposure for more than 4 hours per day) or low, and measured blood pressure (mmHg) and categorized participants by hypertension stage (normal, elevated, Stage 1, Stage 2). We applied adjusted logistic regression models to identify associations with hypertension risk, and we further examined the noise-BMI, noise-gender, and noise-residence interactions on hypertension risk in separate models. Results High occupational noise exposure was associated with increases in blood pressure among participants with elevated blood pressure (Estimate = 0.23, 95% CI: 1.09, 1.46, p = 0.0009), in Stage 1 hypertension (Estimate = 0.15, 95% CI: 1.06, 1.25, p = 0.0008), and in Stage 2 hypertension (Estimate = 0.41 95% CI: 1.31, 1.73, p<0.0001). Likewise, noise exposure BMI interaction was consistently positively associated with increases in blood pressure in participants with elevated blood pressure (Estimate = 0.71, 95% CI: 1.55, 2.69, p<0.0001), in Stage 1 hypertension (Estimate = 0.78, 95% CI: 1.82, 2.61, p<0.0001), and in Stage 2 hypertension (Estimate = 2.06, 95% CI: 5.64, 10.81, p<0.0001). The noise exposure-male interaction showed higher risk for hypertension compared to the noise exposure-female interaction in participants with elevated blood pressure (Estimate = 1.24, 95% CI: 2.56, 4.71, p<0.0001), Stage 1 (Estimate = 1.67, 95% CI: 4.34, 6.42, p<0.0001) and Stage 2 hypertension (Estimate = 1.70, 95% CI: 3.86, 7.77, p<0.0001). Finally, we found that noise exposure-urban interaction was consistently associated with an increase in blood pressure in elevated blood pressure (Estimate = 0.32, 95% CI: 1.19, 1.62, p<0.0001) and in Stage 2 hypertension (Estimate = 0.44, 95% CI: 1.31, 1.80, p<0.0001).	[Cayir, Akin] Canakkale Onsekiz Mart Univ, Vocat Hlth Coll, Canakkale, Turkey; [Cayir, Akin; Byun, Hyang-Min] Newcastle Univ, Inst Cellular Med, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Barrow, Timothy M.] Univ Sunderland, Fac Hlth Sci & Wellbeing, Sunderland, Tyne & Wear, England; [Wang, Hao; Liu, Hongbin] Tianjin Res Inst Family Planning, Tianjin, Peoples R China; [Li, Changping] Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Tianjin, Peoples R China; [Ding, Ning; Li, Yan] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Kang, Choong-Min] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Guo, Liqiong] Tianjin Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tianjin, Peoples R China; [Li, Peng-hui] Tianjin Univ Technol, Sch Environm Sci & Safety Engn, Tianjin, Peoples R China	Canakkale Onsekiz Mart University; Newcastle University - UK; University of Sunderland; Tianjin Medical University; Tianjin Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Tianjin Medical University; Tianjin University of Technology	Li, PH (corresponding author), Tianjin Univ Technol, Sch Environm Sci & Safety Engn, Tianjin, Peoples R China.	lipenghui406@163.com	Byun, Hyang-Min/X-2843-2018	Byun, Hyang-Min/0000-0002-6278-3165; guo, liqiong/0000-0002-1141-9646; Barrow, Timothy/0000-0003-4551-3857; CAYIR, AKIN/0000-0002-2014-6635	National Natural Science Foundation of China [41601548, 81602827]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, Grant numbers 81602827 to LG and National Natural Science Foundation of China, Grant numbers 41601548 to 2-P-hL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babisch W, 2014, NOISE HEALTH, V16, P1, DOI 10.4103/1463-1741.127847; Babisch W, 2011, NOISE HEALTH, V13, P201, DOI 10.4103/1463-1741.80148; Barrow TM, 2019, BREAST CANCER RES TR, V173, P217, DOI 10.1007/s10549-018-4979-4; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Chang TY, 2013, AM J EPIDEMIOL, V177, P818, DOI 10.1093/aje/kws300; Chen CM, 2004, BIOMED ENVIRON SCI, V17; CHEN SC, 2017, BMC PUBLIC HEALTH, V17; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Commission E, HLTH EFF NOIS ENV 20; de Souza TCF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1671-z; Ganzeboom H. B., 2010, ANN C INT SOC SURV P; Garcia A., 2001, ENV URBAN NOISE; Guo LQ, 2017, ENVIRON RES, V153, P73, DOI 10.1016/j.envres.2016.11.017; Hammer MS, 2014, ENVIRON HEALTH PERSP, V122, P115, DOI 10.1289/ehp.1307272; Houthuijs D, 2014, 20140130 RIVM; Hurtley C., 2009, NIGHT NOISE GUIDELIN; Inoue M, 2005, ARCH ENVIRON OCCUP H, V60, P106, DOI 10.3200/AEOH.60.2.106-110; Jabbari K, 2016, BIOTECHNOLOGY HLTH S, V3, P49, DOI DOI 10.17795/BHS-40735; Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775; Lee JH, 2009, AM J IND MED, V52, P509, DOI 10.1002/ajim.20692; Lee RS, 2011, PSYCHOPHARMACOLOGY, V218, P303, DOI 10.1007/s00213-011-2307-3; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Sbihi H, 2008, OCCUP ENVIRON MED, V65, P643, DOI 10.1136/oem.2007.035709; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Stokholm ZA, 2013, EPIDEMIOLOGY, V24, P135, DOI 10.1097/EDE.0b013e31826b7f76; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; WHO, 2011, BURDEN DIS ENV NOISE; WHO, 2014, PROJ MORT CAUS DEATH; Zhong J, 2016, CIRC RES, V118, P119, DOI 10.1161/CIRCRESAHA.115.305206	31	9	10	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209041	10.1371/journal.pone.0209041	http://dx.doi.org/10.1371/journal.pone.0209041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596670	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000454627200027
J	Evans, JC; Dall, SRX; Kight, CR				Evans, Julian C.; Dall, Sasha R. X.; Kight, Caitlin R.			Effects of ambient noise on zebra finch vigilance and foraging efficiency	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; PREDATION RISK; BEHAVIORAL ECOLOGY; TRAFFIC NOISE; URBAN NOISE; INFORMATION; CALLS; FREQUENCY; ATTENTION; ANIMALS	Ambient noise can affect the availability of acoustic information to animals, altering both foraging and vigilance behaviour. Using captive zebra finches Taeniopygia guttata, we examined the effect of ambient broadband noise on foraging decisions. Birds were given a choice between foraging in a quiet area where conspecific calls could be heard or a noisy area where these calls would be masked. Birds foraging in noisy areas spent a significantly more time vigilant than those in quiet areas, resulting in less efficient foraging. Despite this there was no significant difference in the amount of time spent in the two noise regimes. However there did appear a preference for initially choosing quiet patches during individuals' second trial. These results emphasise how masking noise can influence the foraging and anti-predation behaviour of animals, which is particularly relevant as anthropogenic noise becomes increasingly prevalent in the natural world.	[Evans, Julian C.; Dall, Sasha R. X.] Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, England; [Kight, Caitlin R.] Univ Exeter, Exeter, Devon, England	University of Exeter; University of Exeter	Evans, JC (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, England.	jevansbio@gmail.com						[Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Chan AAYH, 2011, APPL ANIM BEHAV SCI, V131, P1, DOI 10.1016/j.applanim.2011.01.007; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Coolen I, 2001, ANIM BEHAV, V61, P895, DOI 10.1006/anbe.2000.1678; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dukas R, 2000, BEHAV ECOL, V11, P502, DOI 10.1093/beheco/11.5.502; Francis C.D., 2012, ORNITHOL MONOGR, V74, P101, DOI [10.1525/om.2012.74.1.101, DOI 10.1525/OM.2012.74.1.101]; Francis CD, 2015, GLOBAL CHANGE BIOL, V21, P1809, DOI 10.1111/gcb.12862; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Grade AM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0113; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hanna D, 2011, J EXP BIOL, V214, P3549, DOI 10.1242/jeb.060194; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Hilton GM, 1999, OIKOS, V87, P295, DOI 10.2307/3546744; Hollen LI, 2009, ANIM BEHAV, V78, P791, DOI 10.1016/j.anbehav.2009.07.021; Kern JM, 2016, ENVIRON POLLUT, V218, P988, DOI 10.1016/j.envpol.2016.08.049; Kight CR, 2015, INTEGR COMP BIOL, V55, P418, DOI 10.1093/icb/icv070; Kight CR, 2012, ECOL APPL, V22, P1989, DOI 10.1890/12-0133.1; Kleist NJ, 2017, ECOL APPL, V27, P260, DOI 10.1002/eap.1437; Kondo N, 2009, JPN PSYCHOL RES, V51, P197, DOI 10.1111/j.1468-5884.2009.00399.x; Krebs H, 1997, PHYSIOL BEHAV, V62, P151, DOI 10.1016/S0031-9384(97)00026-7; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; Mathot KJ, 2008, BEHAV ECOL, V19, P131, DOI 10.1093/beheco/arm114; Meillere A, 2015, BEHAV ECOL, V26, P569, DOI 10.1093/beheco/aru232; Morris-Drake A, 2016, CURR BIOL, V26, pR911, DOI 10.1016/j.cub.2016.08.064; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Peng C, 2015, INT J ENV RES PUB HE, V12, P12304, DOI 10.3390/ijerph121012304; Perillo A, 2017, IBIS, V159, P638, DOI 10.1111/ibi.12481; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Potvin DA, 2011, P ROY SOC B-BIOL SCI, V278, P2464, DOI 10.1098/rspb.2010.2296; Purser J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017478; Quinn JL, 2006, J AVIAN BIOL, V37, P601; R Development Core Team, 2016, R LANG ENV STAT COMP; Rabin LA, 2006, BIOL CONSERV, V131, P410, DOI 10.1016/j.biocon.2006.02.016; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Shannon G, 2016, BEHAV ECOL, V27, P1370, DOI 10.1093/beheco/arw058; Shannon G, 2014, ANIM BEHAV, V94, P135, DOI 10.1016/j.anbehav.2014.06.004; Siemers BM, 2011, P ROY SOC B-BIOL SCI, V278, P1646, DOI 10.1098/rspb.2010.2262; Simpson SD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10544; Simpson SD, 2015, GLOBAL CHANGE BIOL, V21, P586, DOI 10.1111/gcb.12685; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Slabbekoorn H, 2009, CURR BIOL, V19, pR693, DOI 10.1016/j.cub.2009.07.002; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; The Audacity Team, 2012, AUDACITY; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Voellmy IK, 2014, ANIM BEHAV, V89, P191, DOI 10.1016/j.anbehav.2013.12.029; Wale MA, 2013, ANIM BEHAV, V86, P111, DOI 10.1016/j.anbehav.2013.05.001; Wale MA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1194; Ware HE, 2015, P NATL ACAD SCI USA, V112, P12105, DOI 10.1073/pnas.1504710112; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; Zann RA., 1996, ZEBRA FINCH SYNTHESI	64	12	13	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209471	10.1371/journal.pone.0209471	http://dx.doi.org/10.1371/journal.pone.0209471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596692	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200049
J	Lang, HD; France, EF; Williams, B; Humphris, G; Wells, M				Lang, Heidi; France, Emma F.; Williams, Brian; Humphris, Gerry; Wells, Mary			The existence and importance of patients' mental images of their head and neck cancer: A qualitative study	PLOS ONE			English	Article							COMMON-SENSE MODEL; PATIENTS DRAWINGS; BREAST-CANCER; OF-LIFE; ILLNESS; RECURRENCE; PICTURE; HEALTH; FEAR; REPRESENTATIONS	Objectives To explore the existence and importance of mental images of cancer among people with head and neck cancers with a focus on the perceived origins and meaning of mental images, their development over time, and their relationship to illness beliefs. Methods A longitudinal qualitative study consisting of 44 in-depth semi-structured interviews with 25 consecutive, newly-diagnosed head and neck cancer patients. Participants were invited to draw their images during the interviews. Follow-up interviews occurred after treatment completion. Analysis drew upon the principles of Interpretative Phenomenological Analysis (IPA). Results Many participants had mental images of their cancer which appeared to both embody and influence their beliefs about their illness, and affect their emotional response. For those who held them, mental images appeared to constitute an important part of their cognitive representation (understanding) of their illness. For some, their images also had a powerful emotional impact, being either reassuring or frightening. Images often appeared to originate from early clinical encounters, and remained fairly stable throughout treatment. Images could be conceptualised as 'concrete' (the perceived reality) and/or 'similic' (figurative). Patients' images reflected the perceived meaning, properties or 'intent' of the cancer-that is beliefs concerning the disease's identity, consequences and prognosis (likelihood of cure or control). Conclusions People with head and neck cancer may develop a mental image of their disease, often generated early within clinical encounters, which can both reflect and influence their understanding of the cancer. Such images tend to be stable over time. We theorise that careful use of images in early consultations could avoid or minimise some distress, including fears of outcome or recurrence. Concrete or similic images and language could be employed later to change perceptions and reduce distress.	[Lang, Heidi; Wells, Mary] Univ Dundee, Sch Nursing & Midwifery, Dundee, Scotland; [France, Emma F.] Univ Stirling, Fac Hlth Sci & Sport, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling, Scotland; [Williams, Brian] Univ Dundee, Social Dimens Hlth Inst, Dundee, Scotland; [Humphris, Gerry] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Williams, Brian] Edinburgh Napier Univ, Sch Hlth & Social Care, Edinburgh, Midlothian, Scotland; [Wells, Mary] Imperial Coll Healthcare NHS Trust, Nursing Directorate, London, England	University of Dundee; University of Stirling; University of Dundee; University of St Andrews; Edinburgh Napier University; Imperial College London	France, EF (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Nursing Midwifery & Allied Hlth Profess Res Unit, Stirling, Scotland.	emma.france@stir.ac.uk	Humphris, Gerry/AAX-8013-2020	Humphris, Gerry/0000-0002-4601-8834; Wells, Mary/0000-0001-5789-2773; France, Emma/0000-0003-0876-7030	Chief Scientist Office Scotland [CZS/1/48]	Chief Scientist Office Scotland	This study was supported by the Chief Scientist Office Scotland, grant number: CZS/1/48, URL http://www.cso.scot.nhs.uk/.The funder played no role in this research.	Appleton L, 2014, EUR J ONCOL NURS, V18, P378, DOI 10.1016/j.ejon.2014.03.012; Ashley L, 2015, PSYCHO-ONCOLOGY, V24, P1463, DOI 10.1002/pon.3812; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Broadbent E, 2004, J PSYCHOSOM RES, V57, P583, DOI 10.1016/j.jpsychores.2004.03.014; Broadbent E, 2006, PSYCHOSOM MED, V68, P910, DOI 10.1097/01.psy.0000242121.02571.10; Buchmann L, 2013, LARYNGOSCOPE, V123, P1424, DOI 10.1002/lary.23886; Cameron LD, 2008, PSYCHOL HEALTH, V23, P91, DOI 10.1080/14768320701342383; Campbell S., 1982, J PSYCHOSOM OBST GYN, V1, P57, DOI [DOI 10.3109/01674828209081226, 10.3109/01674828209081226]; Chen AM, 2013, JAMA OTOLARYNGOL, V139, P885, DOI 10.1001/jamaoto.2013.4072; Corter AL, 2013, BRIT J HEALTH PSYCH, V18, P168, DOI 10.1111/bjhp.12003; Ghazali N, 2013, PSYCHO-ONCOLOGY, V22, P807, DOI 10.1002/pon.3069; Gould RV, 2010, PSYCHOL HEALTH, V25, P633, DOI 10.1080/08870440902811163; Harpel TS, 2010, J FAM ISSUES, V31, P257, DOI 10.1177/0192513X09348491; Harrington KJ, 2012, CLIN J ONCOL NURS, V16, P408, DOI 10.1188/12.CJON.408-412; Harrow A, 2008, PATIENT EDUC COUNS, V73, P339, DOI 10.1016/j.pec.2008.07.014; Humphris Gerry M, 2006, Int J Surg, V4, P37, DOI 10.1016/j.ijsu.2005.12.004; Humphris GM, 2003, INT J ORAL MAX SURG, V32, P486, DOI 10.1054/ijom.2002.0399; Ji EK, 2005, ULTRASOUND OBST GYN, V25, P473, DOI 10.1002/uog.1896; Klein J, 2014, ORAL ONCOL, V50, P254, DOI 10.1016/j.oraloncology.2014.01.015; Lanceley A, 2013, BRIT J PSYCHOTHER, V29, P182, DOI 10.1111/bjp.12023; Lang HD, 2013, PSYCHO-ONCOLOGY, V22, P2648, DOI 10.1002/pon.3343; Leventhal H, 2003, SELF REGULATION HLTH, P42, DOI DOI 10.1093/RHEUMATOLOGY/KEM060; Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2; List MA, 2000, J CLIN ONCOL, V18, P877, DOI 10.1200/JCO.2000.18.4.877; Llewellyn CD, 2006, ORAL ONCOL, V42, P726, DOI 10.1016/j.oraloncology.2005.11.013; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Luckett T, 2011, SUPPORT CARE CANCER, V19, P871, DOI 10.1007/s00520-011-1119-7; McCorry NK, 2013, PSYCHO-ONCOLOGY, V22, P692, DOI 10.1002/pon.3054; McWhirter JE, 2012, J CANCER EDUC, V27, P202, DOI 10.1007/s13187-012-0355-y; Morgan S, 2008, EUR J CANCER, V44, P1483, DOI 10.1016/j.ejca.2008.04.001; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Paddison JS, 2009, J SURG RES, V151, P145, DOI 10.1016/j.jss.2008.01.030; Penson RT, 2004, ONCOLOGIST, V9, P708, DOI 10.1634/theoncologist.9-6-708; Reynolds L, 2007, J PSYCHOSOM RES, V63, P525, DOI 10.1016/j.jpsychores.2007.03.007; Rogers SN, 2010, EUR ARCH OTO-RHINO-L, V267, P1943, DOI 10.1007/s00405-010-1307-y; Scharloo M, 2010, SUPPORT CARE CANCER, V18, P1137, DOI 10.1007/s00520-009-0728-x; Smith JA., 1999, QUALITATIVE HLTH PSY, P218, DOI [10.4135/9781446217870.n14, DOI 10.4135/9781446217870.N14]; Sontag Susan, 1978, ILLNESS METAPHOR; The Scottish Government, 2012, SCOTT IND MULT DEPR; Tschiesner U, 2013, EUR ARCH OTO-RHINO-L, V270, P3133, DOI 10.1007/s00405-013-2446-8; Wells M, 2015, EUROPEAN J CANC CARE, V24; Winterling J, 2009, EUR J CANCER CARE, V18, P585, DOI 10.1111/j.1365-2354.2008.00933.x	42	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209215	10.1371/journal.pone.0209215	http://dx.doi.org/10.1371/journal.pone.0209215			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596669	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200033
J	Alanjary, M; Medema, MH				Alanjary, Mohammad; Medema, Marnix H.			Mining bacterial genomes to reveal secret synergy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CLUSTER	The medical treatment of infectious diseases often requires combination therapies that blend two molecules to enhance drug efficacy. Nature does the same. In a new article, Mrak et al. identify and functionally characterize natural products from Streptomyces rapamycinicus that show synergistic antifungal activity with the well-known immunosuppressant metabolite rapamycin, produced by the same strain. The genomic co-association of the two biosynthetic gene clusters paves the way toward new strategies to discover synergistic pairs of antibiotics through large-scale genome mining.	[Alanjary, Mohammad; Medema, Marnix H.] Wageningen Univ, Bioinformat Grp, Wageningen, Netherlands	Wageningen University & Research	Medema, MH (corresponding author), Wageningen Univ, Bioinformat Grp, Wageningen, Netherlands.	marnix.medema@wur.nl	Medema, Marnix H./AAR-3138-2021	Medema, Marnix H./0000-0002-2191-2821				Alanjary M, 2017, NUCLEIC ACIDS RES, V45, pW42, DOI 10.1093/nar/gkx360; Arp J, 2018, P NATL ACAD SCI USA, V115, P3758, DOI 10.1073/pnas.1721790115; Belousoff MJ, 2011, P NATL ACAD SCI USA, V108, P2717, DOI 10.1073/pnas.1019406108; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Mast Y, 2011, MICROB BIOTECHNOL, V4, P192, DOI 10.1111/j.1751-7915.2010.00213.x; Mrak P, 2018, J BIOL CHEM, V293, P19982, DOI 10.1074/jbc.RA118.005314; Navarro-Munoz J.C., 2018, BIORXIV, DOI [10.1101/445270, DOI 10.1101/445270]; WARD JM, 1993, FEMS MICROBIOL LETT, V110, P239; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110	9	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19996	19997		10.1074/jbc.H118.006669	http://dx.doi.org/10.1074/jbc.H118.006669			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593529	Green Published, hybrid			2022-12-26	WOS:000454685900005
J	DiMaio, J; Ruthel, G; Cannon, JJ; Malfara, MF; Povelones, ML				DiMaio, John; Ruthel, Gordon; Cannon, Joshua J.; Malfara, Madeline F.; Povelones, Megan L.			The single mitochondrion of the kinetoplastid parasite Crithidia fasciculata is a dynamic network	PLOS ONE			English	Article							CELL-CYCLE; TRYPANOSOMA-BRUCEI; MOLECULAR MACHINERY; DNA-REPLICATION; FUSION; FISSION; PROTEIN; DIVISION; EVENTS; GROWTH	Mitochondria are central organelles in cellular metabolism. Their structure is highly dynamic, allowing them to adapt to different energy requirements, to be partitioned during cell division, and to maintain functionality. Mitochondrial dynamics, including membrane fusion and fission reactions, are well studied in yeast and mammals but it is not known if these processes are conserved throughout eukaryotic evolution. Kinetoplastid parasites are some of the earliest-diverging eukaryotes to retain a mitochondrion. Each cell has only a single mitochondrial organelle, making them an interesting model for the role of dynamics in controlling mitochondrial architecture. We have investigated the mitochondrial division cycle in the kinetoplastid Crithidia fasciculata. The majority of mitochondrial biogenesis occurs during the G1 phase of the cell cycle, and the mitochondrion is divided symmetrically in a process coincident with cytokinesis. Live cell imaging revealed that the mitochondrion is highly dynamic, with frequent changes in the topology of the branched network. These remodeling reactions include tubule fission, fusion, and sliding, as well as new tubule formation. We hypothesize that the function of this dynamic remodeling is to homogenize mitochondrial contents and to facilitate rapid transport of mitochondria-encoded gene products from the area containing the mitochondrial nucleoid to other parts of the organelle.	[DiMaio, John; Cannon, Joshua J.; Malfara, Madeline F.; Povelones, Megan L.] Penn State Univ, Sci Div, Brandywine Campus, Media, PA 19063 USA; [Ruthel, Gordon] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Cannon, Joshua J.] Thomas Jefferson Univ, Dept Med Lab Sci & Biotechnol, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Pennsylvania; Jefferson University	Povelones, ML (corresponding author), Penn State Univ, Sci Div, Brandywine Campus, Media, PA 19063 USA.	mlp29@psu.edu	Ruthel, Gordon/GYU-9133-2022	Cannon, Joshua/0000-0001-8206-1947; Ruthel, Gordon/0000-0001-9193-5589	National Science Foundation [MCB-1651517]; Penn State; NIH [S10 OD021633-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021633] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Penn State; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation under grant number MCB-1651517 to MLP and by Penn State internal funding to JD, JJC, MFM, and MLP. The Penn Vet Imaging Core (GR) is supported by an NIH Shared Instrument Grant S10 OD021633-01 to Bruce Freedman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17779-z; Benz C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177200; Biebinger S, 1996, EXP PARASITOL, V83, P252, DOI 10.1006/expr.1996.0072; BROWN R C, 1973, International Journal for Parasitology, V3, P691, DOI 10.1016/0020-7519(73)90095-7; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; Chanez AL, 2006, J CELL SCI, V119, P2968, DOI 10.1242/jcs.03023; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; CLARK TB, 1964, J PROTOZOOL, V11, P400, DOI 10.1111/j.1550-7408.1964.tb01770.x; COSGROVE WB, 1970, J PROTOZOOL, V17, P172, DOI 10.1111/j.1550-7408.1970.tb02350.x; Esseiva AC, 2004, EMBO REP, V5, P268, DOI 10.1038/sj.embor.7400095; Field MC, 2004, TRAFFIC, V5, P905, DOI 10.1111/j.1600-0854.2004.00234.x; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; GRONDAL EJM, 1990, NUCLEIC ACIDS RES, V18, P1333, DOI 10.1093/nar/18.6.1333; Guilbride DL, 1998, J CELL SCI, V111, P675; Harsman A, 2017, TRAFFIC, V18, P96, DOI 10.1111/tra.12463; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hughes L, 2017, J CELL SCI, V130, P637, DOI 10.1242/jcs.198887; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jakob M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36565; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Jongsma MLM, 2015, TRENDS CELL BIOL, V25, P112, DOI 10.1016/j.tcb.2014.10.005; Kanfer G, 2016, BIOCHEM SOC T, V44, P510, DOI 10.1042/BST20150274; Lackner LL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-35; Lackner LL, 2013, CURR OPIN CELL BIOL, V25, P471, DOI 10.1016/j.ceb.2013.02.011; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Logan DC, 2006, BBA-MOL CELL RES, V1763, P430, DOI 10.1016/j.bbamcr.2006.01.003; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Merz S, 2007, BIOL CHEM, V388, P917, DOI 10.1515/BC.2007.110; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Morgan GW, 2004, J BIOL CHEM, V279, P10692, DOI 10.1074/jbc.M312178200; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Ochsenreiter T, 2008, MOL CELL BIOL, V28, P5595, DOI 10.1128/MCB.00637-08; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Ovciarikova J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42746; PASION SG, 1994, J CELL SCI, V107, P3515; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Rafelski SM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-71; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Scolaro EJ, 2005, J EUKARYOT MICROBIOL, V52, P17, DOI 10.1111/j.1550-7408.2005.3315r.x; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tetaud E, 2002, MOL BIOCHEM PARASIT, V120, P195, DOI 10.1016/S0166-6851(02)00002-6; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Voleman L, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0361-y; Wallace F. G., 1943, JOUR PARASITOL, V29, P196, DOI 10.2307/3273098; Westermann B, 2008, J BIOL CHEM, V283, P13501, DOI 10.1074/jbc.R800011200; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Wheeler RJ, 2011, MOL MICROBIOL, V79, P647, DOI 10.1111/j.1365-2958.2010.07479.x; WOODWARD R, 1990, J CELL SCI, V95, P49; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2013, CELL MOL LIFE SCI, V70, P951, DOI 10.1007/s00018-012-1066-6; Zheng ZF, 2005, EUKARYOT CELL, V4, P556, DOI 10.1128/EC.4.3.556-566.2005	59	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0202711	10.1371/journal.pone.0202711	http://dx.doi.org/10.1371/journal.pone.0202711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592713	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900001
J	von Borstel, UK; Tonepohl, B; Appel, AK; Voss, B; Brandt, H; Naderi, S; Gauly, M				von Borstel, Uta Koenig; Toenepoehl, Bjoern; Appel, Anne K.; Voss, Barbara; Brandt, Horst; Naderi, Saeid; Gauly, Matthias			Suitability of traits related to aggression and handleability for integration into pig breeding programmes: Genetic parameters and comparison between Gaussian and binary trait specifications	PLOS ONE			English	Article							BEHAVIORAL-CHARACTERISTICS; INDIVIDUAL AGGRESSIVENESS; SKIN-LESIONS; SCORES; TESTS; PERSONALITIES; CONSISTENCY; GROWTH; CATTLE; SOWS	Changes in husbandry systems as well as consumers' increasing demands for animal welfare lead to increasing importance of traits such as handleability and aggressiveness in pigs. However, before using such novel traits for selection decisions, information on genetic parameters for these traits for the specific population is required. Therefore, weight gain and behaviour-related traits were recorded in 1004 pigs (814 Pietrain x German Landrace crossbred, 190 German Landrace purebred) at different ages. Behaviour indicators and tests were assessed and conducted, respectively under commercial farm conditions and included scoring of skin lesions (twice) and behaviour during backtests (twice), injections (once), handling (twice) and weighing (three times). Since behaviour scores often exhibit suboptimal statistical properties for parametric analyses, variance components were estimated using an animal model assuming a normal (Gaussian, GA; all traits) and additionally a binary distribution of variables (BI; using a logit-link function for all behaviour traits). Heritabilities for behavioural traits ranged from 0.02 +/- 0.04 (finishing pig handling test; BI) to 0.36 +/- 0.08 (backtest 2; GA) suggesting that some of the traits are potentially useful for genetic selection (e. g. finishing pig weighing test: h(2) (GA) = 0.20 +/- 0.07). Only minor differences were observed for results from binary and Gaussian analyses of the same traits suggesting that either approach might yield valid results. However, four-fold cross-validation using correlations between breeding values of a sub-set of animals for the sample trait finishing pig weighing score indicated slight superiority of the logit model (r = 0.85 +/- 0.04 vs. r = 0.77 +/- 0.03). Generally, only weak to moderate associations were found between behavioural reactions to the same test at different ages (r(p) <= 0.11 for weighing at different ages; r(p) = 0.30 but r(g) (GA) = 0.84 +/- 0.11 for the backtests) as well as between reactions to different tests. Therefore, for inclusion of behaviour traits into breeding programmes, and considering high labour input required for some tests such as the backtest, it is recommended to assess behaviour during situations that are relevant and identical to practical conditions, while the use of indicator traits generally does not appear to be a very promising alternative.	[von Borstel, Uta Koenig; Toenepoehl, Bjoern; Appel, Anne K.; Naderi, Saeid; Gauly, Matthias] Georg August Univ Gottingen, Livestock Prod Syst, Dept Anim Sci, Gottingen, Germany; [von Borstel, Uta Koenig; Brandt, Horst] Justus Liebig Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany; [Appel, Anne K.; Voss, Barbara] BHZP GmbH, Dahlenburg Ellringen, Germany; [Gauly, Matthias] Univ Bolzano, Fac Sci & Technol, Piazza Univ, Bolzano, Italy	University of Gottingen; Justus Liebig University Giessen; Free University of Bozen-Bolzano	von Borstel, UK (corresponding author), Georg August Univ Gottingen, Livestock Prod Syst, Dept Anim Sci, Gottingen, Germany.; von Borstel, UK (corresponding author), Justus Liebig Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany.	koenigvb@gwdg.de		Konig von Borstel, Uta/0000-0002-7313-1197	German Federal Ministry of Food, Agriculture and Consumer Protection via the Federal Office for Agriculture and Food [PGI-06.01-28-1-35.026-08]; German Research Foundation; Open Access Publication Funds of the University of Gottingen	German Federal Ministry of Food, Agriculture and Consumer Protection via the Federal Office for Agriculture and Food; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the University of Gottingen	The study was a part of the project "investigations of possibilities to integrate behaviour traits into pig breeding programmes" funded by the German Federal Ministry of Food, Agriculture and Consumer Protection (http://www.bmel.de/DE/Startseite/startseite_node.html) via the Federal Office for Agriculture and Food in the framework of the programme "innovation facilitation", grant number: PGI-06.01-28-1-35.026-08. Funding was received by MG, BT and AA. BHZP GmbH (Bundes Hybrid Zucht Programm) provided support in the form of salary for author BV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Furthermore, we acknowledge support by the German Research Foundation and the Open Access Publication Funds of the University of Gottingen.	Appel AK, 2013, J ANIM SCI, V91, P5557, DOI 10.2527/jas.2013-6694; Arey DS, 1998, LIVEST PROD SCI, V56, P61, DOI 10.1016/S0301-6226(98)00144-4; Boissy A, 2005, LIVEST PROD SCI, V93, P23, DOI 10.1016/j.livprodsci.2004.11.003; BOIVIN X, 1992, APPL ANIM BEHAV SCI, V32, P313, DOI 10.1016/S0168-1591(05)80024-3; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Brown JA, 2009, APPL ANIM BEHAV SCI, V118, P28, DOI 10.1016/j.applanim.2009.02.005; Bunter K, 2004, AGBU PIG GEN WORKSH; Cammack KM, 2009, THERIOGENOLOGY, V71, P651, DOI 10.1016/j.theriogenology.2008.09.029; Cassady JP, 2007, J ANIM SCI, V85, P218, DOI 10.2527/jas.2006-310; D'Eath RB, 2009, ANIMAL, V3, P1544, DOI 10.1017/S1751731109990528; DEMPSTER ER, 1950, GENETICS, V35, P212; Erhard HW, 1997, APPL ANIM BEHAV SCI, V54, P137, DOI 10.1016/S0168-1591(97)00068-3; Erhard HW, 1997, APPL ANIM BEHAV SCI, V54, P123, DOI 10.1016/S0168-1591(97)00069-5; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; FORKMAN B, 1995, APPL ANIM BEHAV SCI, V45, P31, DOI 10.1016/0168-1591(95)00601-N; GENG S, 1982, AM J ENOL VITICULT, V33, P131; GRANDIN T, 1993, APPL ANIM BEHAV SCI, V36, P1, DOI 10.1016/0168-1591(93)90094-6; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Holl JW, 2010, J ANIM SCI, V88, P455, DOI 10.2527/jas.2008-1559; Hoy S., 2005, Neue Landwirtschaft, P50; JENSEN P, 1995, APPL ANIM BEHAV SCI, V45, P43, DOI 10.1016/0168-1591(95)00591-F; JENSEN P, 1995, APPL ANIM BEHAV SCI, V44, P245, DOI 10.1016/0168-1591(95)00617-2; Koeck A, 2010, J DAIRY SCI, V93, P4351, DOI 10.3168/jds.2009-2955; LAWRENCE AB, 1991, APPL ANIM BEHAV SCI, V30, P73, DOI 10.1016/0168-1591(91)90086-D; Madsen P., 2013, USERS GUIDE DMU VERS; Marquer P., 2010, STAT FOCUS, V8, P1; MEESE GB, 1973, ANIM BEHAV, V21, P326, DOI 10.1016/S0003-3472(73)80074-0; Melotti L, 2011, APPL ANIMAL BEHAV SC, V133, P3; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Scheffler K, 2014, APPL ANIM BEHAV SCI, V160, P38, DOI 10.1016/j.applanim.2014.08.010; Scheffler K, 2014, LIVEST SCI, V167, P297, DOI 10.1016/j.livsci.2014.04.017; Spoolder HAM, 1996, APPL ANIM BEHAV SCI, V49, P185, DOI 10.1016/0168-1591(96)01033-7; Tonepohl B, 2013, APPL ANIM BEHAV SCI, V144, P108, DOI 10.1016/j.applanim.2013.01.004; Tonepohl B, 2012, APPL ANIM BEHAV SCI, V140, P137, DOI 10.1016/j.applanim.2012.05.002; Tonepohl B, 2011, P JOINT C GERM SOC A, pB23; Tsuruta S, 2004, J DAIRY SCI, V87, P1457, DOI 10.3168/jds.S0022-0302(04)73297-X; Turner SP, 2006, ANIM SCI, V82, P615, DOI 10.1079/ASC200678; Turner SP, 2009, J ANIM SCI, V87, P3076, DOI 10.2527/jas.2008-1558; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; van der Kooij EV, 2002, APPL ANIM BEHAV SCI, V75, P293, DOI 10.1016/S0168-1591(01)00203-9; Vazquez AI, 2009, J DAIRY SCI, V92, P739, DOI 10.3168/jds.2008-1325; Velie BD, 2009, J ANIM SCI, V87, P2767, DOI 10.2527/jas.2008-1328; von Borstel UK, 2012, APPL ANIM BEHAV SCI, V139, P251, DOI 10.1016/j.applanim.2012.04.007; Yin T, 2014, J DAIRY SCI, V97, P2444, DOI 10.3168/jds.2013-7143; Yoder CL, 2011, LIVEST SCI, V136, P93, DOI 10.1016/j.livsci.2010.08.004; Zebunke M, 2015, APPL ANIM BEHAV SCI, V169, P17, DOI 10.1016/j.applanim.2015.05.002	46	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0204211	10.1371/journal.pone.0204211	http://dx.doi.org/10.1371/journal.pone.0204211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592711	Green Published, gold			2022-12-26	WOS:000454621900002
J	He, F; Chuang, CC; Zhou, TY; Jiang, Q; Sedlock, DA; Zuo, L				He, Feng; Chuang, Chia-Chen; Zhou, Tingyang; Jiang, Qing; Sedlock, Darlene A.; Zuo, Li			Redox correlation in muscle lengthening and immune response in eccentric exercise	PLOS ONE			English	Article							TNF-ALPHA OVEREXPRESSION; SKELETAL-MUSCLE; OXIDATIVE STRESS; LYMPHOCYTE APOPTOSIS; VITAMIN-E; INFLAMMATORY RESPONSES; DAMAGE; SUPPLEMENTATION; LEUKOCYTE; DIAPHRAGM	This study was designed to examine the potential involvement of reactive oxygen species in skeletal muscle dysfunction linked with stretching in a mouse model and to explore the effects of combined antioxidant intake on peripheral leukocyte apoptosis following eccentrically-biased downhill runs in human subjects. In the mouse model, diaphragmatic muscle was stretched by 30% of its optimal length, followed by 5-min contraction. Muscle function and extracellular reactive oxygen species release was measured ex vivo. In human models, participants performed two trials of downhill running either with or without antioxidant supplementation, followed by apoptotic assay of inflammatory cells in the blood. The results showed that stretch led to decreased muscle function and prominent ROS increase during muscle contraction. In human models, we observed an elevation in circulating leukocyte apoptosis 24-48 hours following acute downhill runs. However, there is an attenuated leukocyte apoptosis following the second bout of downhill run. Interestingly, the combination of ascorbic acid (vitamin C) and a-tocopherol (vitamin E) supplementation attenuated the decrease in B-cell lymphoma 2 (Bcl-2) at 24 hours following acute downhill running. These data collectively suggest that significant ROS formation can be induced by muscle-lengthening associated with eccentric exercise, which is accompanied by compromised muscle function. The combination of antioxidants supplementation appears to have a protective role via the attenuation of decrease in anti-apoptotic protein.	[He, Feng; Sedlock, Darlene A.] Purdue Univ, Coll Hlth & Human Sci, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [He, Feng] Calif State Univ Chico, Dept Kinesiol, Chico, CA 95929 USA; [Chuang, Chia-Chen; Zhou, Tingyang; Zuo, Li] Ohio State Univ, Coll Med, Radiol Sci & Resp Therapy Div, Sch Hlth & Rehabil Sci,Wexner Med Ctr, Columbus, OH 43210 USA; [Chuang, Chia-Chen; Zhou, Tingyang; Zuo, Li] Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA; [Jiang, Qing] Purdue Univ, Coll Hlth & Human Sci, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Zuo, Li] Univ Maine, Coll Arts & Sci, Mol Physiol & Biophys Lab, Presque Isle, ME USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; California State University System; California State University Chico; Ohio State University; Ohio State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Maine System; University of Maine Orono; University of Maine Presque Isle	Sedlock, DA (corresponding author), Purdue Univ, Coll Hlth & Human Sci, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA.; Zuo, L (corresponding author), Ohio State Univ, Coll Med, Radiol Sci & Resp Therapy Div, Sch Hlth & Rehabil Sci,Wexner Med Ctr, Columbus, OH 43210 USA.; Zuo, L (corresponding author), Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA.; Zuo, L (corresponding author), Univ Maine, Coll Arts & Sci, Mol Physiol & Biophys Lab, Presque Isle, ME USA.	sedlock@purdue.edu; zuo.4@osu.edu			Wastl Human Performance Laboratory; Purdue Research Foundation; Ohio State University College of Medicine-Health and Rehabilitation Sciences Fund [013000]; American Physiology Society S&R Foundation Ryuji Ueno Award; Purdue University Bilsland Strategic Initiative Fellowship; Donald L. Corrigan Professional Development Grant	Wastl Human Performance Laboratory; Purdue Research Foundation; Ohio State University College of Medicine-Health and Rehabilitation Sciences Fund; American Physiology Society S&R Foundation Ryuji Ueno Award; Purdue University Bilsland Strategic Initiative Fellowship; Donald L. Corrigan Professional Development Grant	The human portion of this study was supported by Wastl Human Performance Laboratory, Donald L. Corrigan Professional Development Grant, Purdue Research Foundation, and Purdue University Bilsland Strategic Initiative Fellowship. The animal portion of this study was funded by The Ohio State University College of Medicine-Health and Rehabilitation Sciences Fund 013000 and American Physiology Society S&R Foundation Ryuji Ueno Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2001, ACTA PHYSIOL SCAND, V171, P311, DOI 10.1046/j.1365-201x.2001.00833.x; Bedoui S, 2002, J NEUROIMMUNOL, V132, P25, DOI 10.1016/S0165-5728(02)00278-3; Begum-Haque S, 2009, MICROB PATHOGENESIS, V47, P281, DOI 10.1016/j.micpath.2009.09.004; Brooks SV, 2008, J PHYSIOL-LONDON, V586, P3979, DOI 10.1113/jphysiol.2008.155382; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Close GL, 2004, EUR J APPL PHYSIOL, V91, P615, DOI 10.1007/s00421-003-1012-2; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Espino J, 2011, J PINEAL RES, V51, P195, DOI 10.1111/j.1600-079X.2011.00876.x; FRANCHI MV, 2017, FRONT PHYSIOL, V8; HARTMANN A, 1995, MUTAT RES LETT, V346, P195, DOI 10.1016/0165-7992(95)90035-7; He F, 2015, INT J SPORTS MED, V36, P407, DOI 10.1055/s-0034-1395630; HE F, 2016, FRONT PHYSIOL, V7; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hody S, 2013, MED SCI SPORT EXER, V45, P1460, DOI 10.1249/MSS.0b013e3182894a33; Hyldahl RD, 2017, EXERC SPORT SCI REV, V45, P24, DOI 10.1249/JES.0000000000000095; Jackson MJ, 2005, PHILOS T R SOC B, V360, P2285, DOI 10.1098/rstb.2005.1773; Jiang Q, 2007, J LIPID RES, V48, P1221, DOI 10.1194/jlr.D700001-JLR200; Kayan M, 2012, J MEMBRANE BIOL, V245, P833, DOI 10.1007/s00232-012-9491-x; Kolbeck RC, 1997, AM J RESP CRIT CARE, V156, P140, DOI 10.1164/ajrccm.156.1.9610041; Kruger K, 2011, J APPL PHYSIOL, V110, P1226, DOI 10.1152/japplphysiol.01295.2010; Kruger K, 2009, AM J PHYSIOL-REG I, V296, pR1518, DOI 10.1152/ajpregu.90994.2008; Lagranha CJ, 2004, MED SCI SPORT EXER, V36, P210, DOI 10.1249/01.MSS.0000113490.98089.B1; Liao P, 2010, AM J PHYSIOL-REG I, V298, pR599, DOI 10.1152/ajpregu.00480.2009; Lin YS, 1999, MED SCI SPORT EXER, V31, P1594, DOI 10.1097/00005768-199911000-00015; Margaritelis NV, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12648; Marsh SA, 2005, J MOL CELL CARDIOL, V38, P445, DOI 10.1016/j.yjmcc.2004.11.026; Maruhashi Y, 2007, J PHYSIOL SCI, V57, P211, DOI 10.2170/physiolsci.RP013006; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Moldoveanu AI, 2000, J APPL PHYSIOL, V89, P1499, DOI 10.1152/jappl.2000.89.4.1499; Mooren FC, 2004, MED SCI SPORT EXER, V36, P1476, DOI 10.1249/01.MSS.0000139897.34521.E9; Moreira A, 2009, BRIT MED BULL, V90, P111, DOI 10.1093/bmb/ldp010; Navalta JW, 2011, CLINICS, V66, P197, DOI 10.1590/S1807-59322011000200003; Navalta JW, 2005, MED SCI SPORT EXER, V37, P369, DOI 10.1249/01.MSS.0000155433.08698.C1; Nieman DC, 2002, J APPL PHYSIOL, V92, P1970, DOI 10.1152/japplphysiol.00961.2001; Nikolaidis MG, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/707941; Park KS, 2011, EUR J APPL PHYSIOL, V111, P2349, DOI 10.1007/s00421-011-1907-2; Park KS, 2006, MED SCI SPORT EXER, V38, pS412, DOI 10.1249/00005768-200605001-01736; Peake J, 2005, EXERC IMMUNOL REV, V11, P64; Peake JM, 2007, J NUTR BIOCHEM, V18, P357, DOI 10.1016/j.jnutbio.2006.10.005; Petersen EW, 2001, AM J PHYSIOL-CELL PH, V280, pC1570, DOI 10.1152/ajpcell.2001.280.6.C1570; Phaneuf S, 2001, MED SCI SPORT EXER, V33, P393, DOI 10.1097/00005768-200103000-00010; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; PIZZA FX, 1995, MED SCI SPORT EXER, V27, P363; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; SANDSTROM PA, 1994, J LEUKOCYTE BIOL, V55, P221, DOI 10.1002/jlb.55.2.221; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Scheel-Toellner D, 2004, BIOCHEM SOC T, V32, P679, DOI 10.1042/BST0320679; Silva LA, 2013, BRAZ J MED BIOL RES, V46, P14, DOI 10.1590/1414-431X20121956; Silva LA, 2011, CELL BIOCHEM FUNCT, V29, P43, DOI 10.1002/cbf.1716; SMITH LL, 1989, EUR J APPL PHYSIOL O, V58, P833, DOI 10.1007/BF02332215; Syu GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024385; Tuan TC, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2006.029314; Wang JS, 2005, EUR J APPL PHYSIOL, V95, P290, DOI 10.1007/s00421-005-0005-8; Wijnhoven JH, 2006, RESP MED, V100, P1064, DOI 10.1016/j.rmed.2005.09.029; Wretman C, 2001, J PHYSIOL-LONDON, V535, P155, DOI 10.1111/j.1469-7793.2001.00155.x; Zhang DQ, 2016, ONCOTARGET, V7, P41622, DOI 10.18632/oncotarget.9517; Zollner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045661; Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058; Zuo L, 2015, AM J PHYSIOL-CELL PH, V309, pC759, DOI 10.1152/ajpcell.00174.2015; Zuo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109884; Zuo L, 2014, AM J PHYSIOL-REG I, V306, pR75, DOI 10.1152/ajpregu.00425.2013; Zuo L, 2011, AM J PHYSIOL-REG I, V301, pR1025, DOI 10.1152/ajpregu.00126.2011	67	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208799	10.1371/journal.pone.0208799	http://dx.doi.org/10.1371/journal.pone.0208799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589838	Green Published, gold, Green Submitted			2022-12-26	WOS:000454418200010
J	Luo, YC; Wang, L; Yang, L; Tan, M; Wu, YQ; Li, YH; Li, ZQ				Luo, Yunchao; Wang, Lin; Yang, Le; Tan, Ming; Wu, Yiqian; Li, Yuhang; Li, Zhongqiu			Puppet resting behavior in the Tibetan antelope (Pantholops hodgsonii)	PLOS ONE			English	Article							NATURE-RESERVE; ASIATIC IBEX; SLEEP; XINJIANG; BUDGET; LIMB	Rest contributes a large part of animals' daily life, and animals usually rest in two ways, standing or in recumbence. Small or medium sized ungulates bed to rest in most cases, and standing rest is very rare and hardly seen. Here we described a standing rest behavior of Tibetan antelopes (Pantholops hodgsonii) living on the Tibet Plateau which has not been reported before. We named the standing rest behavior Puppet behavior, since the antelope stand still for a certain time. Of the 304 individuals observed, 48.3% (98/203) of adult and sub-adult males expressed the Puppet behavior, whereas only 6.3% (6/96) of females did, indicating an obvious sexual difference. Puppet behavior occurred more frequently at noon and in the afternoon on sunny and cloudy days, meaning that daytime and weather were both influential factors. Puppet behavior was usually accompanied with rumination and sometimes ended with leg-shaking. Our results suggest that Puppet behavior may be an adaptive form of rest, which may serve a thermoregulatory and anti-predation function, and may be simpler and safer than recumbent rest.	[Luo, Yunchao; Wang, Lin; Tan, Ming; Wu, Yiqian; Li, Yuhang; Li, Zhongqiu] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Yang, Le] Tibet Plateau Inst Biol, Lhasa, Peoples R China	Nanjing University	Li, ZQ (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China.	lizq@nju.edu.cn	Luo, Yunchao/GPW-6380-2022	Luo, Yunchao/0000-0002-6102-0326; Wang, Lin/0000-0003-3048-1776	National Natural Science Foundation of the People's Republic of China [31360141, 31772470, J1103512]; West Light Foundation of Chinese Academy of Sciences	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	We sincerely thank the National Natural Science Foundation of the People's Republic of China (No. 31360141 for Le Yang, No. 31772470 for Zhongqiu Li, and No. J1103512 for Lingdong Kong) and West Light Foundation of Chinese Academy of Sciences (2015, for Le Yang) for supporting this study financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WILDLIFE TEBETAN STE; BENEDICT FRANCIS G., 1938, JOUR MAMMAL, V19, P175, DOI 10.2307/1374612; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Bleisch WV, 2009, ORYX, V43, P191, DOI 10.1017/S0030605308001506; BOYD LE, 1988, APPL ANIM BEHAV SCI, V21, P5, DOI 10.1016/0168-1591(88)90098-6; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chang YH, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0948; [陈金良 CHEN JinLiang], 2008, [生态学报, Acta Ecologica Sinica], V28, P1104; [夏参军 Xia Canjun], 2013, [兽类学报, Acta Theriologica Sinica], V33, P144; [刘伟 Liu Wei], 2012, [干旱区地理, Arid Land Geography], V35, P607; ELGAR MA, 1988, ANIM BEHAV, V36, P1407, DOI 10.1016/S0003-3472(88)80211-2; Gravett N, 2017, APPL CATEGOR STRUCT, V12; Hansen MN, 2007, APPL ANIM BEHAV SCI, V105, P265, DOI 10.1016/j.applanim.2006.04.032; KLINGEL H, 1974, Zeitschrift fuer Tierpsychologie, V36, P37; Leslie David M. Jr., 2008, Mammalian Species, P1, DOI 10.1644/817.1; Li CW, 2009, WILDLIFE RES, V36, P379, DOI 10.1071/WR08117; [李磊磊 Li Leilei], 2017, [山地学报, Mountain Research], V35, P9; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066261; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lutermann H, 2010, ANIM BEHAV, V79, P1211, DOI 10.1016/j.anbehav.2010.02.017; Lyamin OI, 2002, PHYSIOL BEHAV, V76, P265, DOI 10.1016/S0031-9384(02)00722-9; Moehlman PD, 1998, APPL ANIM BEHAV SCI, V60, P125, DOI 10.1016/S0168-1591(98)00162-2; Opp MR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-8; Pedersen GR, 2004, J EQUINE VET SCI, V24, P153, DOI 10.1016/j.jevs.2004.03.013; Schmidt MH, 2014, NEUROSCI BIOBEHAV R, V47, P122, DOI 10.1016/j.neubiorev.2014.08.001; Schuurman SO, 2003, J ANAT, V202, P355, DOI 10.1046/j.1469-7580.2003.00166.x; Siegel JM, 2008, TRENDS NEUROSCI, V31, P208, DOI 10.1016/j.tins.2008.02.001; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; TOBLER I, 1992, SLEEP, V15, P1; Tobler I, 1996, J SLEEP RES, V5, P21, DOI 10.1046/j.1365-2869.1996.00010.x; vanDierendonck MC, 1996, APPL ANIM BEHAV SCI, V50, P95, DOI 10.1016/0168-1591(96)01089-1; Voss U, 2004, REV NEUROSCIENCE, V15, P33; Xu F, 2012, PAK J ZOOL, V44, P389; Xu F, 2012, EUR J WILDLIFE RES, V58, P71, DOI 10.1007/s10344-011-0542-x; Li ZQ, 2008, BEHAV PROCESS, V78, P25, DOI 10.1016/j.beproc.2007.11.011	35	6	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0204379	10.1371/journal.pone.0204379	http://dx.doi.org/10.1371/journal.pone.0204379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589844	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200002
J	Oliveira-Silva, I; Silva, VA; Cunha, RM; Foster, C				Oliveira-Silva, Iranse; Silva, Vinicius Araujo; Cunha, Raphael Martins; Foster, Carl			Autonomic changes induced by precompetitive stress in cyclists in relation to physical fitness and anxiety	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PERFORMANCE; COMPETITION; GENDER	Cycling is a sport which requires great physical effort from athletes. The stress and anxiety of competition might interfere greatly with performance, by impacting the autonomic system. Physiological alterations, such as situations that irritate, frighten or excite the individual can cause a stress response, defined as a response of the organism to reestablish the homeostasis, regardless of its relationship to a sports situation. The aim of this study was to present data on the autonomic changes induced by precompetitive stress in cyclists and their relation with physical fitness and anxiety. Twelve healthy cyclists aged between 18 and 40 years, with previous experience in competition at the regional level, participated in the study. Heart rate variability (HRV) and physical fitness (body mass index, body fat and aerobic capacity) were measured 5 days before the Mountain Bike championship and remeasured 45 minutes before the start of the race (HRV and Anciety). Paired T test, effect size and correlational test were used. Cycling competition is a stressful situation capable of altering autonomic and hemodynamic parameters. We observed the increase in SDNN, reflecting an increase in sympathetic autonomic control. There were correlations between physical fitness with some autonomic parameters, while anxiety correlated with the years of experience in competition.	[Oliveira-Silva, Iranse; Silva, Vinicius Araujo; Cunha, Raphael Martins] Univ Ctr Anapolis UniEVANGELICA, Dept Phys Educ, Anapolis, Brazil; [Foster, Carl] Univ Wisconsin, Dept Exercise & Sport Sci, La Crosse, WI 54601 USA	Centro Universitario de Anapolis; University of Wisconsin System	Oliveira-Silva, I (corresponding author), Univ Ctr Anapolis UniEVANGELICA, Dept Phys Educ, Anapolis, Brazil.	iranse.silva@unievangelica.edu.br	Cunha, Raphael/AAF-8375-2021; Oliveira-Silva, Iransé/H-7046-2015	Oliveira-Silva, Iransé/0000-0003-2692-1548				Aleman KB, 2010, SPORTS MED, V40, P77, DOI 10.2165/11319640-000000000-00000; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; BILLMAN GE, 2011, FRONT PHYSIOL, V2; Boullosa DA, 2012, EUR J APPL PHYSIOL, V112, P2233, DOI 10.1007/s00421-011-2202-y; Buchheit M, 2004, AM J PHYSIOL-HEART C, V287, pH2813, DOI 10.1152/ajpheart.00490.2004; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Camm AJ, 1996, CIRCULATION, V93, P1043; Chidley JB, 2015, INT J SPORT PHYSIOL, V10, P183, DOI 10.1123/ijspp.2014-0135; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dellal A, 2015, ASIAN J SPORTS MED, V6; Earnest CP, 2004, BRIT J SPORT MED, V38, P568, DOI 10.1136/bjsm.2003.005140; Edmonds R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127749; Gillham E, 2014, J SPORT BEHAV, V37, P37; Gimenes Fernandes M, 2012, PSICOLOGIA REFLEXAO, V25; Hanton S., 2008, INT REV SPORT EXER P, V1:1, P45, DOI [https://doi.org/10.1080/17509840701827445, DOI 10.1080/17509840701827445]; Hautala AJ, 2010, AM J PHYSIOL-HEART C, V298, pH874, DOI 10.1152/ajpheart.00856.2009; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hynynen E, 2011, EUR J APPL PHYSIOL, V111, P733, DOI 10.1007/s00421-010-1698-x; Hynynen E, 2009, AVIAT SPACE ENVIR MD, V80, P976, DOI 10.3357/ASEM.2542.2009; Impellizzeri FM, 2007, SPORTS MED, V37, P59, DOI 10.2165/00007256-200737010-00005; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jandackova VK, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002365; Kivlighan KT, 2006, PSYCHONEUROENDOCRINO, V31, P703, DOI 10.1016/j.psyneuen.2006.01.007; Knechtle Beat, 2014, Asian J Sports Med, V5, P73; Kurimay D, 2017, J HUM KINET, V55, P75, DOI 10.1515/hukin-2017-0007; LIPP Marilda Emmanuel Novaes, 1996, PESQUISAS STRESS BRA; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; Mateo M, 2012, EUR J APPL PHYSIOL, V112, P113, DOI 10.1007/s00421-011-1962-8; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Medeiros AR, 2016, INT J PERF ANAL SPOR, V16, P581, DOI 10.1080/24748668.2016.11868910; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Mellalieu S.D., 2006, LIT REV SPORT PSYCHO, P1; Morales J, 2013, INT J SPORTS MED, V34, P144, DOI 10.1055/s-0032-1323719; Oliveira-Silva I, 2016, REV CEREUS, V8, P100; Oliveira-Silva I, 2015, AEROSP MED HUM PERF, V86, P875, DOI 10.3357/AMHP.4296.2015; Patel DR, 2010, J PEDIATR ADOL GYNEC, V23, P325, DOI 10.1016/j.jpag.2010.04.004; Patil SG, 2013, EFFECT OF YOGA ON SH; Piacentini MF, 2015, J SPORT MED PHYS FIT, V55, P329; Plews DJ, 2012, EUR J APPL PHYSIOL, V112, P3729, DOI 10.1007/s00421-012-2354-4; Ramis Y, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00572; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Sperlich B, 2012, INT J SPORT PHYSIOL, V7, P47, DOI 10.1123/ijspp.7.1.47; Zhao RF, 2015, ANN NONINVAS ELECTRO, V20, P158, DOI 10.1111/anec.12189	43	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209834	10.1371/journal.pone.0209834	http://dx.doi.org/10.1371/journal.pone.0209834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589905	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200058
J	Ho, S; Gooderham, GK; Handy, TC				Ho, Simon; Gooderham, G. Kyle; Handy, Todd C.			Self-reported free-living physical activity and executive control in young adults	PLOS ONE			English	Article							COGNITIVE FUNCTION; AEROBIC EXERCISE; CARDIOVASCULAR EXERCISE; ATTENTION SYSTEM; AGING BRAIN; FITNESS; TASK; ADOLESCENTS; INTENSITY; CHILDREN	To what extent do our free-living physical activity (PA) levels impact our cognition? For example, if we engage in more intense PA from one week to the next, does this have a corresponding influence on cognitive performance? Across three studies, young adults completed a validated self-report questionnaire (the International Physical Activity Questionnaire, or IPAQ) assessing their involvement in PA at low, moderate, and vigorous intensities over the past week, as well as computer-based measures of executive control and attentional function. In Experiment 1 we found no significant effect of PA intensity on any of our measures of executive control. In a pair of follow-up control studies we examined whether these null findings could be attributed to testing fatigue and task complexity (Experiment 2), or low cognitive demands of the task (Experiment 3). Despite simplifying the task, reducing testing time, and increasing the cognitive load of the task, we still found no significant impact of weekly PA intensity on our measures of executive control. Taken together, our results show that self-reported PA over the past week, at any intensity level, does not appear to have a substantive impact on executive control.	[Ho, Simon; Gooderham, G. Kyle; Handy, Todd C.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Ho, S (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	simon@psych.ubc.ca		Gooderham, Geoffrey/0000-0002-6014-5653; Ho, Simon/0000-0003-3080-8900	NSERC; Kitty Heller Alter Ego Foundation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Kitty Heller Alter Ego Foundation	The present investigation was funded by an NSERC Discovery Grant awarded to TCH (http://www.nserc-crsng.gc.ca), and graduate fellowships from the Kitty Heller Alter Ego Foundation awarded to SH and GKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; American College of Sports Medicine, 2017, ACSMS GUIDELINES EXE, DOI [10.1006/brcg.2001.1507, DOI 10.1006/BRCG.2001.1507]; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P71, DOI 10.1016/j.yfrne.2017.04.002; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Berchicci M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00048; Berchicci M, 2013, J GERONTOL A-BIOL, V68, P1337, DOI 10.1093/gerona/glt094; Boucard GK, 2012, J SPORT EXERCISE PSY, V34, P808, DOI 10.1123/jsep.34.6.808; Chang YK, 2017, PSYCHOPHYSIOLOGY, V54, P289, DOI 10.1111/psyp.12784; Chang YK, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00156; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Corder K, 2009, AM J CLIN NUTR, V89, P862, DOI 10.3945/ajcn.2008.26739; Cox EP, 2016, J SCI MED SPORT, V19, P616, DOI 10.1016/j.jsams.2015.09.003; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dietrich A, 2004, BRAIN COGNITION, V55, P516, DOI 10.1016/j.bandc.2004.03.002; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; Falck RS, 2016, BRIT J SPORT MED, V50, P464, DOI 10.1136/bjsports-2014-094413; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Friedman D, 2009, COGN AFFECT BEHAV NE, V9, P91, DOI 10.3758/CABN.9.1.91; Gothe N, 2013, J PHYS ACT HEALTH, V10, P488, DOI 10.1123/jpah.10.4.488; Gourgouvelis J, 2018, PEERJ, V6, DOI 10.7717/peerj.4675; Grasten A, 2012, ADV PHYS EDU, V2, P132, DOI DOI 10.4236/APE.2012.23023; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Guiney H, 2015, NEUROPSYCHOLOGY, V29, P1, DOI 10.1037/neu0000124; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Herting MM, 2013, J COGNITIVE NEUROSCI, V25, P595, DOI 10.1162/jocn_a_00344; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Ho S., 2017, COGNITIVE BATTERY; Hsu CL, 2018, BRIT J SPORT MED, V52, P184, DOI 10.1136/bjsports-2016-096846; IPAQ Group, 2005, IPAQ SCOR PROT; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Kamijo K, 2013, J SPORT EXERCISE PSY, V35, P398, DOI 10.1123/jsep.35.4.398; Kamijo K, 2011, CLIN NEUROPHYSIOL, V122, P81, DOI 10.1016/j.clinph.2010.06.007; Kamijo K, 2010, INT J PSYCHOPHYSIOL, V75, P304, DOI 10.1016/j.ijpsycho.2010.01.002; Kamijo K, 2009, CLIN NEUROPHYSIOL, V120, P511, DOI 10.1016/j.clinph.2008.11.022; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Kim GH, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00198; Kwak L, 2009, J PEDIATR-US, V155, P914, DOI 10.1016/j.jpeds.2009.06.019; Labelle V, 2014, J SPORT EXERCISE PSY, V36, P258, DOI 10.1123/jsep.2013-0115; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lee H, 2012, COMPUT HUM BEHAV, V28, P1934, DOI 10.1016/j.chb.2012.05.013; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lee TMC, 2014, PSYCHONEUROENDOCRINO, V39, P214, DOI 10.1016/j.psyneuen.2013.09.019; Liu-Ambrose T, 2012, NEUROBIOL AGING, V33, P1690, DOI 10.1016/j.neurobiolaging.2011.05.010; Loprinzi PD, 2015, MAYO CLIN PROC, V90, P450, DOI 10.1016/j.mayocp.2014.12.023; Ludyga S, 2018, RES Q EXERCISE SPORT, V89, P164, DOI 10.1080/02701367.2018.1438575; Magnie MN, 2000, PSYCHOPHYSIOLOGY, V37, P369, DOI 10.1111/1469-8986.3730369; Marques A, 2018, BRIT J SPORT MED, V52, P1039, DOI 10.1136/bjsports-2016-097361; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moore RD, 2013, BRAIN COGNITION, V82, P43, DOI 10.1016/j.bandc.2013.02.006; O'Connor PJ, 2015, J INT NEUROPSYCH SOC, V21, P802, DOI 10.1017/S1355617715000685; Padilla C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00049; Padilla C, 2013, APPL COGNITIVE PSYCH, V27, P505, DOI 10.1002/acp.2929; Pellicer-Chenoll M, 2015, HEALTH EDUC RES, V30, P436, DOI 10.1093/her/cyv016; Perez L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101478; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pindus DM, 2015, PSYCHOL RES-PSYCH FO, V79, P715, DOI 10.1007/s00426-014-0612-2; Polich J, 1997, ELECTROEN CLIN NEURO, V103, P493, DOI 10.1016/S0013-4694(97)96033-8; Pontifex MB, 2007, CLIN NEUROPHYSIOL, V118, P570, DOI 10.1016/j.clinph.2006.09.029; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Samani A, 2018, NEUROPSYCHOLOGIA, V108, P73, DOI 10.1016/j.neuropsychologia.2017.11.029; Schmit C, 2015, NEUROPSYCHOLOGIA, V68, P71, DOI 10.1016/j.neuropsychologia.2015.01.006; Scisco JL, 2008, INT J PSYCHOPHYSIOL, V69, P52, DOI 10.1016/j.ijpsycho.2008.02.009; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Smith M, 2016, J HUM KINET, V51, P27, DOI 10.1515/hukin-2015-0167; Soga K, 2015, PSYCHOL SPORT EXERC, V16, P7, DOI 10.1016/j.psychsport.2014.08.010; Spitzer MWH, 2016, TRENDS NEUROSCI EDUC, V5, P30, DOI 10.1016/j.tine.2016.02.003; Stillman CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162100; Stroth S, 2009, NEUROPSYCHOL REHABIL, V19, P223, DOI 10.1080/09602010802091183; Stroth S, 2009, BRAIN RES, V1269, P114, DOI 10.1016/j.brainres.2009.02.073; ten Brinke LF, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0730-6; Themanson JR, 2006, NEUROBIOL AGING, V27, P1335, DOI 10.1016/j.neurobiolaging.2005.07.002; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Vandelanotte C., 2005, J PHYS ACT HEALTH, V2, P63, DOI DOI 10.1123/JPAH.2.1.63; Vanhelst J, 2016, J PEDIATR-US, V168, P126, DOI 10.1016/j.jpeds.2015.09.029; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Wagner G, 2017, BIOL PSYCHOL, V124, P65, DOI 10.1016/j.biopsycho.2017.01.003; Wang CC, 2013, J SPORT EXERCISE PSY, V35, P358, DOI 10.1123/jsep.35.4.358; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; Wiedemann RG, 2014, CLIN OBES, V4, P309, DOI 10.1111/cob.12071; Wilckens KA, 2018, BEHAV SLEEP MED, V16, P569, DOI 10.1080/15402002.2016.1253013; Ziegler G, 2012, HUM BRAIN MAPP, V33, P2377, DOI 10.1002/hbm.21374	89	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209616	10.1371/journal.pone.0209616	http://dx.doi.org/10.1371/journal.pone.0209616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586447	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400076
J	Zhang, C; Song, XZ; Zhang, Q; Pang, YY; Lv, JH; Tang, BP; Cheng, YX; Yang, XZ				Zhang, Cong; Song, Xiao-zhe; Zhang, Qian; Pang, Yang-yang; Lv, Jia-huan; Tang, Bo-ping; Cheng, Yong-xu; Yang, Xiao-zhen			Changes in bud morphology, growth-related genes and nutritional status during cheliped regeneration in the Chinese mitten crab, Eriocheir sinensis	PLOS ONE			English	Article							INTESTINAL ENZYME-ACTIVITIES; L-TRYPTOPHAN; FIDDLER-CRAB; DECAPOD CRUSTACEAN; LIMB REGENERATION; HORMONAL-CONTROL; IMMUNE-RESPONSE; PORCELAIN CRABS; MOLT CYCLE; AUTOTOMY	During pond culture of Eriocheir sinensis, a high limb-impairment rate restricts the industry development and quality. Therefore, research on limb autotomy and regeneration has important practical significance for the industrial development and basic biology of E. sinensis. This study evaluated the changes in bud morphology, growth-related gene expression and nutritional status during cheliped regeneration in E. sinensis. The study found that the new cheliped was pre-formed in the bud and then regenerated with the completion of molting of E. sinensis. The new cheliped was similar in morphology to the normal cheliped after the first molting but smaller in size. The qRT-PCR results of growth-related genes showed that the expression levels of EcR-mRNA (ecdysteroid receptor) and Chi-mRNA (chitinase) were significantly up-regulated, whereas the expression of MIH-mRNA (molt-inhibiting hormone) was significantly down-regulated (P < 0.05). The nutritional status during the regeneration process showed that the hepatopancreas total lipid content decreased significantly within 28 days and was significantly lower in the autotomy group than in the control group at 14 d and 21 d (P < 0.05). The hepatopancreas fatty acid composition results showed that saturated fatty acids (SFA), highly unsaturated fatty acids (HUFA) and n-3/n-6 were significantly higher in the autotomy group than in the control group at 21 d (P < 0.05), whereas the Sigma n-6 PUFA and Sigma n-3 PUFA at 1 d and 7 d, and the monounsaturated fatty acid (MUFA) at 28 d in the autotomy group were significantly lower than in the control group (P < 0.05). Moreover, the levels of eicosatetraenoic acid (ARA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) showed that DHA was significantly lower at 7 d and significantly higher at 21 d in the autotomy group than in the control group (P < 0.05), whereas ARA and EPA were not significantly different between the two groups. Muscle L-tryptophan content was significantly lower at 1 d and significantly higher at 7 d in the autotomy group than in the control group (P < 0.05). These results indicate that during the cheliped regeneration process, crabs could accelerate molting and regeneration by regulating growth-related gene expression (e.g., EcR-mRNA and MIH-mRNA) and nutrient metabolism (e.g., lipid metabolism).	[Zhang, Cong; Song, Xiao-zhe; Zhang, Qian; Pang, Yang-yang; Lv, Jia-huan; Cheng, Yong-xu; Yang, Xiao-zhen] Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Zhang, Cong; Song, Xiao-zhe; Zhang, Qian; Pang, Yang-yang; Lv, Jia-huan; Cheng, Yong-xu; Yang, Xiao-zhen] Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China; [Zhang, Cong; Song, Xiao-zhe; Zhang, Qian; Pang, Yang-yang; Lv, Jia-huan; Cheng, Yong-xu; Yang, Xiao-zhen] Shanghai Ocean Univ, Engn Res Ctr Aquaculture, Shanghai, Peoples R China; [Tang, Bo-ping] Yancheng Teachers Univ, Jiangsu Key Lab Bioresources Saline Soils, Jiangsu Prov Key Lab Coastal Wetland Bioresources, Jiangsu Synthet Innovat Ctr Coastal Bioagr,Sch Oc, Yancheng, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Yancheng Teachers University	Cheng, YX; Yang, XZ (corresponding author), Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Cheng, YX; Yang, XZ (corresponding author), Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China.; Cheng, YX; Yang, XZ (corresponding author), Shanghai Ocean Univ, Engn Res Ctr Aquaculture, Shanghai, Peoples R China.	zny119@163.com; xzyang@shou.edu.cn			Shanghai Agricultural Commission [2015D1-7]; Aquaculture Engineering Research Platform in Shanghai by Shanghai Science and Technology Commission [16DZ2281200]; China Agriculture Research System [CARS-48]	Shanghai Agricultural Commission; Aquaculture Engineering Research Platform in Shanghai by Shanghai Science and Technology Commission; China Agriculture Research System	the Extension of Chinese Mitten Crab Eriocheir Sinensis Aquaculture Technology that was found from Shanghai Agricultural Commission [grant number 2015D1-7], the Aquaculture Engineering Research Platform in Shanghai Established by Shanghai Science and Technology Commission [grant number 16DZ2281200]), and the China Agriculture Research System [grant number CARS-48].	Alvarez JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136916; BARCLAY MC, 1983, J EXP MAR BIOL ECOL, V68, P229, DOI 10.1016/0022-0981(83)90055-2; CHANG ES, 1993, ANNU REV ENTOMOL, V38, P161, DOI 10.1146/annurev.en.38.010193.001113; Cheng Yong-Xu, 1998, Acta Zoologica Sinica, V44, P420; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; Delaney DG, 2011, BIOL INVASIONS, V13, P2935, DOI 10.1007/s10530-011-9975-0; Esteban S, 2004, MOL CELL BIOCHEM, V267, P39, DOI 10.1023/B:MCBI.0000049363.97713.74; Farhat, 2014, AQUAC RES, V45, P1224, DOI 10.1111/are.12066; Fleming PA, 2007, BIOL REV, V82, P481, DOI 10.1111/j.1469-185X.2007.00020.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frisch AJ, 2011, MAR BIOL, V158, P1645, DOI 10.1007/s00227-011-1678-7; He J, 2016, AQUACULTURE, V457, P79, DOI 10.1016/j.aquaculture.2016.02.004; He Jie, 2013, Shengtaixue Zazhi, V32, P2077; HOPKINS PM, 1989, J EXP ZOOL, V252, P293, DOI 10.1002/jez.1402520312; HOPKINS PM, 1992, AM ZOOL, V32, P450; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; JUANES F, 1992, MAR ECOL PROG SER, V87, P239, DOI 10.3354/meps087239; Knope ML, 2014, MAR ECOL-EVOL PERSP, V35, P471, DOI 10.1111/maec.12103; KONO M, 1995, FISHERIES SCI, V61, P727, DOI 10.2331/fishsci.61.727; Kramer KJ, 1997, INSECT BIOCHEM MOLEC, V27, P887, DOI 10.1016/S0965-1748(97)00078-7; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; LIPCIUS RN, 1982, MAR BIOL, V68, P241, DOI 10.1007/BF00409591; Liu L, 2018, GENE, V658, P113, DOI 10.1016/j.gene.2018.03.015; Lopez-Patino MA, 2013, AQUACULTURE, V388, P165, DOI 10.1016/j.aquaculture.2013.01.023; Ma MingJun, 2014, Journal of Fisheries of China, V38, P1889; Mariappan P, 2000, J BIOSCIENCES, V25, P301, DOI 10.1007/BF02703939; MCVEAN A, 1979, J MAR BIOL ASSOC UK, V59, P341, DOI 10.1017/S0025315400042648; MOHRHERR CJ, 1987, J CRUSTACEAN BIOL, V7, P302, DOI 10.2307/1548610; MORRISON WR, 1964, J LIPID RES, V5, P600; Munoz JLP, 2009, J CHROMATOGR B, V877, P2173, DOI 10.1016/j.jchromb.2009.06.001; Munoz-Perez JL, 2016, J COMP PHYSIOL B, V186, P471, DOI 10.1007/s00360-016-0966-4; Perazzolo LM, 1997, DEV COMP IMMUNOL, V21, P385, DOI 10.1016/S0145-305X(97)00022-0; Priya TAJ, 2009, COMP BIOCHEM PHYS B, V153, P121, DOI 10.1016/j.cbpb.2009.02.009; Quinitio ET, 2011, AQUACULTURE, V318, P229, DOI 10.1016/j.aquaculture.2011.05.034; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riquelme-Bugueno R, 2006, CRUSTACEANA, V79, P925, DOI 10.1163/156854006778815973; Sainio EL, 1996, AMINO ACIDS, V10, P21, DOI 10.1007/BF00806091; Shen YuChun, 2012, Journal of Fisheries of China, V36, P290; Slos S, 2009, BIOL LETTERS, V5, P90, DOI 10.1098/rsbl.2008.0501; SMITH LD, 1991, BIOL BULL, V180, P416, DOI 10.2307/1542342; SPINDLERBARTH M, 1990, MAR BIOL, V106, P49, DOI 10.1007/BF02114673; Stueckle TA, 2008, COMP BIOCHEM PHYS C, V147, P366, DOI 10.1016/j.cbpc.2008.01.004; Sui LY, 2011, AQUACULTURE, V315, P16, DOI 10.1016/j.aquaculture.2010.06.021; Sun YP, 2015, AQUACULT INT, V23, P235, DOI 10.1007/s10499-014-9811-5; Tang L, 2013, AQUACULTURE, V412, P23, DOI 10.1016/j.aquaculture.2013.07.002; Tian ZhiHuan, 2013, Acta Hydrobiologica Sinica, V37, P899; Wasson K, 2002, BEHAV ECOL, V13, P481, DOI 10.1093/beheco/13.4.481; [吴旭干 WU Xugan], 2007, [中国水产科学, Journal of Fishery Sciences of China], V14, P911; Wu XG, 2007, AQUACULTURE, V273, P602, DOI 10.1016/j.aquaculture.2007.09.030; Wu XG, 2010, J FOOD COMPOS ANAL, V23, P154, DOI 10.1016/j.jfca.2009.08.007; Yang XZ, 2018, DEV COMP IMMUNOL, V81, P33, DOI 10.1016/j.dci.2017.11.003; [姚琴琴 Yao Qinqin], 2015, [中国水产科学, Journal of Fishery Sciences of China], V22, P185; Zhang C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00269; Zhang ED, 2018, FISH SHELLFISH IMMUN, V75, P158, DOI 10.1016/j.fsi.2018.01.009	54	4	4	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209617	10.1371/journal.pone.0209617	http://dx.doi.org/10.1371/journal.pone.0209617			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586462	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400077
J	Ye, LY; Cao, Z; Lai, XR; Wang, WW; Guo, ZQ; Yan, LL; Wang, YY; Shi, Y; Zhou, NM				Ye, Lingyan; Cao, Zheng; Lai, Xiangru; Wang, Weiwei; Guo, Zhiqiang; Yan, Lili; Wang, Yuyan; Shi, Ying; Zhou, Naiming			Niacin fine-tunes energy homeostasis through canonical GPR109A signaling	FASEB JOURNAL			English	Article						obesity; de novo lipogenesis; thermogenesis; intestinal fat absorption	PROTEIN-COUPLED RECEPTOR; DE-NOVO LIPOGENESIS; NICOTINIC-ACID; OXIDATIVE STRESS; ADIPOSE-TISSUE; FATTY LIVER; MOLECULAR-IDENTIFICATION; INSULIN-SECRETION; PUMA-G; OBESITY	The incidence of overweight and obesity has become a global public health problem, constituting a major risk factor for numerous comorbidities. Despite tremendous efforts, effective pharmacological agents for the treatment of obesity are still limited. Here, we showed that in contrast to lactate receptor GPR81, niacin receptor GPR109A-deficient mice had progressive weight gain and hepatic fat accumulation. Using high-fat diet-induced mouse model of obesity, we demonstrated that niacin treatment apparently protected against obesity without affecting food intake in wild-type mice but not in GPR109A-deficient mice. Further investigation showed that niacin treatment led to a remarkable inhibition of hepatic de novo lipogenesis. Additionally, we demonstrated that niacin treatment triggered brown adipose tissue and/or white adipose tissue thermogenic activity via activation of GPR109A. Moreover, we observed that mice exposed to niacin exhibited a dramatic decrease in intestinal absorption of sterols and fatty acids. Taken together, our findings demonstrate that acting on GPR109A, niacin shows the potential to maintain energy homeostasis through multipathways, representing a potential approach to the treatment of obesity, diabetes and cardiovascular disease.	[Ye, Lingyan; Cao, Zheng; Lai, Xiangru; Wang, Weiwei; Guo, Zhiqiang; Yan, Lili; Wang, Yuyan; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Shi, Y; Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	shi_y@zju.edu.cn; zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022		Ministry of Science and Technology of China [2012CB910402]; National Natural Science Foundation of China [81173106, 31200621, 31771543]; Zhejiang Provincial Natural Science Foundation of China [LY15C050001]; Siyuan Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Siyuan Foundation	The authors thank Dr. Stefan Offermanns (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany) for providing GPR109A KO (C57BL) breeders and critical comments. Junying Li (Center of Analysis and Measurement, Zhejiang University), Qiong Huang (Core Facilities, School of Medicine, Zhejiang University), and Shenghui Hong (Laboratory Animal Center, Zhejiang University) are acknowledged for their technical assistance. This work was supported by grants from the Ministry of Science and Technology of China (2012CB910402 to N.Z.), the National Natural Science Foundation of China (81173106, 31200621, and 31771543 to N.Z. and Y.S.), the Zhejiang Provincial Natural Science Foundation of China (LY15C050001 to N.Z.), and the Siyuan Foundation (to N.Z. and Y.S.). The authors declare no conflicts of interest.	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Besnard P, 2002, MOL CELL BIOCHEM, V239, P139, DOI 10.1023/A:1020505512364; Buhler S, 2018, J ANIM PHYSIOL AN N, V102, pE87, DOI 10.1111/jpn.12705; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chang AM, 2006, J CLIN ENDOCR METAB, V91, P3303, DOI 10.1210/jc.2006-0913; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Chen LH, 2015, MOL CELL ENDOCRINOL, V404, P56, DOI 10.1016/j.mce.2015.01.029; Chen YL, 2018, J HEPATOL, V69, P687, DOI 10.1016/j.jhep.2018.04.004; Cho KH, 2009, AM J PHYSIOL-RENAL, V297, pF106, DOI 10.1152/ajprenal.00126.2009; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cunningham JW, 2014, CLIN CARDIOL, V37, P693, DOI 10.1002/clc.22304; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Digby JE, 2009, CURR OPIN LIPIDOL, V20, P321, DOI 10.1097/MOL.0b013e32832d3b9d; Dou XB, 2013, J NUTR BIOCHEM, V24, P1520, DOI 10.1016/j.jnutbio.2012.12.012; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; FOLCH J, 1957, J BIOL CHEM, V226, P497; FULCHER GR, 1992, DIABETES, V41, P1400, DOI 10.2337/diabetes.41.11.1400; Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200; Ganji SH, 2015, METABOLISM, V64, P982, DOI 10.1016/j.metabol.2015.05.002; Ganji SH, 2014, AM J PHYSIOL-GASTR L, V306, pG320, DOI 10.1152/ajpgi.00181.2013; Ganji SH, 2009, ATHEROSCLEROSIS, V202, P68, DOI 10.1016/j.atherosclerosis.2008.04.044; GARG A, 1990, JAMA-J AM MED ASSOC, V264, P723, DOI 10.1001/jama.264.6.723; Gautam J, 2018, BRIT J PHARMACOL, V175, P2581, DOI 10.1111/bph.14174; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Goldberg RB, 2008, MAYO CLIN PROC, V83, P470, DOI 10.4065/83.4.470; Graff EC, 2016, METABOLISM, V65, P102, DOI 10.1016/j.metabol.2015.10.001; Guyton JR, 1998, AM J CARDIOL, V82, P737, DOI 10.1016/S0002-9149(98)00448-2; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hu M, 2012, J LIPID RES, V53, P802, DOI 10.1194/jlr.P023614; Kamanna VS, 2013, CURR OPIN LIPIDOL, V24, P239, DOI 10.1097/MOL.0b013e3283613a68; KATSURADA A, 1990, EUR J BIOCHEM, V190, P435, DOI 10.1111/j.1432-1033.1990.tb15593.x; Kolovou GD, 2008, HELL J CARDIOL, V49, P79; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kwon WY, 2011, CRIT CARE MED, V39, P328, DOI 10.1097/CCM.0b013e3181feeae4; Li HM, 2011, PANCREAS, V40, P615, DOI 10.1097/MPA.0b013e31820b4b23; Li Q, 2014, ALCOHOL CLIN EXP RES, V38, P1982, DOI 10.1111/acer.12396; Li XY, 2010, BIOCHEM PHARMACOL, V80, P1450, DOI 10.1016/j.bcp.2010.07.023; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848; Mielenz M, 2013, J DAIRY SCI, V96, P278, DOI 10.3168/jds.2012-5816; Mitrofanov VA, 2005, B EXP BIOL MED+, V140, P702, DOI 10.1007/s10517-006-0059-6; Moreira FA, 2009, BEST PRACT RES CL EN, V23, P133, DOI 10.1016/j.beem.2008.09.003; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Olsen MK, 2017, SCAND J GASTROENTERO, V52, P442, DOI 10.1080/00365521.2016.1267791; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shehadah A, 2010, NEUROBIOL DIS, V40, P277, DOI 10.1016/j.nbd.2010.05.034; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Shi YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40000; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wang N, 2016, GEN COMP ENDOCR, V237, P98, DOI 10.1016/j.ygcen.2016.08.011; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wong TP, 2015, NUTRIENTS, V7, P7543, DOI 10.3390/nu7095352; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129; Xu F, 2009, DIABETES, V58, pA3, DOI 10.2337/db08-1637	74	18	19	4	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4765	4779		10.1096/fj.201801951R	http://dx.doi.org/10.1096/fj.201801951R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596513	Green Submitted, Bronze			2022-12-26	WOS:000462888500011
J	Hong, S; Hwang, I; Gim, E; Yang, J; Park, S; Yoon, SH; Lee, WW; Yu, JW				Hong, Sujeong; Hwang, Inhwa; Gim, Eunji; Yang, Jungmin; Park, Sangjun; Yoon, Sung-Hyun; Lee, Won-Woo; Yu, Je-Wook			Brefeldin A-sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activation	FASEB JOURNAL			English	Article						BFA; BIG1; inflammasome; IL-1 secretion	NLRP3 INFLAMMASOME ACTIVATION; CELL-DEATH; INTERLEUKIN-1; EXCHANGE; PROTEIN; MECHANISM; LOCALIZATION; MITOCHONDRIA; PYROPTOSOME; MONOCYTES	Endoplasmic reticulum (ER)-Golgi vesicle trafficking plays a pivotal role in the conventional secretory pathway of many cytokines; however, the precise release mechanism of a major inflammasome mediator, IL-1, is not thought to follow the conventional ER-Golgi route and remains elusive. Here, we found that perturbation of ER-Golgi trafficking by brefeldin A (BFA) treatment attenuated nucleotide-binding oligomerization domain-like receptor family, pyrin-domain-containing 3 (NLRP3) inflammasome activation in mouse bone marrow-derived macrophages (BMDMs). BFA treatment inhibited NLRP3-mediated inflammasome assembly and caspase-1 activation but did not block IL-1 secretion from BMDMs following BFA administration after NLRP3 inflammasome activation. Consistently, short-hairpin RNA-dependent knockdown of BFA-inhibited guanine nucleotide-exchange protein 1 (BIG1), a molecular target of BFA and an initiator of Golgi-specific vesicle trafficking, abolished NLRP3-dependent apoptosis-associated speck-like protein containing a caspase-recruitment domain oligomerization and caspase-1 activation in BMDMs. Similarly, knockdown of Golgi-specific BFA-resistance guanine nucleotide exchange factor 1, another target of BFA, clearly attenuated NLRP3-mediated caspase-1 activation in BMDMs. Mechanistically, inhibition of BIG1-mediated vesicle trafficking did not impair NLRP3-activating signal 2-promoted events, such as potassium efflux and mitochondrial rearrangement, but caused significant impairment of signal 1-triggered priming steps, including NF-B-mediated pathways. These data suggest that BFA-targeted vesicle trafficking at the Golgi contributes to activation of the NLRP3 inflammasome signaling.Hong, S., Hwang, I., Gim, E., Yang, J., Park, S., Yoon, S.-H., Lee, W.-W., Yu, J.-W. Brefeldin A-sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activation.	[Hong, Sujeong; Hwang, Inhwa; Gim, Eunji; Yang, Jungmin; Park, Sangjun; Yoon, Sung-Hyun; Yu, Je-Wook] Yonsei Univ, Brain Korea Program Leading Univ & Students PLUS, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Yu, JW (corresponding author), Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.	jewookyu@yuhs.ac		Yoon, SungHyun/0000-0002-8267-4740; Yu, Je-Wook/0000-0001-5943-4071; Lee, Won-Woo/0000-0002-5347-9591; Hwang, Inhwa/0000-0001-5235-3519	National Research Foundation of Korea - Korean Government [2014R1A4A1008625, 2015M3A9B6073856, 2017R1A2B2007467]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea Grants 2014R1A4A1008625, 2015M3A9B6073856, and 2017R1A2B2007467 funded by the Korean Government. The authors declare no conflicts of interest.	AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Burns K, 2003, CURR OPIN IMMUNOL, V15, P26, DOI 10.1016/S0952-7915(02)00017-1; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Galindo A, 2016, CELL REP, V16, P839, DOI 10.1016/j.celrep.2016.06.022; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13129; Jin HS, 2017, IMMUNE NETW, V17, P77, DOI 10.4110/in.2017.17.2.77; Kay J, 2004, RHEUMATOLOGY, V43, P2, DOI 10.1093/rheumatology/keh201; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KUNO K, 1994, J LEUKOCYTE BIOL, V56, P542, DOI 10.1002/jlb.56.5.542; Kurokawa K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4653; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.97, 10.1038/nrd.2018.149]; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MATSUSHIMA K, 1986, J IMMUNOL, V136, P2883; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Yang J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00333; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2016, ARCH PHARM RES, V39, P1503, DOI 10.1007/s12272-016-0827-4; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	40	19	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4547	4558		10.1096/fj.201801585R	http://dx.doi.org/10.1096/fj.201801585R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30592629	Bronze			2022-12-26	WOS:000459794800115
J	Sepulveda-Villegas, M; Roman, S; Rivera-Iniguez, I; Ojeda-Granados, C; Gonzalez-Aldaco, K; Torres-Reyes, LA; Jose-Abrego, A; Panduro, A				Sepulveda-Villegas, Maricruz; Roman, Sonia; Rivera-Iniguez, Ingrid; Ojeda-Granados, Claudia; Gonzalez-Aldaco, Karina; Alberto Torres-Reyes, Luis; Jose-Abrego, Alexis; Panduro, Arturo			High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population	PLOS ONE			English	Article							INSULIN-RESISTANCE; TRANSIENT ELASTOGRAPHY; POSTPRANDIAL LIPEMIA; DISEASE; ASSOCIATION; FIBROSIS; PREVENTION; DIAGNOSIS; CIRRHOSIS; RISK	Objective To identify nonalcoholic steatohepatitis (NASH) and liver stiffness in Mexican subjects with different body mass index (BMI). Methods A cross-sectional study was conducted in 505 adults. Risk for NASH was defined as the presence of one or more of the following biochemical and metabolic parameters (BMPs): fasting glucose >= 100 mg/dl, triglycerides (TG) >= 150 mg/dl, homeostatic model assessment of insulin resistance (HOMA-IR) >= 2.5, aspartate aminotransferase (AST) >54 IU/L and alanine aminotransferase (ALT) >42 IU/L. Body mass index measurement and nutritional assessment were performed by standard procedures. Liver fibrosis stage was determined by liver stiffness measurement using transitional elastography (TE) or by liver biopsy (LB). Results Risk for NASH was 57% (290/505). Most BMPs values incremented by BMI category. Among 171 at-risk patients, 106 subjects were evaluated by TE and 65 subjects by LB. Abnormal liver stiffness (>= 6.0 kPa) was prevalent in 54% (57/106) of the cases, whereas by LB, 91% (59/65) of patients with obesity had NASH and liver fibrosis. Furthermore, liver fibrosis was prevalent in 46% (6/13) in normal weight individuals, whereas 4.6% (3/65) of patients with a BMI >= 35 kg/m(2) showed no histopathological abnormalities. Overall, 67.8% (116/171) of the patients had abnormal liver stiffness or NASH. The normal weight patients with liver damage consumed relatively a higher fat-rich diet compared to the other groups whereas the remaining subgroups shared a similar dietary pattern. Conclusion Young patients with overweight and obesity showed a high prevalence of altered BMPs related to abnormal liver stiffness assessed by TE and NASH by LB. Early diagnostic strategies are required to detect the risk for NASH and avoid further liver damage in populations with a rising prevalence of obesity by defining the risk factors involved in the onset and progression of NASH.	[Panduro, Arturo] Civil Hosp Guadalajara, Dept Mol Biol Med, Guadalajara, Jalisco, Mexico; Univ Guadalajara, Hlth Sci Ctr, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara	Panduro, A (corresponding author), Civil Hosp Guadalajara, Dept Mol Biol Med, Guadalajara, Jalisco, Mexico.	apanduro@prodigy.net.mx	Rivera-Iniguez, Ingrid/GPK-5643-2022; Panduro, Arturo/AAO-7392-2020; JOSE-ABREGO, ALEXIS/F-9404-2019	JOSE-ABREGO, ALEXIS/0000-0002-8565-5908; Torres-Reyes, Luis Alberto/0000-0002-3060-9445; Rivera Iniguez, Ingrid/0000-0001-6129-6528	Programa para el Desarrollo Profesional Docente-Universidad de Guadalajara [CA478]	Programa para el Desarrollo Profesional Docente-Universidad de Guadalajara	This work was funded by Programa para el Desarrollo Profesional Docente-Universidad de Guadalajara CA478 (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenavoli L, 2016, WORLD J GASTROENTERO, V22, P7006, DOI 10.3748/wjg.v22.i31.7006; Aguilar-Salinas CA, 2014, METABOLISM, V63, P887, DOI 10.1016/j.metabol.2014.03.012; Aguilar-Salinas CA, 2010, SALUD PUBLICA MEXICO, V52, pS44, DOI 10.1590/s0036-36342010000700008; Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; Aslam M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145730; Botero Rafael Claudino, 2015, Clin Liver Dis (Hoboken), V5, P8, DOI 10.1002/cld.438; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Campos-Perez W, 2016, J FOOD NUTR RES J FO, V4, P729, DOI DOI 10.12691/JFNR-4-11-5; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Encuesta Nacional de Salud y Nutricion de Medio Camino (ENSANUT), 2016, ENCUESTA NACL SALUD; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fierbinteanu-Braticevici C, 2011, J GASTROINTEST LIVER, V20, P153; Fox CS, 2015, DIABETES CARE, V38, P1777, DOI 10.2337/dci15-0012; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Grandison GA, 2012, CLIN LIVER DIS, V16, P567, DOI 10.1016/j.cld.2012.05.001; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kumar R, 2017, J CLIN TRANSL HEPATO, V5, P216, DOI 10.14218/JCTH.2016.00068; Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517; Leon-Mimila P, 2015, EXP MOL PATHOL, V98, P178, DOI 10.1016/j.yexmp.2015.01.012; Lupsor M, 2010, J GASTROINTEST LIVER, V19, P53; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Naveau S, 2014, OBES SURG, V24, P1693, DOI 10.1007/s11695-014-1235-9; Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003; Ojeda-Granados C, 2017, J PERS MED, V7, DOI 10.3390/jpm7040016; Panduro A, 2016, WORLD J GASTROENTERO, V22, P5137, DOI 10.3748/wjg.v22.i22.5137; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Pedrini MT, 2006, DIABETOLOGIA, V49, P1612, DOI 10.1007/s00125-006-0262-z; Ramos-Lopez O., 2015, Journal of Nutrition and Food Sciences, V5, P353; Ramos-Lopez O., 2013, REV ENDOCRINOL NUTR, V21, P7; Ramos-Lopez O, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020101; Ramos-Lopez O, 2015, WORLD J GASTROENTERO, V21, P11552, DOI 10.3748/wjg.v21.i41.11552; Ramos-Lopez O, 2015, ANN HEPATOL, V14, P729, DOI 10.1016/S1665-2681(19)30768-9; Robotin MC, 2011, WORLD J HEPATOL, V3, P31, DOI 10.4254/wjh.v3.i2.31; Roman S, 2015, WORLD J GASTROENTERO, V21, P3449, DOI 10.3748/wjg.v21.i12.3449; Roman S, 2013, WORLD J GASTROENTERO, V19, P7972, DOI 10.3748/wjg.v19.i44.7972; Sepulveda-Flores Ricardo N, 2002, Ann Hepatol, V1, P36; Sporea I, 2013, MED ULTRASON, V15, P106, DOI 10.11152/mu.2013.2066.152.is1aj2; Stanciu C, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.28969v2; Torres-Valadez R, 2017, J TRANSL INTERN MED, V5, P49, DOI 10.1515/jtim-2017-0003; Tremblay AJ, 2004, CLIN BIOCHEM, V37, P785, DOI 10.1016/j.clinbiochem.2004.03.008; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; World Health Organization, 2017, OB OV; Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	51	22	22	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0208926	10.1371/journal.pone.0208926	http://dx.doi.org/10.1371/journal.pone.0208926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608932	gold, Green Published, Green Submitted			2022-12-26	WOS:000454952800015
J	Dowling, M; Samuelson, J; Fadl-Alla, B; Pondenis, HC; Byrum, M; Barger, AM; Fan, TM				Dowling, Matthew; Samuelson, Jonathan; Fadl-Alla, Bahaa; Pondenis, Holly C.; Byrum, Mark; Barger, Anne M.; Fan, Timothy M.			Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR ANALYSIS; MESSENGER-RNA; SPLENIC HEMANGIOSARCOMA; PERIPHERAL-BLOOD; TUMOR-CELLS; CANCER; DOGS; DIAGNOSIS; THERAPY	Background Canine hemangiosarcoma (cHSA) is a highly metastatic mesenchymal cancer that disseminates by hematogenous and direct implantation routes. Therapies for cHSA are generally ineffective, in part due to advanced clinical disease stage at the time of diagnosis. The validation of conventional molecular methods for detecting novel biomarkers preferentially expressed by cHSA could lead to more timely diagnosis, earlier therapeutic interventions, and improved outcomes. In humans, prostate-specific membrane antigen (PSMA) is a transmembrane protein overexpressed by prostate carcinoma and tumor-associated endothelium of various solid cancer histologies. Importantly, the preferential overexpression of PSMA by certain cancers has been leveraged for the development of diagnostic molecular imaging reagents and targeted therapeutics. Recently, PSMA has been qualitatively demonstrated to be expressed in cHSA cell lines, however, quantitative PSMA expressions and the potential utility of PSMA transcript identification in biologic fluids to support the presence of microscopic cHSA burden has not been reported. Therefore, this study sought to characterize the differential quantitative expressions of PSMA between cHSA and non-malignant tissues, and to determine the potential diagnostic utility of PCR-generated PSMA amplicons as a surrogate of rare cHSA cells dwelling within peritoneal and pericardial cavities. Methods Quantitative gene and protein expressions for PSMA were compared between one normal endothelial and six cHSA cell lines by RT-PCR, western blot analysis, and fluorescent microscopy. Additionally, gene and protein expressions of PSMA in normal canine tissues were characterized. Graded expressions of PSMA were determined in spontaneously-arising cHSA tumor samples and the feasibility of qualitative PCR as a molecular diagnostic to detect PSMA transcripts in whole blood from healthy dogs and hemorrhagic effusions from cHSA-bearing dogs were evaluated. Results PSMA gene and protein expressions were elevated (up to 6-fold) in cHSA cells compared with non-malignant endothelium. By immunohistochemistry, protein expressions of PSMA were detectable in all cHSA tissue samples evaluated. As predicted by human protein atlas data, PSMA's expression was comparably identified at substantial levels in select normal canine tissues including kidney, liver, and intestine. In young healthy pet dogs, PSMA amplicons could not be identified in circulating whole blood yet were detectable in hemorrhagic effusions collected from pet dogs with confirmed cHSA or PSMA-expressing cancer. Conclusions PSMA is quantitatively overexpressed in cHSA compared to normal endothelium, but its protein expression is not restricted to only cHSA tumor tissues, as specific visceral organs also substantively express PSMA. Optimized qualitative PCR methods failed to amplify PSMA amplicons sufficiently for visible detection in circulating whole blood derived from healthy young dogs, yet PSMA transcripts were readily identifiable in hemorrhagic effusions collected from pet dogs with histologically confirmed cHSA or PSMA-expressing cancer. While preliminary, findings derived from a limited cohort of normal and diseased pet dogs provocatively raise the potential value of PSMA amplicon detection as an ancillary molecular diagnostic test for supporting the presence of microscopic cHSA disease burden within hemorrhagic body cavity effusions.	[Dowling, Matthew; Pondenis, Holly C.; Byrum, Mark; Barger, Anne M.; Fan, Timothy M.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Samuelson, Jonathan; Fadl-Alla, Bahaa] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Fan, TM (corresponding author), Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA.	t-fan@illinois.edu		Samuelson, Jonathan/0000-0002-3593-7202; Fan, Timothy/0000-0003-2510-7050; Pondenis, Holly/0000-0003-1708-3570	NIH HHS [T35 OD011145] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmadzadehfar H, 2017, EUR J NUCL MED MOL I, V44, P1448, DOI 10.1007/s00259-017-3716-2; Akhtar N, 2004, NEOPLASIA, V6, P106, DOI 10.1593/neo.03334; Anidjar M, 2001, PROSTATE, V46, P2; Aranaz A, 2015, METHODS MOL BIOL, V1247, P19, DOI 10.1007/978-1-4939-2004-4_2; Avery PR, 2014, J VET INTERN MED, V28, P538, DOI 10.1111/jvim.12304; Barrio M, 2016, EXPERT REV MOL DIAGN, V16, P1177, DOI 10.1080/14737159.2016.1243057; Bednarova S, 2017, TRANSL ANDROL UROL, V6, P413, DOI 10.21037/tau.2017.03.53; Bouchelouche K, 2016, SEMIN NUCL MED, V46, P522, DOI 10.1053/j.semnuclmed.2016.07.006; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chang SS, 1999, CANCER RES, V59, P3192; Chevalier S, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0155-6; Christensen NI, 2009, AUST VET J, V87, P175, DOI 10.1111/j.1751-0813.2009.00421.x; Clifford CA, 2000, J VET INTERN MED, V14, P479, DOI 10.1892/0891-6640(2000)014&lt;0479:TOCHAB&gt;2.3.CO;2; Comazzi S, 2011, VET J, V188, P149, DOI 10.1016/j.tvjl.2010.03.011; Decker B, 2015, MOL CANCER RES, V13, P993, DOI 10.1158/1541-7786.MCR-14-0689; EATON CL, 1988, PROSTATE, V12, P129, DOI 10.1002/pros.2990120204; Fankhauser CD, 2019, WORLD J UROL, V37, P457, DOI 10.1007/s00345-018-2408-2; Ferdinandus J, 2018, CURR OPIN UROL, V28, P197, DOI [10.1097/MOU.0000000000000486, 10.1097/M0U.0000000000000486]; Fosmire SP, 2004, LAB INVEST, V84, P562, DOI 10.1038/labinvest.3700080; Gorden BH, 2014, AM J PATHOL, V184, P985, DOI 10.1016/j.ajpath.2013.12.025; Gourni E, 2017, MOLECULES, V22, DOI [10.3390/molecules.22040523, DOI 10.3390/MOLECULES.22040523]; Hammond TN, 2008, JAVMA-J AM VET MED A, V232, P553, DOI 10.2460/javma.232.4.553; Hinkle GH, 1998, CANCER, V83, P739, DOI 10.1002/(SICI)1097-0142(19980815)83:4<739::AID-CNCR16>3.0.CO;2-T; Hofman MS, 2018, UROL CLIN N AM, V45, P503, DOI 10.1016/j.ucl.2018.03.016; ISRAELI RS, 1994, CANCER RES, V54, P6306; Joung JY, 2010, J KOREAN MED SCI, V25, P1291, DOI 10.3346/jkms.2010.25.9.1291; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kiess AP, 2015, Q J NUCL MED MOL IM, V59, P241; Kim Jong-Hyuk, 2015, Vet Sci, V2, P388, DOI 10.3390/vetsci2040388; Klintzsch S, 2010, VET J, V185, P272, DOI 10.1016/j.tvjl.2009.07.018; Kurek R, 2004, CLIN CANCER RES, V10, P5808, DOI 10.1158/1078-0432.CCR-1004-03; Lai CL, 2008, PROSTATE, V68, P477, DOI 10.1002/pros.20720; Lamerato-Kozicki AR, 2006, EXP HEMATOL, V34, P870, DOI 10.1016/j.exphem.2006.04.013; Lana SE, 2006, J VET INTERN MED, V20, P329, DOI 10.1892/0891-6640(2006)20[329:UOPCRF]2.0.CO;2; LeRoy BE, 2006, PROSTATE, V66, P1213, DOI 10.1002/pros.20408; LORIC S, 1995, CLIN CHEM, V41, P1698; Mealey KL, 2008, JAVMA-J AM VET MED A, V233, P921, DOI 10.2460/javma.233.6.921; Mitsiades C, 2004, CLIN EXP METASTAS, V21, P495, DOI 10.1007/s10585-004-3217-0; Mochizuki Hiroyuki, 2015, Vet Sci, V2, P231, DOI 10.3390/vetsci2030231; Mochizuki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129534; Moore AS, 2017, JAVMA-J AM VET MED A, V251, P559, DOI 10.2460/javma.251.5.559; Nevedomskaya E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051359; Oh SW, 2018, KOREAN J RADIOL, V19, P819, DOI 10.3348/kjr.2018.19.5.819; Olson WC, 2014, FRONT BIOSCI-LANDMRK, V19, P12, DOI 10.2741/4193; PRYMAK C, 1988, J AM VET MED ASSOC, V193, P706; Ramos-Vara JA, 2014, VET PATHOL, V51, P42, DOI 10.1177/0300985813505879; Rigau M, 2011, PROSTATE, V71, P1736, DOI 10.1002/pros.21390; Sato M, 2016, VET J, V215, P38, DOI 10.1016/j.tvjl.2016.05.012; Schmidt DE, 2015, TRENDS CARDIOVAS MED, V25, P578, DOI 10.1016/j.tcm.2015.01.013; Seelig DM, 2014, J VET INTERN MED, V28, P878, DOI 10.1111/jvim.12343; Sethi S, 2013, INT J MOL SCI, V14, P14771, DOI 10.3390/ijms140714771; Silver DA, 1997, CLIN CANCER RES, V3, P81; Slovin SF, 2005, EXPERT OPIN THER TAR, V9, P561, DOI 10.1517/14728222.9.3.561; Talesa VN, 2009, CANCER BIOMARK, V5, P241, DOI 10.3233/CBM-2009-0109; Tang L, 2015, ACS NANO, V9, P5072, DOI 10.1021/acsnano.5b00166; Teo MY, 2016, CANCER J, V22, P347, DOI 10.1097/PPO.0000000000000221; Thalheim L, 2013, J VET INTERN MED, V27, P1509, DOI 10.1111/jvim.12185; Thamm DH, 2012, VET COMP ONCOL, V10, P292, DOI 10.1111/j.1476-5829.2011.00298.x; Thamm DH, 2006, RES VET SCI, V81, P76, DOI 10.1016/j.rvsc.2005.09.005; Tong R, 2010, MICROSC RES TECHNIQ, V73, P901, DOI 10.1002/jemt.20824; Wagner S, 2015, ANTICANCER RES, V35, P145; Webster JD, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-32; Wernicke AG, 2011, ARCH PATHOL LAB MED, V135, P1486, DOI 10.5858/arpa.2010-0740-OA; Wills TB, 2009, VET CLIN PATH, V38, P437, DOI 10.1111/j.1939-165X.2009.00152.x; Wu LY, 2014, PROSTATE, V74, P451, DOI 10.1002/pros.22727; Yates DR, 2012, PROSTATE, V72, P1382, DOI 10.1002/pros.22488; Zhang KY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/364738; Zhang Y, 1997, CLIN CANCER RES, V3, P1215	69	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0210297	10.1371/journal.pone.0210297	http://dx.doi.org/10.1371/journal.pone.0210297			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601866	Green Submitted, gold, Green Published			2022-12-26	WOS:000454683200063
J	Roma, P; Mazza, C; Ferracuti, G; Cinti, ME; Ferracuti, S; Burla, F				Roma, Paolo; Mazza, Cristina; Ferracuti, Giorgia; Cinti, Maria Elena; Ferracuti, Stefano; Burla, Franco			Drinking and driving relapse: Data from BAC and MMPI-2	PLOS ONE			English	Article							DUI OFFENDERS; PERSONALITY-TRAITS; SENSATION SEEKING; ALCOHOL-USE; RECIDIVISM; DRUNK; YOUNG; 1ST; INSTRUMENTS; BEHAVIORS	Road traffic injuries are the ninth cause of death across all age groups, globally (WHO, 2015). Many road traffic crashes are caused by Driving Under the Influence (DUI) of alcohol by persons who have previously had their license suspended for the same reason. The aim of this study was to identify specific risk factors and personality characteristics in repeat offenders. The sample was comprised of 260 subjects who were not repeat DUI offenders (DUI-NR), but had a single license suspension between 2010 and 2011; and 97 repeat offenders who received at least two DUI convictions within a period of 5 years. At the time of their first driving license suspension, participants provided their blood alcohol content (BAC) and completed a valid MMPI-2 test. ANOVA and MANOVAs were performed to determine whether there were significant differences in BAC and MMPI-2 profiles between DUI-NR and DUI-R participants and a logistic regression was run to identify whether BAC at the time of the first suspension and specific personality features could predict recidivism. A two-step cluster analysis was run to identify recidivist typologies. Results showed that, relative to DUI-NR participants, DUI-R participants had higher BAC at the time of their first conviction and more problematic MMPI-2 profiles, despite the presence of social desirability responding. The best predictors of recidivism were BAC and the scales of Lie (L), Correction (K), Psychopathic Deviate (4-Pd), Hypomania (9-Ma), and Low Self-Esteem (LSE). Two-step cluster analyses identified two recidivist profiles, according to 32 selected MMPI-2 validity, clinical, content, supplementary, and PSY-5 scales. Comparisons with previous research are discussed and ideas for further study are generated.	[Roma, Paolo; Mazza, Cristina; Ferracuti, Giorgia; Cinti, Maria Elena; Ferracuti, Stefano; Burla, Franco] Sapienza Univ Rome, Fac Med & Dent, Dept Human Neurosci, Rome, Italy	Sapienza University Rome	Roma, P (corresponding author), Sapienza Univ Rome, Fac Med & Dent, Dept Human Neurosci, Rome, Italy.	paolo.roma@uniroma1.it	Roma, Paolo/AAR-3679-2020; Ferracuti, Stefano/K-8437-2012	burla, franco/0000-0003-4857-8410; Ferracuti, Stefano/0000-0003-1150-1460; Roma, Paolo/0000-0002-1031-0948				Agabio R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008581.pub2; Anderson BJ, 2000, ADDICTION, V95, P915, DOI 10.1046/j.1360-0443.2000.9569158.x; Beirness DJ, 2007, CAN J PUBLIC HEALTH, V98, P476, DOI 10.1007/BF03405442; Butcher J. N., 2001, MMPI 2 MINNESOTA MUL, VRev; C'de Baca J, 2001, J SUBST ABUSE TREAT, V21, P207, DOI 10.1016/S0740-5472(01)00204-5; Cavaiola AA, 2003, ADDICT BEHAV, V28, P971, DOI 10.1016/S0306-4603(01)00291-X; Cavaiola AA, 2007, ADDICT BEHAV, V32, P855, DOI 10.1016/j.addbeh.2006.06.029; Chou SP, 2005, DRUG ALCOHOL DEPEN, V80, P223, DOI 10.1016/j.drugalcdep.2005.03.013; Craig RJ, 1989, ALCOHOLISM TREATMENT, V6, P97; Di Donato R, 2010, RIV PSICHIATR, V45, P163; DONOVAN DM, 1983, J STUD ALCOHOL, V44, P395, DOI 10.15288/jsa.1983.44.395; DONOVAN DM, 1986, J CONSULT CLIN PSYCH, V54, P563, DOI 10.1037/0022-006X.54.4.563; Eensoo D, 2005, ALCOHOL ALCOHOLISM, V40, P140, DOI 10.1093/alcalc/agh135; Fell JC, 1995, TRAFFIC TECH TECHNOL; Fitts MS, 2017, TRAFFIC INJ PREV, V18, P237, DOI 10.1080/15389588.2016.1186273; Freeman J, 2005, ADDICT BEHAV, V30, P1230, DOI 10.1016/j.addbeh.2004.10.007; Hittner JB, 2006, ADDICT BEHAV, V31, P1383, DOI 10.1016/j.addbeh.2005.11.004; Hubicka B, 2010, SOC PSYCH PSYCH EPID, V45, P723, DOI 10.1007/s00127-009-0111-8; Impinen A, 2009, TRAFFIC INJ PREV, V10, P220, DOI 10.1080/15389580902822725; Jonah BA, 1997, ACCIDENT ANAL PREV, V29, P651, DOI 10.1016/S0001-4575(97)00017-1; Lapham SC, 1997, J STUD ALCOHOL, V58, P524, DOI 10.15288/jsa.1997.58.524; MCKINLEY J. C., 1995, MMPI 2 MINNESOTA MUL; MCMILLEN DL, 1992, ADDICT BEHAV, V17, P407, DOI 10.1016/0306-4603(92)90001-C; MCMILLEN DL, 1992, ADDICT BEHAV, V17, P525, DOI 10.1016/0306-4603(92)90062-Z; Miller PG, 2015, AM J DRUG ALCOHOL AB, V41, P16, DOI 10.3109/00952990.2014.966199; Morrison L, 2002, INJ PREV, V8, P111, DOI 10.1136/ip.8.2.111; Nichols DS., 2011, ESSENTIALS MMPI 2 AS; Nochajski TH, 2006, CLIN PSYCHOL REV, V26, P179, DOI 10.1016/j.cpr.2005.11.006; NOCHAJSKI TH, 1994, ANN M RES SOC ALC MA; Okamura K, 2014, ADDICT BEHAV, V39, P1779, DOI 10.1016/j.addbeh.2014.07.007; Pancheri P, 1996, INT ADAPTATIONS MMPI, P416; REYNOLDS JR, 1991, J COUNS PSYCHOL, V38, P289, DOI 10.1037/0022-0167.38.3.289; Rider R, 2006, ACCIDENT ANAL PREV, V38, P482, DOI 10.1016/j.aap.2005.11.004; Robertson AA, 2009, ACCIDENT ANAL PREV, V41, P1080, DOI 10.1016/j.aap.2009.06.008; Roma P, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01064; Roma P, 2014, EUR J PSYCHOL ASSESS, V30, P110, DOI 10.1027/1015-5759/a000192; ROSS HL, 1988, ACCIDENT ANAL PREV, V20, P379, DOI 10.1016/0001-4575(88)90020-6; Ryb GE, 2006, ACCIDENT ANAL PREV, V38, P567, DOI 10.1016/j.aap.2005.12.001; Shim IH, 2016, INT J MENT HEALTH AD, V14, P149, DOI 10.1007/s11469-015-9577-7; Sirigatti S., 2011, MMPI 2 AGGIORNAMENTO; Tellegen A., 1992, PSYCHOL ASSESS, V4, P145, DOI [10.1037/1040-3590.4.2.145, DOI 10.1037/1040-3590.4.2.145]; Vaucher P, 2016, INT J DRUG POLICY, V32, P70, DOI 10.1016/j.drugpo.2016.03.006; Voas RB, 2002, ACCIDENT ANAL PREV, V34, P263, DOI 10.1016/S0001-4575(01)00025-2; White HR, 2001, J ABNORM PSYCHOL, V110, P600, DOI 10.1037//0021-843X.110.4.600; World Health Organisation, 2018, NONC DIS COUNTR PROF; YU J, 1995, J STUD ALCOHOL, V56, P60, DOI 10.15288/jsa.1995.56.60	46	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209116	10.1371/journal.pone.0209116	http://dx.doi.org/10.1371/journal.pone.0209116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1BB	30601844	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200039
J	Benz, C; Lo, W; Fathallah, N; Connor-Guscott, A; Benns, HJ; Urbaniak, MD				Benz, Corinna; Lo, Winston; Fathallah, Nadin; Connor-Guscott, Ashley; Benns, Henry J.; Urbaniak, Michael D.			Dynamic regulation of the Trypanosoma brucei transferrin receptor in response to iron starvation is mediated via the 3 ' UTR	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEIN; LIFE-CYCLE STAGES; GENE-EXPRESSION; COMPLEX; PROTEIN; LEVEL; SITE	The bloodstream form of the parasite Trypanosoma brucei obtains iron from its mammalian host by receptor-mediated endocytosis of host transferrin through its own unique transferrin receptor (TbTfR). Expression of TbTfR rapidly increases upon iron starvation by post-transcriptional regulation through a currently undefined mechanism that is distinct from the mammalian iron response system. We have created reporter cell lines by fusing the TbTfR 3'UTR or a control Aldolase 3'UTR to reporter genes encoding GFP or firefly Luciferase, and inserted the fusions into a bloodstream form cell line at a tagged ribosomal RNA locus. Fusion of the TbTfR 3'UTR is sufficient to significantly repress the expression of the reporter proteins under normal growth conditions. Under iron starvation conditions we observed upregulation of the mRNA and protein level of the TbTfR 3'UTR fusions only, with a magnitude and timing consistent with that reported for upregulation of the TbTfR. We conclude that the dynamic regulation of the T. brucei transferrin receptor in response to iron starvation is mediated via its 3'UTR, and that the effect is independent of genomic location.	[Benz, Corinna; Lo, Winston; Fathallah, Nadin; Connor-Guscott, Ashley; Benns, Henry J.; Urbaniak, Michael D.] Univ Lancaster, Fac Hlth & Med, Biomed & Life Sci, Lancaster, England	Lancaster University	Urbaniak, MD (corresponding author), Univ Lancaster, Fac Hlth & Med, Biomed & Life Sci, Lancaster, England.	m.urbaniak@lancaster.ac.uk	Benz, Corinna/AAD-8702-2021	Benz, Corinna/0000-0003-4367-2758; Benns, Henry/0000-0003-3757-7404	Biotechnology and Biological Sciences Research Council [BB/M009556/1]; BBSRC [BB/M009556/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CB and MDU are funded by a New Investigator Research Grant (BB/M009556/1) from the Biotechnology and Biological Sciences Research Council (https://bbsrc.ukri.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Ansorge I, 1999, MOL BIOCHEM PARASIT, V101, P81, DOI 10.1016/S0166-6851(99)00060-2; Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; Domingo-Sananes MR, 2015, J CELL BIOL, V211, P455, DOI 10.1083/jcb.201506114; Fast B, 1999, BIOCHEM J, V342, P691, DOI 10.1042/0264-6021:3420691; Gadelha C, 2015, MOL CELL PROTEOMICS, V14, P1911, DOI 10.1074/mcp.M114.047647; Gerrits H, 2002, MOL BIOCHEM PARASIT, V119, P237, DOI 10.1016/S0166-6851(01)00417-0; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; JEFFERIES D, 1991, MOL CELL BIOL, V11, P338, DOI 10.1128/MCB.11.1.338; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Lai D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks241; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; Monk SL, 2013, J CELL SCI, V126, P2294, DOI 10.1242/jcs.126011; Mussmann R, 2004, J BIOL CHEM, V279, P40690, DOI 10.1074/jbc.M404697200; Mussmann R, 2003, MOL MICROBIOL, V47, P23, DOI 10.1046/j.1365-2958.2003.03245.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rico E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006279; Ridewood S, 2017, MOL MICROBIOL, V106, P614, DOI 10.1111/mmi.13838; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Soysa R, 2014, MOL BIOCHEM PARASIT, V195, P1, DOI 10.1016/j.molbiopara.2014.05.002; Steverding D, 2003, TRENDS PARASITOL, V19, P125, DOI 10.1016/S1471-4922(03)00006-0; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Taylor MC, 2010, PARASITOLOGY, V137, P899, DOI 10.1017/S0031182009991880; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; van Luenen HGAM, 2005, MOL MICROBIOL, V58, P151, DOI 10.1111/j.1365-2958.2005.04831.x; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111	35	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0206332	10.1371/journal.pone.0206332	http://dx.doi.org/10.1371/journal.pone.0206332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596656	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000454627200007
J	Degeling, C; Gilbert, GL; Annand, E; Taylor, M; Walsh, MG; Ward, MP; Wilson, A; Johnson, J				Degeling, Chris; Gilbert, Gwendolyn L.; Annand, Edward; Taylor, Melanie; Walsh, Michael G.; Ward, Michael P.; Wilson, Andrew; Johnson, Jane			Managing the risk of Hendra virus spillover in Australia using ecological approaches: A report on three community juries	PLOS ONE			English	Article							PUBLIC DELIBERATION; LAND MANAGEMENT; HEALTH-POLICY; HORSE OWNERS; QUEENSLAND; DISEASE; CONSERVATION; GOVERNANCE; INFECTION; VETERINARIANS	Background Hendra virus (HeV) infection is endemic in Australian flying-fox populations. Habitat loss has increased the peri-urban presence of flying-foxes, increasing the risk of contact and therefore viral 'spillovers' into horse and human populations. An equine vaccine is available and horse-husbandry practices that minimize HeV exposure are encouraged, but their adoption is suboptimal. Ecological approaches-such as habitat creation and conservation-could complement vaccination and behavioural strategies by reducing spillover risks, but these are controversial. Methods We convened three community juries (two regional; one metropolitan) to elicit the views of well-informed citizens on the acceptability of adding ecological approaches to current interventions for HeV risk. Thirty-one participants of diverse backgrounds, mixed genders and ages were recruited using random-digit-dialling. Each jury was presented with balanced factual evidence, given time to ask questions of expert presenters and, after deliberation, come to well-reasoned conclusions. Results All juries voted unanimously that ecological strategies should be included in HeV risk management strategies but concluded that current interventions-including vaccination and changing horse-husbandry practices-must remain the priority. The key reasons given for adopting ecological approaches were: (i) they address underlying drivers of disease emergence, (ii) the potential to prevent spillover of other bat-borne pathogens, and (iii) there would be broader community benefits. Juries differed regarding the best mechanism to create/conserve flying-fox habitat: participants in regional centres favoured direct government action, whereas the metropolitan jury preferred to place the burden on landholders. Conclusions Informed citizens acknowledge the value of addressing the drivers of bat-borne infectious risks but differ substantially as to the best implementation strategies. Ecological approaches to securing bat habitat could find broad social support in Australia, but disagreement about how best to achieve them indicates the need for negotiation with affected communities to co-develop fair, effective and locally appropriate policies.	[Degeling, Chris] Univ Wollongong, Sch Hlth & Soc, Australian Ctr Hlth Engagement Evidence & Values, Wollongong, NSW, Australia; [Gilbert, Gwendolyn L.; Johnson, Jane] Univ Sydney, Sch Publ Hlth, Sydney Hlth Eth, Sydney, NSW, Australia; [Gilbert, Gwendolyn L.; Annand, Edward; Walsh, Michael G.; Johnson, Jane] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Annand, Edward; Ward, Michael P.] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia; [Annand, Edward] EquiEpiVet, Picton, NSW, Australia; [Taylor, Melanie] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Walsh, Michael G.; Johnson, Jane] Univ Sydney, Sydney Med Sch, Westmead Clin Sch, Westmead, NSW, Australia; [Wilson, Andrew] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW, Australia	University of Wollongong; University of Sydney; University of Sydney; University of Sydney; Macquarie University; University of Sydney; University of Sydney	Degeling, C (corresponding author), Univ Wollongong, Sch Hlth & Soc, Australian Ctr Hlth Engagement Evidence & Values, Wollongong, NSW, Australia.	degeling@uow.edu.au	Degeling, Chris/ABE-2049-2020; Johnson, Jane/AAQ-6529-2021; Ward, Michael Patrick/GRX-1851-2022; Taylor, Melanie R/H-5248-2017; Ward, Michael Patrick/W-1897-2019; Ward, Michael/C-5758-2009	Degeling, Chris/0000-0003-4279-3443; Ward, Michael Patrick/0000-0002-9921-4986; Taylor, Melanie R/0000-0002-8862-9510; Ward, Michael/0000-0002-9921-4986; Wilson, Andrew/0000-0002-1809-7846; Annand, Edward J/0000-0002-4619-3667; Walsh, Michael/0000-0002-6441-3635	National Health and Medical Research Council of Australia [APP1083079]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Project Grant (APP1083079) from the National Health and Medical Research Council of Australia to CD, GLG, MPW and AW. The funder provided support in the form of salaries for authors CD and JJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. EA is employed by the commercial entity EquiEpiVet. This company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided support in the form of salary and research materials. The specific roles of this author is articulated in the 'author contributions' section.	Adamson Sheena, 2011, N S W Public Health Bull, V22, P105, DOI 10.1071/NB11003; Aldred J, 2000, ECOL ECON, V34, P217, DOI 10.1016/S0921-8009(00)00159-2; Argent N, 2011, AUST GEOGR, V42, P183, DOI 10.1080/00049182.2011.572824; Ball MC, 2014, AUST VET J, V92, P213, DOI 10.1111/avj.12170; Barr M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-117; Blacksher E, 2012, HASTINGS CENT REP, V42, P14, DOI 10.1002/hast.26; Bradshaw CJA, 2012, J PLANT ECOL, V5, P109, DOI 10.1093/jpe/rtr038; Braunack-Mayer AJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-501; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Broder CC, 2016, VACCINE, V34, P3525, DOI 10.1016/j.vaccine.2016.03.075; Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016; Buckley K, 1972, MEANJIN Q, V31; Burgess MM, 2014, PUBLIC UNDERST SCI, V23, P48, DOI 10.1177/0963662512472160; Cocklin C, 2007, J ENVIRON MANAGE, V85, P986, DOI 10.1016/j.jenvman.2006.11.009; Comerford E, 2014, J ENVIRON MANAGE, V141, P169, DOI 10.1016/j.jenvman.2014.01.049; Cook R, 2004, MANHATTAN PRINCIPLES; Currey K, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10020039; Decker DJ, 2010, ILAR J, V51, P255, DOI 10.1093/ilar.51.3.255; Degeling C, 2018, HEALTH EXPECT, V21, P90, DOI 10.1111/hex.12589; Degeling C, 2017, ECOHEALTH, V14, P783, DOI 10.1007/s10393-017-1264-7; Degeling C, 2017, SOC SCI MED, V179, P166, DOI 10.1016/j.socscimed.2017.03.003; Degeling C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2617-1; Degeling C, 2015, SOC SCI MED, V131, P114, DOI 10.1016/j.socscimed.2015.03.009; Degeling C, 2013, SOC SCI MED, V82, P156, DOI 10.1016/j.socscimed.2012.12.024; Department of the Environment and Energy, 2018, MON FLYING FOX POP C; Dibden J, 2006, RURAL GOVERNANCE INT, V10, P175; DiMatteo MR, 2007, MED CARE, V45, P521, DOI 10.1097/MLR.0b013e318032937e; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140670; Evans Megan C., 2016, Pacific Conservation Biology, V22, P130, DOI 10.1071/PC15052; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field HE, 2016, CURR OPIN VIROL, V16, P120, DOI 10.1016/j.coviro.2016.02.004; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fish RD, 2014, J ENVIRON PLANN MAN, V57, P233, DOI 10.1080/09640568.2012.738326; Fishkin J., 2011, PEOPLE SPEAK; Giles JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27859-3; Goyen KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180062; Greiner R, 2011, LAND USE POLICY, V28, P257, DOI 10.1016/j.landusepol.2010.06.006; Higgins V, 2001, SOCIOL RURALIS, V41, P358, DOI 10.1111/1467-9523.00188; Higgins V, 2014, J RURAL STUD, V36, P463, DOI 10.1016/j.jrurstud.2014.10.003; Hing S, 2016, WILDLIFE RES, V43, P51, DOI 10.1071/WR15183; Hobson-West P, 2003, HEALTH RISK SOC, V5, P273, DOI 10.1080/13698570310001606978; Irwin A, 2013, SOC STUD SCI, V43, P118, DOI 10.1177/0306312712462461; Jemison Micaela, 2017, Australian Zoologist, V38, P505, DOI 10.7882/AZ.2017.002; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Karpowitz C., 2014, DELIBERATION DEMOCRA; Karpowitz C., 2016, J PUBLIC DELIBERATIO, V12, P1, DOI DOI 10.16997/JDD.255; Kessler MK, 2018, ANN NY ACAD SCI, V1429, P78, DOI 10.1111/nyas.13910; Kirkland PD, 2015, EMERG INFECT DIS, V21, P2182, DOI 10.3201/eid2112.151324; Kung N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080897; Kung NY, 2015, ONE HEALTH, V1, P24, DOI 10.1016/j.onehlt.2015.07.002; Lane MB, 2004, AUST GEOGR STUD, V42, P103, DOI 10.1111/j.1467-8470.2004.00246.x; Liverani M, 2013, ENVIRON HEALTH PERSP, V121, P873, DOI 10.1289/ehp.1206001; Lockie S, 2009, CURR SOCIOL, V57, P407, DOI 10.1177/0011392108101590; MacDonald NE, 2018, VACCINE, V36, P5811, DOI 10.1016/j.vaccine.2018.08.042; Mahalingam S, 2012, LANCET INFECT DIS, V12, P799, DOI 10.1016/S1473-3099(12)70158-5; Manyweathers J, 2017, TRANSBOUND EMERG DIS, V64, P1898, DOI 10.1111/tbed.12588; Manyweathers J, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1006-7; Marsh GA, 2011, EMERG INFECT DIS, V17, P2232, DOI 10.3201/eid1712.111162; Martin G, 2018, ECOHEALTH, V15, P509, DOI 10.1007/s10393-018-1322-9; Mendez D, 2013, AUST VET J, V91, P323, DOI 10.1111/avj.12091; Mendez DH, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0215-6; Mendez DH, 2012, EMERG INFECT DIS, V18, P83, DOI 10.3201/eid1801.111006; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; Moon K, 2013, LAND USE POLICY, V31, P17, DOI 10.1016/j.landusepol.2011.08.011; Moon K, 2012, J ENVIRON MANAGE, V113, P292, DOI 10.1016/j.jenvman.2012.09.003; Moon K, 2011, J RURAL STUD, V27, P331, DOI 10.1016/j.jrurstud.2011.04.001; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; One Health Ethics, 2018, COMM PERSP ON HLTH; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004796; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Quinn EK, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-144; Recher Harry F., 2017, Australian Zoologist, V39, P257, DOI 10.7882/AZ.2015.024; Roberts BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042532; Roberts BJ, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P277; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Roth RJ, 2012, GEOFORUM, V43, P363, DOI 10.1016/j.geoforum.2012.01.006; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Schemann K, 2018, AUST VET J, V96, P132, DOI 10.1111/avj.12679; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Sherval M, 2014, AUST GEOGR, V45, P185, DOI 10.1080/00049182.2014.899028; Simmons BA, 2018, LAND USE POLICY, V75, P399, DOI 10.1016/j.landusepol.2018.03.049; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Street J, 2014, SOC SCI MED, P109; Thiriet D., 2010, AUSTRALASIAN J NATUR, V13, P161; Thomas R, 2017, HEALTH EXPECT, V20, P626, DOI 10.1111/hex.12493; Vincenot C, 2016, NATURE, V539, P168, DOI 10.1038/539168d; Wallace RG, 2015, SOC SCI MED, V129, P68, DOI 10.1016/j.socscimed.2014.09.047; Walsh MG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08065-z; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; West Carole, 2002, P176; Wiethoelter AK, 2017, PREV VET MED, V148, P28, DOI 10.1016/j.prevetmed.2017.09.013; Wiethoelter AK, 2017, PREV VET MED, V140, P67, DOI 10.1016/j.prevetmed.2017.03.003; Wilson SJ, 2016, ZOONOSES PUBLIC HLTH, V63, P374, DOI 10.1111/zph.12238	97	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209798	10.1371/journal.pone.0209798	http://dx.doi.org/10.1371/journal.pone.0209798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596719	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200087
J	Iwai, T; Hoshi, M; Oebisu, N; Aono, M; Takami, M; Ieguchi, M; Nakamura, H				Iwai, Tadashi; Hoshi, Manabu; Oebisu, Naoto; Aono, Masanari; Takami, Masatugu; Ieguchi, Makoto; Nakamura, Hiroaki			Diagnostic value of tumor-fascia relationship in superficial soft tissue masses on magnetic resonance imaging	PLOS ONE			English	Article							BENIGN; MRI; SARCOMAS; DEPTH; SIZE; BONE	Purpose Many surgeons participate in the management of superficial soft tissue masses, and a pre-operative incorrect diagnosis frequently results in dismal oncological outcomes. The aim of this study was to identify distinguishing magnetic resonance imaging features between malignant and non-malignant lesions. Methods The clinicopathological data for 219 patients (men 114; women 105) with superficial soft tissue masses treated from January 2007 to December 2016 in our institution were retrospectively analyzed. The median age at the first visit was 55.6 years (range 1-90 years). MRI findings of tumor size, margin, lobulation, intratumoral hemorrhage, peritumoral edema, and tumor-fascia relationship were compared with the final histological diagnosis and tumor grade. Results Univariate analysis revealed significant relationships between histologically malignant lesions and tumor size >= 5 cm (p = 0.035), positive peritumoral edema (p = 0.031), and tumor-fascia relationship (p<0.001), but not margin (p = 0.107), lobulation (p = 0.071), and intratumoral hemorrhage (p = 0.17). In addition, using multivariate analysis, the tumor-fascia relationship (p<0.001) and tumor size were significant factors. A significant correlation between tumor-fascia relationship and malignancy (p<0.001) was observed; such a relationship was, however, not observed for tumor grade (p = 0.43). Conclusions Tumors measuring >= 5 cm and the tumor-fascia relationship on magnetic resonance imaging are highly indicative of malignancy. When superficial soft tissue masses cross the superficial fascia and form obtuse angles with the fascia, sarcoma should be considered. The tumor-fascia relationship can offer surgeons useful information regarding the status of superficial soft tissue masses.	[Iwai, Tadashi; Hoshi, Manabu; Oebisu, Naoto; Aono, Masanari; Takami, Masatugu; Ieguchi, Makoto; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Osaka, Japan; [Aono, Masanari] Osaka City Gen Hosp, Dept Orthoped Surg, Osaka, Osaka, Japan; [Takami, Masatugu] Hanwasumiyoshi Gen Hosp, Dept Orthoped Surg, Osaka, Osaka, Japan; [Ieguchi, Makoto] Fuchu Hosp, Dept Orthoped Surg, Izumi, Osaka, Japan	Osaka Metropolitan University; Osaka City General Hospital	Iwai, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Osaka, Japan.	qq329xpd@opal.ocn.ne.jp	Iwai, Tadashi/AAY-2812-2021	Iwai, Tadashi/0000-0001-8267-7389; Hoshi, Manabu/0000-0001-5456-6470				Arai E, 2010, CLIN ORTHOP RELAT R, V468, P3028, DOI 10.1007/s11999-010-1392-7; BERQUIST TH, 1990, AM J ROENTGENOL, V155, P1251, DOI 10.2214/ajr.155.6.2122675; Calleja M, 2012, SKELETAL RADIOL, V41, P1517, DOI 10.1007/s00256-012-1385-6; Casali PG, 2014, ANN ONCOL, V25, P102, DOI 10.1093/annonc/mdu254; Chung WJ, 2012, BRIT J RADIOL, V85, pE831, DOI 10.1259/bjr/27487871; Dangoor A, 2016, CLIN SARCOMA RES, V6, DOI 10.1186/s13569-016-0060-4; Datir A, 2008, CLIN RADIOL, V63, P373, DOI 10.1016/j.crad.2007.08.016; De Schepper AM, 2000, EUR RADIOL, V10, P213, DOI 10.1007/s003300050037; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Galant J, 1998, SKELETAL RADIOL, V27, P657, DOI 10.1007/s002560050455; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hoshi M, 2008, JPN J CLIN ONCOL, V38, P701, DOI 10.1093/jjco/hyn093; Japanese Orthopedic Association, 2012, JAP ORTH ASS MUSC TU; Kawaguchi N, 2004, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000116308.86761.f5; KRANSDORF MJ, 1989, AM J ROENTGENOL, V153, P541, DOI 10.2214/ajr.153.3.541; Lachenmayer A, 2009, WORLD J SURG, V33, P1641, DOI 10.1007/s00268-009-0051-1; Lewis JJ, 2000, ANN SURG, V231, P655, DOI 10.1097/00000658-200005000-00005; Morel M, 2011, SKELETAL RADIOL, V40, P271, DOI 10.1007/s00256-009-0855-y; Ogura K, 2017, J ORTHOP SCI, V22, P755, DOI 10.1016/j.jos.2017.03.017; Peterson JJ, 2003, SKELETAL RADIOL, V32, P493, DOI 10.1007/s00256-003-0647-8; Potter BK, 2008, CLIN ORTHOP RELAT R, V466, P3093, DOI 10.1007/s11999-008-0529-4; Salas S, 2009, EUR J CANCER, V45, P2091, DOI 10.1016/j.ejca.2009.03.006; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108	23	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209642	10.1371/journal.pone.0209642	http://dx.doi.org/10.1371/journal.pone.0209642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596710	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200069
J	Santos, IR; Maximiano, MR; Almeida, RF; da Cunha, RNV; Lopes, R; Scherwinski-Pereira, JE; Mehta, A				Santos, Ivonaldo Reis; Maximiano, Mariana Rocha; Almeida, Raphael Ferreira; Vieira da Cunha, Raimundo Nonato; Lopes, Ricardo; Scherwinski-Pereira, Jonny Everson; Mehta, Angela			Genotype-dependent changes of gene expression during somatic embryogenesis in oil palm hybrids (Elaeis oleifera x E-guineensis)	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; IN-VITRO; ANTIOXIDANT ENZYMES; PLANT-CELLS; IDENTIFICATION; REGENERATION; CYTOSKELETON; ACQUISITION; INDUCTION; PROTEINS	To understand the molecular processes triggered during the different steps of somatic embryogenesis (SE) in oil palm, the expression of 19 genes associated to SE identified in proteomic and transcriptomic studies was investigated by qRT-PCR. To evaluate the differential expression of these genes, two interspecific hybrid genotypes (Elaeis oleifera x Elaeis guineensis) contrasting for the acquisition of embryogenic competence were used. Aclorophyllated leaves of both hybrids, one responsive (B351733) and the other non-responsive (B352933) to SE were submitted to callus induction and collected at different time points: 0 (before induction), 14, 30, 90 and 150 days of callus induction (doi). The results obtained showed that all evaluated genes were downregulated at 14 doi in the responsive genotype when compared to the non-responsive. It was also possible to observe that most of the genes changed their expression behavior at 30 doi and were upregulated thereafter until 150 doi, with the exception of the pathogenesis-related PRB1-3-like (PRB1-3) gene, which did not show differential expression at 30 doi and was downregulated at 90 and 150 doi when compared to the non-responsive hybrid. These results indicate that 30 doi is a turning point in gene expression, probably associated to embryogenic competence acquisition. We also show that the expression behavior of the responsive genotype is more stable than that of the non-responsive when the different induction time points are compared to 0 doi (before induction). Moreover, the results obtained in this study corroborate our hypothesis that the regulation of genes involved in the control of oxidative stress and energy metabolism are crucial for the acquisition of embryogenic competence in oil palm.	[Santos, Ivonaldo Reis; Maximiano, Mariana Rocha; Almeida, Raphael Ferreira; Scherwinski-Pereira, Jonny Everson; Mehta, Angela] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Santos, Ivonaldo Reis; Almeida, Raphael Ferreira] Univ Brasilia, Programa Posgrad Bot, Brasilia, DF, Brazil; [Maximiano, Mariana Rocha] Univ Fed Juiz De Fora, Programa Posgrad Ciencias Biol Imunol & DIP Genet, Juiz De Fora, MG, Brazil; [Vieira da Cunha, Raimundo Nonato; Lopes, Ricardo] Embrapa Amazonia Ocidental, Manaus, AM, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Federal de Juiz de Fora; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Scherwinski-Pereira, JE; Mehta, A (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	jonny.pereira@embrapa.br; angela.mehta@embrapa.br	Maximiano, Mariana Rocha/AAM-5607-2020; Maximiano, Mariana R/L-1499-2016	Maximiano, Mariana Rocha/0000-0002-5889-6984; Scherwinski-Pereira, Jonny/0000-0001-6271-332X; Reis, Ivonaldo/0000-0002-1193-7742; lopes, ricardo/0000-0002-5559-9685	Embrapa; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Fundacao de Apoio a Pesquisa do Distrito Federal-FAPDF	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito Federal-FAPDF(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This research was supported by Embrapa (https://www.embrapa.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES (http://www.capes.gov.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (http://www.cnpq.br/) and Fundacao de Apoio a Pesquisa do Distrito Federal-FAPDF (http://www.fap.df.gov.br/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RF, 2017, CLONAGEM GENITORES P; Araldi CG, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2219-2; Baba AI, 2008, PLANT SCI, V175, P717, DOI 10.1016/j.plantsci.2008.07.014; Balslev H, 1986, PUBLICACIONES MUSEO, V5, P45; Balzon TA, 2013, IN VITRO CELL DEV-PL, V49, P41, DOI 10.1007/s11627-012-9479-3; Barkla BJ, 2009, PLANT CELL, V21, P4044, DOI 10.1105/tpc.109.069211; Bauwe H, 2012, CURR OPIN PLANT BIOL, V15, P269, DOI 10.1016/j.pbi.2012.01.008; Blazquez S, 2009, PLANT CELL TISS ORG, V97, P49, DOI 10.1007/s11240-009-9497-y; Chan PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099774; Chan PL, 2010, NORMALIZED EMBRYOID, P10; Chugh A, 2002, CURR SCI INDIA, V83, P715; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui KR, 1999, PLANT SCI, V146, P9, DOI 10.1016/S0168-9452(99)00087-4; Cyrne L, 2003, FREE RADICAL BIO MED, V34, P385, DOI 10.1016/S0891-5849(02)01300-X; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Diaz-Vivancos P, 2011, PLANT GROWTH REGUL, V65, P119, DOI 10.1007/s10725-011-9581-2; Dong J-Z, 2000, MOL BIOL WOODY PLANT, P51, DOI 10.1007/978-94-017-2311-4_3; Dudits D., 1995, In vitro embryogenesis in plants., P267; Escobar R, 1982, INT C OIL PALM AGR 8; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; GODOY JA, 1994, PLANT MOL BIOL, V26, P1921, DOI 10.1007/BF00019503; Gomes HT, 2014, PLANT GROWTH REGUL, V74, P199, DOI 10.1007/s10725-014-9901-4; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hormaza P, 2012, SCI AGR, V69, P275, DOI 10.1590/S0103-90162012000400007; Ikeda M, 2006, EMBRYOGENESIS RELATE, P153; Kanchanapoom K., 1999, SCI ASIA, V25, P195, DOI [10.2306/scienceasia1513-1874.1999.25.195, DOI 10.2306/SCIENCEASIA1513-1874.1999.25.195]; Konan KE, 2010, PLANT CELL REP, V29, P1, DOI 10.1007/s00299-009-0787-y; Konieczny R, 2008, ACTA PHYSIOL PLANT, V30, P71, DOI 10.1007/s11738-007-0092-8; Libik M, 2005, PLANT CELL REP, V23, P834, DOI 10.1007/s00299-004-0886-8; Lin HC, 2009, PLANT MOL BIOL, V70, P173, DOI 10.1007/s11103-009-9464-3; Lippert D, 2005, PROTEOMICS, V5, P461, DOI 10.1002/pmic.200400986; Liu YL, 2016, J PROTEOMICS, V131, P61, DOI 10.1016/j.jprot.2015.10.010; Lopes R, 2012, PESQUI AGROPECU BRAS, V47, P1496, DOI 10.1590/S0100-204X2012001000012; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Miyazawa Y, 1999, PLANT PHYSIOL, V121, P461, DOI 10.1104/pp.121.2.461; Morel A, 2014, PHYSIOL PLANTARUM, V152, P184, DOI 10.1111/ppl.12158; Moretzsohn MC, 2002, EUPHYTICA, V124, P35, DOI 10.1023/A:1015606304653; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nolan KE, 2003, PLANT PHYSIOL, V133, P218, DOI 10.1104/pp.103.020917; Or KH, 2017, APPL ACOUST, V119, P9, DOI 10.1016/j.apacoust.2016.12.002; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Pan ZY, 2010, PLANT CELL TISS ORG, V103, P145, DOI 10.1007/s11240-010-9762-0; Pattarapimol T, 2015, J OIL PALM RES, V27, P1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RABECHAULT H, 1970, CR ACAD SCI D NAT, V270, P3067; Rajanaidu N., 1986, Workshop Proceedings of the Palm Oil Research Institute of Malaysia, P84; Ree JF, 2015, IN VITRO CELL DEV-PL, V51, P589, DOI 10.1007/s11627-015-9722-9; Rode C, 2011, PLANT MOL BIOL, V75, P305, DOI 10.1007/s11103-010-9729-x; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Roowi SH, 2010, MOL BIOTECHNOL, V46, P1, DOI 10.1007/s12033-010-9262-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanputawong S., 2011, International Journal of Agricultural Technology, V7, P531; Santos MO, 2009, PLANT SIGNAL BEHAV, V4, P1111, DOI 10.4161/psb.4.12.9900; Scherwinski-Pereira JE, 2010, IN VITRO CELL DEV-PL, V46, P378, DOI 10.1007/s11627-010-9279-6; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Sghaier-Hammami B, 2009, J PROTEOMICS, V73, P161, DOI 10.1016/j.jprot.2009.07.003; Shao J, 2007, J PROTEOME RES, V6, P4556, DOI [10.1021/PR070474Y, DOI 10.1021/PR070474Y]; Sharifi G, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-3; Silva RD, 2014, J PROTEOMICS, V104, P112, DOI 10.1016/j.jprot.2014.03.013; Simms D., 1993, FOCUS, V15, P532, DOI DOI 10.1016/0003-267061)80041-X; Sin T, 2016, J PROTEOMICS, V143, P334, DOI 10.1016/j.jprot.2016.04.039; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Somleva MN, 2000, PLANT CELL REP, V19, P718, DOI 10.1007/s002999900169; STARITSKY G, 1970, Euphytica, V19, P288, DOI 10.1007/BF01904205; Thomas C, 2004, PLANT PHYSIOL BIOCH, V42, P35, DOI 10.1016/j.plaphy.2003.10.008; THOMAS RL, 1969, EUPHYTICA, V18, P92, DOI 10.1007/BF00397785; Tonietto A, 2012, PLANT MOL BIOL REP, V30, P1393, DOI 10.1007/s11105-012-0425-7; Torres GA, 2010, PLANT DIS, V94, P1163, DOI 10.1094/PDIS-94-9-1163A; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wilde H, 1995, GENE EXPRESSION SOMA, P41; Xia W, 2014, J BIOTECHNOL, V184, P63, DOI 10.1016/j.jbiotec.2014.05.008; Youssefian S, 2001, PLANT PHYSIOL, V126, P1001, DOI 10.1104/pp.126.3.1001; Zeven A. C., 1964, GRANA PALYNOL, V5, P121, DOI DOI 10.1080/00173136409429132; Zhang SG, 2010, PLANT CELL TISS ORG, V100, P21, DOI 10.1007/s11240-009-9612-0; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zheng YJ, 2017, J FUNCT FOODS, V28, P48, DOI 10.1016/j.jff.2016.11.021; Zhou T, 2016, MOL CELL PROTEOMICS	81	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209445	10.1371/journal.pone.0209445	http://dx.doi.org/10.1371/journal.pone.0209445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596686	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200048
J	Xia, D; Zhao, BQ; Liu, DX; Deng, YS; Cheng, H; Yan, YJ; Ding, SW; Cai, CF				Xia, Dong; Zhao, Bingqin; Liu, Daxiang; Deng, Yusong; Cheng, Hu; Yan, Yujie; Ding, Shuwen; Cai, Chongfa			Effect of soil moisture on soil disintegration characteristics of different weathering profiles of collapsing gully in the hilly granitic region, South China	PLOS ONE			English	Article							AGGREGATE STABILITY; ORGANIC-MATTER; PARTICLE DENSITY; EROSION; TEXTURE; CLAY; BREAKDOWN; ERODIBILITY; SIZE	Collapsing gully erosion is the main important and specific soil erosion type in the red soil region of tropical and subtropical South China. Knowledge of the soil disintegration characteristics within different weathering profiles (surface layer, red soil layer, sandy soil layer and detritus layer) and its relationships with soil particle size distribution and soil properties is important in understanding the mechanism of the forming process and development of the collapsing gully. In this paper, we conducted an experiment on four collapsing gullies located four counties (Tongcheng County, Gan County, Anxi County and Wuhua County) in the hilly granitic region of southern China. The anti-disintegration ability of the different weathering profiles with two different moisture conditions (the air-dried condition and the natural state condition) were determined by the anti-disintegration index (Kc) and measured by the submerging test. The results show that the coarse particles are higher in the sandy soil layer and the detritus layer of collapsing gully than that in the surface layer and the red soil layer, but the finer particles show the inversed order. The Kc values reduce significantly from the surface layer to the detritus layer. In the surface layer and the red soil layer, the Kc values in the natural state condition are much higher than that in the air-dried condition. The results highlight that, the sandy soil layer and the detritus layer are easily to disintegrate compare with the surface layer and the red soil layer, and in the case of low soil water content, the soil in any layer of collapsing gully is easy to disintegrate. The regression equation shows a very significant and positive relationship between the Kc values and the < 0.002 mm particles contents and the SOM (soil organic matter) (p<0.01), and negative relationship between the Kc values and the contents of other soil particle size. The results revealed that the repulsive force produced by compressed air in the soil exceeds the suction between the soil particles is the predominant factor to soil disintegrate rates in the air-dried state condition. Whereas the soil contained a certain amount of water can reduce the degree of disintegration. The results also indicated that the more contents of the cementation agents (like clay and SOM) in the soil of the different layers of collapsing gully, the higher Kc values (it means the more difficult to disintegrate).	[Xia, Dong; Cheng, Hu; Yan, Yujie] China Three Gorges Univ, Coll Hydraul & Environm Engn, Engn Res Ctr Ecoenvironm Three Gorges Reservoir R, Minist Educ, Yichang, Peoples R China; [Zhao, Bingqin; Liu, Daxiang] China Three Gorges Univ, Coll Civil Engn & Architecture, Yichang, Peoples R China; [Deng, Yusong; Ding, Shuwen; Cai, Chongfa] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Hubei, Peoples R China	China Three Gorges University; China Three Gorges University; Huazhong Agricultural University	Cai, CF (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Hubei, Peoples R China.	hzaucfcai@163.com		Xia, Dong/0000-0002-2841-9773	Changjiang River Scientific Research Institute of Changjiang Water Resources Commission Open Research Program [CKWV2016387/KY]; National Natural Science Foundation of China [41601287, 41630858]	Changjiang River Scientific Research Institute of Changjiang Water Resources Commission Open Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The publication of this paper was funded by the Changjiang River Scientific Research Institute of Changjiang Water Resources Commission Open Research Program (CKWV2016387/KY) for DX (www.crsri.cn/index.asp).The research of this paper was funded by the National Natural Science Foundation of China, No. 41601287 for DX, and No. 41630858 for CC (www.nsfc.gov.cn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezketa E, 1999, J SUSTAIN AGR, V14, P83, DOI 10.1300/J064v14n02_08; Annabi M, 2017, CATENA, V153, P157, DOI 10.1016/j.catena.2017.02.010; BALABANE M, 1992, SOIL BIOL BIOCHEM, V24, P89, DOI 10.1016/0038-0717(92)90263-W; Barik K, 2011, J ANIM PLANT SCI, V21, P186; Barral MT, 1998, SOIL TILL RES, V46, P261, DOI 10.1016/S0167-1987(98)00092-0; Barthes BG, 2008, GEODERMA, V143, P14, DOI 10.1016/j.geoderma.2007.10.003; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Canton Y, 2009, CATENA, V77, P192, DOI 10.1016/j.catena.2008.12.011; Chen JL, 2018, GEODERMA, V317, P56, DOI 10.1016/j.geoderma.2017.12.006; CHUGH YP, 1981, ENG GEOL, V17, P241, DOI 10.1016/0013-7952(81)90001-6; Dal Ferro N, 2012, EUR J SOIL SCI, V63, P152, DOI 10.1111/j.1365-2389.2012.01427.x; Deng YS, 2016, J INTEGR AGR, V15, P1863, DOI 10.1016/S2095-3119(15)61223-0; Deng YS, 2017, SOLID EARTH, V8, P499, DOI 10.5194/se-8-499-2017; Deng YS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173555; [邓羽松 Deng Yusong], 2016, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V25, P63; Ding SW, 1995, J NANCHANG I TECHNOL, P50; Ding WF, 2016, J MT SCI-ENGL, V13, P831, DOI 10.1007/s11629-015-3447-4; Feng M.H., 2009, YANGTZE RIVER, V40, P66; Filho CC, 2002, SOIL TILL RES, V65, P45; [葛宏力 GE Hongli], 2007, [水土保持通报, Bulletin of Soil and Water Conservation], V27, P128; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Grosse AK, 2015, J ENVIRON ENG LANDSC, V23, P1, DOI 10.3846/16486897.2014.919924; HAYNES RJ, 1990, J SOIL SCI, V41, P73, DOI 10.1111/j.1365-2389.1990.tb00046.x; Jaksik O, 2015, CATENA, V127, P287, DOI 10.1016/j.catena.2015.01.010; Jiang FS, 2014, SOIL SCI SOC AM J, V78, P1741, DOI 10.2136/sssaj2014.04.0132; Kan Guo-shi, 2009, Shengtaixue Zazhi, V28, P2032; KEMPER WD, 1987, SOIL SCI SOC AM J, V51, P860, DOI 10.2136/sssaj1987.03615995005100040004x; Kim CK, 2010, ENG GEOL, V113, P1, DOI 10.1016/j.enggeo.2009.09.004; Lado M, 2004, SOIL SCI SOC AM J, V68, P1992, DOI 10.2136/sssaj2004.1992; Lan HX, 2003, J ASIAN EARTH SCI, V21, P353, DOI 10.1016/S1367-9120(02)00020-2; Lan Z. X., 2013, THESIS; Le Bissonnais Y, 2007, EUR J SOIL SCI, V58, P188, DOI 10.1111/j.1365-2389.2006.00823.x; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; LEVY GJ, 1995, SOIL SCI, V160, P352, DOI 10.1097/00010694-199511000-00004; LI Si-ping, 1992, J SOIL WATER CONSERV, V6, P29; Li ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154591; [刘丹露 Liu Danlu], 2016, [中国水土保持科学, Science of Soil and Water Conservation], V14, P17; [刘瑾 Liu Jin], 2009, [水文地质工程地质, Hydrogeology & Engineering Geology], V36, P77; Liu J, 2009, CATENA, V77, P175, DOI 10.1016/j.catena.2008.12.016; [刘希林 Liu Xilin], 2016, [水土保持学报, Journal of Soil and Water Conservation], V30, P80; Luk SH, 1997, CATENA, V29, P97, DOI 10.1016/S0341-8162(96)00049-5; Luk SH, 1997, CATENA, V29, P93, DOI 10.1016/S0341-8162(96)00048-3; Mamedov AI, 2007, SOIL SCI SOC AM J, V71, P1909, DOI 10.2136/sssaj2007.0096; Mbagwu JSC, 1998, SOIL TILL RES, V45, P133, DOI 10.1016/S0933-3630(96)00133-X; Nadeu E, 2011, J SOIL SEDIMENT, V11, P667, DOI 10.1007/s11368-011-0348-1; Nciizah Adornis D., 2014, South African Journal of Plant and Soil, V31, P213, DOI 10.1080/02571862.2014.944594; Nie XD, 2018, SOIL TILL RES, V175, P82, DOI 10.1016/j.still.2017.08.010; Ruhlmann J, 2006, GEODERMA, V130, P272, DOI 10.1016/j.geoderma.2005.01.024; Sarah P, 2005, GEOMORPHOLOGY, V70, P1, DOI 10.1016/j.geomorph.2005.03.007; Schjonning P, 2017, GEODERMA, V286, P83, DOI 10.1016/j.geoderma.2016.10.020; Sheng JA, 1997, CATENA, V29, P211, DOI 10.1016/S0341-8162(96)00057-4; Shi DM, 1985, SOIL WATER CONSERV C, V12, P6, DOI DOI 10.14123/J.CNKI.SWCC.1985.12.002; Shi P, 2017, EUR J SOIL SCI, V68, P853, DOI 10.1111/ejss.12472; Shi ZH, 2010, CATENA, V81, P240, DOI 10.1016/j.catena.2010.04.007; SIOH M, 1990, PHYS GEOGR, V11, P260; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; University of Illinois Gamble JC, 1971, DURABILITY PLASTICIT, P171; Vaisberg LA, 2003, J MIN SCI+, V39, P87, DOI 10.1023/A:1025769429101; Vermang J, 2009, SOIL SCI SOC AM J, V73, P718, DOI 10.2136/sssaj2007.0134; [王艳忠 Wang Yanzhong], 2008, [生态环境, Ecology and Environment], V17, P403; Wu N.S., 2006, J HEBEI I ARCHIT SCI, V23, P58; Xi C. F., 1990, Geojournal, V20, P365, DOI 10.1007/BF00174976; Xia D, 2016, J INTEGR AGR, V15, P2873, DOI [10.1016/s2095-3119(16)61348-5, 10.1016/S2095-3119(16)61348-5]; Xia D, 2015, NAT HAZARDS, V79, P455, DOI 10.1007/s11069-015-1852-1; [谢小康 XIE Xiaokang], 2010, [山地学报, Journal of Mountain Science], V28, P294; Xu J., 1992, IAHS PUBL, V209, P455; Xu J, 2017, GEOENVIRONMENTAL DIS, V4, P1, DOI [10.1186/s40677-017-0084-y, DOI 10.1186/S40677-017-0084-Y]; Xu JX, 1996, CATENA, V27, P249, DOI 10.1016/0341-8162(96)00014-8; [颜波 YAN Bo], 2009, [水文地质工程地质, Hydrogeology & Engineering Geology], V36, P68; Zeng P., 2012, THESIS; ZHANG PS, 1995, J RARE EARTH, V13, P37; Zhang S., 2009, THESIS; Zhang S, 2013, ROCK SOIL MECH, V34, P1668; Zhang XF, 2012, J MATER SCI TECHNOL, V28, P241, DOI 10.1016/S1005-0302(12)60048-6; Zhang XiaoYuan, 2013, Acta Pedologica Sinica, V50, P214; Zhao J., 2006, CHINA WATER RESOURCE, V16, P47; Zhao ShiWei, 2006, Agricultural Sciences in China, V5, P530, DOI 10.1016/S1671-2927(06)60088-6; Zheng M., 2005, CHIN J ROCK MECH ENG, V24, P5337; Zhong BL, 2013, LAND USE POLICY, V32, P119, DOI 10.1016/j.landusepol.2012.10.005; [周红艺 Zhou Hongyi], 2017, [水土保持学报, Journal of Soil and Water Conservation], V31, P74; Zhou XJ, 2004, SCI SOIL WATER CONSE, V2, P28; Zhu H. J., 1990, Geojournal, V20, P375	82	7	8	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209427	10.1371/journal.pone.0209427	http://dx.doi.org/10.1371/journal.pone.0209427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596706	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200046
J	Jhilmeet, N; Lowe, DM; Riou, C; Scriba, TJ; Coussens, A; Goliath, R; Wilkinson, RJ; Wilkinson, KA				Jhilmeet, Nishtha; Lowe, David M.; Riou, Catherine; Scriba, Thomas J.; Coussens, Anna; Goliath, Rene; Wilkinson, Robert J.; Wilkinson, Katalin Andrea			The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis	PLOS ONE			English	Article							CD4(+) T-CELLS; EXPRESSION; THERAPY; RESPONSES	HIV-1 co-infection is a leading cause of susceptibility to tuberculosis (TB), with the risk of TB being increased at all stages of HIV-1 infection. Antiretroviral treatment (ART) is the most effective way to reduce the risk of TB in HIV-1 co-infected people. Studying protective, ART-induced, immune restoration in HIV-1 infected individuals sensitised by Mycobacterium tuberculosis (Mtb) can thus help identify mechanisms of protection against TB. In order to understand ART-mediated prevention of TB in HIV-1 infected adults, we investigated the expression of 30 genes in whole blood from HIV-1 infected patients during the first 6 months of ART-induced immune reconstitution. The 30 selected genes were previously described to be differentially expressed between sorted Mtb specific central and effector memory CD4 T cells. HIV-1 infected persons sensitised by Mtb were recruited in Khayelitsha, South Africa, when initiating ART. RNA was extracted from whole blood at initiation and 1, 3 and 6 months of ART. qRT-PCR was used to determine gene expression and three reference 'housekeeping' genes were used to calculate the fold change in the expression of each gene relative to day 0 of ART. Results were assessed longitudinally. We observed a decrease in the expression of a number of genes at 6 months of ART, reflecting a decrease in immune activation. However, following correction for multiple comparisons and increasing CD4 counts, only the decrease in CD27 gene expression remained statistically significant. While not statistically significant, a number of genes also showed increased expression at various timepoints, illustrating the broad regeneration of the T cell pool in HIV-1 infected adults on ART. Our findings generate hypotheses underlying ART-induced protective immune reconstitution and may pave the way for future studies to evaluate ART mediated prevention of TB in HIV-1 infected persons.	[Jhilmeet, Nishtha; Lowe, David M.; Riou, Catherine; Coussens, Anna; Goliath, Rene; Wilkinson, Robert J.; Wilkinson, Katalin Andrea] Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Scriba, Thomas J.] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, Cape Town, South Africa; [Scriba, Thomas J.; Coussens, Anna] Univ Cape Town, Dept Pathol, Cape Town, South Africa; [Wilkinson, Robert J.; Wilkinson, Katalin Andrea] Univ Cape Town, Dept Med, Cape Town, South Africa; [Wilkinson, Robert J.; Wilkinson, Katalin Andrea] Francis Crick Inst, London, England; [Wilkinson, Robert J.] Imperial Coll London, Dept Med, London, England; [Lowe, David M.] UCL, Inst Immun & Transplantat, Royal Free Campus, London, England; [Coussens, Anna] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; Francis Crick Institute; Imperial College London; University of London; University College London; Walter & Eliza Hall Institute	Wilkinson, KA (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa.; Wilkinson, KA (corresponding author), Univ Cape Town, Dept Med, Cape Town, South Africa.; Wilkinson, KA (corresponding author), Francis Crick Inst, London, England.	katalin.wilkinson@crick.ac.uk	Coussens, Anna Kathleen/AAN-2949-2021; Wilkinson, Katalin/AAF-6805-2020; Scriba, Thomas/AAH-9413-2020; Wilkinson, Katalin/AAQ-7713-2021; Scriba, Thomas/GPX-2573-2022	Coussens, Anna Kathleen/0000-0002-7086-2621; Wilkinson, Katalin/0000-0002-9796-2040; Scriba, Thomas/0000-0002-0641-1359; Wilkinson, Robert/0000-0002-2753-1800	Wellcome Trust [104803, 087754, 203135]; South African National Research Foundation [443386]; European Union [643381]; UKRI [FC001218]; Cancer Research UK [FC001218]; Wellcome [104803, 087754, 203135, FC001218]; MRC [MC_U117588499] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); South African National Research Foundation(National Research Foundation - South Africa); European Union(European Commission); UKRI(UK Research & Innovation (UKRI)); Cancer Research UK(Cancer Research UK); Wellcome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research supported by The Wellcome Trust (104803, 087754, 203135) to RJW, The South African National Research Foundation (443386), the European Union Horizon 2020 research and innovation programme under grant agreement No 643381 to RJW and The Francis Crick Institute which receives support from UKRI (FC001218), Cancer Research UK (FC001218) and Wellcome (FC001218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research supported by Wellcome (104803, 087754, 203135), The South African National Research Foundation (443386), the European Union Horizon 2020 research and innovation programme under grant agreement No 643381 and The Francis Crick Institute which receives support from UKRI (FC001218), Cancer Research UK (FC001218) and Wellcome (FC001218).	Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Chapman JR, 2015, PLOS ONE, V10; Chiacchio T, 2018, IMMUNOL LETT, V198, P33, DOI 10.1016/j.imlet.2018.04.001; Chiacchio T, 2014, J INFECTION, V69, P533, DOI 10.1016/j.jinf.2014.06.009; Deaglio S, 2001, LEUKEMIA RES, V25, P1, DOI 10.1016/S0145-2126(00)00093-X; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Horvati K, 2016, J INFECTION, V72, P179, DOI 10.1016/j.jinf.2015.10.012; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lindenstrom T, 2018, EBIOMEDICINE, V27, P27, DOI 10.1016/j.ebiom.2017.12.004; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Lowe DM, 2015, ANN AM THORAC SOC, V12, P1627, DOI 10.1513/AnnalsATS.201507-463OC; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Mahnke Yolanda D, 2016, Pathog Immun, V1, P260; Mpande CAM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00324; Petruccioli E, 2015, J INFECTION, V71, P526, DOI 10.1016/j.jinf.2015.07.009; Portevin D, 2014, LANCET INFECT DIS, V14, P931, DOI 10.1016/S1473-3099(14)70884-9; Riou C, 2017, FRONT IMMUNOL, V8, P1, DOI 10.3389/fimmu.2017.00968; Riou C, 2015, J IMMUNOL, V195, P2273, DOI 10.4049/jimmunol.1500803; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schuetz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027284; Scriba TJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006687; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Wilkinson KA, 2016, AM J RESP CRIT CARE, V193, P1307, DOI 10.1164/rccm.201601-0116LE; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209516	10.1371/journal.pone.0209516	http://dx.doi.org/10.1371/journal.pone.0209516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589870	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200025
J	Norgaard, CH; Sogaard, NB; Biccler, JL; Pilgaard, L; Eskesen, MH; Kjartansdottir, TH; Bogsted, M; El-Galaly, TC				Norgaard, Caroline Holm; Sogaard, Nikoline Buus; Biccler, Jorne Lionel; Pilgaard, Laura; Eskesen, Mathias Holmsgaard; Kjartansdottir, Thordis Helga; Bogsted, Martin; El-Galaly, Tarec Christoffer			Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study	PLOS ONE			English	Article							INTERNATIONAL PROGNOSTIC INDEX; QUALITY-OF-LIFE; DIAGNOSIS; GUIDELINES; SURVIVAL; STAGE	Introduction The majority of newly diagnosed chronic lymphocytic leukemia (CLL) patients are followed initially by watch and wait (WAW). Clinical practice varies and the value of frequent follow-up visits remains unclear. Thus, in this study we investigated the clinical value of follow-up visits for patients with CLL. Methods We collected data from diagnosis and follow-up visits for patients diagnosed with CLL and managed by WAW in the North Denmark Region between 2007-2014. High-and low-risk group patients were determined by Binet stage, IgVH status, and cytogenetics at diagnosis. The effect of risk group allocation on the probability of receiving CLL-directed treatment within two years was included in a multivariable logistic regression model adjusted for age and blood test results. Results 273 patients were included in the study with a median follow-up of 3 years (IQR: 1.6-5.4). Overall, the median interval between follow-up visits was 98 days (95% CI: 96-100) (high-risk patients: 91 days [ 95% CI: 86-95] vs. low-risk patients: 105 days [ 95% CI: 100-110]). Among 2,312 follow-up visits, only 387 (17%) were associated with interventions. At the following time points: 6 months, 1 year, and 1.5 years, patients with low-risk CLL had significantly lower odds of initiating treatment compared to patients with high-risk CLL. Conclusion WAWplays an important role in managing CLL. Interventions at follow-up visits were infrequent and low-risk patients had significantly lower risk of treatment initiation. We question the value of routine follow-up in CLL in the absence of changes in symptoms and/or blood test results.	[Norgaard, Caroline Holm; Sogaard, Nikoline Buus; Biccler, Jorne Lionel; Pilgaard, Laura; Eskesen, Mathias Holmsgaard; Kjartansdottir, Thordis Helga; Bogsted, Martin; El-Galaly, Tarec Christoffer] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Norgaard, Caroline Holm] Aalborg Univ Hosp, Unit Epidemiol & Biostat, Aalborg, Denmark; [Biccler, Jorne Lionel; Bogsted, Martin; El-Galaly, Tarec Christoffer] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Biccler, Jorne Lionel; Bogsted, Martin; El-Galaly, Tarec Christoffer] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital	Norgaard, CH (corresponding author), Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark.; Norgaard, CH (corresponding author), Aalborg Univ Hosp, Unit Epidemiol & Biostat, Aalborg, Denmark.	caroline.noergaard@rn.dk	Noergaard, Caroline Holm/I-4852-2018	Noergaard, Caroline Holm/0000-0003-3279-4872; Bogsted, Martin/0000-0001-9192-1814				ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Baliakas P, 2016, J INTERN MED, V279, P347, DOI 10.1111/joim.12455; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Christensen I, 2018, NATL RETNINGSLINJER; da Cunha-Bang C, 2016, CLIN EPIDEMIOL, V8, P561, DOI 10.2147/CLEP.S99486; Del Giudice I, 2011, HAEMATOL-HEMATOL J, V96, P626, DOI 10.3324/haematol.2010.028779; Dickinson R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-311; Eichhorst B, 2015, ANN ONCOL, V26, pV78, DOI 10.1093/annonc/mdv303; Ghia P, 2014, HAEMATOLOGICA, V99, P965, DOI 10.3324/haematol.2013.096107; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2018, BLOOD, V131, P2745, DOI 10.1182/blood-2017-09-806398; Hallek M, 2016, LANCET ONCOL, V17, P779, DOI 10.1016/S1470-2045(16)30029-8; Hallek M, 2010, ANN ONCOL, V21, P154, DOI 10.1093/annonc/mdq373; Levin TT, 2007, GEN HOSP PSYCHIAT, V29, P251, DOI 10.1016/j.genhosppsych.2007.01.014; Molica S, 2016, AM J HEMATOL, V91, P1090, DOI 10.1002/ajh.24493; Oscier D, 2012, BRIT J HAEMATOL, V159, P541, DOI 10.1111/bjh.12067; Overend Aldyn, 2008, Can Oncol Nurs J, V18, P64; Pepper C, 2012, BRIT J HAEMATOL, V156, P499, DOI 10.1111/j.1365-2141.2011.08974.x; Scheike TH, 2008, BIOMETRIKA, V95, P205, DOI 10.1093/biomet/asm096; Shanafelt TD, 2007, BRIT J HAEMATOL, V139, P255, DOI 10.1111/j.1365-2141.2007.06791.x; Shanafelt Tait D, 2009, Hematology Am Soc Hematol Educ Program, P421, DOI 10.1182/asheducation-2009.1.421; Trial C, 1999, CHEMOTHERAPEUTIC OPT, P861; VERHEUL HA, 1993, LANCET, V341, P872, DOI 10.1016/0140-6736(93)93073-A; Wang MC, 1999, J AM STAT ASSOC, V94, P146, DOI 10.2307/2669690	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208180	10.1371/journal.pone.0208180	http://dx.doi.org/10.1371/journal.pone.0208180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589850	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200004
J	Sun, Y; Tsai, PJ; Chu, CL; Huang, WC; Bee, YS				Sun, Yng; Tsai, Pei-Jhen; Chu, Chin-Liang; Huang, Wei-Chun; Bee, Youn-Shen			Epidemiology of benign essential blepharospasm: A nationwide population-based retrospective study in Taiwan	PLOS ONE			English	Article							ACUTE PSYCHOLOGICAL STRESS; ADULT-ONSET DYSTONIA; FOCAL DYSTONIAS; EYE SYMPTOMS; RISK-FACTORS; DRY EYE; PREVALENCE; HEMOCONCENTRATION; ACTIVATION; BLINKING	Importance This study provides a nationwide, population-based data on the incidence of benign essential blepharospasm in Asian adults. Background To describe the incidence, patient demographics, and risk factors associated with benign essential blepharospasm. Design Population-based retrospective study. Participants and samples A total of 1325 patients with benign essential blepharospasm were identified. Methods Patients with diagnosis of blepharopsasm between January 2000 and December 2013 were sampled using the Longitudinal Health Insurance Database 2000. Secondary blepharospasm that may be related to neurological, trauma, and ocular surface disease were excluded. Main outcome measured Multivariate conditional logistic regression was used to estimate the odds ratios for potential risk factors of benign essential blepharospasm. Results The mean annual incidence was 0.10% (0.07% for males, and 0.12% for females). The peak incidence was in the 50 to 59-year-old age group (0.19%). People living in urban regions have more risk of developing blepharospasm comparing to people living in less urban regions (p < 0.01). White-collar workers also have higher chance of having blepharospasm (p<0.001). Significant difference between control group and case group in hyperlipidemia (p <0.001), sleep disorders (p <0.001), mental disorders (depression, anxiety, obsessive compulsive disorder) (p <0.001), dry eye-related diseases (dry eye, Sjogren's syndrome) (p < 0.001), Parkinson's disease (p <0.004), and rosacea (p <0.021) were also identified. Conclusions and relevance Higher level of urbanization, white-collar work, sleep disorders, mental health diseases, dry eye-related diseases, Parkinsonism, and rosacea are possible risk factors for benign essential blepharospasm.	[Sun, Yng; Tsai, Pei-Jhen; Bee, Youn-Shen] Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Sun, Yng] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chu, Chin-Liang] Rong Xin Mental Hlth Clin, Kaohsiung, Taiwan; [Huang, Wei-Chun] Kaohsiung Vet Gen Hosp, Crit Care Ctr, Kaohsiung, Taiwan; [Huang, Wei-Chun] Kaohsiung Vet Gen Hosp, Cardiovasc Med Ctr, Kaohsiung, Taiwan; [Huang, Wei-Chun] Fooyin Univ, Dept Phys Therapy, Kaohsiung, Taiwan; [Huang, Wei-Chun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Bee, Youn-Shen] Yuh Ing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Bee, Youn-Shen] Natl Def Med Ctr, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Fooyin University; National Yang Ming Chiao Tung University; National Defense Medical Center	Bee, YS (corresponding author), Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.; Bee, YS (corresponding author), Yuh Ing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan.; Bee, YS (corresponding author), Natl Def Med Ctr, Taipei, Taiwan.	ysbee@vghks.gov.tw						Abbruzzese G, 2008, J NEUROL NEUROSUR PS, V79, P392, DOI 10.1136/jnnp.2007.124594; Anderson RL, 1998, OPHTHALMIC PLAST REC, V14, P305, DOI 10.1097/00002341-199809000-00002; Bachen EA, 2002, PSYCHOSOM MED, V64, P587, DOI 10.1097/01.PSY.0000021943.35402.8A; Bacon SL, 2004, BIOL PSYCHOL, V65, P237, DOI 10.1016/S0301-0511(03)00113-3; Bali Jatinder, 2007, Indian Journal of Ophthalmology, V55, P289; Banefelt J, 2016, EUR J HEALTH ECON, V17, P1117, DOI 10.1007/s10198-015-0749-y; Battistella G, 2017, CEREB CORTEX, V27, P1203, DOI 10.1093/cercor/bhv313; Bernstein CJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0562-y; Birdsill AC, 2013, OBESITY, V21, P1313, DOI 10.1002/oby.20170; Bradley EA, 2003, OPHTHALMIC PLAST REC, V19, P177, DOI 10.1097/01.IOP.0000065203.88182.CF; Conte A, 2017, MOV DISORD CLIN PRAC, V4, P733, DOI 10.1002/mdc3.12499; Conte A, 2016, PARKINSONISM RELAT D, V22, pS111, DOI 10.1016/j.parkreldis.2015.09.001; Coscarelli JM, 2010, SEMIN OPHTHALMOL, V25, P104, DOI 10.3109/08820538.2010.488564; Defazio G, 1998, J NEUROL NEUROSUR PS, V64, P25, DOI 10.1136/jnnp.64.1.25; Defazio G, 2004, LANCET NEUROL, V3, P673, DOI 10.1016/S1474-4422(04)00907-X; Defazio G, 2002, MOVEMENT DISORD, V17, P7, DOI 10.1002/mds.1275; Defazio G, 2001, NEUROLOGY, V56, P1579, DOI 10.1212/WNL.56.11.1579; Defazio G, 2012, MOVEMENT DISORD, V27, P305, DOI 10.1002/mds.24026; Dresel C, 2011, MOVEMENT DISORD, V26, P1496, DOI 10.1002/mds.23497; Duffey P O, 1998, Adv Neurol, V78, P121; Evinger C, 2002, MOVEMENT DISORD, V17, pS75, DOI 10.1002/mds.10065; Fahn S, 1998, Adv Neurol, V78, P1; Hall TA, 2005, J NEURO-OPHTHALMOL, V25, P280, DOI 10.1097/01.wno.0000189063.43423.04; Hallett M, 2008, NEUROLOGY, V71, P1275, DOI 10.1212/01.wnl.0000327601.46315.85; Hertenstein E, 2016, SLEEP MED REV, V26, P95, DOI 10.1016/j.smrv.2015.04.004; Horiuchi M, 2010, J ST MARIANNA U, P103; Huang XF, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00235; Hwang Wen-Juh, 2012, Acta Neurol Taiwan, V21, P108; Jankovic J, 2001, PARKINSONISM RELAT D, V8, P109, DOI 10.1016/S1353-8020(01)00025-6; Jinnah HA, 2013, MOVEMENT DISORD, V28, P926, DOI 10.1002/mds.25567; Khan TT, 2014, ORBIT, V33, P276, DOI 10.3109/01676830.2014.904379; KHODADOUST AA, 1968, AM J OPHTHALMOL, V65, P339, DOI 10.1016/0002-9394(68)93082-1; Kuyper DJ, 2011, MOVEMENT DISORD, V26, P1206, DOI 10.1002/mds.23709; Lu R, 2014, AM J OPHTHALMOL, V157, P591, DOI 10.1016/j.ajo.2013.11.014; Macerollo A, 2015, J CLIN NEUROSCI, V22, P608, DOI 10.1016/j.jocn.2014.09.014; Marsden C D, 1976, Adv Neurol, V14, P259; Martino D, 2005, MOVEMENT DISORD, V20, P1564, DOI 10.1002/mds.20635; MCCANN BS, 1995, PSYCHOSOM MED, V57, P165, DOI 10.1097/00006842-199503000-00009; MULDOON MF, 1995, ARCH INTERN MED, V155, P615, DOI 10.1001/archinte.155.6.615; NAKASHIMA K, 1995, MOVEMENT DISORD, V10, P440, DOI 10.1002/mds.870100406; National Health Insurance Administration MoH Executive Yuan, 2014, 2014 2015 NAT INS AN; NUTT JG, 1988, MOVEMENT DISORD, V3, P188, DOI 10.1002/mds.870030302; Rana AQ, 2012, EUR NEUROL, V68, P318, DOI 10.1159/000341621; Steptoe A, 2005, HEALTH PSYCHOL, V24, P601, DOI 10.1037/0278-6133.24.6.601; STOJANOVIC M, 1995, J NEUROL, V242, P508, DOI 10.1007/BF00867421; Suzuki Y, 2011, NEUROIMAGE, V56, P1, DOI 10.1016/j.neuroimage.2011.01.081; Tolosa E, 1988, Adv Neurol, V49, P73; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P825, DOI 10.1016/S0002-9394(14)71700-3; Warner T, 2000, J NEUROL, V247, P787; Yang WC, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-016-0401-6	50	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209558	10.1371/journal.pone.0209558	http://dx.doi.org/10.1371/journal.pone.0209558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586395	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400072
J	Mousavi, SA; Kasaeian, A; Pourkasmaee, M; Ghavamzadeh, A; Alimoghaddam, K; Vaezi, M; Fumani, HK; Babakhani, D; Tavakoli, S				Mousavi, Seied Asadollah; Kasaeian, Amir; Pourkasmaee, Maziar; Ghavamzadeh, Ardeshir; Alimoghaddam, Kamran; Vaezi, Mohammad; Fumani, Hosein Kamranzadeh; Babakhani, Davoud; Tavakoli, Sahar			Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran	PLOS ONE			English	Article							BODY-MASS INDEX; CLINICOPATHOLOGICAL FEATURES; SUBTYPES; WOMEN; PATTERNS; RISK; METAANALYSIS; OUTCOMES; THERAPY; OBESITY	Background Breast cancer is the second leading cause of death due to cancer in women. Triple negative breast cancer (TNBC) is a subgroup with unique behavior. There is a controversy in organ involvement in metastasis. In this study, we planned to define the prognostic factors, survival, and recurrence incidence of patients. Materials and method Among the 583 patients with breast mass referred to hematology and oncology clinic in Shariati hospital, Tehran, Iran from March 2005 to March 2015, fifty four patients entered the survival analysis whom we followed for two years until March 2017. Overall survival (OS) and disease-free survival (DFS) and Cumulative recurrence incidences (RI) were estimated. Univariate and multivariate Cox proportional hazards regression was performed to assess risk factors in predicting OS and DFS. Results Median follow up for the patients was 5.00 years. The five-year OS, DFS and RI were 86.13% (95% CI (71.42-93.59), 63.09% (95% CI (47.04-75.49) and 32.15% (95% CI (19.52-47.43) respectively. Among the factors studied OS, DFS and RI differed significantly only between patients with and without nodal involvement (P = 0.004, P = 0.003, and P = 0.02 respectively). On the other hand, based on the univariate modeling, patients with nodal involvement had a higher risk of breast cancer-specific death (HR: 17.99, P = 0.004). Furthermore, patients with nodal involvement had a higher risk of breast cancer-specific death or recurrence (HR = 5.64, P = 0.008). In Multivariate model, just the nodal involvement significantly changed the hazard for OS (HR = 23.91, P = 0.001). As the nodal involvement was the only significant risk factor at the 0.2 level of significance, we can consider the hazard ratio of lymph node positivity in DFS univariate models as adjusted hazard. Conclusion The only factor with significant effect on OS, DFS and RI was nodal involvement in the pathology report.	[Mousavi, Seied Asadollah; Pourkasmaee, Maziar; Ghavamzadeh, Ardeshir; Alimoghaddam, Kamran; Vaezi, Mohammad; Fumani, Hosein Kamranzadeh; Babakhani, Davoud; Tavakoli, Sahar] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Dept Biostat & Epidemiol, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences	Pourkasmaee, M (corresponding author), Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran.	mkasmaee@hotmail.com	Kasaeian, Amir/C-8290-2017	Kasaeian, Amir/0000-0003-2018-9368; Pourkasmaee, maziar/0000-0003-3873-3528				Abdollahi Alireza, 2016, Int J Hematol Oncol Stem Cell Res, V10, P200; Aghili Mahdi, 2013, Acta Med Iran, V51, P560; Anders CK, 2009, SEMINARS ONCOLOGY; BALSLEV I, 1994, BREAST CANCER RES TR, V32, P281, DOI 10.1007/BF00666005; Bao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094815; Bao PP, 2016, CANCER CAUSE CONTROL, V27, P229, DOI 10.1007/s10552-015-0700-7; Billar JAY, 2010, ANN SURG ONCOL, V17, pS384, DOI 10.1245/s10434-010-1260-4; Blamey RW, 2007, EUR J CANCER, V43, P1548, DOI 10.1016/j.ejca.2007.01.016; Bulut N, 2015, J BUON, V20, P1276; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Cakar B, 2015, ONCOL RES TREAT, V38, P518, DOI 10.1159/000439551; Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Fatima N, 2013, ASIAN PAC J CANCER P, V14, P43, DOI 10.7314/APJCP.2013.14.1.43; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gadi VK, 2017, J ONCOL PRACT, V13, P293, DOI 10.1200/JOP.2017.022632; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Gui Y, 2016, BIOMARK MED, V10, P771, DOI 10.2217/bmm-2015-0064; Hicks DG, 2006, AM J SURG PATHOL, V30, P1097; Kashi ASY, 2017, INTERNATIONAL JOURNA, V10; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kim Minsung, 2016, Journal of Breast Disease, V4, P116, DOI 10.14449/jbd.2016.4.2.116; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Malmgren JA, 2013, TRIPLE NEGATIVE BREA; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mirzania Mehrzad, 2017, Int J Hematol Oncol Stem Cell Res, V11, P37; Mousavi Seyyed Asadolah, 2013, Int J Hematol Oncol Stem Cell Res, V7, P5; Najafi B, 2013, ASIAN PAC J CANCER P, V14, P5811, DOI 10.7314/APJCP.2013.14.10.5811; O'Rorke MA, 2016, CANCER TREAT REV, V47, P12, DOI 10.1016/j.ctrv.2016.05.001; Ovcaricek T, 2011, RADIOL ONCOL, V45, P46, DOI 10.2478/v10019-010-0054-4; Pan YB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172324; Parise CA, 2009, BREAST J, V15, P593, DOI 10.1111/j.1524-4741.2009.00822.x; Penault-Llorca F, 2012, ANN ONCOL, V23, P19, DOI 10.1093/annonc/mds190; Pierobon M, 2013, BREAST CANCER RES TR, V137, P307, DOI 10.1007/s10549-012-2339-3; Rouzier R, 2016, ABSTRACT P3 07 63 KI; Seshie B, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0014-4; Sharma D, 2016, INDIAN J CANCER, V53, P566, DOI 10.4103/ijc.IJC_534_16; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Soliman NA, 2016, CANCER BIOL MED, V13, P496, DOI 10.20892/j.issn.2095-3941.2016.0066; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steward LT, 2014, ONCOL LETT, V7, P548, DOI 10.3892/ol.2013.1700; Thomas K, 2017, AM J HEMATOLOG ONCOL, V13; van Roozendaal LM, 2016, BREAST CANCER RES TR, V156, P465, DOI 10.1007/s10549-016-3757-4; Wang SL, 2011, INT J RADIAT ONCOL, V80, P1095, DOI 10.1016/j.ijrobp.2010.03.038; Widschwendter P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0639-3; Zeeneldin AA, 2013, J EGYPT NATL CANCER, V25, P199, DOI 10.1016/j.jnci.2013.09.003; Zhu WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128345	56	6	7	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0208701	10.1371/journal.pone.0208701	http://dx.doi.org/10.1371/journal.pone.0208701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608935	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800014
J	Merlevede, A; Ahl, H; Troein, C				Merlevede, Adriaan; Ahl, Henrik; Troein, Carl			Homology and linkage in crossover for linear genomes of variable length	PLOS ONE			English	Article							EVOLUTION; SEQUENCE	The use of variable-length genomes in evolutionary computation has applications in optimisation when the size of the search space is unknown, and provides a unique environment to study the evolutionary dynamics of genome structure. Here, we revisit crossover for linear genomes of variable length, identifying two crucial attributes of successful recombination algorithms: the ability to retain homologous structure, and to reshuffle variant information. We introduce direct measures of these properties-homology score and linkage scoreand use them to review existing crossover algorithms, as well as two novel ones. In addition, we measure the performance of these crossover methods on three different benchmark problems, and find that variable-length genomes out-perform fixed-length variants in all three cases. Our homology and linkage scores successfully explain the difference in performance between different crossover methods, providing a simple and insightful framework for crossover in a variable-length setting.	[Merlevede, Adriaan; Ahl, Henrik; Troein, Carl] Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, Lund, Sweden	Lund University	Troein, C (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, Lund, Sweden.	carl@thep.lu.se		Ahl, Henrik/0000-0002-0655-806X	Swedish Research Council [2010-5219]; Knut and Alice Wallenberg Foundation [2013.0073]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	CT and AM were supported by grant 2010-5219 from the Swedish Research Council, http://vr.se/.CT was supported by grant 2013.0073 from the Knut and Alice Wallenberg Foundation, http://kaw.wallenberg.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2012, METHODS MOL BIOL, V855, P259, DOI 10.1007/978-1-61779-582-4_9; Banzhaf W, 2006, NAT REV GENET, V7, P729, DOI 10.1038/nrg1921; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Brameier MF., 2007, LINEAR GENETIC PROGR; Burke DS, 1998, EVOL COMPUT, V6, P387, DOI 10.1162/evco.1998.6.4.387; Calabretta R, 2000, ARTIF LIFE, V6, P69, DOI 10.1162/106454600568320; Cartwright RA, 2009, MOL BIOL EVOL, V26, P473, DOI 10.1093/molbev/msn275; Eiben AE, 2002, INFORM PROCESS LETT, V82, P1, DOI 10.1016/S0020-0190(02)00204-1; FELSENSTEIN J, 1974, GENETICS, V78, P737; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Francone FD, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1021; Fullmer B., 1992, Toward a Practice of Autonomous Systems. Proceedings of the First European Conference on Artificial Life, P255; Gen M., 2010, INTRO EVOLUTIONARY A; Goldberg D. E., 1990, Complex Systems, V4, P415; Griffiths A.J.F., 2015, INTRO GENETIC ANAL, V10th; HARVEY I, 1992, PARALLEL PROBLEM SOLVING FROM NATURE, 2, P269; HIRSCHBERG DS, 1975, COMMUN ACM, V18, P341, DOI 10.1145/360825.360861; Holland J. H., 1992, Scientific American (International Edition), V267, P44, DOI 10.1038/scientificamerican0792-66; Hu T, 2010, J ARTIFICIAL EVOLUTI, P1; Hutt B, 2007, IEEE T EVOLUT COMPUT, V11, P118, DOI 10.1109/TEVC.2006.878096; Lalejini A, 2017, FOURTEENTH EUROPEAN CONFERENCE ON ARTIFICIAL LIFE (ECAL 2017), P257; Langdon W. B., 2000, Genetic Programming and Evolvable Machines, V1, P95, DOI 10.1023/A:1010024515191; Langdon WB, 1998, SOFT COMPUTING IN ENGINEERING DESIGN AND MANUFACTURING, P13; LANGDON WB, 2002, FDN GENETIC PROGRAMM; Lehman J, 2015, ARTIF LIFE, V21, P21, DOI 10.1162/ARTL_a_00150; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Mahfoud S. W., 1995, THESIS U ILLINOIS UR; MANIEZZO V, 1994, IEEE T NEURAL NETWOR, V5, P39, DOI 10.1109/72.265959; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Notredame C, 2007, PLOS COMPUT BIOL, V3, P1405, DOI 10.1371/journal.pcbi.0030123; O'Neill M, 2001, IEEE T EVOLUT COMPUT, V5, P349, DOI 10.1109/4235.942529; O'Neill M., 2003, Genetic Programming and Evolvable Machines, V4, P67, DOI 10.1023/A:1021877127167; Pearson William R, 2013, Curr Protoc Bioinformatics, VChapter 3, DOI 10.1002/0471250953.bi0301s42; Platel MD, 2003, LECT NOTES COMPUT SC, V2610, P194; REECK GR, 1987, CELL, V50, P667, DOI 10.1016/0092-8674(87)90322-9; Sakka S, 2004, ROMOCO' 04: PROCEEDINGS OF THE FOURTH INTERNATIONAL WORKSHOP ON ROBOT MOTION AND CONTROL, P29; Sprave J., 1998, Evolutionary Programming VII. 7th International Conference, EP98. Proceedings, P261, DOI 10.1007/BFb0040779; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Sudholt D, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P689, DOI 10.1145/2330163.2330260; Zebulum RS, 2000, EVOL COMPUT, V8, P93, DOI 10.1162/106365600568112	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209712	10.1371/journal.pone.0209712	http://dx.doi.org/10.1371/journal.pone.0209712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605463	Green Submitted, Green Published, gold			2022-12-26	WOS:000454759900019
J	Schuetz, JM; Grundy, A; Lee, DG; Lai, AS; Kobayashi, LC; Richardson, H; Long, JR; Zheng, W; Aronson, KJ; Spinelli, JJ; Brooks-Wilson, AR				Schuetz, Johanna M.; Grundy, Anne; Lee, Derrick G.; Lai, Agnes S.; Kobayashi, Lindsay C.; Richardson, Harriet; Long, Jirong; Zheng, Wei; Aronson, Kristan J.; Spinelli, John J.; Brooks-Wilson, Angela R.			Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; PHYSICAL-ACTIVITY; POLYMORPHISMS; IDENTIFICATION; HAPLOTYPE; SURVIVAL; WOMEN; IL6	Background Inflammation contributes to breast cancer development through its effects on cell damage. This damage is usually dealt with by key genes involved in apoptosis and autophagy pathways. Methods We tested 206 single nucleotide polymorphisms (SNPs) in 54 genes related to inflammation, apoptosis and autophagy in a population-based breast cancer study of women of European (658 cases and 795 controls) and East Asian (262 cases and 127 controls) descent. Logistic regression was used to estimate odds ratios for breast cancer risk, and case-only analysis to compare breast cancer subtypes (defined by ER/PR/HER2 status), with adjustment for confounders. We assessed statistical interactions between the SNPs and lifestyle factors (smoking status, physical activity and body mass index). Results and conclusion Although no SNP was associated with breast cancer risk among women of European descent, we found evidence for an association among East Asians for rs1800925 (IL-13) and breast cancer risk (OR = 2.08; 95% CI: 1.32-3.28; p = 0.000779), which remained statistically significant after multiple testing correction (p(adj) = 0.0350). This association was replicated in a meta-analysis of 4305 cases and 4194 controls in the Shanghai Breast Cancer Genetics Study (OR 1.12, 95% CI: 1.03-1.21, p = 0.011). Further, we found evidence of an interaction between rs7874234 (TSC1) and physical activity among women of East Asian descent.	[Schuetz, Johanna M.; Brooks-Wilson, Angela R.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Grundy, Anne] CRCHUM, Montreal, PQ, Canada; [Grundy, Anne] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Lee, Derrick G.; Lai, Agnes S.; Spinelli, John J.] British Columbia Canc Agcy, Dept Canc Control Res, Vancouver, BC, Canada; [Lee, Derrick G.] St Francis Xavier Univ, Dept Math Stat & Comp Sci, Antigonish, NS, Canada; [Kobayashi, Lindsay C.] Harvard TH Chan Sch Publ Hlth, Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Kobayashi, Lindsay C.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Richardson, Harriet; Aronson, Kristan J.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Richardson, Harriet; Aronson, Kristan J.] Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON, Canada; [Long, Jirong; Zheng, Wei] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Nashville, TN USA; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada	British Columbia Cancer Agency; Universite de Montreal; Universite de Montreal; British Columbia Cancer Agency; Saint Francis Xavier University - Canada; Harvard University; Harvard T.H. Chan School of Public Health; Georgetown University; Queens University - Canada; Queens University - Canada; Vanderbilt University; University of British Columbia; Simon Fraser University	Brooks-Wilson, AR (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.; Brooks-Wilson, AR (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	abrooks-wilson@bcgsc.ca	Brooks-Wilson, Angela/E-9399-2012	Brooks-Wilson, Angela/0000-0003-1009-6408; Lee, Derrick/0000-0003-0079-8385; Kobayashi, Lindsay/0000-0003-2725-3107; Long, Jirong/0000-0002-7433-9766	Canadian Institutes of Health Research [69036]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant (FRN#69036) from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Crew KD, 2007, CARCINOGENESIS, V28, P2548, DOI 10.1093/carcin/bgm211; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dorjgochoo T, 2013, CANCER EPIDEMIOL, V37, P619, DOI 10.1016/j.canep.2013.06.005; Dossus L, 2010, CARCINOGENESIS, V31, P455, DOI 10.1093/carcin/bgp307; Ebner F, 2010, J CANCER RES CLIN, V136, P1369, DOI 10.1007/s00432-010-0788-9; Engel C, 2010, CANCER EPIDEM BIOMAR, V19, P2859, DOI 10.1158/1055-9965.EPI-10-0517; Erdei E, 2010, CYTOKINE, V51, P18, DOI 10.1016/j.cyto.2010.03.014; Gerger A, 2010, BREAST CANCER RES TR, V119, P701, DOI 10.1007/s10549-009-0417-y; Grundy A, 2016, ENVIRON MOL MUTAGEN, V57, P269, DOI 10.1002/em.22013; Grundy A, 2013, CANCER EPIDEMIOL, V37, P606, DOI 10.1016/j.canep.2013.04.006; Han W, 2010, ONCOL REP, V23, P763, DOI 10.3892/or_00000696; Jin GJ, 2014, TUMOR BIOL, V35, P12091, DOI 10.1007/s13277-014-2510-z; Kaarvatn MH, 2012, SCAND J IMMUNOL, V76, P329, DOI 10.1111/j.1365-3083.2012.02736.x; Khan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109973; Kim SH, 2015, BREAST CANCER RES TR, V149, P681, DOI 10.1007/s10549-015-3279-5; Knappskog S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036263; Kobayashi LC, 2013, BREAST CANCER RES TR, V139, P851, DOI 10.1007/s10549-013-2596-9; Lin WY, 2015, HUM MOL GENET, V24, P285, DOI 10.1093/hmg/ddu431; Loza MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001035; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Milne RL, 2017, NAT GENET, V49, P1767, DOI 10.1038/ng.3785; Murray JL, 2013, BREAST CANCER RES TR, V138, P917, DOI 10.1007/s10549-013-2445-x; Osorio A, 2006, HUM MUTAT, V27, P242, DOI 10.1002/humu.20283; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2014, R LANG ENV STAT COMP; Rose DP, 2015, CANCERS, V7, P2147, DOI 10.3390/cancers7040883; Rose DP, 2014, BIOFACTORS, V40, P1, DOI 10.1002/biof.1109; Schuetz JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075170; Sergentanis TN, 2010, BREAST CANCER RES TR, V120, P229, DOI 10.1007/s10549-009-0471-5; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shi J, 2017, BREAST CANCER RES TR, V165, P201, DOI 10.1007/s10549-017-4323-4; Shi J, 2016, TUMOR BIOL, V37, P6379, DOI 10.1007/s13277-015-4417-8; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPI-06-0667; Snoussi K, 2005, EUR CYTOKINE NETW, V16, P253; Tang H, 2015, EBIOMEDICINE, V2, P255, DOI 10.1016/j.ebiom.2015.01.008; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034400; Xu YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090090; Yang RX, 2010, BREAST CANCER RES TR, V121, P693, DOI 10.1007/s10549-009-0633-5; Zheng WT, 2018, LEUKEMIA, V32, P1157, DOI 10.1038/s41375-017-0008-6; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209010	10.1371/journal.pone.0209010	http://dx.doi.org/10.1371/journal.pone.0209010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601841	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200029
J	Brinkhof, B; Jia, HD; Zhang, B; Cui, ZF; Ye, H; Wang, H				Brinkhof, Bas; Jia, Huidong; Zhang, Bo; Cui, Zhanfeng; Ye, Hua; Wang, Hui			Improving characterisation of human Multipotent Stromal Cells cultured in 2D and 3D: Design and evaluation of primer sets for accurate gene expression normalisation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TIME	Human Multipotent Stromal Cells (MSCs) are a valuable resource for regenerative medicine and are widely studied. They can be isolated from a variety of tissues and differentiate into multiple cell types (multi-potent). Many reports have been published using human MSCs and to be able to compare outcome, or be able to identify differences between MSCs, several cell surface markers have been proposed. Nevertheless, still many differences remain. Gene expression is known to be different between cell stage and origin. Furthermore, cells cultured on a culture dish (2D) show different gene expression profiles as compared to cells grown on scaffolds (3D). Even the RNA extraction method and the selection of genes used for normalisation have a role in gene expression profiling. To be able to compare gene expression data from samples cultured in different dimensions and RNA extracted using a variety of protocols we set out to define a set of reference genes suitable to normalise qPCR data from a very heterogeneous sample set. Hereto, Trizol was used to extract RNA from human MSCs cultured in 3D and 2D to validate newly designed and previously published primer sets. Subsequently, RNA from fresh human MSC samples and samples stored in RLT-buffer, Trizol or RNAlater was extracted using RNeasy and Trizol methods. All samples have been used to rank the candidate reference genes according to their stability after qPCR enabling identification of the most suitable reference gene(s) for normalisation of a heterogeneous sample set. The most stably expressed reference genes indicated superior normalisation of MSC marker gene expression over the least stable reference genes.	[Brinkhof, Bas; Jia, Huidong; Zhang, Bo; Cui, Zhanfeng; Ye, Hua; Wang, Hui] Univ Oxford, Dept Engn Sci, Oxford, England	University of Oxford	Ye, H; Wang, H (corresponding author), Univ Oxford, Dept Engn Sci, Oxford, England.	hua.ye@eng.ox.ac.uk; hui.wang@eng.ox.ac.uk	Wang, Hui/E-6764-2012; Brinkhof, Bas/S-8687-2017	Brinkhof, Bas/0000-0003-3617-0709; Zhang, Bo/0000-0003-2537-1468; Cui, Zhanfeng/0000-0002-9251-9752	 [DFR01180];  [DFR00150]; BBSRC [BB/H008608/1] Funding Source: UKRI	; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project has been financially supported and publication approved by China Regenerative Medicine International (CRMI), DFR01180; DFR00150. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Kasoju N, 2017, BIOTECHNOL ADV, V35, P407, DOI 10.1016/j.biotechadv.2017.04.005; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lemma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149481; Li XY, 2015, BIOTECHNOL LETT, V37, P67, DOI 10.1007/s10529-014-1652-9; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Schuierer S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3827-y; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Su XD, 2016, STEM CELLS DEV, V25, P1355, DOI 10.1089/scd.2016.0031; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209772	10.1371/journal.pone.0209772	http://dx.doi.org/10.1371/journal.pone.0209772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596738	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200082
J	Lim, JY; Park, YM; Kang, M; Lee, SJ; Baek, K; Na, J; Choi, HS				Lim, Jae-Yol; Park, Young Min; Kang, Minsuk; Lee, Seung Jin; Baek, Kwangha; Na, Jina; Choi, Hong-Shik			Angiolytic laser stripping versus CO2 laser microflap excision for vocal fold leukoplakia: Long-term disease control and voice outcomes	PLOS ONE			English	Article							PULSED DYE-LASER; LARYNGEAL DYSPLASIA; MANAGEMENT	Background and purpose Vocal fold leukoplakia, white plaque on the epithelium, has the potential for malignant transformation regardless of dysplasia grade. It is treated with different laser types (CO2 or angiolytic) and various techniques (vaporization, stripping, or excision); however, only a few studies exist regarding comparative laser surgery results. This study was conducted to investigate clinical outcomes of CO2 versus angiolytic laser microdissection with regard to long-term disease control and voice preservation in vocal fold leukoplakia. Materials and methods Seventy patients with vocal fold leukoplakia treated by CO2 or angiolytic laser (pulsed dye laser or potassium titanyl phosphate) were identified retrospectively. Data regarding patient characteristics, treatment details, treatment outcomes including disease control (recurrence and progression) and the Voice Handicap Index, GRBAS scale, and acoustics were evaluated. The mean follow-up duration after initial treatment was 32 +/- 26 months. Results The study group comprised 14 patients who underwent CO2 laser microflap excision and 56 who underwent angiolytic laser stripping. Of the patients treated with CO2 laser, 11 (79%) had no recurrence and three (21%) showed recurrent leukoplakia, of which one patient (7%) showed histologic grade progression. Of patients who underwent angiolytic laser stripping, 12 had disease recurrence (21%), among whom three (5%) showed disease progression. Laser surgery type, disease extent, and histologic grade showed no significant differences in recurrence or progression rates. The postoperative Voice Handicap Index significantly improved (P = .03) and the G score significantly decreased (P < .001) in the angiolytic laser treatment group. In contrast, the Voice Handicap Index increased postoperatively in the CO2 laser group (P = .046). Conclusions The long-term recurrence or progression rates were not significantly different between angiolytic and CO2 laser treatment. The angiolytic laser stripping group showed better voice preservation compared with the CO2 laser group. Angiolytic laser stripping is suggested as an effective treatment option for vocal fold leukoplakia with comparable disease control and better voice preservation.	[Lim, Jae-Yol; Park, Young Min; Kang, Minsuk; Lee, Seung Jin; Baek, Kwangha; Na, Jina; Choi, Hong-Shik] Yonsei Univ, Gangnam Severance Hosp, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Choi, HS (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Otorhinolaryngol, Coll Med, Seoul, South Korea.	hschoi@yuhs.ac	Lee, Seung Jin/AAW-6031-2021	Lee, Seung Jin/0000-0001-6200-0004; Park, Young Min/0000-0002-7593-8461; im, jaeyeol/0000-0002-9757-6414	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1625]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1625). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byeon HK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/820654; Chang JW, 2017, CLIN OTOLARYNGOL, V42, P715, DOI 10.1111/coa.12618; FRANCO RA, 2003, THE ANNALS OF OTOLOG, V112, P751, DOI DOI 10.1177/000348940311200902; Hartnick CJ, 2003, LARYNGOSCOPE, V113, P1085, DOI 10.1097/00005537-200306000-00033; Hu HC, 2017, JAMA OTOLARYNGOL, V143, P485, DOI 10.1001/jamaoto.2016.4129; Hwang CS, 2013, OTOLARYNG HEAD NECK, V148, P804, DOI 10.1177/0194599813479909; ISENBERG JS, 2008, THE ANNALS OF OTOLOG, V117, P74, DOI DOI 10.1177/000348940811700114; Karatayli-Ozgursoy S, 2015, JAMA OTOLARYNGOL, V141, P313, DOI 10.1001/jamaoto.2014.3736; Kishimoto Y, 2016, EUR ARCH OTO-RHINO-L, V273, P1221, DOI 10.1007/s00405-015-3887-z; Koss SL, 2017, LARYNGOSCOPE, V127, P1644, DOI 10.1002/lary.26445; Lee DH, 2015, EUR ARCH OTO-RHINO-L, V272, P1719, DOI 10.1007/s00405-015-3587-8; Minni A, 2008, EUR ARCH OTO-RHINO-L, V265, P189, DOI 10.1007/s00405-007-0480-0; Park YM, 2014, AURIS NASUS LARYNX, V41, P459, DOI 10.1016/j.anl.2014.05.013; Weller MD, 2010, CLIN OTOLARYNGOL, V35, P364, DOI 10.1111/j.1749-4486.2010.02181.x; Zeitels SM, 2004, ANN OTO RHINOL LARYN, V113, P265, DOI 10.1177/000348940411300403; ZEITELS SM, 2006, THE ANNALS OF OTOLOG, V115, P679, DOI DOI 10.1177/000348940611500905; Zeitels Steven M, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P394, DOI 10.1097/MOO.0b013e3282f1fbb2	17	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209691	10.1371/journal.pone.0209691	http://dx.doi.org/10.1371/journal.pone.0209691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596718	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200071
J	Masu, T; Atsukawa, M; Nakatsuka, K; Shimizu, M; Miura, D; Arai, T; Harimoto, H; Kondo, C; Kaneko, K; Futagami, S; Kawamoto, C; Takahashi, H; Iwakiri, K				Masu, Takushi; Atsukawa, Masanori; Nakatsuka, Katsuhisa; Shimizu, Masumi; Miura, Daishu; Arai, Taeang; Harimoto, Hirotomo; Kondo, Chisa; Kaneko, Keiko; Futagami, Seiji; Kawamoto, Chiaki; Takahashi, Hidemi; Iwakiri, Katsuhiko			Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression	PLOS ONE			English	Article							BREAST-CANCER; PHASE-III; THERAPY; GEMCITABINE; SURVIVAL; PLUS; HER2; PACLITAXEL; CD137; OVEREXPRESSION	Because human epidermal growth factor-like receptor (HER) 2 is expressed on the surface of human pancreatic carcinoma cells to varying degrees, trastuzumab, an anti-HER2 monoclonal antibody (mAb), is expected to exert antibody-dependent, natural killer (NK) cell-mediated cytotoxicity (ADCC) against the cells. However, some reports found that the effect of trastuzumab against human pancreatic carcinoma cells was limited because most express only limited HER2. We examined whether anti-CD137 stimulating mAb could enhance trastuzumab-mediated ADCC against Panc-1, a human pancreatic cancer cell line with low HER2 expression, in vitro. Supplementation of anti-CD137 mAb could improve trastuzumab-mediated ADCC against Panc-1 which was insufficient without this stimulating antibody. The ADCC differed in individual cells, and this was related to the expression of CD137 on the surface of NK cells after trastuzumab stimulation in association with the Fc gamma-RIIIA polymorphism. NK cells with Fc gamma-RIIIA-VV/VF showed high levels of ADCC against Panc-1, but those with Fc gamma-RIIIA-FF did not show optimal ADCC. In addition, trastuzumab-mediated ADCC against the human pancreatic cancer cell line Capan-1 with high HER2 expression was generally high and not affected by the Fc gamma-RIIIA polymorphism. These results demonstrated that in Fc gamma-RIIIA-VV/VF-carrying healthy individuals, trastuzumab plus aCD137 mAb could induce effective ADCC against HER2-low-expressing pancreatic cancer cell lines, and that such an approach may result in similar findings in patients with pancreatic cancer.	[Masu, Takushi; Atsukawa, Masanori; Nakatsuka, Katsuhisa; Arai, Taeang; Harimoto, Hirotomo; Kondo, Chisa; Kaneko, Keiko; Futagami, Seiji; Kawamoto, Chiaki; Iwakiri, Katsuhiko] Nippon Med Sch, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan; [Shimizu, Masumi; Takahashi, Hidemi] Nippon Med Sch, Dept Microbiol & Immunol, Tokyo, Japan; [Miura, Daishu] Toranomon Gen Hosp, Div Breast & Thyroid Surg, Tokyo, Japan	Nippon Medical School; Nippon Medical School; Toranomon Hospital	Atsukawa, M (corresponding author), Nippon Med Sch, Div Gastroenterol & Hepatol, Dept Internal Med, Tokyo, Japan.	momogachi@yahoo.co.jp						Assenat E, 2015, ONCOTARGET, V6, P12796, DOI 10.18632/oncotarget.3473; Bang YJ, 2010, LANCET, V376, P1302; Baselga J, 2001, ANN ONCOL, V12, P35, DOI 10.1023/A:1011163824080; BERCHUCK A, 1990, CANCER RES, V50, P4087; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Boero S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0680-0; Bottcher S, 2005, J IMMUNOL METHODS, V306, P128, DOI 10.1016/j.jim.2005.08.004; Bowles JA, 2011, J IMMUNOL METHODS, V304, P88, DOI [10.1158/1078-0432.CCR-11-0239, DOI 10.1158/1078-0432.CCR-11-0239]; Buchler P, 2001, J GASTROINTEST SURG, V5, P139, DOI 10.1016/S1091-255X(01)80025-1; Burstein HJ, 2005, NEW ENGL J MED, V353, P1652, DOI 10.1056/NEJMp058197; Chou A, 2013, GENOME MED, V5, DOI 10.1186/gm482; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Fujimoto TT, 2001, BRIT J HAEMATOL, V115, P125, DOI 10.1046/j.1365-2141.2001.03109.x; Ghansah T, 2013, CANCER IMMUNOL IMMUN, V62, P1083, DOI 10.1007/s00262-013-1407-9; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Gunturu KS, 2012, THER ADV MED ONCOL, V5, P143, DOI [10.1177/1756283X10363751, DOI 10.1177/1756283X10363751]; Harder J, 2012, BRIT J CANCER, V106, P1033, DOI 10.1038/bjc.2012.18; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Houot R, 2012, ONCOIMMUNOLOGY, V1, P957, DOI 10.4161/onci.19974; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hussain MHA, 2007, J CLIN ONCOL, V25, P2218, DOI 10.1200/JCO.2006.08.0994; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Kimura K, 2006, CLIN CANCER RES, V12, P4925, DOI 10.1158/1078-0432.CCR-06-0544; Kohrt HE, 2012, J CLIN INVEST, V122, P1066, DOI 10.1172/JCI61226; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Lin W, 2008, BLOOD, V112, P699, DOI 10.1182/blood-2007-11-122465; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Miura D, 2014, J NIPPON MED SCH, V81, P211, DOI 10.1272/jnms.81.211; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Ouyang GQ, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0813-9; Petricevic B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-307; Rolitsky CD, 1999, INT J GYNECOL PATHOL, V18, P138, DOI 10.1097/00004347-199904000-00007; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Strome SE, 2007, ONCOLOGIST, V12, P1084, DOI 10.1634/theoncologist.12-9-1084; Sugita N, 1999, CLIN EXP IMMUNOL, V117, P350; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Varchetta S, 2007, CANCER RES, V67, P11991, DOI 10.1158/0008-5472.CAN-07-2068; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Wilken JA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-7; Wilkowski R., 2008, V177, P79	47	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0200664	10.1371/journal.pone.0200664	http://dx.doi.org/10.1371/journal.pone.0200664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596643	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200002
J	Odd, D; Williams, AG; Winter, C; Draycott, T				Odd, David; Williams, Alessandra Glover; Winter, Cathy; Draycott, Timothy			Associations between early term and late/post term infants and development of epilepsy: A cohort study	PLOS ONE			English	Article							RISK; BIRTH; DELIVERY; AGE	Background While life-long impacts exist for infants born one or two weeks early little evidence exists for those infants born after their due date. However interventions could be used to expedite birth if the risks of continuing the pregnancy are higher than intervening. It is known that the risk of epilepsy in childhood is higher in infants exposed to perinatal compromise and therefore may be useful as a proxy for intrapartum compromise. The aim of this work is to quantify the likelihood of children developing epilepsy based on their gestational age at birth (37-39 weeks or. 41 weeks). Methods The work is based on term infants born in Sweden between 1983 and 1993 (n = 1,030,168), linked to data on disability pension, child mortality and in-patient epilepsy care. The reference group was defined as infants born at 39 or 40 completed weeks of gestation; compared with infants born at early term (37/38 weeks) or late/post term (41 weeks or more). Primary outcome was defined a-priori as a diagnosis of epilepsy before 20 years of age. Secondary outcomes were childhood mortality (before five years of age), and registered for disability pension before 20 years of age. Logistic regression models were used to assess any association of the outcomes with gestational age at birth. Findings In the unadjusted results, infants born 7 or more days after their due date had higher risks of epilepsy and disability pension than the reference group, but similar risks of child death. Early term infants showed higher risks of epilepsy, disability pension and child death. After adjustment for confounders, there remained a higher risk of epilepsy for both early term (OR 1.19 (1.11-1.29)) and late/post term infants (OR 1.13 (1.06-1.22)). Interpretation Infants born at 37/38 week or 41 weeks and above, when compared to those born at 39 or 40 weeks gestation, have an increased risk of developing epilepsy. This data could be useful in helping women and care givers make decisions with regard to the timing of induction of labour.	[Odd, David; Winter, Cathy; Draycott, Timothy] North Bristol NHS Trust, Dept Womens & Childrens Hlth, Bristol, Avon, England; [Odd, David; Draycott, Timothy] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Williams, Alessandra Glover] Royal United Hosp, Bath, Avon, England	North Bristol NHS Trust; University of Bristol	Odd, D (corresponding author), North Bristol NHS Trust, Dept Womens & Childrens Hlth, Bristol, Avon, England.; Odd, D (corresponding author), Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England.	david.odd@nbt.nhs.uk		Glover Williams, Alessandra/0000-0002-0172-5076	North Bristol NHS Trust Springboard Fund (Round 9) [13]; NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust; University of Bristol	North Bristol NHS Trust Springboard Fund (Round 9); NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust; University of Bristol	This research has been carried out through funding by the North Bristol NHS Trust Springboard Fund (Round 9, Ref: 13). The funder had no role in the study design, data collection, analysis, interpretation of the data, writing of the report or decision to submit the paper for publication. This study was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.; We are thankful to Finn Rasmussen, professor emeritus from the Department of public health sciences, Karolinska Institutet, Sweden for his advice on most aspects of this study including critical comments to the last versions of this paper. The corresponding author (DO) had full access to the data and had final responsibility for the decision to submit for publication. This study was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.	[Anonymous], 1974, VAL CONT SWED MED BI; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Chiossi G, 2013, OBSTET GYNECOL, V121, P561, DOI 10.1097/AOG.0b013e3182822193; Chiossim G., 2013, OBS GYNECOL, V121; Costeloe KL, 2012, BMJ2, V345; Daskalakis GJ, 2005, BJOG-INT J OBSTET GY, V112, P97, DOI 10.1111/j.1471-0528.2004.00285.x; Davies-Tuck M, 2018, WOMEN BIRTH, V31, P339, DOI 10.1016/j.wombi.2018.08.168; Department of Health (UK), NEW AMB HALV RAT STI; Draycott T, 2006, BJOG-INT J OBSTET GY, V113, P177, DOI 10.1111/j.1471-0528.2006.00800.x; Grobman WA, 2018, NEW ENGL J MED, V379, P513, DOI 10.1056/NEJMoa1800566; Gulmezoglu AM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945.pub3; Hilder L, 2007, EUR J OBSTET GYN R B, V132, P167, DOI 10.1016/j.ejogrb.2006.07.010; Jacquemyn Yves, 2015, BJOG, V122, P982, DOI 10.1111/1471-0528.13400; Kingdon C, 2009, BJOG-INT J OBSTET GY, V116, P886, DOI 10.1111/j.1471-0528.2009.02119.x; Linder N, 2017, ARCH DIS CHILD-FETAL, V102, pF286, DOI 10.1136/archdischild-2015-308553; Liu X, 2017, EPILEPSIA, V58, P1902, DOI 10.1111/epi.13914; Martinez-Biarge M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.031; MIDDLETON P, 2018, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004945; Mishanina E, 2014, CAN MED ASSOC J, V186, P665, DOI 10.1503/cmaj.130925; Moster D, 2010, JAMA-J AM MED ASSOC, V304, P976, DOI 10.1001/jama.2010.1271; National Institute for Health and Clinical Excellence (NICE), 2008, IND LAB CG70; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; Odd David, 2017, J Neonatal Perinatal Med, V10, P347, DOI 10.3233/NPM-16152; Odd DE, 2008, ACTA PAEDIATR, V97, P1275, DOI 10.1111/j.1651-2227.2008.00862.x; Odd DE, 2009, LANCET, V373, P1615, DOI 10.1016/S0140-6736(09)60244-0; Odd DE, 2018, BMJ PAEDIAT OPEN, V2; Odd DE, 2010, ARCH DIS CHILD; Persson M, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k207; Royal College of Gynaecologists and Obstetricians, EACH BAB COUNTS; Smith Gordon, 2015, BJOG, V122, P982, DOI 10.1111/1471-0528.13399; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Sun Y, 2008, AM J EPIDEMIOL, V167, P262, DOI 10.1093/aje/kwm316; Widdows K, 2018, LIVES CARE BUNDLE IN; Wolke D, 2008, J PEDIATR, V152, P256, DOI 10.1016/j.jpeds.2007.06.043	34	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210181	10.1371/journal.pone.0210181	http://dx.doi.org/10.1371/journal.pone.0210181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596766	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000454627200149
J	Powell, B; Szleifer, I; Dhaher, YY				Powell, Bethany; Szleifer, Igal; Dhaher, Yasin Y.			In silico study of principal sex hormone effects on post-injury synovial inflammatory response	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; GROWTH-FACTOR; KNEE OSTEOARTHRITIS; CYTOKINE PRODUCTION; IL-10 EXPRESSION; TNF-ALPHA; BETA; DEGRADATION; METALLOPROTEINASES; ACTIVATION	Following an anterior cruciate ligament injury, premenopausal females tend to experience poorer outcomes than males, and sex hormones are thought to contribute to the disparity. Evidence seems to suggest that the sex hormones estrogen, progesterone, and testosterone may regulate the inflammation caused by macrophages, which invade the knee after an injury. While the individual effects of hormones on macrophage inflammation have been studied in vitro, their combined effects on post-injury inflammation in the knee have not been examined, even though both males and females have detectable levels of both estrogen and testosterone. In the present work, we developed an in silico kinetic model of the postinjury inflammatory response in the human knee joint and the hormonal influences that may shape that response. Our results indicate that post-injury, sex hormone concentrations observed in females may lead to a more pro-inflammatory, catabolic environment, while the sex hormone concentrations observed in males may lead to a more anti-inflammatory environment. These findings suggest that the female hormonal milieu may lead to increased catabolism, potentially worsening post-injury damage to the cartilage for females compared to males. The model developed herein may inform future in vitro and in vivo studies that seek to uncover the origins of sex differences in outcomes and may ultimately serve as a starting point for developing targeted therapies to prevent or reduce the cartilage damage that results from post-injury inflammation, particularly for females.	[Powell, Bethany; Szleifer, Igal] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Powell, Bethany] Valparaiso Univ, Dept Mech Engn & Bioengn, Valparaiso, IN 46383 USA; [Szleifer, Igal] Northwestern Univ, Dept Chem, Evanston, IL USA; [Szleifer, Igal] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Dhaher, Yasin Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Dhaher, Yasin Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA	Northwestern University; Valparaiso University; Northwestern University; Northwestern University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Dhaher, YY (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA.; Dhaher, YY (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA.	y-dhaher@northwestern.edu	Szleifer, Igal/B-6920-2009	Szleifer, Igal/0000-0002-8708-0335	National Institutes of Health [T32 HD07418]; National Institute of Biomedical Imaging and Bioengineering [U01 EB015410-01A1]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR069176-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health T32 HD07418, https://www.nih.gov/; National Institute of Biomedical Imaging and Bioengineering U01 EB015410-01A1, https://www.nibib.nih.gov/; and National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR069176-01A1, https://www.niams.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WD, 2015, MOL BIOSYST, V11, P3332, DOI 10.1039/c5mb00488h; Asano K, 2006, J PHARM PHARMACOL, V58, P359, DOI 10.1211/jpp.58.3.0010; Bigoni M, 2013, J ORTHOP RES, V31, P315, DOI 10.1002/jor.22208; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; CHANTRY D, 1989, J IMMUNOL, V142, P4295; Cimmino MA, 2005, SEMIN ARTHRITIS RHEU, V34, P29, DOI 10.1016/j.semarthrit.2004.03.009; Cobbold CA, 2000, J THEOR BIOL, V204, P257, DOI 10.1006/jtbi.2000.2012; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Della Beffa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072494; Edd SN, 2017, OSTEOARTHR CARTILAGE, V25, P899, DOI 10.1016/j.joca.2016.12.029; Fang M, 2013, CELL BIOCHEM BIOPHYS, V67, P607, DOI 10.1007/s12013-013-9548-1; Ganesan K, 2012, RHEUMATOL INT, V32, P3181, DOI 10.1007/s00296-011-2146-x; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; Greenspan FS, 2004, BASIC CLIN ENDOCRINO, pxvi; Guery JC, 2012, JOINT BONE SPINE, V79, P560, DOI 10.1016/j.jbspin.2012.09.010; Haller JM, 2015, CLIN ORTHOP RELAT R, V473, P3280, DOI 10.1007/s11999-015-4441-4; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Heard BJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-126; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Huang HF, 2004, FERTIL STERIL, V81, P1235, DOI 10.1016/j.fertnstert.2003.10.027; Huang TL, 2011, J ORTHOP RES, V29, P495, DOI 10.1002/jor.21261; Irie K, 2003, KNEE, V10, P93, DOI 10.1016/S0968-0160(02)00083-2; Kamanna VS, 1996, J AM SOC NEPHROL, V7, pA2159; Kar S, 2016, ARCH BIOCHEM BIOPHYS, V594, P37, DOI 10.1016/j.abb.2016.02.008; KLAPPROTH J, 1989, EUR J IMMUNOL, V19, P1485, DOI 10.1002/eji.1830190821; Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906; Kou XX, 2015, J IMMUNOL, V194, P2810, DOI 10.4049/jimmunol.1303188; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Li RT, 2011, AM J SPORT MED, V39, P2595, DOI 10.1177/0363546511424720; Lieberthal J, 2015, OSTEOARTHR CARTILAGE, V23, P1825, DOI 10.1016/j.joca.2015.08.015; Little JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097329; Liu LM, 2014, IMMUNOL INVEST, V43, P693, DOI 10.3109/08820139.2014.917095; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; MURAKAMI S, 1995, AM J SPORT MED, V23, P763, DOI 10.1177/036354659502300622; Nagaraja S, 2014, J IMMUNOL, V192, P1824, DOI 10.4049/jimmunol.1302481; Orlowsky EW, 2015, J RHEUMATOL, V42, P363, DOI 10.3899/jrheum.140382; Pedersen BK, 2017, EUR J CLIN INVEST, V47, P600, DOI 10.1111/eci.12781; Rosenberg JH, 2017, MOL CELL BIOCHEM, V434, P171, DOI 10.1007/s11010-017-3047-4; Rovensky Jozef, 2004, Endocr Regul, V38, P143; Salamonsen LA, 1998, TRENDS ENDOCRIN MET, V9, P305, DOI 10.1016/S1043-2760(98)00078-2; Saren P, 1996, J IMMUNOL, V157, P4159; SCHINDLER R, 1990, BLOOD, V75, P40; Shah K, 2014, AM J PHYSIOL-CELL PH, V306, pC3, DOI 10.1152/ajpcell.00281.2013; Sitruk-Ware R, 2010, CONTRACEPTION, V82, P410, DOI 10.1016/j.contraception.2010.04.004; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Sun YX, 2012, IMMUNOL LETT, V146, P25, DOI 10.1016/j.imlet.2012.04.007; Szabo G, 2015, ALCOHOL RES-CURR REV, V37, P159; Thomassen MJ, 1996, CLIN IMMUNOL IMMUNOP, V80, P321, DOI 10.1006/clin.1996.0130; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Tsuchida AI, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0441-0; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Yorifuji M, 2016, J ORTHOP SCI, V21, P381, DOI 10.1016/j.jos.2016.01.004	57	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209582	10.1371/journal.pone.0209582	http://dx.doi.org/10.1371/journal.pone.0209582			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596697	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200058
J	Jha, P; Kim, CM; Kim, DM; Yoon, NR; Jha, B; Park, JW; Chung, JK				Jha, Piyush; Kim, Choon-Mee; Kim, Dong-Min; Yoon, Na-Ra; Jha, Babita; Park, Jung Wook; Chung, Jae Keun			First detection and identification of Candidatus Neoehrlichia mikurensis in South Korea	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; EHRLICHIA-CHAFFEENSIS; RODENTS; TICKS; AGENT; BOVIS	Candidatus Neoehrlichia mikurensis (Ca. N. mikurensis; family Anaplasmataceae) is an emerging tick-borne pathogen that causes a systemic inflammatory syndrome with thrombotic complications. We report here the first identification of Ca. N. mikurensis in organ samples from small mammals captured in southwest South Korea. Nested PCR of groEL and 16S rRNA genes was used to confirm the identity of the bacteria present, and successfully amplified fragments were sequenced. All captured animals were identified as striped field mice (Apodemus agrarius), approximately 28.6% (4/14) and 21.4% (3/14) of which were found to be PCR-positive for Ca. N. mikurensis and Anaplasma phagocytophilum, respectively. The detection of Ca. N. mikurensis in these animals represents the first evidence of this pathogen in South Korea. Carriage of this bacterium by rodents highlights the need for more detailed investigation of their role in its transmission to humans.	[Jha, Piyush; Kim, Dong-Min; Yoon, Na-Ra; Jha, Babita] Chosun Univ, Sch Med, Deaprtment Internal Med, Gwangju, South Korea; [Kim, Choon-Mee] Chosun Univ, Sch Med, Dept Premed Sci, Gwangju, South Korea; [Park, Jung Wook; Chung, Jae Keun] Hlth & Environm Res Inst Gwangju City, Div Infect Dis Invest, Gwangju, South Korea	Chosun University; Chosun University	Kim, DM (corresponding author), Chosun Univ, Sch Med, Deaprtment Internal Med, Gwangju, South Korea.	drongkim@chosun.ac.kr		park, jungwook/0000-0003-2906-9709; Kim, Dong-Min/0000-0001-6373-0922	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI16C2118]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI16C2118). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2011, EMERG INFECT DIS, V17, P1716, DOI 10.3201/eid1709.101058; Beninati T, 2006, Eur J Clin Microbiol Infect Dis, V25, P677, DOI 10.1007/s10096-006-0196-x; Chae JS, 2008, J VET SCI, V9, P285, DOI 10.4142/jvs.2008.9.3.285; Chae JS, 2003, ANN NY ACAD SCI, V990, P118, DOI 10.1111/j.1749-6632.2003.tb07349.x; Fertner ME, 2012, EURO SURVEILL, V17; Grankvist A, 2014, CLIN INFECT DIS, V58, P1716, DOI 10.1093/cid/ciu189; Heo EJ, 2002, J CLIN MICROBIOL, V40, P3082, DOI 10.1128/JCM.40.8.3082-3085.2002; Kang JG, 2011, VECTOR-BORNE ZOONOT, V11, P929, DOI 10.1089/vbz.2010.0214; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Kim CM, 2003, VECTOR-BORNE ZOONOT, V3, P17, DOI 10.1089/153036603765627424; Kim KH, 2014, EMERG INFECT DIS, V20, P1708, DOI 10.3201/eid2010.131680; Li H, 2012, EMERG INFECT DIS, V18, P1636, DOI 10.3201/eid1810.120594; Maurer FP, 2013, J CLIN MICROBIOL, V51, P169, DOI 10.1128/JCM.01955-12; 오재영, 2009, Journal of Bacteriology and Virology, V39, P257; Munderloh UG, 2007, VECTOR-BORNE ZOONOT, V7, P418, DOI 10.1089/vbz.2007.0640; Palmer SR, 2011, OXFORD TXB ZOONOSES, P45; Pan H, 2003, ANN NY ACAD SCI, V990, P107, DOI 10.1111/j.1749-6632.2003.tb07346.x; Pan L, 2011, J CLIN MICROBIOL, V49, P4117, DOI 10.1128/JCM.01085-11; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Rar VA, 2010, TICKS TICK-BORNE DIS, V1, P57, DOI 10.1016/j.ttbdis.2010.01.002; Richter D, 2012, J CLIN MICROBIOL, V50, P943, DOI 10.1128/JCM.05802-11; Sanogo YO, ANN N Y ACAD SCI; Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999; Silaghi C, 2016, EXP APPL ACAROL, V68, P279, DOI 10.1007/s10493-015-9935-y; Silaghi C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-285; Takano A, 2009, MICROBIOL IMMUNOL, V53, P101, DOI 10.1111/j.1348-0421.2008.00093.x; von Loewenich FD, 2010, J CLIN MICROBIOL, V48, P2630, DOI 10.1128/JCM.00588-10; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09; Yabsley MJ, 2008, VET MICROBIOL, V131, P301, DOI 10.1016/j.vetmic.2008.04.004	29	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209685	10.1371/journal.pone.0209685	http://dx.doi.org/10.1371/journal.pone.0209685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592745	gold, Green Submitted, Green Published			2022-12-26	WOS:000454621900038
J	Murozuka, E; Massange-Sanchez, JA; Nielsen, K; Gregersen, PL; Braumann, I				Murozuka, Emiko; Massange-Sanchez, Julio A.; Nielsen, Kasper; Gregersen, Per L.; Braumann, Ilka			Genome wide characterization of barley NAC transcription factors enables the identification of grain-specific transcription factors exclusive for the Poaceae family of monocotyledonous plants	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ENDOSPERM-SPECIFIC EXPRESSION; ARABIDOPSIS-THALIANA; PATTERN-FORMATION; DRAFT GENOME; PROTEIN; GENES; SEQUENCE; SENESCENCE; ETHYLENE	The plant NAC transcription factors depict one of the largest plant transcription factor families. They regulate a wide range of different developmental processes and most probably played an important role in the evolutionary diversification of plants. This makes comparative studies of the NAC transcription factor family between individual species and genera highly relevant and such studies have in recent years been greatly facilitated by the increasing number of fully sequenced complex plant genomes. This study combines the characterization of the NAC transcription factors in the recently sequenced genome of the cereal crop barley with expression analysis and a comprehensive phylogenetic characterization of the NAC transcription factors in other monocotyledonous plant species. Our results provide evidence for the emergence of a NAC transcription factor subclade that is exclusively expressed in the grains of the Poaceae family of grasses. These notably comprise a number of cereal crops other than barley, such as wheat, rice, maize or millet, which are all cultivated for their starchy edible grains. Apparently, the grain specific subclade emerged from a well described subgroup of NAC transcription factors associated with the senescence process. A promoter exchange subsequently resulted in grain specific expression. We propose to designate this transcription factor subclade Grain-NACs and we discuss their involvement in programmed cell death as well as their potential role in the evolution of the Poaceae grain, which doubtlessly is of central importance for human nutrition.	[Murozuka, Emiko; Nielsen, Kasper; Braumann, Ilka] Carlsberg Res Lab, Copenhagen, Denmark; [Massange-Sanchez, Julio A.; Gregersen, Per L.] Aarhus Univ, Dept Mol Biol & Genet, Slagelse, Denmark	Aarhus University	Braumann, I (corresponding author), Carlsberg Res Lab, Copenhagen, Denmark.	ilka.braumann@carlsberg.com	Gregersen, Per L/R-1950-2018; Gregersen, Per/P-8896-2019; Massange, Julio/M-5447-2019	Gregersen, Per L/0000-0001-8243-0976; Gregersen, Per/0000-0001-8243-0976; Massange, Julio/0000-0002-6910-9229; Nielsen, Kasper/0000-0002-5510-7767	Carlsberg Foundation [2014_01_0013/CF15-0476/CF16-0506]; National Council for Science and Technology Mexico [332648]	Carlsberg Foundation(Carlsberg Foundation); National Council for Science and Technology Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The current study has received funding from the Carlsberg Foundation (http://www.carlsbergfondet.dk/da; grant numbers 2014_01_0013/CF15-0476/CF16-0506 to the Carlsberg Research Laboratory) and from the National Council for Science and Technology Mexico (http://www.conacyt.gob.mx; grant number 332648 to JAM-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Bai F, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00780; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Bauer E, 2017, PLANT J, V89, P853, DOI 10.1111/tpj.13436; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Borrill P, 2017, G3-GENES GENOM GENET, V7, P3019, DOI 10.1534/g3.117.043679; Borrill P, 2016, PLANT PHYSIOL, V170, P2172, DOI 10.1104/pp.15.01667; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Cenci A, 2014, PLANT MOL BIOL, V85, P63, DOI 10.1007/s11103-013-0169-2; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Charrad M, 2014, J STAT SOFTW, V61, P1; Chow CN, 2016, NUCLEIC ACIDS RES, V44, pD1154, DOI 10.1093/nar/gkv1035; Christiansen MW, 2014, J EXP BOT, V65, P4009, DOI 10.1093/jxb/eru046; Christiansen Michael W, 2011, BMC Res Notes, V4, P302, DOI 10.1186/1756-0500-4-302; Clavijo BJ, 2017, GENOME RES, V27, P885, DOI 10.1101/gr.217117.116; Colmsee C, 2015, MOL PLANT, V8, P964, DOI 10.1016/j.molp.2015.03.009; Diaz I, 2005, PLANT J, V42, P652, DOI 10.1111/j.1365-313X.2005.02402.x; Diaz I, 2002, PLANT J, V29, P453, DOI 10.1046/j.0960-7412.2001.01230.x; El Mannai Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102165; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Feldman M., 2015, ALIEN INTROGRESSION, P21, DOI [10.1007/978-3-319-23494-6_2, DOI 10.1007/978-3-319-23494-6_2]; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Graham LE, 2012, ANNU PLANT REV, V44, P305, DOI 10.1002/9781118223086.ch12; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Hao YJ, 2010, PLANTA, V232, P1033, DOI 10.1007/s00425-010-1238-2; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kadier Y, 2017, PLANT GROWTH REGUL, V83, P301, DOI 10.1007/s10725-017-0295-y; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kelemen Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141044; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Kim HJ, 2014, J EXP BOT, V65, P4023, DOI 10.1093/jxb/eru112; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Kosugi S, 2000, NUCLEIC ACIDS RES, V28, P960, DOI 10.1093/nar/28.4.960; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laudencia-Chingcuanco DL, 2006, J APPL GENET, V47, P287, DOI 10.1007/BF03194638; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mathew IE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01638; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Moreno-Risueno MA, 2008, PLANT J, V53, P882, DOI 10.1111/j.1365-313X.2007.03382.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; O'Shea C, 2017, J BIOL CHEM, V292, P512, DOI 10.1074/jbc.M116.753426; O'Shea C, 2015, BIOCHEM J, V465, P281, DOI 10.1042/BJ20141045; Oda-Yamamizo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23609; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pereira-Santana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141866; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Podzimska-Sroka Dagmara, 2015, Plants-Basel, V4, P412, DOI 10.3390/plants4030412; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ravel C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00621; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romero I, 1998, PLANT J, V14, P273, DOI 10.1046/j.1365-313X.1998.00113.x; Rubio-Somoza I, 2006, PLANT J, V47, P269, DOI 10.1111/j.1365-313X.2006.02777.x; Rubio-Somoza I, 2006, PLANT J, V45, P17, DOI 10.1111/j.1365-313X.2005.02596.x; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Sabelli PA, 2013, P NATL ACAD SCI USA, V110, pE1827, DOI 10.1073/pnas.1304903110; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; Sreenivasulu N, 2010, INT REV CEL MOL BIO, V281, P49, DOI 10.1016/S1937-6448(10)81002-0; Stalberg K, 1996, PLANTA, V199, P515, DOI 10.1007/BF00195181; Stender EG, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1010967; Takaiwa F, 1996, PLANT MOL BIOL, V30, P1207, DOI 10.1007/BF00019553; Takasaki H, 2015, PLANT J, V84, P1114, DOI 10.1111/tpj.13067; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; THOMAS MS, 1990, PLANT CELL, V2, P1171, DOI 10.1105/tpc.2.12.1171; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; Warnes G.R., 2016, PACKAGE GPLOTS VARIO, DOI DOI 10.1111/J.0022-3646.1997.00569.X; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417; Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579; You J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122027; Young TE, 2000, PLANT MOL BIOL, V44, P283, DOI 10.1023/A:1026588408152; Zemlyanskaya EV, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02044; Zhao CS, 2008, PLANT J, V53, P425, DOI 10.1111/j.1365-313X.2007.03350.x; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhu GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139794; Zhu TT, 2012, EVOLUTION, V66, P1833, DOI 10.1111/j.1558-5646.2011.01553.x; Zimmermann R, 2005, PLANT MOL BIOL, V58, P669, DOI 10.1007/s11103-005-7702-x	112	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209769	10.1371/journal.pone.0209769	http://dx.doi.org/10.1371/journal.pone.0209769			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592743	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900040
J	Garg, A; Gupta, A; Mishra, A; Singh, M; Yadav, S; Nityanand, S				Garg, Akanksha; Gupta, Anshul; Mishra, Ashish; Singh, Manoj; Yadav, Sanjeev; Nityanand, Soniya			Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: Experience from a tertiary care centre in North India	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; HEMATOLOGICAL MALIGNANCIES; STIMULATED DONORS; FUNGAL-INFECTIONS; G-CSF; EFFICACY; CHILDREN; THERAPY; CANCER; SAFETY	Bacterial and fungal infections still remain an important cause of mortality in patients with hematological malignancies and in recipients of hematopoietic stem cell transplants (HSCT) especially in developing countries like India. Granulocyte transfusions (GTX) from healthy donors may lead to early clearance of index infection and thus prevent mortality. The aim of the present study was to evaluate the efficacy of GTX in combating life-threatening infections and preventing mortality in patients of hematological disorders/recipients of HSCT with severe neutropenia. This study was a prospective, observational analysis of patients with different hematological disorders/recipients of HSCT, who received GTX from January 2014 to December 2017. All patients had an Absolute neutrophil Count (ANC) < 0.5 x 10(9)/L and a life threatening sepsis defined by presence of hemodynamic instability/impending septic shock/continuous high fever despite the use of the highest line of antimicrobials. A total of 143 granulocyte collections were done for 66 infectious episodes (IEs) in 60 patients. Multidrug resistant organisms (MDROs) were observed in 47/66 IEs (71.2%) and fungal infections were seen in 9/66 IEs (13.6%). Resolution of index infection after GTX was seen in 45/66 IEs (68.2%), and the 30 day overall survival (OS) was 67.7%. OS was significantly higher in patients who received GTX within 7 days of neutropenic sepsis (p = 0.01). Patients with MDROs who received early GTX therapy had a better OS as compared to those who received late GTX (p = 0.02). GTX were well tolerated and only 6 patients' developed mild features of transfusion related acute lung injury (TRALI) which was managed conservatively, and 1 patient demonstrated hypocalcemic tetany. GTX may be of particular relevance in countries like India, where the incidence of infections is very high in neutropenic patients and there is an increasing emergence of MDROs.	[Garg, Akanksha; Gupta, Anshul; Mishra, Ashish; Singh, Manoj; Yadav, Sanjeev; Nityanand, Soniya] Sanjay Gandhi Post Grad Inst Med Sci, Dept Hematol, Raebareli Rd, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences	Nityanand, S (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Hematol, Raebareli Rd, Lucknow, Uttar Pradesh, India.	soniya_nityanand@yahoo.co.in	Garg, Akanksha/AAV-7278-2021					Al-Tanbal H, 2010, TRANSFUSION MED, V20, P160, DOI 10.1111/j.1365-3148.2009.00988.x; Ang AL, 2011, TRANSFUSION MED, V21, P13, DOI 10.1111/j.1365-3148.2010.01035.x; Atay D, 2011, J PEDIAT HEMATOL ONC, V33, pE220, DOI 10.1097/MPH.0b013e31821ffdf1; Cesaro S, 2003, SUPPORT CARE CANCER, V11, P101, DOI 10.1007/s00520-002-0394-8; Cherif H, 2013, SCAND J INFECT DIS, V45, P112, DOI 10.3109/00365548.2012.714906; Coburn B, 2013, ANTIMICROB AGENTS CH, V57, P1989, DOI 10.1128/AAC.00111-13; Diaz R, 2014, PEDIATR HEMAT ONCOL, V31, P425, DOI 10.3109/08880018.2013.868562; Dignani MC, 1997, LEUKEMIA, V11, P1621, DOI 10.1038/sj.leu.2400811; Dreniak A, 2009, HAEMATOLOGICA, V94, P1644, DOI [10.3324/haematol.2009.013680, DOI 10.3324/HAEMATOL.2009.013680]; Drewniak A, 2008, HAEMATOL-HEMATOL J, V93, P1058, DOI 10.3324/haematol.12489; Ecdc, 2013, SURV REP; Grigull L, 2006, SUPPORT CARE CANCER, V14, P910, DOI 10.1007/s00520-006-0041-x; Heim KF, 2011, TRANSFUSION, V51, P1154, DOI 10.1111/j.1537-2995.2010.02993.x; Illerhaus G, 2002, ANN HEMATOL, V81, P273, DOI 10.1007/s00277-002-0439-6; Kikuta A, 2006, VOX SANG, V91, P70, DOI 10.1111/j.1423-0410.2006.00776.x; Kim KH, 2011, CYTOTHERAPY, V13, P490, DOI 10.3109/14653249.2010.529889; Lee JJ, 2004, HAEMATOLOGICA, V89, P632; Lee JJ, 2001, LEUKEMIA, V15, P203, DOI 10.1038/sj.leu.2402007; Marfin AA, 2015, J INTENSIVE CARE MED, V30, P79, DOI 10.1177/0885066613498045; Massey E, 2012, TRANSFUSION MED, V22, P277, DOI 10.1111/j.1365-3148.2012.01152.x; Mikulska M, 2014, J INFECTION, V68, P321, DOI 10.1016/j.jinf.2013.12.006; Mousset S, 2005, ANN HEMATOL, V84, P734, DOI 10.1007/s00277-005-1055-z; Nikolajeva O, 2015, BONE MARROW TRANSPL, V50, P846, DOI 10.1038/bmt.2015.53; Ofran Y, 2007, VOX SANG, V93, P363, DOI 10.1111/j.1423-0410.2007.00971.x; Ozturkmen S, 2013, TRANSFUS APHER SCI, V48, P381, DOI 10.1016/j.transci.2013.04.022; Peters C, 1999, BRIT J HAEMATOL, V106, P689, DOI 10.1046/j.1365-2141.1999.01619.x; Price TH, 2000, BLOOD, V95, P3302, DOI 10.1182/blood.V95.11.3302.010k35_3302_3309; Price TH, 2015, BLOOD, V126, P2153, DOI 10.1182/blood-2015-05-645986; Quillen K, 2009, HAEMATOL-HEMATOL J, V94, P1661, DOI 10.3324/haematol.2009.010231; Rutella S, 2003, CYTOTHERAPY, V5, P19, DOI 10.1080/14653240310000047; Sachs UJ, 2003, TRANSFUSION, V43, P1683, DOI 10.1111/j.0041-1132.2003.00568.x; Sachs UJH, 2006, TRANSFUSION, V46, P1909, DOI 10.1111/j.1537-2995.2006.00996.x; Safdar A, 2004, CANCER, V101, P2859, DOI 10.1002/cncr.20710; Safdar A, 2014, ACTA HAEMATOL-BASEL, V131, P50, DOI 10.1159/000351174; Seidel MG, 2009, J PEDIAT HEMATOL ONC, V31, P166, DOI 10.1097/MPH.0b013e318196a6f9; Shankar K, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26740; Teofili L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159569; Thacker N, 2014, INDIAN J CANCER, V51, P442, DOI 10.4103/0019-509X.175310; Uppuluri R, 2017, INDIAN J HEMATOL BLO, V33, P207, DOI 10.1007/s12288-016-0727-2; Valentini CG, 2017, BIOL BLOOD MARROW TR, V23, P2034, DOI 10.1016/j.bbmt.2017.07.029; Vamvakas EC, 1996, J CLIN APHERESIS, V11, P1	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209832	10.1371/journal.pone.0209832	http://dx.doi.org/10.1371/journal.pone.0209832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589898	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200057
J	Langille, E; Lemieux, V; Garant, D; Bergeron, P				Langille, Evan; Lemieux, Vincent; Garant, Dany; Bergeron, Patrick			Development of small blood volume assays for the measurement of oxidative stress markers in mammals	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TOTAL PLASMA MALONDIALDEHYDE; ACID; ANTIOXIDANTS; HERITABILITY; REPRODUCTION; TBARS; TESTS; COST; FRAP	Measuring oxidative stress has become increasingly valuable in ecological studies, especially when different markers are measured on the same individual. However, many of the current methods lack sensitivity for analysis of low blood volume samples, which represent a challenge for longitudinal field studies of small organisms. Small blood volumes can usually only be analysed by using a single assay, therefore providing limited information on individual's oxidative profile. In this study, we used blood collected from a population of wild eastern chipmunks (Tamias striatus) and modified methods presented in the literature to improve analytical selectivity and sensitivity required for small blood volumes. Specifically, we proposed a modified malondialdehyde (MDA) analysis protocol by HPLC and also optimized both the uric acid independent ferric reducing antioxidant power (FRAP) and hypochlorous acid shock capacity (HASC) assays. Development of the three modified methods was achieved with a sensitivity and repeatability that meets standards of field ecology while allowing measurement of all three assays in duplicate using less than 60 mu L of plasma. Availability of these tests using small blood volumes will provide ecologists with a more comprehensive portrait of an individual's oxidative profile and a better understanding of its determinants and interactions with the environment.	[Langille, Evan; Lemieux, Vincent; Bergeron, Patrick] Bishops Univ, Sherbrooke, PQ, Canada; [Langille, Evan] Mem Univ Newfoundland, Chem Dept, St John, NF, Canada; [Lemieux, Vincent; Garant, Dany] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada	Bishops University; Memorial University Newfoundland; University of Sherbrooke	Langille, E (corresponding author), Bishops Univ, Sherbrooke, PQ, Canada.; Langille, E (corresponding author), Mem Univ Newfoundland, Chem Dept, St John, NF, Canada.	ealangille@mun.ca		Langille, Evan/0000-0002-1152-2758	Natural Sciences and Engineering Research Council of Canada (NSERC); Quebec Center for Biodiversity Science (QCBS); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Center for Biodiversity Science (QCBS); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grants to PB and DG (http://www.nserc-crsng.gc.ca) and a Quebec Center for Biodiversity Science (QCBS) seed grant (https://qcbs.ca) to PB and DG. VL was supported by a scholarship from Fonds de Recherche du Quebec - Nature et Technologies (FRQNT) (http://www.frqnt.gouv.qc.ca/en/accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, J CHROMATOGR B, V775, P121, DOI 10.1016/S1570-0232(02)00273-8; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bergeron P, 2011, FUNCT ECOL, V25, P1063, DOI 10.1111/j.1365-2435.2011.01868.x; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; BUTTKUS H, 1972, J AM OIL CHEM SOC, V49, P440, DOI 10.1007/BF02582530; CARLSEN MH, 2010, NUTR J, V9, DOI DOI 10.1186/1475-2891-9-1; Celi P, 2010, VET J, V183, P217, DOI 10.1016/j.tvjl.2008.09.018; Christensen LL, 2016, P R SOC B, V283, P1; Christensen LL, 2015, ECOL EVOL, V5, P5096, DOI 10.1002/ece3.1771; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Costantini D., 2014, OXIDATIVE STRESS HOR; Costantini D, 2012, J EXP BIOL, V215, P374, DOI 10.1242/jeb.062034; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Cram DL, 2015, FUNCT ECOL, V29, P229, DOI 10.1111/1365-2435.12317; Degala HL, 2018, FOOD CONTROL, V90, P113, DOI 10.1016/j.foodcont.2018.02.042; Delhaye J, 2016, MALAR J BIOMED CENTR, V15, P1, DOI [10.1186/s12936-015-1044-1, DOI 10.1186/S12936-015-1044-1]; Di Silvestro R, 2017, J SCI FOOD AGR, V97, P641, DOI 10.1002/jsfa.7782; Duplancic D, 2011, MOLECULES, V16, P7058, DOI 10.3390/molecules16087058; Eikenaar C, 2018, ECOL EVOL, V8, P2721, DOI 10.1002/ece3.3756; Fazio F, 2018, J VET BEHAV, V26, P5, DOI 10.1016/j.jveb.2018.03.010; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Geiger S, 2012, MOL ECOL, V21, P1500, DOI 10.1111/j.1365-294X.2011.05331.x; Giera M, 2012, CHROMATOGRAPHIA, V75, P433, DOI 10.1007/s10337-012-2237-1; Griffin SP, 2004, J EXP MAR BIOL ECOL, V302, P201, DOI 10.1016/j.jembe.2003.10.008; Halliwell B., FREE RADICALS BIOL M; Hong YL, 2000, CLIN BIOCHEM, V33, P619, DOI 10.1016/S0009-9120(00)00177-6; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Janssens L, 2018, FUNCT ECOL, V32, P1036, DOI 10.1111/1365-2435.13068; KNIGHT JA, 1988, CLIN CHEM, V34, P2433; Kusaki M, 2017, J STROKE CEREBROVASC, V26, P1191, DOI 10.1016/j.jstrokecerebrovasdis.2017.01.003; Lopez-Arrabe J, 2016, PHYSIOL BIOCHEM ZOOL, V89, P83, DOI 10.1086/685476; Losdat S, 2014, J EVOLUTION BIOL, V27, P1990, DOI 10.1111/jeb.12454; Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035; Meineri G, 2018, CAN J ANIM SCI, P1, DOI [10.1093/jas/skx051, DOI 10.1093/JAS/SKX051]; Monaghan P, 2014, FREE RADICALS EVOLUT; Moselhy HF, 2013, J LIPID RES, V54, P852, DOI 10.1194/jlr.D032698; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Pattison DI, 2003, CHEM RES TOXICOL, V16, P439, DOI 10.1021/tx025670s; Pennathur S, 2010, FREE RADICAL BIO MED, V49, P205, DOI 10.1016/j.freeradbiomed.2010.04.003; Rao PVLNS, 2015, J ANTIOXIDANT ACTIVI, V1, P22, DOI DOI 10.14302/ISSN.2471-2140.JAA-14-617; Ruykys L, 2012, AUST VET J, V90, P331, DOI 10.1111/j.1751-0813.2012.00956.x; Salmon P, 2018, SCI TOTAL ENVIRON, V622, P635, DOI 10.1016/j.scitotenv.2017.11.354; Seljeskog E, 2006, CLIN BIOCHEM, V39, P947, DOI 10.1016/j.clinbiochem.2006.03.012; Sepp T, 2012, PHYSIOL BIOCHEM ZOOL, V85, P299, DOI 10.1086/664827; Siti HN, 2015, VASC PHARMACOL, V71, P40, DOI 10.1016/j.vph.2015.03.005; St-Hilaire E, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2320-6; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Sun Q, 2001, MEAT SCI, V57, P55, DOI 10.1016/S0309-1740(00)00076-0; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Vassalle C, 2004, CLIN CHEM LAB MED, V42, P84, DOI 10.1515/CCLM.2004.016; Viblanc VA, 2018, FUNCT ECOL, V32, P722, DOI 10.1111/1365-2435.13032; Xinglong W, 2014, MOL BASIS DIS, V1842, P1240, DOI [10.1016/j.bbadis.2013.10.015, DOI 10.1016/J.BBADIS.2013.10.015]; Xu YC, 2014, FUNCT ECOL, V28, P402, DOI 10.1111/1365-2435.12168; YOUNG IS, 1991, ANN CLIN BIOCHEM, V28, P504, DOI 10.1177/000456329102800514	57	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209802	10.1371/journal.pone.0209802	http://dx.doi.org/10.1371/journal.pone.0209802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589904	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200056
J	Goetzl, EJ; Elahi, FM; Mustapic, M; Kapogiannis, D; Pryhoda, M; Gilmore, A; Gorgens, KA; Davidson, B; Granholm, AC; Ledreux, A				Goetzl, Edward J.; Elahi, Fanny M.; Mustapic, Maja; Kapogiannis, Dimitrios; Pryhoda, Moira; Gilmore, Anah; Gorgens, Kimberly A.; Davidson, Bradley; Granholm, Anne-Charlotte; Ledreux, Aurelie			Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury	FASEB JOURNAL			English	Article						biomarkers; exosome immunoabsorption; proteinopathic neurodegeneration	BARRIER DISRUPTION; BIOMARKERS; EPIDEMIOLOGY; PATHOGENESIS; AQUAPORIN-4; ANNEXINS; HYPOXIA; BETA; TAU	Neuron-derived exosomes (NDEs) were enriched by anti-L1CAM antibody immunoabsorption from plasmas of subjects ages 18-26 yr within 1 wk after a sports-related mild traumatic brain injury (acute mTBI) (n = 18), 3 mo or longer after the last of 2-4 mTBIs (chronic mTBI) (n = 14) and with no recent history of TBI (controls) (n = 21). Plasma concentrations of NDEs, assessed by counts and levels of extracted exosome marker CD81, were significantly depressed by a mean of 45% in acute mTBI (P < 0.0001), but not chronic mTBI, compared with controls. Mean CD81-normalized NDE levels of a range of functional brain proteins were significantly abnormal relative to those of controls in acute but not chronic mTBI, including ras-related small GTPase 10, 73% decrease; annexin VII, 8.8-fold increase; ubiquitin C-terminal hydrolase L1, 2.5-fold increase; AII spectrin fragments, 1.9-fold increase; claudin-5, 2.7-fold increase; sodium-potassium-chloride cotransporter-1, 2.8-fold increase; aquaporin 4, 8.9-fold increase (3.6-fold increase in chronic mTBI); and synaptogyrin-3, 3.1-fold increase (1.3-fold increase in chronic mTBI) (all acute mTBI proteins P < 0.0001). In chronic mTBI, there were elevated CD81-normalized NDE levels of usually pathologic beta-amyloid peptide 1-42 (1.6-fold, P < 0.0001), P-T181-tau (2.2-fold, P < 0.0001), P-S396-tau (1.6-fold, P < 0.01), IL-6 (16-fold, P < 0.0001), and prion cellular protein (PRPc) (5.1-fold, P < 0.0001) with lesser or greater (IL-6, PRPc) increases in acute mTBI. Increases in NDE levels of most neurofunctional proteins in acute, but not chronic, mTBI, and elevations of most NDE neuropathological proteins in chronic and acute mTBI delineated phase-specificity. Longitudinal studies of more mTBI subjects may identify biomarkers predictive of and etiologically involved in mTBI-induced neurodegeneration.	[Goetzl, Edward J.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Med, San Francisco, CA 94143 USA; [Elahi, Fanny M.] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Cellular & Mol Neurosci Sect, Lab Neurosci, Baltimore, MD 21224 USA; [Pryhoda, Moira; Davidson, Bradley] Univ Denver, Dept Mech Engn, Human Dynam Lab, Denver, CO USA; [Gilmore, Anah; Granholm, Anne-Charlotte; Ledreux, Aurelie] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO USA; [Gorgens, Kimberly A.] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Denver; University of Denver; University of Denver	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Mustapic, Maja/AAV-3212-2020; Ledreux, Aurélie/M-3967-2018; Pryhoda, Moira/AAQ-1580-2021; Kapogiannis, Dimitrios/AAW-4934-2020	Ledreux, Aurélie/0000-0001-6232-7672; Kapogiannis, Dimitrios/0000-0003-2181-3118; Elahi, Fanny/0000-0003-4663-4992; Mustapic, Maja/0000-0003-0511-2047	Knoebel Institute for Healthy Aging; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000975] Funding Source: NIH RePORTER	Knoebel Institute for Healthy Aging; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Judith H. Goetzl (Geriatric Research Center, San Francisco, CA, USA) for preparation of the graphic illustrations. This research described was supported by a pilot grant from the Knoebel Institute for Healthy Aging (to A.-C.G.), and by the Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (to M.M. and D.K.). The authors declare no conflicts of interest.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bucci C, 2014, MEMBRANES, V4, P642, DOI 10.3390/membranes4040642; Buki A, 2000, J NEUROSCI, V20, P2825; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Leong DF., 2015, CONCUSSION, V1, pCNC8; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Shah R, 2018, NEW ENGL J MED, V379, P958, DOI 10.1056/NEJMra1704286; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Stern RA, 2016, JAMA NEUROL, V73, P1280, DOI 10.1001/jamaneurol.2016.3169; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Unsain N, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00010; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087	49	46	47	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5082	5088		10.1096/fj.201802319R	http://dx.doi.org/10.1096/fj.201802319R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30605353	Green Published, Bronze			2022-12-26	WOS:000462888500037
J	Roisman, LC; Han, S; Chuei, MJ; Connor, AR; Cappai, R				Roisman, Laila C.; Han, Sen; Chuei, Mun Joo; Connor, Andrea R.; Cappai, Roberto			The crystal structure of amyloid precursor-like protein 2 E2 domain completes the amyloid precursor protein family	FASEB JOURNAL			English	Article						APLP2; dimerization; X-ray macromolecule structure; copper; zinc	COPPER-BINDING DOMAIN; ALZHEIMERS-DISEASE; APP; HEPARIN; APLP2; HOMOLOG; REVEAL; BETA; MICE; SITE	The amyloid precursor-like protein 2 (APLP2) molecule is a type I transmembrane protein that is crucial for survival, cell-cell adhesion, neuronal development, myelination, cancer metastasis, modulation of metal, and glucose and insulin homeostasis. Moreover, the importance of the amyloid precursor protein (APP) family in biology and disease is very well known because of its central role in Alzheimer disease. In this study, we determined the crystal structure of the independently folded E2 domain of APLP2 and compared that with its paralogues APP and APLP2, demonstrating high overall structural similarities. The crystal structure of APLP2 E2 was solved as an antiparallel dimer, and analysis of the protein interfaces revealed a distinct mode of dimerization that differs from the previously reported dimerization of either APP or APLP1. Analysis of the APLP2 E2 metal binding sites suggested it binds zinc and copper in a similar manner to APP and APLP1. The structure of this key protein might suggest a relationship between the distinct mode of dimerization and its biologic functions.	[Roisman, Laila C.; Han, Sen; Chuei, Mun Joo; Connor, Andrea R.; Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Roisman, Laila C.; Han, Sen; Chuei, Mun Joo; Connor, Andrea R.; Cappai, Roberto] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia; [Roisman, Laila C.] Soroka Univ, Med Ctr, Y Rager 151, IL-85101 Beer Sheva, Israel	University of Melbourne; University of Melbourne; University of Melbourne; Ben Gurion University; Soroka Medical Center	Roisman, LC (corresponding author), Soroka Univ, Med Ctr, Y Rager 151, IL-85101 Beer Sheva, Israel.	dr.roisman@gmail.com	Roisman, Laila C./P-9129-2019	Roisman, Laila C./0000-0001-8455-9327	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the Australian Synchrotron, especially the staff at the MX2 Beamline, for friendly and helpful assistance with data collection; Dr. Zhiguang Xiao (Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne), for helpful review of the manuscript; and Nathan Gerstman for helpful visual crystal screening. This work was supported by funding from the National Health and Medical Research Council of Australia (to R.C). The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Cheng F, 2014, J BIOL CHEM, V289, P20871, DOI 10.1074/jbc.M114.552810; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Dahms SO, 2015, ACTA CRYSTALLOGR D, V71, P494, DOI 10.1107/S1399004714027114; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; Dinet V, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0245-z; Dunsing V, 2017, MOL BIOL CELL, V28, P3609, DOI 10.1091/mbc.E17-07-0459; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenton H, 1998, BRAIN RES, V779, P262, DOI 10.1016/S0006-8993(97)00958-X; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Heber S, 2000, J NEUROSCI, V20, P7951; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoopes JT, 2010, J BIOL CHEM, V285, P2165, DOI 10.1074/jbc.M109.018432; JIN LW, 1994, J NEUROSCI, V14, P5461; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Kong GKW, 2007, J MOL BIOL, V367, P148, DOI 10.1016/j.jmb.2006.12.041; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 2011, BIOCHEMISTRY-US, V50, P5453, DOI 10.1021/bi101846x; Leveugle B, 1997, NEUROCHEM INT, V30, P543, DOI 10.1016/S0197-0186(96)00103-9; Ludewig S, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00161; Mayer MC, 2014, J BIOL CHEM, V289, P19019, DOI 10.1074/jbc.M114.570382; Maynard CJ, 2005, INT J EXP PATHOL, V86, P147, DOI 10.1111/j.0959-9673.2005.00434.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; MULTHAUP G, 1994, FEBS LETT, V355, P151, DOI 10.1016/0014-5793(94)01176-1; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Needham BE, 2014, METALLOMICS, V6, P598, DOI 10.1039/c3mt00358b; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Pandey P, 2015, ONCOTARGET, V6, P2064, DOI 10.18632/oncotarget.2990; Shariati SAM, 2013, J CELL SCI, V126, P1268, DOI 10.1242/jcs.122440; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Truong PH, 2019, GLIA, V67, P525, DOI 10.1002/glia.23561; Truong PH, 2019, NEUROCHEM RES, V44, P1356, DOI 10.1007/s11064-018-2669-6; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108; Yang G, 2005, NEUROSCI LETT, V384, P66, DOI 10.1016/j.neulet.2005.04.040; Young TR, 2018, BIOCHEMISTRY-US, V57, P4165, DOI 10.1021/acs.biochem.8b00572	51	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5076	5081		10.1096/fj.201802315R	http://dx.doi.org/10.1096/fj.201802315R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30608876				2022-12-26	WOS:000462888500036
J	Mehta, K; Chacko, LA; Chug, MK; Jhunjhunwala, S; Ananthanarayanan, V				Mehta, Kritika; Chacko, Leeba Ann; Chug, Manjyot Kaur; Jhunjhunwala, Siddharth; Ananthanarayanan, Vaishnavi			Association of mitochondria with microtubules inhibits mitochondrial fission by precluding assembly of the fission protein Dnm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; microtubule; in vivo imaging; Schizosaccharomyces pombe; cell biology; cytoskeleton; molecular motor; mitosis; Dnm1; mitochondrial dynamics	DYNAMIN-RELATED PROTEIN; AXONAL-TRANSPORT; CELL-DIVISION; FUSION; YEAST; GTPASE; DRP1; KINESIN; PHOSPHORYLATION; ORGANIZATION	Mitochondria are organized as tubular networks in the cell and undergo fission and fusion. Although several of the molecular players involved in mediating mitochondrial dynamics have been identified, the precise cellular cues that initiate mitochondrial fission or fusion remain largely unknown. In fission yeast (Schizosaccharomyces pombe), mitochondria are organized along microtubule bundles. Here, we employed deletions of kinesin-like proteins to perturb microtubule dynamics and used high-resolution and time-lapse fluorescence microscopy, revealing that mitochondrial lengths mimic microtubule lengths. Furthermore, we determined that compared with WT cells, mutant cells with long microtubules exhibit fewer mitochondria, and mutant cells with short microtubules have an increased number of mitochondria because of reduced mitochondrial fission in the former and elevated fission in the latter. Correspondingly, upon onset of closed mitosis in fission yeast, wherein interphase microtubules assemble to form the spindle within the nucleus, we observed increased mitochondrial fission. We found that the consequent rise in the mitochondrial copy number is necessary to reduce partitioning errors during independent segregation of mitochondria between daughter cells. We also discovered that the association of mitochondria with microtubules physically impedes the assembly of the fission protein Dnm1 around mitochondria, resulting in inhibition of mitochondrial fission. Taken together, we demonstrate a mechanism for the regulation of mitochondrial fission that is dictated by the interaction between mitochondria and the microtubule cytoskeleton.	[Mehta, Kritika; Chacko, Leeba Ann; Chug, Manjyot Kaur; Jhunjhunwala, Siddharth; Ananthanarayanan, Vaishnavi] Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Ananthanarayanan, V (corresponding author), Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore 560012, Karnataka, India.	vaishnavi@iisc.ac.in	Chug, Manjyot Kaur/AFQ-2443-2022; Ananthanarayanan, Vaishnavi/AAJ-7170-2020; Jhunjhunwala, Siddharth/K-1526-2013	Ananthanarayanan, Vaishnavi/0000-0003-2936-7853; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Chacko, Leeba Ann/0000-0001-5636-504X; Mehta, Kritika/0000-0002-4312-9950	Department of Science and Technology (India)-Innovation of Science Pursuit for Inspired Research (INSPIRE) Faculty Award; Department of Biotechnology (India) Innovative Young Biotechnologist Award; Science and Engineering Research Board (SERB; India) Early Career Research Award; SERB Early Career Research Award	Department of Science and Technology (India)-Innovation of Science Pursuit for Inspired Research (INSPIRE) Faculty Award(Department of Science & Technology (India)); Department of Biotechnology (India) Innovative Young Biotechnologist Award; Science and Engineering Research Board (SERB; India) Early Career Research Award; SERB Early Career Research Award(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	This work was supported by the Department of Science and Technology (India)-Innovation of Science Pursuit for Inspired Research (INSPIRE) Faculty Award, the Department of Biotechnology (India) Innovative Young Biotechnologist Award, and the Science and Engineering Research Board (SERB; India) Early Career Research Award (to V. A.) and by the SERB Early Career Research Award (to S. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Basu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179397; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; BIRKY CW, 1983, INT REV CYTOL, P49; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Brazer SCW, 2000, YEAST, V16, P149, DOI 10.1002/(SICI)1097-0061(20000130)16:2<149::AID-YEA514>3.0.CO;2-C; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Chiron S, 2008, J CELL BIOL, V182, P41, DOI 10.1083/jcb.200712147; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Ferreira-da-Silva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122308; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fu CH, 2011, CURR BIOL, V21, P1431, DOI 10.1016/j.cub.2011.07.013; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Guillou E, 2005, FEBS LETT, V579, P1109, DOI 10.1016/j.febslet.2004.12.083; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; HENNIS AS, 1984, J CELL SCI, V70, P1; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jajoo R, 2016, SCIENCE, V351, P169, DOI 10.1126/science.aaa8714; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KANTERSMOLER G, 1994, BIOTECHNIQUES, V16, P798; Kruger N, 2008, CURR BIOL, V18, pR646, DOI 10.1016/j.cub.2008.06.069; Lawrence Elizabeth, 2013, Commun Integr Biol, V6, pe27557, DOI 10.4161/cib.27557; Li TP, 2015, SCI REP-UK, V5, DOI 10.1038/srep11023; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100	56	26	26	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3385	3396		10.1074/jbc.RA118.006799	http://dx.doi.org/10.1074/jbc.RA118.006799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602572	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000461853900007
J	Konarzewska, P; Wang, YN; Han, GS; Goh, KJ; Gao, YG; Carman, GM; Xue, CY				Konarzewska, Paulina; Wang, Yina; Han, Gil-Soo; Goh, Kwok Jian; Gao, Yong-Gui; Carman, George M.; Xue, Chaoyang			Phosphatidylserine synthesis is essential for viability of the human fungal pathogen Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylserine; phospholipid metabolism; inositol phospholipid; fungi; microbial pathogenesis; antifungal drug; Cryptococcus neoformans; mitochondria; phosphatidylserine synthase; reactive oxygen species; virulence	SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; GLOBAL BURDEN; YEAST; SYNTHASE; MITOCHONDRIAL; GENE; IDENTIFICATION; MENINGITIS; RESISTANCE	Phospholipids are an integral part of the cellular membrane structure and can be produced by a de novo biosynthetic pathway and, alternatively, by the Kennedy pathway. Studies in several yeast species have shown that the phospholipid phosphatidylserine (PS) is synthesized from CDP-diacylglycerol and serine, a route that is different from its synthesis in mammalian cells, involving a base-exchange reaction from preexisting phospholipids. Fungal-specific PS synthesis has been shown to play an important role in fungal virulence and has been proposed as an attractive drug target. However, PS synthase, which catalyzes this reaction, has not been studied in the human fungal pathogen Cryptococcus neoformans. Here, we identified and characterized the PS synthase homolog (Cn Cho1) in this fungus. Heterologous expression of Cn CHO1 in a Saccharomyces cerevisiae cho1 Delta mutant rescued the mutant's growth defect in the absence of ethanolamine supplementation. Moreover, an Sc cho1 Delta mutant expressing Cn CHO1 had PS synthase activity, confirming that the Cn CHO1 encodes PS synthase. We also found that PS synthase in C. neoformans is localized to the endoplasmic reticulum and that it is essential for mitochondrial function and cell viability. Of note, its deficiency could not be complemented by ethanolamine or choline supplementation for the synthesis of phosphatidylethanolamine (PE) or phosphatidylcholine (PC) via the Kennedy pathway. These findings improve our understanding of phospholipid synthesis in a pathogenic fungus and indicate that PS synthase may be a useful target for antifungal drugs.	[Konarzewska, Paulina; Wang, Yina; Xue, Chaoyang] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Xue, Chaoyang] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Han, Gil-Soo; Carman, George M.; Xue, Chaoyang] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Goh, Kwok Jian; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, Singapore 117597, Singapore	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xue, CY (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, ICPH Bldg,Rm W250H,225 Warren St, Newark, NJ 07103 USA.	xuech@njms.rutgers.edu	Wang, Yina/N-8534-2017; Gao, Yong Gui/A-2187-2011; Gao, Yonggui/A-9473-2015	Wang, Yina/0000-0003-1909-728X; Gao, Yonggui/0000-0001-7298-0835; Goh, Kwok Jian/0000-0002-9825-8071; Carman, George/0000-0003-4951-8233	National Institutes of Health [R01AI123315, R37GM028140]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01AI123315 (to C. X.) and R37GM028140 (to G. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE MS, 1984, J BIOL CHEM, V259, P857; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; Cassilly CD, 2018, J FUNGI, V4, DOI 10.3390/jof4010028; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; COUSMINER JJ, 1981, CAN J MICROBIOL, V27, P544, DOI 10.1139/m81-080; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Davis SE, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00815-17, 10.1128/iai.00815-17]; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Farine L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16787; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Harashima T, 2002, MOL CELL, V10, P163, DOI 10.1016/S1097-2765(02)00569-5; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Hu G, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12718; Huang W, 2016, MBIO, V7, DOI 10.1128/mBio.00478-16; Idnurm A, 2010, GENETICS, V185, P153, DOI 10.1534/genetics.109.113027; Ingavale SS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000155; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KOHLWEIN SD, 1988, J BACTERIOL, V170, P3778, DOI 10.1128/jb.170.8.3778-3781.1988; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu TB, 2014, INFECT IMMUN, V82, P557, DOI 10.1128/IAI.00994-13; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; Ory JJ, 2004, YEAST, V21, P919, DOI 10.1002/yea.1139; Panatala R, 2015, J CELL SCI, V128, P2021, DOI 10.1242/jcs.102715; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1993, J MED VET MYCOL, V31, P175; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Shor E, 2016, MICROB CELL, V3, P358, DOI 10.15698/mic2016.08.521; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Xue CY, 2010, MBIO, V1, DOI 10.1128/mBio.00084-10	44	9	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2329	2339		10.1074/jbc.RA118.006738	http://dx.doi.org/10.1074/jbc.RA118.006738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30602568	Green Published, hybrid			2022-12-26	WOS:000458895400011
J	Khan, A; Shams, S; Khan, S; Khan, MI; Khan, S; Ali, A				Khan, Asar; Shams, Sumaira; Khan, Saima; Khan, Muhammad Iftikhar; Khan, Sardar; Ali, Abid			Evaluation of prevalence and risk factors associated with Cryptosporidium infection in rural population of district Buner, Pakistan	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; WATERBORNE TRANSMISSION; PROTOZOAN PARASITES; NORTH-WEST; CHILDREN; HUMANS; IDENTIFICATION; OUTBREAKS; GIARDIA; EPIDEMIOLOGY	Background Cryptosporidium spp are important intestinal protozoan parasites that cause diarrhea in humans, domestic and wild animals. Its infection remains a main public health concern however, the epidemics in human being is still unclear, particularly in developing countries. There are several factors that may enhance the spreading of this parasite in human population especially in young children. Methodology A questionnaire was designed to obtain the demographic and clinical data from the participants. A total of 425 stool samples were collected from suspected children (aged 3-10 years) in different hospitals and villages. The initial screening was performed with modified Ziehl Neelsen (mZN) staining technique followed by polymerase chain reaction (PCR). Several potential risk factors were also assessed through the obtained information from suspected individuals. Results Out of all 425 collected samples, 127 were observed positive by mZN with a prevalence of 29.88% (127/425). The 127 mZN positive samples together with 50 mZN negative samples were processed for molecular analysis through PCR assay. Among them, 71 out of 127 mZN positive samples and 4 out of 50 mZN negative samples were found positive by PCR. The molecular analysis showed that Cryptosporidium parvum was the main cause of infection in children. The results revealed that individuals exposed to diarrhea were more likely to be infected with Cryptosporidium infection while several environmental factors may also play a key role in spreading of this parasite. Conclusions/Significance of the study The current high prevalence of Cryptosporidium infection may be due to the lack of awareness and routine based testing in identification of this parasite in District Buner. Further studies are required to determine the importance of Cryptosporidium infection in this area as well as across the country and to find out the possible risk factors that may be associated with the occurrence of this protozoan. There is, however, an urgent need for laboratory based observational studies to develop a more dynamic estimate of the cryptosporidial disease burden in the region.	[Khan, Asar; Shams, Sumaira; Khan, Saima; Khan, Muhammad Iftikhar; Ali, Abid] Abdul Wali Khan Univ Mardan, Dept Zool, Mardan, Pakistan; [Khan, Muhammad Iftikhar] Univ Swat, Ctr Biotechnol & Microbiol, Swat, Pakistan; [Khan, Sardar] Univ Peshawar, Dept Environm Sci, Peshawar, Pakistan	University of Peshawar	Ali, A (corresponding author), Abdul Wali Khan Univ Mardan, Dept Zool, Mardan, Pakistan.	uop_ali@yahoo.com	Khan, Sardar/C-2883-2009; Ali, Abid/J-6171-2016; Khan, Asar/L-5438-2016	Khan, Sardar/0000-0002-7060-1771; Ali, Abid/0000-0001-6411-6625; Khan, Asar/0000-0002-0813-2732	Pakistan Science Foundation (PSF)	Pakistan Science Foundation (PSF)	The authors acknowledge the financial support provided by Pakistan Science Foundation (PSF) for research facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our sincere thanks to Mr. Kausar Saeed & Mr. Bakht Tarin Khan (Lecturers, Department of Zoology, University of Buner) for allowing us to use their lab facilities for samples collection and processing. We would also like to thank Dr. Muhammad Farooq (District Children Specialist) for guiding and facilitating in sample collection. The authors acknowledge the financial support provided by Pakistan Science Foundation (PSF) for research facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2018, INT J HYG ENVIR HEAL, V221, P743, DOI 10.1016/j.ijheh.2018.04.006; Akinbo FO, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.5506; Al-Shamiri AH, 2010, IRAN J PARASITOL, V5, P26; Ali S, 2014, J PAK MED ASSOC, V64, P613; Ayaz Sultan, 2011, Pakistan Journal of Life and Social Sciences, V9, P67; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Becker DJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004080; Bodhidatta L, 2016, J VET MED RES, V3, P1059; Bodley-Tickell AT, 2002, WATER RES, V36, P1880, DOI 10.1016/S0043-1354(01)00398-0; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Chalmers RM, 2010, J WATER HEALTH, V8, P311, DOI 10.2166/wh.2009.185; Connelly JT, 2008, ANAL BIOANAL CHEM, V391, P487, DOI 10.1007/s00216-008-1967-2; Crannell ZA, 2014, ANAL CHEM, V86, P2565, DOI 10.1021/ac403750z; Carvalho Thaís Batista de, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P269, DOI 10.1590/S0036-46652006000500006; Desai Niyati T, 2012, Trop Parasitol, V2, P91, DOI 10.4103/2229-5070.105173; Efstratiou A, 2017, WATER RES, V123, P96, DOI 10.1016/j.watres.2017.06.042; El-Badry AA, 2010, J MED BIOMED SCI; ElBakri A, 2014, INT J INFECT DIS, V21, P160, DOI 10.1016/j.ijid.2014.03.757; Elsafi SH, 2013, PARASITOL RES, V112, P1641, DOI 10.1007/s00436-013-3319-1; EPA, 2013, BAS INF PATH IND DRI; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Garcia-R JC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005736; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Hunter PR, 2002, CLIN MICROBIOL REV, V15, P145, DOI 10.1128/CMR.15.1.145-154.2002; Iqbal J, 2011, J MED MICROBIOL, V60, P647, DOI 10.1099/jmm.0.028001-0; Jagai JS, 2009, ENVIRON RES, V109, P465, DOI 10.1016/j.envres.2009.02.008; Josephine SYN, 2012, EXP PARASITOL, V130, P437, DOI 10.1016/j.exppara.2012.01.014; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Khan SM, 2010, VET PARASITOL, V171, P41, DOI 10.1016/j.vetpar.2010.03.008; Khushdil Arshad, 2016, J Ayub Med Coll Abbottabad, V28, P575; Korpe PS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004564; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Latif Baha, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P885, DOI 10.1016/j.apjtb.2015.05.021; Lee Jong-Kyu, 2005, Korean Journal of Parasitology, V43, P111, DOI 10.3347/kjp.2005.43.3.111; Liu H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-25; Mahmoudi MR, 2015, PARASITOL RES, V114, P4669, DOI 10.1007/s00436-015-4712-8; Rosado-Garcia FM, 2017, INT J HYG ENVIR HEAL, V220, P783, DOI 10.1016/j.ijheh.2017.03.008; Marquardt WC, 2000, J PARASITOL VECTOR B; Matthys B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-195; Mirzaei Mohammad, 2007, Korean Journal of Parasitology, V45, P133, DOI 10.3347/kjp.2007.45.2.133; Mumtaz Shahina, 2011, J Ayub Med Coll Abbottabad, V23, P72; Mumtaz S, 2010, AFR J BIOTECHNOL, V9, P1230; Nasir A, 2009, INT J AGRIC BIOL, V11, P221; Nichols RAB, 2010, APPL ENVIRON MICROB, V76, P5977, DOI 10.1128/AEM.00915-10; Quandt SA, 2004, PUBLIC HEALTH REP, V119, P568, DOI 10.1016/j.phr.2004.09.006; Rahi A.A., 2013, AM J LIFE SCI, V1, P256; Raja Kapeel, 2014, J Nephropathol, V3, P127, DOI 10.12860/jnp.2014.25; Ryan U, 2014, CRYPTOSPORIDIUM PARA, P3, DOI DOI 10.1007/978-3-7091-1562-6_2; Ryan U, 2015, INT J PARASITOL, V45, P367, DOI 10.1016/j.ijpara.2015.01.009; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Shafiq MAB, 2015, PAK J ZOOL, V47, P1715; Sherchand SP, 2016, ECON MICROBIOL, V4, P641; Sirisena UM, 2014, CEYLON MED J, V59, P75, DOI 10.4038/cmj.v59i3.7467; Siwila J, 2007, T ROY SOC TROP MED H, V101, P733, DOI 10.1016/j.trstmh.2007.01.006; Squire SA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2111-y; Striepen B, 2013, NATURE, V503, P189, DOI 10.1038/503189a; Thivierge K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004534; Todd ECD, 2009, J FOOD PROTECT, V72, P202, DOI 10.4315/0362-028X-72.1.202; ValDerrama AL, 2009, EPIDEMIOL INFECT, V137, P1781, DOI 10.1017/S0950268809002842; Wells B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0684-x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xiao SM, 2012, WATER RES, V46, P4272, DOI 10.1016/j.watres.2012.05.012; Yang Y, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0223-9; Yu Jae-Ran, 2004, Korean Journal of Parasitology, V42, P1, DOI 10.3347/kjp.2004.42.1.1	65	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209188	10.1371/journal.pone.0209188	http://dx.doi.org/10.1371/journal.pone.0209188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601870	Green Submitted, gold, Green Published			2022-12-26	WOS:000454683200047
J	Watanabe, C; Matsushita, J; Azami, T; Tsukiyama-Fujii, S; Tsukiyama, T; Mizuno, S; Takahashi, S; Ema, M				Watanabe, Chisato; Matsushita, Jun; Azami, Takuya; Tsukiyama-Fujii, Setsuko; Tsukiyama, Tomoyuki; Mizuno, Seiya; Takahashi, Satoru; Ema, Masatsugu			Generating Vegfr3 reporter transgenic mouse expressing membrane-tagged Venus for visualization of VEGFR3 expression in vascular and lymphatic endothelial cells	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; FLK1 EXPRESSION; ANIMAL-MODEL; ANGIOGENESIS; MICE	Vascular endothelial growth factor receptor 3 (Vegfr3) has been widely used as a marker for lymphatic and vascular endothelial cells during mouse embryonic development and in adult mouse, making it valuable for studying angiogenesis and lymphangiogenesis under normal and pathological conditions. Here, we report the generation of a novel transgenic (Tg) mouse that expresses a membrane-localized fluorescent reporter protein, Gap43-Venus, under the control of the Vegfr3 regulatory sequence. Vegfr3-Gap43-Venus BAC Tg recapitulated endogenous Vegfr3 expression in vascular and lymphatic endothelial cells during embryonic development and tumor development. Thus, this Tg mouse line contributes a valuable model to study angiogenesis and lymphangiogenesis in physiological and pathological contexts.	[Watanabe, Chisato; Matsushita, Jun; Azami, Takuya; Tsukiyama-Fujii, Setsuko; Tsukiyama, Tomoyuki; Ema, Masatsugu] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Otsu, Shiga, Japan; [Mizuno, Seiya; Takahashi, Satoru] Univ Tsukuba, Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Int Inst Integrat Sleep Med, Life Sci Ctr, Tsukuba, Ibaraki, Japan	Shiga University of Medical Science; University of Tsukuba; University of Tsukuba; University of Tsukuba	Ema, M (corresponding author), Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Otsu, Shiga, Japan.	mema@belle.shiga-med.ac.jp	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719; Ema, Masatsugu/0000-0003-0645-6183; Azami, Takuya/0000-0002-3759-9710	Japan Science and Technology Agency (JST) [18H02363]; Ministry of Education, Culture, Sports, Science and Technology	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Japan Science and Technology Agency (JST) (to ME) and a Grant-in-Aid for Scientific Research (B, 18H02363), the Ministry of Education, Culture, Sports, Science and Technology (to ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alishekevitz D, 2016, CELL REP, V17, P1344, DOI 10.1016/j.celrep.2016.09.083; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311; Deng Y, 2015, ARTERIOSCL THROM VAS, V35, P421, DOI 10.1161/ATVBAHA.114.304881; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ishitobi H, 2011, DEVELOPMENT, V138, P5357, DOI 10.1242/dev.065565; Ishitobi H, 2010, EXP ANIM TOKYO, V59, P615, DOI 10.1538/expanim.59.615; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Matsumoto K, 2014, J BIOCHEM, V156, P1, DOI 10.1093/jb/mvu031; Matsumoto K, 2012, GENESIS, V50, P561, DOI 10.1002/dvg.22031; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Zhong W, 2017, ANGIOGENESIS, V20, P581, DOI 10.1007/s10456-017-9572-7	21	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0210060	10.1371/journal.pone.0210060	http://dx.doi.org/10.1371/journal.pone.0210060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601868	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200062
J	Bennett, RE; Leuenberger, W; Leja, BBB; Caceres, AS; Johnson, K; Larkin, J				Bennett, Ruth E.; Leuenberger, Wendy; Bosarreyes Leja, Bianca B.; Sagone Caceres, Alejandro; Johnson, Kirsten; Larkin, Jeffery			Conservation of Neotropical migratory birds in tropical hardwood and oil palm plantations	PLOS ONE			English	Article							COFFEE PLANTATIONS; HABITAT QUALITY; BIODIVERSITY; VEGETATION; DIVERSITY; FOREST; COVER; COMMUNITIES; LANDSCAPES; PATTERNS	Tropical forests in the Americas are undergoing rapid conversion to commercial agriculture, and many migratory bird species that use these forests have experienced corresponding populations declines. Conservation research for migratory birds in the tropics has focused overwhelmingly on shade coffee plantations and adjacent forest, but both cover types are now in decline, creating an urgent need to evaluate conservation opportunities in other agricultural systems. Here we compare how a community of 42 Neotropical migratory bird species and a subset of five conservation-priority species differ in usage and habitat associations among a secondary forest baseline and four expanding commercial plantation systems in Guatemala: African oil palm, teak, rubber, and mixed-native hardwoods. We found that mixed-native hardwood plantations supported the highest richness and diversity of all migrants and that the three hardwood plantation types generally outperformed oil palm in richness and diversity metrics. Despite this, oil palm supported high abundance of several common and widespread species also experiencing range-wide population declines and may therefore play an important role in conserving common species. Mature secondary forest hosted low abundance and diversity of the full migratory community, but high abundance and richness of conservation priority migrants along with native hardwood and teak plantations. Likewise, the percentage of forest cover on the landscape was positively associated with priority migrant abundance and richness but negatively associated with the abundance of migrants in general, highlighting how individual species within the broad group of Neotropical migratory landbirds respond differently to anthropogenic changes in land use. Across all cover types, the retention of tall overstory trees increased the abundance, richness, and diversity of all migrants, which indicates that vertical structural diversity and remnant trees are important habitat features for birds in agricultural landscapes. Our findings show that conservation opportunities exist in hardwood and oil palm plantations, though the species likely to benefit from conservation action will vary among plantation types. For the subset of conservation priority migrants, our results suggest that conservation efforts should combine strategies that retain and restore secondary forest, promote the adoption of native hardwood and teak plantations, and promote the retention of tall, remnant trees in agricultural landscapes.	[Bennett, Ruth E.] Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA; [Bennett, Ruth E.] Cornell Lab Ornithol, Conservat Sci Program, Ithaca, NY 14850 USA; [Leuenberger, Wendy] SUNY Syracuse, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Bosarreyes Leja, Bianca B.] Univ San Carlos, Ciudad De Guatemala, Guatemala; [Sagone Caceres, Alejandro] Asociac Guatemalteca Hist Nat, Ciudad De Guatemala, Guatemala; [Johnson, Kirsten; Larkin, Jeffery] Indiana Univ Penn, Indiana, PA USA; [Larkin, Jeffery] Amer Bird Conservancy, The Plains, VA USA	Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Universidad de San Carlos de Guatemala; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania	Bennett, RE (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.; Bennett, RE (corresponding author), Cornell Lab Ornithol, Conservat Sci Program, Ithaca, NY 14850 USA.	reb349@cornell.edu		Leuenberger, Wendy/0000-0001-6567-9913; Bennett, Ruth/0000-0003-4024-0538; Bosarreyes, Bianca/0000-0002-8253-9100	American Bird Conservancy	American Bird Conservancy	JL received funding for this study from the American Bird Conservancy, https://abcbirds.org/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen A., 2001, AGR TECHNOLOGIES TRO; [Anonymous], 2014, PRIVATE FINANCING SU; [Anonymous], 2015, APP MOUNT JOINT VENT; Aratrakorn S, 2006, BIRD CONSERV INT, V16, P71, DOI 10.1017/S0959270906000062; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Askins RA, 1990, CURR ORNITHOL, V7, P57; Bakermans MH, 2009, BIOL CONSERV, V142, P2476, DOI 10.1016/j.biocon.2009.05.018; Barton K., 2016, MUMIN MULTIMODEL INF; BENNETT RYAN T, 2012, THESIS; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carpio Malavassi IM, 1992, MADERAS COSTA RICA 1; Chan EKW, 2008, BIOTROPICA, V40, P623, DOI 10.1111/j.1744-7429.2008.00420.x; Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Cruz-Angon A, 2005, J APPL ECOL, V42, P150, DOI 10.1111/j.1365-2664.2004.00983.x; Davis A.S., 2012, CHALLENGING PARADIGM, P293, DOI [10.1007/978-94-007-5326-6_15, DOI 10.1007/978-94-007-5326-6_15, DOI 10.1007/978-94-007-5326-6_]; De Beenhouwer M, 2013, AGR ECOSYST ENVIRON, V175, P1, DOI 10.1016/j.agee.2013.05.003; DeGraaf R.M., 1995, NEOTROPICAL MIGRATOR; FAO, 2016, STAT WORLD S FOR 201; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Gifford G., 2016, THESIS; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; Greenberg R, 1997, CONSERV BIOL, V11, P448, DOI 10.1046/j.1523-1739.1997.95464.x; GREENBERG R, 1987, ECOLOGY, V68, P130, DOI 10.2307/1938813; Hall JS, 2011, FOREST ECOL MANAG, V261, P1553, DOI 10.1016/j.foreco.2010.12.011; Hallett JT, 2011, J FOREST, V109, P288; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harms TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173041; Harvey CA, 2004, LIVE FENCES ISOLATED, P261; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Holdridge L., 1964, LIFE ZONE ECOLOGY; Jha S, 2014, BIOSCIENCE, V64, P416, DOI 10.1093/biosci/biu038; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Johnson MD, 2001, J ANIM ECOL, V70, P546, DOI 10.1046/j.1365-2656.2001.00522.x; Jun C, 2014, NATURE, V514, P434, DOI 10.1038/514434c; Kaimowitz D, 2008, INT FOREST REV, V10, P485, DOI 10.1505/ifor.10.3.485; Komar O, 2006, BIRD CONSERV INT, V16, P1, DOI 10.1017/S0959270906000074; Lamb D, 1998, RESTOR ECOL, V6, P271, DOI 10.1046/j.1526-100X.1998.00632.x; Luskin MS, 2011, BASIC APPL ECOL, V12, P540, DOI 10.1016/j.baae.2011.06.004; Montagnini F., 2004, J SUSTAIN FOREST, V21, P51, DOI DOI 10.1300/J091V21N01_03; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Najera A, 2010, AGROFOREST SYST, V80, P203, DOI 10.1007/s10457-010-9278-y; Nichols JD, 2012, INT FOREST REV, V14, P402, DOI 10.1505/146554812804715892; NUDDS T D, 1977, Wildlife Society Bulletin, V5, P113; Oksanen J., 2019, R PACKAGE VERSION; Onyekwelu JC, 2011, TROP FOREST, P399, DOI 10.1007/978-3-642-19986-8_27; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Petit LJ, 1999, ECOGRAPHY, V22, P292, DOI 10.1111/j.1600-0587.1999.tb00505.x; Phalan B, 2016, SCIENCE, V351, P450, DOI 10.1126/science.aad0055; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; Philpott SM, 2012, AGR ECOSYST ENVIRON, V149, P171, DOI 10.1016/j.agee.2011.02.015; Piotto D, 2010, NEW FOREST, V39, P369, DOI 10.1007/s11056-009-9177-0; RCore Team, 2020, R LANG ENV STAT COMP; Rice RA, 2000, AMBIO, V29, P167, DOI 10.1579/0044-7447-29.3.167; RICH TD, 2004, PARTNERS FLIGHT N AM; Robbins C.S., 1981, Studies in Avian Biology, P301; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Rosenberg K., 2016, PARTNERS FLIGHT LAND, P119; Rotenberg JA, 2007, AUK, V124, P316, DOI 10.1642/0004-8038(2007)124[316:EROATG]2.0.CO;2; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Sauer J.R., 2017, N AM BREEDING BIRD S; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Streed E, 2006, J FOREST, V104, P276; Suarez-Rubio M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067593, 10.1371/journal.pone.0081143]; Tabacchi E, 2000, HYDROL PROCESS, V14, P2959, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2959::AID-HYP129&gt;3.0.CO;2-B; Taylor CM, 2016, ECOL APPL, V26, P424, DOI 10.1890/14-1410; Villasenor JF, 2007, THESIS; Villasenor-Gomez Jose Fernando, 2008, Studies in Avian Biology, V37, P53; Zuur Alain F., 2009, P1	75	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210293	10.1371/journal.pone.0210293	http://dx.doi.org/10.1371/journal.pone.0210293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596798	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200156
J	Calixto, NM; dos Santos, DB; Bezerra, JPCB; Silva, LD				Calixto, Nicole Melo; dos Santos, Daniela Braz; Barreto Bezerra, Jose Clecildo; Silva, Lourival de Almeida			In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets	PLOS ONE			English	Article							SUCCINATE-DEHYDROGENASE INHIBITORS; PRAZIQUANTEL; RESISTANCE; DISCOVERY; DRUGBANK; DERIVATIVES; MECHANISMS; DESIGN; VITRO	Schistosomiasis is a neglected parasitosis caused by Schistosoma spp. Praziquantel is used for the chemoprophylaxis and treatment of this disease. Although this monotherapy is effective, the risk of resistance and its low efficiency against immature worms compromises its effectiveness. Therefore, it is necessary to develop new schistosomicide drugs. However, the development of new drugs is a long and expensive process. The repositioning of approved drugs has been proposed as a quick, cheap, and effective alternative to solve this problem. This study employs chemogenomic analysis with use of bioinformatics tools to search, identify, and analyze data on approved drugs with the potential to inhibit Schistosoma mansoni energy metabolism enzymes. The TDR Targets Database, Gene DB, Protein, DrugBank, Therapeutic Targets Database (TTD), Promiscuous, and PubMed databases were used. Fifty-nine target proteins were identified, of which 18 had one or more approved drugs. The results identified 20 potential drugs for schistosomiasis treatment; all approved for use in humans.	[Calixto, Nicole Melo; Silva, Lourival de Almeida] Inst Fed Educ Ciencia & Tecnol Goiano, Dept Bioinformat, Campus Ceres, Ceres, Go, Brazil; [dos Santos, Daniela Braz; Barreto Bezerra, Jose Clecildo] Univ Fed Goias Goiania, Inst Patol Trop & Saude Publ, LAERPH Lab Parasite Host Relationship Study, Goiania, Go, Brazil	Instituto Federal Goiano	Silva, LD (corresponding author), Inst Fed Educ Ciencia & Tecnol Goiano, Dept Bioinformat, Campus Ceres, Ceres, Go, Brazil.	lourival.silva@ifgoiano.edu.br		SILVA, LOURIVAL DE ALMEIDA/0000-0003-0774-0960	Brazilian National Council for Scientific and Technological Development (CNPq/MS/DECIT) [37/2014, 470298/2014-6]; Instituto Federal de Educacao, Ciencia e Tecnologia Goiano/GO	Brazilian National Council for Scientific and Technological Development (CNPq/MS/DECIT); Instituto Federal de Educacao, Ciencia e Tecnologia Goiano/GO	This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq/MS/DECIT n. 37/2014. Projeto 470298/2014-6 to CBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Instituto Federal de Educacao, Ciencia e Tecnologia Goiano/GO.	Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P89; [Anonymous], 2010, PHARM MED; Antila H, 2017, SCI REP, P1, DOI [10.1038/S41598-016-0028-X, DOI 10.1038/S41598-016-0028-X]; Beatty L, 2013, EMERG MED INT, V2013, DOI 10.1155/2013/638057; Bispo NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059288; Chai JY, 2013, INFECT CHEMOTHER, V45, P32, DOI 10.3947/ic.2013.45.1.32; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; Cupit PM, 2015, FUTURE MED CHEM, V7, P701, DOI [10.4155/FMC.15.11, 10.4155/fmc.15.11]; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Silva LAF, 2015, CASE REP OTOLARYNGOL, V2015, DOI 10.1155/2015/890508; Greenberg RM, 2013, PARASITOLOGY, V140, P1534, DOI 10.1017/S0031182013000231; Horn NA, 2003, ANAESTHESIA, V58, P312, DOI 10.1046/j.1365-2044.2003.03076.x; Hou YP, 2018, PESTIC BIOCHEM PHYS, V149, P81, DOI 10.1016/j.pestbp.2018.06.002; Hou YP, 2018, PESTIC BIOCHEM PHYS, V149, P20, DOI 10.1016/j.pestbp.2018.05.004; Ioset JR, 2011, FUTURE MED CHEM, V3, P1361, DOI [10.4155/fmc.11.102, 10.4155/FMC.11.102]; Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293; Kasinathan RS, 2010, MOL BIOCHEM PARASIT, V173, P25, DOI 10.1016/j.molbiopara.2010.05.003; Khanna I, 2012, DRUG DISCOV TODAY, V17, P1088, DOI 10.1016/j.drudis.2012.05.007; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lee HS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-80; Lepore R, 2011, J CHEM INF MODEL, V51, P3005, DOI 10.1021/ci2001764; Liu ZC, 2013, DRUG DISCOV TODAY, V18, P110, DOI 10.1016/j.drudis.2012.08.005; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Lv XH, 2017, PEST MANAG SCI, V73, P1585, DOI 10.1002/ps.4488; Ma DL, 2013, CHEM SOC REV, V42, P2130, DOI 10.1039/c2cs35357a; Manneck T, 2012, PARASITOLOGY, V139, P497, DOI 10.1017/S0031182011002204; Oprea TI, 2015, ASSAY DRUG DEV TECHN, V13, P299, DOI 10.1089/adt.2015.29011.tiodrrr; Padhy BM, 2011, J POSTGRAD MED, V57, P153, DOI 10.4103/0022-3859.81870; Pancera Christiane Finardi, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P159, DOI 10.1590/S0036-46651997000300007; Panic G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003962; Panic G, 2014, INT J PARASITOL-DRUG, V4, P185, DOI 10.1016/j.ijpddr.2014.07.002; Pelkonen O, 2011, CLIN PHARMACOKINET, V50, P483, DOI 10.2165/11592400-000000000-00000; Pravdic D, 2012, EUR J PHARMACOL, V690, P149, DOI 10.1016/j.ejphar.2012.07.003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva-Moraes V, 2013, MEM I OSWALDO CRUZ, V108, P600, DOI 10.1590/0074-0276108052013011; von Eichborn J, 2011, NUCLEIC ACIDS RES, V39, pD1060, DOI 10.1093/nar/gkq1037; Wang HZ, 2017, CHEMMEDCHEM, V12, P1033, DOI 10.1002/cmdc.201700196; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yang H, 2016, NUCLEIC ACIDS RES, V44, pD1069, DOI 10.1093/nar/gkv1230; Yao TT, 2017, J AGR FOOD CHEM, V65, P3204, DOI 10.1021/acs.jafc.7b00249; Ye B, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-12; You H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00176	47	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0203340	10.1371/journal.pone.0203340	http://dx.doi.org/10.1371/journal.pone.0203340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596650	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200004
J	Vinci, G; Cozzolino, V; Mazzei, P; Monda, H; Spaccini, R; Piccolo, A				Vinci, Giovanni; Cozzolino, Vincenza; Mazzei, Pierluigi; Monda, Hiarhi; Spaccini, Riccardo; Piccolo, Alessandro			An alternative to mineral phosphorus fertilizers: The combined effects of Trichoderma harzianum and compost on Zea mays, as revealed by H-1 NMR and GC-MS metabolomics	PLOS ONE			English	Article							PHOSPHATE STATUS; PLANT; NUTRITION; GROWTH; ROOT; PHOTOSYNTHESIS; MICROORGANISMS; BIOCONTROL; LEAVES	The ability of Trichoderma harzianum (strain OMG-08) as plant growth promoting fungus (PGPF), was tested on Zea mays plants grown in soil pots added with different inorganic (triple superphosphate and rock phosphate) and organic (cow and horse manure composts) P fertilizers. The effect of treatments was evaluated by following the variations of plants dry biomass and nutrient content, as well as the metabolic changes in plant leaves by both GC-MS and NMR spectroscopy. A synergic effect was observed in treatments with both composts and fungus inoculation, in which not only plant growth and P uptake were enhanced, but also the expression of different metabolites related to an improved photosynthetic activity. Conversely, the combination of Trichoderma with inorganic fertilizers was less effective and even showed a reduction of plants shoot biomass and N content. The corresponding plant metabolome revealed metabolic compounds typical of biotic or abiotic stresses, which may be attributed to a reduced capacity of inorganic fertilizers to provide a sufficient P availability during plant growth. Our findings also indicate that the molecular composition of compost differentiated the Trichoderma activity in sustaining plant growth. The positive effects of the combined Trichoderma and compost treatment suggest that it may become an alternative to the phosphorus mineral fertilization.	[Vinci, Giovanni; Cozzolino, Vincenza; Mazzei, Pierluigi; Monda, Hiarhi; Spaccini, Riccardo; Piccolo, Alessandro] Univ Napoli Federico II, Ctr Interdipartimentale Ric Risonanza Magnet Nucl, Portici, NA, Italy	University of Naples Federico II	Vinci, G; Piccolo, A (corresponding author), Univ Napoli Federico II, Ctr Interdipartimentale Ric Risonanza Magnet Nucl, Portici, NA, Italy.	giovanni.vinci@unina.it; alessandro.piccolo@unina.it	Monda, H./AAE-8275-2020; piccolo, alessandro/AAU-7540-2020	COZZOLINO, Vincenza/0000-0001-9312-0244; Monda, Hiarhi/0000-0003-1468-6296; SPACCINI, Riccardo/0000-0002-9828-1992; Mazzei, Pierluigi/0000-0002-5312-4969	European Community [312117]	European Community(European Commission)	This work was funded from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 312117 (BIOFECTOR).	Alfano G, 2007, PHYTOPATHOLOGY, V97, P429, DOI 10.1094/PHYTO-97-4-0429; Avis TJ, 2008, SOIL BIOL BIOCHEM, V40, P1733, DOI 10.1016/j.soilbio.2008.02.013; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Barker AV, 2010, SCI TECHNOLOGY ORGAN, P224; Benitez T, 2004, INT MICROBIOL, V7, P249; Berglund T, 1996, FEBS LETT, V380, P188, DOI 10.1016/0014-5793(96)00027-0; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Cozzolino V, 2016, BIOL FERT SOILS, V52, P15, DOI 10.1007/s00374-015-1046-8; de Santiago A, 2013, SOIL BIOL BIOCHEM, V57, P598, DOI 10.1016/j.soilbio.2012.06.020; Den Herder G, 2010, TRENDS PLANT SCI, V15, P600, DOI 10.1016/j.tplants.2010.08.009; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; Ertani A, 2011, J PLANT NUTR SOIL SC, V174, P496, DOI 10.1002/jpln.201000075; Field CB, 1986, EC PLANT FORM FUNCTI, P35; FOYER C, 1986, PLANTA, V167, P369, DOI 10.1007/BF00391341; FREDEEN AL, 1989, PLANT PHYSIOL, V89, P225, DOI 10.1104/pp.89.1.225; Gericke S., 1952, Z PFLANZENERNAHRUNG, V59, P32; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Hargreaves JC, 2008, AGR ECOSYST ENVIRON, V123, P1, DOI 10.1016/j.agee.2007.07.004; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Heffer P, 2012, 80 IFA ANN C DOH QAT; Jiang XD, 2011, J BIOSCI BIOENG, V111, P121, DOI 10.1016/j.jbiosc.2010.09.004; Joshi V, 2010, AMINO ACIDS, V39, P933, DOI 10.1007/s00726-010-0505-7; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Koliaei A. A., 2011, Asian Journal of Agricultural Sciences, V3, P223; Lekfeldt JDS, 2016, CHEM BIOL TECHNOL AG, V3, DOI 10.1186/s40538-016-0074-4; [李梦龙 Li Menglong], 2017, [高分子通报, Polymer Bulletin], P1; Li RX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130081; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lopez-Bucio J, 2015, SCI HORTIC-AMSTERDAM, V196, P109, DOI 10.1016/j.scienta.2015.08.043; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Marra R, 2006, CURR GENET, V50, P307, DOI 10.1007/s00294-006-0091-0; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Ortiz-Castro R, 2009, PLANT SIGNAL BEHAV, V4, P701, DOI 10.4161/psb.4.8.9047; Pessarakli M., 1996, HDB PHOTOSYNTHESIS, P173; Puglisi E, 2009, CHEMOSPHERE, V77, P829, DOI 10.1016/j.chemosphere.2009.07.077; RAO IM, 1995, PLANT PHYSIOL, V107, P1313, DOI 10.1104/pp.107.4.1313; Reddy MS, 2002, BIORESOURCE TECHNOL, V84, P187, DOI 10.1016/S0960-8524(02)00040-8; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Savy D, 2018, SCI TOTAL ENVIRON, V645, P411, DOI 10.1016/j.scitotenv.2018.07.153; Savy D, 2016, PLANT SOIL, V402, P221, DOI 10.1007/s11104-015-2780-2; Schluter U, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-442; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Schroder JJ, 2011, CHEMOSPHERE, V84, P822, DOI 10.1016/j.chemosphere.2011.01.065; Sengupta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00656; Shoresh M, 2008, PLANT PHYSIOL, V147, P2147, DOI 10.1104/pp.108.123810; Spaccini R, 2009, SOIL BIOL BIOCHEM, V41, P1164, DOI 10.1016/j.soilbio.2009.02.026; t'Kindt R, 2009, J CHROMATOGR B, V877, P3572, DOI 10.1016/j.jchromb.2009.08.041; Takahama U, 1998, PLANT CELL PHYSIOL, V39, P681, DOI 10.1093/oxfordjournals.pcp.a029422; Thonar C, 2017, CHEM BIOL TECHNOL AG, V4, DOI 10.1186/s40538-017-0088-6; Tiwari P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/203735; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; Vinci G, 2018, PLANT SOIL, P1; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Whipps JM, 2004, CAN J BOT, V82, P1198, DOI [10.1139/b04-082, 10.1139/B04-082]; Winter G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00534; Yedidia I, 2001, PLANT SOIL, V235, P235, DOI 10.1023/A:1011990013955	56	26	26	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209664	10.1371/journal.pone.0209664	http://dx.doi.org/10.1371/journal.pone.0209664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589863	Green Published, gold, Green Submitted			2022-12-26	WOS:000454418200042
J	Mei, GX; Mamaeva, N; Ganapathy, S; Wang, P; DeGrip, WJ; Rothschild, KJ				Mei, Gaoxiang; Mamaeva, Natalia; Ganapathy, Srividya; Wang, Peng; DeGrip, Willem J.; Rothschild, Kenneth J.			Raman spectroscopy of a near infrared absorbing proteorhodopsin: Similarities to the bacteriorhodopsin O photointermediate	PLOS ONE			English	Article							RESONANCE RAMAN; RETINAL CHROMOPHORE; SENSORY RHODOPSIN; SCHIFF-BASE; ESCHERICHIA-COLI; ALL-TRANS; PRIMARY PHOTOPRODUCT; VIBRATIONAL ANALYSIS; DIFFERENCE SPECTRA; STRUCTURAL-CHANGES	Microbial rhodopsins have become an important tool in the field of optogenetics. However, effective in vivo optogenetics is in many cases severely limited due to the strong absorption and scattering of visible light by biological tissues. Recently, a combination of opsin sitedirected mutagenesis and analog retinal substitution has produced variants of proteorhodopsin which absorb maximally in the near-infrared (NIR). In this study, UV-Visible-NIR absorption and resonance Raman spectroscopy were used to study the double mutant, D212N/F234S, of green absorbing proteorhodopsin (GPR) regenerated with MMAR, a retinal analog containing a methylamino modified beta-ionone ring. Four distinct subcomponent absorption bands with peak maxima near 560, 620, 710 and 780 nm are detected with the NIR bands dominant at pH <7.3, and the visible bands dominant at pH 9.5. FT-Raman using 1064-nm excitation reveal two strong ethylenic bands at 1482 and 1498 cm(-1) corresponding to the NIR subcomponent absorption bands based on an extended linear correlation between lambda(max) and gamma(C = C). This spectrum exhibits two intense bands in the fingerprint and HOOP mode regions that are highly characteristic of the O-640 photointermediate from the light-adapted bacteriorhodopsin photocycle. In contrast, 532-nm excitation enhances the 560-nm component, which exhibits bands very similar to light-adapted bacteriorhodopsin and/or the acid-purple form of bacteriorhodopsin. Native GPR and its mutant D97N when regenerated with MMAR also exhibit similar absorption and Raman bands but with weaker contributions from the NIR absorbing components. Based on these results it is proposed that the NIR absorption in GPR-D212N/F234S with MMAR arises from an O-like chromophore, where the Schiff base counterion D97 is protonated and the MMAR adopts an all-trans configuration with a non-planar geometry due to twists in the conjugated polyene segment. This configuration is characterized by extensive charge delocalization, most likely involving nitrogens atoms in the MMAR chromophore.	[Mei, Gaoxiang; Mamaeva, Natalia; Rothschild, Kenneth J.] Boston Univ, Mol Biophys Lab, Photon Ctr, Boston, MA 02215 USA; [Mei, Gaoxiang; Mamaeva, Natalia; Rothschild, Kenneth J.] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [Ganapathy, Srividya; DeGrip, Willem J.] Leiden Univ AR, Leiden Inst Chem, Dept Biophys Organ Chem, Leiden, Netherlands; [Wang, Peng] Bruker Corp, Billerica, MA USA	Boston University; Boston University; Leiden University; Bruker Corporation	Rothschild, KJ (corresponding author), Boston Univ, Mol Biophys Lab, Photon Ctr, Boston, MA 02215 USA.; Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	kjr@bu.edu	Rothschild, Kenneth/P-6177-2018; DeGrip, Willem/L-4335-2015	Rothschild, Kenneth/0000-0002-2847-6671; DeGrip, Willem/0000-0001-7637-4920; Mei, Gaoxiang/0000-0002-1244-5694	National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems [CBET-1264434]; research program of BioSolar Cells (BSC Core Project Grant) [C2.9]; Dutch Ministry of Economic Affairs	National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems(National Science Foundation (NSF)); research program of BioSolar Cells (BSC Core Project Grant); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by the National Science Foundation Division of Chemical, Bioengineering, Environmental and Transport Systems, https://www.nsf.gov/div/index.jsp?div=CBET, Grant CBET-1264434 to KJR. WDJ and SG were supported by the research program of BioSolar Cells (BSC Core Project Grant C2.9), co-financed by the Dutch Ministry of Economic Affairs. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PW is an employee of Bruker Corporation. This funder provided support in the form of salary for PW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Argade PV, BIOMEMBRANES 1, P643; ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Bamann C, 2014, BBA-BIOENERGETICS, V1837, P614, DOI 10.1016/j.bbabio.2013.09.010; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bayraktar H, 2012, PHOTOCHEM PHOTOBIOL, V88, P90, DOI 10.1111/j.1751-1097.2011.01011.x; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bergo V, 2004, BIOCHEMISTRY-US, V43, P9075, DOI 10.1021/bi0361968; Bergo V, 2003, BIOPHYS J, V84, P960, DOI 10.1016/S0006-3495(03)74912-1; Bergo V, 2002, PHOTOCHEM PHOTOBIOL, V76, P341, DOI 10.1562/0031-8655(2002)076<0341:AFTISO>2.0.CO;2; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; BOGOMOLNI R A, 1974, Journal of Supramolecular Structure, V2, P775, DOI 10.1002/jss.400020520; BOUSCHE O, 1992, PHOTOCHEM PHOTOBIOL, V56, P1085, DOI 10.1111/j.1751-1097.1992.tb09732.x; Bovee-Geurts PHM, 2017, BBA-BIOENERGETICS, V1858, P118, DOI 10.1016/j.bbabio.2016.11.003; BRAIMAN M, 1980, BIOCHEMISTRY-US, V19, P5421, DOI 10.1021/bi00564a042; BRAIMAN M, 1982, P NATL ACAD SCI-BIOL, V79, P403, DOI 10.1073/pnas.79.2.403; BRAIMAN MS, 1988, ANNU REV BIOPHYS BIO, V17, P541; Brown LS, 2015, PROTEIN SCI, V24, P1333, DOI 10.1002/pro.2700; Brown LS, 1996, BIOCHEMISTRY-US, V35, P16048, DOI 10.1021/bi9622938; Bruni GN, 2017, P NATL ACAD SCI USA, V114, P9445, DOI 10.1073/pnas.1703084114; Chernov KG, 2017, CHEM REV, V117, P6423, DOI 10.1021/acs.chemrev.6b00700; DENG H, 1985, PHOTOCHEM PHOTOBIOL, V41, P467, DOI 10.1111/j.1751-1097.1985.tb03513.x; DERGUINI F, 1983, J AM CHEM SOC, V105, P646, DOI 10.1021/ja00341a068; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; DUNACH M, 1990, J BIOL CHEM, V265, P16978; EYRING G, 1980, BIOCHEMISTRY-US, V19, P2410, DOI 10.1021/bi00552a020; Fabian H, 2006, INFRARED SPECTRSCOPY; Facciotti MT, 2004, FEBS LETT, V564, P301, DOI 10.1016/S0014-5793(04)00208-X; Flytzanis NC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5894; FODOR SPA, 1989, J BIOL CHEM, V264, P18280; Furutani Y, 2006, BIOCHEMISTRY-US, V45, P11836, DOI 10.1021/bi0610597; Ganapathy S., 2018, THESIS; Ganapathy S, 2017, J AM CHEM SOC, V139, P2338, DOI 10.1021/jacs.6b11366; Ganapathy S, 2015, BIOCHEM J, V467, P333, DOI 10.1042/BJ20141210; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; HE YW, 1993, BIOCHEMISTRY-US, V32, P2282, DOI 10.1021/bi00060a021; Hempelmann F, 2011, J AM CHEM SOC, V133, P4645, DOI 10.1021/ja111116a; Herwig L, 2017, CELL CHEM BIOL, V24, P415, DOI 10.1016/j.chembiol.2017.02.008; Heyes CD, 2002, J BIOL CHEM, V277, P29437, DOI 10.1074/jbc.M203435200; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hontani Y, 2018, J PHYS CHEM LETT, V9, P6469, DOI 10.1021/acs.jpclett.8b02780; Horspool, 2003, CRC HDB ORGANIC PHOT; Ikeda D, 2007, BIOCHEMISTRY-US, V46, P5365, DOI 10.1021/bi700143g; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kajimoto K, 2017, J PHYS CHEM B, V121, P4431, DOI 10.1021/acs.jpcb.7b02421; Kandori H, 1997, BIOCHEMISTRY-US, V36, P5134, DOI 10.1021/bi9629788; Kim JYH, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-2; Kim SY, 2008, BBA-BIOENERGETICS, V1777, P504, DOI 10.1016/j.bbabio.2008.03.010; Kloppmann E, 2005, PROTEINS, V61, P953, DOI 10.1002/prot.20744; Kraj JM, 2008, BIOCHEMISTRY-US, V47, P3447, DOI 10.1021/bi7018964; Kralj JM, 2008, J PHYS CHEM B, V112, P11770, DOI 10.1021/jp802629e; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; KREBS MP, 1993, P NATL ACAD SCI USA, V90, P1987, DOI 10.1073/pnas.90.5.1987; Krebs RA, 2003, J PHYS CHEM B, V107, P7877, DOI 10.1021/jp034574c; Krebs Richard A, 2002, BMC Physiol, V2, P5, DOI 10.1186/1472-6793-2-5; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; LEWIS A, 1974, P NATL ACAD SCI USA, V71, P4462, DOI 10.1073/pnas.71.11.4462; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mohammed AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep20986; Muthyala R, 2001, PHOTOCHEM PHOTOBIOL, V74, P837, DOI 10.1562/0031-8655(2001)074<0837:TNOTDC>2.0.CO;2; MYERS AB, 1983, J CHEM PHYS, V79, P603, DOI 10.1063/1.445807; Nadeau JL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00315; Ni QZ, 2018, J AM CHEM SOC, V140, P4085, DOI 10.1021/jacs.8b00022; Nogly P, 2018, SCIENCE, V361, DOI 10.1126/science.aat0094; Ogren JI, 2014, BIOCHEMISTRY-US, V53, P3961, DOI 10.1021/bi500445c; Olson DK, 2018, ISME J, V12, P1047, DOI 10.1038/s41396-018-0074-4; PALINGS I, 1989, BIOCHEMISTRY-US, V28, P1498, DOI 10.1021/bi00430a012; PANDE C, 1985, PHOTOCHEM PHOTOBIOL, V42, P549, DOI 10.1111/j.1751-1097.1985.tb01608.x; PARKER FS, 1983, APPL INFRARED RAMAN; Piatkevich KD, 2018, NAT CHEM BIOL, V14, P352, DOI 10.1038/s41589-018-0004-9; Prince RC, 2017, CHEM REV, V117, P5070, DOI 10.1021/acs.chemrev.6b00545; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; RATH P, 1993, J BIOL CHEM, V268, P17742; RATH P, 1993, BIOCHEMISTRY-US, V32, P2272, DOI 10.1021/bi00060a020; Ren L, 2001, BIOCHEMISTRY-US, V40, P13906, DOI 10.1021/bi0116487; Richter HT, 1996, BIOCHEMISTRY-US, V35, P15461, DOI 10.1021/bi9612430; ROTHSCHILD KJ, 1979, BIOPHYS J, V25, P473, DOI 10.1016/S0006-3495(79)85317-5; ROTHSCHILD KJ, 1983, SCIENCE, V219, P1333, DOI 10.1126/science.6828860; ROTHSCHILD KJ, 1984, PHOTOCHEM PHOTOBIOL, V40, P675, DOI 10.1111/j.1751-1097.1984.tb05359.x; Rouhani S, 2001, J MOL BIOL, V313, P615, DOI 10.1006/jmbi.2001.5066; Saint Clair EC, 2012, J PHYS CHEM B, V116, P14592, DOI 10.1021/jp309996a; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; SAWATZKI J, 1990, P NATL ACAD SCI USA, V87, P5903, DOI 10.1073/pnas.87.15.5903; Shain WJ, 2018, BIOMED OPT EXPRESS, V9, P1771, DOI 10.1364/BOE.9.001771; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; SMITH SO, 1987, J AM CHEM SOC, V109, P3108, DOI 10.1021/ja00244a038; SMITH SO, 1983, BIOCHEMISTRY-US, V22, P6141, DOI 10.1021/bi00295a016; SMITH SO, 1985, BIOPHYS J, V47, P251, DOI 10.1016/S0006-3495(85)83899-6; SONAR S, 1993, BIOCHEMISTRY-US, V32, P2263, DOI 10.1021/bi00060a019; Song, 1995, CRC HDB ORGANIC PHOT, P1521; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; STOECKENIUS W, 1976, SCI AM, V234, P38, DOI 10.1038/scientificamerican0676-38; Tajkhorshid E, 2000, BIOPHYS J, V78, P683, DOI 10.1016/S0006-3495(00)76626-4; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Walter JM, 2010, CURR OPIN BIOTECH, V21, P265, DOI 10.1016/j.copbio.2010.03.007; Wang WJ, 2014, BIOESSAYS, V36, P65, DOI 10.1002/bies.201300094; Wang WJ, 2012, SCIENCE, V338, P1340, DOI 10.1126/science.1226135; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Xiao S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26240-8; Xu YX, 2017, CURR OPIN CHEM BIOL, V39, P1, DOI 10.1016/j.cbpa.2017.04.005; Yi A, 2016, BIOCHEMISTRY-US, V55, P2371, DOI 10.1021/acs.biochem.6b00104	102	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209506	10.1371/journal.pone.0209506	http://dx.doi.org/10.1371/journal.pone.0209506			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586409	Green Published, gold			2022-12-26	WOS:000454416400069
J	Sato, W; Ikeda, K; Urano, T; Abe, Y; Nakasato, N; Horie-Inoue, K; Takeda, S; Inoue, S				Sato, Wataru; Ikeda, Kazuhiro; Urano, Tomohiko; Abe, Yayoi; Nakasato, Norie; Horie-Inoue, Kuniko; Takeda, Satoru; Inoue, Satoshi			Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-kappa B signaling	PLOS ONE			English	Article							RESPONSIVE FINGER PROTEIN; E3 UBIQUITIN LIGASE; KINASE-C; EXPRESSION; ESTROGEN; TRIM25; 14-3-3-SIGMA; INFLAMMATION; CARCINOMA; IL-18	Endometrial cancer is common among postmenopausal women and its incidence is increasing in developed countries. Considering that >80% of endometrial cancers are assumed to be estrogen-related, higher estrogen exposure will be relevant to tumorigenesis. Therefore, the roles of estrogen target genes will be important to understand the pathophysiological mechanisms. We previously revealed that estrogen-responsive RING finger protein Efp contributes to breast cancer progression through the protein degradation of cell cycle checkpoint 14-3-3 sigma. We and others also proposed that Efp has tumor-promoting activities in estrogen receptor (ER)-negative cancer cells. In addition, Efp plays a role in type I interferon production by activating antiviral signaling, which provokes nuclear factor-kappa B (NF-kappa B) signaling. In the present study, we investigate whether Efp plays a critical role in endometrial cancer biology. We show that siRNA-mediated Efp knockdown represses the proliferation and migration of endometrial cancer ER-positive Ishikawa and ER-negative HEC-1A cells. Efp knockdown increases 14-3-3 sigma protein levels and decreases the rates proliferative stage cells. Efp siRNA significantly inhibits the in vivo tumor growth of endometrial cancer cells in both subcutaneous and orthotopic xenograft models. Intriguingly, Efp knockdown represses NF-kappa B-dependent transactivation and transcription of target genes, such as IL6ST and IL18, in endometrial cancer cells. Overall, Efp would exert a tumor-promoting role through modulating NF-kappa B pathway and 14-3-3 sigma protein degradation in endometrial cancer regardless of its estrogen receptor status. Our results indicate that Efp could be a potential diagnostic and therapeutic target for endometrial cancer.	[Sato, Wataru; Ikeda, Kazuhiro; Abe, Yayoi; Nakasato, Norie; Horie-Inoue, Kuniko; Inoue, Satoshi] Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Hidaka, Saitama, Japan; [Urano, Tomohiko] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Abe, Yayoi; Takeda, Satoru] Juntendo Univ, Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Nakasato, Norie; Takeda, Satoru] Saitama Med Univ, Dept Obstet & Gynecol, Saitama Med Ctr, Kawagoe, Saitama, Japan; [Inoue, Satoshi] Tokyo Metropolitan Inst Gerontol, Funct Biogerontol, Itabashi Ku, Tokyo, Japan	Saitama Medical University; University of Tokyo; Juntendo University; Saitama Medical University; Tokyo Metropolitan Institute of Gerontology	Inoue, S (corresponding author), Saitama Med Univ, Div Gene Regulat & Signal Transduct, Res Ctr Genom Med, Hidaka, Saitama, Japan.; Inoue, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Funct Biogerontol, Itabashi Ku, Tokyo, Japan.	sinoue07@saitama-med.ac.jp	Urano, Tomohiko/AFS-9574-2022	Urano, Tomohiko/0000-0002-1771-024X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Practical Research for Innovative Cancer Control [JP18ck0106194]; Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and Development, AMED; Japan Society for the Promotion of Science, Japan [16K09809, 15K15073, 26293223, 16K15496]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan; Takeda Science Foundation; Cell Innovation Program, Development of Innovative Research on Cancer Therapeutics (P-DIRECT)	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Practical Research for Innovative Cancer Control; Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Innovation Program, Development of Innovative Research on Cancer Therapeutics (P-DIRECT)	This work was partially supported by Grants of the Cell Innovation Program, Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Grants-in-Aid, and Support Project of Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by the Practical Research for Innovative Cancer Control (JP18ck0106194) and the Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and Development, AMED; by Grants from the Japan Society for the Promotion of Science, Japan (16K09809, 15K15073, 26293223, 16K15496); by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan; by the Takeda Science Foundation.; We thank for Dr. Yukikazu Natori (RNAi Co., Ltd.) for the technical advice. This work was partially supported by Grants of the Cell Innovation Program, Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Grants-in-Aid, and Support Project of Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by the Practical Research for Innovative Cancer Control (JP18ck0106194) and the Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED; by Grants from the Japan Society for the Promotion of Science, Japan (16K09809, 15K15073, 26293223, 16K15496); by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan; by the Takeda Science Foundation.	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Chandrasekar B, 2003, BIOCHEM BIOPH RES CO, V303, P1152, DOI 10.1016/S0006-291X(03)00496-0; Dai HY, 2010, ONCOL REP, V23, P795, DOI 10.3892/or_00000700; Dai HY, 2009, ONCOL REP, V21, P395, DOI 10.3892/or_00000235; Dong XY, 2012, BIOCHEM J, V444, P581, DOI 10.1042/BJ20111890; Fong P, 2014, MED SCI MONIT BASIC, V20, P146, DOI 10.12659/MSMBR.892514; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gao C, 2014, GYNECOL ONCOL, V134, P190, DOI 10.1016/j.ygyno.2014.04.060; Guo XJ, 2016, CLIN CANCER RES, V22, P5939, DOI 10.1158/1078-0432.CCR-15-1144; Hochner-Celnikier D, 1997, MOL HUM REPROD, V3, P1019, DOI 10.1093/molehr/3.12.1019; Ikeda K, 1997, BIOCHEM BIOPH RES CO, V236, P765, DOI 10.1006/bbrc.1997.7046; Ikeda K, 2012, ADV EXP MED BIOL, V770, P27; Ikeda Y, 2015, BRIT J CANCER, V113, P1477, DOI 10.1038/bjc.2015.369; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Ito K, 2005, CLIN CANCER RES, V11, P7384, DOI 10.1158/1078-0432.CCR-05-0187; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kojima H, 1999, J IMMUNOL, V162, P5063; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Nakajima A, 2007, BIOCHEM BIOPH RES CO, V357, P245, DOI 10.1016/j.bbrc.2007.03.134; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; ORIMO A, 1995, J BIOL CHEM, V270, P24406, DOI 10.1074/jbc.270.41.24406; Orimo A, 1999, P NATL ACAD SCI USA, V96, P12027, DOI 10.1073/pnas.96.21.12027; Park IH, 2017, ONCOTARGET, V8, P32722, DOI 10.18632/oncotarget.16281; Qin Y, 2016, TECHNOL CANCER RES T, V15, P707, DOI 10.1177/1533034615595903; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Rouette A, 2012, INT J CANCER, V130, P1755, DOI 10.1002/ijc.26183; Sakuma M, 2005, GYNECOL ONCOL, V99, P664, DOI 10.1016/j.ygyno.2005.07.103; Saso S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3954; Steiner M, 2012, GYNECOL ONCOL, V127, P231, DOI 10.1016/j.ygyno.2012.06.039; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki T, 2005, CLIN CANCER RES, V11, P6148, DOI 10.1158/1078-0432.CCR-05-0040; Takayama K, 2018, ONCOGENE, V37, P2165, DOI 10.1038/s41388-017-0095-x; Tierney BJ, 2014, GYNECOL ONCOL, V135, P133, DOI 10.1016/j.ygyno.2014.07.087; Ueyama K, 2010, CANCER GENE THER, V17, P624, DOI 10.1038/cgt.2010.19; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Wallace AE, 2010, J ENDOCRINOL, V206, P141, DOI 10.1677/JOE-10-0072; Walsh LA, 2017, CELL REP, V20, P1623, DOI 10.1016/j.celrep.2017.07.052; Xu S, EXPERT OPIN THER TAR, V17, P1303; Yang Y, 2015, BIOCHEM BIOPH RES CO, V459, P379, DOI 10.1016/j.bbrc.2015.02.108; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang P, 2015, ONCOGENE, V34, P5729, DOI 10.1038/onc.2015.21; Zhao KW, 2011, BIOCHEM J, V437, P323, DOI 10.1042/BJ20101388; Zhu ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19070	48	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208351	10.1371/journal.pone.0208351	http://dx.doi.org/10.1371/journal.pone.0208351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586414	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400017
J	Schubert, MC; Gimmon, Y; Millar, J; Brewer, KJ; Roberts, D; Shelhamer, M; Rohde, C; Serrador, JM				Schubert, Michael C.; Gimmon, Yoav; Millar, Jennifer; Brewer, Kelly J.; Roberts, Dale; Shelhamer, Mark; Rohde, Charles; Serrador, Jorge M.			Veterans have greater variability in their perception of binocular alignment	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SKEW DEVIATION; OLDER-ADULTS; HEAD; FALLS; GAIT; PROBABILITY; SPECIFICITY; RELIABILITY; SENSITIVITY	Introduction A significant population of our wounded veterans suffer long-term functional consequences of visual deficit, disorientation, dizziness, and an impaired ability to read. These symptoms may be related to damage within the otolith pathways that contribute to ocular alignment. The purpose of this study was to compare perception of vertical and torsional ocular alignment between veterans and healthy controls in an upright and supine test position. Materials and methods Veterans (n = 26) with reports of dizziness were recruited from the East Orange Veterans Administration Hospital. Healthy controls (n = 26) were recruited from both Johns Hopkins University and the East Orange VA. Each subject performed 20 trials each of a novel vertical and torsional binocular alignment perception test. Veterans underwent semicircular canal and otolith pathway function testing. Results 88% of the Veterans had an absent otolith response. Only the veterans had an abnormally large variability in perception of both vertical and torsional ocular alignment, and in both upright and supine position. Neither post-traumatic stress disorder, nor depression contributed to the misperception in binocular alignment. Conclusions Our novel method of measuring vertical and torsional misalignment distinguishes veterans with dizziness from healthy controls. The high prevalence of absent otolith function seems to explain this result. Further studies are needed to better understand the fundamental mechanism responsible for the increased variability of perception of binocular alignment.	[Schubert, Michael C.; Gimmon, Yoav; Shelhamer, Mark] Dept Otolaryngol Head & Neck Surg, Lab Vestibular NeuroAdaptat, Baltimore, MD 21287 USA; [Schubert, Michael C.; Millar, Jennifer] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Brewer, Kelly J.; Serrador, Jorge M.] Dept Vet Affairs, War Related Illness & Injury Study Ctr, Ventnor City, NJ USA; [Roberts, Dale] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rohde, Charles] Johns Hopkins Univ, Sch Med, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Serrador, Jorge M.] Rutgers Sch Grad Studies, Dept Pharmacol Physiol & Neurosci, New Jersey Med Sch, Newark, NJ USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rutgers State University New Brunswick; Rutgers State University Medical Center	Schubert, MC (corresponding author), Dept Otolaryngol Head & Neck Surg, Lab Vestibular NeuroAdaptat, Baltimore, MD 21287 USA.; Schubert, MC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA.	mschube1@jhmi.edu		schubert, michael/0000-0002-5975-374X	Department of Defense under the Neurosensory and Rehabilitation Research Award Program [W81XWH-15-1-0442]	Department of Defense under the Neurosensory and Rehabilitation Research Award Program(United States Department of Defense)	Michael C Schubert was funded by the Department of Defense under the Neurosensory and Rehabilitation Research Award Program (Grant award #W81XWH-15-1-0442). The sponsors had no role in study design, data collection, data analysis, decision to publish, or manuscript publication. http://cdmrp.army.mil/funding/dmrdp.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; Beaton KH, 2017, J NEUROSCI METH, V283, P7, DOI 10.1016/j.jneumeth.2017.03.009; Beaton KH, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00081; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bohannon RW, 2015, ARCH PHYS MED REHAB, V96, P472, DOI 10.1016/j.apmr.2014.10.006; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; BRANDT T, 1994, ANN NEUROL, V36, P337, DOI 10.1002/ana.410360304; Brodsky MC, 2006, SURV OPHTHALMOL, V51, P105, DOI 10.1016/j.survophthal.2005.12.008; Buster TW, 2016, BRAIN INJURY, V30, P1249, DOI 10.1080/02699052.2016.1183822; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen HS, 2014, J VESTIBUL RES-EQUIL, V24, P33, DOI 10.3233/VES-130475; Defense and Veterans Brain Injury Center, 2009, TBI FACTS; Defense Veterans Brain Injury Center, 2008, OIF OEF FACT SHEET; Dobie DJ, 2006, J GEN INTERNAL ME S3, V21, P64, DOI [10.1111/j.1525-1497.2006, DOI 10.1111/J.1525-1497.2006]; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Guimaraes R M, 1980, Int Rehabil Med, V2, P177; HALMAGYI GM, 1995, NEUROLOGY, V45, P1927, DOI 10.1212/WNL.45.10.1927; HALMAGYI GM, 1979, ANN NEUROL, V6, P80, DOI 10.1002/ana.410060122; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Nguyen KD, 2010, OTOL NEUROTOL, V31, P793, DOI 10.1097/MAO.0b013e3181e3d60e; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Roland PS, 2000, OTOLARYNG HEAD NECK, V122, P319, DOI 10.1016/S0194-5998(00)70041-6; Rustemeyer J, 2007, BRIT J ORAL MAX SURG, V45, P556, DOI 10.1016/j.bjoms.2007.01.003; Sadeghi H, 2003, GAIT POSTURE, V17, P197, DOI 10.1016/S0966-6362(02)00089-9; Schubert MC, 2017, J VESTIBUL RES-EQUIL, V27, P173, DOI 10.3233/VES-170618; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whitney SL, 2004, J VESTIBUL RES-EQUIL, V14, P397; Wong AMF, 2011, ARCH OPHTHALMOL-CHIC, V129, P1570, DOI 10.1001/archophthalmol.2011.335; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; Yorke A., 2013, ARCH PHYS MED REHAB, V94, P2313, DOI [10.1016/j.apmr.2013.07.007, DOI 10.1016/J.APMR.2013.07.007]; YOUNG ED, 1977, ACTA OTO-LARYNGOL, V84, P352, DOI 10.3109/00016487709123977; Zamyslowska-Szmytke E, 2011, J OCCUP ENVIRON MED, V53, P441, DOI 10.1097/JOM.0b013e3182143f46	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209622	10.1371/journal.pone.0209622	http://dx.doi.org/10.1371/journal.pone.0209622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586453	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400078
J	Suzuki, A; Ito, M; Hamaguchi, T; Mori, H; Takeda, Y; Baba, R; Watanabe, T; Kurokawa, K; Asakawa, S; Hirayama, M; Ohno, K				Suzuki, Anzu; Ito, Mikako; Hamaguchi, Tomonori; Mori, Hiroshi; Takeda, Yuka; Baba, Ryuko; Watanabe, Takeshi; Kurokawa, Ken; Asakawa, Susumu; Hirayama, Masaaki; Ohno, Kinji			Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease	PLOS ONE			English	Article							HUMAN FECAL MICROBIOTA; GUT MICROBIOTA; MOLECULAR-HYDROGEN; DOUBLE-BLIND; INJURY; GAS; H-2; METABOLISM; EXPRESSION; LACTULOSE	Oral administration of hydrogen water ameliorates Parkinson's disease (PD) in rats, mice, and humans. We previously reported that the number of putative hydrogen-producing bacteria in intestinal microbiota is low in PD compared to controls. We also reported that the amount of hydrogen produced by ingestion of lactulose is low in PD patients. The decreased hydrogen production by intestinal microbiota may be associated with the development and progression of PD. We measured the amount of hydrogen production using gas chromatography by seven bacterial strains, which represented seven major intestinal bacterial groups/genera/species. Blautia coccoides and Clostridium leptum produced the largest amount of hydrogen. Escherichia coli and Bacteroides fragilis constituted the second group that produced hydrogen 34- to 93-fold lower than B. coccoides. Bifidobacterium pseudocatenulatum and Atopobium parvulum constituted the third group that produced hydrogen 559- to 2164-fold lower than B. coccoides. Lactobacillus casei produced no detectable hydrogen. Assuming that taxonomically neighboring strains have similar hydrogen production, we simulated hydrogen production using intestinal microbiota that we previously reported, and found that PD patients produce a 2.2-fold lower amount of intestinal hydrogen compared to controls. The lower amount of intestinal hydrogen production in PD was also simulated in cohorts of two other countries. The number of hydrogen-producing intestinal bacteria may be associated with the development and progression of PD. Further studies are required to prove its beneficial effect.	[Suzuki, Anzu; Ito, Mikako; Hamaguchi, Tomonori; Ohno, Kinji] Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi, Japan; [Suzuki, Anzu; Takeda, Yuka; Hirayama, Masaaki] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Mori, Hiroshi; Kurokawa, Ken] Natl Inst Genet, Ctr Informat Biol, Genome Evolut Lab, Mishima, Shizuoka, Japan; [Baba, Ryuko; Watanabe, Takeshi; Asakawa, Susumu] Nagoya Univ, Dept Biol Mech & Funct, Lab Soil Biol & Chem, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Nagoya University	Ohno, K (corresponding author), Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi, Japan.	ohnok@med.nagoya-u.ac.jp	Hirayama, Masaaki/ABH-2669-2020; Ito, Mikako/I-1941-2012; Hirayama, Masaaki/I-9341-2018; Watanabe, Takeshi/I-6887-2014	Hirayama, Masaaki/0000-0003-0092-7837; Mori, Hiroshi/0000-0003-0806-7704; Watanabe, Takeshi/0000-0001-5476-5648; Ito, Mikako/0000-0002-1351-7602	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW); Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Ministry of Health, Labor and Welfare (MHLW), and the Japan Agency for Medical Research and Development (AMED).	Aguirre M, 2017, BENEF MICROBES, V8, P31, DOI 10.3920/BM2016.0113; Aoki K, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-12; Baba R, 2016, MICROBES ENVIRON, V31, P226, DOI 10.1264/jsme2.ME16036; Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y; BIRCHER J, 1966, LANCET, V1, P890; Braak H, 2002, J NEUROL S3, V249; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; Carbonero F, 2012, NAT REV GASTRO HEPAT, V9, P504, DOI 10.1038/nrgastro.2012.85; CHRISTL SU, 1992, GASTROENTEROLOGY, V102, P1269; Eckermann JM, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-7; Farahmand Fatemeh, 2016, Acta Med Iran, V54, P614; FLORENT C, 1985, J CLIN INVEST, V75, P608, DOI 10.1172/JCI111738; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fugelsang KC, 2007, LACTIC ACID BACTERIA; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Greening C, 2016, ISME J, V10, P761, DOI 10.1038/ismej.2015.153; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Hayashi H, 2006, FEMS MICROBIOL LETT, V257, P202, DOI 10.1111/j.1574-6968.2006.00171.x; Heintz-Buschart A, 2018, MOVEMENT DISORD, V33, P88, DOI 10.1002/mds.27105; Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942; Ichihara M, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0035-1; Ito M, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-15; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Li DZ, 2014, J BONE MINER METAB, V32, P494, DOI 10.1007/s00774-013-0530-1; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Li Y, 2015, SHOCK, V44, P90, DOI 10.1097/SHK.0000000000000382; Li Y, 2015, J SURG RES, V196, P136, DOI 10.1016/j.jss.2015.02.042; Liao CH, 2001, CHEMOSPHERE, V44, P1193, DOI 10.1016/S0045-6535(00)00278-2; Liu BJ, 2017, NEUROLOGY, V88, P1996, DOI 10.1212/WNL.0000000000003961; MASUDA T, 1973, Journal of Radiation Research, V14, P339, DOI 10.1269/jrr.14.339; Matchett GA, 2009, BRAIN RES, V1259, P90, DOI 10.1016/j.brainres.2008.12.066; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; McDowall JS, 2014, P NATL ACAD SCI USA, V111, pE3948, DOI 10.1073/pnas.1407927111; Minato T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187307; Murakami Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176992; Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002; Nishiwaki H, 2018, FREE RADICAL RES, V52, P434, DOI 10.1080/10715762.2018.1439166; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Okai S, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.103, 10.1038/nmicrobiol.2016.103]; Perlamutrov Yuri N., 2016, Microbial Ecology in Health and Disease, V27, P30418, DOI 10.3402/mehd.v27.30418; Peters JW, 2015, BBA-MOL CELL RES, V1853, P1350, DOI 10.1016/j.bbamcr.2014.11.021; Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Sobue S, 2017, BIOCHEM BIOPH RES CO, V493, P318, DOI 10.1016/j.bbrc.2017.09.024; Sondergaard D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34212; Song GH, 2015, FREE RADICAL BIO MED, V87, P58, DOI 10.1016/j.freeradbiomed.2015.06.018; Spulber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042078; STROCCHI A, 1992, GASTROENTEROLOGY, V102, P1424, DOI 10.1016/0016-5085(92)90790-6; Svensson E, 2015, ANN NEUROL, V78, P522, DOI 10.1002/ana.24448; Tolosa E, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e318198dace; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Van de Wiele T., 2015, IMPACT FOOD BIOACTIV, P305, DOI [10.1007/978-3-319-16104-4, DOI 10.1007/978-3-319-16104-4_27]; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Voskuijl W, 2004, GUT, V53, P1590, DOI 10.1136/gut.2004.043620; Wolf PG, 2016, GUT MICROBES, V7, P235, DOI 10.1080/19490976.2016.1182288; Xie Q, 2014, MOL MED REP, V10, P1143, DOI 10.3892/mmr.2014.2283; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yoritaka A, 2013, MOVEMENT DISORD, V28, P836, DOI 10.1002/mds.25375; Zhai X, 2013, FREE RADICAL BIO MED, V65, P731, DOI 10.1016/j.freeradbiomed.2013.08.004	67	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208313	10.1371/journal.pone.0208313	http://dx.doi.org/10.1371/journal.pone.0208313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586410	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400015
J	Liu, YG; Teng, YS; Cheng, P; Kong, H; Lv, YP; Mao, FY; Wu, XL; Hao, CJ; Chen, WS; Yang, SM; Zhang, JY; Peng, LS; Wang, TT; Han, B; Ma, Q; Zou, QM; Zhuang, Y				Liu, Yu Gang; Teng, Yong Sheng; Cheng, Ping; Kong, Hui; Lv, Yi Pin; Mao, Fang Yuan; Wu, Xiao Long; Hao, Chuan Jie; Chen, Weisan; Yang, Shi Ming; Zhang, Jin Yu; Peng, Liu Sheng; Wang, Ting Ting; Han, Bin; Ma, Qiang; Zou, Quan Ming; Zhuang, Yuan			Abrogation of cathepsin C by Helicobacter pylori impairs neutrophil activation to promote gastric infection	FASEB JOURNAL			English	Article						CtsC; gastric epithelial cells; cagA; TGF-beta 1	DIPEPTIDYL-PEPTIDASE-I; EPITHELIAL-CELLS; SERINE PROTEASES; B ACTIVATION; H. PYLORI; NK CELL; CAGA; EXPRESSION; PROTEIN; TGF-BETA-1	Cathepsin C (CtsC) functions as a central coordinator for activation of many serine proteases in immune cells. However, CtsC expression in gastric epithelial cells and its role in Helicobacter pylori infection remain unclear. Real-time PCR, Western blot, and immunohistochemistry analyses identified that CtsC was decreased in gastric mucosa of H. pylori-infected patients and mice. Isolated gastric epithelial cells and cell lines were stimulated with H. pylori and/or TGF-beta 1 showed that down-regulation of CtsC in gastric epithelial cells largely depended on H. pylori cagA via Src/ERK and Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathways, and the effect could be synergistically augmented by TGF-beta 1 in an autocrine manner. In human gastric mucosa, CtsC expression was negatively correlated with bacteria colonization; accordingly, provision of exogenous active CtsC overwhelmed H. pylori persistence in gastric mucosa of mice. In the presence of active CtsC, isolated human neutrophils activated via NF-kappa B pathway with augmented bactericidal capacity in vitro. We also found that neutrophils activated and cleared bacteria in active CtsC-injected mice and that there was no bactericidal capacity in mice that were simultaneously neutrophil-depleted by Ly6G antibody. Our findings identified a mechanism that H. pylori abrogate CtsC to impair neutrophil activation and to ensure persistence in gastric mucosa. Efforts to enable and boost this neutrophil activation pathway by active CtsC may therefore become valuable strategies in treating H. pylori infection.	[Liu, Yu Gang; Teng, Yong Sheng; Cheng, Ping; Kong, Hui; Lv, Yi Pin; Mao, Fang Yuan; Wu, Xiao Long; Hao, Chuan Jie; Zhang, Jin Yu; Peng, Liu Sheng; Wang, Ting Ting; Zou, Quan Ming; Zhuang, Yuan] Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Yang, Shi Ming] Third Mil Med Univ, Dept Gastroenterol, XinQiao Hosp, Chongqing, Peoples R China; [Chen, Weisan] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Han, Bin] North Sichuan Med Coll, Affiliated Hosp, Dept Pharm, Nanchong, Peoples R China; [Ma, Qiang] North Sichuan Med Coll, Affiliated Hosp, Dept Clin Lab, Nanchong, Peoples R China	Army Medical University; Army Medical University; La Trobe University; North Sichuan Medical University; North Sichuan Medical University	Zou, QM; Zhuang, Y (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	qmzou@tmmu.edu.cn; yuanzhuang1983@yahoo.com	wang, tingting/AAK-2640-2020; Teng, Yong-sheng/CAG-8033-2022; Chen, Weisan/E-7828-2012; Mao, Fangyuan/CAF-1614-2022	Chen, Weisan/0000-0002-5221-9771; 	National Natural Science Foundation of China [81870394]; National Key Research and Development Program of China [2016YFC1302200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Yong-Liang Zhao (Xinan Hospital, Chongqing, China), Gang Guo (Third Military Medical University), and Lijuan Wu (General Hospital of Western Theater Command, Chengdu, China) for their helpful comments and constructive suggestions; Jia Han (Dianjiang County Hospital of Traditional Chinese Medicine, Chongqing, China) for his help in obtaining fresh nontumor gastric tissues; Xin Liu (Second Affiliated Hospital of Kunming Medical University, Kunming, China) and Rui Zhang (General Hospital of Western Theater Command) for their involvement in experiments and statistical analysis of the revised manuscript; and Dan Li (Guangdong University of Foreign Studies, Guangzhou, China) for her language revision. This work was funded by the National Natural Science Foundation of China (Grant 81870394) and National Key Research and Development Program of China (Grant 2016YFC1302200). The authors declare no conflicts of interest.	Abdoh Qusay, 2018, Lancet, V391 Suppl 2, pS32, DOI 10.1016/S0140-6736(18)30398-2; Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Akk AM, 2008, J IMMUNOL, V180, P3535, DOI 10.4049/jimmunol.180.5.3535; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Andoniou CE, 2011, IMMUNOL CELL BIOL, V89, P540, DOI 10.1038/icb.2010.115; Bauer B, 2012, CELL HOST MICROBE, V11, P576, DOI 10.1016/j.chom.2012.04.013; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Fan K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-96; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Gerber A, 2001, J INTERF CYTOK RES, V21, P11, DOI 10.1089/107999001459114; Hamon Y, 2016, J BIOL CHEM, V291, P8486, DOI 10.1074/jbc.M115.707109; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Jo Y, 2010, GUT LIVER, V4, P43, DOI 10.5009/gnl.2010.4.1.43; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Korkmaz B, 2009, J BIOL CHEM, V284, P19896, DOI 10.1074/jbc.M901471200; Krueger S, 2009, J PATHOL, V217, P581, DOI 10.1002/path.2485; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Liu ZH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15196; Liu ZF, 2012, J CELL BIOCHEM, V113, P1080, DOI 10.1002/jcb.23440; Lv YP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0493-1; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Meade JL, 2006, BLOOD, V107, P3665, DOI 10.1182/blood-2005-03-1140; Mikula M, 2003, J MICROBIOL METH, V55, P351, DOI 10.1016/S0167-7012(03)00166-0; Moghaddasian M, 2014, GENE, V538, P182, DOI 10.1016/j.gene.2013.11.079; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pagano MB, 2007, P NATL ACAD SCI USA, V104, P2855, DOI 10.1073/pnas.0606091104; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rahimian G, 2014, MICROB PATHOGENESIS, V67-68, P1, DOI 10.1016/j.micpath.2013.12.006; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Ramarao N, 2000, MOL MICROBIOL, V37, P1389, DOI 10.1046/j.1365-2958.2000.02089.x; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Roussel Y, 2005, J MICROBIOL METH, V62, P71, DOI 10.1016/j.mimet.2005.01.011; Ruffell B, 2013, GENE DEV, V27, P2086, DOI 10.1101/gad.224899.113; Shao LL, 2019, FASEB J, V33, P264, DOI 10.1096/fj.201701456RR; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Suban D, 2012, BIOCHIMIE, V94, P719, DOI 10.1016/j.biochi.2011.10.018; Sutherland RE, 2014, BIOCHEM BIOPH RES CO, V450, P818, DOI 10.1016/j.bbrc.2014.06.062; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Tsai CC, 2015, VIRULENCE, V6, P755, DOI 10.1080/21505594.2015.1043505; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Ueha S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00071; Wei LM, 2014, PATHOG DIS, V72, P45, DOI 10.1111/2049-632X.12182; Whitmore LC, 2017, J IMMUNOL, V198, P1793, DOI 10.4049/jimmunol.1601292; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Wu MS, 2007, J INFECT DIS, V196, P1386, DOI 10.1086/522520; Wu ZQ, 2015, NUCLEIC ACIDS RES, V43, P3167, DOI 10.1093/nar/gkv161; Yong X, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0111-0	61	7	8	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5018	5033		10.1096/fj.201802016RR	http://dx.doi.org/10.1096/fj.201802016RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596522	Bronze			2022-12-26	WOS:000462888500031
J	Wu, CH; Silvers, CR; Messing, EM; Lee, YF				Wu, Chia-Hao; Silvers, Christopher R.; Messing, Edward M.; Lee, Yi-Fen			Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); extracellular vesicles; inflammation; cytokine; unfolded protein response (UPR); exosome (vesicle); bladder cancer; cell stress; extracellular vesicles; filed cancerization; urothelial carcinoma	ER STRESS; IN-VITRO; EXOSOMES; INHIBITOR; PROMOTES; INFLAMMATION; GROWTH; ACID; DHA	The field cancerization effect has been proposed to explain bladder cancer's multifocal and recurrent nature, yet the mechanisms of this effect remain unknown. In this work, using cell biology, flow cytometry, and qPCR analyses, along with a xenograft mouse tumor model, we show that chronic exposure to tumor-derived extracellular vesicles (TEVs) results in the neoplastic transformation of nonmalignant human SV-HUC urothelial cells. Inhibition of EV uptake prevented this transformation. Transformed cells not only possessed several oncogenic properties, such as increased genome instability, loss of cell-cell contact inhibition, and invasiveness, but also displayed altered morphology and cell structures, such as an enlarged cytoplasm with disrupted endoplasmic reticulum (ER) alignment and the accumulation of smaller mitochondria. Exposure of SV-HUC cells to TEVs provoked the unfolded protein response in the endoplasmic reticulum (UPRER). Prolonged induction of UPRER signaling activated the survival branch of the UPRER pathway, in which cells had elevated expression of inositol-requiring enzyme 1 (IRE1), NF-B, and the inflammatory cytokine leptin, and incurred loss of the pro-apoptotic protein C/EBP homologous protein (CHOP). More importantly, inhibition of ER stress by docosahexaenoic acid prevented TEV-induced transformation. We propose that TEVs promote malignant transformation of predisposed cells by inhibiting pro-apoptotic signals and activating tumor-promoting ER stress-induced unfolded protein response and inflammation. This study provides detailed insight into the mechanisms underlying the bladder cancer field effect and tumor recurrence.	[Wu, Chia-Hao; Lee, Yi-Fen] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Silvers, Christopher R.; Messing, Edward M.; Lee, Yi-Fen] Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Lee, YF (corresponding author), Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	yifen_lee@urmc.rochester.edu			NCI, National Institutes of Health [R01 CA173986]; NATIONAL CANCER INSTITUTE [R01CA173986] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NCI, National Institutes of Health Grant R01 CA173986 (to Y.-F. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abd Elmageed ZY, 2014, STEM CELLS, V32, P983, DOI 10.1002/stem.1619; Abdollah F, 2013, CANCER EPIDEMIOL, V37, P219, DOI 10.1016/j.canep.2013.02.002; ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Beckham CJ, 2014, J UROLOGY, V192, P583, DOI 10.1016/j.juro.2014.02.035; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Chen C, 2017, CANCER LETT, V388, P21, DOI 10.1016/j.canlet.2016.11.027; Choi D, 2017, SEMIN CELL DEV BIOL, V67, P11, DOI 10.1016/j.semcdb.2017.01.003; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cianciulli AM, 2003, HUM PATHOL, V34, P214, DOI 10.1053/hupa.2003.30; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; D'Eliseo D, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020015; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dutta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097580; Felicetti F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0811-2; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Griffiths SG, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5040025; Hamam D, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0360-9; Heusermann W, 2016, J CELL BIOL, V213, P173, DOI 10.1083/jcb.201506084; Javeed N, 2015, CLIN CANCER RES, V21, P1722, DOI 10.1158/1078-0432.CCR-14-2022; JENSEN KLD, 1992, ULTRASTRUCT PATHOL, V16, P51, DOI 10.3109/01913129209074550; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Kanada M, 2016, TRENDS CANCER, V2, P84, DOI 10.1016/j.trecan.2015.12.005; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kreger BT, 2016, J BIOL CHEM, V291, P19774, DOI 10.1074/jbc.M116.725705; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Lobb RJ, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600432; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maia J, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00018; Marleau AM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-134; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Michell AR, 2008, ANNU REV PHYSIOL, V70, P379, DOI 10.1146/annurev.physiol.69.040705.141330; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Parada B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/368178; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Richards KE, 2017, ONCOGENE, V36, P1770, DOI 10.1038/onc.2016.353; Said N, 2013, J CLIN INVEST, V123, P751, DOI 10.1172/JCI64782; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Segditsas S, 2009, ONCOGENE, V28, P146, DOI 10.1038/onc.2008.361; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Silvers CR, 2017, ONCOTARGET, V8, P91199, DOI 10.18632/oncotarget.20043; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Steinbichler TB, 2017, SEMIN CANCER BIOL, V44, P170, DOI 10.1016/j.semcancer.2017.02.006; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tuzesi A, 2017, ONCOTARGET, V8, P90164, DOI 10.18632/oncotarget.21621; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75	62	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3207	3218		10.1074/jbc.RA118.006682	http://dx.doi.org/10.1074/jbc.RA118.006682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593508	Green Published, hybrid			2022-12-26	WOS:000464980100019
J	Kelsall, IR; Kristariyanto, YA; Knebel, A; Wood, NT; Kulathu, Y; Alpi, AF				Kelsall, Ian R.; Kristariyanto, Yosua A.; Knebel, Axel; Wood, Nicola T.; Kulathu, Yogesh; Alpi, Arno F.			Coupled monoubiquitylation of the co-E3 ligase DCNL1 by Ariadne-RBR E3 ubiquitin ligases promotes cullin-RING ligase complex remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification; ubiquitin; ubiquitin ligase; ubiquitylation (ubiquitination); cell signaling; ARIH1; ARIH2; coupled monoubiquitylation; DCNL1; NEDD8 E3 ligase	CONJUGATING ENZYMES; STRUCTURAL BASIS; MECHANISM; LIGATION; BINDING; SCF; SUBSTRATE; FAMILY; NEDDYLATION; SPECIFICITY	Cullin-RING E3 ubiquitin ligases (CRLs) are large and diverse multisubunit protein complexes that contribute to about one-fifth of ubiquitin-dependent protein turnover in cells. CRLs are activated by the attachment of the ubiquitin-like protein neural precursor cell expressed, developmentally down-regulated 8 (NEDD8) to the cullin subunits. This cullin neddylation is essential for a plethora of CRL-regulated cellular processes and is vital for life. In mammals, neddylation is promoted by the five co-E3 ligases, defective in cullin neddylation 1 domain-containing 1-5 (DCNL1-5); however, their functional regulation within the CRL complex remains elusive. We found here that the ubiquitin-associated (UBA) domain-containing DCNL1 is monoubiquitylated when bound to CRLs and that this monoubiquitylation depends on the CRL-associated Ariadne RBR ligases TRIAD1 (ARIH2) and HHARI (ARIH1) and strictly requires the DCNL1's UBA domain. Reconstitution of DCNL1 monoubiquitylation in vitro revealed that autoubiquitylated TRIAD1 mediates binding to the UBA domain and subsequently promotes a single ubiquitin attachment to DCNL1 in a mechanism previously dubbed coupled monoubiquitylation. Moreover, we provide evidence that DCNL1 monoubiquitylation is required for efficient CRL activity, most likely by remodeling CRLs and their substrate receptors. Collectively, this work identifies DCNL1 as a critical target of Ariadne RBR ligases and coupled monoubiquitylation of DCNL1 as an integrated mechanism that affects CRL activity and client-substrate ubiquitylation at multiple levels.	[Kelsall, Ian R.; Kristariyanto, Yosua A.; Knebel, Axel; Wood, Nicola T.; Kulathu, Yogesh; Alpi, Arno F.] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland	University of Dundee	Alpi, AF (corresponding author), Max Planck Inst Biochem, Dept Mol Machines & Signaling, D-82152 Martinsried, Germany.	aalpi@biochem.mpg.de		Knebel, Axel/0000-0002-9197-6054; Wood, Nicola/0000-0002-3347-6625; Alpi, Arno/0000-0002-9572-7266; Kelsall, Ian/0000-0002-7501-6504	RCUK; Medical Research Council; Max-Planck-Gesellschaft; MRC [MC_UU_00018/3, MC_UU_12016/6] Funding Source: UKRI	RCUK(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Max-Planck-Gesellschaft(Max Planck Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by RCUK, Medical Research Council, and Max-Planck-Gesellschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Alpi AF, 2016, BIOCHEM J, V473, P3401, DOI 10.1042/BCJ20160028; Bandau S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-36; Broderick SR, 2010, NEOPLASIA, V12, P476, DOI 10.1593/neo.10202; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Dove KK, 2017, P NATL ACAD SCI USA, V114, pE6576, DOI 10.1073/pnas.1705060114; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Heir P, 2013, MOL CELL BIOL, V33, P1621, DOI 10.1128/MCB.01342-12; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hoeller D, 2010, SUBCELL BIOCHEM, V54, P31, DOI 10.1007/978-1-4419-6676-6_3; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang G, 2015, J BIOL CHEM, V290, P296, DOI 10.1074/jbc.M114.560169; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Keuss MJ, 2016, J CELL SCI, V129, P1441, DOI 10.1242/jcs.181784; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kristariyanto YA, 2015, MOL CELL, V58, P83, DOI 10.1016/j.molcel.2015.01.041; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Reitsma JM, 2017, CELL, V171, P1326, DOI 10.1016/j.cell.2017.10.016; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2017, NAT CHEM BIOL, V13, P850, DOI 10.1038/nchembio.2386; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Straube R, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005869; Thomas Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199197; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou HB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01243-7; Ziemba A, 2013, J BIOL CHEM, V288, P34882, DOI 10.1074/jbc.M113.509190	50	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2651	2664		10.1074/jbc.RA118.005861	http://dx.doi.org/10.1074/jbc.RA118.005861			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30587576	Green Published, hybrid			2022-12-26	WOS:000459601600008
J	Zarzo-Arias, A; Penteriani, V; Delgado, MD; Torre, PP; Garcia-Gonzalez, R; Mateo-Sanchez, MC; Garcia, PV; Dalerum, F				Zarzo-Arias, Alejandra; Penteriani, Vincenzo; del Mar Delgado, Maria; Peon Torre, Paloma; Garcia-Gonzalez, Ricardo; Cruz Mateo-Sanchez, Maria; Vazquez Garcia, Pablo; Dalerum, Fredrik			Identifying potential areas of expansion for the endangered brown bear (Ursus arctos) population in the Cantabrian Mountains (NW Spain)	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; LONG-TERM TRENDS; HUMAN DISTURBANCE; FOOD-HABITS; R PACKAGE; CONSERVATION; MODEL; SUITABILITY; MANAGEMENT; CLIMATE	Many large carnivore populations are expanding into human-modified landscapes and the subsequent increase in coexistence between humans and large carnivores may intensify various types of conflicts. A proactive management approach is critical to successful mitigation of such conflicts. The Cantabrian Mountains in Northern Spain are home to the last remaining native brown bear (Ursus arctos) population of the Iberian Peninsula, which is also amongst the most severely threatened European populations, with an important core group residing in the province of Asturias. There are indications that this small population is demographically expanding its range. The identification of the potential areas of brown bear range expansion is crucial to facilitate proactive conservation and management strategies towards promoting a further recovery of this small and isolated population. Here, we used a presence-only based maximum entropy (MaxEnt) approach to model habitat suitability and identify the areas in the Asturian portion of the Cantabrian Mountains that are likely to be occupied in the future by this endangered brown bear population following its range expansion. We used different spatial scales to identify brown bear range suitability according to different environmental, topographic, climatic and human impact variables. Our models mainly show that: (1) 4977 km(2) are still available as suitable areas for bear range expansion, which represents nearly half of the territory of Asturias; (2) most of the suitable areas in the western part of the province are already occupied (77% of identified areas, 2820 km(2)), 41.4% of them occurring inside protected areas, which leaves relatively limited good areas for further expansion in this part of the province, although there might be more suitable areas in surrounding provinces; and (3) in the eastern sector of the Asturian Cantabrian Mountains, 62% (2155 km(2)) of the land was classified as suitable, and this part of the province hosts 44.3% of the total area identified as suitable areas for range expansion. Our results further highlight the importance of increasing: (a) the connectivity between the currently occupied western part of Asturias and the areas of potential range expansion in the eastern parts of the province; and (b) the protection of the eastern sector of the Cantabrian Mountains, where most of the future population expansion may be expected.	[Zarzo-Arias, Alejandra; Penteriani, Vincenzo; del Mar Delgado, Maria; Dalerum, Fredrik] Oviedo Univ, Res Unit Biodivers, UMIB, UO CSIC PA, Campus Mieres, Mieres, Spain; [Penteriani, Vincenzo] CSIC, Pyrenean Inst Ecol IPE, Zaragoza, Spain; [Peon Torre, Paloma] Direcc Gen Biodiversidad, Consejeria Ordenac Terr Infraestructuras & Medio, Oviedo, Spain; [Garcia-Gonzalez, Ricardo] CSIC, Pyrenean Inst Ecol IPE, Jaca, Spain; [Cruz Mateo-Sanchez, Maria] Tech Univ Madrid, ETSI Montes Forestal & Medio Nat, ECOGESFOR Res Grp, Ciudad Univ S-N, Madrid, Spain; [Vazquez Garcia, Pablo] Univ Valencia, Inst Cavanilles, Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Dalerum, Fredrik] Stockholm Univ, Dept Zool, Stockholm, Sweden; [Dalerum, Fredrik] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Pretoria, South Africa	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Universidad Politecnica de Madrid; University of Valencia; Stockholm University; University of Pretoria	Zarzo-Arias, A; Penteriani, V (corresponding author), Oviedo Univ, Res Unit Biodivers, UMIB, UO CSIC PA, Campus Mieres, Mieres, Spain.; Penteriani, V (corresponding author), CSIC, Pyrenean Inst Ecol IPE, Zaragoza, Spain.	UO260473@uniovi.es; penteriani@ipe.csic.es	Zarzo-Arias, Alejandra/AAT-5513-2021; Dalerum, Fredrik/M-6068-2017; Penteriani, Vincenzo/H-1463-2015	Zarzo-Arias, Alejandra/0000-0001-5496-0144; Dalerum, Fredrik/0000-0001-9737-8242; PEON TORRE, PALOMA/0000-0002-8439-8225; Garcia-Gonzalez, Ricardo/0000-0001-5625-8690; Penteriani, Vincenzo/0000-0002-9333-7846; Delgado, Maria del Mar/0000-0002-3009-738X	Gobierno del Principado de Asturias (FEDER) [CN-17-023]; Spanish Ministry of Economy, Industry and Competitiveness (MINECO) [CGL2017-82782-P]; Agencia Estatal de Investigacion (AEI); Fondo Europeo de Desarrollo Regional (FEDER, EU); Ramon & Cajal research contracts from the Spanish Ministry of Economy, Industry and Competitiveness [RYC-2014-16263, RYC-2013-14662]	Gobierno del Principado de Asturias (FEDER)(Principality of Asturias); Spanish Ministry of Economy, Industry and Competitiveness (MINECO)(Spanish Government); Agencia Estatal de Investigacion (AEI); Fondo Europeo de Desarrollo Regional (FEDER, EU)(Spanish Government); Ramon & Cajal research contracts from the Spanish Ministry of Economy, Industry and Competitiveness	The research was financially supported by the Gobierno del Principado de Asturias (with FEDER co-financing) with the project CN-17-023 to VP and M.M.D. VP was financially supported by the Excellence Project CGL2017-82782-P financed by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO), the Agencia Estatal de Investigacion (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER, EU). M.M.D. (RYC-2014-16263) and F.D. (RYC-2013-14662) were supported by Ramon & Cajal research contracts from the Spanish Ministry of Economy, Industry and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bassi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124698; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Burnham KP, 2003, MODEL SELECTION MULT; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; CLEVENGER AP, 1990, INT C BEAR, V8, P205; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ericksson T, 2018, BIOL CONSERV; Fernandez-Gil A, 2013, COMPORTAMIENTO CONSE, P296; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gonzalez EG, 2016, PEERJ, V4, DOI 10.7717/peerj.1928; Hijmans R.J., 2017, CIRCLES, V9, P1, DOI DOI 10.1016/J.JHYDROL.2011.07.022; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huck M, 2010, ACTA THERIOL, V55, P177, DOI 10.4098/j.at.0001-7051.114.2009; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Jerina K, 2003, ECOL MODEL, V170, P453, DOI 10.1016/S0304-3800(03)00245-X; Kaartinen S, 2009, BIODIVERS CONSERV, V18, P3503, DOI 10.1007/s10531-009-9657-8; Kaczensky P., 2013, STATUS MANAGEMENT DI, P272; Kobler A, 2000, ECOL MODEL, V135, P291, DOI 10.1016/S0304-3800(00)00384-7; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Martin J, 2012, J APPL ECOL, V49, P621, DOI 10.1111/j.1365-2664.2012.02139.x; Martin J, 2010, CAN J ZOOL, V88, P875, DOI 10.1139/Z10-053; Cano IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1832; Sanchez MCM, 2014, INT J GEOGR INF SCI, V28, P1531, DOI 10.1080/13658816.2013.776684; Mateo-Sanchez MC, 2014, ANIM CONSERV, V17, P430, DOI 10.1111/acv.12109; Mateo-Sanchez MC, 2016, LANDSCAPE ECOL, V31, P1261, DOI 10.1007/s10980-015-0324-z; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; MORAN PAP, 1950, BIOMETRIKA, V37, P178, DOI 10.1093/biomet/37.1-2.178; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x; Naves J, SPATIOTEMPORAL UNPUB; Naves J, 2006, J MAMMAL, V87, P899, DOI 10.1644/05-MAMM-A-318R2.1; Oberosler V, 2017, MAMM BIOL, V87, P50, DOI 10.1016/j.mambio.2017.05.005; Palomero G, 2007, URSUS, V18, P145, DOI 10.2192/1537-6176(2007)18[145:TINADO]2.0.CO;2; Penteriani V, CASE CANTABRIA UNPUB; Penteriani V, 2018, URSUS, P2; Penteriani V, 2016, SCI REP-UK, V6, DOI 10.1038/srep20552; Perez T, 2014, WILDLIFE BIOL, V20, P300, DOI 10.2981/wlb.00069; Perez T, 2010, URSUS, V21, P104, DOI 10.2192/09SC018.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Pinheiro J, 2000, MIXED EFFECTS MODELS; Posillico M, 2004, BIOL CONSERV, V118, P141, DOI 10.1016/j.biocon.2003.07.017; Pyare S, 2004, ANIM CONSERV, V7, P71, DOI 10.1017/S1367943003001203; R Core Team, 2021, R LANGUAGE ENV STAT; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Rodriguez C, 2007, ENVIRON CONSERV, V34, P36, DOI 10.1017/S0376892906003535; Rondinini C, 2005, CONSERV BIOL, V19, P1488, DOI 10.1111/j.1523-1739.2005.00204.x; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; Stahl P, 2001, J APPL ECOL, V38, P674, DOI 10.1046/j.1365-2664.2001.00625.x; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Swenson JE, 2000, ACTION PLAN CONSERVA, P69; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Whiteman A, 2017, WILDLIFE RES, V44, P309, DOI 10.1071/WR16164; Young N., 2011, MAXENT MODEL V3 3 3E, DOI DOI 10.1145/1015330.1015412; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005	68	26	26	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209972	10.1371/journal.pone.0209972	http://dx.doi.org/10.1371/journal.pone.0209972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608946	Green Submitted, gold, Green Published			2022-12-26	WOS:000454952800034
J	Van Rossem, R; Pannecoucke, I				Van Rossem, Ronan; Pannecoucke, Isabelle			Poverty and a child's height development during early childhood: A double disadvantage? A study of the 2006-2009 birth cohorts in Flanders	PLOS ONE			English	Article							LONG-TERM CONSEQUENCES; SOCIOECONOMIC-STATUS; SOCIAL INEQUALITIES; ADULT HEALTH; 1ST YEAR; GROWTH; LIFE; UNDERNUTRITION; ASSOCIATION; STRESS	Introduction Poverty is a well-known risk factor for a child's health and development. This paper aimed to establish whether poverty negatively affected both intra-uterine growth and early childhood growth, i.e., whether children facing poverty were at a double disadvantage. Methods For this study, we made use of routinely collected data on child development throughout early childhood from the 2006-2009 birth cohorts in Kind & Gezin's Ikaros database collected during 2,605,975 consultations with 273,935 children from birth to 730 days old. Indicators for child development at birth were gestational age and height-at-birth. A standardized height-for-age indicator captured height development throughout early childhood. A multidimensional indicator measured the risk of poverty. For the analysis of development at birth, we used linear and logistic regression; for the analysis of height development during early childhood, we estimated linear and logistic growth curve models. Results The risk of poverty negatively affected both gestational age and height-at-birth. Throughout early childhood, we observed a negative relation between the risk of poverty and height-for-age indicators. However, the effect varied throughout childhood. Children at risk of poverty ( over) compensated for their smaller stature at birth, and between ages 6 and 18 months, approximately, the negative effects of risk of poverty decreased substantially or disappeared. However, towards the end of the period studied, children born in households at risk of poverty started to lag again in height development. Conclusion This study found that the risk of poverty indeed negatively affected a child's growth, both in utero and in early childhood. However, the results suggest that developmental lags later in childhood were not merely an extension of such lags at birth.	[Van Rossem, Ronan; Pannecoucke, Isabelle] Univ Ghent, Dept Sociol, Ghent, Belgium; [Pannecoucke, Isabelle] Flemish Housing Council, Brussels, Belgium	Ghent University	Van Rossem, R (corresponding author), Univ Ghent, Dept Sociol, Ghent, Belgium.	ronan.vanrossem@ugent.be		Van Rossem, Ronan/0000-0002-3218-0128	Fonds Wetenschappelijk Onderzoek (Research Council Flanders) [G0A2612N]	Fonds Wetenschappelijk Onderzoek (Research Council Flanders)	This work received support from Fonds Wetenschappelijk Onderzoek (Research Council Flanders), grant G0A2612N (RVR, IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; Case A, 2010, DEMOGRAPHY, V47, pS65, DOI 10.1353/dem.2010.0007; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Spyrides MHC, 2008, J PEDIAT-BRAZIL, V84, P237, DOI [10.2223/JPED.1797, 10.1590/S0021-75572008000300009]; De Maeseneer J, 2007, C SCHAADT ARM GEZ NA; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; De Onis M., 2017, NUTR HLTH DEV WORLD, P119, DOI DOI 10.1007/978-3-319-43739-2_6; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; De Spiegelaere M., 2017, WAT BETEKENEN ARMOED; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Dubois L, 2003, PUBLIC HEALTH NUTR, V6, P773, DOI 10.1079/PHN2003497; Duncan GJ, 2000, CHILD DEV, V71, P188, DOI 10.1111/1467-8624.00133; Evans GW, 2002, CHILD DEV, V73, P1238, DOI 10.1111/1467-8624.00469; Finch BK, 2011, ECON HUM BIOL, V9, P272, DOI 10.1016/j.ehb.2011.02.005; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Haelterman E, 2007, PERINATALE GEZONDHEI; HEINIG MJ, 1993, AM J CLIN NUTR, V58, P152, DOI 10.1093/ajcn/58.2.152; Hoppenbrouwers K, 2011, SWVG FEITEN CIJFERS, V2011, P1; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Kind en Gezin, 2008, NON TRADITIONAL REF; Kind en Gezin, 2010, KIND VLAAND 2009; Kind en Gezin, 2010, JAARV 2009; Kind en Gezin, 2014, KIND VLAAND 2013; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Li L, 2004, ARCH DIS CHILD, V89, P1018, DOI 10.1136/adc.2003.035162; MACKENBACH JP, 1991, LANCET, V338, P764, DOI 10.1016/0140-6736(91)91492-D; Matijasevich A, 2012, PAEDIATR PERINAT EP, V26, P236, DOI 10.1111/j.1365-3016.2011.01251.x; McEwen CA, 2016, ANN REV SOCIOL, V43; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Oreopoulos P, 2008, J HUM RESOUR, V43, P88; Petersen CB, 2009, PAEDIATR PERINAT EP, V23, P66, DOI 10.1111/j.1365-3016.2008.00977.x; Pillas D, 2014, PEDIATR RES, V76, P418, DOI 10.1038/pr.2014.122; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Richard SA, 2012, ADV NUTR, V3, P250, DOI 10.3945/an.111.001099; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Silva LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037356; Silva LM, 2010, INT J EPIDEMIOL, V39, P1250, DOI 10.1093/ije/dyq069; Silva LM, 2009, FETAL ORIGINS SOCIOE; Steenssens K, 2008, KINDEREN ARMOEDE STA; TANNER JM, 1992, HORM RES, V38, P106, DOI 10.1159/000182580; UNICEF Belgie, 2014, NON TRADITIONAL REF; Vanderlinden K, 2015, J IMMIGR MINOR HEALT, V17, P319, DOI 10.1007/s10903-014-0072-1; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; VICTORA CG, 1992, J NUTR, V122, P1105, DOI 10.1093/jn/122.5.1105; Wilkinson R, 2005, IMPACT INEQUALITY MA; World Health Organization, 1995, PHYS STAT US INT ANT	50	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209170	10.1371/journal.pone.0209170	http://dx.doi.org/10.1371/journal.pone.0209170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1BB	30601853	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200042
J	Gebrehiwot, AG; Melka, DS; Kassaye, YM; Rehan, IF; Rangappa, S; Hinou, H; Kamiyama, T; Nishimura, SI				Gebrehiwot, Abrha G.; Melka, Daniel Seifu; Kassaye, Yimenashu Mamo; Rehan, Ibrahim F.; Rangappa, Shobith; Hinou, Hiroshi; Kamiyama, Toshiya; Nishimura, Shin-Ichiro			Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers	PLOS ONE			English	Article							SIALIC-ACID; QUANTITATIVE GLYCOMICS; IMMUNOGLOBULIN-G; GLYCOSYLATION; HYPERTENSION; ASSOCIATION; MECHANISMS; COMPLEXITY; BRAIN	Background Most glycomics studies have focused on understanding disease mechanisms and proposing serum markers for various diseases, yet the influence of ethnic variation on the identified glyco-biomarker remains poorly addressed. This study aimed to investigate the inter-ethnic serum N-glycan variation among US origin control, Japanese, Indian, and Ethiopian healthy volunteers. Methods Human serum from 54 healthy subjects of various ethnicity and 11 Japanese hepatocellular carcinoma (HCC) patients were included in the study. We employed a comprehensive glycoblotting-assisted MALDI-TOF/MS-based quantitative analysis of serum N-glycome and fluorescence HPLC-based quantification of sialic acid species. Data representing serum N-glycan or sialic acid levels were compared among the ethnic groups using SPSS software. Results Total of 51 N-glycans released from whole serum glycoproteins could be reproducibly quantified within which 33 glycoforms were detected in all ethnicities. The remaining N-glycans were detected weakly but exclusively either in the Ethiopians (13 glycans) or in all the other ethnic groups (5 glycans). Highest abundance (p < 0.001) of high mannose, core-fucosylated, hyperbranched/hypersialylated N-glycans was demonstrated in Ethiopians. In contrast, only one glycan (m/z 2118) significantly differed among all ethnicities being highest in Indians and lowest in Ethiopians. Glycan abundance trend in Ethiopians was generally close to that of Japanese HCC patients. Glycotyping analysis further revealed ethnic-based disparities mainly in the branched and sialylated structures. Surprisingly, some of the glycoforms greatly elevated in the Ethiopian subjects have been identified as serum biomarkers of various cancers. Sialic acid level was significantly increased primarily in Ethiopians, compared to the other ethnicities. Conclusion The study revealed ethnic-specific differences in healthy human serum N-glycome with highest abundance of most glycoforms in the Ethiopian ethnicity. The results strongly emphasized the need to consider ethnicity matching for accurate glyco-biomarker identification. Further large-scale study employing various ethnic compositions is needed to verify the current result.	[Gebrehiwot, Abrha G.; Rehan, Ibrahim F.; Rangappa, Shobith; Hinou, Hiroshi; Nishimura, Shin-Ichiro] Hokkaido Univ, Div Drug Discovery Res, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Gebrehiwot, Abrha G.; Rehan, Ibrahim F.; Rangappa, Shobith; Hinou, Hiroshi; Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Melka, Daniel Seifu; Kassaye, Yimenashu Mamo] Addis Ababa Univ, Sch Med, Dept Biochem, Addis Ababa, Ethiopia; [Rehan, Ibrahim F.] South Valley Univ, Dept Anim Behav & Husb, Fac Vet Med, Qena, Egypt; [Kamiyama, Toshiya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Kita Ku, N15,W7, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Addis Ababa University; Egyptian Knowledge Bank (EKB); South Valley University Egypt; Hokkaido University	Nishimura, SI (corresponding author), Hokkaido Univ, Div Drug Discovery Res, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido, Japan.; Nishimura, SI (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido, Japan.	shin@sci.hokudai.ac.jp	Hinou, Hiroshi/AAZ-4262-2020; Hinou, Hiroshi/A-4395-2012; Rangappa, Shobith/AAI-2169-2020	Hinou, Hiroshi/0000-0003-2223-7300; Hinou, Hiroshi/0000-0003-2223-7300; Rangappa, Shobith/0000-0002-9800-7192; Rehan, Ibrahim/0000-0002-5632-0199	Ministry of Education, Culture, Sports, Science, and Technology Japan (MEXT); JSPS KAKENHI [25220206]; JSPS Core-to-Core Program B. Asia-Africa Science Platforms; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science, and Technology Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core Program B. Asia-Africa Science Platforms; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partly supported by the Ministry of Education, Culture, Sports, Science, and Technology Japan (MEXT) and JSPS KAKENHI Grant Number 25220206, JSPS Core-to-Core Program B. Asia-Africa Science Platforms, and by Japan Science and Technology Agency (JST) through a grant for "Development of Systems and Technology for Advanced Measurement and Analysis (SENTAN)"and "The Matching Program for innovations in Future Drug Discovery and Medical Care". The funders had no role in study design, data collection and data analysis, decision to publish, or preparation of the manuscript.	Ajit V, 2009, BIOL ROLES GLYCANS E; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Clerc F, 2016, GLYCOCONJUGATE J, V33, P309, DOI 10.1007/s10719-015-9626-2; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Cummings RD, 2014, CHEM BIOL, V21, P1, DOI 10.1016/j.chembiol.2013.12.010; Diamandis EP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-87; Ding N, 2011, AGE AGEING, V40, P568, DOI 10.1093/ageing/afr084; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Eleftherios PD, 2010, JNCI-J NATL CANCER I, V102, P1462, DOI [10.1093/jnci/djq306, DOI 10.1093/JNCI/DJQ306]; Ellman N, 2015, ATHEROSCLEROSIS, V240, P311, DOI 10.1016/j.atherosclerosis.2015.03.027; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Gao Q, 2017, OMICS, V21, P380, DOI 10.1089/omi.2017.0044; Gizaw ST, 2016, BBA-GEN SUBJECTS, V1860, P1716, DOI 10.1016/j.bbagen.2016.03.009; Gizaw ST, 2015, BBA-GEN SUBJECTS, V1850, P1704, DOI 10.1016/j.bbagen.2015.04.006; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hatakeyama S, 2014, J UROLOGY, V191, P805, DOI 10.1016/j.juro.2013.10.052; Hirose K, 2011, BIOCHEMISTRY-US, V50, P4757, DOI 10.1021/bi101940x; Inafuku S, 2015, INVEST OPHTH VIS SCI, V56, P5316, DOI 10.1167/iovs.15-16747; Ishibashi Y, 2014, PROSTATE, V74, P1521, DOI 10.1002/pros.22869; Kamiyama T, 2013, HEPATOLOGY, V57, P2314, DOI 10.1002/hep.26262; Keser T, 2017, DIABETOLOGIA, V60, P2352, DOI 10.1007/s00125-017-4426-9; Kirwan A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/490531; Kita Y, 2007, MOL CELL PROTEOMICS, V6, P1437, DOI 10.1074/mcp.T600063-MCP200; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Liu D, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1616-2; Liu JN, 2018, J HUM HYPERTENS, V32, P555, DOI 10.1038/s41371-018-0071-0; Lu JP, 2011, J PROTEOME RES, V10, P4959, DOI 10.1021/pr2004067; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Menni C, 2018, CIRC RES, V122, P1555, DOI 10.1161/CIRCRESAHA.117.312174; Menni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082558; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nishimura SI, 2011, ADV CARBOHYD CHEM BI, V65, P219, DOI 10.1016/B978-0-12-385520-6.00005-4; Nishimura SI, 2005, ANGEW CHEM INT EDIT, V44, P91, DOI 10.1002/anie.200461685; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pilobello KT, 2007, CURR OPIN CHEM BIOL, V11, P300, DOI 10.1016/j.cbpa.2007.05.002; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Rehan IF, 2015, J AGR FOOD CHEM, V63, P10578, DOI 10.1021/acs.jafc.5b04304; Smith KD, 2012, GLYCOSYLATION, P201, DOI 10.5772/48177; Tahmasebi H, 2018, CRIT REV CL LAB SCI, V55, P359, DOI 10.1080/10408363.2018.1476455; Terashima M, 2014, STEM CELL RES, V13, P454, DOI 10.1016/j.scr.2014.10.006; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005462; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875; Wang YX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003379; Yogesh KV, 2018, MEDCHEMCOMM, V9, P1351, DOI 10.1039/c8md00162f; Yu XW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004112	54	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209515	10.1371/journal.pone.0209515	http://dx.doi.org/10.1371/journal.pone.0209515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592755	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900030
J	Carrillo, DD; Sikorski, K; Khnykin, D; Wu, WW; Lund-Johansen, F				Carrillo, Daniel de la Rosa; Sikorski, Krzysztof; Khnykin, Denis; Wu, Weiwei; Lund-Johansen, Fridtjof			High-resolution antibody array analysis of proteins from primary human keratinocytes and leukocytes	PLOS ONE			English	Article							ACCURATE; CELLS	Antibody array analysis of labeled proteomes has high throughput and is simple to perform, but validation remains challenging. Here, we used differential detergent fractionation and size exclusion chromatography in sequence for high-resolution separation of biotinylated proteins from human primary keratinocytes and leukocytes. Ninety-six sample fractions from each cell type were analyzed with microsphere-based antibody arrays and flow cytometry (microsphere affinity proteomics; MAP). Monomeric proteins and multi-molecular complexes in the cytosol, cytoplasmic organelles, membranes and nuclei were resolved as discrete peaks of antibody reactivity across the fractions. The fractionation also provided a two-dimensional matrix for assessment of specificity. Thus, antibody reactivity peaks were considered to represent specific binding if the position in the matrix was in agreement with published information about i) subcellular location, ii) size of the intended target, and iii) cell type-dependent variation in protein expression. Similarities in the reactivity patterns of either different antibodies to the same protein or antibodies to similar proteins were used as additional supporting evidence. This approach provided validation of several hundred proteins and identification of monomeric proteins and protein complexes. High-resolution MAP solves many of the problems associated with obtaining specificity with immobilized antibodies and a protein label. Thus, laboratories with access to chromatography and flow cytometry can perform large-scale protein analysis on a daily basis. This opens new possibilities for cell biology research in dermatology and validation of antibodies.	[Carrillo, Daniel de la Rosa] Univ Oslo, Inst Clin Med, Oslo, Norway; [Carrillo, Daniel de la Rosa] Oslo Univ Hosp, Dept Dermatol, Oslo, Norway; [Sikorski, Krzysztof; Wu, Weiwei; Lund-Johansen, Fridtjof] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Sikorski, Krzysztof; Lund-Johansen, Fridtjof] Univ Oslo, KG Jebsen Ctr Canc Immunotherapy, Oslo, Norway; [Khnykin, Denis] Oslo Univ Hosp, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Carrillo, DD (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.; Carrillo, DD (corresponding author), Oslo Univ Hosp, Dept Dermatol, Oslo, Norway.	daniel.carrillo@medisin.uio.no		Lund-Johansen, Fridtjof/0000-0002-2445-1258	Arne E. Ingels Grant [RR kontrakt 36051, 14634]; Research Council of Norway Functional Genomics (FUGE) [187606]	Arne E. Ingels Grant; Research Council of Norway Functional Genomics (FUGE)	This research is supported by Arne E. Ingels Grant (RR kontrakt 36051 to DRC and 14634 to FLJ), https://www.unifor.no/fund.aspx?fund=77; and The Research Council of Norway Functional Genomics (FUGE) (187606 to FLJ), https://www.forskningsradet.no/prognett-fuge/Home_page/1226993493114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Borrebaeck CAK, 2009, J PROTEOMICS, V72, P928, DOI 10.1016/j.jprot.2009.01.027; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Haab BB, 2001, GENOME BIOL, V2; Haudek-Prinz VJ, 2012, J PROTEOMICS, V76, P150, DOI 10.1016/j.jprot.2012.07.012; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Holm A, 2012, NEW BIOTECHNOL, V29, P578, DOI 10.1016/j.nbt.2011.07.008; Kirkland TN, 1998, PROG CLIN BIOL RES, V397, P79; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Larance M, 2013, MOL CELL PROTEOMICS, V12, P638, DOI 10.1074/mcp.M112.024547; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Lund- Johansen F, 2016, NATURE METHODS; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Moon KM, 2012, INT J MOL SCI, V13, P1239, DOI 10.3390/ijms13011239; Ramsby Melinda, 2011, Cold Spring Harb Protoc, V2011, pprot5592, DOI 10.1101/pdb.prot5592; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Sikorski K, 2018, NAT METHODS, V15, P909, DOI 10.1038/s41592-018-0179-8; Slaastad H, 2011, PROTEOMICS, V11, P4578, DOI 10.1002/pmic.201000744; Stuchly J, 2012, CYTOM PART A, V81A, P120, DOI 10.1002/cyto.a.22011; Thakar K, 2013, MOL CELL PROTEOMICS, V12, P664, DOI 10.1074/mcp.M112.024877; Treindl F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12852; Wu WW, 2009, MOL CELL PROTEOMICS, V8, P245, DOI 10.1074/mcp.M800171-MCP200	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209271	10.1371/journal.pone.0209271	http://dx.doi.org/10.1371/journal.pone.0209271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589857	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200017
J	Gaonkar, CC; Piredda, R; Minucci, C; Mann, DG; Montresor, M; Sarno, D; Kooistra, WHCF				Gaonkar, Chetan C.; Piredda, Roberta; Minucci, Carmen; Mann, David G.; Montresor, Marina; Sarno, Diana; Kooistra, Wiebe H. C. F.			Annotated 18S and 28S rDNA reference sequences of taxa in the planktonic diatom family Chaetocerotaceae	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; GENUS CHAETOCEROS; CRITICAL CRITERIA; GLOBAL DIVERSITY; LATERAL TRANSFER; IDENTIFICATION; MORPHOLOGY; DATABASE; INTRON; BACILLARIOPHYCEAE	The species-rich diatom family Chaetocerotaceae is common in the coastal marine phytoplankton worldwide where it is responsible for a substantial part of the primary production. Despite its relevance for the global cycling of carbon and silica, many species are still described only morphologically, and numerous specimens do not fit any described taxa. Nowadays, studies to assess plankton biodiversity deploy high throughput sequencing metabarcoding of the 18S rDNA V4 region, but to translate the gathered metabarcodes into biologically meaningful taxa, there is a need for reference barcodes. However, 18S reference barcodes for this important family are still relatively scarce. We provide 18S rDNA and partial 28S rDNA reference sequences of 443 morphologically characterized chaetocerotacean strains. We gathered 164 of the 216 18S sequences and 244 of the 413 28S sequences of strains from the Gulf of Naples, Atlantic France, and Chile. Inferred phylogenies showed 84 terminal taxa in seven principal clades. Two of these clades included terminal taxa whose rDNA sequences contained spliceosomal and Group IC1 introns. Regarding the commonly used metabarcode markers in planktonic diversity studies, all terminal taxa can be discriminated with the 18S V4 hypervariable region; its primers fit their targets in all but two species, and the V4-tree topology is similar to that of the 18S. Hence V4-metabarcodes of unknown Chaetocerotaceae are assignable to the family. Regarding the V9 hypervariable region, most terminal taxa can be discriminated, but several contain introns in their primer targets. Moreover, poor phylogenetic resolution of the V9 region affects placement of metabarcodes of putative but unknown chaetocerotacean taxa, and hence, uncertainty in taxonomic assignment, even of higher taxa.	[Gaonkar, Chetan C.; Piredda, Roberta; Minucci, Carmen; Montresor, Marina; Sarno, Diana; Kooistra, Wiebe H. C. F.] Stn Zool Anton Dohrn, Integrat Marine Ecol Dept, Naples, Italy; [Mann, David G.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Mann, David G.] Inst Recerca & Tecnol Agroalimentaries, San Carlos de la Rapita, Catalonia, Spain; [Gaonkar, Chetan C.] Kochi Univ, Fac Agr & Marine Sci, Nanko Ku, Kochi, Japan	Stazione Zoologica Anton Dohrn di Napoli; IRTA; Kochi University	Montresor, M; Sarno, D; Kooistra, WHCF (corresponding author), Stn Zool Anton Dohrn, Integrat Marine Ecol Dept, Naples, Italy.	marina.montresor@szn.it; diana.sarno@szn.it; kooistra@szn.it	Piredda, Roberta/ABC-8987-2020; Mann, David G/I-9018-2014	Piredda, Roberta/0000-0002-6672-439X; Mann, David G/0000-0003-0522-6802; Kooistra, Wiebe/0000-0002-8641-9739; Montresor, Marina/0000-0002-2475-1787; SARNO, DIANA/0000-0001-9697-5301	Stazione Zoologica Anton Dohrn (SZN); project FIRB Biodiversitalia - Italian Ministry of Education, University and Research [RBAP10A2T4]; EU [227799, 654008]	Stazione Zoologica Anton Dohrn (SZN); project FIRB Biodiversitalia - Italian Ministry of Education, University and Research; EU(European Commission)	CCG has been supported by a PhD fellowship from Stazione Zoologica Anton Dohrn (SZN). RB was supported by the project FIRB Biodiversitalia (RBAP10A2T4) funded by the Italian Ministry of Education, University and Research. WK was supported by the EU funded project ASSEMBLE (grant agreement 227799) and Horizon 2020 Framework Programme grant 654008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelmann A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001199; Alverson AJ, 2008, PROTIST, V159, P339, DOI 10.1016/j.protis.2008.04.001; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; [Anonymous], [No title captured]; Ashworth MP, 2013, J PHYCOL, V49, P1207, DOI 10.1111/jpy.12131; Balzano S, 2017, J PHYCOL, V53, P161, DOI 10.1111/jpy.12489; Barnard R, 2004, MAR ECOL PROG SER, P11; Bhattacharya D, 2001, CURR GENET, V40, P82, DOI 10.1007/s002940100227; Bhattacharya D, 2000, MOL BIOL EVOL, V17, P1971, DOI 10.1093/oxfordjournals.molbev.a026298; Bosak S, 2017, PHYTOTAXA, V314, P1, DOI 10.11646/phytotaxa.314.1.1; Bosak S, 2015, PHYCOLOGIA, V54, P130, DOI 10.2216/14-62; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Chamnansinp A, 2013, J PHYCOL, V49, P1128, DOI 10.1111/jpy.12121; Cullings KW, 1992, MOL ECOL, V1, P233, DOI 10.1111/j.1365-294X.1992.tb00182.x; D'Alcala MR, 2004, SCI MAR, V68, P65; De Vargas C, 2017, TARA OCEANS CONSORTI, DOI [10.1594/PANGAEA.873275, DOI 10.1594/PANGAEA.873275]; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Doyle J. J., 1987, PHYTOCHEM B, P11; Forster D, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw120; Gaonkar CC, 2017, J PHYCOL, V53, P889, DOI 10.1111/jpy.12554; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gran HH, 1897, PROTOPHYTA DIATOMACE; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Guiry, 2018, ALGAEBASE; Han JC, 2018, J PHYCOL, V54, P105, DOI 10.1111/jpy.12605; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hu SK, 2015, J EUKARYOT MICROBIOL, V62, P688, DOI 10.1111/jeu.12217; Irimia M, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016071; Ishi KI, 2011, PHYCOLOGIA, V50, P351, DOI 10.2216/10-36.1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim JH, 2015, J PHYCOL, V51, P159, DOI 10.1111/jpy.12263; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kooistra WHCF, 2010, PHYCOLOGIA, V49, P471, DOI 10.2216/09-59.1; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; Lee SD, 2014, PHYCOLOGIA, V53, P614, DOI 10.2216/14-51R2.1; Lee SD, 2014, PHYCOLOGIA, V53, P174, DOI 10.2216/13-154.1; Li Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189549; Li Y, 2015, J PHYCOL, V51, P469, DOI 10.1111/jpy.12290; Lundholm N., 2013, PHYCOLOGIA, V52, P600, DOI [10.2216/13-168.1, DOI 10.2216/13-168.1]; Malviya S, 2016, P NATL ACAD SCI USA, V113, pE1516, DOI 10.1073/pnas.1509523113; MARINO D, 1991, Diatom Research, V6, P317; Massana R, 2015, ENVIRON MICROBIOL, V17, P4035, DOI 10.1111/1462-2920.12955; Mordret S, 2018, MOL ECOL RESOUR, V18, P974, DOI 10.1111/1755-0998.12781; Muller KM, 2005, J PHYCOL, V41, P380, DOI 10.1111/j.1529-8817.2005.03146.x; Piredda R, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rambaut A., SEQUENCE ALIGNMENT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rines J. E. B., 2000, Phycological Research, V48, P161, DOI 10.1046/j.1440-1835.2000.00195.x; Rines JEB, 1999, BOT MAR, V42, P539, DOI 10.1515/BOT.1999.061; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sarno D, 1997, PHYCOLOGIA, V36, P257, DOI 10.2216/i0031-8884-36-4-257.1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Zimmermann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108793	61	26	29	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208929	10.1371/journal.pone.0208929	http://dx.doi.org/10.1371/journal.pone.0208929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586452	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400045
J	McGrath-Morrow, SA; Ndeh, R; Collaco, JM; Rothblum-Oviatt, C; Wright, J; O'Reilly, MA; Singer, BD; Lederman, HM				McGrath-Morrow, Sharon A.; Ndeh, Roland; Collaco, Joseph M.; Rothblum-Oviatt, Cynthia; Wright, Jennifer; O'Reilly, Michael A.; Singer, Benjamin D.; Lederman, Howard M.			Inflammation and transcriptional responses of peripheral blood mononuclear cells in classic ataxia telangiectasia	PLOS ONE			English	Article							PULMONARY-FUNCTION; ADHESION MOLECULE; BREAST-CANCER; ATM GENE; EXPRESSION; IMMUNODEFICIENCY; INTERLEUKIN-6; MALIGNANCIES; SENESCENCE; PROGNOSIS	Introduction Classic ataxia telangiectasia (A-T) is an autosomal recessive disease characterized by early onset ataxia, immune deficiency, sino-pulmonary disease, lymphoid/solid malignancies and telangiectasias. Prior studies have suggested that chronic inflammation and premature aging may contribute to the development of malignancy and pulmonary disease in people with A-T. To further examine the link between A-T and inflammation, we hypothesized that subjects with classic A-T would have greater enrichment of inflammatory pathways in peripheral blood mononuclear cells (PBMCs) compared to non A-T age-matched controls. To test this hypothesis we used RNAseq as an unsupervised approach to identify biological processes altered in people with classic A-T. Methods PBMCs were isolated from subjects with classic A-T and compared to non-A-T age-matched healthy controls. RNAseq with differential gene expression analyses was then performed. Selected genes were validated by RT-qPCR using cohorts of subjects consisting of classic A-T, mild A-T or non-A-T controls. Subjects with mild A-T were characterized by later onset/mild neurologic features and normal/near normal immune status. Results RNAseq revealed 310 differentially expressed genes (DEGs) including genes involved in inflammation, immune regulation, and cancer. Using gene set enrichment analysis, A-T subjects were found to have biological processes enriched for inflammatory and malignancy pathways. In examining a cohort of A-T subjects in which baseline serum IL8 and IL6 levels were measured previously, an association was found between higher serum IL8 levels and higher likelihood of developing malignancy and/or death in a subsequent 4-6 year period. Conclusion RNAseq using PBMCs from subjects with classic A-T uncovered differential expression of immune response genes and biological processes associated with inflammation, immune regulation, and cancer. Follow-up of A-T subjects over a 4-6 year period revealed an association between higher baseline serum IL8 levels and malignancy/death. These findings support a role for inflammation as a contributing factor in A-T phenotypes.	[McGrath-Morrow, Sharon A.; Ndeh, Roland; Collaco, Joseph M.] Johns Hopkins Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21205 USA; [Rothblum-Oviatt, Cynthia] A T Childrens Project, Coconut Creek, FL USA; [Wright, Jennifer; Lederman, Howard M.] Johns Hopkins Med Inst, Eudowood Div Pediat Allergy & Immunol, Baltimore, MD 21205 USA; [O'Reilly, Michael A.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Singer, Benjamin D.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Singer, Benjamin D.] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Singer, Benjamin D.] Northwestern Univ, Simpson Querrey Ctr Epigenet, Feinberg Sch Med, Chicago, IL 60611 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Rochester; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	McGrath-Morrow, SA (corresponding author), Johns Hopkins Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21205 USA.	smcgrath@jhmi.edu	Singer, Benjamin D./P-2392-2019	Singer, Benjamin D./0000-0001-5775-8427; McGrath-Morrow, Sharon/0000-0002-1576-5394	A-T Children's Project, Coconut Creek, Florida; NIH/NHLBI [2R01HL114800]; NIH/NHLBI grant [K08HL128867]; Parker B. Francis Research Opportunity Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL128867] Funding Source: NIH RePORTER	A-T Children's Project, Coconut Creek, Florida; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parker B. Francis Research Opportunity Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SAMM is supported by the A-T Children's Project, Coconut Creek, Florida and by NIH/NHLBI grant 2R01HL114800. BDS is supported by NIH/NHLBI grant K08HL128867 and the Parker B. Francis Research Opportunity Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2017, NAT IMMUNOL, V18, P813, DOI 10.1038/ni.3753; Becker EBE, 2012, J NEUROL NEUROSUR PS, V83, P437, DOI 10.1136/jnnp-2011-301506; Bianchi A, 2010, CELL CYCLE, V9, P1647, DOI 10.4161/cc.9.8.11517; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Cabana MD, 1998, PEDIATRICS, V102, P98, DOI 10.1542/peds.102.1.98; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Casamassimi A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081652; Chan JY, 2011, CANCER SCI, V102, P1855, DOI 10.1111/j.1349-7006.2011.02021.x; Correia NC, 2016, LEUKEMIA, V30, P1968, DOI 10.1038/leu.2016.169; Dhodapkar KM, 2001, HUM PATHOL, V32, P396, DOI 10.1053/hupa.2001.23526; El-Mokhtar MA, 2018, MED MICROBIOL IMMUN, V207, P307, DOI 10.1007/s00430-018-0552-3; Elizondo DM, 2016, J LEUKOCYTE BIOL, V100, P855, DOI 10.1189/jlb.2HI1115-525R; Fang EF, 2017, AUTOPHAGY, V13, P442, DOI 10.1080/15548627.2016.1257467; Giuliani A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2309034; Gorczynski RM, 2017, CANCER MANAG RES, V9, P601, DOI 10.2147/CMAR.S147326; Gumy-Pause F, 2004, LEUKEMIA, V18, P238, DOI 10.1038/sj.leu.2403221; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hunter JE, 2016, ONCOGENE, V35, P3476, DOI 10.1038/onc.2015.399; Jerzak KJ, 2018, CURR ONCOL, V25, pE176, DOI 10.3747/co.25.3707; Jin WJ, 2014, WORLD J GASTROENTERO, V20, P16334, DOI 10.3748/wjg.v20.i43.16334; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kozlowski M, 2015, MOL CELL, V59, P713, DOI 10.1016/j.molcel.2015.08.010; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Mavrou A, 2008, ANTICANCER RES, V28, P401; McGrath-Morrow SA, 2018, J BIOL CHEM, V293, P11772, DOI 10.1074/jbc.RA118.003589; McGrath-Morrow SA, 2016, J PEDIATR-US, V171, P256, DOI 10.1016/j.jpeds.2016.01.002; McGrath-Morrow SA, 2010, J PEDIATR-US, V156, P682, DOI 10.1016/j.jpeds.2009.12.007; Menotta M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195388; Menotta M, 2018, MOL CELL BIOCHEM, V438, P153, DOI 10.1007/s11010-017-3122-x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mohan V, 2019, CEREB CORTEX, V29, P963, DOI 10.1093/cercor/bhy004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamura K, 2014, MOL GENET GENOM MED, V2, P332, DOI 10.1002/mgg3.72; Rodenas-Cuadrado P, 2014, EUR J HUM GENET, V22, P171, DOI 10.1038/ejhg.2013.100; Schoenaker MHD, 2018, EUR J MED GENET, V61, P284, DOI 10.1016/j.ejmg.2017.12.012; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Staples ER, 2008, CLIN EXP IMMUNOL, V153, P214, DOI 10.1111/j.1365-2249.2008.03684.x; Suarez F, 2015, J CLIN ONCOL, V33, P202, DOI 10.1200/JCO.2014.56.5101; Takada H, 2005, ONCOGENE, V24, P8051, DOI 10.1038/sj.onc.1208952; Tsukamoto H, 2018, CANCER SCI, V109, P523, DOI 10.1111/cas.13433; van Os NJH, 2016, CLIN GENET, V90, P105, DOI 10.1111/cge.12710; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Watanabe S, 2017, CANCER SCI, V108, P563, DOI 10.1111/cas.13184; Zaki-Dizaji M, 2018, INFLAMM RES, V67, P559, DOI 10.1007/s00011-018-1142-y; Zhu YM, 2003, J BIOL CHEM, V278, P29366, DOI 10.1074/jbc.M301785200	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209496	10.1371/journal.pone.0209496	http://dx.doi.org/10.1371/journal.pone.0209496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586396	Green Submitted, gold, Green Published			2022-12-26	WOS:000454416400067
J	Sattler, EC; Reithmair, M; Steinlein, OK				Sattler, Elke C.; Reithmair, Marlene; Steinlein, Ortrud K.			Kidney cancer characteristics and genotype-phenotype-correlations in Birt-Hogg-Dube syndrome	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; PNEUMOTHORAX; TUMORS; DIAGNOSIS; SPECTRUM; RISK	Birt-Hogg-Dube syndrome (BHDS) is a genetic tumor syndrome characterized by lung cysts, pneumothorax, fibrofolliculomas and renal cell cancer. The diagnosis of BHDS is usually considered if kidney cancer occurs before age 50 years, is multifocal and/or bilateral or of the oncocytoma/hybrid oncocytoma-chromophobe type. Using a sample of 50 BHDS families with a total of 178 patients we analyzed how many kidney cancer patients fulfilled one or more of these criteria. Furthermore, we addressed the question if genotype-phenotype-correlations exist that can be used for risk stratification. Renal cell cancer occurred in 34/178 (19.1%) patients, and the reported male bias was not observed. Furthermore, most kidney malignancies occurred after the age of 50 years. Thus, the majority of tumors did not show the typical hallmarks of BHDS. A below-average tumor frequency (17.2%) was observed for the known mutational hotspot c.1285delC/dupC that was the cause of BHDS in 24% of families. Unexpected was the high tumor frequency (66.7%) associated with mutation c.887C>G within a single family, a finding that merits further exploration.	[Sattler, Elke C.] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Dermatol & Allergol, Munich, Germany; [Reithmair, Marlene; Steinlein, Ortrud K.] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Human Genet, Munich, Germany	University of Munich; University of Munich	Steinlein, OK (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Human Genet, Munich, Germany.	Ortrud.Steinlein@med.uni-muenchen.de		Eggert, Marlene/0000-0002-9113-9643	Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LudwigMaximilians-Universitat Munchen e.V.	Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LudwigMaximilians-Universitat Munchen e.V.	This study was supported by the Verein zur Forderung von Wissenschaft und Forschung an der Medizinischen Fakultat der LudwigMaximilians-Universitat Munchen e.V. to MR (no grant number or URL available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benusiglio PR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0163-z; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Choyke PL, 2003, RADIOLOGY, V226, P33, DOI 10.1148/radiol.2261011296; Gupta S, 2007, AM J ROENTGENOL, V209, P1291; Hasumi H, 2016, INT J UROL, V23, P204, DOI 10.1111/iju.13015; HORNSTEIN OP, 1975, ARCH DERMATOL FORSCH, V253, P161, DOI 10.1007/BF00582068; Houweling AC, 2011, BRIT J CANCER, V105, P1912, DOI 10.1038/bjc.2011.463; Iribe Y, 2015, PATHOL INT, V65, P126, DOI 10.1111/pin.12254; Iwabuchi C, 2018, J DERMATOL SCI, V89, P77, DOI 10.1016/j.jdermsci.2017.10.014; Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; Laviolette LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15866; MAHER ER, 1990, J MED GENET, V27, P311, DOI 10.1136/jmg.27.5.311; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Prasad SR, 2006, RADIOGRAPHICS, V26, P1795, DOI 10.1148/rg.266065010; Sattler EC, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0558-0; Sattler EC, 2018, BRIT J DERMATOL, V178, pE132, DOI 10.1111/bjd.15937; Schmidt LS, 2015, NAT REV UROL, V12, P558, DOI 10.1038/nrurol.2015.206; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Syngal S, 2015, AM J GASTROENTEROL, V110, P223, DOI 10.1038/ajg.2014.435; Woodward ER, 2008, CLIN CANCER RES, V14, P5925, DOI 10.1158/1078-0432.CCR-08-0608; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393	23	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209504	10.1371/journal.pone.0209504	http://dx.doi.org/10.1371/journal.pone.0209504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586397	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400068
J	Smith, SC; Zhou, CZ; Stevie, FA; Garcia, R				Smith, Stephen C.; Zhou, Chuanzhen; Stevie, Fred A.; Garcia, Roberto			Imaging and quantitative analysis of insecticide in mosquito net fibers using Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS)	PLOS ONE			English	Article							WASH RESISTANCE; OLYSET(R) NET; POLYMERS; EFFICACY	Time-of-flight secondary ion mass spectrometry (ToF-SIMS) analysis was used to qualitatively and quantitatively assess the distribution of permethrin insecticide on the surfaces and interiors of Olyset long-lasting insecticidal net (LLIN) fibers. Total insecticide content in LLINs has been established using many analytical methods. However, it is important to quantify the bioavailable portion residing on the fiber surfaces for incorporated LLINs. ToF-SIMS is a very surface sensitive technique and can directly image the spatial distribution of permethrin insecticide on the surface of Olyset fibers. Surface permethrin appeared as patchy deposits which were easily removed by acetone and reappeared after several days as interior permethrin migrated (bloomed) from the fiber interior. After a wash/incubation cycle, permethrin deposits were more diffuse and less concentrated than those on the as-received fibers. ToF-SIMS is particularly sensitive to detect the Cl- ion, which is the characteristic ion of permethrin. Ion implantation and quantification of dopants using SIMS is well established in the semiconductor industry. In this study, quantitative depth profiling was carried out using 35 Cl- ion implantation to correlate secondary ion yield with permethrin concentration, yielding a limit of detection of 0.051 wt% for permethrin. In some cases, surface concentration differed greatly from the fiber interior (>1 mu m below the surface). Two-and three-dimensional mapping of Cl at sub-micrometer resolution showed permethrin to be dissolved throughout the fiber, with about 2 vol% residing in disperse, high-concentration domains. This suggests that these fibers fall into the class of monolithic sustained-release devices. It is expected that ToF-SIMS can be a valuable tool to provide insight into the insecticide release behavior of other LLIN products, both current and future.	[Smith, Stephen C.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Zhou, Chuanzhen; Stevie, Fred A.; Garcia, Roberto] North Carolina State Univ, Analyt Instrumentat Facil, Raleigh, NC 27695 USA	Centers for Disease Control & Prevention - USA; University of North Carolina; North Carolina State University	Smith, SC (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.	fred_stevie@ncsu.edu			CDC Innovation Fund; State of North Carolina; National Science Foundation [ECCS-1542015]	CDC Innovation Fund; State of North Carolina; National Science Foundation(National Science Foundation (NSF))	This study was financially supported by the CDC Innovation Fund. This work was performed in part at the Analytical Instrumentation Facility (AIF) at North Carolina State University, which is supported by the State of North Carolina and the National Science Foundation (award number ECCS-1542015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the following persons for their assistance in the course of this work: Charles B. Mooney (North Carolina State University Analytical Instrumentation Facility) for the SEM micrograph used in Fig 1; John Lucas (Sumitomo Chemical Company) for the samples of unused Olyset netting; and John E. Gimnig (Centers for Disease Control and Prevention) for samples of depleted Olyset netting. The authors also express gratitude to the CDC Innovation Fund for providing financial support for this work.; This work was performed in part at the Analytical Instrumentation Facility (AIF) at North Carolina State University, which is supported by the State of North Carolina and the National Science Foundation (award number ECCS-1542015). The AIF is a member of the North Carolina Research Triangle Nanotechnology Network (RTNN), a site in the National Nanotechnology Coordinated Infrastructure (NNCI).	[Anonymous], 2012, GLOB TUB REP 2012; Ansari MA, 2006, BIOEFFICACY OLYSET J, V22, P102, DOI [10.2987/8756-971X(2006)22[102:BOONAM]2.0.CO;2, DOI 10.2987/8756-971X(2006)22[102:BOONAM]2.0.CO;2]; Azondekon R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-6; Bart JCJ, 2006, PLASTICS ADDITIVES: ADVANCED INDUSTRIAL ANALYSIS, P403; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Billingham NC, 1990, OXIDATION INHIBITION, V2, P250; CALVERT PD, 1979, J APPL POLYM SCI, V24, P357, DOI 10.1002/app.1979.070240205; CIPAC, 2012, CIPAC HDB N, P34; CIPAC, 2009, CIPAC HDB M, P41; Collaborative International Pesticides Analytical Council (CIPAC), 2009, CIPAC HDB M, P159; Crecelius AC, 2014, ANAL CHIM ACTA, V808, P10, DOI 10.1016/j.aca.2013.07.033; Fan L -T., 1989, CONTROLLED RELEASE Q, P9; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Hanton SD, 2001, CHEM REV, V101, P527, DOI 10.1021/cr9901081; Itoh T, 2009, ACS SYM SER, V1014, P153, DOI 10.1021/bk-2009-1014.ch011; Itoh Takaaki, 1996, Medical Entomology and Zoology, V47, P171; Jeyalakshmi T, 2006, J AM MOSQUITO CONTR, V22, P107, DOI 10.2987/8756-971X(2006)22[107:CEAPOP]2.0.CO;2; Lengeler C, 1996, NET GAIN NEW METHOD; Lewis D. H., 1977, Proceedings of a Symposium at the 173rd Meeting of the American Chemical Society on Controlled Release Pesticides, New Orleans, Louisiana, 1977; ed. by H.B. Scher. (ACS Symposium Series, 53)., P1; Mahoney CM, 2010, MASS SPECTROM REV, V29, P247, DOI 10.1002/mas.20233; Maxwell C. A., 2006, Journal of Vector Borne Diseases, V43, P1; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; Okuno T, 2008, PCT patent appl, Patent No. [WO2008/ 004711 A2, 2008004711A2]; Sharma SK, 2006, J MED ENTOMOL, V43, P884, DOI 10.1603/0022-2585(2006)43[884:WRABOO]2.0.CO;2; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; Weng L-T, 2013, TOF SIMS MAT ANAL MA, P503; WHO, 2012, GLOB PLAN INS RES MA; WHOPES, WHOCDSWHOPES20014; World Health Organization, 2015, ACHIEVING MALARIA MD; Zhou CZ, 2016, J VAC SCI TECHNOL B, V34, DOI 10.1116/1.4940394	30	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209119	10.1371/journal.pone.0209119	http://dx.doi.org/10.1371/journal.pone.0209119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586430	gold, Green Submitted, Green Published			2022-12-26	WOS:000454416400053
J	Aggarwal, S; Gabrovsek, L; Langeberg, LK; Golkowski, M; Ong, SE; Smith, FD; Scott, JD				Aggarwal, Stacey; Gabrovsek, Laura; Langeberg, Lorene K.; Golkowski, Martin; Ong, Shao-En; Smith, F. Donelson; Scott, John D.			Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase-anchoring protein (AKAP); protein kinase A (PKA); cell signaling; signal transduction; breast cancer; cancer biology; cell migration; mitochondria; signaling islands	EPITHELIAL-MESENCHYMAL TRANSITION; DEPENDENT PROTEIN-KINASE; ANCHORING PROTEIN; PROGRESSION; FISSION; DRP1; PHOSPHORYLATION; DEGRADATION; REGULATOR; MIGRATION	Breast cancer screening and new precision therapies have led to improved patient outcomes. Yet, a positive prognosis is less certain when primary tumors metastasize. Metastasis requires a coordinated program of cellular changes that promote increased survival, migration, and energy consumption. These pathways converge on mitochondrial function, where distinct signaling networks of kinases, phosphatases, and metabolic enzymes regulate these processes. The protein kinase A-anchoring protein dAKAP1 compartmentalizes protein kinase A (PKA) and other signaling enzymes at the outer mitochondrial membrane and thereby controls mitochondrial function and dynamics. Modulation of these processes occurs in part through regulation of dynamin-related protein 1 (Drp1). Here, we report an inverse relationship between the expression of dAKAP1 and mesenchymal markers in breast cancer. Molecular, cellular, and in silico analyses of breast cancer cell lines confirmed that dAKAP1 depletion is associated with impaired mitochondrial function and dynamics, as well as with increased glycolytic potential and invasiveness. Furthermore, disruption of dAKAP1-PKA complexes affected cell motility and mitochondrial movement toward the leading edge in invasive breast cancer cells. We therefore propose that depletion of dAKAP1-PKA signaling islands from the outer mitochondrial membrane augments progression toward metastatic breast cancer.	[Aggarwal, Stacey; Gabrovsek, Laura; Langeberg, Lorene K.; Golkowski, Martin; Ong, Shao-En; Smith, F. Donelson; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, 1959 NE Pacific St, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Smith, FD; Scott, JD (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, 1959 NE Pacific St, Seattle, WA 98195 USA.	smithdon@uw.edu; scottjdw@uw.edu		Aggarwal, Stacey/0000-0002-7346-0716	National Institutes of Health [DK105542]; Dept. of Molecular and Cellular Biology at the University of Washington; U.S. Dept. of Defense [CA150370]; National Institutes of Health Grant from NIGMS [PHS NRSA T32GM007270]; National Institutes of Health Grant from NIAMS [AR065459]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Molecular and Cellular Biology at the University of Washington; U.S. Dept. of Defense(United States Department of Defense); National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Grant from NIAMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health Grant PHS NRSA T32GM007270 from NIGMS.; Supported in part by a grant from the Dept. of Molecular and Cellular Biology at the University of Washington.; Supported by Grant CA150370 from the U.S. Dept. of Defense and National Institutes of Health Grant AR065459 from NIAMS.; Supported by National Institutes of Health Grant DK105542.	Aggarwal-Howarth S, 2017, BIOCHEM SOC T, V45, P371, DOI 10.1042/BST20160329; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Caino MC, 2017, J CLIN INVEST, V127, P3755, DOI 10.1172/JCI93172; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chiarugi P, 2016, CANCER LETT, V380, P272, DOI 10.1016/j.canlet.2015.10.027; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cunniff B, 2016, MOL BIOL CELL, V27, P2662, DOI 10.1091/mbc.E16-05-0286; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Flippo KH, 2018, J NEUROSCI, V38, P8233, DOI 10.1523/JNEUROSCI.0649-18.2018; Glaven JA, 1996, J BIOL CHEM, V271, P27374, DOI 10.1074/jbc.271.44.27374; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Kjallquist U, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4021-6; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lawrence RT, 2015, CELL REP, V11, P630, DOI 10.1016/j.celrep.2015.03.050; Li J, 2017, ONCOGENE, V36, P4901, DOI 10.1038/onc.2017.98; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Ma YL, 2008, J BIOL CHEM, V283, P11743, DOI 10.1074/jbc.M710494200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Merrill RA, 2014, INT J BIOCHEM CELL B, V48, P92, DOI 10.1016/j.biocel.2013.12.012; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noone AM, 2018, SEER CANC STAT REV 1; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pattabiraman DR, 2016, SCIENCE, V351, P1042, DOI 10.1126/science.aad3680; Pelicano H, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0434-6; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rinaldi L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.241; Saris NEL, 2005, BIOCHEMISTRY-MOSCOW+, V70, P187, DOI 10.1007/s10541-005-0100-9; Sciacovelli M, 2017, FEBS J, V284, P3132, DOI 10.1111/febs.14090; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Smith FD, 2018, P NATL ACAD SCI USA, V115, pE11465, DOI 10.1073/pnas.1816614115; Smith FD, 2017, SCIENCE, V356, P1288, DOI 10.1126/science.aaj1669; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	74	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3152	3168		10.1074/jbc.RA118.006741	http://dx.doi.org/10.1074/jbc.RA118.006741			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30598507	hybrid, Green Published			2022-12-26	WOS:000464980100015
J	Chun, HR; Korolnek, T; Lee, CJ; Coyne, HJ; Winge, DR; Kim, BE; Petris, MJ				Chun, Haarin; Korolnek, Tamara; Lee, Chul-Jin; Coyne, H. Jerome, III; Winge, Dennis R.; Kim, Byung-Eun; Petris, Michael J.			An extracellular histidine-containing motif in the zinc transporter ZIP4 plays a role in zinc sensing and zinc-induced endocytosis in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metal homeostasis; endocytosis; zinc; transport; trafficking; cellular import; extracellular sensing; metal toxicity; protein trafficking; ZIP4	BIOCHEMICAL-CHARACTERIZATION; PROTEIN; MUTATIONS; SLC39A4; GENE; LOCALIZATION; FAMILY; MODEL	Zinc is an essential trace element that serves as a cofactor for enzymes in critical biochemical processes and also plays a structural role in numerous proteins. Zinc transporter ZIP4 (ZIP4) is a zinc importer required for dietary zinc uptake in the intestine and other cell types. Studies in cultured cells have reported that zinc stimulates the endocytosis of plasma membrane-localized ZIP4 protein, resulting in reduced cellular zinc uptake. Thus, zinc-regulated trafficking of ZIP4 is a key means for regulating cellular zinc homeostasis, but the underlying mechanisms are not well understood. In this study, we used mutational analysis, immunoblotting, HEK293 cells, and immunofluorescence microscopy to identify a histidine-containing motif ((HTH)-H-398) in the first extracellular loop that is required for high sensitivity to low zinc concentrations in a zinc-induced endocytic response of mouse ZIP4 (mZIP4). Moreover, using synthetic peptides with selective substitutions and truncated mZIP4 variants, we provide evidence that histidine residues in this motif coordinate a zinc ion in mZIP4 homodimers at the plasma membrane. These findings suggest that (HTH)-H-398 is an important zinc-sensing motif for eliciting high-affinity zinc-stimulated endocytosis of mZIP4 and provide insight into cellular mechanisms for regulating cellular zinc homeostasis in mammalian cells.	[Chun, Haarin; Korolnek, Tamara; Kim, Byung-Eun] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Kim, Byung-Eun] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Lee, Chul-Jin] NICHD, Unit Struct & Chem Biol Membrane Prot, NIH, Bethesda, MD 20892 USA; [Coyne, H. Jerome, III; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Coyne, H. Jerome, III; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Petris, Michael J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Coyne, H. Jerome, III] Beckman Coulter, Chaska, MN 55318 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Beckman Coulter Inc.	Kim, BE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Petris, MJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	bekim@umd.edu; petrism@missouri.edu		Winge, Dennis/0000-0003-1160-1189; Korolnek, Tamara/0000-0003-2562-0831; Chun, Haarin/0000-0002-2668-6296	National Institutes of Health [DK110195, DK66333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK110195 (to B.-E. K.) and DK66333 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Huang LP, 2007, FEBS J, V274, P3986, DOI 10.1111/j.1742-4658.2007.05933.x; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Kury S, 2016, EUR J HUM GENET, V24, DOI 10.1038/ejhg.2015.203; Kury Sebastien, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9178; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Nakano A, 2003, J INVEST DERMATOL, V120, P963, DOI 10.1046/j.1523-1747.2003.12243.x; Pawa S, 2008, AM J MED SCI, V336, P430, DOI 10.1097/MAJ.0b013e31815f2c05; PRASAD AS, 1995, NUTRITION, V11, P93; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Schmitt S, 2009, HUM MUTAT, V30, P926, DOI 10.1002/humu.20988; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11979	40	11	11	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2815	2826		10.1074/jbc.RA118.005203	http://dx.doi.org/10.1074/jbc.RA118.005203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593504	Green Published, hybrid			2022-12-26	WOS:000459601600020
J	You, YY; Chen, JL; Zhu, FM; Xu, Q; Han, L; Gao, X; Zhang, XY; Luo, HBR; Miao, JM; Sun, XD; Ren, HY; Du, Y; Guo, LJ; Wang, XY; Wang, Y; Chen, SZ; Huang, N; Li, JY				You, Yuanyuan; Chen, Junli; Zhu, Feimei; Xu, Qian; Han, Lu; Gao, Xiang; Zhang, Xiaoyu; Luo, Hongbo R.; Miao, Junming; Sun, Xiaodong; Ren, Hongyu; Du, Yu; Guo, Lijuan; Wang, Xiaoying; Wang, Yi; Chen, Shanze; Huang, Ning; Li, Jingyu			Glutaredoxin 1 up-regulates deglutathionylation of alpha 4 integrin and thereby restricts neutrophil mobilization from bone marrow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutathionylation; reactive oxygen species (ROS); integrin; neutrophil; inflammation; alpha 4 integrin; glutaredoxin; immune response; neutrophil mobilization; vascular cell adhesion molecular 1 (VCAM-1)	PROTEIN S-GLUTATHIONYLATION; REACTIVE OXYGEN; PLASMA GLUTAREDOXIN; LIGAND-BINDING; CELLS; ADHESION; VLA-4; INFLAMMATION; THIOREDOXIN; RECRUITMENT	alpha 4 integrin plays a crucial role in retention and release of neutrophils from bone marrow. Although alpha 4 integrin is known to be a potential target of reactive oxygen species (ROS)-induced cysteine glutathionylation, the physiological significance and underlying regulatory mechanism of this event remain elusive. Here, using in vitro and in vivo biochemical and cell biology approaches, we show that physiological ROS-induced glutathionylation of alpha 4 integrin in neutrophils increases the binding of neutrophil-associated alpha 4 integrin to vascular cell adhesion molecule 1 (VCAM-1) on human endothelial cells. This enhanced binding was reversed by extracellular glutaredoxin 1 (Grx1), a thiol disulfide oxidoreductase promoting protein deglutathionylation. Furthermore, in a murine inflammation model, Grx1 disruption dramatically elevated alpha 4 glutathionylation and subsequently enhanced neutrophil egress from the bone marrow. Corroborating this observation, intravenous injection of recombinant Grx1 into mice inhibited alpha 4 glutathionylation and thereby suppressed inflammation-induced neutrophil mobilization from the bone marrow. Taken together, our results establish ROS-elicited glutathionylation and its modulation by Grx1 as pivotal regulatory mechanisms controlling alpha 4 integrin affinity and neutrophil mobilization from the bone marrow under physiological conditions.	[You, Yuanyuan; Chen, Junli; Zhu, Feimei; Xu, Qian; Miao, Junming; Ren, Hongyu; Du, Yu; Guo, Lijuan; Wang, Xiaoying; Wang, Yi; Chen, Shanze; Huang, Ning; Li, Jingyu] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Pathophysiol, Chengdu 610041, Sichuan, Peoples R China; [Sun, Xiaodong] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Pharmacol, Chengdu 610041, Sichuan, Peoples R China; [Han, Lu; Gao, Xiang] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Han, Lu; Gao, Xiang] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Xiaoyu] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Zhang, Xiaoyu] Peking Union Med Coll, Tianjin 300020, Peoples R China; [Luo, Hongbo R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Luo, Hongbo R.] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Luo, Hongbo R.] Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Huang, N; Li, JY (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Pathophysiol, Chengdu 610041, Sichuan, Peoples R China.	ninghuang2018@163.com; jingyuli@scu.edu.cn	Zhang, xiaoyu/GXA-3206-2022; Li, Jingyu/GSD-1924-2022; Li, Jing/GYU-5036-2022		National Science Foundation of China [81803648, 81770580, 31701098, 81803183, 81470931, 31401188]; Sichuan University [2018SCUH0039, 2014ASCU11042]; Applied Basic Research Program of Sichuan Province [2016JY0027]; Science Foundation for Excellent Youth Scholars of Sichuan University [2016SCU04A08]; Sichuan Association for Science and Technology [2018RCTJ04]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan University(Sichuan University); Applied Basic Research Program of Sichuan Province; Science Foundation for Excellent Youth Scholars of Sichuan University; Sichuan Association for Science and Technology	Supported by National Science Foundation of China Grant 81803648 and Sichuan University Grant 2018SCUH0039.; Supported by National Science Foundation of China Grant 81770580.; Supported by Applied Basic Research Program of Sichuan Province Grant 2016JY0027.; Supported by National Science Foundation of China Grant 31701098.; Supported by Grant National Science Foundation of China 81803183.; Supported by National Science Foundation of China Grant 81470931.; Supported by National Science Foundation of China Grant 31401188, Science Foundation for Excellent Youth Scholars of Sichuan University Grant 2016SCU04A08, Sichuan Association for Science and Technology 2018RCTJ04, and Sichuan University Grant 2014ASCU11042.	Anathy V, 2018, NAT MED, V24, P1128, DOI 10.1038/s41591-018-0090-y; Bajrami B, 2016, J EXP MED, V213, P1999, DOI 10.1084/jem.20160393; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; Burdon PCE, 2005, BLOOD, V105, P2543, DOI 10.1182/blood-2004-08-3193; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Du YT, 2014, ACTA DIABETOL, V51, P225, DOI 10.1007/s00592-013-0498-2; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Giganti D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02528-7; Harp JA, 2005, VET IMMUNOL IMMUNOP, V104, P99, DOI 10.1016/j.vetimm.2004.10.007; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Hyun YM, 2017, J LEUKOCYTE BIOL, V102, P617, DOI 10.1189/jlb.1RU1216-521R; Ibbotson GC, 2001, NAT MED, V7, P465, DOI 10.1038/86539; Kirveskari J, 2000, J LEUKOCYTE BIOL, V68, P243; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuipers I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038984; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Liu SY, 2008, EUR J IMMUNOL, V38, P410, DOI 10.1002/eji.200737556; Miller OG, 2019, ANTIOXID REDOX SIGN, V30, P1352, DOI 10.1089/ars.2017.7411; Nakamura H, 1998, FREE RADICAL BIO MED, V24, P1176, DOI 10.1016/S0891-5849(97)00429-2; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Peltoniemi MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-133; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Petty JM, 2009, J IMMUNOL, V182, P604, DOI 10.4049/jimmunol.182.1.604; Popov D, 2014, ARCH PHYSIOL BIOCHEM, V120, P123, DOI 10.3109/13813455.2014.944544; Pujades C, 1996, BIOCHEM J, V313, P899, DOI 10.1042/bj3130899; Rettig MP, 2012, LEUKEMIA, V26, P34, DOI 10.1038/leu.2011.197; Richter R, 2017, TRANSFUS MED HEMOTH, V44, P151, DOI 10.1159/000477262; Rose DM, 2002, IMMUNOL REV, V186, P118, DOI 10.1034/j.1600-065X.2002.18611.x; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Sevilla F, 2015, J EXP BOT, V66, P2945, DOI 10.1093/jxb/erv146; Shelton MD, 2008, MOL CELLS, V25, P332; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Stojkov D, 2017, J CELL BIOL, V216, P4073, DOI 10.1083/jcb.201611168; Tafani M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3907147; TAKADA Y, 1989, EMBO J, V8, P1361, DOI 10.1002/j.1460-2075.1989.tb03516.x; THOMAS JA, 1995, METHOD ENZYMOL, V251, P423, DOI 10.1016/0076-6879(95)51145-8; Tseng A, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00134; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; Valcarcell M, 2014, J INVEST DERMATOL, V134, P470, DOI 10.1038/jid.2013.342; Yang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070979; Yu YM, 2013, J BIOL CHEM, V288, P32314, DOI 10.1074/jbc.M113.501668; Yuan Y, 2013, RADIAT RES, V179, P62, DOI 10.1667/RR3119.1; Zhang X, 2017, CELL REP, V20, P224, DOI 10.1016/j.celrep.2017.05.070; Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47; Zhu HY, 2017, J IMMUNOL, V198, P2854, DOI 10.4049/jimmunol.1602006	51	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2616	2627		10.1074/jbc.RA118.006096	http://dx.doi.org/10.1074/jbc.RA118.006096			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30598505	hybrid, Green Published			2022-12-26	WOS:000459601600005
J	Cai, CC; Ge, T; Zhang, MX				Cai, Chuanchuan; Ge, Tao; Zhang, Mingxu			Study on dielectric properties of high organic sulfur coking coal and modeling sulfur compounds	PLOS ONE			English	Article							DESULFURIZATION	Coking coal is geologically scarce resource and most of them cannot be directly used in steel making due to their higher sulfur content. One desulfurization method that has great potential for massive application is microwave desulfurization, which removes the relatively stubborn organic sulfur under mild conditions. The dielectric properties of coals determine the efficiency of the microwave energy absorption. The key to describing the mechanism of microwave desulfurization and further improvement of the desulfurization efficiency is the dielectric response of organic sulfur compounds in coal to microwave. This study focuses on existing formand microwave response of organic sulfur components of three typical coking coal in China. Resultsshowed that the major organic sulfur in selected coals is thiophene which has a stable structure and is the most difficult to be removed. Several dielectric peaks (dielectric loss) andsignificant differencesofeach selected coal samples are observed. The microwave absorption peaks of the model sulfur compounds are identified to be within 9-11GHz. The real parts of the relative dielectric constants (hereinafter referred to as epsilon') shows a decreasing trend as: diphenyl sulfoxide > diphenyl sulfone > diphenyl sulfide > dibenzothiophene > Octadecane thiol. Response to microwaveare observed to be distinctively different between sulfur-containing and sulfur-free model compounds. The dielectric polarization of mixture (coal mixed with model sulfur compounds) is greater than pure coal. Meanwhile the higher the sulfur content of the coal, the greater the epsilon' is. Sulfur component-sin coal can significantly influence its polarization.	[Cai, Chuanchuan; Ge, Tao; Zhang, Mingxu] Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan, Peoples R China	Anhui University of Science & Technology	Cai, CC (corresponding author), Anhui Univ Sci & Technol, Dept Mat Sci & Engn, Huainan, Peoples R China.	flychuan2006@126.com			Anhui Provincial Natural Science Foundation [1608085QE123]; China Postdoctoral Science Foundation Project [2018M632519]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); China Postdoctoral Science Foundation Project(China Postdoctoral Science Foundation)	This work is financially supported by Anhui Provincial Natural Science Foundation (NO. 1608085QE123) to CC and the China Postdoctoral Science Foundation Project (2018M632519) to TG.	[蔡川川 Cai Chuanchuan], 2013, [煤炭学报, Journal of China Coal Society], V38, P1656; Chelgani SC, 2011, FUEL, V90, P3156, DOI 10.1016/j.fuel.2011.06.045; Huang Wenhui, 2010, COAL GEOLOGY CHINA, V22, P1; [黄煜镔 HUANG Yu-bin], 2010, [煤炭学报, Journal of China Coal Society], V35, P135; Juan Martinez-Vega, 2013, DIELECTRIC MAT ELECT; [马双忱 Ma Shuangchen], 2011, [化学通报, Chemistry], V74, P41; Ma XM, 2015, INT J MINER PROCESS, V139, P31, DOI 10.1016/j.minpro.2015.04.009; Tao G, 2018, ASIA-PAC J CHEM ENG, V13, DOI 10.1002/apj.2214; Tao X., 2014, INT J COAL SCI TECHN, V1, P113, DOI [10.1007/ s40789-014-0006-5, DOI 10.1007/S40789-014-0006-5]; Tao XX, 2016, FUEL, V181, P1027, DOI 10.1016/j.fuel.2016.05.005; [王晴东 Wang Qingdong], 2016, [煤炭学报, Journal of China Coal Society], V41, P1540; Xu N., 2014, J CHEM PHARM RES, V6, P898; Yang, 2013, CATTLE FACE RECOGNIT, P1; YANG JK, 1987, FUEL, V66, P1745, DOI 10.1016/0016-2361(87)90377-2; Zhang B, 2017, INT J MINER PROCESS, V168, P136, DOI 10.1016/j.minpro.2017.10.004; Zhang SF, 2015, J IRON STEEL RES INT, V22, P897, DOI 10.1016/S1006-706X(15)30087-X	16	13	13	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0208125	10.1371/journal.pone.0208125	http://dx.doi.org/10.1371/journal.pone.0208125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605468	Green Published, Green Submitted, gold			2022-12-26	WOS:000454759900009
J	Pechmann, A; Wellmann, S; Stoecklin, B; Kruger, M; Zieger, B				Pechmann, Astrid; Wellmann, Sven; Stoecklin, Benjamin; Krueger, Marcus; Zieger, Barbara			Increased von Willebrand factor parameters in children with febrile seizures	PLOS ONE			English	Article							LABORATORY DIAGNOSIS; VASOPRESSIN; COPEPTIN	Introduction Primary blood coagulation and wound sealing are orchestrated by von Willebrand factor (VWF), a large multimeric glycoprotein. Upon release of arginine vasopressin (AVP), VWF containing high molecular weight multimers is secreted. By measuring copeptin, the C-terminal part of the AVP prohormone, we recently found strongly increased AVP levels in children with febrile seizures (FS) as compared to children with fever but without seizures. It is unknown if increased AVP levels in FS are of any biological function. Therefore, our a priori hypothesis was that children with FS have increased VWF parameters in parallel with higher AVP levels. Methods We conducted a prospective, cross-sectional study of children aged between 6 months and 5 years. Children that presented at our emergency department with fever or a recent FS (within four hours) were evaluated to be included to the study. We measured serum copeptin and VWF parameters, including analyses of VWF: Antigen (WVF:Ag), VWF: collagen binding activity (VWF:CB) and VWF multimers in children with FS, febrile infections without seizures and additionally, in a non-febrile control group. Results We included 54 children in our study, 30 with FS, 10 in the febrile control group, and 14 in the non-febrile control group. Serum copeptin levels were significantly higher in children with FS (median [IQR] 24.73 pmol/l [13.65-68.65]) compared to the febrile control group (5.66 pmol/l [4.15-8.07], p = 0.002) and the non-febrile control group (4.78 pmol/l [3.33-5.3], p< 0.001). VWF:CB levels were also significantly higher in children with FS (VWF: CB 2.29 U/ml [1.88-2.97]) as compared to the febrile (VWF:CB 1.41 U/ml [1.27-1.93], p = 0.048) and the non-febrile control group (VWF:CB 1.15 U/ml [0.98-1.21], p<0.001). VWF:Ag tended to be higher in children with FS compared to both control groups. Multivariate regression analysis revealed FS and copeptin as major determinants of VWF:CB. Conclusions Our results suggest that increased secretion of AVP in children with FS is associated with higher plasma levels of VWF parameters. Especially VWF:CB may serve as additional bio-marker in the diagnosis of FS.	[Pechmann, Astrid] Univ Freiburg, Dept Neuropediat & Muscle Disorders, Med Ctr, Fac Med, Freiburg, Germany; [Wellmann, Sven; Stoecklin, Benjamin] Univ Basel, Dept Neonatol, Univ Childrens Hosp Basel UKBB, Basel, Switzerland; [Krueger, Marcus] Municipal Hosp Munich Campus Harlaching & Schwabi, Dept Neonatol, Munich, Germany; [Zieger, Barbara] Univ Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Med Ctr,Fac Med, Freiburg, Germany	University of Freiburg; University of Basel; University of Freiburg	Pechmann, A (corresponding author), Univ Freiburg, Dept Neuropediat & Muscle Disorders, Med Ctr, Fac Med, Freiburg, Germany.	astrid.pechmann@uniklinik-freiburg.de	Yue, Yuhang/AAW-9279-2021	Stoecklin, Benjamin/0000-0003-0021-0262				Baumann RJ, 1996, PEDIATRICS, V97, P773; Bergman DA, 1996, PEDIATRICS, V97, P769; Bolignano D, 2014, CLIN CHEM LAB MED, V52, P1447, DOI 10.1515/cclm-2014-0379; Christ-Crain M, 2016, NAT REV ENDOCRINOL, V12, P168, DOI 10.1038/nrendo.2015.224; de Faria FC, 2016, INDIAN J HEMATOL BLO, V32, P135, DOI 10.1007/s12288-015-0627-x; Desch Karl C, 2018, F1000Res, V7, P96, DOI 10.12688/f1000research.13056.1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fetveit A, 2008, EUR J PEDIATR, V167, P17, DOI 10.1007/s00431-007-0577-x; Flood VH, 2014, SEMIN THROMB HEMOST, V40, P41, DOI 10.1055/s-0033-1363166; Heilmann C, 2010, THROMB HAEMOSTASIS, V103, P962, DOI 10.1160/TH09-07-0497; Jones Tonia, 2007, Int J Med Sci, V4, P110; Kallas A, 2001, ANN HEMATOL, V80, P466; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; L'Abate P, 2013, RESP PHYSIOL NEUROBI, V185, P222, DOI 10.1016/j.resp.2012.10.011; Leung AK., 2018, DRUGS CONTEXT, V7, P212536, DOI [10.7573/dic.212536, DOI 10.7573/DIC.212536]; Nagaki S, 1996, LIFE SCI, V58, P2233, DOI 10.1016/0024-3205(96)00218-4; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Patel N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4240; Richmond Charlotte A, 2003, J Neurosci Nurs, V35, P281; Roberts JC, 2015, INT J LAB HEMATOL, V37, P11, DOI 10.1111/ijlh.12345; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Schuchmann S, 2011, EPILEPSIA, V52, P1949, DOI 10.1111/j.1528-1167.2011.03259.x; Sharma R, 2017, BLOOD, V130, P2386, DOI 10.1182/blood-2017-05-782029; Shinnar S, 2002, J CHILD NEUROL, V17, pS44, DOI 10.1177/08830738020170010601; Stocklin B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124663; Sutor AH, 2001, SEMIN THROMB HEMOST, V27, P287, DOI 10.1055/s-2001-15267; Verity CM, 1998, NEW ENGL J MED, V338, P1723, DOI 10.1056/NEJM199806113382403; Vestergaard M, 2007, AM J EPIDEMIOL, V165, P911, DOI 10.1093/aje/kwk086	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0210004	10.1371/journal.pone.0210004	http://dx.doi.org/10.1371/journal.pone.0210004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605489	Green Submitted, Green Published, gold			2022-12-26	WOS:000454759900027
J	Hehrlein, C; Schorch, B; Kress, N; Arab, A; von zur Muhlen, C; Bode, C; Epting, T; Haberstroh, J; Mey, L; Schwarzbach, H; Kinscherf, R; Stachniss, V; Schiestel, S; Kovacs, A; Fischer, H; Nennig, E				Hehrlein, Christoph; Schorch, Bjoern; Kress, Nadia; Arab, Amina; von zur Muehlen, Constantin; Bode, Christoph; Epting, Thomas; Haberstroh, Joerg; Mey, Lilly; Schwarzbach, Hans; Kinscherf, Ralf; Stachniss, Vitus; Schiestel, Stefanie; Kovacs, Adalbert; Fischer, Harald; Nennig, Ernst			Zn-alloy provides a novel platform for mechanically stable bioresorbable vascular stents	PLOS ONE			English	Article							MAGNESIUM ALLOYS; BIODEGRADABLE METALS; ARTERY; CELLS; CYTOTOXICITY; MULTICENTER; SCAFFOLDS; RESPONSES; BEHAVIOR; LESIONS	Metallic Zn alloys have recently gained interest as potential candidates for developing platforms of bioresorbable vascular stents (BVS). Previous studies revealed that Mg alloys used for BVS can degrade too early, whereas PLLA materials may fail to provide effective scaffolding properties. Here we report on results of a new bioresorbable, metallic stent made from a Zn-Ag alloy studied in a porcine animal model of thrombosis and restenosis. While the tensile strength (MPa) of Zn-3Ag was higher than that of PLLA and resembled Mg's (WE43), fracture elongation (%) of Zn-3Ag was much greater (18-fold) than the PLLA's or Mg alloy's (WE43). Zn-3Ag exposed to HAoSMC culture medium for 30 days revealed degradation elements consisting of Zn, O, N, C, P, and Na at a 6 nm surface depth. Platelet adhesion rates and blood biocompatibility did not differ between Zn-3Ag, PLLA, Mg (WE43), and non-resorbable Nitinol (NiTi) stent materials. Balloon-expandable Zn-3Ag alloy BVS implanted into iliofemoral arteries of 15 juvenile domestic pigs were easily visible fluoroscopically at implantation, and their bioresorption was readily detectable via X-ray over time. Histologically, arteries with Zn-3Ag BVS were completely endothelialized, covered with neointima, and were patent at 1, 3, and 6 months follow-up with no signs of stent thrombosis. Zn-3Ag alloy appears to be a promising material platform for the fabrication of a new generation of bioresorbable vascular stents.	[Hehrlein, Christoph; Schorch, Bjoern; Kress, Nadia; Arab, Amina; von zur Muehlen, Constantin; Bode, Christoph] Univ Freiburg, Fac Med, Heart Ctr, Dept Cardiol & Angiol 1, Freiburg, Germany; [Epting, Thomas] Univ Freiburg, Fac Med, Med Ctr, Dept Lab Med, Freiburg, Germany; [Haberstroh, Joerg] Univ Freiburg, Fac Med, Med Ctr, Div Expt Surg,Ctr Expt Models & Transgen Serv, Freiburg, Germany; [Mey, Lilly; Schwarzbach, Hans; Kinscherf, Ralf] Philipps Univ Marburg, Dept Med Cell Biol, Inst Anat & Cell Biol, Marburg, Germany; [Stachniss, Vitus] Univ Marburg, Sch Dent, Dept Operat Dent & Endodont, Marburg, Germany; [Stachniss, Vitus] Univ Med Ctr Giessen & Marburg, Marburg, Germany; [Schiestel, Stefanie; Kovacs, Adalbert] Limedion GmbH, Mannheim, Germany; [Fischer, Harald; Nennig, Ernst] Optimed GmbH, Ettlingen, Germany	Universitats Herzzentrum Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Philipps University Marburg; Philipps University Marburg; University Hospital of Giessen & Marburg	Hehrlein, C (corresponding author), Univ Freiburg, Fac Med, Heart Ctr, Dept Cardiol & Angiol 1, Freiburg, Germany.	christoph.hehrlein@universitaets-herzzentrum.de	Schorch, Björn/T-2522-2019; Kinscherf, Ralf/AAV-7164-2021	Schorch, Bjorn/0000-0001-8311-0210	BMBF research foundation, Germany [13GW0035B]; Optimed GmbH; Limedion GmbH	BMBF research foundation, Germany; Optimed GmbH; Limedion GmbH	All authors received financial support from the BMBF research foundation, Germany (13GW0035B). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Optimed GmbH and Limedion GmbH provided support in the form of research materials and salaries for authors (Optimed GmbH: E. N. and H. F., Limedion GmbH: S. S. and A. K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045; Bowen PK, 2016, ADV HEALTHC MATER, V5, P1121, DOI 10.1002/adhm.201501019; Campos CM, 2014, CATHETER CARDIO INTE, V84, P46, DOI 10.1002/ccd.25541; Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x; Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gong HB, 2015, J BIOMED MATER RES B, V103, P1632, DOI 10.1002/jbm.b.33341; Haude M, 2016, LANCET, V387, P31, DOI 10.1016/S0140-6736(15)00447-X; Hehrlein C, 1996, CIRCULATION, V93, P641, DOI 10.1161/01.CIR.93.4.641; Hehrlein Christoph, 1999, Int J Cardiovasc Intervent, V2, P21; Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651; Kfoury G, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00032; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; King SB, 2000, CIRCULATION, V102, P81; Konstantinos K, 2016, J MECH BEHAV BIOMED, V40, P240; Ma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26661; Ma J, 2015, ACS BIOMATER SCI ENG, V1, P1174, DOI 10.1021/acsbiomaterials.5b00319; Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042; Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250; MURPHY JG, 1992, CIRCULATION, V86, P1596, DOI 10.1161/01.CIR.86.5.1596; Niu JL, 2016, MAT SCI ENG C-MATER, V69, P407, DOI 10.1016/j.msec.2016.06.082; Persaud-Sharma Dharam, 2013, J Biomim Biomater Tissue Eng, V17, P25, DOI 10.4028/www.scientific.net/JBBTE.17.25; Saper RB, 2009, AM FAM PHYSICIAN, V79, P768; Serruys PW, 2016, LANCET, V388, P2479, DOI 10.1016/S0140-6736(16)32050-5; Shearier ER, 2016, ACS BIOMATER SCI ENG, V2, P634, DOI 10.1021/acsbiomaterials.6b00035; Sikora-Jasinska M, 2017, MAT SCI ENG C-MATER, V77, P1170, DOI 10.1016/j.msec.2017.04.023; Tan LP, 2006, J BIOMED MATER RES B, V79B, P102, DOI 10.1002/jbm.b.30518; Tenekecioglu E, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0207-5; Wan P, 2013, MAT SCI ENG C-MATER, V33, P2885, DOI 10.1016/j.msec.2013.03.017; Werner M, 2014, JACC-CARDIOVASC INTE, V7, P305, DOI 10.1016/j.jcin.2013.09.009; Wu ZX, 2015, NATURE, V526, P62, DOI 10.1038/nature15364; Yang HT, 2018, ACTA BIOMATER, V71, P200, DOI 10.1016/j.actbio.2018.03.007; Yang HT, 2017, BIOMATERIALS, V145, P92, DOI 10.1016/j.biomaterials.2017.08.022; Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028; Zhu DH, 2017, ACS APPL MATER INTER, V9, P27453, DOI 10.1021/acsami.7b06654	35	25	25	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209111	10.1371/journal.pone.0209111	http://dx.doi.org/10.1371/journal.pone.0209111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601854	Green Published, gold, Green Submitted			2022-12-26	WOS:000454683200038
J	Stanev, D; Moustakas, K				Stanev, Dimitar; Moustakas, Konstantinos			Modeling musculoskeletal kinematic and dynamic redundancy using null space projection	PLOS ONE			English	Article							MATHEMATICAL-MODELS; MUSCLE; PROPRIOCEPTORS; SIMULATIONS; SYSTEMS; TENDON	The coordination of the human musculoskeletal system is deeply influenced by its redundant structure, in both kinematic and dynamic terms. Noticing a lack of a relevant, thorough treatment in the literature, we formally address the issue in order to understand and quantify factors affecting the motor coordination. We employed well-established techniques from linear algebra and projection operators to extend the underlying kinematic and dynamic relations by modeling the redundancy effects in null space. We distinguish three types of operational spaces, namely task, joint and muscle space, which are directly associated with the physiological factors of the system. A method for consistently quantifying the redundancy on multiple levels in the entire space of feasible solutions is also presented. We evaluate the proposed muscle space projection on segmental level reflexes and the computation of the feasible muscle forces for arbitrary movements. The former proves to be a convenient representation for interfacing with segmental level models or implementing controllers for tendon driven robots, while the latter enables the identification of force variability and correlations between muscle groups, attributed to the system's redundancy. Furthermore, the usefulness of the proposed framework is demonstrated in the context of estimating the bounds of the joint reaction loads, where we show that misinterpretation of the results is possible if the null space forces are ignored. This work presents a theoretical analysis of the redundancy problem, facilitating application in a broad range of fields related to motor coordination, as it provides the groundwork for null space characterization. The proposed framework rigorously accounts for the effects of kinematic and dynamic redundancy, incorporating it directly into the underlying equations using the notion of null space projection, leading to a complete description of the system.	[Stanev, Dimitar; Moustakas, Konstantinos] Univ Patras, Dept Elect & Comp Engn, Patras, Achaia, Greece	University of Patras	Stanev, D (corresponding author), Univ Patras, Dept Elect & Comp Engn, Patras, Achaia, Greece.	stanev@ece.upatras.gr			EC Horizon 2020 project OACTIVE: Advanced personalised, multi-scale computer models preventing OsteoArthritis [777159]; EC FP7 project NoTremor: Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinsons Disease [610391]	EC Horizon 2020 project OACTIVE: Advanced personalised, multi-scale computer models preventing OsteoArthritis; EC FP7 project NoTremor: Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinsons Disease	This work was supported in part by the EC Horizon 2020 project OACTIVE: Advanced personalised, multi-scale computer models preventing OsteoArthritis, Grant Agreement No. 777159 to KM (url: http://oactive.eu/) and by the EC FP7 project NoTremor: Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinsons Disease, Grant Agreement No. 610391 to KM (url:http://notremor.eu/notremor/).There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghili F, 2005, IEEE T ROBOT, V21, P834, DOI 10.1109/TRO.2005.851380; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; AVIS D, 1992, DISCRETE COMPUT GEOM, V8, P295, DOI 10.1007/BF02293050; BAERLOCHER P, 2001, INVERSE KINEMATICS T; Bernshtein NA, 1967, COORDINATION REGULAT; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Deshpande AD, 2010, IEEE T BIO-MED ENG, V57, P2034, DOI 10.1109/TBME.2010.2048326; Erdemir A, 2007, CLIN BIOMECH, V22, P131, DOI 10.1016/j.clinbiomech.2006.09.005; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FISHER WD, 1992, INT J ROBOT RES, V11, P299, DOI 10.1177/027836499201100403; Houk J.C., 2011, COMPREHENSIVE PHYSL, DOI [10.1002/cphy.cp010208, DOI 10.1002/CPHY.CP010208]; Inouye JM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004737; Khatib O, 2009, J PHYSIOL-PARIS, V103, P211, DOI 10.1016/j.jphysparis.2009.08.004; KHATIB O, 1995, INT J ROBOT RES, V14, P19, DOI 10.1177/027836499501400103; Kutch JJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002434; Kutch JJ, 2011, J BIOMECH, V44, P1264, DOI 10.1016/j.jbiomech.2011.02.014; Latash ML, 2010, MED LITH, V46, P382, DOI 10.3390/medicina46060054; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Le Cavorzin P, 2003, MOVEMENT DISORD, V18, P1257, DOI 10.1002/mds.10532; Loeb GE, 2001, J PHYSIOL-LONDON, V533, P111, DOI 10.1111/j.1469-7793.2001.0111b.x; LOEB GE, 1990, COLD SH Q B, V55, P791; Mileusnic MP, 2006, J NEUROPHYSIOL, V96, P1772, DOI 10.1152/jn.00868.2005; Mileusnic MP, 2006, J NEUROPHYSIOL, V96, P1789, DOI 10.1152/jn.00869.2005; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; Razavian RS, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00121; Righetti L, 2011, IEEE INT CONF ROBOT, P1085, DOI 10.1109/ICRA.2011.5980156; Sentis L, 2007, SYNTHESIS CONTROL WH; Stanev D, 2018, IEEE T BIO-MED ENG, V65, P307, DOI 10.1109/TBME.2017.2764630; Steele KM, 2015, J NEUROPHYSIOL, V113, P2102, DOI 10.1152/jn.00769.2013; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; Valero-Cuevas Francisco J, 2009, IEEE Rev Biomed Eng, V2, P110, DOI 10.1109/RBME.2009.2034981; Valero-Cuevas FJ, 2009, ADV EXP MED BIOL, V629, P619, DOI 10.1007/978-0-387-77064-2_33; Vempala S., 2005, COMBINATORIAL COMPUT, V52, P573; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhang DG, 2009, IEEE T BIO-MED ENG, V56, P2359, DOI 10.1109/TBME.2009.2023979; [No title captured]	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209171	10.1371/journal.pone.0209171	http://dx.doi.org/10.1371/journal.pone.0209171			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601838	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200043
J	Zhang, XX; Wang, X; Wang, ML; Cao, JG; Xiao, JB; Wang, QX				Zhang, Xinxin; Wang, Xin; Wang, Minglong; Cao, Jianguo; Xiao, Jianbo; Wang, Quanxi			Effects of different pretreatments on flavonoids and antioxidant activity of Dryopteris erythrosora leave	PLOS ONE			English	Article							CONSTITUENTS; ROOT; GLYCOSIDES; QUERCETIN; BIOSYNTHESIS; INHIBITION; RADIATION; GENETICS; RHIZOME; CLOVER	Flavonoids are secondary metabolites of plants that often have medical applications. The influences of different sample drying pretreatments on flavonoids and antioxidant activity of ferns have not studies. Dryopteris erythrosora leaves used to analyze flavonoid alterations resulting from drying pretreatments. The total flavonoid content of D. erythrosora leaves exposed to different pretreatments was significantly different. The total flavonoid content of samples initially air-dried in shade and then oven-dried at 75 degrees C were the highest (7.6%), while samples initially dried at 75 degrees C had the lowest content (2.17%). Antioxidant activities of D. erythrosora leaves with different pretreatments varied. Group B first air-dried in the shade and then oven-dried at 75 degrees C and group C first air-dried in the sun and then oven-dried at 75 degrees C, both showed relatively stronger antioxidant activity. The best pretreatment for preserving the flavonoids was to first dry the plant material in the shade and then complete the drying process in an oven at 75 degrees C. It was tentatively identified 22 flavonoids among the four different pretreatments by HPLC-ESI-TOF-MS.	[Zhang, Xinxin; Wang, Xin; Wang, Minglong; Cao, Jianguo; Xiao, Jianbo; Wang, Quanxi] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Zhang, Xinxin] Harbin Normal Univ, Coll Life Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Wang, Minglong; Xiao, Jianbo] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China; [Wang, Quanxi] Chinese Acad Sci, Shanghai Key Lab Plant Funct Genom & Resources, Shanghai Chenshan Bot Garden, Shanghai, Peoples R China	Shanghai Normal University; Harbin Normal University; University of Macau; Chinese Academy of Sciences	Wang, QX (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China.; Wang, QX (corresponding author), Chinese Acad Sci, Shanghai Key Lab Plant Funct Genom & Resources, Shanghai Chenshan Bot Garden, Shanghai, Peoples R China.	wangqx@shnu.edu.cn	Xiao, Jianbo/C-7323-2012; Xiao, Jian/GYU-4351-2022	Xiao, Jianbo/0000-0003-3311-770X; 	Shanghai Engineering Research Center of Plant Germplasm Resources [17DZ2252700]	Shanghai Engineering Research Center of Plant Germplasm Resources	Funded by Grant numbers: 17DZ2252700. URLs of Shanghai Engineering Research Center of Plant Germplasm Resources: http://pgdc.shnu.edu.cn.Quanxi Wang received the funding.; The work was sponsored by Shanghai Engineering Research Center of Plant Germplasm Resources (No. 17DZ2252700). The authors had permission from Shanghai Forestry Bureau to collect specimens.	Agati G, 2002, PHOTOCHEM PHOTOBIOL, V76, P350, DOI 10.1562/0031-8655(2002)076&lt;0350:FDITOP&gt;2.0.CO;2; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; BECK AB, 1971, AUST J CHEM, V24, P1509, DOI 10.1071/CH9711509; Bergquist SA, 2007, J SCI FOOD AGR, V87, P2464, DOI 10.1002/jsfa.2956; Chaaban H, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.13203; Dai JY, 2008, ACTA PHARMACOL SIN, V29, P1086, DOI 10.1111/j.1745-7254.2008.00850.x; Delmas D, 2012, ANTI-CANCER AGENT ME, V12, P835, DOI 10.2174/187152012802650093; Denikeeva MF, 1973, CHEM NAT COMPD, V6, P532; Fedosov AI, 2016, PHARM CHEM, V8, P118; Guvenalp Z, 2015, PHARM BIOL, V53, P888, DOI 10.3109/13880209.2014.948633; Hamrouni-Sellami I, 2013, FOOD BIOPROCESS TECH, V6, P806, DOI 10.1007/s11947-012-0877-7; HIRAOKA A, 1978, BIOCHEM SYST ECOL, V6, P171, DOI 10.1016/0305-1978(78)90003-0; Imperato F, 2007, AM FERN J, V97, P233, DOI 10.1640/0002-8444(2007)97[233:TNFGKO]2.0.CO;2; Imperato F, 2007, AM FERN J, V97, P124, DOI 10.1640/0002-8444(2007)97[124:SN]2.0.CO;2; Imperato F, 2006, AM FERN J, V96, P93, DOI 10.1640/0002-8444(2006)96[93:SN]2.0.CO;2; Islam MN, 2013, ACTA CHROMATOGR, V25, P555, DOI 10.1556/AChrom.25.2013.3.11; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin M, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0972-z; Ledesma-Escobar CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148056; Li HM, 2015, HELV CHIM ACTA, V98, P1177, DOI 10.1002/hlca.201500123; Li PL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46266; Li SP, 2014, J MEX CHEM SOC, V58, P374; Li W, 2002, PHYTOCHEMISTRY, V60, P351, DOI 10.1016/S0031-9422(02)00093-6; Lin LG, 2014, CHEM BIODIVERS, V11, P776, DOI 10.1002/cbdv.201300183; Lister CE, 1996, J SCI FOOD AGR, V71, P313, DOI [10.1002/(SICI)1097-0010(199607)71:3<313::AID-JSFA586>3.0.CO;2-N, 10.1002/(SICI)1097-0010(199607)71:3&lt;313::AID-JSFA586&gt;3.0.CO;2-N]; Ma CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114105; Min BS, 2001, CHEM PHARM BULL, V49, P546, DOI 10.1248/cpb.49.546; MIYAICHI Y, 1988, CHEM PHARM BULL, V36, P2371, DOI 10.1248/cpb.36.2371; MIYAICHI Y, 1989, CHEM PHARM BULL, V37, P794; MIYAICHI Y, 1987, CHEM PHARM BULL, V35, P3720; NIKAIDO T, 1989, CHEM PHARM BULL, V37, P1392, DOI 10.1248/cpb.37.1392; Ren Q, 2017, ACTA CHROMATOGR, V29, P399, DOI 10.1556/1326.2017.29.3.10; Ryan KG, 1998, PHOTOCHEM PHOTOBIOL, V68, P323, DOI 10.1562/0031-8655(1998)068<0323:URIIIQ>2.3.CO;2; Ryan KG, 2002, PHYTOCHEMISTRY, V59, P23, DOI 10.1016/S0031-9422(01)00404-6; Song KiTae, 2013, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V58, P119, DOI 10.7740/kjcs.2013.58.2.119; Tada A, 2015, FOOD HYG SAFE SCI, V56, P217, DOI 10.3358/shokueishi.56.217; Tattini M, 2000, NEW PHYTOL, V148, P69, DOI 10.1046/j.1469-8137.2000.00743.x; Taujenis L, 2015, CHEMIJA, V26, P107; TOMIMORI T, 1990, CHEM PHARM BULL, V38, P3488, DOI 10.1248/cpb.38.3488; Utenova BT, 2007, ARKIVOC, P6, DOI 10.3998/ark.5550190.0008.902; van der Merwe JD, 2010, J AGR FOOD CHEM, V58, P2214, DOI 10.1021/jf903917a; Nguyen VT, 2016, DRY TECHNOL, V34, P324, DOI 10.1080/07373937.2015.1053566; Wang L, 2017, J SEP SCI, V40, P3817, DOI 10.1002/jssc.201700477; Wang X, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0173003; Wang X, 2017, IND CROP PROD, V97, P137, DOI 10.1016/j.indcrop.2016.12.013; Wang X, 2016, MOLECULES, V21, DOI 10.3390/molecules21030360; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie YH, 2015, FOOD CHEM, V186, P113, DOI 10.1016/j.foodchem.2014.05.024; Xu HX, 2010, J SCI FOOD AGR, V90, P1783, DOI 10.1002/jsfa.4012; [赵倩 Zhao Qian], 2012, [中草药, Chinese Traditional and Herbal Drugs], V43, P1484; Zhu Y, 2014, MOLECULES, V19, P10440, DOI 10.3390/molecules190710440	51	14	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0200174	10.1371/journal.pone.0200174	http://dx.doi.org/10.1371/journal.pone.0200174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601805	Green Published, gold, Green Submitted			2022-12-26	WOS:000454683200001
J	Kamal, M; Kenawy, MA; Rady, MH; Khaled, AS; Samy, AM				Kamal, Mahmoud; Kenawy, Mohamed A.; Rady, Magda Hassan; Khaled, Amany Soliman; Samy, Abdallah M.			Mapping the global potential distributions of two arboviral vectors Aedes aegypti and Ae. albopictus under changing climate	PLOS ONE			English	Article							DIPTERA-CULICIDAE; STEGOMYIA AEGYPTI; YELLOW-FEVER; CHIKUNGUNYA; DENGUE; VIRUS; MOSQUITOS; POPULATIONS; PERFORMANCE; STRATEGIES	Background Aedes aegypti and Ae. albopictus are the primary vectors that transmit several arboviral diseases, including dengue, chikungunya, and Zika. The world is presently experiencing a series of outbreaks of these diseases, so, we still require to better understand the current distributions and possible future shifts of their vectors for successful surveillance and control programs. Few studies assessed the influences of climate change on the spatial distributional patterns and abundance of these important vectors, particularly using the most recent climatic scenarios. Here, we updated the current potential distributions of both vectors and assessed their distributional changes under future climate conditions. Methods We used ecological niche modeling approach to estimate the potential distributions of Ae. aegypti and Ae. albopictus under present-day and future climate conditions. This approach fits ecological niche model from occurrence records of each species and environmental variables. For each species, future projections were based on climatic data from 9 general circulation models (GCMs) for each representative concentration pathway (RCP) in each time period, with a total of 72 combinations in four RCPs in 2050 and 2070. All ENMs were tested using the partial receiver operating characteristic (pROC) and a set of 2,048 and 2,003 additional independent records for Ae. aegypti and Ae. albopictus, respectively. Finally, we used background similarity test to assess the similarity between the ENMs of Ae. aegypti and Ae. albopictus. Results The predicted potential distribution of Ae. aegypti and Ae. albopictus coincided with the current and historical known distributions of both species. Aedes aegypti showed a markedly broader distributional potential across tropical and subtropical regions than Ae. albopictus. Interestingly, Ae. albopictus was markedly broader in distributional potential across temperate Europe and the United States. All ecological niche models (ENMs) were statistically robust (P < 0.001). ENMs successfully anticipated 98% (1,999/2,048) and 99% (1,985/2,003) of additional independent records for both Ae. aegypti and Ae. albopictus, respectively (P < 0.001). ENMs based on future conditions showed similarity between the overall distributional patterns of future-day and present-day conditions; however, there was a northern range expansion in the continental USA to include parts of Southern Canada in case of Ae. albopictus in both 2050 and 2070. Future models also anticipated further expansion of Ae. albopictus to the East to include most of Europe in both time periods. Aedes aegypti was anticipated to expand to the South in East Australia in 2050 and 2070. The predictions showed differences in distributional potential of both species between diverse RCPs in 2050 and 2070. Finally, the background similarity test comparing the ENMs of Ae. aegypti and Ae. albopictus was unable to reject the null hypothesis of niche similarity between both species (P > 0.05). Conclusion These updated maps provided details to better guide surveillance and control programs of Ae. aegypti and Ae. albopictus. They have also significant public health importance as a baseline for predicting the emergence of arboviral diseases transmitted by both vectors in new areas across the world.	[Kamal, Mahmoud; Kenawy, Mohamed A.; Rady, Magda Hassan; Khaled, Amany Soliman; Samy, Abdallah M.] Ain Shams Univ, Entomol Dept, Fac Sci, Cairo, Egypt; [Khaled, Amany Soliman] Ain Shams Univ, Res & Training Ctr Vectors Dis, Fac Sci, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	Kamal, M; Samy, AM (corresponding author), Ain Shams Univ, Entomol Dept, Fac Sci, Cairo, Egypt.	mkasu@sci.asu.edu.eg; samy@sci.asu.edu.eg	Samy, Abdallah/B-4375-2010; Kamal, Mahmoud/GQZ-2260-2022	Samy, Abdallah/0000-0003-3978-1134; Kamal, Mahmoud/0000-0001-7447-0433				Abozeid S, 2018, LANCET INFECT DIS, V18, P142, DOI 10.1016/S1473-3099(18)30018-5; Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Benallal KE, 2016, ACTA TROP, V164, P411, DOI 10.1016/j.actatropica.2016.09.027; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135; Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Derraik JGB, 2004, AUST NZ J PUBL HEAL, V28, P433, DOI 10.1111/j.1467-842X.2004.tb00025.x; Doosti S, 2016, IRAN J PUBLIC HEALTH, V45, P1064; Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0; Duncombe J, 2013, GEOSPATIAL HEALTH, V8, P255, DOI 10.4081/gh.2013.71; Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245; Engering A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.5; European Centre for Disease Prevention and Control (ECDC), 2017, COMM DIS THREATS REP; Gandon S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0086; Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1; Izri A, 2011, CLIN MICROBIOL INFEC, V17, P1116, DOI 10.1111/j.1469-0691.2010.03443.x; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915; Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244; Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5; Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430; Minard G, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2202-9; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Obenauer JF, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0078-1; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Qiao HJ, 2016, ECOGRAPHY, V39, P805, DOI 10.1111/ecog.01961; R Development Core Team, 2015, LANG ENV STAT COMP; Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863; Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150489; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Zayed A, 2012, ACTA TROP, V123, P62, DOI 10.1016/j.actatropica.2012.03.004	57	86	88	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210122	10.1371/journal.pone.0210122	http://dx.doi.org/10.1371/journal.pone.0210122			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596764	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200144
J	Jiao, ZG; Sun, JL; Wang, CQ; Dong, YM; Xiao, SH; Gao, XL; Cao, QW; Li, LB; Li, WD; Gao, C				Jiao, Zigao; Sun, Jianlei; Wang, Chongqi; Dong, Yumei; Xiao, Shouhua; Gao, Xuli; Cao, Qiwei; Li, Libin; Li, Wendong; Gao, Chao			Genome-wide characterization, evolutionary analysis of WRKY genes in Cucurbitaceae species and assessment of its roles in resisting to powdery mildew disease	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EXPRESSION ANALYSIS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS WRKY33; DEFENSE RESPONSES; SALICYLIC-ACID; PLANT; RICE; SUPERFAMILY; FAMILY	The WRKY proteins constitute a large family of transcription factors that have been known to play a wide range of regulatory roles in multiple biological processes. Over the past few years, many reports have focused on analysis of evolution and biological function of WRKY genes at the whole genome level in different plant species. However, little information is known about WRKY genes in melon (Cucumis melo L.). In the present study, a total of 56 putative WRKY genes were identified in melon, which were randomly distributed on their respective chromosomes. A multiple sequence alignment and phylogenetic analysis using melon, cucumber and watermelon predicted WRKY domains indicated that melon WRKY proteins could be classified into three main groups (I-III). Our analysis indicated that no recent duplication events of WRKY genes were detected in melon, and strong purifying selection was observed among the 85 orthologous pairs of Cucurbitaceae species. Expression profiles of CmWRKY derived from RNA-seq data and quantitative RT-PCR (qRT-PCR) analyses showed distinct expression patterns in various tissues, and the expression of 16 CmWRKY were altered following powdery mildew infection in melon. Besides, we also found that a total of 24 WRKY genes were co-expressed with 11 VQ family genes in melon. Our comparative genomic analysis provides a foundation for future functional dissection and understanding the evolution of WRKY genes in cucurbitaceae species, and will promote powdery mildew resistance study in melon.	[Jiao, Zigao; Sun, Jianlei; Wang, Chongqi; Dong, Yumei; Xiao, Shouhua; Gao, Xuli; Cao, Qiwei; Li, Libin; Li, Wendong; Gao, Chao] Shandong Acad Agr Sci, Shandong Key Lab Greenhouse Vegetable Biol, Expt Stn Vegetable Sci Observat Huang Huai Area, Inst Vegetables & Flowers,Minist Agr, Jinan, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences	Gao, C (corresponding author), Shandong Acad Agr Sci, Shandong Key Lab Greenhouse Vegetable Biol, Expt Stn Vegetable Sci Observat Huang Huai Area, Inst Vegetables & Flowers,Minist Agr, Jinan, Shandong, Peoples R China.	gsuperman114@163.com		Gao, Xuli/0000-0001-9814-8342	National Technical System of Watermelon and Melon Industry [CARS-25]; National Key Research and Development Program of China [2018YFD0100705]; Natural Science Foundation of Shandong Province [ZR2018LC017]; Agricultural Science and Technology Innovation Project of Shandong Academy of Agricultural Sciences [CXGC2018E08]	National Technical System of Watermelon and Melon Industry; National Key Research and Development Program of China; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Agricultural Science and Technology Innovation Project of Shandong Academy of Agricultural Sciences	This work was financially supported by grants from the National Technical System of Watermelon and Melon Industry (CARS-25), the National Key Research and Development Program of China (2018YFD0100705), the Natural Science Foundation of Shandong Province (ZR2018LC017) and Agricultural Science and Technology Innovation Project of Shandong Academy of Agricultural Sciences (CXGC2018E08).	Amato A, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01979; Andolfo G, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0323-2; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39000; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; COHEN R, 1993, PLANT DIS, V77, P513, DOI 10.1094/PD-77-0513; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gu YZ, 2017, J EXP BOT, V68, P2717, DOI 10.1093/jxb/erx147; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hu YR, 2013, PLANT J, V74, P730, DOI 10.1111/tpj.12159; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang SX, 2012, MOL GENET GENOMICS, V287, P495, DOI 10.1007/s00438-012-0696-6; Jang JY, 2010, PLANT PATHOLOGY J, V26, P110, DOI 10.5423/PPJ.2010.26.2.110; Jiang JJ, 2017, J INTEGR PLANT BIOL, V59, P86, DOI 10.1111/jipb.12513; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kim KC, 2006, PLANT PHYSIOL, V142, P1180, DOI 10.1104/pp.106.082487; Kloth KJ, 2016, J EXP BOT, V67, P3383, DOI 10.1093/jxb/erw159; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Li N, 2014, PLANT CELL REP, V33, P1493, DOI 10.1007/s00299-014-1633-4; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Luo DL, 2017, J AGR FOOD CHEM, V65, P3627, DOI 10.1021/acs.jafc.7b00915; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Vo KTX, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02220; Wang GD, 2016, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01211, 10.3389/fpls.2015.00417]; Wang XT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00615; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xing DH, 2008, MOL PLANT, V1, P459, DOI 10.1093/mp/ssn020; Yang XZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191308; Yang Y, 2016, J EXP BOT, V67, P4727, DOI 10.1093/jxb/erw252; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang Y, 2016, PLANT PHYSIOL BIOCH, V108, P478, DOI 10.1016/j.plaphy.2016.08.013; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	53	14	15	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0199851	10.1371/journal.pone.0199851	http://dx.doi.org/10.1371/journal.pone.0199851			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589839	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200001
J	Mizoguchi, A; Takayama, A; Arai, T; Kawauchi, J; Sudo, H				Mizoguchi, Atsuko; Takayama, Aiko; Arai, Taiga; Kawauchi, Junpei; Sudo, Hiroko			MicroRNA-8073: Tumor suppressor and potential therapeutic treatment	PLOS ONE			English	Article							CELL-PROLIFERATION; SERUM MICRORNA; CANCER; GROWTH; METASTASIS; EXPRESSION; TARGETS; FOXM1	The comprehensive screening of intracellular and extracellular microRNAs was performed to identify novel tumor suppressors. We found that miR-8073 was present in exosome and predominantly exported from colorectal cancer cells. Treatment with a synthetic miR-8073 mimic resulted in a dramatic decrease in the proliferation of various types of cancer cells, which was not observed in similarly treated normal cells. As little is known about the biological functions of miR-8073, its target mRNAs were analyzed by both mRNA expression and in silico sequence analyses, leading to five probable target candidates (FOXM1, MBD3, CCND1, KLK10, and CASP2) that enhance survival during the regulation of the cell cycle, cell proliferation, and apoptosis. We experimentally confirmed that miR-8073 binds the 3'-UTR of each of these mRNA target candidates and that the introduction of a synthetic miR-8073 mimic into cancer cells reduced levels of protein expression. Finally, the antiproliferative effects of miR-8073 were validated in vivo: the subcutaneous injection of a synthetic miR-8073 mimic suppressed colorectal tumor volume to 43% in tumor-bearing xenografted mice. These results suggest that because miR-8073 binds, and thus reduces the levels of, these oncogenic targets, cancer cells must actively downregulate miR-8073 as a survival mechanism. The introduction of miR-8073 into tumors could thus inhibit tumor growth, indicating its great potential for cancer therapeutics.	[Mizoguchi, Atsuko; Takayama, Aiko; Arai, Taiga; Kawauchi, Junpei; Sudo, Hiroko] Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa, Japan	Toray Industries, Inc.	Mizoguchi, A (corresponding author), Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa, Japan.	atsuko_mizoguchi@nts.toray.co.jp		TAKAYAMA, AIKO/0000-0003-4745-052X; mizoguchi, atsuko/0000-0002-9389-5709; Arai, Taiga/0000-0003-3249-612X				Al-Haidari AA, 2017, ONCOTARGET, V8, P14887, DOI 10.18632/oncotarget.14841; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Armand-Labit Virginie, 2017, BioMolecular Concepts, V8, P61, DOI 10.1515/bmc-2017-0002; Duan N, 2015, INT J CLIN EXP PATHO, V8, P10250; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Ghanbari M, 2015, CIRC-CARDIOVASC GENE, V8, P473, DOI 10.1161/CIRCGENETICS.114.000968; Guha M, 2010, ONCOGENE, V29, P1280, DOI 10.1038/onc.2009.428; Han C, 2017, BBA-GENE REGUL MECH, V1860, P227, DOI 10.1016/j.bbagrm.2016.12.004; He WA, 2014, P NATL ACAD SCI USA, V111, P4525, DOI 10.1073/pnas.1402714111; Hofsli E, 2013, BRIT J CANCER, V108, P1712, DOI 10.1038/bjc.2013.121; Horiguchi H, 2016, HAEMATOLOGICA, V101, P437, DOI 10.3324/haematol.2015.134932; Kojima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118220; Kosaka N, 2013, ADV DRUG DELIVER REV, V65, P376, DOI 10.1016/j.addr.2012.07.011; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Li LJ, 2017, ONCOTARGET, V8, P32298, DOI 10.18632/oncotarget.15764; Li XQ, 2012, WORLD J GASTROENTERO, V18, P882, DOI 10.3748/wjg.v18.i9.882; Ninio-Many L, 2013, J CELL SCI, V126, P2867, DOI 10.1242/jcs.123414; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Shimomura A, 2016, CANCER SCI, V107, P326, DOI 10.1111/cas.12880; Su AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071309; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634; Xu L, 2017, MOL MED REP, V16, P4659, DOI 10.3892/mmr.2017.7143; Yoshioka Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20424; Zhang L, 2016, J CELL MOL MED, V20, P1150, DOI 10.1111/jcmm.12805; Zhao LJ, 2017, ONCOL REP, V38, P3522, DOI 10.3892/or.2017.6047	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209750	10.1371/journal.pone.0209750	http://dx.doi.org/10.1371/journal.pone.0209750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589909	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200048
J	Bakken, TE; Hodge, RD; Miller, JA; Yao, ZZ; Nguyen, TN; Aevermann, B; Barkan, E; Bertagnolli, D; Casper, T; Dee, N; Garren, E; Goldy, J; Graybuck, LT; Kroll, M; Lasken, RS; Lathia, K; Parry, S; Rimorin, C; Scheuermann, RH; Schork, NJ; Shehata, SI; Tieu, M; Phillips, JW; Bernard, A; Smith, KA; Zeng, HK; Lein, ES; Tasic, B				Bakken, Trygve E.; Hodge, Rebecca D.; Miller, Jeremy A.; Yao, Zizhen; Thuc Nghi Nguyen; Aevermann, Brian; Barkan, Eliza; Bertagnolli, Darren; Casper, Tamara; Dee, Nick; Garren, Emma; Goldy, Jeff; Graybuck, Lucas T.; Kroll, Matthew; Lasken, Roger S.; Lathia, Kanan; Parry, Sheana; Rimorin, Christine; Scheuermann, Richard H.; Schork, Nicholas J.; Shehata, Soraya I.; Tieu, Michael; Phillips, John W.; Bernard, Amy; Smith, Kimberly A.; Zeng, Hongkui; Lein, Ed S.; Tasic, Bosiljka			Single-nucleus and single-cell transcriptomes compared in matched cortical cell types	PLOS ONE			English	Article							RNA-SEQ; DIVERSITY; MOUSE; CLASSIFICATION; RETENTION; SUITE	Transcriptomic profiling of complex tissues by single-nucleus RNA-sequencing (snRNA-seq) affords some advantages over single-cell RNA-sequencing (scRNA-seq). snRNA-seq provides less biased cellular coverage, does not appear to suffer cell isolation-based transcriptional artifacts, and can be applied to archived frozen specimens. We used well-matched snRNA-seq and scRNA-seq datasets from mouse visual cortex to compare cell type detection. Although more transcripts are detected in individual whole cells (similar to 11,000 genes) than nuclei (similar to 7,000 genes), we demonstrate that closely related neuronal cell types can be similarly discriminated with both methods if intronic sequences are included in snRNA-seq analysis. We estimate that the nuclear proportion of total cellular mRNA varies from 20% to over 50% for large and small pyramidal neurons, respectively. Together, these results illustrate the high information content of nuclear RNA for characterization of cellular diversity in brain tissues.	[Bakken, Trygve E.; Hodge, Rebecca D.; Miller, Jeremy A.; Yao, Zizhen; Thuc Nghi Nguyen; Barkan, Eliza; Bertagnolli, Darren; Casper, Tamara; Dee, Nick; Garren, Emma; Goldy, Jeff; Graybuck, Lucas T.; Kroll, Matthew; Lathia, Kanan; Parry, Sheana; Rimorin, Christine; Shehata, Soraya I.; Tieu, Michael; Phillips, John W.; Bernard, Amy; Smith, Kimberly A.; Zeng, Hongkui; Lein, Ed S.; Tasic, Bosiljka] Allen Inst Brain Sci, Seattle, WA 98109 USA; [Aevermann, Brian; Lasken, Roger S.; Scheuermann, Richard H.; Schork, Nicholas J.] J Craig Venter Inst, La Jolla, CA USA	Allen Institute for Brain Science; J. Craig Venter Institute	Tasic, B (corresponding author), Allen Inst Brain Sci, Seattle, WA 98109 USA.	bosiljkat@alleninstitute.org	Bakken, Trygve E./R-4622-2017	Bakken, Trygve E./0000-0003-3373-7386; Bernard, Amy/0000-0003-2540-1153; Dee, Nick/0000-0002-2831-9254; Schork, Nicholas/0000-0003-0920-5013; Barkan, Eliza/0000-0001-7871-4327; Nguyen, Thuc Nghi/0000-0002-6466-5883	NEI NIH HHS [R01 EY023173] Funding Source: Medline; NIMH NIH HHS [U01 MH105982] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aronesty E., 2011, EXPR ANAL; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bernard A, 2009, CURR OPIN NEUROBIOL, V19, P530, DOI 10.1016/j.conb.2009.09.010; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ecker JR, 2017, NEURON, V96, P542, DOI 10.1016/j.neuron.2017.10.007; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Heiberger RM, 2017, ANAL VARIANCE DESIGN, DOI [10.2143/EP.6.2.505355, DOI 10.2143/EP.6.2.505355]; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Lake BB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04426-w; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mauger O, 2016, NEURON, V92, P1266, DOI 10.1016/j.neuron.2016.11.032; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Paxinos G, 2012, PAXINOS FRANKLINS MO; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Sigl-Glockner J, 2017, CELL REP, V20, P2575, DOI 10.1016/j.celrep.2017.08.069; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2018, CURR OPIN NEUROBIOL, V50, P242, DOI 10.1016/j.conb.2018.04.021; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005	54	177	177	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209648	10.1371/journal.pone.0209648	http://dx.doi.org/10.1371/journal.pone.0209648			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586455	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400079
J	Olchowy, C; Maciag, EJ; Sanchez-Montanez, A; Olchowy, A; Delgado, I; Vazquez, E				Olchowy, Cyprian; Maciag, Ewa J.; Sanchez-Montanez, Angel; Olchowy, Anna; Delgado, Ignacio; Vazquez, Elida			Measurements of signal intensity of globus pallidus and dentate nucleus suggest different deposition characteristics of macrocyclic GBCAs in children	PLOS ONE			English	Article							T1-WEIGHTED MR-IMAGES; MAGNETIC-RESONANCE; CONTRAST-AGENT; GADOLINIUM DEPOSITION; BRAIN; ADMINISTRATIONS; DIMEGLUMINE; TISSUE	Introduction The safety of using GBCAs to enhance the visibility of body structures is currently discussed due to possible gadolinium retention in brain structures. The aim of the study was to evaluate the effect of multiple exposures to macrocyclic GBCAs in children. Materials and methods This retrospective, single-center study included data from 43 patients who had received. 4 injections of macrocyclic GBCAs during MRI examinations over performed over 8 to 84 months. Signal intensity was measured on unenhanced T1-weighted MRI, and globus pallidus to thalamus (GP/Th) and dentate nucleus to pons (DN/P) ratios were calculated. The differences in ratios were tested with the Student's t-test or the Wilcoxon rank sum test. For categorical data, Pearson's chi-squared test was used. Relationships were analyzed with the Spearman's rank correlation coefficient. Results Patients with the mean age of 7.5 years (SD = 4.2) received 8.19 (SD = 3.63) injections of GBCAs on average. Differences in GP/Th and DN/P ratios between the first and the last measurement were insignificant. Children before the end of myelination process (<= 2 years of age) had the first GP/Th ratio values significantly lower than those >2 years of age (p = 0.0284), which than increased at the final scan and reached the level similar to values obtained in the group of >2 years of age. Conclusions Maturation of the brain may affect both signal intensity of brain structures and susceptibility to GBCAs; thus, assessment of signal intensity of the brain structures should be conducted taking into account the age of a child.	[Olchowy, Cyprian] Wroclaw Med Univ, Dept Oral Surg, Wroclaw, Poland; [Maciag, Ewa J.; Sanchez-Montanez, Angel; Delgado, Ignacio; Vazquez, Elida] Vall dHebron Univ Hosp, Pediat Radiol Dept, Barcelona, Spain; [Olchowy, Anna] Wroclaw Med Univ, Dept Expt Dent, Wroclaw, Poland	Wroclaw Medical University; Hospital Universitari Vall d'Hebron; Wroclaw Medical University	Olchowy, C (corresponding author), Wroclaw Med Univ, Dept Oral Surg, Wroclaw, Poland.	cyprian.olchowy@gmail.com	Vazquez, Elida/F-8362-2016	Olchowy, Cyprian/0000-0002-6559-3973				Amin R, 2017, TOXICOL SCI, V156, P520, DOI 10.1093/toxsci/kfx013; Aubert-Broche B, 2008, LECT NOTES COMPUT SC, V5242, P180, DOI 10.1007/978-3-540-85990-1_22; Bjornerud A, 2017, RADIOLOGY, V285, P434, DOI 10.1148/radiol.2017170391; Bolles GM, 2018, AM J NEURORADIOL, DOI [10.1097/RLI.0000000000000252, DOI 10.1097/RLI.0000000000000252]; Cao Y, 2016, AM J ROENTGENOL, V206, P414, DOI 10.2214/AJR.15.15327; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; Espagnet MCR, 2017, PEDIATR RADIOL, V47, P1345, DOI 10.1007/s00247-017-3874-1; Flood TF, 2016, RADIOLOGY; Hu HCH, 2016, PEDIATR RADIOL, V46, P1590, DOI 10.1007/s00247-016-3646-3; Kanda T, 2016, JPN J RADIOL, V34, P3, DOI 10.1007/s11604-015-0503-5; Kanda T, 2015, RADIOLOGY, V275, P803, DOI 10.1148/radiol.14140364; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Lancelot E, 2017, PEDIATR RADIOL, V47, P1692, DOI 10.1007/s00247-017-3947-1; Marcos HB, 1997, RADIOLOGY, V205, P493, DOI 10.1148/radiology.205.2.9356634; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Miller JH, 2015, PEDIATRICS, V136, pE1637, DOI 10.1542/peds.2015-2222; Murata N, 2016, INVEST RADIOL, V51, P447, DOI 10.1097/RLI.0000000000000252; NOVAK Z, 1993, INVEST RADIOL, V28, P828; Olchowy C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171704; Quattrocchi CC, 2015, INVEST RADIOL, V50, P470, DOI 10.1097/RLI.0000000000000154; Radbruch A, 2017, RADIOLOGY; Radbruch A, 2015, INVEST RADIOL, V50, P805, DOI 10.1097/RLI.0000000000000227; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Roberts DR, 2016, BRAIN DEV-JPN, V38, P331, DOI 10.1016/j.braindev.2015.08.009; ROFSKY NM, 1994, JMRI-J MAGN RESON IM, V4, P805, DOI 10.1002/jmri.1880040611; Webb JAW, 2005, EUR RADIOL, V15, P1234, DOI 10.1007/s00330-004-2583-y; Weberling LD, 2015, INVEST RADIOL, V50, P743, DOI 10.1097/RLI.0000000000000206	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208589	10.1371/journal.pone.0208589	http://dx.doi.org/10.1371/journal.pone.0208589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586415	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400026
J	Soteras, F; More, M; Ibanez, AC; Iglesias, MD; Cocucci, AA				Soteras, Florencia; More, Marcela; Ibanez, Ana C.; del Rosario Iglesias, Maria; Cocucci, Andrea A.			Range overlap between the sword-billed hummingbird and its guild of long-flowered species: An approach to the study of a coevolutionary mosaic	PLOS ONE			English	Article							ANGRAECUM-SESQUIPEDALE; PASSIFLORA-MIXTA; EVOLUTION; SPECIALIZATION; NETWORKS; MODELS; DISTRIBUTIONS; POLLINATORS; MORPHOLOGY; ORCHIDS	The coevolutionary process among free-living mutualists with extremely long matching traits may favor the formation of mutualistic interaction networks through coevolutionary escalation, complementarity and convergence. These networks may be geographically structured; the links among the species of a local network are shaped by the biotic composition of the community, thus creating selection mosaics at broader geographical scales. Therefore, to fully understand a coevolutionary process, it is crucial to visualize the geographical structure of the interaction network across the landscape. In this study we focused on the poorly known interaction system between Ensifera ensifera and its guild of long-flowered plant species. We combined occurrence data and environmental variables to predict E. ensifera distribution, in addition to range polygons available for plant species in order to evaluate the geographical variation in bill length and plant species richness. A positive relationship between bill length and plant species richness within the E. ensifera range suggests a geographical structuring of the interaction networks. At mid-latitude locations of E. ensifera range, where hummingbirds attained the longest bills, richness of long-flowered plant species was higher than at low latitude locations. These locations likely represent coevolutionary vortices where long-lasting reciprocal selection probably drove the evolution of long traits, consequently drawing new plant species into the coevolutionary network. Conversely, areas where the sword-billed hummingbird was absent or had shorter bills probably represent coevolutionary coldspots. Our results provide a first insight into this phenotypically specialized plant-pollinator network across the landscape and show candidate areas to test the predictions of the coevolutionary hypothesis, such as reciprocal selection.	[Soteras, Florencia; More, Marcela; Ibanez, Ana C.; del Rosario Iglesias, Maria; Cocucci, Andrea A.] Univ Nacl Cordoba, Lab Ecol Evolut & Biol Floral, IMBIV, CONICET, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Soteras, F (corresponding author), Univ Nacl Cordoba, Lab Ecol Evolut & Biol Floral, IMBIV, CONICET, Cordoba, Argentina.	fsoteras@conicet.gov.ar	Moré, Marcela/I-3873-2019	Moré, Marcela/0000-0003-2982-8939; Cocucci, Andrea/0000-0002-3464-3309; Soteras, Florencia/0000-0003-2189-8529	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) [BID 2012 PICT 1553, BID 2015 PICT 338]; Secretaria de Investigacion Ciencia y Tecnica de la Universidad Nacional de Cordoba; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCYT Argentina) [PE/13/02]; Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC Peru) [PE/13/02]; Sigma Xi [A-9697857640]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)(FONCyT); Secretaria de Investigacion Ciencia y Tecnica de la Universidad Nacional de Cordoba; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCYT Argentina); Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC Peru); Sigma Xi	This work was financially supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and the Universidad Nacional de Cordoba. A.C.I. is a fellow of CONICET, and F.S., M.M., M.d.R.I., and A.A.C. are staff from CONICET. In addition, this study was supported by the following funders which supported data collection of the manuscript: Fondo para la Investigacion Cientifica y Tecnologica (FONCyT), http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt (BID 2012 PICT 1553 granted to A.A.C., BID 2015 PICT 338 granted to F.S.); Secretaria de Investigacion Ciencia y Tecnica de la Universidad Nacional de Cordoba, https://www.unc.edu.ar/ciencia-y-tecnolog%C3%ADa/subsidios-secyt (Secyt UNC granted to A.A.C.). The following two Institutions jointly granted a field trip to Peru to A.C.I. Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCYT Argentina, https://www.argentina.gob.ar/ciencia) -and Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC Peru, http://portal.concytec.gob.pe/) (PE/13/02 granted to A.A.C.) and Sigma Xi A-9697857640 (https://www.sigmaxi.org/programs/grants-in-aid) which granted to A.C. I. a trip to EEUU where the New York Botanical Garden was visited to revise herbarium voucher specimens.	Abrahamczyk S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0888; Abrahamczyk S, 2017, J BIOGEOGR, V44, P1847, DOI 10.1111/jbi.12962; Maglianesi MA, 2014, ECOLOGY, V95, P3325, DOI 10.1890/13-2261.1; Alexandersson R, P BIOL SCI, V269, P631, DOI [10.1098/rspb.2001, DOI 10.1098/RSPB.2001]; Amico GC, 2007, AM J BOT, V94, P558, DOI 10.3732/ajb.94.4.558; Anderson B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-204; Anderson B, 2009, NEW PHYTOL, V182, P533, DOI 10.1111/j.1469-8137.2009.02764.x; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Arditti J, 2012, BOT J LINN SOC, V169, P403, DOI 10.1111/j.1095-8339.2012.01250.x; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Benkman CW, 2001, EVOLUTION, V55, P282, DOI 10.1111/j.0014-3820.2001.tb01293.x; BROWN JH, 1985, AUK, V102, P251, DOI 10.2307/4086767; Darwin C., 1877, VARIOUS CONTRIVANCES; Duenas-Gomez H, 2001, CALDASIA, V23, P81; eBird, 2016, EBIRD ONL DAT BIRD D; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Escobar L., 1988, FLORA COLOMBIA; Gutierrez A, 2004, ORNITOL NEOTROP, V15, P205; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Holm-Nielsen LB, 1988, FLORA ECUADOR N 31; Keel SHK, 1984, REVISION GENUS SALPI; Killip E.P, 1938, AM SPECIES PASSIFLOR; Kuijt J., 1988, SYST BOT MONOGR, V19, P61, DOI DOI 10.2307/25027693; Lindberg AB, 2001, J TROP ECOL, V17, P323, DOI 10.1017/S0266467401001213; Maitner B., 2018, BIEN TOOLS ACCESSING; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Muchhala N, 2009, P R SOC B, V276, P2147, DOI 10.1098/rspb.2009.0102; Netz C, 2017, BIOL J LINN SOC, V122, P469, DOI 10.1093/biolinnean/blx086; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Perez JO, 2017, PLANT SYST EVOL, V303, P531, DOI 10.1007/s00606-017-1390-2; Pauw A, 2009, EVOLUTION, V63, P268, DOI 10.1111/j.1558-5646.2008.00547.x; Pelayo RC, 2011, INTERCIENCIA, V36, P587; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; QGIS Development Team, 2016, QGIS GEOGR INF SYST; Ridgely R., 2011, HUMMINGBIRDS OF ECUA; Sanchez Oses C., 2003, THESIS; Sazatornil FD, 2016, J ANIM ECOL, V85, P1586, DOI 10.1111/1365-2656.12509; Segura S, 2003, GENET RESOUR CROP EV, V50, P555, DOI 10.1023/A:1024424012134; Snow D.W., 1980, Bulletin of the British Museum (Natural History) Zoology, V38, P105; STEINER KE, 1991, EVOLUTION, V45, P1493, DOI [10.2307/2409895, 10.1111/j.1558-5646.1991.tb02651.x]; Stinchcombe JR, 2002, P ROY SOC B-BIOL SCI, V269, P1241, DOI 10.1098/rspb.2002.2015; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Tinoco BA, 2017, OIKOS, V126, P52, DOI 10.1111/oik.02998; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; VOGEL S, 1985, J KANSAS ENTOMOL SOC, V58, P359; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Weinstein BG, 2017, ECOL LETT, V20, P326, DOI 10.1111/ele.12730; Wester P, 2011, ANN MO BOT GARD, V98, P101, DOI 10.3417/2007035; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wood J. R. I., 2007, Kew Bulletin, V62, P177; Wood John R. I., 2014, Curtis's Botanical Magazine, V31, P143, DOI 10.1111/curt.12064	58	8	8	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209742	10.1371/journal.pone.0209742	http://dx.doi.org/10.1371/journal.pone.0209742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586466	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400089
J	Lee, SJ; Kim, J; Ko, J; Lee, EJ; Koh, HJ; Yoon, JS				Lee, Sung Jun; Kim, Jinjoo; Ko, JaeSang; Lee, Eun Jig; Koh, Hyoung Jun; Yoon, Jin Sook			Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts	PLOS ONE			English	Article							TWEAK/FN14 PATHWAY; T-LYMPHOCYTES; OPHTHALMOPATHY; CYTOKINE; DISEASE; FN14; PATHOGENESIS; STIMULATION; EXPRESSION; AXIS	Tumor necrosis factor-like weak inducer of apoptosis (TWEAK), along with its receptor fibroblast growth factor-inducible (Fn) 14, is associated with various biological activities including inflammation. However, its role in the pathogenesis of Graves' orbitopathy (GO) is unknown. In this study, we investigated the mechanism by which TWEAK regulates inflammatory signaling in orbital fibroblasts from GO patients. We found that TWEAK and tumor necrosis factor-alpha (TNFA) mRNA levels were upregulated in GO as compared to non-GO tissue samples. TWEAK, TNF receptor (TNFR) 1, TNFR2, and TNFR superfamily member 12A mRNA, and TWEAK and Fn14 protein levels were increased by interleukin (IL)-1 beta and TNF-alpha treatment. Treatment with exogenous recombinant TWEAK increased the transcript and protein expression of the pro-inflammatory cytokines IL-6, IL-8, and monocyte chemoattractant protein-1 to a greater extent in GO than in non-GO cells, while treatment with the anti-Fn14 antibody ITEM4 suppressed TWEAK-induced pro-inflammatory cytokine release and hyaluronan production. Additionally, the serum level of TWEAK was higher in Graves' disease patients with (341.86 +/- 86.3 pg/ml) as compared to those without (294.09 +/- 41.44 pg/ml) GO and healthy subjects (255.33 +/- 39.38 pg/ml), and was positively correlated with clinical activity score (r = 0.629, P < 0.001) and thyroid binding immunoglobulin level (r = 0.659, P < 0.001). These results demonstrate that TWEAK/Fn14 signaling contributes to GO pathogenesis. Moreover, serum TWEAK level is a potential diagnostic biomarker for inflammatory GO, and modulating TWEAK activity may be an effective therapeutic strategy for suppressing inflammation and tissue remodeling in GO.	[Lee, Sung Jun] Yonsei Bon Eye Clin, Seoul, South Korea; [Lee, Sung Jun; Kim, Jinjoo; Ko, JaeSang; Koh, Hyoung Jun; Yoon, Jin Sook] Yonsei Univ, Inst Vis Res, Severance Hosp, Dept Ophthalmol,Coll Med, Seoul, South Korea; [Lee, Eun Jig] Yonsei Univ, Coll Med, Dept Endocrinol, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, JS (corresponding author), Yonsei Univ, Inst Vis Res, Severance Hosp, Dept Ophthalmol,Coll Med, Seoul, South Korea.	yoonjs@yuhs.ac	Ko, JaeSang/AAS-6259-2021	Koh, Hyoung Jun/0000-0002-5932-8516; Ko, JaeSang/0000-0002-3011-7213; Yoon, Jin Sook/0000-0002-8751-9467; Lee, Eun Jig/0000-0002-9876-8370	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2017R1A2B4009565]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017R1A2B4009565). JSY received the grant. (www.nrf.re.kr).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn RS, 2003, J CLIN ENDOCR METAB, V88, P1939, DOI 10.1210/jc.2002-030010; Brown SAN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065248; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Burkly LC, 2011, ADV EXP MED BIOL, V691, P305, DOI 10.1007/978-1-4419-6612-4_32; Campbell S, 2004, FRONT BIOSCI-LANDMRK, V9, P2273, DOI 10.2741/1395; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Enwere EK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00034; Feldon SE, 2005, INVEST OPHTH VIS SCI, V46, P3913, DOI 10.1167/iovs.05-0605; GRUBECKLOEBENSTEIN B, 1994, J CLIN INVEST, V93, P2738, DOI 10.1172/JCI117289; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V146, P540, DOI 10.1111/j.1365-2249.2006.03233.x; Iyer S, 2012, BEST PRACT RES CL EN, V26, P281, DOI 10.1016/j.beem.2011.10.003; Jang SY, 2013, EYE, V27, P964, DOI 10.1038/eye.2013.120; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kawakami Yuko, 2007, Allergol Int, V56, P403, DOI 10.2332/allergolint.O-07-486; Kuriyan AE, 2008, CURR OPIN OPHTHALMOL, V19, P499, DOI 10.1097/ICU.0b013e3283131557; Lazarus JH, 2012, BEST PRACT RES CL EN, V26, P273, DOI 10.1016/j.beem.2011.10.005; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Otto EA, 1996, J CLIN ENDOCR METAB, V81, P3045, DOI 10.1210/jc.81.8.3045; Pappa A, 2000, BRIT J OPHTHALMOL, V84, P517, DOI 10.1136/bjo.84.5.517; Park MC, 2008, SCAND J RHEUMATOL, V37, P173, DOI 10.1080/03009740801898608; Poveda J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00447; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Saas P, 2000, GLIA, V32, P102, DOI 10.1002/1098-1136(200010)32:1<102::AID-GLIA100>3.0.CO;2-U; Wajant H, 2013, BRIT J PHARMACOL, V170, P748, DOI 10.1111/bph.12337; WIERSINGA WM, 1988, J ENDOCRINOL INVEST, V11, P615, DOI 10.1007/BF03350193; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wilhelm A, 2016, J PATHOL, V239, P109, DOI 10.1002/path.4707; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wong YK, 2001, J CELL BIOCHEM, V82, P58, DOI 10.1002/jcb.1118; Yoon JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026261; Zhang L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26700-1	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209583	10.1371/journal.pone.0209583	http://dx.doi.org/10.1371/journal.pone.0209583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576385	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400060
J	Bradford, HN; Krishnaswamy, S				Bradford, Harlan N.; Krishnaswamy, Sriram			Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; serine protease; thrombin; proteolytic enzyme; enzyme kinetics; proteolysis; hemostasis; blood clotting; factor V; prothrombinase	HUMAN-FACTOR-X; CATALYZED ACTIVATION; HUMAN PROTHROMBINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; THROMBIN; CLEAVAGE; DOMAIN; SUBSTRATE; VENOM	The proteolytic conversion of factor V to factor Va is central for amplified flux through the blood coagulation cascade. Heterodimeric factor Va is produced by cleavage at three sites in the middle of factor V by thrombin, yielding an N terminus-derived heavy chain and a C terminus-derived light chain. Here, we show that light chain formation resulting from the C-terminal cleavage is the rate-limiting step in the formation of fully cleaved Va. This rate-limiting step also corresponded to and was sufficient for the ability of cleaved factor V to bind Xa and assemble into the prothrombinase complex. Meizothrombin, the proteinase intermediate in thrombin formation, cleaves factor V more slowly than does thrombin, resulting in a pronounced defect in the formation of the light chain. A similar to 100-fold reduced rate of meizothrombin-mediated light chain formation by meizothrombin corresponded to equally slow production of active cofactor and an impaired ability to amplify flux through the coagulation cascade initiated in plasma. We show that this defect arises from the occlusion of anion-binding exosite 2 in the catalytic domain by the covalently retained propiece in meizothrombin. Our findings provide structural insights into the prominent role played by exosite 2 in the rate-limiting step of factor V activation. They also bear on how factor V is converted into a cofactor capable of assembling into prothrombinase.	[Bradford, Harlan N.; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@pennmedicine.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	NHLBI, National Institutes of Health [R01 HL-125422, P01 HL-139420]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL139420, R01HL125422] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health, Grants R01 HL-125422 and P01 HL-139420 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Corral-Rodriguez MA, 2011, BLOOD, V117, P7164, DOI 10.1182/blood-2010-10-315309; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Bradford HN, 2013, J BIOL CHEM, V288, P27789, DOI 10.1074/jbc.M113.502005; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2006, J BIOL CHEM, V281, P18569, DOI 10.1074/jbc.M600752200; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; COTE HCF, 1994, J BIOL CHEM, V269, P11374; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FOSTER WB, 1983, J BIOL CHEM, V258, P3970; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Khan AR, 1998, PROTEIN SCI, V7, P815; KIM DJ, 1994, BIOTECHNOL LETT, V16, P549, DOI 10.1007/BF00128598; KISIEL W, 1981, METHOD ENZYMOL, V80, P275; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; Lu WP, 2003, ANAL BIOCHEM, V316, P58, DOI 10.1016/S0003-2697(03)00034-4; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1990, BLOOD, V76, P1; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; Nakayama D, 2011, FEBS LETT, V585, P3020, DOI 10.1016/j.febslet.2011.08.022; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OMarcaigh AS, 1996, BLOOD, V88, P2611, DOI 10.1182/blood.V88.7.2611.bloodjournal8872611; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; RABIET MJ, 1986, J BIOL CHEM, V261, P5045; ROSING J, 1986, J BIOL CHEM, V261, P4224; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Shaw MA, 2016, BLOOD, V128, P721, DOI 10.1182/blood-2015-11-680280; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; STUBBS MT, 1995, TRENDS BIOCHEM SCI, V20, P23, DOI 10.1016/S0968-0004(00)88945-8; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TANS G, 1994, J BIOL CHEM, V269, P15969; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110	54	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2422	2435		10.1074/jbc.RA118.006510	http://dx.doi.org/10.1074/jbc.RA118.006510			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30578302	Green Published, hybrid			2022-12-26	WOS:000458895400019
J	Kim, HM; Park, YJ; Park, KH; Woo, SJ				Kim, Hyeong Min; Park, Young Joo; Park, Kyu Hyung; Woo, Se Joon			Visual field defects and changes in central retinal artery occlusion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LOCAL INTRAARTERIAL FIBRINOLYSIS; PROGNOSIS; EFFICACY; TIME	Objectives To investigate the characteristics and temporal changes in visual field defects (VFDs) in eyes with acute central retinal artery occlusion (CRAO). Design Retrospective, observational case series Methods A total of 119 patients diagnosed with acute non-arteritic CRAO through examination with Goldmann perimetry were included among the patients who visited Seoul National University Bundang Hospital between January 2009 and December 2016. They were treated with either conservative treatments or intra-arterial thrombolysis (IAT). The baseline features and temporal changes of visual field examination results and the association with clinical parameters including visual acuity, optical coherence tomography (OCT) findings, and the CRAO stages. Results All of the 119 patients showed visual field defect and suffered unilateral acute CRAO. We observed five characteristic VFDs: peripheral constriction only (8%), paracentral scotoma (3%), central and cecocentral scotoma (19%), temporal island (59%), and no visual field (10%). Severe VFDs were associated with severe CRAO stages, poor baseline BCVA, delayed retinal arterial perfusion, and severe retinal morphologic changes on OCT. We found improvements in the visual field in 39% of all cases during the follow-up periods. Mild CRAO stages, good baseline BCVA, mild retinal morphologic changes, and mild initial VFDs were significantly associated with visual field improvement. Conclusions The five characteristic types of VFDs and their improvement in eyes with CRAO are associated with baseline features related to the severity of retinal ischemia. We suggest that the	[Kim, Hyeong Min; Park, Young Joo; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Coll Med, Seongnam, South Korea	Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Coll Med, Seongnam, South Korea.	sejoon1@snu.ac.kr	Woo, Se Joon/I-7357-2013	Woo, Se Joon/0000-0003-3692-7169	National Research Foundation (NRF) [2016R1D1A1B03934724]; NRF Bio & Medical Technology Development Program - Korean government (MSIP) [2018M3A9B5021319]; NRF Bio & Medical Technology Development Program - Korean government (MSIT) [2018M3A9B5021319]	National Research Foundation (NRF); NRF Bio & Medical Technology Development Program - Korean government (MSIP); NRF Bio & Medical Technology Development Program - Korean government (MSIT)	This study was supported by the National Research Foundation (NRF) grant 2016R1D1A1B03934724 and the NRF Bio & Medical Technology Development Program (Grant No. 2018M3A9B5021319) funded by the Korean government (MSIP and MSIT). The funding organization had no role in the design or conduct of this study.; This study was supported by the National Research Foundation (NRF) grant 2016R1D1A1B03934724 and the NRF Bio & Medical Technology Development Program (Grant No. 2018M3A9B5021319) funded by the Korean government (MSIP and MSIT). The funding organization had no role in the design or conduct of this study.	Ahn SJ, 2015, AM J OPHTHALMOL, V159, P667, DOI 10.1016/j.ajo.2015.01.001; Ahn SJ, 2013, INVEST OPHTH VIS SCI, V54, P7746, DOI 10.1167/iovs.13-12952; AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ARRUGA J, 1982, OPHTHALMOLOGY, V89, P1336; Atebara NH, 1995, OPHTHALMOLOGY, V102, P2029, DOI 10.1016/S0161-6420(95)30758-0; AUGSBURGER JJ, 1980, BRIT J OPHTHALMOL, V64, P913, DOI 10.1136/bjo.64.12.913; Bjarnhall G, 2002, ACTA OPHTHALMOL SCAN, V80, P652, DOI 10.1034/j.1600-0420.2002.800617.x; BROWN GC, 1982, OPHTHALMOLOGY, V89, P14; BROWN GC, 1979, ARCH OPHTHALMOL-CHIC, V97, P84; DAVID NJ, 1961, ARCH NEUROL-CHICAGO, V5, P165, DOI 10.1001/archneur.1961.00450140047004; Hayreh SS, 2007, RETINA-J RET VIT DIS, V27, P276, DOI 10.1097/01.iae.0000238095.97104.9b; Hayreh SS, 2005, AM J OPHTHALMOL, V140, P376, DOI 10.1016/j.ajo.2005.03.038; HAYREH SS, 1980, BRIT J OPHTHALMOL, V64, P896, DOI 10.1136/bjo.64.12.896; Hayreh SS, 2002, ACTA OPHTHALMOL SCAN, V80, P355, DOI 10.1034/j.1600-0420.2002.800403.x; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Lutty GA, 1996, ARCH OPHTHALMOL-CHIC, V114, P971, DOI 10.1001/archopht.1996.01100140179011; McLeod D, 2015, PROG RETIN EYE RES, V49, P82, DOI 10.1016/j.preteyeres.2015.06.001; Mueller AJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1377, DOI 10.1001/archopht.121.10.1377; Schmidt DP, 2002, AM J NEURORADIOL, V23, P1301; Schumacher M, 2010, OPHTHALMOLOGY, V117, P1367, DOI 10.1016/j.ophtha.2010.03.061	21	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209118	10.1371/journal.pone.0209118	http://dx.doi.org/10.1371/journal.pone.0209118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605464	Green Published, gold			2022-12-26	WOS:000454759900013
J	Naidu, BM; Yusoff, MFM; Abdullah, S; Musa, KI; Yaacob, NM; Mohamad, MS; Sahril, N; Aris, T				Naidu, Balkish Mahadir; Yusoff, Muhammad Fadhli Mohd; Abdullah, Sarimah; Musa, Kamarul Imran; Yaacob, Najib Majdi; Mohamad, Maria Safura; Sahril, Norhafizah; Aris, Tahir			Factors associated with the severity of hypertension among Malaysian adults	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; CARDIOVASCULAR RISK; WEIGHT-LOSS; PREVALENCE; PREHYPERTENSION; POPULATION; EPIDEMIOLOGY; DETERMINANTS; CHOLESTEROL	High blood pressure is a worldwide problem and major global health burden. Whether alone or combined with other metabolic diseases, high blood pressure increases the risk of cardiovascular disease. This study is a secondary data analysis from the National Health and Morbidity Survey 2015, a population-based study that was conducted nationwide in Malaysia using a multi-stage stratified cluster sampling design. A total of 15,738 adults >= 18-years-old were recruited into the study, which reports the prevalence of hypertension stages among adults in Malaysia using the JNC7 criteria and determinants of its severity. The overall prevalence of raised blood pressure was 66.8%, with 45.8% having prehypertension, 15.1% having Stage 1 hypertension, and 5.9% having Stage 2 hypertension. In the multivariate analysis, a higher likelihood of having prehypertension was observed among respondents with advancing age, males (OR = 2.74, 95% CI: 2.41-3.12), Malay ethnicity (OR = 1.21, 95% CI: 1.02-1.44), lower socioeconomic status, and excessive weight. The factors associated with clinical hypertension (Stages 1 and 2) were older age, rural residency (Stage 1 OR = 1.22, Stage 2 OR = 1.28), Malay ethnicity (Stage 2 OR = 1.64), diabetes (Stage 2 OR = 1.47), hypercholesterolemia (Stage 1 OR = 1.34, Stage 2 OR = 1.82), being overweight (Stage 1 OR = 2.86, Stage 2 OR = 3.44), obesity (Stage 1 OR = 9.01, Stage 2 OR = 13.72), and lower socioeconomic status. Almost 70% of Malaysian adults are at a risk of elevated blood pressure. The highest prevalence was in the prehypertension group, which clearly predicts a future incurable burden of the disease. Public health awareness, campaigns through mass and social media, and intervention in the work place should be a priority to control this epidemic.	[Naidu, Balkish Mahadir; Abdullah, Sarimah; Musa, Kamarul Imran; Yaacob, Najib Majdi; Sahril, Norhafizah] Univ Sains Malaysia, Sch Med Sci, Hlth Campus, Kelantan, Malaysia; [Naidu, Balkish Mahadir] Fed Govt Adm Ctr, Dept Stat, Putrajaya, Malaysia; [Yusoff, Muhammad Fadhli Mohd; Mohamad, Maria Safura; Sahril, Norhafizah; Aris, Tahir] Minist Hlth Malaysia, Inst Publ Hlth, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; Kementerian Kesihatan Malaysia	Naidu, BM (corresponding author), Univ Sains Malaysia, Sch Med Sci, Hlth Campus, Kelantan, Malaysia.; Naidu, BM (corresponding author), Fed Govt Adm Ctr, Dept Stat, Putrajaya, Malaysia.; Yusoff, MFM (corresponding author), Minist Hlth Malaysia, Inst Publ Hlth, Kuala Lumpur, Malaysia.	balkishmahadir@gmail.com; fadhli_my@moh.gov.my	bin Yaacob, Najib Majdi/U-7218-2019; Abdullah, Sarimah/N-5424-2015; bin Yaacob, Najib Majdi/N-3949-2015; Musa, Kamarul Imran/N-3198-2015	bin Yaacob, Najib Majdi/0000-0002-6860-1430; Abdullah, Sarimah/0000-0002-7966-5966; bin Yaacob, Najib Majdi/0000-0002-6860-1430; Musa, Kamarul Imran/0000-0002-3708-0628				Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210; Ani AN, 2012, INT J BIOMED, V2, P132; [Anonymous], 2008, CAUS OF DEATH 2008; Aris T, 2015, NATL HLTH MORBIDITY, VII; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bjertness MB, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3275-7; Blacher J, 2005, NAT CLIN PRACT CARD, V2, P450, DOI 10.1038/ncpcardio0307; Brown MJ, 2000, HYPERTENSION, V35, P1038, DOI 10.1161/01.HYP.35.5.1038; Chiu YH, 2006, J HYPERTENS, V24, P821, DOI 10.1097/01.hjh.0000222750.82820.19; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Statistics, 2010, POP DISTR BAS DEM CH; Feisul IM, 2014, MALAYSIAN J NUTR, V20; Gebreselassie KZ, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/959256; Geeta A, 2009, SINGAP MED J, V50, P1013; Grossman E, 2002, J HYPERTENS, V20, pS60; Grotto I, 2006, HYPERTENSION, V48, P254, DOI 10.1161/01.HYP.0000227507.69230.fc; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; Ho B K, 2014, Malays Fam Physician, V9, P12; HUNT JC, 1983, ANN INTERN MED, V98, P724, DOI 10.7326/0003-4819-98-5-724; Hussain MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160922; Institute for Public Health (IPH), 2011, NAT HLTH MORB SURV 2, V2; Institute for Public Health (IPH), 2014, NAT HLTH MORB SURV 2, V2; Institute for Public Health (IPH), 2015, NAT HLTH MORB SURV 2, VI, DOI [10.1016/S0140-6736(12)60735-1, DOI 10.1016/S0140-6736(12)60735-1]; Institute for Public Health (IPH), 2008, NON TRADITIONAL REF; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; Ko-Ko-Zaw, 2011, ASIA-PAC J PUBLIC HE, V23, P496, DOI 10.1177/1010539509349147; Lee J. O, 2013, INT J BIOSCIENCE BIO, V5, P45; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lwin-MM-Khin, 2011, SE ASIAN J TROP MED, V42, P208; Manios ED, 2008, AM J HYPERTENS, V21, P153, DOI 10.1038/ajh.2007.43; Ministry of Health. (MOH), 2014, CLIN PRACT GUID MAN; (MOH) Ministry of Health Malaysia, 2013, MAL DIET GUID 2013; Nang EEK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-141; Pereira AC, 2006, ATHEROSCLEROSIS, V184, P193, DOI 10.1016/j.atherosclerosis.2005.03.035; Qureshi AI, 2005, STROKE, V36, P1859, DOI 10.1161/01.STR.0000177495.45580.f1; Rampal L, 2008, PUBLIC HEALTH, V122, P11, DOI 10.1016/j.puhe.2007.05.008; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Shishani K, 2013, J IMMIGR MINOR HEALT, V15, P43, DOI 10.1007/s10903-011-9533-y; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Wang Haofen, 2013, CHINA DIGITAL MED, V8, P5, DOI DOI 10.1371/J0URNAL.P0NE.0062469; Wang HHX, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0239-4; Wang WY, 2006, HYPERTENSION, V47, P403, DOI 10.1161/01.HYP.0000200710.29498.80; WHO, 2013, NON TRADITIONAL REF; WHO, 2011, GLOB STAT REP NONC D; WHO, 2002, WORLD HLTH REP 2002; Winnicki M, 2006, AM J HYPERTENS, V19, P1103, DOI 10.1016/j.amjhyper.2006.04.016; Yadav S, 2008, INDIAN J MED RES, V128, P712; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	54	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0207472	10.1371/journal.pone.0207472	http://dx.doi.org/10.1371/journal.pone.0207472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605462	Green Published, gold, Green Submitted			2022-12-26	WOS:000454759900008
J	Cardenas, JC; Drame, PM; Luque-Burgos, KA; Berrio, JD; Entrena-Mutis, E; Gonzalez, MU; Carvajal, DJ; Gutierrez-Silva, LY; Cardenas, LD; Colpitts, TM; Mores, CN; Londono-Renteria, B				Cardenas, Jenny C.; Drame, Papa M.; Luque-Burgos, Karina A.; Berrio, Juan D.; Entrena-Mutis, Elsi; Gonzalez, Maria U.; Carvajal, Daisy J.; Gutierrez-Silva, Lady Y.; Cardenas, Lucio D.; Colpitts, Tonya M.; Mores, Christopher N.; Londono-Renteria, Berlin			IgG1 and IgG4 antibodies against Aedes aegypti salivary proteins and risk for dengue infections	PLOS ONE			English	Article							SECONDARY INFECTION; MOSQUITO BITES; ENDEMIC-AREA; PUERTO-RICO; VIRUS; RESPONSES; IGM; ENHANCEMENT; DIAGNOSIS; FEATURES	Dengue virus (DENV) is an arbovirus responsible for a significant number of deaths in Latin America. This virus is transmitted through the bite of Aedes aegypti, the main mosquito vector, and Ae. albopictus. During blood uptake, the mosquito injects its saliva into the host to facilitate the feeding process. Mosquito saliva contains potent immunogens capable of inducing antibody production directly related to mosquito bite exposure intensity and disease risk. In this study, we first determined the DENV infection status by two different DENV non-structural protein 1 (NS1) based rapid tests and qRT-PCR, then measured the levels of IgG1 and IgG4 antibodies against salivary proteins of Ae. aegypti female mosquitoes in volunteers living in a dengue endemic area. Our results show that people with a positive DENV diagnosis present higher levels of IgG4 antibodies than people with a negative diagnostic test, and that these antibody levels were higher in people with secondary DENV infections. With this study, we show that detection of IgG4 antibodies against mosquito saliva may be a reliable method to evaluate the risk of dengue infection.	[Cardenas, Jenny C.] Hosp Local Los Patios, Lab Clin, Los Patios, Norte De Santan, Colombia; [Cardenas, Jenny C.; Drame, Papa M.; Londono-Renteria, Berlin] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Luque-Burgos, Karina A.; Berrio, Juan D.; Entrena-Mutis, Elsi; Gonzalez, Maria U.] Hosp Erasmo Meoz de Cucuta, Lab Clin, Cucuta, Norte De Santan, Colombia; [Carvajal, Daisy J.; Cardenas, Lucio D.] Univ Pamplona, Grp Invest Enfermedades Parasitarias & Infecciosa, Pamplona, Norte De Santan, Colombia; [Gutierrez-Silva, Lady Y.] ESE Hosp Emiro Quintero Canizares, Lab Clin, Ocana, Norte De Santan, Colombia; [Colpitts, Tonya M.] Boston Univ, Sch Med, NEIDL, Dept Microbiol, Boston, MA 02118 USA; [Mores, Christopher N.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC USA	Kansas State University; Boston University; George Washington University	Londono-Renteria, B (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	blondono@ksu.edu	Londono, Berlin/I-8830-2019	Londono, Berlin/0000-0001-5956-5274; Berrio Saavedra, Juan Diego/0000-0002-4697-5175; Mores, Christopher/0000-0001-6678-9049; Carvajal Barrera, Daisy Janeth/0000-0002-5666-7555; Colpitts, Tonya/0000-0003-3915-1554	NIH [1K22 AI103067-01]; Colciencias-The Colombian Administrative Department of Science, Technology, and Innovation (BLR)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colciencias-The Colombian Administrative Department of Science, Technology, and Innovation (BLR)	This work was supported by Colciencias The Colombian Administrative Department of Science, Technology, and Innovation (BLR); NIH 1K22 AI103067-01 (TMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the IMEX Group for donating the rapid DENGUE Duo tests. We also thank the bacteriology and microbiology students of the University of Pamplona for their collaboration with sample collection. A very special thanks to the community of the Patios for allowing us, once again, to carry out our studies and to Paula Rozo-Lopez for her valuable help editing the manuscript. Funding support: Colciencias-The Colombian Administrative Department of Science, Technology, and Innovation (BLR); NIH 1K22 AI103067-01 (TMC)	Aggarwal A, 1998, Indian Pediatr, V35, P727; Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; Arboleda Margarita, 2006, Biomed., V26, P286; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176; Carballo I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149330; Cassab Alexander, 2011, Rev. salud pública, V13, P115, DOI 10.1590/S0124-00642011000100010; Cavailler P, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1849-8; Changal KH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2053-6; COBRA C, 1995, AM J EPIDEMIOL, V142, P1204, DOI 10.1093/oxfordjournals.aje.a117579; Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941; da Rocha ACVM, 2004, MEM I OSWALDO CRUZ, V99, P709, DOI 10.1590/S0074-02762004000700008; Faulkner H, 2001, PARASITE IMMUNOL, V23, P509, DOI 10.1046/j.1365-3024.2001.00408.x; Gregory CJ, 2010, AM J TROP MED HYG, V82, P922, DOI 10.4269/ajtmh.2010.09-0552; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673; L'Ambert G, 2012, J VECTOR ECOL, V37, P269, DOI 10.1111/j.1948-7134.2012.00227.x; Lee TH, 2017, EXPERT REV ANTI-INFE, V15, P67, DOI 10.1080/14787210.2017.1248405; Londono-Renteria B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00380; Londono-Renteria B, 2015, BIOMEDICA, V35, P572, DOI 10.7705/biomedica.v35i4.2530; Londono-Renteria B, 2015, AM J TROP MED HYG, V93, P869, DOI 10.4269/ajtmh.15-0130; Londono-Renteria B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081211; Londono-Renteria BL, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00111; Mizumoto K, 2014, J VECTOR DIS, V51, P153; Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649; Mussi ADH, 2007, ACTA TROP, V104, P108, DOI 10.1016/j.actatropica.2007.07.011; Nawa M, 2005, CLIN DIAGN LAB IMMUN, V12, P1235, DOI 10.1128/CDLI.12.10.1235-1237.2005; Tuan NM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003638; Palosuo K, 1997, INT ARCH ALLERGY IMM, V114, P367, DOI 10.1159/000237696; Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6; Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002; Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Restrepo BN, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/872608; Rizzo C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0549-8; Rizzo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096130; Ruiz D, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-66; Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753; Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Tabachnick WJ, 2016, INSECTS, V7, DOI 10.3390/insects7040050; Tee H P, 2009, Med J Malaysia, V64, P316; Villabona-Arenas CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004653; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1	49	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208455	10.1371/journal.pone.0208455	http://dx.doi.org/10.1371/journal.pone.0208455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601814	gold, Green Published, Green Submitted			2022-12-26	WOS:000454683200011
J	Chen, QF; Huang, T; Shen, LJ; Li, W				Chen, Qi-Feng; Huang, Tao; Shen, Lujun; Li, Wang			Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study	PLOS ONE			English	Article							INTRACRANIAL METASTASIS; EXTRAHEPATIC METASTASES; CLINICAL-FEATURES; CANCER; RADIOTHERAPY; PATIENT	Background Population-based estimates of the incidence and prognosis of brain metastases at diagnosis of hepatocellular carcinoma (HCC) are lacking. The aim of this study was to characterize the incidence proportion and survival of newly diagnosed hepatocellular carcinoma with brain metastases (HCCBM). Materials and methods Data from Surveillance, Epidemiology, and End Results (SEER) program between 2010 and 2014 was evaluated. Patients with HCCBM were included. Multivariable logistic and Cox regression were performed to identify predictors of the presence of brain metastases at diagnosis and prognostic factors of overall survival (OS). We also built a nomogram based on Cox model to predict prognosis for HCCBM patients. Results We identified 97 patients with brain metastases at the time of diagnosis of HCC, representing 0.33% of the entire cohort. Logistic regression showed patients with bone or lung metastases had greater odds of having brain metastases at diagnosis. Median OS for HCCBM was 2.40 months. Cox regression revealed unmarried and bone metastases patients suffered significantly shorter survival time. A nomogram was developed with internal validation concordance index of 0.639. Conclusions This study provided population-based estimates of the incidence and prognosis for HCCBM patients. The nomogram could be a convenient individualized predictive tool for prognosis.	[Chen, Qi-Feng; Huang, Tao; Shen, Lujun; Li, Wang] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Chen, Qi-Feng; Huang, Tao; Shen, Lujun; Li, Wang] Sun Yat Sen Univ, Canc Ctr, Dept Med Imaging & Intervent Radiol, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Li, W (corresponding author), Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Li, W (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Med Imaging & Intervent Radiol, Guangzhou, Guangdong, Peoples R China.	liwang@sysucc.org.cn	Shen, Lujun/GQQ-3457-2022					Chang L, 2004, SURG NEUROL, V62, P172, DOI 10.1016/j.surneu.2003.10.002; Chen CY, 2015, ONCOL LETT, V9, P721, DOI 10.3892/ol.2014.2733; Chen QF, 2017, CARDIOVASC INTER RAD, V40, P1748, DOI 10.1007/s00270-017-1736-8; Chen SF, 2007, EUR J NEUROL, V14, P408, DOI 10.1111/j.1468-1331.2007.01681.x; Choi HJ, 2009, J NEURO-ONCOL, V91, P307, DOI 10.1007/s11060-008-9713-3; Del Ben M, 2003, J EXP CLIN CANC RES, V22, P641; Hammond WJ, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26919; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Jang Se Youn, 2015, Brain Tumor Res Treat, V3, P48, DOI 10.14791/btrt.2015.3.1.48; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; Kim M, 1998, J NEURO-ONCOL, V36, P85, DOI 10.1023/A:1005716408970; KUGA Y, 1990, Neurologia Medico-Chirurgica, V30, P768, DOI 10.2176/nmc.30.768; LEE JP, 1988, SURG NEUROL, V30, P316, DOI 10.1016/0090-3019(88)90306-0; LOO KT, 1994, PATHOLOGY, V26, P119, DOI 10.1080/00313029400169321; Martin AM, 2017, JAMA ONCOL, V3, P1069, DOI 10.1001/jamaoncol.2017.0001; Murakami K, 1996, NEURORADIOLOGY, V38, pS31, DOI 10.1007/BF02278115; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Okimoto Kenichiro, 2013, Case Rep Gastroenterol, V7, P182, DOI 10.1159/000350673; Seinfeld J, 2006, J NEURO-ONCOL, V76, P93, DOI 10.1007/s11060-005-4175-3; SHUANGSHOTI S, 1991, Journal of the Medical Association of Thailand, V74, P531; SHUANGSHOTI S, 1989, Journal of the Medical Association of Thailand, V72, P307; Tawada A, 2014, CASE REP ONCOL, V7, P199, DOI 10.1159/000360982; Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414; WAKISAKA S, 1990, NEUROSURGERY, V26, P863, DOI 10.1227/00006123-199005000-00021; Wu WR, 2017, J CANCER, V8, P2312, DOI 10.7150/jca.19056; Xu QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088317; Yamakawa Y, 2015, HEPATOL RES, V45, P1071, DOI 10.1111/hepr.12457	27	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209293	10.1371/journal.pone.0209293	http://dx.doi.org/10.1371/journal.pone.0209293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601858	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200055
J	Lane, J; Rohan, EMF; Sabeti, F; Essex, RW; Maddess, T; Dawel, A; Robbins, RA; Barnes, N; He, XM; McKone, E				Lane, Jo; Rohan, Emilie M. F.; Sabeti, Faran; Essex, Rohan W.; Maddess, Ted; Dawel, Amy; Robbins, Rachel A.; Barnes, Nick; He, Xuming; McKone, Elinor			Impacts of impaired face perception on social interactions and quality of life in age-related macular degeneration: A qualitative study and new community resources	PLOS ONE			English	Article							VISUAL FUNCTION; LOW-VISION; DEVELOPMENTAL PROSOPAGNOSIA; INDIVIDUALIZED MEASURE; IMAGE-ENHANCEMENT; RECOGNITION; REHABILITATION; PERFORMANCE; ADJUSTMENT; EXPERIENCE	Aims Previous studies and community information about everyday difficulties in age-related macular degeneration (AMD) have focussed on domains such as reading and driving. Here, we provide the first in-depth examination of how impaired face perception impacts social interactions and quality of life in AMD. We also develop a Faces and Social Life in AMD brochure and information sheet, plus accompanying conversation starter, aimed at AMD patients and those who interact with them (family, friends, nursing home staff). Method Semi-structured face-to-face interviews were conducted with 21 AMD patients covering the full range from mild vision loss to legally blind. Thematic analysis was used to explore the range of patient experiences. Results Patients reported faces appeared blurred and/or distorted. They described recurrent failures to recognise others' identity, facial expressions and emotional states, plus failures of alternative non-face strategies (e.g., hairstyle, voice). They reported failures to follow social nuances (e.g., to pick up that someone was joking), and feelings of missing out ('I can't join in'). Concern about offending others (e.g., by unintentionally ignoring them) was common, as were concerns of appearing fraudulent ('Other people don't understand'). Many reported social disengagement. Many reported specifically face-perception-related reductions in social life, confidence, and quality of life. All effects were observed even with only mild vision loss. Patients endorsed the value of our Faces and Social Life in AMD Information Sheet, developed from the interview results, and supported future technological assistance (digital image enhancement). Conclusion Poor face perception in AMD is an important domain contributing to impaired social interactions and quality of life. This domain should be directly assessed in quantitative quality of life measures, and in resources designed to improve community understanding. The identity-related social difficulties mirror those in prosopagnosia, of cortical rather than retinal origin, implying findings may generalise to all low-vision disorders.	[Lane, Jo; Dawel, Amy; McKone, Elinor] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Lane, Jo; Dawel, Amy; McKone, Elinor] Australian Natl Univ, ARC Ctr Excellence Cognit & Its Disorders, Canberra, ACT, Australia; [Rohan, Emilie M. F.; Sabeti, Faran; Maddess, Ted] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Sabeti, Faran] Univ Canberra, Discpline Optometry & Vis Sci, Bruce, Australia; [Essex, Rohan W.] Australian Natl Univ, Acad Unit Ophthalmol, Canberra, ACT, Australia; [Robbins, Rachel A.] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Barnes, Nick] Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia; [Barnes, Nick] CSIRO, Data61, Canberra, ACT, Australia; [He, Xuming] ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai, Peoples R China	Australian National University; Australian National University; Australian National University; John Curtin School of Medical Research; University of Canberra; Australian National University; Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); ShanghaiTech University	McKone, E (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.; McKone, E (corresponding author), Australian Natl Univ, ARC Ctr Excellence Cognit & Its Disorders, Canberra, ACT, Australia.	elinor.mckone@anu.edu.au	Robbins, Rachel A/A-5542-2008; Dawel, Amy/AAY-2083-2020; Barnes, Nick/Y-2744-2018; Sabeti, Faran/AAR-1767-2021; Maddess, Teddy L/A-3200-2008	Dawel, Amy/0000-0001-6668-3121; Barnes, Nick/0000-0002-9343-9535; Maddess, Teddy L/0000-0003-4591-3658; SABETI, Faran/0000-0001-9187-7569; McKone, Elinor/0000-0003-1655-4297; Robbins, Rachel/0000-0001-9363-4528; Essex, Rohan/0000-0001-5323-0334; Lane, Jo/0000-0002-2518-1050	Australian Research Council [CE110001021, DP150100684]; National Health and Medical Research Council [1063458]; Rebecca Cooper Medical Foundation Grant	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Foundation Grant	This research was supported by Australian Research Council grants CE110001021 (www.ccd.edu.au; EM, JL, AD) and DP150100684 (EM), National Health and Medical Research Council Project Grant 1063458 (https://www.nhmrc.gov.au/TM, ER and FS), Rebecca Cooper Medical Foundation Grant (FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1543, DOI 10.1001/archopht.1988.01060140711040; Asper Lisa, 2000, Clin Exp Optom, V83, P49; Bach AM, 2016, GLOB QUALIT NURS RES, V3, DOI 10.1177/2333393616651351; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barteselli G, 2014, EYE, V28, P1231, DOI 10.1038/eye.2014.189; Bennion AE, 2012, SOC SCI MED, V75, P976, DOI 10.1016/j.socscimed.2012.04.023; Boucart M, 2008, VISUAL NEUROSCI, V25, P603, DOI 10.1017/S0952523808080656; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BULLIMORE MA, 1991, INVEST OPHTH VIS SCI, V32, P2020; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Cimarolli VR, 2012, CLIN REHABIL, V26, P748, DOI 10.1177/0269215511429162; Crabb DP, 2013, OPHTHALMOLOGY, V120, P1120, DOI 10.1016/j.ophtha.2012.11.043; Csaky K, 2017, INVEST OPHTH VIS SCI, V58, P3456, DOI 10.1167/iovs.17-22339; Dalrymple KA, 2014, J PSYCHOSOM RES, V77, P144, DOI 10.1016/j.jpsychores.2014.06.001; Davis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028800; Dawel A., J EXP PSYCHOL APPL; Dawel A, PERSONAL DISORD; de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Ehrlich JR, 2017, AM J OPHTHALMOL, V176, P26, DOI 10.1016/j.ajo.2016.12.021; Evans BJW, 2007, OPHTHAL PHYSL OPT, V27, P417, DOI 10.1111/j.1475-1313.2007.00488.x; FERRIS FL, 1993, AM J OPHTHALMOL, V116, P735; Finger RP, 2008, QUAL LIFE RES, V17, P559, DOI 10.1007/s11136-008-9327-4; Fusch PI, 2015, QUAL REP, V20, P1408; Gopinath B, 2014, MATURITAS, V77, P263, DOI 10.1016/j.maturitas.2013.12.001; Hammarberg K, 2016, HUM REPROD, V31, P498, DOI 10.1093/humrep/dev334; Heerey EA, 2015, CURR DIR PSYCHOL SCI, V24, P285, DOI 10.1177/0963721415570731; Heraghty J, 2012, AM J PUBLIC HEALTH, V102, P1655, DOI 10.2105/AJPH.2012.300657; Hooper P, 2008, CAN J OPHTHALMOL, V43, P180, DOI 10.3129/i08-001; Irons J, 2014, J VISION, V14, DOI 10.1167/14.2.12; Irons JL, 2017, VISION RES, V137, P61, DOI 10.1016/j.visres.2017.06.002; Johnson AP, 2017, INVEST OPHTH VIS SCI, V58, P2520, DOI 10.1167/iovs.16-21349; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lowe JB, 2000, OPTOMETRY VISION SCI, V77, P260, DOI 10.1097/00006324-200005000-00013; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Marakis TP, 2017, QUAL LIFE RES, V26, P183, DOI 10.1007/s11136-016-1407-2; Marmor DJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P117, DOI 10.1001/archophthalmol.2009.366; Marty MA, 2011, PRINCIPLES PRACTICE, P152; Mason M., 2010, FORUM QUAL SOC RES, V11; Mitchell J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-97; Mitchell Jan, 2005, Health Qual Life Outcomes, V3, P25, DOI 10.1186/1477-7525-3-25; Mitchell J, 2004, QUAL LIFE RES, V13, P1548, DOI 10.1023/B:QURE.0000031348.51292.4a; Murray E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20089-7; Owsley C, 2006, REHABIL PSYCHOL, V51, P23, DOI 10.1037/0090-5550.51.1.23; Pachana NA, 2007, INT PSYCHOGERIATR, V19, P103, DOI 10.1017/S1041610206003504; Palermo R, 2017, Q J EXP PSYCHOL, V70, P218, DOI 10.1080/17470218.2016.1161058; PELI E, 1994, J OPT SOC AM A, V11, P1929, DOI 10.1364/JOSAA.11.001929; PELI E, 1991, INVEST OPHTH VIS SCI, V32, P2337; Puell MC, 2012, INVEST OPHTH VIS SCI, V53, P7310, DOI 10.1167/iovs.11-8649; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sheldon S, 2014, OPTOMETRY VISION SCI, V91, P1000, DOI 10.1097/OPX.0000000000000314; Sinha P, 1996, NATURE, V384, P404, DOI 10.1038/384404a0; Stanford P, 2009, BRIT J VISUAL IMPA, V27, P129, DOI 10.1177/0264619609102216; Taylor DJ, 2018, OPHTHAL PHYSL OPT, V38, P98, DOI 10.1111/opo.12419; Taylor DJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011504; Tejeria L, 2002, BRIT J OPHTHALMOL, V86, P1019, DOI 10.1136/bjo.86.9.1019; van Rheede JJ, 2015, INVEST OPHTH VIS SCI, V56, P4802, DOI 10.1167/iovs.14-16311; Villegas EA, 2008, INVEST OPHTH VIS SCI, V49, P4688, DOI 10.1167/iovs.08-2316; Wang SW, 2008, CLIN REHABIL, V22, P816, DOI 10.1177/0269215508091435; Whelan E, 2007, SOCIOL HEALTH ILL, V29, P957, DOI 10.1111/j.1467-9566.2007.01024.x; Wilson Amanda, 2008, Vis Impair Res, V10, P23, DOI 10.1080/13882350802053731; Wong EYH, 2004, J VISUAL IMPAIR BLIN, V98, P629, DOI 10.1177/0145482X0409801007; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th; Yardley L, 2008, J PSYCHOSOM RES, V65, P445, DOI 10.1016/j.jpsychores.2008.03.013	66	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209218	10.1371/journal.pone.0209218	http://dx.doi.org/10.1371/journal.pone.0209218			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596660	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200034
J	Song, H; Cho, J; Lee, S; Park, JY; Choi, BM; Kim, MS; Kim, WG; Lee, MC; Kim, HI				Song, Hanlim; Cho, Jongwook; Lee, Sunwoo; Park, Ji-Young; Choi, Byung-Moon; Kim, Min Sun; Kim, Weon Gyeong; Lee, Min-Cheol; Kim, Hyoung-Ihl			Transcortical photothrombotic pyramidotomy model with persistent motor deficits	PLOS ONE			English	Article							CORTICOSPINAL TRACT; CAPSULAR INFARCT; RECOVERY; DORSAL; STROKE; RATS	Traditional pyramidotomy models have a high mortality rate from breathing difficulties and show early recovery from the induced motor deficits. This study establishes a novel pyramidotomy technique in Sprague Dawley rats that generates persistent motor deficits and has a reduced mortality rate. We used viral neural tracing to identify the course and relative distribution of forelimb and hindlimb motor fibers (n = 9). On basis of the neural tracing data, the medullary pyramid was targeted dorsally from the cerebellar cortex for photothrombotic infarct lesioning (n = 18). The photothrombotic technique selectively destroyed the corticospinal fibers in the medullary pyramid with relative preservation of neighboring grey-matter tissue. MicroPET imaging using 2-deoxy-2-[F-18]-fluoro-D-glucose (FDG-microPET) showed a decrease in regional cerebral glucose metabolism (rCGM) in the bilateral pyramid and ipsilateral sensory cortex (p < 0.001, FDR q < 0.05). In addition, the trapezoid bodies and superior olivary nuclei showed a decrease in rCGM, compatible with damage caused during the introduction of the optical fiber. Connected structures such as the inferior colliculi and auditory cortices also showed decreases in rCGM in both hemispheres (p < 0.001, FDR q < 0.05). There was a significant and persistent decrease in motor and sensory function in the contralateral limb following pyramidotomy, as demonstrated by performance in the single pellet reaching task and the foot-fault test. There was no operative mortality or loss of respiratory function in this study. These results indicate that photothrombotic pyramidotomy with a dorsal transcortical approach is a safe and reliable technique for generating a pyramidotomy model with persistent motor deficits.	[Song, Hanlim; Cho, Jongwook; Lee, Sunwoo; Park, Ji-Young; Kim, Hyoung-Ihl] Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea; [Choi, Byung-Moon] Univ Ulsan, Dept Anesthesiol & Pain Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Kim, Min Sun] Wonkwang Univ, Dept Physiol, Sch Med, Iksan, South Korea; [Kim, Weon Gyeong] Nambu Univ, Dept Nursing, Gwangju, South Korea; [Lee, Min-Cheol] Chonnam Natl Univ, Dept Pathol, Sch Med, Gwangju, South Korea; [Kim, Hyoung-Ihl] Presbyterian Med Ctr, Dept Neurosurg, Jeonju, South Korea	Gwangju Institute of Science & Technology (GIST); University of Ulsan; Asan Medical Center; Wonkwang University; Nambu University; Chonnam National University	Kim, HI (corresponding author), Gwangju Inst Sci & Technol, Dept Biomed Sci & Engn, Gwangju, South Korea.; Kim, HI (corresponding author), Presbyterian Med Ctr, Dept Neurosurg, Jeonju, South Korea.	hyoungihl@gist.ac.kr		Song, Hanlim/0000-0001-6701-4296	Basic Science Research Program through National Research Foundation of Korea - Ministry of Science and ICT [NRF-2016R1A2B3009660]; "Biomedical Integrated Technology Research" Project through a Gwangju Institute of Science and Technology [NN16540]; Research Institute of Clinical Medicine, Chonnam University Hospital [CRI 13072-3]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Science and ICT; "Biomedical Integrated Technology Research" Project through a Gwangju Institute of Science and Technology; Research Institute of Clinical Medicine, Chonnam University Hospital	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Basic Science Research Program through National Research Foundation of Korea funded by the Ministry of Science and ICT (NRF-2016R1A2B3009660; www.nrf.re.kr) to H-IK, the "Biomedical Integrated Technology Research" Project through a grant provided by Gwangju Institute of Science and Technology (NN16540; www.gist.ac.kr) to H-IK in 2017 and "the Research Institute of Clinical Medicine, Chonnam University Hospital (CRI 13072-3; www.cnuh.com) to M-CL.	Bashkatov AN, 2011, TISSUE OPTICAL PROPE; Carmel JB, 2013, EUR J NEUROSCI, V37, P1090, DOI 10.1111/ejn.12119; Cho J, 2016, NEUROREHAB NEURAL RE, V30, P941, DOI 10.1177/1545968316650282; Fanardjian VV, 2001, BEHAV BRAIN RES, V122, P139, DOI 10.1016/S0166-4328(01)00159-0; Hou TT, 2015, NEURAL REGEN RES, V10, P644, DOI 10.4103/1673-5374.155441; Jin D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9074; Kim D, 2015, J CEREBR BLOOD F MET, V35, P11, DOI 10.1038/jcbfm.2014.178; Kim HS, 2014, J CEREBR BLOOD F MET, V34, P683, DOI 10.1038/jcbfm.2014.2; Kim K, 2012, J CLIN NEUROL, V8, P116, DOI 10.3988/jcn.2012.8.2.116; Liu ZW, 2013, STROKE, V44, P1951, DOI 10.1161/STROKEAHA.113.001162; McKenna JE, 1999, J NEUROSCI, V19, P1885; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Petrosyan T, 2015, SOMATOSENS MOT RES, V32, P21, DOI 10.3109/08990220.2014.940078; SAETHER K, 1987, BRAIN RES, V419, P87, DOI 10.1016/0006-8993(87)90571-3; Song HL, 2017, J CEREBR BLOOD F MET, V37, P2928, DOI 10.1177/0271678X16679421; Starkey ML, 2011, EXP NEUROL, V232, P81, DOI 10.1016/j.expneurol.2011.08.006	16	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0204842	10.1371/journal.pone.0204842	http://dx.doi.org/10.1371/journal.pone.0204842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596648	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200005
J	Valdivieso, DA; Baughan, TG; Canavati, UM; Rey, AM; Trotter, CL; Burrell, DR; Buonora, JE; Ceremuga, TE				Valdivieso, Debra A.; Baughan, Thomas G., II; Canavati, Ursuline M.; Rey, Allison M.; Trotter, Cristal L.; Burrell, Destynni R.; Buonora, John E.; Ceremuga, Tomas Eduardo			Effects of pregabalin on neurobehavior in an adult male rat model of PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WATER-MAZE; ANXIETY; MEMORY	Posttraumatic stress disorder (PTSD) can be a very debilitating condition. Effective approaches to prevent and treat PTSD are important areas of basic science research. Pregabalin (PGB), a gabapentinoid derivative of gamma-aminobutyric acid, possesses the potential to positively affect neurobehavioral changes associated with PTSD. Using a rodent model of PTSD, the aims of this study were to determine the effects of PGB as a possible prevention for the development of PTSD-like symptoms and its use as a possible treatment. A prospective, experimental, between groups design was used in conjunction with a three-day restraint/shock PTSD stress model. Sixty rats were randomly assigned between two groups, non-stressed and stressed (PTSD). Each of the main two groups was then randomly assigned into six experimental groups: control vehicle, control PGB, control naive, PTSD vehicle, PTSD Pre-PGB (prophylactic), PTSD Post-PGB (non-prophylactic). The neurobehavioral components of PTSD were evaluated using the elevated plus maze (EPM), Morris water maze (MWM), and forced swim test (FST). Pregabalin administered 24 hours before the initial PTSD event or for 10 days following the last PTSD stress event did not statistically improve mean open arm exploration on the EPM, spatial memory, and learning in the MWM or behavioral despair measured by the FST (p > 0.05).	[Valdivieso, Debra A.; Baughan, Thomas G., II; Canavati, Ursuline M.; Rey, Allison M.; Trotter, Cristal L.; Burrell, Destynni R.; Buonora, John E.; Ceremuga, Tomas Eduardo] AMEDDC&S, Acad Hlth Sci, US Army Grad Program Anesthesia Nursing, Ft Sam Houston, TX 78234 USA		Ceremuga, TE (corresponding author), AMEDDC&S, Acad Hlth Sci, US Army Grad Program Anesthesia Nursing, Ft Sam Houston, TX 78234 USA.	Thomas.E.Ceremuga.civ@mail.mil		Ceremuga, Tomas/0000-0002-4313-4696	TriService Nursing Research Program (TSNRP) [HU0001-14-1-TS16, N14-001]	TriService Nursing Research Program (TSNRP)	This research was supported by the TriService Nursing Research Program (TSNRP) to T.E.C. (USU Grant Number: HU0001-14-1-TS16, USU Project Number: N14-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hamid WK, 2014, EARLY SCI MED, V19, P549, DOI 10.1163/15733823-00196P02; [Anonymous], 2016, PHARMACOLOGICAL TREA; [Anonymous], 2015, SYMPTOMS OF PTSD; [Anonymous], 2015, DEPRESSION TRAUMA AN; Armenta RF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1590-5; Averill LA, 2017, NEUROSCI LETT, V649, P147, DOI 10.1016/j.neulet.2016.11.064; Baldwin DS, 2013, NEUROPSYCH DIS TREAT, V9, P883, DOI 10.2147/NDT.S36453; Baldwin David S, 2007, Neuropsychiatr Dis Treat, V3, P185, DOI 10.2147/nedt.2007.3.2.185; Baniasadi M, 2014, J PSYCHIATR PRACT, V20, P419, DOI 10.1097/01.pra.0000456590.12998.41; Barone F, 2008, DECREASES STRESS IND, P11; Brown E, EVALUATION ANXIOLYTI, DOI [10.14719/pst.2015.2.1.91, DOI 10.14719/PST.2015.2.1.91]; Castagne V, 2011, CURRENT PROTOCOLS IN; Ceremuga TE, 2015, PLANT SCI TODAY, V2, P11, DOI 10.14719/pst.2015.2.1.91; Cohen J, 1977, STATISTICAL POWER AN; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Dremencov E, 2004, NEUROREPORT, V15, P1983, DOI 10.1097/00001756-200408260-00030; Faul F, STATISTICAL POWER AN; Fischer H., 2015, A GUIDE TO U S MILIT; Friedman M., 2016, PTSD HISTORY AND OVE; Gelenberg AJ, 2000, J CLIN PSYCHIAT, V61, P712, DOI 10.4088/JCP.v61n1002; Goldstein RB, 2016, SOC PSYCH PSYCH EPID, V51, P1137, DOI 10.1007/s00127-016-1208-5; Goswami S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00089; Gradus J.L., 2017, EPIDEMIOLOGY OF PTSD; Heese T, ANXIOLYTIC EFFECTS O; Housen T, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000419; Ivanova JI, 2011, AM J MANAG CARE, V17, pE314; Jeong DU, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0345-4; Jeong DU, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/568587; Leiter E, EVALUATION OF THE AN; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Lonsdorf TB, 2014, SOC COGN AFFECT NEUR, V9, P1973, DOI 10.1093/scan/nsu018; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; Mertz H., 2011, UNC SCHOOL OF MEDICI; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nass J, 2017, CURR NEUROPHARMACOL, V15, P831, DOI 10.2174/1570159X15666161111113514; Patel R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.205; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Ravnefjord A, 2008, BRIT J PHARMACOL, V155, P407, DOI 10.1038/bjp.2008.259; Ressler KJ, 2010, BIOL PSYCHIAT, V67, P1117, DOI 10.1016/j.biopsych.2010.04.027; Richter-Levin G, 1998, PSYCHIAT RES, V79, P73, DOI 10.1016/S0165-1781(98)00030-4; Robbins MT, 2007, PHYSIOL BEHAV, V91, P544, DOI 10.1016/j.physbeh.2007.04.009; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; Schoner J, 2017, J CELL MOL MED, V21, P2248, DOI 10.1111/jcmm.13161; SERVATIUS RJ, 1995, BIOL PSYCHIAT, V38, P539, DOI 10.1016/0006-3223(94)00369-E; Wenk Gary L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805as26; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T	47	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209494	10.1371/journal.pone.0209494	http://dx.doi.org/10.1371/journal.pone.0209494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596711	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200051
J	Hagman, H; Bendahl, PO; Lidfeldt, J; Belting, M; Johnsson, A				Hagman, Helga; Bendahl, Par-Ola; Lidfeldt, Jon; Belting, Mattias; Johnsson, Anders			Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer	PLOS ONE			English	Article							CHEMOTHERAPY PLUS BEVACIZUMAB; NON-INFERIORITY; GROWTH; BIOMARKERS; TRIAL; FLUOROURACIL; CONTINUATION; OXALIPLATIN; PROGRESSION; IRINOTECAN	Background Prolonged angiogenesis inhibition may improve treatment outcome in metastatic colorectal cancer (mCRC) patients. However, due to the complexity of the angiogenic pathways there is a lack of valid predictive biomarkers for anti-angiogenic agents. Here, we describe and optimize a procedure for simultaneous dynamic profiling of multiple angiogenesis related proteins in patient serum to explore associations with the response and acquired resistance to anti-angiogenic therapy. Materials and methods Patients (n=22) were selected from a clinical trial investigating maintenance treatment with bevacizumab alone after response to induction chemotherapy + bevacizumab in mCRC. Serum samples were analysed for 55 unique angiogenesis related proteins using a commercial proteome profiler array and a publicly available image analysis program for quantification. Samples were collected at baseline before induction treatment start, at start of maintenance treatment, and at end of treatment after tumour progression. Main results and conclusion For eight proteins, the antibody array signals were below detection range in all patient samples. None of the proteins showed levels at baseline or at start of maintenance with strong evidence for correlation to time to progression (lowest nominal p-value 0.03). The dynamic ranges of protein levels measured during the induction treatment period and during the maintenance period were analysed separately for time trends. Evidence for changing trends (up/down) in the levels of MMP-8, TIMP-4 and EGF was observed both during response to induction treatment and at progressive disease, respectively. For three of the proteins (IL-8, Activin A and IGFBP-2), weak evidence for correlation between increasing protein levels during induction with chemotherapy and bevacizumab and time to progression was observed. In conclusion, semi-quantitative profiling of angiogenesis related proteins in patient serum may be a versatile tool to screen for protein patterns aiming at identifying resistance mechanisms of anti-angiogenic treatment in patients with mCRC.	[Hagman, Helga; Bendahl, Par-Ola; Lidfeldt, Jon; Belting, Mattias; Johnsson, Anders] Lund Univ, Sect Oncol & Pathol, Dept Clin Sci Lund, Lund, Sweden; [Hagman, Helga; Belting, Mattias; Johnsson, Anders] Skane Univ Hosp, Dept Oncol, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Hagman, H (corresponding author), Lund Univ, Sect Oncol & Pathol, Dept Clin Sci Lund, Lund, Sweden.; Hagman, H (corresponding author), Skane Univ Hosp, Dept Oncol, Lund, Sweden.	helga.hagman@med.lu.se		Lidfeldt, Jon/0000-0002-8440-6512	Swedish Cancer Fund; Swedish Research Council; BioCARE Cancer Foundation; Mrs. Berta Kamprad's Cancer Foundation; Futurum - the academy for healthcare	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); BioCARE Cancer Foundation; Mrs. Berta Kamprad's Cancer Foundation; Futurum - the academy for healthcare	This project was funded by the Swedish Cancer Fund (www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society) (MB); the Swedish Research Council (www.vr.se/inenglish) (MB); BioCARE (www.med.lu.se/english/biocare) (MB), and Mrs. Berta Kamprad's Cancer Foundations (www.ikea.com/ms/sv_SE/catalog_categories/berta_kamprads_stiftelse.html) (AJ); and by Futurum - the academy for healthcare (https://plus.rjl.se/infopage.jsf?nodeId=41483) (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abajo A, 2012, BRIT J CANCER, V107, P287, DOI 10.1038/bjc.2012.242; Alidzanovic L, 2016, ONCOTARGET; Bai L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17717; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Feldser D, 1999, CANCER RES, V59, P3915; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fornai F, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0080-1; Hagman H, 2016, ANN ONCOL, V27, P140, DOI 10.1093/annonc/mdv490; Hayashi H, 2014, ONCOTARGET, V5, P2588, DOI 10.18632/oncotarget.1811; Hegewisch-Becker S, 2015, LANCET ONCOL, V16, P1355, DOI 10.1016/S1470-2045(15)00042-X; Huang RP, 2007, EXPERT REV PROTEOMIC, V4, P299, DOI 10.1586/14789450.4.2.299; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Johnsson A, 2013, ANN ONCOL, V24, P2335, DOI 10.1093/annonc/mdt236; Koeberle D, 2015, ANN ONCOL, V26, P709, DOI 10.1093/annonc/mdv011; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Liu YM, 2013, CANCER MED-US, V2, P234, DOI 10.1002/cam4.71; Loupakis F, 2011, BRIT J CANCER, V104, P1262, DOI 10.1038/bjc.2011.85; Loupakis F, 2007, J CLIN ONCOL, V25, P1816, DOI 10.1200/JCO.2006.10.3051; Martinetti A, 2014, CANCERS, V6, P1753, DOI 10.3390/cancers6031753; Masi G, 2015, ANN ONCOL, V26, P724, DOI 10.1093/annonc/mdv012; Osterlund P, 2011, BRIT J CANCER, V104, P599, DOI 10.1038/bjc.2011.2; Poon RTP, 2001, J CLIN ONCOL, V19, P1207, DOI 10.1200/JCO.2001.19.4.1207; Qu CY, 2015, WORLD J GASTROENTERO, V21, P5072, DOI 10.3748/wjg.v21.i16.5072; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Sanchez-Carbayo M, 2006, CLIN CHEM, V52, P1651, DOI 10.1373/clinchem.2005.059592; Scartozzi M, 2009, ANN ONCOL, V20, P227, DOI 10.1093/annonc/mdn637; Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3; Trachana SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156403; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Vigneri PG, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00230; Yau SW, 2015, J CELL COMMUN SIGNAL, V9, P125, DOI 10.1007/s12079-015-0261-2	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209838	10.1371/journal.pone.0209838	http://dx.doi.org/10.1371/journal.pone.0209838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592740	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900049
J	Sen, A; Duperron, S; Hourdez, S; Piquet, B; Leger, N; Gebruk, A; Le Port, AS; Svenning, MM; Andersen, AC				Sen, Arunima; Duperron, Sebastien; Hourdez, Stephane; Piquet, Berenice; Leger, Nelly; Gebruk, Andrey; Le Port, Anne-Sophie; Svenning, Mette Marianne; Andersen, Ann C.			Cryptic frenulates are the dominant chemosymbiotrophic fauna at Arctic and high latitude Atlantic cold seeps	PLOS ONE			English	Article							MOSBY MUD VOLCANO; TARGETED OLIGONUCLEOTIDE PROBES; DISSOLVED ORGANIC-MATTER; 16S RIBOSOMAL-RNA; HYDROTHERMAL VENT; EASTERN PACIFIC; HABITAT HETEROGENEITY; MOLECULAR CHARACTERIZATION; PHYLOGENETIC RELATIONSHIP; MACROFAUNAL COMMUNITIES	We provide the first detailed identification of Barents Sea cold seep frenulate hosts and their symbionts. Mitochondrial COI sequence analysis, in combination with detailed morphological investigations through both light and electron microscopy was used for identifying frenulate hosts, and comparing them to Oligobrachia haakonmosbiensis and Oligobrachia webbi, two morphologically similar species known from the Norwegian Sea. Specimens from sites previously assumed to host O. haakonmosbiensis were included in our molecular analysis, which allowed us to provide new insight on the debate regarding species identity of these Oligobrachia worms. Our results indicate that high Arctic seeps are inhabited by a species that though closely related to Oligobrachia haakonmosbiensis, is nonetheless distinct. We refer to this group as the Oligobrachia sp. CPL-clade, based on the colloquial names of the sites they are currently known to inhabit. Since members of the Oligobrachia sp. CPL-clade cannot be distinguished from O. haakonmosbiensis or O. webbi based on morphology, we suggest that a complex of cryptic Oligobrachia species inhabit seeps in the Norwegian Sea and the Arctic. The symbionts of the Oligobrachia sp. CPL-clade were also found to be closely related to O. haakonmosbiensis symbionts, but genetically distinct. Fluorescent in situ hybridization and transmission electron micrographs revealed extremely dense populations of bacteria within the trophosome of members of the Oligobrachia sp. CPL-clade, which is unusual for frenulates. Bacterial genes for sulfur oxidation were detected and small rod shaped bacteria (round in cross section), typical of siboglinid-associated sulfur-oxidizing bacteria, were seen on electron micrographs of trophosome bacteriocytes, suggesting that sulfide constitutes the main energy source. We hypothesize that specific, local geochemical conditions, in particular, high sulfide fluxes and concentrations could account for the unusually high symbiont densities in members of the Oligrobrachia sp. CPL-clade.	[Sen, Arunima; Svenning, Mette Marianne] UiT Arctic Univ Norway, Ctr Arctic Gas Hydrate Environm & Climate CAGE, Tromso, Norway; [Duperron, Sebastien; Piquet, Berenice; Leger, Nelly] Sorbonne Univ, CNRS, MNHN,UMR7208, IRD,UCN,UA,Biol Organismes & Ecosyst Aquat BOREA, Paris, France; [Duperron, Sebastien] CNRS, MNHN, MCAM, UMR7245, Paris, France; [Hourdez, Stephane; Piquet, Berenice; Le Port, Anne-Sophie; Andersen, Ann C.] Sorbonne Univ, CNRS, Equipe Adaptat & Biol Invertebres Marins Condit E, Stn Biol Roscoff, Roscoff, France; [Gebruk, Andrey] Shirshov Inst Oceanol, Moscow, Russia; [Svenning, Mette Marianne] UiT Arctic Univ Norway, Dept Arctic Marine Biol, Tromso, Norway; [Hourdez, Stephane] Sorbonne Univ, CNRS, LECOB, Observ Oceanol Banyuls,UMR8222, Banyuls sur Mer, France	UiT The Arctic University of Tromso; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Russian Academy of Sciences; Shirshov Institute of Oceanology; UiT The Arctic University of Tromso; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Sen, A (corresponding author), UiT Arctic Univ Norway, Ctr Arctic Gas Hydrate Environm & Climate CAGE, Tromso, Norway.	arunima.sen@uit.no	Gebruk, Andrey/A-9041-2016	duperron, sebastien/0000-0002-6422-6821; Sen, Arunima/0000-0001-7847-2137; ANDERSEN, Ann C./0000-0003-3962-100X	Centre for Arctic Gas Hydrate, Environment and Climate (CAGE); Research Council of Norway through its Centres of Excellence scheme [223259]; RSF [14-50-00095]; RFBR [18-05-60228]; UiT The Arctic University of Norway; Research Council of Norway; Government of France	Centre for Arctic Gas Hydrate, Environment and Climate (CAGE); Research Council of Norway through its Centres of Excellence scheme; RSF(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR)); UiT The Arctic University of Norway; Research Council of Norway(Research Council of Norway); Government of France	This study was funded through the Centre for Arctic Gas Hydrate, Environment and Climate (CAGE) and the Research Council of Norway through its Centres of Excellence scheme, project number 223259, and an Aurora grant from the Research Council of Norway and Government of France to AS and AA. Processing of material from the Laptev Sea was partly funded by the RSF Grant 14-50-00095 and the RFBR Grant 18-05-60228. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway.; We would like to thank the captains and crews of Helmer Hanssen, G. O Sars, Pourquoi pas?, Akademik Mstislav Keldysh and the chief scientists Michael Carroll, Jochen Knies, Aivo Lepland, Herve Nouze and Michael Flint. We would also like to thank the engineers who provided valuable assistance during these cruises and the ROV teams of Victor, 30K and AEgir. We are grateful to JoLynn Carroll, Emmelie Astrom, Katarzyna Melaniuk, Andrey Vedenin and Paul Dando for discussions and help with logistics and to Sergey Galkin and Andrey Vedenin for taking samples in the Laptev Sea. We thank Trine Dahl and the Geosciences laboratory at UiT-The Arctic University for providing microscopes and bench space for post cruise sample processing, and Pavel Serov for constructing Fig 2. We are grateful to the Institute of Biology Paris-Seine Imaging Facility, supported by the Conseil Regional Ile-de France, CNRS and Sorbonne Universite, for use of their confocal microscope. We very much appreciate Dr. Sophie Le Panse and her skills and advice concerning the preparation of our samples and for helping acquire TEM images at the MERIMAGE platform, and Dr. Colomban De Vargas for allowing us to use the PHENOM scanning microscope at Roscoff Marine Station. We are grateful to Tine Lander Rasmussen, Torleiv Brattegard, Emmelie Astrom, Cheshtaa Chitkara, Naima El bani Altuna, Steiner Iversen and the crew of Johan Ruud for attempting to collect O. webbi samples. We appreciate Dr. Mari Heggernes Eilertsen and an anonymous reviewer for their comments that helped us refine the manuscript. This study was funded through the Centre for Arctic Gas Hydrate, Environment and Climate (CAGE) and the Research Council of Norway through its Centres of Excellence scheme, project number 223259, and an Aurora grant from the Research Council of Norway and Government of France to AS and AA. Processing of material from the Laptev Sea was partly funded by the RSF Grant 14-50-00095 and the RFBR Grant 18-05-60228. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andreassen K, 2017, SCIENCE, V356, P948, DOI 10.1126/science.aal4500; Astrom EKL, 2018, LIMNOL OCEANOGR, V63, pS209, DOI 10.1002/lno.10732; Astrom EKL, 2016, MAR ECOL PROG SER, V552, P1, DOI 10.3354/meps11773; Beesley PL, 2000, POLYCHAETES ALLIES S; Beinart RA, 2012, P NATL ACAD SCI USA, V109, pE3241, DOI 10.1073/pnas.1202690109; Bergquist DC, 2003, J EXP MAR BIOL ECOL, V289, P197, DOI 10.1016/S0022-0981(03)00046-7; Borda E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1876; BRATTEGARD TORLEIV, 1966, SARSIA, V22, P55; Bright M, 2005, SYMBIOSIS, V38, P1; Bright M, 2003, INVERTEBR BIOL, V122, P347; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; Cordes EE, 2010, MAR ECOL-EVOL PERSP, V31, P51, DOI 10.1111/j.1439-0485.2009.00334.x; Cowart DA, 2014, HYDROBIOLOGIA, V736, P139, DOI 10.1007/s10750-014-1900-y; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; Dando PR, 2008, DEEP-SEA RES PT I, V55, P966, DOI 10.1016/j.dsr.2008.04.002; DANDO PR, 1986, OPHELIA, V26, P135, DOI 10.1080/00785326.1986.10421984; Dattagupta S, 2007, MAR ECOL-EVOL PERSP, V28, P193, DOI 10.1111/j.1439-0485.2006.00130.x; Dattagupta S, 2006, J EXP BIOL, V209, P3795, DOI 10.1242/jeb.02413; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; Decker C, 2012, MAR ECOL-EVOL PERSP, V33, P231, DOI 10.1111/j.1439-0485.2011.00486.x; Decker C, 2012, MAR ECOL-EVOL PERSP, V33, P205, DOI 10.1111/j.1439-0485.2011.00503.x; Deguchi M, 2007, ACTA ZOOL-STOCKHOLM, V88, P129, DOI 10.1111/j.1463-6395.2007.00260.x; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S., 2015, HYDROCARBON LIPID MI, P343, DOI [10.1007/8623_2015_73, DOI 10.1007/8623_2015_73]; Duperron S, 2009, FEMS MICROBIOL ECOL, V69, P395, DOI 10.1111/j.1574-6941.2009.00724.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilertsen MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23076-0; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gebruk AV, 2003, SARSIA, V88, P394, DOI 10.1080/00364820310003190; Georgieva MN, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0559-y; Glasby CJ, 2000, POLYCHAETES ALLIES S, V4A, P331; Halanych KM, 2005, HYDROBIOLOGIA, V535, P297, DOI 10.1007/s10750-004-1437-6; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; Hilario A, 2010, DEEP-SEA RES PT I, V57, P143, DOI 10.1016/j.dsr.2009.10.004; Hilario A, 2008, SCI MAR, V72, P361; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; Hong WL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15745; Hovland M, 2006, MAR GEOL, V228, P15, DOI 10.1016/j.margeo.2005.12.005; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Hutchings P, 2018, INVERTEBR SYST, V32, P1, DOI 10.1071/IS17035; IVANOV AV, 1963, POGONOPHORA; Jakobsson M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052219; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Johnson SB, 2008, J SHELLFISH RES, V27, P43, DOI 10.2983/0730-8000(2008)27[43:DBOLLR]2.0.CO;2; Kim Dongsung, 2000, Ocean Research (Seoul), V22, P1; Kimura H, 2003, MAR BIOTECHNOL, V5, P261, DOI 10.1007/s10126-002-0073-2; Kojima S, 2002, MAR BIOL, V141, P57, DOI 10.1007/s00227-002-0818-5; Kojima S, 2001, MAR BIOL, V139, P211; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; LAMMERS S, 1995, GEOL RUNDSCH, V84, P59; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Latour P, GEOCHEMISTRY BLOW OU; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Levin LA, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00072; Losekann T, 2008, ENVIRON MICROBIOL, V10, P3237, DOI 10.1111/j.1462-2920.2008.01712.x; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Miglietta MP, 2010, DEEP-SEA RES PT II, V57, P1916, DOI 10.1016/j.dsr2.2010.05.007; Naganuma Takeshi, 1997, Journal of Oceanography, V53, P193; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Nygren A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198356; Nygren A, 2014, ZOOL SCR, V43, P172, DOI 10.1111/zsc.12044; Paull CK, 2015, GEOCHEM GEOPHY GEOSY, V16, P3160, DOI 10.1002/2015GC005928; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rasmussen TL, 2018, CAGE WP3 WP6 CRUISE; Rasmussen TL, 2017, GEO 3111 RECONSTRUCT; Rodrigues CF, 2011, ANTON LEEUW INT J G, V100, P83, DOI 10.1007/s10482-011-9567-0; Rouse GW, 2008, BIOL BULL-US, V214, P67, DOI 10.2307/25066661; Rybakova E, 2013, BIOGEOSCIENCES, V10, P3359, DOI 10.5194/bg-10-3359-2013; Savvichev AS, 2018, GEOMICROBIOL J, V35, P411, DOI 10.1080/01490451.2017.1382612; SCHMALJOHANN R, 1990, MAR ECOL PROG SER, V61, P119, DOI 10.3354/meps061119; SCHMALJOHANN R, 1987, SARSIA, V72, P91, DOI 10.1080/00364827.1987.10419707; Sen A, 2018, BIOGEOSCIENCES, V15, P4533, DOI 10.5194/bg-15-4533-2018; Serov P, 2017, P NATL ACAD SCI USA, V114, P6215, DOI 10.1073/pnas.1619288114; Smirnov RV, 2014, MAR BIOL RES, V10, P972, DOI 10.1080/17451000.2013.872799; Smirnov RV, 2000, SARSIA, V85, P141, DOI 10.1080/00364827.2000.10414563; Southward A. J, 1970, Sarsia, V45, P69; SOUTHWARD AJ, 1979, J MAR BIOL ASSOC UK, V59, P133, DOI 10.1017/S0025315400046233; SOUTHWARD AJ, 1982, AM ZOOL, V22, P647; SOUTHWARD AJ, 1981, NATURE, V293, P616, DOI 10.1038/293616a0; SOUTHWARD EC, 1982, J MAR BIOL ASSOC UK, V62, P889, DOI 10.1017/S0025315400070417; Stiller J, 2013, SYST BIODIVERS, V11, P35, DOI 10.1080/14772000.2013.772925; Thornhill Daniel J., 2008, Communicative & Integrative Biology, V1, P163; VRIJENHOEK RC, 1994, DEEP-SEA RES PT I, V41, P1171, DOI 10.1016/0967-0637(94)90039-6; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; WEBB MICHAEL, 1964, SARSIA, V16, P47; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P641; Won Y, 2003, MOL ECOL, V12, P169, DOI 10.1046/j.1365-294X.2003.01726.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	97	17	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209273	10.1371/journal.pone.0209273	http://dx.doi.org/10.1371/journal.pone.0209273			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592732	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900019
J	Kosmala, M; Hufkens, K; Richardson, AD				Kosmala, Margaret; Hufkens, Koen; Richardson, Andrew D.			Integrating camera imagery, crowdsourcing, and deep learning to improve high-frequency automated monitoring of snow at continental-to-global scales	PLOS ONE			English	Article							LAND-COVER; SPATIAL-RESOLUTION; MODIS; PHOTOGRAPHY; CLASSIFICATION; RETRIEVAL; QUALITY; PHOTOS; AREA	Snow is important for local to global climate and surface hydrology, but spatial and temporal heterogeneity in the extent of snow cover make accurate, fine-scale mapping and monitoring of snow an enormous challenge. We took 184,453 daily near-surface images acquired by 133 automated cameras and processed them using crowdsourcing and deep learning to determine whether snow was present or absent in each image. We found that the crowdsourced data had an accuracy of 99.1% when compared with expert evaluation of the same imagery. We then used the image classification to train a deep convolutional neural network via transfer learning, with accuracies of 92% to 98%, depending on the image set and training method. The majority of neural network errors were due to snow that was present not being detected. We used the results of the neural networks to validate the presence or absence of snow inferred from the MODIS satellite sensor and obtained similar results to those from other validation studies. This method of using automated sensors, crowdsourcing, and deep learning in combination produced an accurate high temporal dataset of snow presence across a continent. It holds broad potential for real-time large-scale acquisition and processing of ecological and environmental data in support of monitoring, management, and research objectives.	[Kosmala, Margaret; Hufkens, Koen; Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hufkens, Koen] INRA, Unite Mixte Rech Interact Sol Plante Atmosphere, Villenave Dornon, France; [Richardson, Andrew D.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ USA; [Richardson, Andrew D.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ USA	Harvard University; INRAE; Northern Arizona University; Northern Arizona University	Kosmala, M (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	mkosmala@gmail.com	Richardson, Andrew/F-5691-2011	Richardson, Andrew/0000-0002-0148-6714; Hufkens, Koen/0000-0002-5070-8109	U.S. National Science Foundation's Macrosystems Biology program [EF-1065029, EF-1702697]	U.S. National Science Foundation's Macrosystems Biology program	The development of PhenoCam has been supported by the U.S. National Science Foundation's Macrosystems Biology program (awards EF-1065029 and EF-1702697 to AR). http://www.nsf.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2013, DIVIDE CONQUER ATOMI, P21; Amato A, 2014, PROCEEDINGS OF THE 2014 9TH INTERNATIONAL CONFERENCE ON COMPUTER VISION, THEORY AND APPLICATIONS (VISAPP 2014), VOL 3, P211; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Arsenault KR, 2014, HYDROL PROCESS, V28, P980, DOI 10.1002/hyp.9636; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Barrett A.P., 2003, NATL OPERATIONAL HYD; Barry R.G., 2002, POLAR GEOGR, V26, P235, DOI [10.1080/789610195, DOI 10.1080/789610195]; Bengio Y, 2012, P ICML WORKSH UNS TR, P17; Bernard E, 2013, ISPRS J PHOTOGRAMM, V75, P92, DOI 10.1016/j.isprsjprs.2012.11.001; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Buus-Hinkler J, 2006, REMOTE SENS ENVIRON, V105, P237, DOI 10.1016/j.rse.2006.06.016; Campbell JL, 2005, FRONT ECOL ENVIRON, V3, P314, DOI 10.2307/3868565; Chen XW, 2014, IEEE ACCESS, V2, P514, DOI 10.1109/ACCESS.2014.2325029; Cohen J., 1994, Weather, V49, P150, DOI 10.1002/j.1477-8696.1994.tb05997.x; Denil M., 2013, ADV NEURAL INFORM PR, P2148, DOI DOI 10.5555/2999792.2999852; Donahue J, 2015, PROC CVPR IEEE, P2625, DOI 10.1109/CVPR.2015.7298878; Dyer J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010031; Eamer J, 2007, GLOBAL OUTLOOK ICE S; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Frei A, 2012, ADV SPACE RES, V50, P1007, DOI 10.1016/j.asr.2011.12.021; Gascoin S, 2015, HYDROL EARTH SYST SC, V19, P2337, DOI 10.5194/hess-19-2337-2015; Graybeal DY, 2006, J APPL METEOROL CLIM, V45, P178, DOI 10.1175/JAM2330.1; Hall DK, 2001, IEEE T GEOSCI REMOTE, V39, P432, DOI 10.1109/36.905251; Hall DK, 2007, HYDROL PROCESS, V21, P1534, DOI 10.1002/hyp.6715; Hinkler J, 2002, INT J REMOTE SENS, V23, P4669, DOI 10.1080/01431160110113881; Jones H., 2001, SNOW ECOLOGY INTERDI; Keenan TF, 2014, ECOL APPL, V24, P1478, DOI 10.1890/13-0652.1; Kosmala M, 2016, FRONT ECOL ENVIRON, V14, P551, DOI 10.1002/fee.1436; Kosmala M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090726; KUDO G, 1991, ARCTIC ALPINE RES, V23, P436, DOI 10.2307/1551685; Kussul N, 2017, IEEE GEOSCI REMOTE S, V14, P778, DOI 10.1109/LGRS.2017.2681128; Kuter S, 2018, REMOTE SENS ENVIRON, V205, P236, DOI 10.1016/j.rse.2017.11.021; Lawrence DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL025080; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee HT, 2009, ACM T WEB, V3, DOI 10.1145/1541822.1541823; LISTON GE, 1995, J APPL METEOROL, V34, P1705, DOI 10.1175/1520-0450-34.7.1705; Mote TL, 2008, J APPL METEOROL CLIM, V47, P2008, DOI 10.1175/2007JAMC1823.1; Painter TH, 2009, REMOTE SENS ENVIRON, V113, P868, DOI 10.1016/j.rse.2009.01.001; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Parajka J, 2012, HYDROL PROCESS, V26, P3327, DOI 10.1002/hyp.8389; Pedersen SH, 2016, ARCT ANTARCT ALP RES, V48, P653, DOI 10.1657/AAAR0016-028; Raleigh MS, 2013, REMOTE SENS ENVIRON, V128, P44, DOI 10.1016/j.rse.2012.09.016; Richardson AD, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.28; Riggs G. A., 2015, MODIS TERRA SNOW COV, DOI [10.5067/MODIS/MOD10A1.006, DOI 10.5067/MODIS/MOD10A1.006]; Rittger K, 2013, ADV WATER RESOUR, V51, P367, DOI 10.1016/j.advwatres.2012.03.002; Romanovsky VE, 2010, PERMAFROST PERIGLAC, V21, P106, DOI 10.1002/ppp.689; Romero A, 2016, IEEE T GEOSCI REMOTE, V54, P1349, DOI 10.1109/TGRS.2015.2478379; Salomonson VV, 2004, REMOTE SENS ENVIRON, V89, P351, DOI 10.1016/j.rse.2003.10.016; Salvatori R, 2011, ITAL J REMOTE SENS, V43, P137, DOI 10.5721/ItJRS201143211; Scott GJ, 2017, IEEE GEOSCI REMOTE S, V14, P549, DOI 10.1109/LGRS.2017.2657778; Serreze MC, 1999, WATER RESOUR RES, V35, P2145, DOI 10.1029/1999WR900090; Sirguey P, 2009, REMOTE SENS ENVIRON, V113, P160, DOI 10.1016/j.rse.2008.09.008; Tingxin Yan, 2010, ACM MOBISYS, DOI DOI 10.1145/1814433.1814443; Todhunter PE, 2001, J AM WATER RESOUR AS, V37, P1263, DOI 10.1111/j.1752-1688.2001.tb03637.x; Wang JY, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOPS (ICCVW), P452, DOI 10.1109/ICCVW.2013.66; Wang JL, 2016, PROCEEDINGS OF 2016 IEEE ADVANCED INFORMATION MANAGEMENT, COMMUNICATES, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (IMCEC 2016), P1097, DOI 10.1109/IMCEC.2016.7867381; Wu ZX, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P461, DOI 10.1145/2733373.2806222; Xing HF, 2018, ISPRS J PHOTOGRAMM, V141, P237, DOI 10.1016/j.isprsjprs.2018.04.025; Xu G, 2017, ENVIRON MODELL SOFTW, V91, P127, DOI 10.1016/j.envsoft.2017.02.004; Zhang TJ, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000157; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342; Zhou BL, 2018, IEEE T PATTERN ANAL, V40, P1452, DOI 10.1109/TPAMI.2017.2723009	62	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209649	10.1371/journal.pone.0209649	http://dx.doi.org/10.1371/journal.pone.0209649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589858	gold, Green Submitted, Green Published			2022-12-26	WOS:000454418200037
J	Bil, M; Andrasik, R; Sedonik, J; Cicha, V				Bil, Michal; Andrasik, Richard; Sedonik, Jiri; Cicha, Vojtech			ROCA - An ArcGIS toolbox for road alignment identification and horizontal curve radii computation	PLOS ONE			English	Article							CURVATURE; HIGHWAY; CRASHES	We present the ROCA (ROad Curvature Analyst) software, in the form of an ESRI ArcGIS Toolbox, intended for vector line data processing. The software segments road network data into tangents and horizontal curves. Horizontal curve radii and azimuth of tangents are then automatically computed. Simultaneously, additional frequently used road section characteristics are calculated, such as the sinuosity of a road section (detour ratio), the number of turns along an individual road section and the average cumulative angle for a road section. The identification of curves is based on the naive Bayes classifier and users are allowed to prepare their own training data files. We applied ROCA software to secondary roads within the Czech road network (9,980 km). The data processing took less than ten minutes. Approximately 43% of the road network in question consists of 42,752 horizontal curves. The ROCA software outperforms other existing automatic methods by 26% with respect to the percentage of correctly identified curves. The segmented secondary roads within the Czech road network can be viewed on the roca.cdvgis.cz/czechia web-map application. We combined data on road geometry with road crashes database to develop the crash modification factors for horizontal curves with various radii. We determined that horizontal curves with radii of 50 m are approximately 3.7 times more hazardous than horizontal curves with radii accounting for 1000 m. ROCA software can be freely downloaded for non-commercial use from https://roca.cdvinfo.cz/website.	[Bil, Michal; Andrasik, Richard; Sedonik, Jiri; Cicha, Vojtech] CDV Transport Res Ctr, Brno, Czech Republic	Transport Research Centre CDV	Bil, M (corresponding author), CDV Transport Res Ctr, Brno, Czech Republic.	michal.bil@cdv.cz	Andrášik, Richard/AAJ-6246-2020; Bíl, Michal/AAQ-2544-2021		Ministry of Transport [CZ.1.05/2.1.00/03.0064]	Ministry of Transport	The article was produced with the financial support of the Ministry of Transport within the program of long-term conceptual development of research institutions on the research infrastructure acquired from the Operation Program Research and Development for Innovations (CZ.1.05/2.1.00/03.0064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian S, 2016, ACCIDENT ANAL PREV, V95, P8, DOI 10.1016/j.aap.2016.06.005; Andrasik R, 2016, J GEOGR SYST, V18, P249, DOI 10.1007/s10109-016-0230-1; Cardoso J. L, 2005, 3 INT S HIGHW GEOM D; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Dougherty G., 2013, PATTERN RECOGNITION; Elvik R, 2013, ACCIDENT ANAL PREV, V59, P487, DOI 10.1016/j.aap.2013.07.010; ESRI, 2013, ARCGIS DESKT REL 10; Findley DJ, 2012, PUBLIC WORKS MANAG P, V17, P189, DOI 10.1177/1087724X11419307; Findley DJ, 2012, ACCIDENT ANAL PREV, V45, P296, DOI 10.1016/j.aap.2011.07.018; Fitzpatrick K, 2010, J TRANSP ENG, V136, P827, DOI 10.1061/(ASCE)TE.1943-5436.0000145; Forman G, 2004, LECT NOTES COMPUTER, P3202; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; Hans, 2012, J TRANSP SAF SECUR, V4, P179, DOI [10.1080/19439962.2011.646001, DOI 10.1080/19439962.2011.646001]; Hauer E., 1999, TRANSP RES REC, V1665, P22, DOI DOI 10.3141/1665-04; Haynes R, 2008, ACCIDENT ANAL PREV, V40, P843, DOI 10.1016/j.aap.2007.09.013; Imran M, 2006, COMPUT-AIDED CIV INF, V21, P383, DOI 10.1111/j.1467-8667.2006.00444.x; James G, 2015, INTRO STAT LEARNING; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Johnston I.R., 1982, P 11 AUSTR ROAD RES, V11, P115; Jurewicz C, 2010, P AUSTR ROAD SAF RES; Khan G, 2014, TRANSPORT RES REC, V2386, P147; Krammes R.A., 1995, TRANSP RES REC, V1500, P162; Li ZX, 2015, TRANSPORT RES REC, P172, DOI 10.3141/2472-20; McBean PA, 1982, 1053 TRRL; Othman S, 2012, J TRANSP ENG-ASCE, V138, P1151, DOI 10.1061/(ASCE)TE.1943-5436.0000408; Persaud B, 2000, TRANSPORT RES REC, P14; Rasdorf W, 2012, J COMPUT CIVIL ENG, V26, P191, DOI 10.1061/(ASCE)CP.1943-5487.0000127; Sakshaug K., ETTEKT OVERHOYDE KUR; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Wang C, 2009, J TRANSP GEOGR, V17, P385, DOI 10.1016/j.jtrangeo.2008.06.003; Xu H, 2016, TRANSPORT RES REC, P50, DOI 10.3141/2595-06; Zegeer C.V., 1992, TRANSP RES REC, V1356, P11	32	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208407	10.1371/journal.pone.0208407	http://dx.doi.org/10.1371/journal.pone.0208407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586417	Green Submitted, gold, Green Published			2022-12-26	WOS:000454416400020
J	Bishanga, DR; Drake, M; Kim, YM; Mwanamsangu, AH; Makuwani, AM; Zoungrana, J; Lemwayi, R; Rijken, MJ; Stekelenburg, J				Bishanga, Dunstan R.; Drake, Mary; Kim, Young-Mi; Mwanamsangu, Amasha H.; Makuwani, Ahmad M.; Zoungrana, Jeremie; Lemwayi, Ruth; Rijken, Marcus J.; Stekelenburg, Jelle			Factors associated with institutional delivery: Findings from a cross-sectional study in Mara and Kagera regions in Tanzania	PLOS ONE			English	Article							DISTRICT; PREGNANCY; EDUCATION; NEPAL	In Tanzania, maternal mortality has stagnated over the last 10 years, and some of the areas with the worst indicators are in the Lake and Western Zones. This study investigates the factors associated with institutional deliveries among women aged 15-49 years in two regions of the Lake Zone. Data were extracted from a cross-sectional household survey of 1,214 women aged 15-49 years who had given birth in the 2 years preceding the survey in Mara and Kagera regions. Logistic regression analyses were conducted to explore the influence of various factors on giving birth in a facility. About two-thirds (67.3%) of women gave birth at a health facility. After adjusting for possible confounders, six factors were significantly associated with institutional delivery: region (adjusted odds ratio [aOR], 95% confidence interval [CI]: 0.54 [0.41-0.71]), number of children (aOR, 95% CI: 0.61 [0.42-0.91]), household wealth index (aOR, 95% CI: 1.47 [1.09-2.27]), four or more antenatal care visits (aOR, 95% CI: 1.97 [1.12-3.47]), knowing three or more pregnancy danger signs (aOR, 95% CI: 1.87 [1.27-2.76]), and number of birth preparations (aOR, 95% CI: 6.09 [3.32-11.18]). Another three factors related to antenatal care were also significant in the bivariate analysis, but these were not significantly associated with place of delivery after adjusting for all variables in an extended multivariable regression model. Giving birth in a health facility was associated both with socio-demographic factors and women's interactions with the health care system during pregnancy. The findings show that national policies and programs promoting institutional delivery in Tanzania should tailor interventions to specific regions and reach out to low-income and high-parity women. Efforts are needed not just to increase the number of antenatal care visits made by pregnant women, but also to improve the quality and content of the interaction between women and service providers.	[Bishanga, Dunstan R.; Drake, Mary; Mwanamsangu, Amasha H.; Zoungrana, Jeremie; Lemwayi, Ruth] Jhpiego Tanzania, Dar Es Salaam, Tanzania; [Bishanga, Dunstan R.; Drake, Mary; Stekelenburg, Jelle] Univ Groningen, Univ Med Ctr Groningen, Dept Global Hlth, Hlth Sci, Groningen, Netherlands; [Kim, Young-Mi] Jhpiego, Baltimore, MD USA; [Makuwani, Ahmad M.] Tanzania Minist Hlth Community Dev Gender Elderly, Dar Es Salaam, Tanzania; [Rijken, Marcus J.] Univ Med Ctr Utrecht, Dept Obstet & Gynecol, Div Woman & Baby, Utrecht, Netherlands; [Rijken, Marcus J.] Univ Med Ctr Utrecht, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynecol, Leeuwarden, Netherlands	Jhpiego; University of Groningen; Jhpiego; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Medical Center Leeuwarden	Bishanga, DR (corresponding author), Jhpiego Tanzania, Dar Es Salaam, Tanzania.; Bishanga, DR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Global Hlth, Hlth Sci, Groningen, Netherlands.	dunstan.bishanga@jhpiego.org	; Stekelenburg, Jelle/B-3129-2017	Kim, Young Mi/0000-0002-8815-4957; Rijken, Marcus/0000-0003-0914-5508; Mwanamsangu, Amasha/0000-0003-0702-3304; Stekelenburg, Jelle/0000-0002-2732-6620	U.S. Agency for International Development (USAID) [AID-OAA-A-14-00028]; Maternal can Child Survival Program (MCSP)	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Maternal can Child Survival Program (MCSP)	This work was supported by the U.S. Agency for International Development (USAID), under the terms of the Cooperative Agreement No. AID-OAA-A-14-00028, for the Maternal can Child Survival Program (MCSP). The USAID agreement officer representative (AOR) for the project was consulted during design of the study and conceptualization of this manuscript.	Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; [Anonymous], 2015, SUSTAINABLE DEVELOPM; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Armstrong CE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3404-3; Audo M O, 2005, East Afr Med J, V82, P547; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Chowdhury AM, 2003, SKILLED ATTENDANCE A; Demilew YM, 2016, AFR HEALTH SCI, V16, P10, DOI 10.4314/ahs.v16i1.2; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P1498, DOI 10.1111/tmi.12214; Feyissa TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097194; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Freedman DA, 2006, AM STAT, V60, P299, DOI 10.1198/000313006X152207; GOUDAR SS, 2015, REPROD HEALTH S2, V12; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Mageda K, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.51.6347; Ministry of Health and Social Welfare [United Republic of Tanzania], 2014, THE NATIONAL ROAD MA; Ministry of Health and Welfare, 2016, TANZ DEM HLTH SURV M, P172, DOI DOI 10.1017/CBO9781107415324.004; Monica Munjial, 2009, Health and Population - Perspectives and Issues, V32, P131; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Moyer Cheryl A, 2013, Afr J Reprod Health, V17, P30; Mselle LT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-174; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mustafa M. H., 2015, BMC Health Services Research, V15; Mutiso S M, 2008, East Afr Med J, V85, P275; National Bureau of Statistics, 2010, TANZANIA DEMOGRAPHIC; National Bureau of Statistics and Office of the Chief Government Statistician-Zanzibar, 2005, TANZ DEM HLTH SURV 2; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; Olayemi O, 2009, J BIOSOC SCI, V41, P493, DOI 10.1017/S0021932009003356; Pembe Andrea B, 2010, BMC Pregnancy Childbirth, V10, P35, DOI 10.1186/1471-2393-10-35; Renkert S, 2001, HEALTH PROMOT INT, V16, P381, DOI 10.1093/heapro/16.4.381; Rutaremwa G, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0943-8; Sarker Malabika, 2010, BMC Res Notes, V3, P209, DOI 10.1186/1756-0500-3-209; Shah R, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0454-y; Sialubanje C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0652-7; Singh K, 2015, HEALTH CARE WOMEN IN, V36, P57, DOI 10.1080/07399332.2013.824971; Tanzania Ministry of Health and Social Welfare, 2013, MID TERM REVIEW OF T; Wai KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144135; WHO, 2016, WHO TECH REP SER, V997, P1; Wilunda C, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0327-0	42	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209672	10.1371/journal.pone.0209672	http://dx.doi.org/10.1371/journal.pone.0209672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586467	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400083
J	Margos, G; Gofton, A; Wibberg, D; Dangel, A; Marosevic, D; Loh, SM; Oskam, C; Fingerle, V				Margos, Gabriele; Gofton, Alex; Wibberg, Daniel; Dangel, Alexandra; Marosevic, Durdica; Loh, Siew-May; Oskam, Charlotte; Fingerle, Volker			The genus Borrelia reloaded	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; RELAPSING-FEVER; LYME-DISEASE; SP-NOV; CANDIDATUS BORRELIA; INADEQUATE EVIDENCE; ECHIDNA TICKS; 2 GENERA; DIVISION; IDENTIFICATION	The genus Borrelia, originally described by Swellengrebel in 1907, contains tick- or louse-transmitted spirochetes belonging to the relapsing fever (RF) group of spirochetes, the Lyme borreliosis (LB) group of spirochetes and spirochetes that form intermittent clades. In 2014 it was proposed that the genus Borrelia should be separated into two genera; Borrelia Swellengrebel 1907 emend. Adeolu and Gupta 2014 containing RF spirochetes and Borreliella Adeolu and Gupta 2014 containing LB group of spirochetes. In this study we conducted an analysis based on a method that is suitable for bacterial genus demarcation, the percentage of conserved proteins (POCP). We included RF group species, LB group species and two species belonging to intermittent clades, Borrelia turcica Guner et al. 2004 and Candidatus Borrelia tachyglossi Loh et al. 2017. These analyses convincingly showed that all groups of spirochetes belong into one genus and we propose to emend, and re-unite all groups in, the genus Borrelia.	[Margos, Gabriele; Dangel, Alexandra; Marosevic, Durdica; Fingerle, Volker] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany; [Margos, Gabriele; Dangel, Alexandra; Marosevic, Durdica; Fingerle, Volker] Natl Reference Ctr Borrelia, Oberschleissheim, Germany; [Gofton, Alex; Loh, Siew-May; Oskam, Charlotte] Murdoch Univ, Vector & Waterborne Pathogens Res Grp, Sch Vet & Life Sci, South St, Murdoch, WA, Australia; [Wibberg, Daniel] Univ Bielefeld, Cebitec, Bielefeld, Germany	Bavarian Health & Food Safety Authority; Murdoch University; University of Bielefeld	Margos, G (corresponding author), Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany.; Margos, G (corresponding author), Natl Reference Ctr Borrelia, Oberschleissheim, Germany.	gabriele.margos@lgl.bayern.de	Gofton, Alexander W/GOJ-8010-2022; Dangel, Alexandra/Y-8811-2019; Oskam, Charlotte/N-4097-2018	Gofton, Alexander W/0000-0002-5039-6117; Dangel, Alexandra/0000-0001-6737-5681; Marosevic, Durdica/0000-0001-6195-333X; MARGOS, Gabriele/0000-0001-5304-9615; Oskam, Charlotte/0000-0001-8886-2120	Australian Postgraduate Award; International Postgraduate Research Scholarship; Australian Research Council [LP160100200]; Bayer HealthCare (Germany); Bayer Australia; Murdoch University Small Grant Scheme; Robert-Koch-Institute via the German National Reference Centre for Borrelia; ESCMID via a ESGBOR Study Group grant 2015	Australian Postgraduate Award(Australian Government); International Postgraduate Research Scholarship(Australian Government); Australian Research Council(Australian Research Council); Bayer HealthCare (Germany)(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Australia; Murdoch University Small Grant Scheme; Robert-Koch-Institute via the German National Reference Centre for Borrelia; ESCMID via a ESGBOR Study Group grant 2015	This study was part-funded by the Australian Postgraduate Award (AG), the International Postgraduate Research Scholarship (SML), the Australian Research Council (LP160100200 to CO), Bayer HealthCare (Germany) and Bayer Australia, the Murdoch University Small Grant Scheme (CO), the Robert-Koch-Institute via the German National Reference Centre for Borrelia (VF), and ESCMID via a ESGBOR Study Group grant 2015 (GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek M, 2018, BMC GENOMICS, V19, DOI [10.1186/s12864-018-4809-4, 10.1186/S12864-018-4809-4]; Adeolu M, 2014, ANTON LEEUW INT J G, V105, P1049, DOI 10.1007/s10482-014-0164-x; BARANTON G, 1992, INT J SYST BACTERIOL, V42, P378, DOI 10.1099/00207713-42-3-378; Barbour AG, 2017, INT J SYST EVOL MICR, V67, P2058, DOI 10.1099/ijsem.0.001815; Becker NS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3016-4; Burkot TR, 2001, EMERG INFECT DIS, V7, P471, DOI 10.3201/eid0703.017323; CANICA MM, 1993, SCAND J INFECT DIS, V25, P441, DOI 10.3109/00365549309008525; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Cutler SJ, 1997, INT J SYST BACTERIOL, V47, P958, DOI 10.1099/00207713-47-4-958; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FUKUNAGA M, 1995, FEMS MICROBIOL LETT, V134, P255, DOI 10.1111/j.1574-6968.1995.tb07947.x; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gofton AW, 2018, INFECT GENET EVOL, V66, P72, DOI 10.1016/j.meegid.2018.09.013; Guner ES, 2004, INT J SYST EVOL MICR, V54, P1649, DOI 10.1099/ijs.0.03050-0; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Loh SM, 2017, INT J SYST EVOL MICR, V67, P1075, DOI 10.1099/ijsem.0.001929; Loh SM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1627-x; Margos G, 2017, INT J SYST EVOL MICR, V67, P1081, DOI 10.1099/ijsem.0.001717; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Marosevic D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005865; Miller SC, 2013, J BACTERIOL, V195, P3629, DOI 10.1128/JB.00347-13; Qin QL, 2014, J BACTERIOL, V196, P2210, DOI 10.1128/JB.01688-14; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; Skerman VBD, 1980, APPROVED LIST BACTER; Stevenson B, 2018, TICKS TICK-BORNE DIS, DOI [10.1016/j.ttbdis.2018.08.01030154058, DOI 10.1016/J.TTBDIS.2018.08.01030154058]; Takano A, 2011, ENV MICROBIOL REP, V3, P632, DOI 10.1111/j.1758-2229.2011.00280.x; Takano A, 2010, ENVIRON MICROBIOL, V12, P134, DOI 10.1111/j.1462-2920.2009.02054.x	27	50	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208432	10.1371/journal.pone.0208432	http://dx.doi.org/10.1371/journal.pone.0208432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586413	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400023
J	Wang, TY; Chen, J; Hou, Y; Yu, Y; Wang, B				Wang, Tianyi; Chen, Jing; Hou, Yue; Yu, Yang; Wang, Bing			BAP31 deficiency contributes to the formation of amyloid-beta plaques in Alzheimer's disease by reducing the stability of RTN3	FASEB JOURNAL			English	Article						BACE1; APP; RIDNs	ENDOPLASMIC-RETICULUM; PRECURSOR PROTEIN; BACE1; EXPRESSION; PHOSPHORYLATION; ASSOCIATION; INHIBITION; BIOGENESIS; ACTIVATION; SECRETASE	Reticulon (RTN) 3 reduces amyloid-beta (A beta) plaques (APs) by negative modulation of beta-secretase 1 (BACE1) activity. However, RTN3 aggregates easily, which offsets RTN3's inhibitory effect on BACE1 activity and exacerbates AP deposition. We found that BAP31 was a binding partner of RTN3 and positively correlated with the expression level of RTN3. To further explore how BAP31 is involved in Alzheimer's disease (AD), conditional knockout mice with targeted BAP31 deletion (B-KO) in the hippocampus and cerebral cortex were generated and hybridized with amyloid precursor protein (APP) PS1 transgenic (AD model) mice to obtain B-KO-AD mice. BAP31 knock out in primary hippocampal neurons decreased RTN3 monomer availability and enhanced the level of RTN3 aggregates, indicating that BAP31 deficiency increases the instability of RTN3. More importantly, these effects contributed to BACE1-mediated APP processing and were responsible for the increased APs in the hippocampus and cerebral cortex of B-KO-AD mice. Thus, elevated expression of BAP31 in the human brain is likely to reduce the formation of both RTN3 aggregates and A by enhancing the stability of RTN3.	[Wang, Tianyi; Chen, Jing; Hou, Yue; Yu, Yang; Wang, Bing] Northeastern Univ, Coll Life Sci & Hlth, 195 Chuangxin Rd, Shenyang 110819, Liaoning, Peoples R China	Northeastern University - China	Wang, B (corresponding author), Northeastern Univ, Coll Life Sci & Hlth, 195 Chuangxin Rd, Shenyang 110819, Liaoning, Peoples R China.	wangbing@mail.neu.edu.cn		Chen, Jing/0000-0002-0351-2525; wang, bing/0000-0002-6549-8837	National Natural Science Foundation of China [31370784, 31500754, 31670770, 2016YFC1302402]; Fundamental Research Funds for the Central Universities of China [N172008008, N130120001, N141008001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	The authors thank Dr. Mwichie Namusamba (College of Life Science and Health, Northeastern University) who gave us so much useful advice on writing and improving the manuscript. This work was supported by the National Natural Science Foundation of China (Grants 31370784, 31500754, 31670770, and 2016YFC1302402) and the Fundamental Research Funds for the Central Universities of China (Grants N172008008, N130120001, and N141008001). The authors declare no conflicts of interest.	Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; He WX, 2006, J MOL BIOL, V363, P625, DOI 10.1016/j.jmb.2006.07.094; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jiang ST, 2012, NEUROSCI LETT, V515, P125, DOI 10.1016/j.neulet.2012.03.026; Marwarha G, 2017, J ALZHEIMERS DIS, V57, P907, DOI 10.3233/JAD-161130; Marwarha G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070773; MASLIAH E, 1993, AM J PATHOL, V142, P871; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Niu KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44809; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Ogen-Shtern N, 2016, BRAIN RES, V1648, P658, DOI 10.1016/j.brainres.2016.03.044; Prior M, 2010, NEUROSCI BIOBEHAV R, V34, P1201, DOI 10.1016/j.neubiorev.2010.01.017; Sarajarvi T, 2009, J BIOL CHEM, V284, P34433, DOI 10.1074/jbc.M109.036202; Sharoar MG, 2016, MOL PSYCHIATR, V21, P1263, DOI 10.1038/mp.2015.181; Sharoar MG, 2017, REV NEUROSCIENCE, V28, P145, DOI 10.1515/revneuro-2016-0054; Shi Q, 2014, J NEUROSCI, V34, P13954, DOI 10.1523/JNEUROSCI.1588-14.2014; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Shim S, 2011, CELL MOL LIFE SCI, V68, P2115, DOI 10.1007/s00018-010-0561-x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Su JH, 1996, BRAIN RES, V739, P79, DOI 10.1016/S0006-8993(96)00811-6; Su JH, 1998, ACTA NEUROPATHOL, V96, P463, DOI 10.1007/s004010050920; Suen KC, 2003, J BIOL CHEM, V278, P49819, DOI 10.1074/jbc.M306503200; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Wojcik S, 2007, ACTA NEUROPATHOL, V114, P517, DOI 10.1007/s00401-007-0281-y; Xu JL, 2018, J LIPID RES, V59, P35, DOI [10.1194/jlr.M077016, 10.1194/jlr.m077016]; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Yang Z, 2014, MOL MICROBIOL, V93, P1043, DOI 10.1111/mmi.12716; Zhou WH, 2004, ANN NY ACAD SCI, V1035, P49, DOI 10.1196/annals.1332.004	39	10	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4936	4946		10.1096/fj.201801702R	http://dx.doi.org/10.1096/fj.201801702R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596517	Bronze			2022-12-26	WOS:000462888500024
J	Quarta, S; Mitric, M; Kalpachidou, T; Mair, N; Schiefermeier-Mach, N; Andratsch, M; Qi, YM; Langeslag, M; Malsch, P; Rose-John, S; Kress, M				Quarta, Serena; Mitric, Miodrag; Kalpachidou, Theodora; Mair, Norbert; Schiefermeier-Mach, Natalia; Andratsch, Manfred; Qi, Yanmei; Langeslag, Michiel; Malsch, Philipp; Rose-John, Stefan; Kress, Michaela			Impaired mechanical, heat, and cold nociception in a murine model of genetic TACE/ADAM17 knockdown	FASEB JOURNAL			English	Article						pain; sensory neuron; neuroimmune interactions	NECROSIS-FACTOR-ALPHA; IN-VIVO; PAIN; INTERLEUKIN-6; RECEPTOR; ADAM17; NEURONS; SKIN; DISINTEGRIN; TACE	TNF--converting enzyme, a member of the ADAM (A disintegrin and metalloproteinase) protease family and also known as ADAM17, regulates inflammation and regeneration in health and disease. ADAM17 targets are involved in pain development and hypersensitivity in animal models of inflammatory and neuropathic pain. However, the role of ADAM17 in the pain pathway is largely unknown. Therefore, we used the hypomorphic ADAM17 (ADAM17(ex/ex)) mouse model to investigate the importance of ADAM17 in nociceptive behavior, morphology, and function of primary afferent nociceptors. ADAM17(ex/ex) mice were hyposensitive to noxious stimulation, showing elevated mechanical thresholds as well as impaired heat and cold sensitivity. Despite these differences, skin thickness and innervation were comparable to controls. Although dorsal root ganglia of ADAM17(ex/ex) mice exhibited normal morphology of peptidergic and nonpeptidergic neurons, a small but significant reduction in the number of isolectin -4-positive neurons was observed. Functional electrical properties of unmyelinated nociceptors showed differences in resting membrane potential, afterhyperpolarization, and firing patterns in specific subpopulations of sensory neurons in ADAM17(ex/ex) mice. However, spinal cord morphology and microglia activity in ADAM17(ex/ex) mice were not altered. Our data suggest that ADAM17 contributes to the processing of painful stimuli, with a complex mode of action orchestrating the function of neurons along the pain pathway.Quarta, S., Mitri, M., Kalpachidou, T., Mair, N., Schiefermeier-Mach, N., Andratsch, M., Qi, Y., Langeslag, M., Malsch, P., Rose-John, S., Kress, M. Impaired mechanical, heat, and cold nociception in a murine model of genetic TACE/ADAM17 knockdown.	[Quarta, Serena; Mitric, Miodrag; Kalpachidou, Theodora; Mair, Norbert; Schiefermeier-Mach, Natalia; Andratsch, Manfred; Qi, Yanmei; Langeslag, Michiel; Malsch, Philipp; Kress, Michaela] Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Schopfstr 41, A-6020 Innsbruck, Austria; [Rose-John, Stefan] Christian Albrechts Univ Kiel, Dept Biochem, Kiel, Germany; [Schiefermeier-Mach, Natalia] Hlth Univ Appl Sci Tyrol, Innsbruck, Austria	Medical University of Innsbruck; University of Kiel	Kress, M (corresponding author), Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Schopfstr 41, A-6020 Innsbruck, Austria.	michaela.kress@i-med.ac.at	Kalpachidou, Theodora/AAW-6538-2020; Schiefermeier-Mach, Natalia/AAW-6428-2021	Schiefermeier-Mach, Natalia/0000-0001-6638-5298; Kalpachidou, Theodora/0000-0002-7924-7772; Kress, Michaela/0000-0002-8921-7470; Langeslag, Michiel/0000-0003-4883-7339	Austrian Research Funding Agency FWF [P18444, P28611]; Innsbruck Medical University (Grant MUI-start) [ST201506016]; German Science Foundation [CRC877]; German Science Foundation (Cluster of Excellence "Inflammation at Interfaces")	Austrian Research Funding Agency FWF(Austrian Science Fund (FWF)); Innsbruck Medical University (Grant MUI-start); German Science Foundation(German Research Foundation (DFG)); German Science Foundation (Cluster of Excellence "Inflammation at Interfaces")	The authors thank T. Martha, K. Braun, and M. Doblander (all from Innsbruck Medical University) for expert technical assistance. This work was supported by the Austrian Research Funding Agency FWF (Grants P18444 and P28611, to M. K.) and Innsbruck Medical University (Grant MUI-start ST201506016, to S.Q.). The work of S.R.-J. was supported by the German Science Foundation (CRC877, Project A1, and the Cluster of Excellence "Inflammation at Interfaces"). The authors declare no conflicts of interest.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Ahmed Z, 2006, BRAIN, V129, P1517, DOI 10.1093/brain/awl080; Andratsch M, 2009, J NEUROSCI, V29, P13473, DOI 10.1523/JNEUROSCI.1822-09.2009; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Barabas ME, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-9; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Benatti C, 2018, PSYCHONEUROENDOCRINO, V87, P74, DOI 10.1016/j.psyneuen.2017.10.011; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Braun O, 2013, J INTERF CYTOK RES, V33, P254, DOI 10.1089/jir.2012.0096; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Brooke MA, 2014, J INVEST DERMATOL, V134, P2486, DOI 10.1038/jid.2014.228; Cabron AS, 2018, J IMMUNOL, V201, P3106, DOI 10.4049/jimmunol.1701556; Camprubi-Robles M, 2013, J NEUROSCI, V33, P2582, DOI 10.1523/JNEUROSCI.4479-12.2013; Capone C, 2016, ELIFE, V5, DOI 10.7554/eLife.17536; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Constantin CE, 2008, J NEUROSCI, V28, P5072, DOI 10.1523/JNEUROSCI.4476-07.2008; Cuevas-Olguin R, 2017, SYNAPSE, V71, DOI 10.1002/syn.21984; FORSTER C, 1990, J NEUROSCI METH, V31, P109, DOI 10.1016/0165-0270(90)90155-9; Garcia-Oscos F, 2012, BIOL PSYCHIAT, V71, P574, DOI 10.1016/j.biopsych.2011.11.018; Gelling RW, 2008, ENDOCRINOLOGY, V149, P6053, DOI 10.1210/en.2008-0775; Goddard DR, 2001, GLIA, V34, P267, DOI 10.1002/glia.1060; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hodes GE, 2015, NAT NEUROSCI, V18, P1386, DOI 10.1038/nn.4113; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kefaloyianni E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87023; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; Kuner R, 2017, NAT REV NEUROSCI, V18, P20, DOI 10.1038/nrn.2016.162; Langeslag M, 2014, PFLUG ARCH EUR J PHY, V466, P2153, DOI 10.1007/s00424-014-1443-0; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Lindfors PH, 2006, J NEUROSCI, V26, P1953, DOI 10.1523/JNEUROSCI.4065-05.2006; Malsch P, 2014, J NEUROSCI, V34, P9845, DOI 10.1523/JNEUROSCI.5161-13.2014; Morley SJ, 2016, ELIFE, V5, DOI 10.7554/eLife.20813; Namer B, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00335; Nicolaou A, 2017, ARTERIOSCL THROM VAS, V37, P247, DOI 10.1161/ATVBAHA.116.308682; Obreja O, 2005, BRAIN, V128, P1634, DOI 10.1093/brain/awh490; Obreja O, 2002, PAIN, V96, P57, DOI 10.1016/S0304-3959(01)00420-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9512; Quarta S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00317; Quarta S, 2014, J NEUROSCI, V34, P13222, DOI 10.1523/JNEUROSCI.1209-13.2014; Quarta S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-73; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schmidt S, 2018, J EXP MED, V215, P1205, DOI 10.1084/jem.20171696; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; Smith AK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-61; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sun YY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-23; Tanabe Y, 2008, NEUROSCI LETT, V444, P16, DOI 10.1016/j.neulet.2008.08.023; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Weisshaar CL, 2017, NEUROSCI LETT, V655, P82, DOI 10.1016/j.neulet.2017.07.006; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	61	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4418	4431		10.1096/fj.201801901R	http://dx.doi.org/10.1096/fj.201801901R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30586315	hybrid, Green Published			2022-12-26	WOS:000459794800105
J	Castle, AR; Daude, N; Gilch, S; Westaway, D				Castle, Andrew R.; Daude, Nathalie; Gilch, Sabine; Westaway, David			Application of high-throughput, capillary-based Western analysis to modulated cleavage of the cellular prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion disease; neurodegeneration; proteolysis; high-throughput screening (HTS); glycoprotein; protein misfolding; capillary Western; PrPC; simple Western	ALPHA-CLEAVAGE; PEPTIDE APTAMERS; AMINO-TERMINUS; IMPAIRMENT; DOMAIN; PRPC	The cellular prion protein (PrPC) is a glycoprotein that is processed through several proteolytic pathways. Modulators of PrPC proteolysis are of interest because full-length PrPC and its cleavage fragments differ in their propensity to misfold, a process that plays a key role in the pathogenesis of prion diseases. PrPC may also act as a receptor for neurotoxic, oligomeric species of other proteins that are linked to neurodegeneration. Importantly, the PrPC C-terminal fragment C1 does not contain the reported binding sites for these oligomers. Western blotting would be a simple end point detection method for cell-based screening of compound libraries for effects on PrPC proteolysis or overall expression level. However, traditional Western blotting methods provide unreliable quantification and have only low throughput. Consequently, we explored capillary-based Western technology as a potential alternative; we believe that this study is the first to report analysis of PrPC using such an approach. We successfully optimized the detection and quantification of the deglycosylated forms of full-length PrPC and its C-terminal cleavage fragments C1 and C2, including simultaneous quantification of beta-tubulin levels to control for loading error. We also developed and tested a method for performing all cell culture, lysis, and deglycosylation steps in 96-well microplates prior to capillary Western analysis. These advances represent steps along the way to the development of an automated, high-throughput screening pipeline to identify modulators of PrPC expression levels or proteolysis.	[Castle, Andrew R.; Daude, Nathalie; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, 2-04 Brain & Aging Res Bldg, Edmonton, AB T6G 2M8, Canada; [Castle, Andrew R.; Westaway, David] Univ Alberta, Dept Med, Edmonton, AB T6G 2G3, Canada; [Gilch, Sabine] Univ Calgary, Fac Vet Med, Calgary Prion Res Unit, Dept Ecosyst & Publ Hlth, Calgary, AB T2N 1N4, Canada; [Gilch, Sabine] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Westaway, David] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada	University of Alberta; University of Alberta; University of Calgary; University of Calgary; University of Alberta	Westaway, D (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, 2-04 Brain & Aging Res Bldg, Edmonton, AB T6G 2M8, Canada.	david.westaway@ualberta.ca		Castle, Andrew/0000-0003-2590-9555	Canadian Institutes of Health Research [MOP123525, MOP137094]; Alberta Prion Research Institute [APRIEP 201600033]; Canada Research Chairs Program (CRC Tier 1 Grant) [230404]; Canada Foundation for Innovation [NIF21633]; Alzheimer's Society of Alberta and Northwest Territories/University Hospital Foundation "Hope for Tomorrow" catalyst grant	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Prion Research Institute; Canada Research Chairs Program (CRC Tier 1 Grant)(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alzheimer's Society of Alberta and Northwest Territories/University Hospital Foundation "Hope for Tomorrow" catalyst grant	Funding was provided by Canadian Institutes of Health Research Grants MOP123525 and MOP137094 (to D. W.), Alberta Prion Research Institute Grant APRIEP 201600033 (to D. W. and A. C.), Canada Research Chairs Program (CRC Tier 1 Grant 230404 (to D. W.), Canada Foundation for Innovation Grant NIF21633 (to D. W.), and an Alzheimer's Society of Alberta and Northwest Territories/University Hospital Foundation "Hope for Tomorrow" catalyst grant (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Altmeppen HC, 2013, FEBS J, V280, P4338, DOI 10.1111/febs.12196; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Corda E, 2018, MOL NEUROBIOL, V55, P7758, DOI 10.1007/s12035-018-0944-9; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Fourier A, 2018, MOL NEUROBIOL, V55, P3537, DOI 10.1007/s12035-017-0607-2; Fourier A, 2019, ANAL BIOANAL CHEM, V411, P267, DOI 10.1007/s00216-018-1437-4; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilch S, 2007, J MOL BIOL, V371, P362, DOI 10.1016/j.jmb.2007.05.052; HILZ H, 1975, EUR J BIOCHEM, V56, P103, DOI 10.1111/j.1432-1033.1975.tb02211.x; Johanssen VA, 2014, BIOCHEM J, V459, P103, DOI 10.1042/BJ20131378; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lau A, 2015, EMBO MOL MED, V7, P339, DOI 10.15252/emmm.201404588; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lewis V, 2009, J NEUROPATH EXP NEUR, V68, P1125, DOI 10.1097/NEN.0b013e3181b96981; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Orr ME, 2015, NEUROBIOL AGING, V36, P1496, DOI 10.1016/j.neurobiolaging.2014.12.004; Saleem F, 2014, PRION, V8, P221, DOI 10.4161/pri.28939; Smith SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026908; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011	26	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2642	2650		10.1074/jbc.RA118.006367	http://dx.doi.org/10.1074/jbc.RA118.006367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30578300	hybrid, Green Published			2022-12-26	WOS:000459601600007
J	Ilic, B; Unkovic, N; Knezevic, A; Savkovic, Z; Grbic, ML; Vukojevic, J; Jovanovic, Z; Makarov, S; Lucic, L				Ilic, Bojan; Unkovic, Nikola; Knezevic, Aleksandar; Savkovic, Zeljko; Grbic, Milica Ljaljevic; Vukojevic, Jelena; Jovanovic, Zvezdana; Makarov, Slobodan; Lucic, Luka			Multifaceted activity of millipede secretions: Antioxidant, antineurodegenerative, and anti-Fusarium effects of the defensive secretions of Pachyiulus hungaricus (Karsch, 1881) and Megaphyllum unilineatum (C. L. Koch, 1838) (Diplopoda: Julida)	PLOS ONE			English	Article							ACID METHYL-ESTERS; IN-VITRO; ANTIFUNGAL; INHIBITORS; BENZOQUINONES	Members of the millipede order Julida rely on dominantly quinonic defensive secretions with several minor, non-quinonic components. The free radical-scavenging activities of ethanol, methanol, hexane, and dichloromethane extracts of defensive secretions emitted by Pachyiulus hungaricus (Karsch, 1881) and Megaphyllum unilineatum (C. L. Koch, 1838) were investigated using the ABTS, DPPH, and total reducing power (TRP) tests. The obtained extracts were also tested for inhibition of acetylcholinesterase and tyrosinase activity. Finally, the antifungal potential of both julid extracts was evaluated against seven Fusarium species. Secretions of both species showed activity against free radicals, acetylcholinesterase, tyrosinase, and all of the selected fungal species. The secretions of P. hungaricus exhibited a more potent antioxidative effect than did those of M. unilineatum, while there were no significant differences of antiacetylcholinesterase activity between the tested extracts. Only the hexane extract of M. unilineatum showed an effect on tyrosinase activity stronger than that of P. hungaricus. Fusarium sporotrichioides, F. graminearum, and F. verticillioides were the fungi most resistant to secretions of both julids. The Fusarium species most susceptible to the secretion of P. hungaricus was F. avenaceum, while the concentrations of M. unilienatum extracts needed to inhibit and completely suppress fungal growth were lowest in the case of their action on F. lateritium. Our data support previous findings that julid defensive secretions possess an antimicrobial potential and reveal their antioxidative and antineurodegenrative properties. Bearing in mind the chemical complexity of the tested defensive secretions, we presume that they can also exhibit other biological activities.	[Ilic, Bojan; Jovanovic, Zvezdana; Makarov, Slobodan; Lucic, Luka] Univ Belgrade, Dept Anim Dev, Fac Biol, Belgrade, Serbia; [Unkovic, Nikola; Knezevic, Aleksandar; Savkovic, Zeljko; Grbic, Milica Ljaljevic; Vukojevic, Jelena] Univ Belgrade, Dept Algol Mycol & Lichenol, Fac Biol, Belgrade, Serbia	University of Belgrade; University of Belgrade	Ilic, B (corresponding author), Univ Belgrade, Dept Anim Dev, Fac Biol, Belgrade, Serbia.	bojan.ilic@bio.bg.ac.rs	Savkovic, Zeljko/ABD-5646-2021	Ilic, Bojan/0000-0001-9051-0415; Savkovic, Zeljko/0000-0002-6678-4958; Lucic, Luka/0000-0001-8397-7279; Knezevic, Aleksandar/0000-0002-2776-9675	Serbian Ministry of Education, Science, and Technological Development [173038, 173032]	Serbian Ministry of Education, Science, and Technological Development(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Serbian Ministry of Education, Science, and Technological Development (Grants Nos. 173038 and 173032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey-Izquierdo A, 2008, J ANTIMICROB CHEMOTH, V61, P805, DOI 10.1093/jac/dkn022; Ambarish CN, 2015, INT J TROP INSECT SC, V35, P117, DOI 10.1017/S1742758415000132; BICKOFF EM, 1951, J AM OIL CHEM SOC, V28, P65, DOI 10.1007/BF02612094; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; Bodner M, 2017, CHEMOECOLOGY, V27, P171, DOI 10.1007/s00049-017-0242-4; Bodner M, 2016, J CHEM ECOL, V42, P249, DOI 10.1007/s10886-016-0680-4; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Brewer MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068005, 10.1371/journal.pone.0079935]; Brewer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037240; BURTON GW, 1985, J AM CHEM SOC, V107, P7053, DOI 10.1021/ja00310a049; Carcamo HA, 2000, CAN J FOREST RES, V30, P817, DOI 10.1139/cjfr-30-5-817; Carroll JF, 2005, J CHEM ECOL, V31, P63, DOI 10.1007/s10886-005-0974-4; Davoodbasha M, 2018, MICROB PATHOGENESIS, V115, P233, DOI 10.1016/j.micpath.2017.12.049; Eisner T, 1978, HDB EXPT PHARM, V48, P41; El-Najjar N, 2011, PHYTOCHEM REV, V10, P353, DOI 10.1007/s11101-011-9209-1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Enghoff H., 2015, TREATISE ZOOLOGY ANA, V2, P363, DOI 10.1163/9789004188273_017; Enghoff H, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/651768; Fernandez R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18562-w; Gruner H.-E., 1993, LEHRB SPEZIELLE, V4, P1; Gulaboski R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01865; HANEL H, 1988, MYCOSES, V31, P148, DOI 10.1111/j.1439-0507.1988.tb03718.x; HARAGUCHI H, 1986, AGR BIOL CHEM TOKYO, V50, P1905, DOI 10.1080/00021369.1986.10867670; Hopkin P.S., 1992, BIOL MILLIPEDES; Huh S, 2010, BIOL PHARM BULL, V33, P1242, DOI 10.1248/bpb.33.1242; Ilic B, 2018, J APPL ENTOMOL, V142, P775, DOI 10.1111/jen.12526; Jamwal VS, 2014, RESEARCHGATE, V2, P37; Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063; Kissling J, 2005, PHYTOTHER RES, V19, P984, DOI 10.1002/ptr.1770; Krueger MC, 2016, ENVIRON MICROBIOL, V363, P1; Likhitwitayawuid K, 2001, J NAT PROD, V64, P1457, DOI 10.1021/np0101806; Lima LARS, 2012, FOOD RES INT, V48, P873, DOI 10.1016/j.foodres.2012.07.016; Lin VCH, 2011, INT J MOL SCI, V12, P4819, DOI 10.3390/ijms12084819; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Makarov SE, 2015, THE MYRIAPODA, V2, P69, DOI DOI 10.1163/9789004188273; Mans DR., 2016, J TRANSL SCI, V3, P371, DOI [DOI 10.15761/JTS.1000164, 10.15761/JTS.1000164]; Mans DRA, 2016, J TRANSL SCI, V2, P170; Mans DRA, 2017, J TRANSL SCI, V3, P1, DOI DOI 10.15761/JTS.1000197; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Minelli A, 2013, ARTHROPOD BIOL EVOLU, P1, DOI DOI 10.1007/978-3-662-45798-6_1; Mostert S, 2017, EUR J MED CHEM, V135, P196, DOI 10.1016/j.ejmech.2017.04.055; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pinto MEA, 2017, AN ACAD BRAS CIENC, V89, P1671, DOI 10.1590/0001-3765201720160908; Rodriguez J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19996-6; Roginsky V, 2003, CHEM PHYS LIPIDS, V125, P49, DOI 10.1016/S0009-3084(03)00068-9; Roginsky V, 2001, FREE RADICAL RES, V35, P55, DOI 10.1080/10715760100300591; Shear WA, 2015, BIOCHEM SYST ECOL, V61, P78, DOI 10.1016/j.bse.2015.04.033; Shimizu N, 2012, J CHEM ECOL, V38, P23, DOI 10.1007/s10886-012-0063-4; Sierwald P, 2007, ANNU REV ENTOMOL, V52, P401, DOI 10.1146/annurev.ento.52.111805.090210; Stankovic S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167249; Uchimiya M, 2009, CHEMOSPHERE, V77, P451, DOI 10.1016/j.chemosphere.2009.07.025; Unkovic N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190922; Venturini TP, 2016, J MED MICROBIOL, V65, P770, DOI 10.1099/jmm.0.000301; Vivar I, 2013, INT BIODETER BIODEGR, V84, P372, DOI 10.1016/j.ibiod.2012.05.021; Wahrendorf MS, 2006, J ETHNOPHARMACOL, V106, P51, DOI 10.1016/j.jep.2005.12.007; WEATHERS.J, 1967, Q REV CHEM SOC, V21, P287, DOI 10.1039/qr9672100287; Weldon PJ, 2003, NATURWISSENSCHAFTEN, V90, P301, DOI 10.1007/s00114-003-0427-2; Williams LAD, 1997, NATURWISSENSCHAFTEN, V84, P143, DOI 10.1007/s001140050364; Zaborska W, 2002, J ENZYM INHIB MED CH, V17, P247, DOI 10.1080/1475636021000011670; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209999	10.1371/journal.pone.0209999	http://dx.doi.org/10.1371/journal.pone.0209999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605481	gold, Green Published, Green Submitted			2022-12-26	WOS:000454759900026
J	Genthial, R; Gerbaix, M; Farlay, D; Vico, L; Beaurepaire, E; Debarre, D; Gourrier, A				Genthial, Rachel; Gerbaix, Maude; Farlay, Delphine; Vico, Laurence; Beaurepaire, Emmanuel; Debarre, Delphine; Gourrier, Aurelien			Third harmonic generation imaging and analysis of the effect of low gravity on the lacuno-canalicular network of mouse bone	PLOS ONE			English	Article							MICROSCOPY; RECONSTRUCTION	The lacuno-canalicular network (LCN) hosting the osteocytes in bone tissue represents a biological signature of the mechanotransduction activity in response to external biomechanical loading. Using third-harmonic generation (THG) microscopy with sub-micrometer resolution, we investigate the impact of microgravity on the 3D LCN structure in mice following space flight. A specific analytical procedure to extract the LCN characteristics from THG images is described for ex vivo studies of bone sections. The analysis conducted in different anatomical quadrants of femoral cortical bone didn't reveal any statistical differences between the control, habitat control and flight groups, suggesting that the LCN connectivity is not affected by one month space flight. However, significant variations are systematically observed within each sample. We show that our current lack of understanding of the extent of the LCN heterogeneity at the organ level hinders the interpretation of such investigations based on a limited number of samples and we discuss the implications for future biomedical studies.	[Genthial, Rachel; Debarre, Delphine; Gourrier, Aurelien] Univ Grenoble Alpes, CNRS, LIPhy, Grenoble, France; [Gerbaix, Maude; Vico, Laurence] Univ Lyon, INSERM, U1059, St Etienne, France; [Gerbaix, Maude] French Natl Ctr Space Studies, Paris, France; [Farlay, Delphine] Univ Lyon, INSERM, UMR1033, Lyon, France; [Beaurepaire, Emmanuel] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci, Palaiseau, France; [Genthial, Rachel] McGill Univ, Dept Biol, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; McGill University	Debarre, D; Gourrier, A (corresponding author), Univ Grenoble Alpes, CNRS, LIPhy, Grenoble, France.	delphine.debarre@univ-grenoble-alpes.fr; aurelien.gourrier@univ-grenoble-alpes.fr	FARLAY, Delphine/AGF-1234-2022; Vico, Laurence/O-1927-2018; Vico, Laurence/ABG-7239-2020; Beaurepaire, Emmanuel/C-6343-2014	FARLAY, Delphine/0000-0001-6487-0337; Vico, Laurence/0000-0002-2110-287X; Vico, Laurence/0000-0002-2110-287X; Beaurepaire, Emmanuel/0000-0002-2082-8214; Gourrier, Aurelien/0000-0001-9526-5746; Debarre, Delphine/0000-0002-0513-6172	Russian Federal Space Agency; Russian Academy of Science; French National Centre for Space Study (CNES) [4800000899]; Universite Grenoble Alpes [AGIR-AGI13SMI14]; Agence National de la Recherche [ANR-13-BS09-0006-03]; France BioImaging [ANR-10-INBS-04]; Equipex Morphoscope2 [ANR-11-EQPX-0029]	Russian Federal Space Agency; Russian Academy of Science(Russian Academy of Sciences); French National Centre for Space Study (CNES); Universite Grenoble Alpes; Agence National de la Recherche(French National Research Agency (ANR)); France BioImaging(French National Research Agency (ANR)); Equipex Morphoscope2	The Russian Federal Space Agency and the Russian Academy of Science supported this project by flying the Bion-M1 space mission and organizing the post-flight operations. This work was part of a larger project of LV financially supported by the French National Centre for Space Study (CNES, grant 4800000899). AG and DD obtained the PhD grant for RG from the Universite Grenoble Alpes (AGIR-AGI13SMI14, "Non-linear optical imaging of bone tissue"). Operational costs were supported by a grant from the Agence National de la Recherche under contracts ANR-13-BS09-0006-03 (AG). The consortium LabEx Tec 21 provided access to the confocal microscope (ANR-11-LABX-0030) and the THG measurements were performed using instruments funded by ANR-10-INBS-04 (France BioImaging), ANR-11-EQPX-0029 (Equipex Morphoscope2).	Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Aptel F, 2010, INVEST OPHTH VIS SCI, V51, P2459, DOI 10.1167/iovs.09-4586; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Blaber EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061372; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Ciani C, 2009, BONE, V44, P1015, DOI 10.1016/j.bone.2009.01.376; Debarre D, 2004, OPT LETT, V29, P2881, DOI 10.1364/OL.29.002881; Debarre D, 2007, OPT EXPRESS, V15, P8913, DOI 10.1364/OE.15.008913; Dong P, 2014, BONE, V60, P172, DOI 10.1016/j.bone.2013.12.008; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Genthial R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03548-5; Gerbaix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03014-2; Grotz KA, 1999, CALCIFIED TISSUE INT, V65, P8, DOI 10.1007/s002239900650; Kamel-ElSayed SA, 2015, BONE, V76, P129, DOI 10.1016/j.bone.2015.02.011; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lee WJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3469848; Mabilleau G, 2016, BONE, V90, P99, DOI 10.1016/j.bone.2016.06.008; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Olivier N, 2009, OPT LETT, V34, P3145, DOI 10.1364/OL.34.003145; Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Sharma D, 2012, BONE, V51, P488, DOI 10.1016/j.bone.2012.05.014; Sun CK, 2004, J STRUCT BIOL, V147, P19, DOI 10.1016/j.jsb.2003.10.017; Sun CK, 2003, OPT LETT, V28, P2488, DOI 10.1364/OL.28.002488; Tokarz D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186846; Tommasini SM, 2012, BONE, V50, P596, DOI 10.1016/j.bone.2011.12.012; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; You LD, 2004, ANAT REC PART A, V278A, P505, DOI 10.1002/ar.a.20050	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209079	10.1371/journal.pone.0209079	http://dx.doi.org/10.1371/journal.pone.0209079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601851	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200035
J	Pradhan, S; Pradhan, MM; Dutta, A; Shah, NK; Joshi, PL; Pradhan, K; Sharma, SK; Daumerie, PG; Banerji, J; Duparc, S; Mendis, K; Murugasampillay, S; Valecha, N; Anvikar, AR				Pradhan, Sreya; Pradhan, Madan Mohan; Dutta, Ambarish; Shah, Naman K.; Joshi, Pyare Lal; Pradhan, Khageshwar; Sharma, S. K.; Daumerie, Penny Grewal; Banerji, Jaya; Duparc, Stephan; Mendis, Kamini; Murugasampillay, Shiva; Valecha, Neena; Anvikar, Anupkumar R.			Improved access to early diagnosis and complete treatment of malaria in Odisha, India	PLOS ONE			English	Article							IMPLEMENTATION; IMPACT; POLICY	Background In 2013, the Comprehensive Case Management Programme (CCMP) was initiated to assess the impact of universal access to diagnosis and treatment and improved surveillance on malaria transmission in different settings in Odisha state, India. Methods Pairs of intervention and control sub-districts (blocks), matched on malaria incidence were selected in four districts with different transmission intensities. CCMP activities included training and supervision, ensuring no stock-outs of malaria tests and drugs, analysing verified surveillance data, stratifying areas based on risk factors, and appointing alternative providers to underserved areas. Composite risk scores were calculated for each sub-centre using principal component analysis. Post-pre changes (2013-2015 versus 2011-2012) for annual blood examination rates (ABER) and annual parasite incidence (API) across intervention and control groups were assessed using difference-in-difference (DID) estimates, adjusted for malaria transmission risk. Results In the intervention sub-centres, the mean increase in ABER was 6.41 tests/sub-centre (95% CI 4.69, 8.14; p<0.01) and in API was 9.2 cases diagnosed/sub-centre (95% CI 5.18, 13.21; p<0.01). The control sub-centres reported lower increases in ABER (2.84 [95% CI 0.35, 5.34]; p<0.05) and API (3.68 [95% CI 0.45, 6.90]; p<0.05). The control-adjusted post-pre changes in API showed that 5.52 more cases (95% CI 0.34, 10.70; p<0.05) were diagnosed, and a 3.6 more cases (95% CI 0.58, 6.56; p<0.05) were tested per sub-centre in the intervention versus control areas. Larger differences in post-pre changes in API between intervention and control sub-centres were registered in the higher transmission-risk areas compared with the lower risk areas. All the changes were statistically significant. Conclusions Intensive intervention activities targeted at improved access to malaria diagnosis and treatment produced a substantial increase in blood examination and case notification, especially in inaccessible, hard-to-reach pockets. CCMP provides insights into how to achieve universal coverage of malaria services through a routine, state-run programme.	[Pradhan, Sreya; Pradhan, Madan Mohan] Govt Odisha, Natl Vector Borne Dis Control Programme, Bhubaneswar, Odisha, India; [Dutta, Ambarish] Indian Inst Publ Hlth, Bhubaneswar, Odisha, India; [Dutta, Ambarish] Kalinga Inst Ind Technol, Bhubaneswar, Odisha, India; [Shah, Naman K.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Pradhan, Khageshwar] Natl Inst Malaria Res Field Unit, Rourkela, India; [Sharma, S. K.; Valecha, Neena; Anvikar, Anupkumar R.] Natl Inst Malaria Res, New Delhi, India; [Daumerie, Penny Grewal; Banerji, Jaya; Duparc, Stephan] Med Malaria Venture, Geneva, Switzerland; [Murugasampillay, Shiva] Global Publ Hlth, Geneva, Switzerland	Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); Kalinga Institute of Industrial Technology (KIIT); University of North Carolina; University of North Carolina Chapel Hill; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Valecha, N; Anvikar, AR (corresponding author), Natl Inst Malaria Res, New Delhi, India.	neenavalecha@gmail.com; anvikar@gmail.com	Duparc, Stephan/AAH-8758-2020	Duparc, Stephan/0000-0002-9649-4847; Dutta, Ambarish/0000-0002-4019-7472	Medicines for Malaria Venture	Medicines for Malaria Venture	The study was funded by Medicines for Malaria Venture. NV, MMP, ARA were the grant recipients.; The authors acknowledge the Indian Council of Medical Research for permitting to conduct the study; National Vector Borne Disease Control Programme, Delhi; staff of NIMR Delhi and its field unit in Rourkela and NVBDCP Odisha. Acknowledgments are also due to Block Level Managers Mr Alok Mishra, Mr Chandrasekhar Pattanaik, Ms Sharda Singh, Mr Abhishek Sawn and District officials who played a crucial role in implementing interventions. Copy editing services were provided by Naomi Richardson of Magenta Communications Ltd, Abingdon, UK and funded by Medicines for Malaria Venture.	[Anonymous], 2012, STRATEGIC PLAN MALAR; [Anonymous], NON TRADITIONAL REF; Anvikar AR, 2014, INDIAN J MED RES, V139, P205; Chanda E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-369; Dash AP, 2008, J BIOSCIENCES, V33, P583, DOI 10.1007/s12038-008-0076-x; Directorate of National Vector Borne Disease Control Programme, 2016, OP MAN MAL EL IND; Gerstl S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0933-7; Gohel A, 2015, INT J RES MED SCI, V3, P3510; Hales S, 2016, B WORLD HEALTH ORGAN, V94, P58, DOI 10.2471/BLT.15.167585; HENDERSON WG, 1990, CONTROL CLIN TRIALS, V11, P199, DOI 10.1016/0197-2456(90)90014-S; Kokwaro G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S2; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Lechner M., 2010, ECONOMETRICS, V4, P165, DOI DOI 10.1561/0800000014; Lemma H, 2010, TROP MED INT HEALTH, V15, P241, DOI 10.1111/j.1365-3156.2009.02447.x; Linn NYY, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2384-4; Lourenco C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-508; Ministry of Statistics and Programme Implementation, 2015, IND STAT GDP PER CAP; Moonasar D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-294; Novotny J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1200-2; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Pradhan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149126; Sharma S K, 2001, Indian J Public Health, V45, P93; Sundararajan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081966; Valadez JJ, 2014, TROP MED INT HEALTH, V19, P1226, DOI 10.1111/tmi.12354; WHO, 2017, WORLD MALARIA REPORT; World Health Organization, 2015, GUID TREATM MAL, Vthird	26	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208943	10.1371/journal.pone.0208943	http://dx.doi.org/10.1371/journal.pone.0208943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601833	Green Published, gold, Green Submitted			2022-12-26	WOS:000454683200026
J	Tanaree, A; Assanangkornchai, S; Isaranuwatchai, W; Thavorn, K; Coyte, PC				Tanaree, Athip; Assanangkornchai, Sawitri; Isaranuwatchai, Wanrudee; Thavorn, Kednapa; Coyte, Peter C.			Integrated treatment program for alcohol related problems in community hospitals, Songkhla province of Thailand: A social return on investment analysis	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; QUALITY-OF-LIFE; COST-EFFECTIVENESS; CARE; INTERVENTION; CONSUMPTION; DEPENDENCE; RELAPSE; BENEFIT; ACAMPROSATE	Objectives To estimate the impacts and social value relative to the cost of the Integrated Management of Alcohol Intervention Program in the Health Care System (i-MAP) on direct beneficiaries, using a Social Return on Investment (SROI) analysis. Method A mixed-method approach was conducted among stakeholders and 113 drinkers (29 low-risk, 43 high-risk, and 41 dependent drinkers) who consecutively received i-MAP at four community hospitals in Songkhla province of Thailand. Resources for program implementation as well as drinking and a list of psychosocial outcomes, selected through stakeholder interviews, were measured among participants during and at the sixth month after participation, respectively. SROI (societal benefit-to-cost) ratio of i-MAP was estimated over a 5-year time horizon and shown in 2017 Thai baht, where US$1.00 = 33.1 baht. One-way and probabilistic sensitivity analyses of key parameters were performed among treatment subgroups. Results Baseline estimates of the annual cost and 5-year social value of i-MAP were 25.5 and 51.0 million baht, respectively, yielding an estimated SROI ratio of 2.0, with a possible range of 1.3 to 2.4. Value created by the program was mostly attributed to broader gains to society (productivity gains and averted crime costs) and drinkers. Subgroup analyses suggested that the SROI ratio for high-risk drinkers was twice that for dependent drinkers (2.8 vs. 1.5). The probabilistic sensitivity analysis showed that more than 99% of the simulated treatments for both high-risk and dependent groups yielded benefits beyond the corresponding costs. Conclusions By considering societal perspective, the i-MAP program has demonstrated its social value is twice its investment cost and potential for the program to be implemented nationwide.	[Tanaree, Athip; Assanangkornchai, Sawitri] Prince Songkla Univ, Epidemiol Unit, Fac Med, Hat Yai, Songkhla, Thailand; [Isaranuwatchai, Wanrudee; Coyte, Peter C.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Thavorn, Kednapa] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada	Prince of Songkla University; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Assanangkornchai, S (corresponding author), Prince Songkla Univ, Epidemiol Unit, Fac Med, Hat Yai, Songkhla, Thailand.	savitree.a@psu.ac.th		Thavorn, Kednapa/0000-0003-4738-8447; Assanangkornchai, Sawitri/0000-0003-2174-3287	Centre for Alcohol Studies (CAS) of the Thai Health Promotion Foundation; Thai Health Promotion Foundation [59-10-34]; Graduate scholarship, Faculty of Medicine, Prince of Songkla University [03-01]	Centre for Alcohol Studies (CAS) of the Thai Health Promotion Foundation; Thai Health Promotion Foundation; Graduate scholarship, Faculty of Medicine, Prince of Songkla University	This research was conducted as part of PhD study of A.T. which was supported by scholarship from the Centre for Alcohol Studies (CAS) of the Thai Health Promotion Foundation. The research was additionally supported by the Thai Health Promotion Foundation (grant number 59-10-34) and Graduate scholarship, Faculty of Medicine, Prince of Songkla University (grant number 03-01). All funders had neither involvement in the study design, the report writing nor the decision on manuscript submission. The results presented and their interpretation are the authors', and do not necessarily represent the views of the CAS, the Thai Health Promotion Foundation or Prince of Songkla University.	Arvidson M, 2014, INT J PUBLIC SECT MA, V27, P225, DOI 10.1108/IJPSM-03-2013-0045; Bank of Thailand, THAIL MACR IND 2017; Banke-Thomas AO, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1935-7; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Barbosa C, 2015, J SUBST ABUSE TREAT, V53, P1, DOI 10.1016/j.jsat.2015.01.003; Bradley KA, 2014, JAMA-J AM MED ASSOC, V311, P1861, DOI 10.1001/jama.2014.3629; Bradly J, 2013, SOCIAL RETURN INVEST; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Coccaro EF, 2012, AM J PSYCHIAT, V169, P577, DOI 10.1176/appi.ajp.2012.11081259; Corbin WR, 2013, ADDICT BEHAV, V38, P1912, DOI 10.1016/j.addbeh.2012.12.005; Dawson DA, 2007, ALCOHOL CLIN EXP RES, V31, P2036, DOI 10.1111/j.1530-0277.2007.00536.x; Dee TS, 2001, HEALTH ECON, V10, P257, DOI 10.1002/hec.588; Donovan D, 2005, J STUD ALCOHOL, P119, DOI 10.15288/jsas.2005.s15.119; Eckley L., 2013, BEFRIENDING QUAYS SO; Feeney GFX, 2006, ALCOHOL ALCOHOLISM, V41, P321, DOI 10.1093/alcalc/agl007; Feeney GFX, 2002, AUST NZ J PSYCHIAT, V36, P622, DOI 10.1046/j.1440-1614.2002.01019.x; Fleming MF, 2002, ALCOHOL CLIN EXP RES, V26, P36, DOI 10.1111/j.1530-0277.2002.tb02429.x; Funk M., 2008, INT MENT HLTH PRIM C; Gmel G, 2003, ALCOHOL RES HEALTH, V27, P52; Godfrey C, 2005, BMJ-BRIT MED J, V331, P544; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Homish GG, 2006, DRUG ALCOHOL DEPEN, V83, P185, DOI 10.1016/j.drugalcdep.2005.10.017; Humphreys K, 2002, ADDICTION, V97, P126, DOI 10.1046/j.1360-0443.2002.00004.x; Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501; Kittirattanapaiboon P, 2017, J MENT HLTH THAI, V25, P1; Kittirattanapaiboon P, 2014, HALF DECADE INTEGRAT; Kuendig H, 2006, ALCOHOL ALCOHOLISM, V41, P464, DOI 10.1093/alcalc/agl018; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Lavoie D, 2010, DRUG ALCOHOL REV, V29, P608, DOI 10.1111/j.1465-3362.2010.00224.x; Leifman H., 2000, STAT ALCOHOL DRUGS C; Leonard K. E, 2001, J SUBST USE, V6, P235, DOI [10.1080/146598901753325075, DOI 10.1080/146598901753325075]; LoCastro JS, 2009, J STUD ALCOHOL DRUGS, V70, P186, DOI 10.15288/jsad.2009.70.186; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; McCollister KE, 2010, DRUG ALCOHOL DEPEN, V108, P98, DOI 10.1016/j.drugalcdep.2009.12.002; Millar R, 2013, PUBLIC MANAG REV, V15, P923, DOI 10.1080/14719037.2012.698857; Miller Brenda A, 2011, Int J Child Adolesc health, V4, P367; Monteiro MG, 2011, ALCOHOL RES HEALTH, V34, P257; Moos RH, 2006, ADDICTION, V101, P212, DOI 10.1111/j.1360-0443.2006.01310.x; Mortimer D, 2005, ALCOHOL ALCOHOLISM, V40, P549, DOI 10.1093/alcalc/agh192; Mosquera NJ, 2017, ADICCIONES, V851; National Health Security Office of Thailand, 2014, STAND PRIC LIST MED; National Statistial Office, 2016, STAT YB THAIL 2016; National Statistical Office, 2015, SMOK DRINK BEH SURV; National Statistical Office, 2012, SMOK DRINK BEH SURV; Nicholls J., 2009, GUIDE SOCIAL RETURN; Office of the Secretariat to the National Mental Health Commission, 2013, RES IMPL INT MAN ALC; Permsuwan Unchalee, 2008, J Med Assoc Thai, V91 Suppl 2, pS53; Petrie D, 2011, EXPERT REV PHARM OUT, V11, P351, DOI [10.1586/ERP.11.28, 10.1586/erp.11.28]; Poikolainen K, 1999, PREV MED, V28, P503, DOI 10.1006/pmed.1999.0467; Popova S, 2011, INT J ENV RES PUB HE, V8, P3351, DOI 10.3390/ijerph8083351; Raistrick D, 2006, REV EFFECTIVENESS TR; RAMBERG JS, 1979, TECHNOMETRICS, V21, P201, DOI 10.2307/1268517; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Room R, 2002, ALCOHOL DEV SOC PUBL; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; Schreiber L., 2011, FRONT PSYCHIATRY, V2, P1, DOI [10.3389/fpsyt.2011.00001, DOI 10.3389/FPSYT.2011.00001]; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Stautz K, 2013, CLIN PSYCHOL REV, V33, P574, DOI 10.1016/j.cpr.2013.03.003; Thai Health Promotion Foundation, 2014, SOC RET INV SROI SEL; Thai Health Promotion Foundation, 2012, HLTH PROM FUND SUST; Thavorncharoensap M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-323; The Wage Committee, 2017, MIN DAIL WAG 2017; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Whiteford HA, 2013, PSYCHOL MED, V43, P1569, DOI 10.1017/S0033291712001717; Willis E, 2016, DEMENTIA; Windle G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011634; Zarkin GA, 2008, ARCH GEN PSYCHIAT, V65, P1214, DOI 10.1001/archpsyc.65.10.1214	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209210	10.1371/journal.pone.0209210	http://dx.doi.org/10.1371/journal.pone.0209210			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1BB	30601850	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200049
J	Bastaki, H; Marston, L; Cassell, J; Rait, G				Bastaki, Hamad; Marston, Louise; Cassell, Jackie; Rait, Greta			Imported malaria in the UK, 2005 to 2016: Estimates from primary care electronic health records	PLOS ONE			English	Article							SURVEILLANCE; TRAVELERS; PERIODS	Objective To investigate trends in the incidence of imported malaria in the UK between 2005 and 2016. Design Analysis of longitudinal electronic health records (EHRs) in The Health Improvement Network (THIN) primary care database. Setting UK primary care Participants In total, we examined 12,349,003 individuals aged 0 to 99 years. Outcome measure The rate of malaria recordings in THIN was calculated per year between 2005 and 2016. Rate ratios exploring differences by age, sex, location of general practice, socioeconomic status and ethnicity were estimated using multivariable Poisson regression. Results A total of 1,474 individuals with a first diagnosis of malaria were identified in THIN between 2005 and 2016. The incidence of recorded malaria followed a decreasing trend dropping from a rate of 3.33 in 2005 to 1.36 cases per 100,000 person years at risk in 2016. Multivariable Poisson regression showed that adults of working age (20 to 69 years), men, those registered with a general practice in London, higher social deprivation and non-white ethnicity were associated with higher rates of malaria recordings. Conclusion There has been a decrease in the number of malaria recordings in UK primary care over the past decade. This decrease exceeds the rate of decline reported in national surveillance data; however there are similar associations with age, sex and deprivation. Improved geographic information on the distribution of cases and the potential for automation of case identification suggests that EHRs could provide a complementary role for investigating malaria trends over time.	[Bastaki, Hamad; Marston, Louise; Rait, Greta] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Cassell, Jackie] Univ Brighton, Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England	University of London; University College London; University of Brighton; University of Sussex	Bastaki, H (corresponding author), UCL, Res Dept Primary Care & Populat Hlth, London, England.	h.bastaki@ucl.ac.uk	Marston, Louise/A-8535-2012	Marston, Louise/0000-0002-9973-1131; Bastaki, Hamad/0000-0002-6980-5005				Basatemur E, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2748; Bastaki H, 2017, TRAVEL MED INFECT DI; Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235; Blak Betina T, 2011, Inform Prim Care, V19, P251; Cathcart SJ, 2010, EPIDEMIOL INFECT, V138, P1052, DOI 10.1017/S0950268809991130; Cowie MR, 2017, CLIN RES CARDIOL, V106, P1, DOI 10.1007/s00392-016-1025-6; ECDC, 2017, MAL ANN EP REP 2016; Fonseca AG, 2016, EUR J PUBLIC HEALTH, V26, P403, DOI 10.1093/eurpub/ckw052; Horsfall L, 2013, PHARMACOEPIDEM DR S, V22, P64, DOI 10.1002/pds.3368; IQVIA, 2018, THIN HES DAT LINK; Lalloo DG, 2016, J INFECTION, V72, P635, DOI 10.1016/j.jinf.2016.02.001; Legros F, 2003, MED MALADIES INFECT, V33, P3; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; MRL, 2007, MAL REF LAB REF DIAG; MRL, 2017, MAL REF LAB MAL REP; NHS Digital, 2018, HES DAT; ONS, 2018, ETHN FACTS FIG REG E; ONS, 2016, UK RES VIS ABR; ONS, 2018, ETHN FACTS FIG SOC S; Pavli A, 2015, J INFECT PUBLIC HEAL, V8, P47, DOI 10.1016/j.jiph.2014.07.002; PHE, 2017, MAL IMP UK 2016 IMPL; Rees E, 2017, TRAVEL MED INFECT DI; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; Schlagenhauf P, 2010, CLIN INFECT DIS, V50, P826, DOI 10.1086/650575; Shallcross LJ, 2015, BRIT J GEN PRACT, V65, pE668, DOI 10.3399/bjgp15X686929; Sharma M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010210; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Society RP, 2015, BRIT NATL FORMULARY; StataCorp, 2015, STAT STAT SOFTW REL; Stienlauf S, 2005, J TRAVEL MED, V12, P136, DOI 10.2310/7060.2005.12308; Stoney RJ, 2016, AM J TROP MED HYG, V94, P136, DOI 10.4269/ajtmh.15-0565; UCL, 2017, THIN DAT DAT STRUCT; Van Hest NAH, 2002, EPIDEMIOL INFECT, V129, P371, DOI 10.1017/S0950268802007306; Willcox ML, 2013, BMJ-BRIT MED J, P346; World Health Organization, 2017, DEPRESSION; Zuckerman JN, 2009, TRAVEL MED INFECT DI, V7, P329, DOI 10.1016/j.tmaid.2009.10.002	36	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210040	10.1371/journal.pone.0210040	http://dx.doi.org/10.1371/journal.pone.0210040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596782	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200132
J	Lazzarini, R; Gomez-Quiroz, LE; Gonzalez-Marquez, H; Villavicencio-Guzman, L; Salazar-Garcia, M; Sanchez-Gomez, C				Lazzarini, Roberto; Enrique Gomez-Quiroz, Luis; Gonzalez-Marquez, Humberto; Villavicencio-Guzman, Laura; Salazar-Garcia, Marcela; Sanchez-Gomez, Concepcion			The proximal segment of the embryonic outflow (conus) does not participate in aortic vestibule development	PLOS ONE			English	Article							TRUNCUS ARTERIOSUS; CHICK-EMBRYO; INTERVENTRICULAR SEPTUM; HEART FORMS; MORPHOGENESIS; APOPTOSIS; TRACT; CELLS; MALFORMATIONS	Objective There is no consensus on the embryonic components or morphogenetic processes involved in mature ventricular outflow tract development. Our goal was to use in vivo labelling to investigate the prospective fate of the myocardium of each conal wall. The conal and atrioventricular cushion mesenchyme changes during transformation into mature structures and their role in apoptosis were also investigated. Methods Plastic labels were placed at the cephalic and caudal conal limits of chicken embryo hearts (stage 22HH) and traced up to stage 36HH. Histological analyses, scanning electron microscopy and apoptotic detection using Lysotracker-Red were performed. The conal longitudinal length and medial displacement were registered. Muscle myosin was identified by immunofluorescence. Results Labels positioned in the myocardium of each conal wall moved to the right ventricle (RV), shifting from the arterial subvalvular myocardial zone to the apex. No labels were found in the aortic vestibule. At stage 22HH, the conus was a tubular structure composed of myocardium and endocardium with scarce mesenchyme. The dorso-left conal myocardial wall gradually lost continuity and the free ends separated, while the myocardium was distributed to the RV free wall (24HH-28HH). At stage 22HH, conal crests were not observed, but they were apparent at the dorsal zone of the conus at stage 26HH; towards stage 30HH, they fused to form the supraventricular crest, and the pulmonary infundibulum was evident. The ventro-superior cushion of the AV canal was reorganized into the fibrous and muscular structures lined the aortic vestibule. Conclusions The posterior conus is an erroneous concept. The conal myocardium is reorganized in the free wall of the RV. Internally, the conal lumen is transformed into the pulmonary infundibulum. The aortic vestibule is formed from the ventro-superior cushion of the AV canal. Thus, the ventricular outflow tracts have different embryonic origins.	[Lazzarini, Roberto] Univ Autonoma Metropolitana, Ciencias Biol & Salud, Mexico City, DF, Mexico; [Enrique Gomez-Quiroz, Luis; Gonzalez-Marquez, Humberto] Univ Autonoma Metropolitana Iztapalapa, Dept Ciencias Salud, Mexico City, DF, Mexico; [Villavicencio-Guzman, Laura; Salazar-Garcia, Marcela; Sanchez-Gomez, Concepcion] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Biol Desarrollo & Teratogenesis Expt, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Hospital Infantil de Mexico Federico Gomez	Sanchez-Gomez, C (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Biol Desarrollo & Teratogenesis Expt, Mexico City, DF, Mexico.	csgomez_2000@yahoo.com	Gonzalez-Marquez, Humberto/T-7830-2018; Marquez, Humberto Gonzalez/AAB-2809-2019	Gonzalez-Marquez, Humberto/0000-0003-3792-9094; Marquez, Humberto Gonzalez/0000-0003-3792-9094; Lazzarini, Roberto/0000-0003-3537-1576; Gomez-Quiroz, Luis Enrique/0000-0002-5704-5985; Sanchez-Gomez, Concepcion/0000-0002-3522-1781	Children's Hospital of Mexico Federico Gomez [HIM-2013-060]; Universidad Autonoma Metropolitana [-36970]	Children's Hospital of Mexico Federico Gomez; Universidad Autonoma Metropolitana	This work was supported by the Children's Hospital of Mexico Federico Gomez. Grant number HIM-2013-060 to CS-G and the Scholarship for postgraduate studies Universidad Autonoma Metropolitana Grant number -36970 to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson, 1982, ATLAS FOTOGRAFICO AN; Anderson RH, 2003, HEART, V89, P1110, DOI 10.1136/heart.89.9.1110; ANDERSON RH, 1974, BRIT HEART J, V36, P242; ANDERSON RH, 1976, BRIT HEART J, V38, P558; Anderson RH, 2014, CARDIOVASC DEV DIS, V1, P177, DOI DOI 10.3390/JCDD1030177; Anderson RH, 2016, WORLD J PEDIATR CONG, V7, P561, DOI 10.1177/2150135116651114; Anderson RH, 2013, J CARDIOVASC TRANSL, V6, P118, DOI 10.1007/s12265-012-9434-z; ARGUELLO C, 1978, J MOL CELL CARDIOL, V10, P307, DOI 10.1016/0022-2828(78)90380-2; ASAMI I, 1969, Z ANAT ENTWICKLUNGS, V128, P1, DOI 10.1007/BF00522490; Bosada FM, 2016, DEVELOPMENT, V143, P1041, DOI 10.1242/dev.130575; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cheng G, 2002, DEV DYNAM, V223, P119, DOI 10.1002/dvdy.1244; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Davis CL, 1927, CONTRIB EMBRYOL, V19, P247; de la Cruz MV, 1998, CARDIOVAS MOL MORPH, P131; DELACRUZ MV, 1989, J ANAT, V165, P121; DELACRUZ MV, 1977, J ANAT, V123, P661; DELACRUZ MV, 1982, COEUR-REV CARD MED-C, V13, P443; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Garcia-Pelaez Isabel, 2007, ARCH MEX ANAT NUEVA, V2, P21; GARCIAPELAEZ I, 1984, ACTA ANAT, V118, P224; Gomez CS, 2005, ANAT REC PART A, V283A, P202, DOI 10.1002/ar.a.20138; GOOR DA, 1972, CIRCULATION, V46, P375, DOI 10.1161/01.CIR.46.2.375; GRANT RP, 1962, CIRCULATION, V25, P756, DOI 10.1161/01.CIR.25.5.756; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; John B.deC.M.Saunders, 1962, CONTRIB EMBRYOL CARN, V37, P87; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2012, CURR TOP DEV BIOL, V100, P33, DOI 10.1016/B978-0-12-387786-4.00002-6; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Kramer TC, 1942, AM J ANAT, V71, P343, DOI 10.1002/aja.1000710303; Liu AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040869; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Molin DGM, 2002, CARDIOVASC RES, V56, P312, DOI 10.1016/S0008-6363(02)00542-4; Netter FH, 1969, CIBA COLLECTION MED, V5, P119; NISHIBATAKE M, 1987, CIRCULATION, V75, P255, DOI 10.1161/01.CIR.75.1.255; Nomura-Kitabayashi A, 2009, AM J PHYSIOL-HEART C, V297, pH1617, DOI 10.1152/ajpheart.00304.2009; ORTSLLORCA F, 1982, J ANAT, V134, P41; PATTEN BM, 1948, ANAT REC, V102, P299, DOI 10.1002/ar.1091020305; Pexieder T, 1978, Birth Defects Orig Artic Ser, V14, P29; Rana MS, 2007, CIRC RES, V100, P1000, DOI 10.1161/01.RES.0000262688.14288.b8; SEICHERT V., 1965, FOLIA MORPHOL, V13, P228; THOMPSON RP, 1987, ANAT RECORD, V218, P434, DOI 10.1002/ar.1092180411; THOMPSON RP, 1979, AM J ANAT, V156, P251, DOI 10.1002/aja.1001560206; Van Praagh R, 1985, Heart Vessels, V1, P193; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Watanabe M, 1998, DEVELOPMENT, V125, P3809; Watanabe M, 2001, DEV BIOL, V240, P274, DOI 10.1006/dbio.2001.0466; Ya J, 1998, CIRC RES, V82, P464, DOI 10.1161/01.RES.82.4.464; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209930	10.1371/journal.pone.0209930	http://dx.doi.org/10.1371/journal.pone.0209930			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596770	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200110
J	Weise, L; Boecker, M; Gauggel, S; Falkenburger, B; Drueke, B				Weise, Lorenz; Boecker, Maren; Gauggel, Siegfried; Falkenburger, Bjoern; Drueke, Barbara			A reaction-time adjusted PSI method for estimating performance in the stop-signal task	PLOS ONE			English	Article							RESPONSE-INHIBITION	A central experimental task in executive control research is the Stop-signal task, which allows measuring the ability to inhibit dominant responses. A crucial aspect of this task consists of varying the delay between the Go- and Stop-signal. Since the time necessary to administer the task can be long, a method of optimal delay choice was recently proposed: the PSI method. In a behavioral experiment, we show a variant of this method, the PSI marginal method, to be unable to deal with the Go-response slowing often observed in the Stop-signal task. We propose the PSI adjusted method, which is able to deal with this response slowing by correcting the estimation process for the current reaction time. In several sets of behavioral simulations, as well as another behavioral experiment, we document and compare the statistical properties of the PSI marginal method, our PSI adjusted method, and the traditional staircase method, both when reaction times are constant and when they are linearly increasing. The results show the PSI adjusted method's performance to be comparable to the PSI marginal method in the case of constant Go-response times, and to outperform the PSI marginal method as well as the staircase methods when there is response slowing. The PSI adjusted method thus offers the possibility of efficient estimation of Stop-signal reaction times in the face of response slowing.	[Weise, Lorenz; Boecker, Maren; Gauggel, Siegfried; Drueke, Barbara] Rhein Westfal TH Aachen, Dept Med Psychol & Med Sociol, Aachen, Germany; [Falkenburger, Bjoern] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Falkenburger, Bjoern] Rhein Westfal TH Aachen, Forschungszentrum Julich GmbH, JARA BRAIN Inst Mol Neurosci & Neuroimaging, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; RWTH Aachen University	Weise, L (corresponding author), Rhein Westfal TH Aachen, Dept Med Psychol & Med Sociol, Aachen, Germany.	lweise@ukaachen.de			START grant of the Medical Faculty of the RWTH Aachen University [123/16]	START grant of the Medical Faculty of the RWTH Aachen University	This study was supported by a START grant of the Medical Faculty of the RWTH Aachen University (grant number 123/16) to BD. The funding organization played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Forschungszentrum Julich GmbH provided support in the form of salaries for author BF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions.	Bishop C. M, 2006, PATTERN RECOGNITION; Bissett PG, 2013, J EXP PSYCHOL HUMAN, V39, P941, DOI 10.1037/a0033049; Boecker M, 2013, INT J PSYCHOPHYSIOL, V87, P234, DOI 10.1016/j.ijpsycho.2012.09.009; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Cai Y, 2016, J COGNITIVE NEUROSCI, V28, P177, DOI 10.1162/jocn_a_00888; Elchlepp H, 2017, BIOL PSYCHOL, V123, P250, DOI 10.1016/j.biopsycho.2016.10.005; Greenhouse I, 2012, J NEUROPHYSIOL, V107, P384, DOI 10.1152/jn.00704.2011; Hu S, 2015, NEUROIMAGE, V119, P286, DOI 10.1016/j.neuroimage.2015.06.032; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Leotti LA, 2010, J EXP PSYCHOL HUMAN, V36, P430, DOI 10.1037/a0016802; Livesey EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165525; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Prins N, 2013, J VISION, V13, DOI 10.1167/13.7.3; Prins N, 2012, J VISION, V12, DOI 10.1167/12.6.25; Schall JD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0193; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P1212, DOI 10.1037/0096-1523.34.5.1212; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Vink M, 2015, EUR J NEUROSCI, V41, P1086, DOI 10.1111/ejn.12879; Zandbelt BB, 2011, BIOL PSYCHIAT, V70, P1151, DOI 10.1016/j.biopsych.2011.07.028	22	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210065	10.1371/journal.pone.0210065	http://dx.doi.org/10.1371/journal.pone.0210065			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596788	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200136
J	Ward, AL; Reddyvari, P; Borisova, R; Shilabin, AG; Lampson, BC				Ward, Amber L.; Reddyvari, Pushpavathi; Borisova, Ralitsa; Shilabin, Abbas G.; Lampson, Bert C.			An inhibitory compound produced by a soil isolate of Rhodococcus has strong activity against the veterinary pathogen R-equi	PLOS ONE			English	Article							GENOME; TAXONOMY; BIOSYNTHESIS	Complete genome sequencing of dozens of strains of the soil bacterium Rhodococcus has revealed the presence of many cryptic biosynthetic gene clusters, presumably dedicated to the production of small molecules. This has sparked a renewed interest in this underex-plored member of the Actinobacteria as a potential source of new bioactive compounds. Reported here is the discovery of a potent inhibitory molecule produced by a newly isolated strain of Rhodococcus, strain MTM3W5.2. This small inhibitory molecule shows strong activity against all Rhodococcus species tested, including the veterinary pathogen R. equi, and some closely related genera. It is not active against other Gram positive or Gram negative bacteria. A screen of random transposon mutants identified a gene required to produce this inhibitory compound. This gene is a large multi-domain, type I polyketide synthase that is part of a very large multi-gene biosynthetic gene cluster in the chromosome of strain MTM3W5.2. The high resolution mass spectrum of a major chromatogram peak from a broth culture extract of MTM3W5.2 shows the presence of a compound at m/z 911.5490 atomic mass units. This compound is not detected in the culture extracts from a non-producing mutant strain of MTM3W5.2. A large gene cluster containing at least 14 different type I polyketide synthase genes is proposed to be required to synthesize this antibiotic-like compound.	[Ward, Amber L.; Borisova, Ralitsa; Lampson, Bert C.] East Tennessee State Univ, Dept Hlth Sci, Johnson City, TN 37614 USA; [Reddyvari, Pushpavathi; Shilabin, Abbas G.] East Tennessee State Univ, Dept Chem, Johnson City, TN 37614 USA; [Ward, Amber L.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38101 USA; [Ward, Amber L.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA; [Borisova, Ralitsa] React Biol Corp, Malvern, PA USA	East Tennessee State University; East Tennessee State University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Lampson, BC (corresponding author), East Tennessee State Univ, Dept Hlth Sci, Johnson City, TN 37614 USA.	lampson@etsu.edu			RDC grant from the office of research and sponsored programs at East Tennessee State University [16-006sm]; dept. of Health Sciences; dept. of Chemistry; department of Health Sciences; department of Chemistry; School of Graduate Studies at ETSU	RDC grant from the office of research and sponsored programs at East Tennessee State University; dept. of Health Sciences; dept. of Chemistry; department of Health Sciences; department of Chemistry; School of Graduate Studies at ETSU	This work was supported by an RDC grant (16-006sm) (A.S.) from the office of research and sponsored programs at East Tennessee State University. Additional funds were provided by the dept. of Health Sciences (B.L.) and the dept. of Chemistry (A.S.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to acknowledge the support of the department of Health Sciences, the department of Chemistry, and the School of Graduate Studies at ETSU. We also thank the assistance of Tyler King with the purification of the inhibitory compound and Tom Barber for the isolation of many Rhodococcus strains via enrichment culture methods. Also, many thanks to Prof. David Bemis at the Univ. of Tennessee College of Veterinary Medicine for the R. equi strains.	Barbey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066642; Bosello M, 2011, J AM CHEM SOC, V133, P4587, DOI 10.1021/ja1109453; Brameyer S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00166; Carr G, 2010, J NAT PROD, V73, P422, DOI 10.1021/np900632r; Carrano CJ, 2001, BIOMETALS, V14, P119, DOI 10.1023/A:1016633529461; Ceniceros A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3966-1; Chiba H, 1999, J ANTIBIOT, V52, P695, DOI 10.7164/antibiotics.52.695; de Carvalho CCCR, 2005, APPL MICROBIOL BIOT, V67, P715, DOI 10.1007/s00253-005-1932-3; Doroghazi JR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-611; Gillor O, 2008, APPL MICROBIOL BIOT, V81, P591, DOI 10.1007/s00253-008-1726-5; GOODFELLOW M, 1979, J GEN MICROBIOL, V112, P95, DOI 10.1099/00221287-112-1-95; Goodfellow M, 1980, BERGEYS MANUAL SYSTE, V5, P2362; Gurtler V, 2004, FEMS MICROBIOL REV, V28, P377, DOI 10.1016/j.femsre.2004.01.001; ICHIYAMA S, 1989, MICROBIOL IMMUNOL, V33, P503, DOI 10.1111/j.1348-0421.1989.tb01999.x; Iwatsuki M, 2007, J ANTIBIOT, V60, P357, DOI 10.1038/ja.2007.48; Jiang CY, 2012, APPL ENVIRON MICROB, V78, P994, DOI 10.1128/AEM.06701-11; Kim BG, 2009, J IND MICROBIOL BIOT, V36, P1425, DOI 10.1007/s10295-009-0629-5; Kitagawa W, 2008, MICROBES ENVIRON, V23, P167, DOI 10.1264/jsme2.23.167; Kitagawa W, 2008, J ANTIBIOT, V61, P680, DOI 10.1038/ja.2008.96; Kurosawa K, 2008, J AM CHEM SOC, V130, P1126, DOI 10.1021/ja077821p; Lu FJ, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0875-6; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Nachtigall J, 2010, J ANTIBIOT, V63, P567, DOI 10.1038/ja.2010.79; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Rappert S, 2007, BIODEGRADATION, V18, P585, DOI 10.1007/s10532-006-9091-5; Sallam KI, 2006, J BIOTECHNOL, V121, P13, DOI 10.1016/j.jbiotec.2005.07.007; Vazquez-Boland JA, 2013, VET MICROBIOL, V167, P9, DOI 10.1016/j.vetmic.2013.06.016; Vicente CM, 2014, APPL MICROBIOL BIOT, V98, P9311, DOI 10.1007/s00253-014-5998-7; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wei W, 2017, BRIEF BIOINFORM, V18, P357, DOI 10.1093/bib/bbw019; Withers TR, 2014, JOVE-J VIS EXP, V10, P3; Zhang JL, 2002, INT J SYST EVOL MICR, V52, P2121, DOI 10.1099/00207713-52-6-2121; Zhu F, 2011, P NATL ACAD SCI USA, V108, P12943, DOI 10.1073/pnas.1107336108	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209275	10.1371/journal.pone.0209275	http://dx.doi.org/10.1371/journal.pone.0209275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592730	Green Published, Green Submitted, gold			2022-12-26	WOS:000454621900020
J	Flegr, J; Milinski, M; Kankova, S; Hula, M; Hlavacova, J; Sykorova, K				Flegr, Jaroslav; Milinski, Manfred; Kankova, Sarka; Hula, Martin; Hlavacova, Jana; Sykorova, Katerina			Latent toxoplasmosis and olfactory functions of Rh positive and Rh negative subjects	PLOS ONE			English	Article							GENDER-DIFFERENCES; SCHIZOPHRENIA; GONDII; INFECTION; ATTRACTION; HYPOTHESIS; DOPAMINE; DISORDER; AVERSION; BEHAVIOR	Backgrounds The prevalence of toxoplasmosis is higher in schizophrenics than in the general population. It has been suggested that certain symptoms of schizophrenia, including changes in olfactory functions, are in fact symptoms of toxoplasmosis that can be easily detected in schizophrenics only due to the increased prevalence of toxoplasmosis in this population. Schizophrenics have impaired identification of odors and lower sensitivity of odor detection, however, no information about these parameters of non-schizophrenic Toxoplasma-infected subjects is available. Methods Here we searched for differences in olfactory functions between 62 infected and 61 noninfected non-schizophrenic subjects using the case-controls experimental design. Results The infected men scored better than the non-infected controls in the standard odor-identification test. The infected women rated all smells as more intensive while the infected men rated nearly all smells as less intensive. Infected women rated the pleasantness of the smell of the cat urine as higher than the non-infected women and the opposite was true for the men-in contrast, higher pleasantness of odor in infected men and lower in infected women were observed and described in the 2011 study. Toxoplasmosis, Rh, and toxoplasmosis-Rh interaction were not associated with the rated pleasantness of the smell of other stimuli. However, our sample contained only 17 Rh negative men and 30 Rh negative women. Therefore, all results concerning the main effects of Rh factor and the interaction with Rh factor must be considered only preliminary. Conclusions Our results suggest that latent toxoplasmosis is associated with changes in the olfactory functions in humans; however, the observed changes differ from those observed in schizophrenics.	[Flegr, Jaroslav; Kankova, Sarka; Hula, Martin; Hlavacova, Jana; Sykorova, Katerina] Charles Univ Prague, Div Biol, Fac Sci, Prague, Czech Republic; [Flegr, Jaroslav; Hula, Martin] Natl Inst Mental Hlth, Appl Neurosci & Brain Imaginat, Klecany, Czech Republic; [Milinski, Manfred] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany	Charles University Prague; National Institute of Mental Health - Czech Republic; Max Planck Society	Flegr, J (corresponding author), Charles Univ Prague, Div Biol, Fac Sci, Prague, Czech Republic.; Flegr, J (corresponding author), Natl Inst Mental Hlth, Appl Neurosci & Brain Imaginat, Klecany, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Hlaváčová, Jana/AAL-6076-2021; Flegr, Jaroslav/AAG-7568-2021; Hůla, Martin/AGO-6308-2022; Šárka, Kaňková/F-8514-2019	Flegr, Jaroslav/0000-0002-0822-0126; Hlaváčová, Jana/0000-0002-2011-895X; Flegr, Jaroslav/0000-0002-0822-0126; Hůla, Martin/0000-0003-2796-1226; Šárka, Kaňková/0000-0002-3087-7538; Sykorova, Katerina/0000-0003-2236-3446	Charles University Research Centre Program [204056]; Czech Science Foundation [P407/16/20958, 18-13692S]	Charles University Research Centre Program; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Charles University Research Centre Program No. 204056 and the Czech Science Foundation (Grant No. P407/16/20958, 18-13692S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulai- Saiku S, 2018, F1000 RES, V6, P1; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Celik T, 2015, FOLIA PARASITOLOGICA, V62; Dass SAH, 2014, MOL ECOL, V23, P6114, DOI 10.1111/mec.12888; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 2017, EUR PSYCHIAT, V40, P82, DOI 10.1016/j.eurpsy.2016.09.001; FLEGR J, 2014, PLOS ONE, V0009; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Holub D, 2013, ACTA PSYCHIAT SCAND, V127, P227, DOI 10.1111/acps.12031; Horacek J, 2012, WORLD J BIOL PSYCHIA, V13, P501, DOI 10.3109/15622975.2011.573809; Kamath V, 2011, PSYCHIAT RES, V187, P30, DOI 10.1016/j.psychres.2010.12.011; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Lindova J, 2006, INT J PARASITOL, V36, P1485, DOI 10.1016/j.ijpara.2006.07.008; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Mack DG, 1999, INT J PARASITOL, V29, P1351, DOI 10.1016/S0020-7519(99)00152-6; Milinski M, 2001, BEHAV ECOL, V12, P140, DOI 10.1093/beheco/12.2.140; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Pearce BD, 2013, SCHIZOPHR RES, V150, P258, DOI 10.1016/j.schres.2013.07.028; Poirotte C, 2016, CURR BIOL, V26, pR98, DOI 10.1016/j.cub.2015.12.020; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Priplatova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112771; Rupp CI, 2010, CURR OPIN PSYCHIATR, V23, P97, DOI 10.1097/YCO.0b013e328336643f; Scepichin V, 1995, CHROMATICKY ASOCIACN; Sutterland AL, 2015, ACTA PSYCHIAT SCAND, V132, P161, DOI 10.1111/acps.12423; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Van Toller S, 1994, PERFUMERY PSYCHOL BI; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Wang HL, 2006, ACTA PSYCHIAT SCAND, V114, P40, DOI 10.1111/j.1600-0447.2006.00780.x; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, P297, DOI 10.1097/00004850-199711000-00002; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x	41	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209773	10.1371/journal.pone.0209773	http://dx.doi.org/10.1371/journal.pone.0209773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7KM	30589911	Green Published, gold			2022-12-26	WOS:000454418200049
J	Krol, JE				Krol, Jaroslaw E.			Regulatory loop between the CsrA system and NhaR, a high salt/high pH regulator	PLOS ONE			English	Article							BINDING PROTEIN CSRA; ESCHERICHIA-COLI; NA+/H+ ANTIPORTER; TRANSLATIONAL REPRESSION; POLYSACCHARIDE ADHESIN; H-NS; TRANSCRIPTION; GENE; BACTERIAL; PROMOTER	In E. coli, under high pH/high salt conditions, a major Na+/H+ antiporter (NhaA) is activated to maintain an internal pH level. Its expression is induced by a specific regulator NhaR, which is also responsible for osmC and pgaA regulation. Here I report that the NhaR regulator affects the carbon storage regulatory Csr system. I found that the expression of all major components of the Csr system-CsrA regulator, CsrB and CsrC small RNAs, and the CsrB and CsrC stability were indirectly affected by nhaR mutation under stress conditions. Using a combination of experimental and in silico analyses, I concluded that the mechanism of regulation included direct and indirect activation of a two-component system (TCS) response regulator-UvrY. NhaR regulation involved interactions with the regulators H-NS and SdiA and was affected by a naturally occurring spontaneous IS5 insertion in the promoter region. A regulatory circuit was proposed and discussed.	[Krol, Jaroslaw E.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Krol, Jaroslaw E.] Drexel Univ, Dept Microbiol & Immunol, Ctr Surg Infect & Biofilms, Ctr Adv Microbial Proc,Coll Med, Philadelphia, PA 19104 USA	State University System of Florida; University of Florida; Drexel University	Krol, JE (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.; Krol, JE (corresponding author), Drexel Univ, Dept Microbiol & Immunol, Ctr Surg Infect & Biofilms, Ctr Adv Microbial Proc,Coll Med, Philadelphia, PA 19104 USA.	jek322@drexel.edu		, Jaroslaw/0000-0002-2755-8739	University of Florida CRIS project [FLA-MCS-004949]; Center for Genomic Sciences, Genomics Core Facility, Clinical and Translational Research Institute, Drexel College of Medicine; NIH [GM066794]	University of Florida CRIS project; Center for Genomic Sciences, Genomics Core Facility, Clinical and Translational Research Institute, Drexel College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Dr. Tony Romeo NIH grant GM066794 and grant FLA-MCS-004949 from the University of Florida CRIS project.; This work was supported by Dr. Tony Romeo NIH grant GM066794 and grant FLA-MCS-004949 from the University of Florida CRIS project. The author thanks Dr. Garth Ehrlich, FAAAS, Professor of Microbiology and Immunology, Professor of Otolaryngology-Head and Neck Surgery, Executive Director for the Center for Advanced Microbial Processing (CAMP), Center for Genomic Sciences, Genomics Core Facility, Clinical and Translational Research Institute, Drexel College of Medicine, for the financial support in publishing this paper. The author would like to thank Drs. Archana Pannuri for help with Western blotting, Christopher Vakulskas for supplying the uvrY-Flag construct, and Manish Kumar for help in biofilm experiments. I thank Jocelyn Hammond for English Language editing and comments.	Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Camacho MI, 2015, J BACTERIOL, V197, P983, DOI 10.1128/JB.02325-14; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donato GM, 1999, J BACTERIOL, V181, P941, DOI 10.1128/JB.181.3.941-948.1999; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dover N, 2001, J BACTERIOL, V183, P644, DOI 10.1128/JB.183.2.644-653.2001; Dover N, 1996, J BACTERIOL, V178, P6508, DOI 10.1128/jb.178.22.6508-6517.1996; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; Goller C, 2006, J BACTERIOL, V188, P8022, DOI 10.1128/JB.01106-06; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Krol JE, 2011, APPL ENVIRON MICROB, V77, P5079, DOI 10.1128/AEM.00090-11; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Mondragon V, 2006, J BACTERIOL, V188, P8303, DOI 10.1128/JB.01052-06; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; Padan E, 1999, NOVART FDN SYMP, V221, P183; Padan E, 1999, NOVART FDN SYMP, V221, P196; Pannuri A, 2012, J BACTERIOL, V194, P79, DOI 10.1128/JB.06209-11; PINNER E, 1993, J BIOL CHEM, V268, P1729; Potts AH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01613-1; Proksch E, 2018, J DERMATOL, V45, P1044, DOI 10.1111/1346-8138.14489; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; ROMEO T, 1989, J BACTERIOL, V171, P2773, DOI 10.1128/jb.171.5.2773-2782.1989; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Sen N, 2009, BIOINFORMATION, V3, P415, DOI 10.6026/97320630003415; SHARMA S, 1986, NUCLEIC ACIDS RES, V14, P2301; Sowa SW, 2017, NUCLEIC ACIDS RES, V45, P1673, DOI 10.1093/nar/gkx048; Sturny R, 2003, J BACTERIOL, V185, P4298, DOI 10.1128/JB.185.15.4298-4304.2003; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Toesca I, 2001, MICROBIOL-SGM, V147, P2795, DOI 10.1099/00221287-147-10-2795; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; White-Ziegler CA, 2009, J BACTERIOL, V191, P1106, DOI 10.1128/JB.00599-08; Yakhnin H, 2011, J BACTERIOL, V193, P6162, DOI 10.1128/JB.05975-11; Yakhnin H, 2011, MOL MICROBIOL, V81, P689, DOI 10.1111/j.1365-2958.2011.07723.x; Yamamoto K, 2001, MOL MICROBIOL, V41, P1187, DOI 10.1046/j.1365-2958.2001.02585.x; Yang TY, 2010, NUCLEIC ACIDS RES, V38, P3936, DOI 10.1093/nar/gkq177	54	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209554	10.1371/journal.pone.0209554	http://dx.doi.org/10.1371/journal.pone.0209554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589862	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200029
J	Geno, KA; Spencer, BL; Bae, S; Nahm, MH				Geno, K. Aaron; Spencer, Brady L.; Bae, Sejong; Nahm, Moon H.			Ficolin-2 binds to serotype 35B pneumococcus as it does to serotypes 11A and 31, and these serotypes cause more infections in older adults than in children	PLOS ONE			English	Article							CONJUGATE VACCINE; DISCOVERY; DISEASE; LECTIN; RECOGNITION; REPLACEMENT; VARIANTS; CARRIAGE; SUBTYPES; PATHWAY	Among 98 serotypes of Streptococcus pneumoniae, only a small subset regularly causes invasive pneumococcal diseases (IPD). We previously demonstrated that serotype 11A binds to ficolin-2 and has low invasiveness in children. Epidemiologic data suggested, however, that serotype 11A IPD afflicts older adults, possibly indicating reduced ficolin-2-mediated immune protection. Therefore, we studied the epidemiology of ficolin-2-bound serotypes. We obtained IPD case data from the United States Centers for Disease Control and Prevention. We studied three prominent ficolin-2-bound serotypes and their acetyltransferase-deficient variants for ficolin-2 binding and ficolin-2-mediated complement deposition with flow-cytometry. We determined the age distributions of these serotypes from the obtained epidemiologic data. We discovered that the serotype 35B capsule is a novel ficolin- 2 ligand due to O-acetylation via WciG. Ficolin-2-mediated complement deposition was observed on serotypes 11A and 35B but not serotype 31 or any O-acetyl transferase deficient derivatives of these serotypes. Serotypes 11A, 35B, and 31 cause more IPD among older adults than children. Studies of the three serotypes provide additional evidence for ficolin-2 providing innate immunity against IPD. The skewed age distribution of the three serotypes suggests that older adults have reduced ficolin-2-mediated immunity and are more susceptible to these serotypes.	[Geno, K. Aaron; Spencer, Brady L.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Bae, Sejong] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Spencer, Brady L.] Univ Colorado Anschutz, Dept Immunol & Microbiol, Sch Med, Aurora, CO USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Anschutz Medical Campus	Nahm, MH (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	nahm@uab.edu		Spencer, Brady/0000-0003-4374-6403; bae, sejong/0000-0001-9982-3223	National Institute on Aging [AG050607]; National Heart Lung and Blood Institute [HL105346]; NATIONAL INSTITUTE ON AGING [R01AG050607] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institute on Aging (https://www.nia.nih.gov) award AG050607 (MHN) and National Heart Lung and Blood Institute (https://www.nhlbi.nih.gov) award HL105346 (KAG). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brady AM, 2014, J INFECT DIS, V210, P1155, DOI 10.1093/infdis/jiu195; Brady AM, 2014, CLIN VACCINE IMMUNOL, V21, P1323, DOI 10.1128/CVI.00370-14; Burton RL, 2012, CLIN VACCINE IMMUNOL, V19, P835, DOI 10.1128/CVI.00086-12; Calix JJ, 2014, J CLIN MICROBIOL, V52, P758, DOI 10.1128/JCM.02695-13; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Chochua S, 2017, EMERG INFECT DIS, V23, P922, DOI 10.3201/eid2306.170071; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Geno KA, 2017, J CLIN MICROBIOL, V55, P1416, DOI 10.1128/JCM.00054-17; Geno KA, 2015, J IMMUNOL METHODS, V424, P106, DOI 10.1016/j.jim.2015.05.008; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Geno KA, 2016, PEERJ, V4, DOI 10.7717/peerj.2705; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Kjaer TR, 2015, STRUCTURE, V23, P342, DOI 10.1016/j.str.2014.10.024; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Park IH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097825; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Staples M, 2017, CLIN MICROBIOL INFEC, V23, P476, DOI 10.1016/j.cmi.2016.12.029; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Weinberger DM, 2016, AM J EPIDEMIOL, V183, P1055, DOI 10.1093/aje/kwv283	29	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209657	10.1371/journal.pone.0209657	http://dx.doi.org/10.1371/journal.pone.0209657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586458	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400081
J	Liu, S; Zhu, YB; Wang, L; Chen, W; Zhang, XL; Zhang, YZ				Liu, Song; Zhu, Yanbin; Wang, Lin; Chen, Wei; Zhang, Xiaolin; Zhang, Yingze			Incidence and risk factors for foot fractures in China: A retrospective population-based survey	PLOS ONE			English	Article							ASSOCIATION; EPIDEMIOLOGY; METAANALYSIS; OBESITY; SITE; MEN	Purpose The literature lacks population-based epidemiologic studies on the incidence and risk factors for traumatic foot fractures. The purpose of this study was to update information concerning the incidence of foot fractures in China and to identify associated risk factors. Methods All the data on foot fractures were available from the China National Fracture Survey (CNFS), which was conducted between January and May in 2015. A total of 8 provinces, 24 urban cities and 24 rural counties in China were selected, using stratified random sampling and the probability proportional to size method. Individuals who had lived in their current residence for 6 months or longer were personally interviewed about any foot fracture that had occurred in 2014. Questionnaires were completed by every participant for data collection and quality control was accomplished by our research team members. The information included age, gender, height, weight, ethnic group, education, occupation, smoking, alcohol consumption, sleeping time per day, dietary habits and others. Fracture was initially identified by patients' self report and further confirmed by their providing medical records. Results A total of 512187 individuals participated in the CNFS. There were 201 patients with foot fractures in 2014. Mean age at the time of fracture was 45.4 years. The incidence rate of foot fractures was 39.2 (95%CI: 33.8-44.7)/100000/year. Fall and traffic accident were the most common causes for foot fractures and over 60% of these occurred at home or on the road. Alcohol consumption, history of previous fracture and average sleep time <7h/d were identified as independent risk factors for foot fractures both in males and females. Cigarette smoking was identified as a significant risk factor for foot fracture in males. For females, BMI >24 kg/m(2) was a risk factor whilst living in the west region was associated with a lower incidence rate of foot fracture. Conclusions The present study shows an incidence of 39.2/100000/year of foot fractures in China. Specific public health policies focusing on decreasing alcohol consumption and encouraging individuals to obtain sufficient sleep should be implemented. Females with a higher BMI should focus more on foot health care, especially in those with history of previous fracture.	[Liu, Song; Zhu, Yanbin; Wang, Lin; Chen, Wei; Zhang, Yingze] Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Liu, Song; Zhu, Yanbin; Wang, Lin; Chen, Wei; Zhang, Yingze] Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Zhang, Xiaolin] Hebei Med Univ, Dept Stat & Epidemiol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yingze] Chinese Acad Engn, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Key Lab Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Chinese Acad Engn, Beijing, Peoples R China.	drzhang2013@126.com	Chen, Wei/GRX-2231-2022	Zhang, YIngze/0000-0001-8042-6105	Hebei Province Medical Science Special Major Projects Research Fund	Hebei Province Medical Science Special Major Projects Research Fund	This study was supported by the Hebei Province Medical Science Special Major Projects Research Fund.	Abrahamsen Bo, 2014, Bonekey Rep, V3, P574, DOI 10.1038/bonekey.2014.69; Aiyenuro O, 2013, SURGERY, V31, P474; Chen W, 2017, LANCET GLOB HEALTH, V5, pE807, DOI 10.1016/S2214-109X(17)30222-X; Clark MK, 2003, OSTEOPOROSIS INT, V14, P396, DOI 10.1007/s00198-003-1387-2; Compston J, 2013, CURR OSTEOPOROS REP, V11, P30, DOI 10.1007/s11914-012-0127-y; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Hasselman CT, 2003, J BONE JOINT SURG AM, V85A, P820, DOI 10.2106/00004623-200305000-00008; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kannus P, 2008, J GERONTOL A-BIOL, V63, P642, DOI 10.1093/gerona/63.6.642; Kannus P, 2016, INT ORTHOP, V40, P509, DOI 10.1007/s00264-015-2875-7; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Premaor MO, 2013, J BONE MINER RES, V28, P1771, DOI 10.1002/jbmr.1878; Rao YS, 2015, J MED ALLIED SCI, V5, P2; Reyes C, 2015, BONE, V73, P127, DOI 10.1016/j.bone.2014.12.019; Roux C, 2017, OSTEOPOROSIS INT, V28, P1765, DOI 10.1007/s00198-017-3976-5; Ry VDV, 2016, OSTEOPOROSIS INT, V27, P1; Scholes S, 2014, AGE AGEING, V43, P234, DOI 10.1093/ageing/aft167; Stone KL, 2008, ARCH INTERN MED, V168, P1768, DOI 10.1001/archinte.168.16.1768; Urruela A., 2011, AGING HLTH, V7, P591, DOI [10.2217/ahe.11.45, DOI 10.2217/AHE.11.45]; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215; Vestergaard P, 2003, J INTERN MED, V254, P572, DOI 10.1111/j.1365-2796.2003.01232.x; Wu ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168990; Zhu YB, 2017, INT WOUND J, V14, P982, DOI 10.1111/iwj.12743	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209740	10.1371/journal.pone.0209740	http://dx.doi.org/10.1371/journal.pone.0209740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586463	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400088
J	Meyer, JG; Softic, S; Basisty, N; Rardin, MJ; Verdin, E; Gibson, BW; Ilkayeva, O; Newgard, CB; Kahn, CR; Schilling, B				Meyer, Jesse G.; Softic, Samir; Basisty, Nathan; Rardin, Matthew J.; Verdin, Eric; Gibson, Bradford W.; Ilkayeva, Olga; Newgard, Christopher B.; Kahn, C. Ronald; Schilling, Birgit			Temporal dynamics of liver mitochondrial protein acetylation and succinylation and metabolites due to high fat diet and/or excess glucose or fructose	PLOS ONE			English	Article							DATA-INDEPENDENT ACQUISITION; LYSINE ACETYLATION; ACYL-COA; ACID OXIDATION; QUANTITATIVE PROTEOMICS; CALORIE RESTRICTION; SIRT3; STOICHIOMETRY; QUANTIFICATION; CITRATE	Dietary macronutrient composition alters metabolism through several mechanisms, including post-translational modification (PTM) of proteins. To connect diet and molecular changes, here we performed short-and long-term feeding of mice with standard chow diet (SCD) and high-fat diet (HFD), with or without glucose or fructose supplementation, and quantified liver metabolites, 861 proteins, and 1,815 protein level-corrected mitochondrial acetylation and succinylation sites. Nearly half the acylation sites were altered by at least one diet; nutrient-specific changes in protein acylation sometimes encompass entire pathways. Although acetyl-CoA is an intermediate in both sugar and fat metabolism, acetyl-CoA had a dichotomous fate depending on its source; chronic feeding of dietary sugars induced protein hyperacetylation, whereas the same duration of HFD did not. Instead, HFD resulted in citrate accumulation, anaplerotic metabolism of amino acids, and protein hypo-succinylation. Together, our results demonstrate novel connections between dietary macronutrients, protein post-translational modifications, and regulation of fuel selection in liver.	[Meyer, Jesse G.; Basisty, Nathan; Verdin, Eric; Schilling, Birgit] Buck Inst Res Aging, Novato, CA 94945 USA; [Softic, Samir; Kahn, C. Ronald] Harvard Med Sch, Dept Med, Joslin Diabet Ctr, Boston, MA USA; [Softic, Samir] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Rardin, Matthew J.; Gibson, Bradford W.] Amgen Inc, Therapeut Discovery, Discovery Attribute Sci, San Francisco, CA USA; [Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Div Endocrinol Metab & Nutr, Durham, NC 27710 USA; [Meyer, Jesse G.] Univ Wisconsin, Dept Chem, Dept Biomol Chem, Natl Ctr Quantitat Biol Complex Syst, 1101 Univ Ave, Madison, WI 53706 USA	Buck Institute for Research on Aging; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Amgen; Duke University; Duke University; Duke University; Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison	Meyer, JG (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Meyer, JG (corresponding author), Univ Wisconsin, Dept Chem, Dept Biomol Chem, Natl Ctr Quantitat Biol Complex Syst, 1101 Univ Ave, Madison, WI 53706 USA.	jessegmeyer@gmail.com	Verdin, Eric/AAB-7999-2019; Basisty, Nathan B/J-9294-2014; Kahn, Ronald/AAY-2435-2021; Meyer, Jesse/AAC-7591-2019; Softic, Samir/ABD-4612-2020	Basisty, Nathan B/0000-0001-6173-1139; Kahn, Ronald/0000-0002-7583-9228; Meyer, Jesse/0000-0003-2753-3926; 	National Institutes of Health - NIDDK [R24 DK085610]; NIH Office of the Director [S10 0D016281]; NIH-NIA [T32 AG000266]; NIH-HD [K12 HD000850]; Glenn Foundation for Biomedical Research; NIH-NIDDK [R01 DK033201, P30 DK36836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK033201, P30DK036836, R24DK085610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health - NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-HD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Biomedical Research; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by EV, R24 DK085610, National Institutes of Health - NIDDK, https://www.niddk.nih.gov/; BWG, S10 0D016281, NIH Office of the Director, https://www.cdc.gov/about/; JGM, T32 AG000266, NIH-NIA, https://www.nia.nih.gov/; SS, K12 HD000850, NIH-HD, https://www.nichd.nih.gov/; NB, N/A, Glenn Foundation for Biomedical Research, https://www.afar.org/research/funding/glenn-postdoc/; CRK, R01 DK033201, P30 DK36836,NIH-NIDDK, https://www.niddk.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Basisty N, 2018, SIMULTANEOUS QUANTIF, DOI [10.1002/pmic.201800123, DOI 10.1002/PMIC.201800123]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Bheda P, 2016, ANNU REV BIOCHEM, V85, P405, DOI 10.1146/annurev-biochem-060815-014537; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305; Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620; Collins BC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00249-5; Deutsch EW, 2015, PROTEOM CLIN APPL, V9, P745, DOI 10.1002/prca.201400164; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; FRAYN KN, 1995, AM J CLIN NUTR, V62, p250S, DOI 10.1093/ajcn/62.1.250S; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; James AM, 2017, CELL REP, V18, P2105, DOI 10.1016/j.celrep.2017.02.018; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kori Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09918-3; LAPIDUS RG, 1993, ARCH BIOCHEM BIOPHYS, V306, P246, DOI 10.1006/abbi.1993.1507; Levin E, 2017, SCIENCE, V355, P733, DOI 10.1126/science.aah4634; Li F, 2015, MOL CELL, V60, P661, DOI 10.1016/j.molcel.2015.10.017; Lumpkin RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01271-3; Mauvoisin D, 2017, CELL REP, V20, P1729, DOI 10.1016/j.celrep.2017.07.065; McDonnell E, 2016, CELL REP, V17, P1463, DOI 10.1016/j.celrep.2016.10.012; Merrell MD, 2011, DRUG METAB REV, V43, P317, DOI 10.3109/03602532.2011.577781; Meyer JG, 2017, NAT METHODS, V14, P646, DOI 10.1038/nmeth.4334; Meyer JG, 2016, J AM SOC MASS SPECTR, V27, P1758, DOI 10.1007/s13361-016-1476-z; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Newman JC, 2017, CELL METAB, V26, P547, DOI 10.1016/j.cmet.2017.08.004; NEWSHOLME EA, 1977, BIOCHEM J, V166, P123, DOI 10.1042/bj1660123; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; PARMEGGIANI A, 1963, BIOCHEM BIOPH RES CO, V12, P268, DOI 10.1016/0006-291X(63)90294-8; Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; R Development Core Team, 2008, R A LANGUAGE AND ENV; RANDLE PJ, 1963, LANCET, V1, P785; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Robles MS, 2017, CELL METAB, V25, P118, DOI 10.1016/j.cmet.2016.10.004; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; SAXHOLM HJK, 1982, MOL CELL BIOCHEM, V46, P129; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Softic S, 2017, J CLIN INVEST, V127, P4059, DOI 10.1172/JCI94585; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; Teo GS, 2015, J PROTEOMICS, V129, P108, DOI 10.1016/j.jprot.2015.09.013; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Trub AG, 2018, TRENDS BIOCHEM SCI, V43, P369, DOI 10.1016/j.tibs.2018.02.002; Tsou CC, 2015, NAT METHODS, V12, P258, DOI [10.1038/NMETH.3255, 10.1038/nmeth.3255]; Ussar S, 2016, MOL METAB, V5, P795, DOI 10.1016/j.molmet.2016.07.004; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; van de Wier B, 2013, FEBS LETT, V587, P2461, DOI 10.1016/j.febslet.2013.06.019; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Weinert BT, 2017, MOL CELL PROTEOMICS, V16, P759, DOI 10.1074/mcp.M117.067587; White PJ, 2016, MOL METAB, V5, P538, DOI 10.1016/j.molmet.2016.04.006; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu DX, 2016, SCI REP-UK, V6, DOI 10.1038/srep37478	78	28	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208973	10.1371/journal.pone.0208973	http://dx.doi.org/10.1371/journal.pone.0208973			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586434	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400048
J	Nilson, F; Damsager, J; Lauritsen, J; Bonander, C				Nilson, Finn; Damsager, John; Lauritsen, Jens; Bonander, Carl			The effect of breed-specific dog legislation on hospital treated dog bites in Odense, Denmark-A time series intervention study	PLOS ONE			English	Article							EPIDEMIOLOGY; DEMOGRAPHY; INJURIES; CHILDREN	As dog bite injuries are a considerable problem in modern society, in order to reduce such injuries, breed-specific legislation has been introduced in a number of countries. Whilst many studies have shown a lack of effect with such legislation, the commonly used methodology is known to be flawed. Therefore, the aim of this study is to investigate the effect of the Danish breed-specific legislation on the number of dog bite injuries using more credible methods. A time series intervention method was used on a detailed dataset from Odense University Hospital, Denmark, regarding dog bite injuries presented to the emergency department. The results indicate that banning certain breeds has a highly limited effect on the overall levels of dog bite injuries, and that an enforcement of the usage of muzzle and leash in public places for these breeds also has a limited effect. Despite using more credible and sound methods, this study supports previous studies showing that breed-specific legislation seems to have no effect on dog bite injuries. In order to minimise dog bite injuries in the future, it would seem that other interventions or non-breed-specific legislation should be considered as the primary option.	[Nilson, Finn; Damsager, John] Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden; [Nilson, Finn; Bonander, Carl] Karlstad Univ, Ctr Publ Safety, Karlstad, Sweden; [Lauritsen, Jens] Odense Univ Hosp, Dept Orthoped & Traumatol, Accid Anal Grp, Odense, Denmark; [Lauritsen, Jens] Univ Southern Denmark, Dept Clin Med, Odense, Denmark; [Bonander, Carl] Univ Gothenburg, Inst Med, Hlth Metr Unit, Gothenburg, Sweden	Karlstad University; Karlstad University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Gothenburg	Nilson, F (corresponding author), Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden.; Nilson, F (corresponding author), Karlstad Univ, Ctr Publ Safety, Karlstad, Sweden.	finn.nilson@kau.se	; Nilson, Finn/H-2383-2017	Bonander, Carl/0000-0002-1189-9950; Nilson, Finn/0000-0002-6928-0683; Lauritsen, Jens/0000-0001-9281-8990				Abadie A, 2015, AM J POLIT SCI, V59, P495, DOI 10.1111/ajps.12116; Beaver BV, 2001, J AM VET MED ASSOC, V218, P1732, DOI 10.2460/javma.2001.218.1732; Bonander C., 2016, ASSESSING EFFECTS SO; Box G. E. P., 2015, TIME SERIES ANAL FOR; Boyle P, 1991, CANC REGISTRATION PR, V95; Chapman S, 2000, BRIT MED J, V320, P1512, DOI 10.1136/bmj.320.7248.1512; Chiam SC, 2014, J PAEDIATR CHILD H, V50, P791, DOI 10.1111/jpc.12642; Collier S, 2006, J VET BEHAV, V1, P17, DOI 10.1016/j.jveb.2006.04.011; Cornelissen JMR, 2010, VET J, V186, P292, DOI 10.1016/j.tvjl.2009.10.001; D'Onise K, 2017, INJURY PREVENTION; Kimble RM, 2011, MED J AUSTRALIA, V195, P635, DOI 10.5694/mja11.11319; Klaassen B, 1996, INJURY, V27, P89, DOI 10.1016/0020-1383(96)83411-5; Mariti C., 2015, DOG BEHAV, V2, P25; NOMESCO, 1997, NOMESCO CLASS EXT CA; Overall KL, 2001, J AM VET MED ASSOC, V218, P1923, DOI 10.2460/javma.2001.218.1923; Ozanne-Smith J, 2001, Inj Prev, V7, P321, DOI 10.1136/ip.7.4.321; Patronek GJ, 2013, JAVMA-J AM VET MED A, V243, P1726, DOI 10.2460/javma.243.12.1726; Patronek GJ, 2010, JAVMA-J AM VET MED A, V237, P788, DOI 10.2460/javma.237.7.788; Pischke J.S., 2014, MASTERING METRICS PA; Raghavan M, 2012, INJURY PREVENTION; Roberts SE, 2003, BRIT MED J, V327, P771, DOI 10.1136/bmj.327.7418.771; Rosado B, 2007, J VET BEHAV, V2, P166, DOI 10.1016/j.jveb.2007.07.010; Rosado B, 2009, VET J, V179, P383, DOI 10.1016/j.tvjl.2008.02.002; Sacks J J, 1996, Inj Prev, V2, P52, DOI 10.1136/ip.2.1.52; Shuler CM, 2008, JAVMA-J AM VET MED A, V232, P542, DOI 10.2460/javma.232.4.542; Suilleabhain PO, 2015, VET J, V204, P357, DOI 10.1016/j.tvjl.2015.04.021; Villalbi JR, 2010, INJURY PREV, V16, DOI 10.1136/ip.2010.026997; Voith VL, 2009, J APPL ANIM WELF SCI, V12, P253, DOI 10.1080/10888700902956151; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208393	10.1371/journal.pone.0208393	http://dx.doi.org/10.1371/journal.pone.0208393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586418	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400018
J	Geronimo, I; Ntarima, P; Piens, K; Gudmundsson, M; Hansson, H; Sandgren, M; Payne, CM				Geronimo, Inacrist; Ntarima, Patricia; Piens, Kathleen; Gudmundsson, Mikael; Hansson, Henrik; Sandgren, Mats; Payne, Christina M.			Kinetic and molecular dynamics study of inhibition and transglycosylation in Hypocrea jecorina family 3-glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; carbohydrate-binding protein; inhibition mechanism; enzyme kinetics; molecular dynamics; cellulose; biofuel; transglycosylation	3 BETA-GLUCOSIDASE; ASPERGILLUS-NIGER; TRICHODERMA-REESEI; CRYSTAL-STRUCTURES; ENZYMES; MODEL; OLIGOSACCHARIDES; RESIDUE; CLONING; CEL3A	-Glucosidases enhance enzymatic biomass conversion by relieving cellobiose inhibition of endoglucanases and cellobiohydrolases. However, the susceptibility of these enzymes to inhibition and transglycosylation at high glucose or cellobiose concentrations severely limits their activity and, consequently, the overall efficiency of enzyme mixtures. We determined the impact of these two processes on the hydrolytic activity of the industrially relevant family 3 -glucosidases from Hypocrea jecorina, HjCel3A and HjCel3B, and investigated the underlying molecular mechanisms through kinetic studies, binding free energy calculations, and molecular dynamics (MD) simulations. HjCel3B had a 7-fold higher specificity for cellobiose than HjCel3A but greater tendency for glucose inhibition. Energy decomposition analysis indicated that cellobiose has relatively weak electrostatic interactions with binding site residues, allowing it to be easily displaced by glucose and free to inhibit other hydrolytic enzymes. HjCel3A is, thus, preferable as an industrial -glucosidase despite its lower activity caused by transglycosylation. This competing pathway to hydrolysis arises from binding of glucose or cellobiose at the product site after formation of the glycosyl-enzyme intermediate. MD simulations revealed that binding is facilitated by hydrophobic interactions with Trp-37, Phe-260, and Tyr-443. Targeting these aromatic residues for mutation to reduce substrate affinity at the product site would therefore potentially mitigate transglycosidic activity. Engineering improved variants of HjCel3A and other structurally similar -glucosidases would have a significant economic effect on enzymatic biomass conversion in terms of yield and production cost as the process can be consequently conducted at higher substrate loadings.	[Geronimo, Inacrist; Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA; [Ntarima, Patricia; Piens, Kathleen] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Gudmundsson, Mikael; Hansson, Henrik; Sandgren, Mats; Payne, Christina M.] Swedish Univ Agr Sci, Dept Mol Sci, Box 7015, S-75007 Uppsala, Sweden; [Piens, Kathleen] Oxyrane, B-9000 Ghent, Belgium	University of Kentucky; Ghent University; Swedish University of Agricultural Sciences	Payne, CM (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA.; Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, Box 7015, S-75007 Uppsala, Sweden.	mats.sandgren@slu.se; christy.payne@uky.edu	Payne, Christina/ABE-8330-2020; Geronimo, Inacrist/D-3383-2018	Payne, Christina/0000-0001-5264-0964; Geronimo, Inacrist/0000-0002-4968-500X; Gudmundsson, Mikael/0000-0002-8095-4423; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534	Swedish University of Agricultural Sciences August T. Larsson Guest Researcher Programme; National Science Foundation Experimental Program [1355438]; Swedish Governmental Agency for Innovation Systems (VINNOVA) [2015-04835]	Swedish University of Agricultural Sciences August T. Larsson Guest Researcher Programme; National Science Foundation Experimental Program; Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova)	This work was supported in part by the Swedish University of Agricultural Sciences August T. Larsson Guest Researcher Programme (to C.M.P.), National Science Foundation Experimental Program to Stimulate Competitive Research Grant 1355438 (to I.G.), and Swedish Governmental Agency for Innovation Systems (VINNOVA) Grant 2015-04835. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Bohlin C, 2013, APPL MICROBIOL BIOT, V97, P159, DOI 10.1007/s00253-012-3875-9; Bohlin C, 2010, BIOTECHNOL BIOENG, V107, P943, DOI 10.1002/bit.22885; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauve M, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-3; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Decker CH, 2000, J AGR FOOD CHEM, V48, P4929, DOI 10.1021/jf000434d; Deng YQ, 2006, J CHEM THEORY COMPUT, V2, P1255, DOI 10.1021/ct060037v; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Geronimo I, 2018, ORG BIOMOL CHEM, V16, P316, DOI 10.1039/c7ob02558k; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Gudmundsson M, 2016, ACTA CRYSTALLOGR D, V72, P860, DOI 10.1107/S2059798316008482; Guo B, 2016, APPL MICROBIOL BIOT, V100, P4959, DOI 10.1007/s00253-016-7342-x; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hakkinen M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-134; Jiang W, 2009, J CHEM THEORY COMPUT, V5, P2583, DOI 10.1021/ct900223z; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joshi MD, 2001, BIOCHEMISTRY-US, V40, P10115, DOI 10.1021/bi0105429; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Kawai R, 2004, CARBOHYD RES, V339, P2851, DOI 10.1016/j.carres.2004.09.019; Korotkova OG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P569, DOI 10.1134/S0006297909050137; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Krogh KBRM, 2010, APPL MICROBIOL BIOT, V86, P143, DOI 10.1007/s00253-009-2181-7; Langston J, 2006, BBA-PROTEINS PROTEOM, V1764, P972, DOI 10.1016/j.bbapap.2006.03.009; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mallajosyula SS, 2012, J CHEM THEORY COMPUT, V8, P759, DOI 10.1021/ct200792v; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Ntarima P, 2000, BIOCHEM J, V347, P865, DOI 10.1042/0264-6021:3470865; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; PERLACK R.D., 2005, DOEGO1020052135 OAK; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raman EP, 2010, J PHYS CHEM B, V114, P12981, DOI 10.1021/jp105758h; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Seidle HF, 2006, ARCH BIOCHEM BIOPHYS, V455, P110, DOI 10.1016/j.abb.2006.09.016; Seidle HF, 2005, ARCH BIOCHEM BIOPHYS, V444, P66, DOI 10.1016/j.abb.2005.09.013; Seidle HF, 2005, ARCH BIOCHEM BIOPHYS, V436, P254, DOI 10.1016/j.abb.2005.02.017; Seidle HF, 2004, PROTEIN J, V23, P11, DOI 10.1023/B:JOPC.0000016254.58189.2a; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Sorensen A, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030612; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; Tengborg C, 2001, BIOTECHNOL PROGR, V17, P110, DOI 10.1021/bp000145+; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-105; TOMME P, 1988, METHOD ENZYMOL, V160, P187; VANTILBEURGH H, 1988, METHOD ENZYMOL, V160, P45; Vinzant TB, 2001, APPL BIOCHEM BIOTECH, V91-3, P99, DOI 10.1385/ABAB:91-93:1-9:99; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838	61	3	3	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3169	3180		10.1074/jbc.RA118.007027	http://dx.doi.org/10.1074/jbc.RA118.007027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30602567	Green Published, hybrid			2022-12-26	WOS:000464980100016
J	Fu, ZY; Zhang, GM; Shi, Q; Zhou, DD; Tang, J; Liu, L; Chen, QC				Fu, Ziying; Zhang, Guimin; Shi, Qing; Zhou, Dandan; Tang, Jia; Liu, Long; Chen, Qicai			Behaviorally relevant frequency selectivity in single- and double-on neurons in the inferior colliculus of the Pratt's roundleaf bat, Hipposideros pratti	PLOS ONE			English	Article							CF-FM-BAT; AUDITORY-CORTEX; SENSITIVE NEURONS; TARGET RANGE; ECHOLOCATION; INHIBITION; ECHOES; INFORMATION; RESPONSES; COMPONENT	Frequency analysis is a fundamental function of the auditory system, and it is essential to study the auditory response properties using behavior-related sounds. Our previous study has shown that the inferior collicular (IC) neurons of CF-FM (constant frequency-frequency modulation) bats could be classified into single-on (SO) and double-on (DO) neurons under CF-FM stimulation. Here, we employed Pratt's roundleaf bats, Hipposideros pratti, to investigate the frequency selectivity of SO and DO neurons in response to CF and behav-iorrelated CF-FM sounds using in vivo extracellular recordings. The results demonstrated that the bandwidths (BWs) of iso-frequency tuning curves had no significant differences between the SO and the DO neurons when stimulated by CF sounds. However, the SO neurons had significant narrower BWs than DO neurons when stimulated with CF-FM sounds. In vivo intracellular recordings showed that both SO and DO neurons had significantly shorter post-spike hyperpolarization latency and excitatory duration in response to CF-FM in comparison to CF stimuli, suggesting that the FM component had an inhibitory effect on the responses to the CF component. These results suggested that SO neurons had higher frequency selectivity than DO neurons under behavior-related CF-FM stimulation, making them suitable for detecting frequency changes during echolocation.	[Fu, Ziying; Zhang, Guimin; Shi, Qing; Zhou, Dandan; Tang, Jia; Chen, Qicai] Cent China Normal Univ, Sch Life Sci, Wuhan, Hubei, Peoples R China; [Fu, Ziying; Zhang, Guimin; Shi, Qing; Zhou, Dandan; Tang, Jia; Chen, Qicai] Cent China Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China; [Liu, Long] Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China	Central China Normal University; Central China Normal University; National University of Defense Technology - China	Chen, QC (corresponding author), Cent China Normal Univ, Sch Life Sci, Wuhan, Hubei, Peoples R China.; Chen, QC (corresponding author), Cent China Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China.	chenqc@mail.ccnu.edu.cn	Fu, Ziying/N-7127-2013	Fu, Ziying/0000-0002-0065-8297	 [31200832];  [31571232];  [31772454]	; ; 	The work was supported by grants #31200832 to ZF, #31571232 to QC, and #31772454 to JT from National Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz MJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0314-17.2017; Beetz MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35991; Beetz MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29102; Bohn KM, 2018, CAN J ZOOL, V96, P787, DOI 10.1139/cjz-2017-0188; Corcoran AJ, 2017, J EXP BIOL, V220, P4554, DOI 10.1242/jeb.163063; DEATHERAGE BH, 1969, J ACOUST SOC AM, V46, P362, DOI 10.1121/1.1911698; Fu ZY, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-015-0123-x; Fu ZY, 2014, NEUROSCI LETT, V576, P97, DOI 10.1016/j.neulet.2014.05.061; Fu ZY, 2011, ZOOL STUD, V50, P537; Fu ZY, 2010, BRAIN RES, V1306, P39, DOI 10.1016/j.brainres.2009.10.002; GRINNELL AD, 1973, J COMP PHYSIOL, V82, P179, DOI 10.1007/BF00696152; Grinnell AD, 2018, J COMP PHYSIOL A, V204, P519, DOI 10.1007/s00359-018-1263-3; Kato HK, 2017, NEURON, V95, P412, DOI 10.1016/j.neuron.2017.06.019; KOBER R, 1990, J ACOUST SOC AM, V87, P882, DOI 10.1121/1.398898; Li YL, 2015, NEUROSCIENCE, V289, P443, DOI 10.1016/j.neuroscience.2015.01.016; Luo F, 2008, J NEUROPHYSIOL, V99, P284, DOI 10.1152/jn.00935.2007; Macias S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29129; Nam H, 2018, HEARING RES, V358, P1, DOI 10.1016/j.heares.2017.12.008; Neuweiler G, 2003, J COMP PHYSIOL A, V189, P245, DOI 10.1007/s00359-003-0406-2; ONEILL WE, 1982, J NEUROSCI, V2, P17; Schnitzler HU, 2011, J COMP PHYSIOL A, V197, P541, DOI 10.1007/s00359-010-0569-6; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHULLER G, 1971, Z VERGL PHYSIOL, V74, P153, DOI 10.1007/BF00339929; SCHULLER G, 1979, J COMP PHYSIOL, V132, P39, DOI 10.1007/BF00617730; Sctoiitzler H. U., 1968, Zeitschrift fuer Vergleichende Physiologie, V57, P376; SIMMONS JA, 1975, AM SCI, V63, P204; SIMMONS JA, 1971, J EXP ZOOL, V176, P315, DOI 10.1002/jez.1401760307; SUGA N, 1979, SCIENCE, V206, P351, DOI 10.1126/science.482944; SUGA N, 1979, SCIENCE, V203, P270, DOI 10.1126/science.760193; SUGA N, 1995, NEUROSCI RES, V21, P287, DOI 10.1016/0168-0102(94)00868-G; SUGA N, 1974, J EXP BIOL, V61, P379; SUGA N, 1975, J EXP BIOL, V63, P161; Tang J, 2015, J COMP PHYSIOL A, V201, P783, DOI 10.1007/s00359-015-1018-3; Tang J, 2011, BRAIN RES, V1385, P114, DOI 10.1016/j.brainres.2011.02.031; Tao C, 2017, CELL REP, V19, P521, DOI 10.1016/j.celrep.2017.03.061; Tressler J, 2009, J COMP PHYSIOL A, V195, P923, DOI 10.1007/s00359-009-0468-x; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wohlgemuth MJ, 2016, P NATL ACAD SCI USA, V113, P2508, DOI 10.1073/pnas.1517451113; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209446	10.1371/journal.pone.0209446	http://dx.doi.org/10.1371/journal.pone.0209446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601861	gold, Green Published, Green Submitted			2022-12-26	WOS:000454683200060
J	Han, M; Kim, YD; Park, HJ; Hwang, IG; Choi, J; Ha, J; Heo, JH; Nam, HS				Han, Minho; Kim, Young Dae; Park, Hyung Jong; Hwang, In Gun; Choi, Junghye; Ha, Jimin; Heo, Ji Hoe; Nam, Hyo Suk			Prediction of functional outcome using the novel asymmetric middle cerebral artery index in cryptogenic stroke patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; INFARCT VOLUME; TERM; PULSATILITY; ULTRASOUND; SONOGRAPHY; PARAMETERS; PROGNOSIS; ACCURACY	Background Etiology is unknown in approximately one-quarter of stroke patients after evaluation, which is termed cryptogenic stroke (CS). The prognosis of CS patients is largely undetermined. We created a novel index from transcranial Doppler parameters including mean flow velocity (MV) and pulsatility index (PI) and investigated whether the calculation of asymmetry in the novel parameter can predict functional outcomes in CS patients. Methods We made the middle cerebral artery (MCA) index (%) as a novel parameter, which was calculated as 100 X (MCA MV + MCA PI X 10) /(MCA MV-MCA PI X 10). The MCA asymmetry index (%) was also calculated as 100 X (vertical bar Rt MCA index-Lt MCA index vertical bar) /(Rt MCA index + Lt MCA index) /2. Poor functional outcomes were defined as modified Rankin Scale score (mRS) >= 3 at 3 months after stroke onset. Results A total of 377 CS patients were included. Among them, 52 (13.8%) patients had a poor outcome. The overall MCA asymmetry index was two-fold higher in CS patients with a poor outcome (10.26%) compared to those with a good outcome (5.41%, p = 0.002). In multivariable analysis, the overall MCA asymmetry index (OR, 1.054, 95% CI, 1.013-1.096, p = 0.009) and the cutoff value of the overall MCA asymmetry index >9 were associated with poor outcomes at 3 months (OR, 3.737, 95% CI, 1.530-9.128, p = 0.004). Conclusion We demonstrated that the novel asymmetric MCA index can predict short-term functional outcomes in CS patients.	[Han, Minho; Kim, Young Dae; Park, Hyung Jong; Hwang, In Gun; Choi, Junghye; Ha, Jimin; Heo, Ji Hoe; Nam, Hyo Suk] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Han, Minho] Yonsei Univ, Dept Sci Aging, Grad Sch, Seoul, South Korea; [Ha, Jimin] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Nam, HS (corresponding author), Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.	hsnam@yuhs.ac	Han, Minho/AAX-9385-2020	Han, Minho/0000-0003-2951-0963; Hwang, In Gun/0000-0002-5193-4060; Kim, Young Dae/0000-0001-5750-2616; NAM, HYO SUK/0000-0002-4415-3995; Heo, Ji Hoe/0000-0001-9898-3321	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2016R1C1B2016028]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIP) (2016R1C1B2016028). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Allendoerfer J, 2006, LANCET NEUROL, V5, P835, DOI 10.1016/S1474-4422(06)70551-8; Aoki J, 2013, J NEUROL SCI, V334, P26, DOI 10.1016/j.jns.2013.07.011; Balestrino M, 1998, J Stroke Cerebrovasc Dis, V7, P139, DOI 10.1016/S1052-3057(98)80141-9; Baracchini C, 2000, STROKE, V31, P2942, DOI 10.1161/01.STR.31.12.2942; Brint SU, 1996, NEUROL RES, V18, P163; Cho HJ, 2010, J NEUROL NEUROSUR PS, V81, P412, DOI 10.1136/jnnp.2009.190322; Dhamoon MS, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00305; Fonseca AC, 2015, EUR J NEUROL, V22, P618, DOI 10.1111/ene.12673; Ghorbani Abbas, 2015, Adv Biomed Res, V4, P54, DOI 10.4103/2277-9175.151574; Graziadio S, 2012, EXP NEUROL, V238, P168, DOI 10.1016/j.expneurol.2012.08.031; Gujjar AR, 2011, J CLIN MONIT COMPUT, V25, P121, DOI 10.1007/s10877-011-9288-y; Gupta D, 2016, J STROKE CEREBROVASC, V25, P2109, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.004; Isozaki Makoto, 2017, Surg Neurol Int, V8, P6, DOI 10.4103/2152-7806.198733; Jeong SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196014; Kim Y, 2016, YONSEI MED J, V57, P950, DOI 10.3349/ymj.2016.57.4.950; Kincaid MS, 2008, CURR OPIN ANESTHESIO, V21, P552, DOI 10.1097/ACO.0b013e32830edc0b; Leanyvari Z, 2002, J CLIN ULTRASOUND, V30, P33, DOI 10.1002/jcu.10040; Lee BI, 2001, CEREBROVASC DIS, V12, P145, DOI 10.1159/000047697; Lee KY, 2000, STROKE, V31, P1111, DOI 10.1161/01.STR.31.5.1111; Li LX, 2015, LANCET NEUROL, V14, P903, DOI 10.1016/S1474-4422(15)00132-5; Nayak AR, 2011, NEUROL SCI, V32, P855, DOI 10.1007/s10072-011-0718-x; Nezu T, 2018, J NEUROL, V265, P628, DOI 10.1007/s00415-018-8742-x; Nezu T, 2016, STROKE, V47, P2209, DOI 10.1161/STROKEAHA.116.014178; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Restrepo L, 2003, J NEUROIMAGING, V13, P34, DOI 10.1177/1051228402239715; Shen QM, 1999, J CLIN MONIT COMPUT, V15, P179, DOI 10.1023/A:1009925811965; Shen W, 2015, INT J CLIN EXP MED, V8, P18319; Song TJ, 2014, J CLIN NEUROL, V10, P222, DOI 10.3988/jcn.2014.10.3.222; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; Toni D, 1998, STROKE, V29, P1144, DOI 10.1161/01.STR.29.6.1144; Wakerley BR, 2015, J NEUROIMAGING, V25, P111, DOI 10.1111/jon.12100; Wijnhoud AD, 2011, ACTA NEUROL SCAND, V124, P238, DOI 10.1111/j.1600-0404.2010.01462.x; Yoo J, 2012, CEREBROVASC DIS, V33, P286, DOI 10.1159/000334980; ZANETTE EM, 1989, STROKE, V20, P899, DOI 10.1161/01.STR.20.7.899; Zareie H, 2013, INT J STROKE, V8, P228, DOI 10.1111/j.1747-4949.2012.00801.x	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208918	10.1371/journal.pone.0208918	http://dx.doi.org/10.1371/journal.pone.0208918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601840	Green Published, gold, Green Submitted			2022-12-26	WOS:000454683200025
J	Kim, ES; Zaya, DN; Fant, JB; Ashley, MV				Kim, Eun Sun; Zaya, David N.; Fant, Jeremie B.; Ashley, Mary V.			Reproductive trade-offs maintain bract color polymorphism in Scarlet Indian paintbrush (Castilleja coccinea)	PLOS ONE			English	Article							POLLINATOR-MEDIATED SELECTION; ANNUAL LINANTHUS-PARRYAE; FLOWER-COLOR; NATURAL-SELECTION; SELF-FERTILIZATION; SEED PREDATORS; FLORAL TRAITS; MORNING GLORY; EVOLUTION; POPULATIONS	Populations of scarlet Indian paintbrush (Castilleja coccinea) in the Midwestern United States exhibit a bract color polymorphism, with each population having predominantly yellow or scarlet bracts. We investigated a possible mechanism for this maintenance of bract color polymorphism in C. coccinea by conducting hand-pollination experiments in two nearby populations, one predominantly yellow and one predominantly scarlet. The hand-pollination treatments were either self-pollination or cross pollination using pollen from within and between populations. Both color morphs were used as pollen donors for the within and between crosses. We found that both color morphs of C. coccinea were self-compatible. When the scarlet morph was the maternal plant it had higher seed set. When pollinators were excluded, the yellow morph outperformed the scarlet morph in fruit set and seed set. The apparent trade-offs between a higher reproductive output in the scarlet morph and a reproductive assurance advantage in the yellow morph may explain the maintenance of the polymorphism in C. coccinea. While many previous studies have provided evidence for pollinator preference playing a role in floral color polymorphism, the results of the current study indicate that reproductive assurance, which would be important for fluctuations in pollinator abundance or colonizing new areas, may act as a selective agent to maintain such polymorphisms.	[Kim, Eun Sun; Ashley, Mary V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Zaya, David N.] Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Fant, Jeremie B.] Chicago Bot Garden, Inst Plant Conservat, Glencoe, IL USA; [Fant, Jeremie B.] Northwestern Univ, Plant Biol & Conservat, Evanston, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Illinois Natural History Survey; Northwestern University	Ashley, MV (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	ashley@uic.edu	Fant, Jeremie B/AAA-4962-2019	Fant, Jeremie B/0000-0001-9276-1111				Arista M, 2013, J ECOL, V101, P1613, DOI 10.1111/1365-2745.12151; Armbruster WS, 2002, J EVOLUTION BIOL, V15, P468, DOI 10.1046/j.1420-9101.2002.00399.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERTIN RI, 1982, CAN J ZOOL, V60, P210, DOI 10.1139/z82-029; Braum A, 2014, INVESTIGATING DRIVER; BROWN BA, 1984, EVOLUTION, V38, P796, DOI 10.1111/j.1558-5646.1984.tb00352.x; Cariveau D, 2004, OIKOS, V104, P15, DOI 10.1111/j.0030-1299.2004.12641.x; Carlson JE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0583; Carlson JE, 2010, AM J BOT, V97, P934, DOI 10.3732/ajb.0900348; Carpenter F.L., 1983, P215; CHUANG TI, 1992, SYST BOT, V17, P417, DOI 10.2307/2419482; Coberly LC, 2003, MOL ECOL, V12, P1113, DOI 10.1046/j.1365-294X.2003.01786.x; Dart SR, 2012, ANN BOT-LONDON, V109, P599, DOI 10.1093/aob/mcr266; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Eastman J, 2014, WILDFLOWERS E US; Eckhart VM, 2006, OIKOS, V112, P412, DOI 10.1111/j.0030-1299.2006.14289.x; Elle E, 2003, AM J BOT, V90, P888, DOI 10.3732/ajb.90.6.888; ELMQVIST T, 1993, OIKOS, V68, P207, DOI 10.2307/3544832; EPLING C, 1960, EVOLUTION, V14, P238, DOI 10.2307/2405830; Epling C, 1942, GENETICS, V27, P0317; EPPERSON BK, 1987, EVOLUTION, V41, P1302, DOI 10.1111/j.1558-5646.1987.tb02468.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Frey FM, 2007, AM J BOT, V94, P437, DOI 10.3732/ajb.94.3.437; Fry JD, 1997, EVOLUTION, V51, P66, DOI [10.2307/2410961, 10.1111/j.1558-5646.1997.tb02389.x]; Galen C, 1999, BIOSCIENCE, V49, P631, DOI 10.2307/1313439; Gervasi DDL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14691; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Hersch-Green EI, 2012, AM J BOT, V99, P1680, DOI 10.3732/ajb.1200253; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Irwin RE, 2005, AM NAT, V165, P225, DOI 10.1086/426714; Irwin RE, 2003, ECOLOGY, V84, P1733, DOI 10.1890/0012-9658(2003)084[1733:TROHIT]2.0.CO;2; Johnson SD, 2010, PHILOS T R SOC B, V365, P499, DOI 10.1098/rstb.2009.0243; Jones KN, 2001, AM J BOT, V88, P447, DOI 10.2307/2657109; Kalisz S, 2004, NATURE, V430, P884, DOI 10.1038/nature02776; Kay Q.O.N., 1978, Linnean Society Symposium Series, P175; KAYE TN, 2003, FITNESS EFFECTS INBR; KREBS SL, 1990, THEOR APPL GENET, V79, P825, DOI 10.1007/BF00224252; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LEVIN DA, 1995, EVOLUTION, V49, P1017, DOI [10.2307/2410423, 10.1111/j.1558-5646.1995.tb02336.x]; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; Lloyd DG, INT J PLANT SCI, P358; MILLER RB, 1981, EVOLUTION, V35, P763, DOI [10.1111/j.1558-5646.1981.tb04936.x, 10.2307/2408246]; Moeller DA, 2006, ECOLOGY, V87, P1510, DOI 10.1890/0012-9658(2006)87[1510:GSOPCR]2.0.CO;2; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2021, R LANGUAGE ENV STAT; RAUSHER MD, 1993, EVOLUTION, V47, P1688, DOI [10.2307/2410213, 10.1111/j.1558-5646.1993.tb01261.x]; Robertson C., 1891, T ACAD SCI ST LOUIS, V5, P569; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schemske DW, 2001, EVOLUTION, V55, P1269, DOI 10.1111/j.0014-3820.2001.tb00650.x; Schoen DJ, INT J PLANT SCI, P381, DOI [10.2307/2995678, DOI 10.2307/2995678]; Smithson A, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P237, DOI 10.1017/CBO9780511542268.013; Sobral M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132522; Spira T, 2011, WILDFLOWERS PLANT CO; STANTON ML, 1987, AM J BOT, V74, P178, DOI 10.2307/2444019; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; Streisfeld MA, 2007, J EVOLUTION BIOL, V20, P122, DOI 10.1111/j.1420-9101.2006.01216.x; Streisfeld MA, 2005, EVOLUTION, V59, P2548, DOI 10.1111/j.0014-3820.2005.tb00968.x; Takahashi Y, 2015, J PLANT RES, V128, P933, DOI 10.1007/s10265-015-0750-7; Torrey J, 1843, FLORA STATE NEW YORK, VII; Warren J, 2001, NEW PHYTOL, V151, P237, DOI 10.1046/j.1469-8137.2001.00159.x; WASER NM, 1981, EVOLUTION, V35, P376, DOI 10.1111/j.1558-5646.1981.tb04896.x; WASER NM, 1983, NATURE, V302, P422, DOI 10.1038/302422a0; Williamson S, 2001, FIELD GUIDE HUMMINGB; Wright S, 1943, GENETICS, V28, P139	70	1	1	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209176	10.1371/journal.pone.0209176	http://dx.doi.org/10.1371/journal.pone.0209176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601846	gold, Green Published, Green Submitted			2022-12-26	WOS:000454683200045
J	Lambregts, MMC; Bernards, AT; van der Beek, MT; Visser, LG; de Boer, MG				Lambregts, Merel M. C.; Bernards, Alexandra T.; van der Beek, Martha T.; Visser, Leo G.; de Boer, Mark G.			Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; PREDICTING BACTEREMIA; ANTIBIOTIC-THERAPY; DE-ESCALATION; DIAGNOSIS; SEPSIS	Background Blood cultures are considered the gold standard to distinguish bacteremia from non-bacteremic systemic inflammation. In current clinical practice, bacteraemia is considered unlikely if blood cultures have been negative for 48-72 hours. Modern BC systems have reduced this time-to-positivity (TTP), questioning whether the time frame of 48-72 hrs is still valid. This study investigates the distribution of TTP, the probability of blood culture positivity after 24 hours, and identifies clinical predictors of prolonged TTP. Methods Adult patients with monomicrobial bacteremia in an academic hospital were included retrospectively over a three-year period. Clinical data were retrieved from the medical records. Predictors of TTP >24 hours were determined by uni-and multivariate analyses. The residual probability of bacteremia was estimated for the scenario of negative BCs at 24 hours after bedside collection. Results The cohort consisted of 801 patients, accounting for 897 episodes of bacteremia. Mean age was 65 years (IQR 54-73), 534 (59.5%) patients were male. Median TTP was 15.7 (IQR 13.5-19.3) hours. TTP was. 24 hours in 85.3% of episodes. Antibiotic pre-treatment (adjusted OR 1.77; 95% CI 1.14-2.74, p<0.01) was independently associated with prolonged TTP. The probability of bacteremia, if BC had remained negative for 24 hours, was 1.8% (95% CI 1.46-2.14). Conclusion With adequate hospital logistics, the probability of positive blood cultures after 24 hours of negative cultures was low. Combined with clinical reassessment, knowledge of this low probability may contribute to prioritization of the differential diagnosis and decisions on antimicrobial therapy. As a potential antibiotic stewardship tool, this strategy warrants further prospective investigation.	[Lambregts, Merel M. C.; Visser, Leo G.; de Boer, Mark G.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Bernards, Alexandra T.; van der Beek, Martha T.] Leiden Univ, Med Ctr, Dept Microbiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lambregts, MMC (corresponding author), Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands.	m.m.c.lambregts@lumc.nl	de Boer, mark/AGE-5167-2022; Visser, Leo/AAH-5755-2021	de Boer, mark/0000-0002-5009-6499; Lambregts, Merel/0000-0003-3637-9115				Barlam TF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw045; Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278; Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; Bignardi GE, 2015, J INFECTION, V70, P546, DOI 10.1016/j.jinf.2014.12.006; Chirouze C, 2002, CLIN INFECT DIS, V35, P156, DOI 10.1086/341023; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Esper AM, 2011, CRIT CARE MED, V39, P2728, DOI 10.1097/CCM.0b013e318236f27e; Garnacho-Montero J, 2014, INTENS CARE MED, V40, P32, DOI 10.1007/s00134-013-3077-7; Halm EA, 2001, J GEN INTERN MED, V16, P599, DOI 10.1046/j.1525-1497.2001.016009599.x; Hoenigl M, 2013, CLIN BIOCHEM, V46, P225, DOI 10.1016/j.clinbiochem.2012.11.004; Jones AE, 2007, ANN EMERG MED, V50, P34, DOI 10.1016/j.annemergmed.2006.10.020; Kerremans JJ, 2009, J CLIN MICROBIOL, V47, P3520, DOI 10.1128/JCM.01092-09; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Kim SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116728; Lambregts MMC, 2017, EUR J HAEMATOL; Lin HH, 2013, J MICROBIOL IMMUNOL, V46, P48, DOI 10.1016/j.jmii.2012.03.012; Martinez JA, 2007, CLIN MICROBIOL INFEC, V13, P709, DOI 10.1111/j.1469-0691.2007.01736.x; McGowan KL, 2000, PEDIATRICS, V106, P251, DOI 10.1542/peds.106.2.251; Metersky ML, 2004, AM J RESP CRIT CARE, V169, P342, DOI 10.1164/rccm.200309-1248OC; Morrison J, 2014, AM J EMERG MED, V32, P511, DOI 10.1016/j.ajem.2014.01.046; Ning Y, 2016, EUR J CLIN MICROBIOL, V35, P619, DOI 10.1007/s10096-016-2580-5; Pardo J, 2014, ANN PHARMACOTHER, V48, P33, DOI 10.1177/1060028013511229; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reimer LG, 1997, CLIN MICROBIOL REV, V10, P444, DOI 10.1128/CMR.10.3.444; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Shah SS, 2008, PEDIATRICS, V121, P135, DOI 10.1542/peds.2007-1387; Srigley JA, 2013, AM J INFECT CONTROL, V41, P1116, DOI 10.1016/j.ajic.2013.04.017; Tarai B, 2018, EUR J CLIN MICROBIOL, V37, P435, DOI 10.1007/s10096-018-3188-8; Wiersinga W J, 2017, Ned Tijdschr Geneeskd, V161, pD1551; Wildi K, 2011, EUR J CLIN MICROBIOL, V30, P1615, DOI 10.1007/s10096-011-1268-0; Zhang Q, 2016, INFECTION, V44, P583, DOI 10.1007/s15010-016-0890-2; Zilahi G, 2016, J THORAC DIS, V8, P3774, DOI 10.21037/jtd.2016.12.89	35	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208819	10.1371/journal.pone.0208819	http://dx.doi.org/10.1371/journal.pone.0208819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601829	Green Submitted, gold, Green Published			2022-12-26	WOS:000454683200024
J	Da Silva, WM; Bei, JL; Amigo, N; Valacco, MP; Amadio, A; Zhang, Q; Wu, XJ; Yu, T; Larzabal, M; Chen, Z; Cataldi, A				Da Silva, Wanderson Marques; Bei, Jinlong; Amigo, Natalia; Pia Valacco, Maria; Amadio, Ariel; Zhang, Qi; Wu, Xiuju; Yu, Ting; Larzabal, Mariano; Chen, Zhuang; Cataldi, Angel			Quantification of enterohemorrhagic Escherichia coli O157:H7 protein abundance by high-throughput proteome	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS; EXPRESSION; INTIMIN; O157-H7; COLONIZATION; MUTAGENESIS; INFECTION; SEQUENCE; REQUIRES; BINDING	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a human pathogen responsible for diarrhea, hemorrhagic colitis and hemolytic uremic syndrome (HUS). To promote a comprehensive insight into the molecular basis of EHEC O157:H7 physiology and pathogenesis, the combined proteome of EHEC O157:H7 strains, Clade 8 and Clade 6 isolated from cattle in Argentina, and the standard EDL933 (clade 3) strain has been analyzed. From shotgun proteomic analysis a total of 2,644 non-redundant proteins of EHEC O157:H7 were identified, which correspond approximately 47% of the predicted proteome of this pathogen. Normalized spectrum abundance factor analysis was performed to estimate the protein abundance. According this analysis, 50 proteins were detected as the most abundant of EHEC O157:H7 proteome. COG analysis showed that the majority of the most abundant proteins are associated with translation processes. A KEGG enrichment analysis revealed that Glycolysis/Gluconeogenesis was the most significant pathway. On the other hand, the less abundant detected proteins are those related to DNA processes, cell respiration and prophage. Among the proteins that composed the Type III Secretion System, the most abundant protein was EspA. Altogether, the results show a subset of important proteins that contribute to physiology and pathogenicity of EHEC O157:H7.	[Da Silva, Wanderson Marques; Amigo, Natalia; Larzabal, Mariano; Cataldi, Angel] Natl Inst Agr Technol, CICVyA, Inst Biotechnol, Buenos Aires, DF, Argentina; [Bei, Jinlong; Zhang, Qi; Wu, Xiuju; Yu, Ting; Chen, Zhuang] Guangdong Acad Agr Sci GDAAS, AGRO Biol Gene Res Ctr, Guangzhou, Guangdong, Peoples R China; [Pia Valacco, Maria] Univ Buenos Aires, Fac Exact & Nat Sci, Mass Spectrometry Facil, CEQUIBIEM, Buenos Aires, DF, Argentina; [Pia Valacco, Maria] CNR, CONICET, Buenos Aires, DF, Argentina; [Amadio, Ariel] Natl Inst Agr Technol, Rafaela Expt Stn, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Cataldi, A (corresponding author), Natl Inst Agr Technol, CICVyA, Inst Biotechnol, Buenos Aires, DF, Argentina.	cataldi.angeladrian@inta.gob.ar		Larzabal, Mariano/0000-0002-1358-6982	Fondo para la Investigacion Cientifica y Tecnologica (FONCYT), Argentina [0211]; INTA, Argentina [PNBIO1131034]; Presidential Foundation of Guangdong Academy of Agricultural Sciences [201320]; Science and Technology Program of Guangdong Province, China [2016B070701013]; FONCYT, Argentina [0211]; CONICET fellowship	Fondo para la Investigacion Cientifica y Tecnologica (FONCYT), Argentina(FONCyT); INTA, Argentina; Presidential Foundation of Guangdong Academy of Agricultural Sciences; Science and Technology Program of Guangdong Province, China; FONCYT, Argentina(FONCyT); CONICET fellowship(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The present study was supported by grants PICT 2012-#0211 from Fondo para la Investigacion Cientifica y Tecnologica (FONCYT), Argentina, PNBIO1131034 INTA, Argentina; Presidential Foundation of Guangdong Academy of Agricultural Sciences (No.: 201320), and Science and Technology Program of Guangdong Province, (2016B070701013) China. WMdS, MPV, AA, ML and AC are CONICET fellows. NA holds a CONICET fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by grants PICT #0211 from FONCYT, Argentina, PNBIO1131034 INTA, Argentina; Presidential Foundation of Guangdong Academy of Agricultural Sciences (No.: 201320), and Science and Technology Program of Guangdong Province, (2016B070701013) China.	Aguilera L, 2009, INT MICROBIOL, V12, P187, DOI 10.2436/20.1501.01.97; Alpert C, 2009, ENVIRON MICROBIOL, V11, P751, DOI 10.1111/j.1462-2920.2008.01798.x; Amigo N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166883; Amigo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127710; Bertin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098367; Bose T, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00128; Carruthers MD, 2009, FEMS MICROBIOL LETT, V295, P96, DOI 10.1111/j.1574-6968.2009.01587.x; Cha MK, 1996, J BACTERIOL, V178, P5610, DOI 10.1128/jb.178.19.5610-5614.1996; Cornick NA, 2002, INFECT IMMUN, V70, P2704, DOI 10.1128/IAI.70.5.2704-2707.2002; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; Dean-Nystrom EA, 1998, INFECT IMMUN, V66, P4560; Ebel F, 1998, MOL MICROBIOL, V30, P147, DOI 10.1046/j.1365-2958.1998.01046.x; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Ferraris JR, 2002, PEDIATR NEPHROL, V17, P809, DOI 10.1007/s00467-002-0936-9; Fratamico PM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00644; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goncalves NS, 2003, INFECT IMMUN, V71, P2960, DOI 10.1128/IAI.71.5.2960-2965.2003; Harris SM, 2012, INT J FOOD MICROBIOL, V159, P186, DOI 10.1016/j.ijfoodmicro.2012.09.007; Henderson B, 2014, BIOCHEM SOC T, V42, P1671, DOI 10.1042/BST20140273; Higgins LM, 1999, SCIENCE, V285, P588, DOI 10.1126/science.285.5427.588; Iizumi Y, 2007, CELL HOST MICROBE, V2, P383, DOI 10.1016/j.chom.2007.09.012; Etcheverria AI, 2013, VIRULENCE, V4, P366, DOI 10.4161/viru.24642; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Islam N, 2016, APPL ENVIRON MICROB, V82, P4371, DOI 10.1128/AEM.00977-16; Jiang WN, 1997, J BIOL CHEM, V272, P196; Kakkanat A, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0176290j, 10.1371/journal.pone.0176290]; Kalule JB, 2017, J PROTEOMICS, V5, pS1874; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim Y, 2007, J FOOD PROTECT, V70, P300, DOI 10.4315/0362-028X-70.2.300; Kormutakova R, 2000, BIOMETALS, V13, P135, DOI 10.1023/A:1009272122989; Kudva IT, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-48; Kudva IT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-103; Li H, 2017, J MASS SPECTROM, V52, P319, DOI 10.1002/jms.3932; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Mei GY, 2015, INT J FOOD MICROBIOL, V215, P7, DOI 10.1016/j.ijfoodmicro.2015.07.029; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Murashko ON, 2017, P NATL ACAD SCI USA, V114, pE8025, DOI 10.1073/pnas.1703731114; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Njoroge JW, 2012, MBIO, V3, DOI 10.1128/mBio.00280-12; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Otto A, 2014, PROTEOMICS, V14, P547, DOI 10.1002/pmic.201300403; Otto A, 2012, CURR OPIN MICROBIOL, V15, P364, DOI 10.1016/j.mib.2012.02.005; Pieper R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026554; RAWLINGS M, 1992, J BIOL CHEM, V267, P5751; Ribeiro CBA, 2013, GENET MOL RES, V12, P4909, DOI 10.4238/2013.October.24.1; Rivas M, 2010, PATHOGENIC ESCHERICH, P142; Sadiq SM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0020-2013; Scallan E, EMERG INFECT DIS, V117, P7; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Sharma VK, 2016, PLOS ONE, V22; Singh R, 2015, J FOOD PROTECT, V78, P31, DOI 10.4315/0362-028X.JFP-13-529; Smirnova G, 2016, ARCH MICROBIOL, V198, P913, DOI 10.1007/s00203-016-1247-z; Stevens MP, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0007-2013; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Valkova D, 2007, CENT EUR J BIOL, V2, P182, DOI 10.2478/s11535-007-0019-9; Vidovic S, 2016, CRIT REV MICROBIOL, V42, P83, DOI 10.3109/1040841X.2014.889654; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Yan DP, 2013, CELL SIGNAL, V25, P1887, DOI 10.1016/j.cellsig.2013.05.020; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhou X, 2003, INFECT IMMUN, V71, P2120, DOI 10.1128/IAI.71.4.2120-2129.2003; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	66	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0208520	10.1371/journal.pone.0208520	http://dx.doi.org/10.1371/journal.pone.0208520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596662	gold, Green Published			2022-12-26	WOS:000454627200015
J	Habert, P; Bentatou, Z; Aldebert, P; Finas, M; Bartoli, A; Bal, L; Lalande, A; Rapacchi, S; Guye, M; Kober, F; Bernard, M; Jacquier, A				Habert, Paul; Bentatou, Zakarya; Aldebert, Philippe; Finas, Mathieu; Bartoli, Axel; Bal, Laurence; Lalande, Alain; Rapacchi, Stanislas; Guye, Maxime; Kober, Frank; Bernard, Monique; Jacquier, Alexis			Exercise stress CMR reveals reduced aortic distensibility and impaired right-ventricular adaptation to exercise in patients with repaired tetralogy of Fallot	PLOS ONE			English	Article							PULMONARY VALVE-REPLACEMENT; CONGENITAL HEART-DISEASE; RATE-PRESSURE PRODUCT; PHYSICAL-EXERCISE; STROKE VOLUME; ARTERIAL STIFFNESS; ASCENDING AORTA; CARDIAC MRI; REGURGITATION; TREADMILL	Background The aim of our study was to evaluate the feasibility of exercise cardiac magnetic resonance (CMR) in patients with repaired tetralogy of Fallot (RTOF) and to assess right and left ventricular adaptation and aortic wall response to exercise in comparison with volunteers. Methods 11 RTOF and 11 volunteers underwent prospective CMR at rest and during exercise. A supine bicycle ergometer was employed to reach twice the resting heart rate during continuous exercise, blood pressure and heart rate were recorded. Bi-ventricular parameters and aortic stiffness were assessed using accelerated cine sequences and flow-encoding CMR. A t-test was used to compare values between groups. A Mann Whitney test was used to compare values within groups. Results In RTOF both ventricles showed an impaired contractile reserve (RVEF rest 36.2 +/- 8.3%, +1.3 +/- 3.9% increase after exercise; LVEF rest 53.8 +/- 6.1%, +5.7 +/- 6.4% increase after exercise) compared to volunteers (RVEF rest 50.5 +/- 5.0%, +10.4 +/- 7.1% increase after exercise, p = 0.039; LVEF rest 61.9 +/- 3.1%, +12.2 +/- 4.7% increase after exercise, p = 0.014). RTOF showed a reduced distensibility of the ascending aorta during exercise compared to volunteers (RTOF: 3.4 +/- 1.9 10-3.mmHg(-1)vs volunteers: 5.1 +/- 1.4 10-3.mmHg(-1); p = 0.027). Ascending aorta distensibility was correlated to cardiac work in the volunteers but not in RTOF. Conclusion RTOF showed an impaired contractile reserve for both ventricles. The exercise unmasked a reduced distensibility of the ascending aorta in RTOF, which may be an early sign of increased aortic rigidity.	[Habert, Paul; Bentatou, Zakarya; Aldebert, Philippe; Finas, Mathieu; Bal, Laurence; Rapacchi, Stanislas; Guye, Maxime; Kober, Frank; Bernard, Monique; Jacquier, Alexis] Aix Marseille Univ, CNRS, CRMBM, Marseille, France; [Habert, Paul; Bartoli, Axel; Jacquier, Alexis] La Timone Hosp, Dept Radiol & Cardiovasc Imaging, Marseille, France; [Aldebert, Philippe] La Timone Hosp, Dept Cardiol, Marseille, France; [Aldebert, Philippe] La Timone Hosp, Dept Infect Dis, Marseille, France; [Bal, Laurence] La Timone Hosp, Dept Vasc Surg & Vasc Med, Marseille, France; [Lalande, Alain] Univ Burgundy, LE2I, UMR CNRS 6306, Dijon, France; [Lalande, Alain] Univ Hosp Dijon, MRI Dept, Dijon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Bourgogne; CHU Dijon Bourgogne	Habert, P (corresponding author), Aix Marseille Univ, CNRS, CRMBM, Marseille, France.; Habert, P (corresponding author), La Timone Hosp, Dept Radiol & Cardiovasc Imaging, Marseille, France.	paul.habert@ap-hm.fr	Rapacchi, Stanislas Pierre Alain/AAA-6401-2020; Kober, Frank/L-8737-2013; Lalande, Alain/T-1050-2017; Jacquier, Alexis/ABD-6454-2020; BERNARD, Monique/Q-7254-2017	Rapacchi, Stanislas Pierre Alain/0000-0002-8925-495X; Kober, Frank/0000-0002-7869-3615; BERNARD, Monique/0000-0002-3179-8698; Lalande, Alain/0000-0002-7970-366X	Direction generale de l'offre de soin (DGOS); Hospital Clinical Research Programme [2014-A00354-43]	Direction generale de l'offre de soin (DGOS); Hospital Clinical Research Programme	The funds allocated for this study were allowed as part of a hospital clinical research program no 2014-A00354-43 to AJ. This is a public fund from the Direction generale de l'offre de soin (DGOS), which depends on the ministry of health.; We would like to thank the Hospital Clinical Research Programme 2014-A00354-43 for enrolling the patients, for a study named: "Evaluation des facteurs predictifs du remodelage ventriculaire droit et gauche apres remplacement valvulaire pulmonaire dans une population de patients operes d'une tetralogie de Fallot".	Bal-Theoleyre L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157704; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Beier J, 1996, INT J CARDIOL, V53, P179, DOI 10.1016/0167-5273(95)02524-3; BERGER HJ, 1981, NEW ENGL J MED, V305, P799, DOI 10.1056/NEJM198110013051405; Bergovec M, 1993, Int J Card Imaging, V9, P39, DOI 10.1007/BF01142931; BEVEGARD S, 1960, ACTA PHYSIOL SCAND, V49, P279, DOI 10.1111/j.1748-1716.1960.tb01953.x; Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0; CARVALHO JS, 1992, BRIT HEART J, V67, P470; Chong WY, 2006, AM J CARDIOL, V97, P905, DOI 10.1016/j.amjcard.2005.09.141; Claessen G, 2014, MED SCI SPORT EXER, V46, P1717, DOI 10.1249/MSS.0000000000000282; Conte S, 1999, EUR J CARDIO-THORAC, V15, P143, DOI 10.1016/S1010-7940(98)00306-6; Davlouros PA, 2004, INT J CARDIOL, V97, P91, DOI 10.1016/j.ijcard.2004.08.013; Duppen N, 2015, CIRC-CARDIOVASC IMAG, V8, P63, DOI [10.1016/j.mri.2009.07.001, DOI 10.1016/J.MRI.2009.07.001]; Eyskens B, 2000, AM J CARDIOL, V85, P221, DOI 10.1016/S0002-9149(99)00640-2; Feltes TF, 2011, CIRCULATION, V123, P2607, DOI 10.1161/CIR.0b013e31821b1f10; Foster EL, 2012, MAGN RESON MED, V67, P880, DOI 10.1002/mrm.23059; Frigiola A, 2013, CIRCULATION, V128, P1861, DOI 10.1161/CIRCULATIONAHA.113.001600; Gerche A. L., 2013, CIRCULATION CARDIOVA, V6, P329, DOI DOI 10.1161/CIRCIMAGING.112.980037; Geva T, 2013, CIRCULATION, V128, P1855, DOI 10.1161/CIRCULATIONAHA.113.005878; Geyer L, 2011, J CARDIOVASC MAGN R, V13, pP29; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Groenink M, 2001, RADIOLOGY, V219, P535, DOI 10.1148/radiology.219.2.r01ma01535; HELBING WA, 1995, AM J CARDIOL, V76, P589, DOI 10.1016/S0002-9149(99)80161-1; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; Hui SC, 2000, MED SCI SPORT EXER, V32, P1520, DOI 10.1097/00005768-200008000-00023; ILBAWI MN, 1987, J THORAC CARDIOV SUR, V93, P36; Jekic M, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-3; JONSSON H, 1995, J THORAC CARDIOV SUR, V110, P416, DOI 10.1016/S0022-5223(95)70238-5; Kalff V, 2014, J NUCL CARDIOL, V21, P400, DOI 10.1007/s12350-013-9850-8; Knauth AL, 2008, HEART, V94, P211, DOI 10.1136/hrt.2006.104745; KONDO C, 1991, AM J ROENTGENOL, V157, P9, DOI 10.2214/ajr.157.1.2048544; Lalande A, 2008, J MAGN RESON IMAGING, V28, P1180, DOI 10.1002/jmri.21565; Lapierre C, 2016, DIAGN INTERV IMAG, V97, P531, DOI 10.1016/j.diii.2016.01.009; Le TT, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0322-1; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Moro PJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-54; MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901; Naeije R, 2013, AM J RESP CRIT CARE, V187, P576, DOI 10.1164/rccm.201211-2090CI; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Ohyama Y, 2016, EUR HEART J-CARD IMG, V17, P1044, DOI 10.1093/ehjci/jev332; Ohyama Y, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004426; Parish V, 2013, INT J CARDIOL, V166, P96, DOI 10.1016/j.ijcard.2011.10.142; POLINER LR, 1980, CIRCULATION, V62, P528, DOI 10.1161/01.CIR.62.3.528; Raman SV, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003811; Raman SV, 2008, J AM COLL CARDIOL, V52, P1884, DOI 10.1016/j.jacc.2008.08.046; REBERGEN SA, 1993, CIRCULATION, V88, P2257, DOI 10.1161/01.CIR.88.5.2257; Redheuil A, 2011, J AM COLL CARDIOL, V58, P1262, DOI 10.1016/j.jacc.2011.06.012; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; REDUTO LA, 1980, AM J CARDIOL, V45, P1013, DOI 10.1016/0002-9149(80)90170-8; Roest AAW, 2003, RADIOLOGY, V226, P278, DOI 10.1148/radiol.2261011164; Roest AAW, 2002, RADIOLOGY, V223, P204, DOI 10.1148/radiol.2231010924; Roest AAW, 2001, AM J CARDIOL, V87, P601, DOI 10.1016/S0002-9149(00)01438-7; Rogers T, 2014, CHEST, V145, P30, DOI 10.1378/chest.13-1759; Rose JL, 2010, MAGN RESON IMAGING, V28, P255, DOI 10.1016/j.mri.2009.07.001; Rose JL, 2005, COMPUT CARDIOL, V32, P411; Rutz T, 2012, AM J CARDIOL, V110, P103, DOI 10.1016/j.amjcard.2012.02.055; SHAHER RM, 1983, ANN THORAC SURG, V35, P421, DOI 10.1016/S0003-4975(10)61595-0; Singh GK, 1998, AM J CARDIOL, V81, P1378, DOI 10.1016/S0002-9149(98)00171-4; Stohr EJ, 2011, AM J PHYSIOL-HEART C, V301, pH478, DOI 10.1152/ajpheart.00314.2011; Tan JL, 2005, CIRCULATION, V112, P961, DOI 10.1161/CIRCULATIONAHA.105.537928; Thavendiranathan P, 2014, J MAGN RESON IMAGING, V39, P1146, DOI 10.1002/jmri.24263; Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X; Vaujois L, 2016, DIAGN INTERV IMAG, V97, P549, DOI 10.1016/j.diii.2016.02.007; Wald RM, 2009, CIRCULATION, V119, P1370, DOI 10.1161/CIRCULATIONAHA.108.816546; Weber TF, 2011, EUR J RADIOL, V80, P103, DOI 10.1016/j.ejrad.2010.06.045; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	66	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0208749	10.1371/journal.pone.0208749	http://dx.doi.org/10.1371/journal.pone.0208749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596647	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200021
J	Kim, EJ; Nam, YK				Kim, Eun Jeong; Nam, Yoon Kwon			Anesthetic protocol for microinjection-related handling of Siberian sturgeon (Acipenser baerii; Acipenseriformes) prolarvae	PLOS ONE			English	Article							TRICAINE METHANESULFONATE; CLOVE OIL; EFFICACY; EUGENOL; MS-222; EUTHANASIA; MS222; CELLS	An anesthetic protocol was optimized for microinjection-related handling of Siberian sturgeon (Acipenser baerii; Acipenseriformes) prolarvae, an extant primitive fish species commonly grown in aquaculture. Comparative examinations of three selected anesthetics (clove oil, lidocaine, and MS-222) with a dosage regime of 50, 100, 200, and 400 mg/L indicated that MS-222 was the most efficient agent for Siberian sturgeon prolarvae, as evidenced by the fast induction of anesthesia with quick and uniform recovery. Meanwhile, clove oil should be avoided, due to prolonged recovery times varying widely between individuals. None of the tested anesthetics significantly affected prolarval viability at any of the dosage regimes tested in this study. Based on an analysis of the duration of an unconscious state in air, we recommend a dose of 200 mg/L MS-222 for microinjection. Recovery time after use of this dose was influenced by the prolarval age and the development of gills, in which prolarvae older than 3 days after hatching required longer recovery times than did younger prolarvae. Post-recovery behavioral assessment showed no apparent difference between MS-222-anesthetized and non-anesthetized prolarvae in their swimming behavior and phototactic responses. Applicability of currently developed anesthetic protocol using MS-222 in larval microinjection was demonstrated with the injection of a visible dye to the anesthetized prolarvae, followed by the analysis of post-recovery viability. Taken together, the present anesthetic protocol based on 200 mg/L of MS-222 could provide researchers with practical usefulness with good safety margins for the micromanipulation and other related handlings of Siberian sturgeon prolarvae.	[Kim, Eun Jeong; Nam, Yoon Kwon] Pukyong Natl Univ, Dept Marine Biomat & Aquaculture, Busan, South Korea	Pukyong National University	Nam, YK (corresponding author), Pukyong Natl Univ, Dept Marine Biomat & Aquaculture, Busan, South Korea.	yoonknam@pknu.ac.kr			Korea Institute of Marine Science & Technology (KIMST) - Ministry of Oceans and Fisheries [20170327]	Korea Institute of Marine Science & Technology (KIMST) - Ministry of Oceans and Fisheries	This research was supported by the grant from the Korea Institute of Marine Science & Technology (KIMST) funded by the Ministry of Oceans and Fisheries (Project #20170327) to Yoon Kwon Nam.; This research was supported by the grant from the Korea Institute of Marine Science & Technology (KIMST) funded by the Ministry of Oceans and Fisheries (20170327). Authors thanks Dr. Chulhong Park for his assistance on the artificial breeding of sturgeon broodfish.	Akbulut B, 2012, TURK J FISH AQUAT SC, V12, P667, DOI 10.4194/1303-2712-v12_3_15; Akbulut B, 2011, TURK J FISH AQUAT SC, V11, P463, DOI 10.4194/1303-2712-v11_3_17; Astin JW, 2017, METHOD CELL BIOL, V138, P31, DOI 10.1016/bs.mcb.2016.08.002; Baldisserotto B, 2018, VET ANAESTH ANALG, V45, P48, DOI 10.1016/j.vaa.2017.08.009; Cho YS, 2007, COMP BIOCHEM PHYS B, V147, P178, DOI 10.1016/j.cbpb.2007.01.001; Collymore C, 2016, J AM ASSOC LAB ANIM, V55, P816; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Di Marco P, 2011, J APPL ICHTHYOL, V27, P611, DOI 10.1111/j.1439-0426.2011.01701.x; Ellett F, 2017, ZEBRAFISH, V14, P140, DOI 10.1089/zeb.2016.1402; Falahatkar B, 2017, AQUAC RES, V48, P4578, DOI 10.1111/are.13084; Feng G, 2011, J APPL ICHTHYOL, V27, P595, DOI 10.1111/j.1439-0426.2011.01711.x; Gisbert E, 2003, ENVIRON BIOL FISH, V67, P311, DOI 10.1023/A:1025851502232; Gisbert E, 1999, J APPL ICHTHYOL, V15, P237, DOI 10.1111/j.1439-0426.1999.tb00242.x; Gisbert E., 2018, SIBERIAN STURGEON AC, P131; Gisbert E., 2018, SIBERIAN STURGEON AC, P159; Gomulka P, 2008, ACTA VET BRNO, V77, P447, DOI 10.2754/avb200877030447; Hoseini SM, 2015, AQUAC RES, V46, P405, DOI 10.1111/are.12188; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Kim DS, 2005, ICHTHYOL RES, V52, P94, DOI 10.1007/s10228-004-0257-z; MARKING LL, 1985, FISHERIES, V10, P2, DOI 10.1577/1548-8446(1985)010<0002:ABANIF>2.0.CO;2; MARKOWITZ K, 1992, ORAL SURG ORAL MED O, V73, P729, DOI 10.1016/0030-4220(92)90020-Q; Martins T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197846; Matsche MA, 2011, J APPL ICHTHYOL, V27, P600, DOI 10.1111/j.1439-0426.2011.01714.x; Nordgreen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092116; Park Chulhong, 2013, Fisheries and Aquatic Sciences, V16, P15, DOI 10.5657/FAS.2013.0015; Park Chulhong, 2013, Fisheries and Aquatic Sciences, V16, P25, DOI 10.5657/FAS.2013.0025; Park IS, 2011, LAB ANIMAL, V40, P45, DOI 10.1038/laban0211-45; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Psenicka M, 2015, THERIOGENOLOGY, V83, P1085, DOI 10.1016/j.theriogenology.2014.12.010; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Robles V, 2017, AQUACULTURE, V472, P4, DOI 10.1016/j.aquaculture.2016.03.004; Rombough PJ, 2007, COMP BIOCHEM PHYS A, V148, P463, DOI 10.1016/j.cbpa.2007.06.415; Ronnestad I, 2000, FISH PHYSIOL BIOCHEM, V22, P225, DOI 10.1023/A:1007801510056; Roubach R, 2005, AQUAC RES, V36, P1056, DOI 10.1111/j.1365-2109.2005.01319.x; Saito T, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128314; Samaee SM, 2017, ZEBRAFISH, V14, P581, DOI 10.1089/zeb.2017.1425; Skar MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179344; Strykowski JL, 2015, J AM ASSOC LAB ANIM, V54, P81; Taylor PW, 1999, N AM J AQUACULT, V61, P150, DOI 10.1577/1548-8454(1999)061<0150:COAAAF>2.0.CO;2; Tonelli FMP, 2017, BIOTECHNOL ADV, V35, P832, DOI 10.1016/j.biotechadv.2017.06.002; Trifonov VA, 2016, CHROMOSOMA, V125, P661, DOI 10.1007/s00412-016-0609-2; Valentim AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147747; Wanner GA, 2006, N AM J FISH MANAGE, V26, P587, DOI 10.1577/M05-090.1; Webb MAH, 2011, GEN COMP ENDOCR, V170, P313, DOI 10.1016/j.ygcen.2010.11.024; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209928	10.1371/journal.pone.0209928	http://dx.doi.org/10.1371/journal.pone.0209928			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596742	Green Submitted, gold, Green Published			2022-12-26	WOS:000454627200109
J	Seo, N; Chung, YE; An, C; Choi, JY; Park, MS; Kim, MJ				Seo, Nieun; Chung, Yong Eun; An, Chansik; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin			Feasibility of radiation dose reduction with iterative reconstruction in abdominopelvic CT for patients with inappropriate arm positioning	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; IMAGE QUALITY; COMPUTED-TOMOGRAPHY; ABDOMINAL CT; TRAUMA CT; ALGORITHM; STANDARD; IMPACT; SIZE	Background The arms-down position increases computed tomography (CT) radiation dose. Iterative reconstruction (IR) could enhance image quality without increasing radiation dose in patients with arms-down position. Aim To investigate the feasibility of reduced-dose CT with IR for patients with inappropriate arm positioning Methods Twenty patients who underwent two-phase abdominopelvic CT including standard-dose and reduced-dose CT (performed with 80% of the radiation dose of the standard protocol) with their arms positioned in the abdominal area were included in this study. Reduced-dose CT images were reconstructed using filtered back projection (FBP), hybrid IR, and iterative model reconstruction (IMR). These images were compared with standard-dose CT images reconstructed with FBP. Objective image noise in the liver and subcutaneous fat was measured by standard deviation for the quantitative analysis. Then, two radiologists qualitatively assessed beam hardening artifacts, artificial texture, noise, sharpness, and overall image quality in consensus. Results Reduced-dose CT with all IR levels had lower objective image noise compared to standard-dose CT with FBP reconstruction (P < 0.05). Quantitatively measured beam hardening artifacts were similar in reduced-dose CT with iDose levels 5-6 and fewer with IMR compared to standard-dose CT. In the qualitative analysis, beam hardening artifacts and noise decreased as the IR levels increased. However, artificial texture was significantly aggravated with iDose 5-6 and IMR, and overall image quality significantly worsened with IMR. Conclusions IR algorithms can reduce beam hardening artifacts in a reduced-dose CT setting in patients with arms-down position, and an intermediate level of hybrid IR allows radiologists to obtain the best image quality. Because the retrospective and single-center nature of our study limited the number of patients, multicenter prospective clinical studies are required to validate our results.	[Seo, Nieun; Chung, Yong Eun; An, Chansik; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin] Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Dept Radiol, Seoul, South Korea.	yelv@yuhs.ac	An, Chansik/Z-1632-2019; Kim, Myeong-Jin/E-1623-2011	Choi, Jin-Young/0000-0002-9025-6274; Chung, Yong Eun/0000-0003-0811-9578; Kim, Myeong-Jin/0000-0001-7949-5402; Seo, Nieun/0000-0001-8745-6454; Park, Mi-Suk/0000-0001-5817-2444; An, Chansik/0000-0002-0484-6658	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2014R1A1A2057091]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2014R1A1A2057091) to YEC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2014R1A1A2057091).	Bayer J, 2011, J TRAUMA, V70, P900, DOI 10.1097/TA.0b013e3181edc80e; Benneker LM, 2007, EMERG RADIOL, V13, P349, DOI 10.1007/s10140-007-0577-1; Brink M, 2008, RADIOLOGY, V249, P661, DOI 10.1148/radiol.2492080169; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Habets J, 2012, INT J CARDIOVAS IMAG, V28, P2099, DOI 10.1007/s10554-012-0041-5; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Jeong S, 2015, AM J ROENTGENOL, V204, P307, DOI 10.2214/AJR.14.12745; Kahn J, 2014, EUR J RADIOL, V83, pE67, DOI 10.1016/j.ejrad.2013.10.002; Kalra MK, 2005, CURR PROBL DIAGN RAD, V34, P171, DOI 10.1067/j.cpradiol.2005.06.002; Karlo C, 2011, EMERG RADIOL, V18, P285, DOI 10.1007/s10140-011-0948-5; Lambert L, 2017, ONCOL LETT, V13, P2490, DOI 10.3892/ol.2017.5723; Laqmani A, 2016, EUR J RADIOL, V85, P1971, DOI 10.1016/j.ejrad.2016.09.001; Linsenmaier U, 2002, EUR RADIOL, V12, P1728, DOI 10.1007/s00330-001-1225-x; McCollough Cynthia, 2014, AAPM Rep, V2014, P6; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; Mehta D., 2013, MED PHYS INT, V1, P147; Nelson RC, 2011, J CARDIOVASC COMPUT, V5, P286, DOI 10.1016/j.jcct.2011.07.001; Park M, 2014, INVEST RADIOL, V49, P195, DOI 10.1097/RLI.0000000000000014; Pickhardt PJ, 2012, AM J ROENTGENOL, V199, P1266, DOI 10.2214/AJR.12.9382; Rizzo S, 2006, AM J ROENTGENOL, V186, P673, DOI 10.2214/AJR.04.1513; Scibelli A., 2011, IDOSE4 ITERATIVE REC; Shin HJ, 2013, KOREAN J RADIOL, V14, P886, DOI 10.3348/kjr.2013.14.6.886; Song JS, 2015, RADIOL MED, V120, P259, DOI 10.1007/s11547-014-0441-9; Sucha D, 2014, INT J CARDIOVAS IMAG, V30, P785, DOI 10.1007/s10554-014-0379-y; Taylor S, 2017, EUR RADIOL, V27, P365, DOI 10.1007/s00330-016-4333-3; Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; Yasaka K, 2017, ACTA RADIOL, V58, P1085, DOI 10.1177/0284185116684675; Yoon JH, 2014, J COMPUT ASSIST TOMO, V38, P859, DOI 10.1097/RCT.0000000000000145; Yuki H, 2016, ACTA RADIOL, V57, P295, DOI 10.1177/0284185115575537	29	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209754	10.1371/journal.pone.0209754	http://dx.doi.org/10.1371/journal.pone.0209754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596739	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200078
J	Bayliss, M; Trotman-Lucas, M; Janus, J; Kelly, ME; Gibson, CL				Bayliss, Michaela; Trotman-Lucas, Melissa; Janus, Justyna; Kelly, Michael E.; Gibson, Claire L.			Pre-stroke surgery is not beneficial to normotensive rats undergoing sixty minutes of transient focal cerebral ischemia	PLOS ONE			English	Article							ARTERY OCCLUSION; ANIMAL-MODELS; TEMPORAL EVOLUTION; INJURY; WISTAR; EDEMA; TRANSLATION; SENSITIVITY; INFARCTION; PLATFORM	Experimental stroke in rodents, via middle cerebral artery occlusion (MCAO), can be associated with a negative impact on wellbeing and mortality. In hypertensive rodents, pre-stroke craniotomy increased survival and decreased body weight loss post-MCAO. Here we determined the effect, in normotensive Sprague-Dawley rats following 60 minutes MCAO, with or without pre-surgical craniotomy, on post-stroke outcomes in terms of weight loss, neurological deficit, lesion volume and functional outcomes. There was no effect of pre-stroke craniotomy on indicators of wellbeing including survival rate (P = 0.32), body weight loss (P = 0.42) and neurological deficit (P = 0.75). We also assessed common outcome measures following experimental stroke and found no effect of pre-stroke craniotomy on lesion volume as measured by T2-weighted MRI (P = 0.846), or functional performance up to 28 days post-MCAO (staircase test, P = 0.32; adhesive sticker test, P = 0.49; cylinder test, P = 0.38). Thus, pre-stroke craniotomy did not improve animal welfare in terms of body weight loss and neurological deficit. However, it is important, given that a number of drug delivery studies utilise the craniotomy procedure, to note that there was no effect on lesion volume or functional outcome following experimental stroke.	[Bayliss, Michaela; Trotman-Lucas, Melissa; Gibson, Claire L.] Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England; [Janus, Justyna; Kelly, Michael E.] Univ Leicester, Preclin Imaging Facil, Core Biotechnol Serv, Leicester, Leics, England	University of Leicester; University of Leicester	Gibson, CL (corresponding author), Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England.	claire.gibson@nottingham.ac.uk	trotman-lucas, melissa/Y-5096-2019	trotman-lucas, melissa/0000-0002-7735-7476; Bayliss, Michaela/0000-0003-2375-6890; Gibson, Claire/0000-0002-3358-7341	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/M001768/1]	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	This work was supported by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs; NC/M001768/1 to CG and MK).	Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Aspey BS, 2000, NEUROPATH APPL NEURO, V26, P232, DOI 10.1046/j.1365-2990.2000.00221.x; Carswell HVO, 2000, AM J PHYSIOL-HEART C, V278, pH290, DOI 10.1152/ajpheart.2000.278.1.H290; Carswell HVO, 1999, HYPERTENSION, V33, P681, DOI 10.1161/01.HYP.33.2.681; COYLE P, 1983, STROKE, V14, P605, DOI 10.1161/01.STR.14.4.605; Dirnagl U, 2014, STROKE, V45, P1510, DOI 10.1161/STROKEAHA.113.004075; Dogan A, 1998, NEUROL RES, V20, P265; du Sert NP, 2017, J CEREBR BLOOD F MET, V37, P3488, DOI 10.1177/0271678X17709185; DUVERGER D, 1988, J CEREBR BLOOD F MET, V8, P449, DOI 10.1038/jcbfm.1988.86; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hoehn M, 2001, J MAGN RESON IMAGING, V14, P491, DOI 10.1002/jmri.1213; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Jiang Q, 1997, J NEUROL SCI, V145, P15, DOI 10.1016/S0022-510X(96)00286-9; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kreuter J., ADV DRUG DELIV REV, V23, P65; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Li FH, 2000, NEUROLOGY, V54, P689, DOI 10.1212/WNL.54.3.689; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; O'Collins VE, 2013, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, P531, DOI 10.1016/B978-0-12-415894-8.00023-3; Ord ENJ, 2012, J NEUROSCI METH, V211, P305, DOI 10.1016/j.jneumeth.2012.09.001; Rhim T, 2013, PHARM RES-DORDR, V30, P2429, DOI 10.1007/s11095-012-0959-2; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Trotman-Lucas M, 2017, DIS MODEL MECH, V10, P931, DOI 10.1242/dmm.029108; Walberer M, 2006, LAB ANIM-UK, V40, P1, DOI 10.1258/002367706775404426; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wardlaw J M, 2003, Cochrane Database Syst Rev, pCD000213	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209370	10.1371/journal.pone.0209370	http://dx.doi.org/10.1371/journal.pone.0209370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592760	Green Published, Green Submitted, gold			2022-12-26	WOS:000454621900023
J	Guarino, S; Arif, MA; Millar, JG; Colazza, S; Peri, E				Guarino, Salvatore; Arif, Mokhtar Abdulsattar; Millar, Jocelyn G.; Colazza, Stefano; Peri, Ezio			Volatile unsaturated hydrocarbons emitted by seedlings of Brassica species provide host location cues to Bagrada hilaris	PLOS ONE			English	Article							INVASIVE STINK BUG; WEEVIL CEUTORHYNCHUS-ASSIMILIS; PHEROMONE-BAITED TRAPS; HEMIPTERA-PENTATOMIDAE; ANTIFUNGAL ACTIVITY; FEEDING DAMAGE; OILSEED RAPE; HETEROPTERA; BEHAVIOR; IMPACT	Bagrada hilaris Burmeister, is a stink bug native to Asia and Africa and invasive in the United States, Mexico, and more recently, South America. This species can cause serious damage to various vegetable crops in the genus Brassica, with seedlings being particularly susceptible to B. hilaris feeding activity. In this study, the role of volatile organic compounds (VOCs) emitted by seedlings of three Brassica species on the host preference of B. hilaris was evaluated. In dual choice arena and olfactometer bioassays, adult painted bugs preferred B. oleracea var. botrytis and B. napus over B. carinata. Volatiles from B. oleracea seedlings were collected and bioassayed with B. hilaris adults and late stage nymphs, using electroantennographic (EAG) and behavioral (olfactometer) techniques. When crude extracts of the VOCs from B. oleracea var. botrytis seedlings and liquid chromatography fractions thereof were bioassayed, B. hilaris adults and nymphs were attracted to the crude extract, and to a non-polar fraction containing hydrocarbons, whereas there were no responses to the more polar fractions. GC-MS analysis indicated that the main constituents of the non-polar fraction was an as yet unidentified diterpene hydrocarbon, with trace amounts of several other diterpene hydrocarbons. The major diterpene occurred in VOCs from both of the preferred host plants B. oleracea and B. napus, but not in VOCs of B. carinata. Our results suggest that this diterpene, alone or in combination with one or more of the minor compounds, is a key mediator in this insect-plant interaction, and could be a good candidate for use in lures for monitoring B. hilaris in the field.	[Guarino, Salvatore; Arif, Mokhtar Abdulsattar; Colazza, Stefano; Peri, Ezio] Univ Palermo, Dipartimento Sci Agr Alimentari & Forestali, Palermo, Italy; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of Palermo; University of California System; University of California Riverside	Guarino, S (corresponding author), Univ Palermo, Dipartimento Sci Agr Alimentari & Forestali, Palermo, Italy.	salvatore.guarino@unipa.it	Guarino, Salvatore/AAH-4217-2020; Arif, Mokhtar Abdulsattar/AAC-9652-2021	Arif, Mokhtar Abdulsattar/0000-0003-0945-8811; Guarino, Salvatore/0000-0001-6670-3997; colazza, stefano/0000-0001-8023-7814; Millar, Jocelyn/0000-0001-7639-9001	Iraqi Government; Italian Ministry of Foreign Affairs (MAE)	Iraqi Government; Italian Ministry of Foreign Affairs (MAE)(Ministry of Foreign Affairs and International Cooperation (Italy))	The authors thank Rosario Cappadona of the Cooperative of Caper Producers of Pantelleria and Erik Vallini and Gabriele Lasagni of Bonomo and Giglio Srl for their helpful assistance during the collection of insects in the field. Part of this work was made under the Project "High Studies Programme (Master and Ph.D.) for Iraqi officials at Italian Academic Institutions (HiS-Pro)" supported by the Iraqi Government and the Italian Ministry of Foreign Affairs (MAE).	Badenes-Perez FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095766; Barker AM, 2006, CHEMOECOLOGY, V16, P209, DOI 10.1007/s00049-006-0349-5; BARTLET E, 1993, ENTOMOL EXP APPL, V68, P295, DOI 10.1007/BF02380783; Beran F, 2014, P NATL ACAD SCI USA; Bi YH, 2016, J AGR FOOD CHEM, V64, P8525, DOI 10.1021/acs.jafc.6b03645; Blight MM, 1995, J CHEM ECOL, V21, P1649, DOI 10.1007/BF02033667; Boege K, 2005, OECOLOGIA, V143, P117, DOI 10.1007/s00442-004-1779-9; Borges M, 2011, J APPL ENTOMOL, V135, P68, DOI 10.1111/j.1439-0418.2010.01507.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Bruinsma M, 2009, J EXP BOT, V60, P2575, DOI 10.1093/jxb/erp101; Bundy C.S., 2018, INVASIVE STINK BUGS, P205, DOI DOI 10.1201/9781315371221-3; Bundy CS, 2012, SOUTHWEST ENTOMOL, V37, P411, DOI 10.3958/059.037.0317; Carrasco D, 2015, CURR OPIN INSECT SCI, V8, P1, DOI 10.1016/j.cois.2015.01.014; Chabaane Y, 2015, J ECOL, V103, P109, DOI 10.1111/1365-2745.12304; Chen XQ, 2017, J AGR FOOD CHEM, V65, P4456, DOI 10.1021/acs.jafc.7b01500; Conti E, 2008, EUROPEAN J ENTOMOLOG, V105; Csonka Eva, 2007, Acta Phytopathologica et Entomologica Hungarica, V42, P343, DOI 10.1556/APhyt.42.2007.2.16; Cullen EM, 2006, ENTOMOL EXP APPL, V119, P163, DOI 10.1111/j.1570-7458.2006.00407.x; FRAENKEL G, 1969, ENTOMOL EXP APPL, V12, P473, DOI 10.1007/BF00297079; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; GUARINO S, 2017, STINKBUGS BIORATIONA, P180; Guarino S, 2008, EUR J ENTOMOL, V105, P613, DOI 10.14411/eje.2008.082; Guarino S, 2017, ARTHROPOD-PLANT INTE, V11, P649, DOI 10.1007/s11829-017-9516-6; Himanen SJ, 2017, VOLATILE ORGANIC COM; Hua J, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700327; Huang TI, 2014, CROP PROT, V59, P7, DOI 10.1016/j.cropro.2014.01.007; Huang TI, 2014, ARTHROPOD-PLANT INTE, V8, P89, DOI 10.1007/s11829-014-9289-0; ISMAN MB, 1977, J CHEM ECOL, V3, P613, DOI 10.1007/BF00988061; Torres-Acosta RI, 2017, SOUTHWEST ENTOMOL, V42, P919, DOI 10.3958/059.042.0332; Joseph SV, 2017, ARTHROPOD-PLANT INTE, V11, P577, DOI 10.1007/s11829-017-9501-0; Koga J, 1997, PHYTOCHEMISTRY, V44, P249, DOI 10.1016/S0031-9422(96)00534-1; Leskey TC, 2015, ENVIRON ENTOMOL, V44, P746, DOI 10.1093/ee/nvv049; Ludwig SW, 2001, CROP PROT, V20, P247, DOI 10.1016/S0261-2194(00)00150-2; McCormick AC, 2014, PLANT CELL ENVIRON, V37, P1836, DOI 10.1111/pce.12357; METCALF RL, 1987, CRIT REV PLANT SCI, V5, P251, DOI 10.1080/07352688709382242; Palumbo JC, 2010, PLANT HLTH PROG, P10; Palumbo JC, 2016, ANNU REV ENTOMOL, V61, P453, DOI 10.1146/annurev-ento-010715-023843; Rather Ajaz Hassan, 2010, Journal of Plant Protection Research, V50, P229, DOI 10.2478/v10045-010-0040-2; Reed DA, 2013, J INTEGR PEST MANAG, V4, pC1, DOI 10.1603/IPM13007; Rhoades D.F., 1979, HERBIVORES THEIR INT; Salah MA, 2003, J AGR FOOD CHEM, V51, P7607, DOI 10.1021/jf034682w; Sanchez-Pena SR, 2014, SOUTHWEST ENTOMOL, V39, P375, DOI 10.3958/059.039.0219; Schoonhoven L. M., 2005, Insect-plant biology; Vaughan MM, 2013, PLANT CELL; Wang Q, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01761; White WH, 1933, USDA FARMERS B, V1712, P1; Yamanaka T, 2011, AGR FOREST ENTOMOL, V13, P321, DOI 10.1111/j.1461-9563.2011.00521.x	49	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209870	10.1371/journal.pone.0209870	http://dx.doi.org/10.1371/journal.pone.0209870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589910	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200064
J	Renne, J; Gutberlet, M; Voskrebenzev, A; Kern, A; Kaireit, T; Hinrichs, J; Zardo, P; Warnecke, G; Kruger, M; Braubach, P; Jonigk, D; Haverich, A; Wacker, F; Vogel-Claussen, J; Zinne, N				Renne, Julius; Gutberlet, Marcel; Voskrebenzev, Andreas; Kern, Agilo; Kaireit, Till; Hinrichs, Jan; Zardo, Patrick; Warnecke, Gregor; Krueger, Marcus; Braubach, Peter; Jonigk, Danny; Haverich, Axel; Wacker, Frank; Vogel-Claussen, Jens; Zinne, Norman			Multiparametric MRI for organ quality assessment in a porcine Ex-Vivo lung perfusion system	PLOS ONE			English	Article							SEGMENTAL ALLERGEN CHALLENGE; DONOR LUNGS; FOURIER DECOMPOSITION; TRANSPLANTATION; QUANTIFICATION; INFLAMMATION; VENTILATION; REPRODUCIBILITY; PRESERVATION; STEROIDS	Introduction Ex-vivo lung perfusion (EVLP) is an emerging technique promising an expansion of the donor pool and improvements in the outcome after lung transplantation. Reliable biomarkers for local assessment of organ function in the EVLP system are intensely sought after. This study aims to evaluate the feasibility of multiparametric functional magnetic resonance imaging (fMRI) in an EVLP system in a porcine aspiration model. Material and methods Seven female pigs were anesthetized and gastric juice was instilled in the right lower lobe bronchus to simulate aspiration. Left lungs served as control. Lungs were removed and installed in a modified EVLP system. In the 12-hour EVLP run three sequential MRI scans were performed. Oxygen-washout time, Fourier Decomposition derived ventilation and perfusion, and dynamic contrast enhanced imaging derived perfusion were calculated. P-aO2: F-iO2 ratio was determined and correlated. End-point histology and computed tomography served as control. Results All animals completed the protocol. MRI structural images showed infiltrates in lungs after aspiration comparable to CT scans. Ventilation was significantly (p = 0.016) reduced while perfusion was increased (p = 0.016) in lungs after aspiration. Non-contrast dependent Fourier decomposition perfusion showed good correlation (R-2 = 0.67) to dynamic contrast enhanced derived perfusion. Oxygen washout time was significantly increased (p = 0.016) in lungs after aspiration and showed a correlation with the P-aO2:F-iO2 ratio (R-2 = 0.54). Conclusion Multiparametric fMRI for local assessment of organ function is feasible in EVLP and detects alterations in lung function following aspiration with correlation to clinical parameters. fMRI may improve organ assessment in ex-vivo perfusion systems, leading to a better selection of segments suitable for transplant.	[Renne, Julius; Gutberlet, Marcel; Voskrebenzev, Andreas; Kern, Agilo; Kaireit, Till; Hinrichs, Jan; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Dept Intervent & Diagnost Radiol, Hannover, Germany; [Renne, Julius; Gutberlet, Marcel; Voskrebenzev, Andreas; Hinrichs, Jan; Warnecke, Gregor; Braubach, Peter; Jonigk, Danny; Vogel-Claussen, Jens; Zinne, Norman] Integrated Res & Treatment Ctr Transplantat IfB T, Hannover, Germany; [Zardo, Patrick; Warnecke, Gregor; Krueger, Marcus; Haverich, Axel; Zinne, Norman] Hannover Med Sch, Clin Cardiothorac & Transplantat Surg, Hannover, Germany; [Braubach, Peter; Jonigk, Danny] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Wacker, Frank; Vogel-Claussen, Jens] German Ctr Lung Res, BREATH, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Renne, J (corresponding author), Hannover Med Sch, Dept Intervent & Diagnost Radiol, Hannover, Germany.; Renne, J (corresponding author), Integrated Res & Treatment Ctr Transplantat IfB T, Hannover, Germany.	renne.julius@mh-hannover.de	Kern, Agilo Luitger/AFR-7583-2022; Haverich, Axel/AAC-7552-2022; Vogel-Claussen, Jens/Q-3374-2019; Krüger, Marcus/C-4809-2019	Kern, Agilo Luitger/0000-0003-4157-9808; Kruger, Marcus/0000-0001-5250-5658; Vogel-Claussen, Jens/0000-0001-5595-6948	Federal ministry of education and research [HilF 79201004]; Deutsche Forschungsgemeinschaft (Cluster of Excellence REBIRTH, DFG EXC 62)	Federal ministry of education and research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (Cluster of Excellence REBIRTH, DFG EXC 62)	This work has been supported by the Federal ministry of education and research under the integrated research and treatment center transplantation (SU-B06), via start-up funding of the home university for young researchers (HilF 79201004), and by the Deutsche Forschungsgemeinschaft (Cluster of Excellence REBIRTH, DFG EXC 62, NZ and JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J CANCER RES CLIN, DOI DOI 10.1007/S00432-017-2521-4; Bauman G, 2009, MAGN RESON MED, V62, P656, DOI 10.1002/mrm.22031; Becker S, 2016, TRANSPL INT, V29, P88, DOI 10.1111/tri.12649; Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Egan TM, 2006, ANN THORAC SURG, V81, P1205, DOI 10.1016/j.athoracsur.2005.09.034; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Loor G, 2017, TRANSPLANTATION, V101, P2303, DOI 10.1097/TP.0000000000001616; Martens A, 2016, TRANSPL INT, V29, P1237, DOI 10.1111/tri.12823; Meers CM, 2011, J SURG RES, V170, pE141, DOI 10.1016/j.jss.2011.05.062; Meers CM, 2011, J SURG RES, V170, pE159, DOI 10.1016/j.jss.2011.05.015; Meers CM, 2011, J SURG RES, V166, pE175, DOI 10.1016/j.jss.2009.09.028; Meers CM, 2011, J SURG RES, V166, pE195, DOI 10.1016/j.jss.2010.10.015; Renne J, 2016, PNEUMOLOGIE, V70, P813, DOI 10.1055/s-0042-117747; Renne J, 2015, RADIOLOGY, V274, P267, DOI 10.1148/radiol.14132607; Renne J, 2015, J MAGN RESON IMAGING, V41, P60, DOI 10.1002/jmri.24535; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033; Valenza F, 2014, TRANSPL INT, V27, P553, DOI 10.1111/tri.12295; Verleden SE, 2017, AM J TRANSPLANT, V17, P1912, DOI 10.1111/ajt.14255; Vogel-Claussen J, 2014, AM J RESP CRIT CARE, V189, P650, DOI 10.1164/rccm.201310-1825OC; Vogl M, 2016, J HEART LUNG TRANSPL, V35, P1227, DOI 10.1016/j.healun.2016.05.024; Voskrebenzev A, 2018, MAGN RESON MED, V79, P2306, DOI 10.1002/mrm.26893; Voskrebenzev A, 2017, MAGN RESON MED, V78, P1496, DOI 10.1002/mrm.26526; Voskrebenzev A, 2016, MAGN RESON MED, V76, P1542, DOI 10.1002/mrm.26047; Wagner CE, 2016, J THORAC CARDIOV SUR, V151, P538, DOI 10.1016/j.jtcvs.2015.07.075; Warnecke G, 2012, LANCET, V380, P1851, DOI 10.1016/S0140-6736(12)61344-0; Wild JM, 2012, INSIGHTS IMAGING, V3, P345, DOI 10.1007/s13244-012-0176-x; Yeung JC, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015628; Yeung JC, 2012, J HEART LUNG TRANSPL, V31, P1120, DOI 10.1016/j.healun.2012.08.016; Zinne N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193168; Zollner FG, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0109-0	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209103	10.1371/journal.pone.0209103	http://dx.doi.org/10.1371/journal.pone.0209103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589907	Green Published, gold, Green Submitted			2022-12-26	WOS:000454418200015
J	Toptan, T; Brusadelli, MG; Turpin, B; Witte, DP; Surralles, J; Velleuer, E; Schramm, M; Dietrich, R; Brakenhoff, RH; Moore, PS; Chang, Y; Wells, SI				Toptan, Tuna; Brusadelli, Marion G.; Turpin, Brian; Witte, David P.; Surralles, Jordi; Velleuer, Eunike; Schramm, Martin; Dietrich, Ralf; Brakenhoff, Ruud H.; Moore, Patrick S.; Chang, Yuan; Wells, Susanne I.			Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; HEAD; MCV; SEROPREVALENCE; INFECTION; PHENOTYPE; TISSUES; PATHWAY; SEARCH; COMMON	Fanconi anemia is a rare genome instability disorder with extreme susceptibility to squamous cell carcinoma of the head and neck and anogenital tract. In patients with this inherited disorder, the risk of head and neck cancer is 800-fold higher than in the general population, a finding which might suggest a viral etiology. Here, we analyzed the possible contribution of human polyomaviruses to FA-associated head and neck squamous cell carcinoma (HNSCC) by a pan-polyomavirus immunohistochemistry test which detects the T antigens of all known human polyomaviruses. We observed weak reactivity in 17% of the HNSCC samples suggesting that based on classical criteria, human polyomaviruses are not causally related to squamous cell carcinomas analyzed in this study.	[Toptan, Tuna; Moore, Patrick S.; Chang, Yuan] Univ Pittsburgh, Hillman Canc Ctr, Pittsburgh, PA USA; [Brusadelli, Marion G.; Turpin, Brian; Wells, Susanne I.] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Witte, David P.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Pathol, Cincinnati, OH 45229 USA; [Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Dept Genet, Barcelona, Spain; [Surralles, Jordi] Univ Autonoma Barcelona, Biomed Res Inst, Hosp Santes Creus & St Pau, Barcelona, Spain; [Surralles, Jordi] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Velleuer, Eunike] Hosp Neuwerk Maria Aposteln, Dept Pediat, Monchengladbach, Germany; [Schramm, Martin] Heinrich Heine Univ, Inst Pathol, Dept Cytopathol, Dusseldorf, Germany; [Dietrich, Ralf] Deutsch Fanconi Anamie Hilfe eV, Unna Siddinghausen, Germany; [Brakenhoff, Ruud H.] Vrije Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Otolaryngol Head & Neck Surg, Amsterdam, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Autonomous University of Barcelona; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Heinrich Heine University Dusseldorf; University of Amsterdam; Vrije Universiteit Amsterdam	Wells, SI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Oncol, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA.	susanne.wells@cchmc.org	Moore, Patrick S./F-3960-2011; Moore, Patrick/GVR-8294-2022; Grabmair, Tuna Toptan/AAN-6129-2021; Chang, Yuan/F-4146-2011; Surrallés, Jordi/AAE-7667-2020; Velleuer, Eunike/U-6355-2019	Moore, Patrick S./0000-0002-8132-858X; Grabmair, Tuna Toptan/0000-0002-5399-9263; Chang, Yuan/0000-0003-1125-4041; Velleuer, Eunike/0000-0003-4328-9556	University of Pittsburgh Skin SPORE Career Enhancement Program [R01 CA102357, R35CA197463]; NATIONAL CANCER INSTITUTE [R35CA197463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	University of Pittsburgh Skin SPORE Career Enhancement Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by R01 CA102357 to SIW and by R35CA197463 to PSM. TT was supported in part by University of Pittsburgh Skin SPORE Career Enhancement Program funding.	Alter BP, 2013, INT J CANCER, V133, P1513, DOI 10.1002/ijc.28157; Castello G, 1998, ACTA HAEMATOL-BASEL, V100, P39, DOI 10.1159/000040861; de Araujo MR, 2011, ORAL DIS, V17, P572, DOI 10.1111/j.1601-0825.2011.01803.x; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fischer N, 2010, INT J CANCER, V126, P2133, DOI 10.1002/ijc.24877; Gueiderikh A, 2017, GENET MOL BIOL, V40, P398, DOI [10.1590/1678-4685-GMB-2016-0213, 10.1590/1678-4685-gmb-2016-0213]; Hoskins EE, 2012, J VIROL, V86, P8131, DOI 10.1128/JVI.00408-12; Katzenellenbogen RA, 2015, CLIN VACCINE IMMUNOL, V22, P413, DOI 10.1128/CVI.00665-14; Khoury R, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010047; Knies K, 2017, J CLIN INVEST, V127, P3013, DOI 10.1172/JCI92069; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kutler DI, 2016, LARYNGOSCOPE, V126, P870, DOI 10.1002/lary.25726; Kutler DI, 2003, J NATL CANCER I, V95, P1718, DOI 10.1093/jnci/djg091; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Loyo M, 2010, INT J CANCER, V126, P2991, DOI 10.1002/ijc.24737; Myers KC, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26599; Myers KC, 2011, BRIT J HAEMATOL, V154, P234, DOI 10.1111/j.1365-2141.2011.08721.x; Park S, 2016, MBIO, V7, DOI 10.1128/mBio.00628-16; Rigatti LH, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00334-16; Rodriguez A, 2017, CURR BIOL, V27, pR986, DOI 10.1016/j.cub.2017.07.043; Sauter SL, 2015, CANCER EPIDEM BIOMAR, V24, P864, DOI 10.1158/1055-9965.EPI-15-0097-T; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Starrett GJ, 2017, MBIO, V8, DOI 10.1128/mBio.02079-16; Sumpter R, 2017, J CELL SCI, V130, P2657, DOI 10.1242/jcs.204909; Tanio S, 2015, MOL CLIN ONCOL, V3, P1301, DOI 10.3892/mco.2015.629; Tolstov YL, 2010, BLOOD, V115, P4973, DOI 10.1182/blood-2010-03-273177; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Toptan T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85562; van Zeeburg HJT, 2005, CANCER RES, V65, P1271, DOI 10.1158/0008-5472.CAN-04-3665; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Winer RL, 2015, ORAL DIS, V21, P349, DOI 10.1111/odi.12286; Yom SS, 2006, ORAL SURG ORAL MED O, V101, P761, DOI 10.1016/j.tripleo.2005.10.068; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209235	10.1371/journal.pone.0209235	http://dx.doi.org/10.1371/journal.pone.0209235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589865	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200016
J	Leight, J; Sharma, V; Brown, W; Costica, L; Sule, FA; Nyqvist, MB				Leight, Jessica; Sharma, Vandana; Brown, Willa; Costica, Laura; Sule, Fatima Abdulaziz; Nyqvist, Martina Bjorkman			Associations between birth kit use and maternal and neonatal health outcomes in rural Jigawa state, Nigeria: A secondary analysis of data from a cluster randomized controlled trial	PLOS ONE			English	Article							CLEAN DELIVERY KIT; INTERVENTION; MORTALITY; IMPACT; DEATH; CARE	Background The burden of maternal and neonatal mortality remains persistently high in Nigeria. Sepsis contributes significantly to both maternal and newborn mortality, and safe delivery kits have long been promoted as a cost-effective intervention to ensure hygienic delivery practices and reduce sepsis. However, there is limited evidence on the effectiveness of home birth kit distribution by community health workers, and particularly the impact of this intervention on health outcomes. This paper reports a secondary analysis of data from a cluster randomized trial in rural northern Nigeria in which birth kits were distributed by community health workers to pregnant women in their homes, analyzing non-experimental variation in receipt and use of birth kits. More specifically, associations between pregnant women's baseline characteristics and receipt and use of birth kits, and associations between birth kit use, care utilization and maternal and newborn outcomes were assessed. Methods and findings Baseline, post-birth and endline data related to 3,317 births observed over a period of three years in 72 intervention communities in Jigawa state, Nigeria, were analyzed using hierarchical, logistic regression models. In total, 140 women received birth kits, and 72 women used the kits. There were no associations between baseline demographic characteristics, health history, and knowledge and attitudes and receipt of a kit, suggesting that community health workers did not systematically target the distribution of birth kits. However, women who used the kit reported reduced odds of past pregnancy complications (OR = 0.44, 95% CI: 0.19-1.00) as well as significantly higher odds of feeling generally healthy at baseline (OR = 2.00, 95% CI: 1.06-3.76), of exposure to radio media (OR = 1.97, 95% CI: 1.21-3.22), and of perceiving themselves as having a low-risk pregnancy (OR = 3.05, 95% CI: 1.39-6.68). While there were no significant associations between birth kit use and facility based delivery, skilled birth attendance or post-natal care, women who used a kit exhibited significantly lower odds of completing four or more ANC visits (adjusted OR = 0.39, 95% CI: 0.18-0.85) and significantly higher odds of reporting prolonged labor (adjusted OR = 4.75, 95% CI: 1.36-16.59), and post-partum bleeding (adjusted OR = 3.25, 95% CI: 1.11-9.52). Conclusions This evidence suggests that use of birth kits is low in a rural population characterized by minimal baseline utilization of maternal and neonatal health services, and the use of birth kits was not associated with reductions in maternal or neonatal morbidity. While further research is required to understand how the effectiveness of birth kits may be shaped by the mechanism through which women access and utilize the kits, our findings suggest that the provision of kits to women outside of the formal health system may be associated with increased risk of adverse outcomes.	[Leight, Jessica; Sule, Fatima Abdulaziz] Amer Univ, Econ Dept, Washington, DC 20016 USA; [Sharma, Vandana] Harvard TH Chan Sch Publ Hlth, Cambridge, MA USA; [Brown, Willa] MIT, Abdul Latif Jameel Poverty Act Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Costica, Laura] Planned Parenthood Federat Nigeria, Abuja, Nigeria; [Nyqvist, Martina Bjorkman] Stockholm Sch Econ, Stockholm, Sweden	American University; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Stockholm School of Economics	Leight, J (corresponding author), Amer Univ, Econ Dept, Washington, DC 20016 USA.	leight@american.edu		Sule, Fatima Abdulaziz/0000-0001-8684-0630; Leight, Jessica/0000-0002-1691-9682	John D. and Catherine T. MacArthur Foundation; U.S. Agency for International Development [FY14-G11-6990, GHS-A-00-09-00015-00]	John D. and Catherine T. MacArthur Foundation; U.S. Agency for International Development(United States Agency for International Development (USAID))	The John D. and Catherine T. MacArthur Foundation (https://www.macfound.org/) provided the primary funding for this research in a grant awarded to MB, JL and VS. (No grant number was assigned.) The U.S. Agency for International Development provided secondary funding under Subgrant FY14-G11-6990 under cooperative agreement GHS-A-00-09-00015-00 (https://www.urc-chs.com/projects/translating-research-actiontraction-project); the principal investigator for the award was VS, and MB, JL and FAS were coinvestigators. The funders provided funding for all research activities and provided salary support for VS, FAS and LC. However, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Akinyemi JO, 2012, BMC PEDIAT, V15; Aleman A, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0436-9; Balsara ZP, 2009, J PERINATOL, V29, P673, DOI 10.1038/jp.2009.80; Beun M, 2017, J HLTH POPULATION NU, V4, P367; Cameron A., 2010, HDB EMPIRICAL EC FIN, V3666, P1, DOI [10.1201/b10440-2, DOI 10.1201/B10440-2]; Colomar M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0299-0; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; GARNER P, 1994, J TROP PEDIATRICS, V40, P24, DOI 10.1093/tropej/40.1.24; GREENLAND S, 1994, AM J EPIDEMIOL, V139, P747, DOI 10.1093/oxfordjournals.aje.a117069; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hundley VA, 2012, MIDWIFERY, V28, P204, DOI 10.1016/j.midw.2011.03.004; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; KAPOOR S K, 1991, Indian Journal of Pediatrics, V58, P341, DOI 10.1007/BF02754963; Khan K, 2007, LANCET, V367; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Leight J., 2016, AEA RCT REGISTRY; Meegan ME, 2001, LANCET, V358, P640, DOI 10.1016/S0140-6736(01)05787-7; Morrison J, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1263, DOI 10.1177/1010539512458950; Mosha F, 2005, Tanzan Health Res Bull, V7, P185; Nigeria Demographic Health Survey, 2014, NIG DEM HLTH SURV; NPC (National Population Commission), 2006, POP HOUS CENS FED RE; Okeke E, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1688-8; Pagel C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-151; PPFN, 2012, PPFN PROGR IMPL PLAN; PPFN, 2012, PPFN TRAIN MAN CORPS; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Seward N, 2012, PLOS MED, P204; Seward N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136152; Sharma V, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0124-y; Sharma V, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1341-5; SHEINER LB, 1995, CLIN PHARMACOL THER, V57, P6, DOI 10.1016/0009-9236(95)90260-0; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Tsu V., 2000, CLEAN HOME DELIVERY; UNICEF, 2009, STATE WORLDS CHILDRE; Wang P, 2016, TROP MED INT HEALTH, V21, P515, DOI 10.1111/tmi.12678; WHO,, 1994, ESSENTIAL NEWBORN CA; Winani S, 2007, J MIDWIFERY WOM HEAL, V52, P37, DOI 10.1016/j.jmwh.2006.09.004; Word Health Organization, 2018, INF YOUNG CHILD FEED; World Health Organization, 1998, CAR UMB CORD REV EV	41	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208885	10.1371/journal.pone.0208885	http://dx.doi.org/10.1371/journal.pone.0208885			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586441	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400043
J	Tan, HM; Low, WY				Tan, Hui Ming; Low, Wai Yee			Rapid birth-death evolution and positive selection in detoxification-type glutathione S-transferases in mammals	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENES; IDENTIFICATION; METABOLISM; EXPRESSION; REDUCTASE; RESIDUES; ENZYME; SITES	Glutathione S-Transferases (GSTs) are phase II detoxification enzymes that may have evolved in response to changes of environmental substrates. GST genes formed a multigene family and in mammals, there are six classes known as Alpha, Mu, Omega, Pi, Theta, and Zeta. Recent studies in phase I detoxification system specifically the cytochrome P450s provided a general explanation on why genes from a common origin such as those in a multigene family have both phylogenetically stable and unstable genes. Genes that participate in core functions of organisms such as development and physiology are stable whereas genes that play a role in detoxification are unstable and evolve in a process known as birth-death evolution, which is characterised by frequent gene gains and losses. The generality of the birth-death model at explaining the evolution of detoxification enzymes beyond the phase I enzyme has not been comprehensively explored. This work utilized 383 Gst genes and 300 pseudogenes across 22 mammalian species to study gene gains and losses. GSTs vary greatly in their phylogenetic stability despite their overall sequence similarity. Stable Gst genes from Omega and Zeta classes do not show fluctuation in gene numbers from human to opossum. These genes play a role in biosynthesis related functions. Unstable genes that include Alpha, Mu, Pi and Theta undergo frequent gene gain and loss in a process known as birth-death evolution. Gene members of these four classes are well known for their roles in detoxification. Our positive selection screen identified five positively selected sites in mouse GSTA3. Previous studies showed two of these sites (108H and 208E) were biochemically tested as important residues that conferred catalytic activity against the toxic aflatoxin B-1-8,9-epoxide. The functional significance against aflatoxin of the remaining three positively selected sites warrant further investigation.	[Tan, Hui Ming; Low, Wai Yee] Perdana Univ, Ctr Bioinformat, Sch Data Sci, Serdang, Selangor, Malaysia; [Low, Wai Yee] Univ Adelaide, Davies Res Ctr, Sch Anim & Vet Sci, Roseworthy, SA, Australia	Perdana University; University of Adelaide	Low, WY (corresponding author), Perdana Univ, Ctr Bioinformat, Sch Data Sci, Serdang, Selangor, Malaysia.; Low, WY (corresponding author), Univ Adelaide, Davies Res Ctr, Sch Anim & Vet Sci, Roseworthy, SA, Australia.	wai.low@adelaide.edu.au	low, waiyee/AAM-2200-2021	low, waiyee/0000-0002-0749-765X	Perdana University	Perdana University	Publication of this article was funded by Perdana University.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Ames RM, 2015, BIOINFORMATICS, V31, P416, DOI 10.1093/bioinformatics/btu645; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chowdhury UK, 2006, TOXICOL APPL PHARM, V216, P446, DOI 10.1016/j.taap.2006.06.014; da Fonseca RR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-281; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Force A, 1999, GENETICS, V151, P1531; Goldman N, 1994, MOL BIOL EVOL; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; Hughes AL, 2001, ENCY LIFE SCI, V2008, P1; Ilic Z, 2018, TUMOR BIOL, V40; Ishikawa T, 1998, J BIOL CHEM, V273, P28708, DOI 10.1074/jbc.273.44.28708; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Jancova P, 2012, TOPICS ON DRUG METABOLISM, P35; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Kawashima A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100059; Kulmuni J, 2013, HEREDITY, V110, P538, DOI 10.1038/hdy.2012.122; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; McDonell L, 2012, GENOME, V55, P147, DOI 10.1139/G2012-002; Nebert Daniel W., 2004, Human Genomics, V1, P460; Niimura Y, 2007, PLOS ONE, P2; OTA T, 1994, MOL BIOL EVOL, V11, P469; Paiva L, 2008, PHARMACOGENET GENOM, V18, P1, DOI 10.1097/FPC.0b013e3282f29663; Sabbagh A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-62; Sakai H, 2007, GENE, V389, P196, DOI 10.1016/j.gene.2006.11.007; Schmuck EM, 2005, PHARMACOGENET GENOM, V15, P493, DOI 10.1097/01.fpc.0000165725.81559.e3; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Su C, 1999, IMMUNOGENETICS, V50, P301, DOI 10.1007/s002510050606; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Van Ness KP, 1998, TOXICOL APPL PHARM, V152, P166, DOI 10.1006/taap.1998.8493; Weiner AM, 1986, HUM GENET; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209336	10.1371/journal.pone.0209336	http://dx.doi.org/10.1371/journal.pone.0209336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586459	gold, Green Submitted, Green Published			2022-12-26	WOS:000454416400057
J	Kawagishi, N; Suda, G; Nakamura, A; Kimura, M; Maehara, O; Suzuki, K; Nakamura, A; Ohara, M; Izumi, T; Umemura, M; Nakai, M; Sho, T; Natsuizaka, M; Morikawa, K; Ogawa, K; Kudo, Y; Nishida, M; Miyoshi, H; Sakamoto, N				Kawagishi, Naoki; Suda, Goki; Nakamura, Akinobu; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Miyoshi, Hideaki; Sakamoto, Naoya			Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; METABOLISM-ASSOCIATED GENES; HEPATOCELLULAR-CARCINOMA; LIPID-METABOLISM; OXIDATIVE STRESS; DISEASE; CHOLESTEROL; EXPRESSION; THERAPY; DACLATASVIR	Aim We comprehensively analyzed how hepatitis C virus (HCV) eradication by interferon (IFN)-free direct-acting-antiviral-agents (DAAs) affects liver steatosis and atherogenic risk. Methods Patients treated with IFN-free-DAAs who underwent transient elastography before and at 24-weeks post-treatment, including controlled attenuation parameter (CAP), and achieved sustained viral response (SVR) were enrolled. The association between changes in liver steatosis, lipid-metabolism, and genetic and clinical factors was analyzed. Results A total of 117 patients were included. The mean CAP and low-density lipoprotein cholesterol (LDL-C) levels were significantly elevated at SVR24. However, baseline LDL-C and CAP values were significantly negatively correlated with changes in these values after HCV eradication, indicating that in patients with high baseline values, the values generally decreased after HCV eradication. Mean small-dense LDL-C (sdLDL-C), which has greater atherogenic potential, was significantly elevated only in patients with both dyslipidemia (LDL-C > 140 mg/dL) and liver steatosis (CAP > 248 dB/m) at SVR24. Those patients had significant higher baseline BMI, LDL-C, and total-cholesterol levels. Conclusions Generally, successful HCV eradication by IFN-free-DAAs decreases CAP and LDL-C in patients with high baseline values. However, elevated LDL-C was accompanied with elevated sdLDL-C only in patients with liver steatosis and dyslipidemia at SVR24; therefore, those patients may require closer monitoring.	[Kawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Nakamura, Akinobu] Hokkaido Univ, Grad Sch Med, Fac Med, Dept Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan; [Nakamura, Akinobu; Miyoshi, Hideaki] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Kudo, Yusuke; Nishida, Mutsumi] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido, Japan; [Miyoshi, Hideaki] Hokkaido Univ, Fac Med, Div Diabet & Obes, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Suda, G; Sakamoto, N (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan.	gsudgast@pop.med.hokudai.ac.jp; sakamoto@med.hokudai.ac.jp	Sakamoto, Naoya/G-2734-2012	Sakamoto, Naoya/0000-0003-0061-059X	Japan Agency for Medical Research and Development (AMED) [17fk0210102h0001]; Japan Society for the Promotion of Science (JSPS) KAKENHI [16K09334]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Goki Suda received the following fundings: The Japan Agency for Medical Research and Development (AMED), Grant Number 16fk0210102h0001, 17fk0210106h0501, URL https://www.amed.go.jp/; and Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant number 16K09334, URL https://www.jsps.go.jp/.Naoya Skamoto received funding from the Japan Agency for Medical Research and Development (AMED). Grant number is 17fk0210102h0001. URL is https://www.amed.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Babiker A, 2017, J CLIN TRANSL HEPATO, V5, P343, DOI 10.14218/JCTH.2017.00021; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Cheng Y, 2005, WORLD J GASTROENTERO, V11, P7591, DOI 10.3748/wjg.v11.i48.7591; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; Czaja AJ, 1998, J HEPATOL, V29, P198, DOI 10.1016/S0168-8278(98)80004-4; Fujihara K, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/507245; Fujinaga H, 2011, ONCOLOGY-BASEL, V81, P11, DOI 10.1159/000333253; Fujino T, 2010, HEPATOL RES, V40, P923, DOI 10.1111/j.1872-034X.2010.00700.x; Hashimoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163644; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Hiramatsu N, 2015, HEPATOL RES, V45, P152, DOI 10.1111/hepr.12393; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Honda A, 2011, HEPATOL RES, V41, P697, DOI 10.1111/j.1872-034X.2011.00838.x; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; Hsu YC, 2015, GUT, V64, P495, DOI 10.1136/gutjnl-2014-308163; Ivanova EA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1273042; Jung HJ, 2014, CLIN MOL HEPATOL, V20, P38, DOI 10.3350/cmh.2014.20.1.38; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kurosaki M, 2010, HEPATOL RES, V40, P870, DOI 10.1111/j.1872-034X.2010.00692.x; Li L, 2014, GENET MOL RES, V13, P10150, DOI 10.4238/2014.December.4.9; Meissner EG, 2015, HEPATOLOGY, V61, P790, DOI 10.1002/hep.27424; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Nakamuta M, 2009, INT J MOL MED, V24, P825, DOI 10.3892/ijmm_00000299; Ogasawara N, 2018, J MED VIROL, V90, P313, DOI 10.1002/jmv.24950; Ohya K, 2018, J MED VIROL, V90, P919, DOI 10.1002/jmv.25023; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Salameh H, 2016, J CLIN TRANSL HEPATO, V4, P175, DOI 10.14218/JCTH.2016.00009; Shinohara E, 1997, HEPATOLOGY, V25, P1502, DOI 10.1002/hep.510250632; Sookoian S, 2015, HEPATOLOGY, V61, P515, DOI 10.1002/hep.27556; Suda G, 2018, J GASTROENTEROL, V53, P119, DOI 10.1007/s00535-017-1353-y; Suda G, 2017, HEPATOL RES, V47, P1127, DOI 10.1111/hepr.12851; Suda G, 2017, J GASTROENTEROL, V52, P1122, DOI 10.1007/s00535-017-1328-z; Suda G, 2016, J GASTROENTEROL, V51, P733, DOI 10.1007/s00535-016-1162-8; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Syed GH, 2014, J VIROL, V88, P2519, DOI 10.1128/JVI.02727-13; Tanaka A, 2007, WORLD J GASTROENTERO, V13, P5180, DOI 10.3748/wjg.v13.i39.5180; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Tsukuda Y, 2017, J MED VIROL, V89, P857, DOI 10.1002/jmv.24692; Vidali M, 2008, J HEPATOL, V48, P399, DOI 10.1016/j.jhep.2007.10.011	44	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209615	10.1371/journal.pone.0209615	http://dx.doi.org/10.1371/journal.pone.0209615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576386	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400065
J	Muller, MF; Colomer, J; Serra, T				Mueller, Mara F.; Colomer, Jordi; Serra, Teresa			Temperature-driven response reversibility and short-term quasi-acclimation of Daphnia magna	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; THERMAL TOLERANCE; MICROCRUSTACEAN DAPHNIA; DEPENDENT BIOGEOGRAPHY; CLIMATE-CHANGE; BODY-SIZE; FOOD; CLADOCERA; CONSEQUENCES; ACCUMULATION	Analysing the effect water temperature has on Daphnia magna is essential in anticipating the impact climate change will have on this freshwater zooplanktonic keystone species. While many authors have followed this line of research, few have covered an extensive temperature range or complex temperature change scenarios. Global warming is mostly associated with increased extreme temperature events, such as heat waves, as well as earlier and more intense thermal stratification. Both of these events may directly influence D. magna fitness, especially in those populations performing diel vertical migration (DVM). We analysed the effect water temperatures, ranging from 11 to 29 degrees C, have on the filtration capacity (FC) of D. magna, to anticipate the effects of acclimation, temperature change rate (TCR) and potential reversibility of responses to such conditions. Results show that sudden temperature changes have an immediate negative impact on the FC of D. magna and is more severe at higher temperatures and higher TCRs. However, D. magna individuals have shown themselves to be capable of quasi-acclimating to temperatures ranging from 11 to 25 degrees C in around a week and achieving much higher FCs; albeit never reaching the optimal FC achieved at 20 degrees C. That said, 29 degrees C is lethal for D. magna individuals within approximately five days. Finally, non-optimal temperature acclimated individuals can recover maximal FC within 2-4 days of the optimal long-term acclimation temperature (20 degrees C) being re-established, thus proving temperature responses to be reversible.	[Mueller, Mara F.; Colomer, Jordi; Serra, Teresa] Univ Girona, Dept Phys, Girona, Spain	Universitat de Girona	Serra, T (corresponding author), Univ Girona, Dept Phys, Girona, Spain.	teresa.serra@udg.edu	Müller, Mara F./HHZ-4279-2022; Serra, Teresa/L-9279-2014; Colomer, Jordi/Y-5386-2018	Müller, Mara F./0000-0001-6547-1004; Serra, Teresa/0000-0002-6075-5849; Colomer, Jordi/0000-0002-9330-0269	University of Girona; INNOQUA project from the European Union's Horizon 2020 research and innovation program [Ares2016-1770486]	University of Girona; INNOQUA project from the European Union's Horizon 2020 research and innovation program	This work was supported by the University of Girona funding MPCUdG2016 and by the INNOQUA project from the European Union's Horizon 2020 research and innovation program (Ares2016-1770486) to MFM, TS, and JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Girona funding MPCUdG2016 and by the INNOQUA project from the European Union's Horizon 2020 research and innovation program (Ares2016-1770486) to MFM, TS, and JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Bae E, 2016, ECOTOX ENVIRON SAFE, V132, P366, DOI 10.1016/j.ecoenv.2016.06.034; Berger SA, 2007, OECOLOGIA, V150, P643, DOI 10.1007/s00442-006-0550-9; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; BURNS CW, 1969, LIMNOL OCEANOGR, V14, P693, DOI 10.4319/lo.1969.14.5.0693; CALABAN MJ, 1982, LIMNOL OCEANOGR, V27, P262, DOI 10.4319/lo.1982.27.2.0262; CARVALHO GR, 1987, J ANIM ECOL, V56, P469, DOI 10.2307/5061; Chen LL, 2012, PROCEDIA ENVIRON SCI, V13, P80, DOI 10.1016/j.proenv.2012.01.007; DAWIDOWICZ P, 1994, INT VER THEOR ANGEW, V25, P2396; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Geerts AN, 2015, NAT CLIM CHANGE, V5, P665, DOI 10.1038/NCLIMATE2628; GERRITSEN J, 1982, LIMNOL OCEANOGR, V27, P254, DOI 10.4319/lo.1982.27.2.0254; Giebelhausen B, 2001, FRESHWATER BIOL, V46, P281, DOI 10.1046/j.1365-2427.2001.00630.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GOPHEN M, 1976, FRESHWATER BIOL, V6, P451, DOI 10.1111/j.1365-2427.1976.tb01634.x; Guderley H., 1998, Society for Experimental Biology Seminar Series, V66, P58; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Heugens EHW, 2003, ENVIRON SCI TECHNOL, V37, P2145, DOI 10.1021/es0264347; Hoefnagel KN, 2018, ECOL EVOL, V8, P3828, DOI 10.1002/ece3.3933; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jansen M, 2017, MOL ECOL, V26, P2291, DOI 10.1111/mec.14040; Lamkemeyer T, 2003, CAN J ZOOL, V81, P237, DOI 10.1139/Z03-001; Lampert Winfried, 1993, Advances in Limnology, V39, P79; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; Loureiro C, 2015, CHEMOSPHERE, V139, P126, DOI 10.1016/j.chemosphere.2015.05.081; Maceda-Veiga A, 2015, WATER RES, V83, P141, DOI 10.1016/j.watres.2015.06.036; MACISAAC HJ, 1985, PHYSIOL ZOOL, V58, P350, DOI 10.1086/physzool.58.3.30156006; MacKay MD, 2009, LIMNOL OCEANOGR, V54, P2315, DOI 10.4319/lo.2009.54.6_part_2.2315; MCKEE D, 1995, J PLANKTON RES, V17, P1095, DOI 10.1093/plankt/17.5.1095; MCMAHON JW, 1965, CAN J ZOOLOG, V43, P603, DOI 10.1139/z65-060; Mikulski A, 2005, J PLANKTON RES, V27, P757, DOI 10.1093/plankt/fbi048; Montagnes DJS, 2008, GLOBAL CHANGE BIOL, V14, P2823, DOI 10.1111/j.1365-2486.2008.01700.x; MOURELATOS S, 1990, LIMNOL OCEANOGR, V35, P1101, DOI 10.4319/lo.1990.35.5.1101; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Pascual J., 2018, ESTACIO METEOROLOGIC; Pau C, 2013, WATER RES, V47, P181, DOI 10.1016/j.watres.2012.09.047; Paul RJ, 2004, J THERM BIOL, V29, P655, DOI 10.1016/j.jtherbio.2004.08.035; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; PRECHT H, 1949, Z NATURFORSCH B, V4, P26; Riessen HP, 2012, P NATL ACAD SCI USA, V109, P15377, DOI 10.1073/pnas.1209938109; Rinke K, 2003, LIMNOLOGICA, V33, P293, DOI 10.1016/S0075-9511(03)80024-5; Schalau K, 2008, OECOLOGIA, V157, P531, DOI 10.1007/s00442-008-1081-3; Seidl MD, 2005, J THERM BIOL, V30, P532, DOI 10.1016/j.jtherbio.2005.06.004; Serra T, 2016, INT J ENVIRON SCI TE, V13, P1433, DOI 10.1007/s13762-016-0985-4; SHELFORD V. E., 1931, ECOLOGY, V12, P455, DOI 10.2307/1928991; Shiny KJ, 2005, BIORESOURCE TECHNOL, V96, P55, DOI 10.1016/j.biortech.2004.01.008; St-Pierre J, 1998, J EXP BIOL, V201, P2961; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Stillman JH, 2008, INTEGR COMP BIOL, V48, P852, DOI 10.1093/icb/icn096; Straile D, 2000, OECOLOGIA, V122, P44, DOI 10.1007/PL00008834; Straile D., 2002, P R SOC LON B, V269, P91; Tsui MTK, 2004, AQUAT TOXICOL, V70, P245, DOI 10.1016/j.aquatox.2004.09.006; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Van Doorslaer W, 2009, EVOLUTION, V63, P1867, DOI 10.1111/j.1558-5646.2009.00679.x; Wojtal-Frankiewicz A, 2012, AQUAT ECOL, V46, P37, DOI 10.1007/s10452-011-9380-x; Wu S, 2008, TECHNICAL PAPER INTE; Yampolsky LY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2744; Zeis B, 2004, CAN J ZOOL, V82, P1605, DOI 10.1139/Z04-141	63	26	26	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209705	10.1371/journal.pone.0209705	http://dx.doi.org/10.1371/journal.pone.0209705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576390	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400073
J	Brewer, PD; Romenskaia, I; Mastick, CC				Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley			A high-throughput chemical-genetics screen in murine adipocytes identifies insulin-regulatory pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; insulin; membrane trafficking; glucose transporter type 4 (GLUT4); drug discovery; chemical genetics; drug repurposing; library screening; small molecule	GLUCOSE-TRANSPORT; GLUT4 TRANSLOCATION; MAMMALIAN TARGET; ADIPOSE-TISSUE; AKT SUBSTRATE; PLASMA-MEMBRANE; RAB-GAP; PROTEIN; 3T3-L1; RAPAMYCIN	Pathways linking activation of the insulin receptor to downstream targets of insulin have traditionally been studied using a candidate gene approach. To elucidate additional pathways regulating insulin activity, we performed a forward chemical-genetics screen based on translocation of a glucose transporter 4 (Glut4) reporter expressed in murine 3T3-L1 adipocytes. To identify compounds with known targets, we screened drug-repurposing and natural product libraries. We identified, confirmed, and validated 64 activators and 65 inhibitors that acutely increase or rapidly decrease cell-surface Glut4 in adipocytes stimulated with submaximal insulin concentrations. These agents were grouped by target, chemical class, and mechanism of action. All groups contained multiple hits from a single drug class, and several comprised multiple structurally unrelated hits for a single target. Targets include the -adrenergic and adenosine receptors. Agonists of these receptors increased and inverse agonists/antagonists decreased cell-surface Glut4 independently of insulin. Additional activators include insulin sensitizers (thiazolidinediones), insulin mimetics, dis-inhibitors (the mTORC1 inhibitor rapamycin), cardiotonic steroids (the Na+/K+-ATPase inhibitor ouabain), and corticosteroids (dexamethasone). Inhibitors include heterocyclic amines (tricyclic antidepressants) and 21 natural product supplements and herbal extracts. Mechanisms of action include effects on Glut4 trafficking, signal transduction, inhibition of protein synthesis, and dissipation of proton gradients. Two pathways that acutely regulate Glut4 translocation were discovered: de novo protein synthesis and endocytic acidification. The mechanism of action of additional classes of activators (tanshinones, dalbergiones, and coumarins) and inhibitors (flavonoids and resveratrol) remains to be determined. These tools are among the most sensitive, responsive, and reproducible insulin-activity assays described to date.	[Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Reno Sch Med, Dept Pharmacol, Mailstop 318, Reno, NV 89557 USA; [Brewer, Paul Duffield] AnaptysBio Inc, San Diego, CA 92121 USA; [Romenskaia, Irina] Univ Nevada, Dept Biochem, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Reno Sch Med, Dept Pharmacol, Mailstop 318, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	National Institutes of Health from NIGMS [P20 GM103440]; American Diabetes Association [1-12-BS-132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant P20 GM103440 from NIGMS and American Diabetes Association Grant 1-12-BS-132. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadian M, 2007, FUTURE LIPIDOL, V2, P229, DOI 10.2217/17460875.2.2.229; Alves DS, 2015, J AM SOC NEPHROL, V26, P2765, DOI 10.1681/ASN.2013101040; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Basit A, 2012, VASC HEALTH RISK MAN, V8, P463, DOI 10.2147/HIV.S33194; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Brewer PD, 2016, BIOCHEM J, V473, P1315, DOI 10.1042/BCJ20160020; Brewer PD, 2016, J BIOL CHEM, V291, P773, DOI 10.1074/jbc.M115.694919; Brewer PD, 2014, J BIOL CHEM, V289, P17280, DOI 10.1074/jbc.M114.555714; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; CAIN CC, 1988, J CELL BIOL, V106, P269, DOI 10.1083/jcb.106.2.269; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CAIN CC, 1986, J CELL PHYSIOL, V129, P65, DOI 10.1002/jcp.1041290110; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chen YC, 2007, J AFFECT DISORDERS, V103, P257, DOI 10.1016/j.jad.2007.01.023; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Dragunow M, 2007, J BIOMOL SCREEN, V12, P999, DOI 10.1177/1087057107306502; ECKEL J, 1990, BIOCHEM J, V272, P691, DOI 10.1042/bj2720691; Edwards SR, 2007, J BIOL CHEM, V282, P13395, DOI 10.1074/jbc.M700498200; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; FUJIWARA T, 1988, DIABETES, V37, P1549, DOI 10.2337/diabetes.37.11.1549; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Ghaeli P, 2004, J CLIN PSYCHOPHARM, V24, P386, DOI 10.1097/01.jcp.0000132441.27854.0d; Goldman SDB, 2009, BIOANALYSIS, V1, P1445, DOI 10.4155/BIO.09.128; Gomez-Zorita S, 2013, J PHYSIOL BIOCHEM, V69, P585, DOI 10.1007/s13105-012-0229-0; Griggs RB, 2015, PAIN, V156, P469, DOI 10.1097/01.j.pain.0000460333.79127.be; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; Herman M., 2012, ASBMB TODAY, V2012, P30; Hino K, 2011, J BIOMOL SCREEN, V16, P628, DOI 10.1177/1087057111403474; Hu X, 2011, BIOORG MED CHEM LETT, V21, P4441, DOI 10.1016/j.bmcl.2011.06.020; HUNDAL HS, 1992, J BIOL CHEM, V267, P5040; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; JOOST HG, 1985, BIOCHEM PHARMACOL, V34, P649, DOI 10.1016/0006-2952(85)90259-X; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KASHIWAGI A, 1982, BIOCHEM BIOPH RES CO, V107, P1151, DOI 10.1016/0006-291X(82)90642-8; KASHIWAGI A, 1983, J BIOL CHEM, V258, P3685; Kawazoe Y, 2004, CHEM BIOL, V11, P907, DOI 10.1016/j.chembiol.2004.04.017; KLETZIEN RF, 1992, MOL PHARMACOL, V41, P393; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Lahrita L, 2015, J ETHNOPHARMACOL, V168, P229, DOI 10.1016/j.jep.2015.03.082; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lanzerstorfer P, 2014, BRIT J PHARMACOL, V171, P5237, DOI 10.1111/bph.12845; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lebeck J, 2014, J MOL ENDOCRINOL, V52, pR165, DOI 10.1530/JME-13-0268; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Liao TV, 2014, DRUGS, V74, P183, DOI 10.1007/s40265-013-0171-7; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu F, 2009, BIOCHEM J, V418, P413, DOI 10.1042/BJ20082051; Liu Q, 2010, J STEROID BIOCHEM, V120, P155, DOI 10.1016/j.jsbmb.2010.03.090; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Loubatieres-Mariani Marie-Madeleine, 2007, Journal de la Societe de Biologie, V201, P121, DOI 10.1051/jbio:2007014; Malide D, 2000, J CELL SCI, V113, P4203; Merlin J, 2018, CELL SIGNAL, V42, P54, DOI 10.1016/j.cellsig.2017.09.023; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Montagut G, 2010, J NUTR BIOCHEM, V21, P961, DOI 10.1016/j.jnutbio.2009.08.001; Moraes LA, 2010, J THROMB HAEMOST, V8, P577, DOI 10.1111/j.1538-7836.2009.03732.x; Mukaida S, 2017, PHARMACOL RES, V116, P87, DOI 10.1016/j.phrs.2016.12.022; MULLER G, 1995, DIABETES RES CLIN PR, V28, pS115, DOI 10.1016/0168-8227(95)01089-V; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Nakabayashi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-453; OMATSUKANBE M, 1992, FEBS LETT, V314, P246, DOI 10.1016/0014-5793(92)81481-Z; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Pinent M, 2004, ENDOCRINOLOGY, V145, P4985, DOI 10.1210/en.2004-0764; Pinent M, 2005, J AGR FOOD CHEM, V53, P5932, DOI 10.1021/jf050601f; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qiang GF, 2014, DIABETES, V63, P1394, DOI 10.2337/db13-0334; REED BC, 1981, P NATL ACAD SCI-BIOL, V78, P2908, DOI 10.1073/pnas.78.5.2908; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Sacramento JF, 2015, EUR J PHARM SCI, V70, P107, DOI 10.1016/j.ejps.2015.01.011; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; SALANS LB, 1974, J CLIN INVEST, V53, P848, DOI 10.1172/JCI107625; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sennoune S, 2000, EUR J BIOCHEM, V267, P2071, DOI 10.1046/j.1432-1327.2000.01211.x; Shearer J, 2014, NUTR REV, V72, P121, DOI 10.1111/nure.12124; Shimizu M, 1996, PHARMACOL TOXICOL, V78, P254, DOI 10.1111/j.1600-0773.1996.tb00214.x; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Syamsudin Inawati, 2008, RES J PHARM, V2, P20; Thomas I, 2017, PEDIATR DIABETES, V18, P10, DOI 10.1111/pedi.12473; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Vazirani RP, 2016, DIABETES, V65, P1577, DOI 10.2337/db15-1128; Vijayakumar MV, 2010, J BIOSCIENCES, V35, P525, DOI 10.1007/s12038-010-0060-0; VRIJSEN R, 1986, J BIOL CHEM, V261, P505; Wang F, 2015, INT J IMMUNOPATH PH, V28, P362, DOI 10.1177/0394632015598849; Xu YK, 2016, J CELL SCI, V129, P2085, DOI 10.1242/jcs.174805; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	106	8	8	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4103	4118		10.1074/jbc.RA118.006986	http://dx.doi.org/10.1074/jbc.RA118.006986			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30591588	Green Published, hybrid			2022-12-26	WOS:000461854400023
J	Avci, D; Malchus, NS; Heidasch, R; Lorenz, H; Richter, K; Nessling, M; Lemberg, MK				Avci, Doenem; Malchus, Nicole S.; Heidasch, Ronny; Lorenz, Holger; Richter, Karsten; Nessling, Michelle; Lemberg, Marius K.			The intramembrane protease SPP impacts morphology of the endoplasmic reticulum by triggering degradation of morphogenic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intramembrane proteolysis; endoplasmic reticulum-associated protein degradation (ERAD); organelle; proteolysis; cellular regulation; organelle morphology; substrate identification; tail-anchored protein	SIGNAL PEPTIDE PEPTIDASE; HOMOTYPIC FUSION; MEMBRANES; EXPRESSION; CELLS; IDENTIFICATION; ORGANIZATION; INHIBITION; SECRETION; SUBSTRATE	The endoplasmic reticulum (ER), as a multifunctional organelle, plays crucial roles in lipid biosynthesis and calcium homeostasis as well as the synthesis and folding of secretory and membrane proteins. Therefore, it is of high importance to maintain ER homeostasis and to adapt ER function and morphology to cellular needs. Here, we show that signal peptide peptidase (SPP) modulates the ER shape through degradation of morphogenic proteins. Elevating SPP activity induces rapid rearrangement of the ER and formation of dynamic ER clusters. Inhibition of SPP activity rescues the phenotype without the need for new protein synthesis, and this rescue depends on a pre-existing pool of proteins in the Golgi. With the help of organelle proteomics, we identified certain membrane proteins to be diminished upon SPP expression and further show that the observed morphology changes depend on SPP-mediated cleavage of ER morphogenic proteins, including the SNARE protein syntaxin-18. Thus, we suggest that SPP-mediated protein abundance control by a regulatory branch of ER-associated degradation (ERAD-R) has a role in shaping the early secretory pathway.	[Avci, Doenem; Malchus, Nicole S.; Heidasch, Ronny; Lorenz, Holger; Lemberg, Marius K.] Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Richter, Karsten; Nessling, Michelle] German Canc Res Ctr, Cent Unit Elect Microscopy, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Lemberg, MK (corresponding author), Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany.	m.lemberg@zmbh.uni-heidelberg.de	Lemberg, Marius K/B-8881-2016	Lemberg, Marius K/0000-0002-0996-1268	Deutsche Forschungsgemeinschaft [LE 2749/2-1, ZUK 49/2 6.1 DKFZ-ZMBH-Alliance, INST 35/1485-1 FUGG]; Boehringer Ingelheim Fonds fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds fellowship(Boehringer Ingelheim)	This work was supported by Deutsche Forschungsgemeinschaft Grants LE 2749/2-1, ZUK 49/2 6.1 DKFZ-ZMBH-Alliance, and INST 35/1485-1 FUGG and a Boehringer Ingelheim Fonds fellowship (to N. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON RGW, 1983, J CELL SCI, V63, P1; Avci D, 2015, TRENDS CELL BIOL, V25, P611, DOI 10.1016/j.tcb.2015.07.003; Avci D, 2014, MOL CELL, V56, P630, DOI 10.1016/j.molcel.2014.10.012; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Chen CY, 2014, EMBO J, V33, P2492, DOI 10.15252/embj.201488208; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fecher-Trost C, 2013, J BIOL CHEM, V288, P16629, DOI 10.1074/jbc.M113.469726; Fidzianska A, 2004, ACTA NEUROPATHOL, V107, P197, DOI 10.1007/s00401-003-0794-y; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Gillingham AK, 2014, DEV CELL, V31, P358, DOI 10.1016/j.devcel.2014.10.007; Gong FC, 1996, P NATL ACAD SCI USA, V93, P2219, DOI 10.1073/pnas.93.5.2219; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hsu FF, 2019, ONCOGENE, V38, P1688, DOI 10.1038/s41388-018-0539-y; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Valenzuela JI, 2011, MOL CELL NEUROSCI, V48, P269, DOI 10.1016/j.mcn.2011.07.001; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; Korkhov VM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-59; Lee M, 2015, J CELL BIOL, V210, P451, DOI 10.1083/jcb.201501043; Lemberg MK, 2011, TRAFFIC, V12, P1109, DOI 10.1111/j.1600-0854.2011.01219.x; Lenormand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060813; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mentrup T, 2017, EUR J CELL BIOL, V96, P372, DOI 10.1016/j.ejcb.2017.03.002; Miyazaki K, 2012, J CELL SCI, V125, P5658, DOI 10.1242/jcs.105304; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; Omi K, 2005, BIOCHEM BIOPH RES CO, V338, P1229, DOI 10.1016/j.bbrc.2005.10.061; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; PARMLEY RT, 1976, CANCER RES, V36, P1717; Pendin D, 2011, CURR OPIN CELL BIOL, V23, P435, DOI 10.1016/j.ceb.2011.04.007; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Renvoise B, 2010, CURR OPIN NEUROBIOL, V20, P531, DOI 10.1016/j.conb.2010.07.001; Richter K, 2005, EXP CELL RES, V303, P128, DOI 10.1016/j.yexcr.2004.09.022; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Simmen T, 2018, CURR OPIN CELL BIOL, V53, P61, DOI 10.1016/j.ceb.2018.04.014; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Stefanovic-Barrett S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745603; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Wei JW, 2017, CNS NEUROSCI THER, V23, P257, DOI 10.1111/cns.12672; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038	72	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2786	2800		10.1074/jbc.RA118.005642	http://dx.doi.org/10.1074/jbc.RA118.005642			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30578301	hybrid, Green Published			2022-12-26	WOS:000459601600018
J	Gutgsell, AR; Ghodge, SV; Bowers, AA; Neher, SB				Gutgsell, Aspen R.; Ghodge, Swapnil V.; Bowers, Albert A.; Neher, Saskia B.			Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipase; hydrogen exchange mass spectrometry; mutagenesis; peptides; protein-protein interaction; lipid metabolism; triglyceride; angiopoietin-like protein 4; lipoprotein lipase	ANGIOPOIETIN-LIKE PROTEINS; METABOLISM; DOMAIN; HYPERTRIGLYCERIDEMIA; VARIANTS; BINDING; TISSUES; PLASMA; RISK	Cardiovascular disease has been the leading cause of death throughout the world for nearly 2 decades. Hypertriglyceridemia affects more than one-third of the population in the United States and is an independent risk factor for cardiovascular disease. Despite the frequency of hypertriglyceridemia, treatment options are primarily limited to diet and exercise. Lipoprotein lipase (LPL) is an enzyme responsible for clearing triglycerides from circulation, and its activity alone can directly control plasma triglyceride concentrations. Therefore, LPL is a good target for triglyceride-lowering therapeutics. One approach for treating hypertriglyceridemia may be to increase the amount of enzymatically active LPL by preventing its inhibition by angiopoietin-like protein 4 (ANGPTL4). However, little is known about how these two proteins interact. Therefore, we used hydrogen-deuterium exchange MS to identify potential binding sites between LPL and ANGPTL4. We validated sites predicted to be located at the protein-protein interface by using chimeric variants of LPL and an LPL peptide mimetic. We found that ANGPTL4 binds LPL near the active site at the lid domain and a nearby alpha-helix. Lipase lid domains cover the active site to control both enzyme activation and substrate specificity. Our findings suggest that ANGPTL4 specifically inhibits LPL by binding the lid domain, which could prevent substrate catalysis at the active site. The structural details of the LPL-ANGPTL4 interaction uncovered here may inform the development of therapeutics targeted to disrupt this interaction for the management of hypertriglyceridemia.	[Gutgsell, Aspen R.; Neher, Saskia B.] Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,CB7260, Chapel Hill, NC 27599 USA; [Ghodge, Swapnil V.; Bowers, Albert A.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Neher, SB (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,CB7260, Chapel Hill, NC 27599 USA.	neher@email.unc.edu		Neher, Saskia/0000-0003-4165-6674	National Institutes of Health [R01HL125654, R35GM125005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM125005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL125654 (to S. B. N.) and R35GM125005 (to A. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P606, DOI 10.1073/pnas.0605957104; BENGTSSON G, 1979, BIOCHIM BIOPHYS ACTA, V575, P471, DOI 10.1016/0005-2760(79)90118-8; Bengtsson-Olivecrona P., 1991, METHOD ENZYMOL, V197, P345; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Biterova E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25237-7; Brahm AJ, 2015, NAT REV ENDOCRINOL, V11, P352, DOI 10.1038/nrendo.2015.26; Dallinga-Thie GM, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0745-6; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dijk W, 2016, J LIPID RES, V57, P1949, DOI 10.1194/jlr.M067363ERR; Dijk W, 2014, TRENDS ENDOCRIN MET, V25, P146, DOI 10.1016/j.tem.2013.12.005; DUGI KA, 1995, J BIOL CHEM, V270, P25396, DOI 10.1074/jbc.270.43.25396; Fang J, 2011, INT J MASS SPECTROM, V302, P19, DOI 10.1016/j.ijms.2010.06.039; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Goldberg IJ, 1996, J LIPID RES, V37, P693; Graham MJ, 2017, NEW ENGL J MED, V377, P222, DOI 10.1056/NEJMoa1701329; Griffon N, 2006, J LIPID RES, V47, P1803, DOI 10.1194/jlr.M500552-JLR200; Gusarova V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04611-z; Hayne CK, 2018, BIOCHEMISTRY-US, V57, P241, DOI 10.1021/acs.biochem.7b01009; Hayne CK, 2017, BIOCHEMISTRY-US, V56, P525, DOI 10.1021/acs.biochem.6b00945; Karalis D, 2017, ADV THER, V34, P300, DOI 10.1007/s12325-016-0462-y; Karpe F, 1998, J LIPID RES, V39, P2387; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Li Y, 2014, ATHEROSCLEROSIS, V237, P597, DOI 10.1016/j.atherosclerosis.2014.10.016; Li YC, 2014, J DRUG TARGET, V22, P679, DOI 10.3109/1061186X.2014.928715; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.20958; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.12095; NEVILLE MC, 1991, J LIPID RES, V32, P251; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; Noto D, 2017, ACTA DIABETOL, V54, P111, DOI 10.1007/s00592-016-0931-4; Oganesyan I, 2018, METHODS, V144, P27, DOI 10.1016/j.ymeth.2018.04.023; Peng J, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0625-0; Rader DJ, 2016, CELL METAB, V23, P405, DOI 10.1016/j.cmet.2016.01.005; Reimund M, 2017, J LIPID RES, V58, P279, DOI 10.1194/jlr.D071787; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sandoval JC, 2010, J ATHEROSCLER THROMB, V17, P914, DOI 10.5551/jat.4929; SANTAMARINAFOJO S, 1994, INT J CLIN LAB RES, V24, P143, DOI 10.1007/BF02592444; Segel I., 1993, ENZYME KINETICS BEHA, P125; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sniderman AD, 2018, J LIPID RES, V59, P1266, DOI 10.1194/jlr.R082271; Stitziel NO, 2017, J AM COLL CARDIOL, V69, P2054, DOI 10.1016/j.jacc.2017.02.030; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Tenenbaum A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0159-y; Vadas O, 2017, METHOD ENZYMOL, V583, P143, DOI 10.1016/bs.mie.2016.09.008; Wu MJ, 2018, J LIPID RES, V59, P2456, DOI 10.1194/jlr.D086793; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; Zhang R, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150272; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102	60	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2678	2689		10.1074/jbc.RA118.005932	http://dx.doi.org/10.1074/jbc.RA118.005932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591589	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000459601600010
J	Tian, MY; Zeng, TL; Liu, MD; Han, S; Lin, HY; Lin, Q; Li, L; Jiang, TT; Li, G; Lin, H; Zhang, T; Kang, QF; Deng, XM; Wang, HR				Tian, Maoyuan; Zeng, Taoling; Liu, Mingdong; Han, Shang; Lin, Huayue; Lin, Qi; Li, Li; Jiang, Tingting; Li, Gao; Lin, Hong; Zhang, Ting; Kang, Qiaofeng; Deng, Xianming; Wang, Hong-Rui			A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						high-throughput screening (HTS); E3 ubiquitin ligase; ubiquitylation (ubiquitination); inhibitor; cellular regulation; protein degradation; epithelial-mesenchymal transition (EMT); auto-ubiquitination; chemical screen; HECT domain; SMAD ubiquitin regulatory factor 1 (SMURF1); ubiquitin-reference technique (URT)	TGF-BETA; PROTEASOME INHIBITORS; PROTEIN; SMURF2; DEGRADATION; RECEPTOR; POLARITY; PATHWAY; TARGETS; CANCER	Accumulating evidence indicates that a wide range of E3 ubiquitin ligases are involved in the development of many human diseases. Searching for small-molecule modulators of these E3 ubiquitin ligases is emerging as a promising drug discovery strategy. Here, we report the development of a cell-based high-throughput screening method to identify modulators of E3 ubiquitin ligases by integrating the ubiquitin-reference technique (URT), based on a fusion protein of ubiquitin located between a protein of interest and a reference protein moiety, with a Dual-Luciferase system. Using this method, we screened for small-molecule modulators of SMAD ubiquitin regulatory factor 1 (SMURF1), which belongs to the NEDD4 family of E3 ubiquitin ligases and is an attractive therapeutic target because of its roles in tumorigenesis. Using RAS homolog family member B (RHOB) as a SMURF1 substrate in this screen, we identified a potent SMURF1 inhibitor and confirmed that it also blocks SMURF1-dependent degradation of SMAD family member 1 (SMAD1) and RHOA. An in vitro auto-ubiquitination assay indicated that this compound inhibits both SMURF1 and SMURF2 activities, indicating that it may be an antagonist of the catalytic activity of the HECT domain in SMURF1/2. Moreover, cell functional assays revealed that this compound effectively inhibits protrusive activity in HEK293T cells and blocks transforming growth factor beta (TGF beta)-induced epithelial-mesenchymal transition (EMT) in MDCK cells, similar to the effects on these processes caused by SMURF1 loss. In summary, the screening approach presented here may have great practical potential for identifying modulators of E3 ubiquitin ligases.	[Tian, Maoyuan; Zeng, Taoling; Liu, Mingdong; Han, Shang; Lin, Huayue; Lin, Qi; Li, Li; Jiang, Tingting; Li, Gao; Lin, Hong; Zhang, Ting; Kang, Qiaofeng; Deng, Xianming; Wang, Hong-Rui] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China	Xiamen University	Deng, XM; Wang, HR (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China.	xmdeng@xmu.edu.cn; wanghr@xmu.edu.cn	LIN, QI/HDO-8145-2022	Li, Li/0000-0002-7720-6731; Deng, Xianming/0000-0002-9354-5864; Wang, Hong-Rui/0000-0002-2916-8849	National Natural Science Foundation of China [U1605222, 81472459, 31070771, 31601132, U1405223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China U1605222, 81472459, and 31070771 (to H.-R. W.); 31601132 (to T. Z.); and U1405223 (to X. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Cao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04965; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Foote Peter K, 2017, Curr Protoc Chem Biol, V9, P174, DOI 10.1002/cpch.24; Gandolfi S, 2017, CANCER METAST REV, V36, P561, DOI 10.1007/s10555-017-9707-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Roeten MSF, 2018, CANCER CHEMOTH PHARM, V81, P227, DOI 10.1007/s00280-017-3489-0; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2017, ANNU REV BIOCHEM, V86, P123, DOI 10.1146/annurev-biochem-061516-044859; Wang D, 2017, CANCER METAST REV, V36, P683, DOI 10.1007/s10555-017-9703-z; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5901; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yi S, 2005, METHOD ENZYMOL, V399, P654, DOI 10.1016/S0076-6879(05)99043-5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 2017, ONCOTARGET, V8, P50521, DOI 10.18632/oncotarget.10648; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	39	19	20	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2880	2891		10.1074/jbc.RA118.003822	http://dx.doi.org/10.1074/jbc.RA118.003822			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30587574	Green Published, hybrid			2022-12-26	WOS:000459601600025
J	Windgassen, TA; Leroux, M; Sandler, SJ; Keck, JL				Windgassen, Tricia A.; Leroux, Maxime; Sandler, Steven J.; Keck, James L.			Function of a strand-separation pin element in the PriA DNA replication restart helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA repair; DNA replication; DNA-protein interaction; DNA damage response; protein complex; protein cross-linking; DNA replication restart; DNA strand-separation mechanisms; PriA; primosome assembly; strand-separation pin	ESCHERICHIA-COLI K-12; PHI X174-TYPE PRIMOSOME; CRYSTAL-STRUCTURE; STRUCTURAL MECHANISMS; COMPLEX-FORMATION; HIGH-THROUGHPUT; LAGGING-STRAND; SOS EXPRESSION; PROTEIN PRIA; NUCLEIC-ACID	DNA helicases are motor proteins that couple the chemical energy of nucleoside triphosphate hydrolysis to the mechanical functions required for DNA unwinding. Studies of several helicases have identified strand-separating "pin" structures that are positioned to intercept incoming dsDNA and promote strand separation during helicase translocation. However, pin structures vary among helicases and it remains unclear whether they confer a conserved unwinding mechanism. Here, we tested the biochemical and cellular roles of a putative pin element within the Escherichia coli PriA DNA helicase. PriA orchestrates replication restart in bacteria by unwinding the lagging-strand arm of abandoned DNA replication forks and reloading the replicative helicase with the help of protein partners that combine with PriA to form what is referred to as a primosome complex. Using in vitro protein-DNA cross-linking, we localized the putative pin (a beta-hairpin within a zinc-binding domain in PriA) near the ssDNA-dsDNA junction of the lagging strand in a PriA-DNA replication fork complex. Removal of residues at the tip of the beta-hairpin eliminated PriA DNA unwinding, interaction with the primosome protein PriB, and cellular function. We isolated a spontaneous intragenic suppressor mutant of the priA beta-hairpin deletion mutant in which 22 codons around the deletion site were duplicated. This suppressor variant and an Ala-substituted beta-hairpin PriA variant displayed wildtype levels of DNA unwinding and PriB binding in vitro. These results suggest essential but sequence nonspecific roles for the PriA pin element and coupling of PriA DNA unwinding to its interaction with PriB.	[Windgassen, Tricia A.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Leroux, Maxime; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	National Science Foundation [DGE-1256259]; National Institutes of Health [GM098885]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Graduate Research Fellowship Grant DGE-1256259 (to T. A. W.) and National Institutes of Health Grant GM098885 (to J. L. K. and S. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarattuthodiyil S, 2014, NUCLEIC ACIDS RES, V42, P11707, DOI 10.1093/nar/gku845; Bhattacharyya B, 2014, PROTEIN SCI, V23, P1498, DOI 10.1002/pro.2533; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bleichert F, 2017, SCIENCE, V355, DOI 10.1126/science.aah6317; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chen HW, 2004, J BIOL CHEM, V279, P38503, DOI 10.1074/jbc.M404769200; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Flores MJ, 2002, MOL MICROBIOL, V44, P783, DOI 10.1046/j.1365-2958.2002.02913.x; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Fujiyama S, 2014, FEBS J, V281, P5356, DOI 10.1111/febs.13080; Fujiyama S, 2014, BBA-PROTEINS PROTEOM, V1844, P299, DOI 10.1016/j.bbapap.2013.10.015; GALARDY RE, 1973, NATURE-NEW BIOL, V242, P127, DOI 10.1038/newbio242127a0; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/195162; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P837, DOI 10.1111/gtc.12001; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Liu Z, 2014, NUCLEIC ACIDS RES, V42, P9470, DOI 10.1093/nar/gku633; Lopper M, 2004, STRUCTURE, V12, P1967, DOI 10.1016/j.str.2004.09.004; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Mangiameli SM, 2017, ELIFE, V6, DOI 10.7554/eLife.19848; Manthei KA, 2015, P NATL ACAD SCI USA, V112, P4292, DOI 10.1073/pnas.1416746112; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Masai H, 1999, BIOCHIMIE, V81, P847, DOI 10.1016/S0300-9084(99)00211-4; Massoni SC, 2013, DNA REPAIR, V12, P1072, DOI 10.1016/j.dnarep.2013.09.003; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; McCool JD, 2001, P NATL ACAD SCI USA, V98, P8203, DOI 10.1073/pnas.121007698; Michel B, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00013-18; Michel B, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00102-17; Mizukoshi T, 2003, J BIOL CHEM, V278, P42234, DOI 10.1074/jbc.C300285200; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Pike ACW, 2015, P NATL ACAD SCI USA, V112, P4286, DOI 10.1073/pnas.1417594112; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 1996, GENETICS, V143, P5; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stylianidou S, 2016, MOL MICROBIOL, V102, P690, DOI 10.1111/mmi.13486; Swan MK, 2014, ACTA CRYSTALLOGR D, V70, P1465, DOI 10.1107/S139900471400501X; Szymanski MR, 2010, J MOL BIOL, V402, P344, DOI 10.1016/j.jmb.2010.07.008; Szymanski MR, 2010, J MOL BIOL, V398, P8, DOI 10.1016/j.jmb.2010.02.009; Szymanski MR, 2010, J BIOL CHEM, V285, P9683, DOI 10.1074/jbc.M109.094789; Tanaka T, 2003, GENES CELLS, V8, P251, DOI 10.1046/j.1365-2443.2003.00630.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2004, NAT STRUCT MOL BIOL, V11, P494, DOI 10.1038/nsmb0604-494; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Windgassen TA, 2018, P NATL ACAD SCI USA, V115, pE9075, DOI 10.1073/pnas.1809842115; Windgassen TA, 2018, NUCLEIC ACIDS RES, V46, P504, DOI 10.1093/nar/gkx1203; Windgassen TA, 2016, NUCLEIC ACIDS RES, V44, P9745, DOI 10.1093/nar/gkw690; Winkelman JT, 2015, MOL CELL, V59, P768, DOI 10.1016/j.molcel.2015.06.037; ZAVITZ KH, 1993, J BIOL CHEM, V268, P4337	81	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2801	2814		10.1074/jbc.RA118.006870	http://dx.doi.org/10.1074/jbc.RA118.006870			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593500	Green Published, hybrid			2022-12-26	WOS:000459601600019
J	Ibanez-Alamo, JD; Ruhmann, J; Perez-Contreras, T; Soler, M				Ibanez-Alamo, Juan Diego; Ruhmann, Josse; Perez-Contreras, Tomas; Soler, Manuel			Migration behavior and performance of the great spotted cuckoo (Clamator glandarius)	PLOS ONE			English	Article							PARASITE INTERACTIONS; SATELLITE TRACKING; BREEDING-SEASON; MATING PATTERNS; BROOD-PARASITE; MODEL SYSTEM; HOST; MAGPIE; BIRDS; MOVEMENTS	The study of brood parasitism has traditionally been focused on the breeding period, but recent evidence suggests that it urgently needs a new spatio-temporal perspective to explore novel avenues on brood parasite-host co-evolutionary interactions. Many brood parasites are migrants, but their ecology outside their short breeding season is poorly known. The great spotted cuckoo (Clamator glandarius) is one of the classical models in the study of brood parasitism, however, there is very little information on its migratory strategy, route and wintering grounds. Furthermore, there is no previous information on the geographical distribution of mortality and its causes in this species; information that is critical to understand the fluctuations in cuckoo populations and detect potential conservation risks. Using satellite tracking technology, we provide novel insight into the migratory behavior and performance of the great spotted cuckoo. We found individuals from southern Spain to be long-distance nocturnal migrants that use the East Atlantic Flyway for both post and pre-breeding migration, and that winter in the western Sahel. We found evidence of individual variation in their migration route, particularly regarding their post-breeding behavior in Spain. Our study also suggests that the south of Morocco is the most dangerous area due to a large number of deaths during the post-breeding migratory period. Furthermore, we found that natural predation seems to be the main cause of death, probably due to raptors, although human activities (i.e. hunting) could also played a role in the southern Mediterranean shore. Our study offers novel findings and challenges traditional ideas on the ecology of this species providing a good example of how the new spatio-temporal perspective can expand our knowledge on brood parasites.	[Ibanez-Alamo, Juan Diego; Ruhmann, Josse] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Perez-Contreras, Tomas; Soler, Manuel] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain	University of Groningen; University of Granada	Ibanez-Alamo, JD (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands.	j.d.ibanez-alamo@rug.nl	Pérez-Contreras, Tomás/N-2523-2019; Ibáñez-Álamo, Juan Diego/H-7624-2019	Pérez-Contreras, Tomás/0000-0002-2271-1706; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Spanish Ministerio de Economia y Competitividad/FEDER [CGL2011-25634/BOS, CGL2017-89338-P]	Spanish Ministerio de Economia y Competitividad/FEDER(Spanish Government)	This study was partially funded by the Spanish Ministerio de Economia y Competitividad/FEDER (research projects CGL2011-25634/BOS and CGL2017-89338-P to M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Alvarez A F, 1974, ACTA VERTEBR, V1, P43; [Anonymous], 2021, LANG ENV STAT COMP; ARIASDEREYNA L, 1987, J ORNITHOL, V128, P231, DOI 10.1007/BF01661697; Ban M, 2018, J ORNITHOL, V159, P337, DOI 10.1007/s10336-017-1508-x; Bolopo D, 2017, IBIS, V159, P103, DOI 10.1111/ibi.12429; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Brochet AL, 2016, BIRD CONSERV INT, V26, P1, DOI 10.1017/S0959270915000416; Catry I, 2011, IBIS, V153, P154, DOI 10.1111/j.1474-919X.2010.01073.x; Cramp S., 1985, HDB BIRDS EUROPE MID; Davies NB, 2000, ANIM BEHAV, V60, DOI [10.1006/anbe.2000.1568, DOI 10.1006/ANBE.2000.1568]; del Hoyo J., 2016, HDB BIRDS WORLD ALIV; Delibes M., 1975, Ardeola, V21, P183; Diaz M., 1996, AVES IBERICAS PASERI; Diaz-Ruiz F, 2015, BIRD STUDY, V62, P516, DOI 10.1080/00063657.2015.1080660; Ibanez-Alamo JD, 2012, HORM BEHAV, V61, P590, DOI 10.1016/j.yhbeh.2012.02.008; DUFTY AM, 1982, AUK, V99, P316; Eason P, 2016, BIRD CONSERV INT, V26, P39, DOI 10.1017/S0959270915000180; Erritzoe J., 2012, CUCKOOS OF THE WORLD, V1st; EURING, 2015, EURING EXCH COD 2000; FRY CH, 1988, BIRDS AFRICA; Dios ISG, 2006, ARDEOLA, V53, P39; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hewson CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12296; Kenward R. E., 2001, MANUAL WILDLIFE TAGG; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Liminana R, 2008, ARDEA, V96, P81, DOI 10.5253/078.096.0109; Macias-Sanchez E, 2013, IBIS, V155, P605, DOI 10.1111/ibi.12045; Martinez JG, 1998, MOL ECOL, V7, P289, DOI 10.1046/j.1365-294X.1998.00348.x; Martinez JG, 1999, EVOLUTION, V53, P269, DOI 10.1111/j.1558-5646.1999.tb05352.x; Moller Anders P., 2012, Chinese Birds, V3, P259; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; MUNDY PJ, 1977, OSTRICH, V48, P72, DOI 10.1080/00306525.1977.9634084; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Parejo D, 2007, ANIM COGN, V10, P81, DOI 10.1007/s10071-006-0055-2; Payne R, 2016, HDB BIRDS WORLD ALIV; Payne RB., 2005, CUCKOOS BIRD FAMILIE, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Poysa H, 2006, BEHAV ECOL, V17, P459, DOI 10.1093/beheco/arj049; Rappe A, 1965, AVES, V2, P27; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rodriguez-Ruiz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115615; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; ROTHSTEIN SI, 1984, ECOLOGY, V65, P77, DOI 10.2307/1939460; Sauder JD, 2012, WILDLIFE SOC B, V36, P813, DOI 10.1002/wsb.157; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Soler JJ, 2000, OECOLOGIA, V125, P309, DOI 10.1007/s004420000487; SOLER JJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P201, DOI 10.1007/BF00177797; Soler JJ, 2012, ENCICLOPEDIA VIRTUAL; Soler JJ, 2014, OECOLOGIA, V175, P105, DOI 10.1007/s00442-014-2901-2; SOLER M, 1994, CONDOR, V96, P802, DOI 10.2307/1369485; SOLER M, 1994, BEHAV ECOL SOCIOBIOL, V35, P295, DOI 10.1007/s002650050100; SOLER M, 1995, EVOLUTION, V49, P770, DOI 10.1111/j.1558-5646.1995.tb02312.x; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler Manuel, 1999, Animal Cognition, V2, P97, DOI 10.1007/s100710050029; Soler M, 2014, BIOL REV, V89, P688, DOI 10.1111/brv.12075; Soler Manuel, 2002, Avian Science, V2, P25; Strandberg R, 2010, BIOL LETTERS, V6, P297, DOI 10.1098/rsbl.2009.0785; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Telleria JL, 1981, MIGRACION AVES ESTRE; VALVERDE J. A, 1967, ESTRUCTURA COMUNIDAD; Vega ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168940; Vogl W, 2004, BEHAVIOUR, V141, P881, DOI 10.1163/1568539042265671; Willemoes M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16402; Willemoes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083515; Williams HM, 2016, J ORNITHOL, V157, P461, DOI 10.1007/s10336-015-1308-0; [No title captured]	71	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0208436	10.1371/journal.pone.0208436	http://dx.doi.org/10.1371/journal.pone.0208436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608941	Green Published, gold			2022-12-26	WOS:000454952800012
J	Giorgi, M; Sotiriou, V; Fanchini, N; Conigliaro, S; Bignardi, C; Nowlan, NC; Dall'Ara, E				Giorgi, Mario; Sotiriou, Vivien; Fanchini, Niccolo'; Conigliaro, Simone; Bignardi, Cristina; Nowlan, Niamh C.; Dall'Ara, Enrico			Prenatal growth map of the mouse knee joint by means of deformable registration technique	PLOS ONE			English	Article							SYNOVIAL JOINT; MORPHOGENESIS	Joint morphogenesis is the process during which distinct and functional joint shapes emerge during pre-and post-natal joint development. In this study, a repeatable semi-automatic protocol capable of providing a 3D realistic developmental map of the prenatal mouse knee joint was designed by combining Optical Projection Tomography imaging (OPT) and a deformable registration algorithm (Sheffield Image Registration toolkit, ShIRT). Eleven left limbs of healthy murine embryos were scanned with OPT (voxel size: 14.63 mu m) at two different stages of development: Theiler stage (TS) 23 (approximately 14.5 embryonic days) and 24 (approximately 15.5 embryonic days). One TS23 limb was used to evaluate the precision of the displacement predictions for this specific case. The remaining limbs were then used to estimate Developmental Tibia and Femur Maps. Acceptable uncertainties of the displacement predictions computed from repeated images were found for both epiphyses (between 1.3 mu m and 1.4 mu m for the proximal tibia and between 0.7 mu m and 1.0 mu m for the femur, along all directions). The protocol was found to be reproducible with maximum Modified Housdorff Distance (MHD) differences equal to 1.9 mu m and 1.5 mu m for the tibial and femoral epiphyses respectively. The effect of the initial shape of the rudiment affected the developmental maps with MHD of 21.7 mu m and 21.9 mu m for the tibial and femoral epiphyses respectively, which correspond to 1.4 and 1.5 times the voxel size. To conclude, this study proposes a repeatable semi-automatic protocol capable of providing mean 3D realistic developmental map of a developing rudiment allowing researchers to study how growth and adaptation are directed by biological and mechanobiological factors.	[Giorgi, Mario; Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Giorgi, Mario; Dall'Ara, Enrico] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Giorgi, Mario] Certara UK Ltd, Certara QSP, Simcyp Div, Sheffield, S Yorkshire, England; [Sotiriou, Vivien; Nowlan, Niamh C.] Imperial Coll London, Dept Bioengn, London, England; [Fanchini, Niccolo'; Conigliaro, Simone; Bignardi, Cristina] Politecn Torino, Dept Mech, Turin, Italy	University of Sheffield; University of Sheffield; Certara UK Ltd; Imperial College London; Polytechnic University of Turin	Giorgi, M (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Giorgi, M (corresponding author), Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.; Giorgi, M (corresponding author), Certara UK Ltd, Certara QSP, Simcyp Div, Sheffield, S Yorkshire, England.	m.giorgi@sheffield.ac.uk	Dall'Ara, Enrico/ABA-5046-2020; Bignardi, Cristina/AAG-6780-2020	Dall'Ara, Enrico/0000-0003-1471-5077; Bignardi, Cristina/0000-0002-7065-2552; Sotiriou, Vivien/0000-0003-2892-2915; Giorgi, Mario/0000-0001-7763-8545; Nowlan, Niamh/0000-0002-9083-6279	Engineering and Physical Sciences Research Council [EP/K03877X/1]; European Research Council under the European Union's Seventh Framework Programme (ERC Grant) [336306]; EPSRC [EP/K03877X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council under the European Union's Seventh Framework Programme (ERC Grant)(European Research Council (ERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was partially funded by the Engineering and Physical Sciences Research Council EP/K03877X/1 (https://epsrc.ukri.org/), and the European Research Council under the European Union's Seventh Framework Programme (ERC Grant agreement no. [336306]) (https://ec.europa.eu/research/fp7/index_en.cfm).	Barber DC, 2007, MED IMAGE ANAL, V11, P648, DOI 10.1016/j.media.2007.06.011; Barber D. C., 2005, Journal of Medical Engineering & Technology, V29, P53, DOI 10.1080/03091900412331289889; Bernardini F, 1999, IEEE T VIS COMPUT GR, V5, P349, DOI 10.1109/2945.817351; Dall'Ara E, 2014, J BIOMECH, V47, P2956, DOI 10.1016/j.jbiomech.2014.07.019; Dall'Ara E, 2017, FRONT MATER, V4, DOI 10.3389/fmats.2017.00031; Dubuisson M, 1994, P 12 INT C PATT REC; Galea GL, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00052; Giorgi M, 2018, MED ENG PHYS, V62, P7, DOI 10.1016/j.medengphy.2018.09.001; Giorgi m, 2018, NUMERICAL METHODS AD, P17; Giorgi M, 2016, WIRES SYST BIOL MED, V8, P485, DOI 10.1002/wsbm.1356; Giorgi M, 2015, J BIOMECH, V48, P3390, DOI 10.1016/j.jbiomech.2015.06.002; Giorgi M, 2014, J BIOMECH, V47, P989, DOI 10.1016/j.jbiomech.2014.01.002; Heegaard JH, 1999, J ORTHOPAED RES, V17, P509, DOI 10.1002/jor.1100170408; Hogervorst T, 2012, CLIN ORTHOP RELAT R, V470, P3284, DOI 10.1007/s11999-012-2511-4; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Johnson M., 1986, TRENDS GENET, V2, P298, DOI DOI 10.1016/0168-9525(86)90275-1; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; Mikic B, 2000, J ORTHOPAED RES, V18, P406, DOI 10.1002/jor.1100180312; Nowlan NC, 2014, J ORTHOP RES, V32, P777, DOI 10.1002/jor.22606; Nowlan NC, 2014, J ANAT, V224, P482, DOI 10.1111/joa.12143; Nowlan NC, 2010, BONE, V46, P1275, DOI 10.1016/j.bone.2009.11.026; Osborne A. C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P448; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Palanca M, 2017, J BIOMECH, V58, P27, DOI 10.1016/j.jbiomech.2017.04.007; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P664, DOI 10.1101/pdb.prot5639; Roddy KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017526; Sandell LJ, 2012, NAT REV RHEUMATOL, V8, P77, DOI 10.1038/nrrheum.2011.199; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Theiler K, 1972, HOUSE MOUSE DEV NORM; Turkowski K., 1990, GRAPHICS GEMS, P147, DOI [10.1.1.116.7898, DOI 10.1016/B978-0-08-050753-8.50042-5]; Varzi D, 2015, BONE, V81, P495, DOI 10.1016/j.bone.2015.08.026	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0197947	10.1371/journal.pone.0197947	http://dx.doi.org/10.1371/journal.pone.0197947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605480	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000454759900001
J	Westfall, AK; Miller, MA; Murray, CM; Falk, BG; Guyer, C; Romagosa, CM				Westfall, Aundrea K.; Miller, Melissa A.; Murray, Christopher M.; Falk, Bryan G.; Guyer, Craig; Romagosa, Christina M.			Host-specific phenotypic variation of a parasite co-introduced with invasive Burmese pythons	PLOS ONE			English	Article							MEASUREMENT ERROR; MORPHOLOGY; VARIABILITY; DIGENEA; SNAKES	Invasive Burmese pythons (Python bivittatus Kuhl, 1820) have introduced a lung parasite, Raillietiella orientalis, (Hett, 1915) from the python's native range in Southeast Asia to its introduced range in Florida, where parasite spillover from pythons to two families and eight genera of native snakes has occurred. Because these novel host species present a diversity of ecological and morphological traits, and because these parasites attach to their hosts with hooks located on their cephalothorax, we predicted that R. orientalis would exhibit substantial, host-associated phenotypic plasticity in cephalothorax shape. Indeed, geometric morphometric analyses of 39 parasites from five host species revealed significant variation among host taxa in R. orientalis cephalothorax shape. We observed differences associated with host ecology, where parasites from semi-aquatic and aquatic snakes exhibited the greatest morphological similarity. Morphological analyses of R. orientalis recovered from invasive pythons, native pit vipers, and terrestrial snakes each revealed distinct shapes. Our results suggest R. orientalis can exhibit significant differences in morphology based upon host species infected, and this plasticity may facilitate infection with this non-native parasite in a wide array of novel squamate host species.	[Westfall, Aundrea K.; Miller, Melissa A.; Murray, Christopher M.; Guyer, Craig] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Falk, Bryan G.] US Geol Survey, Ft Collins, CO USA; [Romagosa, Christina M.] Univ Florida, Wildlife Ecol & Conservat, Gainesville, FL USA; [Murray, Christopher M.] Tennessee Technol Univ, Dept Biol Sci, Cookeville, TN USA	Auburn University System; Auburn University; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; Tennessee Technological University	Miller, MA (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	melissamiller@auburn.edu		Westfall, Aundrea/0000-0003-4849-4831; Miller, Melissa/0000-0002-6743-6808	Auburn University Center for Environmental Studies at the Urban-Rural Interface; Auburn University	Auburn University Center for Environmental Studies at the Urban-Rural Interface; Auburn University	Funded by Auburn University Center for Environmental Studies at the Urban-Rural Interface (https://cws.auburn.edu/CESURI/); to MAM; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Auburn University Dissertation Fellowship Grants (http://www.auburn.edu/); to MAM. Any use of trade, firm, or product names are for descriptive purposes only and does not imply endorsement by the U. S. Government.	Bakkes DK, 2017, ZOOMORPHOLOGY, V136, P403, DOI 10.1007/s00435-017-0357-8; BLANKESPOOR HD, 1974, AM MIDL NAT, V92, P415, DOI 10.2307/2424306; Cheang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057592; Christoffersen M. L., 2013, Zoologische Mededelingen (Leiden), V87, P1; DELEON GPP, 1995, J PARASITOL, V81, P818, DOI 10.2307/3283989; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DOWNES BJ, 1990, SYST ZOOL, V39, P162, DOI 10.2307/2992453; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; Dunn AM, 2012, FUNCT ECOL, V26, P1262, DOI 10.1111/j.1365-2435.2012.02041.x; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Gibbons J.W., 2004, N AM WATERSNAKES NAT; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Hildebrand J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1095-8; HUBER JT, 1988, CAN ENTOMOL, V120, P893, DOI 10.4039/Ent120893-10; Hugot JP, 2007, INFECT GENET EVOL, V7, P168, DOI 10.1016/j.meegid.2006.08.001; Hugot JP, 1996, ADV MORPHOMETRICS; Kelehear Crystal, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P20, DOI 10.1016/j.ijppaw.2013.12.003; Kelehear C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024936; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kmentova N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39605; LILLYWHITE HB, 1987, AM ZOOL, V27, P81; Lymbery Alan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P171, DOI 10.1016/j.ijppaw.2014.04.002; Mastitsky SE, 2010, DIVERS DISTRIB, V16, P798, DOI 10.1111/j.1472-4642.2010.00693.x; Meshaka Walter E. Jr., 2000, Florida Scientist, V63, P84; Michel J F, 1972, Int J Parasitol, V2, P297, DOI 10.1016/0020-7519(72)90067-7; Michel J.F., 1972, International J Parasit, V2, P305, DOI 10.1016/0020-7519(72)90068-9; MICHEL JF, 1976, INT J PARASITOL, V6, P83, DOI 10.1016/0020-7519(76)90014-X; Mideo N, 2012, FUTURE MICROBIOL, V7, P17, DOI [10.2217/fmb.11.134, 10.2217/FMB.11.134]; Miller MA, 2018, ECOL EVOL, V8, P830, DOI 10.1002/ece3.3557; Paterson RA, 2013, ANIM BEHAV, V86, P1301, DOI 10.1016/j.anbehav.2013.09.036; de Leon GPP, 2010, J PARASITOL, V96, P453, DOI 10.1645/GE-2260.1; Perkins SL, 2011, PARASITOLOGY, V138, P1664, DOI 10.1017/S0031182011000679; Perry SF, 2013, REPTILIAN LUNGS FUNC, V79; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Pritchard MH, 1982, COLLECTION PRESERVAT, P61; ROHLF FJ, 2004, TPSDIG2 STONY BROOK; Snow RW, 2007, BIOL BOAS PYTHONS; Vandame R, 2000, CAN J ZOOL, V78, P2037, DOI 10.1139/cjz-78-11-2037; Vignon M, 2010, PARASITOL INT, V59, P183, DOI 10.1016/j.parint.2010.01.006; Zardus JD, 2014, MAR BIOL, V161, P45, DOI 10.1007/s00227-013-2312-7; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	41	1	1	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209252	10.1371/journal.pone.0209252	http://dx.doi.org/10.1371/journal.pone.0209252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601869	Green Submitted, gold, Green Published			2022-12-26	WOS:000454683200052
J	Champion, L; Economides, M; Chandler, C				Champion, Louise; Economides, Marcos; Chandler, Chris			The efficacy of a brief app-based mindfulness intervention on psychosocial outcomes in healthy adults: A pilot randomised controlled trial	PLOS ONE			English	Article							STRESS REDUCTION; MISSING DATA; GENDER-DIFFERENCES; SMARTPHONE APP; EFFECT SIZES; LIFE; SATISFACTION; RUMINATION; MIND; MEDITATION	Background Previous evidence suggests that mindfulness training may improve aspects of psychosocial well-being. Whilst mindfulness is traditionally taught in person, consumers are increasingly turning to mindfulness-based smartphone apps as an alternative delivery medium for training. Despite this growing trend, few studies have explored whether mindfulness delivered via a smartphone app can enhance psychosocial well-being within the general public. Methods The present pilot randomised controlled trial compared the impact of engaging with the self-guided mindfulness meditation (MM) app 'Headspace' (n = 38) for a period of 10 or 30 days, to a wait-list (WL) control (n = 36), using a cohort of adults from the general population. The Satisfaction with Life Scale, Perceived Stress Scale, and Wagnild Resilience Scale were administered online at baseline and after 10 and 30 days of the intervention. Results Twelve participants (MM n = 9, WL n = 3) were lost to follow-up for unknown reasons. Relative to the WL control, the MM app positively impacted self-reported satisfaction with life, stress, and resilience at day 10, with further improvements emerging at day 30 (Cohen's d = 0.57, 1.42, 0.63 respectively). The rate of improvement was largest at the 10-day assessment point, dropping moderately by day 30. Participants that rated the MM app as easy to engage with experienced the largest self-reported benefits. Moreover, the MM app was able to protect against an unexpected increase in perceived stress that emerged in the control group. Conclusions This pilot randomised controlled trial shows that self-reported improvements in psychosocial outcomes can be achieved at low cost through short-term engagement with a mindfulness-based smartphone app, and should be followed up with more substantive studies.	[Champion, Louise; Chandler, Chris] London Metropolitan Univ, Sch Social Sci, London, England; [Economides, Marcos] Headspace Inc, Los Angeles, CA 90404 USA	London Metropolitan University; University of Greenwich	Economides, M (corresponding author), Headspace Inc, Los Angeles, CA 90404 USA.	m_econ@outlook.com						Armijo-Olivo S, 2009, PHYS THER REV, V14, P36, DOI 10.1179/174328809X405928; Austin EJ, 1998, PERS INDIV DIFFER, V24, P421, DOI 10.1016/S0191-8869(97)00175-X; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Baer RA, 2012, J CLIN PSYCHOL, V68, P755, DOI 10.1002/jclp.21865; Bajaj B, 2016, PERS INDIV DIFFER, V93, P63, DOI 10.1016/j.paid.2015.09.005; Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Beckman HB, 2012, ACAD MED, V87, P815, DOI 10.1097/ACM.0b013e318253d3b2; Bennike IH, 2017, J COGN ENHANCE, V1, P172, DOI 10.1007/s41465-017-0020-9; Blankers M, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1448; Bogosian A, 2015, MULT SCLER J, V21, P1184, DOI 10.1177/1352458515576261; Broderick PC, 1998, J EARLY ADOLESCENCE, V18, P173, DOI 10.1177/0272431698018002003; Brown KW, 2007, PSYCHOL INQ, V18, P211, DOI 10.1080/10478400701598298; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Carmody J, 2009, J CLIN PSYCHOL, V65, P627, DOI 10.1002/jclp.20555; Cavanagh K, 2018, MINDFULNESS, V9, P1191, DOI 10.1007/s12671-017-0856-1; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crane RS, 2012, MINDFULNESS, V3, P76, DOI 10.1007/s12671-011-0073-2; Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512; Deyo M, 2009, EXPLORE-NY, V5, P265, DOI 10.1016/j.explore.2009.06.005; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Economides M, 2018, MINDFULNESS, V9, P1584, DOI 10.1007/s12671-018-0905-4; Enders CK, 2017, BEHAV RES THER, V98, P4, DOI 10.1016/j.brat.2016.11.008; Falkenstrom F, 2010, PERS INDIV DIFFER, V48, P305, DOI 10.1016/j.paid.2009.10.022; Folch-Fortuny A, 2015, CHEMOMETR INTELL LAB, V146, P77, DOI 10.1016/j.chemolab.2015.05.006; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gotink RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124344; Howells A, 2016, J HAPPINESS STUD, V17, P163, DOI 10.1007/s10902-014-9589-1; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Jha AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116889; Johnson DP, 2013, PERS INDIV DIFFER, V55, P367, DOI 10.1016/j.paid.2013.03.019; Johnson S, 2015, MINDFULNESS, V6, P88, DOI 10.1007/s12671-013-0234-6; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Khoury B, 2015, J PSYCHOSOM RES, V78, P519, DOI 10.1016/j.jpsychores.2015.03.009; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Laurie J, 2016, INT J MED INFORM, V96, P38, DOI 10.1016/j.ijmedinf.2016.02.010; Lim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118221; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Ly KH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003440; Lyubomirsky S., 2008, THE HOW OF HAPPINESS; Lyubomirsky S, 2013, CURR DIR PSYCHOL SCI, V22, P57, DOI 10.1177/0963721412469809; Mahmood L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153923; Mak WWS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3746; Mani M, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4328; Morgan D, 2003, PSYCHOTHER RES, V13, P123, DOI [10.1080/713869628, 10.1093/ptr/kpg004]; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nam SW, 2016, INT J MENT HEALTH AD, V14, P969, DOI 10.1007/s11469-016-9667-1; Parks AC, 2012, EMOTION, V12, P1222, DOI 10.1037/a0028587; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Plaza I, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2733; Roeser RW, 2013, J EDUC PSYCHOL, V105, P787, DOI 10.1037/a0032093; Rojiani R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00551; Santorelli S. F., 2014, MINDFULNESS BASED ST; Schueller SM, 2010, J POSIT PSYCHOL, V5, P192, DOI 10.1080/17439761003790948; Shapiro D H Jr, 1992, Int J Psychosom, V39, P62; Shapiro SL, 2008, J CLIN PSYCHOL, V64, P840, DOI 10.1002/jclp.20491; Sharma G., 2017, INT J APPL RES, V3, P749, DOI DOI 10.22271/ALLRESEARCH.2017.V3.I3I; Spijkerman MPJ, 2016, CLIN PSYCHOL REV, V45, P102, DOI 10.1016/j.cpr.2016.03.009; Stawarczyk D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00363; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Sterling M., 2011, J PHYSIOTHER; Sterling M, 2011, J PHYSIOTHER, V57, P259, DOI 10.1016/S1836-9553(11)70060-1; Teare MD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-264; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; Van Dam NT, 2018, PERSPECT PSYCHOL SCI, V13, P36, DOI 10.1177/1745691617709589; van Emmerik AAP, 2017, MINDFULNESS, V6, P189; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wen L, 2017, ACAD PSYCHIATR, V41, P646, DOI 10.1007/s40596-017-0768-3; Wylde CM, 2017, J PEDIATR NURS, V36, P205, DOI 10.1016/j.pedn.2017.06.008	70	57	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209482	10.1371/journal.pone.0209482	http://dx.doi.org/10.1371/journal.pone.0209482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596696	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000454627200050
J	Kim, YA; Park, YS; Youk, T; Lee, H; Lee, K				Kim, Young Ah; Park, Yoon Soo; Youk, Taemi; Lee, Hyukmin; Lee, Kyungwon			Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; SEQUENCE TYPE 131; KLEBSIELLA-PNEUMONIAE; COMMUNITY-ONSET; ANTIBIOTIC USE; MAJOR CAUSE; INFECTION; EPIDEMIOLOGY; HOSPITALS; EMERGENCE	The purpose of this study is to determine the correlation between use of antimicrobials, such as fluoroquinolone, cefoxitin, and cefotaxime, and Escherichia coli resistance using a nationwide database. Nationwide data on antimicrobial consumption for 12 years (2002 to 2013) were acquired from a database of subjects (n = 1,025,340) included in the National Health Insurance Service-National Sample Cohort. National antimicrobial resistance rates of E. coli were obtained from the Korean Antimicrobial Resistance Monitoring System, which has been administered by the Korean Centers for Disease Control and Prevention since 2002. Fluoroquinolone-resistance rates of E. coli isolated from general hospitals have continuously increased since 2002 and were correlated with nationwide fluoroquinolone use (r = 0.82, P = 0.0012) or ciprofloxacin use (r = 0.90, P<0.0001). Cefotaxime-resistance rates of E. coli isolated from general hospitals markedly increased since 2008 and were correlated with nationwide cefotaxime use (r = 0.94, P<0.0001) or third-generation cephalosporin use (r = 0.96, P<0.0001). Cefoxitin-resistance rates of E. coli isolated from general hospitals peaked in 2010 and significantly correlated with cephamycin use at a two-year interval (r = 0.64, P = 0.0256). In conclusion, consumption of antimicrobials such as fluoroquinolone, cefoxitin, and cefotaxime is well correlated with the resistance rates of E. coli to these agents. This study provides background data for national antimicrobial management policies to reduce antimicrobial resistance.	[Kim, Young Ah] Natl Hlth Insurance Serv Ilsan Hosp, Dept Lab Med, Goyang, South Korea; [Park, Yoon Soo] Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Goyang, South Korea; [Youk, Taemi] Natl Hlth Insurance Serv Ilsan Hosp, Res Inst, Goyang, South Korea; [Lee, Hyukmin; Lee, Kyungwon] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Hyukmin; Lee, Kyungwon] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea	National Health Insurance Service; National Health Insurance Service; National Health Insurance Service; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, YS (corresponding author), Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Goyang, South Korea.; Lee, H (corresponding author), Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Lee, H (corresponding author), Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea.	yspark@nhimc.or.kr; hmlee.labmed@gmail.com		Lee, Kyungwon/0000-0003-3788-2134; Lee, Hyukmin/0000-0002-8523-4126	National Health Insurance Service Ilsan Hospital [2016-20-001]	National Health Insurance Service Ilsan Hospital	This study was funded by grants from the National Health Insurance Service Ilsan Hospital (2016-20-001) (YAK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; BAUERNFEIND A, 1989, INFECTION, V17, P316, DOI 10.1007/BF01650718; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; Burke L, 2012, J HOSP INFECT, V81, P192, DOI 10.1016/j.jhin.2012.04.021; Cha MK, 2016, DIAGN MICR INFEC DIS, V84, P102, DOI 10.1016/j.diagmicrobio.2015.10.015; Cheng AC, 2012, EMERG INFECT DIS, V18, P1453, DOI 10.3201/eid1809.111515; CLSI, 2017, PERF STAND ANT SUSC; Dexter C, 2015, EXPERT REV ANTI-INFE, V13, P567, DOI 10.1586/14787210.2015.1025055; Doi Y, 2007, EMERG INFECT DIS, V13, P1121, DOI 10.3201/eid1307.070094; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gross AE, 2014, ANTIMICROB AGENTS CH, V58, P5262, DOI 10.1128/AAC.02582-14; Hjaltested EKR, 2003, SCAND J INFECT DIS, V35, P21, DOI 10.1080/0036554021000026996; Hombach M, 2012, J ANTIMICROB CHEMOTH, V67, P622, DOI 10.1093/jac/dkr524; Johnson JR, 2013, J INFECT DIS, V207, P919, DOI 10.1093/infdis/jis933; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P1005, DOI 10.1093/jac/dkg488; Kang CI, 2008, EUR J CLIN MICROBIOL, V27, P85, DOI 10.1007/s10096-007-0401-6; Kim BN, 2012, INFECT CHEMOTHER, V44, P250, DOI 10.3947/ic.2012.44.4.250; Kim DS, 2010, J KOREAN ACAD MANAG, V2, P47; Kim SY, 2016, DIAGN MICR INFEC DIS, V84, P97, DOI 10.1016/j.diagmicrobio.2015.10.016; Kim YA, 2017, INT J INFECT DIS, V54, P39, DOI 10.1016/j.ijid.2016.11.010; Korean Centers for Disease Control and Prevention, 2013, KOREAN ANTIMICROBIAL; Lee E.K., 2003, FORUM HLTH SOCIAL AF, V77, P72; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee Y, 2014, KOREAN J NOSOCOMIAL, V19, P29, DOI DOI 10.14192/KJNIC.2014.19.1.29; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Monnet DL, 1998, INFECT CONT HOSP EP, V19, P388; Nagel JL, 2016, INFECT DIS CLIN N AM, V30, P771, DOI 10.1016/j.idc.2016.04.012; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; Park MJ, 2013, ANN LAB MED, V33, P353, DOI 10.3343/alm.2013.33.5.353; Park SY, 2017, KOREAN J INTERN MED, V32, P146, DOI 10.3904/kjim.2015.113; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Schjorring Susanne, 2011, Int J Microbiol, V2011, P312956, DOI 10.1155/2011/312956; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shibayama Keigo, 2015, Annals of Clinical Microbiology, V18, P111; Turnidge J, 2005, LANCET, V365, P548; Voulgari E, 2016, ANTIMICROB AGENTS CH, V60, P1862, DOI 10.1128/AAC.01514-15; World Health Organization, DEF DAIL DOS; Zerr DM, 2016, ANTIMICROB AGENTS CH, V60, P4237, DOI 10.1128/AAC.00187-16	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209580	10.1371/journal.pone.0209580	http://dx.doi.org/10.1371/journal.pone.0209580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596704	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200057
J	Soto-Yeber, L; Soto-Ortiz, J; Godoy, P; Godoy-Herrera, R				Soto-Yeber, Luis; Soto-Ortiz, Jose; Godoy, Pablo; Godoy-Herrera, Raul			The behavior of adult Drosophila in the wild	PLOS ONE			English	Article							AGGREGATION PHEROMONE; MELANOGASTER; COURTSHIP; RESPONSES; SELECTION; ACETATE	Little is known about how Drosophila adults behave in the wild, including mating, allocation of food and space, and escape from predators. This lack of information has negative implications for our ability to understand the capabilities of the nervous system to integrate sensory cues necessary for the adaptation of organisms in natural conditions. We characterized a set of behavioral routines of D. melanogaster and D. simulans adults in three ecologically different orchards: grape, apple and prickly pear. We also investigated how the flies identify conspecifics and aliens in the wild to better understand relationships between group formation and adaptation of Drosophila to breeding sites. We characterized the locations by recording in each orchard humidity, temperature, illumination conditions, pH of fruits, the presence/absence of other Drosophila species and the predator ant Linepithema humile. Our findings suggest that the home range of these species of Drosophila includes decaying fruits and, principally, a variety of microhabitats that surround the fruits. The ecological heterogeneity of the orchards and odors emitted by adult D. melanogaster and D. simulans influence perch preferences, cluster formation, court and mating, egg-laying site selection, and use of space. This is one of the first large examinations of the association between changing, complex environments and a set of adult behaviors of Drosophila. Therefore, our results have implications for understanding the genetic differentiation and evolution of populations of species in the genus Drosophila.	[Soto-Yeber, Luis; Soto-Ortiz, Jose] Univ Bio Bio, Fac Ciencias, Dept Ciencias Basicas, Campus Fernando May,Ave Coihueco S-N, Chillan, Chile; [Godoy, Pablo; Godoy-Herrera, Raul] Univ Chile, Fac Med, ICBM, Programa Genet Humana, Santiago 1027, Chile; [Godoy, Pablo] Concordia Univ, Ctr Struct & Funct Genom, Loyola Campus, Montreal, PQ, Canada	Universidad del Bio-Bio; Universidad de Chile; Concordia University - Canada	Godoy-Herrera, R (corresponding author), Univ Chile, Fac Med, ICBM, Programa Genet Humana, Santiago 1027, Chile.	raulgodoy.herrera@gmail.com	Godoy, Pablo/E-8774-2016	Godoy, Pablo/0000-0002-3736-2465				Allee W., 1949, PRINCIPLES ANIMAL EC; Alvarado A, 2017, ELIFE, V6, DOI 10.7554/eLife.31058; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Batista MRD, 2017, PEERJ, V5, DOI 10.7717/peerj.3063; Beltrami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039393; BRNCIC D, 1987, Revista Chilena de Entomologia, V15, P37; BRNCIC D, 1970, ESSAYS EVOLUTION GEN, P401; Burdick AB, 1957, DROSOPH INF SER, V28, P170; Carson H.L., 1983, Genetics and Biology of Drosophila, V3d, P1; Coyne JA, 2002, EVOLUTION, V56, P2424, DOI 10.1111/j.0014-3820.2002.tb00168.x; Del Pino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136363; Del Pino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102159; del Solar E, 1973, B SOC BIOL CONCEPCIO, V46, P127; DELPINO F, 1991, REV BRAS GENET, V14, P33; DELSOLAR E, 1968, GENETICS, V58, P275; Dierick HA, 2007, NAT PROTOC, V2, P2712, DOI 10.1038/nprot.2007.404; DILLWITH JW, 1981, INSECT BIOCHEM, V11, P247, DOI 10.1016/0020-1790(81)90002-0; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P325, DOI 10.1017/CBO9780511711909.016; Godoy-Herrera R, 2007, BEHAV GENET, V37, P595, DOI 10.1007/s10519-007-9151-6; GODOYHERRERA R, 1984, REV BRAS GENET, V7, P41; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GROMKO MH, 1993, ANIM BEHAV, V45, P253, DOI 10.1006/anbe.1993.1031; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; JAENIKE J, 1991, J ANIM ECOL, V60, P913, DOI 10.2307/5421; Jennings JH, 2014, J INSECT PHYSIOL, V61, P16, DOI 10.1016/j.jinsphys.2013.12.004; Kohn NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081272; Korol A, 2000, P NATL ACAD SCI USA, V97, P12637, DOI 10.1073/pnas.220041397; Lihoreau M, 2016, J EXP BIOL, V219, P668, DOI 10.1242/jeb.127431; Markow TA, 2015, ELIFE, V4, DOI 10.7554/eLife.06793; Mast JD, 2014, ELIFE, V3, DOI 10.7554/eLife.04205; McCullagh P, 1989, GEN LINEAR MODELS; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Michalak P, ISRAEL P NATL ACAD S, V98, P13195, DOI [10.1073/pnas, DOI 10.1073/PNAS]; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; POWELL JR, 1997, DROSOPHILA MODEL; Ramdya P, 2015, NATURE, V519, P233, DOI 10.1038/nature14024; SCHANER AM, 1987, J CHEM ECOL, V13, P1777, DOI 10.1007/BF00980218; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sperlich D., 1962, DROSOPHILA INF SERV, V36, P118; Stamps JA, 2016, BIOL REV, V91, P534, DOI 10.1111/brv.12186	45	26	26	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209917	10.1371/journal.pone.0209917	http://dx.doi.org/10.1371/journal.pone.0209917			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596767	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200105
J	Zou, GY; Xiao, YZ; Wang, MS; Zhang, HM				Zou, Guangyu; Xiao, Yanzhong; Wang, Miaosen; Zhang, Hongmei			Detection of bitterness and astringency of green tea with different taste by electronic nose and tongue	PLOS ONE			English	Article							SENSORY EVALUATION; QUALITY; PREDICTION; BLACK	An electronic nose was used to evaluate the bitterness and astringency of green tea, and the possible application of the sensor was assessed for the evaluation of different tasting green tea samples. Three different grades of green tea were measured with the electronic nose and electronic tongue. The sensor array of the E-nose was optimized by correlation analysis. The relationship between the signal of the optimized sensor array and the bitterness and astringency of green tea was developed using multiple linear regression (MLR), partial least squares regression (PLSR), and back propagation neural network (BPNN). BPNN is a multilayer feedforward neural network trained by an error propagation algorithm. The results showed that the BPNN model possessed good ability to predict the bitterness and astringency of green tea, with high correlation coefficients (R = 0.98 for bitterness and R = 0.96 for astringency) and relatively lower root mean square errors (RMSE) (0.25 for bitterness and 0.32 for astringency) for the calibration set. The R value is 0.92 and 0.87, and the RMSE is 0.34 and 0.55, for bitterness and astringency, respectively, of the prediction set. These results indicate that the electronic nose could be used as a feasible and reliable method to evaluate the taste of green tea. These results can provide a theoretical reference for rapid detection of the bitter and astringent taste of green tea using volatile odor information.	[Zou, Guangyu; Xiao, Yanzhong; Wang, Miaosen; Zhang, Hongmei] Henan Agr Univ, Sch Mech & Elect Engn, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Zhang, HM (corresponding author), Henan Agr Univ, Sch Mech & Elect Engn, Zhengzhou, Henan, Peoples R China.	hmzh86022625@sina.com		Zou, Guangyu/0000-0003-3182-8217	Chinese National Foundation of Nature and Science [31501213]; special Fund for Henan Agriculture Research System [S2015-02-G07]; Fund for Youth teachers of Universities of Henan Province [2015GGJS-077]; National Agricultural Industry Technology System [CARS-03]	Chinese National Foundation of Nature and Science; special Fund for Henan Agriculture Research System; Fund for Youth teachers of Universities of Henan Province; National Agricultural Industry Technology System	This study was funded by the Chinese National Foundation of Nature and Science through project 31501213, the special Fund for Henan Agriculture Research System through project S2015-02-G07, the Fund for Youth teachers of Universities of Henan Province through project 2015GGJS-077 and National Agricultural Industry Technology System through project CARS-03).; This work is supported by the financial support of the Chinese National Foundation of Nature and Science through Project 31501213, the special Fund for Henan Agriculture Research System through Project S2015-02-G07, the Fund for Youth teachers of Universities of Henan Province through Project 2015GGJS-077 and National Agricultural Industry Technology System through Project CARS-03).	Amanda Martin, 2008, INT J FOOD ENG, V4, P99; Cheng Huan, 2012, T CHINESE SOC AGR EN, V28, P375; Eifler J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021026; Gao L, 2016, INT J FOOD SCI TECH, V51, P1338, DOI 10.1111/ijfs.13103; Guoli Wang, 2011, Journal of Computers, V6, P2143, DOI 10.4304/jcp.6.10.2143-2148; Hayashi N, 2013, FOOD RES INT, V53, P816, DOI 10.1016/j.foodres.2013.01.017; Ito Y, 2005, MOL NUTR FOOD RES, V49, P61, DOI 10.1002/mnfr.200400021; KING BM, 1982, J AGR FOOD CHEM, V30, P838, DOI 10.1021/jf00113a010; Lippolis V, 2016, INT J FOOD MICROBIOL, V218, P71, DOI 10.1016/j.ijfoodmicro.2015.11.011; Liu DongMei, 2016, Journal of Henan Agricultural Sciences, V45, P35; Liu Panpan, 2014, Journal of Chinese Institute of Food Science and Technology, V14, P173; Narukawa M, 2010, INT J FOOD SCI TECH, V45, P1579, DOI 10.1111/j.1365-2621.2010.02304.x; Pu BQ., 2017, FOOD INDUSTRY, V38, P301; Radi, 2016, COMPUT ELECTRON AGR, V121, P429, DOI 10.1016/j.compag.2015.11.013; Sanaeifar A, 2016, MEASUREMENT, V82, P105, DOI 10.1016/j.measurement.2015.12.041; Scharbert S, 2005, J AGR FOOD CHEM, V53, P5377, DOI 10.1021/jf050294d; Scharbert S, 2004, J AGR FOOD CHEM, V52, P3498, DOI 10.1021/jf049802u; Tudu B, 2009, SENSOR ACTUAT B-CHEM, V138, P90, DOI 10.1016/j.snb.2009.02.025; Wan Xiaochun, 2010, CHINESE TEAS; Wei ZB, 2015, FOOD CHEM, V177, P89, DOI 10.1016/j.foodchem.2014.12.100; Yao JA, 2010, APPL MECH MATER, V29-32, P2804, DOI 10.4028/www.scientific.net/AMM.29-32.2804; Yashin A. Y., 2015, Journal of Food Research, V4, P56; Yu PG, 2014, FOOD CHEM, V155, P9, DOI 10.1016/j.foodchem.2014.01.046; Zhang HM, 2011, ADV MATER RES-SWITZ, V239-242, P2096, DOI 10.4028/www.scientific.net/AMR.239-242.2096; Zhang YingNa, 2017, Journal of Tea Science, V37, P1; [周锡樑 ZHOU Xiliang], 2007, [氨基酸和生物资源, Amino Acids & Biotic Resources], V29, P46	26	18	19	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0206517	10.1371/journal.pone.0206517	http://dx.doi.org/10.1371/journal.pone.0206517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596674	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200008
J	Ulens, C				Ulens, Chris			Structure of a transporter domain emerges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN	Magnesium homeostasis relies on transporters like the CNNM family, but little information on these proteins' structure and regulation limits our understanding of their biology and functions in disease. New characterization of a conserved cytoplasmic domain now confirms the presence of a self-liganded architecture that is indispensable for Mg2+ efflux and suggests a possible role for a dimeric assembly.	[Ulens, Chris] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, B-3000 Leuven, Belgium	KU Leuven	Ulens, C (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, B-3000 Leuven, Belgium.	chris.ulens@kuleuven.be			 [KU Leuven C1-grant C14/17/093]		This work was supported by KU Leuven C1-grant C14/17/093. The author declares that he has no conflicts of interest with the contents of this article.	Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Chen YS, 2018, J BIOL CHEM, V293, P19998, DOI 10.1074/jbc.RA118.005672; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Li MH, 2017, NATURE, V542, P60, DOI 10.1038/nature20819; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070	10	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20008	20009		10.1074/jbc.H118.006869	http://dx.doi.org/10.1074/jbc.H118.006869			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593530	Green Published, hybrid			2022-12-26	WOS:000454685900007
J	Berlanga, M; Palau, M; Guerrero, R				Berlanga, Mercedes; Palau, Montserrat; Guerrero, Ricardo			Gut microbiota dynamics and functionality in Reticulitermes grassei after a 7-day dietary shift and ciprofloxacin treatment	PLOS ONE			English	Article							BACTERIAL DIVERSITY; PROTIST COMMUNITIES; TERMITE; WOOD; LIGNOCELLULOSE; FLAVIPES; COEVOLUTION; RESILIENCE; SPIROCHETE; RESISTANCE	Gut microbial structure in animals depends on the host, dietary habits and local environment. A random event, dietary change or antibiotic treatment may alter the gut environment with possible repercussions for the bacterial community composition and functionality and ultimately host fitness. The present study was focused on the composition, structure and functionality of gut microbiota in Reticulitermes grassei and the data obtained was compared with sequence surveys of three other Reticulitermes species. Each Reticulitermes species had a significantly different bacterial gut microbiota (pairwise significance tests using the Kolmogorov-Smirnov test), but a similar pattern of distribution (P-test in weighted Unifrac). The core gut microbiota from the analyzed Reticulitermes species contained 16 bacterial operational taxonomic units. Enzymes (KO) were detected from 14 pathways related to carbohydrate metabolism. R. grassei and R. hesperus, based on relative abundance of KO, had the most similar carbohydrate pathway patterns. In addition, we described the gut microbiota and functionality pathways in R. grassei after a 7-day dietary shift and antibiotic (ciprofloxacin) treatment. Both factors, but above all the antibiotic, altered the relative abundance of certain microbial groups, although the changes were not statistically significant (P-test in weighted Unifrac). The cellulose diet enhanced the carbohydrate pathways related to propanoate, butanoate, ascorbate, and glyoxylate metabolism. The antibiotic treatment affected galactose metabolism, the citrate cycle and inositol phosphate metabolism. Those functional changes may be related to changes in the abundance of several bacterial groups. Our findings provide insights into the stability of the gut microbiota in R. grassei and a resilience response to dietary shift or antibiotic treatment disturbance after 7 days.	[Berlanga, Mercedes; Palau, Montserrat] Univ Barcelona, Fac Pharm & Food Sci, Sect Microbiol, Dept Biol Environm & Hlth, Barcelona, Spain; [Guerrero, Ricardo] Univ Barcelona, Fac Med, Dept Pathol & Expt Therapeut, Lab Mol Microbiol & Antimicrobials,IDIBELL, Barcelona, Spain; [Guerrero, Ricardo] Acad Europaea Barcelona Knowledge Hub, Barcelona, Spain	University of Barcelona; University of Barcelona	Berlanga, M (corresponding author), Univ Barcelona, Fac Pharm & Food Sci, Sect Microbiol, Dept Biol Environm & Hlth, Barcelona, Spain.	mberlanga@ub.edu	Berlanga, Mercedes/I-4287-2016	Berlanga, Mercedes/0000-0002-7305-7046; Guerrero, Ricardo/0000-0001-5019-9933	Catalan Government [2014SGR1181, 2017SGR1733]	Catalan Government	This study was funded by Catalan Government SGR projects 2014SGR1181 and 2017SGR1733 to RG and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Berlanga M, 2007, INT MICROBIOL, V10, P133, DOI 10.2436/20.1501.01.19; Berlanga M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02619; Berlanga M, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0569-5; Berlanga M, 2016, SYMBIOSIS, V68, P49, DOI 10.1007/s13199-016-0388-9; Berlanga M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152400; Berlanga M, 2011, INT MICROBIOL, V14, P83, DOI 10.2436/20.1501.01.138; Boucias DG, 2013, MOL ECOL, V22, P1836, DOI 10.1111/mec.12230; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas AM, 2018, B ENTOMOL RES, V108, P532, DOI 10.1017/S0007485317001043; Ceppa F, 2019, INT J FOOD SCI NUTR, V70, P1, DOI 10.1080/09637486.2018.1462309; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Davis CK, 2012, FEMS MICROBIOL ECOL, V80, P671, DOI 10.1111/j.1574-6941.2012.01338.x; Dedeine F, 2016, MOL PHYLOGENET EVOL, V94, P778, DOI 10.1016/j.ympev.2015.10.020; Desai MS, 2012, ISME J, V6, P1302, DOI 10.1038/ismej.2011.194; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Duarte S, 2017, J APPL ENTOMOL, V141, P300, DOI 10.1111/jen.12331; Perez-Cobas AE, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv022; Faust K, 2015, CURR OPIN MICROBIOL, V25, P56, DOI 10.1016/j.mib.2015.04.004; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Ferrer M, 2017, BIOCHEM PHARMACOL, V134, P114, DOI 10.1016/j.bcp.2016.09.007; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Geng A, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1015-1; Guerrero R, 2013, INT MICROBIOL, V16, P133, DOI 10.2436/20.1501.01.188; Harrison MC, 2018, NAT ECOL EVOL, V2, P557, DOI 10.1038/s41559-017-0459-1; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Hooper DC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025320; Huang XF, 2013, MICROB ECOL, V65, P531, DOI 10.1007/s00248-013-0219-y; Kuwahara H, 2017, ISME J, V11, P766, DOI 10.1038/ismej.2016.143; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Legendre F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130127; Lewis JL, 2004, ANN ENTOMOL SOC AM, V97, P1242, DOI 10.1603/0013-8746(2004)097[1242:PCFFCA]2.0.CO;2; Li H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01169; Matsuura K, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P255, DOI 10.1007/978-90-481-3977-4_10; Mukherjee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01126-3; Nalepa CA, 2015, ECOL ENTOMOL, V40, P323, DOI 10.1111/een.12197; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Ohkuma M, 2015, P NATL ACAD SCI USA, V112, P10224, DOI 10.1073/pnas.1423979112; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Peterson BE, 2015, INSECT BIOCHEM MOLEC, V59, P80, DOI 10.1016/j.ibmb.2015.02.009; Peterson BF, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3126-z; Pomer L, 2011, BIOTECHVANA BIOINFOR, V2011; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; Raychoudhury R, 2013, INSECT MOL BIOL, V22, P155, DOI 10.1111/imb.12011; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Scharf ME, 2015, ANNU REV ENTOMOL, V60, P77, DOI 10.1146/annurev-ento-010814-020902; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033; Stein GE, 2006, CLIN INFECT DIS, V42, P1598, DOI 10.1086/503907; Su LJ, 2017, APPL BIOCHEM BIOTECH, V181, P32, DOI 10.1007/s12010-016-2197-2; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Waidele L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02518; Wang Y, 2016, ECOL EVOL, V6, P8235, DOI 10.1002/ece3.2497; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zheng H, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00656-17	68	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209789	10.1371/journal.pone.0209789	http://dx.doi.org/10.1371/journal.pone.0209789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30590374	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200052
J	Mannino, G; Abdi, G; Maffei, ME; Barbero, F				Mannino, Giuseppe; Abdi, Gholamreza; Maffei, Massimo Emilio; Barbero, Francesca			Origanum vulgare terpenoids modulate Myrmica scabrinodis brain biogenic amines and ant behaviour	PLOS ONE			English	Article							LARGE BLUE; DOPAMINE; SEROTONIN; CARVACROL; ORGANIZATION; INHIBITION; ANTIFUNGAL; OCTOPAMINE; MECHANISM; WORKERS	Coordinated social behaviour is fundamental for ant ecological success. However, even distantly-related organisms, such as plants, have evolved the ability to manipulate ant collective performances to their own advantage. In the parasitic system encompassing Maculinea butterflies, Myrmica ants, and Origanum vulgare plants, the ant-plant interaction elicits the release of a volatile terpenoid compound (carvacrol) which is used by the gravid butterfly to locate the ideal oviposition site. Here we show that this ant-plant association is maintained by the effect of O. vulgare terpenoids on ant behaviour and that food plants might gain protection by Myrmica ants by chemically manipulating workers to forage in their surroundings. The variation in the locomotor ability of three ant species (Formica cinerea, Tetramorium caespitum, and Myrmica scabrinodis) was studied after treatment with the two major O. vulgare terpenoid volatile compounds (i.e., carvacrol and thymol). The brain levels of three biogenic amines (dopamine, tyramine and serotonin) were analysed in ants exposed to the O. vulgare terpenoids by HPLC-ESI-MS/MS. Carvacrol and thymol increased the locomotor activity of all ant species tested, but if blended reduced the movement propensity of Myrmica scabrinodis. Dopamine and tyramine production was positively correlated with the worker locomotor activity. In Myrmica ants, both brain biogenic ammines were negatively correlated with the aggressive behaviour. Blends of O. vulgare volatiles affected the locomotor ability while increased the aggressiveness of Myrmica workers by altering the aminergic regulation in the ant brains. This behavioural manipulation, might enhance partner fidelity and plant protection. Our findings provide new insights supporting a direct role of plant volatiles in driving behavioural changes in social insects through biogenic amine modulation.	[Mannino, Giuseppe; Abdi, Gholamreza; Maffei, Massimo Emilio; Barbero, Francesca] Univ Turin, Dept Life Sci & Syst Biol, Innovat Ctr, Turin, Italy	University of Turin	Barbero, F (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Innovat Ctr, Turin, Italy.	francesca.barbero@unito.it	Mannino, Giuseppe/AAG-3518-2019; Barbero, Francesca/J-3555-2016; abdi, gholamreza/AAC-9373-2021; Maffei, Massimo E/K-9593-2015; Abdi, Gholamreza/H-1845-2018	Mannino, Giuseppe/0000-0003-0047-978X; Barbero, Francesca/0000-0003-2667-0435; Maffei, Massimo E/0000-0001-6814-2353; Abdi, Gholamreza/0000-0002-1983-4369	PhD Program in Pharmaceutical and Biomolecular Sciences of the University of Turin	PhD Program in Pharmaceutical and Biomolecular Sciences of the University of Turin	This work was supported by the PhD Program in Pharmaceutical and Biomolecular Sciences of the University of Turin.	ADAMS ES, 1990, ANIM BEHAV, V39, P321, DOI 10.1016/S0003-3472(05)80877-2; Agliassa C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092805; Ahn YJ, 1998, J CHEM ECOL, V24, P81, DOI 10.1023/A:1022388829078; Alekseyenko OV, 2013, P NATL ACAD SCI USA, V110, P6151, DOI 10.1073/pnas.1303446110; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Barbero F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121966; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Crocoll C, 2010, PLANT MOL BIOL, V73, P587, DOI 10.1007/s11103-010-9636-1; Csata E, 2017, SCI REP-UK, V7, DOI 10.1038/srep46323; Dejean A, 2008, BIOL J LINN SOC, V93, P63, DOI 10.1111/j.1095-8312.2007.00927.x; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; FRANKS NR, 1992, ANIM BEHAV, V44, P357, DOI 10.1016/0003-3472(92)90041-7; FRANKS NR, 1983, BEHAV ECOL SOCIOBIOL, V12, P261, DOI 10.1007/BF00302894; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Grasso DA, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv002; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2014, ECOL LETT, V17, P185, DOI 10.1111/ele.12215; Hojo MK, 2015, CURR BIOL, V25, P2260, DOI 10.1016/j.cub.2015.07.016; HOLLDOBLER B, 1981, BEHAV ECOL SOCIOBIOL, V9, P301, DOI 10.1007/BF00299887; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; Holldobler B., 1990, pi; Holldobler B., NEUROETHOLOGY BEHAV; Hoyer SC, 2005, ARTHROPOD STRUCT DEV, V34, P429, DOI 10.1016/j.asd.2005.03.003; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P60, DOI 10.1159/000113355; Iba M, 1995, ZOOL SCI, V12, P695, DOI 10.2108/zsj.12.695; ICH, 2005, INT C HARM TECHN REQ, P1; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Kamhi JF, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00074; Kamhi JF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0704; Kamhi JF, 2013, BRAIN BEHAV EVOLUT, V82, P220, DOI 10.1159/000356091; Koptur S., 2017, INSECT PLANT INTERAC, P89; Kordali S, 2008, BIORESOURCE TECHNOL, V99, P8788, DOI 10.1016/j.biortech.2008.04.048; Libersat F, 2004, BIOSCIENCE, V54, P17, DOI 10.1641/0006-3568(2004)054[0017:MATOOB]2.0.CO;2; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Monzote L, 2009, TOXICOL APPL PHARM, V240, P337, DOI 10.1016/j.taap.2009.08.001; Muscedere ML, 2012, J COMP PHYSIOL A, V198, P219, DOI 10.1007/s00359-011-0701-2; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Patricelli D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1111; Patricelli D, 2011, ANIM BEHAV, V82, P791, DOI 10.1016/j.anbehav.2011.07.011; Penick CA, 2014, J EXP BIOL; Radchenko AG, 2010, FAUNA MUNDI, V3, P1; Rao A, 2010, ANTIMICROB AGENTS CH, V54, P5062, DOI 10.1128/AAC.01050-10; RegnaultRoger C, 1995, J STORED PROD RES, V31, P291, DOI 10.1016/0022-474X(95)00025-3; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Smith AR, 2013, J COMP PHYSIOL A, V199, P1117, DOI 10.1007/s00359-013-0854-2; Szczuka A, 2013, ACTA NEUROBIOL EXP, V73, P495; Theraulaz G, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P309; THOMAS JA, 1984, BIOL CONSERV, V28, P325, DOI 10.1016/0006-3207(84)90040-5; TRANIELLO JFA, 1984, BEHAV ECOL SOCIOBIOL, V15, P65, DOI 10.1007/BF00310217; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x; Yu Q, 2014, MOL PSYCHIATR, V19, P688, DOI 10.1038/mp.2014.10	57	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209047	10.1371/journal.pone.0209047	http://dx.doi.org/10.1371/journal.pone.0209047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586439	Green Published, gold			2022-12-26	WOS:000454416400050
J	Ano, Y; Hoshi, A; Ayabe, T; Ohya, R; Uchida, S; Yamada, K; Kondo, K; Kitaoka, S; Furuyashiki, T				Ano, Yasuhisa; Hoshi, Ayaka; Ayabe, Tatsuhiro; Ohya, Rena; Uchida, Shinichi; Yamada, Koji; Kondo, Keiji; Kitaoka, Shiho; Furuyashiki, Tomoyuki			Iso-alpha-acids, the bitter components of beer, improve hippocampus-dependent memory through vagus nerve activation	FASEB JOURNAL			English	Article						dopamine; amnesia; beer; hop	SYNAPTIC PLASTICITY; ALCOHOL-CONSUMPTION; DORSAL HIPPOCAMPUS; LOCUS-COERULEUS; FOOD-INTAKE; RECEPTOR; TASTE; KINASE; GUT; CONSOLIDATION	Iso-alpha-acids (IAAs) are hop-derived bitter acids of beer. Epidemiologic studies suggest that moderate alcohol consumption is beneficial for cognitive function, but they do not show the ingredients in alcoholic beverages. Previously, we reported that long-term consumption of IAAs prevents inflammation and Alzheimer pathologies in mice, but their effects on cognitive function have not been evaluated. In the present study, we demonstrated that the consumption of IAAs improves spatial and object recognition memory functions not only in normal Crl:CD1(ICR) male mice but also in mice with pharmacologically induced amnesia. IAA consumption increased the total and extracellular levels of dopamine in the hippocampus of mice and Sprague-Dawley male rats, respectively. Dopamine D-1 receptor antagonist treatment and knockdown of dopamine D-1 receptor expression in the hippocampus attenuated IAA-induced spatial memory improvement. Furthermore, vagotomy attenuated the effects of IAAs in improving spatial and object recognition memory functions and increasing the total level of dopamine in the hippocampus. These results suggest that the consumption of IAAs activates dopamine D-1 receptor-signaling in the hippocampus in a vagus nerve-dependent manner and, consequently, improves spatial and object recognition memory functions. Vagal activation with food components including IAAs may be an easy and safe approach to improve cognitive functions.	[Ano, Yasuhisa; Hoshi, Ayaka; Ayabe, Tatsuhiro; Ohya, Rena; Kondo, Keiji] Kirin Co Ltd, Res Labs Hlth Sci & Food Technol, Yokohama, Kanagawa, Japan; [Uchida, Shinichi; Yamada, Koji] Kyowa Hakko Kirin Co Ltd, Cent Nervous Syst Res Labs, Div Res & Dev, Cent Nervous Syst CNS Res & Dev Unit, Shizuoka, Japan; [Kitaoka, Shiho; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo, Japan; [Kitaoka, Shiho; Furuyashiki, Tomoyuki] Japan Agcy Med Res & Dev Ctr Res Excellence Sci &, Tokyo, Japan	Kyowa Kirin Ltd; Kobe University	Ano, Y (corresponding author), Kirin Co, Res Labs Hlth Sci & Food Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	yasuhisa_ano@kirin.co.jp	Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399; Ayabe, Tatsuhiro/0000-0002-5023-4986	Kirin Co.; Centers of Research Excellence in Science and Technology (CREST) Grant from Japan Agency for Medical Research and Development (AMED) [JP18gm0910012]; Japan Society for the Promotion of Science [16H05132, 17K19457, 17K08593]; Ministry of Education, Culture, Sports, Science, and Technology in Japan [18H05429]	Kirin Co.; Centers of Research Excellence in Science and Technology (CREST) Grant from Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Kirin Co. and, in part by a Centers of Research Excellence in Science and Technology (CREST) Grant from Japan Agency for Medical Research and Development (AMED; JP18gm0910012 to T.F.); Grants-in-Aid for Scientific Research (16H05132 and 17K19457 to T.F., 17K08593 to S.K.) from the Japan Society for the Promotion of Science; and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (18H05429 to T.F.). The authors declare no conflicts of interest.	Ano Y, 2018, NEUROBIOL AGING, V72, P23, DOI 10.1016/j.neurobiolaging.2018.07.016; Ano Y, 2017, J BIOL CHEM, V292, P3720, DOI 10.1074/jbc.M116.763813; Arntzen KA, 2010, ACTA NEUROL SCAND, V122, P23, DOI 10.1111/j.1600-0404.2010.01371.x; Ayabe T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23213-9; Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Berman DE, 1998, J NEUROSCI, V18, P10037; Blum S, 1999, J NEUROSCI, V19, P3535; Breit S, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00044; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Chan JP, 2017, BEHAV BRAIN RES, V321, P61, DOI 10.1016/j.bbr.2016.12.026; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; da Silva WCN, 2012, NEUROBIOL LEARN MEM, V97, P271, DOI 10.1016/j.nlm.2012.01.005; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Egan JM, 2008, MOL INTERV, V8, P78, DOI 10.1124/mi.8.2.5; Farrand AQ, 2017, BRAIN STIMUL, V10, P1045, DOI 10.1016/j.brs.2017.08.008; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Furini CRG, 2014, BEHAV BRAIN RES, V271, P212, DOI 10.1016/j.bbr.2014.06.027; Hagena Hardy, 2016, Front Synaptic Neurosci, V8, P31; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Hebert AE, 2002, LEARN MEMORY, V9, P156, DOI 10.1101/lm.48502; Horvat P, 2015, NEUROLOGY, V84, P287, DOI 10.1212/WNL.0000000000001164; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Lee KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135578; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Liu AF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0858-0; MacIntosh CG, 2001, J CLIN ENDOCR METAB, V86, P5830, DOI 10.1210/jc.86.12.5830; Matsui Toshifumi, 2011, Nihon Rinsho, V69 Suppl 10 Pt 2, P217; Moran TH, 1997, AM J PHYSIOL-REG I, V272, pR1245; Nagai T, 2007, LEARN MEMORY, V14, P117, DOI 10.1101/lm.461407; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Papaleonidopoulos V, 2018, SYNAPSE, V72, DOI 10.1002/syn.22033; Perez-Pardo P, 2017, EUR J PHARMACOL, V817, P86, DOI 10.1016/j.ejphar.2017.05.042; Pioli EY, 2014, BEHAV BRAIN RES, V261, P249, DOI 10.1016/j.bbr.2013.12.009; Schafe GE, 2000, J NEUROSCI, V20, P8177; Shinohara R, 2018, MOL PSYCHIATR, V23, P1717, DOI 10.1038/mp.2017.177; Smucny J, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00043; Suarez AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04639-1; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takeuchi T, 2016, NATURE, V537, P357, DOI 10.1038/nature19325; Taniguchi Y, 2013, J AGR FOOD CHEM, V61, P3121, DOI 10.1021/jf3047187; Watson C, 2006, RAT BRAIN STEREOTAXI; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yamasaki M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8602690; Yang KC, 2017, EUR J NEUROSCI, V45, P138, DOI 10.1111/ejn.13406	48	14	15	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4987	4995		10.1096/fj.201801868RR	http://dx.doi.org/10.1096/fj.201801868RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601670	Green Published, hybrid			2022-12-26	WOS:000462888500028
J	Patil, R; Mohanty, B; Liu, BA; Chandrashekaran, IR; Headey, SJ; Williams, ML; Clements, CS; Ilyichova, O; Doak, BC; Genissel, P; Weaver, RJ; Vuillard, L; Halls, ML; Porter, CJH; Scanlon, MJ				Patil, Rahul; Mohanty, Biswaranjan; Liu, Bonan; Chandrashekaran, Indu R.; Headey, Stephen J.; Williams, Martin L.; Clements, Craig S.; Ilyichova, Olga; Doak, Bradley C.; Genissel, Patrick; Weaver, Richard J.; Vuillard, Laurent; Halls, Michelle L.; Porter, Christopher J. H.; Scanlon, Martin J.			A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; fatty acid-binding protein; nuclear magnetic resonance (NMR); peroxisome proliferator-activated receptor (PPAR); drug delivery; nuclear receptor; transcription factor; GW7647; PPAR agonist	NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; RETINOIC ACID; AMIDE-PROTON; DRUG-BINDING; ASSIGNMENT; PROGRAM; ALPHA; IDENTIFICATION; LOCALIZATION	Peroxisome proliferator-activated receptor (PPAR) is a transcriptional regulator of lipid metabolism. GW7647 is a potent PPAR agonist that must reach the nucleus to activate this receptor. In cells expressing human fatty acid-binding protein 1 (FABP1), GW7647 treatment increases FABP1's nuclear localization and potentiates GW7647-mediated PPAR activation; GW7647 is less effective in cells that do not express FABP1. To elucidate the underlying mechanism, here we substituted residues in FABP1 known to dictate lipid signaling by other intracellular lipid-binding proteins. Substitutions of Lys-20 and Lys-31 to Ala in the FABP1 helical cap affected neither its nuclear localization nor PPAR activation. In contrast, Ala substitution of Lys-57, Glu-77, and Lys-96, located in the loops adjacent to the ligand-binding portal region, abolished both FABP1 nuclear localization and GW7647-induced PPAR activation but had little effect on GW7647-FABP1 binding affinity. Using solution NMR spectroscopy, we determined the WT FABP1 structure and analyzed the dynamics in the apo and GW7647-bound structures of both the WT and the K57A/E77A/K96A triple mutant. We found that GW7647 binding causes little change in the FABP1 backbone, but solvent exposes several residues in the loops around the portal region, including Lys-57, Glu-77, and Lys-96. These residues also become more solvent-exposed upon binding of FABP1 with the endogenous PPAR agonist oleic acid. Together with previous observations, our findings suggest that GW7647 binding stabilizes a FABP1 conformation that promotes its interaction with PPAR. We conclude that full PPAR agonist activity of GW7647 requires FABP1-dependent transport and nuclear localization processes.	[Patil, Rahul; Mohanty, Biswaranjan; Chandrashekaran, Indu R.; Headey, Stephen J.; Williams, Martin L.; Clements, Craig S.; Ilyichova, Olga; Doak, Bradley C.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia; [Liu, Bonan; Porter, Christopher J. H.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, 381 Royal Parade, Parkville, Vic 3052, Australia; [Halls, Michelle L.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, 381 Royal Parade, Parkville, Vic 3052, Australia; [Genissel, Patrick; Weaver, Richard J.; Vuillard, Laurent] Inst Rech Servier, 125 Chemin Ronde, F-78290 Croissy Sur Seine, France	Monash University; Monash University; Monash University; Servier; Institut de Recherches Internationales Servier	Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia.; Porter, CJH (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, 381 Royal Parade, Parkville, Vic 3052, Australia.; Halls, ML (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, 381 Royal Parade, Parkville, Vic 3052, Australia.	michelle.halls@monash.edu; chris.porter@monash.edu; martin.scanlon@monash.edu	Doak, Bradley C/A-4313-2013; Porter, Christopher JH/C-6333-2011; Weaver, Richard J/GLT-0453-2022; Mohanty, Biswaranjan/E-2080-2018	Doak, Bradley C/0000-0001-8422-675X; Porter, Christopher JH/0000-0003-3474-7551; Weaver, Richard J/0000-0001-6439-6030; Chandrashekaran, Indu/0000-0002-7080-427X; Mohanty, Biswaranjan/0000-0002-6921-343X; Williams, Martin/0000-0002-9483-3008; Headey, Stephen/0000-0001-8015-7064	Les Laboratories Servier; ARC [DP120102930, DP150102587]; Monash Graduate Scholarship (MGS); Monash International Postgraduate Research Scholarship (MIPRS); National Health and Medical Research Council of Australia RD Wright Fellowship [1061687]	Les Laboratories Servier(Servier); ARC(Australian Research Council); Monash Graduate Scholarship (MGS)(Monash University); Monash International Postgraduate Research Scholarship (MIPRS)(Monash University); National Health and Medical Research Council of Australia RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by funding from Les Laboratories Servier and by ARC Grants DP120102930 and DP150102587. P. G., R. J. W., and L. V. were employed by Les Laboratories Servier, a commercial company, at the time this study was conducted.; Supported by Monash Graduate Scholarship (MGS) and Monash International Postgraduate Research Scholarship (MIPRS).; Supported by National Health and Medical Research Council of Australia RD Wright Fellowship 1061687.	Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Cai J, 2012, BIOPHYS J, V102, P2585, DOI 10.1016/j.bpj.2012.04.039; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; D'Onofrio M, 2017, BBA-PROTEINS PROTEOM, V1865, P1152, DOI 10.1016/j.bbapap.2017.06.025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Huang H, 2014, FEBS J, V281, P2266, DOI 10.1111/febs.12780; Hughes MLR, 2015, J BIOL CHEM, V290, P13895, DOI 10.1074/jbc.M114.605998; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAIKAUS RM, 1990, EXPERIENTIA, V46, P617, DOI 10.1007/BF01939701; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Patil R, 2014, ACS CHEM BIOL, V9, P2526, DOI 10.1021/cb5005178; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Sharma A, 2011, J BIOL CHEM, V286, P31924, DOI 10.1074/jbc.M111.270165; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Velkov T, 2007, CHEM BIOL, V14, P453, DOI 10.1016/j.chembiol.2007.03.009; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	40	6	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3720	3734		10.1074/jbc.RA118.006848	http://dx.doi.org/10.1074/jbc.RA118.006848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30598509	hybrid, Green Published			2022-12-26	WOS:000461853900033
J	Tambaro, S; Galan-Acosta, L; Leppert, A; Chen, GF; Biverstal, H; Presto, J; Nilsson, P; Johansson, J				Tambaro, Simone; Galan-Acosta, Lorena; Leppert, Axel; Chen, Gefei; Biverstal, Henrik; Presto, Jenny; Nilsson, Per; Johansson, Jan			Blood-brain and blood-cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein assembly; protein domain; protein misfolding; neuroscience; neurodegenerative disease; protein aggregation	AMYLOID-BETA-PEPTIDE; SP-C GENE; MOUSE MODEL; PROTEIN-C; BARRIER; EXPRESSION; DEMENTIA; NEURODEGENERATION; PERMEABILITY; TOXICITY	Targeting toxicity associated with beta-amyloid (A beta) misfolding and aggregation is a promising therapeutic strategy for preventing or managing Alzheimer's disease. The BRICHOS domains from human prosurfactant protein C (proSP-C) and integral membrane protein 2B (Bri2) efficiently reduce neurotoxicity associated with A beta 42 fibril formation both in vitro and in vivo. In this study, we evaluated the serum half-lives and permeability into the brain and cerebrospinal fluid (CSF) of recombinant human (rh) proSP-C and Bri2 BRICHOS domains injected intravenously into WT mice. We found that rh proSP-C BRICHOS has a longer blood serum half-life compared with rh Bri2 BRICHOS and passed into the CSF but not into the brain parenchyma. As judged by Western blotting, immunohistochemistry, and ELISA, rh Bri2 BRICHOS passed into both the CSF and brain. Intracellular immunostaining for rh Bri2 BRICHOS was observed in the choroid plexus epithelium as well as in the cerebral cortex. Our results indicate that intravenously administered rh proSP-C and Bri2 BRICHOS domains have different pharmacokinetic properties and blood-brain/blood-CSF permeability in mice. The finding that rh Bri2 BRICHOS can reach the brain parenchyma after peripheral administration may be harnessed in the search for new therapeutic strategies for managing Alzheimer's disease.	[Tambaro, Simone; Galan-Acosta, Lorena; Leppert, Axel; Chen, Gefei; Biverstal, Henrik; Presto, Jenny; Nilsson, Per; Johansson, Jan] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, S-14183 Huddinge, Sweden	Karolinska Institutet	Johansson, J (corresponding author), Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, S-14183 Huddinge, Sweden.	janne.johansson@ki.se	Chen, Gefei/J-2919-2013; Tambaro, Simone/ABF-9304-2020	Chen, Gefei/0000-0002-5543-5963; Galan-Acosta, Lorena/0000-0002-6340-3398; Leppert, Axel/0000-0001-6223-3350; Johansson, Jan/0000-0002-8719-4703; Tambaro, Simone/0000-0001-7000-7556	Swedish Research Council; Center for Innovative Medicine at Karolinska Institutet; Stockholm City Council; Hallstens forskningsstiftelse; Alzheimerfonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Innovative Medicine at Karolinska Institutet; Stockholm City Council; Hallstens forskningsstiftelse; Alzheimerfonden	This work was supported by the Swedish Research Council, Center for Innovative Medicine at Karolinska Institutet and Stockholm City Council, Hallstens forskningsstiftelse, and Alzheimerfonden. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Arosio P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10948; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Baron BW, 2017, APPL IMMUNOHISTO M M, V25, P489, DOI 10.1097/PAI.0000000000000329; Biverstal H, 2015, BBA-PROTEINS PROTEOM, V1854, P835, DOI 10.1016/j.bbapap.2015.04.005; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Casals C, 2008, FEBS J, V275, P536, DOI 10.1111/j.1742-4658.2007.06220.x; Chen GF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02056-4; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Del Campo M, 2014, NEUROBIOL AGING, V35, P1596, DOI 10.1016/j.neurobiolaging.2014.01.007; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Dolfe L, 2018, J ALZHEIMERS DIS REP, V2, P27, DOI 10.3233/ADR-170051; GLASSER SW, 1990, J BIOL CHEM, V265, P21986; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; Goure WF, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt272; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hermansson E, 2014, DIS MODEL MECH, V7, P659, DOI 10.1242/dmm.014787; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Johansson H, 2009, J MOL BIOL, V389, P227, DOI 10.1016/j.jmb.2009.04.021; Johansson H, 2006, J BIOL CHEM, V281, P21032, DOI 10.1074/jbc.M603001200; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Khan A, 2017, EXPERT REV NEUROTHER, V17, P697, DOI 10.1080/14737175.2017.1326819; Kim J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-15; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; Kurudenkandy FR, 2014, J NEUROSCI, V34, P11416, DOI 10.1523/JNEUROSCI.1195-14.2014; Lashley T, 2008, NEUROPATH APPL NEURO, V34, P492, DOI 10.1111/j.1365-2990.2008.00935.x; Liddelow SA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00032; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Mohandas E, 2009, Indian J Psychiatry, V51, P55, DOI 10.4103/0019-5545.44908; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nerelius C, 2009, BIOCHEMISTRY-US, V48, P3778, DOI 10.1021/bi900135c; Pardridge WA, 2009, ALZHEIMERS DEMENT, V5, P427, DOI 10.1016/j.jalz.2009.06.003; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Poska H, 2016, BIOCHEM J, V473, P3683, DOI 10.1042/BCJ20160277; Sanchez-Covarrubias L, 2014, CURR PHARM DESIGN, V20, P1422, DOI 10.2174/13816128113199990463; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Tambaro S, 2013, NEUROPHARMACOLOGY, V70, P268, DOI 10.1016/j.neuropharm.2013.02.009; UENO M, 1994, ACTA NEUROL SCAND, V90, P400; Ueno M, 2000, ACTA NEUROPATHOL, V99, P385, DOI 10.1007/s004010051140; Villasenor R, 2017, J CEREBR BLOOD F MET, V37, P3683, DOI 10.1177/0271678X17697340; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Yerbury JJ, 2010, CELL STRESS CHAPERON, V15, P115, DOI 10.1007/s12192-009-0122-0; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889	56	7	7	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2606	2615		10.1074/jbc.RA118.004538	http://dx.doi.org/10.1074/jbc.RA118.004538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30598503	hybrid, Green Published			2022-12-26	WOS:000459601600004
J	Fan, F; Warshaviak, DT; Hamadeh, HK; Dunn, RT				Fan, Fan; Warshaviak, Dora Toledo; Hamadeh, Hisham K.; Dunn, Robert T., II			The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs	PLOS ONE			English	Article							IN-SILICO TOXICOLOGY; A(2A) RECEPTORS; PHARMACOLOGY; PREDICTION; DATABASE; CLASSIFICATION; MOLECULES; DISCOVERY; CURATION; PITFALLS	Safety pharmacology screening against a wide range of unintended vital targets using in vitro assays is crucial to understand off-target interactions with drug candidates. With the increasing demand for in vitro assays, ligand-and structure-based virtual screening approaches have been evaluated for potential utilization in safety profiling. Although ligand based approaches have been actively applied in retrospective analysis or prospectively within well-defined chemical space during the early discovery stage (i.e., HTS screening and lead optimization), virtual screening is rarely implemented in later stage of drug discovery (i.e., safety). Here we present a case study to evaluate ligand-based 3D QSAR models built based on in vitro antagonistic activity data against adenosine receptor 2A (A2A). The resulting models, obtained from 268 chemically diverse compounds, were used to test a set of 1,897 chemically distinct drugs, simulating the real-world challenge of safety screening when presented with novel chemistry and a limited training set. Due to the unique requirements of safety screening versus discovery screening, the limitations of 3D QSAR methods (i.e., chemotypes, dependence on large training set, and prone to false positives) are less critical than early discovery screen. We demonstrated that 3D QSAR modeling can be effectively applied in safety assessment prior to in vitro assays, even with chemotypes that are drastically different from training compounds. It is also worth noting that our model is able to adequately make the mechanistic distinction between agonists and antagonists, which is important to inform subsequent in vivo studies. Overall, we present an in-depth analysis of the appropriate utilization and interpretation of pharmacophore-based 3D QSAR models for safety screening.	[Fan, Fan; Hamadeh, Hisham K.; Dunn, Robert T., II] Amgen Res, Dept Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Warshaviak, Dora Toledo] Schrodinger Inc, San Diego, CA USA; [Warshaviak, Dora Toledo] Amgen Inc, Dept Mol Engn, Thousand Oaks, CA 91320 USA; [Fan, Fan] Amgen Res, Dept Comparat Biol & Safety Sci, Cambridge, MA 02141 USA; [Warshaviak, Dora Toledo] A2 Biotherapeut, Agoura Hills, CA USA; [Hamadeh, Hisham K.] Genmab Inc, Princeton, NJ USA; [Dunn, Robert T., II] Charles River Lab, Shrewsbury, MA USA	Amgen	Fan, F (corresponding author), Amgen Res, Dept Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA.; Fan, F (corresponding author), Amgen Res, Dept Comparat Biol & Safety Sci, Cambridge, MA 02141 USA.	ffan@amgen.com			Amgen Inc.; Schrodinger	Amgen Inc.(Amgen); Schrodinger(Austrian Science Fund (FWF))	The funder (Amgen Inc.) provided support in the form of salaries for authors [FF, DTW, HDH, RTD] and the decision to publish, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Prior to joining Amgen Inc., and at the initial planning stage of the presented study, DTW was an employee for Schrodinger Inc., during which Schrodinger provided salary for DTW. However, Schrodinger Inc. did not have any additional role in the study design, data collection and analysis, preparation of the manuscript or the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5729, DOI 10.1111/bph.13347; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bowes J, 2012, NAT REV DRUG DISCOV, V11, P909, DOI 10.1038/nrd3845; Chang LCW, 2007, J MED CHEM, V50, P828, DOI 10.1021/jm0607956; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285; Concil NR, 2007, TOXICITY TESTING 21; Cronin MTD, 2003, J MOL STRUC-THEOCHEM, V622, P39, DOI 10.1016/S0166-1280(02)00616-4; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Dixit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026071; Dixon SL, 2006, CHEM BIOL DRUG DES, V67, P370, DOI 10.1111/j.1747-0285.2006.00384.x; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fan F, 2015, TOXICOL SCI, V145, P283, DOI 10.1093/toxsci/kfv052; Fourches D, 2010, J CHEM INF MODEL, V50, P1189, DOI 10.1021/ci100176x; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Fredholm BB, 2003, CURR TOP MED CHEM, V3, P413, DOI 10.2174/1568026033392200; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Gibb Steven, 2008, Reprod Toxicol, V25, P136, DOI 10.1016/j.reprotox.2007.10.013; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Gregori-Puigjane E, 2008, COMB CHEM HIGH T SCR, V11, P669, DOI 10.2174/138620708785739952; Hamon J, 2009, FUTURE MED CHEM, V1, P645, DOI 10.4155/FMC.09.51; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Huang ZL, 2011, CURR TOP MED CHEM, V11, P1047, DOI 10.2174/156802611795347654; Jaakola VP, 2010, CURR OPIN STRUC BIOL, V20, P401, DOI 10.1016/j.sbi.2010.05.002; Jaakola VP, 2010, J BIOL CHEM, V285, P13032, DOI 10.1074/jbc.M109.096974; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Mansouri K, 2016, METHODS MOL BIOL, V1425, P361, DOI 10.1007/978-1-4939-3609-0_16; Morphy R, 2006, J MED CHEM, V49, P2969, DOI 10.1021/jm0512185; Muster WG, 2008, DRUG DISCOV TODAY, V13, P303, DOI 10.1016/j.drudis.2007.12.007; Mustyala KK, 2012, J RECEPT SIG TRANSD, V32, P102, DOI 10.3109/10799893.2012.660532; Nigsch F, 2008, J CHEM INF MODEL, V48, P2313, DOI 10.1021/ci800079x; Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P495, DOI 10.1080/10629360802083871; Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P397, DOI 10.1080/10629360802083848; Polanski J, 2006, J CHEM INF MODEL, V46, P2310, DOI 10.1021/ci050314b; Raies AB, 2016, WIRES COMPUT MOL SCI, V6, P147, DOI 10.1002/wcms.1240; Redfern WS, 2002, FUND CLIN PHARMACOL, V16, P161, DOI 10.1046/j.1472-8206.2002.00098.x; Richard AM, 2008, TOXICOL MECH METHOD, V18, P103, DOI 10.1080/15376510701857452; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Scior T, 2009, CURR MED CHEM, V16, P4297, DOI 10.2174/092986709789578213; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shen HY, 2009, CURR NEUROPHARMACOL, V7, P195, DOI 10.2174/157015909789152191; Sprous DG, 2010, CURR TOP MED CHEM, V10, P619, DOI 10.2174/156802610791111506; Todeschini R., 2008, MOL MODELING BASIC P; Urban L., 2012, POLYPHARMACOLOGY DRU, P15, DOI [10.1002/9781118098141.ch2, DOI 10.1002/9781118098141.CH2]; Valerio LG, 2009, TOXICOL APPL PHARM, V241, P356, DOI 10.1016/j.taap.2009.08.022; Vedani A, 2006, BASIC CLIN PHARMACOL, V99, P195, DOI 10.1111/j.1742-7843.2006.pto_471.x; Vedani A, 2009, ATLA-ALTERN LAB ANIM, V37, P477, DOI 10.1177/026119290903700506; Warren I, 2013, COMPUTATIONAL TOXICOLOGY: METHODS AND APPLICATIONS FOR RISK ASSESSMENT, P151; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; Whitebread S, 2016, DRUG DISCOV TODAY, V21, P1232, DOI 10.1016/j.drudis.2016.04.021; Williams AJ, 2011, DRUG DISCOV TODAY, V16, P747, DOI 10.1016/j.drudis.2011.07.007; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yang X, 2016, PURINERG SIGNAL	60	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0204378	10.1371/journal.pone.0204378	http://dx.doi.org/10.1371/journal.pone.0204378			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605479	Green Submitted, Green Published, gold			2022-12-26	WOS:000454759900003
J	Fernandez, A; Kirsch, I; Noel, L; Rodondi, PY; Kaptchuk, TJ; Suter, MR; Decosterd, I; Berna, C				Fernandez, Aurore; Kirsch, Irving; Noel, Louis; Rodondi, Pierre Yves; Kaptchuk, Ted J.; Suter, Marc R.; Decosterd, Isabelle; Berna, Chantal			A test of positive suggestions about side effects as a way of enhancing the analgesic response to NSAIDs	PLOS ONE			English	Article							DOUBLE-BLIND; POSTHERPETIC NEURALGIA; NOXIOUS-STIMULATION; PLACEBO ANALGESIA; CONTROLLED-TRIAL; PAIN; ANXIETY; BRAIN; HYPERALGESIA; EXPECTATION	Side effects are frequent in pharmacological pain management, potentially preceding analgesia and limiting drug tolerability. Discussing side effects is part of informed consent, yet can favor nocebo effects. This study aimed to test whether a positive suggestion regarding side effects, which could act as reminders of the medication having been absorbed, might favor analgesia in a clinical interaction model. Sixty-six healthy males participated in a study "to validate pupillometry as an objective measure of analgesia". Participants were unknowingly randomized double-blind to positive vs control information about side effects embedded in a video regarding the study drugs. Sequences of moderately painful heat stimuli applied before and after treatment with diclofenac and atropine served to evaluate analgesia. Atropine was deceptively presented as a co-analgesic, but used to induce side effects. Adverse events (AE) were collected with the General Assessment of Side Effects (GASE) questionnaire prior to the second induced pain sequence. Debriefing fully informed participants regarding the purpose of the study and showed them the two videos. The combination of medication led to significant analgesia, without a between-group difference. Positive information about side effects increased the attribution of AE to the treatment compared to the control information. The total GASE score was correlated with analgesia, i.e., the more AEs reported, the stronger the analgesia. Interestingly, there was a significant between-groups difference on this correlation: the GASE score and analgesia correlated only in the positive information group. This provides evidence for a selective link between AEs and pain relief in the group who received the suggestion that AEs could be taken as a sign "that help was on the way". During debriefing, 65% of participants said they would prefer to receive the positive message in a clinical context. Although the present results cannot be translated immediately to clinical pain conditions, they do indicate the importance of testing this type of modulation in a clinical context.	[Fernandez, Aurore; Noel, Louis; Suter, Marc R.; Decosterd, Isabelle; Berna, Chantal] Lausanne Univ Hosp CHUV, Pain Ctr, Dept Anesthesiol, Lausanne, Switzerland; [Fernandez, Aurore; Noel, Louis; Rodondi, Pierre Yves; Suter, Marc R.; Decosterd, Isabelle; Berna, Chantal] Univ Lausanne UNIL, FBM, Lausanne, Switzerland; [Kirsch, Irving; Kaptchuk, Ted J.; Berna, Chantal] Harvard Med Sch, Program Placebo Studies, Boston, MA USA; [Rodondi, Pierre Yves] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Rodondi, Pierre Yves] Univ Fribourg, Inst Family Med, Fribourg, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Harvard University; Harvard Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Fribourg	Berna, C (corresponding author), Lausanne Univ Hosp CHUV, Pain Ctr, Dept Anesthesiol, Lausanne, Switzerland.; Berna, C (corresponding author), Univ Lausanne UNIL, FBM, Lausanne, Switzerland.; Berna, C (corresponding author), Harvard Med Sch, Program Placebo Studies, Boston, MA USA.	Chantal.Berna-Renella@chuv.ch	Kirsch, Irving/P-9316-2019; Rodondi, Pierre-Yves/AAU-3708-2020	Noel, Louis/0000-0003-2387-060X; Rodondi, Pierre-Yves/0000-0003-2007-2995; Berna, Chantal/0000-0001-8258-7412	Biology and Medicine Faculty of the University of Lausanne, Switzerland; Swiss National Science Foundation Advanced Post-Doc Mobility Scheme [P3SMP3_151710]; Foundation for the Science of the Therapeutic Encounter (F-STE)	Biology and Medicine Faculty of the University of Lausanne, Switzerland; Swiss National Science Foundation Advanced Post-Doc Mobility Scheme; Foundation for the Science of the Therapeutic Encounter (F-STE)	Chantal Berna was supported by a "Pepiniere" grant from the Biology and Medicine Faculty of the University of Lausanne, Switzerland, a return grant from a Swiss National Science Foundation Advanced Post-Doc Mobility Scheme (P3SMP3_151710), as well as a grant from the Foundation for the Science of the Therapeutic Encounter (F-STE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.B. was supported by a "Pepiniere" grant from the Biology and Medicine Faculty of the University of Lausanne, Switzerland, a return grant from a Swiss National Science Foundation Advanced Post-Doc Mobility Scheme (P3SMP3_151710), as well as a grant from the Foundation for the science of the therapeutic encounter (F-STE). The current affiliation of P.Y.R. is: Institute of Family Medicine, University of Fribourg, Switzerland. Our gratitude goes to Dr. Cecile Courbon, Division of Anesthesiology, for her technical help with the pupilometer and the Lausanne University Hospital multimedia service (SAM) for their support in creating the information videos.	Aissou M, 2012, ANESTHESIOLOGY, V116, P1006, DOI 10.1097/ALN.0b013e318251d1fb; Amanzio M, 2001, PAIN, V90, P205, DOI 10.1016/S0304-3959(00)00486-3; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Barsky AJ, 2017, JAMA-J AM MED ASSOC, V318, P2425, DOI 10.1001/jama.2017.16216; Barvais L, 2003, BRIT J ANAESTH, V91, P347, DOI 10.1093/bja/aeg178; Berna C, 2017, PAIN, V158, P1014, DOI 10.1097/j.pain.0000000000000870; Bingel U, 2014, JAMA-J AM MED ASSOC, V312, P693, DOI 10.1001/jama.2014.8342; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; BRANTHWAITE A, 1981, BRIT MED J, V282, P1576, DOI 10.1136/bmj.282.6276.1576; Butcher BE, 2012, EUR J PAIN, V16, P1005, DOI 10.1002/j.1532-2149.2011.00104.x; Cocco G, 2009, CARDIOLOGY, V112, P174, DOI 10.1159/000147951; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; Colloca L, 2004, LANCET NEUROL, V3, P679, DOI 10.1016/S1474-4422(04)00908-1; Colloca L, 2007, CURR OPIN ANESTHESIO, V20, P435, DOI 10.1097/ACO.0b013e3282b972fb; Compton P, 2003, CLIN EXP PHARMACOL P, V30, P759, DOI 10.1046/j.1440-1681.2003.03907.x; Doering BK, 2015, J PSYCHOSOM RES, V79, P492, DOI 10.1016/j.jpsychores.2015.10.010; Eaves ER, 2016, CULT MED PSYCHIAT, V40, P35, DOI 10.1007/s11013-015-9465-4; Edwards RR, 2006, CLIN J PAIN, V22, P730, DOI 10.1097/01.ajp.0000210914.72794.bc; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Fry JR, 2011, ADV PHYSIOL EDUC, V35, P438, DOI 10.1152/advan.00075.2011; Geers AL, 2006, J BEHAV MED, V29, P171, DOI 10.1007/s10865-005-9040-5; Guglielminotti J, 2013, ANESTH ANALG, V116, P1057, DOI 10.1213/ANE.0b013e31828a7218; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Humphrey N, 2012, CURR BIOL, V22, pR695, DOI 10.1016/j.cub.2012.06.018; Irving G, 2009, CLIN J PAIN, V25, P185, DOI 10.1097/AJP.0b013e3181934276; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kessner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109014; Larson MD, 1997, ANESTHESIOLOGY, V87, P849, DOI 10.1097/00000542-199710000-00019; LARSON MD, 1993, ANESTH ANALG, V76, P1072; Lin SY, 2016, EUR J ANAESTH, V33, P134, DOI 10.1097/EJA.0000000000000307; MAX MB, 1988, CLIN PHARMACOL THER, V43, P363, DOI 10.1038/clpt.1988.44; Mischkowski D, 2018, PAIN, V159, P699, DOI 10.1097/j.pain.0000000000001132; Nickel MM, 2017, PAIN, V158, P2129, DOI 10.1097/j.pain.0000000000001010; Petersen GL, 2012, PAIN, V153, P1292, DOI 10.1016/j.pain.2012.03.011; Price DD, 2007, PAIN, V127, P63, DOI 10.1016/j.pain.2006.08.001; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Rief W, 2011, PHARMACOEPIDEM DR S, V20, P405, DOI 10.1002/pds.2067; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Shah E, 2014, NEUROGASTROENT MOTIL, V26, P482, DOI 10.1111/nmo.12289; Shapiro AK, 1969, INT PHARMACOPSYCHIAT; Sharot T, 2010, PSYCHOL SCI, V21, P1231, DOI 10.1177/0956797610379235; STACHER G, 1986, BRIT J CLIN PHARMACO, V21, P35, DOI 10.1111/j.1365-2125.1986.tb02820.x; Tinnermann A, 2017, SCIENCE, V358, P105, DOI 10.1126/science.aan1221; Vase L, 2005, PAIN, V115, P338, DOI 10.1016/j.pain.2005.03.014; Vase L, 2003, PAIN, V105, P17, DOI 10.1016/S0304-3959(03)00073-3; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Webster RK, 2018, BRIT J HEALTH PSYCH, V23, P436, DOI 10.1111/bjhp.12298; Wells RE, 2012, AM J BIOETHICS, V12, P22, DOI 10.1080/15265161.2011.652798; Wilhelm M, 2018, INT J BEHAV MED, V25, P381, DOI 10.1007/s12529-018-9726-z; Winter M, 2016, BJU INT, V118, P823, DOI 10.1111/bju.13595	55	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209851	10.1371/journal.pone.0209851	http://dx.doi.org/10.1371/journal.pone.0209851			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1ZC	30605458	Green Published, Green Submitted, gold			2022-12-26	WOS:000454759900021
J	Wu, MH				Wu, Meihong			Effect of F0 contour on perception of Mandarin Chinese speech against masking	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY CONTOURS; TONE; RECOGNITION; INFORMATION; INTONATION; YOUNGER; CUES; COMPREHENSION; INTEGRATION; LANGUAGE	Intonation has many perceptually significant functions in language that contribute to speech recognition. This study aims to investigate whether intonation cues affect the unmasking of Mandarin Chinese speech in the presence of interfering sounds. Specifically, intelligibility of multi-tone Mandarin Chinese sentences with maskers consisting of either two-talker speech or steady-state noise was measured in three (flattened, typical, and exaggerated) intonation conditions. Different from most of the previous studies, the present study only manipulate and modify the intonation information but preserve tone information. The results showed that recognition of the final keywords in multi-tone Mandarin Chinese sentences was much better under the original F0 contour condition than the decreased F0 contour or exaggerated F0 contour conditions whenever there was a noise or speech masker, and an exaggerated F0 contour reduced the intelligibility of Mandarin Chinese more under the speech masker condition than that under the noise masker condition. These results suggested that speech in a tone language (Mandarin Chinese) is harder to understand when the intonation is unnatural, even if the tone information is preserved, and an unnatural intonation contour decreases releasing Mandarin Chinese speech from masking, especially in a multi-person talking environment.	[Wu, Meihong] Xiamen Univ, Sch Informat Sci & Engn, Xiamen, Fujian, Peoples R China	Xiamen University	Wu, MH (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Xiamen, Fujian, Peoples R China.	wmh@xmu.edu.cn		wu, meihong/0000-0002-1489-4039				Binns C, 2007, J ACOUST SOC AM, V122, P1765, DOI 10.1121/1.2751394; Braun B, 2011, J PHONETICS, V39, P585, DOI 10.1016/j.wocn.2011.06.002; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Chen F, 2014, J SPEECH LANG HEAR R, V57, P338, DOI 10.1044/1092-4388(2013/12-0324); Cruttenden A., 1997, INTONATION; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Darwin CJ, 2000, J ACOUST SOC AM, V107, P970, DOI 10.1121/1.428278; Darwin CJ, 2003, J ACOUST SOC AM, V114, P2913, DOI 10.1121/1.1616924; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; Ezzatian P, 2011, EAR HEARING, V32, P84, DOI 10.1097/AUD.0b013e3181ee6b8a; Feng YM, 2012, J ACOUST SOC AM, V131, pEL133, DOI 10.1121/1.3670594; Fujisaki H, 2005, SPEECH COMMUN, V47, P59, DOI 10.1016/j.specom.2005.06.009; GRANT KW, 1987, J ACOUST SOC AM, V82, P1172, DOI 10.1121/1.395253; Hawkins S, 2001, ITALIAN J LINGUISTIC, V13; Helfer KS, 2009, J ACOUST SOC AM, V125, P447, DOI 10.1121/1.3035837; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hillenbrand J. M., 2003, J ACOUST SOC AM, V114, P2338, DOI [DOI 10.1121/1.4781079, 10.1121/1.4781079]; Huang JY, 2009, J ACOUST SOC AM, V125, P3983, DOI 10.1121/1.3125342; Huang Y, 2008, HEARING RES, V244, P51, DOI 10.1016/j.heares.2008.07.006; Kraljic T, 2006, PSYCHON B REV, V13, P262, DOI 10.3758/BF03193841; Laures JS, 2003, J COMMUN DISORD, V36, P449, DOI 10.1016/S0021-9924(03)00032-7; Laures JS, 1999, J SPEECH LANG HEAR R, V42, P1148, DOI 10.1044/jslhr.4205.1148; Li L, 2004, J EXP PSYCHOL HUMAN, V30, P1077, DOI 10.1037/0096-1523.30.6.1077; Mattys SL, 2005, J EXP PSYCHOL GEN, V134, P477, DOI 10.1037/0096-3445.134.4.477; Ni JF, 2006, SPEECH COMMUN, V48, P989, DOI 10.1016/j.specom.2006.01.002; PREVOST S, 1994, SPEECH COMMUN, V15, P139, DOI 10.1016/0167-6393(94)90048-5; Prom-on S, 2009, J ACOUST SOC AM, V125, P405, DOI 10.1121/1.3037222; Saito T, 2009, INTONATION GENERATIO; Wang B., 2010, SPEECH PROSODY, V2010; Wang JJ, 2013, J ACOUST SOC AM, V134, pEL91, DOI 10.1121/1.4811159; Weber A, 2006, LANG SPEECH, V49, P367, DOI 10.1177/00238309060490030301; Wolfram S., 1991, MATH SYSTEM DOING MA, V70, P1043; Wu MH, 2012, HEARING RES, V283, P136, DOI 10.1016/j.heares.2011.11.001; Xu Y, 2014, SPEECH COMMUN, V57, P181, DOI 10.1016/j.specom.2013.09.013; Yang ZG, 2007, SPEECH COMMUN, V49, P892, DOI 10.1016/j.specom.2007.05.005; Zhang Z, 2010, 2010 INTERNATIONAL CONFERENCE ON THE DEVELOPMENT OF EDUCATIONAL SCIENCE AND COMPUTER TECHNOLOGY, P378, DOI 10.1109/ISCSLP.2010.5684865	36	4	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209976	10.1371/journal.pone.0209976	http://dx.doi.org/10.1371/journal.pone.0209976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1ZC	30605452	gold, Green Submitted, Green Published			2022-12-26	WOS:000454759900025
J	Delroisse, J; Duchatelet, L; Flammang, P; Mallefet, J				Delroisse, Jerome; Duchatelet, Laurent; Flammang, Patrick; Mallefet, Jerome			De novo transcriptome analyses provide insights into opsin-based photoreception in the lanternshark Etmopterus spinax	PLOS ONE			English	Article							RNA-SEQ; VISUAL PIGMENTS; CELL-ADHESION; COLOR-VISION; RHODOPSIN; PHOTOTRANSDUCTION; LUMINESCENCE; ANNOTATION; RECOVERIN; EVOLUTION	The velvet belly lanternshark (Etmopterus spinax) is a small deep-sea shark commonly found in the Eastern Atlantic and the Mediterranean Sea. This bioluminescent species is able to emit a blue-green ventral glow used in counter-illumination camouflage, mainly. In this study, paired-end Illumina HiSeq (TM) technology has been employed to generate transcriptome data from eye and ventral skin tissues of the lanternshark. About 64 and 49 million Illumina reads were generated from skin and eye tissues respectively. The assembly allowed us to predict 119,749 total unigenes including 94,569 for the skin transcriptome and 94,365 for the eye transcriptome while 74,753 were commonly found in both transcriptomes. A taxonomy filtering was applied to extract a reference transcriptome containing 104,390 unigenes among which 38,836 showed significant similarities to known sequences in NCBI non-redundant protein sequences database. Around 58% of the annotated unigenes match with predicted genes from the Elephant shark (Callorhinchus milii) genome. The transcriptome completeness has been evaluated by successfully capturing around 98% of orthologous genes of the "Core eukaryotic gene dataset" within the E. spinax reference transcriptome. We identified potential "light-interacting toolkit" genes including multiple genes related to ocular and extraocular light perception processes such as opsins, phototransduction actors or crystallins. Comparative gene expression analysis reveals eye-specific expression of opsins, ciliary phototransduction actors, crystallins and vertebrate retinoid pathway actors. In particular, mRNAs from a single rhodopsin gene and its potentially associated peropsin were detected in the eye transcriptome, only, confirming a monochromatic vision of the lanternshark. Encephalopsin mRNAs were mainly detected in the ventral skin transcriptome. In parallel, immunolocalization of the encephalopsin within the ventral skin of the shark suggests a functional relation with the photophores, i.e. epidermal light-producing organs. We hypothesize that extraocular photoreception might be involved in the bioluminescence control possibly acting on the shutter opening and/or the photocyte activity itself. The newly generated reference transcriptome provides a valuable resource for further understanding of the shark biology.	[Delroisse, Jerome; Flammang, Patrick] Univ Mons UMONS, Res Inst Biosci Biol Marine Organisms & Biomimet, Mons, Belgium; [Duchatelet, Laurent; Mallefet, Jerome] Catholic Univ Louvain UCLouvain, Earth & Life Inst, Marine Biol Lab, Louvain La Neuve, Belgium	University of Mons	Delroisse, J (corresponding author), Univ Mons UMONS, Res Inst Biosci Biol Marine Organisms & Biomimet, Mons, Belgium.; Mallefet, J (corresponding author), Catholic Univ Louvain UCLouvain, Earth & Life Inst, Marine Biol Lab, Louvain La Neuve, Belgium.	Jerome.Delroisse@umons.ac.be; Jerome.Mallefet@uclouvain.be	Flammang, Patrick/H-9465-2019; Duchatelet, Laurent/AAG-9444-2021; Duchatelet, Laurent/AAG-6174-2021; Delroisse, Jerome/H-3658-2019; Delroisse, Jérôme/G-1274-2014	Flammang, Patrick/0000-0001-9938-1154; Duchatelet, Laurent/0000-0002-1320-4067; Delroisse, Jerome/0000-0002-9233-6470; Delroisse, Jérôme/0000-0002-9233-6470; mallefet, jerome/0000-0003-0918-3491	F.N.R.S-F.R.S grant (FRFC) [2.4590.11]; WISD-PDR project from the F.R.S.-FNRS; FRIA grant from the F.R.S.-FNRS	F.N.R.S-F.R.S grant (FRFC)(Fonds de la Recherche Scientifique - FNRS); WISD-PDR project from the F.R.S.-FNRS; FRIA grant from the F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS)	This study was support by a F.N.R.S-F.R.S grant awarded to J.M. and P.F. (FRFC grant no. 2.4590.11, http://www.fnrs.be).; J.D., L.D., J.M. and P.F. are respectively Postdoctoral researcher, PhD Student, Research Associate, and Research Director of the Fund for Scientific Research of Belgium (F.R.S.-FNRS). J.D. is currently supported by a WISD-PDR project from the F.R.S.-FNRS. L.D. is supported by a FRIA grant from the F.R.S.-FNRS. Library preparation and sequencing was performed by B.G.I. (Hong Kong). We thank Dr. J. Claes for making the shark schematic presented in the Fig 8. A as well as for the constructive discussions we had about the project. We are grateful to A. Aadnesen, manager of the Espegrend Marine Biological Station (University of Bergen, Norway) where animals were kept and T. Sorlie for his help during field collections. This study is a contribution from the "Centre Interuniversitaire de Biologie Marine" (CIBIM).	Andrews S., 2010, FASTQC QUALITY CONTR; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bleckmann H, 1999, SHARKS, SKATES, AND RAYS, P300; Chana-Munoz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182756; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Chen TT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02995-4; Claes JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104213; Claes JM, 2011, COMP BIOCHEM PHYS C, V153, P231, DOI 10.1016/j.cbpc.2010.11.002; Claes JM, 2010, J EXP BIOL, V213, P3005, DOI 10.1242/jeb.040410; Claes JM, 2010, J EXP MAR BIOL ECOL, V388, P28, DOI 10.1016/j.jembe.2010.03.009; Claes JM, 2010, J EXP BIOL, V213, P1852, DOI 10.1242/jeb.041947; Claes JM, 2009, J EXP BIOL, V212, P3684, DOI 10.1242/jeb.034363; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Cohen J.L., 1990, P465; Compagno L.J.V., 2005, SHARKS WORLD; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; D'Aniello S, 2015, MAR GENOM, V24, P177, DOI 10.1016/j.margen.2015.10.001; Das S, 2016, INTEGR COMP BIOL, V56, P1067, DOI 10.1093/icb/icw117; Davies WL, 2009, GENOME RES, V19, P415, DOI 10.1101/gr.084509.108; Delroisse J, 2017, ZOOL ANZ, V269, P1, DOI 10.1016/j.jcz.2017.05.001; Delroisse J, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160300; Delroisse J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152988; Delroisse J, 2015, MAR GENOM, V23, P109, DOI 10.1016/j.margen.2015.05.014; Delroisse J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1035; Delroisse J, 2014, LUMINESCENCE, V29, P15; Delroisse J, 2013, CAH BIOL MAR, V54, P721; DENTON EJ, 1963, J MAR BIOL ASSOC UK, V43, P65, DOI 10.1017/S0025315400005245; DENTON EJ, 1964, J MAR BIOL ASSOC UK, V44, P219, DOI 10.1017/S0025315400024760; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; Ebert DA., 2013, SHARKS WORLD; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Feuda R, 2014, GENOME BIOL EVOL, V6, P1964, DOI 10.1093/gbe/evu154; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruber S.H., 1978, VISUAL SYSTEM ELASMO, P11; Haltaufderhyde K, 2015, PHOTOCHEM PHOTOBIOL, V91, P117, DOI 10.1111/php.12354; Hara Y., 2018, NATURE ECOLOGY EVOLU, P1; Hart Nathan S., 2006, P337; Hart NS, 2015, INTEGR ZOOL, V10, P38, DOI 10.1111/1749-4877.12095; Hart NS, 2004, J EXP BIOL, V207, P4587, DOI 10.1242/jeb.01314; Hueter RE, 2004, CRC MAR BIOL SER, P325; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Kojima D, 2000, J NEUROSCI, V20, P2845; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Lan Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4720-z; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; McEachran JD, 2004, CRC MAR BIOL SER, P79; Meredith TL, 2010, J EXP BIOL, V213, P3449, DOI 10.1242/jeb.045849; Millott N., 1978, EXTRA OCULAR PHOTOSE; Millott N., 1968, S ZOOL SOC LOND; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Ramirez MD, 2016, GENOME BIOL EVOL, V8, P3640, DOI 10.1093/gbe/evw248; READ TD, 2017, BMC GENOMICS, V18; Renwart M, 2015, ZOOMORPHOLOGY, V134, P107, DOI 10.1007/s00435-014-0235-6; Renwart M, 2014, ZOOMORPHOLOGY, V133, P405, DOI 10.1007/s00435-014-0230-y; RIPPS H, 1990, J EXP ZOOL, P46; Rochon-Duvigneaud A., 1943, VEUX VISION VERTEBRE; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sakmar TP, 1995, ISRAEL J CHEM, V35, P325; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Setty SRG, 2018, J INVEST DERMATOL, V138, P13, DOI 10.1016/j.jid.2017.09.025; Speiser DI, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0350-x; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Theiss SM, 2007, J COMP PHYSIOL A, V193, P67, DOI 10.1007/s00359-006-0171-0; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; VIGHTEICHMANN I, 1983, CELL TISSUE RES, V228, P139; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Walls GL, 1942, BIOL S; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolken J., 1995, LIGHT DETECTORS PHOT; WOLKEN JJ, 1988, COMP BIOCHEM PHYS C, V91, P145, DOI 10.1016/0742-8413(88)90180-6; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	96	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209767	10.1371/journal.pone.0209767	http://dx.doi.org/10.1371/journal.pone.0209767			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596723	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200081
J	Liesirova, K; Abela, E; Pilgrim, T; Bickel, L; Meinel, T; Meisterernst, J; Rajeev, V; Sarikaya, H; Heldner, MR; Dobrocky, T; Siqueira, E; El-Koussy, M; Fischer, U; Gralla, J; Arnold, M; Mattle, HP; Hsieh, K; Jung, S				Liesirova, Kai; Abela, Eugenio; Pilgrim, Thomas; Bickel, Laura; Meinel, Thomas; Meisterernst, Julia; Rajeev, Verma; Sarikaya, Hakan; Heldner, Mirjam R.; Dobrocky, Tomas; Siqueira, Erick; El-Koussy, Marwan; Fischer, Urs; Gralla, Jan; Arnold, Marcel; Mattle, Heinrich P.; Hsieh, Kety; Jung, Simon			Baseline Troponin T level in stroke and its association with stress cardiomyopathy	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ELEVATED TROPONIN; DETERMINANTS; LOCATION	Background Differential diagnosis of elevated high sensitive Troponin T (hsTnT) in acute ischemic stroke includes myocardial infarction (MI) and neurogenic stunned myocardium (NSM). The aim of this study was to identify factors associated with baseline hsTnT levels and MI or NSM in acute ischemic stroke. Methods We studied 204 consecutive patients of the prospective acquired Bern Stroke Database with acute ischemic stroke diagnosed by brain MR. All patient histories and cardiac examinations were reviewed retrospectively. Volumetry of lesions on diffusion and perfusion weighted brain imaging (circular singular value decomposition, Tmax >6sec) was performed. Voxel based analysis was performed to identify brain areas associated with hsTnT elevation. Linear regression analysis was used to identify predictors of baseline hsTnT levels and myocardial infarction. Results Elevated hsTnT was observed in 58 of the 204 patients (28.4%). The mean age was 68.3 years in the normal hsTnT group and 69.7 years in the elevated hsTnT group. Creatinine (p<0.001, OR 6.735, 95% CI 58.734-107.423), baseline NIHSS score (p = 0.029, OR 2.207, 95% CI 0.675-12.096), ST segment depression (p = 0.025, OR 2.259, 95% CI 2.419-35.838), and negative T waves in baseline ECG (p = 0.002, OR 3.209, 95% CI 13.007-54.564) were associated with hsTnT elevation, while infarct location and size were not. Coronary angiography was performed in 30 of the 204 patients (14.7%) and myocardial infarction was diagnosed in 7 of them (23.3%). Predictive factors for myocardial infarction could not be identified. Conclusion Elevated baseline baseline hsTnT was associated with NIHSS, creatinine, ST segment depression and inverted T waves, but not with stroke location or size. None of the factors was helpful to differentiate MI and NSM. Therefore, ancillary investigations such as coronary angiography, cardiac MRI or both may be needed to solve the differential diagnosis.	[Liesirova, Kai; Abela, Eugenio; Meinel, Thomas; Meisterernst, Julia; Sarikaya, Hakan; Heldner, Mirjam R.; Fischer, Urs; Arnold, Marcel; Mattle, Heinrich P.; Jung, Simon] Univ Bern, Bern Univ Hosp, Inselspital, Dept Neurol, Bern, Switzerland; [Pilgrim, Thomas; Dobrocky, Tomas] Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland; [Bickel, Laura; Rajeev, Verma; Siqueira, Erick; El-Koussy, Marwan; Gralla, Jan; Hsieh, Kety] Univ Inst Diagnost & Intervent Neuroradiol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Jung, S (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Neurol, Bern, Switzerland.	simon.jung@insel.ch	Pilgrim, Thomas/AAS-9120-2021	Pilgrim, Thomas/0000-0001-8721-4068; Fischer, Urs/0000-0003-0521-4051; Heldner, Mirjam R/0000-0002-3594-2159; Meinel, Thomas Raphael/0000-0002-0647-9273	Swiss Heart Foundation	Swiss Heart Foundation	This work was supported by Swiss Heart Foundation, https://www.swissheart.ch/de/startseite.html.	Abdi S, 2015, IRAN J NEUROL, V14, P35; Anders B, 2013, CEREBROVASC DIS, V36, P211, DOI 10.1159/000353875; Apak I, 2005, TOHOKU J EXP MED, V205, P93, DOI 10.1620/tjem.205.93; Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; Berganzo K, 2011, CLIN AUTON RES, V21, P65, DOI 10.1007/s10286-010-0088-0; Chalela JA, 2004, NEUROCRIT CARE, V1, P343, DOI 10.1385/NCC:1:3:343; Darki A, 2013, J STROKE CEREBROVASC, V22, P959, DOI 10.1016/j.jstrokecerebrovasdis.2011.12.004; Dombrowski Keith, 2014, Handb Clin Neurol, V119, P3, DOI 10.1016/B978-0-7020-4086-3.00001-1; Faiz KW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-96; Gilgen MD, 2015, STROKE, V46, P2510, DOI 10.1161/STROKEAHA.115.010250; Heldner MR, 2014, STROKE, V45, pE125, DOI 10.1161/STROKEAHA.114.005388; Jung S, 2013, EUR J NEUROL, V20, P865, DOI 10.1111/ene.12069; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Jung S, 2011, STROKE, V42, P1946, DOI 10.1161/STROKEAHA.110.606038; Kerr G, 2009, CEREBROVASC DIS, V28, P220, DOI 10.1159/000226773; Kral M, 2015, INT J CARDIOL, V181, P127, DOI 10.1016/j.ijcard.2014.12.027; Krause T, 2017, ANN NEUROL, V81, P502, DOI 10.1002/ana.24906; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Scheitz JF, 2012, INT J CARDIOL, V157, P239, DOI 10.1016/j.ijcard.2012.01.055; Song HS, 2008, J CLIN NEUROL, V4, P75, DOI 10.3988/jcn.2008.4.2.75; Sykora M, 2009, STROKE, V40, P737, DOI 10.1161/STROKEAHA.108.519967; VISSER CA, 1983, EUR HEART J, V4, P333, DOI 10.1093/oxfordjournals.eurheartj.a061470	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209764	10.1371/journal.pone.0209764	http://dx.doi.org/10.1371/journal.pone.0209764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596715	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200080
J	Quinn, O; Gruber, MAM; Brown, RL; Baty, JW; Bulgarella, M; Lester, PJ				Quinn, Oliver; Gruber, Monica A. M.; Brown, Robert L.; Baty, James W.; Bulgarella, Mariana; Lester, Philip J.			A metatranscriptomic analysis of diseased social wasps (Vespula vulgaris) for pathogens, with an experimental infection of larvae and nests	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; INSECT PATHOGENS; COMMON WASPS; HYMENOPTERA; IDENTIFICATION; SELECTION; VESPIDAE; HOST	Social wasps are a major pest in many countries around the world. Pathogens may influence wasp populations and could provide an option for population management via biological control. We investigated the pathology of nests of apparently healthy common wasps, Vespula vulgaris, with nests apparently suffering disease. First, next-generation sequencing and metatranscriptomic analysis were used to examine pathogen presence. The transcriptome of healthy and diseased V. vulgaris showed 27 known microbial phylotypes. Four of these were observed in diseased larvae alone (Aspergillus fumigatus, Moellerella wisconsensis, Moku virus, and the microsporidian Vavraia culicis). Kashmir Bee Virus (KBV) was found to be present in both healthy and diseased larvae. Moellerella wisconsensis is a human pathogen that was potentially misidentified in our wasps by the MEGAN analysis: it is more likely to be the related bacteria Hafnia alvei that is known to infect social insects. The closest identification to the putative pathogen identified as Vavraia culicis was likely to be another microsporidian Nosema vulgaris. PCR and subsequent Sanger sequencing using published or our own designed primers, confirmed the identity of Moellerella sp. (which may be Hafnia alvei), Aspergillus sp., KBV, Moku virus and Nosema. Secondly, we used an infection study by homogenising diseased wasp larvae and feeding them to entire nests of larvae in the laboratory. Three nests transinfected with diseased larvae all died within 19 days. No pathogen that we monitored, however, had a significantly higher prevalence in diseased than in healthy larvae. RT-qPCR analysis indicated that pathogen infections were significantly correlated, such as between KBV and Aspergillus sp. Social wasps clearly suffer from an array of pathogens, which may lead to the collapse of nests and larval death.	[Quinn, Oliver; Gruber, Monica A. M.; Baty, James W.; Bulgarella, Mariana; Lester, Philip J.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand; [Gruber, Monica A. M.; Lester, Philip J.] Victoria Univ Wellington, Victoria Link Ltd, Pacific Biosecur, Wellington, New Zealand; [Brown, Robert L.] Manaaki Whenua Landcare Res, Biodivers & Conservat, Lincoln, New Zealand	Victoria University Wellington; Victoria University Wellington; Landcare Research - New Zealand	Lester, PJ (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.; Lester, PJ (corresponding author), Victoria Univ Wellington, Victoria Link Ltd, Pacific Biosecur, Wellington, New Zealand.	phil.lester@vuw.ac.nz	Bulgarella, Mariana/U-6951-2019; Bulgarella, Mariana/C-2760-2008; Brown, Robert L/E-7814-2011; Lester, Phil/A-1296-2008	Bulgarella, Mariana/0000-0002-7582-8529; Bulgarella, Mariana/0000-0002-7582-8529; Brown, Robert L/0000-0002-2294-5721; Baty, James/0000-0002-7961-3234; Lester, Phil/0000-0002-1801-5687; Gruber, Monica/0000-0001-6780-8838	Royal Society Marsden grant; National Science Challenge-Biological Heritage programme on Novel Wasp Control Technologies	Royal Society Marsden grant; National Science Challenge-Biological Heritage programme on Novel Wasp Control Technologies	This work was funded by a Royal Society Marsden grant to PJL and MAMG, and supports the National Science Challenge-Biological Heritage programme on Novel Wasp Control Technologies.; We thank David Flynn (School of Chemical and Physical Science, Victoria University of Wellington) for his assistance with the TEM work, and two referees and the Academic Editor for their suggestions that improved this manuscript. This work was funded by a Royal Society Marsden grant to PJL and MAMG, and supports the National Science Challenge-Biological Heritage programme on Novel Wasp Control Technologies.	Andreadis TG, 2007, J AM MOSQUITO CONTR, V23, P3, DOI 10.2987/8756-971X(2007)23[3:MPOM]2.0.CO;2; Boncristiani HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073429; Brown R, 2013, TRENDS ISS CRIME CRI, P1; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; Dobelmann J, 2017, OIKOS, V126, P1208, DOI 10.1111/oik.04117; DONOVAN BJ, 1987, NEW ZEAL J ZOOL, V14, P329, DOI 10.1080/03014223.1987.10423002; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fan QH, 2016, SYST APPL ACAROL-UK, V21, P119, DOI 10.11158/saa.21.1.8; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Glare TR, 1996, NEW ZEAL J ZOOL, V23, P339, DOI 10.1080/03014223.1996.9518093; Gruber MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03508-z; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harcourt SJ, 2002, THESIS, P1; HAY DB, 1993, MED VET ENTOMOL, V7, P271, DOI 10.1111/j.1365-2915.1993.tb00687.x; HICKMANBRENNER FW, 1984, J CLIN MICROBIOL, V19, P460, DOI 10.1128/JCM.19.4.460-463.1984; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Interaminense JA, 2010, J MED MICROBIOL, V59, P941, DOI 10.1099/jmm.0.020453-0; Koch R, 1893, Z HYG INFEKTIONSKR, V14, P319, DOI [10.1007/bf02284324., DOI 10.1007/BF02284324, 10.1007/BF02284324]; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; Lester PJ, 2014, DIVERS DISTRIB, V20, P964, DOI 10.1111/ddi.12223; Lester PJ, 2014, NZ ENTOMOL, V37, P1; Lester PJ, 2017, J ANIM ECOL, V86, P337, DOI 10.1111/1365-2656.12622; Lester PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121358; Lester PJ, 2019, ANN REV ENTOMOL, V64; Li JL, 2015, CURR BIOL, V25, pR652, DOI 10.1016/j.cub.2015.06.031; Merino L, 2007, AGR TEC, V67, P335; MOLLER H, 1991, NEW ZEAL J ZOOL, V18, P171, DOI 10.1080/03014223.1991.10757964; Mondet F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004323; Mordecai GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34983; R Core Team, 2021, R LANGUAGE ENV STAT; Rose EAF, 1999, NEW ZEAL J ZOOL, V26, P179, DOI 10.1080/03014223.1999.9518188; Schwarz RS, 2015, CURR OPIN INSECT SCI, V10, P1, DOI 10.1016/j.cois.2015.04.006; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Spradbery J. P., 1973, Wasps. An account of the biology and natural history of social and solitary wasps, with particular reference to those of the British Isles.; Sy VE, 2014, EVOL APPL, V7, P468, DOI 10.1111/eva.12144; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang Y, 2016, R J, V8, P474, DOI 10.32614/rj-2016-060; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zimmermann Gisbert, 2013, Insects, V4, P425, DOI 10.3390/insects4030425	45	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209589	10.1371/journal.pone.0209589	http://dx.doi.org/10.1371/journal.pone.0209589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596703	Green Submitted, gold, Green Published			2022-12-26	WOS:000454627200059
J	Kesanopoulos, K; Bratcher, HB; Hong, E; Xirogianni, A; Papandreou, A; Taha, MK; Maiden, MCJ; Tzanakaki, G				Kesanopoulos, Konstantinos; Bratcher, Holly B.; Hong, Eva; Xirogianni, Athanasia; Papandreou, Anastasia; Taha, Muhamed-Kheir; Maiden, Martin C. J.; Tzanakaki, Georgina			Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; SEROGROUP-B; STRAIN COVERAGE; DISEASE; IMPACT; IDENTIFICATION; DIVERSITY; VARIANTS; ASSAY	Herd protection, resulting from the interruption of transmission and asymptomatic carriage, is an important element of the effectiveness of vaccines against the meningococcus. Whilst this has been well established for conjugate polysaccharide vaccines directed against the meningococcal capsule, two uncertainties surround the potential herd protection provided by the novel protein-based vaccines that are used in place of serogroup B (MenB) polysaccharide vaccines (i) the strain coverage of such vaccines against carried meningococci, which are highly diverse; and (ii) the generation of a protective immune response in the mucosa. These considerations are essential for realistic estimates of cost-effectiveness of new MenB vaccines. Here the first of these questions is addressed by the whole genome sequence (WGS) analysis of meningococci isolated from healthy military recruits and university students in Greece. The study included a total of 71 MenB isolates obtained from 1420 oropharyngeal single swab samples collected from military recruits and university students on voluntary basis, aged 18-26 years. In addition to WGS analysis to identify genetic lineage and vaccine antigen genes, including the Bexsero Antigen Sequence Type (BAST), the isolates were examined with the serological Meningococcal antigen Typing System (MATS) assay. Comparison of these data demonstrated that the carried meningococcal population was highly diverse with 38% of the carriage isolates showed expression of antigens matching those included in the 4CMenB vaccine. Our data may suggest a limited potential herd immunity to be expected and be driven by an impact on a subset of carriage isolates.	[Kesanopoulos, Konstantinos; Xirogianni, Athanasia; Papandreou, Anastasia; Tzanakaki, Georgina] Natl Sch Publ Hlth, Dept Publ Hlth, NMRL, Athens, Greece; [Bratcher, Holly B.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Peter Medawar Bldg,South Parks Rd, Oxford, England; [Hong, Eva; Taha, Muhamed-Kheir] Inst Pasteur, Invas Bacterial Infect Unit, Paris, France	National & Kapodistrian University of Athens; University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tzanakaki, G (corresponding author), Natl Sch Publ Hlth, Dept Publ Hlth, NMRL, Athens, Greece.	gtzanakaki@esdy.edu.gr	Maiden, Martin C J/C-5055-2014; Tzanakaki, Georgina/AAZ-6598-2021; Xirogianni, Athanasia/ABG-6686-2022	Maiden, Martin C J/0000-0001-6321-5138; Xirogianni, Athanasia/0000-0002-2959-8216	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	Funding for this study was provided by GlaxoSmithKline Biologicals SA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors were solely responsible for final content and interpretation.	Abad R, 2017, J INFECTION, V75, P511, DOI 10.1016/j.jinf.2017.09.021; Arnold R, 2011, VACCINE, V29, P7100, DOI 10.1016/j.vaccine.2011.06.120; BLACKWELL CC, 1992, EPIDEMIOL INFECT, V108, P441, DOI 10.1017/S0950268800049943; Brehony C, 2016, VACCINE, V34, P4690, DOI 10.1016/j.vaccine.2016.08.015; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Buckwalter CM, 2017, J INFECT DIS, V215, P1590, DOI 10.1093/infdis/jix162; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Delbos V, 2013, VACCINE, V31, P4416, DOI 10.1016/j.vaccine.2013.06.080; Dolan-Livengood JM, 2003, GENETIC BASIS NONGRO, DOI [10.1086/527401, DOI 10.1086/527401]; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Drakopoulou Z, 2008, FEMS IMMUNOL MED MIC, V53, P178, DOI 10.1111/j.1574-695X.2008.00406.x; Ganesh K, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0942-5; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Holmes JD, 2008, EPIDEMIOL INFECT, V136, P790, DOI 10.1017/S0950268807009211; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Lemee L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107240; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marshall H, 2016, INT J EVID-BASED HEA, V14, P3, DOI 10.1097/XEB.0000000000000048; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Mowlaboccus S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186839; Plikaytis BD, 2012, CLIN VACCINE IMMUNOL, V19, P1609, DOI 10.1128/CVI.00202-12; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Rodrigues CMC, 2018, EMERG INFECT DIS, V24, P673, DOI 10.3201/eid2404.171480; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Soriano-Gabarro M, 2011, EXPERT REV ANTI-INFE, V9, P761, DOI [10.1586/ERI.11.89, 10.1586/eri.11.89]; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Trotter Caroline L MMC, 2016, HDB MENINGOCOCCAL DI, DOI [10.1007/978-3-319-28119-3, DOI 10.1007/978-3-319-28119-3]; Tryfinopoulou K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167404; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Whittaker R, 2017, VACCINE, V35, P2034, DOI 10.1016/j.vaccine.2017.03.007	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209919	10.1371/journal.pone.0209919	http://dx.doi.org/10.1371/journal.pone.0209919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592763	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900051
J	De Matteo, L; Holtz, Y; Ranwez, V; Berard, S				De Matteo, Lisa; Holtz, Yan; Ranwez, Vincent; Berard, Severine			Efficient algorithms for Longest Common Subsequence of two bucket orders to speed up pairwise genetic map comparison	PLOS ONE			English	Article							R-PACKAGE	Genetic maps order genetic markers along chromosomes. They are, for instance, extensively used in marker-assisted selection to accelerate breeding programs. Even for the same species, people often have to deal with several alternative maps obtained using different ordering methods or different datasets, e.g. resulting from different segregating populations. Having efficient tools to identify the consistency and discrepancy of alternative maps is thus essential to facilitate genetic map comparisons. We propose to encode genetic maps by bucket order, a kind of order, which takes into account the blurred parts of the marker order while being an efficient data structure to achieve low complexity algorithms. The main result of this paper is an O(n log(n)) procedure to identify the largest agreements between two bucket orders of n elements, their Longest Common Subsequence (LCS), providing an efficient solution to highlight discrepancies between two genetic maps. The LCS of two maps, being the largest set of their collinear markers, is used as a building block to compute pairwise map congruence, to visually emphasize maker collinearity and in some scaffolding methods relying on genetic maps to improve genome assembly. As the LCS computation is a key subroutine of all these genetic map related tools, replacing the current LCS subroutine of those methods by ours - to do the exact same work but faster-could significantly speed up those methods without changing their accuracy. To ease such transition we provide all required algorithmic details in this self contained paper as well as an R package implementing them, named LCSLCIS, which is freely available at: https://github.com/holtzy/LCSLCIS.	[De Matteo, Lisa; Berard, Severine] Univ Montpellier, ISEM, CNRS, IRD,EPHE, Montpellier, France; [Holtz, Yan] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Ranwez, Vincent] Univ Montpellier, AGAP, CIRAD, INRA,Montpellier SupAgro, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Queensland; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Berard, S (corresponding author), Univ Montpellier, ISEM, CNRS, IRD,EPHE, Montpellier, France.	Severine.Berard@umontpellier.fr	ranwez, vincent/I-5490-2017	ranwez, vincent/0000-0002-9308-7541				APOSTOLICO A, 1986, INFORM PROCESS LETT, V23, P63, DOI 10.1016/0020-0190(86)90044-X; Bansal MS, 2009, INFORM PROCESS LETT, V109, P238, DOI 10.1016/j.ipl.2008.10.010; Beal R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2793-0; Beal R, 2015, IEEE INT C BIOINFORM, P69, DOI 10.1109/BIBM.2015.7359657; Bonizzoni P, 2007, IEEE ACM T COMPUT BI, V4, P535, DOI 10.1109/TCBB.2007.1066; Brandenburg FJ, 2016, THEOR COMPUT SCI, V636, P66, DOI 10.1016/j.tcs.2016.05.026; Brandenburg FJ, 2013, J COMB OPTIM, V26, P310, DOI 10.1007/s10878-012-9467-x; Bulteau L, 2013, THEOR COMPUT SCI, V494, P122, DOI 10.1016/j.tcs.2012.12.026; Cone Karen C., 2009, P507, DOI 10.1007/978-0-387-77863-1_25; Daykin JW, 2017, MATH COMPUT SCI, V11, P209, DOI 10.1007/s11786-016-0285-x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; DIJKSTRA EW, 1982, SCI COMPUT PROGRAM, V1, P223, DOI 10.1016/0167-6423(82)90016-8; Endelman JB, 2014, BIOINFORMATICS, V30, P1623, DOI 10.1093/bioinformatics/btu091; Endelman JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-407; Fagin R, 2006, SIAM J DISCRETE MATH, V20, P628, DOI 10.1137/05063088X; Fiedler J, 2015, HIGH DENSITY SINGLE, P8; Habib M., 1999, International Journal of Foundations of Computer Science, V10, P147, DOI 10.1142/S0129054199000125; Holtz Y, 2017, BIOINFORMATICS, V33, P1387, DOI 10.1093/bioinformatics/btw816; Holtz Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154609; Holub J., 2003, P AWOCA 2003, P36; HUNT JW, 1977, COMMUN ACM, V20, P350, DOI 10.1145/359581.359603; Jachner S, 2007, J STAT SOFTW, V22, P1; JACOBSON G, 1992, LECT NOTES COMPUT SC, V644, P52; Li GF, 2014, G3-GENES GENOM GENET, V4, P913, DOI 10.1534/g3.113.010165; MAIER D, 1978, J ACM, V25, P322, DOI 10.1145/322063.322075; MASEK WJ, 1980, J COMPUT SYST SCI, V20, P18, DOI 10.1016/0022-0000(80)90002-1; Silfverberg M., 2018, P 27 INT C COMP LING, P1615; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Tang HB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0573-1; WAGNER RA, 1974, J ACM, V21, P168, DOI 10.1145/321796.321811; Wang Y, 2012, MCSCANX TOOLKIT DETE, V40, pe49; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wen WE, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01389; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Xu Y, 2016, VGSC WEB BASED VECTO, V2016, P8	35	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208838	10.1371/journal.pone.0208838	http://dx.doi.org/10.1371/journal.pone.0208838			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589848	Green Published, gold, Green Submitted			2022-12-26	WOS:000454418200011
J	Jemison, LA; Pendleton, GW; Hastings, KK; Maniscalco, JM; Fritz, LW				Jemison, Lauri A.; Pendleton, Grey W.; Hastings, Kelly K.; Maniscalco, John M.; Fritz, Lowell W.			Spatial distribution, movements, and geographic range of Steller sea lions (Eumetopias jubatus) in Alaska	PLOS ONE			English	Article							CONTROL-REGION SEQUENCES; HUMPBACK WHALES; MARINE MAMMALS; CLIMATE-CHANGE; HABITAT USE; DISPERSAL; POPULATION; ABUNDANCE; PATTERNS; FIDELITY	The two stocks of Steller sea lions (Eumetopias jubatus) in Alaska include an endangered western stock, recently recovering in parts of its range following decades of decline, and an eastern stock which was removed from the U.S. Endangered Species List in 2013 following increasing numbers since the 1970s. Information on overlapping distributions of eastern and western sea lions is needed for management considerations. We analyzed >30,000 sightings collected from 2000-2014 of 2,385 sea lions that were branded as pups at 10 Alaskan rookeries to examine mesoscale (mostly <500km) spatial distribution, geographic range, and geographic population structure based on natal rookery, sex, and age during breeding and non-breeding seasons. Analyses of summary movement measures (e.g., natal rookery, sex, and age-class differences in spatial distribution and geographic range) indicate wide variation in rookery-specific movement patterns. Correlations between movement measures and population dynamics suggested movement patterns could be a function of density dependence. Animals from larger rookeries, and rookeries with slower population growth and lower survival, had wider dispersion than animals from smaller rookeries, or rookeries with high growth and survival. Sea lions from the largest rookery, Forrester Island, where survival and population trends are lowest, were the most widely distributed. Analysis of geographic population structure indicated that animals born in the eastern Aleutian Islands had the most distinct movements and had little overlap with other western sea lions. Northern Southeast Alaska, within the eastern stock, is the area of greatest overlap between stocks, and is important to western animals, especially those born in Prince William Sound. Detailed knowledge of distribution and movements of western sea lions is useful for defining recovery and population trend analysis regions that better reflect dispersion and population structure and provides valuable information to managers as critical habitat is re-evaluated and the location of the stock boundary reconsidered.	[Jemison, Lauri A.; Pendleton, Grey W.; Hastings, Kelly K.] Alaska Dept Fish & Game, Div Wildlife Conservat, Douglas, AK 99824 USA; [Maniscalco, John M.] Alaska SeaLife Ctr, Dept Sci, Seward, AK USA; [Fritz, Lowell W.] Natl Marine Fisheries Serv, Marine Mammal Lab, Seattle, WA USA	Alaska Department of Fish & Game; National Oceanic Atmospheric Admin (NOAA) - USA	Jemison, LA (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Douglas, AK 99824 USA.	lauri.jemison@alaska.gov			National Oceanic and Atmospheric Administration/National Marine Fisheries Service [NA05NMF4391148, NA07NMF4390312, NA17FX1079, NA04NMF4390170, NA08NMF4390544, NA11NMF4390200, NA15NMF4390170]; State of Alaska; Coastal Impact Assistance Program, U.S. Fish and Wildlife Service, U.S. Department of Interior	National Oceanic and Atmospheric Administration/National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA); State of Alaska; Coastal Impact Assistance Program, U.S. Fish and Wildlife Service, U.S. Department of Interior	Funding for this research was provided to the Alaska Department of Fish and Game (ADF&G) by the National Oceanic and Atmospheric Administration/National Marine Fisheries Service, through awards NA17FX1079, NA04NMF4390170, NA08NMF4390544, NA11NMF4390200, and NA15NMF4390170. The National Oceanic and Atmospheric Administration/National Marine Fisheries Service additionally provided funding to the Alaska SeaLife Center (awards: NA05NMF4391148 and NA07NMF4390312) and to the Alaska Fisheries Science Center -Marine Mammal Lab. The State of Alaska provided funds to ADF&G. Funding was also provided to ADF&G from the State of Alaska, and from qualified outer continental shelf oil and gas revenues through the Coastal Impact Assistance Program, U.S. Fish and Wildlife Service, U.S. Department of Interior. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, MAR FISH REV; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baker AR, 2005, J MAMMAL, V86, P1075, DOI 10.1644/04-MAMM-A-113R1.1; BAKER CS, 1985, MAR MAMMAL SCI, V1, P304, DOI 10.1111/j.1748-7692.1985.tb00018.x; Balcomb K. C. III, 2001, BAHAMAS J SCI, V5, P1; Baylis AMM, 2017, ECOL EVOL, V7, P3992, DOI 10.1002/ece3.2972; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; Bickham JW, 1996, J MAMMAL, V77, P95, DOI 10.2307/1382712; BIGG MA, 1973, J MAMMAL, V54, P285, DOI 10.2307/1378898; Bigg MA, 1985, CAN SPEC PUBL FISH A, V77, P20; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; BRAHAM HW, 1980, J WILDLIFE MANAGE, V44, P25, DOI 10.2307/3808347; Burkanov V N., 2005, MAR FISH REV, V67, P1; BURNS JJ, 1970, J MAMMAL, V51, P445, DOI 10.2307/1378386; Calambokidis J, 2001, MAR MAMMAL SCI, V17, P769, DOI 10.1111/j.1748-7692.2001.tb01298.x; Calkins DG, 1999, MAR MAMMAL SCI, V15, P462, DOI 10.1111/j.1748-7692.1999.tb00813.x; Calkins DG, 1982, 243 NMFS OUT CONT SH; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; FAY FH, 1974, OCEANOGRAPHY BERING, P383; Fritz L., 2016, 321201672 NOAA NMFSA, V321, P72, DOI DOI 10.7289/V5/TM-AFSC-321; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; Fritz LW, 2015, COUNTS ALASKA STELLE, DOI [10.7289/V5862DDR, DOI 10.7289/V5862DDR]; Fritz LW, 2015, STELLER SEA LION HAU, DOI [10.7289/V58C9T7V, DOI 10.7289/V58C9T7V]; Fuller A., 2012, THESIS; Gales NJ, 1999, WILDLIFE RES, V26, P35, DOI 10.1071/WR98022; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gentry RL, 1970, THESIS; Giardino GV, 2016, MAMM BIOL, V81, P89, DOI 10.1016/j.mambio.2014.12.003; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hastings KK, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170665; Hastings KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176840; Hastings KK, 2009, J WILDLIFE MANAGE, V73, P1040, DOI 10.2193/2007-208; Heath RB, 1996, J ZOO WILDLIFE MED, V27, P35; Hennen D, 2006, ECOL APPL, V16, P704, DOI 10.1890/1051-0761(2006)016[0704:ABTASS]2.0.CO;2; Himes Boor GK, 2012, MAR MAMMAL SCI, V28, pE375, DOI 10.1111/j.1748-7692.2011.00541.x; Horning M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030173; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Kenyon K. W., 1961, Journal of Mammalogy, V43, P223; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; Kirkwood R, 2006, CAN J ZOOL, V84, P1781, DOI 10.1139/Z06-164; Kooyman G. L., 1965, Polar Record, V12, P391; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Laist David W., 1997, P99; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Loughlin Thomas R., 1997, Society for Marine Mammalogy Special Publication, V3, P159; LOUGHLIN TR, 1984, J WILDLIFE MANAGE, V48, P729, DOI 10.2307/3801420; Maniscalco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140982; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; MATE B R, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P455; Mathews EA, 2011, MAR MAMMAL SCI, V27, P852, DOI 10.1111/j.1748-7692.2010.00455.x; McIntyre T, 2014, AFR J MAR SCI, V36, P409, DOI 10.2989/1814232X.2014.976655; Merrick R, 1996, NMFSAFSC68 NOAA US D; MERRICK RL, 1987, FISH B-NOAA, V85, P351; Moore Sue E., 2002, Journal of Cetacean Research and Management, V4, P19; National Marine Fisheries Service, 2008, REC PLAN STELL SEA L; Nerini M., 1984, P423; O'Corry-Crowe G, 2014, MOL ECOL, V23, P5415, DOI 10.1111/mec.12944; Parsons C.M., 2012, J MAR BIOL, V5, DOI DOI 10.1155/2012/807294; Peacock E., 2004, THESIS; Perlov AS, 1971, P UNION I MARINE FIS, V80, P174; Phillips CD, 2011, J MAMMAL, V92, P1091, DOI 10.1644/10-MAMM-A-305.1; Phillips Caleb D., 2009, Occasional Papers Museum of Texas Tech University, V283, P1; Pitcher KW, 2007, FISH B-NOAA, V105, P102; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Rea LD, 2013, SCI TOTAL ENVIRON, V454-455, P454; Reding DM, 2012, MOL ECOL, V21, P3078, DOI 10.1111/j.1365-294X.2012.05595.x; Rehberg MJ, 2009, MAR MAMMAL SCI, V25, P588, DOI 10.1111/j.1748-7692.2008.00278.x; Rehberg M, 2018, ENDANGER SPECIES RES, V37, P11, DOI 10.3354/esr00909; Robertson BC, 2006, BIOL CONSERV, V127, P227, DOI 10.1016/j.biocon.2005.08.011; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; Schroeder B.A., 2003, LOGGERHEAD SEA TURTL, P114; Scordino J., 2006, THESIS; Sigler MF, 2008, MAR MAMMAL SCI, V24, P16, DOI 10.1111/j.1748-7692.2007.00149.x; Simmonds MP, 2007, ORYX, V41, P19, DOI 10.1017/S0030605307001524; Simpkins MA, 2003, POLAR BIOL, V26, P577, DOI 10.1007/s00300-003-0527-7; Stone KD, 2002, MOL PHYLOGENET EVOL, V24, P169, DOI 10.1016/S1055-7903(02)00229-4; Stone KD, 2000, CAN J ZOOL, V78, P1218, DOI 10.1139/cjz-78-7-1218; THORSTEINSON FREDRIK V., 1962, JOUR WILDLIFE MANAGEMENT, V26, P353, DOI 10.2307/3798011; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; U.S. Federal Register, 1990, FR              1126, V55, P49204; Urban R. J., 2003, Journal of Cetacean Research and Management, V5, P281; US Federal Register, 1997, FR; Wilkinson I, 2006, P SEA LIONS WORLD CO; Wilson K, 2012, MAR MAMMAL SCI, V28, pE58, DOI 10.1111/j.1748-7692.2011.00485.x; Womble JN, 2005, MAR ECOL PROG SER, V294, P271, DOI 10.3354/meps294271; York Anne E., 1996, P259	95	4	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208093	10.1371/journal.pone.0208093	http://dx.doi.org/10.1371/journal.pone.0208093			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586412	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400010
J	Cheng, JY; Li, Y; Liu, SQ; Jiang, YJ; Ma, J; Wan, L; Li, QH; Pang, TX				Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang			CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway	FASEB JOURNAL			English	Article						cytokines; cancer; bone marrow microenvironment; crosstalk	BONE-MARROW MICROENVIRONMENT; STEM-CELLS; GENETIC ABERRATIONS; INTERLEUKIN-8; EXPRESSION; CANCER; ANGIOGENESIS; MALIGNANCIES; INHIBITION; SECRETION	The role of proinflammatory cytokines secreted by the bone marrow mesenchymal stromal cells (BM-MSCs) in the progression of acute myeloid leukemia (AML) is poorly understood. We compared C-X-C motif chemokine ligand (CXCL)8 expression levels in the BM-MSCs of patients with AML and normal control subjects and detected significantly higher levels in the former. Furthermore, CXCL8 was up-regulated in cocultures of BM-MSCs and leukemic cell lines compared with either monoculture. CXCL8 expression was significantly higher in MSCs compared with mononuclear cells in patients with de novo AML. To elucidate the function of paracrine CXCL8 in AML, we blocked CXCL8 binding to the C-X-C motif chemokine receptor (CXCR)2 in the AML cells using SB225002. Inhibition of CXCL8/CXCR2 binding decreased proliferation in the AML cells by inducing cell cycle arrest at the G(0)/G(1) phase and apoptosis via decreased AKT phosphorylation. Blocking the PI3K/AKT signaling pathway by a specific inhibitor induced similar apoptosis induction and lower proliferation, suggesting that the PI3K/AKT signaling pathway was also involved in CXCL8 action. Taken together, our findings demonstrate that BM-MSCs are the main source of CXCL8 in the AML bone marrow microenvironment and promote leukemogenesis via the PI3K/AKT signaling pathway, indicating a novel therapeutic target.	[Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Nanjing Rd 288, Tianjin 300020, Peoples R China; [Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang] Chinese Acad Med Sci, Blood Dis Hosp, Nanjing Rd 288, Tianjin 300020, Peoples R China; [Cheng, Jingying; Li, Ying; Liu, Shiqi; Jiang, Yajing; Ma, Jiao; Wan, Li; Li, Qinghua; Pang, Tianxiang] Peking Union Med Coll, Nanjing Rd 288, Tianjin 300020, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pang, TX (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Nanjing Rd 288, Tianjin 300020, Peoples R China.; Pang, TX (corresponding author), Chinese Acad Med Sci, Blood Dis Hosp, Nanjing Rd 288, Tianjin 300020, Peoples R China.; Pang, TX (corresponding author), Peking Union Med Coll, Nanjing Rd 288, Tianjin 300020, Peoples R China.	pang@ihcams.ac.cn			Chinese Academy of Medical Sciences Initiative for Innovative Medicine [CAMS-I2M-2016-1-017]; National Natural Science Foundation of China [81170510]	Chinese Academy of Medical Sciences Initiative for Innovative Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Medical Sciences Initiative for Innovative Medicine (CAMS-I2M-2016-1-017) and the National Natural Science Foundation of China (81170510). The authors declare no conflicts of interest.	Abdul-Aziz AM, 2017, CANCER RES, V77, P303, DOI 10.1158/0008-5472.CAN-16-1095; Blau O, 2011, BLOOD, V118, P5583, DOI 10.1182/blood-2011-03-343467; Brenner AK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00106; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Civini S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-298; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Denizot Y, 1996, BLOOD, V87, P4016, DOI 10.1182/blood.V87.9.4016.bloodjournal8794016; Du L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0745-0; Du MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054572; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Kawano Y, 2015, IMMUNOL REV, V263, P160, DOI 10.1111/imr.12233; Li W, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0172-3; Li X, 2015, ARCH TOXICOL, V89, P121, DOI 10.1007/s00204-014-1226-6; Li YY, 2018, BIOCHEM BIOPH RES CO, V499, P524, DOI 10.1016/j.bbrc.2018.03.181; Li ZL, 2018, FASEB J, V32, P2197, DOI 10.1096/fj.201700895R; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Moudra A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1183860; Mullally A, 2013, CELL STEM CELL, V13, P257, DOI 10.1016/j.stem.2013.08.009; Parmar A, 2011, CANCER RES, V71, P4696, DOI 10.1158/0008-5472.CAN-10-4136; Reikvam H, 2015, STEM CELL RES, V15, P530, DOI 10.1016/j.scr.2015.09.008; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Rotondi M, 2013, J CLIN ENDOCR METAB, V98, P308, DOI 10.1210/jc.2012-2555; Sanmamed MF, 2014, CLIN CANCER RES, V20, P5697, DOI 10.1158/1078-0432.CCR-13-3203; Schinke C, 2015, BLOOD, V125, P3144, DOI 10.1182/blood-2015-01-621631; Shalapour S, 2010, J MOL MED, V88, P249, DOI 10.1007/s00109-009-0583-8; Shao N, 2015, CANCER LETT, V364, P165, DOI 10.1016/j.canlet.2015.05.009; Sharma B, 2013, MOL CANCER THER, V12, P799, DOI 10.1158/1535-7163.MCT-12-0529; Shi Q, 2001, J INTERF CYTOK RES, V21, P553, DOI 10.1089/10799900152547812; Singh JK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3436; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; von der Heide E, 2017, LEUKEMIA, V31, P1069, DOI 10.1038/leu.2016.324; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang JC, 2015, ONCOTARGET, V6, P42825, DOI 10.18632/oncotarget.5739; Wang S, 2013, TRANSL ONCOL, V6, P216, DOI 10.1593/tlo.13133; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang LL, 2015, CELL MOL LIFE SCI, V72, P1959, DOI 10.1007/s00018-015-1846-x	44	21	24	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4755	4764		10.1096/fj.201801931R	http://dx.doi.org/10.1096/fj.201801931R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592634	Bronze			2022-12-26	WOS:000462888500010
J	Kayser, BD; Lhomme, M; Prifti, E; Da Cunha, C; Marquet, F; Chain, F; Naas, I; Pelloux, V; Dao, MC; Kontush, A; Rizkalla, SW; Aron-Wisnewsky, J; Bermudez-Humaran, LG; Oakley, F; Langella, P; Clement, K; Dugail, I				Kayser, Brandon D.; Lhomme, Marie; Prifti, Edi; Da Cunha, Carla; Marquet, Florian; Chain, Florian; Naas, Isabelle; Pelloux, Veronique; Dao, Maria-Carlota; Kontush, Anatol; Rizkalla, Salwa W.; Aron-Wisnewsky, Judith; Bermudez-Humaran, Luis G.; Oakley, Fiona; Langella, Philippe; Clement, Karine; Dugail, Isabelle			Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity	FASEB JOURNAL			English	Article						phosphatidylglycerol synthesis; adipocyte lipolysis; lipidomic profiling; serum phospholipidome	LIPIDOMICS REVEALS; PHOSPHOLIPIDS; EXPRESSION; DISEASE; MICROBIOME; METABOLISM; MECHANISMS; SYSTEM; LIPIDS; LIVER	Lipidomic techniques can improve our understanding of complex lipid interactions that regulate metabolic diseases. Here, a serum phospholipidomics analysis identified associations between phosphatidylglycerols (PGs) and gut microbiota dysbiosis. Compared with the other phospholipids, serum PGs were the most elevated in patients with low microbiota gene richness, which were normalized after a dietary intervention that restored gut microbial diversity. Serum PG levels were positively correlated with metagenomic functional capacities for bacterial LPS synthesis and host markers of low-grade inflammation; transcriptome databases identified PG synthase, the first committed enzyme in PG synthesis, as a potential mediator. Experiments in mice and cultured human-derived macrophages demonstrated that LPS induces PG release. Acute PG treatment in mice altered adipose tissue gene expression toward remodeling and inhibited ex vivo lipolysis in adipose tissue, suggesting that PGs favor lipid storage. Indeed, several PG species were associated with the severity of obesity in mice and humans. Finally, despite enrichment in PGs in bacterial membranes, experiments employing gnotobiotic mice colonized with recombinant PG overproducing Lactococcus lactis showed limited direct contribution of microbial PGs to the host. In summary, PGs are inflammation-responsive lipids indirectly regulated by the gut microbiota via endotoxins and regulate adipose tissue homeostasis in obesity.	[Kayser, Brandon D.; Prifti, Edi; Da Cunha, Carla; Marquet, Florian; Pelloux, Veronique; Dao, Maria-Carlota; Rizkalla, Salwa W.; Aron-Wisnewsky, Judith; Clement, Karine; Dugail, Isabelle] Sorbonne Univ, INSERM, Unite 11662, Nutri Team, Paris, France; [Kontush, Anatol] Sorbonne Univ, INSERM, Unite 11662, Integrat Biol Atherosclerosis Team, Paris, France; [Lhomme, Marie; Prifti, Edi] Inst Cardiometab & Nutr ICAN, ICANalyt Team, Paris, France; [Lhomme, Marie] Inst Cardiometab & Nutr ICAN, Integr Team, Paris, France; [Chain, Florian; Naas, Isabelle; Bermudez-Humaran, Luis G.; Langella, Philippe] Univ Paris Saclay, AgroParisTech, Micalis Inst, Jouy En Josas, France; [Aron-Wisnewsky, Judith; Clement, Karine] Pitie Salpetriere Hop, AP HP, Ctr Rech Nutr Humaine CRNH Ile France, Nutr Dept, Paris, France; [Oakley, Fiona] Newcastle Univ, Inst Cellular Med, Newcastle Fibrosis Res Grp, Newcastle Upon Tyne, Tyne & Wear, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Newcastle University - UK	Clement, K (corresponding author), Sorbonne Univ, INSERM, UMR S1166, Nutri Team, 43-83 Blvd Hop,IE3M, F-75013 Paris, France.; Dugail, I (corresponding author), Sorbonne Univ, INSERM, UMR S1166, Nutri Team, 91 Blvd Hop, F-75013 Paris, France.	karine.clement@inserm.fr; isabelle.dugail@inserm.fr	Dugail, Isabelle/L-1567-2017; Prifti, Edi/F-3967-2019; BERMUDEZ, Luis/AAE-8917-2021; ARON-WISNEWSKY, judith/AAH-7608-2020	Dugail, Isabelle/0000-0003-3631-2252; Prifti, Edi/0000-0001-8861-1305; LHOMME, MARIE/0000-0002-6335-4506; Chain, Florian/0000-0001-8787-3311; Oakley, Fiona/0000-0001-8692-1836; Bermudez Humaran, Luis G./0000-0001-7525-3131	Agence Nationale de la Recherche (ANR MicrObes); Programme Hospitalier de Reserche Clinique (PHRC Microbaria) [AOM10285/P100111]; KOT-Ceprodi; Societe Francaise de Nutrition; Institut Benjamin Delessert; European Union's Seventh Framework Program Metacardis [HEALTH-F4-2012-305312]; European Union's Horizon 2020 Framework Program (EPoS) [634413]; European Foundation; Foundation de France; MRC [G0900535] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL130357] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR MicrObes); Programme Hospitalier de Reserche Clinique (PHRC Microbaria); KOT-Ceprodi; Societe Francaise de Nutrition; Institut Benjamin Delessert; European Union's Seventh Framework Program Metacardis; European Union's Horizon 2020 Framework Program (EPoS); European Foundation(European Science Foundation (ESF)); Foundation de France; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the nurses and technicians and, of course, the patients themselves for their invaluable contribution to this work. The authors also acknowledge Kavya Anjani (INSERM, Paris, Franc) for her contributions, as well as J. C. Bichet (Pitie Salpetriere Hospital) for providing liposuction-derived adipose tissue samples. This work was supported by Agence Nationale de la Recherche (ANR MicrObes), Programme Hospitalier de Reserche Clinique (PHRC Microbaria AOM10285/P100111), KOT-Ceprodi, Association Foundation Coeur et Arteres (clinical investigation), Societe Francaise de Nutrition, and Institut Benjamin Delessert. Support was obtained from European Union's Seventh Framework Program Metacardis under Grant HEALTH-F4-2012-305312, and Horizon 2020 Framework Program (EPoS, Grant 634413). The European Foundation for the Study of Diabetes Albert Renold Travel Fellowship has contributed to the work of B.D.K., and Danone Research to the work of M.-C.D. and K.C. Funding from Foundation de France (to K.C.) was also obtained. MicrObes Consortium collaborators: Aurelie Cotillard; Sean P. Kennedy; Nicolas Pons; Emmanuelle Le Chatelier; Mathieu Almeida; Benoit Quinquis; Nathalie Galleron; Jean-Michel Batto; Pierre Renault; Stanislav Dusko Ehrlich; Herve Blottiere; Marion Leclerc; Tomas de Wouters; Patricia Lepage, Jean-Daniel Zucker, Joel Dore, Salwa W. Rizkalla. The authors declare no conflicts of interest.	Anjani K, 2015, J HEPATOL, V62, P905, DOI 10.1016/j.jhep.2014.11.002; Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benbouziane B, 2013, J BIOTECHNOL, V168, P120, DOI 10.1016/j.jbiotec.2013.04.019; Bernhard W, 2016, ANN ANAT, V208, P146, DOI 10.1016/j.aanat.2016.08.003; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Camont L, 2013, ARTERIOSCL THROM VAS, V33, P2715, DOI 10.1161/ATVBAHA.113.301468; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Dugail I, 2017, BIOCHIMIE, V141, P47, DOI 10.1016/j.biochi.2017.05.005; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Kayser BD, 2017, INT J OBESITY, V41, P917, DOI 10.1038/ijo.2017.63; Kong LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109434; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Meikle PJ, 2008, BIOCHEM J, V411, P71, DOI 10.1042/BJ20071043; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pallister T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13722-4; Prifti E., 2013, 4 INT HUM MICR C, V4; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Titos E, 2016, J IMMUNOL, V197, P3360, DOI 10.4049/jimmunol.1502522; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wu YZ, 2003, AM J RESP CRIT CARE, V168, P692, DOI 10.1164/rccm.200304-467OC; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169	42	15	15	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4741	4754		10.1096/fj.201801897R	http://dx.doi.org/10.1096/fj.201801897R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30608881	Green Submitted, Bronze, Green Published			2022-12-26	WOS:000462888500009
J	Henen, MA; Mahlawat, P; Zwieb, C; Kodali, RB; Hinck, CS; Hanna, RD; Krzysiak, TC; Ilangovan, U; Cano, KE; Hinck, G; Vonberg, M; McCabe, M; Hinck, AP				Henen, Morkos A.; Mahlawat, Pardeep; Zwieb, Christian; Kodali, Ravindra B.; Hinck, Cynthia S.; Hanna, Ramsey D.; Krzysiak, Troy C.; Ilangovan, Udayar; Cano, Kristin E.; Hinck, Garrett; Vonberg, Machell; McCabe, Megan; Hinck, Andrew P.			TGF-2 uses the concave surface of its extended finger region to bind betaglycan's ZP domain via three residues specific to TGF- and inhibin-	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transforming growth factor (TGF-B); cell surface receptor; cell signaling; cardiac development; endocrinology; nuclear magnetic resonance (NMR); betaglycan; finger region; ILV methyl labeling	GROWTH-FACTOR-BETA; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; LIGAND-BINDING; SECONDARY STRUCTURE; STRUCTURAL BASIS; CHEMICAL-SHIFTS; METHYL-GROUPS; RECEPTOR; PROTEIN	Betaglycan (BG) is a membrane-bound co-receptor of the TGF- family that selectively binds transforming growth factor- (TGF-) isoforms and inhibin A (InhA) to enable temporal-spatial patterns of signaling essential for their functions in vivo. Here, using NMR titrations of methyl-labeled TGF-2 with BG's C-terminal binding domain, BG(ZP-C), and surface plasmon resonance binding measurements with TGF-2 variants, we found that the BG(ZP-C)-binding site on TGF-2 is located on the inner surface of its extended finger region. Included in this binding site are Ile-92, Lys-97, and Glu-99, which are entirely or mostly specific to the TGF- isoforms and the InhA -subunit, but they are unconserved in other TGF- family growth factors (GFs). In accord with the proposed specificity-determining role of these residues, BG bound bone morphogenetic protein 2 (BMP-2) weakly or not at all, and TGF-2 variants with the corresponding residues from BMP-2 bound BG(ZP-C) more weakly than corresponding alanine variants. The BG(ZP-C)-binding site on InhA previously was reported to be located on the outside of the extended finger region, yet at the same time to include Ser-112 and Lys-119, homologous to TGF-2 Ile-92 and Lys-97, on the inside of the fingers. Therefore, it is likely that both TGF-2 and InhA bind BG(ZP-C) through a site on the inside of their extended finger regions. Overall, these results identify the BG(ZP-C)-binding site on TGF-2 and shed light on the specificity of BG for select TGF--type GFs and the mechanisms by which BG influences their signaling.	[Henen, Morkos A.; Mahlawat, Pardeep; Kodali, Ravindra B.; Hinck, Cynthia S.; Krzysiak, Troy C.; Hinck, Garrett; Hinck, Andrew P.] Univ Pittsburgh, Dept Struct Biol, Pittsburgh, PA 15260 USA; [Hanna, Ramsey D.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Henen, Morkos A.; Mahlawat, Pardeep; Zwieb, Christian; Hinck, Cynthia S.; Ilangovan, Udayar; Cano, Kristin E.; Hinck, Garrett; Vonberg, Machell; McCabe, Megan; Hinck, Andrew P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA; [Henen, Morkos A.] Mansoura Univ, Fac Pharm, El Goumhria St, Mansoura 35516, Egypt	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; Egyptian Knowledge Bank (EKB); Mansoura University	Hinck, AP (corresponding author), Univ Pittsburgh, Sch Med, Dept Struct Biol, Biomed Sci Tower 3,Rm 2051,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	ahinck@pitt.edu	Henen, Morkos/M-5995-2018	Henen, Morkos/0000-0003-4835-5583; Hinck, Andrew/0000-0003-3320-8054	National Institutes of Health NIGMS [P41-GM103311]	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	David Brinkman is thanked for the initial efforts to generate and characterize several TGF-2 variants; Erich Hellemann for measuring the mass of the TGF-2 variants; Mike Delk for maintaining the NMR instruments, and Profs. Craig Harrison and Daniel Bernard for providing valuable comments on the manuscript. Molecular graphics and analyses were performed with UCSF Chimera. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health NIGMS Grant P41-GM103311).	Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Amero C, 2011, J BIOMOL NMR, V50, P229, DOI 10.1007/s10858-011-9513-5; Baardsnes J, 2009, BIOCHEMISTRY-US, V48, P2146, DOI 10.1021/bi8019004; Bernard DJ, 2002, MOL ENDOCRINOL, V16, P207, DOI 10.1210/me.16.2.207; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bocharov EV, 2000, J BIOMOL NMR, V16, P179, DOI 10.1023/A:1008315600134; BOYD FT, 1989, J BIOL CHEM, V264, P2272; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cull MG, 2000, METHOD ENZYMOL, V326, P430; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Daopin Sun, 1993, Proteins Structure Function and Genetics, V17, P176, DOI 10.1002/prot.340170207; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diestel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067214; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Gans P, 2010, ANGEW CHEM INT EDIT, V49, P1958, DOI 10.1002/anie.200905660; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Huang T, 2016, METHODS MOL BIOL, V1344, P63, DOI 10.1007/978-1-4939-2966-5_4; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kerfah R, 2015, CURR OPIN STRUC BIOL, V32, P113, DOI 10.1016/j.sbi.2015.03.009; Kerfah R, 2015, J BIOMOL NMR, V61, P73, DOI 10.1007/s10858-014-9887-2; Kim SK, 2017, J BIOL CHEM, V292, P7173, DOI 10.1074/jbc.M116.768754; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; LAIHO M, 1990, J BIOL CHEM, V265, P18518; LAIHO M, 1991, J BIOL CHEM, V266, P9108; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Liang YF, 2014, ANGEW CHEM INT EDIT, V53, P548, DOI 10.1002/anie.201308698; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MacConell LA, 2002, ENDOCRINOLOGY, V143, P1066, DOI 10.1210/en.143.3.1066; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Mendoza V, 2009, BIOCHEMISTRY-US, V48, P11755, DOI 10.1021/bi901528w; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Namwanje M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021881; Pederson K, 2017, J BIOMOL NMR, V68, P225, DOI 10.1007/s10858-017-0123-8; Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Saito T, 2017, CELL REP, V19, P1917, DOI 10.1016/j.celrep.2017.05.011; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Villarreal MM, 2016, BIOCHEMISTRY-US, V55, P6880, DOI 10.1021/acs.biochem.6b00566; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; WOODRUFF TK, 1993, ENDOCRINOLOGY, V133, P2998, DOI 10.1210/en.133.6.2998; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhu J, 2012, J BIOL CHEM, V287, P8060, DOI 10.1074/jbc.M111.293381	69	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3065	3080		10.1074/jbc.RA118.005210	http://dx.doi.org/10.1074/jbc.RA118.005210			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30598510	Green Published, hybrid			2022-12-26	WOS:000464980100008
J	Shackleford, GM; Mahdi, MY; Moats, RA; Hawes, D; Tran, HC; Finlay, JL; Hoang, TQ; Meng, EF; Erdreich-Epstein, A				Shackleford, Gregory M.; Mahdi, Min Y.; Moats, Rex A.; Hawes, Debra; Tran, Hung C.; Finlay, Jonathan L.; Hoang, Tuan Q.; Meng, Ellis F.; Erdreich-Epstein, Anat			Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma	PLOS ONE			English	Article							TOPOISOMERASE-I INHIBITORS; INTRATHECAL TOPOTECAN; CEREBROSPINAL-FLUID; NEOPLASTIC MENINGITIS; INTRAVENOUS-INJECTION; LIPOSOMAL CYTARABINE; CLINICAL-TRIAL; OVARIAN-CANCER; CHILDREN; THERAPY	Leptomeningeal metastasis remains a difficult clinical challenge. Some success has been achieved by direct administration of therapeutics into the cerebrospinal fluid (CSF) circumventing limitations imposed by the blood brain barrier. Here we investigated continuous infusion versus bolus injection of therapy into the CSF in a preclinical model of human Group 3 medulloblastoma, the molecular subgroup with the highest incidence of leptomeningeal disease. Initial tests of selected Group 3 human medulloblastoma cell lines in culture showed that D283 Med and D425 Med were resistant to cytosine arabinoside and methotrexate. D283 Med cells were also resistant to topotecan, whereas 1 mu M topotecan killed over 99% of D425 Med cells. We therefore introduced D425 Med cells, modified to express firefly luciferase, into the CSF of immunodeficient mice. Mice were then treated with topotecan or saline in five groups: continuous intraventricular (IVT) topotecan via osmotic pump (5.28 mu g/day), daily bolus IVT topotecan injections with a similar daily dose (6 mu g/day), systemic intraperitoneal injections of a higher daily dose of topotecan (15 mu g/day), daily IVT pumped saline and daily intraperitoneal injections of saline. Bioluminescence analyses revealed that both IVT topotecan treatments effectively slowed leptomeningeal tumor growth in the brains. Histological analysis showed that they were associated with localized brain necrosis, possibly due to backtracking of topotecan around the catheter. In the spines, bolus IVT topotecan showed a trend towards slower tumor growth compared to continuous (pump) IVT topotecan, as measured by bioluminescence. Both continuous and bolus topotecan IVT showed longer survival compared to other groups. Thus, both direct IVT topotecan CSF delivery methods produced better anti-medulloblastoma effect compared to systemic therapy at the dosages used here.	[Shackleford, Gregory M.; Mahdi, Min Y.; Moats, Rex A.] Childrens Hosp Los Angeles, Saban Res Inst, Dept Radiol, Los Angeles, CA 90027 USA; [Hawes, Debra; Erdreich-Epstein, Anat] Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90007 USA; [Hawes, Debra; Erdreich-Epstein, Anat] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA; [Tran, Hung C.; Finlay, Jonathan L.; Erdreich-Epstein, Anat] Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA; [Finlay, Jonathan L.; Erdreich-Epstein, Anat] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA; [Hoang, Tuan Q.; Meng, Ellis F.] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA USA; [Meng, Ellis F.] Univ Southern Calif, Ming Hsieh Dept Elect Engn, Los Angeles, CA USA; [Tran, Hung C.] Kaiser Permanente Cent Bay, Div Pediat Hematol Oncol, Oakland, CA USA; [Finlay, Jonathan L.] Ohio State Univ, Nationwide Childrens Hosp, Div Hematol Oncol & BMT, Columbus, OH 43210 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Shackleford, GM (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dept Radiol, Los Angeles, CA 90027 USA.; Erdreich-Epstein, A (corresponding author), Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90007 USA.; Erdreich-Epstein, A (corresponding author), Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA.; Erdreich-Epstein, A (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA.; Erdreich-Epstein, A (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA.	shacklef@usc.edu; epstein@usc.edu		Erdreich-Epstein, Anat/0000-0003-4269-4373	National Institute of Neurological Disorders and Stroke [NS088965]; Concern Foundation; USC Coulter Translational Research Partnership Program; Barbara Mandel Family Fund; Brad Kamisky Foundation; Rachel Ann Hage Foundation; NSF SBIR [IIP-1353643]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Concern Foundation; USC Coulter Translational Research Partnership Program; Barbara Mandel Family Fund; Brad Kamisky Foundation; Rachel Ann Hage Foundation; NSF SBIR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by funding from the National Institute of Neurological Disorders and Stroke (NS088965 to AEE), Concern Foundation, USC Coulter Translational Research Partnership Program, Barbara Mandel Family Fund, Brad Kamisky Foundation, Grayson's Gift, and Rachel Ann Hage Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors EM and TH have financial interest in Fluid Synchrony LLC (NSF SBIR, award IIP-1353643) in activities that are independent of their roles in this study.	Armstrong DK, 2005, ONCOLOGIST, V10, P686, DOI 10.1634/theoncologist.10-9-686; Armstrong DK, 2004, ONCOLOGIST, V9, P33, DOI 10.1634/theoncologist.9-1-33; Beauchesne P, 2010, LANCET ONCOL, V11, P871, DOI 10.1016/S1470-2045(10)70034-6; Benesch M, 2007, J PEDIAT HEMATOL ONC, V29, P222, DOI 10.1097/MPH.0b013e318041f112; Bernards CM, 2006, ANESTHESIOLOGY, V105, P169, DOI 10.1097/00000542-200607000-00027; BLANEY SM, 1993, CANCER RES, V53, P725; Blaney SM, 2003, J CLIN ONCOL, V21, P143, DOI 10.1200/JCO.2003.04.053; Blaney SM, 2013, PEDIATR BLOOD CANCER, V60, P627, DOI 10.1002/pbc.24309; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Carbonaro DA, 2006, MOL THER, V13, P1110, DOI 10.1016/j.ymthe.2006.02.013; Chikly B, 2013, J BODYW MOV THER, V17, P344, DOI 10.1016/j.jbmt.2013.02.002; Danks MK, 1997, CLIN CANCER RES, V3, P1731; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Fouladi M, 1999, J CLIN ONCOL, V17, P3234, DOI 10.1200/JCO.1999.17.10.3234; FRIEDMAN HS, 1994, CANCER CHEMOTH PHARM, V34, P171; Gaviani P, 2013, NEUROL SCI, V34, P2151, DOI 10.1007/s10072-013-1358-0; Glaberman Ursa, 2005, Expert Opin Drug Deliv, V2, P323, DOI 10.1517/17425247.2.2.323; Guichard S, 2001, CLIN CANCER RES, V7, P3222; HE XM, 1991, LAB INVEST, V64, P833; Heetla HW, 2016, BRIT J CLIN PHARMACO, V81, P101, DOI 10.1111/bcp.12781; Ivanov DP, 2016, J BIOTECHNOL, V236, P10, DOI 10.1016/j.jbiotec.2016.07.028; Jain N, 2008, PEDIATR BLOOD CANCER, V51, P275, DOI 10.1002/pbc.21580; Janss AJ, 1998, ANTI-CANCER DRUG, V9, P641, DOI 10.1097/00001813-199808000-00010; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kato N, 2014, ACTA PAEDIATR, V103, pE251, DOI 10.1111/apa.12587; Kobayashi H, 2005, MOL THER, V11, P776, DOI 10.1016/j.ymthe.2004.10.006; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pardridge W, 1991, PEPTIDE DRUG DELIVER, P99; Park JR, 2011, J CLIN ONCOL, V29, P4351, DOI 10.1200/JCO.2010.34.3293; Pawlik CA, 1998, CLIN CANCER RES, V4, P1995; Pompe RS, 2015, EUR J CANCER, V51, P2634, DOI 10.1016/j.ejca.2015.08.009; Potter SLP, 2012, PEDIATR BLOOD CANCER, V58, P362, DOI 10.1002/pbc.23317; Ramaswamy V, 2017, J CLIN ONCOL, V35, P2355, DOI 10.1200/JCO.2017.72.7842; Rochette A, 2016, BRIT J ANAESTH, V117, P214, DOI 10.1093/bja/aew185; RUDICK RA, 1982, J NEUROSCI METH, V6, P253, DOI 10.1016/0165-0270(82)90088-7; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299; Sasine JP, 2010, ANTI-CANCER AGENT ME, V10, P683; Shackleford GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156907; Sonabend AM, 2011, NEURO-ONCOLOGY, V13, P886, DOI 10.1093/neuonc/nor051; Stastny MJ, 2007, J PEDIAT HEMATOL ONC, V29, P669, DOI 10.1097/MPH.0b013e3181468c68; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tran HC, 2014, J ONCOL PHARM PRACT, V20, P229, DOI 10.1177/1078155213494940; von Bueren AO, 2011, NEURO-ONCOLOGY, V13, P669, DOI 10.1093/neuonc/nor025; Xu JY, 2015, J CELL BIOCHEM, V116, P218, DOI 10.1002/jcb.24976; Yamada A, 2014, PEDIATR BLOOD CANCER, V61, P2316, DOI 10.1002/pbc.25174	48	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0206394	10.1371/journal.pone.0206394	http://dx.doi.org/10.1371/journal.pone.0206394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608927	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800005
J	Augustijn, D; van Tol, N; van der Zaal, BJ; de Groot, HJM; Alia, A				Augustijn, Dieuwertje; van Tol, Niels; van der Zaal, Bert J.; de Groot, Huub J. M.; Alia, A.			High-resolution magic angle spinning NMR studies for metabolic characterization of Arabidopsis thaliana mutants with enhanced growth characteristics	PLOS ONE			English	Article							PLANT-GROWTH; SYSTEMS BIOLOGY; GENE-EXPRESSION; DEFENSE; ACID; CARBON; SUSTAINABILITY; PRODUCTIVITY; SENESCENCE; BETAINE	Developing smart crops which yield more biomass to meet the increasing demand for plant biomass has been an active area of research in last few decades. We investigated metabolic alterations in two Arabidopsis thaliana mutants with enhanced growth characteristics that were previously obtained from a collection of plant lines expressing artificial transcription factors. The metabolic profiles were obtained directly from intact Arabidopsis leaves using high-resolution magic angle spinning (HR-MAS) NMR. Multivariate analysis showed significant alteration of metabolite levels between the mutants and the wild-type Col-0. Interestingly, most of the metabolites that were reduced in the faster-growing mutants are generally involved in the defence against stress. These results suggest a growth-defence trade-off in the phenotypically engineered mutants. Our results further corroborate the idea that plant growth can be enhanced by suppressing defence pathways.	[Augustijn, Dieuwertje; de Groot, Huub J. M.; Alia, A.] Leiden Univ, Leiden Inst Chem, Leiden, Netherlands; [van Tol, Niels; van der Zaal, Bert J.] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Alia, A.] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leipzig University	Alia, A (corresponding author), Leiden Univ, Leiden Inst Chem, Leiden, Netherlands.; Alia, A (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany.	a.alia@chem.leidenuniv.nl	de Groot, Huub/GXV-7380-2022; de Groot, Huub J. M./J-4741-2012	de Groot, Huub J. M./0000-0002-8796-1212; Augustijn, Dieuwertje/0000-0002-7990-3661	Foundation for Fundamental Research on Matter, NL [FOM23]; BioSolar Cell [U2.3]	Foundation for Fundamental Research on Matter, NL; BioSolar Cell	This work was financially supported by the grant from Foundation for Fundamental Research on Matter, NL (http://www.fom.nl/live/english/home.pag) grant number FOM23 and by the grant from BioSolar Cell (http://www.biosolarcells.nl/) grant number U2.3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Andolfo G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01813; Augustijn D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163258; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caretto S, 2015, INT J MOL SCI, V16, P26378, DOI 10.3390/ijms161125967; Chia DW, 2000, PLANTA, V211, P743, DOI 10.1007/s004250000345; Czolpinska M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00302; Davis KF, 2016, GLOBAL ENVIRON CHANG, V39, P125, DOI 10.1016/j.gloenvcha.2016.05.004; Donahue JL, 2010, PLANT CELL, V22, P888, DOI 10.1105/tpc.109.071779; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Euceda LR, 2015, SCAND J CLIN LAB INV, V75, P193, DOI 10.3109/00365513.2014.1003593; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Fusari CM, 2017, PLANT CELL, V29, P2349, DOI 10.1105/tpc.17.00232; GEPSTEIN S, 1981, PLANT PHYSIOL, V68, P349, DOI 10.1104/pp.68.2.349; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Giordano M, 2000, PLANT PHYSIOL, V124, P857, DOI 10.1104/pp.124.2.857; Gloss AD, 2017, GENETIC VARIANTS AFF, DOI [10.1101/156299, DOI 10.1101/156299]; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Greenham K, 2015, NAT REV GENET, V16, P598, DOI 10.1038/nrg3976; Guo T, 2018, PLANT CELL, V30, P871, DOI 10.1105/tpc.17.00959; Haberl H, 2010, CURR OPIN ENV SUST, V2, P394, DOI 10.1016/j.cosust.2010.10.007; Hamamouch N, 2012, J EXP BOT, V63, P3683, DOI 10.1093/jxb/ers058; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Huang J, 2008, PLANT PHYSIOL BIOCH, V46, P647, DOI 10.1016/j.plaphy.2008.04.014; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Igamberdiev AU, 2016, FRONT PLANT SCI, V7, P513, DOI [10.3389/FPLS.2016.00513, DOI 10.3389/FPLS.2016.00513]; KINNERSLEY AM, 1990, PLANT GROWTH REGUL, V9, P137, DOI 10.1007/BF00027441; Kumar A, 2015, OMICS, V19, P581, DOI 10.1089/omi.2015.0106; Li JQ, 2013, PLANT BIOTECHNOL J, V11, P671, DOI 10.1111/pbi.12057; Lindhout BI, 2006, PLANT J, V48, P475, DOI 10.1111/j.1365-313X.2006.02877.x; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; Maurino Veronica G, 2015, Arabidopsis Book, V13, pe0182, DOI 10.1199/tab.0182; Mba C., 2012, AGR FOOD SECURITY, V1, P7, DOI DOI 10.1186/2048-7010-1-7; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Meng PH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007364; Mesa JM, 2017, ECOLOGY, V98, P2528, DOI 10.1002/ecy.1948; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Rommens CM, 2007, TRENDS PLANT SCI, V12, P397, DOI 10.1016/j.tplants.2007.08.001; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Sakamoto A, 2002, PLANT CELL ENVIRON, V25, P163, DOI 10.1046/j.0016-8025.2001.00790.x; Sakurai T, 2013, PLANT CELL PHYSIOL, V54, pE5, DOI 10.1093/pcp/pcs184; Scholes DR, 2015, TRENDS PLANT SCI, V20, P165, DOI 10.1016/j.tplants.2014.11.007; Schwachtje J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18397-5; Sheth BP, 2014, PLANTA, V240, P33, DOI 10.1007/s00425-014-2059-5; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; van Tol N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174236; van Tol N, 2014, PLANT SCI, V225, P58, DOI 10.1016/j.plantsci.2014.05.015; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; YOSHIKAWA M, 1993, CAN J MICROBIOL, V39, P1150, DOI 10.1139/m93-173; Zell MB, 2010, PLANT PHYSIOL, V152, P1251, DOI 10.1104/pp.109.151795; Zust T, 2017, ANNU REV PLANT BIOL, V68, P513, DOI 10.1146/annurev-arplant-042916-040856	63	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209695	10.1371/journal.pone.0209695	http://dx.doi.org/10.1371/journal.pone.0209695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596736	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200072
J	Bogale, TN; Worku, AG; Yalew, AW; Bikis, GA; Kebede, ZT				Bogale, Tariku Nigatu; Worku, Abebaw Gebeyehu; Yalew, Alemayehu Worku; Bikis, Gashaw Andargie; Kebede, Zemene Tigabu			Mothers treatment seeking intention for neonatal danger signs in northwest Ethiopia: A structural equation modeling	PLOS ONE			English	Article							3 DELAYS MODEL; CARE-SEEKING; UNDERSTAND; BEHAVIOR	Background Neonatal mortality contributes to nearly half of under-five mortality in Ethiopia. Treatment seeking for newborn danger signs remains low despite correlations with neonatal mortality. This study tests a theoretical model of factors affecting mothers' treatment seeking intention for neonatal danger signs in northwest Ethiopia. Method A cross sectional study was conducted from March 3-18, 2016 in northwest Ethiopia. A total of 2,158 pregnant women and women who had delivered in the past 6 months were interviewed. Latent variables; knowledge of neonatal danger signs (KDS), household level women empowerment (HLWE) and positive perception toward the behavior of health care providers (PPBHCP) were measured using a Five Point Likert Scale. Socioeconomic status (SES), number of antenatal care attendance, perceived cost of treatment (PCT), average distance to health facilities (ADHF) and treatment seeking intention (TSI) were observed variables in the study. A structural equation modeling was applied to test and estimate the hypothesized model of relationships among latent and observed variables and their direct and indirect effects on TSI. Result KDS, PPBHCP, HLWE, and PCT showed direct, positive and significant association with TSI (beta = 0.41, p<0.001, beta = 0.08, p<0.002, beta = 0.18, p<0.001, and beta = 0.06, p<0.002, respectively). SES was not directly associated with TSI. However, it indirectly influenced TSI through three pathways; KDS, number of ANC attendance and HLWE (beta = 0.05, p<0.05, beta = 0.08, p<0.001 and beta = 0.13, p<0.001, respectively). Number of antenatal care was not directly associated with TSI. But indirectly, it affected TSI through its direct effect on KDS and PPBHCP (beta = 0.05, p<0.05, beta = 0.14, p<0.001, respectively). PPBHCP and HLWE also showed indirect association with TSI through their direct effect on KDS (beta = 0.37, p<0.001, beta = 0.36, p<0.001, respectively). All in all, the model fitted the sample data and explained 31% of the variance in TSI. Conclusion PPBHCP, HLWE, PCT and KDS were associated with mothers' TSI for newborn danger signs.	[Bogale, Tariku Nigatu; Worku, Abebaw Gebeyehu; Bikis, Gashaw Andargie] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Yalew, Alemayehu Worku] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Kebede, Zemene Tigabu] Univ Gondar, Dept Pediat & Child Hlth, Gondar, Ethiopia	University of Gondar; Addis Ababa University; University of Gondar	Bogale, TN (corresponding author), Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.	trknigatu@gmail.com		Worku, Abebaw Gebeyehu/0000-0002-1146-3399	university of Gondar Projects	university of Gondar Projects	This is part of a Ph.D. study manuscript supported by the university of Gondar Projects. the University is following whether findings are presented and published. The university has no role in the design, data collection, analysis and interpretation of the data and in writing the manuscript. All the statements and findings are the responsibility of the investigators.	Abebe D., 2015, REPROD HEALTH, V12, P1, DOI [10.1186/1742-4755-12-1, DOI 10.1186/1742-4755-12-1]; Amare Y, 2008, ETHIOP J HEAL DEV, V27, P3; [Anonymous], 2014, LANCET, P1; [Anonymous], 2012, C PART WHO FRAM CONV, P1; [Anonymous], 2013, APPL 3 DELAYS MODEL; Ba A, 2014, NIGER J PAEDIAT, V41, P199; Bahrami M. A., 2013, World Journal of Medical Sciences, V9, P102; Bay G, 2014, LEVELS TRENDS CHILD; Bowser D, REPORT OF LANDSCAPE; Central statistical Authority, 2017, FED DEM REP ETH CENT; CSA. Ethiopia Demographic and Health Survey, 2011, CENTR STAT AG ADD AB; Davis J., 2013, MEN MATERNAL NEWBORN; Dongre AR, 2009, INDIAN J PEDIATR, V76, P691, DOI 10.1007/s12098-009-0106-1; Ekwochi U, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0127-5; EPHI, 2015, 2014 COUNTR CAS STUD; Federal Republic of Ethiopia Population Census and commission, 2008, SUMM STAT REP 2007 P; Gebeyaw M., 2017, INT J NURSING MIDWIF, V9, P85, DOI [10.5897/ijnm2017.0266, DOI 10.5897/IJNM2017.0266]; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Ha JF, 2010, OCHSNER J, V10, P38; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Hill K., 2010, EXPLORING EVIDENCE D; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Indongo N., 2014, EUR SCI J, V7881, P466; LASSI ZS, 2014, REPROD HEALTH S3, V11; Lee WX, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-300; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Livote EE, 2009, STRUCT EQU MODELING, V16, P556, DOI 10.1080/10705510903008345; Mainuddin Akm, 2015, J Family Reprod Health, V9, P65; Mannava P., 2015, GLOB HLTH, V11, P1, DOI DOI 10.1186/S12992-015-0117-9; Martinez AM, 2012, J PAEDIATR CHILD H, V48, P852, DOI 10.1111/j.1440-1754.2012.02544.x; MoH, 2016, FAM HLTH CARD FED DE; MOH, 2015, HSTP HLTH SECTOR TRA; Nigatu Solomon Gedlu, 2015, BMC Res Notes, V8, P309, DOI 10.1186/s13104-015-1278-6; Nonyane BAS, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010605; Olayinka O, 2012, ARCH APPL SCEINCE RE, V4, P1511; Rajamohanan K, SOC SCI MED, V57, P783; SANDBERG J, 2014, PLOS ONE, V9, P72230, DOI DOI 10.1016/S0277-9536(02)00448-3; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Shah R, 2014, BMC HEALTH SERV RES, P1, DOI [10.1186/1472-6963-14-1, DOI 10.1186/1472-6963-14-1]; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Sheeran A., 2002, EUR REV SOC PSYCHOL; Shewasinad S., 2014, ASSESSMENT MOTHERS C, V2014; Srivastava NM, 2008, INDIAN PEDIATR, V45, P229; Srivastava NM, 2009, BIOMED CENT, V10, P1; Tadala T, 2011, KNOWLEDGE ATTITUDE T; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Tran Hoang T, 2012, WHO South East Asia J Public Health, V1, P239, DOI 10.4103/2224-3151.207020; UN, 2014, EV NEWB DRAFT ACT PL; Upadhyay RP, 2013, J TROP PEDIATRICS, V59, P100, DOI 10.1093/tropej/fms060; Violato C, TEACHNING LEARN MED, V9, P362; Wado Y.D, 2013, WOMENS AUTONOMY REPR; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; Warren C, 2010, ETHIOP J HEALTH DEV, V24, P110; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; WHO, 2009, WHO UNICEF JOINT STA; Wilson C.J., 2005, CANADIAN J COUNSELLI, V39, P15, DOI [DOI 10.1037/T42876-000, 10.1037/t42876-000]; Wondowosen K, 2016, ASSESSMENT HLTH SEEK, V2016	57	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209959	10.1371/journal.pone.0209959	http://dx.doi.org/10.1371/journal.pone.0209959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596745	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200117
J	Diez-Antolinez, R; Hijosa-Valsero, M; Paniagua-Garcia, AI; Garita-Cambronero, J; Gomez, X				Diez-Antolinez, Rebeca; Hijosa-Valsero, Maria; Paniagua-Garcia, Ana I.; Garita-Cambronero, Jerson; Gomez, Xiomar			Yeast screening and cell immobilization on inert supports for ethanol production from cheese whey permeate with high lactose loads	PLOS ONE			English	Article							KLUYVEROMYCES-MARXIANUS; POWDER SOLUTION; FERMENTATION; BATCH; BIOETHANOL; STRAINS; CWP	Eight yeast strains of the genera Saccharomyces and Kluyveromyces were screened to ferment high lactose-load cheese whey permeate (CWP) (> 130 g/L lactose) without nutrient supplementation. The fermentation conditions (temperature, pH and time) were optimized to maximize the fermentation performance (ethanol titer, ethanol yield and lactose consumption) for the two preselected strains, K. marxianus DSM 5422 and S. cerevisiae Ethanol Red, using a response surface methodology (RSM). Under optimized conditions, K. marxianus DSM 5422 attained ethanol titers of 6% (v/v) in only 44 h. Moreover, the feasibility of immobilizing this strain on four different inorganic supports (plastic, glass and Tygon silicone Raschig rings and alumina beads) was assessed. Glass Raschig rings and alumina beads showed a more stable performance over time, yielding ethanol titers of 60 g/L during 1,000 hours, which remarkably reduces yeast cultivation costs. Results demonstrate the feasibility of using CWP for successful ethanol production in a simple and economical process, which represents an attractive alternative for waste treatment in dairy industries.	[Diez-Antolinez, Rebeca; Hijosa-Valsero, Maria; Paniagua-Garcia, Ana I.; Garita-Cambronero, Jerson] Inst Tecnol Agr Castilla & Leon ITACyL, Ctr Biofuels & Bioprod, Leon, Spain; [Diez-Antolinez, Rebeca; Paniagua-Garcia, Ana I.; Gomez, Xiomar] Univ Leon, Nat Resources Inst IRENA, Chem & Environm Bioproc Engn Grp, Leon, Spain	Universidad de Leon	Diez-Antolinez, R (corresponding author), Inst Tecnol Agr Castilla & Leon ITACyL, Ctr Biofuels & Bioprod, Leon, Spain.; Diez-Antolinez, R (corresponding author), Univ Leon, Nat Resources Inst IRENA, Chem & Environm Bioproc Engn Grp, Leon, Spain.	dieantre@itacyl.es	Hijosa-Valsero, María/AAY-6193-2021; Garita-Cambronero, Jerson/B-6502-2016	Hijosa-Valsero, María/0000-0001-9803-2585; Garita-Cambronero, Jerson/0000-0001-8055-0747; Paniagua, Ana Isabel/0000-0003-4083-271X; Diez Antolinez, Rebeca/0000-0001-7604-1886	FEDER European Regional Development funds (FEDER); postdoctoral contract (DOC-INIA) - Spanish National Institute for Agricultural and Food Research and Technology (INIA) [DOC 2013-010]; European Social Fund	FEDER European Regional Development funds (FEDER); postdoctoral contract (DOC-INIA) - Spanish National Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Social Fund(European Social Fund (ESF))	The authors are grateful to FEDER European Regional Development funds (FEDER) for financial support. Maria Hijosa-Valsero is supported by a postdoctoral contract (DOC-INIA, grant number DOC 2013-010) funded by the Spanish National Institute for Agricultural and Food Research and Technology (INIA) and the European Social Fund.	Baldasso C, 2011, DESALINATION, V278, P381, DOI 10.1016/j.desal.2011.05.055; Christensen AD, 2011, J IND MICROBIOL BIOT, V38, P283, DOI 10.1007/s10295-010-0771-0; Diez-Antolinez R, 2016, CHEM ENGINEER TRANS, V49, P529, DOI 10.3303/CET1649089; Diniz RHS, 2014, BIOCATAL AGRIC BIOTE, V3, P111, DOI 10.1016/j.bcab.2013.09.002; Dragone G, 2011, BIOMASS BIOENERG, V35, P1977, DOI 10.1016/j.biombioe.2011.01.045; Dulieu C, 1999, TISS ENG SER, P3; Erguder TH, 2001, WASTE MANAGE, V21, P643, DOI 10.1016/S0956-053X(00)00114-8; Es I, 2015, APPL MICROBIOL BIOT, V99, P2065, DOI 10.1007/s00253-015-6390-y; European Food Safety Authority (EFSA) Panel on Biological Hazards (BIOHAZ), 2018, EFSA J, V16, DOI [10.2903/j.efsa.2018.531510.5281/zenodo.1313616, DOI 10.2903/J.EFSA.2018.531510.5281/ZENODO.1313616]; FDA U, 2018, MICR MICR DER INGR U; Gabardo S, 2015, J IND MICROBIOL BIOT, V42, P1243, DOI 10.1007/s10295-015-1661-2; Gabardo S, 2014, RENEW ENERG, V69, P89, DOI 10.1016/j.renene.2014.03.023; Gabardo S, 2012, J CHEM TECHNOL BIOT, V87, P1194, DOI 10.1002/jctb.3749; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GONCALVES LMD, 1992, APPL MICROBIOL BIOT, V38, P305; Guimaraes PMR, 2010, BIOTECHNOL ADV, V28, P375, DOI 10.1016/j.biotechadv.2010.02.002; Kargi F, 2006, ENZYME MICROB TECH, V38, P711, DOI 10.1016/j.enzmictec.2005.11.006; KOSIKOWSKI FV, 1979, J DAIRY SCI, V62, P1149, DOI 10.3168/jds.S0022-0302(79)83389-5; Kosseva MR, 2009, INT J BIOL MACROMOL, V45, P437, DOI 10.1016/j.ijbiomac.2009.09.005; Koushki M, 2012, J FOOD SCI TECH MYS, V49, P614, DOI 10.1007/s13197-011-0309-0; Lane Melanie M., 2010, Fungal Biology Reviews, V24, P17, DOI 10.1016/j.fbr.2010.01.001; Lee SE, 2012, J MICROBIOL BIOTECHN, V22, P1673, DOI 10.4014/jmb.1202.02049; Ling KC, 2008, 214 USDA RUR BUS COO; MacFaddin J.F., 1985, MEDIA ISOLATION CULT, V1; MAWSON AJ, 1994, BIORESOURCE TECHNOL, V47, P195, DOI 10.1016/0960-8524(94)90180-5; Mollea C., 2019, FOOD INDUSTRY, P549, DOI 10.5772/53159; Mussatto SI, 2010, BIOTECHNOL ADV, V28, P817, DOI 10.1016/j.biotechadv.2010.07.001; OECD, 2018, OECD FAO AGR OUTLOOK, DOI [10.1787/agr_outlook-2018-en, DOI 10.1787/AGR_OUTLOOK-2018-EN]; Ozmihci S, 2007, LETT APPL MICROBIOL, V44, P602, DOI 10.1111/j.1472-765X.2007.02132.x; Ozmihci S, 2009, J CHEM TECHNOL BIOT, V84, P106, DOI 10.1002/jctb.2013; Ozmihci S, 2007, ENZYME MICROB TECH, V41, P876, DOI 10.1016/j.enzmictec.2007.07.015; Parashar A, 2016, J DAIRY SCI, V99, P1859, DOI 10.3168/jds.2015-10059; Parrondo J, 2009, BRAZ J CHEM ENG, V26, P445, DOI 10.1590/S0104-66322009000300001; Pasotti L, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0369-y; Pereira FB, 2010, BIORESOURCE TECHNOL, V101, P7856, DOI 10.1016/j.biortech.2010.04.082; Prazeres AR, 2012, J ENVIRON MANAGE, V110, P48, DOI 10.1016/j.jenvman.2012.05.018; Rubio-Texeira M, 2005, FEMS YEAST RES, V5, P1115, DOI 10.1016/j.femsyr.2005.05.003; Saini P, 2017, PROCESS BIOCHEM, V62, P69, DOI 10.1016/j.procbio.2017.07.013; Sansonetti S, 2010, BIORESOURCE TECHNOL, V101, P9156, DOI 10.1016/j.biortech.2010.07.030; Silveira WB, 2005, ENZYME MICROB TECH, V36, P930, DOI 10.1016/j.enzmictec.2005.01.018; Siso MIG, 1996, BIORESOURCE TECHNOL, V57, P1, DOI 10.1016/0960-8524(96)00036-3; Soupioni M, 2013, BIORESOURCE TECHNOL, V145, P326, DOI 10.1016/j.biortech.2012.12.131; Timson DJ., 2007, DYN BIOCH PROCE BIOT, V1, P63, DOI DOI 10.1046/j.1365-8711.2003.06497.x; Udeh H., 2013, J BREW DISTILL, V4, P19, DOI [10.5897/JBD2013.0041, DOI 10.5897/JBD2013.0041]; Voo WP, 2011, J BIOSCI BIOENG, V111, P294, DOI 10.1016/j.jbiosc.2010.11.010; Zhang Q, 2015, ENERG FUEL, V29, P1019, DOI 10.1021/ef502349v; Zoppellari F, 2013, NEW BIOTECHNOL, V30, P607, DOI 10.1016/j.nbt.2012.11.017	47	14	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210002	10.1371/journal.pone.0210002	http://dx.doi.org/10.1371/journal.pone.0210002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596755	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200123
J	Mesilati-Stahy, R; Argov-Argaman, N				Mesilati-Stahy, Ronit; Argov-Argaman, Nurit			Changes in lipid droplets morphometric features in mammary epithelial cells upon exposure to non-esterified free fatty acids compared with VLDL	PLOS ONE			English	Article							MILK-FAT; GLOBULE SIZE; BOVINE-MILK; SECRETION; LIPOLYSIS; PROTEIN; PHOSPHOLIPIDS; ACCUMULATION; METABOLISM; ACTIVATION	The effects of the macrostructure of long chain fatty acids on the lipid metabolism and biosynthesis of lipid droplets (LD) was studied in mammary epithelial cells (MEC). MEC were exposed to similar compositions and concentrations of fatty acids in the form of either triglycerides (Tg), as part of the very-low-density lipids (VLDL) isolated from lactating cow plasma, or as non-esterified-free fatty acids (FFA). Exposing MEC to FFA resulted in two distinct processes; each independently could increase LD size: an elevation in Tg production and alterations in phospholipid (PL) composition. In particular, the lower PC/PE ratio in the FFA treatment indicated membrane destabilization, which was concomitant with the biosynthesis of larger LD. In addition, 6 fold increase in the cellular concentration of the exogenously added linoleic acid (C18:2) was found in MEC treated with FFA, implying that long chain fatty acids administrated as FFA have higher availability to MEC, enabling greater PL synthesis, more material for the LD envelope, thereby enhancing LD formation. Availability of long chain fatty acids administrated as VLDL-Tg, is dependent on LPL which its activity can be inhibited by the hydrolysis products. Therefore, we used increasing concentrations of albumin, to reduce the allosteric inhibition on LPL by the hydrolysis products. Indeed, a combined treatment of VLDL and albumin, increased LD size and number, similar to the phenotype found in the FFA treatment. These results reveal the role played by the macrostructure of long chain fatty acids in the regulation of LD size in MEC which determine the size of the secreted MFG.	[Mesilati-Stahy, Ronit; Argov-Argaman, Nurit] Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel	Hebrew University of Jerusalem	Argov-Argaman, N (corresponding author), Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel.	argov.nurit@mail.huji.ac.il	argovArgaman, Nurit/AAB-1846-2020		Israeli Dairy Board [820033316]	Israeli Dairy Board	This work was supported by the Israeli Dairy Board #820033316.	Adewuyi AA, 2005, VET QUART, V27, P117, DOI 10.1080/01652176.2005.9695192; ALMAZOV VA, 1986, KARDIOLOGIYA, V26, P39; Altenhofer C, 2015, INT J DAIRY TECHNOL, V68, P519, DOI 10.1111/1471-0307.12220; Avramis CA, 2003, J DAIRY SCI, V86, P2568, DOI 10.3168/jds.S0022-0302(03)73851-X; Avsar YK, 2010, J FOOD PROCESS PRES, V34, P223, DOI 10.1111/j.1745-4549.2008.00335.x; Bauman DE, 2001, LIVEST PROD SCI, V70, P15, DOI 10.1016/S0301-6226(01)00195-6; Bauman DE, 2003, ANNU REV NUTR, V23, P203, DOI 10.1146/annurev.nutr.23.011702.073408; BITMAN J, 1990, J DAIRY SCI, V73, P1208, DOI 10.3168/jds.S0022-0302(90)78784-X; BOBKOVA VI, 1989, KARDIOLOGIYA, V29, P57; Chapman and Hall, 1995, ADV DAIRY CHEM, V2, P37; Cohen BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121645; Cohen BC, 2017, J MAMMARY GLAND BIOL, P1; Corl BA, 2006, J DAIRY SCI, V89, P4172, DOI 10.3168/jds.S0022-0302(06)72462-6; Fei WH, 2011, BIOCHEM BIOPH RES CO, V415, P455, DOI 10.1016/j.bbrc.2011.10.091; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Fleming A, 2017, J DAIRY SCI, V100, P1640, DOI 10.3168/jds.2016-11427; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Fukunaga K, 2008, NUTR RES, V28, P635, DOI 10.1016/j.nutres.2008.05.005; Gavaric DD, 1989, FOOD STRUCTURE, V8, P8; Gross JJ, 2013, J DAIRY SCI, V96, P5008, DOI 10.3168/jds.2012-6245; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Heid HW, 2005, EUR J CELL BIOL, V84, P245, DOI 10.1016/j.ejcb.2004.12.002; Hernell O, 2016, J PEDIATR-US, V173, pS60, DOI 10.1016/j.jpeds.2016.02.077; Hultin M, 1996, J LIPID RES, V37, P1022; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; KINSELLA JE, 1974, INT J BIOCHEM, V5, P417, DOI 10.1016/0020-711X(74)90138-4; Klimov AN, 1995, CARDIOVASC DRUG THER, V9, P779, DOI 10.1007/BF00879871; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Lopez C, 2011, COLLOID SURFACE B, V83, P29, DOI 10.1016/j.colsurfb.2010.10.039; Lu J, 2016, J DAIRY SCI, V99, P4726, DOI 10.3168/jds.2015-10375; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McManaman JL, 2009, CLIN LIPIDOL, V4, P391, DOI 10.2217/CLP.09.15; Mesilati-Stahy R, 2011, J AGR FOOD CHEM, V59, P7427, DOI 10.1021/jf201373j; Michalski MC, 2004, CHEM PHYS LIPIDS, V132, P247, DOI 10.1016/j.chemphyslip.2004.08.007; Michalski MC, 2003, LAIT, V83, P131, DOI 10.1051/lait:2003003; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; O'Mahony JA, 2005, J DAIRY RES, V72, P338, DOI 10.1017/S0022029905001044; Olofsson SO, 2012, ARTERIOSCL THROM VAS, V32, P1334, DOI 10.1161/ATVBAHA.112.251116; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; PEREIRA L, 2012, INT J CELL BIOL, V2012; POSNER I, 1987, BIOCHEMISTRY-US, V26, P3711, DOI 10.1021/bi00386a067; Pownall HJ, 2001, J MOL NEUROSCI, V16, P109, DOI 10.1385/JMN:16:2-3:109; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; SPITSBERG VL, 1995, EUR J BIOCHEM, V230, P872, DOI 10.1111/j.1432-1033.1995.tb20630.x; TASKINEN M-R, 1987, Diabetes Metabolism Reviews, V3, P551; TERPSTRA AHM, 1981, LIPIDS, V16, P114, DOI 10.1007/BF02535684; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Timby N, 2014, AM J CLIN NUTR, V99, P860, DOI 10.3945/ajcn.113.064295; Uchide T, 1999, J VET MED SCI, V61, P1143, DOI 10.1292/jvms.61.1143; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; VEERKAMP JH, 1993, MOL CELL BIOCHEM, V123, P101, DOI 10.1007/BF01076480; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; Wiking L, 2004, INT DAIRY J, V14, P909, DOI 10.1016/j.idairyj.2004.03.005; Wojcicki J, 1995, PHYTOTHER RES, V9, P597, DOI 10.1002/ptr.2650090814; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yonezawa T, 2004, J DAIRY SCI, V87, P2527, DOI 10.3168/jds.S0022-0302(04)73377-9	61	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209565	10.1371/journal.pone.0209565	http://dx.doi.org/10.1371/journal.pone.0209565			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596687	gold, Green Submitted, Green Published			2022-12-26	WOS:000454627200056
J	Xie, L; Lehvavirta, S; Timonen, S; Kasurinen, J; Niemikapee, J; Valkonen, JPT				Xie, Long; Lehvavirta, Susanna; Timonen, Sari; Kasurinen, Jutta; Niemikapee, Juhamatti; Valkonen, Jari P. T.			Species-specific synergistic effects of two plant growth-Promoting microbes on green roof plant biomass and photosynthetic efficiency	PLOS ONE			English	Article							ARBUSCULAR-MYCORRHIZAL FUNGI; BACILLUS-AMYLOLIQUEFACIENS; GLOMUS-INTRARADICES; HELPER BACTERIA; DROUGHT TOLERANCE; LACCARIA-LACCATA; SOIL; RHIZOSPHERE; SUBSTRATE; TRANSPORT	Rhizophagus irregularis, an arbuscular mycorrhizal fungus, and Bacillus amyloliquefaciens, a bacterium, are microorganisms that promote plant growth. They associate with plant roots and facilitate nutrient absorption by their hosts, increase resistance against pathogens and pests, and regulate plant growth through phytohormones. In this study, eight local plant species in Finland (Antennaria dioica, Campanula rotundifolia, Fragaria vesca, Geranium sanguineum, Lotus corniculatus, Thymus serpyllum, Trifolium repens, and Viola tricolor) were inoculated with R. irregularis and/or B. amyloliquefaciens in autoclaved substrates to evaluate the plant growth-promoting effects of different plant/microbe combinations under controlled conditions. The eight plant species were inoculated with R. irregularis, B. amyloliquefaciens, or both microbes or were not inoculated as a control. The impact of the microbes on the plants was evaluated by measuring dry shoot weight, colonization rate by the arbuscular mycorrhizal fungus, bacterial population density, and chlorophyll fluorescence using a plant phenotyping facility. Under dual inoculation conditions, B. amyloliquefaciens acted as a "mycorrhiza helper bacterium" to facilitate arbuscular mycorrhizal fungus colonization in all tested plants. In contrast, R. irregularis did not demonstrate reciprocal facilitation of the population density of B. amyloliquefaciens. Dual inoculation with B. amyloliquefaciens and R. irregularis resulted in the greatest increase in shoot weight and photosynthetic efficiency in T. repens and F. vesca.	[Xie, Long; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Lehvavirta, Susanna] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Timonen, Sari; Kasurinen, Jutta] Univ Helsinki, Dept Microbiol, Helsinki, Finland; [Niemikapee, Juhamatti] Univ Helsinki, Dept Bio & Environm Sci, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	jari.valkonen@helsinki.fi	; Lehvavirta, Susanna/L-3948-2014	Valkonen, Jari/0000-0002-3704-9911; Lehvavirta, Susanna/0000-0002-8148-9981; Xie, Long/0000-0002-3477-3445; Timonen, Sari/0000-0001-9039-5648	China Scholarship Council [20140796003]; Finnish Cultural Foundation; Maiju and Yrjo Rikala Horticultural Foundation, Finland; Helsinki-Uusimaa Regional Council, Finland; Helsinki University Center for Environment	China Scholarship Council(China Scholarship Council); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Maiju and Yrjo Rikala Horticultural Foundation, Finland; Helsinki-Uusimaa Regional Council, Finland; Helsinki University Center for Environment	Long Xie was supported by China Scholarship Council (grant no. 20140796003); by the Finnish Cultural Foundation; and by Maiju and Yrjo Rikala Horticultural Foundation, Finland. Soil and microbial preparations were donated by Kekkila Group and Verdera/Lallemand Inc., respectively. Dr. Susanna Lehvavirta obtained a grant from Helsinki-Uusimaa Regional Council, Finland. Dr. Susanna Lehvavirta obtained a grant from Helsinki University Center for Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2011, SCI TOTAL ENVIRON, V409, P3166, DOI 10.1016/j.scitotenv.2011.05.009; Alam M, 2011, ARCH AGRON SOIL SCI, V57, P889, DOI 10.1080/03650340.2010.498013; Aliasgharzad N., 2012, International Journal of Agriculture: Research and Review, V2, P765; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; BAR-TAL A, 1990, AGRON J, V82, P989, DOI 10.2134/agronj1990.00021962008200050030x; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Barrett DJ, 1995, AUST J PLANT PHYSIOL, V22, P955, DOI 10.1071/PP9950955; Benitez LB, 2012, ARCH MICROBIOL, V194, P177, DOI 10.1007/s00203-011-0743-4; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; BIERMANN B, 1983, NEW PHYTOL, V95, P97, DOI 10.1111/j.1469-8137.1983.tb03472.x; Bucking H, 2005, NEW PHYTOL, V165, P899, DOI 10.1111/j.1469-8137.2004.01274.x; CARON M, 1986, PHYTOPATHOLOGY, V76, P942, DOI 10.1094/Phyto-76-942; CARPENTERBOGGS L, 1995, SOIL BIOL BIOCHEM, V27, P1445, DOI 10.1016/0038-0717(95)00075-P; Chen Y, 2012, MOL MICROBIOL, V85, P418, DOI 10.1111/j.1365-2958.2012.08109.x; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; DeNardo JC, 2005, T ASAE, V48, P1491, DOI 10.13031/2013.19181; Fukumoto J., 1943, J AGR CHEM SOC JPN, V19, P487, DOI DOI 10.1271/NOGEIKAGAKU1924.19.7_487; GARBAYE J, 1993, SYMBIOSIS, V14, P335; GARBAYE J, 1992, BIOL FERT SOILS, V13, P55, DOI 10.1007/BF00337239; GARBAYE J, 1994, NEW PHYTOL, V128, P197, DOI 10.1111/j.1469-8137.1994.tb04003.x; Gonzalez-Guerrero M, 2008, CAN J MICROBIOL, V54, P103, DOI [10.1139/W07-119, 10.1139/w07-119]; GUREVITCH J, 1990, J ECOL, V78, P727, DOI 10.2307/2260895; Henry A, 2012, J ENVIRON MANAGE, V104, P91, DOI 10.1016/j.jenvman.2012.03.040; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; Hu HQ, 2010, BIOL CONTROL, V54, P359, DOI 10.1016/j.biocontrol.2010.06.015; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; John J, 2014, ECOL ENG, V71, P651, DOI 10.1016/j.ecoleng.2014.08.012; Kasim WA, 2013, J PLANT GROWTH REGUL, V32, P122, DOI 10.1007/s00344-012-9283-7; Koide RT, 2000, NEW PHYTOL, V148, P511, DOI 10.1046/j.1469-8137.2000.00776.x; KOIDE RT, 1991, OECOLOGIA, V85, P389, DOI 10.1007/BF00320615; Kostoula O, 2014, XXIX INTERNATIONAL H; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; LATIMER JG, 1991, HORTSCIENCE, V26, P124, DOI 10.21273/HORTSCI.26.2.124; Lee BR, 2007, J EXP BOT, V58, P1271, DOI 10.1093/jxb/erl280; Li B, 2008, LETT APPL MICROBIOL, V46, P450, DOI 10.1111/j.1472-765X.2008.02337.x; LIU AM, 1995, HORTSCIENCE, V30, P242, DOI 10.21273/HORTSCI.30.2.242; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Lu ZH, 2005, PRATACULTURAL SCI, V1, P22; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mansfeld-Giese K, 2002, FEMS MICROBIOL ECOL, V41, P133, DOI 10.1111/j.1574-6941.2002.tb00974.x; Ruiz-Lozano JM, 2016, PLANT CELL ENVIRON, V39, P441, DOI 10.1111/pce.12631; Martinez-Viveros O, 2010, J SOIL SCI PLANT NUT, V10, P293, DOI 10.4067/S0718-95162010000100006; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; McGuire K. L., 2013, PLOS ONE, V8; Medina A, 2003, APPL SOIL ECOL, V22, P15, DOI 10.1016/S0929-1393(02)00112-9; Molineux CJ, 2014, SCI TOTAL ENVIRON, V493, P632, DOI 10.1016/j.scitotenv.2014.06.045; Nautiyal CS, 2013, PLANT PHYSIOL BIOCH, V66, P1, DOI 10.1016/j.plaphy.2013.01.020; Navarro-Fernandez CM, 2011, APPL SOIL ECOL, V48, P31, DOI 10.1016/j.apsoil.2011.02.005; Nuortila C, 2004, NEW PHYTOL, V164, P543, DOI 10.1111/j.1469-8137.2004.01195.x; Nurmi V, 2016, J BENEFIT-COST ANAL, V7, P488, DOI 10.1017/bca.2016.18; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Paknejad F., 2007, Journal of Biological Sciences, V7, P841; Pavicic M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00416; Peck S.W., 1999, GREENBACKS GREEN ROO; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; PRIEST FG, 1987, INT J SYST BACTERIOL, V37, P69, DOI 10.1099/00207713-37-1-69; Raaijmakers JM, 1999, PHYTOPATHOLOGY, V89, P470, DOI 10.1094/PHYTO.1999.89.6.470; Reva ON, 2004, FEMS MICROBIOL ECOL, V48, P249, DOI 10.1016/j.femsec.2004.02.003; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; RUIZLOZANO JM, 1995, APPL ENVIRON MICROB, V61, P456, DOI 10.1128/AEM.61.2.456-460.1995; RuizLozano JM, 1996, PHYSIOL PLANTARUM, V98, P767, DOI 10.1111/j.1399-3054.1996.tb06683.x; Sanders IR, 2003, TRENDS PLANT SCI, V8, P143, DOI 10.1016/S1360-1385(03)00012-8; Sasanelli N, 2009, HELMINTHOLOGIA, V46, P230, DOI 10.2478/s11687-009-0043-6; STARNAUD M, 1994, CAN J PLANT PATHOL, V16, P187, DOI 10.1080/07060669409500751; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Stevens CJ, 2012, J ECOL, V100, P821, DOI 10.1111/j.1365-2745.2012.01963.x; Strack D, 2003, J CHEM ECOL, V29, P1955, DOI 10.1023/A:1025695032113; Strigul NS, 2006, ENVIRON MODELL SOFTW, V21, P1158, DOI 10.1016/j.envsoft.2005.06.003; Takebayashi H, 2007, BUILD ENVIRON, V42, P2971, DOI 10.1016/j.buildenv.2006.06.017; Toro M, 1997, APPL ENVIRON MICROB, V63, P4408, DOI 10.1128/AEM.63.11.4408-4412.1997; TREVORS JT, 1994, J MICROBIOL METH, V19, P247, DOI 10.1016/0167-7012(94)90028-0; Vierheilig H, 2005, PHYSIOL PLANTARUM, V125, P393, DOI 10.1111/j.1399-3054.2005.00564.x; Vivas A, 2003, MYCORRHIZA, V13, P249, DOI 10.1007/s00572-003-0223-z; Yang J, 2008, ATMOS ENVIRON, V42, P7266, DOI 10.1016/j.atmosenv.2008.07.003; Young T, 2015, URBAN FOR URBAN GREE, V14, P959, DOI 10.1016/j.ufug.2015.08.012; Yusran Y., 2009, EFFECTS PSEUDOMONAS; Zhao HM, 2011, GRASSLAND TURF, V6, P6	83	27	27	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209432	10.1371/journal.pone.0209432	http://dx.doi.org/10.1371/journal.pone.0209432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596699	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200047
J	Dias, JNR; Andre, AS; Aguiar, SI; Ministro, J; Oliveira, J; Peleteiro, MC; Rutgen, B; Gano, L; Correia, JDG; Oliveira, SS; Goncalves, J; Gil, S; Tavares, L; Aires-da-Silva, F				Dias, Joana N. R.; Andre, Ana S.; Aguiar, Sandra I.; Ministro, Joana; Oliveira, Joana; Peleteiro, Maria C.; Ruetgen, Barbara; Gano, Lurdes; Correia, Joao D. G.; Oliveira, Soraia S.; Goncalves, Joao; Gil, Solange; Tavares, Luis; Aires-da-Silva, Frederico			Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; DOGS; LINE	Canine diffuse large B-cell lymphoma (DLBCL) is one of the most common cancers in dogs which shares remarkable similarities with its human counterpart, making the dog an excellent model for the investigation of novel therapeutic agents. However, the integration of canine lymphoma in comparative studies has been limited due in part to the lack of suitable xenograft mouse models for preclinical studies. To overcome these limitations, we established and characterized a localized subcutaneous bioluminescent canine DLBCL xenograft mouse model. The canine CLBL-1 cell line stably expressing the luciferase and green fluorescent protein reporters was generated and used to establish the xenograft tumor model. A pilot study was first conducted with three different cell densities (0.1x10(6), 0.5x10(6) and 1x10(6) cells) in SCID mice. All mice presented homogeneous tumor induction within eight days after subcutaneous injection, with a 100% engraftment efficiency and no significant differences were observed among groups. The tumors were highly aggressive and localized at the site of inoculation and reproduced histological features and immunophenotype consistent with canine DLBCL. Importantly, xenograft tumors were detected and quantified by bioluminescent imaging. To assess response to therapy, a therapeutic study with a histone deacetylase inhibitor, panobinostat, was performed. The results demonstrated that panobinostat (20 mg/kg) efficiently inhibited tumor growth and that bioluminescent imaging allowed the monitorization and quantification of tumor response to therapy. In summary, this study provides a bioluminescence canine DLBCL model that offers high engraftment efficiency, preservation of tumor features, and noninvasive monitoring of tumor progression, validating the model as a promising preclinical tool for both veterinary and human medicine.	[Dias, Joana N. R.; Andre, Ana S.; Aguiar, Sandra I.; Peleteiro, Maria C.; Gil, Solange; Tavares, Luis; Aires-da-Silva, Frederico] Univ Lisbon, Fac Med Vet, CIISA, Lisbon, Portugal; [Ministro, Joana; Oliveira, Joana; Oliveira, Soraia S.; Goncalves, Joao] Univ Lisbon, Fac Pharm, Res Inst Med IMed ULisboa, Lisbon, Portugal; [Ruetgen, Barbara] Univ Vet Med, Clin Pathol Unit, Dept Pathobiol, Vienna, Austria; [Gano, Lurdes; Correia, Joao D. G.] Univ Lisbon, CTN, Inst Super Tecn, Ctr Ciencias & Tecnol Nucl, Bobadela Lrs, Portugal	Universidade de Lisboa; Universidade de Lisboa; University of Veterinary Medicine Vienna; Universidade de Lisboa; Instituto Superior Tecnico	Aires-da-Silva, F (corresponding author), Univ Lisbon, Fac Med Vet, CIISA, Lisbon, Portugal.	fasilva@fmv.ulisboa.pt	iMed.ULisboa, M2B/B-5277-2014; Rütgen, Barbara/ADM-6510-2022; Correia, João DG/J-7036-2013; Gano, Lurdes/X-3500-2019; Aguiar, Sandra Isabel Rodrigues/A-3500-2009; André, Ana/R-5549-2019; Silva, Frederico Aires/ABD-9602-2021; Correia, João Domingos Galamba/AAA-2226-2022	iMed.ULisboa, M2B/0000-0002-1245-3715; Correia, João DG/0000-0002-7847-4906; Gano, Lurdes/0000-0001-7186-2060; Aguiar, Sandra Isabel Rodrigues/0000-0002-3041-383X; André, Ana/0000-0002-1916-6401; Silva, Frederico Aires/0000-0002-3821-419X; Correia, João Domingos Galamba/0000-0002-7847-4906; Oliveira, Soraia/0000-0002-3840-6781; Dias, Joana/0000-0003-1905-1871; Tavares, Luis/0000-0001-8671-6285; Gil, Solange/0000-0001-9565-6261	Fundacao para a Ciencia e a Tecnologia, FCT IP [IF/01010/2013, SFRH/BPD/100522/2014, SFRH/BD/90514/2012, SFRH/BD/131468/2017]; CIISA - FCT [UID/CVT/00276/2013]; FCT [UID/Multi/04349/2013]	Fundacao para a Ciencia e a Tecnologia, FCT IP; CIISA - FCT; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank the Portuguese Funding Agency, Fundacao para a Ciencia e a Tecnologia, FCT IP, for financial support: IF/01010/2013 to FAS, SFRH/BPD/100522/2014 to SA and PhD fellowships SFRH/BD/90514/2012 to JD and SFRH/BD/131468/2017 to AA. CIISA has provided support through Project UID/CVT/00276/2013, funded by FCT. LG and JDGC gratefully acknowledge FCT support through the UID/Multi/04349/2013 project.	Aresu L, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00077; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Curran KM, 2017, VET COMP ONCOL, V15, P1269, DOI 10.1111/vco.12263; da Silva FA, 2012, BIOTECHNOL APPL BIOC, V59, P353, DOI 10.1002/bab.1034; Dias Joana N R, 2018, Oncotarget, V9, P28586, DOI 10.18632/oncotarget.25580; Ferraresso S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11724-w; Henry Carolyn J, 2013, Mo Med, V110, P216; Ito D, 2011, J VET INTERN MED, V25, P890, DOI 10.1111/j.1939-1676.2011.0756.x; Ito D, 2014, VET IMMUNOL IMMUNOP, V159, P192, DOI 10.1016/j.vetimm.2014.02.016; Kisseberth WC, 2007, LEUKEMIA RES, V31, P1709, DOI 10.1016/j.leukres.2007.04.003; Kohnken R, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00022; LeBlanc AK, 2016, CLIN CANCER RES, V22, P2133, DOI 10.1158/1078-0432.CCR-15-2347; Marconato L, 2013, HEMATOL ONCOL, V31, P1, DOI 10.1002/hon.2017; Marconato L, 2011, JAVMA-J AM VET MED A, V238, P480, DOI 10.2460/javma.238.4.480; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Nadella MVP, 2008, VET COMP ONCOL, V6, P39, DOI 10.1111/j.1476-5829.2007.00139.x; Nakaichi M, 1996, J VET MED SCI, V58, P469, DOI 10.1292/jvms.58.469; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PaineMurrieta GD, 1997, CANCER CHEMOTH PHARM, V40, P209, DOI 10.1007/s002800050648; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Porrello A, 2006, J EXP CLIN CANC RES, V25, P97; Richards KL, 2011, BLOOD, V118, P5193; Richards KL, 2015, IMMUNOL REV, V263, P173, DOI 10.1111/imr.12238; Roode SC, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0836-z; Rutgen BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040078; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Sehn LH, 2015, BLOOD, V125, P22, DOI 10.1182/blood-2014-05-577189; Seiser EL, 2013, VET COMP ONCOL, V11, P30, DOI 10.1111/j.1476-5829.2011.00299.x; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; STEPLEWSKI Z, 1987, CANCER IMMUNOL IMMUN, V24, P197; STRANDSTROM HV, 1979, AM J VET RES, V40, P1033; Teras LR, 2016, CA-CANCER J CLIN, V66, P443, DOI 10.3322/caac.21357; Tilly H, 2015, ANN ONCOL, V26, pV116, DOI 10.1093/annonc/mdv304; Umeki S, 2013, J VET MED SCI, V75, P467, DOI 10.1292/jvms.12-0448; Weiskopf K, 2016, CANCER IMMUNOL RES, V4, P1072, DOI 10.1158/2326-6066.CIR-16-0105; Xu TT, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00150; Yee NS, 2015, CANCER GROWTH METAST, P115, DOI 10.4137/CGM.S37907; Younes A, 2011, NAT REV CLIN ONCOL, V8, P124, DOI 10.1038/nrclinonc.2011.20	39	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0208147	10.1371/journal.pone.0208147	http://dx.doi.org/10.1371/journal.pone.0208147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592723	Green Published, Green Submitted, gold			2022-12-26	WOS:000454621900006
J	Bhoyar, S; Godet, I; DiGiacomo, JW; Gilkes, DM				Bhoyar, Soumitra; Godet, Ines; DiGiacomo, Josh W.; Gilkes, Daniele M.			A software tool for the quantification of metastatic colony growth dynamics and size distributions in vitro and in vivo	PLOS ONE			English	Article							BREAST-CANCER; SEGMENTATION; MOUSE; CELLS	The majority of cancer-related deaths are due to metastasis, hence improved methods to biologically and computationally model metastasis are required. Computational models rely on robust data that is machine-readable. The current methods used to model metastasis in mice involve generating primary tumors by injecting human cells into immune-compromised mice, or by examining genetically engineered mice that are pre-disposed to tumor development and that eventually metastasize. The degree of metastasis can be measured using flow cytometry, bioluminescence imaging, quantitative PCR, and/or by manually counting individual lesions from metastatic tissue sections. The aforementioned methods are time-consuming and do not provide information on size distribution or spatial localization of individual metastatic lesions. In this work, we describe and provide a MATLAB script for an image-processing based method designed to obtain quantitative data from tissue sections comprised of multiple subpopulations of disseminated cells localized at metastatic sites in vivo. We further show that this method can be easily adapted for high throughput imaging of live or fixed cells in vitro under a multitude of conditions in order to assess clonal fitness and evolution. The inherent variation in mouse studies, increasing complexity in experimental design which incorporate fate-mapping of individual cells, result in the need for a large cohort of mice to generate a robust dataset. High-throughput imaging techniques such as the one that we describe will enhance the data that can be used as input for the development of computational models aimed at modeling the metastatic process.	[Bhoyar, Soumitra; Godet, Ines; DiGiacomo, Josh W.; Gilkes, Daniele M.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Bhoyar, Soumitra; Godet, Ines; DiGiacomo, Josh W.; Gilkes, Daniele M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Gilkes, DM (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.; Gilkes, DM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	dgilkes@jhu.edu	Gilkes, Daniele M/AAI-8133-2020	Gilkes, Daniele M/0000-0003-3984-9338	V Scholar Foundation [U54-CA210173, R00-CA181352, V2016-024]; Susan G. Komen Foundation [CCR17483484]; Jayne Koskinas Ted Giovanis Foundation for Health and Policy; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R00CA181352, U54CA210173] Funding Source: NIH RePORTER	V Scholar Foundation; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Jayne Koskinas Ted Giovanis Foundation for Health and Policy; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in the Gilkes lab is supported by U54-CA210173, R00-CA181352, V Scholar Foundation (V2016-024), by the Susan G. Komen Foundation (CCR17483484), by The Jayne Koskinas Ted Giovanis Foundation for Health and Policy and the Breast Cancer Research Foundation (DMG).	Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Barbolosi D, 2009, MATH BIOSCI, V218, P1, DOI 10.1016/j.mbs.2008.11.008; Braselmann H, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0529-y; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang J, 2016, ADV EXP MED BIOL, V899, P245, DOI 10.1007/978-3-319-26666-4_14; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Deng WT, 2017, ANALYST, V142, P2945, DOI 10.1039/c7an00623c; ELMORE JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI DOI 10.1001/JAMA.2015.1405; Farahani N, 2015, PATHOL LAB MED INT, V7, P23, DOI 10.2147/PLMI.S59826; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Hart D, 1998, BRIT J CANCER, V78, P382, DOI 10.1038/bjc.1998.503; Hartung N, 2014, CANCER RES, V74, P6397, DOI 10.1158/0008-5472.CAN-14-0721; Hoffman RM, 2005, CURR TOP DEV BIOL, V70, P121, DOI 10.1016/S0070-2153(05)70006-5; Hoffman RM, 2016, CANCER METAST REV, V35, P5, DOI 10.1007/s10555-016-9610-8; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Iwata K, 2000, J THEOR BIOL, V203, P177, DOI 10.1006/jtbi.2000.1075; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Pantanowitz Liron, 2010, J Pathol Inform, V1, DOI [10.4103/2153-3539.68332, 10.4103/2153-3539.63821]; Qin YB, 2013, ADV MECH ENG, DOI 10.1155/2013/268046; Raab SS, 2005, CANCER, V104, P2205, DOI 10.1002/cncr.21431; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Roukos V, 2015, NAT PROTOC, V10, P334, DOI 10.1038/nprot.2015.016; Sarnecki JS, 2016, LAB INVEST, V96, P450, DOI 10.1038/labinvest.2015.162; Schneider T, 2002, CLIN EXP METASTAS, V19, P571, DOI 10.1023/A:1020992411420; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; SMITH JR, 1978, P NATL ACAD SCI USA, V75, P1353, DOI 10.1073/pnas.75.3.1353; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Suetsugu A, 2012, ANTICANCER RES, V32, P31; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Wang D., 2016, ARXIV160605718; Wang ZZ, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1604-1; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Wilbur DC, 2011, ACTA CYTOL, V55, P227, DOI 10.1159/000324734; Yamamoto N, 2003, CANCER RES, V63, P7785; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; Yang HG, 2014, PATTERN RECOGN, V47, P2266, DOI 10.1016/j.patcog.2013.11.004; Yankeelov TE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005686	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209591	10.1371/journal.pone.0209591	http://dx.doi.org/10.1371/journal.pone.0209591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589908	gold, Green Published			2022-12-26	WOS:000454418200031
J	Opollo, VS; Nikuze, A; Ben-Farhat, J; Anyango, E; Humwa, F; Oyaro, B; Wanjala, S; Omwoyo, W; Majiwa, M; Akelo, V; Zeh, C; Maman, D				Opollo, Valarie Sarah; Nikuze, Alliance; Ben-Farhat, Jihane; Anyango, Emily; Humwa, Felix; Oyaro, Boaz; Wanjala, Stephen; Omwoyo, Willis; Majiwa, Maxwel; Akelo, Victor; Zeh, Clement; Maman, David			Field evaluation of near point of care Cepheid GeneXpert HIV-1 Qual for early infant diagnosis	PLOS ONE			English	Article							INFECTED CHILDREN; MORTALITY; TRANSMISSION; PREVALENCE; PREVENTION; MOTHERS; CLINICS; AFRICA; ASSAYS; RISK	Background Access to point-of-care HIV testing shortens turn-around times, time to diagnosis and reduces loss to follow-up hence minimizing barriers to early linkage to care and treatment among HIV infected infants. Currently samples for early infant HIV diagnosis are sent to centralized testing facilities which are few and located only at specific regions in Kenya. However, there are Point of Care (POC) early infant diagnosis [EID] technologies elsewhere such as SAMBA and ALERE-Q that are yet to be evaluated in Kenya despite the urgent need for data to inform policy formulation regarding EID. The Cepheid GeneXpert HIV-1 Qual (GeneXpert) technology for POC EID offers a great opportunity to minimize HIV associated morbidity, mortality and loss to follow-up through decentralization of early infant HIV testing to the clinics. This technology also allows for same-day results thus facilitating prompt linkage to care. Methods We evaluated the GeneXpert HIV Qual EID POC in Homabay County against the standard of care platform, Roche CAP/CTM HIV-1 qualitative PCR, using dried blood spots (DBS). Between February-July 2016, DBS samples were collected from HIV exposed children <18 months of age enrolled in a cross-sectional study. Samples were collected by qualified nurse counselors, and were tested by trained technicians using field based GeneXpert and conventional laboratory based Roche CAP/CTM HIV-1 qualitative PCR. Sensitivity and specificity were determined. Results Overall, 3,814 mother/infant pairs were included in the study, out of which 921 infants were HIV exposed as per the mothers' HIV status and based on the infant's HIV rapid test. A total of 969 PCR tests were performed, out of which 30 (3.3%) infants were concordantly positive using both platforms. GeneXpert HIV-1 Qual yielded a sensitivity of 94.1% and specificity of 99.8% with an overall error rate of 0.7%. Conclusion Our findings show that GeneXpert HIV-1 Qual performs well compared to CAP/CTM using DBS samples, suggesting that this technology may be adopted in decentralized laboratories as a near POC device. It may contribute to prompt diagnosis of HIV exposed infants hence enabling early linkage to care, thus advancing further gains in EID.	[Opollo, Valarie Sarah; Anyango, Emily; Humwa, Felix; Oyaro, Boaz; Majiwa, Maxwel; Akelo, Victor] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Nikuze, Alliance; Ben-Farhat, Jihane; Maman, David] Epicentre, Paris, France; [Wanjala, Stephen] Med Sans Frontieres, Nairobi, Kenya; [Omwoyo, Willis] Minist Hlth, Homabay, Kenya; [Zeh, Clement] US Ctr Dis Control & Prevent, Clin Res Ctr, Kisumu, Kenya	Kenya Medical Research Institute	Opollo, VS (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya.	vopollo@kemricdc.org		Maman, David/0000-0002-9839-3011; Wanjala, Stephen/0000-0002-7001-0605	Medecins Sans Frontieres, 8 rue Saint Sabin 75010 Paris France - UNITAID	Medecins Sans Frontieres, 8 rue Saint Sabin 75010 Paris France - UNITAID	This work was funded and sponsored by Medecins Sans Frontieres, 8 rue Saint Sabin 75010 Paris France to DM. The study was also co-funded by UNITAID who provided the Cepheid GeneXpert instruments and cartridges.	Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Ceffa S, 2016, J VIROL METHODS, V229, P35, DOI 10.1016/j.jviromet.2015.12.007; Chohan BH, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-18; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Dunn D, 2008, J INFECT DIS, V197, P398, DOI 10.1086/524686; Ghadrshenas A, 2013, AIDS, V27, pS197, DOI 10.1097/QAD.0000000000000104; Hsiao NY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152672; Hsiao NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055308; Ibrahim M, 2017, JAIDS-J ACQ IMM DEF, V75, pE128, DOI 10.1097/qai.0000000000001384; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2014, JAIDS-J ACQ IMM DEF, V67, pE1, DOI 10.1097/QAI.0000000000000250; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; KNBS, 2009 KEN POP HOUS CE; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; Munyagwa M, 2012, TROP MED INT HEALTH, V17, P836, DOI 10.1111/j.1365-3156.2012.03000.x; Murray TY, 2017, J CLIN MICROBIOL, V55, P3227, DOI 10.1128/JCM.01021-17; Murtagh M., 2011, UNITAID TECHNICAL RE; NASCOP;NACC, 2015, KEN HIV EST REP; National AIDS and STI Control Programme, 2012, KEN AIDS IND SURV PR; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Pharr JR, 2016, JAIDS-J ACQ IMM DEF, V72, pS154, DOI 10.1097/QAI.0000000000001051; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Setty MKHG, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/497046; Sherman GG, 2005, TROP MED INT HEALTH, V10, P1108, DOI 10.1111/j.1365-3156.2005.01495.x; Technau KG, 2017, LANCET HIV, V4, pE442, DOI 10.1016/S2352-3018(17)30097-8; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; UNAIDS, 2016, GLOB DAT UNAIDS AIDS; UNAIDS, 2015, FAST TRACK AIDS FREE; UNAIDS, 2015, AIDS CHANG EV THING; UNITAID/WHO G Switzerland, 2012, HIV AIDS DIAGN TECHN; World Health Organization, 2010, WHO REC DIAGN HIV IN; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	36	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209778	10.1371/journal.pone.0209778	http://dx.doi.org/10.1371/journal.pone.0209778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589900	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200051
J	Bouza, E; Burillo, A; Munoz, P; Valerio, M; Barrio, JM; Hortal, J; Cuerpo, G; Perez-Granda, MJ				Bouza, Emilio; Burillo, Almudena; Munoz, Patricia; Valerio, Maricela; Maria Barrio, Jose; Hortal, Javier; Cuerpo, Gregorio; Jesus Perez-Granda, Maria			Do lower respiratory tract samples contribute to the assessment of carriage of Staphylococcus aureus in patients undergoing mechanical ventilation after major heart surgery?	PLOS ONE			English	Article							SURGICAL SITE INFECTIONS; NASAL CARRIAGE; DECOLONIZATION; PREVENTION; RISK; PREDICTOR; IMPACT	Colonization by Staphylococcus aureus is regularly assessed in patients undergoing major heart surgery (MHS). Despite pre-surgical decontamination attempts, a significant proportion of MHS patients remain colonized by S. aureus at the time of surgery. Nasal sampling can be improved by sampling extra-nasal areas. We evaluated whether processing lower respiratory tract (LRT) secretions enhanced the detection of S. aureus after MHS. Following a standard protocol, nasal swabs and LRT aspirates were obtained from all of the study patients at the time of surgery or in the immediate postoperative period. One swab was used for culture in the microbiology laboratory, and a second swab was used for the Xpert SA Nasal Complete assay. According to our definition of colonization (culture positive and/or PCR positive), 31 of 115 patients (26.9%) were colonized at the time of surgery. Among these, LRT samples only were positive in three patients (2.6% of the whole population and 9.7% of the carriers). The remaining 28 were either positive in the nasal sample or positive in both samples. The yield of the detection of colonization by S. aureus by including also LRT samples in patients undergoing MHS is limited and must be balanced with laboratory workload and demands on laboratory personnel.	[Bouza, Emilio; Burillo, Almudena; Munoz, Patricia; Valerio, Maricela; Jesus Perez-Granda, Maria] Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain; [Bouza, Emilio; Burillo, Almudena; Munoz, Patricia; Valerio, Maricela; Jesus Perez-Granda, Maria] IiSGM, Madrid, Spain; [Bouza, Emilio; Burillo, Almudena; Munoz, Patricia] Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain; [Bouza, Emilio; Munoz, Patricia; Maria Barrio, Jose; Hortal, Javier; Jesus Perez-Granda, Maria] CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain; [Maria Barrio, Jose; Hortal, Javier; Cuerpo, Gregorio; Jesus Perez-Granda, Maria] Hosp Gen Univ Gregorio Maranon, Cardiac Surg Postoperat Care Unit, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; General University Gregorio Maranon Hospital	Burillo, A; Perez-Granda, MJ (corresponding author), Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain.; Burillo, A; Perez-Granda, MJ (corresponding author), IiSGM, Madrid, Spain.; Burillo, A (corresponding author), Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain.; Perez-Granda, MJ (corresponding author), CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain.; Perez-Granda, MJ (corresponding author), Hosp Gen Univ Gregorio Maranon, Cardiac Surg Postoperat Care Unit, Madrid, Spain.	almudena.burillo@gmail.com; massus@hotmail.es	GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015; Bouza, Emilio/D-8661-2014; Muñoz, Patricia/E-9431-2017	GRANDA, MARIA JESUS mjpg PEREZ/0000-0002-0613-2122; Bouza, Emilio/0000-0001-6967-9267; Muñoz, Patricia/0000-0001-5706-5583; Burillo, Almudena/0000-0003-2545-4204	CIBER Enfermedades Respiratorias-CIBERES, Madrid, Spain [CB06/06/0058]; Rafael del Pino Foundation; Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III - European Regional Development Fund (FEDER) "A way of making Europe" [FIS PI10/02869]	CIBER Enfermedades Respiratorias-CIBERES, Madrid, Spain; Rafael del Pino Foundation; Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III - European Regional Development Fund (FEDER) "A way of making Europe"	Supported in part by CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain, the Rafael del Pino Foundation, and by grants from the Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III (FIS PI10/02869), partially financed by the by the European Regional Development Fund (FEDER) "A way of making Europe". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cercenado E, 2012, J CLIN MICROBIOL, V50, P4095, DOI 10.1128/JCM.02409-12; Salas JD, 2016, REV CALID ASSIST, V31, P27, DOI 10.1016/j.cali.2015.08.007; George S, 2016, DIMENS CRIT CARE NUR, V35, P204, DOI 10.1097/DCC.0000000000000192; Giannella M, 2012, CRIT CARE, V16, DOI 10.1186/cc11387; Gibson KE, 2014, INFECT CONT HOSP EP, V35, P1458, DOI 10.1086/678599; Grmek Kosnik I, 2017, ZDRAV VARST, V56, P24, DOI 10.1515/sjph-2017-0004; Hong JC, 2018, ANN THORAC SURG, V105, P47, DOI 10.1016/j.athoracsur.2017.06.033; Jog S, 2008, J HOSP INFECT, V69, P124, DOI 10.1016/j.jhin.2008.02.008; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Lemaignen A, 2018, J HOSP INFECT; Mehta S, 2013, CLIN ORTHOP RELAT R, V471, P2367, DOI 10.1007/s11999-013-2848-3; Munoz P, 2008, J HOSP INFECT, V68, P25, DOI 10.1016/j.jhin.2007.08.010; Perl TM, 2003, SURGERY, V134, pS10, DOI 10.1016/S0039-6060(03)00391-X; Pofahl WE, 2011, AM SURGEON, V77, P27; Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P799, DOI 10.1016/j.jiph.2017.01.007; Reiser M, 2017, J HOSP INFECT, V95, P137, DOI 10.1016/j.jhin.2016.11.004; Ridgway JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079716; Robicsek A, 2008, J CLIN MICROBIOL, V46, P588, DOI 10.1128/JCM.01746-07; Saraswat MK, 2017, ANN THORAC SURG, V104, P1349, DOI 10.1016/j.athoracsur.2017.03.018; Schweizer ML, 2015, JAMA-J AM MED ASSOC, V313, P2162, DOI 10.1001/jama.2015.5387; Sim BLH, 2013, INFECT CONT HOSP EP, V34, P818, DOI 10.1086/671273; Strymish J, 2012, INFECT CONT HOSP EP, V33, P1113, DOI 10.1086/668026; Talwar A, 2016, J ENVIRON BIOL, V37, P247; Verhoeven PO, 2014, EXPERT REV ANTI-INFE, V12, P75, DOI 10.1586/14787210.2014.859985; Witteck A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13217	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0207854	10.1371/journal.pone.0207854	http://dx.doi.org/10.1371/journal.pone.0207854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586363	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400007
J	Obeid, AK; Bruza, PD; Wittek, P				Obeid, Abdul Karim; Bruza, Peter D.; Wittek, Peter			Evaluating probabilistic programming languages for simulating quantum correlations	PLOS ONE			English	Article								This article explores how probabilistic programming can be used to simulate quantum correlations in an EPR experimental setting. Probabilistic programs are based on standard probability which cannot produce quantum correlations. In order to address this limitation, a hypergraph formalism was programmed which both expresses the measurement contexts of the EPR experimental design as well as associated constraints. Four contemporary open source probabilistic programming frameworks were used to simulate an EPR experiment in order to shed light on their relative effectiveness from both qualitative and quantitative dimensions. We found that all four probabilistic languages successfully simulated quantum correlations. Detailed analysis revealed that no language was clearly superior across all dimensions, however, the comparison does highlight aspects that can be considered when using probabilistic programs to simulate experiments in quantum physics.	[Obeid, Abdul Karim; Bruza, Peter D.] Queensland Univ Technol, Sch Informat Syst, Brisbane, Qld, Australia; [Wittek, Peter] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada; [Wittek, Peter] Creat Destruct Lab, Toronto, ON, Canada; [Wittek, Peter] Vector Inst Artificial Intelligence, Toronto, ON, Canada; [Wittek, Peter] Perimeter Inst Theoret Phys, Toronto, ON, Canada	Queensland University of Technology (QUT); University of Toronto; Perimeter Institute for Theoretical Physics	Obeid, AK (corresponding author), Queensland Univ Technol, Sch Informat Syst, Brisbane, Qld, Australia.	abdul.obeid@hdr.qut.edu.au		Bruza, Peter/0000-0001-7999-0534; Obeid, Abdul/0000-0002-9838-1838	Asian Office of Aerospace Research and Development (AOARD) [FA2386-17-1-4016]; Perimeter Institute for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Economic Development and Innovation	Asian Office of Aerospace Research and Development (AOARD); Perimeter Institute for Theoretical Physics; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Economic Development and Innovation	This research was supported by the Asian Office of Aerospace Research and Development (AOARD) grant: FA2386-17-1-4016. This research was supported by Perimeter Institute for Theoretical Physics. Research at Perimeter Institute is supported by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Economic Development and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin A, 2015, COMMUN MATH PHYS, V334, P533, DOI 10.1007/s00220-014-2260-1; Almahairi A., 2016, THEANO PYTHON FRAMEW; Bell J. S., 1964, PHYSICS, V1, P195, DOI [10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bingham E., 2018, PYRO DEEP UNIVERSAL; Bruza PD, 2017, THEORETICAL COMPUTER; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Charles River Analytics, 2017, FIGARO; Chiribella G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.060401; Chiribella G, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.022339; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Ge H, 2016, TURING LANGUAGE PROB; Goodman N, 2017, LABS OPEN SOURCES PY; Goodman N. D., 2014, DESIGN IMPLEMENTATIO; Goodman N.D., 2008, P 24 C UNCERTAINTY A, P220; Gordon Andrew D., 2014, P C FUTURE SOFTWARE, P167, DOI [DOI 10.1145/2593882.2593900, 10.1145/2593882.2593900]; Milch B., 2010, HEURISTICS PROBABILI; Oreshkov O, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2076; Paszke A., 2017, PYTORCH TENSORS DYNA, V1st; Peng T, 2017, RIP THEANO; Pollock FA, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.040405; Pollock FA, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.012127; POPESCU S, 1994, FOUND PHYS, V24, P379, DOI 10.1007/BF02058098; Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55; Shimony A, 2009, STANFORD ENCY PHILOS; Tran D, 2016, EDWARD LIB PROBABILI	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0208555	10.1371/journal.pone.0208555	http://dx.doi.org/10.1371/journal.pone.0208555			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608937	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800013
J	Dhabangi, A; Idro, R; John, CC; Dzik, WH; Siu, GE; Opoka, RO; Ayebare, F; van Hensbroek, MB				Dhabangi, Aggrey; Idro, Richard; John, Chandy C.; Dzik, Walter H.; Siu, Godfrey E.; Opoka, Robert O.; Ayebare, Florence; van Hensbroek, Michael B.			Community perceptions of paediatric severe anaemia in Uganda	PLOS ONE			English	Article							CHILDHOOD MALARIA; CLINICAL PALLOR; CHILDREN; CARE; MODERATE; EPILEPSY; ILLNESS; DISEASE; AFRICA; HEALTH	Background Severe anaemia remains a major cause of morbidity and mortality among children in sub-Saharan Africa. There is limited research on the beliefs and knowledge for paediatric severe anaemia in the region. The effect of these local beliefs and knowledge on the healthcare seeking of paediatric severe anaemia remains unknown. Objective To describe community perceptions of paediatric severe anaemia in Uganda. Methods Sixteen in-depth interviews of caregivers of children treated for severe anaemia and six focus group discussions of community members were conducted in three regions of Uganda between October and November 2017. Results There was no common local name used to describe paediatric severe anaemia, but the disease was understood in context as 'having no blood'. Severe anaemia was identified to be a serious disease and the majority felt blood transfusion was the ideal treatment, but concomitant use of traditional and home remedies was also widespread. Participants articulated signs of severe pediatric anemia, such as palmar, conjunctival, and tongue pallor. Other signs described included jaundice, splenomegaly, difficulty in breathing and poor appetite. Poor feeding, malaria, splenomegaly and evil spirits were perceived to be the common causes of severe anaemia. Other causes included: human immunodeficiency virus (HIV), haemoglobinuria, fever, witchcraft, mosquito bites, and sickle cell. Splenomegaly and jaundice were perceived to be both signs and causes of severe anaemia. Severe anaemia was interpreted to be caused by evil spirits if it was either recurrent, led to sudden death, or manifested with cold extremities. Conclusion The community in Uganda perceived paediatric severe anaemia as a serious disease. Their understanding of the signs and perceived causes of severe anaemia to a large extent aligned with known clinical signs and biological causes. Belief in evil spirits persists and may be one obstacle to seeking timely medical care for paediatric severe anaemia.	[Dhabangi, Aggrey; Siu, Godfrey E.; Ayebare, Florence] Makerere Univ, Child Hlth & Dev Ctr, Coll Hlth Sci, Kampala, Uganda; [Idro, Richard; Opoka, Robert O.] Makerere Univ, Coll Hlth Sci, Dept Paediat & Child Hlth, Kampala, Uganda; [John, Chandy C.] Indiana Univ, Sch Med, Ryan White Ctr Paediat Infect Dis & Global Hlth, Indianapolis, IN 46204 USA; [Dzik, Walter H.] Harvard Univ, Massachusetts Gen Hosp, Dept Pathol Transfus, Boston, MA 02115 USA; [van Hensbroek, Michael B.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Global Child Hlth, Amsterdam, Netherlands	Makerere University; Makerere University; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Massachusetts General Hospital; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Dhabangi, A (corresponding author), Makerere Univ, Child Hlth & Dev Ctr, Coll Hlth Sci, Kampala, Uganda.	adhabangi@gmail.com	John, Chandy/GNP-8431-2022; , Ridro/ABD-3556-2020	John, Chandy/0000-0002-1634-1411; DHABANGI, AGGREY/0000-0002-5615-3925; Boele van Hensbroek, Michael/0000-0003-1907-5427	Research Council of Norway, Global Vaccine Division, Bergen, Norway [234478]	Research Council of Norway, Global Vaccine Division, Bergen, Norway	The study was funded by the Research Council of Norway, Global Vaccine Division, Bergen, Norway (grant number; 234478). None of the authors are employees of the funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Ellis AA, 2013, J BIOSOC SCI, V45, P743, DOI 10.1017/S0021932013000163; Falade CO, 2005, INT Q COMMUNITY HEAL, V24, P347, DOI 10.2190/GN66-9447-3984-4064; Green HK, 2011, PARASITOLOGY, V138, P1534, DOI 10.1017/S0031182011001016; HELMAN CG, 1995, PATIENT EDUC COUNS, V26, P169, DOI 10.1016/0738-3991(95)00753-M; Hodes RM, 1996, ISRAEL J MED SCI, V32, P561; Jilek-Aall L, 1999, EPILEPSIA, V40, P382, DOI 10.1111/j.1528-1157.1999.tb00723.x; Kahissay MH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4052-y; Keikelame MJ, 2015, TRANSCULT PSYCHIATRY, V52, P659, DOI 10.1177/1363461515571626; Kiggundu VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082455; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; LUBY SP, 1995, B WORLD HEALTH ORGAN, V73, P477; Manning L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001972; Ministry of Health Republic of Uganda, 2010, IMP ASS REF 36; Muhe L, 2000, TROP MED INT HEALTH, V5, P805, DOI 10.1046/j.1365-3156.2000.00637.x; Muoneke VU, 2012, INDIAN PEDIATR, V49, P119, DOI 10.1007/s13312-012-0026-4; Mwaka AD, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-84; MWENESI HA, 1995, J BIOSOC SCI, V27, P235, DOI 10.1017/S0021932000022720; Nuwaha F, 2002, TROP MED INT HEALTH, V7, P462, DOI 10.1046/j.1365-3156.2002.00877.x; Ofovwe GE, 2002, J NEUROL SCI, V200, P49, DOI 10.1016/S0022-510X(02)00128-4; Okechukwu A A, 2011, Niger J Med, V20, P109; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Smith Joanna, 2011, Nurse Res, V18, P52; Srivastava A, 2009, FRAMEWORK ANAL QUALI, DOI DOI 10.1002/JIA2.25572; Stoltzfus RJ, 1999, J NUTR, V129, P1675, DOI 10.1093/jn/129.9.1675; Uganda Bureau of Statistics, 2016, UG BUR STAT 2016 17; van Hensbroek MB, 2011, BRIT J HAEMATOL, V154, P690, DOI 10.1111/j.1365-2141.2011.08761.x; Zucker JR, 1997, B WORLD HEALTH ORGAN, V75, P97	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209476	10.1371/journal.pone.0209476	http://dx.doi.org/10.1371/journal.pone.0209476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1ZC	30605461	Green Published, gold, Green Submitted			2022-12-26	WOS:000454759900016
J	Albertson, LK; Sklar, LS; Cooper, SD; Cardinale, BJ				Albertson, Lindsey K.; Sklar, Leonard S.; Cooper, Scott D.; Cardinale, Bradley J.			Aquatic macroinvertebrates stabilize gravel bed sediment: A test using silk net-spinning caddisflies in semi-natural river channels	PLOS ONE			English	Article							ECOSYSTEM ENGINEERS; LARVAE TRICHOPTERA; HABITAT MODIFICATION; SPECIES-DIVERSITY; ALLUVIAL RIVER; SHEAR-STRESS; ABUNDANCE; SIZE; PRODUCTIVITY; METAANALYSIS	Organisms can have large effects on the physical properties of the habitats where they live. For example, measurements in laboratory stream microcosms have shown that the presence of silk net-spinning insect larvae (Trichoptera: Hydropsychidae) can increase the shear force required to initiate movement of riverbed sediments. Few studies, however, have moved beyond laboratory settings to quantify the engineering impacts of aquatic insects under more complex field conditions. To bridge the gap between small-scale laboratory experiments and natural stream ecosystems, we conducted experiments in large (50 m(2)) outdoor river channels where net-spinning aquatic insects were manipulated in sediment patches that were 5 to 25 times larger than in previous studies. We tested whether larvae of two caddisfly species (Arctopsyche californica and Ceratopsyche oslari) influenced the stability of gravel during simulated floods when alone in monoculture and together in polyculture. On average, populations of caddisflies increased the critical shear stress required to initiate sediment movement by 20% compared to treatments without caddisflies. Per capita effects of caddisflies on sediment stability were similar between previous laboratory studies and this field experiment, and Arctopsyche had a larger per capita effect than Ceratopsyche, perhaps because of its larger size and stronger silk. Contrary to prior laboratory flume results, the effects of the two species on critical shear stress when together were similar to the additive expectation of both species when alone, but effects of the two species together were higher than the additive expectation when we accounted for density. Comparisons of total population and per capita effects suggest that caddisfly density, identity, and coexisting species likely have effects on the magnitude of caddisfly impacts on critical shear stress. Our findings imply that consideration of both the abundances and traits of ecosystem engineers is needed to describe and model their effects on sediment mobility.	[Albertson, Lindsey K.; Cooper, Scott D.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Albertson, Lindsey K.] Montana State Univ, Bozeman, MT 59717 USA; [Sklar, Leonard S.] San Francisco State Univ, Dept Earth & Climate Sci, San Francisco, CA 94132 USA; [Sklar, Leonard S.] Concordia Univ, Dept Geog Planning & Environm, De Maisonneuve Blvd W, Montreal, PQ, Canada; [Cardinale, Bradley J.] Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA; [Cardinale, Bradley J.] Univ Michigan, CIGLR, Ann Arbor, MI 48109 USA	University of California System; University of California Santa Barbara; Montana State University System; Montana State University Bozeman; California State University System; San Francisco State University; Concordia University - Canada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Albertson, LK (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.; Albertson, LK (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	lindsey.albertson@montana.edu	Cardinale, Bradley J/I-7076-2013		Montana State University; National Science Foundation Doctoral Dissertation Improvement Grant [1110571]; Mildred E. Mathias Graduate Student Grant; Valentine Eastern Sierra Reserve Student Award; UC-Santa Barbara; Doris and David Dawdy Fund for Hydrologic Science at SFSU; NSF [1332342]	Montana State University; National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Mildred E. Mathias Graduate Student Grant; Valentine Eastern Sierra Reserve Student Award; UC-Santa Barbara; Doris and David Dawdy Fund for Hydrologic Science at SFSU; NSF(National Science Foundation (NSF))	L. Albertson was funded by Montana State University, a National Science Foundation Doctoral Dissertation Improvement Grant (1110571), Mildred E. Mathias Graduate Student Grant, Valentine Eastern Sierra Reserve Student Award, and Worster Award for student research from UC-Santa Barbara. L. Sklar's participation was funded by the Doris and David Dawdy Fund for Hydrologic Science at SFSU. B. Cardinale was funded by NSF grant 1332342. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Bear AD, 2014, SOIL BIOL BIOCHEM, V78, P274, DOI 10.1016/j.soilbio.2014.08.009; Albertson LK, 2015, ECOLOGY, V96, P1329, DOI 10.1890/13-2138.1; Albertson LK, 2014, J GEOPHYS RES-EARTH, V119, P1833, DOI 10.1002/2013JF003024; Albertson LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103417; Allen DC, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1972; Allen DC, 2016, ECOLOGY, V97, P17, DOI 10.1890/15-0800.1; Allen DC, 2011, ECOLOGY, V92, P1013, DOI 10.1890/i0012-9658-92-5-1013; Arnon S, 2010, HYDROL PROCESS, V24, P108, DOI 10.1002/hyp.7490; Braudrick CA, 2009, P NATL ACAD SCI USA, V106, P16936, DOI 10.1073/pnas.0909417106; Buffington JM, 1997, WATER RESOUR RES, V33, P1993, DOI 10.1029/96WR03190; Cardinale BJ, 2004, FUNCT ECOL, V18, P381, DOI 10.1111/j.0269-8463.2004.00865.x; Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; Church M, 2006, ANNU REV EARTH PL SC, V34, P325, DOI 10.1146/annurev.earth.33.092203.122721; Cooper SD, 1998, AUST J ECOL, V23, P27, DOI 10.1111/j.1442-9993.1998.tb00703.x; Cuddington K, 2007, THEOR ECOL SER, P1; CUMMINS K W, 1969, Hydrobiologia, V34, P145, DOI 10.1007/BF00141925; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Diamond J., 1986, COMMUNITY ECOL, P3; Diehl S, 2000, AM NAT, V156, P293, DOI 10.1086/303390; Dietrich W. E., 2006, 4 C RIV COAST EST MO, V1, P79, DOI 10.1201/9781439833896; DIETRICH WE, 1989, NATURE, V340, P215, DOI 10.1038/340215a0; DOWNES BJ, 1993, HYDROBIOLOGIA, V252, P163, DOI 10.1007/BF00008153; Drysdale RN, 2003, SEDIMENT GEOL, V161, P207, DOI 10.1016/S0037-0738(03)00114-3; Drysdale RN, 1999, J SEDIMENT RES, V69, P145, DOI 10.2110/jsr.69.145; ENGLUND G, 1990, ANIM BEHAV, V39, P55, DOI 10.1016/S0003-3472(05)80725-0; Englund G, 2003, ADV ECOL RES, V33, P161, DOI 10.1016/S0065-2504(03)33011-9; Flecker AS, 1997, J N AM BENTHOL SOC, V16, P286, DOI 10.2307/1468258; Gordon ND, 2004, STREAM HYDROLOGY INT; Gribben PE, 2009, ECOL LETT, V12, P1127, DOI 10.1111/j.1461-0248.2009.01366.x; Harding JS, 1997, HYDROBIOLOGIA, V350, P25, DOI 10.1023/A:1003012512998; HAUER FR, 1982, CAN J FISH AQUAT SCI, V39, P1235, DOI 10.1139/f82-164; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; HEINZELMANN C, 1991, J HYDRAUL RES, V29, P355, DOI 10.1080/00221689109498439; Herbst D., 2004, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P133; HILDREW AG, 1979, J ANIM ECOL, V48, P557, DOI 10.2307/4180; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Jenkins TM, 1999, ECOLOGY, V80, P941, DOI 10.1890/0012-9658(1999)080[0941:EOPDOI]2.0.CO;2; Johnson MF, 2009, EARTH SURF PROC LAND, V34, P413, DOI 10.1002/esp.1750; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones CG, 2012, GEOMORPHOLOGY, V157, P75, DOI 10.1016/j.geomorph.2011.04.039; Juras M, 2018, ECOL ENG, V119, P19, DOI 10.1016/j.ecoleng.2018.05.011; Katija K, 2009, NATURE, V460, P624, DOI 10.1038/nature08207; KERANS BL, 1992, CAN J FISH AQUAT SCI, V49, P259, DOI 10.1139/f92-030; Kraufvelin P, 1999, J EXP MAR BIOL ECOL, V240, P229, DOI 10.1016/S0022-0981(99)00061-1; LELAND HV, 1986, GREAT BASIN NAT, V46, P595; LOUDON C, 1990, AM NAT, V135, P360, DOI 10.1086/285051; LOUDON C, 1992, CAN J ZOOL, V70, P1166, DOI 10.1139/z92-163; March JG, 2002, FRESHWATER BIOL, V47, P377, DOI 10.1046/j.1365-2427.2002.00808.x; MILLER JC, 1984, OIKOS, V43, P117, DOI 10.2307/3544253; Moore JW, 2006, BIOSCIENCE, V56, P237, DOI 10.1641/0006-3568(2006)056[0237:AEEIS]2.0.CO;2; Moore JW, 2004, OECOLOGIA, V139, P298, DOI 10.1007/s00442-004-1509-3; Nakano D, 2005, FRESHWATER BIOL, V50, P1492, DOI 10.1111/j.1365-2427.2005.01421.x; Nelson PA, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001144; OCONNOR NA, 1991, OECOLOGIA, V85, P504, DOI 10.1007/BF00323762; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Palmer MA, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004354; Parker G, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000549; Plague GR, 2003, BEHAV ECOL, V14, P221, DOI 10.1093/beheco/14.2.221; R Core Team, 2018, R LANG ENV STAT COMP; Reinhardt L, 2010, EARTH SURF PROC LAND, V35, P78, DOI 10.1002/esp.1912; Rice S, 2016, J GEOPHYS RES SURF; Rice S. P., 2012, GRAVEL BED RIVERS PR, P225; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; Rixen C, 2005, OECOLOGIA, V146, P287, DOI 10.1007/s00442-005-0196-z; SAS Institute Inc, 1989, NON TRADITIONAL REF; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Statzner B, 1999, WATER RESOUR RES, V35, P3495, DOI 10.1029/1999WR900196; Statzner B, 2008, GEOMORPHOLOGY, V93, P267, DOI 10.1016/j.geomorph.2007.02.019; Statzner B, 2012, GEOMORPHOLOGY, V157, P49, DOI 10.1016/j.geomorph.2011.03.022; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Takao A, 2006, J N AM BENTHOL SOC, V25, P545, DOI 10.1899/0887-3593(2006)25[545:PIOANC]2.0.CO;2; Trush WJ, 2000, P NATL ACAD SCI USA, V97, P11858, DOI 10.1073/pnas.97.22.11858; Viles H.A, 1988, BIOGEOMORPHOLOGY; Voelz NJ, 1996, CAN J ZOOL, V74, P654, DOI 10.1139/z96-074; WALLACE JB, 1980, ANNU REV ENTOMOL, V25, P103, DOI 10.1146/annurev.en.25.010180.000535; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wiggins GB, 1977, LARVAE N AM CADDISFL; Wilcock PR, 1996, WATER RESOUR RES, V32, P3361, DOI 10.1029/96WR02277; WILCOCK PR, 1993, J HYDRAUL ENG-ASCE, V119, P491, DOI 10.1061/(ASCE)0733-9429(1993)119:4(491); WILLIAMS NE, 1973, OIKOS, V24, P73, DOI 10.2307/3543254	82	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209087	10.1371/journal.pone.0209087	http://dx.doi.org/10.1371/journal.pone.0209087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601831	gold, Green Published, Green Submitted			2022-12-26	WOS:000454683200037
J	Rossetto, M; Brand, EM; Rodrigues, RM; Serrant, L; Teixeira, LB				Rossetto, Maira; Brand, Evelin Maria; Rodrigues, Renata Mendonca; Serrant, Laura; Teixeira, Luciana Barcellos			Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil	PLOS ONE			English	Article							TUBERCULOSIS/HIV COINFECTION; IMMUNODEFICIENCY-VIRUS; MORTALITY; DETERMINANTS; DISTRICT; STATE; CITY	In locations with a high rate of tuberculosis (TB) and HIV infection, there are a number of strategies to prevent negative outcomes such as opportunistic infections, hospitalizations and death, and this article investigates risk factors for the occurrence of hospitalization and death in cases of TB/HIV co-infection in the south of Brazil. The data are taken from a population-based retrospective cohort study on cases of TB/HIV co-infection from 2009 to 2013 in Porto Alegre, Brazil. Sociodemographic, epidemiological and clinical variables were analyzed. Relative risk (RR) estimates for hospitalization and death were determined by regression models. There were 2,419 co-infection cases, of which 1,527 (63.1%) corresponded to hospitalizations, and 662 (27.4%) to death. The occurrence of hospitalization was associated with <= 7 years of schooling (RR = 3.47, 95% CI: 1.97-6.29), 8-11 years of schooling (RR = 2.56, 95% CI: 1.44-4.69), place of origin-district health authorities Northwest/Humaita/Navegantes/Ilhas (RR = 2.01, 95% CI: 1.44-2.82), type of entry into the surveillance system as in cases of reentry after withdrawal (RR = 1,35, 95% CI: 1.07-1.70), closure in surveillance as in withdrawal of treatment (RR = 1.47, 95% CI: 1.18-1.83) and multidrug-resistant tuberculosis (RR = 3.94, 95% CI: 1.97-8.81). The occurrence of death was associated with age (RR = 1.07, 95% CI: 1,01-1,14), <= 7 years of schooling (RR = 3.94, 95% CI: 2.26-7.09), 8-11 years of schooling (RR = 2.84, 95% CI: 1.61-5.16), place of origin-district health authorities Baltazar (RR = 2.05, 95% CI: 1.48-2.86), type of entry in the surveillance system as cases of re-entry after withdrawal (RR = 1.53, 95% CI: 1.22-1.91), relapse (RR = 1.33, 95% CI: 1.03-1.73). The occurrence of hospitalizations and deaths is high among co-infected patients. Our estimation approach is important in order to identify, from the surveillance data, the risk factors for hospitalization and death in co-infected patients, so that they may receive more attention from the Brazilian national healthcare system.	[Rossetto, Maira] Univ Fed Fronteira Sul, Dept Med, Chapeco, SC, Brazil; [Brand, Evelin Maria; Teixeira, Luciana Barcellos] Univ Fed Rio Grande do Sul, Dept Publ Hlth, Porto Alegre, RS, Brazil; [Rodrigues, Renata Mendonca] Univ Estado Santa Catarina, Sch Nursing, Chapeco, SC, Brazil; [Serrant, Laura] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield, S Yorkshire, England	Universidade Federal da Fronteira Sul; Universidade Federal do Rio Grande do Sul; Universidade do Estado de Santa Catarina; Sheffield Hallam University	Rossetto, M (corresponding author), Univ Fed Fronteira Sul, Dept Med, Chapeco, SC, Brazil.; Teixeira, LB (corresponding author), Univ Fed Rio Grande do Sul, Dept Publ Hlth, Porto Alegre, RS, Brazil.	maira.rossetto@uffs.edu.br; luciana.barcellos@ufrgs.br		Serrant, Laura/0000-0002-9382-9859; Rossetto, Maira/0000-0002-5683-4835				Adejumo Olusola Adedeji, 2017, Niger Med J, V58, P44, DOI 10.4103/0300-1652.218417; Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; Ahmad T, 2017, INT J MYCOBACT, V6, P360, DOI 10.4103/ijmy.ijmy_69_17; Barnabas RV, 2011, AIDS, V25, P1559, DOI 10.1097/QAD.0b013e3283491e3e; Beraldo Aline Ale, 2017, Esc. Anna Nery, V21, pe20170075, DOI 10.1590/2177-9465-ean-2017-0075; Bigna JJR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132394; Brasil, 2016, B EP AIDS DST 2016, V2016, P1; Brasil. Ministerio da Saude, 2016, B EPIDEMIOL, V47, P1; Ceccon RF, 2017, EPIDEMIOL SERV SAUDE, V26, P349, DOI [10.5123/S1679-49742017000200012, 10.5123/s1679-49742017000200012]; Cecilio Hellen Pollyanna Mantelo, 2017, Texto contexto - enferm., V26, pe0230014, DOI 10.1590/0104-07072017000230014; Deribe Kebede, 2015, J Int Assoc Provid AIDS Care, V14, P269, DOI 10.1177/2325957413500528; Fanosie A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150646; Fiebig L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049111; Fregona G, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006688, 10.1590/s1518-8787.2017051006688]; Gao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064915; Gebreweld FH, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-017-0132-y; Gesesew Hailay, 2016, BMC Res Notes, V9, P89, DOI 10.1186/s13104-016-1905-x; Guglielmetti L, 2018, INT J TUBERC LUNG D, V22, P54, DOI 10.5588/ijtld.17.0387; Gupta S, 2014, INT J TUBERC LUNG D, V18, P1149, DOI 10.5588/ijtld.13.0889; Hino P, 2012, ACTA PAUL ENFERM, V25, P755, DOI 10.1590/S0103-21002012000500017; India. Revised National Tuberculosis Control Programe, 2017, ANN STAT REP MIN HLT, V1, P3; Jacobson KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127024; Jappar SB, 2015, SINGAP MED J, V56, P502, DOI 10.11622/smedj.2015134; Javaid A, 2018, CLIN MICROBIOL INFEC, V24, P612, DOI 10.1016/j.cmi.2017.09.012; Krasniqi S, 2017, TUBERC RES TREAT, V2017, DOI 10.1155/2017/4850324; Lai YJ, 2015, BIOMED ENVIRON SCI, V28, P421, DOI 10.3967/bes2015.059; Lemos LD, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.0537.2691; Mabunda TE, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.12; Maffacciolli R, 2017, SAUDE SOC-SAO PAULO, V26, P286, DOI [10.1590/s0104-12902017168038, 10.1590/S0104-12902017168038]; Magno ED, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00019315, 10.1590/0102-311x00019315]; McDonald E, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.11.21067; Naidoo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-396; Nast K., 2014, THESIS; Neto MS, 2012, J BRAS PNEUMOL, V38, P724; Nigeria. The National Strategic Plan for Tuberculosis Control, 2015, NAT STRAT PLAN TUB C; Oshi Daniel Chukwunweolu, 2014, Tuberc Res Treat, V2014, P202983, DOI 10.1155/2014/202983; Porco TC, 2013, CLIN INFECT DIS, V56, P761, DOI 10.1093/cid/cis989; Porto Alegre. Prefeitura Municipal. Gabinete do Prefeito. Secretaria do Planejamento Municipal, 2012, MAP INCL EXCL SOC PO; Ramachandran G, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02464-16, 10.1128/aac.02464-16]; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Reepalu A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156602; Rossetto M., 2016, THESIS; Takarinda Kudakwashe C, 2017, Tuberc Res Treat, V2017, P6232071, DOI 10.1155/2017/6232071; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; Umanah T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1214-3; UNAIDS, 2017, RIGHT HLTH; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2018, TOP 10 CAUS DEATH; Wysocki Anneliese Domingues, 2017, Rev. bras. epidemiol., V20, P161, DOI 10.1590/1980-5497201700010014; Yellappa V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4627-7; Ponce MAZ, 2016, EPIDEMIOL SERV SAUDE, V25, P553, DOI [10.5123/s1679-49742016000300011, 10.5123/S1679-49742016000300011]	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209174	10.1371/journal.pone.0209174	http://dx.doi.org/10.1371/journal.pone.0209174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601842	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200044
J	Bello, FA; Fawole, B; Oluborode, B; Awowole, I; Irinyenikan, T; Awonuga, D; Loto, O; Fabamwo, A; Guest, P; Ganatra, B				Bello, Folasade Adenike; Fawole, Bukola; Oluborode, Babawale; Awowole, Ibraheem; Irinyenikan, Theresa; Awonuga, David; Loto, Olabisi; Fabamwo, Adetokunbo; Guest, Philip; Ganatra, Bela			Trends in misoprostol use and abortion complications: A cross-sectional study from nine referral hospitals in Nigeria	PLOS ONE			English	Article							UNSAFE ABORTION; PREGNANCY; HEALTH	Objective The study aimed to assess the use of misoprostol and complications associated with abortions in referral hospitals in Nigeria, a country with restrictive abortion laws. Methods A cross-sectional study at nine referral hospitals in South-west Nigeria. Nine years' data were retrieved from medical records, including 699 induced abortions. Independent variable was the method of abortion; dependent variables were complications, need for treatment and mortality. Statistical significance was tested with Chi-square, Fishers' exact and chi-square for trend tests (p<0.05). Results There were 699 induced abortions amongst 2,463 abortions found in records. Nearly 70% were surgical abortions, but misoprostol use significantly increased over the study period in a linear trend (chi(2) trend: 30.96, P < 0.001). Patients who used misoprostol were significantly less likely to have infectious morbidity, genital tract injuries or medical complications. There was no difference in incomplete abortion in the groups. Patients were more likely to have in-patient care with surgical abortions (p < 0.001), to need prolonged antibiotic regimens (p = 0.003), need further surgeries or additional specialist care (p = 0.009). Conclusion Misoprostol abortion has significantly increased over time, and was associated with less morbidity and need for further treatment, in this study. It appears to be the safer option.	[Bello, Folasade Adenike; Fawole, Bukola] Univ Ibadan, Dept Obstet & Gynaecol, Ibadan, Nigeria; [Oluborode, Babawale] Obafemi Awolowo Univ, Dept Obstet & Gynaecol, Teaching Hosp Complex, Ilesha, Nigeria; [Awowole, Ibraheem; Loto, Olabisi] Obafemi Awolowo Univ, Dept Obstet & Gynaecol, Ife, Nigeria; [Irinyenikan, Theresa] State Specialist Hosp, Dept Obstet & Gynaecol, Akure, Nigeria; [Awonuga, David] Fed Med Ctr, Dept Obstet & Gynaecol, Abeokuta, Nigeria; [Fabamwo, Adetokunbo] Lagos State Univ, Dept Obstet & Gynaecol, Coll Med, Lagos, Nigeria; [Guest, Philip] Inst Populat & Social Res, Bangkok, Thailand; [Ganatra, Bela] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland	University of Ibadan; Obafemi Awolowo University; Obafemi Awolowo University; Lagos State University; The World Bank; United Nations Population Fund; World Health Organization	Bello, FA (corresponding author), Univ Ibadan, Dept Obstet & Gynaecol, Ibadan, Nigeria.	dr.nikebello@yahoo.com		Bello, Folasade Adenike/0000-0002-3337-3335; Awowole, Ibraheem/0000-0001-7006-0824; Ganatra, Bela/0000-0002-4812-4577	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO)	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO)(World Health Organization)	The study was supported with a grant from UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a co-sponsored program executed by the World Health Organization (WHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun O M, 2013, Afr J Med Med Sci, V42, P111; Aimakhu C O, 2014, Afr J Med Med Sci, V43, P327; Awoyemi BO, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0003-9; Bankole A, 2015, INT PERSPECT SEX R H, V41, P170, DOI 10.1363/4117015; Chigbu B, 2012, East Afr Med J, V89, P172; Dah Talemoh, 2011, Afr J Reprod Health, V15, P42; Fawole AO, 2012, INT J GYNECOL OBSTET, V119, P170, DOI 10.1016/j.ijgo.2012.06.012; Hanschmidt F, 2016, PERSPECT SEX REPRO H, V48, P169, DOI 10.1363/48e8516; Kalu Collins A, 2012, Afr J Reprod Health, V16, P105; Koster W, 2010, SOC SCI MED, V71, P1788, DOI 10.1016/j.socscimed.2010.06.033; Lamina M A, 2015, Ghana Med J, V49, P187, DOI 10.4314/gmj.v49i3.10; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Nigeria Ipas and Society of Gynaecology and Obstetrics of Nigeria, 2010, OFF MIS ALT MAN VACC; Okereke CI, 2010, J BIOSOC SCI, V42, P619, DOI 10.1017/S0021932010000179; Okonofua F, 2014, INT J GYNECOL OBSTET, V125, P49, DOI 10.1016/j.ijgo.2013.10.009; Okonofua F, 2010, INT J GYNECOL OBSTET, V111, P122, DOI 10.1016/j.ijgo.2010.05.020; Omideyi AK, 2011, GLOB PUBLIC HEALTH, V6, pS52, DOI 10.1080/17441692.2011.594073; Prada E, 2015, AFR J REPROD HEALTH, V19, P52; Shochet T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-127; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; United Nations Population Information Network (POPIN), 1994, INT C POP DEV CAIR; US Agency for International Development, 2016, MIS POL SCAL UP PREV; WHO, 1992, PREV MAN UNS AB; World Health Organization, 2018, PREV UNS AB FACT SHE; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2017, ESSE MED LIST	26	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209415	10.1371/journal.pone.0209415	http://dx.doi.org/10.1371/journal.pone.0209415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596683	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200045
J	Kim, B; Kwon, J; Kim, MS; Park, H; Ji, Y; Holzapfel, W; Hyun, CK				Kim, Bobae; Kwon, Jeonghyeon; Kim, Min-Seok; Park, Haryung; Ji, Yosep; Holzapfel, Wilhelm; Hyun, Chang-Kee			Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice	PLOS ONE			English	Article							GUT MICROBIOTA; INSULIN-RESISTANCE; LIVER-DISEASE; OBESITY; ACIDS; AXIS; AMPK	Recently, modulation of gut microbiota by probiotics treatment has been emerged as a promising strategy for treatment of metabolic disorders. Apart from lactic acid bacteria, Bacillus species (Bacillus spp.) have also been paid attention as potential probiotics, but nevertheless, the molecular mechanisms for their protective effect against metabolic dysfunction remain to be elucidated. In this study, we demonstrate that a probiotic mixture composed of 5 different Bacillus spp. protects mice from high-fat diet (HFD)-induced obesity, insulin resistance and non-alcoholic fatty liver disease (NAFLD). Probiotic Bacillus treatment substantially attenuated body weight gain and enhanced glucose tolerance by sensitizing insulin action in skeletal muscle and epididymal adipose tissue (EAT) of HFD-fed mice. Bacillus-treated HFD-fed mice also exhibited significantly suppressed chronic inflammation in the liver, EAT and skeletal muscle, which was observed to be associated with reduced HFD-induced intestinal permeability and enhanced adiponectin production. Additionally, Bacillus treatment significantly reversed HFD-induced hepatic steatosis. In Bacillus-treated mice, hepatic expression of lipid oxidative genes was significantly increased, and lipid accumulation in subcutaneous and mesenteric adipose tissues were significantly decreased, commensurate with down-regulated expression of genes involved in lipid uptake and lipogenesis. Although, in Bacillus-treated mice, significant alterations in gut microbiota composition was not observed, the enhanced expression of tight junction-associated proteins showed a possibility of improving gut barrier function by Bacillus treatment. Our findings provide possible explanations how Bacillus probiotics protect diet-induced obese mice against metabolic disorders, identifying the treatment of probiotic Bacillus as a potential therapeutic approach.	[Kim, Bobae; Kwon, Jeonghyeon; Kim, Min-Seok; Hyun, Chang-Kee] Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea; [Kim, Bobae; Park, Haryung; Ji, Yosep; Holzapfel, Wilhelm; Hyun, Chang-Kee] Handong Global Univ, Dept Adv Green Energy & Environm AGEE, Pohang, Gyungbuk, South Korea; [Ji, Yosep; Holzapfel, Wilhelm] HEM, Pohang, Gyungbuk, South Korea	Handong Global University; Handong Global University	Hyun, CK (corresponding author), Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea.; Hyun, CK (corresponding author), Handong Global Univ, Dept Adv Green Energy & Environm AGEE, Pohang, Gyungbuk, South Korea.	ckhyun@handong.edu	Park, Grace/U-1673-2018		Korea Institute of Planning and Evaluation Technology in Food, Agriculture, Forestry and Fisheries (IPET), the Ministry of Agriculture, Food and Rural Affairs [IPET 316066-3]; Holzapfel Effective Microbes, Pohang, Republic of Korea [HGU 20170133]	Korea Institute of Planning and Evaluation Technology in Food, Agriculture, Forestry and Fisheries (IPET), the Ministry of Agriculture, Food and Rural Affairs; Holzapfel Effective Microbes, Pohang, Republic of Korea	This work was supported by the Korea Institute of Planning and Evaluation Technology in Food, Agriculture, Forestry and Fisheries (IPET), the Ministry of Agriculture, Food and Rural Affairs (IPET 316066-3). The authors also gratefully acknowledge the support from Holzapfel Effective Microbes, Pohang, Republic of Korea (HGU 20170133).	Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Bergstrom A, 2012, FEMS MICROBIOL LETT, V337, P38, DOI 10.1111/1574-6968.12004; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Choi JH, 2016, J CLIN BIOCHEM NUTR, V59, P31, DOI 10.3164/jcbn.15-30; Clarke SF, 2012, GUT MICROBES, V3, P186, DOI 10.4161/gmic.20168; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Dalby MJ, 2017, CELL REP, V21, P1521, DOI 10.1016/j.celrep.2017.10.056; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Elshaghabee FMF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01490; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fak F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046837; Finlayson A, 2015, WORLD J GASTRO ENDOS, V7, P1103, DOI [10.4253/wjge.v7.i13.1103, 10.4291/wjgp.v6.i4.110]; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Ghoneim MAM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1093-1; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; He MQ, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0183-1; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Janssen AWF, 2015, FASEB J, V29, P3111, DOI 10.1096/fj.14-269514; Ji Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00710; Jia GH, 2017, COMPR PHYSIOL, V7, P253, DOI 10.1002/cphy.c160014; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kim E, 2011, EUR J PHARMACOL, V672, P38, DOI 10.1016/j.ejphar.2011.09.172; Kim JI, 2015, MOL CELL BIOL, V35, P1686, DOI 10.1128/MCB.01321-14; Kim MS, 2018, BIOCHEM BIOPH RES CO, V495, P1744, DOI 10.1016/j.bbrc.2017.12.003; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Lee Y, 2016, BRIT J NUTR, V116, P603, DOI 10.1017/S0007114516002270; Louis S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149564; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Ma YY, 2013, WORLD J GASTROENTERO, V19, P6911, DOI 10.3748/wjg.v19.i40.6911; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Muir LA, OBESITY SILVER SPRIN; Murphy EA, 2015, CURR OPIN CLIN NUTR, V18, P515, DOI 10.1097/MCO.0000000000000209; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Paolella G, 2014, WORLD J GASTROENTERO, V20, P15518, DOI 10.3748/wjg.v20.i42.15518; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Scavuzzi BM, 2015, EXPERT OPIN THER TAR, V19, P1127, DOI 10.1517/14728222.2015.1028361; Sumi CD, 2015, CAN J MICROBIOL, V61, P93, DOI 10.1139/cjm-2014-0613; Sun J, 2014, GENES DIS, V1, P132, DOI 10.1016/j.gendis.2014.08.001; Suva M., 2016, J CURR RES SCI MED, V2, P65, DOI [DOI 10.4103/2455-3069.198381, 10.4103/2455-3069.198381]; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ueki A, 2008, INT J SYST EVOL MICR, V58, P346, DOI 10.1099/ijs.0.65486-0; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yadav H, 2013, J BIOL CHEM, V288, P25088, DOI 10.1074/jbc.M113.452516; Zhang ZW, 2018, APPL MICROBIOL BIOT, V102, P8135, DOI 10.1007/s00253-018-9217-9	46	36	38	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210120	10.1371/journal.pone.0210120	http://dx.doi.org/10.1371/journal.pone.0210120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596786	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200143
J	Min, R; Wang, H; Zhang, XY; Li, X; Fang, PQ; Bai, X				Min, Rui; Wang, He; Zhang, Xiaoyan; Li, Xia; Fang, Pengqian; Bai, Xue			Facing the urban-rural gap in patients with chronic kidney disease: Evidence from inpatients with urban or rural medical insurance in central China	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; PREVALENCE; ADULTS; NUTRITION; AWARENESS; MORTALITY	Background In view of the irreversible pathology of progressive exacerbation, the societal burden of chronic kidney disease (CKD) is increasing along with the rise in total health expenditure. Meanwhile, disparities remain among urban and rural citizens with different types of health insurance. This study aimed to assess the socioeconomic disparities between hospitalized CKD patients in urban and rural areas. Method A total of 501 CKD inpatients with urban or rural medical insurance (UMI or RMI, respectively) were selected from the top six tertiary hospitals in Wuhan. Demographic and socioeconomic data were collected as influencing factors. Data evaluation was performed using univariate and multivariate analyses. Result Socioeconomic characteristics showed differences among hospitalized CKD patients with different health insurances. Patients with RMI were younger, and reported lower education levels, poor domestic economic conditions, shorter duration, and less frequent hospital stays than those with UMI (P<0.05). The predictors revealed varying associations between UMI and RMI. Among the hospitalized CKD patients with UMI, male and low-education individuals presented high hospitalization expenses (beta(gender) = -0.406, beta(education) (level) = 0.357, P<0.05). By contrast, no significant difference in this aspect was found among RMI inpatients. Conclusions Care delivery and reimbursement models should be re-designed and implemented to improve equity among different CKD patients. The national health education should also be enhanced to prevent CKD and provide early treatment.	[Min, Rui; Wang, He; Fang, Pengqian; Bai, Xue] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, Xiaoyan] Hubei Univ, Coll Polit & Law & Publ Adm, Wuhan, Hubei, Peoples R China; [Li, Xia] Taihe Hosp Shiyan City, Shiyan City, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University	Fang, PQ; Bai, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	pfang@mails.tjmu.edu.cn; 307596716@qq.com	MIN, Rui/GQP-9076-2022	MIN, Rui/0000-0002-4036-2933	National Natural Science Foundation of China [71333005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by grants from the National Natural Science Foundation of China (No. 71333005).	Agarwal SK, 2005, KIDNEY INT, V68, pS41, DOI 10.1111/j.1523-1755.2005.09808.x; Bosworth BP, 2012, GROWTH HLTH CONSUMPT, V2012; Burtless G., 2008, 10 ANN JOINT C RET R; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chen J, 2005, KIDNEY INT, V68, P2837, DOI 10.1111/j.1523-1755.2005.00757.x; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; De Zeeuw D, 2005, KIDNEY INT, V68, pS25, DOI 10.1111/j.1523-1755.2005.09805.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2013, CLIN PRACTICE GUIDEL; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Expert Group on Early Detection, 2017, CHINESE J PRACTICAL, V2; Gray NA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-278; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Iwagami M, 2017, NEPHROL DIAL TRANSPL, V32, P142, DOI 10.1093/ndt/gfw318; Jing SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053062; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; [赖玮婧 Lai Weijing], 2013, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V33, P448; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Pengqian FANG, 2017, GREEN BOOK HLTH REFO; Stevens LA, 2009, AM J KIDNEY DIS, V53, pS17, DOI 10.1053/j.ajkd.2008.07.047; Tonelli M, 2007, KIDNEY INT, V72, P1023, DOI 10.1038/sj.ki.5002443; Tonelli M, 2007, CAN MED ASSOC J, V177, P1039, DOI 10.1503/cmaj.070343; UNITED STATES RENAL DATA SYSTEM, 2017, 2017 ANN DAT REP EP; Vassalotti JA, 2007, AM J KIDNEY DIS, V50, P169, DOI 10.1053/j.ajkd.2007.06.013; Wagstaff A, 2008, J HEALTH ECON, V27, P990, DOI 10.1016/j.jhealeco.2008.02.002; Wang H.Q., 2016, ECONOMIST, V10, P71; Wang ZS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0023-7; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xu K., 2005, DISTRIBUTION HLTH PA; Xu Y, 2018, PLOS ONE, V13; Xu YJ, 2017, LANCET, V390, pS94, DOI 10.1016/S0140-6736(17)33232-4; Yangyang K., 2017, PREVALENCE ADULT CHR; Yin SF, 2010, LECT NOTES COMPUT SC, V6377, P73; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	39	3	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209259	10.1371/journal.pone.0209259	http://dx.doi.org/10.1371/journal.pone.0209259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596680	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200037
J	Nalley, L; Dixon, B; Chaminuka, P; Naledzani, Z; Coale, MJ				Nalley, Lawton; Dixon, Bruce; Chaminuka, Petronella; Naledzani, Zwiafhela; Coale, Matthew James			The role of public wheat breeding in reducing food insecurity in South Africa	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; IMPACT	Although classified as an upper middle-income country, food insecurity is still a concern throughout South Africa, as was evident in 2014-2015 when a drought left 22% of households food insecure. Further, a range of domestic and international factors make the local currency unstable, leaving South Africa exposed to risk in global wheat and exchange rate markets and increasing its food insecurity vulnerability. As such, agricultural research in South Africa is needed specifically in plant breeding to increase yields and help mitigate future food insecurity. To foster scientific innovation for food security, the South African government funds the Agricultural Research Council (ARC), which conducts holistic research on wheat and other crops. This study estimates the proportions of increases in yield of ARC's wheat cultivars, which are attributable solely to genetic improvements. In total, 25,690 yield observations from 125 countrywide test plots from 1998 to 2014 were utilized to estimate the proportions of yield increases attributable to the ARC. We found that South African farmers who adopted the ARC's wheat varieties experienced an annual yield gain of 0.75%, 0.30%, and 0.093% in winter, facultative, and irrigated spring wheat types, respectively. Using observed area sown to ARC varieties, we estimated that wheat producers gained $106.45 million (2016 USD) during 1992-2015 via the adoption of ARC varieties. We estimated that every dollar invested in the ARC wheat breeding program generated a return of $5.10. Assuming the South African per capita wheat consumption is 60.9 kg/year, our results suggest that the ARC breeding program provided an average of 253,318 additional wheat rations from 1992-2015. Further, the net surplus (consumer plus producer) from the ARC breeding program was estimated at 42.64 million 2016 USD from 1992-2015. Public breeding programs, especially those focused on wheat and other staple foods, must continue if South Africa is to meet growing global food demand, decrease present global food insecurity, and maintain the genetic enhancements that directly enhances yield and benefits low-income consumers.	[Nalley, Lawton; Dixon, Bruce; Coale, Matthew James] Univ Arkansas, Div Agr, Dept Agr Econ, Fayetteville, AR 72701 USA; [Chaminuka, Petronella; Naledzani, Zwiafhela] South African Agr Res Council, Pretoria, South Africa	University of Arkansas System; University of Arkansas Fayetteville	Nalley, L (corresponding author), Univ Arkansas, Div Agr, Dept Agr Econ, Fayetteville, AR 72701 USA.	llnalley@uark.edu	Chaminuka, Petronella/AAA-7228-2020; Nalley, Lawton/AAN-7643-2021	Chaminuka, Petronella/0000-0001-8644-4611; Nalley, Lawton/0000-0002-6718-8189				Alston J, 2006, SCI SCARCITY PRINCIP; Altman M, 2009, AGREKON, V48, P345, DOI 10.1080/03031853.2009.9523831; ARROW KJ, 1962, REV ECON STUD, V29, P155, DOI 10.2307/2295952; Bell MA, 1995, FIELD CROP RES, V44, P55, DOI 10.1016/0378-4290(95)00049-6; Booyse M., 2014, BIOMETRICAL APPROACH; Brennan J. P., 1984, Review of Marketing and Agricultural Economics, V52, P175; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Byerlee D., 1992, Journal of International Development, V4, P477, DOI 10.1002/jid.3380040502; COOPER PJM, 1987, EXP AGR, V23, P113, DOI 10.1017/S001447970001694X; DePauw RM, 2007, EUPHYTICA, V157, P409, DOI 10.1007/s10681-007-9379-5; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fan S., 2006, PUBLIC SPENDING DEV; Finger R, 2010, FOOD POLICY, V35, P175, DOI 10.1016/j.foodpol.2009.11.004; Fischer RA, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P23; Fischer T, 2014, ACIAR MONOGR SER, V158, P1; FOREX, INFL CURR EXCH CALC; Gerpacio RV, 2003, AGR ECON, V29, P319, DOI [10.1016/S0169-5150(03)00059-8, 10.1111/j.1574-0862.2003.tb00168.x]; Greene W.H., 2012, ECONOMETRIC ANAL; Hatting JL, 2000, BIOCONTROL, V45, P179, DOI 10.1023/A:1009981718582; Home Grown Cereal Authority, REC LIST EARL SOWN W; Just R, 1979, AM J AGR ECON, V61, P2; Mandela N., 1994, OP C S AFR AGR UN; Nalley L. L., 2008, Journal of Agricultural and Applied Economics, V40, P913; Nalley L. L., 2008, J INT AGR TRADE DEV, V5, P11; Nalley LL, 2010, AGR ECON-BLACKWELL, V41, P453, DOI 10.1111/j.1574-0862.2010.00457.x; Nhemachena CR, 2016, S AFR J SCI, V112, P75; Pardey P., 2007, SCI TECHNOLOGY SKILL; Pardey PG, 2016, FOOD POLICY, V65, P1, DOI 10.1016/j.foodpol.2016.09.009; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; Ronquest-Ross LC, 2015, S AFR J SCI, V111, DOI 10.17159/SAJS.2015/20140354; Smith V., 2000, 5 USDA; Sosibo NZ, 2017, S AFR J SCI, V113, P41, DOI 10.17159/sajs.2017/20160141; South African Department of Agriculture Forestry and Fisheries, 2017, TRENDS AGR SECT 2017; Southern African Development Community, 41 4 MILL PEOPL SO A; Stander C., 2012, EC CULTIVAR IMPROVEM; Tassey G., 2003, 031 NIST US DEP COMM; TRAXLER G, 1995, AM J AGR ECON, V77, P1, DOI 10.2307/1243883; USDA-Foreign Agricultural Service, 2013, S AFR 2013 14 WHEAT; Van der Merwe J., 2015, QUALITY PRICING PERF; Wohlgenant M.K, 2011, OXFORD HDB EC FOOD C, P0; World Bank, 2015, GLOB EC PROSP HAV FI	41	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209598	10.1371/journal.pone.0209598	http://dx.doi.org/10.1371/journal.pone.0209598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596691	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200062
J	Unterlauft, JD; Rehak, M; Bohm, MRR; Rauscher, FG				Unterlauft, Jan D.; Rehak, Matus; Boehm, Michael R. R.; Rauscher, Franziska G.			Analyzing the impact of glaucoma on the macular architecture using spectral-domain optical coherence tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; GANGLION-CELL LAYER; DIAGNOSTIC-ACCURACY; NEUROPATHY; THICKNESS; DAMAGE; PHOTORECEPTORS; PATHOLOGY; DEFECTS; DEATH	Purpose Using spectral domain optical coherence tomography (SD-OCT) the retina can be segmented automatically to visualize all retinal layers. In glaucoma chronically elevated intraocular pressure leads to a decline of retinal ganglion cells (RGC) which changes retinal architecture. The goal of these analyses was to gain insight into the changes induced by glaucoma within all macular layers using SD-OCT within a closely circumscribed glaucoma cohort. Materials and methods SD-OCT measurements with automated retinal layer segmentation were performed in both eyes of primary open-angle glaucoma patients with a defined monocular absolute visual field scotoma in the central 10 degrees of the visual field and in an age-matched healthy control group. Thickness of single retinal layers and entire retina were compared with special attention to the localization of the visual field scotoma in the glaucomatous eyes. Results 30 eyes of 15 glaucoma patients and 15 eyes of 15 healthy controls were included in this study. Statistical significant thickness differences were detected in the control group between superior and inferior retina for the retinal nerve fiber layer (RNFL), the outer plexiform layer (OPL) and the outer nuclear layer (ONL). In the glaucoma group thickness differences between worse and less affected eyes in the RNFL, the ganglion cell layer (GCL) and the inner plexiform layers (INL) were found. Comparison between healthy and diseased eyes revealed significant thickness differences in the RNFL, GCL, IPL and total retinal thickness but not the outer retinal layers. Conclusion Comparison between SD-OCT measurements of the macula between healthy and glaucomatous eyes in a closely circumscribed disease stage showed a pronounced disease impact on the inner but not the outer retina. These results provide evidence that GCL and IPL thickness seem to be good measures to discriminate between affected and unaffected eyes in testing for glaucoma.	[Unterlauft, Jan D.; Rehak, Matus] Leipzig Univ Hosp, Dept Ophthalmol, Leipzig, Germany; [Boehm, Michael R. R.] Univ Duisburg Essen, Univ Hosp Essen, Dept Ophthalmol, Essen, Germany; [Rauscher, Franziska G.] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Leipzig University; University of Duisburg Essen; Leipzig University	Rauscher, FG (corresponding author), Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.	franziska.rauscher@medizin.uni-leipzig.de	Rauscher, Franziska/AAV-8222-2021; Rehak, Matus/ABC-1073-2021	Rauscher, Franziska/0000-0003-0183-0340; 	German Federal Ministry of Education and Research [031L0026]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	FGR is supported by a grant from the German Federal Ministry of Education and Research: i: DSem - Integrative data semantics in systems medicine (grant number 031L0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal D, 2012, INVEST OPHTH VIS SCI, V53, P4539, DOI 10.1167/iovs.11-9300; Bagga H, 2005, J GLAUCOMA, V14, P358, DOI 10.1097/01.ijg.0000176930.21853.04; Chen Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41100; Choi SS, 2011, BRIT J OPHTHALMOL, V95, P131, DOI 10.1136/bjo.2010.183756; Cifuentes-Canorea P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196112; Ctori I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129005; Davis BM, 2016, ACTA NEUROPATHOL, V132, P807, DOI 10.1007/s00401-016-1609-2; Dong ZM, 2017, PROG RETIN EYE RES, V57, P76, DOI 10.1016/j.preteyeres.2016.11.001; Fard MA, 2016, INVEST OPHTH VIS SCI, V57, P1011, DOI 10.1167/iovs.15-18618; Greenfield DS, 2003, ARCH OPHTHALMOL-CHIC, V121, P41; Hood DC, 2017, PROG RETIN EYE RES, V57, P46, DOI 10.1016/j.preteyeres.2016.12.002; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Jeoung JW, 2013, INVEST OPHTH VIS SCI, V54, P4422, DOI 10.1167/iovs.12-11273; Kim EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182404; Kim KE, 2014, INVEST OPHTH VIS SCI, V55, P3501, DOI 10.1167/iovs.14-13925; Leung CKS, 2010, INVEST OPHTH VIS SCI, V51, P217, DOI 10.1167/iovs.09-3468; Mota Mafalda, 2016, J Curr Glaucoma Pract, V10, P85; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; Ortin-Martinez A, 2015, EXP EYE RES, V132, P17, DOI 10.1016/j.exer.2015.01.006; PANDA S, 1992, INVEST OPHTH VIS SCI, V33, P2532; Pazos M, 2017, OPHTHALMOLOGY, V124, P1218, DOI 10.1016/j.ophtha.2017.03.044; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1995, AUST NZ J OPHTHALMOL, V23, P85, DOI 10.1111/j.1442-9071.1995.tb00135.x; Quigley HA, 1998, AM J OPHTHALMOL, V125, P563, DOI 10.1016/S0002-9394(99)80203-7; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Seo JH, 2012, INVEST OPHTH VIS SCI, V53, P4347, DOI 10.1167/iovs.12-9673; Takayama K, 2012, INVEST OPHTH VIS SCI, V53, P6904, DOI 10.1167/iovs.12-10210; Tatham AJ, 2015, PROG BRAIN RES, V221, P103, DOI 10.1016/bs.pbr.2015.03.001; Velten IM, 2001, BRIT J OPHTHALMOL, V85, P397, DOI 10.1136/bjo.85.4.397; Vincent A, 2010, DOC OPHTHALMOL, V121, P21, DOI 10.1007/s10633-010-9227-0; Wang M, 2009, ARCH OPHTHALMOL-CHIC, V127, P875, DOI 10.1001/archophthalmol.2009.145; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Werner JS, 2011, EYE, V25, P279, DOI 10.1038/eye.2010.218; Yucel Yeni, 2013, J Glaucoma, V22 Suppl 5, pS24, DOI 10.1097/IJG.0b013e3182934a55	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209610	10.1371/journal.pone.0209610	http://dx.doi.org/10.1371/journal.pone.0209610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596720	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200067
J	Schmidt-Pogoda, A; Strecker, JK; Liebmann, M; Massoth, C; Beuker, C; Hansen, U; Konig, S; Albrecht, S; Bock, S; Breuer, J; Sommer, C; Schwab, N; Wiendl, H; Klotz, L; Minnerup, J				Schmidt-Pogoda, Antje; Strecker, Jan-Kolja; Liebmann, Marie; Massoth, Christina; Beuker, Carolin; Hansen, Uwe; Koenig, Simone; Albrecht, Sarah; Bock, Stefanie; Breuer, Johanna; Sommer, Clemens; Schwab, Nicholas; Wiendl, Heinz; Klotz, Luisa; Minnerup, Jens			Dietary salt promotes ischemic brain injury and is associated with parenchymal migrasome formation	PLOS ONE			English	Article							CELLS; DISEASE; STROKE; DYSFUNCTION; MECHANISMS; INDUCTION; ORGANELLE; SUBSETS	Sodium chloride promotes vascular fibrosis, arterial hypertension, pro-inflammatory immune cell polarization and endothelial dysfunction, all of which might influence outcomes following stroke. But despite enormous translational relevance, the functional importance of sodium chloride in the pathophysiology of acute ischemic stroke is still unclear. In the current study, we show that high-salt diet leads to significantly worse functional outcomes, increased infarct volumes, and a loss of astrocytes and cortical neurons in acute ischemic stroke. While analyzing the underlying pathologic processes, we identified the migrasome as a novel, sodium chloride-driven pathomechanism in acute ischemic stroke. The migrasome was previously described in vitro as a migrating organelle, which incorporates and dispatches cytosol of surrounding cells and plays a role in intercellular signaling, whereas a pathophysiological meaning has not been elaborated. We here confirm previously reported characteristics of the migrasome in vivo. Immunohistochemistry, electron microscopy and proteomic analyses further demonstrate that the migrasome incorporates and dispatches cytosol of surrounding neurons following stroke. The clinical relevance of these findings is emphasized by neuropathological examinations, which detected migrasome formation in infarcted brain parenchyma of human stroke patients. In summary, we demonstrate that high-salt diet aggravates stroke outcomes, and we characterize the migrasome as a novel mechanism in acute stroke pathophysiology.	[Schmidt-Pogoda, Antje; Strecker, Jan-Kolja; Liebmann, Marie; Beuker, Carolin; Albrecht, Sarah; Bock, Stefanie; Breuer, Johanna; Schwab, Nicholas; Wiendl, Heinz; Klotz, Luisa; Minnerup, Jens] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany; [Massoth, Christina] Univ Munster, Dept Anesthesiol & Intens Care Med, Munster, Germany; [Hansen, Uwe] Univ Munster, Inst Musculoskeletal Med, Munster, Germany; [Koenig, Simone] Univ Munster, IZKF Core Unit Prote, Munster, Germany; [Sommer, Clemens] Johannes Gutenberg Univ Mainz, Dept Neuropathol, Mainz, Germany	University of Munster; University of Munster; University of Munster; University of Munster; Johannes Gutenberg University of Mainz	Schmidt-Pogoda, A (corresponding author), Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany.	antje.schmidt-pogoda@ukmuenster.de	König, Simone/B-6504-2008; Wiendl, Heinz/AAX-6041-2021	König, Simone/0000-0003-0672-7246; Schwab, Nicholas/0000-0001-5494-9885; Breuer, Judith/0000-0001-8246-0534	Innovative Medical Research (IMF) of the Medical Faculty of the University of Munster [SC221502]; Interdisciplinary Center for Clinical Research (IZKF) of the Medical Faculty of the University of Munster (SEED07); Cluster of Excellence "Cells in Motion" (CIM) of the University of Munster [CIM-PP-2017-06]	Innovative Medical Research (IMF) of the Medical Faculty of the University of Munster; Interdisciplinary Center for Clinical Research (IZKF) of the Medical Faculty of the University of Munster (SEED07); Cluster of Excellence "Cells in Motion" (CIM) of the University of Munster	This study was supported by the Innovative Medical Research (IMF) of the Medical Faculty of the University of Munster (SC221502). ASP received a research grant of the Interdisciplinary Center for Clinical Research (IZKF) of the Medical Faculty of the University of Munster (SEED07). ASP received a research grant of the Cluster of Excellence "Cells in Motion" (CIM) of the University of Munster (CIM-PP-2017-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Beutner C, 2010, NAT PROTOC, V5, P1481, DOI 10.1038/nprot.2010.90; Boegehold MA, 2013, J VASC RES, V50, P458, DOI 10.1159/000355270; Breuer J, 2014, ANN NEUROL, V75, P739, DOI 10.1002/ana.24165; Cosic A, 2016, J PHYSIOL-LONDON, V594, P4917, DOI 10.1113/JP272297; da Rocha-Azevedo B, 2015, CELL RES, V25, P1, DOI 10.1038/cr.2014.146; Deb P., 2010, PATHOPHYSIOLOGY, V17, P197, DOI DOI 10.1016/J.PATHOPHYS.2009.12.001; Distler U, 2016, NAT PROTOC, V11, P795, DOI 10.1038/nprot.2016.042; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Faraco G, 2018, NAT NEUROSCI, V21, P240, DOI 10.1038/s41593-017-0059-z; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hucke S, 2016, J AUTOIMMUN, V67, P90, DOI 10.1016/j.jaut.2015.11.001; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kengne FG, 2011, J AM SOC NEPHROL, V22, P1834, DOI 10.1681/ASN.2010111127; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Koniusz S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00109; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ma L, 2015, CELL RES, V25, P24, DOI 10.1038/cr.2014.135; Pospichalova V, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.25530; Schmidt A, 2017, STROKE, V48, P1061, DOI 10.1161/STROKEAHA.116.015577; Schmitz K, 2015, PHARMACOL THERAPEUT, V148, P85, DOI 10.1016/j.pharmthera.2014.11.015; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Strecker JK, 2017, NEUROCHEM INT, V107, P117, DOI 10.1016/j.neuint.2016.11.006; Strecker JK, 2016, STROKE, V47, P852, DOI 10.1161/STROKEAHA.115.011230; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu DN, 2017, CELL RES, V27, P1397, DOI 10.1038/cr.2017.108	33	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209871	10.1371/journal.pone.0209871	http://dx.doi.org/10.1371/journal.pone.0209871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589884	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200065
J	Schneider, J; Kuny, S; Beker, D; Sauve, Y; Lemieux, H				Schneider, Jillian; Kuny, Sharee; Beker, Donna; Sauve, Yves; Lemieux, Helene			Cardiovascular sexual dimorphism in a diet-induced type 2 diabetes rodent model, the Nile rat (Arvicanthis niloticus)	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; HIGH-FAT MEAL; BLOOD-PRESSURE; HEART-RATE; DIASTOLIC FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; O-DESMETHYLANGOLENSIN; NONINVASIVE TECHNIQUE; CARDIAC-HYPERTROPHY; GENDER-DIFFERENCES	Background The Nile rat (Arvicanthis niloticus) is an emerging laboratory model of type 2 diabetes. When fed standard rodent chow, the majority of males progress from hyperinsulinemia by 2 months to hyperglycemia by 6 months, while most females remain at the hyperinsulinemia-only stage (prediabetic) from 2 months onward. Since diabetic cardiomyopathy is the major cause of type-2 diabetes mellitus (T2DM)-related mortality, we examined whether sexual dimorphism might entail cardiac functional changes. Our ultimate goal was to isolate the effect of diet as a modifiable lifestyle factor. Materials and methods Nile rats were fed either standard rodent chow (Chow group) or a high-fiber diet previously established to prevent type 2 diabetes (Fiber group). Cardiac function was determined with echocardiography at 12 months of age. To isolate the effect of diet alone, only the small subset of animals resistant to both hyperinsulinemia and hyperglycemia were included in this study. Results In males, Chow (compared to Fiber) was associated with elevated heart rate and mitral E/A velocity ratio, and with lower e'-wave velocity, isovolumetric relaxation time, and ejection time. Of note, these clinically atypical types of diastolic dysfunction occurred independently of body weight. In contrast, females did not exhibit changes in cardiovascular function between diets. Conclusions The higher prevalence of T2DM in males correlates with their susceptibility to develop subtle diastolic cardiac dysfunction when fed a Western style diet (throughout most of their life-span) despite no systemic evidence of metabolic syndrome, let alone T2DM.	[Schneider, Jillian; Sauve, Yves] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Kuny, Sharee; Sauve, Yves] Univ Alberta, Dept Ophthalmol & Visual Sci, Edmonton, AB, Canada; [Beker, Donna] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Lemieux, Helene] Univ Alberta, Dept Med, Women & Childrens Hlth Res Inst, Fac St Jean, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Lemieux, H (corresponding author), Univ Alberta, Dept Med, Women & Childrens Hlth Res Inst, Fac St Jean, Edmonton, AB, Canada.	helene.lemieux@ualberta.ca		lemieux, Helene/0000-0002-8864-6062	Canadian Institutes of Health (CIHR) [MOP 125873]; Natural Sciences and Engineering Research Council [RGPIN 402636]; Canadian Foundation for Innovation [12979]; Faculty Saint-Jean startup grant; Frederick Banting and Charles Best Canada Graduate Scholarship; Queen Elizabeth II Graduate Scholarship; Alberta Heritage Foundation for Medical Research Senior Scholarship [200800242]	Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Faculty Saint-Jean startup grant; Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarship; Alberta Heritage Foundation for Medical Research Senior Scholarship(Alberta Heritage Foundation for Medical Research)	Funding provided by Canadian Institutes of Health (CIHR; MOP 125873) to YS, as well as Natural Sciences and Engineering Research Council discovery grant (RGPIN 402636), Canadian Foundation for Innovation equipment grant (12979) and Faculty Saint-Jean startup grant to HL. JS received a Frederick Banting and Charles Best Canada Graduate Scholarship and a Queen Elizabeth II Graduate Scholarship; YS received an Alberta Heritage Foundation for Medical Research Senior Scholarship (200800242).	Anand Rishi G, 2008, J Cardiometab Syndr, V3, P149, DOI 10.1111/j.1559-4572.2008.00003.x; Beckman JA, 2013, EUR HEART J, V34, P2444, DOI 10.1093/eurheartj/eht142; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bjornstad P, 2016, J DIABETES COMPLICAT, V30, P1103, DOI 10.1016/j.jdiacomp.2016.04.008; Bloch KE, 1999, J CRIT CARE, V14, P177, DOI 10.1016/S0883-9441(99)90032-1; Bolsinger J, 2017, J NUTR BIOCHEM, V42, P134, DOI 10.1016/j.jnutbio.2017.01.007; Bolsinger J, 2013, J NUTR BIOCHEM, V24, P1945, DOI 10.1016/j.jnutbio.2013.06.004; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bruder-Nascimento T, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00032; Calabro V, 2016, FOOD FUNCT, V7, P1876, DOI [10.1039/C6FO00048G, 10.1039/c6fo00048g]; CELENTANO A, 1995, AM J CARDIOL, V76, P1173, DOI 10.1016/S0002-9149(99)80330-0; Chaabo F, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-29; Chen J, 2003, AM J PHYSIOL-HEART C, V285, pH2657, DOI 10.1152/ajpheart.00557.2003; Chung AK, 2006, CIRCULATION, V113, P1597, DOI 10.1161/CIRCULATIONAHA.105.574400; Cross TL, 2018, MOL METAB; De Bacquer D, 2000, HEART, V84, P625, DOI 10.1136/heart.84.6.625; DEVEREUX RB, 1983, AM J CARDIOL, V51, P171, DOI 10.1016/S0002-9149(83)80031-9; DEVEREUX RB, 1983, CIRCULATION, V68, P470, DOI 10.1161/01.CIR.68.3.470; DEVEREUX RB, 1984, J AM COLL CARDIOL, V4, P1222, DOI 10.1016/S0735-1097(84)80141-2; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; Erdogan D, 2013, METABOLISM, V62, P1123, DOI 10.1016/j.metabol.2013.02.011; Frankenfeld CL, 2014, EUR J CLIN NUTR, V68, P526, DOI 10.1038/ejcn.2014.23; Frankenfeld CL, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500900; Fu Q, 2004, AM J PHYSIOL-HEART C, V286, pH449, DOI 10.1152/ajpheart.00735.2002; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Golden KL, 2003, AM J PHYSIOL-ENDOC M, V285, pE449, DOI 10.1152/ajpendo.00054.2003; Halter JB, 2014, DIABETES, V63, P2578, DOI 10.2337/db14-0020; HAMMOND IW, 1988, J AM COLL CARDIOL, V12, P996, DOI 10.1016/0735-1097(88)90467-6; Han WH, 2017, INVEST OPHTH VIS SCI, V58, P3826, DOI 10.1167/iovs.17-21929; HARRISON MR, 1991, AM J CARDIOL, V67, P622, DOI 10.1016/0002-9149(91)90902-W; Hayward CS, 2001, CARDIOVASC RES, V49, P340, DOI 10.1016/S0008-6363(00)00280-7; HESELTINE D, 1990, CLIN SCI, V79, P517, DOI 10.1042/cs0790517; HINDERLITER AL, 1991, AM J HYPERTENS, V4, P579, DOI 10.1093/ajh/4.7.579; HIRAMATSU K, 1992, AM J CARDIOL, V70, P1185, DOI 10.1016/0002-9149(92)90053-2; Islam Md Shahidul, 2012, Methods Mol Biol, V933, P161, DOI 10.1007/978-1-62703-068-7_10; Jakulj F, 2007, J NUTR, V137, P935, DOI 10.1093/jn/137.4.935; Johnson MC, 1999, AM J HYPERTENS, V12, P1009, DOI 10.1016/S0895-7061(99)00087-4; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kim HL, 2013, CARDIOVASC ULTRASOUN, V11, P1, DOI [10.1186/1476-7120-11-1, DOI 10.1186/1476-7120-11-1]; Knaapen P, 2007, CIRCULATION, V115, P918, DOI 10.1161/CIRCULATIONAHA.106.660639; Kneffel Z, 2011, ACTA PHYSIOL HUNG, V98, P284, DOI 10.1556/APhysiol.98.2011.3.5; LANCE VQ, 1976, CATHETER CARDIO DIAG, V2, P165, DOI 10.1002/ccd.1810020208; Lehmann MH, 2001, CIRCULATION, V104, P32, DOI 10.1161/hc2601.091738; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Leow SS, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0545-z; Llamas B, 2006, HYPERTENSION, V48, P921, DOI 10.1161/01.HYP.0000244758.50351.29; Lou PH, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13388; Mathews MJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0001-x; McAlister NH, 2006, CAN FAM PHYSICIAN, V52, P869; MESSERLI FH, 1984, ARCH INTERN MED, V144, P477, DOI 10.1001/archinte.144.3.477; Miller LM, 2017, MATURITAS, V99, P37, DOI 10.1016/j.maturitas.2017.02.006; Mitoff PR, 2007, AM HEART J, V154, P575, DOI 10.1016/j.ahj.2007.04.047; Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678; Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623; OKIN PM, 1995, HYPERTENSION, V25, P242, DOI 10.1161/01.HYP.25.2.242; Ommen SR, 2000, CIRCULATION, V102, P1788; Palatini P, 2001, AM HEART J, V142, P1016, DOI 10.1067/mhj.2001.119378; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Petre RE, 2007, AM J PHYSIOL-REG I, V292, pR810, DOI 10.1152/ajpregu.00377.2006; Peverill RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158302; Pires KM, 2017, J MOL CELL CARDIOL, V113, P39, DOI 10.1016/j.yjmcc.2017.10.001; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; RIGGS TW, 1990, AM J CARDIOL, V65, P899, DOI 10.1016/0002-9149(90)91433-7; Semizel E, 2008, CARDIOL YOUNG, V18, P26, DOI 10.1017/S1047951107001722; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; SMITH SA, 1989, BRIT HEART J, V61, P344; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Subramaniam A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020235; Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879; Toedebusch R, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00453; Wainstein RV, 2012, AM J PHYSIOL-HEART C, V302, pH2363, DOI 10.1152/ajpheart.01125.2011; WEISSLER AM, 1961, AM HEART J, V62, P367, DOI 10.1016/0002-8703(61)90403-3; White CR, 2014, COMPR PHYSIOL, V4, P231, DOI 10.1002/cphy.c110049; WHO, 2016, GLOB REP PSOR; Yang H, 1997, J ELECTROCARDIOL, V30, P267, DOI 10.1016/S0022-0736(97)80038-6; Yang KY, 2016, J ENDOCRINOL, V229, P343, DOI 10.1530/JOE-15-0517; ZARICH SW, 1988, J AM COLL CARDIOL, V12, P114, DOI 10.1016/0735-1097(88)90364-6; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	85	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208987	10.1371/journal.pone.0208987	http://dx.doi.org/10.1371/journal.pone.0208987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589871	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200013
J	Wada, T; Sameshima, A; Yonezawa, R; Morita, M; Sawakawa, K; Tsuneki, H; Sasaoka, T; Saito, S				Wada, Tsutomu; Sameshima, Azusa; Yonezawa, Rika; Morita, Mayuko; Sawakawa, Kanae; Tsuneki, Hiroshi; Sasaoka, Toshiyasu; Saito, Shigeru			Impact of central and peripheral estrogen treatment on anxiety and depression phenotypes in a mouse model of postmenopausal obesity	PLOS ONE			English	Article							GLUCOSE-METABOLISM; NEUROTROPHIC FACTOR; HIGH-FAT; ESTRADIOL; RECEPTOR; WOMEN; PERIMENOPAUSAL; EFFICACY; MECHANISMS; THERAPY	Obesity and diabetes increase the risk of depression, and the incidence of these conditions increases rapidly after menopause, but few animal models of postmenopausal obesity have been available. We developed a mouse model of postmenopausal obesity that exhibited anxiety and depressive phenotypes in behavioral tests. To examine the effect of estradiol (E2) in the model, we prepared 4 experimental groups: 1) control, sham-operated female C57BL/6 mice fed a regular diet; 2) OVX-HF, ovariectomized (OVX) mice fed a high-fat diet (HF); 3) E2-SC, OVX-HF mice administered subcutaneous (SC) E2 (50 mu g/kg/day); and 4) E2-ICV, OVX-HF mice administered intracerebroventricular (ICV) E2 (1 mu g/kg/day). OVX-HF mice exhibited anxiety phenotypes in the open field test, but not in the light-dark box test, and E2 treatment via both routes effectively ameliorated it. OVX-HF mice demonstrated depressive phenotypes in the tail suspension test and forced swim test. Both E2 treatments achieved significant improvement in the tail suspension test, but not in the forced swim test. Serum corticosterone levels did not differ among the groups. Hippocampal expression of glucocorticoid receptor mRNA and serotonin 1A receptor mRNA was significantly increased in OVX-HF mice and was decreased in E2-treated mice. The hypothalamic level of pro-brain-derived neurotrophic factor (proBDNF) protein was tended to decrease in OVX-HF mice, but neither E2 treatment increased it. Since this mouse model exhibited anxiety and depressive phenotypes in relatively short experimental periods without genetic manipulations, it would be useful for further exploring psychiatric phenotypes or screening of therapeutic candidates in postmenopausal obesity.	[Wada, Tsutomu; Morita, Mayuko; Sawakawa, Kanae; Tsuneki, Hiroshi; Sasaoka, Toshiyasu] Univ Toyama, Dept Clin Pharmacol, Toyama, Toyama, Japan; [Sameshima, Azusa; Yonezawa, Rika; Saito, Shigeru] Univ Toyama, Dept Obstet & Gynecol, Toyama, Toyama, Japan	University of Toyama; University of Toyama	Wada, T (corresponding author), Univ Toyama, Dept Clin Pharmacol, Toyama, Toyama, Japan.; Saito, S (corresponding author), Univ Toyama, Dept Obstet & Gynecol, Toyama, Toyama, Japan.	twada@pha.u-toyama.ac.jp; s30saito@med.u-toyama.ac.jp	Wada, Tsutomu/AAY-4450-2020	Wada, Tsutomu/0000-0001-5819-8556	JPSP KAKENHI [JP15K09410, JP25861480, JP15K15599]; Akaeda Medical Research Foundation	JPSP KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Akaeda Medical Research Foundation	This work was supported by JPSP KAKENHI Grants (Number JP15K09410 to T.W., JP25861480 to R.Y., and JP15K15599 to T.S.) and a research grant from Akaeda Medical Research Foundation (to R.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Arpels JC, 1996, J REPROD MED, V41, P633; BALL P, 1972, J CLIN ENDOCR METAB, V34, P736, DOI 10.1210/jcem-34-4-736; Benmansour S, 2014, INT J NEUROPSYCHOPH, V17, P765, DOI 10.1017/S146114571300165X; Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-74; Bethea CL, 2002, PSYCHONEUROENDOCRINO, V27, P431, DOI 10.1016/S0306-4530(01)00054-3; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Bromberger JT, 2003, AM J EPIDEMIOL, V158, P347, DOI 10.1093/aje/kwg155; Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251; Cyranowski JM, 2000, ARCH GEN PSYCHIAT, V57, P21, DOI 10.1001/archpsyc.57.1.21; Dale E, 2015, BIOCHEM PHARMACOL, V95, P81, DOI 10.1016/j.bcp.2015.03.011; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; FEIGHNER JP, 1989, PSYCHOPATHOLOGY, V22, P21, DOI 10.1159/000284623; Galter D, 2000, J NEUROSCI RES, V61, P295, DOI 10.1002/1097-4547(20000801)61:3<295::AID-JNR7>3.0.CO;2-4; Galter D, 2000, MOL CELL NEUROSCI, V15, P446, DOI 10.1006/mcne.2000.0841; Gleason CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001833; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Halbreich U, 1997, NEUROLOGY, V48, pS16, DOI 10.1212/WNL.48.5_Suppl_7.16S; Hassan AM, 2012, NUTR NEUROSCI, V26, P1; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jasienska G, 2005, WOMEN HEALTH ISS, V15, P145, DOI 10.1016/j.whi.2005.02.002; Keller MB, 2005, J CLIN PSYCHOPHARM, V25, P79, DOI 10.1097/01.jcp.0000150221.53877.d9; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kiss A, 2012, BEHAV BRAIN RES, V227, P100, DOI 10.1016/j.bbr.2011.10.047; KLAIBER EL, 1971, J CLIN ENDOCR METAB, V33, P630, DOI 10.1210/jcem-33-4-630; Levkovitz Y, 2011, J CLIN PSYCHIAT, V72, P509, DOI 10.4088/JCP.09m05949blu; Mayo-Wilson E, 2014, LANCET PSYCHIAT, V1, P368, DOI 10.1016/S2215-0366(14)70329-3; Meyer MR, 2011, ACTA PHYSIOL, V203, P259, DOI 10.1111/j.1748-1716.2010.02237.x; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morrison MF, 2004, BIOL PSYCHIAT, V55, P406, DOI 10.1016/j.biopsych.2003.08.011; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NOMIKOS GG, 1988, NEUROPHARMACOLOGY, V27, P691, DOI 10.1016/0028-3908(88)90077-9; Ogren SO, 2008, BEHAV BRAIN RES, V195, P54, DOI 10.1016/j.bbr.2008.02.023; Onogi Y, 2017, DIABETES, V66, P1008, DOI 10.2337/db16-0881; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Resnick SM, 1997, NEUROLOGY, V49, P1491, DOI 10.1212/WNL.49.6.1491; Rubinow DR, 2015, DEPRESS ANXIETY, V32, P539, DOI 10.1002/da.22391; Rubinow DR, 1998, BIOL PSYCHIAT, V44, P839, DOI 10.1016/S0006-3223(98)00162-0; Sameshima A, 2015, J ENDOCRINOL, V227, P25, DOI 10.1530/JOE-15-0239; Schachter J, 2018, BRAIN BEHAV IMMUN, V69, P1, DOI 10.1016/j.bbi.2017.08.026; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Sherwin BB, 2009, NAT REV ENDOCRINOL, V5, P620, DOI 10.1038/nrendo.2009.193; SLATER J, 1976, J COMP PHYSIOL PSYCH, V90, P755, DOI 10.1037/h0077248; Soares CD, 2001, ARCH GEN PSYCHIAT, V58, P529; Stahl SM, 2001, J CLIN PSYCHIAT, V62, P317, DOI 10.4088/JCP.v62n0501; Sumner BEH, 2007, NEUROSCI LETT, V417, P95, DOI 10.1016/j.neulet.2007.02.039; Toffol E, 2015, MENOPAUSE, V22, P564, DOI [10.1097/gme.0000000000000323, 10.1097/GME.0000000000000323]; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Tsuneki H, 2016, ENDOCRINOLOGY, V157, P195, DOI 10.1210/en.2015-1488; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Villa A, 2016, ENDOCR REV, V37, P372, DOI 10.1210/er.2016-1007; Wada T, 2017, J ENDOCRINOL, V235, P179, DOI 10.1530/JOE-17-0351; Wada T, 2010, AM J PHYSIOL-ENDOC M, V298, pE881, DOI 10.1152/ajpendo.00649.2009; Walf AA, 2005, NEUROPSYCHOPHARMACOL, V30, P1288, DOI 10.1038/sj.npp.1300708; Walf AA, 2008, STEROIDS, V73, P997, DOI 10.1016/j.steroids.2008.01.025; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Weiser MJ, 2010, BRAIN RES, V1336, P78, DOI 10.1016/j.brainres.2010.03.098; Woods Nancy Fugate, 2005, Am J Med, V118 Suppl 12B, P14; Yonezawa R, 2012, AM J PHYSIOL-ENDOC M, V303, pE445, DOI 10.1152/ajpendo.00638.2011	62	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209859	10.1371/journal.pone.0209859	http://dx.doi.org/10.1371/journal.pone.0209859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7KM	30589890	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200062
J	Cotugno, G; Konstantinova, J; Althoefer, K; Nanayakkara, T				Cotugno, Giuseppe; Konstantinova, Jelizaveta; Althoefer, Kaspar; Nanayakkara, Thrishantha			Modelling the structure of object-independent human affordances of approaching to grasp for robotic hands	PLOS ONE			English	Article							ARM MOVEMENTS; REACH; SYNERGIES; MANIPULATORS; COORDINATION; ADJUSTMENTS; CONSTRAINTS; KINEMATICS	Grasp affordances in robotics represent different ways to grasp an object involving a variety of factors from vision to hand control. A model of grasp affordances that is able to scale across different objects, features and domains is needed to provide robots with advanced manipulation skills. The existing frameworks, however, can be difficult to extend towards a more general and domain independent approach. This work is the first step towards a modular implementation of grasp affordances that can be separated into two stages: approach to grasp and grasp execution. In this study, human experiments of approaching to grasp are analysed, and object-independent patterns of motion are defined and modelled analytically from the data. Human subjects performed a specific action (hammering) using objects of different geometry, size and weight. Motion capture data relating the hand-object approach distance was used for the analysis. The results showed that approach to grasp can be structured in four distinct phases that are best represented by non-linear models, independent from the objects being handled. This suggests that approaching to grasp patterns are following an intentionally planned control strategy, rather than implementing a reactive execution.	[Cotugno, Giuseppe] Kings Coll London, Dept Informat, Ctr Robot Res, London WC2R 2LS, England; [Konstantinova, Jelizaveta; Althoefer, Kaspar] Queen Mary Univ London, Ctr Adv Robot Queen Mary ARQ, Fac Sci & Engn, Mile End Rd, London E1 4NS, England; [Nanayakkara, Thrishantha] Imperial Coll London, Dyson Sch Design Engn, South Kensington Campus, London, England	University of London; King's College London; University of London; Queen Mary University London; Imperial College London	Nanayakkara, T (corresponding author), Imperial Coll London, Dyson Sch Design Engn, South Kensington Campus, London, England.	t.nanyakkara@imperial.ac.uk	Althoefer, Kaspar/AAA-5984-2022; Nanayakkara, Thrishantha/AAM-5964-2020	Nanayakkara, Thrishantha/0000-0002-1882-1232	Horizon 2020 Research and Innovation Programme [287728]; U.K. Engineering and Physical Sciences Research Council (EPSRC) under MOTION [EP/N03211X/2]; EPSRC [EP/N03211X/1, EP/N03211X/2] Funding Source: UKRI	Horizon 2020 Research and Innovation Programme; U.K. Engineering and Physical Sciences Research Council (EPSRC) under MOTION(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded by the Horizon 2020 Research and Innovation Programme under grant agreement 287728 in the framework of the European Union project FourByThree (recipient Prof. K. Althoefer), and the U.K. Engineering and Physical Sciences Research Council (EPSRC) under MOTION Grant: EP/N03211X/2 (recipient Dr. T. Nanayakkara). The grants are funding submission fees.	Aimola E, 2011, NEUROSCI LETT, V502, P84, DOI 10.1016/j.neulet.2011.07.027; Aloimonos J., 1987, International Journal of Computer Vision, V1, P333, DOI 10.1007/BF00133571; Arruda E, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P2881, DOI 10.1109/IROS.2016.7759446; Barck-Holst C, 2009, 2009 INT C ADV ROB, P1; Ben Amor H, 2012, IEEE INT C INT ROBOT, P2043, DOI 10.1109/IROS.2012.6386072; BLUMER A, 1987, INFORM PROCESS LETT, V24, P377, DOI 10.1016/0020-0190(87)90114-1; Bonilla M, 2014, IEEE-RAS INT C HUMAN, P581, DOI 10.1109/HUMANOIDS.2014.7041421; Brown CY, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P2883; Brown E, 2010, P NATL ACAD SCI USA, V107, P18809, DOI 10.1073/pnas.1003250107; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Caliskan Y, 2012, 2012 20 SIGN PROC CO, P1; Calli B, 2011, IEEE INT C INT ROBOT, P995, DOI 10.1109/IROS.2011.6048739; CASTIELLO U, 1992, BEHAV BRAIN RES, V50, P7, DOI 10.1016/S0166-4328(05)80283-9; Catalano MG, 2014, INT J ROBOT RES, V33, P768, DOI 10.1177/0278364913518998; Cotugno G., 2016, IEEE T SYST MAN CYB, P1; Cotugno G, 2018, THESIS; Cotugno G, 2014, IEEE INT CONF ROBOT, P5345, DOI 10.1109/ICRA.2014.6907645; Das P., 2017, P 2017 C INF COMM TE, P1; Deimel R, 2017, IEEE INT C INT ROBOT, P1213; Deimel R, 2016, INT J ROBOT RES, V35, P161, DOI 10.1177/0278364915592961; Della Santina C, 2018, IEEE T ROBOT, V34, P1141, DOI 10.1109/TRO.2018.2830407; Detry R, 2009, 2009 IEEE 8TH INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING, P92; Eppner C, 2015, INT J ROBOT RES, V34, P1021, DOI 10.1177/0278364914559753; Eppner C, 2013, IEEE INT C INT ROBOT, P4000, DOI 10.1109/IROS.2013.6696928; FENSON L, 1976, CHILD DEV, V47, P232; Fitzpatrick P, 2003, IEEE INT CONF ROBOT, P3140; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fras J, 2018, 2018 IEEE RSJ INT C; Fu QS, 2013, IEEE ENG MED BIO, P6893, DOI 10.1109/EMBC.2013.6611142; Gallivan JP, 2018, NATURE REV NEUROSCIE, P1; Gaveau V, 2014, NEUROPSYCHOLOGIA, V55, P25, DOI 10.1016/j.neuropsychologia.2013.12.005; Gentilucci M, 1996, NEUROREPORT, V7, P589, DOI 10.1097/00001756-199601310-00051; Gibson J.J., 1977, PERCEIVING ACTING KN, V1, P67, DOI [DOI 10.2307/1421838, 10.4324/9781315740218]; Greiner T. M., 1991, DTIC DOCUMENT; Gribovskaya Elena, 2011, 2011 IEEE International Conference on Robotics and Automation (ICRA 2011), P4326, DOI 10.1109/ICRA.2011.5980070; Grioli G, 2012, IEEE INT C INT ROBOT, P1251, DOI 10.1109/IROS.2012.6385881; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hausman K, 2015, IEEE INT CONF ROBOT, P3305, DOI 10.1109/ICRA.2015.7139655; Hermans T, 2013, IEEE-RAS INT C HUMAN, P435, DOI 10.1109/HUMANOIDS.2013.7030011; Homberg Bianca S., 2019, Autonomous Robots, V43, P681, DOI 10.1007/s10514-018-9754-1; Jamone L., 2016, IEEE T COGN DEV SYST, P1; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; Kim S, 2014, IEEE T ROBOT, V30, P1049, DOI 10.1109/TRO.2014.2316022; Konstantinova J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171706; Konstantinova J, 2013, IEEE INT C INT ROBOT, P1998, DOI 10.1109/IROS.2013.6696622; Kopicki M, 2014, IEEE INT CONF ROBOT, P5358, DOI 10.1109/ICRA.2014.6907647; Lawrence N, 2011, MOCAP TOOLBOX MATLAB; Lin J, 2000, WORKSHOP ON HUMAN MOTION, PROCEEDINGS, P121, DOI 10.1109/HUMO.2000.897381; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Mason CR, 2001, J NEUROPHYSIOL, V86, P2896, DOI 10.1152/jn.2001.86.6.2896; Medina JR, 2016, IEEE-RAS INT C HUMAN, P324, DOI 10.1109/HUMANOIDS.2016.7803296; Mohan Vishwanathan, 2012, Biomimetic and Biohybrid Systems. Proceedings First International Conference, Living Machines 2012, P180, DOI 10.1007/978-3-642-31525-1_16; Montesano L, 2008, IEEE T ROBOT, V24, P15, DOI 10.1109/TRO.2007.914848; Oikonomidis I., 2011, BMVC, V1, P3; OKADA T, 1982, IEEE T SYST MAN CYB, V12, P289, DOI 10.1109/TSMC.1982.4308818; Peters J., 2003, IEEE RAS INT C HUM R; Pozzi M, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P1946, DOI 10.1109/IROS.2016.7759307; Prattichizzo D, 2013, IEEE T ROBOT, V29, P1440, DOI 10.1109/TRO.2013.2273849; Puhlmann S, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P1954, DOI 10.1109/IROS.2016.7759308; Reimann H, 2010, IEEE INT C INT ROBOT, P5372, DOI 10.1109/IROS.2010.5650603; Runz M, 2018, CORR; Santello M, 1998, J NEUROSCI, V18, P10105; Santello M, 2016, PHYS LIFE REV, V17, P1, DOI 10.1016/j.plrev.2016.02.001; Shimoga KB, 1996, INT J ROBOT RES, V15, P230, DOI 10.1177/027836499601500302; Smeets JBJ, 2016, SYNERGIES GRASPING, P21; Sun L, 2016, IEEE INT CONF ROBOT, P2464, DOI 10.1109/ICRA.2016.7487399; Tikhanoff V, 2013, IEEE-RAS INT C HUMAN, P130, DOI 10.1109/HUMANOIDS.2013.7029967; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Vahrenkamp N, 2018, IEEE ROBOT AUTOM LET, V3, P911, DOI 10.1109/LRA.2018.2792694; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Yang YD, 2010, AUTON ROBOT, V28, P113, DOI 10.1007/s10514-009-9151-x	75	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208228	10.1371/journal.pone.0208228	http://dx.doi.org/10.1371/journal.pone.0208228			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586407	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400014
J	Ekrami, O; Claes, P; White, JD; Zaidi, AA; Shriver, MD; Van Dongen, S				Ekrami, Omid; Claes, Peter; White, Julie D.; Zaidi, Arslan A.; Shriver, Mark D.; Van Dongen, Stefan			Measuring asymmetry from high-density 3D surface scans: An application to human faces	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; FACIAL ASYMMETRY; SYMMETRY; REGISTRATION; MODELS; SEX	Perfect bilateral symmetry is the optimal outcome of the development of bilateral traits in the absence of developmental perturbations. Any random perturbation in this perfect symmetrical state is called Fluctuating Asymmetry (FA). Many studies have been conducted on FA as an indicator of Developmental Instability (DI) and its possible link with stress and individual quality in general and with attractiveness, health and level of masculinity or femininity in humans. Most human studies of facial asymmetry use 2D pictures and a limited number of landmarks. We developed a protocol to utilize high-density 3D scans of human faces to measure the level of asymmetry. A completely symmetric spatially dense anthropometric mask with paired vertices is non-rigidly mapped on target faces using an Iterative Closest Point (ICP) registration algorithm. A set of 19 manually indicated landmarks were used to validate the mapping precision. The protocol's accuracy in FA calculation is assessed, and results show that a spatially dense approach is more accurate. In addition, it generates an integrated asymmetry estimate across the entire face. Finally, the automatic nature of the protocol provides a great advantage by omitting the tedious step of manual landmark indication on the biological structure of interest.	[Ekrami, Omid; Van Dongen, Stefan] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Antwerp, Belgium; [Claes, Peter] Katholieke Univ Leuven, MIRC, Dept Elect Engn ESAT, Fac Engn, Leuven, Belgium; [White, Julie D.; Zaidi, Arslan A.; Shriver, Mark D.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	University of Antwerp; KU Leuven; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ekrami, O (corresponding author), Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Antwerp, Belgium.	omid.ekrami@uantwerpen.be; mds17@psu.edu	White, Julie/HHN-8325-2022; Claes, Peter/X-3923-2018	White, Julie/0000-0002-2235-4817; Shriver, Mark/0000-0003-0006-0479; Ekrami, Omid/0000-0002-6135-8693; Claes, Peter/0000-0001-9489-9819	National Institutes of Health [1-R01-DE027023]; Research Fund KU Leuven (BOF-C1) [C14/15/081]; Research Program of the Fund for Scientific Research-Flanders (Belgium) (FWO) [G078518N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fund KU Leuven (BOF-C1); Research Program of the Fund for Scientific Research-Flanders (Belgium) (FWO)(FWO)	This study was funded by the National Institutes of Health (1-R01-DE027023), the Research Fund KU Leuven (BOF-C1, C14/15/081) and the Research Program of the Fund for Scientific Research-Flanders (Belgium) (FWO, G078518N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Alqattan M, 2015, EUR J ORTHODONT, V37, P1, DOI 10.1093/ejo/cjt075; Amberg Brian, 2007, CVPR '07. IEEE Conference on Computer Vision and Pattern Recognition, P1; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Bellekens B., 2014, AMBIENT 2014 4 INT C, pp 8; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bottema O., 1982, CRUX MATHEMATICORUM, V8, P228; Bro-Nielsen M, 1997, IMMPHD199625 TU DENM; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; CARR JC, 2001, P 28 ANN C COMP GRAP, P67, DOI DOI 10.1145/383259.383266; Charnov Eric L., 1993, P1; Cheong YW, 2011, CHANG GUNG MED J, V34; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Claes P, 2012, INT J ORAL MAXILLOFA, V41; Claes P, 2011, J ANAT, V219, P444, DOI 10.1111/j.1469-7580.2011.01411.x; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; DUDANI SA, 1976, IEEE T SYST MAN CYB, V6, P327; Ferrario VF, 2001, J ORAL MAXIL SURG, V59, P382, DOI 10.1053/joms.2001.21872; Gelfand N, 2003, FOURTH INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P260, DOI 10.1109/IM.2003.1240258; Hill AK, 2017, EVOL HUM BEHAV, V38, P249, DOI 10.1016/j.evolhumbehav.2016.10.008; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Klingenberg Christian Peter, 2003, P427; Klingenberg CP, 2002, EVOLUTION, V56, P1909; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Li H, 2008, COMPUT GRAPH FORUM, V27, P1421, DOI 10.1111/j.1467-8659.2008.01282.x; LimadeFaria A, 1997, BIOSYSTEMS, V43, P115, DOI 10.1016/S0303-2647(97)01694-8; Matabosch C, 2004, IEEE INT CONF ROBOT, P678, DOI 10.1109/ROBOT.2004.1307227; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Polak M., 2003, CAUSES CONSEQUENCES; Pound N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1639; Primozic J, ORTHODONTICS CRANIOF; Redert A., 1999, ACTA STEREOL, V18, P255; Rhodes G, 2001, EVOL HUM BEHAV, V22, P31, DOI 10.1016/S1090-5138(00)00060-X; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Salvi J, 2007, IMAGE VISION COMPUT, V25, P578, DOI 10.1016/j.imavis.2006.05.012; Snyders J, 2014, KULESATPSI1404; Thomas CDL, 2005, COMPUTER GRAPHIC FAC, P55; Tomkins JL, 2002, FLUCTUATING ASYMMETR; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; VANVALEN L, 1962, EVOLUTION, V16, P125; Verhoeven TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059391; Wagemans J, 1997, TRENDS COGN SCI, V1, P346, DOI 10.1016/S1364-6613(97)01105-4; WATSON PJ, 1994, TRENDS ECOL EVOL, V9, P21, DOI 10.1016/0169-5347(94)90227-5; Yuille A. L., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P344, DOI 10.1109/CCV.1988.590011; Yuille AL, 1990, NEURAL COMPUT, V2, P1, DOI 10.1162/neco.1990.2.1.1	46	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0207895	10.1371/journal.pone.0207895	http://dx.doi.org/10.1371/journal.pone.0207895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586353	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400008
J	Griukova, A; Deryabin, P; Sirotkina, M; Shatrova, A; Nikolsky, N; Borodkina, A				Griukova, Anastasiia; Deryabin, Pavel; Sirotkina, Maria; Shatrova, Alla; Nikolsky, Nikolay; Borodkina, Aleksandra			P38 MAPK inhibition prevents polybrene-induced senescence of human mesenchymal stem cells during viral transduction	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; CELLULAR SENESCENCE; DNA-DAMAGE; LENTIVIRAL TRANSDUCTION; EFFICIENCY	The unique capacity of mesenchymal stem cells (MSCs) to migrate to the sites of damage, following intravenous transplantation, along with their proliferation and differentiation abilities make them promising candidates for MSC-based gene therapy. This therapeutic approach requires high efficacy delivery of stable transgenes to ensure their adequate expression in MSCs. One of the methods to deliver transgenes is via the viral transduction of MSCs. However, due to low transduction efficiency of MSCs, various polications are used to promote the association of viral particles with membranes of target cells. Among these polications polybrene is the most widely used one. Unfortunately, viral infection in presence of polybrene was shown to negatively affect proliferation rate of stem cells. The molecular mechanism underlying this effect is not yet uncovered. Therefore, the present study aimed to elucidate the mechanism of this phenomenon as well as to develop an effective approach to overcome the negative impact of polybrene on the properties of human endometrium-derived mesenchymal stem cells (hMESCs) during lentiviral infection. We found that the negative effect on proliferation observed during the viral infection in presence of polybrene is mediated by the polycation itself. Furthermore, we revealed that the treatment with polybrene alone led to the p38 MAPK-dependent premature senescence of hMESCs. These findings allowed us to develop an effective strategy to attenuate the negative polybrene impact on the hMESCs properties during lentiviral infection by inhibiting the activity of p38 MAPK. Importantly, the proposed approach did not attenuate the transduction efficiency of hMESCs, yet prevented polybrene-induced senescence and thereby restored the proliferation of the infected cells. These results provide the plausible means to reduce side effects of polybrene during the viral infection of primary cells, particularly MSCs.	[Griukova, Anastasiia; Deryabin, Pavel; Sirotkina, Maria; Shatrova, Alla; Nikolsky, Nikolay; Borodkina, Aleksandra] Russian Acad Sci, Lab Intracellular Signaling, Inst Cytol, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Borodkina, A (corresponding author), Russian Acad Sci, Lab Intracellular Signaling, Inst Cytol, St Petersburg, Russia.	borodkina618@gmail.com	Deryabin, Pavel/AAF-1610-2021; S, Maria/AAF-3596-2021; Nikolsky, Nikolay/AAB-5657-2021; Borodkina, Aleksandra V/G-8529-2016; Griukova, Anastasiia/AAF-1682-2021	Deryabin, Pavel/0000-0003-2451-2943; Nikolsky, Nikolay/0000-0001-9914-874X; Borodkina, Aleksandra V/0000-0003-1675-7588; 	Russian Science Foundation [14-50-00068]; Russian Foundation for Basic Research [18-29-09101-mk]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The main part of this work was supported by the grant from the Russian Science Foundation (project #14-50-00068) that ensured cultivation of human endometrial mesenchymal stem cells and allowed performing FACS analysis, immunoblotting, lentiviral transcduction and SA-beta-Gal staining. A.V. Borodkina also acknowledges the support of the Russian Foundation for Basic Research (project #18-29-09101-mk) allowed performing migration analysis using the xCELLigence RTCA DP system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasov N, 2016, METHODS MOL BIOL, V1448, P49, DOI 10.1007/978-1-4939-3753-0_4; Ben Messaoud N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135249; Borodkina A, 2018, SUPPLEMENT SERIES ME, V12, P223; Borodkina AV, 2018, ACTA NATURAE, V10, P4, DOI 10.32607/20758251-2018-10-1-4-14; Borodkina A, 2014, AGING-US, V6, P481, DOI 10.18632/aging.100673; Borodkina AV, 2016, CELL CYCLE, V15, P117, DOI 10.1080/15384101.2015.1121326; Burova E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/474931; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Copreni E, 2008, J GENE MED, V10, P1294, DOI 10.1002/jgm.1248; Davis HE, 2002, BIOPHYS CHEM, V97, P159, DOI 10.1016/S0301-4622(02)00057-1; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Feranchak AP, 2001, J CLIN INVEST, V108, P1495, DOI 10.1172/JCI200112190; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Georgakopoulou EA, 2013, AGING-US, V5, P37; Georgakopoulou E, 2016, MECH AGEING DEV, V156, P17, DOI 10.1016/j.mad.2016.03.010; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han MM, 2015, NEUROSCI LETT, V600, P164, DOI 10.1016/j.neulet.2015.06.011; Jin HJ, 2016, STEM CELL TRANSL MED, V5, P427, DOI 10.5966/sctm.2015-0109; Lin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023891; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Nanba D, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt338; Oggu GS, 2017, STEM CELL REV REP, V13, P725, DOI 10.1007/s12015-017-9760-2; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Seitz B, 1998, GRAEF ARCH CLIN EXP, V236, P602, DOI 10.1007/s004170050129; Shlush LI, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-16; Zemel'ko VI, 2011, CELL TISSUE BIOL, V53, P919, DOI [10.1134/S1990519X12010129, DOI 10.1134/S1990519X12010129]; Zhao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092908; Zwaka T., 2016, USE GENETICALLY MODI	30	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209606	10.1371/journal.pone.0209606	http://dx.doi.org/10.1371/journal.pone.0209606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586456	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400075
J	Kohn, GM				Kohn, Gregory Mark			Female vocalizations predict reproductive output in brown-headed cowbirds (Molothrus ater)	PLOS ONE			English	Article							PAIR-BOND; DEVELOPMENTAL ECOLOGY; MATE; SONG; SUCCESS; STIMULATION; ASSOCIATION; COURTSHIP; MONOGAMY; FLOCK	Pair bonds are often maintained through the reciprocal and coordinated exchange of communicative signals. The ability to recognize and appropriately respond to a partner's signals will define a pair's ability to reproduce. Individual variation in responsiveness, by shaping the formation and maintenance of strong pair bonds, will ultimately influence an individual's reproductive output. Throughout the breeding period, female cowbirds (Molothrus ater) respond to male song displays using a vocalization known as the chatter. In this study, we investigated whether variation in chatters remained repeatable across years and predicted reproductive performance. A flock of cowbirds housed in a large aviary complex was observed during the spring of 2011 to 2012. We recorded courtship interactions, including singing behavior for males, and chatters and eggs laid by females. The rate with which females responded to song using chatters remained consistent across years, with some females predictably responding to more songs using chatters than others. During 2012, chattering predicted the number of eggs females laid and her paired status. Paired females were more likely to respond to songs with chatters, and there was a strong positive relationship between the number of eggs laid and the proportion of songs she responded to using chatters. Overall, these findings suggest that variation in female vocal behavior is associated with their reproductive success.	[Kohn, Gregory Mark] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	New Mexico State University	Kohn, GM (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	gmkohn@nmsu.edu						Amy M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140196; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Avital Eytan, 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; Balsby TJS, 2002, ANIM BEHAV, V63, P251, DOI 10.1006/anbe.2001.1920; BELETSKY LD, 1983, Z TIERPSYCHOL, V62, P47; Black JM, 2001, BEHAV ECOL, V12, P640, DOI 10.1093/beheco/12.5.640; BRADLEY JS, 1995, J ANIM ECOL, V64, P31, DOI 10.2307/5825; BRADLEY JS, 1990, J ANIM ECOL, V59, P487, DOI 10.2307/4876; Buesching CD, 1998, FOLIA PRIMATOL, V69, P295, DOI 10.1159/000052718; BURNELL K, 1994, CONDOR, V96, P703, DOI 10.2307/1369473; Chatterjee S., 2015, REGRESSION ANAL EXAM; Cheng MF, 1998, J NEUROSCI, V18, P5477, DOI 10.1523/JNEUROSCI.18-14-05477.1998; CHENG MF, 1992, ANIM BEHAV, V43, P1035, DOI 10.1016/0003-3472(92)90016-3; COULSON JC, 1966, J ANIM ECOL, V35, P269, DOI 10.2307/2394; DUFTY AM, 1982, ANIM BEHAV, V30, P1043, DOI 10.1016/S0003-3472(82)80194-2; Elie JE, 2010, ANIM BEHAV, V80, P597, DOI 10.1016/j.anbehav.2010.06.003; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Engelhardt A, 2012, BEHAV ECOL SOCIOBIOL, V66, P121, DOI 10.1007/s00265-011-1260-9; FOWLER GS, 1995, AM ZOOL, V35, P318; Freeberg TM, 1999, ANIM BEHAV, V57, P421, DOI 10.1006/anbe.1998.0988; Freed-Brown G, 2009, P ROY SOC B-BIOL SCI, V276, P3319, DOI 10.1098/rspb.2009.0580; Friedmann H., 1929, COWBIRDS STUDY BIOL; Garamszegi LZ, 2006, BEHAV ECOLOGY; Hall ML, 2009, ADV STUD BEHAV, V40, P67, DOI 10.1016/S0065-3454(09)40003-2; Hall ML, 2004, BEHAV ECOL SOCIOBIOL, V55, P415, DOI 10.1007/s00265-003-0741-x; HANNON SJ, 1992, ANIM BEHAV, V43, P747, DOI 10.1016/S0003-3472(05)80198-8; King AP, 1990, CONT ISSUES COMP PSY, P331; Kohn G. M., 2012, J COMP PSYCHOL; Kohn GM, 2013, ANIMAL BEHAV; Kohn GM, 2011, ANIM BEHAV, V82, P1015, DOI 10.1016/j.anbehav.2011.07.035; Langmore NE, 1997, ANIM BEHAV, V53, P881, DOI 10.1006/anbe.1996.0306; Langmore NE, 1996, P ROY SOC B-BIOL SCI, V263, P141, DOI 10.1098/rspb.1996.0022; Langmore NE, 1998, TRENDS ECOL EVOL, V13, P136, DOI 10.1016/S0169-5347(97)01241-X; LEHRMAN DANIEL S., 1959, IBIS, V101, P478, DOI 10.1111/j.1474-919X.1959.tb02405.x; LOTT D, 1967, ANIM BEHAV, V15, P433, DOI 10.1016/0003-3472(67)90041-3; Maguire SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063239; Martin P., 2007, MEASURING BEHAV INTR, V3; MATOCHIK JA, 1992, PHYSIOL BEHAV, V51, P783, DOI 10.1016/0031-9384(92)90116-J; O'Loghlen AL, 2010, ANIM BEHAV, V79, P1285, DOI 10.1016/j.anbehav.2010.03.001; Oliveira RF, 2004, ADV STUD BEHAV, V34, P165, DOI 10.1016/S0065-3454(04)34005-2; Ortega C., 1998, COWBIRDS OTHER BROOD; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Royle NJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P2015, DOI 10.1007/s00265-010-1013-1; Smith R. L., 1959, Wilson Bulletin, V71, P141; Smith VA, 2002, ANIM BEHAV, V63, P23, DOI 10.1006/anbe.2001.1886; SMITH WJ, 1994, J THEOR BIOL, V166, P221, DOI 10.1006/jtbi.1994.1019; Snyder-Mackler N, 2011, BEHAVIOUR, V148, P747, DOI 10.1163/000579511X575951; Spoon TR, 2006, ANIM BEHAV, V71, P315, DOI 10.1016/j.anbehav.2005.03.034; Wachtmeister CA, 2001, ANIM BEHAV, V61, P861, DOI 10.1006/anbe.2001.1684; West MJ, 2006, ETHOLOGY, V112, P1095, DOI 10.1111/j.1439-0310.2006.01264.x; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; WEST MJ, 1988, DEV PSYCHOBIOL, V21, P543, DOI 10.1002/dev.420210605; Wheeler B, 2010, LMPERM PERMUTATION T; White DJ, 2007, BEHAVIOUR, V144, P1447, DOI 10.1163/156853907782418259; White DJ, 2002, BEHAV RES METH INS C, V34, P1, DOI 10.3758/BF03195418; WICKLER W, 1980, Z TIERPSYCHOL, V52, P201; YASUKAWA K, 1989, ANIM BEHAV, V38, P866, DOI 10.1016/S0003-3472(89)80118-6	57	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0202067	10.1371/journal.pone.0202067	http://dx.doi.org/10.1371/journal.pone.0202067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586359	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400001
J	McDermott, JJ; Civic, B; Barkan, A				McDermott, James J.; Civic, Bryce; Barkan, Alice			Effects of RNA structure and salt concentration on the affinity and kinetics of interactions between pentatricopeptide repeat proteins and their RNA ligands	PLOS ONE			English	Article							SINGLE-STRANDED RNA; EDITING FACTORS; BINDING; RECOGNITION; STABILITY; MECHANISM; TERMINI	Pentatricopeptide repeat (PPR) proteins are helical repeat proteins that bind specific RNA sequences via modular 1-repeat: 1-nucleotide interactions. Binding specificity is dictated, in part, by hydrogen bonds between the amino acids at two positions in each PPR motif and the Watson-Crick face of the aligned nucleobase. There is evidence that PPR-RNA interactions can compete with RNA-RNA interactions in vivo, and that this competition underlies some effects of PPR proteins on gene expression. Conversely, RNA secondary structure can inhibit the binding of a PPR protein to its specific binding site. The parameters that influence whether PPR-RNA or RNA-RNA interactions prevail are unknown. Understanding these parameters will be important for understanding the functions of natural PPR proteins and for the design of engineered PPR proteins for synthetic biology purposes. We addressed this question by analyzing the effects of RNA structures of varying stability and position on the binding of the model protein PPR10 to its atpH RNA ligand. Our results show that even very weak RNA structures (Delta G degrees similar to 0 kcal/mol) involving only one nucleotide at either end of the minimal binding site impede PPR10 binding. Analysis of binding kinetics using Surface Plasmon Resonance showed that RNA structures reduce PPR10's on-rate and increase its off-rate. Complexes between the PPR proteins PPR10 and HCF152 and their respective RNA ligands have long half-lives (one hour or more), correlating with their functions as barriers to exonucleolytic RNA decay in vivo. The effects of salt concentration on PPR10-RNA binding kinetics showed that electrostatic interactions play an important role in establishing PPR10-RNA interactions but play a relatively small role in maintaining specific interactions once established.	[McDermott, James J.; Civic, Bryce; Barkan, Alice] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Barkan, A (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	abarkan@uoregon.edu		Barkan, Alice/0000-0003-3049-2838	National Science Foundation [MCB-1243641]; National Institutes of Health [T32-GM007759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant to A.B. from the National Science Foundation (MCB-1243641) to AB and by National Institutes of Health Training (Grant T32-GM007759) to JJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant to A.B. from the National Science Foundation (MCB-1243641) and by National Institutes of Health Training Grant T32-GM007759 (J.J.M.). The authors would like to thank Pete Von Hippel for use of his lab instrumentation and for helpful discussions of our data. We are also grateful to Walt Baase for help with the RNA thermal melt experiments, Steve Weitzel for help with the SPR experiments, and Phil Bevilacqua for guidance on the interpretation of RNA melting curves.	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; Coquille S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6729; deLorimier E, 2014, NUCLEIC ACIDS RES, V42, P12768, DOI 10.1093/nar/gku941; Guillaumot D, 2017, P NATL ACAD SCI USA, V114, P8877, DOI 10.1073/pnas.1705780114; Gully BS, 2015, NUCLEIC ACIDS RES, V43, P1918, DOI 10.1093/nar/gkv027; Katsamba PS, 2001, J BIOL CHEM, V276, P21476, DOI 10.1074/jbc.M101624200; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; Kindgren P, 2015, PLANT CELL, V27, P403, DOI 10.1105/tpc.114.134189; Majka J, 2007, ADV BIOCHEM ENG BIOT, V104, P13, DOI 10.1007/10_026; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Miranda RG, 2017, RNA, V23, P586, DOI 10.1261/rna.059568.116; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Rich RL, 2008, J MOL RECOGNIT, V21, P355, DOI 10.1002/jmr.928; Rojas M, NUCLEIC ACIDS RES, DOI [10.1093/nar/gku941, DOI 10.1093/NAR/GKU941]; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Siegfried NA, 2009, METHOD ENZYMOL, V455, P365, DOI 10.1016/S0076-6879(08)04213-4; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137; Zoschke R, 2016, PLANT J, V85, P594, DOI 10.1111/tpj.13093; Zoschke R, 2013, PLANT CELL, V25, P2265, DOI 10.1105/tpc.113.111567; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209713	10.1371/journal.pone.0209713	http://dx.doi.org/10.1371/journal.pone.0209713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576379	Green Submitted, Green Published, gold			2022-12-26	WOS:000454149400075
J	Xie, BC; Nguyen, PM; Idevall-Hagren, O				Xie, Beichen; Phuoc My Nguyen; Idevall-Hagren, Olof			Feedback regulation of insulin secretion by extended synaptotagmin-1	FASEB JOURNAL			English	Article						Ca2+; beta-cell; membrane contact sites; TMEM24; PKC	PROTEIN-KINASE-C; BETA-CELLS; MOUSE DEVELOPMENT; CA2+ CHANNEL; ACTIVATION; RELEASE; MECHANISMS; EXOCYTOSIS; VIABILITY; COMPONENT	Endoplasmic reticulum (ER)-plasma membrane (PM) contacts are dynamic structures with important roles in the regulation of calcium (Ca2+) and lipid homeostasis. The extended synaptotagmins (E-Syts) are ER-localized lipid transport proteins that interact with PM phosphatidylinositol 4,5-bisphosphate in a Ca2+-dependent manner. E-Syts bidirectionally transfer glycerolipids, including diacylglycerol (DAG), between the 2 juxtaposed membranes, but the biologic significance of this transport is still unclear. Using insulin-secreting cells and live-cell imaging, we now show that Ca2+-triggered exocytosis of insulin granules is followed, in sequence, by PM DAG formation and E-Syt1 recruitment. E-Syt1 counteracted the depolarization-induced DAG formation through a mechanism that required both voltage-dependent Ca2+ influx and Ca2+ release from the ER. E-Syt1 knockdown resulted in prolonged accumulation of DAG in the PM, resulting in increased glucose-stimulated insulin secretion. We conclude that Ca2+-triggered exocytosis is temporally coupled to Ca2+-triggered E-Syt1 PM recruitment and removal of DAG to negatively regulate the same process.	[Xie, Beichen; Phuoc My Nguyen; Idevall-Hagren, Olof] Uppsala Univ, Dept Med Cell Biol, BMC Box 571, S-75123 Uppsala, Sweden	Uppsala University	Idevall-Hagren, O (corresponding author), Uppsala Univ, Dept Med Cell Biol, BMC Box 571, S-75123 Uppsala, Sweden.	olof.idevall@mcb.uu.se		Idevall Hagren, Olof/0000-0002-0241-6304; Nguyen, Phuoc My/0000-0003-1396-571X	Swedish Research Council; Goran Gustafsson Foundation; Malin and Lennart Philipson Foundation; Excellence of Diabetes Research in Sweden; Ake Wiberg Foundation; Novo-Nordisk Foundation; Magnus Bergwall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Foundation; Malin and Lennart Philipson Foundation; Excellence of Diabetes Research in Sweden; Ake Wiberg Foundation; Novo-Nordisk Foundation(Novo Nordisk Foundation); Magnus Bergwall Foundation	The authors thank Antje Thonig (Uppsala University) for expert technical assistance and Prof. Anders Tengholm (Uppsala University) for discussions. This study was funded by the Swedish Research Council, the Goran Gustafsson Foundation, the Malin and Lennart Philipson Foundation, Excellence of Diabetes Research in Sweden, Ake Wiberg Foundation, The Novo-Nordisk Foundation, and Magnus Bergwall Foundation (to O.I.-H.). The authors declare no conflicts of interest.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; ARKHAMMAR P, 1989, BIOCHEM J, V264, P207, DOI 10.1042/bj2640207; Bian X, 2018, EMBO J, V37, P219, DOI 10.15252/embj.201797359; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Estevez-Herrera J, 2016, P NATL ACAD SCI USA, V113, pE4098, DOI 10.1073/pnas.1600690113; Fan F, 2015, J CLIN INVEST, V125, P4026, DOI 10.1172/JCI80652; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Frank JA, 2016, NAT CHEM BIOL, V12, P755, DOI 10.1038/nchembio.2141; Gandasi NR, 2017, J CLIN INVEST, V127, P2353, DOI 10.1172/JCI88491; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Henne WM, 2015, CURR OPIN CELL BIOL, V35, P123, DOI 10.1016/j.ceb.2015.05.001; Herdman C, 2014, CELL CYCLE, V13, P2616, DOI 10.4161/15384101.2014.943573; Idevall-Hagren O, 2015, EMBO J, V34, P2291, DOI 10.15252/embj.201591565; Idevall-Hagren O, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003932; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Kaneko YK, 2015, BIOL PHARM BULL, V38, P669, DOI 10.1248/bpb.b15-00060; Kaneko YK, 2013, ENDOCRINOLOGY, V154, P4089, DOI 10.1210/en.2013-1356; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Khan S, 2014, DIABETOLOGIA, V57, P2535, DOI 10.1007/s00125-014-3368-8; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; Liang K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00109; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Pottekat A, 2013, CELL REP, V4, P921, DOI 10.1016/j.celrep.2013.07.050; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Santo-Domingo J, 2017, FASEB J, V31, P1028, DOI 10.1096/fj.201600837R; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Tremblay MG, 2016, CELL CYCLE, V15, P2360, DOI 10.1080/15384101.2016.1203494; Vance JE, 2014, BBA-MOL CELL BIOL L, V1841, P595, DOI 10.1016/j.bbalip.2013.11.014; VIRJI MAG, 1978, ENDOCRINOLOGY, V102, P706, DOI 10.1210/endo-102-3-706; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wuttke A, 2016, J BIOL CHEM, V291, P14986, DOI 10.1074/jbc.M115.698456; Wuttke A, 2013, FASEB J, V27, P1610, DOI 10.1096/fj.12-221499; Yu HJ, 2016, P NATL ACAD SCI USA, V113, P4362, DOI 10.1073/pnas.1517259113; Yuan TY, 2015, DEV CELL, V35, P120, DOI 10.1016/j.devcel.2015.09.004; Zawalich WS, 2001, MOL CELL ENDOCRINOL, V177, P95, DOI 10.1016/S0303-7207(01)00422-1; Zhang H, 2004, J PHYSIOL-LONDON, V561, P133, DOI 10.1113/jphysiol.2004.071241; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	46	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4716	4728		10.1096/fj.201801878R	http://dx.doi.org/10.1096/fj.201801878R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30589572				2022-12-26	WOS:000462888500007
J	Ryan, P; Forrester, TJB; Wroblewski, C; Kenney, TMG; Kitova, EN; Klassen, JS; Kimber, MS				Ryan, Patrick; Forrester, Taylor J. B.; Wroblewski, Charles; Kenney, Tristan M. G.; Kitova, Elena N.; Klassen, John S.; Kimber, Matthew S.			The small RbcS-like domains of the beta-carboxysome structural protein CcmM bind RubisCO at a site distinct from that binding the RbcS subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO); carboxysome; cyanobacteria; protein complex; carbon fixation; crystal structure; photosynthesis; protein-protein interaction; CcmM	SYNECHOCOCCUS PCC7942 REVEALS; GAMMA-CARBONIC ANHYDRASE; BACTERIAL MICROCOMPARTMENT; CRYSTAL-STRUCTURES; SHELL; CONSERVATION; EVOLUTION; FIXATION; FORMS	Carboxysomes are compartments in bacterial cells that promote efficient carbon fixation by sequestering RubisCO and carbonic anhydrase within a protein shell that impedes CO2 escape. The key to assembling this protein complex is CcmM, a multidomain protein whose C-terminal region is required for RubisCO recruitment. This CcmM region is built as a series of copies (generally 3-5) of a small domain, CcmM(S), joined by unstructured linkers. CcmM(S) domains have weak, but significant, sequence identity to RubisCO's small subunit, RbcS, suggesting that CcmM binds RubisCO by displacing RbcS. We report here the 1.35-A structure of the first Thermosynechococcus elongatus CcmM(S) domain, revealing that it adopts a compact, well-defined structure that resembles that of RbcS. CcmM(S), however, lacked key RbcS RubisCO-binding determinants, most notably an extended N-terminal loop. Nevertheless, individual CcmM(S) domains are able to bind RubisCO in vitro with 1.16 mu m affinity. Two or four linked CcmM(S) domains did not exhibit dramatic increases in this affinity, implying that short, disordered linkers may frustrate successive CcmM(S) domains attempting to simultaneously bind a single RubisCO oligomer. Size-exclusion chromatography-coupled right-angled light scattering (SEC-RALS) and native MS experiments indicated that multiple CcmM(S) domains can bind a single RubisCO holoenzyme and, moreover, that RbcS is not released from these complexes. CcmM(S) bound equally tightly to a RubisCO variant in which the alpha/beta domain of RbcS was deleted, suggesting that CcmM(S) binds RubisCO independently of its RbcS subunit. We propose that, instead, the electropositive CcmM(S) may bind to an extended electronegative pocket between RbcL dimers.	[Ryan, Patrick; Forrester, Taylor J. B.; Wroblewski, Charles; Kenney, Tristan M. G.; Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mkimber@uoguelph.ca	Kimber, Matthew/Q-8144-2019; Ryan, Patrick/HDO-1133-2022	Klassen, John/0000-0002-3389-7112; Forrester, Taylor/0000-0002-5609-1453; Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada (NSERC) [04045-2015]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 04045-2015 (to M. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Bathellier C, 2018, PLANT CELL ENVIRON, V41, P705, DOI 10.1111/pce.13149; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; Chen AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056551; Cot SSW, 2008, J BACTERIOL, V190, P936, DOI 10.1128/JB.01283-07; de Araujo C, 2014, PHOTOSYNTH RES, V121, P135, DOI 10.1007/s11120-014-0018-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Fang Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00739; FUKUZAWA H, 1992, P NATL ACAD SCI USA, V89, P4437, DOI 10.1073/pnas.89.10.4437; Hayer-Hartl M, 2017, PROTEIN SCI, V26, P2324, DOI 10.1002/pro.3309; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko Y, 2006, J BACTERIOL, V188, P805, DOI 10.1128/JB.188.2.805-808.2006; Keeling TJ, 2014, PHOTOSYNTH RES, V121, P125, DOI 10.1007/s11120-014-9973-z; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2016, CURR OPIN PLANT BIOL, V31, P66, DOI 10.1016/j.pbi.2016.03.009; Kimber MS, 2014, SUBCELL BIOCHEM, V75, P89, DOI 10.1007/978-94-007-7359-2_6; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larsson AM, 2017, J EXP BOT, V68, P3857, DOI 10.1093/jxb/erx070; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Long BM, 2011, PHOTOSYNTH RES, V109, P33, DOI 10.1007/s11120-011-9659-8; Long BM, 2010, PLANT PHYSIOL, V153, P285, DOI 10.1104/pp.110.154948; Mahinthichaichan P, 2018, J PHYS CHEM B, V122, P9110, DOI 10.1021/acs.jpcb.8b06822; McGurn LD, 2016, BIOCHEM J, V473, P4559, DOI 10.1042/BCJ20160773; Niederhuber MJ, 2017, MOL BIOL CELL, V28, P2734, DOI 10.1091/mbc.E17-01-0069; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Price GD, 2011, PHOTOSYNTH RES, V109, P47, DOI 10.1007/s11120-010-9608-y; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rae BD, 2017, J EXP BOT, V68, P3717, DOI 10.1093/jxb/erx133; Rae BD, 2013, MICROBIOL MOL BIOL R, V77, P357, DOI 10.1128/MMBR.00061-12; Rae BD, 2013, J MOL MICROB BIOTECH, V23, P300, DOI 10.1159/000351342; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Samborska B, 2012, STRUCTURE, V20, P1353, DOI 10.1016/j.str.2012.05.013; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Sutter M, 2017, SCIENCE, V356, P1293, DOI 10.1126/science.aan3289; Sutter M, 2013, PHOTOSYNTH RES, V118, P9, DOI 10.1007/s11120-013-9909-z; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14	43	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2593	2603		10.1074/jbc.RA118.006330	http://dx.doi.org/10.1074/jbc.RA118.006330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591587	Green Published, hybrid			2022-12-26	WOS:000459601600002
J	Yin, L; Harwood, CS				Yin, Liang; Harwood, Caroline S.			Functional divergence of annotated l-isoaspartate O-methyltransferases in an alpha-proteobacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; bacterial metabolism; bioinformatics; enzyme catalysis; enzyme kinetics; enzyme purification; bacterial longevity; methyltransferase; protein damage; protein repair; Rhodopseudomonas palustris	PROTEIN REPAIR METHYLTRANSFERASE; SWISS-MODEL; CARBOXYL METHYLTRANSFERASE; STRESS-SURVIVAL; ACCUMULATION; DEAMIDATION; SEQUENCE; ASPARTYL; OVEREXPRESSION; ASPARAGINYL	Spontaneous formation of isoaspartates (isoDs) often causes protein damage. l-Isoaspartate O-methyltransferase (PIMT) repairs isoD residues by catalyzing the formation of an unstable l-isoaspartyl methyl ester that spontaneously converts to an l-aspartyl residue. PIMTs are widely distributed in all three domains of life and have been studied most intensively in connection with their role in protein repair and aging in plants and animals. Studies of bacterial PIMTs have been limited to Escherichia coli, which has one PIMT. The alpha-proteobacterium Rhodopseudomonas palustris has three annotated PIMT genes, one of which (rpa2580) has been found to be important for cellular longevity in a growth-arrested state. However, the biochemical activities of these three R. palustris PIMTs are unknown. Here, we expressed and characterized all three annotated PIMT proteins, finding that two of them, RPA0376 and RPA2838, had PIMT activity, whereas RPA2580 did not. RPA0376 and RPA2838 single- and double-deletion mutants did not differ in longevity from WT R. palustris and did not exhibit elevated levels of isoD residues in aged cells. Comparative sequence analyses revealed that RPA2580 belongs to a separate phylogenetic group of annotated PIMT proteins present in the alpha-proteobacteria. Our results suggest that this group of proteins is not involved in repair of protein isoD residues. In addition, the bona fide bacterial PIMT enzymes may play a different or subtler role in bacterial physiology than previously suggested.	[Yin, Liang; Harwood, Caroline S.] Univ Washington, Dept Microbiol, HSB K-340B,1705 NE Pacific St, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Harwood, CS (corresponding author), Univ Washington, Dept Microbiol, HSB K-340B,1705 NE Pacific St, Seattle, WA 98195 USA.	csh5@uw.edu	Yin, Liang/H-8171-2013	Yin, Liang/0000-0001-6957-6903; Harwood, Caroline/0000-0003-4450-5177	U.S. Army Research Office (ARO) [W911NF-15-1-0150]	U.S. Army Research Office (ARO)	This work was supported by Grant W911NF-15-1-0150 from the U.S. Army Research Office (ARO). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett EJ, 2003, BIOCHEMISTRY-US, V42, P12844, DOI 10.1021/bi034891+; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Fixen KR, 2014, P NATL ACAD SCI USA, V111, pE237, DOI 10.1073/pnas.1322410111; FU JC, 1991, J BIOL CHEM, V266, P14562; GALLETTI P, 1988, BIOCHEMISTRY-US, V27, P1752, DOI 10.1021/bi00405a055; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Halliday NM, 2010, ANAL BIOCHEM, V403, P20, DOI 10.1016/j.ab.2010.04.021; Hicks WM, 2005, MICROBIOL-SGM, V151, P2151, DOI 10.1099/mic.0.27835-0; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; Kagan RM, 1997, ARCH BIOCHEM BIOPHYS, V348, P320, DOI 10.1006/abbi.1997.0362; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Kumar GNM, 1999, PLANT PHYSIOL, V119, P89, DOI 10.1104/pp.119.1.89; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Pechter KB, 2017, MBIO, V8, DOI 10.1128/mBio.01726-17; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Szymanska G, 1998, J BIOL CHEM, V273, P28516, DOI 10.1074/jbc.273.43.28516; VandenBerg KE, 2016, APPL ENVIRON MICROB, V82, P5444, DOI 10.1128/AEM.00623-16; Villa ST, 2006, PHYSIOL PLANTARUM, V128, P581, DOI 10.1111/j.1399-3054.2006.00772.x; Visick JE, 1998, FEMS MICROBIOL LETT, V167, P19, DOI 10.1111/j.1574-6968.1998.tb13202.x; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998	38	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2854	2861		10.1074/jbc.RA118.006546	http://dx.doi.org/10.1074/jbc.RA118.006546			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30578298	hybrid, Green Published			2022-12-26	WOS:000459601600023
J	Paz, ICDA; Almeida, ICD; Milbradt, EL; Caldara, FR; Tse, MLP				de Lima Almeida Paz, Ibiara Correia; de Lima Almeida, Iane Correia; Milbradt, Elisane Lenita; Caldara, Fabiana Ribeiro; Panhoza Tse, Marcos Livio			Effects of analgesic and noise stimulus in gait score assessment	PLOS ONE			English	Article							BROILER-CHICKENS; LOCOMOTION PROBLEMS; SELECTION; GROWTH	This experiment was carried out aiming to assess walking manner and speed of broiler chickens with different gait scores (GS), with or without sound stimulus, and with or without administration of analgesic. To that end, 1,000 birds were evaluated by the GS test and 74 were selected for walking speed analyses. Weight at slaughter and breast yield values were obtained for comparisons. Walking speed analyses, both with and without analgesic and with and without stimulus were performed. Non-parametric statistics was applied to the GS data that did not meet the assumptions of the statistical model (normality and homogenicity) using Fisher's exact test according to the data behavior (P<0.05). The analyses of data on speed, weight at slaughter, and breast yield were evaluated by ANOVA and compared by Tukey's test (P<0.05). Walking speed differed after acoustic stimulus with or without administration of metamizole sodium. Body weight was also different in each GS. It is thus concluded that the birds may feel discomfort when their GS is higher than 0, but that such discomfort may be suppressed when they are stimulated to walk.	[de Lima Almeida Paz, Ibiara Correia; de Lima Almeida, Iane Correia; Milbradt, Elisane Lenita; Panhoza Tse, Marcos Livio] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci FMVZ, Dept Anim Prod, Botucatu, SP, Brazil; [Caldara, Fabiana Ribeiro] Fed Univ Grande Dourados, Sch Agrarian Sci, Dourados, MS USA	Universidade Estadual Paulista	Paz, ICDA (corresponding author), Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci FMVZ, Dept Anim Prod, Botucatu, SP, Brazil.	ibiarapaz@gmail.com	ICL, Ibiara CLAP Almeida Paz/K-6172-2012; Paz, Ibiara/AFF-8525-2022; Paz, Ibiara/AAF-1033-2022	ICL, Ibiara CLAP Almeida Paz/0000-0003-1086-2213; Caldara, Fabiana Ribeiro/0000-0002-7564-6127; Livio Panhoza Tse, Marcos/0000-0003-4301-4413	FAPESP [2015/19225-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The manuscript was financed by FAPESP, Process 2015/19225-8.	Alves MCF, 2016, BRAZ J POULTRY SCI, V18, P419, DOI 10.1590/1806-9061-2015-0013; Angel R, 2007, J APPL POULTRY RES, V16, P138, DOI 10.1093/japr/16.1.138; Appleby MC, 2010, POULTRY BEHAV WELLFA; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Caplen G, 2013, VET J, V196, P477, DOI 10.1016/j.tvjl.2012.12.007; Carvalho C., 2001, REV PORT CIENCIAS DO, V6, P241; Colborne GR, 2006, AM J VET RES, V67, P1293, DOI 10.2460/ajvr.67.8.1293; Corr SA, 1998, RES VET SCI, V65, P233, DOI 10.1016/S0034-5288(98)90149-7; da Cruz Reis Denise Torres, 2011, Acta Scientiarum Animal Sciences, V33, P101, DOI 10.4025/actascianimsci.v33i1.8090; Fernandes BCD, 2012, REV BRAS ZOOTECN, V41, P1951, DOI 10.1590/S1516-35982012000800021; Danbury TC, 2000, VET REC, V146, P307, DOI 10.1136/vr.146.11.307; Donaduzzi P., 2013, INFORM TECNICAS PROF; Feldman A, MEMORIA DOR COMO SE; Alves MCF, 2016, REV BRAS ZOOTECN, V45, P372, DOI 10.1590/S1806-92902016000700003; Garcia RG, 2012, BRAZ J POULTRY SCI, V14, P121, DOI 10.1590/S1516-635X2012000200006; Kestin S, 1994, LEG WEAKNESS BROILER; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Martinez-Martin P, 2001, CEPHALALGIA, V21, P604, DOI 10.1046/j.1468-2982.2001.00216.x; Mendes A.S., 2012, Arch. zootec., V61, P217, DOI 10.4321/s0004-05922012000200006; Naas IA, 2017, PALESTRA PRINCIPIOS; Naas IA, 2009, J APPL POULTRY RES, V18, P432, DOI 10.3382/japr.2008-00061; Paz ICLA, 2010, BRAZ J POULTRY SCI, V12, P189, DOI 10.1590/S1516-635X2010000300008; Pitsillides AA, 1999, J BONE MINER RES, V14, P980, DOI 10.1359/jbmr.1999.14.6.980; Queiroz Thallita Pereira, 2013, Rev. odontol. UNESP, V42, P78; Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1; Weil K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004487	26	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0208827	10.1371/journal.pone.0208827	http://dx.doi.org/10.1371/journal.pone.0208827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605469	Green Published, gold, Green Submitted			2022-12-26	WOS:000454759900012
J	Botteon, V; Costa, MDZ; Kovaleski, A; Martinelli, LA; Mastrangelo, T				Botteon, Victor; Zamboni Costa, Maria de Lourdes; Kovaleski, Adalecio; Martinelli, Luiz Antonio; Mastrangelo, Thiago			Can stable isotope markers be used to distinguish wild and mass-reared Anastrepha fraterculus flies?	PLOS ONE			English	Article							AMERICAN FRUIT-FLY; DIPTERA TEPHRITIDAE; CARBON ISOTOPES; NITROGEN ISOTOPES; INSECT; DIET; FRACTIONATION; ENRICHMENT; MARKING; DELTA-N-15	The availability of accurate techniques to discriminate between marked laboratory-reared flies and unmarked wild flies captured in monitoring traps is essential for programs that integrate the Sterile Insect Technique (SIT) to manage fruit flies. In this study, the feasibility of using a stable isotope marking technique for the South American fruit fly, Anastrepha fraterculus (Wiedemann), was assessed. Wild flies were collected from apple orchards, which are a target of a SIT project in southern Brazil. To verify if adult flies could be labelled by the stable isotopes from larval diets, larvae were reared on two different C-4-based diets and fruits in laboratory. To evaluate the influence of the two most common attractants applied to capture A. fraterculus (grape juice and CeraTrap (TM)) and the most common preservation method in fruit fly collections (ethanol), laboratory-reared flies were immersed in McPhail traps containing the respective treatments for two periods of time. Samples were analyzed in an elemental analyzer coupled to a Continuous Flow Isotope Ratio Mass Spectrometer (CF-IRMS) at CENA/USP. The delta C-13 signatures of flies reared on artificial diets differed significantly from the delta C-13 of flies whose larvae were reared on fruits and from wild flies. In contrast, the delta N-15 values were less conclusive and the technique could not rely solely on them. In all cases considered, the delta C-13 and delta N-15 signatures from males did not differ from females. Despite the alterations caused by the attractants tested and ethanol, laboratory-flies could be distinguished from the wild ones based on delta C-13 signatures. This is the first comprehensive study to demonstrate that it is possible to distinguish wild A. fraterculus from flies reared on larval diets containing C-4 sugar. The first experimentally derived trophic discrimination factors were also obtained for this species. Thus, intrinsic isotope labelling can serve as a backup to conventional dye marking.	[Botteon, Victor; Zamboni Costa, Maria de Lourdes; Martinelli, Luiz Antonio; Mastrangelo, Thiago] Univ Sao Paulo, CENA, Sao Paulo, Brazil; [Kovaleski, Adalecio] Empresa Brasileira Pesquisa Agr EMBRAPA, Estacao Expt Fruticultura Clima Temperado, Vacaria, RS, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Mastrangelo, T (corresponding author), Univ Sao Paulo, CENA, Sao Paulo, Brazil.	piaui@cena.usp.br	Martinelli, Luiz Antonio/F-7870-2011; Mastrangelo, Thiago/N-3569-2019	Martinelli, Luiz Antonio/0000-0002-7103-7551; Mastrangelo, Thiago/0000-0003-1882-9565; Botteon, Victor Wilson/0000-0002-2660-3796	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior do Brasil (CAPES) [001]; CNPq [401369/2016-1]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior do Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors wish thanks to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior do Brasil (CAPES-Finance Code 001) for a fellowship to VB. Part of the experiments of this study were supported by the CNPq grant number 401369/2016-1 to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja M, 2014, J ECON ENTOMOL, V107, P375, DOI 10.1603/EC13045; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bisognin M, 2013, PESQUI AGROPECU BRAS, V48, P141, DOI 10.1590/S0100-204X2013000200003; Costa MLZ, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew071; Dawson TE, 2001, CURR PLANT SCI BIOT, V40, P1; de Groot P.A., 2004, HDB STABLE ISOTOPE A, P874, DOI DOI 10.1016/B978-044451114-0/50042-9; De Souza RB, 2012, C BRAS FRUT BENT GON, P2248; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dias VS, 2016, BIOL J LINN SOC, V117, P725, DOI 10.1111/bij.12712; Enkerlin W, 1996, J ECON ENTOMOL, V89, P946, DOI 10.1093/jee/89.4.946; Garcia FRM, 2011, FLA ENTOMOL, V94, P151, DOI 10.1653/024.094.0205; Guillen-Aguilar JC, 2016, MANUAL DIFFERENTIATE; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hamer GL, 2012, J MED ENTOMOL, V49, P61, DOI 10.1603/ME11076; Hatch KA, 2006, RAPID COMMUN MASS SP, V20, P3367, DOI 10.1002/rcm.2740; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; Hogsden KL, 2017, NEW ZEAL J MAR FRESH, V51, P455, DOI 10.1080/00288330.2016.1257996; Hola M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125042; Holder PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092384; Hood-Nowotny R, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-6; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Hood-Nowotny R, 2016, FLA ENTOMOL, V99, P166, DOI 10.1653/024.099.sp120; Hood-Nowotny R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045222; Hood-Nowotny R, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7901; Hood-Nowotny R, 2009, J ECON ENTOMOL, V102, P941, DOI 10.1603/029.102.0312; Hyodo F, 2015, ENTOMOL SCI, V18, P295, DOI 10.1111/ens.12128; International Atomic Energy Agency (IAEA), 2009, MAN US STABL IS ENT; Jesus FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137650; Machota JR, 2010, TECNICA CRIAC 1830 D; Markow TA, 2000, FUNCT ECOL, V14, P261, DOI 10.1046/j.1365-2435.2000.00408.x; Marsaro Junior AL, 2014, REV AGR, V89, P65; Mastrangelo T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201026; Walder JMM, 2014, SCI AGR, V71, P281, DOI 10.1590/0103-9016-2013-233; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Nunes AM, 2013, PESQUI AGROPECU BRAS, V48, P1309, DOI 10.1590/S0100-204X2013001000001; Nunes AM, 2012, MOSCAS FRUGIVORAS SE; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Opiyo MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159067; Orozco-Davila D, 2017, ENTOMOL EXP APPL, V164, P176, DOI 10.1111/eea.12581; Ponsard S, 1999, CR ACAD SCI III-VIE, V322, P35, DOI 10.1016/S0764-4469(99)80015-8; Rosa JM, 2017, J ECON ENTOMOL, P1, DOI [10.1093/jee/tow228, DOI 10.1093/JEE/TOW228]; Salles L.A.B, 1995, BIOECOLOGIA CONTROLE; Salles Luis A. B., 1992, Anais da Sociedade Entomologica do Brasil, V21, P479; SAS Institute Inc, 2013, SAS PROPR SOFTW VERS; Sato N, 2016, ENTOMOL EXP APPL, V161, P181, DOI 10.1111/eea.12509; Savaris M, 2013, FLA ENTOMOL, V96, P1597, DOI 10.1653/024.096.0445; SCHROEDER WJ, 1981, P HAWAII ENTOMOL SOC, V23, P437; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shelly T, 2016, ANN ENTOMOL SOC AM, V109, P1, DOI 10.1093/aesa/sav101; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Sugayama RL, 1997, ENTOMOL EXP APPL, V83, P239, DOI 10.1023/A:1002913018833; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vreysen MJB, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P325, DOI 10.1007/1-4020-4051-2_12; Wehi PM, 2010, J INSECT PHYSIOL, V56, P1877, DOI 10.1016/j.jinsphys.2010.08.005; Zart M, 2011, BRAGANTIA, V70, P64, DOI 10.1590/S0006-87052011000100011; Zucchi, 2000, MOSCAS DAS FRUTAS IM, P135; Zucchi R.A., 2007, MOSCAS FRUTA LATINOA, P77	62	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209921	10.1371/journal.pone.0209921	http://dx.doi.org/10.1371/journal.pone.0209921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596760	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200106
J	Hung, CH; Lee, SH; Lin, SY; Lin, SL; Chen, YC				Hung, Chih-Heng; Lee, Shwu-Huey; Lin, Szu-Yuan; Lin, Shun-Ling; Chen, Yi-Chun			The relationship between optic nerve head deformation and visual field defects in myopic eyes with primary open-angle glaucoma	PLOS ONE			English	Article							PARAPAPILLARY CHORIORETINAL ATROPHY; DISC ROTATION; POPULATION; PREVALENCE; DAMAGE; RISK; SUSCEPTIBILITY	Purpose To investigate the relationship between the morphologic features of myopic optic nerve head (ONH) and visual field (VF) defects in myopic subjects with primary open-angle glaucoma (POAG) by intraindividual comparison. Methods Myopic POAG subjects with unilateral glaucomatous VF defect were recruited. The morphologic features of myopic ONH, including optic disc tilt, optic disc rotation, and beta-zone parapapillary atrophy (PPA) were measured from color fundus photographs. The comparisons were performed between the eyes with VF defects and the contralateral eyes without VF defects. Logistic regression analysis was performed to investigate the relationship between various ocular parameters and the presence of VF defects. Results We retrospectively included 100 eyes of 50 myopic POAG subjects. (Mean age: 50.1 +/- 10.0 years). The tilt ratio was similar between the paired eyes. The degree of optic disc rotation (12.96 +/- 7.21 degrees) in eyes with VF defects were statistically greater than the contralateral eyes (6.86 +/- 4.30 degrees; P < 0.001) without VF defect. The beta-zone PPA-to-disc area ratio was significantly greater in eyes with VF defects than the contralateral eyes (P = 0.024) without VF defect. In multivariate logistic regression analysis, the greater degree of optic disc rotation was significantly associated with the presence of VF defects (P < 0.001). However, tilt ratio, beta-zone PPA-to-disc area ratio, refractive error, and axial length were not associated with the presence of VF defects. Conclusions Among the morphologic features of myopic ONH, only the greater degree of the optic disc rotation was associated with the presence of VF defects in myopic subjects with POAG.	[Hung, Chih-Heng; Lee, Shwu-Huey; Lin, Szu-Yuan; Lin, Shun-Ling; Chen, Yi-Chun] Cathay Gen Hosp, Dept Ophthalmol, Taipei, Taiwan	Cathay General Hospital	Chen, YC (corresponding author), Cathay Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.	rebe254cca@gmail.com	Hung, Chou-Heng/GXV-1479-2022	Hung, Chih-Heng/0000-0003-0410-1442				CAHANE M, 1992, OPHTHALMIC RES, V24, P280, DOI 10.1159/000267179; Chen LW, 2016, J GLAUCOMA, V25, pE569, DOI 10.1097/IJG.0000000000000395; Cho BJ, 2013, OPHTHALMOLOGY, V120, P528, DOI 10.1016/j.ophtha.2012.09.004; Cho HK, 2014, SURV OPHTHALMOL, V59, P434, DOI 10.1016/j.survophthal.2013.09.003; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; How ACS, 2009, ARCH OPHTHALMOL-CHIC, V127, P894, DOI 10.1001/archophthalmol.2009.134; Hyung S M, 1992, Korean J Ophthalmol, V6, P32; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P908; Jonas JB, 2002, AM J OPHTHALMOL, V134, P547, DOI 10.1016/S0002-9394(02)01644-6; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P587, DOI 10.1007/BF02169209; Jonas Jost B, 2005, Curr Opin Ophthalmol, V16, P84, DOI 10.1097/01.icu.0000156135.20570.30; Kimura Y, 2012, INVEST OPHTH VIS SCI, V53, P6472, DOI 10.1167/iovs.12-10319; Kuzin AA, 2010, OPHTHALMOLOGY, V117, P1713, DOI 10.1016/j.ophtha.2010.01.035; Lee EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186236; Lee KS, 2014, OPHTHALMOLOGY, V121, P1013, DOI 10.1016/j.ophtha.2013.11.014; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Nagaoka N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138825; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; QUIGLEY HA, 1994, ARCH OPHTHALMOL-CHIC, V112, P644, DOI 10.1001/archopht.1994.01090170088028; Sawada Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161961; Shen L, 2016, OPHTHALMOLOGY, V123, P92, DOI 10.1016/j.ophtha.2015.07.002; Sung MS, 2017, EYE, V31, P1051, DOI 10.1038/eye.2017.33; Sung MS, 2016, OPHTHALMOLOGY, V123, P1484, DOI 10.1016/j.ophtha.2016.03.040; Sung MS, 2016, OPHTHALMOLOGY, V123, P400, DOI 10.1016/j.ophtha.2015.10.018; Tezel G, 2000, OPHTHALMOLOGY, V107, P1194, DOI 10.1016/S0161-6420(00)00114-7; Wadood AC, 2002, AM J OPHTHALMOL, V133, P327, DOI 10.1016/S0002-9394(01)01424-6; Wu SY, 1999, INVEST OPHTH VIS SCI, V40, P2179; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050	30	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209755	10.1371/journal.pone.0209755	http://dx.doi.org/10.1371/journal.pone.0209755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596728	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200079
J	Mura, E; Taruno, A; Yagi, M; Yokota, K; Hayashi, Y				Mura, Emi; Taruno, Akiyuki; Yagi, Minako; Yokota, Kohei; Hayashi, Yukako			Innate and acquired tolerance to bitter stimuli in mice	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; TYMPANI NERVE TRANSECTION; SALIVARY PROTEIN PROFILES; CHORDA TYMPANI; FLUID DEPRIVATION; MOUSE; RECEPTORS; RESPONSES; RATS; GLOSSOPHARYNGEAL	Tolerance to bitter foods and its potentiation by repetitive exposure are commonly experienced and potentially underlie the consumption of bitter foods, but it remains unknown whether permissive and adaptive responses are general phenomena for bitter-tasting substances or specific to certain substances, and they have not been rigorously studied in mice. Here, we investigated the effects of prolonged exposure to a bitter compound on both recognition and rejection behaviors to the same compound in mice. Paired measurements of rejection (RjT) and apparent recognition (aR(c)T) thresholds were conducted using brief-access two-bottle choice tests before and after taste aversion conditioning, respectively. First, RjT was much higher than aR(c)T for the bitter amino acids L-tryptophan and L-isoleucine, which mice taste daily in their food, indicating strong acceptance of those familiar stimuli within the concentration range between RjT and aR(c)T. Next, we tested five other structurally dissimilar bitter compounds, to which mice were naive at the beginning of experiments: denatonium benzoate, quinine-HCl, caffeine, salicin, and epigallocatechin gallate. RjT was moderately higher than aR(c)T for all the compounds tested, indicating the presence of innate acceptance to these various, unfamiliar bitter stimuli in mice. Lastly, a 3-week forced exposure increased RjT for all the bitter compounds except salicin, demonstrating that mice acquire tolerance to a broad array of bitter compounds after long-term exposure to them. Although the underlying mechanisms remain to be determined, our studies provide behavioral evidence of innate and acquired tolerance to various bitter stimuli in mice, suggesting its generality among bitterants.	[Mura, Emi; Yagi, Minako; Yokota, Kohei; Hayashi, Yukako] Kyoto Univ, Grad Sch Agr, Uji, Kyoto, Japan; [Taruno, Akiyuki] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Kyoto, Kyoto, Japan; [Taruno, Akiyuki] JST, PRESTO, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto Prefectural University of Medicine; Japan Science & Technology Agency (JST)	Hayashi, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Uji, Kyoto, Japan.	yhayashi@kais.kyoto-u.ac.jp	Taruno, Akiyuki/AAP-5755-2021	Taruno, Akiyuki/0000-0002-2342-0265; Hayashi, Yukako/0000-0003-3124-1563				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; Delwiche JF, 2001, PERCEPT PSYCHOPHYS, V63, P761, DOI 10.3758/BF03194436; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Dsamou M, 2012, CHEM SENSES, V37, P87, DOI 10.1093/chemse/bjr070; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; GLENDINNING JI, 1992, CHEM SENSES, V17, P1, DOI 10.1093/chemse/17.1.1; Glendinning JI, 2001, J NEUROSCI, V21, P3688, DOI 10.1523/JNEUROSCI.21-10-03688.2001; Golden GJ, 2011, CHEM SENSES, V36, P811, DOI 10.1093/chemse/bjr056; GROTE F W JR, 1973, Learning and Motivation, V4, P314, DOI 10.1016/0023-9690(73)90021-0; Ishiwatari Y, 2012, CHEM SENSES, V37, P497, DOI 10.1093/chemse/bjr135; KALAT JW, 1973, J COMP PHYSIOL PSYCH, V83, P198, DOI 10.1037/h0034424; Keast RSJ, 2002, CHEM SENSES, V27, P123, DOI 10.1093/chemse/27.2.123; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Ma ZM, 2018, NEURON, V98, P547, DOI 10.1016/j.neuron.2018.03.043; Martin LE, 2018, PHYSIOL BEHAV, V184, P150, DOI 10.1016/j.physbeh.2017.11.021; Morzel M, 2014, EUR J PEDIATR, V173, P575, DOI 10.1007/s00431-013-2216-z; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Narukawa M, 2012, BIOSCI BIOTECH BIOCH, V76, P2282, DOI 10.1271/bbb.120560; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; NINOMIYA Y, 1993, NEUROSCI LETT, V163, P197, DOI 10.1016/0304-3940(93)90381-T; Nolan LJ, 1997, PHYSIOL BEHAV, V61, P319, DOI 10.1016/S0031-9384(96)00411-8; Quintana M, 2009, J PROTEOMICS, V72, P822, DOI 10.1016/j.jprot.2009.05.004; ROSENSTEIN D, 1988, CHILD DEV, V59, P1555, DOI 10.1111/j.1467-8624.1988.tb03683.x; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; Schobel N, 2014, CHEM SENSES, V39, P471, DOI 10.1093/chemse/bju014; SCOTT TR, 1987, PHYSIOL BEHAV, V41, P315, DOI 10.1016/0031-9384(87)90394-5; SENGSTAKE CB, 1978, J COMP PHYSIOL PSYCH, V92, P1150, DOI 10.1037/h0077508; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Spector AC, 2002, J NEUROSCI, V22, P1937, DOI 10.1523/JNEUROSCI.22-05-01937.2002; SPECTOR AC, 1986, RADIAT RES, V106, P271, DOI 10.2307/3576799; Steiner J E, 1979, Adv Child Dev Behav, V13, P257, DOI 10.1016/S0065-2407(08)60349-3; STEINER JE, 1974, ANN NY ACAD SCI, V237, P229, DOI 10.1111/j.1749-6632.1974.tb49858.x; StJohn SJ, 1996, BEHAV NEUROSCI, V110, P1456, DOI 10.1037/0735-7044.110.6.1456; Taruno A, 2017, J PHYSIOL-LONDON, V595, P6121, DOI 10.1113/JP274164; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Temple JL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00080; Tordoff MG, 2007, CHEM SENSES, V32, P655, DOI 10.1093/chemse/bjm034; Torregrossa AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105232; Wang L, 2018, NATURE, V558, P127, DOI 10.1038/s41586-018-0165-4; WARREN RP, 1959, J COMP PHYSIOL PSYCH, V52, P263, DOI 10.1037/h0047655; WELLMAN PJ, 1981, PHYSIOL PSYCHOL, V9, P281; WHITE BC, 1985, PHARMACOL BIOCHEM BE, V23, P515, DOI 10.1016/0091-3057(85)90411-3; WHITNEY G, 1994, PHYSIOL BEHAV, V56, P1141, DOI 10.1016/0031-9384(94)90358-1; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210032	10.1371/journal.pone.0210032	http://dx.doi.org/10.1371/journal.pone.0210032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596779	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200129
J	Papiez, A; Azimzadeh, O; Azizova, T; Moseeva, M; Anastasov, N; Smida, J; Tapio, S; Polanska, J				Papiez, Anna; Azimzadeh, Omid; Azizova, Tamara; Moseeva, Maria; Anastasov, Natasa; Smida, Jan; Tapio, Soile; Polanska, Joanna			Integrative multiomics study for validation of mechanisms in radiation-induced ischemic heart disease in Mayak workers	PLOS ONE			English	Article							ENERGY-METABOLISM; MITOCHONDRIA; PA	Previous studies have suggested that exposure to ionizing radiation increases the risk of ischemic heart disease (IHD). The data from the Mayak nuclear worker cohort have indicated enhanced risk for IHD incidence. The goal of this study was to elucidate molecular mechanisms of radiation-induced IHD by integrating proteomics data with a transcriptomics study on post mortem cardiac left ventricle samples from Mayak workers categorized in four radiation dose groups (0 Gy, < 100 mGy, 100-500 mGy, > 500 mGy). The proteomics data that were newly analysed here, originated from a label-free analysis of cardiac samples. The transcriptomics analysis was performed on a subset of these samples. Stepwise linear regression analyses were used to correct the age-dependent changes in protein expression, enabling the separation of proteins, the expression of which was dependent only on the radiation dose, age or both of these factors. Importantly, the majority of the proteins showed only dose-dependent expression changes. Hierarchical clustering of the proteome and transcriptome profiles confirmed the separation of control and high-dose samples. Restrictive (separate p-values) and integrative (combined p-value) approaches were used to investigate the enrichment of biological pathways. The integrative method proved superior in the validation of the key biological pathways found in the proteomics analysis, namely PPAR signalling, TCA cycle and glycolysis/gluconeogenesis. This study presents a novel, improved, and comprehensive statistical approach of analysing biological effects on a limited number of samples.	[Papiez, Anna; Polanska, Joanna] Silesian Tech Univ, Inst Automat Control, Ul Akad 16, PL-44100 Gliwice, Poland; [Azimzadeh, Omid; Anastasov, Natasa; Smida, Jan; Tapio, Soile] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Radiat Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Azizova, Tamara; Moseeva, Maria] Southern Urals Biophys Inst, Ozyorsk, Russia	Silesian University of Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute	Polanska, J (corresponding author), Silesian Tech Univ, Inst Automat Control, Ul Akad 16, PL-44100 Gliwice, Poland.	joanna.polanska@polsl.pl	Anastasov, Natasa/AAW-2478-2020; Moseeva, Maria B./Z-1445-2019; Smida, Jan/P-2486-2014; Azizova, Tamara V./R-5295-2019; Tapio, Soile/CAJ-5871-2022; Polanska, Joanna/H-4513-2013	Anastasov, Natasa/0000-0002-4088-1119; Moseeva, Maria B./0000-0003-3741-6600; Azizova, Tamara V./0000-0001-6954-2674; Polanska, Joanna/0000-0001-8004-9864; Papiez, Anna/0000-0003-0179-1302; Smida, Jan/0000-0001-6055-8207	Silesian University of Technology [BK-200/RAU1/2018]; National Science Center OPUS grant [UMO-2015/19/B/ST6/01736]; Federal Office for Radiation Protection (BfS) [3611S30022]; European Community's Seventh Framework Program (EURATOM) [295823 PROCARDIO]	Silesian University of Technology; National Science Center OPUS grant; Federal Office for Radiation Protection (BfS); European Community's Seventh Framework Program (EURATOM)	This work was supported by Silesian University of Technology grant no. BK-200/RAU1/2018 (A.P.) www.polsl.pl, National Science Center OPUS grant no. UMO-2015/19/B/ST6/01736 (J.P.) www.ncn.gov.pl, and by grants from Federal Office for Radiation Protection (BfS) (#3611S30022) www.bfs.de, and from the European Community's Seventh Framework Program (EURATOM) (#295823 PROCARDIO), https://ec.europa.eu/research/fp7/index_en.cfm to Helmholtz Zentrum Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Azimzadeh O, 2017, EXPERT REV PROTEOMIC, V14, P987, DOI 10.1080/14789450.2017.1388743; Azimzadeh O, 2017, ONCOTARGET, V8, P9067, DOI 10.18632/oncotarget.10424; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Azizova TV, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150169; Azizova TV, 2012, HEALTH PHYS, V103, P3, DOI 10.1097/HP.0b013e3182243a62; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Ferrari R, 1996, J CARDIOVASC PHARM, V28, pS1; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Fisher R.A., 1992, BREAKTHROUGHS STAT, P66, DOI [10.1007/978-1-4612-4380-9_6, DOI 10.1007/978-1-4612-4380-9_6]; Folmes CDL, 2009, J MOL CELL CARDIOL, V47, P142, DOI 10.1016/j.yjmcc.2009.03.005; Fountos BN, 2007, THE DEPARTMENT OF EN; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lehman John J, 2002, Heart Fail Rev, V7, P175; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; Lopaschuk GD, 2002, J MOL CELL CARDIOL, V34, P1075, DOI 10.1006/jmcc.2002.2070; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simonetto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096309; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Walters AM, 2012, CIRC RES, V111, P1222, DOI 10.1161/CIRCRESAHA.112.265660	27	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209626	10.1371/journal.pone.0209626	http://dx.doi.org/10.1371/journal.pone.0209626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596717	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200068
J	Thissen, JB; Isshiki, M; Jaing, C; Nagao, Y; Aldea, DL; Allen, JE; Izui, M; Slezak, TR; Ishida, T; Sano, T				Thissen, James B.; Isshiki, Mariko; Jaing, Crystal; Nagao, Yoshiro; Aldea, Dayanara Lebron; Allen, Jonathan E.; Izui, Masafumi; Slezak, Thomas R.; Ishida, Takafumi; Sano, Tetsuya			A novel variant of torque teno virus 7 identified in patients with Kawasaki disease	PLOS ONE			English	Article							PARVOVIRUS B19 INFECTION; GENOME-WIDE ASSOCIATION; TT VIRUS; YOUNG-CHILDREN; SUSCEPTIBILITY; ARTERITIS; LOCI; MICE	Kawasaki disease (KD), first identified in 1967, is a pediatric vasculitis of unknown etiology that has an increasing incidence in Japan and many other countries. KD can cause coronary artery aneurysms. Its epidemiological characteristics, such as seasonality and clinical picture of acute systemic inflammation with prodromal intestinal/respiratory symptoms, suggest an infectious etiology for KD. Interestingly, multiple host genotypes have been identified as predisposing factors for KD. To explore experimental methodology for identifying etiological agent(s) for KD and to optimize epidemiological study design (particularly the sample size) for future studies, we conducted a pilot study. For a 1-year period, we prospectively enrolled 11 patients with KD. To each KD patient, we assigned two control individuals (one with diarrhea and the other with respiratory infections), matched for age, sex, and season of diagnosis. During the acute phase of disease, we collected peripheral blood, nasopharyngeal aspirate, and feces. We also determined genotypes, to identify those that confer susceptibility to KD. There was no statistically significant difference in the frequency of the risk genotypes between KD patients and control subjects. We also used unbiased metagenomic sequencing to analyze these samples. Metagenomic sequencing and PCR detected torque teno virus 7 (TTV7) in two patients with KD (18%), but not in control subjects (P = 0.111). Sanger sequencing revealed that the TTV7 found in the two KD patients contained almost identical variants in nucleotide and identical changes in resulting amino acid, relative to the reference sequence. Additionally, we estimated the sample size that would be required to demonstrate a statistical correlation between TTV7 and KD. Future larger scale studies with carefully optimized metagenomic sequencing experiments and adequate sample size are warranted to further examine the association between KD and potential pathogens, including TTV7.	[Thissen, James B.; Jaing, Crystal; Aldea, Dayanara Lebron; Allen, Jonathan E.; Slezak, Thomas R.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Isshiki, Mariko; Ishida, Takafumi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Nagao, Yoshiro; Izui, Masafumi; Sano, Tetsuya] Japan Community Hlth Care Org Osaka Hosp, Dept Pediat, Osaka, Japan	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Tokyo	Nagao, Y (corresponding author), Japan Community Hlth Care Org Osaka Hosp, Dept Pediat, Osaka, Japan.	in_the_pacific214@yahoo.co.jp		Isshiki, Mariko/0000-0002-6565-6970; Nagao, Yoshiro/0000-0003-3411-0729; Jaing, Crystal/0000-0001-9933-3005; Thissen, James/0000-0002-4693-5886; Allen, Jonathan/0000-0002-4359-8263				Ames Sasha, 2014, 2014 IEEE 28th International Parallel & Distributed Processing Symposium Workshops (IPDPSW). Proceedings, P556, DOI 10.1109/IPDPSW.2014.200; Ames SK, 2015, GENOME RES, V25, P1056, DOI 10.1101/gr.184879.114; Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; Baker AL, 2009, J PEDIATR-US, V154, P592, DOI 10.1016/j.jpeds.2008.10.006; Biagini P, 2012, VIRUS TAXONOMY, P331; Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002; Burns JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074529; Chang LY, 2014, J FORMOS MED ASSOC, V113, P148, DOI 10.1016/j.jfma.2013.12.008; Chua PK, 2000, PEDIATR INFECT DIS J, V19, P477, DOI 10.1097/00006454-200005000-00019; Fan PC, 2003, J PAEDIATR CHILD H, V39, P55, DOI 10.1046/j.1440-1754.2003.00085.x; FUJITA Y, 1989, PEDIATRICS, V84, P666; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hallett RL, 2000, J GEN VIROL, V81, P2273, DOI 10.1099/0022-1317-81-9-2273; Holman Robert C, 2010, Hawaii Med J, V69, P194; Kakkola L, 2009, CURR TOP MICROBIOL, V331, P53; Katano H, 2012, INT J CLIN EXP PATHO, V5, P814; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T, 1967, Arerugi, V16, P178; Kim Ja Hye, 2012, Korean J Pediatr, V55, P470, DOI 10.3345/kjp.2012.55.12.470; Kusuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113054; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Lefrere JJ, 2000, BLOOD, V95, P347, DOI 10.1182/blood.V95.1.347.001k42_347_351; LEHMAN TJA, 1985, ARTHRITIS RHEUM, V28, P652, DOI 10.1002/art.1780280609; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Murata H, 1987, Prog Clin Biol Res, V250, P523; MURATA H, 1979, MICROBIOL IMMUNOL, V23, P825, DOI 10.1111/j.1348-0421.1979.tb02815.x; Nagao Y, 2016, EPIDEMIOL INFECT, V144, P478, DOI 10.1017/S0950268815001223; Nagao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067934; NIGRO G, 1994, LANCET, V343, P1260, DOI 10.1016/S0140-6736(94)92154-7; Ninomiya M, 2008, J CLIN MICROBIOL, V46, P507, DOI 10.1128/JCM.01703-07; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Ogata S, 2013, INT J CARDIOL, V168, P3825, DOI 10.1016/j.ijcard.2013.06.027; Ogawa S, 2014, CIRC J, V78, P2521, DOI 10.1253/circj.CJ-66-0096; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, CIRC J, V76, P1581, DOI 10.1253/circj.CJ-12-0568; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pitzer VE, 2012, P ROY SOC B-BIOL SCI, V279, P2736, DOI 10.1098/rspb.2011.2464; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Sohn MB, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-242; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TeKippe EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050937; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai HC, 2015, J FORMOS MED ASSOC, V114, P72, DOI 10.1016/j.jfma.2014.07.005; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Wei YP, 2015, BIOMED REP, V3, P821, DOI 10.3892/br.2015.508; YOTO Y, 1994, LANCET, V344, P58, DOI 10.1016/S0140-6736(94)91080-4	46	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209683	10.1371/journal.pone.0209683	http://dx.doi.org/10.1371/journal.pone.0209683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592753	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900037
J	Baba, JS; McKnight, TE; Ericson, MN; Johnson, A; Moise, KJ; Evans, BM				Baba, Justin S.; McKnight, Timothy E.; Ericson, M. Nance; Johnson, Anthony; Moise, Kenneth J., Jr.; Evans, Boyd M., III			Characterization of a reversible thermally-actuated polymer-valve: A potential dynamic treatment for congenital diaphragmatic hernia	PLOS ONE			English	Article							TEMPORARY TRACHEAL OCCLUSION; FLOW-CONTROL; PULMONARY HYPOPLASIA; UNITED-STATES; LUNG GROWTH; MATURATION; LIGATION; MODEL	Background Congenital diaphragmatic hernia (CDH) is a fetal defect comprising an incomplete diaphragm and the herniation of abdominal organs into the chest cavity that interfere with fetal pulmonary development. Though the most promising treatment for CDH is via interventional fetoscopic tracheal occlusion (TO) surgery in-utero, it has produced mixed results due to the static nature of the inserted occlusion. We hypothesize that a suitable noninvasively-actuatable, cyclic-release tracheal occlusion device can be developed to enable dynamic tracheal occlusion (dTO) implementation. Objective To conduct an in-vitro proof-of-concept investigation of the construction of thermo-responsive polymer valves designed for targeted activation within a physiologically realizable temperature range as a first step towards potential development of a noninvasively-actuatable implantable device to facilitate dynamic tracheal occlusion (dTO) therapy. Methods Six thermo-responsive polymer valves, with a critical solution temperature slightly higher than normal physiological body temperature of 37 degrees C, were fabricated using a copolymer of n-isopropylacrylamide (NIPAM) and dimethylacrylamide (DMAA). Three of the valves underwent ethylene oxide (EtO) sterilization while the other three served as controls for EtO-processing compatibility testing. Thermal response actuation of the valves and their steady-state flow performances were evaluated using water and caprine amniotic fluid. Results All six valves consisting of 0.3-mole fraction of DMAA were tested for thermal actuation of caprine amniotic fluid flow at temperatures ranging from 30-44 degrees C. They all exhibited initiation of valve actuation opening at similar to 40 degrees C with full completion at similar to 44 degrees C. The overall average coefficient of variation (CV) for the day-to-day flow performance of the valves tested was less than 12%. Based on a Student t-test, there was no significant difference in the operational characteristics for the EtO processed versus the non-EtO processed valves tested. Conclusions We successfully fabricated and demonstrated physiological realizable temperature range operation of thermo-responsive polymer valves in-vitro and their suitability for standard EtO sterilization processing, a prerequisite for future in-vivo surgical implantation testing.	[Baba, Justin S.; McKnight, Timothy E.; Ericson, M. Nance; Evans, Boyd M., III] Oak Ridge Natl Lab, Elect & Elect Syst Res Div, Oak Ridge, TN 37830 USA; [Baba, Justin S.] Vanderbilt Univ, Dept Biomed Engn, Biophoton Ctr, Nashville, TN 37235 USA; [Johnson, Anthony; Moise, Kenneth J., Jr.] Baylor Coll Med, Dept Obstet, Gynecol, Houston, TX 77030 USA; [Johnson, Anthony; Moise, Kenneth J., Jr.] Univ Texas Houston, McGovern Med Sch Houston, Dept Obstet Gynecol & Reprod Sci, Houston, TX USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Vanderbilt University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Baba, JS (corresponding author), Oak Ridge Natl Lab, Elect & Elect Syst Res Div, Oak Ridge, TN 37830 USA.; Baba, JS (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Biophoton Ctr, Nashville, TN 37235 USA.	babajs@ornl.gov	Baba, Justin S/D-2979-2013	Baba, Justin S/0000-0003-2574-4279	ORNL; U.S. Department of Energy [DE-AC05-00OR22725]; Department of Energy	ORNL; U.S. Department of Energy(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE))	This work was supported in part by ORNL Seed Money funding. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaraj A, 2014, NEUROSURGERY, V74, pS163, DOI 10.1227/NEU.0000000000000220; Andersen FA, 2005, INT J TOXICOL, V24, P21, DOI 10.1080/10915810590953842; Argentiere S, 2012, ADV MICROFLUID; BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609; Balayla J, 2014, J MATERN-FETAL NEO M, V27, P1438, DOI 10.3109/14767058.2013.858691; Balt, BALT NEUR GOLDBALLOO; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Benachi A, 1998, AM J RESP CRIT CARE, V157, P921, DOI 10.1164/ajrccm.157.3.9611023; Berenstein A, 2012, SURG NEUROANGIOGRAPH, V2; Chandrasekharan Praveen Kumar, 2017, Matern Health Neonatol Perinatol, V3, P6, DOI 10.1186/s40748-017-0045-1; Cohen-Katan S, 2009, CONGENITAL DIAPHRAGM, V11, P6; Cooperstein MA, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-19; Davey MG, 2003, J APPL PHYSIOL, V94, P1054, DOI 10.1152/japplphysiol.00733.2002; Davis CF, 1998, ARCH DIS CHILD-FETAL, V79, pF1, DOI 10.1136/fn.79.1.F1; Deprest J, 2004, ULTRASOUND OBST GYN, V24, P121, DOI 10.1002/uog.1711; Deprest JA, 2011, FETAL DIAGN THER, V29, P6, DOI 10.1159/000322844; Deprest JA, 2010, PRENATAL DIAG, V30, P653, DOI 10.1002/pd.2571; DIFIORE JW, 1994, J PEDIATR SURG, V29, P248, DOI 10.1016/0022-3468(94)90328-X; Flageole H, 1998, J PEDIATR SURG, V33, P299, DOI 10.1016/S0022-3468(98)90451-1; Fletcher BL, 2008, ACS NANO, V2, P247, DOI 10.1021/nn700212k; Fletcher BL, 2007, SYNTHETIC MET, V157, P282, DOI 10.1016/j.synthmet.2007.03.004; Ghosh Arijit, 2017, Front Mech Eng, V3, DOI 10.3389/fmech.2017.00007; HARRISON MR, 1993, J PEDIATR SURG, V28, P1411, DOI 10.1016/S0022-3468(05)80338-0; HARRISON MR, 1994, JAMA-J AM MED ASSOC, V271, P382, DOI 10.1001/jama.271.5.382; Ionov L, 2014, MATER TODAY, V17, P494, DOI 10.1016/j.mattod.2014.07.002; Jelin EB, 2011, J PEDIATR SURG, V46, P1150, DOI 10.1016/j.jpedsurg.2011.03.049; Khan PA, 2007, AM J MED GENET C, V145C, P125, DOI 10.1002/ajmg.c.30127; Kirby RS, 2017, 2017 CONGENITAL MALF; Lokuge I, 2007, LANGMUIR, V23, P305, DOI 10.1021/la060813m; McKnight TE, 2014, Patent No. [USOO8657883B2, 8657883]; McKnight TE, 2016, Remote Actuated Valve Implant, Patent No. [USOO9333067B2, 9333067]; Mutlu S, 2003, BOSTON TRANSDUCERS'03: DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2, P802; Nelson SM, 2005, AM J RESP CRIT CARE, V171, P1395, DOI 10.1164/rccm.200409-1284OC; OToole SJ, 1996, J PEDIATR SURG, V31, P546, DOI 10.1016/S0022-3468(96)90493-5; Papadakis K, 1998, J PEDIATR SURG, V33, P1030, DOI 10.1016/S0022-3468(98)90526-7; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Peters EC, 1997, ADV MATER, V9, P630, DOI 10.1002/adma.19970090807; Raval MV, 2011, J PEDIATR SURG, V46, P617, DOI 10.1016/j.jpedsurg.2010.09.047; Robbins J. M., 2007, Morbidity and Mortality Weekly Report, V56, P25; Saitoh T, 2002, ANAL SCI, V18, P203, DOI 10.2116/analsci.18.203; SCURRY JP, 1989, AUST PAEDIATR J, V25, P47; Seaver LH, 2006, OXFORD MONOGRAPHS ME; Shen ZY, 2006, COLLOID POLYM SCI, V284, P1001, DOI 10.1007/s00396-005-1442-y; St Louis AM, 2017, BIRTH DEFECTS RES, V109, P1442, DOI 10.1002/bdr2.1113; WENSTROM KD, 1991, AM J OBSTET GYNECOL, V165, P838, DOI 10.1016/0002-9378(91)90425-Q; Wild YK, 2000, J PEDIATR SURG, V35, P775, DOI 10.1053/jpsu.2000.6067; WILSON JM, 1993, J PEDIATR SURG, V28, P1433, DOI 10.1016/0022-3468(93)90426-L; Yu C, 2003, ANAL CHEM, V75, P1958, DOI 10.1021/ac026455j	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209855	10.1371/journal.pone.0209855	http://dx.doi.org/10.1371/journal.pone.0209855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589888	gold, Green Submitted, Green Published			2022-12-26	WOS:000454418200060
J	Kauf, Z; Damsohn, W; Fangmeier, A				Kauf, Zorica; Damsohn, Walter; Fangmeier, Andreas			Do relationships between leaf traits and fire behaviour of leaf litter beds persist in time?	PLOS ONE			English	Article							FUEL FLAMMABILITY; FOREST; DECOMPOSITION; VEGETATION; PATTERNS; GRASS; CALIFORNIA; DIVERSITY; EMISSIONS; PHYLOGENY	Wildland fires are a dominant disturbance on Earth. On the local scale, fire activity is also influenced by species-specific fire behaviour of leaf litter beds. Thus, researchers strive to identify plant functional traits governing fire behaviour. The currently accepted relationships between morphological characteristics of the individual particles, fuel bed structure and resulting fire behaviour have been established on freshly constructed leaf litter beds. To investigate to what degree these relationships are altered upon exposure of constructed leaf litter beds to outside weather conditions, a novel testing system was designed. It enables outdoor exposure of the constructed litter beds, their subsequent retrieval and fire behaviour testing without disturbing the sample structure. Two treatments were applied on seven monospecific leaf litters. "Fresh treatment" corresponded to the common practice of testing fire behaviour directly after fuel bed construction. In the "settled treatment" constructed fuel beds were exposed for 30 days to outside weather conditions before being tested. The "settled treatment" was designed to address physical changes in the fuel bed structure which occur due to repeated wetting of the fuel bed. Thus, to minimise the effects of decomposition and fragmentation, winter exposure was chosen. Within the "fresh treatment" previously established relationships between size, curl, bulk density and fire behaviour characteristics could be confirmed. In the "settled treatment" the majority of these relationships lost their significance. The "settled treatment" had significantly lower bulk density (BD), rate of spread, maximum flame height and maximum sand temperature at 1 cm depth; and significantly higher flaming duration and amount of unburned residues compared to the "fresh treatment". Species with low initial BD were more affected by the treatment than species with high initial BD. The abrupt change in the fire behaviour of some leaf litter beds and the loss of numerous relationships between morphological characteristics of the individual particles and fire behaviour characteristics upon settled treatment indicate that fast occurring changes in the fuel bed structure should be taken into consideration if we are to understand the relationships between functional traits and local fire activity.	[Kauf, Zorica; Damsohn, Walter; Fangmeier, Andreas] Univ Hohenheim, Inst Landscape & Plant Ecol, Dept Plant Ecol & Ecotoxicol, Stuttgart, Germany	University Hohenheim	Kauf, Z (corresponding author), Univ Hohenheim, Inst Landscape & Plant Ecol, Dept Plant Ecol & Ecotoxicol, Stuttgart, Germany.	zorica.kauf@uni-hohenheim.de						Anderson H. E., 1970, Fire Technology, V6, P312, DOI 10.1007/BF02588932; ANNE G, 2011, FOREST ECOL MANAG, V261, P2223, DOI DOI 10.1016/J.FORECO.2010.09.046; Archibald S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9ead; Balch JK, 2015, BIOSCIENCE, V65, P893, DOI 10.1093/biosci/biv106; Berg B, 2014, SOIL BIOL BIOCHEM, V78, P222, DOI 10.1016/j.soilbio.2014.08.005; Blauw LG, 2015, ECOL EVOL, V5, P3830, DOI 10.1002/ece3.1628; Bond WJ, 2010, NEW PHYTOL, V188, P1137, DOI 10.1111/j.1469-8137.2010.03418.x; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Burrows N. D., 1999, CALMScience, V3, P31; CHAMBERS DP, 1994, AUST J BOT, V42, P739, DOI 10.1071/BT9940739; Clarke PJ, 2014, OECOLOGIA, V176, P1123, DOI 10.1007/s00442-014-3071-y; Cobar-Carranza AJ, 2014, BIOL INVASIONS, V16, P2273, DOI 10.1007/s10530-014-0663-8; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cornelissen JHC, 2017, NEW PHYTOL, V216, P653, DOI 10.1111/nph.14766; Cornwell WK, 2015, NEW PHYTOL, V206, P672, DOI 10.1111/nph.13317; Dias ATC, 2017, J ECOL, V105, P1163, DOI 10.1111/1365-2745.12763; Curt T, 2010, 6 INT C FOR FIR RES; Curt T, 2011, FOREST ECOL MANAG, V261, P2214, DOI 10.1016/j.foreco.2010.12.002; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; Dickinson MB, 2013, CAN J FOREST RES, V43, P321, DOI 10.1139/cjfr-2012-0291; Dickinson MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159997; Emery SM, 2011, FOREST ECOL MANAG, V261, P1401, DOI 10.1016/j.foreco.2011.01.024; Engber EA, 2012, CAN J FOREST RES, V42, P1965, DOI 10.1139/x2012-138; Engber EA, 2011, FIRE ECOL, V7, P32, DOI 10.4996/fireecology.0702032; Fioretto A, 2007, APPL SOIL ECOL, V36, P32, DOI 10.1016/j.apsoil.2006.11.006; Fuentes-Ramirez A, 2016, ECOL APPL, V26, P2311, DOI 10.1002/eap.1371; Gagnon PR, 2015, J ECOL, V103, P1009, DOI 10.1111/1365-2745.12421; Ganteaume A, 2014, INT J WILDLAND FIRE, V23, P1061, DOI 10.1071/WF13045; Ganteaume A, 2013, INT J WILDLAND FIRE, V22, P333, DOI 10.1071/WF12006; Ganteaume A, 2009, INT J WILDLAND FIRE, V18, P951, DOI 10.1071/WF07111; Grootemaat S, 2017, OIKOS, V126, P1428, DOI 10.1111/oik.03886; Grootemaat S, 2015, FUNCT ECOL, V29, P1486, DOI 10.1111/1365-2435.12449; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hessburg PF, 2016, FOREST ECOL MANAG, V366, P221, DOI 10.1016/j.foreco.2016.01.034; Huang YX, 2015, ATMOS ENVIRON, V121, P86, DOI 10.1016/j.atmosenv.2015.06.002; Hyde JC, 2012, INT J WILDLAND FIRE, V21, P596, DOI 10.1071/WF11016; Kane JM, 2008, FOREST ECOL MANAG, V256, P2039, DOI 10.1016/j.foreco.2008.07.039; Kauf Z, 2014, J COMBUST, V2014, DOI 10.1155/2014/970218; Kauf Z, 2015, ENVIRON MANAGE, V55, P687, DOI 10.1007/s00267-014-0427-3; KHEIRALLAH AM, 1990, BIOL FERT SOILS, V10, P202; Kreye JK, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2078; Kreye JK, 2016, INT J WILDLAND FIRE, V25, P1002, DOI 10.1071/WF15214; Langmann B, 2009, ATMOS ENVIRON, V43, P107, DOI 10.1016/j.atmosenv.2008.09.047; Lecerf A, 2017, ECOL MODEL, V362, P65, DOI 10.1016/j.ecolmodel.2017.08.011; Liu YQ, 2014, FOREST ECOL MANAG, V317, P80, DOI 10.1016/j.foreco.2013.02.020; Madrigal J, 2011, J FIRE SCI, V29, P53, DOI 10.1177/0734904110373890; Martin RE, 1994, P 12 C FIR FOR MET 2, P130; Murray BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079205; Ormeno E, 2009, FOREST ECOL MANAG, V257, P471, DOI 10.1016/j.foreco.2008.09.019; Osono T, 2014, PLANT SOIL, V376, P411, DOI 10.1007/s11104-013-1993-5; Pausas JG, 2017, GLOBAL ECOL BIOGEOGR, V26, P889, DOI 10.1111/geb.12596; Pausas JG, 2017, J ECOL, V105, P289, DOI 10.1111/1365-2745.12691; Pausas JG, 2012, NEW PHYTOL, V194, P610, DOI 10.1111/j.1469-8137.2012.04132.x; Pellegrini AFA, 2018, NATURE, V553, P194, DOI 10.1038/nature24668; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Plucinski MP, 2008, INT J WILDLAND FIRE, V17, P628, DOI 10.1071/WF07046; Prior LD, 2018, FIRE-BASEL, V1, DOI 10.3390/fire1010014; Prior LD, 2017, J BIOGEOGR, V44, P1225, DOI 10.1111/jbi.12889; Pyne S, 1996, INTRO WILDLAND FIRE; R Core Team, 2021, R LANGUAGE ENV STAT; Rothermel R. C., 1972, USDA Forests Service Research Paper, Intermountain Forest and Range Experiment Station; Santin C, 2016, GEODERMA, V264, P71, DOI 10.1016/j.geoderma.2015.09.021; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Sikkink PG, 2017, FOREST ECOL MANAG, V405, P150, DOI 10.1016/j.foreco.2017.09.008; Simpson KJ, 2016, J ECOL, V104, P138, DOI 10.1111/1365-2745.12503; Thelen B, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-94; van Altena C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00063; Van Stan JT, 2017, HYDROL PROCESS, V31, P3719, DOI 10.1002/hyp.11292; Varner JM, 2017, BIOL INVASIONS, V19, P2307, DOI 10.1007/s10530-017-1443-z; Varner JM, 2015, CURR FOR REP, V1, P91, DOI 10.1007/s40725-015-0012-x; Weir JR, 2013, FIRE ECOL, V9, P80, DOI 10.4996/fireecology.0903080; Wittkuhn RS, 2017, FOREST ECOL MANAG, V399, P179, DOI 10.1016/j.foreco.2017.05.037; Wyse SV, 2018, ECOSYSTEMS, V21, P886, DOI 10.1007/s10021-017-0195-z; Zhao WW, 2016, ECOL EVOL, V6, P8223, DOI 10.1002/ece3.2451; Zhao WW, 2014, FORESTS, V5, P827, DOI 10.3390/f5040827; Zimmer HC, 2015, INT J WILDLAND FIRE, V24, P349, DOI 10.1071/WF14054; Zylstra P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160715	81	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209780	10.1371/journal.pone.0209780	http://dx.doi.org/10.1371/journal.pone.0209780			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586427	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400094
J	Latimer, RL; Vodstrcil, LA; Fairley, CK; Cornelisse, VJ; Chow, EPF; Read, TRH; Bradshaw, CS				Latimer, Rosie L.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Cornelisse, Vincent J.; Chow, Eric P. F.; Read, Tim R. H.; Bradshaw, Catriona S.			Non-consensual condom removal, reported by patients at a sexual health clinic in Melbourne, Australia	PLOS ONE			English	Article							HIV; MEN; ALCOHOL; RISK; NEGOTIATION	Background Non-consensual removal of condoms, colloquially referred to as 'stealthing', is the removal of a condom during sex by a sexual partner when consent has been given for sex with a condom only. Methods We conducted a cross-sectional survey to determine how commonly women and men who have sex with men (MSM) attending Melbourne Sexual Health Centre had experienced stealthing, and analysed situational factors associated with the event. Responses were linked to demographic information extracted from patient files. Results 1189 of 2883 women (41.2%), and 1063 of 3439 MSM (30.9%) attending the clinic during the study period completed the survey. Thirty-two percent of women (95% CI: 29%, 35%) and 19% of MSM (95% CI: 17%, 22%) reported having ever experienced stealthing. Women who had been stealthed were more likely to be a current sex worker (Adjusted Odds Ratio [AOR] 2.87, 95% CI: 2.01,4.11, p <0.001). MSM who had experienced stealthing were more likely to report anxiety or depression (AOR 2.13, 95% CI: 1.25,3.60, p = 0.005). Both female and male participants who had experienced stealthing were three times less likely to consider it to be sexual assault than participants who had not experienced it (OR 0.29, 95% CI: 0.22,0.4 and OR 0.31, 95% CI: 0.21,0.45 respectively). Conclusions A high proportion of women and MSM attending a sexual health service reported having experienced stealthing. While further investigation is needed into the prevalence of stealthing in the general community, clinicians should be aware of this practice and consider integrating this question into their sexual health consultation. Understanding situational factors would assist in the development of preventive strategies, particularly female sex workers and MSM.	[Latimer, Rosie L.; Vodstrcil, Lenka A.; Fairley, Christopher K.; Cornelisse, Vincent J.; Chow, Eric P. F.; Read, Tim R. H.; Bradshaw, Catriona S.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Vodstrcil, Lenka A.; Fairley, Christopher K.; Cornelisse, Vincent J.; Chow, Eric P. F.; Read, Tim R. H.; Bradshaw, Catriona S.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia	Monash University	Latimer, RL (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.	rlatimer@mshc.org.au	Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019; Chow, Eric P.F./W-6684-2019; Cornelisse, Vincent/P-1346-2015	Vodstrcil, Lenka/0000-0003-3679-9195; Chow, Eric P.F./0000-0003-1766-0657; Cornelisse, Vincent/0000-0003-0657-9677	Australian Government Research Training Program (RTP) Scholarship; NHMRC [1091536, 1091226]	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	RLL and VJC are supported by an Australian Government Research Training Program (RTP) Scholarship. TRHR and EPFC are supported by NHMRC early career fellowship no. 1091536, 1091226, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 2004, J CONSULT CLIN PSYCH, V72, P747, DOI 10.1037/0022-006X.72.5.747; Abbey A, 2002, J STUD ALCOHOL, P118, DOI 10.15288/jsas.2002.s14.118; Alvy LM, 2011, AIDS BEHAV, V15, P1171, DOI 10.1007/s10461-010-9678-z; Brennan J, 2017, PSYCHOL SEX, V8, P318, DOI 10.1080/19419899.2017.1393451; Brodsky A., 2017, COLUMBIA J GENDER LA, V32, P183; Carballo-Dieguez A, 2006, ARCH SEX BEHAV, V35, P473, DOI 10.1007/s10508-006-9078-7; Chow EPF, 2016, AIDS PATIENT CARE ST, V30, P151, DOI 10.1089/apc.2015.0344; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103081; Davis KC, 2016, AIDS BEHAV, V20, pS147, DOI 10.1007/s10461-015-1132-9; Davis KC, 2014, J SEX RES, V51, P454, DOI 10.1080/00224499.2013.776660; Davis KC, 2010, EXP CLIN PSYCHOPHARM, V18, P418, DOI 10.1037/a0020510; de Jong AS, 2016, INT J STD AIDS, V27, P856, DOI 10.1177/0956462415596496; Donovan B., 2012, NEW MEDIA SAVE NEWSP; Grady C., 2017, VOX             1130; Graham Cynthia A, 2006, Sex Health, V3, P255, DOI 10.1071/SH06026; Healicon A., 2016, POLITICS SEXUAL VIOL; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Hickman SE, 1999, J SEX RES, V36, P258, DOI 10.1080/00224499909551996; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Horvath KJ, 2008, J URBAN HEALTH, V85, P744, DOI 10.1007/s11524-008-9299-2; Humphreys T, 2007, J SEX RES, V44, P307, DOI 10.1080/00224490701586706; Jiang J, 2015, SEX TRANSM INFECT, V91, pA30, DOI 10.1136/sextrans-2015-052270.93; Kelley H.H., 1967, NEBRASKA S MOTIVATIO, P192; Kidd P., 2017, GLOBAL HLTH ACTION, V10, DOI [10.1080/16549716.2017.1330511, DOI 10.1080/16549716.2017.1330511]; Klein H, 2014, HEALTH PSYCHOL RES, V2, P54, DOI 10.4081/hpr.2014.1582; Lehrer JA, 2006, PEDIATRICS, V118, P189, DOI 10.1542/peds.2005-1320; Lievore D., 2003, NONREPORTING HIDDEN; McDougal SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105030; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Moore AM, 2010, SOC SCI MED, V70, P1737, DOI 10.1016/j.socscimed.2010.02.009; Musacchio NS, 2006, J ADOLESCENT HEALTH, V39, P452, DOI 10.1016/j.jadohealth.2005.12.021; Perkins R., WORKING GIRLS PROSTI; Pinkerton SD, 2004, AIDS, V18, P2065, DOI 10.1097/00002030-200410210-00011; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; RUBIN HB, 1976, PSYCHOPHARMACOLOGY, V47, P123, DOI 10.1007/BF00735810; Sachs CJ, 2018, SEXUAL ASSAULT INFEC; Weiss KG, 2009, VIOLENCE AGAINST WOM, V15, P810, DOI 10.1177/1077801209333611; Weller SC, 2002, CONDOM EFFECTIVENESS, DOI [10.1002/14651858.cd003255, DOI 10.1002/14651858.CD003255]; Wong P, 1981, WHY PEOPLE ASK WHY Q, P650	39	17	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209779	10.1371/journal.pone.0209779	http://dx.doi.org/10.1371/journal.pone.0209779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586420	Green Published, gold			2022-12-26	WOS:000454416400093
J	Mach, BM; Potter, DA				Mach, Bernadette M.; Potter, Daniel A.			Quantifying bee assemblages and attractiveness of flowering woody landscape plants for urban pollinator conservation	PLOS ONE			English	Article							NATIVE PLANTS; BIODIVERSITY CONSERVATION; SPECIES RICHNESS; NORTH-AMERICAN; GARDEN PLANTS; ALIEN PLANTS; WILD BEES; HYMENOPTERA; CITY; DIVERSITY	Urban and suburban landscapes can be refuges for biodiversity of bees and other pollinators. Public awareness of declining pollinator populations has increased interest in growing plants that provide floral resources for bees. Various publications and websites list "bee-friendly" plants, but such lists are rarely based on empirical data, nor do they emphasize flowering trees and shrubs, which are a major component of urban landscapes. We quantified bee visitation to 72 species of flowering woody landscape plants across 373 urban and suburban sites in Kentucky and southern Ohio, USA, sampling and identifying the bee assemblages associated with 45 of the most bee-attractive species. We found strong plant species effects and variation in seasonal activity of particular bee taxa, but no overall differences in extent of bee visitation or bee genus diversity between native and non-native species, trees and shrubs, or early-, mid-, and late-season blooming plants. Horticulturally-modified varieties of Hydrangea, Prunus, and Rosa with double petals or clusters of showy sterile sepals attracted few bees compared to related plants with more accessible floral rewards. Some of the non-native woody plant species bloomed when floral resources from native plants were scarce and were highly bee-attractive, so their use in landscapes could help extend the flowering season for bees. These data will help city foresters, landscape managers, and the public make informed decisions to create bee-friendly urban and suburban landscapes.	[Mach, Bernadette M.; Potter, Daniel A.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Potter, DA (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	dapotter@uky.edu			Bayer North American Bee Care Center; Horticultural Research Institute; United States Department of Agriculture National Institute of Food and Agriculture Specialty Crop Research Initiative [2016-51181-235399]; University of Kentucky Nursery Research Endowment Fund;  [4];  [2015-34383-23710]	Bayer North American Bee Care Center; Horticultural Research Institute; United States Department of Agriculture National Institute of Food and Agriculture Specialty Crop Research Initiative; University of Kentucky Nursery Research Endowment Fund; ; 	This research was supported by grants from: Bayer North American Bee Care Center (https://beecare.bayer.com/home), BMM, DAP; Horticultural Research Institute (http://www.hriresearch.org/), DAP; United States Department of Agriculture National Institute of Food and Agriculture Specialty Crop Research Initiative grant 2016-51181-235399 facilitated and administered in collaboration with the Interregional Research Project no. 4 grant 2015-34383-23710 (https://nifa.usda.gov/), DAP; University of Kentucky Nursery Research Endowment Fund (http://www.uky.edu/hort/), BMM, DAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock KCR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2849; BATRA SWT, 1985, J KANSAS ENTOMOL SOC, V58, P169; Bellamy CC, 2017, ENVIRON RES, V158, P255, DOI 10.1016/j.envres.2017.06.023; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolmgren K, 2003, EVOLUTION, V57, P2001, DOI 10.1111/j.0014-3820.2003.tb00380.x; Burghardt KT, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00032.1; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cane JH, 2005, BEES POLLINATION CHA; Castillo P., 2014, BEEKEEPING IS RISE U; Clem CS, 2015, J INSECT CONSERV, V19, P987, DOI 10.1007/s10841-015-9815-0; Colding J, 2006, AMBIO, V35, P237, DOI 10.1579/05-A-098R.1; Collins JP, 2000, AM SCI, V88, P416; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Dehnen-Schmutz K, 2011, J APPL ECOL, V48, P1374, DOI 10.1111/j.1365-2664.2011.02061.x; Dicks LV, 2015, ECOL ENTOMOL, V40, P22, DOI 10.1111/een.12226; Diekotter T, 2014, GCB BIOENERGY, V6, P219, DOI 10.1111/gcbb.12080; Dirr M.A., 2011, DIRRS ENCY TREES SHR; Feltham H, 2015, ECOL EVOL, V5, P3523, DOI 10.1002/ece3.1444; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Fleming HR, 2015, POLLINATOR FRIENDLY; Frankie GW, 2009, CALIF AGR, V63, P113, DOI 10.3733/ca.v063n03p113; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Frey K, 2015, BEE FRIENDLY GARDEN; Garbuzov M, 2017, PEERJ, V5, DOI 10.7717/peerj.3066; Garbuzov M, 2015, INSECT SCI, V22, P700, DOI 10.1111/1744-7917.12162; Garbuzov M, 2014, BIOSCIENCE, V64, P1019, DOI 10.1093/biosci/biu150; Garbuzov M, 2014, FUNCT ECOL, V28, P364, DOI 10.1111/1365-2435.12178; GardenResearch. com, 2017, NAT GARD SURV; Gardiner MM, 2013, ENVIRON ENTOMOL, V42, P1123, DOI 10.1603/EN12275; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Godoy O, 2009, PLANT BIOLOGY, V11, P803, DOI 10.1111/j.1438-8677.2008.00185.x; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hall DM, 2017, CONSERV BIOL, V31, P24, DOI 10.1111/cobi.12840; Harmon-Threatt AN, 2015, ECOL ENTOMOL, V40, P471, DOI 10.1111/een.12211; Harrison T, 2015, FUNCT ECOL, V29, P879, DOI 10.1111/1365-2435.12486; Hausmann SL, 2016, INSECT CONSERV DIVER, V9, P97, DOI 10.1111/icad.12145; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Johnson AL, 2017, NEW PHYTOL, V215, P1298, DOI 10.1111/nph.14656; Koh I, 2016, P NATL ACAD SCI USA, V113, P140, DOI 10.1073/pnas.1517685113; La Sorte FA, 2014, GLOBAL ECOL BIOGEOGR, V23, P769, DOI 10.1111/geb.12159; Larson JL, 2014, J INSECT CONSERV, V18, P863, DOI 10.1007/s10841-014-9694-9; Le Feon V, 2018, ECOL EVOL, V8, P1534, DOI 10.1002/ece3.3758; Lerman SB, 2016, ANN ENTOMOL SOC AM, V109, P713, DOI 10.1093/aesa/saw043; Lowenstein DM, 2015, OECOLOGIA, V179, P811, DOI 10.1007/s00442-015-3389-0; MacIvor JS, 2014, URBAN ECOSYST, V17, P139, DOI 10.1007/s11252-013-0321-4; Matteson KC, 2009, CITIES ENV CATE, V2, P5, DOI DOI 10.15365/CATE.2152009; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Matteson KC, 2011, INSECT CONSERV DIVER, V4, P89, DOI 10.1111/j.1752-4598.2010.00103.x; Mayer K, 2017, BIOL INVASIONS, V19, P3613, DOI 10.1007/s10530-017-1594-y; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Moisset B, 2011, INTRO OUR NATIVE BEE; Monarch Watch, 2017, MON WAYST; National Pollinator Garden Network, 2017, MILL POLL GARD CHALL; National Wildlife Federation, 2017, CERT WILDL HAB PROGR; Packer Laurence, 2007, Canadian Journal of Arthropod Identification, V3, P1; Pollinator Partnership, 2017, EC PLANT GUID; Potter Daniel A., 2013, Arboriculture & Urban Forestry, V39, P236; Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rebek EJ, 2008, ENVIRON ENTOMOL, V37, P242, DOI 10.1603/0046-225X(2008)37[242:IVIRTE]2.0.CO;2; Reichard SH, 2003, ANN MO BOT GARD, V90, P64, DOI 10.2307/3298526; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Royal Horticultural Society, 2018, RHS PLANTS POLL; Russo L, 2016, INSECTS, V7, DOI 10.3390/insects7040069; Salisbury A, 2015, J APPL ECOL, V52, P1156, DOI 10.1111/1365-2664.12499; Saunders ME, 2018, INSECT CONSERV DIVER, V11, P13, DOI 10.1111/icad.12243; Shackelford N, 2013, BIOL CONSERV, V158, P55, DOI 10.1016/j.biocon.2012.08.020; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Somme L, 2016, URBAN ECOSYST, V19, P1149, DOI 10.1007/s11252-016-0555-z; TALLAMY D. W., 2007, BRINGING NATURE HOME; Tallamy DW, 2009, CONSERV BIOL, V23, P941, DOI 10.1111/j.1523-1739.2009.01202.x; Tommasi D, 2004, CAN ENTOMOL, V136, P851; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Tuell JK, 2008, ENVIRON ENTOMOL, V37, P707, DOI 10.1603/0046-225X(2008)37[707:VBWAMB]2.0.CO;2; USDA, 2018, USDA AGR PLANT HARD; USDA NISIC, 2018, USDA INV SPEC INF CT; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Williams PH, 2014, BUMBLE BEES N AM IDE; Xerces Society, 2017, POLL FRIENDL PLANT L	85	36	37	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208428	10.1371/journal.pone.0208428	http://dx.doi.org/10.1371/journal.pone.0208428			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586408	Green Published, gold			2022-12-26	WOS:000454416400022
J	Woo, Y; Kim, H; Kim, KC; Han, JA; Jung, YJ				Woo, Yunseo; Kim, Hyeran; Kim, Keun-Cheol; Han, Jeong A.; Jung, Yu-Jin			Tumor-secreted factors induce IL-1 beta maturation via the glucose-mediated synergistic axis of mTOR and NF-kappa B pathways in mouse macrophages	PLOS ONE			English	Article							NLRP3 INFLAMMASOME ACTIVATION; PROINFLAMMATORY CYTOKINE; CANCER-CELLS; PROGRESSION; GROWTH; POLARIZATION	Macrophages are one of the major cell types that produce IL-1 beta. IL-1 beta maturation occurs via inflammasome activation, and mature IL-1 beta is then released from the cell. Secreted IL-1 beta mediates inflammatory reactions in various pathological environments, such as those in infectious, autoimmune, and cancerous diseases. Although the mechanism of IL-1 beta production has been discovered in infectious and autoimmune diseases, its production mechanism in the tumor microenvironment is unclear. Therefore, the mechanism of IL-1 beta production in macrophages in the tumor microenvironment was investigated in this study. First, bone marrow- derived macrophages obtained from C57BL/6 mice were treated with B16F10 tumorconditioned media (TCM) in vitro. TCM increased the levels of IL-1 beta via glucose-mediated activation of the inflammasome. Moreover, TCM enhanced the activation of both NF-kappa B and mTOR pathways in a glucose-dependent manner. In particular, the expression levels of mTORC1 component proteins were dependent on the TCM-induced activation of NF-kappa B signaling. In addition, TCM affected ASC-ASC interactions through increasing intracellular reactive oxygen species levels. Finally, glucose inhibition by inoculation with 2-deoxy-D-glucose in vivo decreased the IL-1 beta levels in both the blood and tumor region of B16F10-bearing C57BL/6 mice relative to those in PBS-injected tumor-bearing mice. These results suggest that glucose supplied from blood vessels might be important for IL-1 beta production in tumor-associated macrophages via the integrated signals of the NF-kappa B and mTOR pathways in the tumor microenvironment.	[Woo, Yunseo; Kim, Hyeran; Kim, Keun-Cheol; Jung, Yu-Jin] Kangwon Natl Univ, Dept Biol Sci, Chunchon, Gangwon, South Korea; [Han, Jeong A.] Kangwon Natl Univ, Dept Biochem & Mol Biol, Sch Med, Chunchon, Gangwon, South Korea	Kangwon National University; Kangwon National University	Jung, YJ (corresponding author), Kangwon Natl Univ, Dept Biol Sci, Chunchon, Gangwon, South Korea.	yjjung@kangwon.ac.kr	Kim, Hyeran/AAB-5165-2021; Jung, Yu-Jin/GNH-4544-2022	Woo, Yunseo/0000-0003-4396-3723; Jung, Yu-Jin/0000-0002-4942-677X	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of the Republic of Korea [HI15C0450]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning of the Republic of Korea [2014M2B2A9030381, 2015M2B2A6028602, 2018R1D1A1B07049097]; Kangwon National University	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of the Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning of the Republic of Korea; Kangwon National University	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare of the Republic of Korea (HI15C0450), and the Basic Science Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, ICT and Future Planning of the Republic of Korea (2014M2B2A9030381, 2015M2B2A6028602, and 2018R1D1A1B07049097) to Y-JJ. Funding was also provided by a research grant from Kangwon National University in 2016 to Y-JJ.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Andersson AK, 2005, J NEUROCHEM, V93, P1327, DOI 10.1111/j.1471-4159.2005.03132.x; Aras S, 2017, BRIT J CANCER, V117, P1583, DOI 10.1038/bjc.2017.356; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Chen GQ, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12324; Cho JH, 2017, ONCOTARGET, V8, P24932, DOI 10.18632/oncotarget.15326; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Flemming A, 2011, NAT REV DRUG DISCOV, V10, DOI 10.1038/nrd3399; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo RS, 2016, ONCOL LETT, V12, P4749, DOI 10.3892/ol.2016.5254; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Khare S, 2016, METHODS MOL BIOL, V1417, P131, DOI 10.1007/978-1-4939-3566-6_8; Kim JK, 2017, IMMUNOL CELL BIOL, V95, P584, DOI 10.1038/icb.2017.23; Kim SR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.460; Kumar S, 2003, AM J PATHOL, V163, P2531, DOI 10.1016/S0002-9440(10)63608-5; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee HJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00541; Liang MD, 2006, J BIOL CHEM, V281, P9227, DOI 10.1074/jbc.M510700200; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Maedler K, 2017, J CLIN INVEST, V127, P1589, DOI 10.1172/JCI92172; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Moon JS, 2015, CELL REP, V12, P102, DOI 10.1016/j.celrep.2015.05.046; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Rojas A, 2016, TUMOR BIOL, V37, P3321, DOI 10.1007/s13277-015-3940-y; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Sousa S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0621-0; Su ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21884; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Wang L, 2016, EBIOMEDICINE, V7, P50, DOI 10.1016/j.ebiom.2016.03.022; Woo Y, 2017, ONCOL LETT, V13, P3579, DOI 10.3892/ol.2017.5872; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	46	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209653	10.1371/journal.pone.0209653	http://dx.doi.org/10.1371/journal.pone.0209653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586442	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400080
J	Mackenzie, AE; Quon, T; Lin, LC; Hauser, AS; Jenkins, L; Inoue, A; Tobin, AB; Gloriam, DE; Hudson, BD; Milligan, G				Mackenzie, Amanda E.; Quon, Tezz; Lin, Li-Chiung; Hauser, Alexander S.; Jenkins, Laura; Inoue, Asuka; Tobin, Andrew B.; Gloriam, David E.; Hudson, Brian D.; Milligan, Graeme			Receptor selectivity between the G proteins G alpha(12) and G alpha(13) is defined by a single leucine-to-isoleucine variation	FASEB JOURNAL			English	Article						GPCR; GPR35; G protein barcode; genome editing	CRYO-EM STRUCTURE; GPR35; AGONIST; IDENTIFICATION; PHARMACOLOGY; ACTIVATION; MIGRATION; POTENT; MODES; GPCRS	Despite recent advances in structural definition of GPCR-G protein complexes, the basis of receptor selectivity between G proteins remains unclear. The G alpha(12) and G alpha(13) subtypes together form the least studied group of heterotrimeric G proteins. G protein-coupled receptor 35 (GPR35) has been suggested to couple efficiently to G alpha(13) but weakly to G alpha(12). Using combinations of cells genome-edited to not express G proteins and bioluminescence resonance energy transfer-based sensors, we confirmed marked selectivity of GPR35 for G alpha(13). Incorporating G alpha(12)/G alpha(13) chimeras and individual residue swap mutations into these sensors defined that selectivity between G alpha(13) and G alpha(12) was imbued largely by a single leucine-to-isoleucine variation at position G.H5.23. Indeed, leucine could not be substituted by other amino acids in G alpha(13) without almost complete loss of GPR35 coupling. The critical importance of leucine at G.H5.23 for GPR35-G protein interaction was further demonstrated by introduction of this leucine into G alpha(q), resulting in the gain of coupling to GPR35. These studies demonstrate that G alpha(13) is markedly the most effective G protein for interaction with GPR35 and that selection between G alpha(13) and G alpha(12) is dictated largely by a single conservative amino acid variation.	[Mackenzie, Amanda E.; Quon, Tezz; Lin, Li-Chiung; Jenkins, Laura; Tobin, Andrew B.; Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow, Lanark, Scotland; [Hauser, Alexander S.; Gloriam, David E.] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan	University of Glasgow; University of Copenhagen; Tohoku University	Hudson, BD; Milligan, G (corresponding author), Univ Glasgow, Ctr Translat Pharmacol, Wolfson Link Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	brian.hudson@glasgow.ac.uk; graeme.milligan@glasgow.ac.uk	Hauser, Alexander/AAV-3436-2020; Gloriam, David E./A-1904-2011; Hudson, Brian/H-4845-2013	Hauser, Alexander/0000-0003-1098-6419; Gloriam, David E./0000-0002-4299-7561; Hudson, Brian/0000-0001-7059-0091	Novo Nordisk Foundation [NNF17OC0031226]; European Research Council [639125]; U.K. Medical Research Council; Glasgow University Leadership Fellowship; U.K. Biotechnology and Biosciences Research Council [BB/P000649/1, BB/P00069X/1]; Japanese Society for the Promotion of Science [17K08264]; Japan Agency for Medical Research and Development Grant [PRIME JP17gm5910013]; BBSRC [BB/P00069X/1, BB/P000649/1] Funding Source: UKRI; MRC [MC_UP_A600_1110, MR/P019366/1] Funding Source: UKRI	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Glasgow University Leadership Fellowship; U.K. Biotechnology and Biosciences Research Council; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development Grant(Japan Agency for Medical Research and Development (AMED)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.E.G. thanks the Novo Nordisk Foundation for Supporting Grant NNF17OC0031226 and the European Research Council for Starting Grant 639125. A.E.M. thanks the U.K. Medical Research Council for an Industrial Collaborative Awards in Science and Engineering Studentship, and B.D.H. was supported by a Glasgow University Leadership Fellowship. These studies were supported by U.K. Biotechnology and Biosciences Research Council Grants BB/P000649/1 (to G.M.) and BB/P00069X/1 (to A.B.T.), Japanese Society for the Promotion of Science Grant-in-Aid for Scientific Research (KAKANHI) 17K08264 (to A.I.), and Japan Agency for Medical Research and Development Grant PRIME JP17gm5910013 (to A.I.). The authors declare no conflicts of interest.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Amir NASBM, 2018, J IMMUNOL, V201, P714, DOI 10.4049/jimmunol.1700884; Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Berlinguer-Palmini R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082180; Bolognini D, 2016, J BIOL CHEM, V291, P18915, DOI 10.1074/jbc.M116.736157; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Carpenter B, 2017, CURR OPIN STRUC BIOL, V45, P124, DOI 10.1016/j.sbi.2017.04.010; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Cooke RM, 2015, DRUG DISCOV TODAY, V20, P1355, DOI 10.1016/j.drudis.2015.08.003; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Funke M, 2013, J MED CHEM, V56, P5182, DOI 10.1021/jm400587g; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Grisshammer R, 2017, PROTEIN SCI, V26, P1493, DOI 10.1002/pro.3200; Guo YJ, 2017, BIOCHEM BIOPH RES CO, V493, P1159, DOI 10.1016/j.bbrc.2017.09.113; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Jenkins L, 2012, J PHARMACOL EXP THER, V343, P683, DOI 10.1124/jpet.112.198945; Jenkins L, 2011, BRIT J PHARMACOL, V162, P733, DOI 10.1111/j.1476-5381.2010.01082.x; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Kamato D, 2017, CELL MOL LIFE SCI, V74, P1379, DOI 10.1007/s00018-016-2405-9; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; MacKenzie AE, 2014, MOL PHARMACOL, V85, P91, DOI 10.1124/mol.113.089482; Malik RU, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08029-3; Manglik A, 2017, BIOCHEMISTRY-US, V56, P5628, DOI 10.1021/acs.biochem.7b00747; Maravillas-Montero JL, 2015, J IMMUNOL, V194, P29, DOI 10.4049/jimmunol.1401704; Mastop M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193705; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Milligan G, 2011, TRENDS PHARMACOL SCI, V32, P317, DOI 10.1016/j.tips.2011.02.002; Moreira IS, 2014, BBA-GEN SUBJECTS, V1840, P16, DOI 10.1016/j.bbagen.2013.08.027; Neetoo-Isseljee Z, 2013, J PHARMACOL EXP THER, V344, P568, DOI 10.1124/jpet.112.201798; Pandy-Szekeres G, 2018, NUCLEIC ACIDS RES, V46, pD440, DOI 10.1093/nar/gkx1109; Park SJ, 2018, BRIT J PHARMACOL, V175, P154, DOI 10.1111/bph.14082; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Semack A, 2016, J BIOL CHEM, V291, P17929, DOI 10.1074/jbc.M116.735720; Sergeev E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14096-3; Shore DM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00069; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Thal DM, 2018, CURR OPIN STRUC BIOL, V51, P28, DOI 10.1016/j.sbi.2018.03.002; Tsukahara T, 2017, PHARMACOL RES, V123, P27, DOI 10.1016/j.phrs.2017.06.009; Van Eps N, 2018, P NATL ACAD SCI USA, V115, P2383, DOI 10.1073/pnas.1721896115; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746	54	11	11	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5005	5017		10.1096/fj.201801956R	http://dx.doi.org/10.1096/fj.201801956R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601679	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000462888500030
J	Michael, JV; Gavrila, A; Nayak, AP; Pera, T; Liberato, JR; Polischak, SR; Shah, SD; Deshpande, DA; Penn, RB				Michael, James V.; Gavrila, Adelina; Nayak, Ajay P.; Pera, Tonio; Liberato, Jennifer R.; Polischak, Steven R.; Shah, Sushrut D.; Deshpande, Deepak A.; Penn, Raymond B.			Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle	FASEB JOURNAL			English	Article						airway remodeling; prostaglandin; asthma; EP receptor	PROTEIN-KINASE-A; PROSTAGLANDIN E-2; EP2 RECEPTOR; AGONISTS; PGE(2); CELLS; PHOSPHOPROTEIN; SENSITIVITY; ACTIVATION; MECHANISMS	Prostaglandin E2 (PGE(2)) is produced in the airway during allergic lung inflammation and both promotes and inhibits features of asthma pathology. These mixed effects relate to 4 E-prostanoid (EP) receptor subtypes (EP1, 2, 3 and 4) expressed at different levels on different resident and infiltrating airway cells. Although studies have asserted both EP2 and EP4 expression in human airway smooth muscle (HASM), a recent study asserted EP4 to be the functionally dominant EP subtype in HASM. Herein, we employ recently-developed subtype-selective ligands to investigate singular or combined EP2 and EP4 receptor activation in regulating HASM signaling and proliferation. The subtype specificity of ONO-AE1-259-01 (EP2 agonist) and ONO-AE1-329 (EP4 agonist) was first demonstrated in human embryonic kidney 293 cells stably expressing different EP receptor subtypes. EP receptor knockdown and subtype-selective antagonists demonstrated EP2 and EP4 receptor responsiveness in HASM cells to the specific ONO compounds, whereas PGE(2) appeared to preferentially signal via the EP4 receptor. Both singular EP2 and EP4 receptor agonists inhibited HASM proliferation, and combined EP2 and EP4 receptor agonism exhibited positive cooperativity in both chronic G(s)-mediated signaling and inhibiting HASM proliferation. These findings suggest both EP2 and EP4 are functionally important in HASM, and their combined targeting optimally inhibits airway smooth muscle proliferation.	[Michael, James V.; Gavrila, Adelina; Nayak, Ajay P.; Pera, Tonio; Liberato, Jennifer R.; Polischak, Steven R.; Shah, Sushrut D.; Deshpande, Deepak A.; Penn, Raymond B.] Thomas Jefferson Univ, Dept Med, Jane & Leonard Korman Lung Ctr, Div Pulm & Crit Care Med,Ctr Translat Med, Philadelphia, PA 19107 USA	Jefferson University	Penn, RB (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Room 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA.	raymond.penn@jefferson.edu		Shah, Sushrut/0000-0002-4201-6532; Michael, James/0000-0001-8796-5259	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL136209, HL58506, HL139035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058506, F32HL139035, R01HL137030, R01HL136209] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL136209 (to R.B.P.), HL58506 (to R.B.P.), and HL139035 (to J.V.M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Aso H, 2013, AM J RESP CELL MOL, V48, P322, DOI 10.1165/rcmb.2012-0158OC; Belvisi MG, 1998, BRIT J PHARMACOL, V125, P1102, DOI 10.1038/sj.bjp.0702104; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Birrell MA, 2015, THORAX, V70, P740, DOI 10.1136/thoraxjnl-2014-206592; Birrell MA, 2013, BRIT J PHARMACOL, V168, P129, DOI 10.1111/j.1476-5381.2012.02088.x; Bogard AS, 2012, J PHARMACOL EXP THER, V342, P586, DOI 10.1124/jpet.112.193425; Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568; Burgess JK, 2004, J ALLERGY CLIN IMMUN, V113, P876, DOI 10.1016/j.jaci.2004.02.029; BUTT E, 1994, J BIOL CHEM, V269, P14509; Bygdeman M, 2003, BEST PRACT RES CL OB, V17, P707, DOI 10.1016/S1521-6934(03)00043-9; Claar D, 2015, EXPERT REV RESP MED, V9, P55, DOI 10.1586/17476348.2015.992783; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; HALBRUGGE M, 1989, EUR J BIOCHEM, V185, P41, DOI 10.1111/j.1432-1033.1989.tb15079.x; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; KAWAKAMI Y, 1973, EUR J CLIN PHARMACOL, V6, P127, DOI 10.1007/BF00562439; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Lazzeri N, 2001, AM J RESP CELL MOL, V24, P44, DOI 10.1165/ajrcmb.24.1.4027; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Lundequist A, 2010, J IMMUNOL, V184, P433, DOI 10.4049/jimmunol.0902835; Maher SA, 2009, AM J RESP CRIT CARE, V180, P923, DOI 10.1164/rccm.200903-0388OC; Markovic T, 2017, DRUG DISCOV TODAY, V22, P57, DOI 10.1016/j.drudis.2016.08.003; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; MELILLO E, 1994, AM J RESP CRIT CARE, V149, P1138, DOI 10.1164/ajrccm.149.5.8173753; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; NIALS AT, 1993, CARDIOVASC DRUG REV, V11, P165, DOI 10.1111/j.1527-3466.1993.tb00274.x; Pan S, 2017, AM J PHYSIOL-LUNG C, V313, pL154, DOI 10.1152/ajplung.00106.2017; Pascual RM, 2001, AM J PHYSIOL-LUNG C, V281, pL1425, DOI 10.1152/ajplung.2001.281.6.L1425; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; Pera T, 2015, FASEB J, V29, P4227, DOI 10.1096/fj.15-273094; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Samuchiwal SK, 2017, J BIOL CHEM, V292, P8195, DOI 10.1074/jbc.M116.769422; Sastre B, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/645383; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Sharma P, 2016, AM J PHYSIOL-LUNG C, V310, P1365, DOI 10.1152/ajplung.00373.2015; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanaka H, 2005, CHEST, V128, P3717, DOI 10.1378/chest.128.5.3717; Tilley SL, 2003, AM J PHYSIOL-LUNG C, V284, pL599, DOI 10.1152/ajplung.00324.2002; WALTERS EH, 1982, THORAX, V37, P438, DOI 10.1136/thx.37.6.438; WALTERS EH, 1982, THORAX, V37, P918, DOI 10.1136/thx.37.12.918; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798	48	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4780	4789		10.1096/fj.201801959R	http://dx.doi.org/10.1096/fj.201801959R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601680	Bronze, Green Published			2022-12-26	WOS:000462888500012
J	Tan, AN; Ke, SY; Chen, Y; Chen, L; Lu, XS; Ding, F; Yang, LH; Tang, Y; Yu, YH				Tan, Anni; Ke, Shiyun; Chen, Yao; Chen, Lei; Lu, Xiaosheng; Ding, Fei; Yang, Liuhong; Tang, Yan; Yu, Yanhong			Expression patterns of C1ql4 and its cell-adhesion GPCR Bai3 in the murine testis and functional roles in steroidogenesis	FASEB JOURNAL			English	Article						testosterone; Leydig cells; ERK1/2; cAMP	COUPLED RECEPTOR BAI3; LEYDIG-CELLS; PROTEIN-KINASE; PATHWAY; BRAIN; ANGIOGENESIS; ADIPONECTIN; ENDOCRINE	C1q-like 4 (C1QL4), a novel member of the C1q- and TNF-related protein family, was found to be highly expressed in rodent and human testis. However, the localization, developmental, and hormonally regulated expression and biologic function of C1ql4 in the testis have not been investigated. Here, we demonstrated that C1ql4 mRNA and protein levels in murine testes gradually increased from the postnatal period to the adult stage and were up-regulated by LH in vivo. In situ hybridization demonstrated that the distribution and expression levels of C1ql4 mRNA varied at different developmental stages, although C1ql4 mRNA was detected in the seminiferous tubule and interstitial Leydig cells. Recombinant C1QL4 did not affect cell proliferation but did increase testosterone production in TM3 Leydig cells, as well as in cultured seminiferous tubules. C1QL4-induced testosterone secretion in Leydig cells was accompanied by increased expression of steroidogenic acute regulatory (StAR) protein and steroidogenic enzymes. During this process, the c-Raf/extracellular signal-regulated protein kinase kinases 1 and 2/ERK1/2/mitogen- and stress-activated protein kinase-1 and cAMP/PKA/cAMP-responsive element binding protein signaling cascades were activated by C1QL4. The cell-adhesion GPCR brain-specific angiogenesis inhibitor 3 (BAI3), a putative receptor of C1QL4, was detected in the seminiferous tubule and interstitial Leydig cells during testicular development. Knockdown of Bai3 expression in Leydig cells led to a reduction in Star expression, accompanied by increases in phosphorylation of ERK1/2 and intercellular cAMP levels. However, C1QL4-induced StAR expression was not completely suppressed in the Bai3-deficient Leydig cells, and phosphorylation of ERK1/2 and intercellular cAMP levels were not significantly changed before and after C1QL4 stimulation. Our results suggested that although BAI3 played a role in C1QL4-induced steroidogenesis, there was an unidentified receptor that mediated C1QL4-activated testosterone secretion in Leydig cells through phosphorylation of ERK1/2 and up-regulation of intracellular cAMP levels. Taken together, our results showed, for the first time to our knowledge, that C1QL4 served as a novel acute regulator of testosterone secretion, and BAI3 functioned as a new receptor that is involved in steroidogenesis in Leydig cells. BAI3-independent ERK1/2 activation and cAMP activation mediated C1QL4-induced testosterone secretion. This study expanded the reproductive roles and mechanisms of C1QL4 and BAI3 signaling pathways.	[Tan, Anni; Ke, Shiyun; Chen, Yao; Lu, Xiaosheng; Ding, Fei; Yang, Liuhong; Tang, Yan; Yu, Yanhong] Chinese Univ Hong Kong, Jinan Univ, Dept Dev & Regenerat Biol, Key Lab Regenerat Med,Minist Educ,Coll Life Sci &, Hong Kong, Peoples R China; [Chen, Lei] Jinan Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Jinan University	Yu, YH (corresponding author), Jinan Univ, Coll Life Sci & Technol, Dept Dev & Regenerat Biol, 601 Huangpu Rd West, Guangzhou 510632, Guangdong, Peoples R China.	yuyhong79@gmail.com		Yu, Yanhong/0000-0002-1652-201X; Tong, Yin Selina/0000-0002-6712-9752	National Natural Science Foundation of China [30900232]; Fundamental Research Funds for the Central Universities [21610202]; Postdoctoral Science Foundation, Funded Project of China [200801259]; Science and Technology Star of Pearl River (Guangzhou City, China) [2013J2200026]; Natural Science Foundation of Guangdong Province [8451063201000105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Postdoctoral Science Foundation, Funded Project of China; Science and Technology Star of Pearl River (Guangzhou City, China); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (30900232), the Fundamental Research Funds for the Central Universities (21610202), the Postdoctoral Science Foundation, Funded Project of China (200801259), the Science and Technology Star of Pearl River (Guangzhou City, China; 2013J2200026), and the Natural Science Foundation of Guangdong Province (8451063201000105). The authors declare no conflicts of interest.	Abdou HS, 2013, ENDOCRINOLOGY, V154, P511, DOI 10.1210/en.2012-1767; Andric SA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1399, DOI 10.1152/ajpendo.00482.2007; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Arakane F, 1998, J BIOL CHEM, V273, P16339, DOI 10.1074/jbc.273.26.16339; Bari MF, 2014, HISTOPATHOLOGY, V64, P547, DOI 10.1111/his.12278; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Caminos JE, 2008, ENDOCRINOLOGY, V149, P3390, DOI 10.1210/en.2007-1582; DUFAU ML, 1977, P NATL ACAD SCI USA, V74, P3419, DOI 10.1073/pnas.74.8.3419; Ge RS, 2005, ENDOCRINOLOGY, V146, P2657, DOI 10.1210/en.2005-0046; Gupta R, 2018, J BIOL CHEM, V293, P18086, DOI 10.1074/jbc.RA118.005403; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Hamoud N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06897-5; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Lanoue V, 2013, MOL PSYCHIATR, V18, P943, DOI 10.1038/mp.2013.46; Liu F, 2017, MOL CELL BIOCHEM, V424, P57, DOI 10.1007/s11010-016-2842-7; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; Matsuda K, 2016, NEURON, V90, P752, DOI 10.1016/j.neuron.2016.04.001; Matzkin ME, 2013, MOL CELL ENDOCRINOL, V370, P130, DOI 10.1016/j.mce.2013.02.017; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Otani M, 2012, CYTOKINE, V58, P238, DOI 10.1016/j.cyto.2012.01.018; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Sigoillot SM, 2015, CELL REP, V10, P820, DOI 10.1016/j.celrep.2015.01.034; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; SYED V, 1985, MOL CELL ENDOCRINOL, V40, P257, DOI 10.1016/0303-7207(85)90181-9; Tremblay JJ, 2015, STEROIDS, V103, P3, DOI 10.1016/j.steroids.2015.08.001; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Yamashita S, 2011, MOL ENDOCRINOL, V25, P1211, DOI 10.1210/me.2011-0059; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024	35	7	7	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4893	4906		10.1096/fj.201801620RR	http://dx.doi.org/10.1096/fj.201801620RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30608882	Bronze			2022-12-26	WOS:000462888500021
J	Santerre, M; Bagashev, A; Gorecki, L; Lysek, KZ; Wang, Y; Shrestha, J; Del Carpio-Cano, F; Mukerjee, R; Sawaya, BE				Santerre, Maryline; Bagashev, Asen; Gorecki, Laura; Lysek, Kyle Z.; Wang, Ying; Shrestha, Jenny; Del Carpio-Cano, Fabiola; Mukerjee, Ruma; Sawaya, Bassel E.			HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); neurodegeneration; neurite outgrowth; microRNA (miRNA); E2F transcription factor; CREB promoter; E2F3; miR-34a; neurodegenerative disease; cognitive disorder; brain derived neurotropic factor	VIRUS TYPE-1 TAT; ELEMENT-BINDING PROTEIN; NEURITE RETRACTION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; TUMOR-SUPPRESSOR; CALCIUM-CHANNEL; TNF-ALPHA; EXPRESSION; CREB	Individuals who are infected with HIV-1 accumulate damage to cells and tissues (e.g. neurons) that are not directly infected by the virus. These include changes known as HIV-associated neurodegenerative disorder (HAND), leading to the loss of neuronal functions, including synaptic long-term potentiation (LTP). Several mechanisms have been proposed for HAND, including direct effects of viral proteins such as the Tat protein. Searching for the mechanisms involved, we found here that HIV-1 Tat inhibits E2F transcription factor 3 (E2F3), CAMP-responsive element-binding protein (CREB), and brain-derived neurotropic factor (BDNF) by up-regulating the microRNA miR-34a. These changes rendered murine neurons dysfunctional by promoting neurite retraction, and we also demonstrate that E2F3 is a specific target of miR-34a. Interestingly, bioinformatics analysis revealed the presence of an E2F3-binding site within the CREB promoter, which we validated with ChIP and transient transfection assays. Of note, luciferase reporter assays revealed that E2F3 up-regulates CREB expression and that Tat interferes with this up-regulation. Further, we show that miR-34a inhibition or E2F3 overexpression neutralizes Tat's effects and restores normal distribution of the synaptic protein synaptophysin, confirming that Tat alters these factors, leading to neurite retraction inhibition. Our results suggest that E2F3 is a key player in neuronal functions and may represent a good target for preventing the development of HAND.	[Santerre, Maryline; Bagashev, Asen; Gorecki, Laura; Lysek, Kyle Z.; Wang, Ying; Shrestha, Jenny; Del Carpio-Cano, Fabiola; Mukerjee, Ruma; Sawaya, Bassel E.] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, FELS Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Bagashev, Asen; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19140 USA; [Bagashev, Asen] Childrens Hosp Philadelphia, Dept Canc Pathobiol, 4300 Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sawaya, BE (corresponding author), Temple Univ, Fels Inst Canc Res, Lewis Katz Sch Med, 3307 N Broad St, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Santerre, Maryline/V-3933-2019; Bagashev, Asen/D-2913-2011	Santerre, Maryline/0000-0003-4650-6552; Bagashev, Asen/0000-0001-9900-8106	National Institutes of Health [R01-NS059327, R01-NS076402, R01-MH093331, R01-AG054411]; NATIONAL INSTITUTE ON AGING [R01AG054411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01-NS059327, R01-NS076402, R01-MH093331, and R01-AG054411 (to B. E. S.). The authors declare that they havenoconflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Amini S, 2005, MOL CELL BIOL, V25, P8126, DOI 10.1128/MCB.25.18.8126-8138.2005; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Bagashev A, 2014, APOPTOSIS, V19, P1202, DOI 10.1007/s10495-014-1003-2; Chang JR, 2011, J BIOL CHEM, V286, P41125, DOI 10.1074/jbc.M111.268466; Chang SJ, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-65; Cheng J, 1998, NEUROSCIENCE, V82, P97, DOI 10.1016/S0306-4522(97)00174-7; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; del Palacio M, 2012, REV MED VIROL, V22, P33, DOI 10.1002/rmv.711; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Edelmann E, 2014, NEUROPHARMACOLOGY, V76, P610, DOI 10.1016/j.neuropharm.2013.05.043; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; EVERALL I, 1995, J NEUROVIROL, V1, P126, DOI 10.3109/13550289509111017; Fitting S, 2008, BRAIN RES, V1232, P139, DOI 10.1016/j.brainres.2008.07.032; Goldschneider D, 2003, CANCER LETT, V197, P99, DOI 10.1016/S0304-3835(03)00089-2; Gorantla S, 2012, TRENDS NEUROSCI, V35, P197, DOI 10.1016/j.tins.2011.12.006; HAYMAN M, 1993, NEUROSCIENCE, V53, P1, DOI 10.1016/0306-4522(93)90278-N; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276; Kida Satoshi, 2012, Exp Neurobiol, V21, P136, DOI 10.5607/en.2012.21.4.136; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Kuhla B, 2006, J NEUROSCI RES, V83, P1591, DOI 10.1002/jnr.20838; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Lesiak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064658; Leuba G, 2008, NEUROBIOL DIS, V30, P408, DOI 10.1016/j.nbd.2008.02.012; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li WX, 2009, NEUROTOX RES, V16, P205, DOI 10.1007/s12640-009-9047-8; LIPTON SA, 1994, MOL NEUROBIOL, V8, P181, DOI 10.1007/BF02780669; LIPTON SA, 1994, DEV NEUROSCI-BASEL, V16, P145, DOI 10.1159/000112101; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mayne M, 2000, J IMMUNOL, V164, P6538, DOI 10.4049/jimmunol.164.12.6538; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Mukerjee R, 2008, CELL CYCLE, V7, P2682, DOI 10.4161/cc.7.17.6450; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; O'Dell RS, 2015, J NEUROSCI, V35, P10659, DOI 10.1523/JNEUROSCI.1629-15.2015; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reimer D, 2011, ONCOGENE, V30, P4038, DOI 10.1038/onc.2011.119; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Sun Y, 2011, MOL CELLS, V31, P483, DOI 10.1007/s10059-011-1036-0; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; TIMMUSK T, 1994, NEUROCHEM INT, V25, P11, DOI 10.1016/0197-0186(94)90046-9; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Valcour Victor G, 2013, Top Antivir Med, V21, P119; WALKER WH, 1995, ENDOCRINOLOGY, V136, P3534, DOI 10.1210/en.136.8.3534; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Webber CA, 2013, NEUROSCIENCE, V252, P512, DOI 10.1016/j.neuroscience.2013.07.046; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Woronowicz A, 2007, GLYCOBIOLOGY, V17, P725, DOI 10.1093/glycob/cwm034; Zhao YN, 2013, BIOCHEM BIOPH RES CO, V435, P597, DOI 10.1016/j.bbrc.2013.05.025	65	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3618	3633		10.1074/jbc.RA118.003744	http://dx.doi.org/10.1074/jbc.RA118.003744			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30591585	hybrid, Green Published			2022-12-26	WOS:000461853900025
J	Schelde, KK; Nicholls, K; Dagnaes-Hansen, F; Bunting, K; Rawsthorne, H; Andersen, B; Finnis, CJA; Williamson, M; Cameron, J; Howard, KA				Schelde, Karen Kraemmer; Nicholls, Karl; Dagnaes-Hansen, Frederik; Bunting, Karen; Rawsthorne, Helen; Andersen, Birgitte; Finnis, Christopher J. A.; Williamson, Miranda; Cameron, Jason; Howard, Kenneth A.			A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						albumin; protein engineering; site-directed mutagenesis; Fc receptor; multidrug transporter; multifunctional protein; cysteine-mediated cross-linking; pharmacokinetics; drug delivery; neonatal Fc receptor	HUMAN SERUM-ALBUMIN; DRUG-DELIVERY; HALF-LIFE; RECEPTOR; PHARMACOKINETICS; GENERATION; INSIGHTS; MOUSE	Human serum albumin is an endogenous ligand transport protein whose long circulatory half-life is facilitated by engagement with the human cellular recycling neonatal Fc receptor (hFcRn). The single free thiol located at Cys-34 in domain I of albumin has been exploited for monoconjugation of drugs. In this work, we increased the drug-to-albumin ratio potential by engineering recombinant human albumin (rHSA) variants with varying hFcRn affinity to contain three free, conjugation-competent cysteines. Structural analysis was used to identify positions for cysteine introduction to maximize rHSA stability and formation of the conjugated product without affecting hFcRn binding. The thiol rHSA variants exhibited up to 95% monomeric stability over 24 months and retained hFcRn engagement compared with a WT unconjugated control demonstrated by Biolayer Interferometry. The additional cysteines were further introduced into a panel of rHSA variants engineered with different affinities for hFcRn. After conjugation with three Alexa Fluor 680 (AF680) fluorophores, hFcRn binding was similar to that of the original triple-thiol nonconjugated rHSA variants (0.88 and 0.25 m for WT albumin with or without 3xAF680 respectively, and 0.04 and 0.02 m for a high hFcRn-binding variant with or without 3xAF680, respectively). We also observed a 1.3-fold increase in the blood circulatory half-life of a high hFcRn-binding triple-thiol variant conjugated with AF680 (t(1/2) = 22.4 h) compared with its WT counterpart (t(1/2) = 17.3 h) in mice. Potential high drug-to-albumin ratios combined with high hFcRn engagement are attractive features of this new class of albumins that offer a paradigm shift for albumin-based drug delivery.	[Schelde, Karen Kraemmer; Howard, Kenneth A.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Nicholls, Karl; Bunting, Karen; Rawsthorne, Helen; Finnis, Christopher J. A.; Williamson, Miranda; Cameron, Jason] Albumedix Ltd, Nottingham NG7 1FD, England; [Andersen, Birgitte] Novozymes AS, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark	Aarhus University; Aarhus University; Novozymes	Howard, KA (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.	kenh@inano.au.dk		Howard, Kenneth/0000-0002-9407-278X	Innovation Fund Denmark [102-2014-3]	Innovation Fund Denmark	This work was supported by Innovation Fund Denmark Grant 102-2014-3. K. N., H. R., and J. C. are employees of Albumedix Ltd., who manufacture and supply albumin for pharmaceutical use.	Andersen JT, 2014, J BIOL CHEM, V289, P13492, DOI 10.1074/jbc.M114.549832; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Bienk K, 2016, J CONTROL RELEASE, V232, P143, DOI 10.1016/j.jconrel.2016.04.013; Caspersen MB, 2017, THER DELIV, V8, P511, DOI 10.4155/tde-2017-0038; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Evans L, 2010, PROTEIN EXPRES PURIF, V73, P113, DOI 10.1016/j.pep.2010.05.009; Howard KA, 2015, THER DELIV, V6, P265, DOI [10.4155/tde.14.124, 10.4155/TDE.14.124]; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kratz F, 2000, J MED CHEM, V43, P1253, DOI 10.1021/jm9905864; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kuhlmann M, 2017, MOL THER-NUCL ACIDS, V9, P284, DOI 10.1016/j.omtn.2017.10.004; Larsen MT, 2018, J CONTROL RELEASE, V287, P132, DOI 10.1016/j.jconrel.2018.07.023; Larsen Maja Thim, 2016, Mol Cell Ther, V4, P3, DOI 10.1186/s40591-016-0048-8; Miyamura S, 2016, J PHARM SCI-US, V105, P1043, DOI 10.1016/j.xphs.2015.12.015; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Petersen SS, 2016, MOL PHARMACEUT, V13, P677, DOI 10.1021/acs.molpharmaceut.5b00605; Roopenian DC, 2015, MABS-AUSTIN, V7, P344, DOI 10.1080/19420862.2015.1008345; Sand KMK, 2014, J BIOL CHEM, V289, P34583, DOI 10.1074/jbc.M114.587675; Schmidt EGW, 2017, J BIOL CHEM, V292, P13312, DOI 10.1074/jbc.M117.794248; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Schmokel J, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa6a9b; Sleep D, 2015, EXPERT OPIN DRUG DEL, V12, P793, DOI 10.1517/17425247.2015.993313; Smith MEB, 2015, ORG BIOMOL CHEM, V13, P7946, DOI 10.1039/c5ob01205h; Viuff D, 2016, J CONTROL RELEASE, V223, P22, DOI 10.1016/j.jconrel.2015.12.019	26	13	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3735	3743		10.1074/jbc.RA118.005870	http://dx.doi.org/10.1074/jbc.RA118.005870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602565	Green Published, hybrid			2022-12-26	WOS:000461853900034
J	Rhee, J; Lee, D; Lim, HJ; Park, MK; Suh, MW; Lee, JH; Hong, YC; Oh, SH				Rhee, Jihye; Lee, Dongwook; Lim, Hyun Jung; Park, Moo Kyun; Suh, Myung Whan; Lee, Jun Ho; Hong, Yun-Chul; Oh, Seung-Ha			Hearing loss in Korean adolescents: The prevalence thereof and its association with leisure noise exposure	PLOS ONE			English	Article							PERSONAL MUSIC SYSTEMS; RISK-FACTORS; CHILDREN; MILD; PERFORMANCE; LANGUAGE; FATIGUE	The increasing use of personal listening devices (PLDs) has been accompanied by a rise in the prevalence of hearing loss (HL) in younger age groups. However, there have been few reports on the relationship between HL and leisure noise exposure (LNE) in adolescents. The purpose of our study was to investigate the prevalence of HL in students attending general middle and high schools and to identify factors affecting HL prevalence. A total of 2,879 nationally representative adolescents in the first years of middle and high school underwent audiometric testing and otological examinations, and completed questionnaires, from June to December 2016. A speech-frequency hearing loss (SFHL) was considered present when the pure tone averages (PTAs) at 0.5, 1, and 2 kHz were >= 15 dB and a high-frequency hearing loss (HFHL) was considered present when the PTAs at 3, 4, 6, and 8 kHz were >= 15 dB. About 17% of Korean adolescents exhibited at least slight HL. The prevalence rates of SFHL and HFHL in the poorer ear were 11.6% and 10.3%, respectively, among Korean adolescents. The use of local area network (LAN) gaming centers and an experience of being asked by others to lower earphone volume were associated with both SFHL and HFHL. It is important to avoid excessive LNE to prevent adolescent HL. Additionally, SFHL or HFHL in the poorer ear was associated with lower academic performance.	[Rhee, Jihye] Vet Hlth Serv Med Ctr, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Dongwook; Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lim, Hyun Jung; Park, Moo Kyun; Suh, Myung Whan; Lee, Jun Ho; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Veterans Health Service Medical Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Oh, SH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	shaoh@snu.ac.kr	Hong, Yun-Chul/J-5725-2012; Suh, Myung-Whan/AAZ-9615-2020	Oh, Seung Ha/0000-0003-1284-5070; Park, Moo Kyun/0000-0002-8635-797X; Suh, Myung-Whan/0000-0003-1301-2249; Rhee, Jihye/0000-0001-8129-3973	Korean society of otolaryngology-head and neck surgery [2016KORL0645]; Korean otology society	Korean society of otolaryngology-head and neck surgery; Korean otology society	Funded by Korean society of otolaryngology-head and neck surgery. Grant number: 2016KORL0645. URL: http://www.korl.or.kr/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Korean otology society Grant number: N/A. URL: http://www.otologicalsociety.or.kr/.Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhanbali S, 2017, EAR HEARING, V38, pE39, DOI 10.1097/AUD.0000000000000361; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; BLAIR JC, 1985, VOLTA REV, V87, P87; Center for Educational Statistics, 2015, LIST ED I 2015 KOR E; Cone BK, 2010, EAR HEARING, V31, P202, DOI 10.1097/AUD.0b013e3181c62263; CRANDELL CC, 1993, EAR HEARING, V14, P210, DOI 10.1097/00003446-199306000-00008; DAVIS JM, 1986, J SPEECH HEAR DISORD, V51, P53, DOI 10.1044/jshd.5101.53; Degeest S, 2017, NOISE HEALTH, V19, P10, DOI 10.4103/1463-1741.199241; Dehnert K, 2015, INT J AUDIOL, V54, P665, DOI 10.3109/14992027.2015.1030510; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Henderson E, 2010, PREVALENCE NOISE IND, P2010; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Hong SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159981; Huang CJ, 2011, J SCHOOL PSYCHOL, V49, P505, DOI 10.1016/j.jsp.2011.07.001; Ivory R, 2014, CURR OPIN OTOLARYNGO, V22, P394, DOI 10.1097/MOO.0000000000000085; Jun HJ, 2015, LARYNGOSCOPE, V125, P690, DOI 10.1002/lary.24913; 신재우, 2005, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V15, P135; KISDI, 2015, KISDI STAT REPORT, V15, P1; Kubba H, 2004, INT J AUDIOL, V43, P123, DOI 10.1080/14992020400050017; Kumar A, 2009, NOISE HEALTH, V11, P132, DOI 10.4103/1463-1741.53357; Kumar UA, 2016, J LARYNGOL OTOL, V130, P717, DOI 10.1017/S0022215116001031; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lie A, 2016, INT ARCH OCC ENV HEA, V89, P351, DOI 10.1007/s00420-015-1083-5; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Lieu JEC, 2012, LARYNGOSCOPE, V122, P2088, DOI 10.1002/lary.23454; Park S-W, 2015, ANAL RESULTS HLTH EX; Quigley SP, 1969, SOME EFFECTS HEARING; 이지영, 2016, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V59, P273, DOI 10.3342/kjorl-hns.2016.59.4.273; Sekhar DL, 2013, J COMMUN HEALTH, V38, P569, DOI 10.1007/s10900-013-9652-6; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Shin J, 2014, KISDI STAT REPORT, V12, P1; Sliwinska-Kowalska M, 2012, NOISE HEALTH, V14, P274, DOI 10.4103/1463-1741.104893; Smith Pauline A., 2000, Noise Health, V2, P41; Sutton GJ, 1997, BRIT J AUDIOL, V31, P39, DOI 10.3109/03005364000000007; Tharpe Anne Marie, 2008, Trends Amplif, V12, P7, DOI 10.1177/1084713807304668; Vogel I, 2010, AM J PUBLIC HEALTH, V100, P1095, DOI 10.2105/AJPH.2009.168690; Wake M, 2006, PEDIATRICS, V118, P1842, DOI 10.1542/peds.2005-3168; Widen S E Olsen, 2004, Noise Health, V7, P59	38	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209254	10.1371/journal.pone.0209254	http://dx.doi.org/10.1371/journal.pone.0209254			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG4NS	30608926	Green Submitted, Green Published, gold			2022-12-26	WOS:000454952800018
J	Tsai, JP; Kuo, R; Sun, JY; Yun, CH; Sung, KT; Liu, CC; Kuo, JY; Hung, CL; Wu, TH; Lin, JL; Hung, TC; Liu, CY; Hou, CJY; Yeh, HI; Bezerra, HG				Tsai, Jui-Peng; Kuo, Richard; Sun, Jing-Yi; Yun, Chun-Ho; Sung, Kuo-Tze; Liu, Chuan-Chuan; Kuo, Jen-Yuan; Hung, Chung-Lieh; Wu, Tung-Hsin; Lin, Jiun-Lu; Hung, Ta-Chuan; Liu, Chia-Yuan; Hou, Charles Jia-Yin; Yeh, Hung-I; Bezerra, Hiram G.			Thoracic aortic calcification across the clinical dysglycemic continuum in a large Asian population free of cardiovascular symptoms	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; ELECTRON-BEAM CT; METABOLIC SYNDROME; VASCULAR CALCIFICATION; COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; HEART-DISEASE; INDEPENDENT PREDICTOR; DIABETES-MELLITUS; CALCIUM SCORE	Thoracic aortic calcification (TAC) is tightly linked to pathological atherosclerosis and associated with certain cardiovascular diseases. While diabetes mellitus (DM) is known as a coronary heart disease equivalent, we examined the presence of TAC across the dysglycemic spectrum of diabetes mellitus (DM). We consecutively studied 3003 asymptomatic ethnic Asians underwent annual cardiovacular health survey, and further categorized them into: 1) 1760 normo-glycemic, 2) 968 pre-diabetic, and 3) 274 overt DM based on dysglycemic indices and medical histories. Several TAC parameters were assessed using non-contrast multi-detector computed tomography (MDCT), and related to dysglycemic indices or diabetes mellitus status. A remarkably graded increases of adjusted total TAC calcium burden, volume and density were seen across Non-diabetes, Pre-diabetes, and diabetes mellitus categories and positively correlated with all dysglycemic profiles (all p<0.001). Multi-variate logistic and linear regression models demonstrated independent associations between greater TAC density and all dysglycemic indices (Coef: 2.5, 1.4, 6.8 for fasting, postprandial sugar and HbA1c) and diabetes mellitus status (all p<0.05). Furthermore, Receiver-operating characteristic curves (ROC) showed fasting sugar and postprandial sugar set at 103mg/dL and 111mg/dL, separately, with HbA1c set at 5.8% all predict the presence of aortic calcification. Dysglycemic status, even without overt diabetes mellitus, were tighly linked to subclinical, pathological thoracic aortic calcification.	[Tsai, Jui-Peng; Sun, Jing-Yi; Sung, Kuo-Tze; Wu, Tung-Hsin] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Tsai, Jui-Peng; Sung, Kuo-Tze; Hung, Chung-Lieh] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Kuo, Richard; Yun, Chun-Ho] Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Kuo, Richard; Yun, Chun-Ho; Sung, Kuo-Tze; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Kuo, Richard; Yun, Chun-Ho] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Liu, Chuan-Chuan; Hung, Chung-Lieh] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei, Taiwan; [Liu, Chuan-Chuan] Mackay Mem Hosp, Hlth Evaluat Ctr, Taipei, Taiwan; [Liu, Chuan-Chuan] Yuanpei Univ Sci & Technol, Dept Med Technol, Hsinchu, Taiwan; [Kuo, Jen-Yuan; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Lin, Jiun-Lu] Mackay Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Hung, Ta-Chuan] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Liu, Chia-Yuan] MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Bezerra, Hiram G.] Univ Hosp Case Med Ctr, Cardiovasc Dept, Cleveland, OH USA	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; National Taiwan University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Case Western Reserve University; Case Western Reserve University Hospital	Wu, TH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Med Coll, Dept Med, Taipei, Taiwan.; Hung, CL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei, Taiwan.	jotaro3791@gmail.com; tung@ym.edu.tw	Kuo, Jen-Yuan/AAX-5448-2021	Lin, Jiun-Lu/0000-0001-5709-4114				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bornfeldt KE, 2014, ARTERIOSCL THROM VAS, V34, P705, DOI 10.1161/ATVBAHA.113.301928; Bragg F, 2016, JAMA CARDIOL, V1, P813, DOI 10.1001/jamacardio.2016.1702; Brodov Y, 2015, ATHEROSCLEROSIS, V238, P4, DOI 10.1016/j.atherosclerosis.2014.10.100; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Carson AP, 2015, DIABETES CARE, V38, P66, DOI 10.2337/dc14-0360; Churchill TW, 2015, J CARDIOVASC COMPUT, V9, P373, DOI 10.1016/j.jcct.2015.04.008; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; de Jong PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102036; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Eisen A, 2008, CIRCULATION, V118, P1328, DOI 10.1161/CIRCULATIONAHA.107.712141; ELLIOTT RJ, 1994, CALCIFIED TISSUE INT, V54, P268, DOI 10.1007/BF00295949; Fan AZ, 2006, J ATHEROSCLER THROMB, V13, P46, DOI 10.5551/jat.13.46; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harper E, 2016, VASC PHARMACOL, V82, P30, DOI 10.1016/j.vph.2016.02.003; Hoffmann U, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003144; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Jacobs PC, 2011, EUR RADIOL, V21, P1577, DOI 10.1007/s00330-011-2112-8; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Katz R, 2016, DIABETIC MED, V33, P912, DOI 10.1111/dme.12958; Kowall B, 2017, J DIABETES COMPLICAT, V31, P234, DOI 10.1016/j.jdiacomp.2016.08.011; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Nemcsik J, 2007, ANGIOLOGY, V58, P413, DOI 10.1177/0003319706291112; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Odink AE, 2010, J HUM HYPERTENS, V24, P86, DOI 10.1038/jhh.2009.42; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Reilly MP, 2004, CIRCULATION, V110, P803, DOI 10.1161/01.CIR.0000138740.84883.9C; Rivera JJ, 2009, AM J CARDIOL, V103, P1562, DOI 10.1016/j.amjcard.2009.02.004; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Takasu J, 2003, ACAD RADIOL, V10, P631, DOI 10.1016/S1076-6332(03)80081-8; Tison GH, 2011, ATHEROSCLEROSIS, V218, P507, DOI 10.1016/j.atherosclerosis.2011.06.047; Tohno Y, 1996, BIOL TRACE ELEM RES, V54, P23, DOI 10.1007/BF02785317; van't Riet E, 2012, EUR J PREV CARDIOL, V19, P23, DOI 10.1097/HJR.0b013e32833b0932; WONG ND, 1994, AM HEART J, V127, P422, DOI 10.1016/0002-8703(94)90133-3; Yahagi K, 2017, ARTERIOSCL THROM VAS, V37, P191, DOI 10.1161/ATVBAHA.116.306256; Yamamoto H, 2003, AM HEART J, V146, P153, DOI 10.1016/S0002-8703(03)00105-4; Yamazoe M, 2016, ARTERIOSCL THROM VAS, V36, P1703, DOI 10.1161/ATVBAHA.116.307612; Zhou XY, 2012, INT J BIOL SCI, V8, P778, DOI 10.7150/ijbs.4538	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0207089	10.1371/journal.pone.0207089	http://dx.doi.org/10.1371/journal.pone.0207089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608944	Green Submitted, Green Published, gold			2022-12-26	WOS:000454952800006
J	Arakaki, X; Lee, R; King, KS; Fonteh, AN; Harrington, MG				Arakaki, Xianghong; Lee, Ryan; King, Kevin S.; Fonteh, Alfred N.; Harrington, Michael G.			Alpha desynchronization during simple working memory unmasks pathological aging in cognitively healthy individuals	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SPECTRAL ENTROPY; NEURAL EFFICIENCY; BAND ACTIVITY; OSCILLATIONS; ATTENTION; CONNECTIVITY; PERFORMANCE; THETA; DEFICITS	Our aim is to explore if cognitive challenge combined with objective physiology can reveal abnormal frontal alpha event-related desynchronization (ERD), in early Alzheimer's disease (AD). We used quantitative electroencephalography (qEEG) to investigate brain activities during N-back working memory (WM) processing at two different load conditions (N = 0 or 2) in an aging cohort. We studied 60-100 year old participants, with normal cognition, and who fits one of two subgroups from cerebrospinal fluid (CSF) proteins: cognitively healthy (CH) with normal amyloid/tau ratio (CH-NAT, n = 10) or pathological amyloid/tau ratio (CH-PAT, n = 14). We recorded behavioral performances, and analyzed alpha power and alpha spectral entropy (SE) at three occasions: during the resting state, and at event-related desynchronization (ERD) [250 similar to 750 ms] during 0-back and 2-back. During 0-back WM testing, the behavioral performance was similar between the two groups, however, qEEG notably differentiated CH-PATs from CH-NATs on the simple, 0-back testing: Alpha ERD decreased from baseline only in the parietal region in CH-NATs, while it decreased in all brain regions in CH-PATs. Alpha SE did not change in CH-NATs, but was increased from baseline in the CH-PATs in frontal and left lateral regions (p<0.01), and was higher in the frontal region (p<0.01) of CH-PATs compared to CH-NATs. The alpha ERD and SE analyses suggest there is frontal lobe dysfunction during WM processing in the CH-PAT stage. Additional power and correlations with behavioral performance were also explored. This study provide pilot information to further evaluate whether this biomarker has clinical significance.	[Arakaki, Xianghong; Lee, Ryan; Fonteh, Alfred N.; Harrington, Michael G.] Huntington Med Res Inst, Neurosci, Pasadena, CA 91105 USA; [King, Kevin S.] Huntington Med Res Inst, Imaging Res, Pasadena, CA USA	Huntington Medical Research Institutes; Huntington Medical Research Institutes	Arakaki, X (corresponding author), Huntington Med Res Inst, Neurosci, Pasadena, CA 91105 USA.	xianghong@hmri.org	King, Kevin S/AFZ-1275-2022	King, Kevin S/0000-0003-4449-2468; Harrington, Michael/0000-0002-7923-8032	L.K. Whittier Foundation; NIA [P01 AG052350]; HMRI; Alexander Family Foundation; Pfeiffer Research Foundation; Jerry Dunlevy Family Foundation; NATIONAL INSTITUTE ON AGING [P01AG052350] Funding Source: NIH RePORTER	L.K. Whittier Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); HMRI; Alexander Family Foundation; Pfeiffer Research Foundation; Jerry Dunlevy Family Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by the L.K. Whittier Foundation 2011-2017, MGH; NIA P01 AG052350, MGH; HMRI, XA; Alexander Family Foundation, MGH; the Pfeiffer Research Foundation, MGH; and the Jerry Dunlevy Family Foundation, MGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Uriguen JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184044; Arakaki X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188101; Babiloni C, 2008, HUM BRAIN MAPP, V29, P1355, DOI 10.1002/hbm.20467; Bachiller A, 2014, EUR ARCH PSY CLIN N, V264, P533, DOI 10.1007/s00406-014-0488-6; Bajo R, 2012, BRAIN CONNECT, V2, P21, DOI 10.1089/brain.2011.0069; Baskaran A, 2012, NEUROPHARMACOLOGY, V63, P507, DOI 10.1016/j.neuropharm.2012.04.021; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Blanco Susana, 2013, ISRN Neurol, V2013, P287327, DOI 10.1155/2013/287327; Bobes MA, 2010, HUM BRAIN MAPP, V31, P247, DOI 10.1002/hbm.20861; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Deiber MP, 2009, NEUROBIOL AGING, V30, P1444, DOI 10.1016/j.neurobiolaging.2007.11.021; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dong SS, 2015, BRAIN RES, V1616, P146, DOI 10.1016/j.brainres.2015.05.003; Lopez ME, 2014, J NEUROSCI, V34, P14551, DOI 10.1523/JNEUROSCI.0964-14.2014; Foster JJ, 2016, J NEUROPHYSIOL, V115, P168, DOI 10.1152/jn.00860.2015; Garcia-Marin V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.028.2009; Gola M, 2013, INT J PSYCHOPHYSIOL, V89, P334, DOI 10.1016/j.ijpsycho.2013.05.007; Golob EJ, 2009, NEUROLOGY, V73, P1649, DOI 10.1212/WNL.0b013e3181c1de77; Grabner RH, 2006, BRAIN RES BULL, V69, P422, DOI 10.1016/j.brainresbull.2006.02.009; Grabner RH, 2004, COGNITIVE BRAIN RES, V20, P212, DOI 10.1016/j.cogbrainres.2004.02.010; Harrington MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079378; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hu L, 2013, J PAIN, V14, P89, DOI 10.1016/j.jpain.2012.10.008; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Kalpouzos G, 2005, J NEUROL, V252, P548, DOI 10.1007/s00415-005-0685-3; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Koppen H, 2011, CEPHALALGIA, V31, P1419, DOI 10.1177/0333102411417900; Lenartowicz A, 2016, NEUROIMAGE-CLIN, V11, P210, DOI 10.1016/j.nicl.2016.01.023; Lenartowicz A, 2014, J NEUROSCI, V34, P1171, DOI 10.1523/JNEUROSCI.1765-13.2014; Li J, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-016-0229-3; Li LY, 2016, IEEE ENG MED BIO, P1862, DOI 10.1109/EMBC.2016.7591083; Lim HK, 2014, BRAIN, V137, P3327, DOI 10.1093/brain/awu271; Lynn Peter A, 2016, Schizophr Res Cogn, V5, P47, DOI 10.1016/j.scog.2016.07.002; Maurer U, 2015, BRAIN TOPOGR, V28, P127, DOI 10.1007/s10548-014-0361-y; McGuinness B, 2010, INT J GERIATR PSYCH, V25, P562, DOI 10.1002/gps.2375; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Mormino EC, 2011, CEREB CORTEX, V21, P2399, DOI 10.1093/cercor/bhr025; Nakamura A, 2018, BRAIN, V141, P1470, DOI 10.1093/brain/awy044; Nakazono T, 2018, NEUROSCI RES, V129, P40, DOI 10.1016/j.neures.2018.02.002; Nava-Mesa MO, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00167; Nowrangi MA, 2015, J ALZHEIMERS DIS, V44, P585, DOI 10.3233/JAD-141937; Nunes Rogean Rodrigues, 2004, Rev. Bras. Anestesiol., V54, P404, DOI 10.1590/S0034-70942004000300013; Olichney JM, 2013, COGN NEUROSCI-UK, V4, P143, DOI 10.1080/17588928.2013.838945; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pagano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131063; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Quandt F, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00305; Ranchet M, 2017, NEUROSCI BIOBEHAV R, V80, P516, DOI 10.1016/j.neubiorev.2017.07.001; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Saliasi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099250; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Shannon CE, 1997, M D COMPUT, V14, P306; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Tian Y, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00437; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Vakkuri A, 2004, ACTA ANAESTH SCAND, V48, P145, DOI 10.1111/j.0001-5172.2004.00323.x; Vanluchene ALG, 2004, ANESTHESIOLOGY, V101, P34, DOI 10.1097/00000542-200407000-00008; Vazquez-Marrufo M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187244; Vorobyov S, 2002, BIOL CYBERN, V86, P293, DOI 10.1007/s00422-001-0298-6; Wilder C, 2018, FASEB J; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Yener Gorsev G, 2013, Suppl Clin Neurophysiol, V62, P237	76	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208517	10.1371/journal.pone.0208517	http://dx.doi.org/10.1371/journal.pone.0208517			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1BB	30601822	gold, Green Submitted, Green Published			2022-12-26	WOS:000454683200013
J	Morimura, N; Mori, Y				Morimura, Naruki; Mori, Yusuke			Social responses of travelling finless porpoises to boat traffic risk in Misumi West Port, Ariake Sound, Japan	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; WHALES ORCINUS-ORCA; NEOPHOCAENA-PHOCAENOIDES; TACHIBANA BAY; BEHAVIOR; AGGRESSION; ECOLOGY; SYSTEMS; SIZE	Anthropogenic effects have created various risks for wild animals. Boat traffic is one of the most fatal risks for marine mammals. Individual behavioral responses of cetaceans, including diving behavior such as changing swimming direction and lengthing inter-breath interval, to passing boats is relatively well known; however, the social function of cetacean responses to boat traffic in a natural setting remains poorly understood. We focused on describing the behavioral responses of single and aggregated finless porpoises to boats passing at Misumi West Port, Ariake Sound, Japan, by using a drone characterized with a high-precision bird's-eye angle. During the study period, we collected 25 episodes of finless porpoise responses to boats passing by. A mean (+/- SEM) of 5.1 +/- 1.0 individuals were observed for each episode. The primary response to passing boats was avoidance by dive, which implies boat traffic is a substantial disturbance to finless porpoises that travel along the seawater surface daily. The diving duration decreased significantly with an increase in the number of aggregated individuals. The diving and floating reaction times were 10.9 +/- 2.3 s and 18.7 +/- 5.0 s, respectively. There was no significant difference between the reaction times indicating that each individual was motivated to keep the group cohesion consistent when floating even after the risk had dissolved, which is comparable to the behavior of porpoises that dive when riskier conditions are present, such as when a boat approaches an aggregation. Our findings provide new insights on the sociality of finless porpoises even though there were limitations, like an inability to identify a specific individual. The drone enabled us to observe the social behavior of finless porpoises and other cetaceans at an unprecedented resolution, which may lead to a better understanding of the evolutionary diversity of intelligence and sociality and the bridge to human evolution.	[Morimura, Naruki; Mori, Yusuke] Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto, Japan	Kyoto University	Morimura, N (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kumamoto Sanctuary, Kumamoto, Japan.	morimura.naruki.5a@kyoto-u.ac.jp		Morimura, Naruki/0000-0002-9117-4828	Japan Society for the Promotion of Science (JSPS; KAKENHI) [15K12048]; Mikimoto Fund for Marine Ecology [091-No.64-5]; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) [16H06283]; JSPS	Japan Society for the Promotion of Science (JSPS; KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mikimoto Fund for Marine Ecology(Mikimoto Fund for Marine Ecology); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was financially supported by grants from the Japan Society for the Promotion of Science (JSPS; KAKENHI No. 15K12048 to Naruki Morimura), the Mikimoto Fund for Marine Ecology (091-No.64-5 to Naruki Morimura), the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT No. 16H06283 to Tetsuro Matsuzawa), and JSPS to the Leading Program in Primatology and Wildlife Science.	Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Brisson-Curadeau E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18202-3; Calleson C. Scott, 2007, Endangered Species Research, V3, P295, DOI 10.3354/esr00056; Christiansen F, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00277; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Dominguez-Sanchez CA, 2018, MAR MAMMAL SCI, V34, P841, DOI 10.1111/mms.12482; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fox KCR, 2017, NAT ECOL EVOL, V1, P1699, DOI 10.1038/s41559-017-0336-y; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hare B, 2015, BEHAVIOUR, V152, P247, DOI 10.1163/1568539X-00003263; Hashimoto M, 2015, ENDANGER SPECIES RES, V27, P87, DOI 10.3354/esr00658; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Hodgson AJ, 2007, J EXP MAR BIOL ECOL, V340, P50, DOI 10.1016/j.jembe.2006.08.006; Jelinski DE, 2002, APPL GEOGR, V22, P393, DOI 10.1016/S0143-6228(02)00051-6; Kasuya T., 1999, HDB MARINE MAMMALS 2, V6, P411; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Lemon M, 2006, BIOL CONSERV, V127, P363, DOI 10.1016/j.biocon.2005.08.016; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Mann J., 2000, CETACEAN SOC FIELD S; Nowacek DP, 2016, ANIM BEHAV, V120, P235, DOI 10.1016/j.anbehav.2016.07.019; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Parsons ECM, 2000, J WILDLIFE DIS, V36, P342, DOI 10.7589/0090-3558-36.2.342; Pomeroy P, 2015, J UNMANNED VEH SYST, V3, P102, DOI 10.1139/juvs-2015-0013; R Core Team, 2018, R LANG ENV STAT COMP; Rees AF, 2018, ENDANGER SPECIES RES, V35, P81, DOI 10.3354/esr00877; Sakai M, 2006, MAR MAMMAL SCI, V22, P966, DOI 10.1111/j.1748-7692.2006.00082.x; Sakai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028836; Scarpaci Carol, 2000, Journal of Cetacean Research and Management, V2, P183; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; SHANE SH, 1986, MAR MAMMAL SCI, V2, P34, DOI 10.1111/j.1748-7692.1986.tb00026.x; Shirakihara K, 2007, MAR BIOL, V150, P1025, DOI 10.1007/s00227-006-0363-8; SHIRAKIHARA M, 1993, MAR MAMMAL SCI, V9, P392, DOI 10.1111/j.1748-7692.1993.tb00472.x; Stacey Pam J., 2002, Aquatic Mammals, V28, P1; Tamaki N, 2006, BEHAV PROCESS, V73, P209, DOI 10.1016/j.beproc.2006.05.010; Tomonaga M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03717; Tyack PL, 2000, CETACEAN SOCIETIES, P270; Visser F, 2016, SCI REP-UK, V6, DOI 10.1038/srep28641; Wang J. Y., 2017, IUCN RED LIST THREAT, V2017, DOI [10.2305/IUCN.UK.2017-3.RLTS.T41754A50381766.en, DOI 10.2305/IUCN.UK.2017-3.RLTS.T41754A50381766.EN]; Watts AC, 2012, REMOTE SENS-BASEL, V4, P1671, DOI 10.3390/rs4061671; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Yagi N, 2010, MAR POLICY, V34, P1300, DOI 10.1016/j.marpol.2010.06.001; Yoshida H, 1997, RES POPUL ECOL, V39, P239, DOI 10.1007/BF02765270	50	4	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208754	10.1371/journal.pone.0208754	http://dx.doi.org/10.1371/journal.pone.0208754			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1BB	30601827	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200022
J	Thornbury, M; Sicheri, J; Slaine, P; Getz, LJ; Finlayson-Trick, E; Cook, J; Guinard, C; Boudreau, N; Jakeman, D; Rohde, J; McCormick, C				Thornbury, Mackenzie; Sicheri, Jacob; Slaine, Patrick; Getz, Landon J.; Finlayson-Trick, Emma; Cook, Jamie; Guinard, Caroline; Boudreau, Nicholas; Jakeman, David; Rohde, John; McCormick, Craig			Characterization of novel lignocellulose-degrading enzymes from the porcupine microbiome using synthetic metagenomics	PLOS ONE			English	Article							NORTH-AMERICAN PORCUPINE; TRANSLATION; INITIATION; LIBRARIES; GENES	Plant cell walls are composed of cellulose, hemicellulose, and lignin, collectively known as lignocellulose. Microorganisms degrade lignocellulose to liberate sugars to meet metabolic demands. Using a metagenomic sequencing approach, we previously demonstrated that the microbiome of the North American porcupine (Erethizon dorsatum) is replete with genes that could encode lignocellulose-degrading enzymes. Here, we report the identification, synthesis and partial characterization of four novel genes from the porcupine microbiome encoding putative lignocellulose-degrading enzymes: beta-glucosidase, alpha-L-arabinofuranosidase, beta-xylosidase, and endo-1,4-beta-xylanase. These genes were identified via conserved catalytic domains associated with cellulose- and hemicellulose-degradation. Phylogenetic trees were created for each of these putative enzymes to depict genetic relatedness to known enzymes. Candidate genes were synthesized and cloned into plasmid expression vectors for inducible protein expression and secretion. The putative beta-glucosidase fusion protein was efficiently secreted but did not permit Escherichia coli (E. coli) to use cellobiose as a sole carbon source, nor did the affinity purified enzyme cleave p-Nitrophenyl beta-D-gluco-pyranoside (p-NPG) substrate in vitro over a range of physiological pH levels (pH 5-7). The putative hemicellulose-degrading beta-xylosidase and alpha-L-arabinofuranosidase enzymes also lacked in vitro enzyme activity, but the affinity purified endo-1,4-beta-xylanase protein cleaved a 6-chloro-4-methylumbelliferyl xylobioside substrate in acidic and neutral conditions, with maximal activity at pH 7. At this optimal pH, K-M, V-max, and k(cat) were determined to be 32.005 +/- 4.72 mu M, 1.16x10(-5) +/- 3.55x10(-7) M/s, and 94.72 s(-1), respectively. Thus, our pipeline enabled successful identification and characterization of a novel hemicellulose-degrading enzyme from the porcupine microbiome. Progress towards the goal of introducing a complete lignocellulose-degradation pathway into E. coli will be accelerated by combining synthetic metagenomic approaches with functional metagenomic library screening, which can identify novel enzymes unrelated to those found in available databases.	[Thornbury, Mackenzie; Sicheri, Jacob; Slaine, Patrick; Getz, Landon J.; Finlayson-Trick, Emma; Cook, Jamie; Guinard, Caroline; Boudreau, Nicholas; Rohde, John; McCormick, Craig] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Jakeman, David] Dalhousie Univ, Dept Chem, Halifax, NS, Canada; [Jakeman, David] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	McCormick, C (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	craig.mccormick@dal.ca	McCormick, Craig/AAH-9069-2019; Getz, Landon/ABC-1692-2020	McCormick, Craig/0000-0003-2794-3722; Getz, Landon/0000-0002-3841-1062; Jakeman, David/0000-0003-3002-3388	Dalhousie Medical Research Foundation; Springboard Innovation Mobilization Program	Dalhousie Medical Research Foundation; Springboard Innovation Mobilization Program	This research was supported by grants from the Dalhousie Medical Research Foundation and the Springboard Innovation Mobilization Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asgeirsson B, 2007, BBA-PROTEINS PROTEOM, V1774, P679, DOI 10.1016/j.bbapap.2007.03.016; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Busk PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114138; Chen HM, 2016, CARBOHYD RES, V421, P33, DOI 10.1016/j.carres.2015.12.010; Cheng JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172545; Cortes-Tolalpa L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01628; de Paula RG, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/1974151; DeMatteo KE, 1997, COMP BIOCHEM PHYS B, V116, P339, DOI 10.1016/S0305-0491(96)00256-8; Finlayson-Trick ECL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189404; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Froger Alexandrine, 2007, J Vis Exp, P253, DOI 10.3791/253; Gharechahi J, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1214-9; Gomez S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0605-z; Graham D, PORCUPINE; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; He J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-56; Hecht A, 2017, NUCLEIC ACIDS RES, V45, P3615, DOI 10.1093/nar/gkx070; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hongzhang C, 2014, BIOTECHNOLOGY LIGNOC, DOI [10.1007/978-94-007-6898-7, DOI 10.1007/978-94-007-6898-7]; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kumar A, 2018, FRONT BIOSCI-LANDMRK, V23, P1789, DOI 10.2741/4673; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazuka A, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1282-x; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez-Alonso M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-4; NEU HC, 1965, J BIOL CHEM, V240, P3685; Ransom-Jones E, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00300-17, 10.1128/msphere.00300-17]; Ravindran R, 2016, BIORESOURCE TECHNOL, V199, P92, DOI 10.1016/j.biortech.2015.07.106; Sadeghi-Khomami A, 2008, CHEM BIOL, V15, P739, DOI 10.1016/j.chembiol.2008.05.017; Sarty D, 2012, CAN J MICROBIOL, V58, P1306, DOI 10.1139/w2012-109; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; Stephens DE, 2007, J BIOTECHNOL, V127, P348, DOI 10.1016/j.jbiotec.2006.06.015; Do TH, 2018, J GEN APPL MICROBIOL, V64, P108, DOI 10.2323/jgam.2017.08.004; VISPO C, 1995, CAN J ZOOL, V73, P967, DOI 10.1139/z95-113; Wi SG, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0419-4; Wijma HJ, 2014, PROTEIN ENG DES SEL, V27, P49, DOI 10.1093/protein/gzt061; Xu B, 2016, J MICROBIOL BIOTECHN, V26, P9, DOI 10.4014/jmb.1504.04021; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zhang WM, 2007, APPL ENVIRON MICROB, V73, P3069, DOI 10.1128/AEM.02970-06; Zhao LS, 2003, BIOCHEMISTRY-US, V42, P14794, DOI 10.1021/bi035501m; Zimmermann S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv938	46	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209221	10.1371/journal.pone.0209221	http://dx.doi.org/10.1371/journal.pone.0209221			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601862	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200050
J	Vu, BN; Green, KE; Phan, HTT; Tran, MH; Ngo, HV; Vo, SH; Ngo, TM; Doan, AH; Bao, A; Dang, LH; Ha, GTT				Bao Ngoc Vu; Green, Kimberly Elizabeth; Huong Thi Thu Phan; Minh Hung Tran; Huu Van Ngo; Son Hai Vo; Trang Minh Ngo; Anh Hong Doan; An Bao; Linh Hong Dang; Giang Thi Tra Ha			Lay provider HIV testing: A promising strategy to reach the undiagnosed key populations in Vietnam	PLOS ONE			English	Article								Background In Vietnam, reaching the remaining one-third of undiagnosed people living with HIV and facilitating their antiretroviral therapy (ART) enrollment requires breakthrough approaches. We piloted lay provider HIV testing as an innovative approach to reach at-risk populations that never or infrequently HIV test at facility-based services. Methods We conducted a cross-sectional survey and analysis of routine program data in two urban provinces (Hanoi and Ho Chi Minh City) and two rural mountainous provinces (Nghe An and Dien Bien) from October 2015 through September 2017. Acceptability of lay provider testing was defined as the proportion of first-time HIV testers utilizing the service, and effectiveness was measured by HIV positivity and ART initiation rates. Univariate and multivariate analyses were used to determine lay provider testing preference and factors associated with that preference. Results Among 1,230 individuals recruited for face-to-face interviews, 74% belonged to key populations: people who inject drugs accounted for 31.4%; men who have sex with men, 60.4%; and female sex workers, 8.2%. Most clients (67%) reported being first-time HIV testers, and the majority (85.8%) preferred lay provider testing to facility-based testing. Multivariate analysis found that clients in urban areas (adjusted odds ratio [aOR] = 2.50; 95% confidence interval [CI]: 1.30-4.90) and those who had a university or higher education (aOR = 1.83; 95% CI: 1.05-3.20) were more likely to prefer lay provider testing. Lay provider testing yielded a higher HIV positivity rate (4.1%), particularly among first-time testers (6.8%), compared to facility-based testing (nationally estimated at 1.6% in 2016) and had a high ART initiation rate (91%). Conclusions Our findings suggest that lay provider HIV testing is an effective approach to reach previously unreached at-risk populations, and, therefore, a critical addition to accelerating Vietnam's attainment of the Joint United Nations Programme on HIV/AIDS 90-90-90 goals.	[Bao Ngoc Vu; Green, Kimberly Elizabeth; Huu Van Ngo; Anh Hong Doan; An Bao; Giang Thi Tra Ha] PATH, Mekong Reg Program, Hanoi, Vietnam; [Huong Thi Thu Phan; Son Hai Vo] Minist Hlth, Vietnam Adm HIV AIDS Control, Hanoi, Vietnam; [Minh Hung Tran; Linh Hong Dang] Ctr Creat Initiat Hlth & Populat, Hanoi, Vietnam; [Trang Minh Ngo] US Agcy Int Dev, Hanoi, Vietnam	United States Agency for International Development (USAID)	Vu, BN (corresponding author), PATH, Mekong Reg Program, Hanoi, Vietnam.	bvu@path.org		Vu, Bao/0000-0002-5529-5411	President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID); USAID; PATH [AID-440-A-14-0002]	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); PATH	This study was made possible through support provided by the President's Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID) via Healthy Markets, a project funded by USAID and implemented by PATH (Cooperative Agreement No. AID-440-A-14-0002). The authors' views expressed in this manuscript do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; FHI 360 for the United States Agency for International Development LINKAGES project, 2015, HIV CASC FRAM KEY PO; FLYNN DE, 2017, BMC RES NOTES, V10, DOI [DOI 10.1186/s13104-016-2339-1, DOI 10.1186/S13104-016-2339-1]; Green KE, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25127; Jackson D, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18744; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, COUNTR FACTSH VIET N; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2017, TASK SHIFT SHAR 90 9; Kanal Koum, 2005, AIDS Res Ther, V2, P5, DOI 10.1186/1742-6405-2-5; Kennedy CE, 2017, AIDS CARE, V29, P1473, DOI 10.1080/09540121.2017.1317710; Ledikwe JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061601; Molesworth AM, 2010, JAIDS-J ACQ IMM DEF, V55, P625, DOI 10.1097/QAI.0b013e3181f98628; Monisha S, 2015, NATURE, V528, pS77, DOI [10.1038/NATURE16044, DOI 10.1038/NATURE16044]; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; National Institute of Hygiene and Epidemiology Vietnam Ministry of Health, 2014, REC NAT HIV TEST ALG; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; UNAIDS, 2014, UND FAST TRACK ACC A; Vannakit R, 2017, 9 IAS C HIV SCI JUL; Vietnam Administration of HIV/AIDS Control (VAAC) Ministry of Health, 2016, RES HIV SENT SURV IN; Vietnam Administration of HIV/AIDS Control (VAAC) Ministry of Health, 2018, NAT HIV TEST PROGR E; Vietnam Ministry of Health (MOH), 2014, OPT VIET NAMS HIV RE; Vietnam Ministry of Health (MOH), 2015, DEC PROM PIL PLAN CO; Vietnam Ministry of Health (MOH), 2018, DEC ISS NAT GUID COM; Walensky RP, 2011, ANN EMERG MED, V58, pS126, DOI 10.1016/j.annemergmed.2011.03.023; WHO, 2007, TREAT TRAIN RET TASK; WHO, 2015, CONSOLIDATED GUIDELI; Wongkanya R, 2018, J VIRUS ERAD, V4, P12	26	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210063	10.1371/journal.pone.0210063	http://dx.doi.org/10.1371/journal.pone.0210063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596777	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200135
J	Gallagher, CP; Howland, KL; Sandstrom, SJ; Halden, NM				Gallagher, Colin P.; Howland, Kimberly L.; Sandstrom, Stephen J.; Halden, Norman M.			Migration tactics affect spawning frequency in an iteroparous salmonid (Salvelinus malma) from the Arctic	PLOS ONE			English	Article							PROTON MICROPROBE ANALYSIS; OTOLITH STRONTIUM; LIFE-HISTORY; TROUT; INSIGHTS; ALPINUS; RIVER; MICROCHEMISTRY; EVOLUTION; BEHAVIOR	Otolith strontium and multi-year mark-recapture information were used to characterize associations between migration patterns and spawning frequencies in an anadromous Dolly Varden (Salvelinus malma) population (Rat River, Northwest Territories, Canada) that undertakes a long migration between freshwater spawning/overwintering (Fish Creek; a tributary to Rat River) and marine feeding habitats (Beaufort Sea) (similar to 800 km round trip). Reconstructions of lifetime annual migration histories among otolith annuli was matched to information on reproductive status (current-year 'spawner' or 'non-spawner') that was known in two different, sometimes successive, years for each fish. Two migratory life histories were observed: fish either migrated annually after smoltification or periodically skipped an annual ocean migration to remain in freshwater and spawn. Different spawning frequencies were detected where fish not migrating annually tended to spawn in alternate years (84.6%) more often than those migrating annually (50%). Additionally, annually migrating fish had lower longevity (<= 9 years vs. <= 13 years). The evaluation of differences in spawning frequency between sexes, independent of migration tactic, revealed males (84.6%) skipped spawning more often than females (51.2%) suggesting fitness trade-offs between life histories differ between sexes. Further, some fish returned from the sea considerably earlier than the majority of other current-year migrants. Our findings demonstrate intrapopulation diversity in migration behaviour and reproductive frequency.	[Gallagher, Colin P.; Howland, Kimberly L.] Fisheries & Oceans Canada, Winnipeg, MB, Canada; [Sandstrom, Stephen J.] Ontario Minist Nat Resources & Forestry, Bracebridge, ON, Canada; [Halden, Norman M.] Univ Manitoba, Dept Geol Sci, Winnipeg, MB, Canada	Fisheries & Oceans Canada; Ministry of Natural Resources & Forestry; University of Manitoba	Gallagher, CP (corresponding author), Fisheries & Oceans Canada, Winnipeg, MB, Canada.	colin.gallagher@dfo-mpo.gc.ca		Gallagher, Colin/0000-0002-5534-9571	Fisheries and Oceans Canada; Gwich'in Renewable Resources Board (Wildlife Studies Fund); Natural Resources Canada Polar Continental Shelf Program; Gwich'in Renewable Resources Board; Ehdiitat RRC; Aklavik Hunters and Trappers Committee; Rat River Working Group; West Side Working Group; Fisheries and Oceans Canada (DFO) Inuvik Office	Fisheries and Oceans Canada; Gwich'in Renewable Resources Board (Wildlife Studies Fund); Natural Resources Canada Polar Continental Shelf Program; Gwich'in Renewable Resources Board; Ehdiitat RRC; Aklavik Hunters and Trappers Committee; Rat River Working Group; West Side Working Group; Fisheries and Oceans Canada (DFO) Inuvik Office	This study was supported by Fisheries and Oceans Canada, Gwich'in Renewable Resources Board (Wildlife Studies Fund), and Natural Resources Canada Polar Continental Shelf Program to Colin Gallagher and Kimberly Howland.; We are thankful for the sampling efforts by harvest monitors John and Tyler Carmichael, Selwyn Kay, Billy Wilson, Jordan McLeod, Dennis Arey, Tracey Loewen, Dana Neumann, Christie Morrison and others, support from Gwich'in Renewable Resources Board, Ehdiitat RRC, Aklavik Hunters and Trappers Committee, Rat River Working Group, West Side Working Group, Fisheries and Oceans Canada (DFO) Inuvik Office (Larry Dow and Ellen Lea), and the otolith technical expertise of Rick Wastle (DFO), Panseok Yang and Zhe Song (University of Manitoba, Department of Geological Sciences). Adriana Rivas Ruiz (DFO) produced the map illustrated in Fig 2.	Armstrong R. H., 1980, CHARRS SALMONID FISH, P99; Avgar T, 2014, CAN J ZOOL, V92, P481, DOI 10.1139/cjz-2013-0076; Babaluk JA, 1997, ARCTIC, V50, P224; Benson K., 2010, GWICHIN TRADITIONAL; Bond MH, 2015, ECOLOGY, V96, P1899, DOI 10.1890/14-1551.1; Bronmark C, 2014, CAN J ZOOL, V92, P467, DOI 10.1139/cjz-2012-0277; Brown RJ, 2018, T AM FISH SOC, DOI [10.1002/tafs.10122, 10.1002/tafs.10051, DOI 10.1002/TAFS.10122]; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chilton D.E., 1982, CAN SPEC PUBL FISH A, V60, P1, DOI 10.1007/s00244-002-1191-6; Clark ID, 1997, ARCTIC ALPINE RES, V29, P240, DOI 10.2307/1552053; COSEWIC, 2010, COSEWIC ASS STAT REP; Courtney MB, 2018, POLAR BIOL, V41, P817, DOI 10.1007/s00300-017-2246-5; CRAIG PC, 1984, T AM FISH SOC, V113, P265, DOI 10.1577/1548-8659(1984)113&lt;265:FUOCWO&gt;2.0.CO;2; DeCicco A, 1989, PHYSL ECOL JPN, V1, P229; DeCicco AL, 1997, FISH ECOLOGY ARCTIC, V19, P175; DFO, 2014, 2014036 DFO CAN SCI, DOI [10.14430/arctic1104, DOI 10.14430/ARCTIC1104]; DFO, 2017, 2016058 DFO CAN SCI; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DUTIL JD, 1986, COPEIA, P945, DOI 10.2307/1445291; Elsdon TS, 2005, MAR ECOL PROG SER, V285, P233, DOI 10.3354/meps285233; Fenkes M, 2016, COMP BIOCHEM PHYS A, V193, P11, DOI 10.1016/j.cbpa.2015.11.012; Fleming IA, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P264; Gallagher C.P., 2013, 2013059 CAN SCI ADV; Gallagher CP, 2016, POLAR BIOL, V39, P1257, DOI 10.1007/s00300-015-1848-z; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Harris LN, 2012, T AM FISH SOC, V141, P1574, DOI 10.1080/00028487.2012.713885; Harris LN, 2015, CAN J FISH AQUAT SCI, V72, P1477, DOI 10.1139/cjfas-2015-0016; Harwood LA, 2009, CAN MANUSCR REP FISH, P2891; Hendry Andrew P., 2004, P92; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Howland KL, 2009, AM FISH S S, V69, P121; Hutchings JA, 1999, J FISH BIOL, V55, P1020, DOI 10.1111/j.1095-8649.1999.tb00737.x; Johnson L., 1980, CHARRS SALMONID FISH, P15; JONSSON B, 1993, J FISH BIOL, V43, P1; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; KALISH JM, 1990, FISH B-NOAA, V88, P657; Kinnison MT, 2001, EVOLUTION, V55, P1656, DOI 10.1111/j.0014-3820.2001.tb00685.x; Kissinger BC, 2016, J GREAT LAKES RES, V42, P267, DOI 10.1016/j.jglr.2015.05.016; Loewen TN, 2016, COMP BIOCHEM PHYS A, V202, P123, DOI 10.1016/j.cbpa.2016.06.017; Loewen TN, 2009, J FISH BIOL, V75, P1473, DOI 10.1111/j.1095-8649.2009.02394.x; MACDONALD JR, 1970, J FISH RES BOARD CAN, V27, P1491, DOI 10.1139/f70-170; McDowall RM, 1999, ICES J MAR SCI, V56, P410, DOI 10.1006/jmsc.1999.0450; Mochnacz NJ, 2010, CAN MANUSCR REP FISH, P2926; Paton C, 2011, J ANAL ATOM SPECTROM, V26, P2508, DOI 10.1039/c1ja10172b; Quinn TP, 2016, CAN J FISH AQUAT SCI, V73, P1015, DOI 10.1139/cjfas-2015-0345; R Core Team, 2016, LANG ENV STAT COMP V, DOI [10.1577/1548-8659, DOI 10.1577/1548-8659]; Radtke R, 1996, MAR ECOL PROG SER, V136, P13, DOI 10.3354/meps136013; Rideout RM, 2011, MAR COAST FISH, V3, P176, DOI 10.1080/19425120.2011.556943; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; ROBSON D. S., 1961, TRANS AMER FISH SOC, V90, P181, DOI 10.1577/1548-8659(1961)90[181:CCAMR]2.0.CO;2; Sandstrom S, 2009, CAN TECH REP FISH AQ, P2842; Sandstrom SJ, 2001, DFO CAN SCI ADVIS SE; Schmidt-Wellenburg CA, 2008, BEHAV ECOL, V19, P1351, DOI 10.1093/beheco/arn066; Stein J. N., 1973, 2 ENV SOC COMM NO PI; Stephenson SA, 2006, ARCTIC, V59, P37; Swanson HK, 2010, CAN J FISH AQUAT SCI, V67, P842, DOI 10.1139/F10-022; Walther BD, 2012, J FISH BIOL, V81, P796, DOI 10.1111/j.1095-8649.2012.03371.x; Yokouchi K, 2011, ENVIRON BIOL FISH, V92, P469, DOI 10.1007/s10641-011-9864-5; Zimmerman CE, 2002, T AM FISH SOC, V131, P986, DOI 10.1577/1548-8659(2002)131&lt;0986:IOSARR&gt;2.0.CO;2	60	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210202	10.1371/journal.pone.0210202	http://dx.doi.org/10.1371/journal.pone.0210202			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596778	gold, Green Submitted, Green Published			2022-12-26	WOS:000454627200152
J	Mason, DH; Dysthe, JC; Franklin, TW; Skorupski, JA; Young, MK; McKelvey, KS; Schwartz, MK				Mason, Daniel H.; Dysthe, Joseph C.; Franklin, Thomas W.; Skorupski, Joseph A.; Young, Michael K.; McKelvey, Kevin S.; Schwartz, Michael K.			qPCR detection of Sturgeon chub (Macrhybopsis gelida) DNA in environmental samples	PLOS ONE			English	Article							MISSOURI RIVER; MEEKI	The Sturgeon chub (Macrhybopsis gelida) is a cyprinid fish native to the Missouri and Mississippi River basins of the U.S. Suspected long-term declines in the size of its distribution have prompted a review of its conservation status by the U.S. Fish and Wildlife Service, a process which depends on reliable methods to delineate the distribution and status of extant populations. To facilitate monitoring of Sturgeon chub populations, we developed a quantitative PCR assay to detect Sturgeon chub DNA in environmental samples. The assay consistently detected Sturgeon chub DNA in concentrations as low as 2 copies per reaction, and did not amplify DNA from non-target fish species that are sympatric in the upper Missouri River basin. Field tests of this assay with environmental samples successfully detected Sturgeon chub from sites known to be occupied. This assay offers an extremely sensitive methodology that can be applied to determine the range of Sturgeon chub, regardless of variation in habitat characteristics.	[Mason, Daniel H.; Dysthe, Joseph C.; Franklin, Thomas W.; Young, Michael K.; McKelvey, Kevin S.; Schwartz, Michael K.] US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59808 USA; [Skorupski, Joseph A.] Wyoming Game & Fish Dept, Cody, WY USA	United States Department of Agriculture (USDA); United States Forest Service	Mason, DH (corresponding author), US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59808 USA.	danielmason@fs.fed.us		Franklin, Thomas/0000-0003-1658-4664; Mason, Daniel/0000-0002-2976-072X; Dysthe, Joseph/0000-0002-6790-7841	Wyoming Game and Fish Department	Wyoming Game and Fish Department	This study was completed through funding from the Wyoming Game and Fish Department. As authors of this study, the funders had a role in all aspects of the study and manuscript preparation.	BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carim K. J., 2016, RMRSGTR355 USDA FOR; Carim KJ, 2016, CONSERVATION GENETIC; CASSELMAN J M, 1990, Polskie Archiwum Hydrobiologii, V37, P521; Everett SR, 2004, HYDROBIOLOGIA, V527, P183, DOI 10.1023/B:HYDR.0000043300.69401.66; Gardner WM., 1999, UPPER MISSOURI RIVER; Gardner WM., 2000, UPPER MISSOURI RIVER; Grisak GG., 1996, THESIS; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; McKelvey KS, 2016, J FISH BIOL, V88, P1215, DOI 10.1111/jfb.12863; Pegg MA, 2003, AQUAT SCI, V65, P63, DOI 10.1007/s000270300005; Quist MC, 2004, T AM FISH SOC, V133, P727, DOI 10.1577/T03-124.1; Ridenour CJ, 2009, RIVER RES APPL, V25, P472, DOI 10.1002/rra.1175; SCHMIDT TR, 1993, COPEIA, P880; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Steffensen Kirk D., 2014, Transactions of the Nebraska Academy of Sciences, V34, P49; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Thomsen PF, 2015, MOL ECOL, V21, P2565; USFWS; Department of the Interior, 2001, FED REG, V82; Welker TL., 2000, THESIS; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	26	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209601	10.1371/journal.pone.0209601	http://dx.doi.org/10.1371/journal.pone.0209601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596729	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200064
J	Pandey, P; Sui, M; Kunwar, S; Pandit, S; Gu, Z; Lee, J				Pandey, Puran; Sui, Mao; Kunwar, Sundar; Pandit, Sanchaya; Gu, Zenan; Lee, Jihoon			Modification of dewetting characteristics for the improved morphology and optical properties of platinum nanostructures using a sacrificial indium layer	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; C-PLANE SAPPHIRE; SILVER NANOPARTICLES; SYSTEMATIC CONTROL; OXYGEN REDUCTION; SIZE; ENHANCEMENT; TEMPERATURE; FABRICATION; EVOLUTION	Metal nanoparticles (NPs) fabricated by means of the solid state dewetting (SSD) approach are applicable in many optoelectronic, biomedical and catalytical applications. However, the fabrication of metallic NPs with the low diffusivity elements such as platinum (Pt) has been challenging for the well-defined configuration and uniformity due to the low diffusivity of Pt atoms and thus the optical properties suffer. In this paper, the evolution of well-defined configuration and improved uniformity of Pt NPs are demonstrated by the altered solid state dewetting (ASSD) approach using a sacrificial indium (In) layer. Upon annealing, the high diffusivity In atoms can lead to the formation of In-Pt alloy due to the inter-mixing at the interface and the dewetting process advances along with the enhanced diffusion of In-Pt alloy atoms. Eventually, well-defined Pt NPs are formed by means of complete desorption of In atoms by sublimation. By the control of In and Pt ratio in the bilayers with the fixed total thickness such as In-4.5 (nm)/Pt-1.5 (nm), In-3 nm/Pt-3 nm, In-1.5 nm/Pt-4.5 nm, the isolated dome shaped Pt NPs of various size are demonstrated, which reflects the significant impact of In component in the dewetting process. The optical characterization of Pt NPs exhibits the formation of quadrupolar resonance and strong dipolar resonance bands in the UV and VIS regions respectively, which are tunable based on the morphology of Pt NPs. In specific, the dipolar resonance peaks demonstrate a red shifting behavior with the increment of size of Pt NPs and gradually become narrower along with the improvement of uniformity of Pt NPs.	[Pandey, Puran; Sui, Mao; Kunwar, Sundar; Pandit, Sanchaya; Gu, Zenan; Lee, Jihoon] Kwangwoon Univ, Coll Elect & Informat, Dept Elect Engn, Seoul, South Korea	Kwangwoon University	Lee, J (corresponding author), Kwangwoon Univ, Coll Elect & Informat, Dept Elect Engn, Seoul, South Korea.	jihoonlee@kw.ac.kr	/B-7688-2019; Pandey, Puran/AFR-7802-2022; KUNWAR, SUNDAR/AAD-1483-2020	/0000-0002-8768-8586; Pandey, Puran/0000-0002-4993-2066; Lee, Jihoon/0000-0002-0508-486X	National Research Foundation of Korea [NRF-2016R1A1A1A05005009, NRF-2018R1A6A1A03025242]; Kwangwoon University	National Research Foundation of Korea(National Research Foundation of Korea); Kwangwoon University	Financial support from the National Research Foundation of Korea (no. NRF-2016R1A1A1A05005009 and NRF-2018R1A6A1A03025242), and in part by the research grant of Kwangwoon University in 2018 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshehri AH, 2012, ACS APPL MATER INTER, V4, P7006, DOI 10.1021/am3022569; Antolini E, 2017, APPL CATAL B-ENVIRON, V217, P201, DOI 10.1016/j.apcatb.2017.05.081; Chen SC, 2014, ACS NANO, V8, P9341, DOI 10.1021/nn503320m; Choi YC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/23/235306; Danielson DT, 2006, J APPL PHYS, V100, DOI 10.1063/1.2357345; Filippo E, 2009, SENSOR ACTUAT B-CHEM, V138, P625, DOI 10.1016/j.snb.2009.02.056; He JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/13/135701; Jeong NC, 2011, LANGMUIR, V27, P14609, DOI 10.1021/la203557f; Kang TD, 2017, J APPL PHYS, V122, DOI 10.1063/1.4993980; Kozanoglu D, 2013, ORG ELECTRON, V14, P1720, DOI 10.1016/j.orgel.2013.04.008; Langhammer C, 2006, NANO LETT, V6, P833, DOI 10.1021/nl060219x; Leem G, 2009, CRYST GROWTH DES, V9, P32, DOI 10.1021/cg8009833; Mayer KM, 2011, CHEM REV, V111, P3828, DOI 10.1021/cr100313v; Mishra YK, 2007, J NANOSCI NANOTECHNO, V7, P1878, DOI 10.1166/jnn.2007.734; Mishra YK, 2013, PLASMONICS, V8, P811, DOI 10.1007/s11468-013-9477-2; Mohapatra S, 2007, J PHYS D APPL PHYS, V40, P7063, DOI 10.1088/0022-3727/40/22/030; Nanda KK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.106102; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Nesselberger M, 2011, J AM CHEM SOC, V133, P17428, DOI 10.1021/ja207016u; Owusu-Ansah E, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921528; Pandey P, 2017, RSC ADV, V7, P55471, DOI 10.1039/c7ra11058h; Pandey P, 2016, APPL SURF SCI, V368, P198, DOI 10.1016/j.apsusc.2016.02.001; Pandey P, 2015, RSC ADV, V5, P66212, DOI 10.1039/c5ra07631e; Ruffino F, 2016, PHYSICA E, V83, P215, DOI 10.1016/j.physe.2016.05.013; Ruffino F, 2015, PHYS STATUS SOLIDI A, V212, P1662, DOI 10.1002/pssa.201431755; San BH, 2013, INT J HYPERTHER, V29, P99, DOI 10.3109/02656736.2012.760137; Schmidl G, 2015, MATER SCI ENG B-ADV, V193, P207, DOI 10.1016/j.mseb.2014.12.001; Shiraishi Y, 2012, ACS CATAL, V2, P1984, DOI 10.1021/cs300407e; Singh SK, 2010, INORG CHEM, V49, P6148, DOI 10.1021/ic1007654; Strobel S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/50/505301; Sui M, 2016, SUPERLATTICE MICROST, V100, P1128, DOI 10.1016/j.spmi.2016.10.083; Thompson CV, 2012, ANNU REV MATER RES, V42, P399, DOI 10.1146/annurev-matsci-070511-155048; Tian Y, 2017, ADV MATER, V29, DOI 10.1002/adma.201701165; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; Wu JL, 2011, ACS NANO, V5, P959, DOI 10.1021/nn102295p; Yallappa S, 2016, NANO-MICRO LETT, V8, P120, DOI 10.1007/s40820-015-0066-0	36	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209803	10.1371/journal.pone.0209803	http://dx.doi.org/10.1371/journal.pone.0209803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596722	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200090
J	Haiwick, G; Hermann, J; Roof, M; Fergen, B; Philips, R; Patterson, A				Haiwick, Greg; Hermann, Joseph; Roof, Michael; Fergen, Brian; Philips, Reid; Patterson, Abby			Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge-dose study	PLOS ONE			English	Article							RESPIRATORY-SYNDROME VIRUS; IMPACT; POPULATION	Vaccination with porcine reproductive and respiratory syndrome (PRRS) Type 2 modified-live vaccines (MLVs) has been shown to improve clinical signs and survival rates in PRRS virus (PRRSV)-challenged pigs. This study evaluated the dose of PRRSV challenge needed to cause and maintain viraemia in PRRS Type 2 MLV-vaccinated pigs and assessed clinical responses to various doses of virulent challenge. This controlled, randomised, blinded vaccination-challenge study involved 95 pigs who were either vaccinated with 2 mL of a PRRS Type 2 MLV on Day 0 or left unvaccinated. On Day 28, pigs were challenged intranasally with virulent PRRSV isolate (dose range <1.5 to 4 log(10) 50% tissue culture infectious dose/mL). Five pigs were left unchallenged and served as environmental controls. Viraemia levels, pyrexia, average daily weight gain and clinical signs were assessed. At all challenge doses, vaccinated groups had reduced viraemia levels and clinical signs, and higher average daily weight gain compared with non-vaccinated groups. Vaccinated groups challenged with <= 2 log had similar viraemia levels and clinical performance (days pyrexic and average daily weight gain) as the non-challenged group. Vaccinated groups had significantly reduced pyrexic days compared with non-vaccinated groups across all challenge doses (P <. 05). Vaccinated pigs challenged with <3 log had significantly improved average daily weight gain (P <. 05). In vaccinated groups, challenge dose correlated positively with viraemia levels and number of days pyrexic, and negatively with average daily weight gain. This is the first study to use a challenge-dose model to evaluate the efficacy of vaccination against PRRSV. PRRS Type 2 MLV was shown to mitigate the consequences of PRRSV infection at all evaluated PRRSV challenge doses. Lower levels of challenge had minimal impact on health and performance of vaccinated pigs, supporting the benefit of vaccinating swine with PRRS Type 2 MLV.	[Haiwick, Greg; Hermann, Joseph; Roof, Michael; Fergen, Brian; Patterson, Abby] Boehringer Ingelheim Anim Hlth Res & Dev, Ames, IA 50010 USA; [Philips, Reid] Boehringer Ingelheim Anim Hlth, Duluth, GA USA	Boehringer Ingelheim	Haiwick, G (corresponding author), Boehringer Ingelheim Anim Hlth Res & Dev, Ames, IA 50010 USA.	greg.haiwick@boehringer-ingelheim.com			Boehringer Ingelheim Animal Health; Boehringer Ingelheim	Boehringer Ingelheim Animal Health(Boehringer Ingelheim); Boehringer Ingelheim(Boehringer Ingelheim)	All authors are employees of Boehringer Ingelheim, who funded the study and developed one of the vaccines evaluated in this study. This commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials. The funder provided support in the form of salaries for authors GH, JH, MR, BF, RP and AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section of this manuscript. The author(s) received no specific funding for this work.; The authors thank Holly Ashford (BSc Biochemistry [Hons]), and Zoe Kelly, (PhD) of Inter-Comm International Ltd, Cambridge, UK, for providing medical writing and editorial support, which was funded by Boehringer Ingelheim Animal Health in accordance with Good Publication Practice guidelines (http://www.ismpp.org/gpp3).	Baker SR, 2012, J SWINE HEALTH PROD, V20, P123; Bales S, 2009, 2009 AD LEM SWIN C S; Cano JP, 2007, VACCINE, V25, P4382, DOI 10.1016/j.vaccine.2007.03.031; Charerntantanakul Wasin, 2012, World J Virol, V1, P23, DOI 10.5501/wjv.v1.i1.23; Cho JG, 2006, CAN J VET RES, V70, P297; Dee S, 2014, AM ASS SWINE VET, P461; Federation of Animal Science Societies, 2010, GUID CAR US AG AN RE; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Linhares DCL, 2012, VACCINE, V30, P407, DOI 10.1016/j.vaccine.2011.10.075; Martelli P, 2009, VACCINE, V27, P3788, DOI 10.1016/j.vaccine.2009.03.028; Murtaugh MP, 2010, VIRUS RES, V154, P18, DOI 10.1016/j.virusres.2010.08.015; Opriessnig T, 2005, J SWINE HEALTH PROD, V13, P246; Patterson A, 2013, AD LEM SWIN C, V194; Patterson A, 2017, AM ASS SWIN VET 2017; Rathkjen PH, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-016-0270-z; Yoon KJ, 1999, VET RES, V30, P629	16	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209784	10.1371/journal.pone.0209784	http://dx.doi.org/10.1371/journal.pone.0209784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592764	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900043
J	Kroiss, SJ; Ahmadzai, M; Ahmed, J; Alam, MM; Chabot-Couture, G; Famulare, M; Mahamud, A; McCarthy, KA; Mercer, LD; Muhammad, S; Safdar, RM; Sharif, S; Shaukat, S; Shukla, H; Lyons, H				Kroiss, Steve J.; Ahmadzai, Maiwand; Ahmed, Jamal; Alam, Muhammad Masroor; Chabot-Couture, Guillaume; Famulare, Michael; Mahamud, Abdirahman; McCarthy, Kevin A.; Mercer, Laina D.; Muhammad, Salman; Safdar, Rana M.; Sharif, Salmaan; Shaukat, Shahzad; Shukla, Hemant; Lyons, Hil			Assessing the sensitivity of the polio environmental surveillance system	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; ERADICATION; POLIOMYELITIS; SEWAGE; CIRCULATION; TRANSMISSION; PERSISTENCE; POPULATION; OUTBREAK; CAMPAIGN	Background The polio environmental surveillance (ES) system has been an incredible tool for advancing polio eradication efforts because of its ability to highlight the spatial and temporal extent of poliovirus circulation. While ES often outperforms, or is more sensitive than AFP surveillance, the sensitivity of the ES system has not been well characterized. Fundamental uncertainty of ES site sensitivity makes it difficult to interpret results from ES, particularly negative results. Methods and findings To study ES sensitivity, we used data from Afghanistan and Pakistan to examine the probability that each ES site detected the Sabin 1, 2, or 3 components of the oral polio vaccine (OPV) as a function of virus prevalence within the same district (estimated from AFP data). Accounting for virus prevalence is essential for estimating site sensitivity because Sabin detection rates should vary with prevalence-high immediately after supplemental immunization activities (SIAs), but low in subsequent months. We found that most ES sites in Pakistan and Afghanistan are highly sensitive for detecting poliovirus relative to AFP surveillance in the same districts. For example, even when Sabin poliovirus is at low prevalence of similar to 0.5-3% in AFP surveillance, most ES sites have similar to 34-50% probability of detecting Sabin. However, there was considerable variation in ES site sensitivity and we flagged several sites for re-evaluation based on low sensitivity rankings and low wild polio virus detection rates. In these areas, adding new sites or modifying collection methods in current sites could improve sensitivity of environmental surveillance. Conclusions Relating ES detections to virus prevalence significantly improved our ability to evaluate site sensitivity compared to evaluations based solely on ES detection rates. To extend our approach to new sites and regions, we provide a preliminary framework for relating ES and AFP detection rates, and descriptions of how detection rates might relate to SIAs and natural seasonality.	[Kroiss, Steve J.; Chabot-Couture, Guillaume; Famulare, Michael; McCarthy, Kevin A.; Mercer, Laina D.; Lyons, Hil] Inst Dis Modeling, Bellevue, WA 98005 USA; [Ahmadzai, Maiwand; Shukla, Hemant] Natl Emergency Operat Ctr Polio Eradicat, Kabul, Afghanistan; [Ahmed, Jamal] World Hlth Org, Geneva, Switzerland; [Alam, Muhammad Masroor; Muhammad, Salman; Sharif, Salmaan; Shaukat, Shahzad] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Alam, Muhammad Masroor; Mahamud, Abdirahman; Sharif, Salmaan; Shaukat, Shahzad] World Hlth Org, Islamabad, Pakistan; [Mahamud, Abdirahman; Safdar, Rana M.] Natl Emergency Operat Ctr Polio Eradicat, Islamabad, Pakistan	World Health Organization; World Health Organization	Kroiss, SJ (corresponding author), Inst Dis Modeling, Bellevue, WA 98005 USA.	skroiss@idmod.org	Shaukat, Shahzad/HHZ-1088-2022	Kroiss, Steve/0000-0003-2416-3667; McCarthy, Kevin/0000-0002-9148-8448; Famulare, Michael/0000-0001-9275-7454	Bill & Melinda Gates through the Global Good Fund, Bellevue, WA, USA	Bill & Melinda Gates through the Global Good Fund, Bellevue, WA, USA	This work was supported by Bill & Melinda Gates through the Global Good Fund, Bellevue, WA, USA. Our funders did not play any role in the collection, analysis, interpretation, writing of final reports, or decision to submit this research.	Al-Amery MM, 2011, INT J AGRON, V2011, DOI 10.1155/2011/230712; Alam MM, 2016, CLIN INFECT DIS, V62, P190, DOI 10.1093/cid/civ831; [Anonymous], 2018, Weekly Epidemiological Record, V93, P153; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Antillon M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005376; Asghar H, 2014, J INFECT DIS, V210, pS294, DOI 10.1093/infdis/jiu384; Berchenko Y, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6786; Blake IM, 2018, NEW ENGL J MED, V379, P834, DOI 10.1056/NEJMoa1716677; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Etsano A, 2016, MMWR-MORBID MORTAL W, V65, P770, DOI 10.15585/mmwr.mm6530a4; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; GELFAND HM, 1962, JAMA-J AM MED ASSOC, V181, P281, DOI 10.1001/jama.1962.03050300001001; HORSTMANN DM, 1973, AM J EPIDEMIOL, V97, P173, DOI 10.1093/oxfordjournals.aje.a121498; HORSTMANN DM, 1946, J CLIN INVEST, V25, P278, DOI 10.1172/JCI101707; Hovi T, 2006, BIOLOGICALS, V34, P123, DOI 10.1016/j.biologicals.2006.02.009; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; HOVI T, 1986, LANCET, V1, P1427; Huang QS, 2005, LANCET, V366, P394, DOI 10.1016/S0140-6736(05)66386-6; Kilpatrick DR, 2011, J VIROL METHODS, V174, P128, DOI 10.1016/j.jviromet.2011.03.020; Kilpatrick DR, 2009, J CLIN MICROBIOL, V47, P1939, DOI 10.1128/JCM.00702-09; Koopman JS, 2017, EPIDEMICS-NETH, V20, P21, DOI 10.1016/j.epidem.2017.02.013; Kroiss SJ, 2017, VACCINE, V35, P5674, DOI 10.1016/j.vaccine.2017.08.048; Lago PM, 2003, INT J EPIDEMIOL, V32, P772, DOI 10.1093/ije/dyg185; Levitt A, 2014, MMWR-MORBID MORTAL W, V63, P356; Lodder WJ, 2012, APPL ENVIRON MICROB, V78, P3800, DOI 10.1128/AEM.07972-11; Manor Y, 2014, EUROSURVEILLANCE, V19, P31, DOI 10.2807/1560-7917.ES2014.19.7.20710; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; Marks F, 2017, LANCET GLOB HEALTH, V5, pE310, DOI 10.1016/S2214-109X(17)30022-0; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; MELNICK JL, 1953, AM J HYG, V58, P207, DOI 10.1093/oxfordjournals.aje.a119602; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; O'reilly KM, AOPULATION SENSITIVI, DOI [10.1186/s12879-018-3070-4, DOI 10.1186/S12879-018-3070-4]; Okonko IO, 2009, SCI RES ESSAYS, V4, P398; PENTTINEN K, 1961, ANN MED EXP BIOL FEN, V39, P195; POYRY T, 1988, APPL ENVIRON MICROB, V54, P371; Ranta J, 2001, RISK ANAL, V21, P1087, DOI 10.1111/0272-4332.t01-1-216174; RIORDAN JT, 1962, YALE J BIOL MED, V34, P512; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Tebbens RJD, 2017, FOOD ENVIRON VIROL, V9, P361, DOI 10.1007/s12560-017-9314-4; WECKER I, 1977, MED MICROBIOL IMMUN, V163, P233, DOI 10.1007/BF02125507; WHO, 2015, 21 INF CONS GLOB POL; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.3.CO;2-8; World Health Organization, 2003, J INTECT DIS, V210, pS324; World Health Organization, 2004, POL LAB MAN, V4, P157; World Health Organization, 2007, WHO POL LAB MAN AL S; ZDRAZILEK J, 1977, INT J EPIDEMIOL, V6, P169, DOI 10.1093/ije/6.2.169	47	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0208336	10.1371/journal.pone.0208336	http://dx.doi.org/10.1371/journal.pone.0208336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592720	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900008
J	Sampei, Z; Haraya, K; Tachibana, T; Fukuzawa, T; Shida-Kawazoe, M; Gan, SW; Shimizu, Y; Ruike, Y; Feng, S; Kuramochi, T; Muraoka, M; Kitazawa, T; Kawabe, Y; Igawa, T; Hattori, K; Nezu, J				Sampei, Zenjiro; Haraya, Kenta; Tachibana, Tatsuhiko; Fukuzawa, Taku; Shida-Kawazoe, Meiri; Gan, Siok Wan; Shimizu, Yuichiro; Ruike, Yoshinao; Feng, Shu; Kuramochi, Taichi; Muraoka, Masaru; Kitazawa, Takehisa; Kawabe, Yoshiki; Igawa, Tomoyuki; Hattori, Kunihiro; Nezu, Junichi			Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody	PLOS ONE			English	Article							DEPENDENT ANTIGEN-BINDING; COMPLEMENT INHIBITOR ECULIZUMAB; SERUM HALF-LIFE; MONOCLONAL-ANTIBODY; IN-VIVO; THERAPEUTIC ANTIBODY; EMICIZUMAB PROPHYLAXIS; HEMOPHILIA-A; PHARMACOKINETICS; IMMUNOGENICITY	Modulating the complement system is a promising strategy in drug discovery for disorders with uncontrolled complement activation. Although some of these disorders can be effectively treated with an antibody that inhibits complement C5, the high plasma concentration of C5 requires a huge dosage and frequent intravenous administration. Moreover, a conventional anti-C5 antibody can cause C5 to accumulate in plasma by reducing C5 clearance when C5 forms an immune complex (IC) with the antibody, which can be salvaged from endosomal vesicles by neonatal Fc receptor (FcRn)-mediated recycling. In order to neutralize the increased C5, an even higher dosage of the antibody would be required. This antigen accumulation can be suppressed by giving the antibody a pH-dependent C5-binding property so that C5 is released from the antibody in the acidic endosome and then trafficked to the lysosome for degradation, while the C5-free antibody returns back to plasma. We recently demonstrated that a pH-dependent C5-binding antibody, SKY59, exhibited long-lasting neutralization of C5 in cynomolgus monkeys, showing potential for subcutaneous delivery or less frequent administration. Here we report the details of the antibody engineering involved in generating SKY59, from humanizing a rabbit antibody to improving the C5-binding property. Moreover, because the pH-dependent C5-binding antibodies that we first generated still accumulated C5, we hypothesized that the surface charges of the ICs partially contributed to a slow uptake rate of the C5-antibody ICs. This idea motivated us to engineer the surface charges of the antibody. Our surface-charge engineered antibody consequently exhibited a high capacity to sweep C5 and suppressed the C5 accumulation in vivo by accelerating the cycle of sweeping: uptake of ICs into cells, release of C5 from the antibody in endosomes, and salvage of the antigen-free antibody. Thus, our engineered anti-C5 antibody, SKY59, is expected to provide significant benefits for patients with complement-mediated disorders.	[Sampei, Zenjiro; Haraya, Kenta; Fukuzawa, Taku; Shida-Kawazoe, Meiri; Kitazawa, Takehisa; Kawabe, Yoshiki] Chugai Pharmaceut Co Ltd, Res Div, Shizuoka, Japan; [Tachibana, Tatsuhiko; Ruike, Yoshinao; Hattori, Kunihiro; Nezu, Junichi] Chugai Pharmaceut Co Ltd, Res Div, Kamakura, Kanagawa, Japan; [Gan, Siok Wan; Shimizu, Yuichiro; Feng, Shu; Kuramochi, Taichi; Muraoka, Masaru; Igawa, Tomoyuki] Chugai Pharmabody Res Pte Ltd, Singapore, Singapore	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Chugai Pharmaceutical Co., Ltd.	Sampei, Z (corresponding author), Chugai Pharmaceut Co Ltd, Res Div, Shizuoka, Japan.	sampei.zenjiro97@chugai-pharm.co.jp	HARAYA, KENTA/AAW-4267-2020	HARAYA, KENTA/0000-0002-9142-5607; Gan, Siok Wan/0000-0002-6982-4492; Tachibana, Tatsuhiko/0000-0001-8339-3986; Kawabe, Yoshiki/0000-0002-6465-7146; Sampei, Zenjiro/0000-0001-5343-4468	Chugai Pharmaceutical Co., Ltd.; Chugai Pharmabody Research Pte. Ltd.	Chugai Pharmaceutical Co., Ltd.; Chugai Pharmabody Research Pte. Ltd.	All the authors are employed by Chugai Pharmaceutical Co., Ltd. or Chugai Pharmabody Research Pte. Ltd. (collectively referred to as "Chugai"), which supported and funded the research described in this report. The study design, data collection and analysis, or preparation of the manuscript were performed by the authors, and their decision to publish was authorized by Chugai.	Alvarez HM, 2012, DRUG METAB DISPOS, V40, P360, DOI 10.1124/dmd.111.042531; Bonvin P, 2015, MABS-AUSTIN, V7, P294, DOI 10.1080/19420862.2015.1006993; Brych SR, 2010, J PHARM SCI-US, V99, P764, DOI 10.1002/jps.21868; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Chiu ML, 2016, CURR OPIN STRUC BIOL, V38, P163, DOI 10.1016/j.sbi.2016.07.012; Davis CB, 1999, DRUG DELIV, V6, P171, DOI 10.1080/107175499266922; De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073; De Groot AS, 2008, CURR OPIN PHARMACOL, V8, P620, DOI 10.1016/j.coph.2008.08.002; Devanaboyina SC, 2013, MABS-AUSTIN, V5, P851, DOI 10.4161/mabs.26389; Dhillon S, 2018, DRUGS, V78, P367, DOI 10.1007/s40265-018-0875-9; Engler FA, 2018, J PHARMACOL EXP THER, V366, P205, DOI 10.1124/jpet.117.246900; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Fukuzawa T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01087-7; Haraya K, 2017, DRUG METAB PHARMACOK, V32, P208, DOI 10.1016/j.dmpk.2017.05.002; Haraya K, 2016, DRUG METAB PHARMACOK, V31, P123, DOI 10.1016/j.dmpk.2015.12.007; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Igawa T, 2014, BBA-PROTEINS PROTEOM, V1844, P1943, DOI 10.1016/j.bbapap.2014.08.003; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2017, YAKUGAKU ZASSHI, V137, P831, DOI 10.1248/yakushi.16-00252-3; Igawa T, 2016, IMMUNOL REV, V270, P132, DOI 10.1111/imr.12392; Igawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063236; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Iwayanagi Y, 2015, J IMMUNOL, V195, P3198, DOI 10.4049/jimmunol.1401470; Kasturirangan S, 2017, J BIOL CHEM, V292, P4361, DOI 10.1074/jbc.M116.770628; Kuramochi T, 2014, METHODS MOL BIOL, V1060, P123, DOI 10.1007/978-1-62703-586-6_7; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Li B, 2014, MABS-AUSTIN, V6, P1255, DOI 10.4161/mabs.29809; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Lowe PJ, 2009, BRIT J CLIN PHARMACO, V68, P61, DOI 10.1111/j.1365-2125.2009.03401.x; Maeda A, 2017, MABS-AUSTIN, V9, P844, DOI 10.1080/19420862.2017.1314873; Mahlangu J, 2018, NEW ENGL J MED, V379, P811, DOI 10.1056/NEJMoa1803550; Moussa EM, 2016, J PHARM SCI-US, V105, P417, DOI 10.1016/j.xphs.2015.11.002; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084; Oldenburg J, 2017, NEW ENGL J MED, V377, P809, DOI 10.1056/NEJMoa1703068; ROETH A, 2017, BLOOD, V130; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Saxena A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00580; Schroter C, 2015, MABS-AUSTIN, V7, P138, DOI 10.4161/19420862.2014.985993; Sheridan D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195909; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Tsubaki M, 2013, INT J BIOL MACROMOL, V52, P139, DOI 10.1016/j.ijbiomac.2012.09.016; Van Walle I, 2007, EXPERT OPIN BIOL TH, V7, P405, DOI 10.1517/14712598.7.3.405; Vincent KJ, 2012, BIOTECHNOL J, V7, P1444, DOI 10.1002/biot.201200250; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Weber CA, 2009, ADV DRUG DELIVER REV, V61, P965, DOI 10.1016/j.addr.2009.07.001; Xiao JJ, 2010, AAPS J, V12, P646, DOI 10.1208/s12248-010-9222-0; Yang DL, 2017, MABS-AUSTIN, V9, P1105, DOI 10.1080/19420862.2017.1359455	52	25	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209509	10.1371/journal.pone.0209509	http://dx.doi.org/10.1371/journal.pone.0209509			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592762	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900029
J	Danilov, SM; Tikhomirova, VE; Kryukova, OV; Balatsky, AV; Bulaeva, NI; Golukhova, EZ; Bokeria, LA; Samokhodskaya, LM; Kost, OA				Danilov, Sergei M.; Tikhomirova, Victoria E.; Kryukova, Olga V.; Balatsky, Alexander V.; Bulaeva, Naida I.; Golukhova, Elena Z.; Bokeria, Leo A.; Samokhodskaya, Larisa M.; Kost, Olga A.			Conformational fingerprint of blood and tissue ACEs: Personalized approach	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MONOCLONAL-ANTIBODIES; HUMAN PLASMA; N-DOMAIN; GLYCOSYLATION; FORMS; INHIBITION; EXPRESSION; MEMBRANE; SEQUENCE	Background The pattern of binding of monoclonal antibodies (mAbs) to 18 epitopes on human angiotensin I-converting enzyme (ACE)-"conformational fingerprint of ACE"-is a sensitive marker of subtle conformational changes of ACE due to mutations, different glycosylation in various cells, the presence of ACE inhibitors and specific effectors, etc. Methodology/Principal findings We described in detail the methodology of the conformational fingerprinting of human blood and tissue ACEs that allows detecting differences in surface topography of ACE from different tissues, as well detecting inter-individual differences. Besides, we compared the sensitivity of the detection of ACE inhibitors in the patient's plasma using conformational fingerprinting of ACE (with only 2 mAbs to ACE, 1G12 and 9B9) and already accepted kinetic assay and demonstrated that the mAbs-based assay is an order of magnitude more sensitive. This approach is also very effective in detection of known (like bilirubin and lysozyme) and still unknown ACE effectors/inhibitors which nature and set could vary in different tissues or different patients. Conclusions/Significance Phenotyping of ACE (and conformational fingerprinting of ACE as a part of this novel approach for characterization of ACE) in individuals really became informative and clinically relevant. Appreciation (and counting on) of inter-individual differences in ACE conformation and accompanying effectors make the application of this approach for future personalized medicine with ACE inhibitors more accurate. This (or similar) methodology can be applied to any enzyme/protein for which there is a number of mAbs to its different epitopes.	[Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA; [Danilov, Sergei M.] Univ Arizona Hlth Sci, Tucson, AZ 85721 USA; [Danilov, Sergei M.; Balatsky, Alexander V.; Samokhodskaya, Larisa M.] Lomonosov Moscow State Univ, Med Ctr, Moscow, Russia; [Tikhomirova, Victoria E.; Kryukova, Olga V.; Kost, Olga A.] Lomonosov Moscow State Univ, Fac Chem, Moscow, Russia; [Tikhomirova, Victoria E.; Kryukova, Olga V.; Bulaeva, Naida I.; Golukhova, Elena Z.; Bokeria, Leo A.; Kost, Olga A.] Bakulev Ctr Cardiovasc Surg, Moscow, Russia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Arizona Health Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Medical Sciences; Bakulev Scientific Center for Cardiovascular Surgery	Danilov, SM (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA.; Danilov, SM (corresponding author), Univ Arizona Hlth Sci, Tucson, AZ 85721 USA.; Danilov, SM (corresponding author), Lomonosov Moscow State Univ, Med Ctr, Moscow, Russia.	danilov@uic.edu	Balatskiy, Alexander/A-8181-2014; Tikhomirova, Victoria/E-4966-2019; Bulaeva, Naida/L-6748-2018	Balatskiy, Alexander/0000-0002-6694-2231; Tikhomirova, Victoria/0000-0003-4368-3430; Bulaeva, Naida/0000-0002-5091-0518	Ministry of Science and Education of Russian Federation [14, Z50.31.0026]	Ministry of Science and Education of Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by the Ministry of Science and Education of Russian Federation grant no. 14.Z50.31.0026 to SMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Science and Education of Russian Federation, grant 14.Z50.31.0026.	Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; BERNSTEIN KE, 1990, BIOCHEM BIOPH RES CO, V167, P310, DOI 10.1016/0006-291X(90)91766-L; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Brogren H, 2008, THROMB RES, V122, P271, DOI 10.1016/j.thromres.2008.04.008; BULL HG, 1985, J BIOL CHEM, V260, P2952; Chung CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056119; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov S M, 2017, Mol Biol (Mosk), V51, P1046, DOI 10.7868/S0026898417060155; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2018, MOL GENET METAB, V123, P501, DOI 10.1016/j.ymgme.2018.02.007; Danilov SM, 2017, J CARDIOVASC PHARM T, V22, P374, DOI 10.1177/1074248416686188; Danilov SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34913; Danilov SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025952; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; DANILOV SM, 1987, BIOTECHNOL APPL BIOC, V9, P319; DAS M, 1977, J BIOL CHEM, V252, P1316; Dufour C, 2000, GENOMICS, V69, P14, DOI 10.1006/geno.2000.6313; EHLERS MRW, 1992, BIOCHEM BIOPH RES CO, V183, P199, DOI 10.1016/0006-291X(92)91628-4; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; Grinshtein SV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P571; Gu Q, 2004, J CHROMATOGR B, V813, P337, DOI 10.1016/j.jchromb.2004.09.031; Hennig R, 2016, BBA-GEN SUBJECTS, V1860, P1728, DOI 10.1016/j.bbagen.2016.03.035; Jokubaitis VJ, 2008, BLOOD, V111, P4055, DOI 10.1182/blood-2007-05-091710; Jones ESW, 2017, SAMJ S AFR MED J, V107, P887, DOI [10.7196/SAMJ.2017.v107i10.12268, 10.7196/samj.2017.v107i10.12268]; Kost OA, 1997, BIOCHEMISTRY-MOSCOW+, V62, P321; Kosta OA, 2018, RUSS J BIOORG CHEM+, V44, P52, DOI 10.1134/S1068162018010107; Kryukova OV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143455; Lauc G, 2016, BBA-GEN SUBJECTS, V1860, P1574, DOI 10.1016/j.bbagen.2015.10.016; Liddy KA, 2013, GENOME MED, V5, DOI 10.1186/gm424; Lui T, 2005, J PROTEOME RES, V4, P2070; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; ORLOVA MA, 1994, RUSS CHEM B+, V43, P1260, DOI 10.1007/BF00698256; Petrov MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049290; RIPKA JE, 1993, BIOCHEM BIOPH RES CO, V196, P503, DOI 10.1006/bbrc.1993.2278; Salvesen G., 2012, HDB PROTEOLYTIC ENZY, V3rd, P480; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Tikhomirova VE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181976; Varki A., 2009, ESSENTIALS OF GLYCOB; Varki A., 2009, ESSENTIALS GLYCOBIOL; WEI L, 1991, J BIOL CHEM, V266, P5540; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	42	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209861	10.1371/journal.pone.0209861	http://dx.doi.org/10.1371/journal.pone.0209861			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589901	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200063
J	Magness, DR; Morton, JM				Magness, Dawn Robin; Morton, John M.			Using climate envelope models to identify potential ecological trajectories on the Kenai Peninsula, Alaska	PLOS ONE			English	Article							SPRUCE BEETLE OUTBREAK; SPECIES DISTRIBUTION; TREELINE ADVANCE; RANDOM FORESTS; DISTURBANCE; ECOSYSTEMS; HABITAT; FUTURE; CLASSIFICATION; CONSERVATION	Managers need information about the vulnerability of historical plant communities, and their potential future conditions, to respond appropriately to landscape change driven by global climate change. We model the climate envelopes of plant communities on the Kenai Peninsula in Southcentral Alaska and forecast to 2020, 2050, and 2080. We assess 6 model outputs representing downscaled climate data from 3 global climate model outputs and 2 representative concentration pathways. We use two lines of evidence, model convergence and empirically measured rates of change, to identify the following plausible ecological trajectories for the peninsula: (1.) alpine tundra and sub-alpine shrub decrease, (2.) perennial snow and ice decrease, (3.) forests remain on the Kenai Lowlands, (4.) the contiguous white-Lutz-Sitka spruce complex declines, and (5.) mixed conifer afforestation occurs along the Gulf of Alaska coast. We suggest that converging models in the context of other lines of evidence is a viable approach to increase certainty for adaptation planning. Extremely dynamic areas with multiple outcomes (i.e., disagreement) among models represent ecological risk, but may also represent opportunities for facilitated adaptation and other managerial approaches to help tip the balance one way or another. By reducing uncertainty, this eclectic approach can be used to inform expectations about the future.	[Magness, Dawn Robin; Morton, John M.] US Fish & Wildlife Serv, Kenai Natl Wildlife Refuge, Soldotna, AK 99669 USA	United States Department of the Interior; US Fish & Wildlife Service	Magness, DR (corresponding author), US Fish & Wildlife Serv, Kenai Natl Wildlife Refuge, Soldotna, AK 99669 USA.	Dawn_Magness@fws.gov						Adalgeirsdottir G, 1998, J GLACIOL, V44, P570, DOI 10.3189/S0022143000002082; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Beever E. A., 2015, CONSERV LETT; Berg EE, 2006, FOREST ECOL MANAG, V227, P275, DOI 10.1016/j.foreco.2006.02.042; Berg EE, 2006, FOREST ECOL MANAG, V227, P219, DOI 10.1016/j.foreco.2006.02.038; Berg EE, 2009, CAN J FOREST RES, V39, P2033, DOI 10.1139/X09-121; Boggs K, 2008, FOREST ECOL MANAG, V255, P3571, DOI 10.1016/j.foreco.2008.02.039; Boucher TV, 2006, FOREST ECOL MANAG, V227, P233, DOI 10.1016/j.foreco.2006.02.051; Bowser ML, 2017, BIODIVERS DATA J, V5, DOI 10.3897/BDJ.5.e10792; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chapin FS, 2010, TRENDS ECOL EVOL, V25, P241, DOI 10.1016/j.tree.2009.10.008; Chapin FS, 1997, CLIMATIC CHANGE, V35, P449, DOI 10.1023/A:1005337705025; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; De Volder A., 1999, FIRE CLIMATE HIST LO; Dial RJ, 2016, GLOBAL CHANGE BIOL, V22, P1841, DOI 10.1111/gcb.13207; Dial RJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000453; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Glick P, 2010, SCANNING CONSERVATIO; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gunderson L. H., 2001, PANARCHY UNDERSTANDI; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hobbs Richard J., 2013, NOVEL ECOSYSTEMS INT; Hodgson JA, 2011, CONSERV LETT, V4, P289, DOI 10.1111/j.1755-263X.2011.00177.x; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Iverson LR, 2011, ECOSYSTEMS, V14, P1005, DOI 10.1007/s10021-011-9456-4; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Klein E, 2005, CAN J FOREST RES, V35, P1931, DOI 10.1139/x05-129; Kramer MG, 2001, ECOLOGY, V82, P2749, DOI 10.1890/0012-9658(2001)082[2749:ACOLTW]2.0.CO;2; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lemke P., 2007, CLIMATE CHANGE 2007; Lloyd AH, 2005, ECOLOGY, V86, P1687, DOI 10.1890/03-0786; Magness DR, 2018, LANDSCAPE ECOL, V33, P547, DOI 10.1007/s10980-018-0617-0; Magness DR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00200.1; Magness DR, 2008, STUD COMPUT INTELL, V122, P209; Michalak JL, 2017, FRONT ECOL ENVIRON, V15, P367, DOI 10.1002/fee.1516; Murphy K., 2010, CONNECTING ALASKA LA; Nichols JD, 2011, J WILDLIFE MANAGE, V75, P6, DOI 10.1002/jwmg.33; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Rice B., 1987, CHANGES HARDING ICEF; Rowland EL, 2016, GLOB ECOL CONSERV, V8, P1, DOI 10.1016/j.gecco.2016.07.006; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Rupp TS, 2007, EARTH INTERACT, V11, DOI 10.1175/EI189.1; Rupp TS, 2001, CLIMATIC CHANGE, V48, P399, DOI 10.1023/A:1010738502596; Rupp TS, 2009, SUMMARY REPORT KENAI; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schneider RR, 2009, CAN J FOREST RES, V39, P1001, DOI 10.1139/X09-033; Schoen ER, 2017, FISHERIES, V42, P538, DOI 10.1080/03632415.2017.1374251; SNAP (Scenarios Network for Arctic Planning), 2012, PRED FUT POT CLIM BI; Speth JG, 2008, PUNCTUATED EQUILIBRI; Stein B.A., 2014, CLIMATE SMART CONSER; USFWS, 2010, RIS URG CHALL STRAT, P34; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; VanLooy J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028060; WILES GC, 1994, GEOL SOC AM BULL, V106, P281, DOI 10.1130/0016-7606(1994)106<0281:LHHRGC>2.3.CO;2; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	62	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208883	10.1371/journal.pone.0208883	http://dx.doi.org/10.1371/journal.pone.0208883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586421	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400042
J	Marquart, ME; Benton, AH; Galloway, RC; Stempak, LM				Marquart, Mary E.; Benton, Angela H.; Galloway, Regina C.; Stempak, Lisa M.			Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis	PLOS ONE			English	Article							EPIDERMIDIS-INDUCED ENDOPHTHALMITIS; PENETRATING OCULAR INJURY; INTRAVITREAL INJECTION; PSEUDOMONAS-AERUGINOSA; BACTERIAL ENDOPHTHALMITIS; VIRULENCE FACTOR; IDENTIFICATION; PNEUMONIAE; MITIS; SENSITIVITIES	The viridans group streptococci comprise multiple species and have gained more recognition in recent years as common etiologic agents of bacterial endophthalmitis. The purpose of this study was to identify the species of human endophthalmitis isolates of viridans streptococci and to characterize their potential virulence attributes. The species of 22 endophthalmitis strains of viridans streptococci were identified by Matrix Assisted Laser Desorption Ionization Time-of-Flight. Susceptibilities to 3 antibiotics commonly used for bacterial endophthalmitis were determined. The extracellular milieu of each strain was tested for cytotoxicity of retinal pigmented epithelial cells, hemolysis of sheep erythrocytes, and protease activity using gelatin zymography. Identified species were Streptococcus mitis/oralis, S. salivarius, S. vestibularis, S. parasanguinis, S. mutans, S. constellatus, and S. gordonii. One strain of S. pseudoporcinus was also identified. All strains were sensitive to vancomycin, 77% were resistant to amikacin, and 27% had intermediate resistance to ceftazidime. Extracellular milieu from all strains except one (S. pseudoporcinus) were largely devoid of toxicity to retinal pigmented epithelial cells and sheep erythrocytes. Twelve strains, 10 of which were S. mitis/oralis, produced protease activity. Interestingly, not all of the S. mitis/oralis strains were proteolytic. These findings highlight the diversity of virulence factor production in ocular strains of the viridans streptococci not only at the group level but also at the species level.	[Marquart, Mary E.; Benton, Angela H.] Univ Mississippi, Med Ctr, Dept Microbiol & Immunol, Jackson, MS 39216 USA; [Galloway, Regina C.; Stempak, Lisa M.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Marquart, ME (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol & Immunol, Jackson, MS 39216 USA.	mmarquart@umc.edu	Benton, Angela/ABB-7737-2020	Benton, Angela/0000-0003-3302-4773				Adam MK, 2014, CAN J OPHTHALMOL, V49, pE154, DOI 10.1016/j.jcjo.2014.09.008; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; Bekal S, 2006, J CLIN MICROBIOL, V44, P2584, DOI 10.1128/JCM.02707-05; Benz MS, 2004, AM J OPHTHALMOL, V137, P38, DOI 10.1016/S0002-9394(03)00896-1; Chen E, 2011, RETINA-J RET VIT DIS, V31, P1525, DOI 10.1097/IAE.0b013e318221594a; Chen XJ, 2012, J OCUL PHARMACOL TH, V28, P329, DOI 10.1089/jop.2011.0204; Chiquet C, 2008, INVEST OPHTH VIS SCI, V49, P1971, DOI 10.1167/iovs.07-1377; Clarke B, 2018, SURV OPHTHALMOL, V63, P677, DOI 10.1016/j.survophthal.2018.02.003; Clinical and Laboratory Standards Institute, 2017, M100 CLSI; COLLINS MD, 1984, SYST APPL MICROBIOL, V5, P402, DOI 10.1016/S0723-2020(84)80041-7; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; Doern CD, 2010, J CLIN MICROBIOL, V48, P3829, DOI 10.1128/JCM.01563-10; Doshi RR, 2012, RETINA-J RET VIT DIS, V32, P473, DOI 10.1097/IAE.0B013E31822C2958; Durand ML, 2017, CLIN MICROBIOL REV, V30, P597, DOI 10.1128/CMR.00113-16; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Garg SJ, 2015, OSLI RETINA, V46, P1028, DOI 10.3928/23258160-20151027-07; Gaudreau C, 2007, J MED MICROBIOL, V56, P1620, DOI 10.1099/jmm.0.47295-0; Gentile RC, 2014, OPHTHALMOLOGY, V121, P1634, DOI 10.1016/j.ophtha.2014.02.001; Goldberg RA, 2013, OPHTHALMOLOGY, V120, P1448, DOI 10.1016/j.ophtha.2012.12.009; Goldberg RA, 2012, AM J OPHTHALMOL, V153, P204, DOI 10.1016/j.ajo.2011.11.035; Gupta A, 2014, GRAEF ARCH CLIN EXP, V252, P1825, DOI 10.1007/s00417-014-2658-7; Harju I, 2017, J CLIN MICROBIOL, V55, P914, DOI 10.1128/JCM.01990-16; Jefferies J, 2007, J BACTERIOL, V189, P627, DOI 10.1128/JB.01092-06; Johnston C, 2010, J CLIN MICROBIOL, V48, P2762, DOI 10.1128/JCM.01746-09; Kim T, 2007, PROTEOMICS, V7, P4203, DOI 10.1002/pmic.200700745; Kuriyan AE, 2014, AM J OPHTHALMOL, V157, P774, DOI 10.1016/j.ajo.2013.12.026; Kurniawan ED, 2018, CLIN EXP OPHTHALMOL, V46, P578, DOI 10.1111/ceo.13130; Marquart ME, 2005, INVEST OPHTH VIS SCI, V46, P3761, DOI 10.1167/iovs.04-1483; McCannel CA, 2011, RETINA-J RET VIT DIS, V31, P654, DOI 10.1097/IAE.0b013e31820a67e4; Melo GB, 2011, EYE, V25, P383, DOI 10.1038/eye.2010.236; Mochizuki Y, 2014, INVEST OPHTH VIS SCI, V55, P240, DOI 10.1167/iovs.13-13151; Moloney TP, 2014, BRIT J OPHTHALMOL, V98, P1492, DOI 10.1136/bjophthalmol-2014-305030; Nakano K, 2010, J PHARMACOL SCI, V113, P120, DOI 10.1254/jphs.09R24FM; Ng EWM, 1997, RETINA-J RET VIT DIS, V17, P521; PLEYER U, 1992, INVEST OPHTH VIS SCI, V33, P2650; Ravindranath RMH, 1997, CURR EYE RES, V16, P1036, DOI 10.1076/ceyr.16.10.1036.9015; Sadaka A, 2012, PROG RETIN EYE RES, V31, P316, DOI 10.1016/j.preteyeres.2012.03.004; Shanks RMQ, 2015, INFECT IMMUN, V83, P2907, DOI 10.1128/IAI.03096-14; Shewmaker PL, 2012, J CLIN MICROBIOL, V50, P3591, DOI 10.1128/JCM.01481-12; Spoerry C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164809; Stoner KA, 2011, J CLIN MICROBIOL, V49, P883, DOI 10.1128/JCM.01965-10; Suwantarat N, 2015, J CLIN MICROBIOL, V53, P3926, DOI 10.1128/JCM.02363-15; Suzuki T, 2008, J CATARACT REFR SURG, V34, P1776, DOI 10.1016/j.jcrs.2008.06.033; Tang A, 2013, INVEST OPHTH VIS SCI, V54, P2821, DOI 10.1167/iovs.13-11788; Todokoro D, 2017, JPN J OPHTHALMOL, V61, P408, DOI 10.1007/s10384-017-0527-8; Wen JC, 2011, ARCH OPHTHALMOL-CHIC, V129, P1551, DOI 10.1001/archophthalmol.2011.227; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Witkin AJ, 2017, OPHTHALMOLOGY, V124, P583, DOI 10.1016/j.ophtha.2016.11.042; Zamir E, 1999, J PEDIAT OPHTH STRAB, V36, P224	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209849	10.1371/journal.pone.0209849	http://dx.doi.org/10.1371/journal.pone.0209849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576393	gold, Green Submitted, Green Published			2022-12-26	WOS:000454149400082
J	Chang, SY; Lu, XL; Wang, S; Wang, ZG; Huo, JS; Huang, J; Shangguan, SF; Li, S; Zou, JZ; Bao, YH; Guo, J; Wang, F; Niu, B; Zhang, T; Qiu, ZY; Wu, JX; Wang, L				Chang, Shaoyan; Lu, Xiaolin; Wang, Shan; Wang, Zhigang; Huo, Junsheng; Huang, Jian; Shangguan, Shaofang; Li, Shen; Zou, Jizhen; Bao, Yihua; Guo, Jin; Wang, Fang; Niu, Bo; Zhang, Ting; Qiu, Zhiyong; Wu, Jianxin; Wang, Li			The effect of folic acid deficiency on FGF pathway via Brachyury regulation in neural tube defects	FASEB JOURNAL			English	Article						T-box transcription factor; encephalocele; mouse model; neural development; methylation modification	INTERSPERSED NUCLEOTIDE ELEMENT-1; FIBROBLAST-GROWTH-FACTOR; NOVO DNA METHYLATION; FATE SPECIFICATION; CELL FATE; GENE; EXPRESSION; INDUCTION; TISSUE; HYPOMETHYLATION	Folate deficiency in early development leads to disturbance in multiple processes, including neurogenesis during which fibroblast growth factor (FGF) pathway is one of the crucial pathways. Whether folic acid (FA) directly affects FGF pathways to influence neurodevelopment and the possible mechanism remains unclear. In this study, we presented evidence that in human FA-insufficient encephalocele, the FGF pathway was interfered. Furthermore, in Brachyury knockout mice devoid of such T-box transcription factors regulating embryonic neuromesodermal bipotency and a key component of FGF pathway, change in expression of Brachyury downstream targets, activator Fgf8 and suppressor dual specificity phosphatase 6 was detected, along with the reduction in expression of other key FGF pathway genes. By using a FA-deficient cell model, we further demonstrated that decrease in Brachyury expression was through alteration in hypermethylation at the Brachyury promoter region under FA deficiency conditions, and suppression of Brachyury promoted the inactivation of the FGF pathway. Correspondingly, FA supplementation partially reverses the effects seen in FA-deficient embryoid bodies. Lastly, in mice with maternal folate-deficient diets, aberrant FGF pathway activity was found in fetal brain dysplasia. Taken together, our findings highlight the effect of FA on FGF pathways during neurogenesis, and the mechanism may be due to the low expression of Brachyury gene via hypermethylation under FA-insufficient conditions.	[Chang, Shaoyan; Lu, Xiaolin; Wang, Shan; Shangguan, Shaofang; Li, Shen; Zou, Jizhen; Bao, Yihua; Guo, Jin; Wang, Fang; Niu, Bo; Zhang, Ting; Qiu, Zhiyong; Wu, Jianxin; Wang, Li] Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, 2 Yabao Rd, Beijing 100020, Peoples R China; [Wang, Zhigang] Peking Union Med Coll, Chinese Acad Med Sci, Beijing, Peoples R China; [Huo, Junsheng; Huang, Jian] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Key Lab Trace Element Nutr, Natl Hlth & Family Planning Commiss Peoples Repub, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Nutrition & Health, Chinese Center for Disease Control & Prevention	Wu, JX; Wang, L (corresponding author), Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, 2 Yabao Rd, Beijing 100020, Peoples R China.	jianxinwu_2000@163.com; lily_wang@yeah.net	lu, xl/HDO-8340-2022; wang, fang/GYD-4295-2022	Wang, Li/0000-0003-1918-0040	National Key Research and Development Program [2016YFC1000502, 2018YFC1002503]; National Natural Science Fund of China [81670802/H0724,81741023]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-1-008]; Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Municipal Administration [XTZD20180402]	National Key Research and Development Program; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences Initiative for Innovative Medicine; Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Municipal Administration	The authors thank the Department of Cell Therapy Center of Xuanwu Hospital for ESCs. This project was supported by the National Key Research and Development Program (2016YFC1000502, 2018YFC1002503), the National Natural Science Fund of China (81670802/H0724,81741023), the Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2016-I2M-1-008), and the Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Municipal Administration (XTZD20180402). The authors declare no conflicts of interest.	Akagi T, 2015, J BIOL CHEM, V290, P22460, DOI 10.1074/jbc.M115.675595; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Briscoe J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0105-1; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chang SY, 2013, J CELL BIOCHEM, V114, P1549, DOI 10.1002/jcb.24496; Chen YJ, 2012, DEV BIOL, V361, P125, DOI 10.1016/j.ydbio.2011.10.019; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Dansranjavin T, 2009, CELL CYCLE, V8, P916, DOI 10.4161/cc.8.6.7934; Doniach T, 1995, CELL, V83, P1067, DOI 10.1016/0092-8674(95)90133-7; Dunlevy LPE, 2006, BIRTH DEFECTS RES A, V76, P544, DOI 10.1002/bdra.20286; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Eom DS, 2012, BIRTH DEFECTS RES A, V94, P804, DOI 10.1002/bdra.23052; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Gentsch GE, 2013, CELL REP, V4, P1185, DOI 10.1016/j.celrep.2013.08.012; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Imbard A, 2013, INT J ENV RES PUB HE, V10, P4352, DOI 10.3390/ijerph10094352; Kimura-Yoshida C, 2015, EBIOMEDICINE, V2, P513, DOI 10.1016/j.ebiom.2015.04.012; Kirillova I, 2000, TERATOLOGY, V61, P347, DOI 10.1002/(SICI)1096-9926(200005)61:5<347::AID-TERA6>3.3.CO;2-R; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; Koch F, 2017, DEV CELL, V42, P514, DOI 10.1016/j.devcel.2017.07.021; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Main H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062959; Martin BL, 2016, SEMIN CELL DEV BIOL, V49, P59, DOI 10.1016/j.semcdb.2015.11.014; Massarwa R, 2014, WIRES DEV BIOL, V3, P59, DOI 10.1002/wdev.120; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Osterhues A, 2013, CRIT REV FOOD SCI, V53, P1180, DOI 10.1080/10408398.2011.575966; Park JC, 2008, BIOCHEM BIOPH RES CO, V365, P221, DOI 10.1016/j.bbrc.2007.10.144; Pfuhlmann K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183488; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Richter B, 2002, J Med Genet, V39, pE14, DOI 10.1136/jmg.39.3.e14; Rochtus A, 2015, MINI-REV MED CHEM, V15, P1095, DOI 10.2174/1389557515666150909144828; Ruan JW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.220; Shimoda N, 2005, DEV DYNAM, V233, P1509, DOI 10.1002/dvdy.20455; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; Storey KG, 1998, DEVELOPMENT, V125, P473; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1998, DEVELOPMENT, V125, P507; Wang L, 2015, CURR MOL MED, V15, P497, DOI 10.2174/1566524015666150630130229; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Yamakoshi K, 2003, GENESIS, V37, P195, DOI 10.1002/gene.10245; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	49	5	7	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4688	4702		10.1096/fj.201801536R	http://dx.doi.org/10.1096/fj.201801536R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592646	Bronze			2022-12-26	WOS:000462888500005
J	Xu, ZW; Isaji, T; Fukuda, T; Wang, YQ; Gu, JG				Xu, Zhiwei; Isaji, Tomoya; Fukuda, Tomohiko; Wang, Yuqin; Gu, Jianguo			O-GlcNAcylation regulates integrin-mediated cell adhesion and migration via formation of focal adhesion complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); cell migration; cell adhesion; integrin; focal adhesions	GLCNAC; CANCER; KINASE; PHOSPHORYLATION; ACTIVATION; FAK; PROTEINS; DYNAMICS; PAXILLIN; NUCLEAR	O-GlcNAcylation is a post-translational modification of a protein serine or threonine residue catalyzed by O-GlcNAc transferase (OGT) in the nucleus and cytoplasm. O-GlcNAcylation plays important roles in the cellular signaling that affect the different biological functions of cells, depending upon cell type. However, whether or not O-GlcNAcylation regulates cell adhesion and migration remains unclear. Here, we used the doxycycline-inducible short hairpin RNA (shRNA) system to establish an OGT knockdown (KD) HeLa cell line and found that O-GlcNAcylation is a key regulator for cell adhesion, migration, and focal adhesion (FA) complex formation. The expression levels of OGT and O-GlcNAcylation were remarkably suppressed 24 h after induction of doxycycline. Knockdown of OGT significantly promoted cell adhesion, but it suppressed the cell migration on fibronectin. The immunostaining with paxillin, a marker for FA plaque, clearly showed that the number of FAs was increased in the KD cells compared with that in the control cells. The O-GlcNAcylation levels of paxillin, talin, and focal adhesion kinase were down-regulated in KD cells. Interestingly, the complex formation between integrin 1, focal adhesion kinase, paxillin, and talin was greatly increased in KD cells. Consistently, levels of active integrin 1 were significantly enhanced in KD cells, whereas they were decreased in cells overexpressing OGT. The data suggest a novel regulatory mechanism for O-GlcNAcylation during FA complex formation, which thereby affects integrin activation and integrin-mediated functions such as cell adhesion and migration.	[Xu, Zhiwei; Isaji, Tomoya; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Wang, Yuqin] Nantong Univ, Pharm Coll, Dept Pharmacol, Nantong 226001, Jiangsu, Peoples R China	Tohoku Medical & Pharmaceutical University; Nantong University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japan Society for the Promotion of Science [15H04354]; National Natural Science Foundation of China [31670807, 18H04868]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 15H04354; National Natural Science Foundation of China Grant 31670807; and Grant-in-Aid for Scientific Research on Innovative Areas 18H04868 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Collins C, 2015, CURR OPIN CELL BIOL, V36, P62, DOI 10.1016/j.ceb.2015.07.004; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001; Ding M, 1996, J BIOL CHEM, V271, P12555, DOI 10.1074/jbc.271.21.12555; Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108; Ferrer CM, 2017, ONCOGENE, V36, P559, DOI 10.1038/onc.2016.228; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Grigera PR, 2005, J CELL SCI, V118, P4931, DOI 10.1242/jcs.02696; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HAGMANN J, 1992, J BIOL CHEM, V267, P14424; Hang QL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00558-16; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ji S, 2011, AMINO ACIDS, V40, P809, DOI 10.1007/s00726-010-0698-9; Jiang MZ, 2019, ONCOGENE, V38, P301, DOI 10.1038/s41388-018-0435-5; Kwak TK, 2010, J BIOL CHEM, V285, P36021, DOI 10.1074/jbc.M110.129601; Lachen-Montes M, 2016, J PROTEOMICS, V148, P149, DOI 10.1016/j.jprot.2016.07.032; Luk CT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14360; Ma A, 2001, MOL BIOL CELL, V12, P1; McFarlane S, 2015, ONCOTARGET, V6, P36762, DOI 10.18632/oncotarget.5461; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Quizi JL, 2013, ONCOGENE, V32, P4656, DOI 10.1038/onc.2012.488; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Segarra M, 2005, FASEB J, V19, P1875, DOI 10.1096/fj.04-3574fje; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tan EP, 2017, BIOCHEM SOC T, V45, P313, DOI 10.1042/BST20160145; Valdembri D, 2012, CURR OPIN CELL BIOL, V24, P582, DOI 10.1016/j.ceb.2012.08.004; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Wolfram T, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-64; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zhang X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15280	58	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3117	3124		10.1074/jbc.RA118.005923	http://dx.doi.org/10.1074/jbc.RA118.005923			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30587575	hybrid, Green Published			2022-12-26	WOS:000464980100012
J	Kaissis, GA; Lohofer, FK; Ziegelmayer, S; Danner, J; Jager, C; Schirren, R; Ankerst, D; Ceyhanid, GO; Friess, H; Rummeny, EJ; Weichert, W; Braren, RF				Kaissis, Georgios A.; Lohoefer, Fabian K.; Ziegelmayer, Sebastian; Danner, Julia; Jaeger, Carsten; Schirren, Rebekka; Ankerst, Donna; Ceyhanid, Gueralp O.; Friess, Helmut; Rummeny, Ernst J.; Weichert, Wilko; Braren, Rickmer F.			Borderline-resectable pancreatic adenocarcinoma: Contour irregularity of the venous confluence in pre-operative computed tomography predicts histopathological infiltration	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CONSENSUS; CRITERIA; CANCER	Purpose The purpose of the current study was to compare CT-signs of portal venous confluence infiltration for actual histopathological infiltration of the vein or the tumor/vein interface (TVI) in borderline resectable pancreatic ductal adenocarcinoma (PDAC). Methods and materials 101 patients with therapy-naive, primarily resected PDAC of the pancreatic head without arterial involvement were evaluated. The portal venous confluence was assessed for contour irregularity (defined as infiltration) and degree of contact. The sensitivity and specificity of contour irregularity versus tumor to vein contact >180 degrees as well as the combination of the signs for tumor cell infiltration of the vessel wall or TVI was calculated. Overall survival (OS) was compared between groups. Results Sensitivity and specificity of contour irregularity for identification of tumor infiltration of the portal venous confluence or the TVI was higher compared to tumor to vessel contact >180 degrees for tumor cell infiltration (96%/79% vs. 91%/38% respectively, p<0.001). The combination of the signs increased specificity to 92% (sensitivity 88%). Patients with contour irregularity/tumor to vein contact >180 degrees/both signs had significantly worse overall survival (16.2 vs. 26.5 months/17.9 vs. 37.4 months/18.5 vs. 26.5 months respectively, all p<0.05). Conclusion Portal venous confluence contour irregularity is a strong predictor of actual tumor cell infiltration of the vessel wall or the TVI and should be noted as such in radiological reports.	[Kaissis, Georgios A.; Lohoefer, Fabian K.; Ziegelmayer, Sebastian; Danner, Julia; Rummeny, Ernst J.; Braren, Rickmer F.] Tech Univ Munich, Klinikum Rechts Isar, Inst Diagnost & Intervent Radiol, Munich, Germany; [Jaeger, Carsten; Schirren, Rebekka; Ceyhanid, Gueralp O.; Friess, Helmut] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany; [Ankerst, Donna] Tech Univ Munich, Dept Math, Garching, Germany; [Weichert, Wilko] Tech Univ Munich, Klinikum Rechts Isar, Dept Gen Pathol & Pathol Anat, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Braren, RF (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Diagnost & Intervent Radiol, Munich, Germany.	rbraren@tum.de	Braren, Rickmer/U-3254-2018	Braren, Rickmer/0000-0001-6039-6957; Ankerst, Donna/0000-0003-4229-2462	German Research Foundation (DFG) within the SFB-Initiative 824 (collaborative research center)	German Research Foundation (DFG) within the SFB-Initiative 824 (collaborative research center)(German Research Foundation (DFG))	This work was supported by funding of the German Research Foundation (DFG, http://www.dfg.de/en/) within the SFB-Initiative 824 (collaborative research center, http://www.sfb824.de/en/), "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" to Rickmer F. Braren (SFB824, project C6) and Wilko Weichert (project Z2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hawary MM, 2014, GASTROENTEROLOGY, V146, P291, DOI 10.1053/j.gastro.2013.11.004; Hough TJ, 1999, AM J ROENTGENOL, V173, P1509, DOI 10.2214/ajr.173.6.10584793; Isaji S, 2018, PANCREATOLOGY, V18, P2, DOI 10.1016/j.pan.2017.11.011; Katz MHG, 2009, ANN SURG ONCOL, V16, P836, DOI 10.1245/s10434-008-0295-2; Kim M, 2018, CLIN RADIOL, V73, P564, DOI 10.1016/j.crad.2018.01.016; Kimura K, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-360; Lu DSK, 1997, AM J ROENTGENOL, V168, P1439, DOI 10.2214/ajr.168.6.9168704; Michalski CW, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0086-1; Mierke F, 2016, ANN SURG ONCOL, V23, pS730, DOI 10.1245/s10434-016-5515-6; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tempero MA, 2017, J NATL COMPR CANC NE, V15, P1028, DOI 10.6004/jnccn.2017.0131; Zaky AM, 2017, RADIOGRAPHICS, V37, P93, DOI 10.1148/rg.2017160054	12	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208717	10.1371/journal.pone.0208717	http://dx.doi.org/10.1371/journal.pone.0208717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601813	gold, Green Published, Green Submitted			2022-12-26	WOS:000454683200019
J	Mya, KS; Kyaw, AT; Tun, T				Mya, Kyaw Swa; Kyaw, Aung Tin; Tun, Thandar			Feeding practices and nutritional status of children age 6-23 months in Myanmar: A secondary analysis of the 2015-16 Demographic and Health Survey	PLOS ONE			English	Article							ANEMIA	Nutritional deficiencies are a major problem among developing countries including Myanmar. They can occur in all age groups, but the impact is more severe among children age 6-23 months as this period is critical for child development, and irreversible damages can occur due to nutritional deficiencies. Proper infant and young child feeding practices are pivotal to tackle nutritional problems and to prevent irreversible consequences among children. To assess the current feeding practices and associations with nutritional status, we conducted a secondary data analysis using the 2015-16 Myanmar Demographic and Health Survey. Multiple logistic regression analysis was done adjusting for covariates and the results were presented by adjusted odds ratios with 95% confidence intervals. A total of 1,222 children age 6-23 months were included in this analysis. Twenty percent were stunted and 43% were moderately anemic. Only 16% of children received a minimum acceptable diet, 25% received diverse food groups, 58% were fed with minimum meal frequency, 85% currently breastfed, and 59% consumed iron-rich foods. Breastfeeding reduced the odds of being stunted. Male sex, perceived small birth size, mother with short stature, and working mother were significant predictors of stunting. Iron-rich food consumption was inversely associated with moderate anemia. Male sex and maternal anemia were also significant predictors of moderate anemia. The study concluded that stunting and anemia among young children in Myanmar are major public health challenges that need urgent action. While further prospective research is needed to determine the effect of feeding practice on linear growth, interventions such as iron supplementation, and nutritional education programs according to the World Health Organization complementary feeding guidelines could help prevent stunting and childhood anemia and might reduce their prevalence in Myanmar.	[Mya, Kyaw Swa; Kyaw, Aung Tin; Tun, Thandar] Univ Publ Hlth, Dept Biostat & Med Demog, Yangon, Myanmar; [Mya, Kyaw Swa; Kyaw, Aung Tin; Tun, Thandar] Univ Publ Hlth, Latha Township, Yangon Region, Myanmar		Mya, KS (corresponding author), Univ Publ Hlth, Dept Biostat & Med Demog, Yangon, Myanmar.; Mya, KS (corresponding author), Univ Publ Hlth, Latha Township, Yangon Region, Myanmar.	kyawswamya@gmail.com		, Kyaw Swa Mya/0000-0003-1286-1409				Aguayo VM, 2016, MATERN CHILD NUTR, V12, P121, DOI 10.1111/mcn.12259; Central Statistical Office and UNICEF, 2011, SWAZ MULT IND CLUST; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Hlaing LM, 2015, EUROPEAN J NUTR FOOD, V5, P953, DOI [10.9734/EJNFS/2015/21182, DOI 10.9734/EJNFS/2015/21182]; Hlaing LM, 2017, MYANMAR HLTH SCI RES, V29; International Institute for Population Sciences India ICF international, 2017, IND DEM HLTH SURV 20; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kounnavong Sengchanh, 2011, Trop Med Health, V39, P95, DOI 10.2149/tmh.2011-13; Krasevec J, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12430; Miah R, 2016, J AIDS CLIN RES, V7, P2; Ministry of Health and Sports-MoHS ICF, 2017, MYANM DEM HLTH SURV; Ministry of Health Nepal; New ERA; and ICF, 2017, NEP DEM HLTH SURV 20; Ministry of Public Health (MOPH) ICF, 2017, AFGH DEM HLTH SURV 2; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; National Institute of Statistics Directorate General for Health and ICF International, 2015, CAMB DEM HLTH SURV 2; Perkins JM, 2018, NUTRITION; Rawat R, 2014, BRIT J NUTR, V111, P172, DOI 10.1017/S0007114513001852; Statistics Indonesia (Badan Pusat Statistik-BPS) National Population and Family Planning Board (BKKBN) and Kementerian Kesehatan (Kemenkes-MOH) and ICF International, 2013, IND DEM HLTH SURV 20; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; UNICEF, 2014, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2021, LEVELS TRENDS CHILD; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, 2016, HLTH GLANC AS PAC 20; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; WHO WBG, 2008, WORLDW PREV AN 1993; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2015, GLOB PREV AN 2011; World Health Organization, 2021, INF YOUNG CHILD FEED; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; Zongrone A, 2012, PUBLIC HEALTH NUTR, V15, P1697, DOI 10.1017/S1368980012001073	33	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209044	10.1371/journal.pone.0209044	http://dx.doi.org/10.1371/journal.pone.0209044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601848	gold, Green Submitted, Green Published			2022-12-26	WOS:000454683200034
J	Garry, DJ; Baker, DA; Persad, MD; Peresleni, T; Kocis, C; Demishev, M				Garry, David J.; Baker, David A.; Persad, Malini D.; Peresleni, Tatyana; Kocis, Christina; Demishev, Michael			Progesterone effects on vaginal cytokines in women with a history of preterm birth	PLOS ONE			English	Article							MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; INTERLEUKIN-1; PARTURITION; PREVENTION; PREGNANCY; DECIDUA; TERM	Objective To determine the effect of intramuscular progesterone on the vaginal immune response of pregnant women with a history of prior preterm birth. Methods A prospective, cohort study of women at 11-16 weeks gestation, >= 18 years of age, and carrying a singleton pregnancy was conducted from June 2016 to August 2017 after IRB approval. Women in the progesterone arm had a history of preterm birth and received weekly intramuscular 17-hydroxyprogesterone caproate. Controls comprised of women with healthy, uncomplicated pregnancies. Excluded were women with vaginitis, diabetes mellitus, hypertension, or other chronic diseases affecting the immune response. A vaginal wash was performed at enrollment, at 26-28 weeks, and at 35-36 weeks gestation. Samples underwent semi-quantitative detection of human inflammatory markers. Immunofluorescence pixel density data was analyzed and a P value < 0.05 was considered significant. Results here were 39 women included, 10 with a prior preterm birth and 29 controls. The baseline demographics and pregnancy outcomes for both groups were similar in age, parity, race, BMI, gestational age at delivery, mode of delivery, and birth weight. Enrollment cytokines in women with a prior preterm birth, including IL-1 alpha (39.2 +/- 25.1% versus 26.1 +/- 13.2%; P = 0.04), IL-1 beta (47.9 +/- 26.4% versus 24.9 +/- 17%; P<0.01), IL-2 (16.7 +/- 9.3% versus 11.3 +/- 6.3%; P = 0.03), and IL-13 (16.9 +/- 12.4% versus 8.2 +/- 7.4%; P = 0.01) were significantly elevated compared to controls. In the third trimester the cytokine densities for IL-1 alpha (26.0 +/- 18.2% versus 22.3 +/- 12.0%; P = 0.49), IL-1 beta (31.8 +/- 15.9% versus 33.1 +/- 16.8%; P = 0.84), IL-2 (10.0 +/- 8.4% versus 10.9 +/- 5.9%; P = 0.71), and IL-13 (9.1 +/- 5.9% versus 10.0 +/- 6.5%; P = 0.71) were all statistically similar between the progesterone arm and controls, respectively. Conclusion There is an increased cytokine presence in vaginal washings of women at risk for preterm birth which appears to be modified following the administration of 17-hydroxyprogesterone caproate to levels similar to healthy controls.	[Garry, David J.; Baker, David A.; Persad, Malini D.; Peresleni, Tatyana; Kocis, Christina; Demishev, Michael] Stony Brook Med, Dept Obstet & Gynecol & Reprod Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Garry, DJ (corresponding author), Stony Brook Med, Dept Obstet & Gynecol & Reprod Med, Stony Brook, NY 11794 USA.	david.garry@stonybrookmedicine.edu		Garry, David/0000-0002-5398-7596	Department of Obstetrics & Gynecology and Reproductive Medicine at Stony Brook Medicine	Department of Obstetrics & Gynecology and Reproductive Medicine at Stony Brook Medicine	This study was investigator funded and no outside sources. The funding from investigators is through the Department of Obstetrics & Gynecology and Reproductive Medicine at Stony Brook Medicine. The "Department of Obstetrics & Gynecology and Reproductive Medicine" had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. There was no salary received as part of funding.	Amsen Derk, 2009, V511, P107, DOI 10.1007/978-1-59745-447-6_5; Baker DA, 2016, ANN INFECT DIS EPIDE, V1, P1002; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Dodd JM, 2009, INT J WOMENS HEALTH, V1, P73; DUDLEY DJ, 1995, AM J REPROD IMMUNOL, V34, P231, DOI 10.1111/j.1600-0897.1995.tb00946.x; Elovitz MA, 2006, AM J OBSTET GYNECOL, V195, P1004, DOI 10.1016/j.ajog.2006.06.013; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Imseis HM, 1997, J SOC GYNECOL INVEST, V4, P90, DOI 10.1016/S1071-5576(97)00003-8; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; Monsanto SP, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.06.024; Newnham JP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00584; Norwitz Errol R, 2011, Rev Obstet Gynecol, V4, P60; Raghupathy R, 2009, J REPROD IMMUNOL, V80, P91, DOI 10.1016/j.jri.2009.01.004; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P969, DOI 10.1016/0002-9378(91)90450-6; ROMERO R, 1989, PROSTAGLANDINS, V37, P13, DOI 10.1016/0090-6980(89)90028-2; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; ROMERO R, 1989, OBSTET GYNECOL, V73, P31; ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x; ROMERO R, 1994, AM J REPROD IMMUNOL, V32, P108, DOI 10.1111/j.1600-0897.1994.tb01101.x; Sadowsky DW, 2003, AM J OBSTET GYNECOL, V188, P252, DOI 10.1067/mob.2003.70; Shields AD, 2005, AM J OBSTET GYNECOL, V193, P1144, DOI 10.1016/j.ajog.2005.05.046; SzekeresBartho J, 1996, AM J REPROD IMMUNOL, V35, P348; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089	23	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209346	10.1371/journal.pone.0209346	http://dx.doi.org/10.1371/journal.pone.0209346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596707	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200041
J	Thanichanon, P; Schmidt-Vogt, D; Epprecht, M; Heinimann, A; Wiesmann, U				Thanichanon, Puwadej; Schmidt-Vogt, Dietrich; Epprecht, Michael; Heinimann, Andreas; Wiesmann, Urs			Balancing cash and food: The impacts of agrarian change on rural land use and wellbeing in Northern Laos	PLOS ONE			English	Article							AGRICULTURAL INTENSIFICATION; BIODIVERSITY; STRATEGIES; EXPANSION; SECURITY; TRENDS; WILD	This study investigates the effects of improved market accessibility on agricultural land use and basic wellbeing, defined by income and rice sufficiency, in Xayaburi province, Lao PDR through a meso-scale and actor-oriented approach with data collection at both district and household level. It also investigates farmers' decision-making as it relates to regional markets. Increasing market accessibility in rural areas facilitates cash crop trade leading to agrarian change from subsistence to commercial agricultural systems. This transformation raises concerns about food security and vulnerability to market uncertainties as farmers are likely to grow cash crops intensively and in place of food crops, leading to lower food production. Meanwhile incomes from cash crop trade are highly vulnerable to market uncertainties. We found that farmers in the south of Xayaburi, where market accessibility is higher than in the north, primarily grow cash crops and do not suffer from rice insufficiency while farmers in the north, where market accessibility is lower, rely more on subsistence agriculture and have a lower level of basic wellbeing. The major factors of better basic wellbeing in the south include: (1) better market accessibility which can mitigate the risks of market uncertainty and create enough income to compensate for and overcome losses in rice production, (2) availability of more arable land due to a larger amount of level terrain which allows farmers to expand cash crop cultivation and continue growing rice at the same time, and (3) farmer strategy to keep a part of their land for growing rice to meet their minimum consumption needs and prevent the risks of rice insufficiency.	[Thanichanon, Puwadej] Ramkhamhang Univ, Dept Geog, Bangkok, Thailand; [Schmidt-Vogt, Dietrich] Freiburg Univ, Fac Environm & Nat Resources, Freiburg, Germany; [Epprecht, Michael; Heinimann, Andreas; Wiesmann, Urs] Univ Bern, CDE, Bern, Switzerland	Ramkhamhaeng University; University of Freiburg; University of Bern	Thanichanon, P (corresponding author), Ramkhamhang Univ, Dept Geog, Bangkok, Thailand.	puwadej111@yahoo.com		Heinimann, Andreas/0000-0001-8905-8169	Centre of Development and Environment (CDE), University of Bern, Switzerland; Swiss Programme for Research on Global Issues for Development (r4d); Swiss National Science Foundation (SNSF); Swiss Agency for Development and Cooperation (SDC) [400440 152167]	Centre of Development and Environment (CDE), University of Bern, Switzerland; Swiss Programme for Research on Global Issues for Development (r4d); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Agency for Development and Cooperation (SDC)	The research was supported by the Centre of Development and Environment (CDE), University of Bern, Switzerland, as well as the Swiss Programme for Research on Global Issues for Development (r4d) supported by the Swiss National Science Foundation (SNSF) and the Swiss Agency for Development and Cooperation (SDC), grant number 400440 152167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2015, GLOBAL ENVIRON CHANG, V34, P48, DOI 10.1016/j.gloenvcha.2015.06.002; Akram-Lodhi H, 2008, PEASANTS GLOBALISATI, P315; Alexandri C, 2015, PROC ECON FINANC, V22, P672, DOI 10.1016/S2212-5671(15)00282-8; Andersson M, 2007, 234 STOCKH SCH EC; [Anonymous], 2012, 3 INT C CONS AGR SE; [Anonymous], TITLE ERROR; Anriquez G., 2007, 0702 ESA FAO UN; Bahera R N, 2015, AMBIO; Bank World, 2008, LAO PEOPL DEM REP PO; Barrios EB, 2008, PROG PLANN, V70, P1, DOI 10.1016/j.progress.2008.04.001; Bijman J., 2008, WU WORKING PAPER, V1, P1; Bonnin C., 2011, THESIS; Borras SM, 2009, J PEASANT STUD, V36, P5, DOI 10.1080/03066150902820297; Broegaard RB, 2017, FOREST POLICY ECON, V84, P92, DOI 10.1016/j.forpol.2016.12.012; CARSWELL G, 1997, 64 IDS; Castella J.-C., 2012, 3 INT C CONSERVATION, P300; Chambers R., 2006, POVERTY FOCUS, P3; Chen HF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150062; Douxchamps S, 2016, REG ENVIRON CHANGE, V16, P1305, DOI 10.1007/s10113-015-0838-6; EDER JF, 1991, HUM ORGAN, V50, P245, DOI 10.17730/humo.50.3.h65j4523w6114380; Edward P., 2006, POVERTY FOCUS, P14; Ellis F, 1988, PEASANT EC FARM HOUS; FAO, 2002, INT C FIN DEV MONT M; Food and Agriculture Organization, 2012, FUT WE WANT END HUNG, P1; Fukuda-Parr S., 2006, POVERTY FOCUS WHAT I, P7; GoL (Government of Lao), 2006, NAT SOC DEV PLAN 200; Gomez K A., 2001, PAPER SIAM SOC LECT; Hanssen C. H., 2007, INT C POV RED FOR TE; Haug R, 2013, FOOD SECUR, V5, P415, DOI 10.1007/s12571-013-0266-8; Hazra CR., 2001, CROP DIVERSIFICATION, P32; Heinimann A., 2006, THESIS; IFAD, 2010, RUR POV REP 2011; Immink M D C, 1991, HOUSEHOLD FOOD SECUR; Kahane R, 2013, AGRON SUSTAIN DEV, V33, P671, DOI 10.1007/s13593-013-0147-8; KAKWANI N., 2006, POVERTY FOCUS, P20; Krahn J, 2003, JUTH PAKAI, V1, P4; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Mabiso A, 2014, FOOD SECUR, V6, P649, DOI 10.1007/s12571-014-0381-1; Mertz O, 2005, AGR SYST, V85, P209, DOI 10.1016/j.agsy.2005.06.007; Messerli P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133418; Patel K., 2015, AGR FOOD SECUR, V4, P1, DOI DOI 10.1186/S40066-015-0036-2; Pelton L.E., 2002, MARKETING CHANNELS R, V2nd; Porter G, 1997, WORLD DEV, V25, P227, DOI 10.1016/S0305-750X(96)00101-5; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Pultrone C., 2012, UNIFORM LAW REV, P262; Rahman S, 2009, FOOD POLICY, V34, P340, DOI 10.1016/j.foodpol.2009.02.004; Rigg J D., 2005, LIVING TRANSITION LA, DOI [10.4324/9780203002032, DOI 10.4324/9780203002032]; Rigg JD, 2006, LAND DEGRAD DEV, V17, P123, DOI 10.1002/ldr.719; Rigg J, 2012, WORLD DEV, V40, P1469, DOI 10.1016/j.worlddev.2012.03.001; Rodrigue JP., 2013, GEOGRAPHY TRANSPORT, DOI DOI 10.4324/9781315618159-2; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Schreinemachers P, 2013, SUSTAINABLE LAND USE, P3; Scott James, 2009, J SOUTHWEST; Stewart F., 2006, POVERTY FOCUS WHAT I, V9, P10; Thongmanivong S., 2006, SUST SLOP LANDS WAT; Thongmanivong S, 2006, MT RES DEV, V26, P237, DOI 10.1659/0276-4741(2006)26[237:RLUALT]2.0.CO;2; Tipraqsa P, 2009, AGR ECON-BLACKWELL, V40, P43, DOI 10.1111/j.1574-0862.2008.00343.x; Turner II B., 1996, J PEASANT STUD, V23, P186; WFP (World Food Programme), 2009, AGR TRANS IMP AGR CO; WFP (World Food Programme), 2007, MARK AN TOOL MARK IN; Wiesmann U., 1998, SUSTAINABLE REGIONAL; Willi Y., 2011, THESIS; Yi ZF, 2014, ECOL INDIC, V36, P788, DOI 10.1016/j.ecolind.2013.03.016; Zeller M, 1997, 53 IFPRI FCND; Zimmerer KS, 2015, CURR OPIN ENV SUST, V14, P49, DOI 10.1016/j.cosust.2015.03.004; Zorya S, 2009, HIGH MARKETING COSTS; [No title captured]	67	4	4	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209166	10.1371/journal.pone.0209166	http://dx.doi.org/10.1371/journal.pone.0209166			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596672	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200030
J	van Oudenhove, L; Cerda, X; Bernstein, C				van Oudenhove, Louise; Cerda, Xim; Bernstein, Carlos			Dominance-discovery and discovery-exploitation trade-offs promote diversity in ant communities	PLOS ONE			English	Article							TRAIL-FOLLOWING BEHAVIOR; FORAGING STRATEGIES; EVOLUTIONARY STABILITY; NICHE DIFFERENTIATION; RESOURCE DISCOVERY; HARVESTER ANT; COMPETITION; COEXISTENCE; RECRUITMENT; FOOD	In ant communities, species coexist by using different foraging strategies. We developed an adaptive dynamics model to gain a better understanding of the factors that promote the emergence and maintenance of strategy diversity. We analysed the consequences of both interspecific competition and resource distribution for the evolutionary dynamics of social foraging in ants. The evolution of social foraging behaviour was represented using a stochastic mutation-selection process involving interactions among colonies. In our theoretical community, ant colonies inhabit an environment where resources are limited, and only one resource type is present. Colony interactions depend on colony-specific foraging strategies (defined as the degree of collective foraging), resource distribution patterns, and the degree of competition asymmetry. At the ecological timescale, we have created a model of foraging processes that reflects trade-offs between resource discovery and resource exploitation and between resource discovery and ant behavioural dominance. At the evolutionary timescale, we have identified the conditions of competition and resource distribution that can lead to the emergence and coexistence of both collective and individual foraging strategies. We suggest that asymmetric competition is an essential component in the emergence of diverse foraging strategies in a sympatric ant community.	[van Oudenhove, Louise] Univ Cote Azur, CNRS, INRA, ISA, Nice, France; [van Oudenhove, Louise; Cerda, Xim] CSIC, Estn Biol Donana, Seville, Spain; [van Oudenhove, Louise; Bernstein, Carlos] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, Lab Biometrie & Biol Evolut, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	van Oudenhove, L (corresponding author), Univ Cote Azur, CNRS, INRA, ISA, Nice, France.; van Oudenhove, L (corresponding author), CSIC, Estn Biol Donana, Seville, Spain.; van Oudenhove, L (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, Lab Biometrie & Biol Evolut, Villeurbanne, France.	louise.vanoudenhove@inra.fr	Cerda, Xim/P-6461-2014	Cerda, Xim/0000-0002-3222-2471	Spanish Ministry of Economy, Industry and Competitiveness (MINIECO); FEDER [CGL2012-36181, CGL2015-65807-P]	Spanish Ministry of Economy, Industry and Competitiveness (MINIECO); FEDER(European Commission)	This work was supported by Spanish Ministry of Economy, Industry and Competitiveness (MINIECO) and FEDER (projects CGL2012-36181 and CGL2015-65807-P to XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2006, AM NAT, V167, P329, DOI 10.1086/499382; Abrams PA, 2006, AM NAT, V168, P645, DOI 10.1086/507878; Adler FR, 2007, AM NAT, V169, P323, DOI 10.1086/510759; Adler FR, 1999, AM NAT, V154, P497, DOI 10.1086/303258; Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; Andersen AN, 2008, AUSTRAL ECOL, V33, P211, DOI 10.1111/j.1442-9993.2007.01810.x; Andersen AN, 2013, AUSTRAL ECOL, V38, P557, DOI 10.1111/aec.12000; Anderson C, 2001, BEHAV ECOL, V12, P111, DOI 10.1093/oxfordjournals.beheco.a000372; Arnan X, 2014, J ANIM ECOL, V83, P1398, DOI 10.1111/1365-2656.12227; Arnan X, 2012, OECOLOGIA, V170, P489, DOI 10.1007/s00442-012-2315-y; Baroni UC, 1989, ETHOL ECOL EVOL, V1, P137, DOI DOI 10.1080/08927014.1989.9525520; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; BERNSTEIN RA, 1975, ECOLOGY, V56, P213, DOI 10.2307/1935314; Bestelmeyer BT, 2000, J ANIM ECOL, V69, P998, DOI 10.1046/j.1365-2656.2000.00455.x; Biesmeijer JC, 2001, BEHAV ECOL SOCIOBIOL, V49, P89, DOI 10.1007/s002650000289; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bonabeau E, 1998, J THEOR BIOL, V195, P157, DOI 10.1006/jtbi.1998.0789; Buehlmann C, 2014, CURR BIOL, V24, P960, DOI 10.1016/j.cub.2014.02.056; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Cerda X, 1998, OIKOS, V82, P99, DOI 10.2307/3546920; Cerda X, 1998, OECOLOGIA, V117, P404, DOI 10.1007/s004420050674; Cerda X, 1997, J ANIM ECOL, V66, P363, DOI 10.2307/5982; Cerda X, 2013, MYRMECOL NEWS, V18, P131; Cerda X, 2009, BEHAV ECOL SOCIOBIOL, V63, P551, DOI 10.1007/s00265-008-0690-5; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; CHRISTIANSEN FB, 1991, AM NAT, V138, P37, DOI 10.1086/285203; COLWELL RK, 1975, ANNU REV ECOL SYST, V6, P281, DOI 10.1146/annurev.es.06.110175.001433; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; de Mazancourt C, 2004, AM NAT, V164, P765, DOI 10.1086/424762; Dechaume-Moncharmont FX, 2005, P ROY SOC B-BIOL SCI, V272, P1689, DOI 10.1098/rspb.2005.3137; Della Rossa F, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S0218127415400015; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; DENEUBOURG JL, 1986, PHYSICA D, V22, P176, DOI 10.1016/0167-2789(86)90239-3; Dercole F, 2008, PRINC SER THEOR COMP, P1; Dercole F, 2016, SCI REP-UK, V6, DOI 10.1038/srep26310; Detrain C, 2002, BIOL BULL-US, V202, P268, DOI 10.2307/1543478; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; EDELSTEINKESHET L, 1994, J MATH BIOL, V32, P303, DOI 10.1007/BF00160163; Feener DH, 1996, ANIM BEHAV, V51, P61, DOI 10.1006/anbe.1996.0005; Feener DJ, 2000, OIKOS, V90, P79, DOI 10.1034/j.1600-0706.2000.900108.x; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; Fowler D, 2014, J ANIM ECOL, V83, P943, DOI 10.1111/1365-2656.12188; Fukami T, 2015, ANNU REV ECOL EVOL S, V46, P1, DOI 10.1146/annurev-ecolsys-110411-160340; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; Geritz Stefan A.H., 2004, P54; Giraldeau L.A., 2000, MG BEH ECOL; Gordon DM, 2013, NATURE, V498, P91, DOI 10.1038/nature12137; GORDON DM, 1983, J KANSAS ENTOMOL SOC, V56, P277; GORDON DM, 1995, ANIM BEHAV, V50, P995, DOI 10.1016/0003-3472(95)80100-6; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; GOSS S, 1989, AM NAT, V134, P273, DOI 10.1086/284980; Holldobler B., 1990, pi; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Houadria M, 2016, ECOLOGY, V97, P225, DOI 10.1890/14-2466.1; Houadria M, 2015, BIOTROPICA, V47, P208, DOI 10.1111/btp.12184; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; JAFFE K, 1992, INSECT SOC, V39, P201, DOI 10.1007/BF01249295; JOHNSON LK, 1987, AM ZOOL, V27, P347; Jordan Raul, 2007, Myrmecological News, V10, P7; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Lanan M, 2014, MYRMECOL NEWS, V20, P53; Landi P, 2013, SIAM J APPL MATH, V73, P1634, DOI 10.1137/12088673X; Lebrun EG, 2007, J ANIM ECOL, V76, P58, DOI 10.1111/j.1365-2656.2006.01173.x; LeBrun EG, 2005, OECOLOGIA, V142, P643, DOI 10.1007/s00442-004-1763-4; Lester PJ, 2010, OIKOS, V119, P659, DOI 10.1111/j.1600-0706.2009.18012.x; Letten AD, 2017, ECOL MONOGR, V87, P161, DOI 10.1002/ecm.1242; Metz J. A. J., 1996, STOCHASTIC SPATIAL S, P183; MOORE PG, 1954, ECOLOGY, V35, P222, DOI 10.2307/1931120; Oster G.F., 1978, Monographs in Population Biology, pi; Palmer TM, 2000, OECOLOGIA, V123, P425, DOI 10.1007/s004420051030; PARK T, 1962, SCIENCE, V138, P1369, DOI 10.1126/science.138.3548.1369; Parr CL, 2010, ANT ECOLOGY, P77; Pearce-Duvet JC, 2010, ECOL ENTOMOL, V35, P549, DOI 10.1111/j.1365-2311.2010.01214.x; PERFECTO I, 1994, OECOLOGIA, V98, P184, DOI 10.1007/BF00341471; Pianka E.R., 1981, THEORETICAL ECOLOGY, P167; Putyatina TS, 2007, ZOOL ZH, V86, P701; Retana J, 2015, ECOLOGY, V96, P2781, DOI 10.1890/14-2326.1.sm; Ruano F, 2000, BEHAV ECOL, V11, P396, DOI 10.1093/beheco/11.4.396; Sanders NJ, 2007, J BIOGEOGR, V34, P1632, DOI 10.1111/j.1365-2699.2007.01714.x; Sanders NJ, 2003, ECOLOGY, V84, P1024, DOI 10.1890/0012-9658(2003)084[1024:RIATOO]2.0.CO;2; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; SAVOLAINEN R, 1989, OIKOS, V56, P3, DOI 10.2307/3566082; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Stuble KL, 2013, OECOLOGIA, V171, P981, DOI 10.1007/s00442-012-2459-9; Sumpter DJT, 2003, BEHAV ECOL SOCIOBIOL, V53, P131, DOI 10.1007/s00265-002-0549-0; Tanner CJ, 2008, ECOL ENTOMOL, V33, P127, DOI 10.1111/j.1365-2311.2007.00950.x; Tanner CJ, 2009, ANIM BEHAV, V77, P297, DOI 10.1016/j.anbehav.2008.10.016; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; TORRES JA, 1984, BIOTROPICA, V16, P284, DOI 10.2307/2387937; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; URBANI CB, 1993, INSECT SOC, V40, P233, DOI 10.1007/BF01242361; van Oudenhove L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055159; van Oudenhove L, 2012, J CHEM ECOL, V38, P802, DOI 10.1007/s10886-012-0130-x; Oudenhove L, 2011, NATURWISSENSCHAFTEN, V98, P1009, DOI 10.1007/s00114-011-0852-6; VEPSALAINEN K, 1990, J ANIM ECOL, V59, P643, DOI 10.2307/4886; Wiescher PT, 2011, ECOL ENTOMOL, V36, P549, DOI 10.1111/j.1365-2311.2011.01301.x; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Zmihorski M, 2016, ECOL ENTOMOL, V41, P276, DOI 10.1111/een.12297	107	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209596	10.1371/journal.pone.0209596	http://dx.doi.org/10.1371/journal.pone.0209596			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596700	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200060
J	Patel, RR; Crane, JS; Lopez, J; Chan, PA; Liu, AY; Tooba, R; James, AS				Patel, Rupa R.; Crane, John S.; Lopez, Julia; Chan, Philip A.; Liu, Albert Y.; Tooba, Rubabin; James, Aimee S.			Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men	PLOS ONE			English	Article							TRANSGENDER WOMEN; DOSING PREFERENCES; NATIONAL SAMPLE; 1-PERCENT GEL; BLACK-MEN; US MEN; PREP; RISK; BEHAVIOR; PERCEPTIONS	Pre-exposure prophylaxis (PrEP) is effective in preventing HIV infections among men who have sex with men (MSM). PrEP uptake and adherence remain low and product preferences are unknown, especially among young African American MSM who are most at-risk. We conducted 26 qualitative interviews from 2014-2016 among young adult HIV-negative African American MSM regarding PrEP product preferences in Missouri. While the pill and injectable were most liked of all modalities, about a quarter preferred rectal products or patches. Most participants preferred a long-acting injectable (LAI) to daily oral pills due to better medication adherence and a dislike for taking pills. Many participants preferred daily oral pills to on-demand oral PrEP due to the inability to predict sex and the perception that insufficient time or medication would not achieve HIV protection with on-demand. A fear of needles and the perception that there would not be therapeutic levels for a long duration were concerns with injectable PrEP. Study findings highlight the need for a range of prevention options for African American MSM and can inform PrEP product development as well as dissemination and implementation efforts.	[Patel, Rupa R.; Crane, John S.] Washington Univ, Div Infect Dis, St Louis, MO 63130 USA; [Lopez, Julia] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA; [Chan, Philip A.] Brown Univ, Div Infect Dis, Providence, RI 02912 USA; [Liu, Albert Y.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Liu, Albert Y.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Tooba, Rubabin] Washington Univ, Sch Med, St Louis, MO USA; [James, Aimee S.] Washington Univ, Div Publ Hlth Sci, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Brown University; University of California System; University of California San Francisco; San Francisco Department of Public Health; Washington University (WUSTL); Washington University (WUSTL)	Patel, RR (corresponding author), Washington Univ, Div Infect Dis, St Louis, MO 63130 USA.	rupapatel@wustl.edu	López, Julia D./AAL-2554-2020	López, Julia D./0000-0002-8197-002X; Tooba, Rubabin/0000-0001-5434-3533; James, Aimee/0000-0002-1411-9307	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000448, KL2TR000450]; National Institutes of Health [R25MH83620]; Washington University in St. Louis Institute for Public Health; National Institute of Mental Health [R01MH114657]; Siteman Cancer Center; Barnes-Jewish Hospital Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002346, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620, R01MH114657] Funding Source: NIH RePORTER	Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University in St. Louis Institute for Public Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Siteman Cancer Center; Barnes-Jewish Hospital Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RRP is supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448, sub-award KL2TR000450, from the National Center for Advancing Translational Sciences of the National Institutes of Health, the National Institutes of Health grant R25MH83620, and the Washington University in St. Louis Institute for Public Health. PAC is supported by the National Institute of Mental Health (R01MH114657). ASJ was supported by the Siteman Cancer Center and the Barnes-Jewish Hospital Foundation.	Agence Nationale de Securite du Medicament et des produits de sante, 2015, ARG ANSM JUST UT TRU; AIDS Vaccine and Advocacy Coalition, ARV BAS PREV PIP; [Anonymous], GUID US PREEXP PROPH; [Anonymous], 2017, NVIVO 11; Antoni G, 2017, INT AIDS C JUL 23 2; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Biello KB, 2018, ARCH SEX BEHAV, V47, P2101, DOI 10.1007/s10508-017-1049-7; Bush S., 2016, RACIAL CHARACTERISTI; Carballo-Dieguez A, 2017, AIDS BEHAV, V21, P3336, DOI 10.1007/s10461-017-1969-1; Carballo-Dieguez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181607; Centers for Disease Control and Prevention, PREEXP PROPH PREV HI; Centers for Disease Control and Prevention, 2016, HIV SURV REP, V28; Closson EF, 2018, AIDS CARE, V30, P191, DOI 10.1080/09540121.2017.1360992; Cranston RD, 2017, CLIN INFECT DIS, V64, P614, DOI 10.1093/cid/ciw832; Eaton LA, 2017, PREV SCI, V18, P505, DOI 10.1007/s11121-017-0756-6; Eaton LA, 2015, AIDS PATIENT CARE ST, V29, P423, DOI 10.1089/apc.2014.0303; Elsesser SA, 2016, AIDS BEHAV, V20, P1400, DOI 10.1007/s10461-015-1238-0; Grant RM, 2017, INTERNATIONAL AIDS C; Grant RM, 2018, CLIN INFECT DIS, V66, P1712, DOI 10.1093/cid/cix1086; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greene GJ, 2017, AIDS BEHAV, V21, P1336, DOI 10.1007/s10461-016-1565-9; Greenwald Z., 2017, INT C HIV TREATM PRE; Haberer JE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21842; Hall EW, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5713; Hendrix CW, 2016, AIDS RES HUM RETROV, V32, P32, DOI [10.1089/aid.2015.0182, 10.1089/AID.2015.0182]; Hess KL, 2017, ANN EPIDEMIOL, V27, P238, DOI 10.1016/j.annepidem.2017.02.003; Hiruy H, 2015, AIDS RES HUM RETROV, V31, P1098, DOI [10.1089/aid.2015.0098, 10.1089/AID.2015.0098]; HIV Prevention Trials Network, HPTN 083 PHAS 2B 3 D; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179; John SA, 2018, AIDS BEHAV, V22, P1184, DOI 10.1007/s10461-017-1907-2; Kerrigan D, 2018, AIDS BEHAV, V22, P3540, DOI 10.1007/s10461-017-2017-x; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Kubicek K, 2015, ARCH SEX BEHAV, V44, P487, DOI 10.1007/s10508-014-0398-8; Lelutiu-Weinberger C, 2016, JAIDS-J ACQ IMM DEF, V73, P547, DOI 10.1097/QAI.0000000000001140; Liu A., ADDRESSING GAPS PROD; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Markowitz M, 2017, LANCET HIV, V4, pE331, DOI 10.1016/S2352-3018(17)30068-1; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McGowan I., 2017, INT AIDS C JUL 23 26; McGowan I, 2016, LANCET HIV, V3, pE569, DOI 10.1016/S2352-3018(16)30113-8; Mera R, 2016, INT AIDS C JUL 18 22; Meyers K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114700; Microbicide Trials Network, MTN 035; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina J-M, 2018, INT AIDS C JUL 23 27; Molina JM, 2017, LANCET HIV, V4, pE402, DOI 10.1016/S2352-3018(17)30089-9; Parsons JT, 2016, AIDS BEHAV, V20, P1390, DOI 10.1007/s10461-016-1370-5; Patel R, 2017, CTR DIS CONTR PREV A; Rolle CP, 2017, JAIDS-J ACQ IMM DEF, V76, P250, DOI 10.1097/QAI.0000000000001497; Schlesinger E, 2016, PHARM RES-DORDR, V33, P1649, DOI 10.1007/s11095-016-1904-6; Serota DP, 2018, CLIN INFECT DIS, V67, P965, DOI 10.1093/cid/ciy297; Smith DK, 2018, ANN EPIDEMIOL, V28, P850, DOI 10.1016/j.annepidem.2018.05.003; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Stack C, 2016, JAIDS-J ACQ IMM DEF, V71, P94, DOI 10.1097/QAI.0000000000000816; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tung E, 2017, C RETR OPP INF FEBR; Vaccher SJ, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00341; Wheeler DP, 2016, INT AIDS C JUL 18 22; WHO, GUID START ANT THER; WRIGHT E, 2018, J VIRUS ERAD, V4, P143; Xiao P, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01644-17	63	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209484	10.1371/journal.pone.0209484	http://dx.doi.org/10.1371/journal.pone.0209484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0GV	30592756	Green Submitted, gold, Green Published			2022-12-26	WOS:000454621900028
J	Ballestin, A; Casado, JG; Abellan, E; Vela, FJ; Alvarez, V; Uson, A; Lopez, E; Marinaro, F; Blazquez, R; Sanchez-Margallo, FM				Ballestin, Alberto; Casado, Javier G.; Abellan, Elena; Javier Vela, F.; Alvarez, Veronica; Uson, Alejandra; Lopez, Esther; Marinaro, Federica; Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco			Ischemia-reperfusion injury in a rat microvascular skin free flap model: A histological, genetic, and blood flow study	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; CEREBRAL-ISCHEMIA; HYPERBARIC-OXYGEN; TIME; APOPTOSIS; SURVIVAL; EXPRESSION; BCL-2; HEAD; RECONSTRUCTION	Ischemia reperfusion injury is associated with tissue damage and inflammation, and is one of the main factors causing flap failure in reconstructive microsurgery. Although ischemia-reperfusion (I/R) injury is a well-studied aspect of flap survival, its biological mechanisms remain to be elucidated. To better understand the biological processes of ischemia reperfusion injury, and to develop further therapeutic strategies, the main objective of this study was to identify the gene expression pattern and histological changes in an I/R injury animal model. Fourteen rats (n = 7/group) were randomly divided into control or ischemia-reperfusion group (8 hours of ischemia). Microsurgical anastomoses were objectively assessed using transit-time-ultrasound technology. Seven days after surgery, flap survival was evaluated and tissue samples were harvested for anatomopathological and gene-expression analyses. The I/R injury reduced the survival of free flaps and histological analyses revealed a subcutaneous edema together with an inflammatory infiltrate. Interestingly, the Arginase 1 expression level as well as the ratio of Arginase 1/Nitric oxide synthase 2 showed a significant increase in the I/R group. In summary, here we describe a well-characterized I/R animal model that may serve to evaluate therapeutic agents under reproducible and controlled conditions. Moreover, this model could be especially useful for the evaluation of arginase inhibitors and different compounds of potential interest in reconstructive microsurgery.	[Ballestin, Alberto; Abellan, Elena; Javier Vela, F.; Miguel Sanchez-Margallo, Francisco] Jesus Uson Minimally Invas Surg Ctr, Dept Microsurg, Caceres, Spain; [Casado, Javier G.; Alvarez, Veronica; Uson, Alejandra; Lopez, Esther; Marinaro, Federica; Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco] Jesus Uson Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain		Ballestin, A (corresponding author), Jesus Uson Minimally Invas Surg Ctr, Dept Microsurg, Caceres, Spain.	aballestin@ccmijesususon.com	Pérez, Verónica Álvarez/AAP-1021-2020; Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; García, Javier/AAH-1330-2020; Vela, F Javier/AAD-3218-2020; Blazquez, Rebeca/D-9523-2017; Marinaro, Federica/T-4724-2017; G Casado, Javier/ABE-9043-2021; Marinaro, Federica/L-3745-2019; Blázquez, Rebeca/Q-2588-2019; Ballestin, Alberto/C-7999-2019	Pérez, Verónica Álvarez/0000-0002-7319-6089; Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Vela, F Javier/0000-0002-6546-0601; Blazquez, Rebeca/0000-0002-1149-8305; Marinaro, Federica/0000-0001-5965-7718; Marinaro, Federica/0000-0001-5965-7718; Blázquez, Rebeca/0000-0002-1149-8305; Ballestin, Alberto/0000-0002-7150-9758; G Casado, Javier/0000-0001-6797-7287; Abellan, Elena/0000-0003-2209-2180; Lopez Nieto, Esther/0000-0002-5051-5913	ISCIII projects [PI16/02164, CD17/00021, PI18/00911, CP17/00021]; Junta de Extremadura [IB16168]; European Union (ERDF/ESF)	ISCIII projects; Junta de Extremadura; European Union (ERDF/ESF)	This work was supported in part by ISCIII projects (PI16/02164, CD17/00021, PI18/00911 and CP17/00021) (FMS-M, JGC), by a project from Junta de Extremadura (IB16168) and co-funded by the European Union (ERDF/ESF) (JGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballestin A, 2018, J RECONSTRUCTIVE MIC; Bansal SS, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003688; Barre-Sinoussi F, 2015, FUTUR SCI OA, V1, DOI [10.4155/fso.15.63, 10.4155/FSO.15.63]; Bennett N, 2000, PLAST RECONSTR SURG, V105, P2266, DOI 10.1097/00006534-200005000-00062; Bizeau A, 2002, Ann Otolaryngol Chir Cervicofac, V119, P31; Bonjour JP, 1999, OSTEOPOROSIS INT, V9, P379, DOI 10.1007/s001980050161; Bui DT, 2007, PLAST RECONSTR SURG, V119, P2092, DOI 10.1097/01.prs.0000260598.24376.e1; Carroll WR, 2000, HEAD NECK-J SCI SPEC, V22, P700, DOI 10.1002/1097-0347(200010)22:7<700::AID-HED10>3.0.CO;2-H; Cetin C, 2001, ANN PLAS SURG, V47, P540; Chafin B, 1999, HEAD NECK-J SCI SPEC, V21, P198, DOI 10.1002/(SICI)1097-0347(199905)21:3<198::AID-HED3>3.3.CO;2-K; Chang KP, 2012, MICROSURG, V32, P642, DOI 10.1002/micr.22046; Chen DH, 2016, J RECONSTR MICROSURG, V32, P580, DOI 10.1055/s-0036-1584205; Chen SM, 2012, BIOMARKERS, V17, P441, DOI 10.3109/1354750X.2012.684152; Chiu YH, 2017, ANN PLAS SURG, V78, pS83, DOI 10.1097/SAP.0000000000001011; Di Giammarco G, 2006, J THORAC CARDIOV SUR, V132, P468, DOI 10.1016/j.jtcvs.2006.02.014; Dragu A, 2011, PLAST RECONSTR SURG, V127, P2293, DOI 10.1097/PRS.0b013e318213a01f; Ericsson Aaron C, 2013, Mo Med, V110, P201; Fitzal F, 2001, J RECONSTR MICROSURG, V17, P535, DOI 10.1055/s-2001-17756; Fogarty CE, 2017, CELL DEATH DIFFER, V24, P1390, DOI 10.1038/cdd.2017.47; Fowler JD, 1999, MICROSURG, V19, P135, DOI 10.1002/(SICI)1098-2752(1999)19:3<135::AID-MICR3>3.0.CO;2-Y; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Fries CA, 2017, MICROSURG, V37, P142, DOI 10.1002/micr.30053; GOTTLIEB LJ, 1994, PLAST RECONSTR SURG, V93, P1503, DOI 10.1097/00006534-199406000-00027; Han HH, 2015, MICROSURG, V35, P645, DOI 10.1002/micr.22522; Harder Y, 2008, J PLAST RECONSTR AES, V61, P503, DOI 10.1016/j.bjps.2007.11.032; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; de G MMH, 2015, INVEST CLIN, V56, P377; Hong JP, 2003, ANN PLAS SURG, V51, P478, DOI 10.1097/01.sap.0000095651.05156.0f; Jazwa A, 2016, VASC PHARMACOL, V86, P18, DOI 10.1016/j.vph.2016.09.003; Jones NF, 2007, PLAST RECONSTR SURG, V119, P2053, DOI 10.1097/01.prs.0000260591.82762.b5; Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186; KOCHI T, 2013, PLOS ONE, V8; Koul Ashok Raj, 2013, Indian J Plast Surg, V46, P247, DOI 10.4103/0970-0358.118600; KRAG C, 1981, BRIT J PLAST SURG, V34, P64, DOI 10.1016/0007-1226(81)90101-6; Li J, 2010, MICROVASC RES, V80, P10, DOI 10.1016/j.mvr.2009.12.002; Li J, 2010, BRAIN RES, V1356, P11, DOI 10.1016/j.brainres.2010.08.012; Liu GY, 2013, BIOMED REP, V1, P861, DOI 10.3892/br.2013.153; Liu YQ, 2015, J PLAST RECONSTR AES, V68, pE147, DOI 10.1016/j.bjps.2015.03.001; Liu YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187637; Lo SL, 2017, J ORAL MAXIL SURG, V75, P867, DOI 10.1016/j.joms.2016.09.025; Ma XL, 2013, CURR NEUROVASC RES, V10, P103, DOI 10.2174/1567202611310020003; Pafitanis G, 2017, J PLAST RECONSTR AES, V70, P1242, DOI 10.1016/j.bjps.2017.05.010; Pernow J, 2013, CARDIOVASC RES, V98, P334, DOI 10.1093/cvr/cvt036; Rao JH, 2014, CURR OPIN ORGAN TRAN, V19, P115, DOI 10.1097/MOT.0000000000000064; Raup-Konsavage WM, 2017, AM J PHYSIOL-RENAL, V313, pF522, DOI 10.1152/ajprenal.00620.2016; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Schein O, 2013, HEAD NECK-J SCI SPEC, V35, P1265, DOI 10.1002/hed.23114; Schluter KD, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00065; Schmidt Y, 2012, PLAST RECONSTR SURG, V129, p174E, DOI 10.1097/PRS.0b013e3182362e53; Selber JC, 2013, PLAST RECONSTR SURG, V131, P270, DOI 10.1097/PRS.0b013e3182789c91; Shaughness G, 2017, PLAST RECONSTR SURG, V139, P1400, DOI 10.1097/PRS.0000000000003350; SHESTAK KC, 1991, PLAST RECONSTR SURG, V88, P259, DOI 10.1097/00006534-199108000-00014; SHIN MS, 1994, PLAST RECONSTR SURG, V94, P661, DOI 10.1097/00006534-199410000-00014; Shosha E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.295; Siemionow M, 2004, MICROSURG, V24, P468, DOI 10.1002/micr.20060; Tratsiakovich Y, 2013, EUR J PHARMACOL, V720, P121, DOI 10.1016/j.ejphar.2013.10.040; van den Heuvel MGW, 2009, J PLAST RECONSTR AES, V62, P721, DOI 10.1016/j.bjps.2009.01.060; Vega S, 2008, PLAST RECONSTR SURG, V122, P329, DOI 10.1097/PRS.0b013e31817f45cb; Walpoth BH, 1998, ANN THORAC SURG, V66, P1097, DOI 10.1016/S0003-4975(98)00653-5; Wang WZ, 2011, PLAST RECONSTR SURG, V128, p685E, DOI 10.1097/PRS.0b013e318230c57b; Wang WZ, 2009, MICROSURG, V29, P72, DOI 10.1002/micr.20587; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241; Xiao YD, 2015, J SURG RES, V199, P732, DOI 10.1016/j.jss.2015.06.038; Yoshida Winston Bonetti, 2005, Acta Cir. Bras., V20, P358, DOI 10.1590/S0102-86502005000500004; Yu PR, 2009, HEAD NECK-J SCI SPEC, V31, P45, DOI 10.1002/hed.20927	67	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209624	10.1371/journal.pone.0209624	http://dx.doi.org/10.1371/journal.pone.0209624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589864	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200034
J	Saldivar, MJB; Massoni, V				Benitez Saldivar, Maria Juliana; Massoni, Viviana			Lack of conspecific visual discrimination between second-year males and females in the Saffron Finch	PLOS ONE			English	Article							DELAYED PLUMAGE MATURATION; SEXUAL DICHROMATISM; REPRODUCTIVE INVESTMENT; MULTIPLE ORNAMENTS; PASSERINE BIRD; OIL DROPLETS; COLOR-VISION; TRADE-OFF; SELECTION; EVOLUTION	Sexually dichromatic birds often show delayed plumage maturation, but second-year (SY) males may or may not be distinguishable from females. In competitive contexts, SY males receive a reduced amount of adult males' aggression, either by mimicking females or through signaling their sex and inexperience as subordinate males. To the human eye, reproductive dull SY male Saffron Finches are indistinguishable from females, whereas after second-year (ASY) males are golden yellow. Our aim is to establish whether SY males are sexually dichromatic with females to the eye of conspecifics. We describe plumage variation in females, SY and ASY males and, in particular, analyze assortative mating by color by comparing a previously disregarded yellow feather patch shared by the three groups. We measured plumage reflectance of the forehead, breast, belly, and axillaries, and used a two-step avian visual model analysis to estimate the ability of Saffron Finches to distinguish between SY males and females. We find that those groups are indistinguishable to conspecifics by color. Furthermore, we find non-significant evidence of assortative mating directly related to the coloration of comparable feather patches between females and each type of male, though body condition of SY males is associated to that of their mates. Our results are compatible with both the female-mimicry and the status signaling hypotheses of evolution and maintenance of delayed plumage maturation. However, the singing behavior of males reveals their presence within the breeding site; the combined effect of song and dull coloration suggest that SY males are honestly revealing their sex and status to conspecifics.	[Benitez Saldivar, Maria Juliana; Massoni, Viviana] Consejo Nacl Invest Cient & Tecn, IEGEBA, Buenos Aires, DF, Argentina; [Massoni, Viviana] Univ Buenos Aires, Fac Cs Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Benitez Saldivar, Maria Juliana] Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Saldivar, MJB (corresponding author), Consejo Nacl Invest Cient & Tecn, IEGEBA, Buenos Aires, DF, Argentina.; Saldivar, MJB (corresponding author), Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina.	jbenitez@ege.fcen.uba.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [11220130100342CO]; Universidad de Buenos Aires [20020130100772BA]; CONICET [4370/2012]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (#CONICET-PIP (2014-2017) 11220130100342CO to VM) and Universidad de Buenos Aires (2014-2017) (#20020130100772BA to VM) through research grants awarded to VM, and CONICET through a doctoral scholarship to MJBS (#4370/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen Trond, 2006, P280; Andersson Malte, 1994; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; Andersson Staffan, 2006, P41; [Anonymous], 2021, LANG ENV STAT COMP; Badyaev AV, 2007, J EVOLUTION BIOL, V20, P1277, DOI 10.1111/j.1420-9101.2007.01354.x; Badyaev AV, 2003, ANNU REV ECOL EVOL S, V34, P27, DOI 10.1146/annurev.ecolsys.34.011802.132441; Badyaev AV, 2003, J EVOLUTION BIOL, V16, P1065, DOI 10.1046/j.1420-9101.2003.00628.x; Saldivar MJB, 2018, BIOACOUSTICS, V27, P327, DOI 10.1080/09524622.2017.1344932; Benitez Saldivar MJ, 2018, MADURACION TARDIA PL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentz AB, 2013, J AVIAN BIOL, V44, P80, DOI 10.1111/j.1600-048X.2012.05730.x; Berggren A, 2004, P ROY SOC B-BIOL SCI, V271, P2123, DOI 10.1098/rspb.2004.2846; Bergmann H, 1934, HOPPE SEYLERS Z F PH, V488, P193; Bitton PP, 2008, BEHAV ECOL SOCIOBIOL, V62, P1543, DOI 10.1007/s00265-008-0583-7; Bulluck LP, 2017, AUK, V134, P229, DOI 10.1642/AUK-16-151.1; Burns K.J., 2017, STUDIES AVIAN BIOL E, V1, P23; Burns KJ, 2012, AUK, V129, P211, DOI 10.1525/auk.2012.11182; Cezilly F, 2004, ENCY ANIMAL BEHAV, P876, DOI DOI 10.1086/670160; Chaine AS, 2013, ANIM BEHAV, V86, P409, DOI 10.1016/j.anbehav.2013.05.034; Cuthill Innes C., 2006, P3; Delhey Kaspar, 2010, BMC Ecology, V10, P13, DOI 10.1186/1472-6785-10-13; Doucet SM, 2007, AUK, V124, P29, DOI 10.1642/0004-8038(2007)124[29:PDAMIL]2.0.CO;2; Doutrelant C, 2008, J EVOLUTION BIOL, V21, P226, DOI 10.1111/j.1420-9101.2007.01451.x; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; Enbody ED, 2017, ECOL EVOL, V7, P4024, DOI 10.1002/ece3.3000; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; ENSTROM DA, 1992, BEHAV ECOL SOCIOBIOL, V30, P35; Facchinetti C, 2011, CONDOR, V113, P907, DOI 10.1525/cond.2011.110010; FLOOD NJ, 1984, EVOLUTION, V38, P267, DOI 10.1111/j.1558-5646.1984.tb00285.x; Freeman-Gallant CR, 2014, J EVOLUTION BIOL, V27, P982, DOI 10.1111/jeb.12369; Friedman NR, 2015, J EVOLUTION BIOL, V28, P2125, DOI 10.1111/jeb.12737; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Grant BR, 1990, BEHAV ECOL, V1, P161, DOI 10.1093/beheco/1.2.161; Greene E, 2000, NATURE, V407, P1000, DOI 10.1038/35039500; GRIFFITH SC, 2006, BIRD COLORATION, V2, P233; Griggio M, 2009, BEHAV ECOL, V20, P1072, DOI 10.1093/beheco/arp099; Grunst AS, 2014, BEHAV ECOL SOCIOBIOL, V68, P1451, DOI 10.1007/s00265-014-1752-5; Harris MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088668; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hastad O, 2008, AM NAT, V171, P831, DOI 10.1086/587529; Hawkins GL, 2012, BIOL REV, V87, P257, DOI 10.1111/j.1469-185X.2011.00193.x; Hill G.E, 2006, BIRD COLORATION FUNC, V2; Hill GE, 2006, BIRD COLORATION MECH, V1; Jacobs AC, 2015, ETHOLOGY, V121, P176, DOI 10.1111/eth.12327; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; Jones JA, 2017, ETHOLOGY, V123, P145, DOI 10.1111/eth.12581; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Karubian J, 2002, EVOLUTION, V56, P1673; Karubian J, 2008, BEHAV ECOL, V19, P508, DOI 10.1093/beheco/arm159; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; LOZANO GA, 1995, WILSON BULL, V107, P153; Lukianchuk KC, 2014, ETHOLOGY, V120, P693, DOI 10.1111/eth.12240; LYON BE, 1986, EVOLUTION, V40, P605, DOI 10.1111/j.1558-5646.1986.tb00511.x; Maia R, 2013, METHODS ECOL EVOL, P38; Maia R, 2018, BEHAV ECOL, V29, P649, DOI 10.1093/beheco/ary017; Mason P., 1985, ORNITHOL MONOGR, P954, DOI DOI 10.2307/40168328; McGraw Kevin J., 2006, P177; McNaught MK, 2002, J EVOLUTION BIOL, V15, P505, DOI 10.1046/j.1420-9101.2002.00431.x; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Milenkaya O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136582; Montgomerie Robert, 2006, P90; MORTON ES, 1990, AUK, V107, P275, DOI 10.2307/4087610; MOUNTJOY DJ, 1988, AUK, V105, P61, DOI 10.1093/auk/105.1.61; Muehter VR, 1997, BEHAV ECOL SOCIOBIOL, V41, P281, DOI 10.1007/s002650050389; Narosky T, 2010, AVES ARGENTINA URUGU, P427; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Olsson P, 2015, J EXP BIOL, V218, P184, DOI 10.1242/jeb.111187; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Palmerio AG, 2012, MADURACION TARDIA PL; Palmerio AG, 2011, IBIS, V153, P421, DOI 10.1111/j.1474-919X.2011.01103.x; Palmerio AG, 2009, CONDOR, V111, P715, DOI 10.1525/cond.2009.080044; Pryke SR, 2010, EVOLUTION, V64, P1301, DOI 10.1111/j.1558-5646.2009.00897.x; Pryke SR, 2001, ANIM BEHAV, V62, P695, DOI 10.1006/anbe.2001.1804; Ridgely R.S., 1989, BIRDS S AM, VI; Rodrigues, 2018, EMU, V119, P1; ROHWER S, 1980, AM NAT, V115, P400, DOI 10.1086/283569; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shultz AJ, 2017, EVOLUTION, V71, P1061, DOI 10.1111/evo.13196; Siefferman L, 2005, ANIM BEHAV, V69, P67, DOI 10.1016/j.anbehav.2003.12.026; Smiseth PT, 2001, BEHAV ECOL, V12, P164, DOI 10.1093/beheco/12.2.164; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Villa GJ, 2018, J AVIAN BIOL, V49, P1; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Wagner RH, 1997, J AVIAN BIOL, V28, P143, DOI 10.2307/3677307; Wilcoxen TE, 2011, IBIS, V153, P70, DOI 10.1111/j.1474-919X.2010.01078.x; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Winkler D.W., 1983, Current Ornithology, V1, P33; Wolf WL, 2004, ANIM BEHAV, V67, P93, DOI 10.1016/j.anbehav.2003.02.009; Wyszecki G., 2000, COLOR SCI CONCEPTS M; Zapata J, 2018, J AVIAN BIOL, V49	98	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209549	10.1371/journal.pone.0209549	http://dx.doi.org/10.1371/journal.pone.0209549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589869	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200027
J	DiCriscio, AS; Hu, YR; Troiani, V				DiCriscio, Antoinette Sabatino; Hu, Yirui; Troiani, Vanessa			Task-induced pupil response and visual perception in adults	PLOS ONE			English	Article							SUPERIOR COLLICULUS; ATTENTIONAL WINDOW; AUTISM; LIGHT; EYE; PUPILLOMETRY; FOREST; SIZE; ALLOCATION; DILATION	We assessed whether there are differences in pupil response that underlie the selection of local vs. global parts of a stimulus array in healthy adults. We designed a Navon Figures eyetracking paradigm (i.e. large figure composed of small figures), requiring an individual to vary only the information attended to within an image. We found that participants have a characteristic constriction of the pupil waveform during selection of local information relative to global information. Because stimuli and lighting conditions were identical across conditions, this indicates that pupil changes may serve in a visual filtering mechanism important for attentional selection. This work represents the first characterization of pupil response in the context of selective attention, suggesting that mechanisms underlying the earliest stages of visual processes could be relevant for perception and visual selection.	[DiCriscio, Antoinette Sabatino; Troiani, Vanessa] Geisinger Autism & Dev Med Inst, Lewisburg, PA 17837 USA; [Hu, Yirui] Geisinger Ctr Hlth Res, Danville, PA USA		DiCriscio, AS; Troiani, V (corresponding author), Geisinger Autism & Dev Med Inst, Lewisburg, PA 17837 USA.	asdicriscio@geisinger.edu; vtroiani@geisinger.edu			Simons Foundation [350225]; Autism Science Foundation, Research Accelerator Award	Simons Foundation; Autism Science Foundation, Research Accelerator Award	This work was supported by the Simons Foundation, 350225 to VT and the Autism Science Foundation, Research Accelerator Award to ASD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2006, J CLIN EXP NEUROPSYC, V28, P1238, DOI 10.1080/13803390500376790; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BINDA P, 2013, J VISION, V13; Binda P, 2017, TRENDS NEUROSCI, V40, P455, DOI 10.1016/j.tins.2017.06.007; Binda P, 2015, J VISION, V15, DOI 10.1167/15.2.1; Binda P, 2015, TRENDS COGN SCI, V19, P1, DOI 10.1016/j.tics.2014.11.002; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Blaser E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04301; Boev AN, 2005, J NEUROSURG, V103, P496, DOI 10.3171/ped.2005.103.6.0496; Brand J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01274; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Celeghin A, 2015, CONSCIOUS COGN, V36, P414, DOI 10.1016/j.concog.2015.05.007; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Dale G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098625; Daniels LB, 2012, VISUAL NEUROSCI, V29, P131, DOI 10.1017/S0952523812000077; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; DiCriscio AS, 2017, J AUTISM DEV DISORD, V47, P1568, DOI 10.1007/s10803-017-3053-0; FILOTEO JV, 1995, J CLIN EXP NEUROPSYC, V17, P654, DOI 10.1080/01688639508405156; Filoteo JV, 1994, NEUROPSYCHOLOGY, V8, P210; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; Geangu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027132; Georgy L, 2016, CORTEX, V81, P151, DOI 10.1016/j.cortex.2016.04.018; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Haro J, 2016, BEHAV RES METHODS, P1, DOI [10.3758/s13428-015-0567-2, DOI 10.3758/S13428-015-0567-2]; Heitmann A, 2001, P 1 INT DRIV S HUM F; Hepach R, 2016, J COGN DEV, V17, P359, DOI 10.1080/15248372.2015.1135801; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Hochstein S, 2000, PERCEPT ECVP ABSTR, V29; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Kostic C, 2016, INVEST OPHTH VIS SCI, V57, P2501, DOI 10.1167/iovs.16-19150; Laeng B, 2014, PSYCHOL SCI, V25, P188, DOI 10.1177/0956797613503556; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Laeng B, 2011, COGN PROCESS, V12, P13, DOI 10.1007/s10339-010-0370-z; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LOEWENFELD I. E., 1993, PUPIL ANATOMY PHYSL, VII; Lomber SG, 2002, P NATL ACAD SCI USA, V99, P4049, DOI 10.1073/pnas.062551899; Lux S, 2008, CORTEX, V44, P21, DOI 10.1016/j.cortex.2005.08.001; Martineau J, 2011, J PSYCHIATR RES, V45, P1077, DOI 10.1016/j.jpsychires.2011.01.008; Mathot S, 2015, CURR DIR PSYCHOL SCI, V24, P374, DOI 10.1177/0963721415593725; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; Minas RK, 2007, APPL PREV PSYCHOL, V12, P140, DOI 10.1016/j.appsy.2007.09.003; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Naber M, 2013, FRONT PSYCHOL, P4; NABER M, 2013, J VISION, V13; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; NAVON D, 1981, PSYCHOL RES-PSYCH FO, V43, P1, DOI 10.1007/BF00309635; Oliveira FTP, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2209; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; Peckham AD, 2016, CLIN PSYCHOL SCI, V4, P451, DOI 10.1177/2167702615594999; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P765, DOI 10.1111/1469-7610.00375; Poirel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020879; R Development C, 2012, TEAM 2009 R LANG ENV; Raney GE, 2014, JOVE-J VIS EXP, DOI 10.3791/50780; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P873, DOI 10.1076/jcen.20.6.873.1111; Sabatino DiCriscio A, J AUTISM DEV DISORD; Sayim B, 2010, J VISION, V10, DOI 10.1167/10.3.10; Shalev L, 2003, J LEARN DISABIL-US, V36, P517, DOI 10.1177/00222194030360060301; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Song YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133237; Unsworth N, 2015, PSYCHON B REV, V22, P757, DOI 10.3758/s13423-014-0747-6; van Beilen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021262; Van der Meer E, 2010, PSYCHOPHYSIOLOGY, V47, P158, DOI 10.1111/j.1469-8986.2009.00884.x; Wang CA, 2015, CURR OPIN NEUROBIOL, V33, P134, DOI 10.1016/j.conb.2015.03.018; Wang CA, 2015, EUR J NEUROSCI, V41, P1102, DOI 10.1111/ejn.12883; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; Wechsler D, 2011, WASH 2 WECHSLER ABBR; Worthington A, 1996, NEUROCASE, V2, P441	70	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209556	10.1371/journal.pone.0209556	http://dx.doi.org/10.1371/journal.pone.0209556			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586398	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400071
J	Varkey, D; Mazard, S; Jeffries, TC; Hughes, DJ; Seymour, J; Paulsen, IT; Ostrowski, M				Varkey, Deepa; Mazard, Sophie; Jeffries, Thomas C.; Hughes, David J.; Seymour, Justin; Paulsen, Ian T.; Ostrowski, Martin			Stormwater influences phytoplankton assemblages within the diverse, but impacted Sydney Harbour estuary	PLOS ONE			English	Article							NEW-SOUTH-WALES; COASTAL WATERS; MARINE; COMMUNITIES; DYNAMICS; BLOOMS; LIGHT; SYNECHOCOCCUS; BIODIVERSITY; TEMPERATURE	Sydney Harbour is subjected to persistent stress associated with anthropogenic activity and global climate change, but is particularly subjected to pulse stress events associated with stormwater input during episodic periods of high rainfall. Photosynthetic microbes underpin metazoan diversity within estuarine systems and are therefore important bioindicators of ecosystem health; yet how stormwater input affects their occurrence and distribution in Sydney Harbour remains poorly understood. We utilised molecular tools (16S/18S rRNA and petB genes) to examine how the phytoplankton community structure (both prokaryotes and eukaryotes) within Sydney Harbour varies between high and low rainfall periods. The relative proportion of phytoplankton sequences was more abundant during the high rainfall period, comprising mainly of diatoms, an important functional group supporting increased productivity within estuarine systems, together with cyanobacteria. Increased spatial variability in the phytoplankton community composition was observed, potentially driven by the steepened physico-chemical gradients associated with stormwater inflow. Conversely, during a low rainfall period, the proportion of planktonic photosynthetic microbes was significantly lower and the persistent phytoplankton were predominantly represented by chlorophyte and dinoflagellate sequences, with lower overall diversity. Differences in phytoplankton composition between the high and low rainfall periods were correlated with temperature, salinity, total nitrogen and silicate. These results suggest that increased frequency of high-rainfall events may change the composition, productivity and health of the estuary. Our study begins to populate the knowledge gap in the phytoplankton community structure and substantial changes associated with transient environmental perturbations, an essential step towards unravelling the dynamics of primary production in a highly urbanised estuarine ecosystem in response to climate change and other anthropogenic stressors.	[Varkey, Deepa; Mazard, Sophie; Paulsen, Ian T.; Ostrowski, Martin] Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia; [Jeffries, Thomas C.] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Hughes, David J.; Seymour, Justin] Univ Technol Sydney, Climate Change Cluster, Ultimo, NSW, Australia	Macquarie University; Western Sydney University; University of Technology Sydney	Varkey, D; Paulsen, IT (corresponding author), Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia.	deepa.varkey@mq.edu.au; ian.paulsen@mq.edu.au	Ostrowski, Martin/A-7118-2010; Hughes, David/K-8960-2019; Mazard, Sophie/AAB-8055-2019; VARKEY, DEEPA RUTH/Q-4193-2019; Paulsen, Ian/K-3832-2012	Ostrowski, Martin/0000-0002-4357-3023; Hughes, David/0000-0003-3778-7460; Mazard, Sophie/0000-0002-1513-6483; VARKEY, DEEPA RUTH/0000-0002-9540-5638; Paulsen, Ian/0000-0001-9015-9418; Jeffries, Thomas/0000-0001-6479-0353; Seymour, Justin/0000-0002-3745-6541	Australian Research Council [DP110103091, DP120102764, DP110102718]; Transfield Foundation Early Career Researcher Grant; Greater Sydney Local Land Services; Australian Government	Australian Research Council(Australian Research Council); Transfield Foundation Early Career Researcher Grant; Greater Sydney Local Land Services; Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian Research Council Discovery Grant DP110102718 to ITP, Australian Government funded International Postgraduate Research Scholarship to DV, Transfield Foundation Early Career Researcher Grant awarded to TCJ, and by the Australian Research Council Discovery Grants, DP110103091 and DP120102764 to JS. Sample collection and physiochemical analyses were funded by Greater Sydney Local Land Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani P, 2001, P LINN SOC N S W, V123, P1; Ajani P, 2011, P LINN SOC N S W, V133, P15; Alexander H, 2015, P NATL ACAD SCI US, V112; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Banks J, 2016, REG STUD MAR SCI, V8, P353, DOI 10.1016/j.rsma.2016.04.007; Banks Joanne L., 2016, Pacific Conservation Biology, V22, P98, DOI 10.1071/PC15048; Beck HJ, 2012, ENVIRON MONIT ASSESS, V184, P637, DOI 10.1007/s10661-011-1992-z; Bricker SB, 2008, HARMFUL ALGAE, V8, P21, DOI 10.1016/j.hal.2008.08.028; Bureau of Meteorology, 2013, MONTHL WEATH REV NEW; Cai HY, 2010, APPL ENVIRON MICROB, V76, P2955, DOI 10.1128/AEM.02868-09; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carstensen J, 2015, ESTUAR COAST SHELF S, V162, P98, DOI 10.1016/j.ecss.2015.05.005; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Cloern JE, 2005, MAR ECOL PROG SER, V285, P11, DOI 10.3354/meps285011; Das P, 2000, MAR FRESHWATER RES, V51, P97, DOI 10.1071/MF97177; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dickman EM, 2008, P NATL ACAD SCI USA, V105, P18408, DOI 10.1073/pnas.0805566105; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards KF, 2016, LIMNOL OCEANOGR, V61, P1232, DOI 10.1002/lno.10282; Gorley C.K., 2006, GETTING STARTED PRIM; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatje V, 2003, MAR POLLUT BULL, V46, P719, DOI 10.1016/S0025-326X(03)00061-4; Hedge L, 2014, LIVING HARBOUR DYNAM; Hose Grant C., 2005, Journal of Water and Health, V3, P349; Hughes DJ, 2018, LIMNOL OCEANOGR, V63, P1891, DOI 10.1002/lno.10814; Humily F, 2014, FEMS MICROBIOL ECOL, V88, P231, DOI 10.1111/1574-6941.12285; Hutchings Pat A., 2013, Australian Zoologist, V36, P255, DOI 10.7882/AZ.2012.031; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; Jeffries TC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01438; Johnston EL, 2015, MAR FRESHWATER RES, V66, P1073, DOI 10.1071/MF15159; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; Litchman E, 2015, J ECOL, V103, P1384, DOI 10.1111/1365-2745.12438; Liu HB, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00089; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mayer-Pinto M, 2015, MAR FRESHWATER RES, V66, P1088, DOI 10.1071/MF15157; Mazard S, 2012, ENVIRON MICROBIOL, V14, P372, DOI 10.1111/j.1462-2920.2011.02514.x; Murrel MC, 2004, J PLANKTON RES, V26, P371, DOI 10.1093/plankt/fbh038; Penna A, 2017, MAR GENOM, V36, P49, DOI 10.1016/j.margen.2017.06.001; Pinckney JL, 1998, MAR BIOL, V131, P371, DOI 10.1007/s002270050330; Pittera J, 2014, ISME J, V8, P1221, DOI 10.1038/ismej.2013.228; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; R Core Team, 2021, R LANGUAGE ENV STAT; REVELANTE N, 1978, AUST J MAR FRESH RES, V29, P9; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siboni N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00460; Sohm JA, 2016, ISME J, V10, P333, DOI 10.1038/ismej.2015.115; Sun MY, 2012, MAR POLLUT BULL, V64, P1029, DOI 10.1016/j.marpolbul.2012.01.035; Tanner EL, 2017, ESTUAR COAST SHELF S, V192, P42, DOI 10.1016/j.ecss.2017.05.004; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Varkey D, 2016, ISME J, V10, P1252, DOI 10.1038/ismej.2015.179; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Winder M, 2017, LIMNOL OCEANOGR, V62, pS258, DOI 10.1002/lno.10650; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	57	5	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209857	10.1371/journal.pone.0209857	http://dx.doi.org/10.1371/journal.pone.0209857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586428	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400099
J	Zhu, X; Qiu, XM; Wu, DW; Chen, SD; Xiong, JW; Du, HX; Dai, ZH; Hoang, J; Peng, AJ; He, SX; Duan, JN; Chen, L				Zhu, Xi; Qiu, Xiangmiao; Wu, Dingwang; Chen, Shidong; Xiong, Jiwen; Du, Hongxuan; Dai, Zihao; Hoang, Jamy; Peng, Anjiao; He, Shixu; Duan, Jianan; Chen, Lei			Reliability of information about the use of antiepileptic drugs during pregnancy from three major web search engines in China	PLOS ONE			English	Article							EPILEPSY; INTERNET; WOMEN; RISKS	Objectives The objective of this study was to assess the reliability of online information, as provided by three major search engines in China, about the usage of antiepileptic drugs (AEDs) during pregnancy. Method Over eight weeks, six physicians conducted a literature search on six computers and six smartphones at a frequency of once per week. During each web search on each computer and smartphone, three major search engines in China were used, namely, Baidu, Sogou and 360. The search terms used were a combination of words, including one AED name (valproate/oxcarbazepine/levetiracetam/lamotrigine) and one Chinese word ("huaiyun" or "renshen", which means pregnancy in Chinese). The top ten websites retrieved from each search were recorded. After the content of each website was evaluated, the sites were categorized into 9 types. Meanwhile, commercial advertisements on each web page were also registered. Results A total of 16,411 search results were assessed. After excluding the redundant web pages, 4840 search results were included in the data analysis. Only 12.05% of the search results were reliable, 47.75% were partly reliable, and 40.21% were unreliable. A total of 4139 (85.52%) webpages contained commercial advertisements. The results from a multivariate analysis suggested that websites with no advertisements and professional websites have an independent positive impact on reliability. Conclusion Overall, little information on AED usage during pregnancy provided by major search engines in China was reliable.	[Zhu, Xi; Qiu, Xiangmiao; Wu, Dingwang; Chen, Shidong; Xiong, Jiwen; Du, Hongxuan; Dai, Zihao; Hoang, Jamy; Peng, Anjiao; He, Shixu; Duan, Jianan; Chen, Lei] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China	Sichuan University	Chen, L (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China.	leilei_25@126.com						Adab N, 2006, OBSTET GYNAECOL, V8, P20, DOI 10.1576/toag.8.1.020.27204; Allen M, 2008, NURS RES, V57, P107, DOI 10.1097/01.NNR.0000313478.47379.98; [Anonymous], BBC NEWS; [Anonymous], 2016, GLOBAL TIMES; Bell GS, 2002, EPILEPSY RES, V52, P139, DOI 10.1016/S0920-1211(02)00135-3; Bjelke M, 2016, MIDWIFERY, V40, P187, DOI 10.1016/j.midw.2016.06.020; De Santis M, 2010, EUR J OBSTET GYN R B, V151, P154, DOI 10.1016/j.ejogrb.2010.04.018; Escoffery C, 2008, EPILEPSY BEHAV, V12, P109, DOI 10.1016/j.yebeh.2007.07.013; Gao LL, 2013, MIDWIFERY, V29, P730, DOI 10.1016/j.midw.2012.07.003; Incitez China, 2014, CHIN SEARCH ENG SHAR; Lagan BM, 2011, MIDWIFERY, V27, P273, DOI 10.1016/j.midw.2009.07.002; Lavi-Blau T, 2016, EPILEPSY BEHAV, V55, P113, DOI 10.1016/j.yebeh.2015.12.002; Levy JA, 2002, J MED SYST, V26, P495, DOI 10.1023/A:1020288508362; Liu JM, 2015, CHINESE MED J-PEKING, V128, P3324, DOI 10.4103/0366-6999.171425; McGrath A, 2014, EPILEPSY BEHAV, V31, P246, DOI 10.1016/j.yebeh.2013.09.044; Mead Nicola, 2003, J Health Serv Res Policy, V8, P33, DOI 10.1258/13558190360468209; Meador KJ, 2014, NAT REV NEUROL, V10, P614, DOI 10.1038/nrneurol.2014.179; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Peterson G, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.4.e33; Tomson T, 2012, LANCET NEUROL, V11, P803, DOI 10.1016/S1474-4422(12)70103-5; Wang ZF, 2012, NEUROLOGY, V78, P1028, DOI 10.1212/WNL.0b013e3182507dc5	21	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208783	10.1371/journal.pone.0208783	http://dx.doi.org/10.1371/journal.pone.0208783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586373	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400034
J	Jablonowski, J; Taesler, P; Fu, QF; Rose, M				Jablonowski, Julia; Taesler, Philipp; Fu, Qiufang; Rose, Michael			Implicit acoustic sequence learning recruits the hippocampus	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; INDEPENDENT ACQUISITION; MEMORY; DISSOCIATION; ORDER; TASK; SYSTEMS	The exclusive role of the medial temporal lobe in explicit memory has been questioned by several studies reporting medial temporal lobe involvement during implicit learning. Prior studies have demonstrated that hippocampal engagement is present during the implicit learning of perceptual associations, however, it is absent during learning response-related associations. Therefore, it was hypothesized that the function of the medial temporal lobe during implicit learning is related to the extraction of perceptual associations in general. While in most implicit learning tasks visual stimuli were used, the aim of the current functional magnetic resonance imaging (fMRI) study was to detect whether activations within medial temporal lobe structures are also found during implicit learning of auditory associations. In a modified version of the classical serial reaction time task, participants reacted to the presentation of five different tones. Unbeknownst to the participants, the tones were presented with an underlying sequential regularity that could be learned. To avoid an influence of response learning on acoustic associative learning, response buttons were remapped in every trial. After learning, two different tests were used to measure participants' conscious knowledge about the underlying sequence in order to assess the amount of implicit memory and to exclude participants with explicit knowledge acquired during learning. fMRI results revealed hippocampal activations for implicit learning of the acoustic sequence. When detecting a relation between implicit learning of acoustic associations and hippocampal activations, this study indicated a relation between hippocampal activations and memory formation of perceptual-based relational representation regardless of explicit knowledge. Thus, present findings suggest a general functional role for the formation of sequenced perceptual associations independent of the involvement of awareness.	[Jablonowski, Julia; Taesler, Philipp; Rose, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Martinistr, Hamburg, Germany; [Fu, Qiufang] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China	University of Hamburg; University Medical Center Hamburg-Eppendorf; Chinese Academy of Sciences; Institute of Psychology, CAS	Jablonowski, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Martinistr, Hamburg, Germany.	j.jablonowski@uke.uni-hamburg.de	, Grace/ABB-4349-2021	Taesler, Philipp/0000-0003-1506-5387	German Research Foundation, DFG [SFB/Transregio 169]	German Research Foundation, DFG(German Research Foundation (DFG))	The present research was supported by the German Research Foundation, DFG; SFB/Transregio 169, B3 (https://www.crossmodallearning.org/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present research was supported by the German Research Foundation (DFG; SFB/Transregio 169). The authors hereby declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Finally, the authors thank Anita Wackenhut for her assistance with the data collection.	Abrahamse EL, 2008, Q J EXP PSYCHOL, V61, P210, DOI 10.1080/17470210701566739; Abrahamse EL, 2010, PSYCHON B REV, V17, P603, DOI 10.3758/PBR.17.5.603; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen J., 1969, STAT POWER ANAL RELA; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Dennis NA, 2006, EXP BRAIN RES, V175, P153, DOI 10.1007/s00221-006-0534-3; Destrebecqz A, 2005, LEARN MEMORY, V12, P480, DOI 10.1101/lm.95605; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; DeVito LM, 2011, J NEUROSCI, V31, P3169, DOI 10.1523/JNEUROSCI.4202-10.2011; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Dienes Z, 2010, CONSCIOUS COGN, V19, P674, DOI 10.1016/j.concog.2009.09.009; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eichenbaum H, 1996, P NATL ACAD SCI USA, V93, P13500, DOI 10.1073/pnas.93.24.13500; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Gheysen F., 2011, FRONT HUM NEUROSCI, V5, P1, DOI DOI 10.3389/FNHUM.2011.00137; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Gheysen F, 2009, EXP BRAIN RES, V197, P163, DOI 10.1007/s00221-009-1902-6; Goschke T, 2007, J EXP PSYCHOL LEARN, V33, P394, DOI 10.1037/0278-7393.33.2.394; Goschke T, 2012, COGNITIVE PSYCHOL, V65, P284, DOI 10.1016/j.cogpsych.2012.04.002; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Haider H, 2014, CONSCIOUS COGN, V26, P145, DOI 10.1016/j.concog.2014.03.005; Haider H, 2013, CONSCIOUS COGN, V22, P82, DOI 10.1016/j.concog.2012.11.003; Haider H, 2011, CONSCIOUS COGN, V20, P658, DOI 10.1016/j.concog.2010.10.021; Heckers S, 2004, HIPPOCAMPAL ACTIVATI, V162, P153, DOI [10.1002/hipo.10189, DOI 10.1002/HIPO.10189]; Henke K, 2003, NEUROPSYCHOLOGIA, V41, P863, DOI 10.1016/S0028-3932(03)00035-6; Henke K, 2003, CONSCIOUS COGN, V12, P31, DOI 10.1016/S1053-8100(02)00006-5; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Ling XL, 2015, EXP BRAIN RES, V233, P1125, DOI 10.1007/s00221-014-4184-6; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Mayr U, 1996, J EXP PSYCHOL LEARN, V22, P350, DOI 10.1037/0278-7393.22.2.350; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Preston AR, 2008, CEREB CORTEX, V18, P2192, DOI 10.1093/cercor/bhm245; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Reber TP, 2012, J NEUROSCI, V32, P6138, DOI 10.1523/JNEUROSCI.5639-11.2012; Remillard G, 2003, J EXP PSYCHOL LEARN, V29, P581, DOI 10.1037/0278-7393.29.4.581; Remillard G, 2009, J EXP PSYCHOL LEARN, V35, P528, DOI 10.1037/a0014646; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Rose M, 2005, UNCONSCIOUS DETECTIO, P918; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Terada S, 2017, NEURON, V94, P1248, DOI 10.1016/j.neuron.2017.05.024; Ziessler M, 2001, J EXP PSYCHOL LEARN, V27, P595, DOI 10.1037/0278-7393.27.3.595	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209590	10.1371/journal.pone.0209590	http://dx.doi.org/10.1371/journal.pone.0209590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF3QK	30576383	Green Submitted, Green Published, gold			2022-12-26	WOS:000454149400062
J	Yang, JW; Larson, G; Konrad, L; Shetty, M; Holy, M; Jantsch, K; Kastein, M; Heo, S; Erdem, FA; Lubec, G; Vaughan, RA; Sitte, HH; Foster, JD				Yang, Jae-Won; Larson, Garret; Konrad, Lisa; Shetty, Madhur; Holy, Marion; Jaentsch, Kathrin; Kastein, Mirja; Heo, Seok; Erdem, Fatma Asli; Lubec, Gert; Vaughan, Roxanne A.; Sitte, Harald H.; Foster, James D.			Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; protein phosphatase; phosphorylation; mass spectrometry (MS); protein-protein interaction; post-translational modification (PTM); dephosphorylation; neurotransmission; okadaic acid; palmitoylation; synaptic transmission	FUNCTIONAL REGULATION; PHOSPHORYLATION; TRAFFICKING; COCAINE; MECHANISMS; EXPRESSION; COMPLEXES	Several protein kinases, including protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and extracellular signal-regulated kinase, play key roles in the regulation of dopamine transporter (DAT) functions. These functions include surface expression, internalization, and forward and reverse transport, with phosphorylation sites for these kinases being linked to distinct regions of the DAT N terminus. Protein phosphatases (PPs) also regulate DAT activity, but the specific residues associated with their activities have not yet been elucidated. In this study, using co-immunoprecipitation followed by MS and immunoblotting analyses, we demonstrate the association of DAT with PP1 and PP2A in the mouse brain and heterologous cell systems. By applying MS in conjunction with a metabolic labeling method, we defined a PP1/2A-sensitive phosphorylation site at Thr-48 in human DAT, a residue that has not been previously reported to be involved in DAT phosphorylation. Site-directed mutagenesis of Thr-48 to Ala (T48A) to prevent phosphorylation enhanced dopamine transport kinetics, supporting a role for this residue in regulating DAT activity. Moreover, T48A-DAT displayed increased palmitoylation, suggesting that phosphorylation/dephosphorylation at this site has an additional regulatory role and reinforcing a previously reported reciprocal relationship between C-terminal palmitoylation and N-terminal phosphorylation.	[Yang, Jae-Won; Konrad, Lisa; Holy, Marion; Jaentsch, Kathrin; Kastein, Mirja; Erdem, Fatma Asli; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria; [Heo, Seok] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria; [Larson, Garret; Shetty, Madhur; Vaughan, Roxanne A.; Foster, James D.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA; [Lubec, Gert] Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria	Medical University of Vienna; Medical University of Vienna; University of North Dakota Grand Forks; Paracelsus Private Medical University	Sitte, HH (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.; Foster, JD (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.	harald.sitte@meduniwien.ac.at; d.foster@med.und.edu	; Konrad, Lisa K./I-7852-2018; Sitte, Harald/N-2681-2013	Shetty, Madhur/0000-0002-6476-2261; Yang, Jae-Won/0000-0001-8928-0130; Erdem, Fatma A./0000-0003-1381-5009; Heo, Seok/0000-0001-6585-9594; Konrad, Lisa K./0000-0001-8725-3139; Sitte, Harald/0000-0002-1339-7444	Austrian Science Fund (FWF) [F3506, P23670]; National Institutes of Health from the COBRE program of the NIGMS [R15 DA031991, R01 DA13147, P20 GM104360]; National Institutes of Health from the INBRE program of the NIGMS [P20 GM103442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442, P20GM104360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA031991] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Institutes of Health from the COBRE program of the NIGMS; National Institutes of Health from the INBRE program of the NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Austrian Science Fund (FWF) Grants F3506 (to H. H. S.) and P23670 (to J.-W. Y.) and National Institutes of Health Grants R15 DA031991 (to J. D. F.), R01 DA13147 (to R. A. V.), and P20 GM104360 (to U. N. D.) from the COBRE program and Grant P20 GM103442 (to U. N. D.) from the INBRE program of the NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batchelor M, 1998, J NEUROSCI, V18, P10304; Bauman AL, 2000, J NEUROSCI, V20, P7571; Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Foster JD, 2003, MOL BRAIN RES, V110, P100, DOI 10.1016/S0169-328X(02)00645-9; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hadlock GC, 2011, J NEUROSCI METH, V196, P303, DOI 10.1016/j.jneumeth.2011.01.023; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Juraszek B, 2016, J NEUROCHEM, V139, P537, DOI 10.1111/jnc.13777; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Melikian HE, 1999, J NEUROSCI, V19, P7699; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Page G, 2004, NEUROCHEM INT, V45, P627, DOI 10.1016/j.neuint.2004.04.002; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rastedt DE, 2017, J CHEM NEUROANAT, V83, P3, DOI 10.1016/j.jchemneu.2017.01.002; Salzer I, 2017, J PHYSIOL-LONDON, V595, P759, DOI 10.1113/JP273274; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; SULZER D, 1995, J NEUROSCI, V15, P4102; Sung U, 2005, BIOCHEM BIOPH RES CO, V333, P671, DOI 10.1016/j.bbrc.2005.05.165; Vaughan RA, 2005, J NEUROSCI METH, V143, P33, DOI 10.1016/j.jneumeth.2004.09.022; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wang Q, 2016, NEUROSCI LETT, V622, P78, DOI 10.1016/j.neulet.2016.04.051; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zhang L, 1997, BIOCHEM PHARMACOL, V53, P677, DOI 10.1016/S0006-2952(96)00898-2; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	38	4	4	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3419	3431		10.1074/jbc.RA118.005251	http://dx.doi.org/10.1074/jbc.RA118.005251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30587577	hybrid, Green Published			2022-12-26	WOS:000461853900010
J	Xu, X; Pan, J; Li, HL; Li, XZ; Fang, F; Wu, DK; Zhou, Y; Zheng, PL; Xiong, L; Zhang, DS				Xu, Xuan; Pan, Jian; Li, Huiling; Li, Xiaozhou; Fang, Fang; Wu, Dengke; Zhou, Yu; Zheng, Peiling; Xiong, Li; Zhang, Dongshan			Atg7 mediates renal tubular cell apoptosis in vancomycin nephrotoxicity through activation of PKC-	FASEB JOURNAL			English	Article						vancomycin; autophagy; apoptosis; ERK1; 2; mTOR	AUTOPHAGY PROTECTS; KIDNEY INJURY; PATHWAY; MODELS; HEALTH; P53	Recent studies have shown that autophagy exhibits a renoprotective role in various models of acute kidney injury (AKI). However, its role in vancomycin (Van)-induced AKI remains largely unclarified. This study was the first to indicate that autophagy was rapidly activated in both human kidney-2 cells and renal tissues, and mammalian target of rapamycin (mTOR) was inactivated via the suppression of ERK1/2 and mTOR during Van treatment. Interestingly, for both in vitro and in vivo experiments, the suppression of autophagy via chloroquine and PT-Atg7-KO significantly ameliorated Van-induced kidney injury and renal tubular cell apoptosis. Global gene expression analysis indicated that the expression levels of 6159 genes were induced by Van treatment in the kidney cortical tissues of PT-Atg7 wild-type mice, and 18 of them were notably suppressed in PT-Atg7-KO mice. These 18 genes were further classified as programmed cell death, protein binding, signal transduction, E3 ubiquitin ligase, nucleoside diphosphate kinase activity, and E1-like activating enzyme. Unexpectedly, following Van treatment, PKC- expression was found to be highest among the 4 genes related to cell death, which was remarkably suppressed in vitro and in PT-Atg7-KO mice. In addition, Atg7 could induce renal cell apoptosis during Van treatment via binding to PKC-. Likewise, the inhibition of PKC ameliorated Van-induced apoptosis in human kidney-2 cells and kidney tissues. Furthermore, the data showed that PT-Atg7-KO exerted a renoprotective effect against Van-induced nephrotoxicity, but this effect was lost after injection with myc-tagged PKC. Taken altogether, these results indicate that Van induces autophagy by suppressing the activation of the ERK1/2 and mTOR signaling pathway. In addition, Atg7 mediates Van-induced AKI through the activation of PKC. In sum, autophagy inhibition may serve as a novel therapeutic target for treating nephrotoxic AKI induced by Van.Xu, X., Pan, J., Li, H., Li, X., Fang, F., Wu, D., Zhou, Y., Zheng, P., Xiong, L., Zhang, D. Atg7 mediates renal tubular cell apoptosis in vancomycin nephrotoxicity through activation of PKC-.	[Xu, Xuan; Pan, Jian; Li, Xiaozhou; Wu, Dengke; Zhou, Yu; Zhang, Dongshan] Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Renmin Rd, Changsha 410011, Hunan, Peoples R China; [Li, Huiling; Fang, Fang] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Zheng, Peiling] Cent S Univ, Xiangya Hosp 2, Dept Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Xiong, Li] Cent S Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Zhang, DS (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Renmin Rd, Changsha 410011, Hunan, Peoples R China.	dongshanzhang@csu.edu.cn		, Dongshan/0000-0002-7387-4804	National Natural Science Foundation of China [81870475, 81570646, 81770951, 81500756]; Excellent Youth Foundation of Hu'nan Scientific Committee [2017JJ1035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Hu'nan Scientific Committee	The National Natural Science Foundation of China [Grants 81870475 and 81570646 (to D.Z.), 81770951 (to H.L.) and 81500756 (to F.F.)] and the Excellent Youth Foundation of Hu'nan Scientific Committee (2017JJ1035) supported this work. The authors declare no conflicts of interest.	Chen JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38868; Chien CT, 2007, TRANSPLANTATION, V84, P1183, DOI 10.1097/01.tp.0000287334.38933.e3; Cui J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11256; Hanrahan TP, 2015, ANAESTH INTENS CARE, V43, P594, DOI 10.1177/0310057X1504300507; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He Q, 2016, J MOL ENDOCRINOL, V57, P251, DOI 10.1530/JME-16-0139; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Kaushal GP, 2016, KIDNEY INT, V89, P779, DOI 10.1016/j.kint.2015.11.021; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Leventhal JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150001; Ma ZN, 2016, ONCOTARGET, V7, P66558, DOI 10.18632/oncotarget.11684; Mei SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22171; Meije Y, 2014, J INFECTION, V68, P548, DOI 10.1016/j.jinf.2014.01.001; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Takabatake Y, 2014, NEPHROL DIAL TRANSPL, V29, P1639, DOI 10.1093/ndt/gft535; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Wang J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.509; Wang ZB, 2014, ANTIOXID REDOX SIGN, V20, P519, DOI 10.1089/ars.2013.5363; Wu D, 2005, J AM SOC NEPHROL, V16, P646, DOI 10.1681/ASN.2004060445; Xu X, 2017, ONCOTARGET, V8, P91577, DOI 10.18632/oncotarget.21244; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Zhan XQ, 2014, J NEUROCHEM, V128, P350, DOI 10.1111/jnc.12471; Zhang DS, 2017, AUTOPHAGY, V13, P631, DOI 10.1080/15548627.2016.1269990; Zhang DS, 2017, J AM SOC NEPHROL, V28, P1131, DOI 10.1681/ASN.2016030337; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902; Zhang DS, 2013, J PHARMACOL EXP THER, V345, P69, DOI 10.1124/jpet.112.202481; Zhang YL, 2015, EXP BIOL MED, V240, P1590, DOI 10.1177/1535370215581306	39	27	27	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4513	4524		10.1096/fj.201801515R	http://dx.doi.org/10.1096/fj.201801515R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30589566				2022-12-26	WOS:000459794800112
J	Chen, XL; Sheng, ZC; Qiu, SL; Yang, HF; Jia, JP; Wang, J; Jiang, CM				Chen, Xiaolan; Sheng, Zhicun; Qiu, Shulei; Yang, Haifeng; Jia, Jiping; Wang, Jing; Jiang, Chunmao			Purification, characterization and in vitro and in vivo immune enhancement of polysaccharides from mulberry leaves	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; ENHANCING ACTIVITY; MORUS-ALBA; EPIMEDIUM POLYSACCHARIDE; PROPOLIS FLAVONE; LEAF; RESPONSES; ADJUVANT; VACCINE; SYSTEM	Mulberry leaf polysaccharide (MLP) was extracted and purified by DEAE-52 cellulose and Sephadex G-100 column chromatography to afford two major purified polysaccharides (MLP-1 and MLP-2). The purified polysaccharides were characterized, and their immuneenhancing properties were investigated. MLP-1 had a molecular weight of 9.31x10(4) Da and was composed of mannose, rhamnose, glucose, galactose, xylose, and arabinose in a molar ratio of 0.71:1.00:2.76:1.13:3.70:2.81. The molecular weight of MLP-2 was 2.22x10(6) Da, and its monosaccharide constituents were mannose, rhamnose, glucose, galactose, and arabinose in a molar ratio of 1.31:8.45:6.94:1.00:11.96. Infrared spectroscopy showed that each MLP had a typical absorption peak characteristic of sugars, and ultraviolet (UV) spectroscopy showed that neither MLP contained nucleic acid or protein components. Then, the abilities of these polysaccharides to stimulate spleen lymphocyte proliferation in mice in vitro were compared by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. MLP-2 was more effective than MLP-1; therefore, MLP-2 was chosen for the study of its immune-enhancing effects in vivo. For the in vivo experiments, 14-day-old chickens immunized with Newcastle disease (ND) vaccine were orally administered MLP-2, and Astragalus polysaccharide (APS) was used as the control. Each chicken was orally administered 4 mg or 8 mg of MLP-2 for seven consecutive days starting three days before ND vaccine immunization. MLP-2 significantly improved the ND serum antibody titer and interleukin-2 (IL-2), interferon-gamma (IFN-gamma) and immunoglobulin A (sIgA) concentrations in tracheal and jejunal wash fluids, and increasing numbers of immune globulin A-positive (IgA(+)) cells in cecal tonsils and increased body weight. These results indicated that MLP-2 could significantly enhance immune activity and could therefore be utilized as an immunopotentiator drug candidate.	[Chen, Xiaolan; Sheng, Zhicun; Qiu, Shulei; Yang, Haifeng; Jia, Jiping; Wang, Jing; Jiang, Chunmao] Jiangsu Agri Anim Husb Vocat Coll, Taizhou, Jiangsu, Peoples R China		Jiang, CM (corresponding author), Jiangsu Agri Anim Husb Vocat Coll, Taizhou, Jiangsu, Peoples R China.	cmj1962@126.com			Natural Science Foundation of China [31702286]; Jiangsu Province Natural Science Foundation [BK20161368]; Natural Science Research Project of Universities in Jiangsu Province of China [16KJB230005]; Jiangsu Overseas Visiting Scholar Program for University Prominent Young & Middle-aged Teacher and Presidents (2018); Qing Lan Project of Colleges and Universities in Jiangsu Province (2018)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Research Project of Universities in Jiangsu Province of China; Jiangsu Overseas Visiting Scholar Program for University Prominent Young & Middle-aged Teacher and Presidents (2018); Qing Lan Project of Colleges and Universities in Jiangsu Province (2018)	This study was financially supported by the Natural Science Foundation of China (31702286), Jiangsu Province Natural Science Foundation (BK20161368), Natural Science Research Project of Universities in Jiangsu Province of China (16KJB230005), Jiangsu Overseas Visiting Scholar Program for University Prominent Young & Middle-aged Teacher and Presidents (2018) and Qing Lan Project of Colleges and Universities in Jiangsu Province (2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by the Natural Science Foundation of China (31702286), Jiangsu Province Natural Science Foundation (BK20161368), Natural Science Research Project of Universities in Jiangsu Province of China (16KJB230005), Jiangsu Overseas Visiting Scholar Program for University Prominent Young & Middle- aged Teacher and Presidents (2018) and Qing Lan Project of Colleges and Universities in Jiangsu Province (2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre MJ, 2009, CARBOHYD RES, V344, P1095, DOI 10.1016/j.carres.2009.03.024; ASANO N, 1994, CARBOHYD RES, V259, P243, DOI 10.1016/0008-6215(94)84060-1; Basu T, 2018, CHEM PHYS LETT, V706, P465, DOI 10.1016/j.cplett.2018.06.053; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Chen XiaoLan, 2015, Chinese Journal of Veterinary Science, V35, P1495; Chen X, 2014, INT J BIOL MACROMOL, V64, P6, DOI 10.1016/j.ijbiomac.2013.11.015; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fan YP, 2010, INT J BIOL MACROMOL, V47, P87, DOI 10.1016/j.ijbiomac.2010.05.017; Feng L, 2016, INT J BIOL MACROMOL, V91, P946, DOI 10.1016/j.ijbiomac.2016.05.030; Guo SD, 2013, PROCESS BIOCHEM, V48, P539, DOI 10.1016/j.procbio.2013.01.014; Hao LM, 2016, CARBOHYD POLYM, V141, P54, DOI 10.1016/j.carbpol.2015.11.048; Hathaway LJ, 1998, VACCINE, V16, P135, DOI 10.1016/S0264-410X(97)88326-0; [侯瑞宏 HOU Ruihong], 2011, [食品科学, Food Science], V32, P280; KIYONO H, 1992, Regional Immunology, V4, P54; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Li YG, 2011, J ETHNOPHARMACOL, V134, P961, DOI 10.1016/j.jep.2011.02.009; Liu ZG, 2016, CARBOHYD POLYM, V142, P141, DOI 10.1016/j.carbpol.2016.01.021; Mohammadian M, 2018, J DRUG DELIV SCI TEC, V44, P205, DOI 10.1016/j.jddst.2017.12.017; Ren Z, 2014, INT J BIOL MACROMOL, V70, P590, DOI 10.1016/j.ijbiomac.2014.07.044; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; Schmidt LD, 2007, J NEUROIMMUNOL, V185, P20, DOI 10.1016/j.jneuroim.2006.10.028; Sun WJ, 2015, CARBOHYD POLYM, V126, P91, DOI 10.1016/j.carbpol.2015.03.034; Wang F, 2010, J FOOD PROCESS ENG, V33, P39, DOI 10.1111/j.1745-4530.2008.00258.x; Wang XY, 2018, INT J BIOL MACROMOL, V107, P1310, DOI 10.1016/j.ijbiomac.2017.09.112; Xie QG, 1999, PROGR STUDY GRAVE EP, P143; Xu WT, 2009, CARBOHYD RES, V344, P217, DOI 10.1016/j.carres.2008.10.021; Yang ShuBao, 2009, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V39, P999; [杨雨　 Yang Yu], 2007, [食品科学, Food Science], V28, P454; Yu ZD, 2016, CARBOHYD POLYM, V148, P318, DOI 10.1016/j.carbpol.2016.04.068; Yuan QX, 2015, CARBOHYD POLYM, V128, P52, DOI 10.1016/j.carbpol.2015.04.028; Zhai LJ, 2011, VACCINE, V29, P5007, DOI 10.1016/j.vaccine.2011.04.097; Zhao XJ, 2015, LIVEST SCI, V177, P88, DOI 10.1016/j.livsci.2015.03.001; Zhao XN, 2016, CARBOHYD POLYM, V141, P190, DOI 10.1016/j.carbpol.2016.01.013; 刘良, 2001, 中国免疫学杂志, V17, P204	35	24	29	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208611	10.1371/journal.pone.0208611	http://dx.doi.org/10.1371/journal.pone.0208611			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601811	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200016
J	Benzekri, NA; Seydi, M; Doye, IN; Toure, M; Sy, MP; Kiviat, NB; Sow, PS; Gottlieb, GS; Hawes, SE				Benzekri, Noelle A.; Seydi, Moussa; Doye, Ibrahima N.; Toure, Macoumba; Sy, Marie Pierre; Kiviat, Nancy B.; Sow, Papa Salif; Gottlieb, Geoffrey S.; Hawes, Stephen E.			Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; BLOOD-PRESSURE; GLOBAL BURDEN; NONCOMMUNICABLE DISEASES; SYSTEMATIC ANALYSIS; POPULATION; INDIVIDUALS; INFECTION	Background Non-communicable diseases, including hypertension (HTN), are increasingly recognized as important causes of morbidity and mortality among people living with HIV (PLHIV) in resource-limited settings. The goals of this study were to determine the prevalence of HTN among PLHIV in Senegal over time and to identify predictors of HTN among HIV-positive versus HIV-negative adults. Methods We conducted a retrospective study using data from individuals enrolled in previous studies in Senegal from 1994-2015. Blood pressure (BP) measurements taken during study visits were used for analysis. HTN was defined as systolic BP >= 140 or diastolic BP >= 90. We used logistic regression to identify predictors of HTN. Results We analyzed data from 2848 adults (1687 HIV-positive, 1161 HIV-negative). Among PLHIV, the prevalence of HTN increased from 11% during 1994-1999 to 22% during 2010-2015. Among HIV-negative individuals, the prevalence of HTN increased from 16% to 32%. Among both groups, the odds of HTN more than doubled from 1994-1999 to 2010-2015 (HIV-positive OR 2.4, 95% CI 1.1-5.0; HIV-negative OR 2.6, 95% CI 1.5-4.6). One quarter of all individuals with HTN had stage 2 HTN. The strongest risk factor for HTN was obesity (HIV-positive OR 3.2, 95% CI 1.7-5.8; p<0.01; HIV-negative OR 7.8, 95% CI 4.5-13.6; p<0.01). Male sex and age >= 50 were also predictive of HTN among both groups. Among HIV-positive subjects, WHO stage 1 or 2 disease was predictive of HTN and among HIV-negative subjects, having no formal education was predictive. Conclusion Over the past 20 years, the prevalence of HTN has doubled among both HIV-positive and HIV-negative adults in Senegal. Our study indicates that there is an increasing need for the integration of chronic disease management into HIV programs in Senegal. Furthermore, our findings highlight the need for enhanced prevention, recognition, and management of non-communicable diseases, including hypertension and obesity, among both HIV-positive and HIV-negative individuals in Senegal.	[Benzekri, Noelle A.; Gottlieb, Geoffrey S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Seydi, Moussa; Toure, Macoumba; Sy, Marie Pierre; Sow, Papa Salif] Ctr Hosp Univ Fann, Serv Malad Infect & Trop, Dakar, Senegal; [Doye, Ibrahima N.] Conseil Natl Lutte Sida, Dakar, Senegal; [Kiviat, Nancy B.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Gottlieb, Geoffrey S.; Hawes, Stephen E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Hawes, Stephen E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Benzekri, NA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	benzekri@uw.edu			National Institutes of Health [NIH/NCI R01 CA62801, NIH/NIDCR R01 DE12925, NIH/NIAID R01 AI48470, NIH/NCI R01 CA111187, NIH/NIAID R01 AI 60466]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The parent studies were supported by the following grants from the National Institutes of Health: NIH/NCI R01 CA62801 (to NBK), NIH/NIDCR R01 DE12925 (to SEH), NIH/NIAID R01 AI48470 (to NBK), NIH/NCI R01 CA111187 (to NBK), NIH/NIAID R01 AI 60466 (to GSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GAP REP; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Arrey WT, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/5639146; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Benzekri NA, 1994, INT J STD AIDS; Bergersen BM, 2006, DRUGS, V66, P1971, DOI 10.2165/00003495-200666150-00006; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Boccara F, 2017, AIDS, V31, pS157, DOI 10.1097/QAD.0000000000001384; Cavallaro FL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41006; Conseil National de Lutte contre le Sida, 2015, RAPP SIT RIP NAT EP; Cottingham J, 2012, LANCET, V380, P172, DOI 10.1016/S0140-6736(12)60732-6; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; Denue B. A., 2012, Archives of Applied Science Research, V4, P1447; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Dimala CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148100; Diouf A, 2012, ISRN AIDS, V2012, DOI [10.5402/2012/621565, DOI 10.5402/2012/621565]; Divala OH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3916-x; Fezeu L, 2010, J EPIDEMIOL COMMUN H, V64, P360, DOI 10.1136/jech.2008.086355; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Gueye N. F. N., 2017, Health, V9, P727, DOI 10.4236/health.2017.94052; Guwatudde D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2546-z; Hawes SE, 2003, J INFECT DIS, V188, P555, DOI 10.1086/376996; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Kagaruki GB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-904; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Nguyen KA, 2015, AIDS REV, V17, P83; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Magodoro Itai M, 2016, BMC Res Notes, V9, P379, DOI 10.1186/s13104-016-2187-z; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Mateen FJ, 2013, J HYPERTENS, V31, P1372, DOI 10.1097/HJH.0b013e328360de1c; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Muhammad Sanusi, 2013, Niger Med J, V54, P185, DOI 10.4103/0300-1652.114591; Muronya W, 2011, T ROY SOC TROP MED H, V105, P644, DOI 10.1016/j.trstmh.2011.07.016; Nduka CU, 2016, J HUM HYPERTENS, V30, P355, DOI 10.1038/jhh.2015.97; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ngatchou W, 2013, VASC HEALTH RISK MAN, V9, P509, DOI 10.2147/VHRM.S42350; Njelekela M, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/5958382; Nsagha Dickson Shey, 2015, Open AIDS J, V9, P51, DOI 10.2174/1874613601509010051; Ogunmola OJ, 2014, VASC HEALTH RISK MAN, V10, P129, DOI 10.2147/VHRM.S58449; Okello S, 2015, J HYPERTENS, V33, P2039, DOI 10.1097/HJH.0000000000000657; Olack B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2610-8; Organization WH, 2009, GLOB HLTH RISKS MORT; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Rabkin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140298; Rodriguez-Arboli E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172089; Sander LD, 2015, TROP MED INT HEALTH, V20, P391, DOI 10.1111/tmi.12443; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; The Joint United Nations Programme on HIV/AIDS (UNAIDS) New York, 2011, CHRON CAR HIV NONC D; Trickey A, 2017, LANCET HIV, V4, pE349, DOI 10.1016/S2352-3018(17)30066-8; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; UN, 2015, MILLENNIUM DEV GOALS; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2016, GLOB AIDS UPD; United Nations Population Fund, 2014, C POP DEV; Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2015, GLOB STRAT WOM CHILD; World Health Organization, 2011, B WORLD HEALTH ORGAN, V89, P137, DOI [10.2471/BLT.10.077925, DOI 10.2471/BLT.10.077925]; Zheng NN, 2004, J VIROL, V78, P13934, DOI 10.1128/JVI.78.24.13934-13942.2004; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	68	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0208635	10.1371/journal.pone.0208635	http://dx.doi.org/10.1371/journal.pone.0208635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596667	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200017
J	Kishi, M; Aono, Y; Sato, S; Koyama, K; Azuma, M; Abe, S; Kawano, H; Kishi, J; Toyoda, Y; Okazaki, H; Ogawa, H; Uehara, H; Nishioka, Y				Kishi, Masami; Aono, Yoshinori; Sato, Seidai; Koyama, Kazuya; Azuma, Momoyo; Abe, Shuichi; Kawano, Hiroshi; Kishi, Jun; Toyoda, Yuko; Okazaki, Hiroyasu; Ogawa, Hirohisa; Uehara, Hisanori; Nishioka, Yasuhiko			Blockade of platelet-derived growth factor receptor-beta, not receptor-alpha ameliorates bleomycin-induced pulmonary fibrosis in mice	PLOS ONE			English	Article							IMATINIB; FIBROBLASTS; CELLS; PDGF	Platelet-derived growth factor (PDGF) has been implicated in the pathogenesis of pulmonary fibrosis. Nintedanib, a multi-kinase inhibitor that targets several tyrosine kinases, including PDGF receptor (PDGFR), was recently approved as an anti-fibrotic agent to reduce the deterioration of FVC in patients with idiopathic pulmonary fibrosis (IPF). However, the effects of PDGFR-alpha or -beta on pulmonary fibrosis remain unclear. In an attempt to clarify their effects, we herein used blocking antibodies specific for PDGFR-alpha (APA5) and -beta (APB5) in a bleomycin (BLM)-induced pulmonary fibrosis mouse model. The effects of these treatments on the growth of lung fibroblasts were examined using the H-3-thymidine incorporation assay in vitro. The anti-fibrotic effects of these antibodies were investigated with the Ashcroft score and collagen content of lungs treated with BLM. Their effects on inflammatory cells in the lungs were also analyzed using bronchoalveolar lavage fluid. We investigated damage to epithelial cells and the proliferation of fibroblasts in the lungs. APA5 and APB5 inhibited the phosphorylation of PDGFR-alpha and -beta as well as the proliferation of lung fibroblasts induced by PDGF-AA and BB. The administration of APB5, but not APA5 effectively inhibited BLM-induced pulmonary fibrosis in mice. Apoptosis and the proliferation of epithelial cells and fibroblasts were significantly decreased by the treatment with APB5, but not by APA5. The late treatment with APB5 also ameliorated fibrosis in lungs treated with BLM. These results suggest that PDGFR-alpha and -beta exert different effects on BLM-induced pulmonary fibrosis in mice. A specific approach using the blocking antibody for PDGFR-beta may be useful for the treatment of pulmonary fibrosis.	[Kishi, Masami; Aono, Yoshinori; Sato, Seidai; Koyama, Kazuya; Azuma, Momoyo; Abe, Shuichi; Kawano, Hiroshi; Kishi, Jun; Toyoda, Yuko; Okazaki, Hiroyasu; Nishioka, Yasuhiko] Tokushima Univ, Grad Sch Biomed Sci, Dept Resp Med & Rheumatol, Tokushima, Japan; [Ogawa, Hirohisa; Uehara, Hisanori] Tokushima Univ, Grad Sch Biomed Sci, Dept Pathol & Lab Med, Tokushima, Japan	Tokushima University; Tokushima University	Nishioka, Y (corresponding author), Tokushima Univ, Grad Sch Biomed Sci, Dept Resp Med & Rheumatol, Tokushima, Japan.	yasuhiko@tokushima-u.ac.jp		Sato, Seidai/0000-0001-7052-764X	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16H0530910];  [0000025921]; STFC [ST/J005428/1, ST/N000668/1] Funding Source: UKRI	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number JP16H0530910) and a grant to the Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases (Y.N.; Code Number: 0000025921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Aono Y, 2005, AM J RESP CRIT CARE, V171, P1279, DOI 10.1164/rccm.200404-531OC; Aono Y, 2014, AM J RESP CELL MOL, V51, P793, DOI 10.1165/rcmb.2013-0455OC; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Azuma M, 2007, AM J RESP CRIT CARE, V176, P1243, DOI 10.1164/rccm.200702-178OC; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Guzy RD, 2015, AM J RESP CELL MOL, V52, P116, DOI 10.1165/rcmb.2014-0184OC; HARRISON JH, 1987, J PHARMACOL EXP THER, V243, P1185; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; McGowan SE, 2008, ANAT REC, V291, P1649, DOI 10.1002/ar.20764; Nishioka Y., 2004, IDIOPATHIC PULMONARY; Nishioka Y, 2013, J MED INVESTIG, V60, P175; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Prasad S, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-7; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sano H, 2002, AM J PATHOL, V161, P135, DOI 10.1016/S0002-9440(10)64165-X; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Wollin L, 2013, AM J RESP CRIT CARE, V187; Yoshida M, 1999, BIOCHEM BIOPH RES CO, V265, P503, DOI 10.1006/bbrc.1999.1647; Zhuo Y, 2004, AM J PHYSIOL-LUNG C, V286, pL182, DOI 10.1152/ajplung.00083.2003	31	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209786	10.1371/journal.pone.0209786	http://dx.doi.org/10.1371/journal.pone.0209786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596712	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200085
J	Wang, H; Wang, GD; Ansari, GAS; Khan, MF				Wang, Hui; Wang, Gangduo; Ansari, G. A. Shakeel; Khan, M. Firoze			Trichloroethene metabolite dichloroacetyl chloride induces apoptosis and compromises phagocytosis in Kupffer Cells: Activation of inflammasome and MAPKs	PLOS ONE			English	Article							OXIDATIVE STRESS; FEMALE MRL; AUTOIMMUNE-RESPONSE; LIVER; MICE; SUPPRESSION; EXPRESSION; PATHWAY; DISEASE; PD-L1	Exposure to trichloroethene (TCE), an occupational and ubiquitous environmental contaminant, is associated with the development of several autoimmune diseases, including autoimmune hepatitis (AIH). However, mechanisms contributing to TCE-mediated AIH are not known. Earlier, we have shown that dichloroacetyl chloride (DCAC), one of the reactive metabolites of TCE with strong acylating capability, can elicit an autoimmune response at much lower dose than TCE in female MRL+/+ mice. Furthermore, Kupffer cells (KCs), the liver resident macrophages, are crucial for hepatic homeostasis, but can also participate in the immunopathogenesis of AIH. However, contribution of KCs in TCE-mediated AIH and the underlying mechanisms are not understood. We hypothesized that increased apoptosis and delayed clearance of apoptotic bodies, due to compromised KC function, will result in the breakdown of self-tolerance, autoimmunity, and ultimately AIH. Therefore, using an in vitro model of immortalized mouse KCs, we investigated the contribution of DCAC in TCE-mediated AIH. KCs were treated with different concentrations of DCAC and apoptosis was measured by Annexin V and PI staining. Also, the impact of DCAC on phagocytic potential of KCs was evaluated. Furthermore, markers of inflammasome (NLRP3 and caspase1) were analyzed by real-time PCR and Western blot analysis. DCAC treatment resulted in significantly increased early and late-stage apoptosis, accompanied with inflammasome activation (NLRP3 increases). DCAC treatment resulted in decreased phagocytic function of KCs in a dose-dependent manner, with reduced MFG-E8 levels (phagocytotic function). Furthermore, DCAC exposure led to induction of phos-ERK and phos-AKT signaling. These findings suggest that DCAC induces apoptosis and inflammasome activation, while compromising the phagocytic function of KCs. Our data support that increased apoptosis and impaired KC function by DCAC could be contributory to TCE-mediated AIH.	[Wang, Hui; Wang, Gangduo; Ansari, G. A. Shakeel; Khan, M. Firoze] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Khan, MF (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	mfkhan@utmb.edu			National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), USA [ES026887, ES016302]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026887, R01ES016302] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), USA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01 Grants ES026887 and ES016302 from the National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), USA. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.; This work was supported by RO1 Grants ES026887 and ES016302 from the National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), USA. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Abe M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/607073; Aizawa Y, 2017, CLIN EXP GASTROENTER, V10, P9, DOI 10.2147/CEG.S101440; Behfarjam F, 2017, TURK J GASTROENTEROL, V28, P110, DOI 10.5152/tjg.2017.17501; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cai P, 2008, TOXICOL APPL PHARM, V228, P68, DOI 10.1016/j.taap.2007.11.031; Cai P, 2007, J IMMUNOTOXICOL, V4, P107, DOI 10.1080/15476910701337225; Cooper GS, 2009, ENVIRON HEALTH PERSP, V117, P696, DOI 10.1289/ehp.11782; Gilbert KM, 2014, TOXICOL APPL PHARM, V279, P284, DOI 10.1016/j.taap.2014.07.003; Gilbert KM, 2009, CHEM RES TOXICOL, V22, P626, DOI 10.1021/tx800409r; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Hopp AK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00055; Huang W, 2017, CELL DEATH DIFFER, V24, P263, DOI 10.1038/cdd.2016.115; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Khan MF, 2006, TOXICOL APPL PHARM, V210, P86, DOI 10.1016/j.taap.2005.08.006; KHAN MF, 1995, TOXICOL APPL PHARM, V134, P155, DOI 10.1006/taap.1995.1179; Khan MF, 1997, IMMUNOPHARM IMMUNOT, V19, P265, DOI 10.3109/08923979709007662; Kondraganti S, 2012, OPEN TOXICOLOGY J, V5, P10; Lash LH, 2006, J TOXICOL ENV HEAL A, V69, P1285, DOI 10.1080/15287390500360133; Lin R, 2016, MOL MED REP, V13, P3874, DOI 10.3892/mmr.2016.4998; Liu F, 2014, STROKE, V45, P3691, DOI 10.1161/STROKEAHA.114.006635; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Luan JY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00758; Martin CJ, 2014, CURR OPIN MICROBIOL, V17, P17, DOI 10.1016/j.mib.2013.10.007; Mataki N, 2007, AM J GASTROENTEROL, V102, P302, DOI 10.1111/j.1572-0241.2006.00948.x; Matta SK, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.22; Mieli-Vergani G, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.17, 10.1038/nrdp.2018.18]; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Navegantes KC, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1141-8; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Peng YH, 2011, SURGERY, V149, P135, DOI 10.1016/j.surg.2010.04.017; Peng YF, 2011, J CLIN INVEST, V121, P2221, DOI 10.1172/JCI43254; Pengal RA, 2006, MOL IMMUNOL, V43, P1557, DOI 10.1016/j.molimm.2005.09.022; Schumann J, 2000, AM J PATHOL, V157, P1671, DOI 10.1016/S0002-9440(10)64804-3; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; SHIN HJ, 2016, SCI REP UK, V6; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Thomas H., 2017, NATURE REV GASTROENT, V14, P197, DOI 10.1038/nrgastro.2017.35; Wang GD, 2015, FREE RADICAL BIO MED, V89, P770, DOI 10.1016/j.freeradbiomed.2015.10.402; Wang GD, 2012, FREE RADICAL RES, V46, P1472, DOI 10.3109/10715762.2012.727209; Wang GD, 2010, FREE RADICAL BIO MED, V49, pS144, DOI 10.1016/j.freeradbiomed.2010.10.403; Wang GD, 2010, ARTHRITIS RHEUM-US, V62, P2064, DOI 10.1002/art.27442; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Wang ZY, 2014, CYTOKINE, V70, P165, DOI 10.1016/j.cyto.2014.07.251; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Wu YT, 2009, AUTOPHAGY, V5, P824, DOI 10.4161/auto.9099; Xu XY, 2012, HUM EXP TOXICOL, V31, P861, DOI 10.1177/0960327112444935; Zannetti C, 2016, J IMMUNOL, V197, P356, DOI 10.4049/jimmunol.1502301; Zhao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018909; Zhong WH, 2016, BIOMED PHARMACOTHER, V83, P302, DOI 10.1016/j.biopha.2016.06.036	53	9	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210200	10.1371/journal.pone.0210200	http://dx.doi.org/10.1371/journal.pone.0210200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596806	gold, Green Submitted, Green Published			2022-12-26	WOS:000454627200151
J	Liu, LZ; Guan, HY; Zhang, Y; Wang, CR; Yang, GL; Ruan, SM; Zhao, HL; Han, XY				Liu, Lanzheng; Guan, Hengyun; Zhang, Ying; Wang, Chunrong; Yang, Guoliang; Ruan, Shiman; Zhao, Huailong; Han, Xiuyun			The prevalence of non-GII.4 norovirus genotypes in acute gastroenteritis outbreaks in Jinan, China	PLOS ONE			English	Article							GII.17 NOROVIRUS; EMERGENCE; VICTORIA; SEQUENCE; STRAINS; WATER	Noroviruses (NoVs) are the leading cause of acute viral gastroenteritis outbreaks. From June 2015 to March 2017, fifteen outbreaks of acute gastroenteritis (AGE) were reported to the Jinan Center for Disease Control and Prevention in China. To identify the circulating NoV genotypes associated with outbreaks in Jinan, China, 414 specimens from the 15 outbreaks were collected and analyzed for the causative viruses, and phylogenetic analysis was performed on the NoV-positive strains. The NoV detection rate was 57.5% (238/414), and a total of 14 outbreaks were caused by NoVs (eight by infection with genogroup II (GII), five by mixed infection with GI and GII, and one by mixed infection with GII and rotavirus (RoV)-A). A total of 75 NoV sequences were obtained from 13 NoV-positive outbreaks and classified into seven genotypes (38 GII.17, 13 GII.2, 4 GII.3, 4 GII.1, 10 GI.6, 5 GI.5 and 1 GI.3), while GII.4 was not identified. The most prevalent genotype changed yearly during the 2015-2017 period. Phylogenetic analysis demonstrated that these NoV genotypes had high homology with the strains circulating worldwide, especially strains from Asian countries and cities. Our study illustrated that multiple non-GII.4 NoV genotypes were prevalent in outbreaks of AGE in Jinan, China. Year-round surveillance of multiple NoV genotypes could help health authorities reduce the impact of NoV outbreaks on public health.	[Liu, Lanzheng; Guan, Hengyun; Wang, Chunrong; Yang, Guoliang; Ruan, Shiman; Zhao, Huailong; Han, Xiuyun] Jinan Ctr Dis Control & Prevent, Viral Dis Inspect Lab, Jinan, Shandong, Peoples R China; [Zhang, Ying] Univ Sydney, China Studies Ctr, Sydney Sch Publ Health, Sydney, NSW, Australia; [Zhang, Ying] Shandong Univ, Climate Change & Hlth Ctr, Jinan, Shandong, Peoples R China	University of Sydney; Shandong University	Wang, CR (corresponding author), Jinan Ctr Dis Control & Prevent, Viral Dis Inspect Lab, Jinan, Shandong, Peoples R China.	jncdcwg@163.com	Zhang, Ying/ABE-2275-2021	Zhang, Ying/0000-0001-6214-2440	Jinan Institute of Science and Technology Development Project of China [201221064]	Jinan Institute of Science and Technology Development Project of China	This work was funded by the Jinan Institute of Science and Technology Development Project of China (grant number 201221064), http://www.jnsti.gov.cn/jnsti/technet to LZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Bartsch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151219; Bert F, 2014, FOOD ENVIRON VIROL, V6, P67, DOI 10.1007/s12560-014-9145-5; Bruggink LD, 2017, EPIDEMIOL INFECT, V145, P1933, DOI 10.1017/S0950268817000681; Bruggink LD, 2017, COMMUN DIS INTELL, V41, pE21; Chan MCW, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00343-17, 10.1128/genomea.00343-17]; Chan MCW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10061; Chen YX, 2017, CURR GERIATR REP, V6, P26, DOI 10.1007/s13670-017-0195-z; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Ding ZY, 2017, J EPIDEMIOL, V27, P274, DOI 10.1016/j.je.2016.07.006; Elliott EJ, 2007, BMJ-BRIT MED J, V334, P35, DOI 10.1136/bmj.39036.406169.80; Gao ZY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1315-z; Han JK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0370-9; Hohne M, 2015, INT J MED MICROBIOL, V305, P612, DOI 10.1016/j.ijmm.2015.08.010; Jung Sunyoung, 2017, Osong Public Health Res Perspect, V8, P86, DOI 10.24171/j.phrp.2017.8.1.12; Kiulia NM, 2014, FOOD ENVIRON VIROL, V6, P221, DOI 10.1007/s12560-014-9160-6; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumazaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142568; Lee GC, 2012, FOOD ENVIRON VIROL, V4, P115, DOI 10.1007/s12560-012-9084-y; Li J, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3224-4; Liao Qiaohong, 2016, Zhonghua Yu Fang Yi Xue Za Zhi, V50, P7, DOI 10.3760/cma.j.issn.0253-9624.2016.01.003; Lu J, 2017, EMERG INFECT DIS, V23, P1188, DOI 10.3201/eid2307.170333; Matsushima Y, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.26.21173; Matsuyama R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173996; Maunula L, 2005, EMERG INFECT DIS, V11, P1716, DOI 10.3201/eid1111.050487; National Virus Reference Laboratory, 2016, UCD NVRL ANN REF VIR; Niendorf S, 2017, EUROSURVEILLANCE, V22, P2, DOI [10.2807/1560-7917.ES.2017.22.4.30447, 10.2807/1560-7917.ES.2017.22.4.304472]; Qiao N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163166; Qin SW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111341; Shinohara Michiyo, 2002, Nihon Rinsho, V60, P1181; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Verhoef L, 2012, VIRUS GENES, V44, P8, DOI 10.1007/s11262-011-0673-x; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Zhou HL, 2017, J INFECTION, V75, P216, DOI 10.1016/j.jinf.2017.06.004	40	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209245	10.1371/journal.pone.0209245	http://dx.doi.org/10.1371/journal.pone.0209245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592717	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900018
J	Mendoza-Topaz, C; Yeow, I; Riento, K; Nichols, BJ				Mendoza-Topaz, C.; Yeow, I.; Riento, K.; Nichols, B. J.			BioID identifies proteins involved in the cell biology of caveolae	PLOS ONE			English	Article							MEMBRANE CURVATURE; PLASMA-MEMBRANE; CAPPING PROTEIN; POLYMERASE-I; CD2AP; ACTIN; EXPRESSION; CAVIN; MICE; PTRF	The mechanisms controlling the abundance and sub-cellular distribution of caveolae are not well described. A first step towards determining such mechanisms would be identification of relevant proteins that interact with known components of caveolae. Here, we applied proximity biotinylation (BioID) to identify a list of proteins that may interact with the caveolar protein cavin1. Screening of these candidates using siRNA to reduce their expression revealed that one of them, CSDE1, regulates the levels of mRNAs and protein expression for multiple components of caveolae. A second candidate, CD2AP, co-precipitated with cavin1. Caveolar proteins were observed in characteristic and previously un-described linear arrays adjacent to cell-cell junctions in both MDCK cells, and in HeLa cells overexpressing an active form of the small GTPase Rac1. CD2AP was required for the recruitment of caveolar proteins to these linear arrays. We conclude that BioID will be useful in identification of new proteins involved in the cell biology of caveolae, and that interaction between CD2AP and cavin1 may have an important role in regulating the sub-cellular distribution of caveolae.	[Mendoza-Topaz, C.; Yeow, I.; Riento, K.; Nichols, B. J.] MRC Lab Mol Biol, Cambridge, England	MRC Laboratory Molecular Biology	Nichols, BJ (corresponding author), MRC Lab Mol Biol, Cambridge, England.	ben@mrc-lmb.cam.ac.uk			UK MRC [MC_U105178778]; MRC [MC_U105178778] Funding Source: UKRI	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by UK MRC grant MC_U105178778 to BN.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Anderson EC, 2015, BIOCHEM SOC T, V43, P1241, DOI 10.1042/BST20150165; Andrews NW, 2014, TRENDS CELL BIOL, V20; Bitsikas V, 2014, ELIFE, V3, DOI 10.7554/eLife.03970; Cerezo A, 2009, MOL CELL BIOL, V29, P5046, DOI 10.1128/MCB.00315-09; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Cochran JN, 2015, HUM MOL GENET, V24, P6667, DOI 10.1093/hmg/ddv371; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Echarri A, 2015, J CELL SCI, V128, P2747, DOI 10.1242/jcs.153940; Echarri A, 2012, J CELL SCI, V125, P3097, DOI 10.1242/jcs.090134; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Harrison BJ, 2016, J NEUROSCI, V36, P4259, DOI 10.1523/JNEUROSCI.2423-15.2016; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Kovtun O, 2014, DEV CELL, V31, P405, DOI 10.1016/j.devcel.2014.10.002; Kwon SH, 2016, J BIOL CHEM, V291, P25462, DOI 10.1074/jbc.M116.729202; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2016, ELIFE, V5, DOI 10.7554/eLife.17508; Ludwig A, 2016, J CELL SCI, V129, P3077, DOI 10.1242/jcs.191262; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Ray S, 2015, BIOCHEM SOC T, V43, P323, DOI 10.1042/BST20140271; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Russo LM, 2013, FEBS LETT, V587, P3738, DOI 10.1016/j.febslet.2013.09.045; Schaefer A, 2017, J IMMUNOL, V198, P4823, DOI 10.4049/jimmunol.1601987; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shvets E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7867; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sorensson J, 2002, J AM SOC NEPHROL, V13, P2639, DOI 10.1097/01.ASN.0000033277.32822.23; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Stralfors P, 2012, ADV EXP MED BIOL, V729, P111, DOI 10.1007/978-1-4614-1222-9_8; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Tinton SA, 2005, BIOCHEM J, V385, P155, DOI 10.1042/BJ20040963; Tolvanen TA, 2015, J CELL SCI, V128, P4588, DOI 10.1242/jcs.175075; Torres VA, 2006, J CELL SCI, V119, P1812, DOI 10.1242/jcs.02894; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; van Duijn TJ, 2010, J BIOL CHEM, V285, P20137, DOI 10.1074/jbc.M109.099481; Volonte D, 1999, FEBS LETT, V445, P431, DOI 10.1016/S0014-5793(99)00164-7; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Wurth L, 2016, CANCER CELL, V30, P694, DOI 10.1016/j.ccell.2016.10.004; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhao JP, 2013, MOL CELL BIOL, V33, P38, DOI 10.1128/MCB.00734-12	64	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209856	10.1371/journal.pone.0209856	http://dx.doi.org/10.1371/journal.pone.0209856			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589899	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200061
J	Brown, JW; Schaub, BM; Klusas, BL; Tran, AX; Duman, AJ; Haney, SJ; Boris, AC; Flanagan, MP; Delgado, N; Torres, G; Rolon-Martinez, S; Vaasjo, LO; Miller, MW; Gillette, R				Brown, Jeffrey W.; Schaub, Brittany M.; Klusas, Bennett L.; Tran, Andrew X.; Duman, Alexander J.; Haney, Samantha J.; Boris, Abigail C.; Flanagan, Megan P.; Delgado, Nadia; Torres, Grace; Rolon-Martinez, Solymar; Vaasjo, Lee O.; Miller, Mark W.; Gillette, Rhanor			A role for dopamine in the peripheral sensory processing of a gastropod mollusc	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FEEDING MOTOR PROGRAM; IN-VITRO ANALOG; PLEUROBRANCHAEA-CALIFORNICA; SEA SLUG; SEROTONIN-IMMUNOREACTIVITY; BIOGENIC-AMINES; BUCCAL GANGLIA; POND SNAIL; APLYSIA	Histological evidence points to the presence of dopamine (DA) in the cephalic sensory organs of multiple gastropod molluscs, suggesting a possible sensory role for the neurotransmitter. We investigated the sensory function of DA in the nudipleuran Pleurobranchaea californica, in which the central neural correlates of sensation and foraging behavior have been well characterized. Tyrosine hydroxylase-like immunoreactivity (THli), a signature of the dopamine synthetic pathway, was similar to that found in two other opisthobranchs and two pulmonates previously studied: 1) relatively few (<100) THli neuronal somata were observed in the central ganglia, with those observed found in locations similar to those documented in the other snails but varying in number, and 2) the vast majority of THli somata were located in the peripheral nervous system, were associated with ciliated, putative primary sensory cells, and were highly concentrated in chemotactile sensory organs, giving rise to afferent axons projecting to the central nervous system. We extended these findings by observing that applying a selective D-2/D-3 receptor antagonist to the chemo-and mechanosensory oral veil-tentacle complex of behaving animals significantly delayed feeding behavior in response to an appetitive stimulus. A D-1 blocker had no effect. Recordings of the two major cephalic sensory nerves, the tentacle and large oral veil nerves, in a deganglionated head preparation revealed a decrease of stimulus-evoked activity in the former nerve following application of the same D2/D3 antagonist. Broadly, our results implicate DA in sensation and engender speculation regarding the foraging-based decisions the neurotransmitter may serve in the nervous system of Pleurobranchaea and, by extension, other gastropods.	[Brown, Jeffrey W.; Gillette, Rhanor] Univ Illinois, Program Biophys & Computat Biol, Urbana, IL 61801 USA; [Brown, Jeffrey W.] Univ Illinois, Coll Med, Urbana, IL 61820 USA; [Schaub, Brittany M.; Klusas, Bennett L.; Haney, Samantha J.; Boris, Abigail C.; Gillette, Rhanor] Univ Illinois, Sch Mol & Cellular Biol, Urbana, IL USA; [Tran, Andrew X.; Duman, Alexander J.; Flanagan, Megan P.] Univ Illinois, Sch Integrat Biol, Urbana, IL USA; [Delgado, Nadia; Torres, Grace; Rolon-Martinez, Solymar; Vaasjo, Lee O.; Miller, Mark W.] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA; [Delgado, Nadia; Torres, Grace; Rolon-Martinez, Solymar; Vaasjo, Lee O.; Miller, Mark W.] Univ Puerto Rico, Dept Anat & Neurobiol, Med Sci Campus, San Juan, PR 00936 USA; [Gillette, Rhanor] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Gillette, Rhanor] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Brown, JW (corresponding author), Univ Illinois, Program Biophys & Computat Biol, Urbana, IL 61801 USA.; Brown, JW (corresponding author), Univ Illinois, Coll Med, Urbana, IL 61820 USA.	jwbrown4@illinois.edu	Chicago, David Berkowitz/B-7239-2019	Chicago, David Berkowitz/0000-0001-6519-1061; Vaasjo, Lee O/0000-0003-0398-7341; Klusas, Bennett/0000-0002-2495-7208; Rolon-Martinez, Solymar/0000-0002-4653-9568; Brown, Jeffrey/0000-0002-1036-0945	National Institutes of Health [RCMI G12-MD007600, NIGMS GM103642]; National Science Foundation [DBI-0115825, DBI-0932955, HRD-1137725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103642] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by the National Institutes of Health: RCMI G12-MD007600 (MWM) and NIGMS GM103642 (MWM) https://www.nih.gov/,the National Science Foundation: DBI-0115825 (MWM), DBI-0932955 (MWM), and HRD-1137725 (MWM). https://www.nsf.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBAS EA, 1991, ANNU REV NEUROSCI, V14, P9, DOI 10.1146/annurev.ne.14.030191.000301; AUDESIRK G, 1980, J COMP PHYSIOL, V141, P101, DOI 10.1007/BF00611883; BAKER H, 1983, J NEUROSCI, V3, P69; Barron AB, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00163; Baxter DA, 2006, LEARN MEMORY, V13, P669, DOI 10.1101/lm.339206; BICKER G, 1982, J COMP PHYSIOL, V149, P235, DOI 10.1007/BF00619217; BICKER G, 1982, J COMP PHYSIOL, V149, P221, DOI 10.1007/BF00619216; BILLY AJ, 1989, NEUROSCI LETT, V105, P200, DOI 10.1016/0304-3940(89)90037-2; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; CARPENTER D, 1971, International Journal of Neuroscience, V2, P49, DOI 10.3109/00207457109146992; Carrigan ID, 2015, J COMP NEUROL, V523, P2409, DOI 10.1002/cne.23795; COHAN CS, 1983, J EXP BIOL, V102, P43; Croll RP, 2003, CELL TISSUE RES, V314, P437, DOI 10.1007/s00441-003-0778-1; Croll RP, 1999, J COMP NEUROL, V404, P297, DOI 10.1002/(SICI)1096-9861(19990215)404:3<297::AID-CNE2>3.0.CO;2-I; CROLL RP, 1990, BRAIN RES, V525, P101, DOI 10.1016/0006-8993(90)91325-B; Croll RP, 2001, CELL TISSUE RES, V305, P417, DOI 10.1007/s004410100394; Croll RP, 2001, J COMP NEUROL, V441, P91, DOI 10.1002/cne.1399; Diaz-Rios M, 2002, J COMP NEUROL, V445, P29, DOI 10.1002/cne.10152; Diaz-Rios M, 2005, J NEUROPHYSIOL, V93, P2142, DOI 10.1152/jn.00003.2004; DICKINSON PS, 1979, J COMP PHYSIOL, V131, P277, DOI 10.1007/BF00610435; ELEKES K, 1991, J COMP NEUROL, V307, P214, DOI 10.1002/cne.903070205; Elliott CJH, 2002, J EXP BIOL, V205, P877; EMERY DG, 1992, MICROSC RES TECHNIQ, V22, P307, DOI 10.1002/jemt.1070220402; Faller S, 2008, ZOOMORPHOLOGY, V127, P227, DOI 10.1007/s00435-008-0066-4; Gillette R, 2000, P NATL ACAD SCI USA, V97, P3585, DOI 10.1073/pnas.97.7.3585; Gillette R, 2015, INTEGR COMP BIOL, V55, P1058, DOI 10.1093/icb/icv081; Hernadi L, 1999, J COMP NEUROL, V411, P274, DOI 10.1002/(SICI)1096-9861(19990823)411:2<274::AID-CNE8>3.0.CO;2-9; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hirayama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102240; Hirayama K, 2012, CURR BIOL, V22, P118, DOI 10.1016/j.cub.2011.10.055; JING J, 1995, J NEUROPHYSIOL, V74, P1900, DOI 10.1152/jn.1995.74.5.1900; Jing J, 2009, REV NEUROSCIENCE, V20, P405; Kabotyanski EA, 1998, J NEUROPHYSIOL, V79, P605, DOI 10.1152/jn.1998.79.2.605; Kabotyanski EA, 2000, J NEUROPHYSIOL, V83, P374, DOI 10.1152/jn.2000.83.1.374; Kemenes G, 1994, Neurosci Behav Physiol, V24, P77, DOI 10.1007/BF02355656; Kiehn Lana, 2001, BMC Physiology, V1, pUnpaginated, DOI 10.1186/1472-6793-1-9; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; KYRIAKIDES MA, 1989, J NEUROBIOL, V20, P635, DOI 10.1002/neu.480200704; Lechner HA, 2000, J NEUROSCI, V20, P3377, DOI 10.1523/JNEUROSCI.20-09-03377.2000; LEE RM, 1974, J NEUROBIOL, V5, P545, DOI 10.1002/neu.480050606; MAGOSKI NS, 1995, J NEUROPHYSIOL, V74, P1287, DOI 10.1152/jn.1995.74.3.1287; MARTIN JR, 1976, J COMP PHYSIOL PSYCH, V90, P1011, DOI 10.1037/h0078658; Martinez-Rubio C, 2009, J COMP NEUROL, V514, P329, DOI 10.1002/cne.21991; MATERA EM, 1982, CELL TISSUE RES, V222, P25; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Moroz LL, 1997, J COMP NEUROL, V382, P176, DOI 10.1002/(SICI)1096-9861(19970602)382:2<176::AID-CNE3>3.0.CO;2-0; Mozzachiodi R, 2003, LEARN MEMORY, V10, P478, DOI 10.1101/lm.65303; Mukai ST, 2004, J EXP BIOL, V207, P2507, DOI 10.1242/jeb.01052; Murphy AD, 2001, PROG NEUROBIOL, V63, P383, DOI 10.1016/S0301-0082(00)00049-6; Nargeot R, 1999, J NEUROPHYSIOL, V81, P1983, DOI 10.1152/jn.1999.81.4.1983; Nargeot R, 1997, J NEUROSCI, V17, P8093; Narusuye K, 2002, J NEUROPHYSIOL, V88, P2778, DOI 10.1152/jn.00757.2001; NELSON GM, 1986, COMP BIOCHEM PHYS A, V83, P113, DOI 10.1016/0300-9629(86)90097-6; Noboa V, 2013, J EXP BIOL, V216, P3231, DOI 10.1242/jeb.079384; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; OSBORNE NN, 1971, Z ZELLFORSCH MIK ANA, V112, P15, DOI 10.1007/BF00665618; Quinlan EM, 1997, J NEUROPHYSIOL, V78, P812, DOI 10.1152/jn.1997.78.2.812; ROSEN SC, 1991, J NEUROSCI, V11, P3630; SALIMOVA NB, 1987, ACTA BIOL HUNG, V38, P203; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Serrano GE, 2006, J NEUROPHYSIOL, V96, P2056, DOI 10.1152/jn.00282.2006; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; Sudlow LC, 1998, J COMP NEUROL, V395, P466; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SYED NI, 1993, J EXP BIOL, V174, P19; TEYKE T, 1993, BRAIN RES, V630, P226, DOI 10.1016/0006-8993(93)90661-6; TRIMBLE DL, 1984, J NEUROBIOL, V15, P37, DOI 10.1002/neu.480150105; Vallejo D, 2014, J COMP NEUROL, V522, P2532, DOI 10.1002/cne.23548; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005; Wentzell MM, 2009, BRAIN BEHAV EVOLUT, V74, P219, DOI 10.1159/000258668; WIELAND SJ, 1983, J NEUROSCI, V3, P1735; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wyeth RC, 2011, J COMP NEUROL, V519, P1894, DOI 10.1002/cne.22607; Yafremava LS, 2011, J NEUROPHYSIOL, V105, P2885, DOI 10.1152/jn.00124.2011	80	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208891	10.1371/journal.pone.0208891	http://dx.doi.org/10.1371/journal.pone.0208891			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586424	gold, Green Published			2022-12-26	WOS:000454416400044
J	Moskowitz, NA; Roland, AB; Fischer, EK; Ranaivorazo, N; Vidoudez, C; Aguilar, MT; Caldera, SM; Chea, J; Cristus, MG; Crowdis, JP; DeMessie, B; desJardins-Park, CR; Effenberger, AH; Flores, F; Giles, M; He, EY; Izmaylov, NS; Lee, CC; Pagel, NA; Phu, KK; Rosen, LU; Seda, DA; Shen, Y; Vargas, S; Murray, AW; Abebe, E; Trauger, SA; Donoso, DA; Vences, M; O'Connell, LA				Moskowitz, Nora A.; Roland, Alexandre B.; Fischer, Eva K.; Ranaivorazo, Ndimbintsoa; Vidoudez, Charles; Aguilar, Marianne T.; Caldera, Sophia M.; Chea, Jacqueline; Cristus, Miruna G.; Crowdis, Jett P.; DeMessie, Bluye; desJardins-Park, Caroline R.; Effenberger, Audrey H.; Flores, Felipe; Giles, Michael; He, Emma Y.; Izmaylov, Nike S.; Lee, ChangWon C.; Pagel, Nicholas A.; Phu, Krystal K.; Rosen, Leah U.; Seda, Danielle A.; Shen, Yong; Vargas, Santiago; Murray, Andrew W.; Abebe, Eden; Trauger, Sunia A.; Donoso, David A.; Vences, Miguel; O'Connell, Lauren A.			Seasonal changes in diet and chemical defense in the Climbing Mantella frog (Mantella laevigata)	PLOS ONE			English	Article							POISON FROGS; SKIN ALKALOIDS; PUMILIOTOXIN ALKALOIDS; DENDROBATES-PUMILIO; EVOLUTION; PATTERNS; ANTS; MADAGASCAR; SODIUM; DECAHYDROQUINOLINE	Poison frogs acquire chemical defenses from the environment for protection against potential predators. These defensive chemicals are lipophilic alkaloids that are sequestered by poison frogs from dietary arthropods and stored in skin glands. Despite decades of research focusing on identifying poison frog alkaloids, we know relatively little about how environmental variation and subsequent arthropod availability impacts alkaloid loads in poison frogs. We investigated how seasonal environmental variation influences poison frog chemical profiles through changes in the diet of the Climbing Mantella (Mantella laevigata). We collected M. laevigata females on the Nosy Mangabe island reserve in Madagascar during the wet and dry seasons and tested the hypothesis that seasonal differences in rainfall is associated with changes in diet composition and skin alkaloid profiles of M. laevigata. The arthropod diet of each frog was characterized into five groups (i.e. ants, termites, mites, insect larvae, or 'other') using visual identification and cytochrome oxidase 1 DNA barcoding. We found that frog diet differed between the wet and dry seasons, where frogs had a more diverse diet in the wet season and consumed a higher percentage of ants in the dry season. To determine if seasonality was associated with variation in frog defensive chemical composition, we used gas chromatography / mass spectrometry to quantify alkaloids from individual skin samples. Although the assortment of identified alkaloids was similar across seasons, we detected significant differences in the abundance of certain alkaloids, which we hypothesize reflects seasonal variation in the diet of M. laevigata. We suggest that these variations could originate from seasonal changes in either arthropod leaf litter composition or changes in frog behavioral patterns. Although additional studies are needed to understand the consequences of long-term environmental shifts, this work suggests that alkaloid profiles are relatively robust against short-term environmental perturbations.	[Moskowitz, Nora A.; Fischer, Eva K.; O'Connell, Lauren A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Roland, Alexandre B.; Murray, Andrew W.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Ranaivorazo, Ndimbintsoa] Univ Antananarivo, Dept Biol, Fac Sci, Antananarivo, Madagascar; [Vidoudez, Charles; Trauger, Sunia A.] Harvard Univ, FAS Small Mol Mass Spectrometry Facil, Cambridge, MA 02138 USA; [Aguilar, Marianne T.; Caldera, Sophia M.; Chea, Jacqueline; Cristus, Miruna G.; Crowdis, Jett P.; DeMessie, Bluye; desJardins-Park, Caroline R.; Effenberger, Audrey H.; Flores, Felipe; Giles, Michael; He, Emma Y.; Izmaylov, Nike S.; Lee, ChangWon C.; Pagel, Nicholas A.; Phu, Krystal K.; Rosen, Leah U.; Seda, Danielle A.; Shen, Yong; Vargas, Santiago; Murray, Andrew W.; O'Connell, Lauren A.] Harvard Univ, LS50 Integrated Sci Freshman Class, Cambridge, MA 02138 USA; [Abebe, Eden] Cambridge Rindge & Latin High Sch, Cambridge, MA USA; [Donoso, David A.] Escuela Politec Nacl, Dept Biol, Quito, Ecuador; [Vences, Miguel] Braunschweig Univ Technol, Zool Inst, Braunschweig, Germany	Stanford University; Harvard University; University Antananarivo; Harvard University; Harvard University; Escuela Politecnica Nacional Ecuador; Braunschweig University of Technology	O'Connell, LA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; O'Connell, LA (corresponding author), Harvard Univ, LS50 Integrated Sci Freshman Class, Cambridge, MA 02138 USA.	loconnel@stanford.edu	Donoso, David A/A-2059-2016; ROLAND, Alexandre-Benoit/AAT-4454-2021	Donoso, David A/0000-0002-3408-1457; ROLAND, Alexandre-Benoit/0000-0002-9463-9838; Shen, Yong/0000-0002-4866-838X; Effenberger, Audrey/0000-0003-2405-2166; Crowdis, Jett/0000-0003-4777-7303; Vidoudez, Charles/0000-0003-0953-7800; O'Connell, Lauren/0000-0002-2706-4077; Rosen, Leah Ursula/0000-0002-4757-7515; Vences, Miguel/0000-0003-0747-0817; Phu, Krystal K/0000-0003-0297-2850; Lee, ChangWon/0000-0001-7534-0526; Fischer, Eva K/0000-0002-2916-0900	Harvard University Bauer Fellowship; National Science Foundation [IOS-1557684]; National Geographic Society [9685-15]; Howard Hughes Medical Institute Professor's Award [520008146]	Harvard University Bauer Fellowship; National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Howard Hughes Medical Institute Professor's Award	This work was supported by Harvard University Bauer Fellowship (http://archive.sysbio.harvard.edu/CSB/research/fellows.html) to LAO; National Science Foundation (www.nsf.gov) IOS-1557684 to LAO; National Geographic Society (www.nationalgeographic.org/grants) 9685-15 to LAO; Howard Hughes Medical Institute Professor's Award (www.hhmi.org/developing-scientists/hhmiprofessors) 520008146 to AWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriamaharavo NR, 2015, J CHEM ECOL, V41, P837, DOI 10.1007/s10886-015-0616-4; Born Marga, 2010, PHYLLOMEDUSA, V9, P37; Braekman JC, 1996, J BRAZIL CHEM SOC, V7, P251, DOI 10.5935/0103-5053.19960040; Cardwell JP, 1996, J ZOOL, V240, P75, DOI 10.1111/j.1469-7998.1996.tb05487.x; Clark VC, 2006, J CHEM ECOL, V32, P2219, DOI 10.1007/s10886-006-9144-6; Clark VC, 2005, P NATL ACAD SCI USA, V102, P11617, DOI 10.1073/pnas.0503502102; Daly JW, 2007, J CHEM ECOL, V33, P871, DOI 10.1007/s10886-007-9261-x; Daly John W., 1996, American Museum Novitates, V3177, P1; Daly JW, 2000, J CHEM ECOL, V26, P73, DOI 10.1023/A:1005437427326; DALY JW, 1984, TOXICON, V22, P905, DOI 10.1016/0041-0101(84)90182-X; Daly JW, 1997, TOXICON, V35, P1131, DOI 10.1016/S0041-0101(96)00212-7; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; DALY JW, 1994, J CHEM ECOL, V20, P943, DOI 10.1007/BF02059589; DALY JW, 1980, SCIENCE, V208, P1383, DOI 10.1126/science.6246586; DALY JW, 1991, NEUROCHEM RES, V16, P1207, DOI 10.1007/BF00966697; DALY JW, 1990, BIOCHEM PHARMACOL, V40, P315, DOI 10.1016/0006-2952(90)90694-G; Daly JW, 1999, ALKALOIDS AMPHIBIAN; Darst CR, 2005, AM NAT, V165, P56, DOI 10.1086/426599; DONNELLY MA, 1991, COPEIA, P723; Donoso DA, 2017, ECOL INDIC, V83, P515, DOI 10.1016/j.ecolind.2017.03.022; Donoso DA, 2010, OECOLOGIA, V164, P201, DOI 10.1007/s00442-010-1607-3; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hahn DA, 2002, BIOTROPICA, V34, P348, DOI 10.1111/j.1744-7429.2002.tb00548.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jones TH, 1999, J CHEM ECOL, V25, P1179, DOI 10.1023/A:1020898229304; Kaspari M, 2000, BIOTROPICA, V32, P703, DOI 10.1646/0006-3606(2000)032[0703:AAAMGI]2.0.CO;2; LEVINGS SC, 1984, BIOTROPICA, V16, P125, DOI 10.2307/2387844; LOVENBERG T, 1986, NEUROCHEM RES, V11, P1609, DOI 10.1007/BF00965779; McGugan JR, 2016, J CHEM ECOL, V42, P537, DOI 10.1007/s10886-016-0715-x; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; PAWLIK JR, 1993, CHEM REV, V93, P1911, DOI 10.1021/cr00021a012; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Santos JC, 2016, CHEM SIGNALS VERTEBR, V13, P305, DOI DOI 10.1007/978-3-319-22026-0_21; Saporito RA, 2004, P NATL ACAD SCI USA, V101, P8045, DOI 10.1073/pnas.0402365101; Saporito RA, 2007, TOXICON, V50, P757, DOI 10.1016/j.toxicon.2007.06.022; Saporito RA, 2007, P NATL ACAD SCI USA, V104, P8885, DOI 10.1073/pnas.0702851104; Saporito RA, 2006, J CHEM ECOL, V32, P795, DOI 10.1007/s10886-006-9034-y; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; Saporito RA, 2011, J CHEM ECOL, V37, P213, DOI 10.1007/s10886-011-9914-7; Saporito RA, 2009, HETEROCYCLES, V79, P277, DOI 10.3987/REV-08-SR(D)11; Savitzky AH, 2012, CHEMOECOLOGY, V22, P141, DOI 10.1007/s00049-012-0112-z; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Summers K, 2001, P NATL ACAD SCI USA, V98, P6227, DOI 10.1073/pnas.101134898; Takada W, 2005, J CHEM ECOL, V31, P2403, DOI 10.1007/s10886-005-7109-9; Tarvin RD, 2016, MOL BIOL EVOL, V33, P1068, DOI 10.1093/molbev/msv350; Vences M, 1998, ZOOL ANZ, V236, P217; Vences Miguel, 1998, Salamandra, V34, P245; Woodhead C, 2007, HERPETOL J, V17, P225	48	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0207940	10.1371/journal.pone.0207940	http://dx.doi.org/10.1371/journal.pone.0207940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586404	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400009
J	Larsen, RB; Herrmann, B; Sistiaga, M; Brinkhof, J; Santos, J				Larsen, Roger B.; Herrmann, Bent; Sistiaga, Manu; Brinkhof, Jesse; Santos, Juan			Catch and release patterns for target and bycatch species in the Northeast Atlantic deep-water shrimp fishery: Effect of using a sieve panel and a Nordmore grid	PLOS ONE			English	Article							BROWN SHRIMP; CRANGON-CRANGON; BY-CATCH; TECHNICAL MEASURES; ARTIFICIAL-LIGHT; REDUCE BYCATCH; PERFORMANCE; DEVICE; NET; SELECTION	The Nordmore grid and the sieve panel are two of the main devices used to reduce fish bycatch in trawl fisheries targeting shrimp species. However, even when using such devices, some small-sized fish enter the codend of the trawl together with the targeted shrimp. Therefore, bycatch reduction remains a problem in some shrimp fisheries. One such fishery is the Northeast Atlantic deep-water shrimp (Pandalus borealis) fishery where it is mandatory to use a Nordmore grid. In this study, the bycatch reduction efficiencies and patterns for several fish species using the standard Nordmore grid and an experimental sieve panel were investigated and compared. The effect of combining these devices was also explored. The bycatch reduction patterns differed significantly between the two devices and a more efficient bycatch reduction was obtained by combining them. However, while the loss of commercial-sized shrimp was only between 0 and 2% for the Nordmore grid, it was between 37 and 56% for the tested sieve panel, making this completely unacceptable for commercial fishing. Therefore, before a sieve panel can be considered as an option for the fishery, other sieve panel designs that have a significantly lower loss of shrimp catches need to be identified.	[Larsen, Roger B.; Herrmann, Bent; Brinkhof, Jesse] Arctic Univ Norway, UiT, Tromso, Norway; [Herrmann, Bent; Sistiaga, Manu] SINTEF Ocean, Trondheim, Norway; [Santos, Juan] Thunen Inst Balt Sea Fisheries, Rostock, Germany	UiT The Arctic University of Tromso; SINTEF; Johann Heinrich von Thunen Institute	Larsen, RB (corresponding author), Arctic Univ Norway, UiT, Tromso, Norway.	roger.larsen@uit.no	Larsen, Roger B./AAY-4314-2021	Larsen, Roger B./0000-0003-2884-5817; Herrmann, Bent/0000-0003-1325-6198	Norwegian Seafood Research Fund [901303]; Norwegian Seafood Research Fund (FHF) [901303]; UiT The Arctic University of Norway	Norwegian Seafood Research Fund; Norwegian Seafood Research Fund (FHF); UiT The Arctic University of Norway	This study was part of the project "Optimizing shrimp trawl fisheries", which is funded by The Norwegian Seafood Research Fund (project no. 901303). We are grateful to UiT The Arctic University of Norway for its support with the research vessel, the Directorate of Fisheries in Norway for granting the fishing permit (number 16/12094) and the Norwegian Seafood Research Fund (FHF project number 901303) for funding the experiments. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SINTEF Ocean provided support in the form of salaries for authors BH and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; We are grateful for all the valuable comments from the academic editor and two anonymous reviewers, who we believe have strengthened our manuscript significantly. We are grateful to UiT The Arctic University of Norway for its support with the research vessel, the Directorate of Fisheries in Norway for granting the fishing permit (number 16/12094) and the Norwegian Seafood Research Fund (FHF project number 901303) for funding the experiments. We thank the crew of RV "Helmer Hanssen" and assistants Helene Gjesteland, Hanna Danielsen, Nadine Jacques, Valentina Lanci, Ivan Tatone, John T. Eilertsen, Ilmar Brinkhof and Hermann Pettersen for valuable assistance on board. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alzorriz N, 2016, FISH RES, V175, P116, DOI 10.1016/j.fishres.2015.11.023; ANTHONY PD, 1983, MAR BEHAV PHYSIOL, V10, P145, DOI 10.1080/10236248309378614; Brcic J, 2015, FISH RES, V172, P352, DOI 10.1016/j.fishres.2015.07.035; Broadhurst MK, 1996, MAR FRESHWATER RES, V47, P991, DOI 10.1071/MF9960991; Broadhurst MK, 2000, REV FISH BIOL FISHER, V10, P27, DOI 10.1023/A:1008936820089; Brothers G, 1996, SIZE SORTING SHRIMP, P2; Catchpole TL, 2008, ICES J MAR SCI, V65, P267, DOI 10.1093/icesjms/fsn016; CEFAS, 2003, STUD CONS TECHN INN; Eayrs S, 2007, GUIDE BYCATCH REDUCT; Graham N, 2003, FISH RES, V59, P393, DOI 10.1016/S0165-7836(02)00015-2; Grimaldo E, 2006, FISH RES, V77, P53, DOI 10.1016/j.fishres.2005.09.001; Grimaldo E, 2005, FISH RES, V76, P187, DOI 10.1016/j.fishres.2005.06.010; Gullestad P, 2014, ICES J MAR SCI, V71, P173, DOI 10.1093/icesjms/fst094; Hannah RW, 2015, FISH RES, V170, P60, DOI 10.1016/j.fishres.2015.05.010; He PG, 2007, ICES J MAR SCI, V64, P1551, DOI 10.1093/icesjms/fsm098; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; ISAKSEN B, 1992, FISH RES, V13, P335, DOI 10.1016/0165-7836(92)90086-9; Isaksen B., 1997, P 7 RUSS NORW S GEAR, P133; Karlsen L, 1989, P WORLD S FISH GEAR, P30; Karlsen L., 1977, EXPT SELECTIVE PRAWN, P28; Larsen RB, 2018, FISH RES, V204, P441, DOI 10.1016/j.fishres.2018.03.023; Larsen RB, 2017, MAR COAST FISH, V9, P479, DOI 10.1080/19425120.2017.1360421; Nguyen Khanh Q., 2017, Aquaculture and Fisheries, V2, P124, DOI 10.1016/j.aaf.2017.05.001; Notti E, 2016, MAR COAST FISH, V8, P81, DOI 10.1080/19425120.2015.1095827; Polet H, 2004, FISH RES, V69, P35, DOI 10.1016/j.fishres.2004.04.007; Polet H, 2002, FISH RES, V54, P217, DOI 10.1016/S0165-7836(00)00289-7; RASMUSSEN B, 1973, FAO FISH REP, V139, P50; Revill AS, 2004, FISH RES, V68, P113, DOI 10.1016/j.fishres.2004.02.001; Revill AS, 1999, 97SE025 EUR COMM; Rose C, 2014, ICES 2014; Sabu S, 2013, FISH TECHNOL, V50, P219; Sistiaga M, 2017, J OCEAN TECH, V12, P60; Sistiaga M, 2010, FISH RES, V105, P187, DOI 10.1016/j.fishres.2010.05.006; Wileman D., 1996, 215 ICES COOP RES, P126, DOI 10.17895/ices.pub.4628	36	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209621	10.1371/journal.pone.0209621	http://dx.doi.org/10.1371/journal.pone.0209621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576391	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400066
J	Benedetto, R; Cabrita, I; Schreiber, R; Kunzelmann, K				Benedetto, Roberta; Cabrita, Ines; Schreiber, Rainer; Kunzelmann, Karl			TMEM16A is indispensable for basal mucus secretion in airways and intestine	FASEB JOURNAL			English	Article						anoctamin 1; cystic fibrosis; asthma; Ca2+ signaling	ACTIVATED CHLORIDE CHANNEL; GOBLET CELL HYPERPLASIA; BICARBONATE; MODULATION; MECHANISM; TRANSPORT; OVEREXPRESSION; ANOCTAMINS; REGULATOR; PROTEIN	Transmembrane member 16A (TMEM16A) is the Ca2+-activated chloride channel in airways and intestine. It has been associated with goblet cell metaplasia, as expression of TMEM16A is strongly up-regulated in cystic fibrosis and asthma during mucus hypersecretion. However, the possible role of TMEM16A for mucus production or mucus secretion remains obscure, and whether TMEM16A controls the function of intestinal goblet cells is entirely unknown. Basal mucus secretion in lungs occurs through low levels of ATP in the airway surface liquid. Here, we report for the first time that TMEM16A is essential for basal secretion of mucus in airways and intestine. Airway-ciliated and intestinal epithelial-specific knockout of TMEM16A (TMEM16A(flox/flox)FoxJ1, TMEM16A(flox/flox)Vil1) leads to accumulation of mucus in airway club (Clara) cells and intestinal goblet cells, respectively. Acute ATP-induced mucus secretion by airway club cells is inhibited when TMEM16A is knocked out in ciliated cells, possibly as a result of compromised release of prosecretory cytokines. Knockdown or inhibition of TMEM16A in human Calu3 airway epithelial cells indicates compromised IL-8 release. In intestinal goblet cells lacking expression of TMEM16A, mucus accumulates as a result of compromised ATP-induced secretion. In contrast, cholinergic mucus secretion by compound exocytosis is independent of TMEM16A. The data demonstrate a previously unrecognized role of TMEM16A for membrane exocytosis and describe a novel, ATP-driven pathway for intestinal mucus secretion. We conclude that ATP-dependent mucus secretion in both airways and intestine requires TMEM16A. The present results may form the basis for a novel, therapeutic approach for the treatment of mucus hypersecretion in inflammatory airway and intestinal disease.Benedetto, R., Cabrita, I., Schreiber, R., Kunzelmann, K. TMEM16A is indispensable for basal mucus secretion in airways and intestine.	[Benedetto, Roberta; Cabrita, Ines; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany	University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@ur.de		Cabrita, Ines/0000-0002-1349-7605	Cystic Fibrosis Trust [SRC 013]; Gilead Stiftung; DFG [KU756/14-1]; Cystic Fibrosis Trust [SRC013] Funding Source: researchfish	Cystic Fibrosis Trust; Gilead Stiftung(Gilead Sciences); DFG(German Research Foundation (DFG)); Cystic Fibrosis Trust	The excellent technical assistance by P. Seeberger and E. Tartler (Institut fur Psychologie, Universitat Regensburg) is gratefully acknowledged. The authors thank Ernst Tamm and Margit Schimmel (Institute for Anatomy, University of Regensburg) for providing electron microscopy images. The supply of mice with a floxed TMEM16A gene by Jason R. Rock (Boston University School of Medicine, Boston, MA, USA) and FoxJ1-Cre mice by Michael J. Holtzman and Y. Zhang (Washington University School of Medicine, St. Louis, MO, USA) is gratefully acknowledged. This work was supported by Cystic Fibrosis Trust (SRC 013), Personalized Therapies for All (DFG KU756/14-1), and Gilead Stiftung. The authors declare no conflicts of interest.	Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Benedetto R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10910-0; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Cabrita I, 2017, FASEB J, V31, P2123, DOI 10.1096/fj.201600797RR; Caci E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131775; Chambers LA, 2007, RESP PHYSIOL NEUROBI, V159, P256, DOI 10.1016/j.resp.2007.06.005; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Gorrieri G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36016; Gupta R, 2019, AM J RESP CELL MOL, V60, P209, DOI 10.1165/rcmb.2018-0156OC; He M, 2017, P NATL ACAD SCI USA, V114, pE11161, DOI 10.1073/pnas.1714448115; Houy S, 2017, ELIFE, V6, DOI 10.7554/eLife.27000; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Jeon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067989; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kondo M, 2017, CLIN EXP ALLERGY, V47, P795, DOI 10.1111/cea.12887; Kondo M, 2012, ALLERGOL INT, V61, P133, DOI 10.2332/allergolint.11-OA-0307; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; Kunzelmann K, 2017, J CYST FIBROS, V16, P653, DOI 10.1016/j.jcf.2017.06.005; KUROSUMI K, 1981, ARCH HISTOL JAPON, V44, P263, DOI 10.1679/aohc1950.44.263; Lin JC, 2015, EXP CELL RES, V334, P260, DOI 10.1016/j.yexcr.2015.02.026; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Matos JE, 2005, J PHYSIOL-LONDON, V564, P269, DOI 10.1113/jphysiol.2004.080002; Miner K, 2017, AM J RESP CRIT CARE, V195; MORRISON KJ, 1990, AM J PHYSIOL, V258, pL254, DOI 10.1152/ajplung.1990.258.6.L254; Neureither F, 2017, CEREBELLUM, V16, P929, DOI 10.1007/s12311-017-0867-4; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Rogers DF, 2006, ANN MED, V38, P116, DOI 10.1080/07853890600585795; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Schreiber R, 2015, PFLUG ARCH EUR J PHY, V467, P1203, DOI 10.1007/s00424-014-1559-2; Schreiber R, 2008, PFLUG ARCH EUR J PHY, V457, P431, DOI 10.1007/s00424-008-0543-0; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Sirianant L, 2016, PFLUG ARCH EUR J PHY, V468, P805, DOI 10.1007/s00424-016-1789-6; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Thorn Peter, 2012, Commun Integr Biol, V5, P61; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wang P, 2018, J ALLERGY CLIN IMMUN, V141, P1259, DOI 10.1016/j.jaci.2017.05.053; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	53	46	46	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4502	4512		10.1096/fj.201801333RRR	http://dx.doi.org/10.1096/fj.201801333RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30586313	Bronze			2022-12-26	WOS:000459794800111
J	Huang, YC; Chanou, A; Kranz, G; Pan, M; Kohlbauer, V; Ettinger, A; Gires, O				Huang, Yuanchi; Chanou, Anna; Kranz, Gisela; Pan, Min; Kohlbauer, Vera; Ettinger, Andreas; Gires, Olivier			Membrane-associated epithelial cell adhesion molecule is slowly cleaved by -secretase prior to efficient proteasomal degradation of its intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial cell adhesion molecule (EpCAM); gamma-secretase; proteasome degradation; regulated intramembrane proteolysis; protein processing; live-cell imaging; sheddase; cell adhesion; proteolytic processing; transmembrane protein; cell signaling	REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; EPCAM EXPRESSION; EP-CAM; ANTIGEN; TUMOR; CANCER; CONTRIBUTES; MAINTENANCE	Regulated intramembrane proteolysis (RIP) is a key mechanism for activating transmembrane proteins such as epithelial cell adhesion molecule (EpCAM) for cellular signaling and degradation. EpCAM is highly expressed in carcinomas and progenitor and embryonic stem cells and is involved in the regulation of cell adhesion, proliferation, and differentiation. Strictly sequential cleavage of EpCAM through RIP involves initial shedding of the extracellular domain by -secretase (ADAM) and -secretase (BACE) sheddases, generating a membrane-tethered C-terminal fragment EpCTF. Subsequently, the rate-limiting -secretase complex catalyzes intramembrane cleavage of EpCTF, generating an extracellular EpCAM-A-like fragment and an intracellular EpICD fragment involved in nuclear signaling. Here, we have combined biochemical approaches with live-cell imaging of fluorescent protein tags to investigate the kinetics of -secretase-mediated intramembrane cleavage of EpCTF. We demonstrate that -secretase-mediated proteolysis of exogenously and endogenously expressed EpCTF is a slow process with a 50% protein turnover in cells ranging from 45 min to 5.5 h. The slow cleavage was dictated by -secretase activity and not by EpCTF species, as indicated by cross-species swapping experiments. Furthermore, both human and murine EpICDs generated from EpCTF by -secretase were degraded efficiently (94-99%) by the proteasome. Hence, proteolytic cleavage of EpCTF is a comparably slow process, and EpICD generation does not appear to be suited for rapidly transducing extracellular cues into nuclear signaling, but appears to provide steady signals that can be further controlled through efficient proteasomal degradation. Our approach provides an unbiased bioassay to investigate proteolytic processing of EpCTF in single living cells.	[Huang, Yuanchi; Chanou, Anna; Kranz, Gisela; Pan, Min; Kohlbauer, Vera; Gires, Olivier] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, Marchioninistr 15, D-81377 Munich, Germany; [Huang, Yuanchi] Xi An Jiao Tong Univ, Honghui Hosp, Dept Spinal Surg, Xian 710054, Shaanxi, Peoples R China; [Ettinger, Andreas] Inst Epigenet & Stem Cells, Marchioninistr 25, D-81377 Munich, Germany; [Gires, Olivier] Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, D-85764 Neuherberg, Germany	University of Munich; Xi'an Jiaotong University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Huang, YC; Gires, O (corresponding author), Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, Marchioninistr 15, D-81377 Munich, Germany.	huangychell@163.com; olivier.gires@med.uni-muenchen.de	Pan, Min/HDM-7621-2022	Pan, Min/0000-0002-8419-9357; Ettinger, Andreas/0000-0001-6436-010X	Deutsche Forschungsgemeinschaft [GI 540/3-1, GI 540/3-2]; ERC-StG Grant [280840]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC-StG Grant	This work was funded in part by Deutsche Forschungsgemeinschaft Grants GI 540/3-1 and GI 540/3-2 (to O.G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by ERC-StG Grant 280840 (to M. E. Torres-Padilla).	Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Bolduc DM, 2014, P NATL ACAD SCI USA, V111, P14643, DOI 10.1073/pnas.1416637111; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Denzel S, 2012, INT J EXP PATHOL, V93, P341, DOI 10.1111/j.1365-2613.2012.00826.x; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Gaber A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31482-7; Gerlach JC, 2018, J CELL PHYSIOL, V233, P4841, DOI 10.1002/jcp.26286; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Hachmeister M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071836; Hsu YT, 2016, CANCER RES, V76, P6171, DOI 10.1158/0008-5472.CAN-16-0752; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuan II, 2017, SCI REP-UK, V7, DOI 10.1038/srep41852; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Liang KH, 2018, CANCER LETT, V433, P165, DOI 10.1016/j.canlet.2018.06.040; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2008, FRONT BIOSCI-LANDMRK, V13, P5195, DOI 10.2741/3075; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Pan M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006624; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Sankpal NV, 2017, ONCOGENE, V36, P3706, DOI 10.1038/onc.2016.504; Sankpal NV, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3070; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Sarrach S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20131-8; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Tsaktanis T, 2015, J BIOL CHEM, V290, P24574, DOI 10.1074/jbc.M115.662700; Wang HX, 2017, ONCOTARGET, V8, P1884, DOI 10.18632/oncotarget.12242; Yu T, 2017, SCI REP-UK, V7, DOI 10.1038/srep46315	49	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3051	3064		10.1074/jbc.RA118.005874	http://dx.doi.org/10.1074/jbc.RA118.005874			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30598504	Green Published, hybrid			2022-12-26	WOS:000464980100007
J	Jia, WS; Liang, D; Li, N; Liu, MJ; Dong, ZJ; Li, JY; Dong, XH; Yue, YY; Hu, P; Yao, JH; Zhao, QS				Jia, Wenshuang; Liang, Dong; Li, Nan; Liu, Meijing; Dong, Zhangji; Li, Jingyun; Dong, Xiaohua; Yue, Yunyun; Hu, Ping; Yao, Jihua; Zhao, Qingshun			Zebrafish microRNA miR-210-5p inhibits primitive myelopoiesis by silencing foxj1b and slc3a2a mRNAs downstream of gata4/5/6 transcription factor genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zebrafish; microRNA (miRNA); microRNA mechanism; post-transcriptional regulation; transcription factor; foxj1b; gata4/5/6; miR-210-5p; primitive myelopoiesis; slc3a2a	CELL-DEVELOPMENT; HYPOXIA; EXPRESSION; PROGNOSIS	Zebrafish gata4/5/6 genes encode transcription factors that lie on the apex of the regulatory hierarchy in primitive myelopoiesis. However, little is known about the roles of microRNAs in gata4/5/6-regulated processes. Performing RNA-Seq deep sequencing analysis of the expression changes of microRNAs in gata4/5/6-knockdown embryos, we identified miR-210-5p as a regulator of zebrafish primitive myelopoiesis. Knocking down gata4/5/6 (generating gata5/6 morphants) significantly increased miR-210-5p expression, whereas gata4/5/6 overexpression greatly reduced its expression. Consistent with inhibited primitive myelopoiesis in the gata5/6 morphants, miR-210-5p overexpression repressed primitive myelopoiesis, indicated by reduced numbers of granulocytes and macrophages. Moreover, knocking out miR-210 partially rescued the defective primitive myelopoiesis in zebrafish gata4/5/6-knockdown embryos. Furthermore, we show that the restrictive role of miR-210-5p in zebrafish primitive myelopoiesis is due to impaired differentiation of hemangioblast into myeloid progenitor cells. By comparing the set of genes with reduced expression levels in the gata5/6 morphants to the predicted target genes of miR-210-5p, we found that foxj1b and slc3a2a, encoding a forkhead box transcription factor and a solute carrier family 3 protein, respectively, are two direct downstream targets of miR-210-5p that mediate its inhibitory roles in zebrafish primitive myelopoiesis. In summary, our results reveal that miR-210-5p has an important role in the genetic network controlling zebrafish primitive myelopoiesis.	[Jia, Wenshuang; Li, Nan; Liu, Meijing; Dong, Zhangji; Li, Jingyun; Dong, Xiaohua; Yue, Yunyun; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Liang, Dong; Hu, Ping] Nanjing Med Univ, Dept Prenatal Diag, Obstet & Gynecol Hosp, Nanjing Matern & Child Hlth Care Hosp, Nanjing 210004, Jiangsu, Peoples R China; [Yao, Jihua] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Nanjing University; Nanjing Medical University; Fudan University	Liang, D (corresponding author), Nanjing Med Univ, Dept Prenatal Diag, Obstet & Gynecol Hosp, Nanjing Matern & Child Hlth Care Hosp, Nanjing 210004, Jiangsu, Peoples R China.; Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	liangdong@njmu.edu.cn; qingshun@nju.edu.cn			National Natural Science Foundation of China [31271569, 31471355, 81500244]; State Key Laboratory of Genetic Engineering, Fudan University [SKLGE-1408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Genetic Engineering, Fudan University	This work was supported by National Natural Science Foundation of China Grants 31271569, 31471355, and 81500244 and State Key Laboratory of Genetic Engineering, Fudan University Grant SKLGE-1408. The authors declare that they have no conflicts of interest with the contents of this article.	Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Borthwick F, 2010, CLIN SCI, V119, P265, DOI 10.1042/CS20100266; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Dong ZJ, 2014, INT J BIOCHEM CELL B, V55, P329, DOI 10.1016/j.biocel.2014.08.020; Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fogelstrand P, 2009, J EXP MED, V206, P2397, DOI 10.1084/jem.20082845; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Gomes I, 2002, BLOOD, V100, P107, DOI 10.1182/blood.V100.1.107; Hsia N, 2005, EXP HEMATOL, V33, P1007, DOI 10.1016/j.exphem.2005.06.013; Hu P, 2008, DEV DYNAM, V237, P3798, DOI 10.1002/dvdy.21801; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kurkewich JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006887; Lee TY, 2013, J INTERF CYTOK RES, V33, P34, DOI 10.1089/jir.2012.0062; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mei YY, 2014, CANCER SCI, V105, P463, DOI 10.1111/cas.12370; Peterkin T, 2007, DEV BIOL, V311, P623, DOI 10.1016/j.ydbio.2007.08.018; Peterkin T, 2009, DEVELOPMENT, V136, P1465, DOI 10.1242/dev.032748; Shalaby SM, 2016, IUBMB LIFE, V68, P673, DOI 10.1002/iub.1529; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Takesono A, 2012, P NATL ACAD SCI USA, V109, P3371, DOI 10.1073/pnas.1200642109; Tang Xiaoqiong, 2015, Med Sci Monit, V21, P3427; Tian T, 2009, BIOCHEM BIOPH RES CO, V380, P537, DOI 10.1016/j.bbrc.2009.01.111; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; Velu CS, 2009, BLOOD, V113, P4720, DOI 10.1182/blood-2008-11-190215; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614	45	5	5	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2732	2743		10.1074/jbc.RA118.005079	http://dx.doi.org/10.1074/jbc.RA118.005079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593510	hybrid, Green Published			2022-12-26	WOS:000459601600014
J	Xi, G; Shen, XC; Wai, C; White, MF; Clemmons, DR				Xi, Gang; Shen, Xinchun; Wai, Christine; White, Morris F.; Clemmons, David R.			Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin receptor substrate 1 (IRS-1); p53; insulin resistance; myocardin; Kruppel-like factor 4 (KLF4); atherosclerosis; inflammation; metabolic regulation; cardiovascular disease; smooth muscle	MAMMALIAN TARGET; DOWN-REGULATION; DIFFERENTIATION MARKERS; SUBSTRATE 1; ACTIVATION; P53; PROLIFERATION; GENE; ATHEROSCLEROSIS; MYOCARDIN	Hyperglycemia and insulin resistance accelerate atherosclerosis by an unclear mechanism. The two factors down-regulate insulin receptor substrate-1 (IRS-1), an intermediary of the insulin/IGF-I signaling system. We previously reported that IRS-1 down-regulation leads to vascular smooth muscle cell (VSMC) dedifferentiation and that IRS-1 deletion from VSMCs in normoglycemic mice replicates this response. However, we did not determine IRS-1's role in mediating differentiation. Here, we sought to define the mechanism by which IRS-1 maintains VSMC differentiation. High glucose or IRS-1 knockdown decreased p53 levels by enhancing MDM2 proto-oncogene (MDM2)-mediated ubiquitination, resulting in decreased binding of p53 to Kruppel-like factor 4 (KLF4). Exposure to nutlin-3, which dissociates MDM2/p53, decreased p53 ubiquitination and enhanced the p53/KLF4 association and differentiation marker protein expression. IRS-1 overexpression in high glucose inhibited the MDM2/p53 association, leading to increased p53 and p53/KLF4 levels, thereby increasing differentiation. Nutlin-3 treatment of diabetic or Irs1(-/-) mice enhanced p53/KLF4 and the expression of p21, smooth muscle protein 22 (SM22), and myocardin and inhibited aortic VSMC proliferation. Injecting normoglycemic mice with a peptide disrupting the IRS-1/p53 association reduced p53, p53/KLF4, and differentiation. Analyzing atherosclerotic lesions in hypercholesterolemic, diabetic pigs, we found that p53, IRS-1, SM22, myocardin, and KLF4/p53 levels are significantly decreased compared with their expression in nondiabetic pigs. We conclude that IRS-1 is critical for maintaining VSMC differentiation. Hyperglycemia- or insulin resistance-induced IRS-1 down-regulation decreases the p53/KLF4 association and enhances dedifferentiation and proliferation. Our results suggest that enhancing IRS-1-dependent p53 stabilization could attenuate the progression of atherosclerotic lesions in hyperglycemia and insulin-resistance states.	[Xi, Gang; Wai, Christine; Clemmons, David R.] Univ N Carolina, Dept Med, Div Endocrinol, Sch Med, Chapel Hill, NC 27599 USA; [Shen, Xinchun] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing 210023, Jiangsu, Peoples R China; [White, Morris F.] Harvard Med Sch, Childrens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing University of Finance & Economics; Harvard University; Boston Children's Hospital; Harvard Medical School	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu			National Institutes of Health [AG02331]; National Natural Science Foundation of China [21476103]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant AG02331. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Natural Science Foundation of China Grant 21476103.	Baroni MG, 1999, ARTERIOSCL THROM VAS, V19, P2975, DOI 10.1161/01.ATV.19.12.2975; Cao RY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175061; Chistiakov DA, 2015, ACTA PHYSIOL, V214, P33, DOI 10.1111/apha.12466; DeStefano MA, 2013, BIOCHEM SOC T, V41, P896, DOI 10.1042/BST20130018; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Frismantiene A, 2016, CELL SIGNAL, V28, P516, DOI 10.1016/j.cellsig.2016.02.014; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Hakuno F, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00073; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lazo PA, 2017, CELL SIGNAL, V33, P49, DOI 10.1016/j.cellsig.2017.02.005; Li G, 2015, CARDIOVASC RES, V105, P75, DOI 10.1093/cvr/cvu235; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Maile LA, 2017, ATHEROSCLEROSIS, V258, P40, DOI 10.1016/j.atherosclerosis.2017.01.030; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nemoto S, 2014, ATHEROSCLEROSIS, V233, P64, DOI 10.1016/j.atherosclerosis.2013.12.032; Nguyen AT, 2013, CIRC RES, V112, P17, DOI 10.1161/CIRCRESAHA.112.281048; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Radhakrishnan Y, 2010, J BIOL CHEM, V285, P15682, DOI 10.1074/jbc.M109.092270; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Sadagurski M, 2013, ENDOCRIN METAB CLIN, V42, P127, DOI 10.1016/j.ecl.2012.11.008; Sentinelli F, 2006, J ENDOCRINOL, V188, P271, DOI 10.1677/joe.1.06290; Shamhart PE, 2009, AM J PHYSIOL-ENDOC M, V297, pE1147, DOI 10.1152/ajpendo.00327.2009; Shi JH, 2012, J BIOL CHEM, V287, P10799, DOI 10.1074/jbc.M111.321836; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; Tsuchiya K, 2007, J ATHEROSCLER THROMB, V14, P303, DOI 10.5551/jat.E525; Turner EC, 2013, BBA-GENE REGUL MECH, V1829, P1191, DOI 10.1016/j.bbagrm.2013.09.002; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Wassmann K, 2010, MOL CELL BIOCHEM, V333, P33, DOI 10.1007/s11010-009-0201-7; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Wu GZ, 2014, CIRCULATION, V130, P1452, DOI 10.1161/CIRCULATIONAHA.114.011675; Wu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094957; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2017, J BIOL CHEM, V292, P2009, DOI 10.1074/jbc.M116.758987; Xi G, 2015, FASEB J, V29, P4772, DOI 10.1096/fj.15-275453; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2014, J BIOL CHEM, V289, P26107, DOI 10.1074/jbc.M114.582809; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng XL, 2014, ARCH BIOCHEM BIOPHYS, V543, P48, DOI 10.1016/j.abb.2013.12.015	50	14	15	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2407	2421		10.1074/jbc.RA118.005398	http://dx.doi.org/10.1074/jbc.RA118.005398			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30578299	hybrid, Green Published			2022-12-26	WOS:000458895400018
J	Jaddi, NS; Abdullah, S				Jaddi, Najmeh Sadat; Abdullah, Salwani			Kidney-inspired algorithm with reduced functionality treatment for classification and time series prediction	PLOS ONE			English	Article							POLYNOMIAL NEURAL-NETWORKS; GREAT DELUGE ALGORITHM; GENETIC ALGORITHM; OPTIMIZATION APPROACH; HYBRID	Optimization of an artificial neural network model through the use of optimization algorithms is the common method employed to search for an optimum solution for a broad variety of real-world problems. One such optimization algorithm is the kidney-inspired algorithm (KA) which has recently been proposed in the literature. The algorithm mimics the four processes performed by the kidneys: filtration, reabsorption, secretion, and excretion. However, a human with reduced kidney function needs to undergo additional treatment to improve kidney performance. In the medical field, the glomerular filtration rate (GFR) test is used to check the health of kidneys. The test estimates the amount of blood that passes through the glomeruli each minute. In this paper, we mimic this kidney function test and the GFR result is used to select a suitable step to add to the basic KA process. This novel imitation is designed for both minimization and maximization problems. In the proposed method, depends on GFR test result which is less than 15 or falls between 15 and 60 or is more than 60 a particular action is performed. These additional processes are applied as required with the aim of improving exploration of the search space and increasing the likelihood of the KA finding the optimum solution. The proposed method is tested on test functions and its results are compared with those of the basic KA. Its performance on benchmark classification and time series prediction problems is also examined and compared with that of other available methods in the literature. In addition, the proposed method is applied to a real-world water quality prediction problem. The statistical analysis of all these applications showed that the proposed method had a ability to improve the optimization outcome.	[Jaddi, Najmeh Sadat; Abdullah, Salwani] Natl Univ Malaysia, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Data Min & Optimizat Res Grp DMO, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Abdullah, S (corresponding author), Natl Univ Malaysia, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Data Min & Optimizat Res Grp DMO, Bangi, Selangor, Malaysia.	salwani@ukm.edu.my			Universiti Kebangsaan Malaysia [DIP-2016-024]	Universiti Kebangsaan Malaysia	This research was supported by the Universiti Kebangsaan Malaysia, DIP-2016-024 to S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolrazzagh-Nezhad M, 2016, COMM COM INF SC, V639, P356, DOI 10.1007/978-3-319-46254-7_28; Abdullah S, 2010, DATABASE THEORY APPL; Aladag CH, 2013, NEURAL PROCESS LETT, V37, P251, DOI 10.1007/s11063-012-9244-y; Bakirtzis AG, 2002, IEEE T POWER SYST, V17, P229, DOI 10.1109/TPWRS.2002.1007886; Benedetti M, 2008, IEEE T ANTENN PROPAG, V56, P1939, DOI 10.1109/TAP.2008.924717; Chen YM, 2010, PATTERN RECOGN LETT, V31, P226, DOI 10.1016/j.patrec.2009.10.013; Dubovik O, 2011, ATMOS MEAS TECH, V4, P975, DOI 10.5194/amt-4-975-2011; Gazzaz NM, 2012, MAR POLLUT BULL, V64, P2409, DOI 10.1016/j.marpolbul.2012.08.005; Hall JE, 2015, GUYTON HALL TXB MED; Han M, 2011, IEEE T NEURAL NETWOR, V22, P1457, DOI 10.1109/TNN.2011.2162341; Hsieh TJ, 2011, APPL SOFT COMPUT, V11, P2510, DOI 10.1016/j.asoc.2010.09.007; Jaddi NS, 2018, ENG APPL ARTIF INTEL, V67, P246, DOI 10.1016/j.engappai.2017.09.012; Jaddi NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170372; Jaddi NS, 2017, COMMUN NONLINEAR SCI, V42, P358, DOI 10.1016/j.cnsns.2016.06.006; Jaddi NS, 2015, APPL SOFT COMPUT, V37, P71, DOI 10.1016/j.asoc.2015.08.002; Jaddi NS, 2016, INFORM PROCESS LETT, V116, P22, DOI 10.1016/j.ipl.2015.08.001; Jaddi NS, 2015, INFORM SCIENCES, V294, P628, DOI 10.1016/j.ins.2014.08.050; Jaddi NS, 2013, TURK J ELECTR ENG CO, V21, P1737, DOI 10.3906/elk-1202-113; Jaddi NS, 2013, J INF SCI ENG, V29, P49; Jaddi NS, 2013, ADV VISUAL INFORM; Jaddi NS, 2013, INF CREAT MULT ICICM; Janiga D, 2017, J PETROL SCI ENG, V154, P354, DOI 10.1016/j.petrol.2017.04.010; Jassadapakorn C., 2011, INT J COMPUT SCI INF, V3, P1; Jassadapakorn C., 2011, J THEORETICAL APPL I, V3, P1; Kalayci EG, 2015, INFORM SYST, V50, P51, DOI 10.1016/j.is.2015.01.013; Kamalzadeh H, 2017, INFORM SYST, V67, P1, DOI 10.1016/j.is.2017.03.004; Karlik B., 2010, INT J ARTIF INTELL E, V1, P111; Lynn N, 2015, SWARM EVOL COMPUT, V24, P11, DOI 10.1016/j.swevo.2015.05.002; Mehrabi M, 2012, INT COMMUN HEAT MASS, V39, P971, DOI 10.1016/j.icheatmasstransfer.2012.05.017; Mohapatra P, 2015, SWARM EVOL COMPUT, V24, P25, DOI 10.1016/j.swevo.2015.05.003; Mousavi SM, 2013, APPL MATH MODEL, V37, P2241, DOI [10.1016/j.apm.2012.05.019, 10.1016/j.apm.2011.11.050]; Nawi NM, 2013, INT C COMP SCI ITS A; Oh SK, 2005, PHYS LETT A, V345, P88, DOI 10.1016/j.physleta.2005.06.100; Oh SK, 2009, APPL SOFT COMPUT, V9, P1068, DOI 10.1016/j.asoc.2009.02.007; Donate JP, 2013, NEURAL COMPUT APPL, V22, P11, DOI 10.1007/s00521-011-0741-0; Salama KM, 2015, SWARM INTELL-US, V9, P229, DOI 10.1007/s11721-015-0112-z; Song Q-k, 2014, INT J HYBRID INF TEC, V7, P33; Valian E., 2011, INT J ARTIFICIAL INT, V2, P36, DOI DOI 10.5121/IJAIA.2011.2304; Zanchettin C, 2011, IEEE T SYST MAN CY B, V41, P1097, DOI 10.1109/TSMCB.2011.2107035	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0208308	10.1371/journal.pone.0208308	http://dx.doi.org/10.1371/journal.pone.0208308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608936	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800009
J	Gosch, M; Cronin, M; Rogan, E; Hunt, W; Luck, C; Jessopp, M				Gosch, Martha; Cronin, Michelle; Rogan, Emer; Hunt, William; Luck, Cian; Jessopp, Mark			Spatial variation in a top marine predator's diet at two regionally distinct sites	PLOS ONE			English	Article							SEALS HALICHOERUS-GRYPUS; GREY SEALS; GRAY SEALS; HABITAT SELECTION; FORAGING BEHAVIOR; FEEDING STRATEGY; PREY CONSUMPTION; IRISH WATERS; MANAGEMENT; CONSEQUENCES	In ecological studies it is often assumed that predator foraging strategies and resource use are geographically and seasonally homogeneous, resulting in relatively static trophic relationships. However, certain centrally placed foragers (e.g. seals) often have terrestrial sites for breeding, resting, and moulting that are geographically distinct, and associated with different habitat types. Therefore, accurate estimations of predator diet at relevant spatial and temporal scales are key to understanding energetic requirements, predator-prey interactions and ecosystem structure. We investigate geographic variation in the diet of grey seals (Halichoerus grypus), a relatively abundant and widely distributed central place forager, to provide insights into geographic variation in resource use. Prey composition was identified using scat samples collected over concurrent timescales and a multivariate approach was used to analyse diet from two contrasting habitats. Regional differences in prey assemblages occurred within all years (2011-2013) and all seasons (ANOSIM, all p<0.05), apart from in winter. Telemetry data were used to identify core foraging areas and habitats most likely associated with scat samples collected at the two haul-out sites. Regional differences in the diet appear to reflect regional differences in the physical habitat features, with seals foraging in deeper waters over sandy substrates showing a higher prevalence of pelagic and bentho-pelagic prey species such as blue whiting and sandeels. Conversely, seals foraging in comparatively shallow waters had a greater contribution of demersal and groundfish species such as cephalopods and flatfish in their diet. We suggest that shallower waters enable seals to spend more time foraging along the benthos while remaining within aerobic dive limits, resulting in more benthic species in the diet. In contrast, the diet of seals hauled-out in areas adjacent to deeper waters indicates that either seals engage in a more pelagic foraging strategy, or that seals can spend less time at the benthos, resulting in comparatively more pelagic prey recovered in the diet. The substantial differences in prey assemblages over a small spatial scale (<300 km) demonstrates the importance of using regionally-specific diet information in ecosystem-based models to better account for different trophic interactions.	[Gosch, Martha; Cronin, Michelle; Hunt, William; Luck, Cian; Jessopp, Mark] Univ Coll Cork, Environm Res Inst, MaREI Ctr, Cork, Ireland; [Gosch, Martha; Rogan, Emer; Luck, Cian; Jessopp, Mark] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland	University College Cork; University College Cork	Gosch, M (corresponding author), Univ Coll Cork, Environm Res Inst, MaREI Ctr, Cork, Ireland.; Gosch, M (corresponding author), Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland.	m.gosch@ucc.ie	Jessopp, Mark/AAI-4786-2020	Jessopp, Mark/0000-0002-2692-3730; Luck, Cian/0000-0002-4116-5181; Gosch, Martha/0000-0002-2333-5925	Irish Research Council Postgraduate scholarship [RS/2012/357]; Department of Agriculture, Food and the Marine under the FishKOSM project [15/S/744]; Higher Education Authority (HEA) under the PRTLI4 programme Environment and Climate Change; National Parks & Wildlife Service (NPWS); Marine Institute under the Marine Research Sub-Programme of the National Development Plan 2007-2013; European Commission's Directorate-General for Maritime Affairs and Fisheries (DG MARE); Beaufort Marine Research Award	Irish Research Council Postgraduate scholarship(Irish Research Council for Science, Engineering and Technology); Department of Agriculture, Food and the Marine under the FishKOSM project; Higher Education Authority (HEA) under the PRTLI4 programme Environment and Climate Change; National Parks & Wildlife Service (NPWS); Marine Institute under the Marine Research Sub-Programme of the National Development Plan 2007-2013; European Commission's Directorate-General for Maritime Affairs and Fisheries (DG MARE); Beaufort Marine Research Award	This work was supported by an Irish Research Council Postgraduate scholarship awarded to MG (RS/2012/357), and funding from the Department of Agriculture, Food and the Marine under the FishKOSM project (15/S/744). Satellite tagging was facilitated by funding from the Higher Education Authority (HEA) under the PRTLI4 programme Environment and Climate Change and by the National Parks & Wildlife Service (NPWS). Research was also supported under the Beaufort Marine Research Award carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the National Development Plan 2007-2013. Information on sediments was derived from data that is made available under the European Marine Observation Data Network (EMODnet) Seabed Habitats project (http://www.emodnet-seabedhabitats.eu/), funded by the European Commission's Directorate-General for Maritime Affairs and Fisheries (DG MARE). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson TJ, 2009, J EXP MAR BIOL ECOL, V379, P34, DOI 10.1016/j.jembe.2009.07.033; Arnett RTP, 2001, J MAR BIOL ASSOC UK, V81, P365, DOI 10.1017/S0025315401003952; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Barnett A, 2010, J EXP MAR BIOL ECOL, V393, P188, DOI 10.1016/j.jembe.2010.07.022; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Benoit D, 1990, CAN B FISH AQUAT SCI, V222, P26; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Bowen WD, 2006, CONSERV BIOL SER, P63, DOI 10.1017/CBO9780511541964.006; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; BOWEN WD, 1993, CAN J FISH AQUAT SCI, V50, P1768, DOI 10.1139/f93-198; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Browne P, 2002, FISH B-NOAA, V100, P423; Carter MID, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15859-8; Chittaro PM, 2004, CORAL REEFS, V23, P235, DOI 10.1007/s00338-004-0376-z; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COOPER LHN, 1949, J MAR BIOL ASSOC UK, V28, P719, DOI 10.1017/S0025315400023547; COSTELLO MJ, 1990, J FISH BIOL, V36, P261, DOI 10.1111/j.1095-8649.1990.tb05601.x; Cronin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160564; Cronin M, 2014, MAR POLICY, V44, P120, DOI 10.1016/j.marpol.2013.08.015; Cronin M, 2013, MAR BIOL, V160, P531, DOI 10.1007/s00227-012-2109-0; Cronin MA, 2011, MAR POLICY, V35, P748, DOI 10.1016/j.marpol.2011.01.006; Cushing DH, 2001, ENCY OCEAN SCI, P364; Ellis JR, 2000, ESTUAR COAST SHELF S, V51, P299, DOI 10.1006/ecss.2000.0677; Fedak M.A., 1986, DIVING ANIMALS MAN, P11; Froese R., 2008, WORLD WIDE WEB ELECT; Gerritsen HD, 2003, J SEA RES, V49, P69, DOI 10.1016/S1385-1101(02)00197-1; Gosch M, 2014, AQUAT BIOL, V20, P155, DOI 10.3354/ab00553; Grellier K, 2006, CAN J FISH AQUAT SCI, V63, P1982, DOI 10.1139/F06-092; Hammill M.O., 2007, NAMMCO Scientific Publications, V6, P135; Hammond P. S., 1990, CAN B FISH AQUAT SCI, p[Bowen, 243]; HAMMOND PS, 1994, J APPL ECOL, V31, P340, DOI 10.2307/2404548; HAMMOND PS, 1994, J APPL ECOL, V31, P737, DOI 10.2307/2404164; Hanson N, 2018, OIKOS, V127, P134, DOI 10.1111/oik.04441; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hindell MA, 2003, J APPL ECOL, V40, P703, DOI 10.1046/j.1365-2664.2003.00832.x; Holland GJ, 2005, MAR ECOL PROG SER, V303, P269, DOI 10.3354/meps303269; Howarth MJ, 2005, SEA6 DEP TRAD IND OF; Huon M, 2017, THESIS; Huon M, 2015, J WILDLIFE MANAGE, V79, P1091, DOI 10.1002/jwmg.929; Jessopp M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063720; Jones EL, 2015, MAR ECOL PROG SER, V534, P235, DOI 10.3354/meps11370; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lundstrom K, 2010, ICES J MAR SCI, V67, P1230, DOI 10.1093/icesjms/fsq022; Marine Institute, 2012, ATL IR GROUNDF TRAWL; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; McHuron EA, 2018, ECOL EVOL, V8, P4340, DOI 10.1002/ece3.3983; Moyle P.B., 2004, INTRO ICHTHYOLOGY, V5th; Noren SR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P482, DOI 10.1086/430228; O Cadhla O., 2013, MONITORING BREEDING; Orr AJ, 2003, WILDLIFE SOC B, V31, P253; Pierce G.J., 1990, P222; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Pinnegar JK, 2002, J APPL ECOL, V39, P377, DOI 10.1046/j.1365-2664.2002.00723.x; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PRIME JH, 1990, J APPL ECOL, V27, P435, DOI 10.2307/2404292; Raine R., 1993, OCCASIONAL PUBLICATI, V2, P99; Riesch R, 2012, BIOL J LINN SOC, V106, P1, DOI 10.1111/j.1095-8312.2012.01872.x; Rogan E, 1995, DEV MAR BIO, V4, P671; Rosen DAS, 2007, PHILOS T R SOC B, V362, P2151, DOI 10.1098/rstb.2007.2108; SAVINO JF, 1989, ENVIRON BIOL FISH, V24, P287, DOI 10.1007/BF00001402; Sjoberg M, 2000, CAN J ZOOL, V78, P1661, DOI 10.1139/cjz-78-9-1661; Smout S, 2014, ICES J MAR SCI, V71, P81, DOI 10.1093/icesjms/fst109; The Department of Housing Planning and Local Government, 2018, NAT MAR PLANN FRAM B; THOMPSON D, 1993, J EXP BIOL, V174, P139; Ushio M, 2018, NATURE, V554, P360, DOI 10.1038/nature25504; Wheeler AJ, 2005, ERLANGEN EARTH C SER, P393, DOI 10.1007/3-540-27673-4_19; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822	71	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209032	10.1371/journal.pone.0209032	http://dx.doi.org/10.1371/journal.pone.0209032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601852	gold, Green Published, Green Submitted			2022-12-26	WOS:000454683200033
J	Kim, SA; Hong, J; Park, WC; Shin, DY; Koh, Y; Kim, I; Lee, DS; Yoon, SS				Kim, Sang-A; Hong, Junshik; Park, Woo Chan; Shin, Dong-Yeop; Koh, Youngil; Kim, Inho; Lee, Dong Soon; Yoon, Sung-Soo			Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype	PLOS ONE			English	Article							LEUKEMIA; SECONDARY; AML; TP53; TRANSPLANTATION; SURVIVAL; FEATURES; IMPACT; MDS	We analyzed treatment outcomes and prognostic factors in adult patients with therapy-related myeloid neoplasms (t-MNs) to select patients who would be benefited by active anticancer treatment. After excluding 18 patients who received palliative care only and 13 patients with acute promyelocytic leukemia, 72 t-MN patients (45 with acute myeloid leukemia and 27 with myelodysplastic syndrome) were retrospectively evaluated. Among them, 10 (13.9%), 32 (44.4%), and 30 patients (41.7%) had favorable, intermediate-and adverse-risk cytogenetics, respectively. Among patients with intermediate-risk cytogenetics, patients with a normal karyotype (NK; N = 20) showed superior allogeneic stem cell transplantation-censored overall survival (AC-OS) and OS compared to those with non-NK-intermediate-risk cytogenetics (P < 0.001). In the multivariate analysis, male sex, age >= 70 years, and unfavorable cytogenetics (non-NK-intermediate plus adverse risk cytogenetics) were associated with inferior AC-OS. Those results suggest that a more-refined subdivision of risk stratification would be necessary in patients with intermediate-risk cytogenetics.	[Kim, Sang-A; Hong, Junshik; Park, Woo Chan; Shin, Dong-Yeop; Koh, Youngil; Kim, Inho; Yoon, Sung-Soo] Seoul Natl Univ Hosp, Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Hong, Junshik; Shin, Dong-Yeop; Koh, Youngil; Kim, Inho; Lee, Dong Soon; Yoon, Sung-Soo] Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea; [Lee, Dong Soon] Seoul Natl Univ Hosp, Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Hong, J (corresponding author), Seoul Natl Univ Hosp, Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Hong, J (corresponding author), Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea.	alertjun@hanmail.net	Yoon, Sung-Soo/J-2773-2012	Kim, Sang-A/0000-0002-8529-0232; Hong, Junshik/0000-0002-7829-397X	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [NRF-2016R1A5A1011974]	National Research Foundation of Korea (NRF) - Korean Government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (No. NRF-2016R1A5A1011974 to SSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MK, 1998, HAEMATOLOGICA, V83, P483; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Borthakur G, 2009, CANCER-AM CANCER SOC, V115, P3217, DOI 10.1002/cncr.24367; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Fianchi L, 2015, AM J HEMATOL, V90, pE80, DOI 10.1002/ajh.23966; Godley LA, 2010, LEUKEMIA LYMPHOMA, V51, P995, DOI 10.3109/10428191003763468; Gustafson SA, 2009, AM J CLIN PATHOL, V131, P647, DOI 10.1309/AJCP5ETHDXO6NCGZ; Hahn T, 2013, J CLIN ONCOL, V31, P2437, DOI 10.1200/JCO.2012.46.6193; Heuser M, 2016, HEMATOL-AM SOC HEMAT, P24, DOI 10.1182/asheducation-2016.1.24; HOYLE CF, 1989, BRIT J HAEMATOL, V72, P45, DOI 10.1111/j.1365-2141.1989.tb07650.x; Hulegardh E, 2015, AM J HEMATOL, V90, P208, DOI 10.1002/ajh.23908; KANTARJIAN HM, 1993, HEMATOL ONCOL CLIN N, V7, P81, DOI 10.1016/S0889-8588(18)30259-4; Kayser S, 2017, LEUKEMIA, V31, P2347, DOI 10.1038/leu.2017.92; Kayser S, 2011, BLOOD, V117, P2137, DOI 10.1182/blood-2010-08-301713; Kern W, 2004, J CLIN ONCOL, V22, P2510, DOI 10.1200/jco.2004.99.301; Krauth MT, 2014, LEUKEMIA, V28, P1449, DOI 10.1038/leu.2014.4; LARSON RA, 1988, BLOOD, V72, P1333; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; McNerney ME, 2017, NAT REV CANCER, V17, P513, DOI 10.1038/nrc.2017.60; Murthy GSG, 2016, BLOOD, V128; Ok CY, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0139-z; Ostgard LSG, 2015, J CLIN ONCOL, V33, P3641, DOI 10.1200/JCO.2014.60.0890; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Yakoub-Agha I, 2000, J CLIN ONCOL, V18, P963, DOI 10.1200/JCO.2000.18.5.963; Zahid MF, 2016, WORLD J STEM CELLS, V8, P231, DOI 10.4252/wjsc.v8.i8.231	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209800	10.1371/journal.pone.0209800	http://dx.doi.org/10.1371/journal.pone.0209800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596716	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200088
J	Cassani, G; Grimm, R; Daelemans, W; Gillis, S				Cassani, Giovanni; Grimm, Robert; Daelemans, Walter; Gillis, Steven			Lexical category acquisition is facilitated by uncertainty in distributional co-occurrences	PLOS ONE			English	Article							CHILD-DIRECTED SPEECH; GRAMMATICAL CATEGORIES; FREQUENT FRAMES; CONTEXTUAL DIVERSITY; SYNTACTIC CATEGORIES; YOUNG-CHILDREN; WORD-FREQUENCY; CUE; INFORMATION; STATISTICS	This paper analyzes distributional properties that facilitate the categorization of words into lexical categories. First, word-context co-occurrence counts were collected using corpora of transcribed English child-directed speech. Then, an unsupervised k-nearest neighbor algorithm was used to categorize words into lexical categories. The categorization outcome was regressed over three main distributional predictors computed for each word, including frequency, contextual diversity, and average conditional probability given all the co-occurring contexts. Results show that both contextual diversity and frequency have a positive effect while the average conditional probability has a negative effect. This indicates that words are easier to categorize in the face of uncertainty: categorization works best for words which are frequent, diverse, and hard to predict given the co-occurring contexts. This shows how, in order for the learner to see an opportunity to form a category, there needs to be a certain degree of uncertainty in the co-occurrence pattern.	[Cassani, Giovanni; Grimm, Robert; Daelemans, Walter; Gillis, Steven] Univ Antwerp, Ctr Computat Linguist & Psycholinguist CLiPS, Antwerp, Belgium	University of Antwerp	Cassani, G (corresponding author), Univ Antwerp, Ctr Computat Linguist & Psycholinguist CLiPS, Antwerp, Belgium.	giovanni.cassani@uantwerpen.be	Gillis, Steven/S-3914-2019; Daelemans, Walter/N-5785-2014	Gillis, Steven/0000-0002-2067-0576; Daelemans, Walter/0000-0002-9832-7890	BOF/TOP grant - Research Council of the University of Antwerp [29072]; IBF/TOP grant from the Research Council of the University of Antwerp [29072]	BOF/TOP grant - Research Council of the University of Antwerp; IBF/TOP grant from the Research Council of the University of Antwerp	This work was supported by BOF/TOP grant (ID 29072) awarded by the Research Council of the University of Antwerp to SG and WD, used to fund GC and RG (https://www.uantwerpen.be/en/research-and-innovation/management/funding/internal-funding/university-research-bof/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an IBF/TOP grant (ID 29072) from the Research Council of the University of Antwerp. We thank Stephan Tulkens and two anonymous reviewers for the useful comments on the manuscript, Antal van den Bosch and Dominiek Sandra for useful feedback about the conceptualization of this work.	Abend O, 2017, COGNITION, V164, P116, DOI 10.1016/j.cognition.2017.02.009; Adelman JS, 2006, PSYCHOL SCI, V17, P814, DOI 10.1111/j.1467-9280.2006.01787.x; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Akhtar N, 1997, DEV PSYCHOL, V33, P952, DOI 10.1037/0012-1649.33.6.952; Alishahi A, 2009, COGSCI 2009 WORKSH P; Alishahi A., 2012, P 2012 JOINT C EMP M, P643; Ambridge B, 2017, HANDBOOK OF CATEGORIZATION IN COGNITIVE SCIENCE, 2ND EDITION, P567, DOI 10.1016/B978-0-08-101107-2.00023-3; Ambridge B, 2015, J CHILD LANG, V42, P239, DOI 10.1017/S030500091400049X; Arnon I, 2017, J MEM LANG, V92, P265, DOI 10.1016/j.jml.2016.07.004; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen RH, 2016, LANG COGN NEUROSCI, V31, P106, DOI 10.1080/23273798.2015.1065336; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bullinaria JA, 2007, BEHAV RES METHODS, V39, P510, DOI 10.3758/BF03193020; Bybee J, 2006, LANGUAGE, V82, P711, DOI 10.1353/lan.2006.0186; Carroll J. B., 1970, Computer Studies in the Humanities and Verbal Behavior, V3, P61; Cartwright TA, 1997, COGNITION, V63, P121, DOI 10.1016/S0010-0277(96)00793-7; Cassani G, FRONTIERS PSYCHOL; Chemla E, 2009, DEVELOPMENTAL SCI, V12, P396, DOI 10.1111/j.1467-7687.2009.00825.x; Christophe A, 2008, LANG SPEECH, V51, P61, DOI 10.1177/00238309080510010501; Chrupala G, 2010, P 14 C COMP NAT LANG, P182; Daelemans W., 2009, TIMBL TILBURG MEMORY; Daelemans Walter, 2005, MEMORY BASED LANGUAG; Dawson M. R. W., 2008, COMP COGNITION BEHAV, V3, P1, DOI DOI 10.3819/CCBR.2008.30008; De Carvalho A, 2017, COGNITION, V163, P67, DOI 10.1016/j.cognition.2017.02.018; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; Erkelens MA, 2009, THESIS; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; Feijoo S, 2015, LANG COMMUN, V45, P1, DOI 10.1016/j.langcom.2015.07.001; Firth J. R., 1957, PAPERS LINGUISTICS; Fitneva SA, 2009, J CHILD LANG, V36, P967, DOI 10.1017/S0305000908009252; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Freudenthal D, 2016, P 38 ANN C COGN SCI, P674; Freudenthal D, 2013, P 35 ANN M COGN SCI, P2327; Freudenthal D, 2008, P 30 ANN M COGN SCI, P1947; Frost RLA, 2016, P 38 ANN M COGN SCI, P81; Gerken L, 2005, J CHILD LANG, V32, P249, DOI 10.1017/S0305000904006786; Gillis S, 2009, COGNITION AND PRAGMA, P201; GOLDSTONE RL, 1994, COGNITION, V52, P125, DOI 10.1016/0010-0277(94)90065-5; Grimm R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00555; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hebb DO, 1949, THE ORGANIZATION OF; Hills TT, 2010, J MEM LANG, V63, P259, DOI 10.1016/j.jml.2010.06.002; Hsu N, 2017, J CHILD LANG, V44, P63, DOI 10.1017/S0305000915000690; Hunt E.B., 1966, AM J PSYCHOL; Johns BT, 2016, PSYCHON B REV, V23, P1214, DOI 10.3758/s13423-015-0980-7; Jones G, 2017, COGNITIVE PSYCHOL, V98, P1, DOI 10.1016/j.cogpsych.2017.07.002; Jones MN, 2017, PSYCHOL LEARN MOTIV, V67, P239, DOI 10.1016/bs.plm.2017.03.008; Jones MN, 2012, CAN J EXP PSYCHOL, V66, P115, DOI 10.1037/a0026727; Kachergis G, 2017, COGNITIVE SCI, V41, P590, DOI 10.1111/cogs.12353; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; Kidd C, 2014, CHILD DEV, V85, P1795, DOI 10.1111/cdev.12263; Kidd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036399; Lany J, 2010, PSYCHOL SCI, V21, P284, DOI 10.1177/0956797609358570; Leibbrandt RE, 2008, P 32 BOST U C LANG S; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; MacWhinney BJ, 2000, THE DATABASE, V2; Maratsos M., 1980, CHILDRENS LANGUAGE, V2, P127; Matthews D, 2010, COGNITIVE SCI, V34, P465, DOI 10.1111/j.1551-6709.2009.01091.x; McCauley SM., 2017, COGNITIVE SCI; McCauley SM, 2014, MENT LEX, V9, P419, DOI 10.1075/ml.9.3.03mcc; Meylan SC, 2017, PSYCHOL SCI, V28, P181, DOI 10.1177/0956797616677753; Mintz TH, 2003, COGNITION, V90, P91, DOI 10.1016/S0010-0277(03)00140-9; Mintz TH, 2002, COGNITIVE SCI, V26, P393, DOI 10.1207/s15516709cog2604_1; Mintz TH, 2014, COGNITIVE PSYCHOL, V75, P1, DOI 10.1016/j.cogpsych.2014.07.003; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Monaghan P, 2004, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P963; Moran S, 2018, COGNITION, V175, P131, DOI 10.1016/j.cognition.2018.02.005; OLGUIN R, 1993, COGNITIVE DEV, V8, P245, DOI 10.1016/S0885-2014(93)80001-A; Parisien C., 2008, CONLL 2008 P 12 C CO, DOI [DOI 10.3115/1596324.1596340, 10.3115/1596324.1596340]; Pelucchi B, 2009, COGNITION, V113, P244, DOI 10.1016/j.cognition.2009.07.011; Pine JM, 2013, COGNITION, V127, P345, DOI 10.1016/j.cognition.2013.02.006; Quinlan R, 1993, C4 5 PROGRAMS MACHIN; Ramscar M, 2007, COGNITIVE SCI, V31, P927, DOI 10.1080/03640210701703576; Ramscar M, 2015, HANDB SPRACH KOMMUN, V39, P75; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; Redington M, 1998, COGNITIVE SCI, V22, P425, DOI 10.1016/S0364-0213(99)80046-9; Reeder PA, 2017, J MEM LANG, V97, P17, DOI 10.1016/j.jml.2017.07.006; Reeder PA, 2013, COGNITIVE PSYCHOL, V66, P30, DOI 10.1016/j.cogpsych.2012.09.001; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rodriguez A, 2004, J COGNITIVE NEUROSCI, V16, P856, DOI 10.1162/089892904970690; Rosa E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179004; Roy BC, 2015, P NATL ACAD SCI USA, V112, P12663, DOI 10.1073/pnas.1419773112; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; SCARBOROUGH DL, 1977, J EXP PSYCHOL HUMAN, V3, P1, DOI 10.1037/0096-1523.3.1.1; Sloutsky VM, 2003, TRENDS COGN SCI, V7, P246, DOI 10.1016/S1364-6613(03)00109-8; Smith NJ, 2013, COGNITION, V128, P302, DOI 10.1016/j.cognition.2013.02.013; St Clair MC, 2010, COGNITION, V116, P341, DOI 10.1016/j.cognition.2010.05.012; Stumper B, 2011, COGNITIVE SCI, V35, P1190, DOI 10.1111/j.1551-6709.2011.01187.x; SUPPES P, 1974, AM PSYCHOL, V29, P103, DOI 10.1037/h0036026; Theakston AL, 2001, J CHILD LANG, V28, P127, DOI 10.1017/S0305000900004608; Tomasello M, 2000, COGNITION, V74, P209, DOI 10.1016/S0010-0277(99)00069-4; TOMASELLO M, 1993, COGNITIVE DEV, V8, P451, DOI 10.1016/S0885-2014(05)80004-8; van Heugten M, 2010, J MEM LANG, V63, P197, DOI 10.1016/j.jml.2010.04.001; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; Vergara-Martinez M, 2017, COGN AFFECT BEHAV NE, V17, P461, DOI 10.3758/s13415-016-0491-7; Walker N, 2017, P 39 ANN C COGN SCI, P1307; Wang H, 2008, PROC ANN BUCLD, P525; Wang H, 2011, PROC ANN BUCLD, P628; Weisleder A, 2010, J CHILD LANG, V37, P1089, DOI 10.1017/S0305000909990067; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wurm LH, 2014, J MEM LANG, V72, P37, DOI 10.1016/j.jml.2013.12.003; Zhang Z, 2015, LANG ACQUIS, V22, P104, DOI 10.1080/10489223.2014.943900	104	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209449	10.1371/journal.pone.0209449	http://dx.doi.org/10.1371/journal.pone.0209449			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0GV	30592738	Green Published, gold			2022-12-26	WOS:000454621900025
J	Thurich, J; Meichsner, D; Furch, ACU; Pfalz, J; Kruger, T; Kniemeyer, O; Brakhage, A; Oelmuller, R				Thuerich, Johannes; Meichsner, Doreen; Furch, Alexandra C. U.; Pfalz, Jeannette; Krueger, Thomas; Kniemeyer, Olaf; Brakhage, Axel; Oelmueller, Ralf			Arabidopsis thaliana responds to colonisation of Piriformospora indica by secretion of symbiosis-specific proteins	PLOS ONE			English	Article							GENE-EXPRESSION; LACCARIA-BICOLOR; BETA-GLUCOSIDASE; PLANT SECRETOME; FUNGUS; TOBACCO; GROWTH; EFFECTOR; ROOTS; CELLS	Plants interact with a wide variety of fungi in a mutualistic, parasitic or neutral way. The associations formed depend on the exchange of nutrients and signalling molecules between the partners. This includes a diverse set of protein classes involved in defence, nutrient uptake or establishing a symbiotic relationship. Here, we have analysed the secretomes of the mutualistic, root-endophytic fungus Piriformospora indica and Arabidopsis thaliana when cultivated alone or in a co-culture. More than one hundred proteins were identified as differentially secreted, including proteins associated with growth, development, abiotic and biotic stress response and mucilage. While some of the proteins have been associated before to be involved in plant-microbial interaction, other proteins are newly described in this context. One plant protein found in the co-culture is PLAT1 (Polycystin, Lipoxygenase, Alpha-toxin and Triacylglycerol lipase). PLAT1 has not been associated with plant-fungal-interaction and is known to play a role in abiotic stress responses. In colonised roots PLAT1 shows an altered gene expression in a stage specific manner and plat1 knock-out plants are colonised stronger. It co-localises with Brassicaceae-specific endoplasmic reticulum bodies (ER-bodies) which are involved in the formation of the defence compound scopolin. We observed degraded ER-bodies in infected Arabidopsis roots and a change in the scopolin level in response to the presence of the fungus.	[Thuerich, Johannes; Meichsner, Doreen; Furch, Alexandra C. U.; Pfalz, Jeannette; Oelmueller, Ralf] Friedrich Schiller Univ Jena, Fac Biol Sci, Matthias Schleiden Inst Genet Bioinformat & Mol B, Plant Physiol, Jena, Germany; [Krueger, Thomas; Kniemeyer, Olaf; Brakhage, Axel] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Mol & Appl Microbiol, Jena, Germany; [Brakhage, Axel] Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Oelmuller, R (corresponding author), Friedrich Schiller Univ Jena, Fac Biol Sci, Matthias Schleiden Inst Genet Bioinformat & Mol B, Plant Physiol, Jena, Germany.	ralf.oelmueller@uni-jena.de	Kniemeyer, Olaf/K-1253-2013	Kniemeyer, Olaf/0000-0002-9493-6402; Kruger, Thomas/0000-0001-8984-3853	Deutsche Forschungsgemeinschaft [CRC1127, CRC/Transregio 124 - FungiNet]; Jena School of Microbial Communication	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jena School of Microbial Communication	This research was funded by Deutsche Forschungsgemeinschaft (CRC1127 - ChemBioSys to JT, AB, and RO), (CRC/Transregio 124 - FungiNet (project Z2) to TK and OK), and the Jena School of Microbial Communication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeaziz ME, 2017, PLANT SCI, V263, P107, DOI 10.1016/j.plantsci.2017.07.006; Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Ahn YO, 2010, PLANT CELL PHYSIOL, V51, P132, DOI 10.1093/pcp/pcp174; Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assis RDB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16325-1; Bakshi M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01262; Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bonfante P, 2015, TRENDS PLANT SCI, V20, P150, DOI 10.1016/j.tplants.2014.12.002; Boyce JM, 2003, PLANT J, V34, P395, DOI 10.1046/j.1365-313X.2003.01734.x; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carminati A, 2013, ANN BOT-LONDON, V112, P277, DOI 10.1093/aob/mcs262; Cheng FY, 2009, J PROTEOME RES, V8, P82, DOI 10.1021/pr800649s; Chiapello M, 2015, RECENT ADV PROTEOMIC, DOI [10.5772/61331, DOI 10.5772/61331]; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI 10.1094/MPMI.2004.17.1.109; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Doll K., 2014, THESIS; Dong SQ, 2013, J EXP BOT, V64, P4529, DOI 10.1093/jxb/ert265; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Filipsky T, 2015, CURR TOP MED CHEM, V15, P415, DOI 10.2174/1568026615666150206152233; Floerl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031435; Foster J, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Francoz E, 2015, TRENDS PLANT SCI, V20, P515, DOI 10.1016/j.tplants.2015.04.008; Gonzalez-Fernandez R, 2012, J PROTEOME RES, V11, P3, DOI 10.1021/pr200873p; Gorsuch PA, 2010, PLANT CELL PHYSIOL, V51, P1488, DOI 10.1093/pcp/pcq112; Gunning BES, 1998, TRENDS PLANT SCI, V3, P417, DOI 10.1016/S1360-1385(98)01336-3; Ham BK, 2012, PLANT CELL, V24, P3630, DOI 10.1105/tpc.112.101063; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; Hilbert M, 2012, NEW PHYTOL, V196, P520, DOI 10.1111/j.1469-8137.2012.04275.x; Hong YW, 2000, P NATL ACAD SCI USA, V97, P8717, DOI 10.1073/pnas.140213697; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Hui FQ, 2015, J ENVIRON SCI, V37, P184, DOI 10.1016/j.jes.2015.06.005; Hyun TK, 2015, TRANSGENIC RES, V24, P651, DOI 10.1007/s11248-015-9868-6; HYUN TK, 2014, PLOS ONE, V9; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Johnson J.M., 2011, ENDOCYT CELL RES, V21, P101; Johnson JM, 2018, PLANT PHYSIOL, V176, P2496, DOI 10.1104/pp.17.01423; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kaffarnik FAR, 2009, MOL CELL PROTEOMICS, V8, P145, DOI 10.1074/mcp.M800043-MCP200; Kai K, 2006, PHYTOCHEMISTRY, V67, P379, DOI 10.1016/j.phytochem.2005.11.006; Kai K, 2008, PLANT J, V55, P989, DOI 10.1111/j.1365-313X.2008.03568.x; Kaiser C, 2015, NEW PHYTOL, V205, P1537, DOI 10.1111/nph.13138; Keymer A, 2017, ELIFE, V6, DOI [10.7554/eLife.29107, 10.7554/eLife.29107.001]; Kim BH, 2012, MOL CELLS, V34, P539, DOI 10.1007/s10059-012-0230-z; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Krause C, 2013, BBA-PROTEINS PROTEOM, V1834, P2429, DOI 10.1016/j.bbapap.2013.03.024; Krijger JJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-722; Kuo WY, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23074; Lahrmann U, 2015, NEW PHYTOL, V207, P841, DOI 10.1111/nph.13411; Lahrmann U, 2012, MOL PLANT MICROBE IN, V25, P727, DOI 10.1094/MPMI-11-11-0291; Lanfranco L, 2018, NEW PHYTOL, V220, P1031, DOI 10.1111/nph.15230; Lippmann R, 2009, INT J MOL SCI, V10, P3012, DOI 10.3390/ijms10073012; Lum G, 2013, TROP PLANT BIOL, V6, P131, DOI 10.1007/s12042-013-9121-5; Ma W, 2010, J PROTEOME RES, V9, P2968, DOI 10.1021/pr901168v; Maier W, 2000, PHYTOCHEMISTRY, V54, P473, DOI 10.1016/S0031-9422(00)00047-9; Marin M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414292; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; McClerklin SA, 2017, INDOLE 3 ACETALDEHYD; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Miyawaki K, 2013, CURR OPIN PLANT BIOL, V16, P598, DOI 10.1016/j.pbi.2013.08.008; Mortier V, 2010, PLANT PHYSIOL, V153, P222, DOI 10.1104/pp.110.153718; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagahashi G, 2004, MYCOL RES, V108, P1079, DOI 10.1017/S0953756204000693; Nagano AJ, 2005, PLANT CELL PHYSIOL, V46, P1140, DOI 10.1093/pcp/pci126; Nakano RT, 2017, PLANT J, V89, P204, DOI 10.1111/tpj.13377; Nakano RT, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00073; Nogueira-Lopez G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00409; Nongbri PL, 2012, SYMBIOSIS, V58, P17, DOI 10.1007/s13199-012-0209-8; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; Pellegrin C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01278; Peskan-Berghofer T, 2015, NEW PHYTOL, V208, P873, DOI 10.1111/nph.13504; Peterson JK, 2003, HORTSCIENCE, V38, P1129, DOI 10.21273/HORTSCI.38.6.1129; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plett JM, 2014, P NATL ACAD SCI USA, V111, P8299, DOI 10.1073/pnas.1322671111; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; PRASAD TK, 1992, PLANT MOL BIOL, V18, P873, DOI 10.1007/BF00019202; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Sherameti I, 2008, PLANT J, V54, P428, DOI 10.1111/j.1365-313X.2008.03424.x; Shin R, 2004, PLANT PHYSIOL, V135, P561, DOI 10.1104/pp.103.035436; Shrivastava N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23994-z; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Strehmel N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071091; Sun C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0268-5; Sun HH, 2014, J EXP BOT, V65, P4305, DOI 10.1093/jxb/eru203; Tawk C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09527-0; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tomchick DR, 2001, BIOCHEMISTRY-US, V40, P7509, DOI 10.1021/bi002893d; Tsai AYL, 2017, PLANT PHYSIOL, V173, P1059, DOI 10.1104/pp.16.01600; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Vahabi K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0419-3; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Virk N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133975; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Xu JH, 2017, PLANT PHYSIOL BIOCH, V117, P51, DOI 10.1016/j.plaphy.2017.05.018; Yin K, 2009, ACTA BIOCH BIOPH SIN, V41, P478, DOI 10.1093/abbs/gmp036; Zhang H, 2007, PLANTA, V226, P839, DOI 10.1007/s00425-007-0530-2; Zhang LS, 2014, PLANT PHYSIOL, V164, P352, DOI 10.1104/pp.113.230698; Zhang XF, 2013, PLANT MOL BIOL, V83, P205, DOI 10.1007/s11103-013-0082-8; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	114	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209658	10.1371/journal.pone.0209658	http://dx.doi.org/10.1371/journal.pone.0209658			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589877	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200041
J	Kumazawa, T; Nishimura, A; Asai, N; Adachi, T				Kumazawa, Toshihiko; Nishimura, Atsuhisa; Asai, Noriyuki; Adachi, Takahiro			Isolation of immune-regulatory Tetragenococcus halophilus from miso	PLOS ONE			English	Article							KILLED LACTOBACILLUS-PLANTARUM; MESENTEROIDES STRAIN NTM048; JAPANESE TRADITIONAL MISO; IFN-GAMMA PRODUCTION; B-CELLS; BLOOD-PRESSURE; PROBIOTICS; PREBIOTICS; HYPERTENSION; COMMENSAL	Tetragenococcus halophilus is a halophilic lactic acid bacterium that exists in the traditional Japanese seasoning miso-a fermented soy paste. Considering the popularity of miso as a component of healthy diet, we attempted to evaluate the immunoregulatory functions of T. halophilus spices isolated from miso. We screened 56 strains that facilitated the upregulation of activation markers such as CD86 and CD69 on B cells and T cells in vitro. Of these, 7 strains (Nos. 1, 3, 13, 15, 19, 30, and 31) were found to preferentially induce the CD86 expression on B cells. Furthermore, DNA microarray analysis revealed that T. halophilus strain No. 1 significantly augmented the gene expressions of CD86, CD70, IL-10, INF-gamma, and IL-22 in B cells. We confirmed these results at the protein level by flow cytometry. Mice feeding diet containing 1% T. halophilus No. 1 exhibited significantly greater IgA production in the serum. Furthermore, a diet containing 1% T. halophilus No. 1 augmented ovoalbumin (OVA)-specific IgG titer in mice upon OVA/alum immunization. Thus, we demonstrated that T. halophilus No. 1 is a strong immunomodulatory strain with potential as a probiotic.	[Kumazawa, Toshihiko; Nishimura, Atsuhisa; Asai, Noriyuki] Ichibiki CO LTD, Nagoya, Aichi, Japan; [Kumazawa, Toshihiko; Adachi, Takahiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Adachi, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo, Japan.	tadachi.imm@mri.tmd.ac.jp		Adachi, Takahiro/0000-0002-3711-8577	ICHIBIKI Co Ltd.; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Canon Foundation	ICHIBIKI Co Ltd.; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canon Foundation(Canon Foundation)	This study was partly funded by ICHIBIKI Co Ltd. The funder provided the source. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Canon Foundation (to T.A.). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.A.), and the Canon Foundation (to T.A.).	Ballesteros-Tato A, 2014, CELL RES, V24, P135, DOI 10.1038/cr.2013.163; Bao Y, 2014, J AUTOIMMUN, V55, P10, DOI 10.1016/j.jaut.2014.04.001; Bao Y, 2014, CELL RES, V24, P161, DOI 10.1038/cr.2013.155; Bao Y, 2011, EUR J IMMUNOL, V41, P657, DOI 10.1002/eji.201040840; Bengmark S, 2006, NUTR HOSP, V21, P72; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Chiba E, 2013, INT IMMUNOPHARMACOL, V17, P373, DOI 10.1016/j.intimp.2013.06.024; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; Du DD, 2014, CLIN EXP HYPERTENS, V36, P359, DOI 10.3109/10641963.2013.827702; Frei R, 2015, CURR OPIN GASTROEN, V31, P153, DOI 10.1097/MOG.0000000000000151; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; He F, 2005, MICROBIOL IMMUNOL, V49, P995; Hirose Y, 2006, J NUTR, V136, P3069, DOI 10.1093/jn/136.12.3069; Hokazono Y, 2003, J IMMUNOL, V171, P1835, DOI 10.4049/jimmunol.171.4.1835; Hong HJ, 2010, J CLIN IMMUNOL, V30, P449, DOI 10.1007/s10875-010-9375-8; Kawashima T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23404-4; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kawashima T, 2011, INT IMMUNOPHARMACOL, V11, P2017, DOI 10.1016/j.intimp.2011.08.013; Kosaka A, 2012, INT IMMUNOPHARMACOL, V14, P729, DOI 10.1016/j.intimp.2012.10.007; Lanfranca MP, 2016, J MOL MED, V94, P523, DOI 10.1007/s00109-016-1391-6; Lee YD, 2016, J MICROBIOL BIOTECHN, V26, P1517, DOI 10.4014/jmb.1601.01044; Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015; Markowiak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091021; Matsuzaki C, 2014, J APPL MICROBIOL, V116, P980, DOI 10.1111/jam.12411; Matsuzaki C, 2016, BIOSCI MICROB FOOD H, V35, P51, DOI 10.12938/bmfh.2015-020; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Mitsuoka Tomotari, 2014, Biosci Microbiota Food Health, V33, P117, DOI [10.12938/bmfh.33.117, 10.12938/bmfh.2014-003]; Murooka Y, 2008, J IND MICROBIOL BIOT, V35, P791, DOI 10.1007/s10295-008-0362-5; Nishimura Ikuko, 2009, Allergology International, V58, P179, DOI 10.2332/allergolint.O-08-548; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Nozue M, 2017, J NUTR, V147, P1749, DOI 10.3945/jn.117.250282; Ohata E, 2011, FOOD SCI TECHNOL RES, V17, P129, DOI 10.3136/fstr.17.129; Onda T, 2003, FOOD SCI TECHNOL RES, V9, P17, DOI 10.3136/fstr.9.17; Park S, 2018, J MICROBIOL, V56, P145, DOI 10.1007/s12275-018-7411-1; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeda S, 2011, INT IMMUNOPHARMACOL, V11, P1976, DOI 10.1016/j.intimp.2011.08.007; Watanabe H, 2006, HYPERTENS RES, V29, P731, DOI 10.1291/hypres.29.731; Watanabe H, 2018, AM J HYPERTENS, V31, P43, DOI 10.1093/ajh/hpx129; Watanabe H, 2013, J TOXICOL PATHOL, V26, P91, DOI 10.1293/tox.26.91; Weiss G, 2011, CYTOKINE, V56, P520, DOI 10.1016/j.cyto.2011.07.024; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Yang X, 2018, J MED INVESTIG, V65, P74, DOI 10.2152/jmi.65.74; Yoshikawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18738; Yoshinaga M, 2012, NUTRITION, V28, P924, DOI 10.1016/j.nut.2011.09.010	50	13	13	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208821	10.1371/journal.pone.0208821	http://dx.doi.org/10.1371/journal.pone.0208821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586377	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400039
J	Rodrigues, FM; Loeckx, M; Hornikx, M; van Remoortel, H; Louvaris, Z; Demeyer, H; Janssens, W; Troosters, T				Rodrigues, Fernanda Machado; Loeckx, Matthias; Hornikx, Miek; van Remoortel, Hans; Louvaris, Zafeiris; Demeyer, Heleen; Janssens, Wim; Troosters, Thierry			Six years progression of exercise capacity in subjects with mild to moderate airflow obstruction, smoking and never smoking controls	PLOS ONE			English	Article							UPTAKE EFFICIENCY SLOPE; OXYGEN-UPTAKE; VENTILATORY INEFFICIENCY; AEROBIC CAPACITY; PROGNOSTIC VALUE; HEART-FAILURE; RISK-FACTORS; COPD; MECHANISMS; RESERVE	Background Exercise capacity is an important feature in patients with COPD. Its impairment drives disability and dependency for daily activities performance. This study evaluated the six years change in exercise capacity in subjects with airflow obstruction and compared this to subjects without airflow obstruction, with and without a smoking history. Methods Cardiopulmonary exercise tests (CPET) were repeatedly performed during a six years follow up period. Peak oxygen uptake (VO(2)peak), work rate (WRpeak), heart rate (HRpeak), minute ventilation (VEpeak), respiratory exchange ratio (RERpeak) and ventilatory reserve (VE/MVV) were collected as effort dependent outcomes. The slopes of oxygen uptake, ventilatory and mechanical efficiency (OUES, Delta VE/Delta VCO2 and Delta VO2/Delta WR) were collected as effort independent outcomes. Results One hundred and thirty-eight subjects were included. Thirty-eight presented airflow obstruction (63 +/- 6 years, 74% men, FEV1 90 +/- 15%(pred)), 44 had a smoking history but no airflow obstruction (61 +/- 5 years, 61% men, FEV1 105 +/- 15%(pred)) and 56 had never smoked (61 +/- 7 years, 57% men, FEV1 117 +/- 18%(pred)). At baseline, the airflow obstruction group had slightly worse exercise capacity in comparison to the never smoking control group, in absolute terms and expressed as percentage of the predicted value (VO(2)peak = 27 +/- 5 versus 32 +/- 8 ml/min/kg, p<0.01; 112 +/- 29 versus 130 +/- 33%(pred), p = 0.04). Most exercise variables showed a statistically significant yearly deterioration, with exception of VE/MVV, Delta VE/Delta VCO2 and Delta VO2/Delta WR. The yearly decline in VO(2)peak and OUES was not faster in subjects with airflow obstruction than in smoking and never smoking controls (VO(2)peak -67 (9) versus -76 (9) ml/min, p = 0.44 and versus -58 (9), p = 0.47; OUES -32 (11) versus -68 (10), p = 0.03 and versus -68 (13), p = 0.03). Conclusions With exception of VO(2)peak, effort dependent variables deteriorated faster in subjects with airflow obstruction compared to never smoking controls. The deterioration of effort independent variables, however, was not accelerated in the airflow obstruction group compared to controls.	[Rodrigues, Fernanda Machado; Loeckx, Matthias; Louvaris, Zafeiris; Demeyer, Heleen; Troosters, Thierry] Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium; [Rodrigues, Fernanda Machado; Loeckx, Matthias; Louvaris, Zafeiris; Demeyer, Heleen; Janssens, Wim; Troosters, Thierry] Univ Hosp Leuven, Dept Resp Dis, Leuven, Belgium; [Loeckx, Matthias] LUNEX Univ, Dept Physiotherapy, Differdange, Luxembourg; [Hornikx, Miek] Univ Hosp Leuven, Dept Cardiovasc Sci, Leuven, Belgium; [van Remoortel, Hans] Belgian Red Cross Flanders, Ctr Evidence Based Practice, Mechelen, Belgium; [Janssens, Wim] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Troosters, T (corresponding author), Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium.; Troosters, T (corresponding author), Univ Hosp Leuven, Dept Resp Dis, Leuven, Belgium.	Thierry.troosters@kuleuven.be	Van Remoortel, Hans/AAH-2425-2019; Machado Rodrigues, Fernanda Maria/AFM-9962-2022; Hornikx, Miek/ABI-5441-2020	Janssens, Wim/0000-0003-1830-2982; Loeckx, Matthias/0000-0002-0397-4973; Louvaris, Zafeiris/0000-0001-8661-8546; Demeyer, Heleen/0000-0001-8925-0564; Rodrigues, Fernanda/0000-0002-2888-5651	Flemish Research Foundation (FWO) [G.0871.13]; National Council for Scientific and Technological Development (CNPq), Brazil [249579/2013-8]; FWO-Flanders [12H7517N, 12U5618N]	Flemish Research Foundation (FWO)(FWO); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FWO-Flanders(FWO)	This work was supported by the Flemish Research Foundation (FWO #G.0871.13). FMR is funded by the National Council for Scientific and Technological Development (CNPq), Brazil (249579/2013-8). HD and ZL are post-doctoral research fellow of the FWO-Flanders (12H7517N and 12U5618N, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman M, 2010, J CARDIOPULM REHABIL, V30, P357, DOI 10.1097/HCR.0b013e3181ebf316; Neder JA, 2015, EUR RESPIR J, V45, P377, DOI 10.1183/09031936.00135514; Arena R, 2004, AM HEART J, V147, P354, DOI 10.1016/j.ahj.2003.07.014; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Barron A, 2016, JACC-HEART FAIL, V4, P252, DOI 10.1016/j.jchf.2015.11.003; Buys R, 2016, EUR J PREV CARDIOL, V23, P1363, DOI 10.1177/2047487316643446; Cahalin LP, 2013, HEART FAIL REV, V18, P79, DOI 10.1007/s10741-012-9332-0; Caviedes IR, 2012, RESP CARE, V57, P583, DOI 10.4187/respcare.01342; Davies LC, 2006, EUR HEART J, V27, P684, DOI 10.1093/eurheartj/ehi672; Decramer M, 2005, RESP MED, V99, pS3, DOI 10.1016/j.rmed.2005.09.010; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Demeyer H, 2014, CHEST, V146, P318, DOI 10.1378/chest.13-1968; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Frisk B, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0095-y; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Graham B.L., 2017, EUR RESPIR J, V2017, P49, DOI DOI 10.1183/13993003.00016-2016; Gross MA, 2009, MED SCI SPORT EXER, V41, P2084, DOI 10.1249/MSS.0b013e3181a8c37a; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Hollenberg M, 2006, J GERONTOL A-BIOL, V61, P851, DOI 10.1093/gerona/61.8.851; Koch B, 2009, EUR RESPIR J, V33, P389, DOI 10.1183/09031936.00074208; McDonough P, 1999, SPORTS MED, V27, P275, DOI 10.2165/00007256-199927050-00001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mirza S, 2018, MAYO CLIN PROC, V93, P1488, DOI 10.1016/j.mayocp.2018.05.026; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Myers J, 2012, J CARDIOPULM REHABIL, V32, P9, DOI 10.1097/HCR.0b013e3182343bdf; Oga T, 2005, CHEST, V128, P62, DOI 10.1378/chest.128.1.62; Perrault H, 2006, CLIN INVEST MED, V29, P117; Rodrigues FM, 2017, CHRON RESP DIS, V14, P289, DOI 10.1177/1479972316687210; ROGERS MA, 1990, J APPL PHYSIOL, V68, P2195, DOI 10.1152/jappl.1990.68.5.2195; Terziyski Kiril V, 2009, Folia Med (Plovdiv), V51, P18; Van Remoortel H, 2014, AM J RESP CRIT CARE, V189, P30, DOI 10.1164/rccm.201307-1240OC; van Remoortel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084365; WASSERMAN K, 1967, J APPL PHYSIOL, V22, P71, DOI 10.1152/jappl.1967.22.1.71	35	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208841	10.1371/journal.pone.0208841	http://dx.doi.org/10.1371/journal.pone.0208841			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586370	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400040
J	O'Driscoll, CA; Gallo, ME; Hoffmann, EJ; Fechner, JH; Schauer, JJ; Bradfield, CA; Mezrich, JD				O'Driscoll, Chelsea A.; Gallo, Madeline E.; Hoffmann, Erica J.; Fechner, John H.; Schauer, James J.; Bradfield, Christopher A.; Mezrich, Joshua D.			Polycyclic aromatic hydrocarbons (PAHs) present in ambient urban dust drive proinflammatory T cell and dendritic cell responses via the aryl hydrocarbon receptor (AHR) in vitro	PLOS ONE			English	Article							PARTICULATE MATTER; METABOLIC-ACTIVATION; MEDIATED ACTIVITY; DIFFERENTIATION; PERSPECTIVE; SIZE; TH17	Atmospheric particulate matter (PM) is a complex component of air pollution that is a composed of inorganic and organic constituents. The chemically-extracted organic fraction (OF) of PM excludes inorganics but retains most organic constituents like polycyclic aromatic hydrocarbons (PAHs). PAHs are ubiquitous environmental toxicants and known aryl hydrocarbon receptor (AHR) ligands. The AHR is a ligand activated transcription factor that responds to endogenous ligands and exogenous ligands including PAHs. Activation of the AHR leads to upregulation of cytochrome P450 (CYP) metabolizing enzymes which are important for the biotransformation of toxicants to less toxic, or in the case of PAHs, more toxic intermediates. Additionally, the AHR plays an important role in balancing regulatory and effector T cell responses. This study aimed to determine whether PAHs present in PM aggravate inflammation by driving inflammatory T cell and dendritic cell (DC) responses and their mechanism of action. This study tests the hypothesis that PAHs present in PM activate the AHR and alter the immune balance shifting from regulation to inflammation. To test this, the effects of SRM1649b OF on T cell differentiation and DC function were measured in vitro. SRM1649b OF enhanced Th17 differentiation in an AHR and CYP-dependent manner and increased the percent of IFN gamma positive DCs in an AHR-dependent manner. SRM1649b PAH mixtures enhanced Th17 differentiation in an AHR-dependent but CYP-independent manner and increased the percent of IFN gamma positive DCs. Cumulatively, these results suggest that PAHs present in PM are active components that contribute to immune responses in both T cells and BMDCs through the AHR and CYP metabolism. Understanding the role of AHR and CYP metabolism of PAHs in immune cells after PM exposure will shed light on new targets that will shift the immune balance from inflammation to regulation.	[O'Driscoll, Chelsea A.; Gallo, Madeline E.; Hoffmann, Erica J.; Fechner, John H.; Mezrich, Joshua D.] Univ Wisconsin, Sch Med & Publ Hlth, Div Transplantat, Dept Surg, Madison, WI 53706 USA; [O'Driscoll, Chelsea A.; Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Environm Toxicol Ctr, Madison, WI USA; [Schauer, James J.] Wisconsin State Lab Hyg, Madison, WI USA; [Schauer, James J.] Univ Wisconsin, Coll Engn, Civil & Environm Engn, Madison, WI USA; [Bradfield, Christopher A.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mezrich, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Div Transplantat, Dept Surg, Madison, WI 53706 USA.	mezrich@surgery.wisc.edu	O'Driscoll, Chelsea/G-3907-2018	O'Driscoll, Chelsea/0000-0003-3504-6669; Hoffmann, Erica/0000-0003-3194-9553; Schauer, James/0000-0002-5405-1511	National Institute of Environmental Health Sciences (NIEHS) [R01 ES023842, R21 ES025304, T32 ES007015]; University of Wisconsin-Carbone Cancer Center Flow Cytometry Laboratory [P30 CA014520, 1S100OD018202-01]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015, R21ES025304, R01ES023842] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Wisconsin-Carbone Cancer Center Flow Cytometry Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (NIEHS) [R01 ES023842 to J.D.M, R21 ES025304 to J.D. M], and [T32 ES007015 (C.A.O)] https://www.niehs.nih.gov/index.cfm.Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to the University of Wisconsin-Carbone Cancer Center Flow Cytometry Laboratory [University of Wisconsin Carbone Cancer Center Support Grant P30 CA014520 and Special BD LSR Fortessa Project Grant 1S100OD018202-01]. Thank you to Brandon Shelton at the Wisconsin State Lab of Hygiene for analysis and preparation of OF and PAH mixture samples.	Agency USEP, 2002, HLTH ASS DOC DIES EN; Andrysik Z, 2011, MUTAT RES-FUND MOL M, V714, P53, DOI 10.1016/j.mrfmmm.2011.06.011; [Anonymous], 2011, AH RECEPTOR BIOL TOX; Carver LA, 1997, LIGAND DEPENDENT INT, DOI [10.1074/jbc.272.17.11452, DOI 10.1074/JBC.272.17.11452]; Cassee FR, 2013, INHAL TOXICOL, V25, P802, DOI 10.3109/08958378.2013.850127; Castaneda AR, 2018, TOXICOL LETT, V292, P85, DOI 10.1016/j.toxlet.2018.04.020; Cooney DJ, 2008, INT J NANOMED, V3, P435; Ehrlich AK, 2018, TOXICOL SCI, V161, P310, DOI 10.1093/toxsci/kfx215; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Institute HE, 2018, STAT GLOB AIR 2018; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Kelly FJ, 2012, ATMOS ENVIRON, V60, P504, DOI 10.1016/j.atmosenv.2012.06.039; Libalova H, 2014, TOXICOL LETT, V225, P350, DOI 10.1016/j.toxlet.2014.01.028; Machala M, 2001, MUTAT RES-GEN TOX EN, V497, P49, DOI 10.1016/S1383-5718(01)00240-6; Mohinta S, 2015, TOXICOL SCI, V145, P233, DOI 10.1093/toxsci/kfv046; Nebert D W, 2000, Ann N Y Acad Sci, V919, P148; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; O'Driscoll CA, 2019, ENVIRON RES, V168, P178, DOI 10.1016/j.envres.2018.09.038; O'Driscoll CA, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-018-0271-3; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Shimada T, 2006, CHEM RES TOXICOL, V19, P288, DOI 10.1021/tx050291v; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Shimada T, 2013, CHEM RES TOXICOL, V26, P529, DOI 10.1021/tx3004906; Shimada T, 2008, CHEM RES TOXICOL, V21, P2313, DOI 10.1021/tx8002998; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vondracek J, 2017, ENVIRON POLLUT, V220, P307, DOI 10.1016/j.envpol.2016.09.064; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	35	28	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209690	10.1371/journal.pone.0209690	http://dx.doi.org/10.1371/journal.pone.0209690			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576387	Green Submitted, gold, Green Published			2022-12-26	WOS:000454149400071
J	Lahav-Ariel, L; Caspi, M; Nadar-Ponniah, PT; Zelikson, N; Hofmann, I; Hanson, KK; Franke, WW; Sklan, EH; Avraham, KB; Rosin-Arbesfeld, R				Lahav-Ariel, Lital; Caspi, Michal; Nadar-Ponniah, Prathamesh T.; Zelikson, Natalie; Hofmann, Ilse; Hanson, Kirsten K.; Franke, Werner W.; Sklan, Ella H.; Avraham, Karen B.; Rosin-Arbesfeld, Rina			Striatin is a novel modulator of cell adhesion	FASEB JOURNAL			English	Article						cell-cell junctions; Wnt signaling; epithelial cells; tight junctions	TIGHT JUNCTIONS; CALMODULIN-BINDING; NEGATIVE REGULATOR; PROTEIN; APC; ORGANIZATION; FAMILY; IDENTIFICATION; MICROTUBULES; MAINTENANCE	The adherens junctions (AJs) and tight junctions (TJs) provide critical adhesive contacts between neighboring epithelial cells and are crucial for epithelial adhesion, integrity, and barrier functions in a wide variety of tissues and organisms. The striatin protein family, which are part of the striatin interaction phosphatases and kinases complex, are multidomain scaffolding proteins that play important biologic roles. We have previously shown that striatin colocalizes with the tumor suppressor protein adenomatous polyposis coli in the TJs of epithelial cells. Here we show that striatin affects junction integrity and cell migration, probably through a mechanism that involves the adhesion molecule E-cadherin. Cells engaged in cell-cell adhesion expressed a high MW-modified form of striatin that forms stable associations with detergent-insoluble, membrane-bound cellular fractions. In addition, striatin has recently been suggested to be a target of the poly (ADP-ribose) polymerases Tankyrase 1, and we have found that striatin interacts with Tankyrase 1 and is subsequently poly-ADP-ribosylated. Taken together, our results suggest that striatin is a novel cell-cell junctional protein that functions to maintain correct cell adhesion and may have a role in establishing the relationship between AJs and TJs that is fundamental for epithelial cell-cell adhesion.	[Lahav-Ariel, Lital; Caspi, Michal; Nadar-Ponniah, Prathamesh T.; Zelikson, Natalie; Sklan, Ella H.; Rosin-Arbesfeld, Rina] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel; [Nadar-Ponniah, Prathamesh T.; Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Nadar-Ponniah, Prathamesh T.; Avraham, Karen B.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Hofmann, Ilse] German Canc Res Ctr DKFZ ZMBH Alliance, Ctr Mol Biol, Div Vasc Oncol & Metastasis, Heidelberg, Germany; [Franke, Werner W.] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany; [Hofmann, Ilse] Heidelberg Univ, Med Fac Mannheim, Dept Vasc Biol & Tumor Angiogenesis CBTM, Heidelberg, Germany; [Hanson, Kirsten K.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Hanson, Kirsten K.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Rosin-Arbesfeld, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel.	arina@tauex.tau.ac.il		Hanson, Kirsten/0000-0002-0154-0979; Franke, Werner W./0000-0002-4873-8448; Nadar Ponniah, Prathamesh Thangaraj/0000-0002-1087-9069	German-Israeli Foundation [1098]; Israel Science Foundation [829/14]; Rising Tide Foundation for Clinical Cancer Research; Gateway for Cancer Research Foundation; United States-Israel Binational Science Foundation [2017173]; U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R01DC011835]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011835] Funding Source: NIH RePORTER	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Rising Tide Foundation for Clinical Cancer Research; Gateway for Cancer Research Foundation; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the German-Israeli Foundation (1098), the Israel Science Foundation (829/14), the Rising Tide Foundation for Clinical Cancer Research, the Gateway for Cancer Research Foundation (to R.R.-A.), the United States-Israel Binational Science Foundation (2017173, to R.R.-A. and K.B.A.), and the U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders Grant R01DC011835 (to K.B.A.). The authors declare no conflicts of interest.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Bahmanyar S, 2009, ADV EXP MED BIOL, V656, P65, DOI 10.1007/978-1-4419-1145-2_6; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Breitman M, 2008, BBA-MOL CELL RES, V1783, P1792, DOI 10.1016/j.bbamcr.2008.04.017; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Ciarlet M, 2001, J VIROL, V75, P11834, DOI 10.1128/JVI.75.23.11834-11850.2001; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; DEJANA E, 1994, CLIN EXP RHEUMATOL, V12, pS25; Del Vecchio G, 2012, MOL PHARMACEUT, V9, P2523, DOI 10.1021/mp3001414; Fearon ER, 2009, CANCER CELL, V16, P366, DOI 10.1016/j.ccr.2009.10.007; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hamada F, 2002, NAT CELL BIOL, V4, P208, DOI 10.1038/ncb755; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Hori K, 2003, FEBS LETT, V554, P30, DOI 10.1016/S0014-5793(03)01074-3; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Liu JX, 2017, MOL MED REP, V16, P8076, DOI 10.3892/mmr.2017.7643; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; MANDEL LJ, 1993, NATURE, V361, P552, DOI 10.1038/361552a0; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Mortensen K, 2003, CELL MOL LIFE SCI, V60, P1007, DOI 10.1007/s00018-003-3022-x; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Nunes FD, 2006, J CELL SCI, V119, P4819, DOI 10.1242/jcs.03233; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Petrova YI, 2016, MOL BIOL CELL, V27, P3233, DOI 10.1091/mbc.E16-01-0058; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Stern JA, 2015, RES VET SCI, V102, P182, DOI 10.1016/j.rvsc.2015.08.009; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; ZOU ZZ, 1989, J HISTOCHEM CYTOCHEM, V37, P15, DOI 10.1177/37.1.2461981	53	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4729	4740		10.1096/fj.201801882R	http://dx.doi.org/10.1096/fj.201801882R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592649	Green Published			2022-12-26	WOS:000462888500008
J	Le Barz, M; Daniel, N; Varin, TV; Naimi, S; Demers-Mathieu, V; Pilon, G; Audy, J; Laurin, E; Roy, D; Urdaci, MC; St-Gelais, D; Fliss, I; Marette, A				Le Barz, Melanie; Daniel, Noemie; Varin, Thibault V.; Naimi, Sabrine; Demers-Mathieu, Veronique; Pilon, Genevieve; Audy, Julie; Laurin, Emilie; Roy, Denis; Urdaci, Maria C.; St-Gelais, Daniel; Fliss, Ismail; Marette, Andre			In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity	FASEB JOURNAL			English	Article						gut integrity; insulin resistance; dairy products	DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GUT MICROBIOTA; ADIPOSE-TISSUE; HIGH-FAT; INTESTINAL INFLAMMATION; SENSITIVITY; MECHANISMS; PREBIOTICS; SUPPLEMENTATION	Given the growing evidence that gut dysfunction, including changes in gut microbiota composition, plays a critical role in the development of inflammation and metabolic diseases, the identification of novel probiotic bacteria with immunometabolic properties has recently attracted more attention. Herein, bacterial strains were first isolated from dairy products and human feces and then screened in vitro for their immunomodulatory activity. Five selected strains were further analyzed in vivo, using a mouse model of diet-induced obesity. C57BL/6 mice were fed a high-fat high-sucrose diet, in combination with 1 of 3 Lactobacillus strains (Lb38, L. plantarum; L79, L. paracasei/casei; Lb102, L. rhamnosus) or Bifidobacterium strains (Bf26, Bf141, 2 different strains of B. animalis ssp. lactis species) administered for 8 wk at 10(9) colony-forming units/d. Whereas 3 strains showed only modest (Lb38, Bf26) or no (L79) effects, Lb102 and Bf141 reduced diet-induced obesity, visceral fat accretion, and inflammation, concomitant with improvement of glucose tolerance and insulin sensitivity. Further analysis revealed that Lb102 and Bf141 enhanced intestinal integrity markers in association with selective changes in gut microbiota composition. We have thus identified 2 new potential probiotic bacterial strains with immunometabolic properties to alleviate obesity development and associated metabolic disturbances.	[Le Barz, Melanie; Daniel, Noemie; Varin, Thibault V.; Pilon, Genevieve; Marette, Andre] Laval Univ, Quebec Heart & Lung Inst, Res Ctr, Cardiol Axis,Dept Med,Fac Med, Quebec City, PQ, Canada; [Le Barz, Melanie; Daniel, Noemie; Varin, Thibault V.; Naimi, Sabrine; Demers-Mathieu, Veronique; Pilon, Genevieve; Roy, Denis; St-Gelais, Daniel; Fliss, Ismail; Marette, Andre] Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Naimi, Sabrine; Demers-Mathieu, Veronique; St-Gelais, Daniel; Fliss, Ismail] Laval Univ, Dairy Sci & Technol Res Ctr, Quebec City, PQ, Canada; [Le Barz, Melanie; Urdaci, Maria C.] Univ Bordeaux, Lab Microbiol & Appl Biochem, Unite Mixte Rech 5248, Gradignan, France; [Demers-Mathieu, Veronique; St-Gelais, Daniel] Agr & Agri Food Canada, St Hyacinthe Res & Dev Ctr, St Hyacinthe, PQ, Canada; [Audy, Julie] Agropur Cooperat, St Hubert, PQ, Canada; [Laurin, Emilie] Ultima Foods, Granby, PQ, Canada; [Le Barz, Melanie] Univ Claude Bernard Lyon1, Lyon Univ, INSA Lyon, CarMeN Lab,INSERM,U1060,INRA,U1235, Oullins, France	Laval University; Quebec Heart & Lung Institute; Laval University; Laval University; UDICE-French Research Universities; Universite de Bordeaux; Agriculture & Agri Food Canada; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Marette, A (corresponding author), Laval Univ, Hop Laval, Quebec Heart & Lung Inst, Cardiol Axis, Pavillon Marguerite dYouville,Bur Y4340, Ste Foy, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	Demers-Mathieu, Veronique/I-1923-2016; Roy, Denis/H-4998-2011; Carmen, Team1/Y-7382-2019	Demers-Mathieu, Veronique/0000-0002-7937-6355; Roy, Denis/0000-0002-4229-9245; Carmen, Team1/0000-0003-4234-1746; Le Barz, Melanie/0000-0002-2112-5254; Naimi, Sabrine/0000-0001-6553-7560; Urdaci, Maria C/0000-0002-0868-0050; Lab, Carmen/0000-0002-5935-3236; Daniel, Noemie/0000-0003-4319-0054; Marette, Andre/0000-0003-3950-5973	Natural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 402030-2010]; Agropur Cooperative Laitiere; Aliments Ultima Food	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agropur Cooperative Laitiere; Aliments Ultima Food	The authors thank B. Marcotte, V. Dumais, and C. Dallaire for their help and advice during the in vitro screening and animal protocols, as well as Dr. Benjamin A. H. Jensen for help in proofreading and revising the text; B.M., V.D., C.D. and B.A.H.J. work in the Laboratory of Andre Marette at the Cardiology Axis of the Quebec Heart and Lung Institute Research Centre (Laval University, QC, Canada). This project was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC; CRDPJ 402030-2010), Agropur Cooperative Laitiere, and Aliments Ultima Foods. J.A. and E.L. are employees of Agropur Cooperative Laitiere and Aliments Ultima Foods, respectively, and were involved in the initial isolation of bacterial strains used in this study. However, they have neither been involved in the in vitro and in vivo screening of the strains nor in the interpretation of the data. The remaining authors declare no conflicts of interest.	Alard J, 2016, ENVIRON MICROBIOL, V18, P1484, DOI 10.1111/1462-2920.13181; Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Cani PD, 2014, DIABETES METAB, V40, P246, DOI 10.1016/j.diabet.2014.02.004; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de LeBlanc AD, 2014, WORLD J GASTROENTERO, V20, P16518, DOI 10.3748/wjg.v20.i44.16518; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Demers-Mathieu V, 2016, J FUNCT FOODS, V24, P327, DOI 10.1016/j.jff.2016.04.025; Demers-Mathieu V, 2015, INT DAIRY J, V45, P31, DOI 10.1016/j.idairyj.2015.01.014; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Galdeano CM, 2004, J APPL MICROBIOL, V97, P673, DOI 10.1111/j.1365-2672.2004.02353.x; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; Hulston CJ, 2015, BRIT J NUTR, V113, P596, DOI 10.1017/S0007114514004097; Jensen BAH, 2016, METABOLISM, V65, P1706, DOI 10.1016/j.metabol.2016.09.002; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Khan MT, 2014, CELL METAB, V20, P753, DOI 10.1016/j.cmet.2014.07.006; Krych L, 2015, GUT MICROBES, V6, P101, DOI 10.1080/19490976.2015.1011876; Le Barz M, 2015, DIABETES METAB J, V39, P291, DOI 10.4093/dmj.2015.39.4.291; Lee Y, 2016, AM J PHYSIOL-GASTR L, V311, pG655, DOI 10.1152/ajpgi.00294.2015; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Minami J, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.5; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nagpal R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30114-4; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; O'Shea EF, 2012, INT J FOOD MICROBIOL, V152, P189, DOI 10.1016/j.ijfoodmicro.2011.05.025; Orel R, 2014, WORLD J GASTROENTERO, V20, P11505, DOI 10.3748/wjg.v20.i33.11505; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Sanchez B, 2010, MICROBIOL-SGM, V156, P3232, DOI 10.1099/mic.0.044057-0; Sanchez M, 2014, BRIT J NUTR, V111, P1507, DOI 10.1017/S0007114513003875; Sarkar A, 2016, MICROBIOL RES, V192, P159, DOI 10.1016/j.micres.2016.07.001; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; van Greevenbroek Marleen M J, 2016, F1000Res, V5; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yan Fang, 2012, Funct Food Rev, V4, P77	63	36	36	5	52	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4921	4935		10.1096/fj.201801672R	http://dx.doi.org/10.1096/fj.201801672R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596521				2022-12-26	WOS:000462888500023
J	Bradford, STJ; Ranghini, EJ; Grimley, E; Lee, PH; Dressler, GR				Bradford, Shayna T. J.; Ranghini, Egon J.; Grimley, Edward; Lee, Pil H.; Dressler, Gregory R.			High-throughput screens for agonists of bone morphogenetic protein (BMP) signaling identify potent benzoxazole compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); BMP signaling; chemical biology; fibrosis; small molecule; SMAD transcription factor; TGF-beta signaling; acute kidney disease; chronic kidney disease; end-stage renal disease; high-throughput screening; sb4	KIELIN/CHORDIN-LIKE PROTEIN; TERMINAL DOMAIN PHOSPHATASES; SMALL-MOLECULE; RENAL FIBROSIS; EXPRESSION; INHIBITION; DISCOVERY; GREMLIN; PATHWAY; TARGETS	Bone morphogenetic protein (BMP) signaling is critical in renal development and disease. In animal models of chronic kidney disease (CKD), re-activation of BMP signaling is reported to be protective by promoting renal repair and regeneration. Clinical use of recombinant BMPs, however, requires harmful doses to achieve efficacy and is costly because of BMPs' complex synthesis. Therefore, alternative strategies are needed to harness the beneficial effects of BMP signaling in CKD. Key aspects of the BMP signaling pathway can be regulated by both extracellular and intracellular molecules. In particular, secreted proteins like noggin and chordin inhibit BMP activity, whereas kielin/chordin-like proteins (KCP) enhance it and attenuate kidney fibrosis or CKD. Clinical development of KCP, however, is precluded by its size and complexity. Therefore, we propose an alternative strategy to enhance BMP signaling by using small molecules, which are simpler to synthesize and more cost-effective. To address our objective, here we developed a small-molecule high-throughput screen (HTS) with human renal cells having an integrated luciferase construct highly responsive to BMPs. We demonstrate the activity of a potent benzoxazole compound, sb4, that rapidly stimulated BMP signaling in these cells. Activation of BMP signaling by sb4 increased the phosphorylation of key second messengers (SMAD-1/5/9) and also increased expression of direct target genes (inhibitors of DNA binding, Id1 and Id3) in canonical BMP signaling. Our results underscore the feasibility of utilizing HTS to identify compounds that mimic key downstream events of BMP signaling in renal cells and have yielded a lead BMP agonist.	[Bradford, Shayna T. J.; Ranghini, Egon J.; Grimley, Edward; Dressler, Gregory R.] Univ Michigan, Coll Pharm, Dept Pathol, 428 Church St, Ann Arbor, MI 48109 USA; [Bradford, Shayna T. J.; Grimley, Edward] Univ Michigan, Coll Pharm, Sch Med, Mol & Cellular Pathol Grad Program, 428 Church St, Ann Arbor, MI 48109 USA; [Lee, Pil H.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dressler, GR (corresponding author), Dept Pathol, BSRB 2049,109 Zina Pitcher Dr, Ann Arbor, MI 48109 USA.	dressler@umich.edu		Grimley, Edward/0000-0003-0438-506X; Lee, Pil/0000-0003-2989-8371; Bradford, Shayna/0000-0003-4049-7384	NIDDK, National Institutes of Health [5R01DK054740-16, 3R01DK054740-1651]; University of Michigan Center for the Discovery of New Medicines; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054740, R01DK073722] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan Center for the Discovery of New Medicines(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants 5R01DK054740-16 and 3R01DK054740-1651. Funding was also provided by the University of Michigan Center for the Discovery of New Medicines directed by V. Groppi. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Baek SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120150; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosukonda D, 2000, KIDNEY INT, V58, P1902, DOI 10.1046/j.1523-1755.2000.00362.x; Bruce DL, 2012, FEBS LETT, V586, P1897, DOI 10.1016/j.febslet.2012.02.001; Cao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04965; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876; Chung YH, 2018, LAB INVEST, V98, P999, DOI 10.1038/s41374-018-0069-9; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Feng LL, 2016, CELL REP, V15, P2063, DOI 10.1016/j.celrep.2016.04.066; Genthe JR, 2017, ACS CHEM BIOL, V12, P2436, DOI 10.1021/acschembio.7b00527; Gomez-Puerto MC, 2019, J PATHOL, V247, P9, DOI 10.1002/path.5170; Grimley E, 2017, ACS CHEM BIOL, V12, P724, DOI 10.1021/acschembio.6b00782; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hill AP, 2010, DRUG DISCOV TODAY, V15, P648, DOI 10.1016/j.drudis.2010.05.016; Himmelfarb J, 2018, J AM SOC NEPHROL, V29, P670, DOI 10.1681/ASN.2017020217; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacob RT, 2012, J BIOMOL SCREEN, V17, P1080, DOI 10.1177/1087057112450186; Kato S, 2011, MOL CELL BIOCHEM, V349, P97, DOI 10.1007/s11010-010-0664-6; Kim MJ, 2018, BIOORG MED CHEM LETT, V28, P684, DOI 10.1016/j.bmcl.2018.01.021; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Manson SR, 2015, VITAM HORM, V99, P91, DOI 10.1016/bs.vh.2015.05.003; Meyers EA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022244; Mezzano S, 2007, NEPHROL DIAL TRANSPL, V22, P1882, DOI 10.1093/ndt/gfm145; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Muchow Ryan D, 2010, Spine J, V10, pe1, DOI 10.1016/j.spinee.2010.06.020; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Okada M, 2009, CELL BIOCHEM FUNCT, V27, P526, DOI 10.1002/cbf.1615; Oxburgh L, 2005, DEV BIOL, V286, P637, DOI 10.1016/j.ydbio.2005.08.024; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rudnicki M, 2007, KIDNEY INT, V71, P325, DOI 10.1038/sj.ki.5002043; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Seth K, 2014, ACS MED CHEM LETT, V5, P512, DOI 10.1021/ml400500e; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soofi A, 2017, J BIOL CHEM, V292, P9051, DOI 10.1074/jbc.M116.771428; Soofi A, 2016, AM J PHYSIOL-GASTR L, V311, pG587, DOI 10.1152/ajpgi.00165.2016; Soofi A, 2013, J AM SOC NEPHROL, V24, P897, DOI 10.1681/ASN.2012070759; Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592; Taylor KR, 2014, CANCER RES, V74, P4565, DOI 10.1158/0008-5472.CAN-14-1298; Turk T, 2009, J HISTOCHEM CYTOCHEM, V57, P623, DOI 10.1369/jhc.2009.953224; Voelker J, 2017, J AM SOC NEPHROL, V28, P953, DOI 10.1681/ASN.2015111230; Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Williams E, 2018, BONE, V109, P251, DOI 10.1016/j.bone.2017.09.004; Xu B, 2011, DEVELOPMENT, V138, P925, DOI 10.1242/dev.062687; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	68	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3125	3136		10.1074/jbc.RA118.006817	http://dx.doi.org/10.1074/jbc.RA118.006817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30602563	Green Published, hybrid			2022-12-26	WOS:000464980100013
J	Song, DG; Kim, D; Jung, JW; Nam, SH; Kim, JE; Kim, HJ; Kim, JH; Lee, SJ; Pan, CH; Kim, S; Lee, JW				Song, Dae-Geun; Kim, Doyeun; Jung, Jae Woo; Nam, Seo Hee; Kim, Ji Eon; Kim, Hye-Jin; Kim, Jong Hyun; Lee, Seo-Jin; Pan, Cheol-Ho; Kim, Sunghoon; Lee, Jung Weon			Glutamyl-prolyl-tRNA synthetase induces fibrotic extracellular matrix via both transcriptional and translational mechanisms	FASEB JOURNAL			English	Article						fibrotic animal model; hepatic stellate cells; prolyl-tRNA-synthetase; signal transduction; STAT6	HEPATIC-FIBROSIS; GENE-EXPRESSION; STELLATE CELLS; TGF-BETA; HALOFUGINONE; FEBRIFUGINE; PROTEIN; LIVER; BINDING; MOUSE	Fibrosis is characterized by the increased accumulation of extracellular matrix (ECM), which drives abnormal cell proliferation and progressive organ dysfunction in many inflammatory and metabolic diseases. Studies have shown that halofuginone, a racemic halogenated derivative, inhibits glutamyl-prolyl-transfer RNA-synthetase (EPRS)-mediated fibrosis. However, the mechanism by which this occurs is unclear. We explored the mechanistic aspects of how EPRS could develop liver fibrotic phenotypes in cells and animal models. Treatment with TGF-1 up-regulated fibronectin and collagen I levels in LX2 hepatic stellate cells. This effect was inhibited in prolyl-transfer RNA synthetase (PRS)-suppressed LX2 cells. Using the promoter luciferase assay, TGF-1-mediated collagen I, 1 chain transcription and 2 basal laminin transcription in LX2 cells were down-regulated by EPRS suppression, suggesting that EPRS may play roles in ECM production at transcriptional levels. Furthermore, signal transducer and activator of transcription (STAT) signaling activation was involved in the effects of TGF-1 on ECM expression in a PRS-dependent manner. This was mediated via a protein-protein complex formation consisting of TGF-1 receptor, EPRS, Janus kinases, and STAT6. Additionally, ECM expression in fibrotic livers overlapped with EPRS expression along fibrotic septa regions and was positively correlated with STAT6 activation in carbon tetrachloride-treated mice. This was less obvious in livers of Eprs(-/+) mice. These findings suggest that, during fibrosis development, EPRS plays roles in nontranslational processes of ECM expression via intracellular signaling regulation upon TGF-1 stimulation.Song, D.-G., Kim, D., Jung, J. W., Nam, S. H., Kim, J. E., Kim, H.-J., Kim, J. H., Lee, S.-J., Pan, C.-H., Kim, S., Lee, J. W. Glutamyl-prolyl-tRNA synthetase induces fibrotic extracellular matrix via both transcriptional and translational mechanisms.	[Song, Dae-Geun; Nam, Seo Hee; Kim, Ji Eon; Kim, Hye-Jin; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Dept Pharm, Seoul, South Korea; [Kim, Doyeun; Kim, Jong Hyun; Kim, Sunghoon; Lee, Jung Weon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Jung, Jae Woo; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Song, Dae-Geun; Pan, Cheol-Ho] KIST, Syst Biotechnol Res Ctr, Gangneung Si, South Korea; [Lee, Seo-Jin] Shingyeong Univ, Dept Life Sci & Biotechnol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST)	Lee, JW (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/F-9149-2012; Kim, Sunghoon/AAE-8314-2020	Lee, Jung Weon/0000-0003-2722-8200	Korea Institute of Science and Technology Gangneung Institute Intramural Research Grant [2Z05310]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - (Ministry of Science); Information and Communications Technology (ICT) and Future Planning Grants [NRF-2018M3A9C8020027, NRF-2017R1A2B3005015]; Tumor Microenvironment Global Core Research Center (GCRC) Grant [2011-0030001]; Medicinal Bioconvergence Research Center Grant [NRF-2013M3A6A4044019]	Korea Institute of Science and Technology Gangneung Institute Intramural Research Grant; Basic Science Research Program through the National Research Foundation of Korea (NRF) - (Ministry of Science); Information and Communications Technology (ICT) and Future Planning Grants; Tumor Microenvironment Global Core Research Center (GCRC) Grant; Medicinal Bioconvergence Research Center Grant	The authors thank Dr. Myung Hee Kim (Korea Research Institute of Bioscience and Biotechnology) for EPRS constructs, Dr. Scott Friedman (Ichan School of Medicine, Mount Sinai, New York, NY, USA) for LX2 cells, and Dr. Jin Ho Chung (Seoul National University) for HFFs. This work was supported by Korea Institute of Science and Technology Gangneung Institute Intramural Research Grant 2Z05310 (to C.-H.P. and D.-G.S.); Basic Science Research Program through the National Research Foundation of Korea (NRF) (funded by the Ministry of Science); Information and Communications Technology (ICT) and Future Planning Grants NRF-2018M3A9C8020027 and NRF-2017R1A2B3005015; Tumor Microenvironment Global Core Research Center (GCRC) Grant 2011-0030001; and Medicinal Bioconvergence Research Center Grant NRF-2013M3A6A4044019 (to J.W.L.). The authors declare no conflicts of interest.	Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; Delgoffe Greg M, 2013, JAKSTAT, V2, pe23060, DOI 10.4161/jkst.23060; Ghosh AK, 2013, EXP BIOL MED, V238, P461, DOI 10.1177/1535370213489441; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner OA, 2014, CLIN CHIM ACTA, V433, P111, DOI 10.1016/j.cca.2014.02.021; Halevy O, 1996, BIOCHEM PHARMACOL, V52, P1057, DOI 10.1016/0006-2952(96)00427-3; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Huang Y, 2017, EXP CELL RES, V352, P420, DOI 10.1016/j.yexcr.2017.02.038; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Jiang SP, 2005, ANTIMICROB AGENTS CH, V49, P1169, DOI 10.1128/AAC.49.3.1169-1176.2005; KAISER E, 1994, GENOMICS, V19, P280, DOI 10.1006/geno.1994.1059; Karsdal MA, 2015, AM J PHYSIOL-GASTR L, V308, pG807, DOI 10.1152/ajpgi.00447.2014; Katayama M, 2010, INTENS CARE MED, V36, P479, DOI 10.1007/s00134-009-1719-6; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kim HJ, 2017, FASEB J, V31, P1461, DOI 10.1096/fj.201600944RR; Kiyokawa H, 2017, CANCER SCI, V108, P1432, DOI 10.1111/cas.13261; Lareu RR, 2007, FEBS LETT, V581, P2709, DOI 10.1016/j.febslet.2007.05.020; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Li XY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00855; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo Y, 2017, J LEUKOCYTE BIOL, V102, P1333, DOI 10.1189/jlb.3RU0417-148RR; Luzina IG, 2015, CYTOKINE, V74, P88, DOI 10.1016/j.cyto.2014.11.008; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; McLaughlin NP, 2014, BIOORGAN MED CHEM, V22, P1993, DOI 10.1016/j.bmc.2014.02.040; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pines M, 2015, MOLECULES, V20, P573, DOI 10.3390/molecules20010573; Roffe S, 2010, EXP CELL RES, V316, P1061, DOI 10.1016/j.yexcr.2010.01.003; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Tag Carmen G, 2015, J Vis Exp, DOI 10.3791/52438; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Tu T, 2015, J GASTROEN HEPATOL, V30, P1696, DOI 10.1111/jgh.13065; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Zhang YE, 2018, CURR OPIN CELL BIOL, V51, P1, DOI 10.1016/j.ceb.2017.10.001; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	38	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4341	4354		10.1096/fj.201801344RR	http://dx.doi.org/10.1096/fj.201801344RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30592630	Bronze			2022-12-26	WOS:000459794800099
J	Kosmyna, N; Lecuyer, A				Kosmyna, Nataliya; Lecuyer, Anatole			A conceptual space for EEG-based brain-computer interfaces	PLOS ONE			English	Article							HYBRID BCI SYSTEM; VIRTUAL-REALITY; EYE TRACKING; COMMUNICATION; REHABILITATION; PERFORMANCE; ALGORITHMS; SSVEP; P300	Brain-Computer Interfaces (BCIs) have become more and more popular these last years. Researchers use this technology for several types of applications, including attention and workload measures but also for the direct control of objects by the means of BCIs. In this work we present a first, multidimensional feature space for EEG-based BCI applications to help practitioners to characterize, compare and design systems, which use EEG-based BCIs. Our feature space contains 4 axes and 9 sub-axes and consists of 41 options in total as well as their different combinations. We presented the axes of our feature space and we positioned our feature space regarding the existing BCI and HCI taxonomies and we showed how our work integrates the past works, and/or complements them.	[Kosmyna, Nataliya] MIT, Media Lab, Cambridge, MA 02139 USA; [Lecuyer, Anatole] Inria Rennes, Rennes, France	Massachusetts Institute of Technology (MIT)	Kosmyna, N (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	nkosmyna@media.mit.edu		Kosmyna, Nataliya/0000-0003-1272-0470				Afergan D, 2014, P ADJ PUBL 27 ANN AC, P13, DOI [10.1145/2658779.2661166, DOI 10.1145/2658779.2661166]; Afergan D, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P3797, DOI 10.1145/2556288.2557230; Amiri S, 2013, BRAIN-COMPUTER INTERFACE SYSTEMS - RECENT PROGRESS AND FUTURE PROSPECTS, P195, DOI 10.5772/56135; Andujar M., 2013, P CHI 13 HUM FACT CO, P703; Ang KK, 2015, CLIN EEG NEUROSCI, V46, P310, DOI 10.1177/1550059414522229; Aslin RN, 2015, ANNU REV PSYCHOL, V66, P349, DOI 10.1146/annurev-psych-010213-115108; Bayliss JD, 2004, CYBERPSYCHOL BEHAV, V7, P694, DOI 10.1089/cpb.2004.7.694; Bayliss JD, 2003, IEEE T NEUR SYS REH, V11, P113, DOI 10.1109/TNSRE.2003.814438; Bayliss JD, 2000, IEEE T REHABIL ENG, V8, P188, DOI 10.1109/86.847811; Beaudouin-Lafon M., 2000, CHI 2000 Conference Proceedings. Conference on Human Factors in Computing Systems. CHI 2000. The Future is Here, P446, DOI 10.1145/332040.332473; Bell CJ, 2008, J NEURAL ENG, V5, P214, DOI 10.1088/1741-2560/5/2/012; Birbaumer N, 2003, IEEE T NEUR SYS REH, V11, P120, DOI 10.1109/TNSRE.2003.814439; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Blankertz B., 2002, ADV NEURAL INFORM; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Buccino AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146610; Calvary G., 2001, TACIT WORKSH CONT FU; Carabalona R., 2010, P 4 INT CONV REH ENG, P7; Vi CT, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P3787, DOI 10.1145/2556288.2557015; Cho BH, 2002, P IEEE VIRT REAL ANN, P156, DOI 10.1109/VR.2002.996518; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Cohen R. A., 2011, BRAIN IMAGING BEHAV, VXVI; Edlinger G, 2011, LECT NOTES COMPUT SC, V6762, P417; Edlinger G, 2009, LECT NOTES ARTIF INT, V5638, P732, DOI 10.1007/978-3-642-02812-0_83; Eskandari P, 2008, IEEE ENG MED BIO, P662, DOI 10.1109/IEMBS.2008.4649239; Evain E A., 2016, BRAIN COMPUTER INTER; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Foley J. D., 1990, Human-computer interaction, selected readings, P67; Fomina T, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/066021; Frey J, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P2283, DOI 10.1145/2858036.2858525; Fruitet J., 2011, INT J BIOELECTROMAGN, V13, P70; Grosse-Wentrup M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056015; Grosse-Wentrup M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025004; Gurkok H., 2011, P 13 INT C MULT INT, P41; Hjelm S. I., 2000, P 1 NORD C HUM COMP, P59; Iturrate I, 2010, IEEE ENG MED BIO, P4181, DOI 10.1109/IEMBS.2010.5627380; Kayagil T, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P1542, DOI 10.1109/ICCME.2007.4382005; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Kos'myna N, 2013, IEEE T COMP INTEL AI, V5, P150, DOI 10.1109/TCIAIG.2012.2230003; Kos'myna Nataliya, 2014, CHI 14 HUM FACT COMP, P479, DOI [10.1145/2559206.2574820, DOI 10.1145/2559206.2574820]; Kosmyna N, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00396; Kosmyna N, 2015, ACM T COMPUT-HUM INT, V22, DOI 10.1145/2808228; Kosmyna N, 2015, LECT NOTES COMPUT SC, V9296, P506, DOI 10.1007/978-3-319-22701-6_37; Koyama S, 2010, J COMPUT NEUROSCI, V29, P73, DOI 10.1007/s10827-009-0196-9; Krepki R, 2007, MULTIMED TOOLS APPL, V33, P73, DOI 10.1007/s11042-006-0094-3; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Lalor E., 2004, BIOMED TECH, V49, P63; Lecuyer A, 2008, COMPUTER, V41, P66, DOI 10.1109/MC.2008.410; Lee EC, 2010, J NEUROSCI METH, V190, P289, DOI 10.1016/j.jneumeth.2010.05.008; Lee JS, 2006, INT OFFSHORE POLAR E, P81, DOI 10.1145/1166253.1166268; Leeb R, 2004, P ANN INT IEEE EMBS, V26, P4503; Leeb R., 2004, 9 COMP VIS WINT WORK, P99; Leeb R., 2005, P 8 ANN INT WORKSH P, P25; Leeb R, 2013, IEEE T COMP INTEL AI, V5, P117, DOI 10.1109/TCIAIG.2013.2242072; Li YQ, 2013, IEEE T BIO-MED ENG, V60, P3156, DOI 10.1109/TBME.2013.2270283; Li YQ, 2010, IEEE ENG MED BIO, P4205, DOI 10.1109/IEMBS.2010.5627394; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F., 2018, J NEURAL ENG; Lotte F, 2008, 4 INT BRAIN COMP INT, P373; Lotte F, 2010, PRESENCE-VIRTUAL AUG, V19, P54, DOI 10.1162/pres.19.1.54; Mano M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00140; Marchesi M., 2013, CHI 13 HUM FACT COMP, P3091, DOI [DOI 10.1145/2468356.2479618, 10.1145/2468356.2479618]; Martinez P., 2007, COMPUT INTEL NEUROSC, V2007, P13, DOI DOI 10.1155/2007/94561; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Mercep Ljubo, 2013, IEEE EUROCON 2013, P1753, DOI 10.1109/EUROCON.2013.6625214; Mercier-Ganady J., 2013, P ACM S VIRT REAL SO, P69; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Miranda E, 2005, PLYMOUTH BRAIN COMPU; Moore MT, 2004, SOC NEUR SAN DIEG CA; Morone G, 2015, ARCH PHYS MED REHAB, V96, pS71, DOI 10.1016/j.apmr.2014.05.026; Muhl C, 2010, J MULTIMODAL USER IN, V4, P11, DOI 10.1007/s12193-010-0046-0; Murphy B., 2010, P NAACL HLT 2010 1 W, P36; Nijholt A, 2010, HUM-COMPUT INT-SPRIN, P1, DOI 10.1007/978-1-84996-272-8; Nijholt A, 2008, IEEE INTELL SYST, V23, P72, DOI 10.1109/MIS.2008.41; Nijholt A, 2009, L N INST COMP SCI SO, V9, P153; Nooh A. A., 2011, P INT C BIOM ENG TEC, V11, P55; Norman D, 1986, USER CTR SYSTEM DESI; Peck Evan M M, 2013, P SIGCHI C HUM FACT, P473, DOI [10.1145/2470654.2470723, DOI 10.1145/2470654.2470723]; Perronnet L, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00193; Pfurtscheller J, 2005, UNFALLCHIRURG, V108, P587, DOI 10.1007/s00113-004-0876-x; Pike M, 2014, 32ND ANNUAL ACM CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2014), P3807, DOI 10.1145/2556288.2556974; Pineda JA, 2003, IEEE T NEUR SYS REH, V11, P181, DOI 10.1109/TNSRE.2003.814445; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Ruiz S, 2014, BIOL PSYCHOL, V95, P4, DOI 10.1016/j.biopsycho.2013.04.010; Scherer Reinhold, 2007, Comput Intell Neurosci, P79826, DOI 10.1155/2007/79826; Schmidt E., 2007, P 4 INT DRIV S HUM F, P138; Shenoy P, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P845; Shin J, 2018, PLOS ONE; Simoens P., 2014, P 5 INT WORKSH MOB C, P29, DOI [10.1145/2609908.2609945, DOI 10.1145/2609908.2609945]; Solovey E, 2012, P SIGCHI C HUM FACT, P2193, DOI DOI 10.1145/2207676.2208372; Solovey ET, 2015, ACM T COMPUT-HUM INT, V21, DOI 10.1145/2687926; Su Y, 2011, J ZHEJIANG U-SCI C, V12, P351, DOI 10.1631/jzus.C1000208; Szafir D., 2012, P ACM ANN C HUMAN FA, P11, DOI DOI 10.1145/2207676.2207679; Tangermann M.W., 2008, P 21 INT C NEUR INF, P1641; Teplan M., 2002, MEASUREMENT SCI REV, V2, P1, DOI DOI 10.1021/PR070350L; Thomas E, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/031001; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Vaughan TM, 2001, SOC NEUR ABSTR, V26; Wei CS, 2013, I IEEE EMBS C NEUR E, P57, DOI 10.1109/NER.2013.6695870; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yuksel BF, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P5372, DOI 10.1145/2858036.2858388; Yuksel BF, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P855; Zander T., 2010, ENHANCING HUMAN COMP; Zhao QB, 2009, CHINESE SCI BULL, V54, P78, DOI 10.1007/s11434-008-0547-3	108	18	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0210145	10.1371/journal.pone.0210145	http://dx.doi.org/10.1371/journal.pone.0210145			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605482	Green Published, gold, Green Submitted			2022-12-26	WOS:000454759900028
J	Griffiths, SA; Cox, RJ; Overdijk, EJR; Mesarich, CH; Saccomanno, B; Lazarus, CM; de Wit, PJGM; Collemare, J				Griffiths, Scott A.; Cox, Russell J.; Overdijk, Elysa J. R.; Mesarich, Carl H.; Saccomanno, Benedetta; Lazarus, Colin M.; de Wit, Pierre J. G. M.; Collemare, Jerome			Assignment of a dubious gene cluster to melanin biosynthesis in the tomato fungal pathogen Cladosporium fulvum	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENE; HETEROLOGOUS EXPRESSION; ELSINOCHROME PHYTOTOXIN; ASPERGILLUS-FUMIGATUS; AVIRULENCE GENE; PATHWAY; MELANIZATION; VIRULENCE; EVOLUTION; IDENTIFICATION	Pigments and phytotoxins are crucial for the survival and spread of plant pathogenic fungi. The genome of the tomato biotrophic fungal pathogen Cladosporium fulvum contains a predicted gene cluster (CfPKS1, CfPRF1, CfRDT1 and CfTSF1) that is syntenic with the characterized elsinochrome toxin gene cluster in the citrus pathogen Elsinoe fawcettii. However, a previous phylogenetic analysis suggested that CfPks1 might instead be involved in pigment production. Here, we report the characterization of the CfPKS1 gene cluster to resolve this ambiguity. Activation of the regulator CfTSF1 specifically induced the expression of CfPKS1 and CfRDT1, but not of CfPRF1. These co-regulated genes that define the CfPKS1 gene cluster are orthologous to genes involved in 1,3-dihydroxynaphthalene (DHN) melanin biosynthesis in other fungi. Heterologous expression of CfPKS1 in Aspergillus oryzae yielded 1,3,6,8-tetrahydroxynaphthalene, a typical precursor of DHN melanin. Delta cfpks1 deletion mutants showed similar altered pigmentation to wild type treated with DHN melanin inhibitors. These mutants remained virulent on tomato, showing this gene cluster is not involved in pathogenicity. Altogether, our results showed that the CfPKS1 gene cluster is involved in the production of DHN melanin and suggests that elsinochrome production in E. fawcettii likely involves another gene cluster.	[Griffiths, Scott A.; Collemare, Jerome] Westerdijk Fungal Biodivers Inst, Fungal Nat Prod, Utrecht, Netherlands; [Griffiths, Scott A.; Overdijk, Elysa J. R.; Mesarich, Carl H.; Saccomanno, Benedetta; de Wit, Pierre J. G. M.; Collemare, Jerome] Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands; [Cox, Russell J.] Leibniz Univ Hannover, Inst Organ Chem, Hannover, Germany; [Overdijk, Elysa J. R.] Wageningen Univ, Cell Biol Lab, Wageningen, Netherlands; [Lazarus, Colin M.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Mesarich, Carl H.] Massey Univ, Inst Agr & Environm, Lab Mol Plant Pathol, Palmerston North, New Zealand	Wageningen University & Research; Leibniz University Hannover; Wageningen University & Research; University of Bristol; Massey University	Collemare, J (corresponding author), Westerdijk Fungal Biodivers Inst, Fungal Nat Prod, Utrecht, Netherlands.; Collemare, J (corresponding author), Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands.	j.collemare@westerdijkinstitute.nl	de Wit, Pierre J. G.M./CAI-9966-2022; Cox, Russell John/F-9190-2015; Mesarich, Carl H/E-4304-2015	Cox, Russell John/0000-0002-1844-0157; Mesarich, Carl H/0000-0002-5207-4074; Saccomanno, Benedetta/0000-0002-4091-1015; Collemare, Jerome/0000-0001-8152-6642	Royal Netherlands Academy of Sciences; DFG [INST 187/621-1]	Royal Netherlands Academy of Sciences; DFG(German Research Foundation (DFG))	SAG, JC, CHM, and PJGMdW were financially supported by a grant from the Royal Netherlands Academy of Sciences. RJC thanks DFG for LCMS equipment (INST 187/621-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SAG, JC, CHM, and PJGMdW were financially supported by a grant from the Royal Netherlands Academy of Sciences. RJC thanks DFG for LCMS equipment (INST 187/621-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beltran-Garcia MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091616; Bergmann S, 2010, APPL ENVIRON MICROB, V76, P8143, DOI 10.1128/AEM.00683-10; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen HF, 2016, BIOORGAN MED CHEM, V24, P1225, DOI 10.1016/j.bmc.2016.01.053; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chen ZJ, 2004, MYCOLOGIA, V96, P1199, DOI 10.2307/3762135; Chiang YM, 2011, FUNGAL GENET BIOL, V48, P430, DOI 10.1016/j.fgb.2010.12.001; Chooi YH, 2017, ENVIRON MICROBIOL, V19, P1975, DOI 10.1111/1462-2920.13711; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; Chung KR, 2008, MICROBIOL-SGM, V154, P3556, DOI 10.1099/mic.0.2008/019414-0; Collemare J, 2011, EFFECTORS PLANT MICR, P377, DOI DOI 10.1002/9781119949138.CH15; Collemare J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085877; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Daub ME, 2005, FEMS MICROBIOL LETT, V252, P197, DOI 10.1016/j.femsle.2005.08.033; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Fan R, 2017, FUNGAL GENET BIOL, V98, P1, DOI 10.1016/j.fgb.2016.11.003; Feng B, 2001, INFECT IMMUN, V69, P1781, DOI 10.1128/IAI.69.3.1781-1794.2001; Fetzner R, 2014, MICROBIOL-SGM, V160, P1845, DOI 10.1099/mic.0.079046-0; Fujii I, 1999, BIOSCI BIOTECH BIOCH, V63, P1445, DOI 10.1271/bbb.63.1445; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Gachomo EW, 2010, MOL BIOL REP, V37, P3583, DOI 10.1007/s11033-010-0007-4; Griffiths S, 2018, MOL PLANT PATHOL, V19, P369, DOI 10.1111/mpp.12527; Griffiths S, 2016, P NATL ACAD SCI USA, V113, P6851, DOI 10.1073/pnas.1603528113; Griffiths S, 2015, FUNGAL GENET BIOL, V84, P52, DOI 10.1016/j.fgb.2015.09.009; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KIMURA N, 1993, J BACTERIOL, V175, P4427, DOI 10.1128/JB.175.14.4427-4435.1993; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Lee JK, 2003, APPL ENVIRON MICROB, V69, P3427, DOI 10.1128/AEM.69.6.3427-3434.2003; Liao HL, 2008, MOL PLANT MICROBE IN, V21, P469, DOI 10.1094/MPMI-21-4-0469; Lin SY, 2012, MOL PLANT MICROBE IN, V25, P1552, DOI 10.1094/MPMI-05-12-0131-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehrabi R, 2015, FUNGAL GENET BIOL, V79, P186, DOI 10.1016/j.fgb.2015.03.016; Mesarich CH, 2014, MOL PLANT MICROBE IN, V27, P846, DOI 10.1094/MPMI-02-14-0050-R; Newman AG, 2016, J AM CHEM SOC, V138, P4219, DOI 10.1021/jacs.6b00633; Okmen B, 2014, MOL MICROBIOL, V92, P10, DOI 10.1111/mmi.12535; Okmen B, 2013, NEW PHYTOL, V198, P1203, DOI 10.1111/nph.12208; Ozturk IK, 2017, FUNGAL GENET BIOL, V106, P42, DOI 10.1016/j.fgb.2017.07.001; Pahirulzaman KAK, 2012, METHOD ENZYMOL, V517, P241, DOI 10.1016/B978-0-12-404634-4.00012-7; Riquelme M, 2013, ANNU REV MICROBIOL, V67, P587, DOI 10.1146/annurev-micro-092412-155652; Saitoh Y, 2010, MYCOSCIENCE, V51, P327, DOI 10.1007/s10267-010-0043-x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schumacher J, 2016, MOL MICROBIOL, V99, P729, DOI 10.1111/mmi.13262; So KK, 2015, MOL CELLS, V38, P1105, DOI 10.14348/molcells.2015.0208; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Sugareva V, 2006, ARCH MICROBIOL, V186, P345, DOI 10.1007/s00203-006-0144-2; TAKANO Y, 1995, MOL GEN GENET, V249, P162, DOI 10.1007/BF00290362; Teichert I, 2011, MYCOTA, V14, P231; Thompson JE, 2000, J BIOL CHEM, V275, P34867, DOI 10.1074/jbc.M006659200; Throckmorton K, 2015, TOXINS, V7, P3572, DOI 10.3390/toxins7093572; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 2001, J BIOL CHEM, V276, P29292, DOI 10.1074/jbc.M101998200; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Upadhyay S, 2016, CELL REP, V14, P2511, DOI 10.1016/j.celrep.2016.02.059; Vagstad AL, 2012, CHEM BIOL, V19, P1525, DOI 10.1016/j.chembiol.2012.10.002; VANDENACKERVEKEN GFJM, 1994, MOL GEN GENET, V243, P277, DOI 10.1007/BF00301063; Watanabe A, 2000, FEMS MICROBIOL LETT, V192, P39, DOI 10.1111/j.1574-6968.2000.tb09356.x; Watanabe A, 2004, CHEM BIOL, V11, P1101, DOI 10.1016/j.chembiol.2004.05.015; Wheeler MH, 2008, EUKARYOT CELL, V7, P1699, DOI 10.1128/EC.00179-08; WOLOSHUK CP, 1983, PHYSIOL PLANT PATHOL, V22, P245; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x; Zhang P, 2017, MOL MICROBIOL, V105, P469, DOI 10.1111/mmi.13711	69	11	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209600	10.1371/journal.pone.0209600	http://dx.doi.org/10.1371/journal.pone.0209600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596695	gold, Green Submitted, Green Published			2022-12-26	WOS:000454627200063
J	Kosoku, A; Uchida, J; Nishide, S; Kabei, K; Shimada, H; Iwai, T; Kuwabara, N; Maeda, K; Naganuma, T; Kumada, N; Takemoto, Y; Ishihara, T; Shintani, A; Nakatani, T				Kosoku, Akihiro; Uchida, Junji; Nishide, Shunji; Kabei, Kazuya; Shimada, Hisao; Iwai, Tomoaki; Kuwabara, Nobuyuki; Maeda, Keiko; Naganuma, Toshihide; Kumada, Norihiko; Takemoto, Yoshiaki; Ishihara, Takuma; Shintani, Ayumi; Nakatani, Tatsuya			ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan	PLOS ONE			English	Article							DOUBLE-BLIND; OUTCOMES; RECIPIENTS; RITUXIMAB; DESENSITIZATION; COMPLICATIONS; INDUCTION; DIALYSIS; EFFICACY; SPOUSAL	Introduction Living donor kidney transplantation is preferable to deceased donor transplantation due to its superior long-term patient and graft survivals. However, ABO blood group incompatibility is a major barrier to living donor kidney transplantation. ABO-incompatible kidney transplantation has been performed in Japan since the late 1980's, but it is still globally uncommon. The objective of this study is to compare the clinical outcomes of ABO-incompatible kidney transplantation (ABO-IKT) with that of ABO-compatible kidney transplantation (ABO-CKT) at an institution where only about two kidney transplants are performed a month on average. Design A single center propensity score-matched cohort study. Patients and methods We retrospectively collected and analyzed the data of 240 patients with end-stage kidney disease (ESKD) who underwent living donor kidney transplantation at Osaka City University Hospital from January 1999 to December 2016, of which 66 patients were ABO-IKT. The remaining 174 patients who underwent ABO-CKT were studied as the control group, and the clinical outcomes of ABO-IKT and ABO-CKT recipients were compared based on propensity score matching. Results After propensity score matching, there were no significant differences in both patient survival and death-censored graft survival rates between the ABO-IKT and ABO-CKT groups. Moreover, there were no significant differences in estimated glomerular filtration rate as well as frequency of acute cellular rejection, antibody-mediated rejection, infectious adverse events, malignancies, and post-operative bleeding between the two groups. Conclusion Currently, ABO-IKT may be an acceptable treatment for patients with ESKD even at a low-volume transplant center.	[Kosoku, Akihiro; Uchida, Junji; Nishide, Shunji; Kabei, Kazuya; Shimada, Hisao; Iwai, Tomoaki; Kuwabara, Nobuyuki; Naganuma, Toshihide; Takemoto, Yoshiaki; Nakatani, Tatsuya] Osaka City Univ, Grad Sch Med, Dept Urol, Osaka, Japan; [Maeda, Keiko] Osaka City Univ Hosp, Dept Nursing, Osaka, Japan; [Kumada, Norihiko] Suita Municipal Hosp, Dept Urol, Suita, Osaka, Japan; [Ishihara, Takuma] Gifu Univ Hosp, Innovat & Clin Res Promot Ctr, Gifu, Japan; [Shintani, Ayumi] Osaka City Univ, Grad Sch Med, Dept Med Stat, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Gifu University; Osaka Metropolitan University	Uchida, J (corresponding author), Osaka City Univ, Grad Sch Med, Dept Urol, Osaka, Japan.	m9492120@msic.med.osaka-cu.ac.jp		Iwai, Tomoaki/0000-0003-2021-0673; Kosoku, Akihiro/0000-0003-0245-2994; Uchida, Junji/0000-0002-0113-8058				Baek CH, 2012, NEPHRON EXTRA, V2, P66, DOI 10.1159/000337339; Barnett ANR, 2014, TRANSPL INT, V27, P187, DOI 10.1111/tri.12234; Chow KV, 2017, TRANSPLANTATION, V101, P1433, DOI 10.1097/TP.0000000000001415; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Ferrari P, 2015, NEPHROL DIAL TRANSPL, V30, P1276, DOI 10.1093/ndt/gfu309; Goldfarb-Rumyantzev A, 2005, NEPHROL DIAL TRANSPL, V20, P167, DOI 10.1093/ndt/gfh541; Haas M, 2006, AM J TRANSPLANT, V6, P1829, DOI 10.1111/j.1600-6143.2006.01356.x; Habicht A, 2011, NEPHROL DIAL TRANSPL, V26, P4124, DOI 10.1093/ndt/gfr215; Hadaya K, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14083; Hart A, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14124; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Krishnan N, 2015, AM J TRANSPLANT, V15, P1728, DOI 10.1111/ajt.13255; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Lentine KL, 2014, TRANSPLANTATION, V98, P54, DOI 10.1097/TP.0000000000000029; Li H, 2014, TRANSPLANTATION, V98, P300, DOI 10.1097/TP.0000000000000054; Masterson R, 2014, AM J TRANSPLANT, V14, P2807, DOI 10.1111/ajt.12920; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Montgomery RA, 2011, CURR OPIN ORGAN TRAN, V16, P439, DOI 10.1097/MOT.0b013e32834897c1; Montgomery RA, 2009, TRANSPLANTATION, V87, P1246, DOI 10.1097/TP.0b013e31819f2024; Ogasawara K, 1998, VOX SANG, V74, P242, DOI 10.1159/000030942; Okumi M, 2016, AM J TRANSPLANT, V16, P886, DOI 10.1111/ajt.13502; Opelz G, 2015, TRANSPLANTATION, V99, P400, DOI 10.1097/TP.0000000000000312; Sautenet B, 2016, TRANSPLANTATION, V100, P391, DOI 10.1097/TP.0000000000000958; Takahashi K, 2006, XENOTRANSPLANTATION, V13, P118, DOI 10.1111/j.1399-3089.2006.00278.x; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; TAKAHASHI K, 1991, TRANSPLANT P, V23, P1078; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Tyden G, 2009, TRANSPLANTATION, V87, P1325, DOI 10.1097/TP.0b013e3181a235fd; Uchida J, 2008, TRANSPL P, V40, P2285, DOI 10.1016/j.transproceed.2008.06.018; Uchida J, 2012, TRANSPL P, V44, P204, DOI 10.1016/j.transproceed.2011.11.006; Uchida J, 2010, TRANSPL P, V42, P3998, DOI 10.1016/j.transproceed.2010.09.043; Uchida J, 2016, UROL INT, V97, P457, DOI 10.1159/000449014; Uchida J, 2014, CLIN TRANSPLANT, V28, P80, DOI 10.1111/ctr.12281; Uchida J, 2012, INT UROL NEPHROL, V44, P1563, DOI 10.1007/s11255-012-0231-z; Uchida J, 2011, UROL INT, V86, P307, DOI 10.1159/000324103; van den Hoogen MWF, 2015, AM J TRANSPLANT, V15, P407, DOI 10.1111/ajt.13052; Wallis CB, 2011, NEPHROL DIAL TRANSPL, V26, P2091, DOI 10.1093/ndt/gfr155; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Woodle ES, 2010, AM J TRANSPLANT, V10, P1460, DOI 10.1111/j.1600-6143.2010.03136.x; Yagisawa T., 2016, RENAL REPLACE THER, V2, P68, DOI [10.1186/s41100-016-0080-9, DOI 10.1186/S41100-016-0080-9]	42	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0208638	10.1371/journal.pone.0208638	http://dx.doi.org/10.1371/journal.pone.0208638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596663	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200018
J	Moon, H; Choi, YJ; Sim, SH				Moon, Hae; Choi, Young Ju; Sim, Sung Hoon			Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?	PLOS ONE			English	Article							ORAL ANTIBIOTICS; FEVER; MASCC	Advances in oncology have enabled physicians to treat low-risk febrile neutropenia (FN) in outpatient settings. This study was aimed to explore the usefulness of the CISNE model and identify better triage in the emergency setting. This is a retrospective cohort study on 400 adult FN patients presenting to the Emergency Department of National Cancer Center, Korea from January 2010 to December 2016. All had been treated with cytotoxic chemotherapy for solid tumors in the previous 30 days. The primary outcome was the frequency of any serious complications during the duration of illness. Apparently stable patients numbered 299 (74.8%) of 400, and the remainder comprised clinically unstable patients. The stable patients fell into three cohorts according to the risk scores: CISNE I (low risk), 56 patients (18.7%); CISNE II (intermediate), 124 (41.5%) and CISNE III (high), 119 (39.8%). The primary outcome occurred in 10.7%, 19.4% and 33.6%, respectively, according to the cohort. Compared with the Multinational Association of Supportive Care in Cancer Risk Index Score (MASCC RIS), CISNE I stratum had significantly lower sensitivity (0.22 vs. 0.95 of MASCC low risk) but higher specificity (0.91 vs. 0.17) to predict zero occurrence of the primary outcome. The CISNE model was useful for identifying low-risk FN patients for outpatient treatment. The combination of the CISNE and MASCC RIS may help emergency physicians cope with FN more confidently.	[Moon, Hae] Natl Canc Ctr, Dept Internal Med, Goyang, Gyeonggi Do, South Korea; [Choi, Young Ju] Natl Canc Ctr, Infect Dis Clin, Goyang, Gyeonggi Do, South Korea; [Sim, Sung Hoon] Natl Canc Ctr, Ctr Breast Canc, Goyang, Gyeonggi Do, South Korea; [Sim, Sung Hoon] Natl Canc Ctr, Res Inst, Div Canc Biol, Translat Canc Res Branch, Goyang, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Sim, SH (corresponding author), Natl Canc Ctr, Ctr Breast Canc, Goyang, Gyeonggi Do, South Korea.; Sim, SH (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Biol, Translat Canc Res Branch, Goyang, Gyeonggi Do, South Korea.	cantusprote@gmail.com		Sim, Sung Hoon/0000-0002-1503-1075	National Cancer Center, Goyang, Korea [1710322-1, 1810301-1]	National Cancer Center, Goyang, Korea	The grant was raised by S.H.S. This work was supported by research grants (No. 1710322-1 and 1810301-1) from the National Cancer Center, Goyang, Korea (http://www.ncc.re.kr/indexEn.ncc).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2018, SUPPORT CARE CANCER, V26, P1465, DOI 10.1007/s00520-017-3985-0; Bitar Roger A, 2015, Perm J, V19, P37, DOI 10.7812/TPP/14-188; Carmona-Bayonas A, 2011, BRIT J CANCER, V105, P612, DOI 10.1038/bjc.2011.284; Carmona-Bayonas A, 2015, J CLIN ONCOL, V33, P465, DOI 10.1200/JCO.2014.57.2347; Chamilos G, 2005, CANCER-AM CANCER SOC, V103, P2629, DOI 10.1002/cncr.21089; Coyne CJ, 2017, ANN EMERG MED, V69, P755, DOI 10.1016/j.annemergmed.2016.11.007; Escalante CP, 2004, SUPPORT CARE CANCER, V12, P657, DOI 10.1007/s00520-004-0613-6; GARDEMBASPAIN M, 1991, ANN ONCOL, V2, P485, DOI 10.1093/oxfordjournals.annonc.a057996; Innes H, 2008, SUPPORT CARE CANCER, V16, P485, DOI 10.1007/s00520-007-0334-8; Kawano Y, 2011, HYPERTENS RES, V34, P281, DOI 10.1038/hr.2010.241; Klastersky J, 2007, INT J ANTIMICROB AG, V30, pS51, DOI 10.1016/j.ijantimicag.2007.06.012; Klastersky J., 2016, WORLD J CLIN INFECT, V6, P37, DOI [10.5495/wjcid.v6.i3.37, DOI 10.5495/WJCID.V6.I3.37]; Klastersky J, 2006, J CLIN ONCOL, V24, P4129, DOI 10.1200/JCO.2005.03.9909; MALIK IA, 1994, CLIN INFECT DIS, V19, P522, DOI 10.1093/clinids/19.3.522; Papadimitris C, 1999, ONCOLOGY-BASEL, V57, P127, DOI 10.1159/000012019; Vidal L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003992.pub3	16	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210019	10.1371/journal.pone.0210019	http://dx.doi.org/10.1371/journal.pone.0210019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596803	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200125
J	Pattabiraman, V; Katz, LS; Chen, JC; McCullough, AE; Trees, E				Pattabiraman, Vaishnavi; Katz, Lee S.; Chen, Jessica C.; McCullough, Andre E.; Trees, Eija			Genome wide characterization of enterotoxigenic Escherichia coli serogroup O6 isolates from multiple outbreaks and sporadic infections from 1975-2016	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; DEVELOPING-COUNTRIES; TOPOISOMERASE-IV; DNA GYRASE; IDENTIFICATION; EPIDEMIOLOGY; MECHANISMS	Enterotoxigenic Escherichia coli (ETEC) are an important cause of diarrhea globally, particularly among children under the age of five in developing countries. ETEC O6 is the most common ETEC serogroup, yet the genome wide population structure of isolates of this serogroup is yet to be determined. In this study, we have characterized 40 ETEC O6 isolates collected between 1975-2016 by whole genome sequencing (WGS) and by phenotypic antimicrobial susceptibility testing. To determine the relatedness of isolates, we evaluated two methods-whole genome high-quality single nucleotide polymorphism (whole genome-hqSNP) and core genome SNP analyses using Lyve-SET and Parsnp respectively. All isolates were tested for antimicrobial susceptibility using a panel of 14 antibiotics. ResFinder 2.1 and a custom quinolone resistance determinants workflow were used for resistance determinant detection. VirulenceFinder 1.5 was used for prediction of the virulence genes. Thirty-seven isolates clustered into three major clades (I, II, III) by whole genome-hqSNP and core genome SNP analyses, while three isolates included in the whole genome-hqSNP analysis only did not cluster with clades I-III by both analyses and formed a distantly related outgroup, designated clade IV. Median number of pairwise whole genome-hqSNPs in clonal ETEC O6 outbreaks ranged from 0 to 5. Of the 40 isolates tested for antimicrobial susceptibility, 18 isolates were pansusceptible. Twenty-two isolates were resistant to at least one antibiotic, nine of which were multidrug resistant. Phenotypic antimicrobial resistance (AR) correlated with AR determinants in 22 isolates. Thirty-two isolates harbored both enterotoxin virulence genes while the remaining 8 isolates had only one of the two virulence genes. In summary, whole genome-hqSNP and core genome SNP analyses from this study revealed similar evolutionary relationships and an overall diversity of ETEC O6 isolates independent of time of isolation. Less than 5 pairwise hqSNPs between ETEC O6 isolates is circumstantially indicative of an outbreak cluster. Findings from this study will be a basis for quicker outbreak detection and control by efficient subtyping by WGS.	[Pattabiraman, Vaishnavi; Katz, Lee S.; Chen, Jessica C.; Trees, Eija] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [McCullough, Andre E.] IHRC Inc, Atlanta, GA USA; [Katz, Lee S.] Univ Georgia, Coll Agr & Environm Sci, Ctr Food Safety, Griffin, GA USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia	Pattabiraman, V (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	Vxe9@cdc.gov	Trees, Eija/AAY-7538-2020; Pattabiraman, Vaishnavi/K-1924-2019	Trees, Eija/0000-0001-6694-2445; Pattabiraman, Vaishnavi/0000-0002-0483-3814	Advanced Molecular Detection (AMD) Initiative at the Centers for Disease Control and Prevention	Advanced Molecular Detection (AMD) Initiative at the Centers for Disease Control and Prevention	This work was supported by the Advanced Molecular Detection (AMD) Initiative at the Centers for Disease Control and Prevention. The funder (IHRC Inc) provided support in the form of salaries for authors [Jessica C. Chen and Andre E. McCullough], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1986, EDWARD EWINGS IDENTI; Begum YA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157415; CDC, PULS STAND OP PROC I; CDC, ENT E COL 2014; CDC, 2018, NAT ANT RES MON SYST; CDC, LAB STAND OP PROC PU; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Ferreira JC, 2018, INFECT GENET EVOL, V60, P66, DOI 10.1016/j.meegid.2018.02.003; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Holmes A, 2015, J CLIN MICROBIOL, V53, P3565, DOI 10.1128/JCM.01066-15; Hooper DC, 2015, ANN NY ACAD SCI, V1354, P12, DOI 10.1111/nyas.12830; Institute CaLS, 2018, PERF STAND ANT SUS S; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Katz LS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00375; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kwon T, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0204-y; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lawrence Dale N., 2004, Curr Infect Dis Rep, V6, P115, DOI 10.1007/s11908-996-0007-7; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Medina AM, 2015, T ROY SOC TROP MED H, V109, P493, DOI 10.1093/trstmh/trv054; Mehla K, 2016, MOL BIOSYST, V12, P890, DOI 10.1039/c5mb00745c; Mitra A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120520; Nadon C, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.23.30544; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Pattabiraman V, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01274-14; PENG H, 1993, J BIOL CHEM, V268, P24481; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Sahl JW, 2015, MBIO, V6, DOI 10.1128/mBio.00501-15; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shin J, 2016, FOODBORNE PATHOG DIS, V13, P535, DOI 10.1089/fpd.2016.2147; Smith P, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.01311-17; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Tyson GH, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw009; von Mentzer A, 2014, NAT GENET, V46, P1321, DOI 10.1038/ng.3145; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Yu DS G, 2017, METHODS ECOLOGY EVOL, V8, P28; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	46	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0208735	10.1371/journal.pone.0208735	http://dx.doi.org/10.1371/journal.pone.0208735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596673	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200019
J	Peverill, RE; Donelan, L; Corben, LA; Delatycki, MB				Peverill, Roger E.; Donelan, Lesley; Corben, Louise A.; Delatycki, Martin B.			Differences in the determinants of right ventricular and regional left ventricular long-axis dysfunction in Friedreich ataxia	PLOS ONE			English	Article							REPEAT LENGTH; TISSUE; ECHOCARDIOGRAPHY; HYPERTROPHY; VELOCITIES; RECOMMENDATIONS; QUANTIFICATION; ASSOCIATION; AGE	Background Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative condition which also has effects on the heart. In 96% of affected individuals FRDA is due to homozygosity of a GAA repeat expansion in intron 1 of the frataxin (FXN) gene. The number of GAA repeats have been shown to relate to disease severity in FRDA, this thought to be via an inverse relationship of GAA repeat number and cellular frataxin levels. We investigated the effects of FRDA on regional long axis function of the left and right ventricles, and also the relationship of long axis systolic (s') and early diastolic (e') peak velocities with GAA repeat number on the shorter (GAA1) and longer FXN alleles (GAA2). Methods The study group of 78 adult subjects (age 32 +/- 9 years) with FRDA and normal left ventricular (LV) ejection fraction were compared to 54 healthy control subjects of similar age, sex and body size. Tissue Doppler imaging (TDI) signals were recorded at the mitral annulus for measurement of s' and e' of the septal, lateral, anterior and inferior walls and at the tricuspid annulus for measurement of right ventricular (RV) s' and e'. Results All the regional LV s' and e', and both RV s' and RV e', were lower in individuals with FRDA compared to controls (p<0.001 for all). On multivariate analysis, which included LV septal wall thickness (SWT), RV s' and RV e' were both inversely correlated with GAA1 (beta = -0.32 & -0.33, respectively, p = 0.01), but not with GAA2, whereas anterior and lateral s' were both inversely correlated with GAA2 (beta = -0.25 and beta = -0.28, p = 0.02) but not with GAA1. Increasing SWT was the most consistent LV structural correlate of lower s' and e', whereas age was a consistent inverse correlate of e' but not of s'. Conclusion There are generalized abnormalities of both LV regional and RV long axis function in FRDA, but there are also regional differences in the association of this dysfunction with the smaller and larger GAA repeats in the FXN gene.	[Peverill, Roger E.; Donelan, Lesley] MonashHeart, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia; [Peverill, Roger E.; Donelan, Lesley] Monash Univ, Dept Med, Sch Clin Sci, Monash Hlth, Clayton, Vic, Australia; [Peverill, Roger E.; Donelan, Lesley] Monash Hlth, Clayton, Vic, Australia; [Corben, Louise A.; Delatycki, Martin B.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic, Australia; [Delatycki, Martin B.] Victorian Clin Genet Serv, Parkville, Vic, Australia	Monash University; Monash University; Murdoch Children's Research Institute	Peverill, RE (corresponding author), MonashHeart, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia.; Peverill, RE (corresponding author), Monash Univ, Dept Med, Sch Clin Sci, Monash Hlth, Clayton, Vic, Australia.; Peverill, RE (corresponding author), Monash Hlth, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				Buckberg GD, 2006, EUR J CARDIO-THORAC, V29, pS272, DOI 10.1016/j.ejcts.2006.02.011; Dalen H, 2010, CIRC-CARDIOVASC IMAG, V3, P614, DOI 10.1161/CIRCIMAGING.109.926022; De Michele G, 1998, J NEUROL, V245, P166, DOI 10.1007/s004150050198; Dedobbeleer C, 2012, EUR HEART J-CARD IMG, V13, P346, DOI 10.1093/ejechocard/jer267; Delatycki MB, 1999, AM J MED GENET, V87, P168, DOI 10.1002/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Filla A, 1996, AM J HUM GENET, V59, P554; Isnard R, 1997, CIRCULATION, V95, P2247, DOI 10.1161/01.CIR.95.9.2247; Kelly M, 2011, J MOL CELL CARDIOL, V51, P848, DOI 10.1016/j.yjmcc.2011.07.001; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lazaropoulos M, 2015, ANN CLIN TRANSL NEUR, V2, P831, DOI 10.1002/acn3.225; Long A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189990; Metz G, 2013, BRAIN, V136, P259, DOI 10.1093/brain/aws309; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Mottram PM, 2011, J AM SOC ECHOCARDIOG, V24, P782, DOI 10.1016/j.echo.2011.04.004; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Oki T, 1999, J AM SOC ECHOCARDIOG, V12, P476, DOI 10.1016/S0894-7317(99)70084-2; PALAGI B, 1988, BRIT HEART J, V59, P692; Pela G, 2004, J AM SOC ECHOCARDIOG, V17, P205, DOI 10.1016/j.echo.2003.12.004; Peverill RE, 2004, J AM SOC ECHOCARDIOG, V17, P1146, DOI 10.1016/j.echo.2004.06.007; Peverill RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158302; Pousset F, 2015, JAMA NEUROL, V72, P1334, DOI 10.1001/jamaneurol.2015.1855; Reetz K, 2015, LANCET NEUROL, V14, P174, DOI 10.1016/S1474-4422(14)70321-7; Regner SR, 2012, AM J CARDIOL, V109, P401, DOI 10.1016/j.amjcard.2011.09.025; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Weidemann F, 2003, AM J CARDIOL, V91, P622, DOI 10.1016/S0002-9149(02)03325-8; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477; Yamada H, 1999, J AM SOC ECHOCARDIOG, V12, P574, DOI 10.1016/S0894-7317(99)70005-2	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209410	10.1371/journal.pone.0209410	http://dx.doi.org/10.1371/journal.pone.0209410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596685	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200044
J	Warrilow, D; Huang, BX; Newton, ND; Harrison, JJ; Johnson, KN; Chow, WK; Hall, RA; Hobson-Peters, J				Warrilow, David; Huang, Bixing; Newton, Natalee D.; Harrison, Jessica J.; Johnson, Karyn N.; Chow, Weng Kong; Hall, Roy A.; Hobson-Peters, Jody			The taxonomy of an Australian nodavirus isolated from mosquitoes	PLOS ONE			English	Article							FLOCK HOUSE VIRUS; RNA POLYMERASE; SEQUENCE; INSIGHTS; PROTEIN; WILD	We describe a virus isolated from Culex annulirostris mosquitoes in Australia. Phylogenetic analysis of its RNA-dependent RNA polymerase sequence and that of other related viruses revealed 6 clades, two of which corresponded wholly or partly with existing genera in the family Nodaviridae. There was greater genetic diversity within the family than previously recognized prompting us to suggest that additional genera should be considered within the family.	[Warrilow, David; Huang, Bixing] Queensland Hlth Forens & Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia; [Newton, Natalee D.; Harrison, Jessica J.; Hall, Roy A.; Hobson-Peters, Jody] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Johnson, Karyn N.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Chow, Weng Kong] Australian Def Force Malaria & Infect Dis Inst, Brisbane, Qld, Australia	Queensland Health; University of Queensland; University of Queensland	Warrilow, D (corresponding author), Queensland Hlth Forens & Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia.; Hobson-Peters, J (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.	David.Warrilow@health.qld.gov.au; j.peters2@uq.edu.au	Newton, Natalee/AAG-6650-2021; Johnson, Karyn N/B-7980-2008	Newton, Natalee/0000-0002-5617-8639; Johnson, Karyn N/0000-0001-8647-8985; Warrilow, David/0000-0002-3221-7605; Harrison, Jessica/0000-0002-3577-9910	Australian Research Council [DP120103994]; Australian Postgraduate Awards	Australian Research Council(Australian Research Council); Australian Postgraduate Awards(Australian Government)	This project was funded by the Australian Research Council (https://www.arc.gov.au/) grant number DP120103994 awarded to RAH. JJH and NDN are supported by Australian Postgraduate Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; [Anonymous], 2017, VIRUS TAXONOMY CLASS, P10; Bai HM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-311; Castorena KM, 2007, J VIROL, V81, P8412, DOI 10.1128/JVI.00189-07; Cerny J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096070; Conceicao-Neto N, 2017, ECOL EVOL, V7, P4135, DOI 10.1002/ece3.2991; Conceicao-Neto N, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0305-5; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Frances SP, 2004, J MED ENTOMOL, V41, P115, DOI 10.1603/0022-2585-41.1.115; Franz CJ, 2012, J VIROL, V86, P11940, DOI 10.1128/JVI.02025-12; Friesen PD., 2007, FIELDS VIROLOGY, V1, P707; Hameed ASS, 2019, J GEN VIROL, V100, P3, DOI 10.1099/jgv.0.001170; Huang BX, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00310-17, 10.1128/genomea.00310-17]; Johnson KN, 2000, J VIROL, V74, P5123, DOI 10.1128/JVI.74.11.5123-5132.2000; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021; Miller DJ, 2002, J VIROL, V76, P9856, DOI 10.1128/JVI.76.19.9856-9867.2002; Miller DJ, 2001, J VIROL, V75, P11664, DOI 10.1128/JVI.75.23.11664-11676.2001; Odegard A, 2010, CURR TOP MICROBIOL, V343, P1, DOI 10.1007/82_2010_35; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; SCHERER WF, 1967, AM J EPIDEMIOL, V86, P271, DOI 10.1093/oxfordjournals.aje.a120737; Schuster S, 2014, J VIROL, V88, P13447, DOI 10.1128/JVI.02144-14; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Simmonds P, 2015, J GEN VIROL, V96, P1193, DOI 10.1099/jgv.0.000016; Van Wynsberghe PA, 2007, J VIROL, V81, P4633, DOI 10.1128/JVI.02267-06; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; WARD CW, 1993, RES VIROLOGY, V144, P419, DOI 10.1016/S0923-2516(06)80059-2; Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210029	10.1371/journal.pone.0210029	http://dx.doi.org/10.1371/journal.pone.0210029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596795	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200128
J	Nakamura, T; Yamada, T; Kataoka, K; Sera, K; Saunders, T; Takatsuji, T; Makie, T; Nose, Y				Nakamura, Tsuyoshi; Yamada, Tomomi; Kataoka, Koshi; Sera, Koichiro; Saunders, Todd; Takatsuji, Toshihiro; Makie, Toshio; Nose, Yoshiaki			Statistical resolutions for large variabilities in hair mineral analysis	PLOS ONE			English	Article							TRACE-ELEMENTS; SCALP HAIR; REFERENCE VALUES; HEALTH; BLOOD	Measuring biomaterials is usually subject to error. Measurement errors are classified into either random errors or biases. Random errors can be well controlled using appropriate statistical methods. But, biases due to unknown, unobserved, or temporary causes, may lead to biased conclusions. This study describes a verification method to examine whether measurement errors are random or not and to determine efficient statistical methods. A number of studies have dealt with associations between hair minerals and exposures such as health, dietary or environmental conditions. Most review papers, however, emphasize the necessity for validation of hair mineral measurements, since large variations can cause highly variable results. To address these issues, we answer the following questions: 1. How can we ascertain the reliability of measurements? 2. How can we assess and control the variability of measurements? 3. How do we efficiently determine associations between hair minerals and exposures? 4. How can we concisely present the reference values? Since hair minerals all have distinctive natures, it would be unproductive to examine each mineral individually to find significant and consistent answers that apply to all minerals. To surmount this difficulty, we used one simple model for all minerals to explore quantitative answers. Hair mineral measurements of six-year-old children were analyzed based on the statistical model. The analysis verified that most of the measurements were reliable, and their inter-individual variations followed two-parameter distributions. These results allow for sophisticated study designs and efficient statistical methods to examine the effects of various kinds of exposures on hair minerals.	[Nakamura, Tsuyoshi; Takatsuji, Toshihiro] Nagasaki Univ, Fac Environm Sci, Nagasaki, Japan; [Yamada, Tomomi] Osaka Univ Hosp, Dept Med Innovat, Osaka, Japan; [Kataoka, Koshi] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan; [Sera, Koichiro] Iwate Med Univ, Cyclotron Res Ctr, Morioka, Iwate, Japan; [Saunders, Todd] Nagasaki Univ, Sch Med, Nagasaki, Japan; [Makie, Toshio] Suzuka Natl Hosp, Suzuka, Mie, Japan; [Nose, Yoshiaki] Kyushu Univ, Sch Med, Fukuoka, Fukuoka, Japan	Nagasaki University; Osaka University; Yokohama City University; Iwate Medical University; Nagasaki University; Kyushu University	Nakamura, T (corresponding author), Nagasaki Univ, Fac Environm Sci, Nagasaki, Japan.	naka@nagasaki-u.ac.jp	Nakamura, Tsuyoshi/AAC-8655-2020	Nakamura, Tsuyoshi/0000-0001-9018-8251	Japanese Society for Promotion of Science [908870, 571563, 260779, 438866]; Japan Society for the Promotion of Science	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors were funded by Japanese Society for Promotion of Science, or Kaken (908870, 571563, 260779, 438866).; We are grateful to Fukuoka College of Obstetricians and Gynecologists, Pediatric Association of Fukuoka District, the Welfare Bureau of Fukuoka City Hall, the children who contributed hair samples, Naoko Kinukawa, Tomoko Maeda and the staff of the Cyclotron Center in Iwate Medical School for kind help. This work is supported in part from the Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science.	Afridi HI, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4201-z; Bailey D., 2018, SIGNIFICANCE, V15, P14, DOI DOI 10.1111/j.1740-9713.2018.01105.x; Beck M, 2003, J NUTR, V133, p5S; Carroll RJ, 1995, MONOGRAPHS STAT APPL, V105; Chojnacka K, 2010, ENVIRON TOXICOL PHAR, V30, P188, DOI 10.1016/j.etap.2010.06.002; Chojnacka K, 2010, ENVIRON TOXICOL PHAR, V29, P314, DOI 10.1016/j.etap.2010.03.010; Dlugaszek M, 2014, TRACE ELEM ELECTROLY, V31, P131, DOI 10.5414/TEX01333; Dongarra G, 2012, ENVIRON TOXICOL PHAR, V34, P160, DOI 10.1016/j.etap.2012.03.005; Dongarra G, 2011, ENVIRON TOXICOL PHAR, V32, P27, DOI 10.1016/j.etap.2011.03.003; Drasch G, 2002, J TRACE ELEM MED BIO, V16, P27, DOI 10.1016/S0946-672X(02)80005-0; Golasik M, 2015, J TRACE ELEM MED BIO, V31, P67, DOI 10.1016/j.jtemb.2015.03.001; Jeruszka-Bielak M, 2011, BIOL TRACE ELEM RES, V144, P63, DOI 10.1007/s12011-011-9030-0; Kataoka K, 2016, INT J PIXE, V26, P93; Kempson IM, 2011, CHEM SOC REV, V40, P3915, DOI 10.1039/c1cs15021a; Kim HN, 2014, BIOL TRACE ELEM RES, V158, P152, DOI 10.1007/s12011-014-9934-6; Kolachi NF, 2012, CLIN NUTR, V31, P967, DOI 10.1016/j.clnu.2012.04.015; Mikulewicz M, 2013, ENVIRON TOXICOL PHAR, V36, P1077, DOI 10.1016/j.etap.2013.09.012; Molina-Villalba I, 2015, CHEMOSPHERE, V124, P83, DOI 10.1016/j.chemosphere.2014.11.016; Nakamura T, 2003, ENVIRONMETRICS, V14, P203, DOI 10.1002/env.577; Namkoong S, 2013, ANN DERMATOL, V25, P67, DOI 10.5021/ad.2013.25.1.67; SAS Institute Inc, AB JMP; Saunders T, 2011, BIOMETRIE MEDIZINISC, V18, P127; Seidel S, 2001, JAMA-J AM MED ASSOC, V285, P67, DOI 10.1001/jama.285.1.67; Shah F, 2011, BIOL TRACE ELEM RES, V141, P131, DOI 10.1007/s12011-010-8736-8; Skalny AV, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4903-x; Suliburska J, 2011, BIOL TRACE ELEM RES, V144, P77, DOI 10.1007/s12011-011-9034-9; Suliburska J, 2011, BIOL TRACE ELEM RES, V139, P137, DOI 10.1007/s12011-010-8650-0; Szynkowska MI, 2015, ENVIRON TOXICOL PHAR, V40, P402, DOI 10.1016/j.etap.2015.07.005; Tamburo E, 2015, ENVIRON TOXICOL PHAR, V39, P70, DOI 10.1016/j.etap.2014.11.005; Tang W, 2012, INTRACTABLE RARE DIS, V1, P1, DOI 10.5582/irdr.2012.v1.1.1; Vanaelst B, 2013, BIOL TRACE ELEM RES, V150, P56; Vanaelst B, 2013, BIOL TRACE ELEM RES, V151, P335, DOI 10.1007/s12011-012-9573-8; Varrica D, 2014, SCI TOTAL ENVIRON, V470, P117, DOI 10.1016/j.scitotenv.2013.09.058; Wolowiec P, 2013, CLIN CHIM ACTA, V419, P139, DOI 10.1016/j.cca.2013.02.001; Yamada T, 2015, SPRINGER P MATH STAT, V136, P111; Yamada T, 2015, INT J PIXE, V25, P73; Yamada T, 2013, J TRACE ELEM MED BIO, V27, P126, DOI 10.1016/j.jtemb.2012.08.003; Yasuda Hiroshi, 2009, Environmental Health and Preventive Medicine, V14, P261, DOI 10.1007/s12199-009-0092-y; Zaichick S, 2010, BIOL TRACE ELEM RES, V134, P41, DOI 10.1007/s12011-009-8456-0	39	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208816	10.1371/journal.pone.0208816	http://dx.doi.org/10.1371/journal.pone.0208816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586366	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400038
J	Diorio, C; Afanasiev, M; Salena, K; Marjerrison, S				Diorio, Caroline; Afanasiev, Michael; Salena, Kristen; Marjerrison, Stacey			'A world of competing sorrows': A mixed methods analysis of media reports of children with cancer abandoning conventional treatment	PLOS ONE			English	Article							PARENTS	Background We aimed to provide health practitioners greater insight into the public perception of traditional and complementary medicine (T&CM) use. Our objectives were to identify news media reports of children abandoning conventional treatment for traditional and complementary medicine, analyze the thematic content of these news articles and estimate the tonality portrayed. Methods LexisNexis and Factiva were searched for terms related to cancer, children and T&CM. Inclusion criteria were children less than 18 years, in curative phase of treatment who attempted to abandon conventional therapy for any traditional and complementary medicine use. A secondary search was performed in LexisNexis, Factiva and Google News Archive with the names of children in identified cases. Qualitative analysis of news media reports was completed using a grounded theory approach. Quantitative analysis of article sentiment was performed using a linear support vector machine. Results Seventeen cases occurring between 2002 and 2016 were included. Five main themes were identified: treatment as torture, power imbalances, rights of parents, evidence versus beliefs and the rights of Indigenous Peoples. Sentiment analysis revealed an overall negative tone, as demonstrated by 73% of the articles. Interpretation A better understanding of factors that lead to abandonment of conventional therapy for traditional and complementary medicine as portrayed in the news media may help healthcare providers prevent the occurrence of these cases.	[Diorio, Caroline; Marjerrison, Stacey] McMaster Childrens Hosp, Hamilton, ON, Canada; [Diorio, Caroline] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Afanasiev, Michael] Swiss Fed Inst Technol, Inst Geophys, Zurich, Switzerland; [Salena, Kristen; Marjerrison, Stacey] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada	McMaster University; University of Pennsylvania; Childrens Hospital of Philadelphia; ETH Zurich; McMaster University	Marjerrison, S (corresponding author), McMaster Childrens Hosp, Hamilton, ON, Canada.; Marjerrison, S (corresponding author), McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada.	marjersi@mcmaster.ca	Marjerrison, Stacey/I-1682-2019	Marjerrison, Stacey/0000-0002-3763-5494; Diorio, Caroline/0000-0002-8005-3836	Hamilton Health Sciences New Investigator Fund [16392]	Hamilton Health Sciences New Investigator Fund	The Hamilton Health Sciences New Investigator Fund (grant 16392), held by SM, supported this work. URL: http://www.hhsresearchadmin.ca/researcher-support/internal-funding/new-investigator-fund/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CALGARY HERALD  0121; [Anonymous], 2015, TRUTH RECONCILIATION; [Anonymous], 2015, COMPL ALT INT HLTH W; Asser SM, 1998, PEDIATRICS, V101, P625, DOI 10.1542/peds.101.4.625; Baker KC, 2016, PEOPLE; Blackwell T., 2014, NATL POST; Boyle D., 2015, DAILY MAIL; Branley A., 2013, NEWCASTLE HERAL 0613; Burns C, 2016, PEDIATR BLOOD CANCER, V63, pS87; Butler D., 2014, OTTAWA CITIZEN; Chapman R., 2012, CBS MINNESOTA   0806; Devlin P., 2016, DAILY MAIL AUST 0408; Diorio C, 2016, J GLOBAL ONCOLOGY; Diorio C, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26501; Ellicott C, 2013, DAILY MAIL; Friedrich P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163090; Friedrich P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135230; Gallant J., 2015, TORONTO STAR; Germanotta T., 2006, VIRGINIAN PILOT 0817; Harris E. A., 2015, NY TIMES; Hasham A, 2014, TORONTO STAR; Hershberger A., 2013, ABC NEWS GOOD MORNIN; Hill DM, 2003, TRADITIONAL MED CONT; Hord JD, 2006, J CLIN ONCOL, V24, P5454, DOI 10.1200/JCO.2006.06.4709; Jenny C, 2007, PEDIATRICS, V120, P1385, DOI 10.1542/peds.2007-2903; Johnson SB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx145; Linehan D., 2009, HAUSERS AGREE CHEMO; Linehan D., 2009, CHEMO FUGITIVES RETU; Loper, 2009, NATURAL LANGUAGE PRO; McLaren L., 2015, GLOBE MAIL; Michele Wernecke EWKW, 2005, NBC NEWS TODAY; Mitchell I, 2015, PAED CHILD HEALT-CAN, V20, P294, DOI 10.1093/pch/20.6.293; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Noble F, 2016, DAILY MAIL AUST 0440; Pearson HA, 2002, PEDIATR RES, V52, P979, DOI 10.1203/01.PDR.0000037142.36005.3D; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rajaraman A., 2011, MINING MASSIVE DATAS; Richardson L, 2015, CAN MED ASSOC J, V187, P162, DOI 10.1503/cmaj.141613; Simpson E., 2011, VIRGINIAN PILOT 0925; Smith R., 2016, GEELONG ADVERTISER; Strauss A, 1997, GROUNDED THEORY PRAC; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Toobin J., 2002, CNN AM MORNING P ZAH; Verville J., 2008, TORONTO STAR; Wernecke K, 2005, NBC NEWS TODAY  0609; WHO, 2014, WHO TRADITIONAL MED, P1; Wilson T., 2005, HLT EMNLP 2005, P347; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Young E., 2016, SYDNEY MORNING HERAL	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209738	10.1371/journal.pone.0209738	http://dx.doi.org/10.1371/journal.pone.0209738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576389	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400076
J	Tadaishi, M; Toriba, Y; Shimizu, M; Kobayashi-Hattori, K				Tadaishi, Miki; Toriba, Yutaro; Shimizu, Makoto; Kobayashi-Hattori, Kazuo			Adenosine stimulates hepatic glycogenolysis via adrenal glands-liver crosstalk in mice	PLOS ONE			English	Article							RECEPTORS; TRANSPORT; INCREASES; INSULIN; TISSUE	Adenosine signaling is involved in glucose metabolism in hepatocytes and myocytes in vitro. However, no information is available regarding the effect of adenosine on glucose metabolism in vivo. Thus, we examined how extracellular adenosine acts on glucose metabolism using mice. Subcutaneous injections of adenosine (10, 25, and 50 mg/kg bodyweight) dose-dependently increased blood glucose levels, with the peak occurring at 30 min post injection. At 30 min after adenosine injection (25 mg/kg bodyweight), glycogen content in the liver, but not the skeletal muscle, was significantly decreased. Hepatic glycogen depletion by fasting for 12 h suppressed the increase of blood glucose levels at 30 min after adenosine injection. These results suggest that adenosine increases blood glucose levels by stimulating hepatic glycogenolysis. To investigate the effect of adenosine on the adrenal gland, we studied the glycogenolysis signal in adrenalectomized (ADX) mice. Adenosine significantly increased the blood glucose levels in sham mice but not in the ADX mice. The decrease in hepatic glycogen content induced by adenosine in the sham mice was partially suppressed in the ADX mice. The level of plasma corticosterone, the main glucocorticoid in mice, was significantly increased in the sham mice by adenosine but its levels were low in ADX mice injected with either PBS or adenosine. These results suggest that adenosine promotes secretion of corticosterone from the adrenal glands, which causes hepatic glycogenolysis and subsequently the elevation of blood glucose levels. Our findings are useful for clarifying the physiological functions of adenosine in glucose metabolism in vivo.	[Tadaishi, Miki; Toriba, Yutaro; Shimizu, Makoto; Kobayashi-Hattori, Kazuo] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan	Tokyo University of Agriculture	Tadaishi, M (corresponding author), Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan.	mt205315@nodai.ac.jp		, Kazuo/0000-0002-0921-2128				ANANDSRIVASTAVA MB, 1989, MOL CELL BIOCHEM, V89, P21; BUXTON DB, 1986, BIOCHEM J, V237, P773, DOI 10.1042/bj2370773; Chen YC, 2010, FEBS LETT, V584, P4442, DOI 10.1016/j.febslet.2010.10.001; Dixon AK, 1996, BRIT J PHARMACOL, V118, P1461, DOI 10.1111/j.1476-5381.1996.tb15561.x; Harada H, 2001, J MED CHEM, V44, P170, DOI 10.1021/jm990499b; JohanssonA SM, 2008, EUR J PHARMACOL, V597, P92, DOI 10.1016/j.ejphar.2008.08.022; Koupenova M, 2012, CIRCULATION, V125, P354, DOI 10.1161/CIRCULATIONAHA.111.057596; Owen O E, 1979, Adv Exp Med Biol, V111, P169; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Sachdeva S, 2013, SAUDI PHARM J, V21, P245, DOI 10.1016/j.jsps.2012.05.011; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thong FSL, 2007, APPL PHYSIOL NUTR ME, V32, P701, DOI 10.1139/H07-039; VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104; Vilela VR, 2014, CHEM-BIOL INTERACT, V220, P1, DOI 10.1016/j.cbi.2014.05.020; Vizi E, 2002, J ALLERGY CLIN IMMUN, V109, P446, DOI 10.1067/mai.2002.121955; Yasuda N, 2003, EUR J PHARMACOL, V459, P159, DOI 10.1016/S0014-2999(02)02832-7	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209647	10.1371/journal.pone.0209647	http://dx.doi.org/10.1371/journal.pone.0209647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576384	gold, Green Submitted, Green Published			2022-12-26	WOS:000454149400069
J	Malik, R; Meng, H; Wongkongkathep, P; Corrales, CI; Sepanj, N; Atlasi, RS; Klarner, FG; Schrader, T; Spencer, MJ; Loo, JA; Wiedau, M; Bitan, G				Malik, Ravinder; Meng, Helen; Wongkongkathep, Piriya; Corrales, Christian I.; Sepanj, Niki; Atlasi, Ryan S.; Klaerner, Frank-Gerrit; Schrader, Thomas; Spencer, Melissa J.; Loo, Joseph A.; Wiedau, Martina; Bitan, Gal			The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						superoxide dismutase (SOD); amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein aggregation; mouse; inhibitor; neurodegeneration; amyloid; protein misfolding; molecular tweezer; motor neuron	AMYOTROPHIC-LATERAL-SCLEROSIS; FIBRIL FORMATION; PROTEIN; MICE; AGGREGATION; TOXICITY; STRATEGIES; PHENOTYPE; SURVIVAL; NEURONS	Mutations in superoxide dismutase 1 (SOD1) cause 15-20% of familial amyotrophic lateral sclerosis (fALS) cases. The resulting amino acid substitutions destabilize SOD1's protein structure, leading to its self-assembly into neurotoxic oligomers and aggregates, a process hypothesized to cause the characteristic motor-neuron degeneration in affected individuals. Currently, effective disease-modifying therapy is not available for ALS. Molecular tweezers prevent formation of toxic protein assemblies, yet their protective action has not been tested previously on SOD1 or in the context of ALS. Here, we tested the molecular tweezer CLR01-a broad-spectrum inhibitor of the self-assembly and toxicity of amyloid proteins-as a potential therapeutic agent for ALS. Using recombinant WT and mutant SOD1, we found that CLR01 inhibited the aggregation of all tested SOD1 forms in vitro. Next, we examined whether CLR01 could prevent the formation of misfolded SOD1 in the G93A-SOD1 mouse model of ALS and whether such inhibition would have a beneficial therapeutic effect. CLR01 treatment decreased misfolded SOD1 in the spinal cord significantly. However, these histological findings did not correlate with improvement of the disease phenotype. A small, dose-dependent decrease in disease duration was found in CLR01-treated mice, relative to vehicle-treated animals, yet motor function did not improve in any of the treatment groups. These results demonstrate that CLR01 can inhibit SOD1 misfolding and aggregation both in vitro and in vivo, but raise the question whether such inhibition is sufficient for achieving a therapeutic effect. Additional studies in other less aggressive ALS models may be needed to determine the therapeutic potential of this approach.	[Malik, Ravinder; Meng, Helen; Corrales, Christian I.; Sepanj, Niki; Atlasi, Ryan S.; Spencer, Melissa J.; Wiedau, Martina; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Wongkongkathep, Piriya; Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Spencer, Melissa J.; Wiedau, Martina; Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Klaerner, Frank-Gerrit; Schrader, Thomas] Univ Duisburg Essen, Fac Chem, D-47057 Essen, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Duisburg Essen	Wiedau, M; Bitan, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	mwiedau@mednet.ucla.edu; gbitan@mednet.ucla.edu	Wongkongkathep, Piriya/E-7139-2011; Bitan, Gal/U-2204-2019	Wongkongkathep, Piriya/0000-0003-0751-8622; Bitan, Gal/0000-0001-7046-3754	Judith and Jean Pape Adams Charitable Foundation; David Vickter Foundation; Prize4Life; RGK Foundation [20143057]; National Institutes of Health/NINDS F32 Fellowship [NS087858]; National Institutes of Health/NIAMS [P30 AR057230]; National Institutes of Health/NIGMS [R01 GM103479]; National Institutes of Health/NCRR [S10 RR028893]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103479] Funding Source: NIH RePORTER	Judith and Jean Pape Adams Charitable Foundation; David Vickter Foundation; Prize4Life; RGK Foundation; National Institutes of Health/NINDS F32 Fellowship; National Institutes of Health/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Judith and Jean Pape Adams Charitable Foundation grant (to G. B.), the David Vickter Foundation (to M. W.), Prize4Life (to G. B. and M. W.), RGK Foundation Grant 20143057 (G. B.), National Institutes of Health/NINDS F32 Fellowship NS087858 (to C. F.), National Institutes of Health/NIAMS Grant P30 AR057230 (to M. J. S.), National Institutes of Health/NIGMS Grant R01 GM103479 (to J. A. L.), and National Institutes of Health/NCRR Grant S10 RR028893 (to J. A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Acharya S, 2014, J BIOL CHEM, V289, P10727, DOI 10.1074/jbc.M113.524520; Atlasi RS, 2018, ACS CHEM BIOL, V13, P2794, DOI 10.1021/acschembio.8b00729; Attar A, 2014, CURR PHARM DESIGN, V20, P2469, DOI 10.2174/13816128113199990496; Attar A, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-23; Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Capote J, 2016, J CELL BIOL, V213, P275, DOI 10.1083/jcb.201510086; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Ferreira N, 2014, NEUROTHERAPEUTICS, V11, P450, DOI 10.1007/s13311-013-0256-8; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALLEWELL RA, 1987, BIO-TECHNOL, V5, P363, DOI 10.1038/nbt0487-363; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hilton JB, 2017, SCI REP-UK, V7, DOI 10.1038/srep42292; Ida M, 2016, J BIOCHEM, V159, P247, DOI 10.1093/jb/mvv091; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kim RB, 2016, AMYOTROPH LAT SCL FR, V17, P1, DOI 10.3109/21678421.2015.1047455; Liu TY, 2012, CHEMMEDCHEM, V7, P359, DOI 10.1002/cmdc.201100585; Malik R, 2018, METHODS MOL BIOL, V1777, P369, DOI 10.1007/978-1-4939-7811-3_24; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; Nichols NL, 2013, RESP PHYSIOL NEUROBI, V189, P429, DOI 10.1016/j.resp.2013.05.016; Nowak RJ, 2010, J MED CHEM, V53, P2709, DOI 10.1021/jm901062p; Nshanian M, 2019, J AM SOC MASS SPECTR, V30, P16, DOI 10.1007/s13361-018-2027-6; Prabhudesai S, 2012, NEUROTHERAPEUTICS, V9, P464, DOI 10.1007/s13311-012-0105-1; Rakhit R, 2006, BBA-MOL BASIS DIS, V1762, P1025, DOI 10.1016/j.bbadis.2006.05.004; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Richter F, 2017, NEUROTHERAPEUTICS, V14, P1107, DOI 10.1007/s13311-017-0544-9; ROGERS DR, 1965, AM J CLIN PATHOL, V44, P59; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sawada H, 2017, EXPERT OPIN PHARMACO, V18, P735, DOI 10.1080/14656566.2017.1319937; Schrader T, 2016, CHEM COMMUN, V52, P11318, DOI 10.1039/c6cc04640a; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Siddique T, 2011, Acta Myol, V30, P117; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Talbiersky P, 2008, J AM CHEM SOC, V130, P9824, DOI 10.1021/ja801441j; Trippier PC, 2014, ACS CHEM NEUROSCI, V5, P823, DOI 10.1021/cn500147v; van Es MA, 2010, J NEUROL NEUROSUR PS, V81, P562, DOI 10.1136/jnnp.2009.181453; Vopel T, 2017, J AM CHEM SOC, V139, P5640, DOI 10.1021/jacs.6b11039; Wei JPJ, 2001, J BIOL CHEM, V276, P44798, DOI 10.1074/jbc.M104708200; Xia GY, 2011, J MED CHEM, V54, P2409, DOI 10.1021/jm101549k; Xu N, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006182; Zheng XY, 2015, J PHYS CHEM B, V119, P4831, DOI 10.1021/acs.jpcb.5b00692	52	20	20	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3501	3513		10.1074/jbc.RA118.005940	http://dx.doi.org/10.1074/jbc.RA118.005940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602569	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000461853900017
J	Batchelor, M; Wolny, M; Baker, EG; Paci, E; Kalverda, AP; Peckham, M				Batchelor, Matthew; Wolny, Marcin; Baker, Emily G.; Paci, Emanuele; Kalverda, Arnout P.; Peckham, Michelle			Dynamic ion pair behavior stabilizes single -helices in proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; myosin; protein conformation; molecular dynamics; protein domain; NMR; alpha-helix; nuclear magnetic resonance; salt bridges	HETERONUCLEAR NMR-SPECTROSCOPY; NUCLEAR-MAGNETIC-RESONANCE; ARGININE SIDE-CHAINS; X-RAY SOLUTION; CHEMICAL-SHIFT; ALPHA-HELICES; SALT BRIDGES; HYDROGEN-BONDS; ASSIGNMENT; DOMAIN	Ion pairs are key stabilizing interactions between oppositely charged amino acid side chains in proteins. They are often depicted as single conformer salt bridges (hydrogen-bonded ion pairs) in crystal structures, but it is unclear how dynamic they are in solution. Ion pairs are thought to be particularly important in stabilizing single -helix (SAH) domains in solution. These highly stable domains are rich in charged residues (such as Arg, Lys, and Glu) with potential ion pairs across adjacent turns of the helix. They provide a good model system to investigate how ion pairs can contribute to protein stability. Using NMR spectroscopy, small-angle X-ray light scattering (SAXS), and molecular dynamics simulations, we provide here experimental evidence that ion pairs exist in a SAH in murine myosin 7a (residues 858-935), but that they are not fixed or long lasting. In silico modeling revealed that the ion pairs within this -helix exhibit dynamic behavior, rapidly forming and breaking and alternating between different partner residues. The low-energy helical state was compatible with a great variety of ion pair combinations. Flexible ion pair formation utilizing a subset of those available at any one time avoided the entropic penalty of fixing side chain conformations, which likely contributed to helix stability overall. These results indicate the dynamic nature of ion pairs in SAHs. More broadly, thermodynamic stability in other proteins is likely to benefit from the dynamic behavior of multi-option solvent-exposed ion pairs.	[Batchelor, Matthew; Wolny, Marcin; Paci, Emanuele; Kalverda, Arnout P.; Peckham, Michelle] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Batchelor, Matthew; Wolny, Marcin; Paci, Emanuele; Kalverda, Arnout P.; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Baker, Emily G.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Leeds; University of Leeds; University of Bristol	Peckham, M (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	m.peckham@leeds.ac.uk	Peckham, Michelle/J-4991-2015; Paci, Emanuele/B-1893-2010	Peckham, Michelle/0000-0002-3754-2028; Paci, Emanuele/0000-0002-4891-2768; Wolny, Marcin/0000-0003-1030-7607; Batchelor, Matthew/0000-0001-6338-5698	Wellcome Trust [FC001029, WT094232]; University of Leeds; Cancer Research UK [FC001029]; UK Medical Research Council [FC001029]; Francis Crick Institute; BBSRC [BB/M005615/1, BB/I007423/1, BB/M009114/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); University of Leeds; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Chi Trinh and Sam Hickman (University of Leeds) collected SAXS data. We thank Derek N. Woolfson (University of Bristol) for facilitating AUC measurements and Peter J. Knight (University of Leeds) for useful discussions on the paper. This work was undertaken on ARC2, part of the High Performance Computing facilities at the University of Leeds. The Wellcome Trust (WT094232) funded the CD spectropolarimeter. For access to the 950-MHz spectrometers, we acknowledge the Astbury BioStructure Laboratory BioNMR Facility, which was funded by the University of Leeds, and the Francis Crick Institute through provision of access to the MRC Biomedical NMR Centre. The Francis Crick Institute receives its core funding from Cancer Research UK (FC001029), the UK Medical Research Council (FC001029), and the Wellcome Trust (FC001029).	Ahlner A, 2013, J BIOMOL NMR, V56, P191, DOI 10.1007/s10858-013-9737-7; Ahmed MC, 2018, PEERJ, V6, DOI 10.7717/peerj.4967; Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Batchelor M, 2015, BIOCHEM SOC T, V43, P58, DOI 10.1042/BST20140302; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bermel W, 2013, J BIOMOL NMR, V55, P231, DOI 10.1007/s10858-013-9704-3; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Birdsall B, 2000, BIOCHEMISTRY-US, V39, P9819, DOI 10.1021/bi000728s; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P29, DOI 10.1016/B978-012164491-8/50004-X; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498; Nguyen D, 2017, BIOCHEMISTRY-US, V56, P5866, DOI 10.1021/acs.biochem.7b00885; Debiec KT, 2014, J PHYS CHEM B, V118, P6561, DOI 10.1021/jp500958r; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Gerecht K, 2017, CHEM COMMUN, V53, P10062, DOI 10.1039/c7cc04821a; Ghosh T, 2003, BIOPHYS J, V85, P3187, DOI 10.1016/S0006-3495(03)74736-5; Gorbet G, 2014, BIOPHYS J, V106, P1741, DOI 10.1016/j.bpj.2014.02.022; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwahara J, 2007, J AM CHEM SOC, V129, P2971, DOI 10.1021/ja0683436; Jie J, 2015, J BIOL CHEM, V290, P23863, DOI 10.1074/jbc.M115.649715; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lang PT, 2010, PROTEIN SCI, V19, P1420, DOI 10.1002/pro.423; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Li JC, 2017, STRUCTURE, V25, P579, DOI 10.1016/j.str.2017.02.002; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Liu AZ, 2000, J BIOMOL NMR, V17, P305, DOI 10.1023/A:1008390813387; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Mackenzie HW, 2017, J BIOMOL NMR, V69, P123, DOI 10.1007/s10858-017-0137-2; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Niklasson M, 2017, J BIOMOL NMR, V69, P93, DOI 10.1007/s10858-017-0141-6; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; PASCAL SM, 1995, BIOCHEMISTRY-US, V34, P11353, DOI 10.1021/bi00036a008; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Platzer G, 2014, J BIOMOL NMR, V60, P109, DOI 10.1007/s10858-014-9862-y; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ropars V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12456; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Simm D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174639; Simm D, 2015, BIOINFORMATICS, V31, P767, DOI 10.1093/bioinformatics/btu700; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Tollinger M, 2002, J AM CHEM SOC, V124, P5714, DOI 10.1021/ja020066p; Tomlinson JH, 2009, J AM CHEM SOC, V131, P4674, DOI 10.1021/ja808223p; Trbovic N, 2009, J AM CHEM SOC, V131, P615, DOI 10.1021/ja806475k; Ulrich AKC, 2016, STRUCTURE, V24, P1972, DOI 10.1016/j.str.2016.09.007; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056; Werbeck ND, 2013, ANGEW CHEM INT EDIT, V52, P3145, DOI 10.1002/anie.201209385; Williamson MP, 2013, CHEM COMMUN, V49, P9824, DOI 10.1039/c3cc45602a; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wolny M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44341; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Worrall JAR, 2002, BIOCHEMISTRY-US, V41, P11721, DOI 10.1021/bi026296y; Yoshimura Y, 2017, ANGEW CHEM INT EDIT, V56, P239, DOI 10.1002/anie.201609605; Zandarashvili L, 2016, J PHYS CHEM LETT, V7, P820, DOI 10.1021/acs.jpclett.6b00019; Zandarashvili L, 2011, J AM CHEM SOC, V133, P9192, DOI 10.1021/ja202219n	81	6	6	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3219	3234		10.1074/jbc.RA118.006752	http://dx.doi.org/10.1074/jbc.RA118.006752			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593502	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000464980100020
J	Nagashima, A; Higaki, T; Koeduka, T; Ishigami, K; Hosokawa, S; Watanabe, H; Matsui, K; Hasezawa, S; Touhara, K				Nagashima, Ayumi; Higaki, Takumi; Koeduka, Takao; Ishigami, Ken; Hosokawa, Satoko; Watanabe, Hidenori; Matsui, Kenji; Hasezawa, Seiichiro; Touhara, Kazushige			Transcriptional regulators involved in responses to volatile organic compounds in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor; plant biochemistry; ligand-binding protein; transcription regulation; transcription corepressor; odorant; chemical sensing; plant volatile perception; volatile organic compounds (VOCs); defense induction; transcriptional co-repressor protein; transcription factor; gene regulation; olfaction	METHYL JASMONATE; TOPLESS; COMMUNICATION; GENOME; GENES; REPRESSION; RESISTANCE; INDUCTION; NEMATODES; EVOLUTION	Field studies have shown that plants growing next to herbivore-infested plants acquire higher resistance to herbivore damage. This increased resistance is partly due to regulation of plant gene expression by volatile organic compounds (VOCs) released by plants that sense environmental challenges such as herbivores. The molecular basis for VOC sensing in plants, however, is poorly understood. Here, we report the identification of TOPLESS-like proteins (TPLs) that have VOC-binding activity and are involved in VOC sensing in tobacco. While screening for volatiles that induce stress-responsive gene expression in tobacco BY-2 cells and tobacco plants, we found that some sesquiterpenes induce the expression of stress-responsive genes. These results provided evidence that plants sense these VOCs and motivated us to analyze the mechanisms underlying volatile sensing using tobacco as a model system. Using a pulldown assay with caryophyllene derivative-linked beads, we identified TPLs as transcriptional co-repressors that bind volatile caryophyllene analogs. Overexpression of TPLs in cultured BY-2 cells or tobacco leaves reduced caryophyllene-induced gene expression, indicating that TPLs are involved in the responses to caryophyllene analogs in tobacco. We propose that unlike animals, which use membrane receptors for sensing odorants, a transcriptional co-repressor plays a role in sensing and mediating VOC signals in plant cells.	[Nagashima, Ayumi; Ishigami, Ken; Hosokawa, Satoko; Watanabe, Hidenori; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 2778562, Japan; [Nagashima, Ayumi; Touhara, Kazushige] Univ Tokyo, Japan Sci & Technol Agcy JST, ERATO Touhara Chemosensory Signal Project, Tokyo 2778562, Japan; [Higaki, Takumi; Hasezawa, Seiichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 2778562, Japan; [Koeduka, Takao; Matsui, Kenji] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Koeduka, Takao; Matsui, Kenji] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Div Agr Sci, Yamaguchi 7538515, Japan; [Touhara, Kazushige] Univ Tokyo, Inst Adv Study, Int Res Ctr Neurointelligence WPI IRCN, Tokyo 1130033, Japan; [Nagashima, Ayumi] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 2268501, Japan; [Higaki, Takumi] Kumamoto Univ, Int Res Org Adv Sci & Technol, Kumamoto 8608555, Japan; [Ishigami, Ken] Tokyo Univ Agr, Fac Life Sci, Dept Chem Life Sci & Agr, Tokyo 1568502, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Yamaguchi University; Yamaguchi University; University of Tokyo; Tokyo Institute of Technology; Kumamoto University; Tokyo University of Agriculture	Touhara, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp	Ishigami, Ken/V-8090-2019	Ishigami, Ken/0000-0002-6917-1532; Nagashima, Ayumi/0000-0002-0736-0928; Touhara, Kazushige/0000-0001-7856-0786	ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (JST), Japan [JPMJER1202]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (JST), Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (JST), Japan (Grant JPMJER1202) and by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adebesin F, 2017, SCIENCE, V356, P1386, DOI 10.1126/science.aan0826; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Causier B, 2012, PLANT SIGNAL BEHAV, V7, P325, DOI 10.4161/psb.19283; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Imanishi S, 1998, PLANT MOL BIOL, V38, P1101, DOI 10.1023/A:1006058700949; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Ki SW, 2000, J BIOL CHEM, V275, P39231, DOI 10.1074/jbc.M006192200; Komsta L., 2011, TESTS OUTLIERS R PAC; LAWTON K, 1992, PLANT MOL BIOL, V19, P735, DOI 10.1007/BF00027070; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Matsui K, 2016, CURR OPIN PLANT BIOL, V32, P24, DOI 10.1016/j.pbi.2016.05.005; Mirabella R, 2015, PLANT J, V83, P1082, DOI 10.1111/tpj.12953; Muller P, 2000, TETRAHEDRON, V56, P1725, DOI 10.1016/S0040-4020(00)00076-4; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Perez AC, 2013, PLANT CELL ENVIRON, V36, P2071, DOI 10.1111/pce.12121; Petre B, 2015, MOL PLANT MICROBE IN, V28, P689, DOI 10.1094/MPMI-01-15-0003-R; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; RCore Team, 2017, R LANG ENV STAT COMP; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Subramanyam K, 2012, PLANTA, V236, P1909, DOI 10.1007/s00425-012-1733-8; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Taddese B, 2014, PLANT PHYSIOL, V164, P287, DOI 10.1104/pp.113.228874; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Widhalm JR, 2015, TRENDS PLANT SCI, V20, P545, DOI 10.1016/j.tplants.2015.06.009; Zou An, 2015, Nucl Receptor Res, V2	39	29	30	4	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2256	2266		10.1074/jbc.RA118.005843	http://dx.doi.org/10.1074/jbc.RA118.005843			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30593507	hybrid, Green Published			2022-12-26	WOS:000458895400005
J	Yin, JL; Wong, WS				Yin, Jun-Lin; Wong, Woon-Seng			Production of santalenes and bergamotene in Nicotiana tabacum plants	PLOS ONE			English	Article							TERPENOID METABOLISM; HEMIPTERA APHIDIDAE; SMALL-SUBUNIT; BIOSYNTHESIS; PHEROMONE; PROTEIN; ARTEMISININ; PRECURSORS; TOBACCO	Terpenes play an important role in plant-insect relationships, and these relationships can potentially be modified by altering the profile of terpenes emitted from plants using metabolic engineering methods. Transgenic plants generated by employing such methods offer the prospect of low-cost sustainable pest management; in this regard, we used chloroplast targeting and cytosolic mevalonic acid pathway enhancement in this study to investigate the interaction of santalenes and bergamotene with insects. The santalene- and bergamotene-emitting transgenic tobacco plants thus generated were utilized to study host preference in the green peach aphid (Myzus persicae (Sulzer)). The results showed that co-expression of either 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) or truncated HMGR with santalene synthase led to the production of higher amounts of santalenes and bergamotene in transgenic tobacco plants, and that these santalene- and bergamotene-emitting plants were attractive to green peach aphids. We accordingly propose that such transgenic plants may have potential application in pest management as a trap crop to prevent green peach aphid infestation of wild-type tobacco plants.	[Yin, Jun-Lin] Yunnan Minzu Univ, YMU HKBU Joint Lab Tradit Nat Med, Kunming, Yunnan, Peoples R China; [Yin, Jun-Lin; Wong, Woon-Seng] Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore, Singapore	Yunnan Minzu University; National University of Singapore	Yin, JL (corresponding author), Yunnan Minzu Univ, YMU HKBU Joint Lab Tradit Nat Med, Kunming, Yunnan, Peoples R China.; Yin, JL (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore, Singapore.	yinjunlin@mail.kib.ac.cn	yin, junlin/AAJ-4522-2021	Yin, Jun-Lin/0000-0001-8508-5629	Singapore National Research Foundation [NRF-CRP8-2011-02]; Natural Science Foundation of China [21768005]; Temasek Life Sciences Laboratory	Singapore National Research Foundation(National Research Foundation, Singapore); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Temasek Life Sciences Laboratory(National University of Singapore)	This work was financially supported by a grant from the Singapore National Research Foundation (Competitive Research Programme Award No. NRF-CRP8-2011-02), Natural Science Foundation of China (No. 21768005) and the Temasek Life Sciences Laboratory.	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11183; Cankar K, 2015, BIOTECHNOL J, V10, P180, DOI [10.1002/biot.201400288, 10.1002/biot.20140028]; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337; Consoli FL, 2002, J CHEM ECOL, V28, P1675, DOI 10.1023/A:1019940932605; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; Diaz-Chavez ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075053; Dudareva N, 2008, CURR OPIN BIOTECH, V19, P181, DOI 10.1016/j.copbio.2008.02.011; Dudareva N, 2013, CURR OPIN BIOTECH, V24, P226, DOI 10.1016/j.copbio.2013.02.002; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Farhi M, 2011, NAT BIOTECHNOL, V29, P1072, DOI 10.1038/nbt.2054; Garabagi F, 2012, PLANT BIOTECHNOL J, V10, P1118, DOI 10.1111/j.1467-7652.2012.00742.x; Goolsby JA, 2005, BIOL CONTROL, V32, P70, DOI 10.1016/j.biocontrol.2004.07.012; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Herbert JJ, 2009, ENVIRON ENTOMOL, V38, P1155, DOI 10.1603/022.038.0423; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jones CG, 2011, J BIOL CHEM, V286, P17445, DOI 10.1074/jbc.M111.231787; Kamphuis LG, 2013, J EXP BOT, V64, P5157, DOI 10.1093/jxb/ert305; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P169, DOI 10.1111/pbi.12022; Lee DW, 2006, PLANT PHYSIOL, V140, P466, DOI 10.1104/pp.105.074575; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Li RY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01970; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Pan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030247; Park YD, 1996, PLANT J, V9, P183, DOI 10.1046/j.1365-313X.1996.09020183.x; Pasoreck EK, 2016, PLANT BIOTECHNOL J, V14, P1862, DOI 10.1111/pbi.12548; Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P158, DOI 10.2987/8756-971X(2006)22[158:FEONMS]2.0.CO;2; Schuman MC, 2015, ELIFE, V4, DOI 10.7554/eLife.04490; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; van Herpen TWJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014222; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Yin JL, 2017, NEW PHYTOL, V213, P1133, DOI 10.1111/nph.14280; Yu XD, 2012, J INTEGR PLANT BIOL, V54, P282, DOI 10.1111/j.1744-7909.2012.01107.x; Zhang YS, 2011, PLANT BIOTECHNOL J, V9, P445, DOI 10.1111/j.1467-7652.2010.00556.x; Zhao C, 2015, GENET MOL RES, V14, P17159, DOI 10.4238/2015.December.16.16	42	6	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0203249	10.1371/journal.pone.0203249	http://dx.doi.org/10.1371/journal.pone.0203249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608920	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800002
J	Hansen, MB; Tietze, A; Haack, S; Kallehauge, J; Mikkelsen, IK; Ostergaard, L; Mouridsen, K				Hansen, Mikkel B.; Tietze, Anna; Haack, Soren; Kallehauge, Jesper; Mikkelsen, Irene K.; Ostergaard, Leif; Mouridsen, Kim			Robust estimation of hemo-dynamic parameters in traditional DCE-MRI models	PLOS ONE			English	Article							CONTRAST-ENHANCED-MRI; PHARMACOKINETIC MODELS; PERFUSION; BLOOD; REPRODUCIBILITY; T-1; PERMEABILITY; RELAXATION; THERAPY; LEAKAGE	Purpose In dynamic contrast enhanced (DCE) MRI, separation of signal contributions from perfusion and leakage requires robust estimation of parameters in a pharmacokinetic model. We present and quantify the performance of a method to compute tissue hemodynamic parameters from DCE data using established pharmacokinetic models. Methods We propose a Bayesian scheme to obtain perfusion metrics from DCE MRI data. Initial performance is assessed through digital phantoms of the extended Tofts model (ETM) and the two-compartment exchange model (2CXM), comparing the Bayesian scheme to the standard Levenberg-Marquardt (LM) algorithm. Digital phantoms are also invoked to identify limitations in the pharmacokinetic models related to measurement conditions. Using computed maps of the extra vascular volume (v(e)) from 19 glioma patients, we analyze differences in the number of un-physiological high-intensity v(e) values for both ETM and 2CXM, using a one-tailed paired t-test assuming un-equal variance. Results The Bayesian parameter estimation scheme demonstrated superior performance over the LM technique in the digital phantom simulations. In addition, we identified limitations in parameter reliability in relation to scan duration for the 2CXM. DCE data for glioma and cervical cancer patients was analyzed with both algorithms and demonstrated improvement in image readability for the Bayesian method. The Bayesian method demonstrated significantly fewer non-physiological high-intensity v(e) values for the ETM (p<0.0001) and the 2CXM (p<0.0001). Conclusion We have demonstrated substantial improvement of the perceptive quality of pharmacokinetic parameters from advanced compartment models using the Bayesian parameter estimation scheme as compared to the LM technique.	[Hansen, Mikkel B.; Tietze, Anna; Mikkelsen, Irene K.; Ostergaard, Leif; Mouridsen, Kim] Aarhus Univ, Ctr Functionally Integrat Neurosci, Inst Clin Med, Aarhus, Denmark; [Hansen, Mikkel B.; Tietze, Anna; Mikkelsen, Irene K.; Ostergaard, Leif; Mouridsen, Kim] Aarhus Univ, MINDLab, Inst Clin Med, Aarhus, Denmark; [Tietze, Anna] Charite Univ Med Berlin, Inst Neuroradiol, Berlin, Germany; [Haack, Soren] Aarhus Univ Hosp, Dept Clin Engn, Aarhus, Denmark; [Haack, Soren] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; [Kallehauge, Jesper; Ostergaard, Leif] Aarhus Univ Hosp, Dept Med Phys, Aarhus, Denmark	Aarhus University; Aarhus University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Aarhus University; Aarhus University; Aarhus University	Hansen, MB (corresponding author), Aarhus Univ, Ctr Functionally Integrat Neurosci, Inst Clin Med, Aarhus, Denmark.; Hansen, MB (corresponding author), Aarhus Univ, MINDLab, Inst Clin Med, Aarhus, Denmark.	mbhansen@cfin.au.dk	Ostergaard, Lars/AAA-3020-2020; Hansen, Mikkel B/A-5899-2009; Østergaard, Leif/A-9281-2008; Tietze, Anna/H-3333-2018	Ostergaard, Lars/0000-0003-2459-0511; Hansen, Mikkel B/0000-0002-8619-1519; Østergaard, Leif/0000-0003-2930-6997; Tietze, Anna/0000-0002-2601-9055; Kallehauge, Jesper Folsted/0000-0003-3705-5390; Ostergaard, Lars/0000-0002-7619-605X	Danish National Research Foundation (CFIN); Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab); Lundbeckfonden; Central region Denmark research grant; VELUX Foundation (ARCADIA)	Danish National Research Foundation (CFIN); Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab); Lundbeckfonden(Lundbeckfonden); Central region Denmark research grant; VELUX Foundation (ARCADIA)	This study was supported by the Danish National Research Foundation (CFIN; KM, LO), the Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab; KM, MBH, LO, IKM, AT), the Lundbeckfonden (AT, IKM, KM), the Central region Denmark research grant (AT), and the VELUX Foundation (ARCADIA; LO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Danish National Research Foundation (CFIN; KM, LO), the Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab; KM, MBH, LO, IKM, AT), and the VELUX Foundation (ARCADIA; LO).	Bisdas S, 2011, ACAD RADIOL, V18, P575, DOI 10.1016/j.acra.2011.01.018; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Dikaios N, 2017, COMPUT MED IMAG GRAP, V56, P1, DOI 10.1016/j.compmedimag.2017.01.003; Dikaios N, 2014, MED IMAGE ANAL, V18, P989, DOI 10.1016/j.media.2014.05.001; DONAHUE KM, 1994, MAGNET RESON MED, V32, P66, DOI 10.1002/mrm.1910320110; Duan C, 2016, MAGNETIC RESONANCE M; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hansen MB, 2016, J MAGN RESON IMAG; Heye T, 2013, RADIOLOGY, V266, P812, DOI 10.1148/radiol.12120255; Heye T, 2013, RADIOLOGY, V266, P801, DOI 10.1148/radiol.12120278; Huang W, 2014, TRANSL ONCOL, V7, P153, DOI 10.1593/tlo.13838; Kallehauge J, 2013, ACTA ONCOL, V52, P1360, DOI 10.3109/0284186X.2013.813637; Li X, 2012, MAGN RESON MED, V68, P261, DOI 10.1002/mrm.23205; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Luypaert R, 2010, PHYS MED BIOL, V55, P6431, DOI 10.1088/0031-9155/55/21/006; Mouridsen K, 2014, J CEREBR BLOOD F MET, V34, P1511, DOI 10.1038/jcbfm.2014.111; Orton MR, 2007, PHYS MED BIOL, V52, P2393, DOI 10.1088/0031-9155/52/9/005; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Patankar TF, 2005, AM J NEURORADIOL, V26, P2455; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Schmid VJ, 2006, LECT NOTES COMPUT SC, V4190, P679; Schmid VJ, 2006, IEEE T MED IMAGING, V25, P1627, DOI 10.1109/TMI.2006.884210; Sharma P, 2006, J MAGN RESON IMAGING, V23, P323, DOI 10.1002/jmri.20504; Shiroishi MS, 2011, TECHNOL CANCER RES T, V10, P59, DOI 10.7785/tcrt.2012.500180; Sommer JC, 2014, J R STAT SOC C-APPL, V63, P695, DOI 10.1111/rssc.12057; Sommer JC, 2014, STAT MED, V33, P1029, DOI 10.1002/sim.5997; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tietze A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202906; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Yang C, 2009, MAGN RESON MED, V61, P851, DOI 10.1002/mrm.21912	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209891	10.1371/journal.pone.0209891	http://dx.doi.org/10.1371/journal.pone.0209891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605459	Green Submitted, Green Published, gold			2022-12-26	WOS:000454759900022
J	Roos, LR; Nair, MS; Rendahl, AK; Pieters, M				Roos, Luiza R.; Nair, Meera Surendran; Rendahl, Aaron K.; Pieters, Maria			Mycoplasma hyorhinis and Mycoplasma hyosynoviae dual detection patterns in dams and piglets	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CARRIER STATE; PIG HERDS; ARTHRITIS; INFECTION; ASSOCIATION; TONSILLAR; ORGANISM; SERUM	Mycoplasma hyorhinis and M. hyosynoviae are agents associated with arthritis in pigs. This study investigated the tonsillar detection patterns of M. hyorhinis and M. hyosynoviae in a swine population with a history of lameness. The plausibility of dual PCR detection of these agents in dams at one and three weeks post-farrowing and their offspring at the same time was determined. The association between M. hyorhinis and M. hyosynoviae detection in piglets and potential development of lameness in wean-to-finish stages was evaluated by correlating individual piglet lameness scores and PCR detection in tonsils. Approximately 40% of dams were detected positive for M. hyorhinis and M. hyosynoviae at both one and three weeks post-farrowing. In first parity dams, M. hyorhinis was detected in higher proportions (57.1% and 73.7%) at both weeks of sampling compared to multi-parity dams. A lower proportion of first parity dams (37.5%) were detected positive at week one with M. hyosynoviae and an increase in this proportion to 50% was identified in week three. Only 8.3% of piglets were detected positive for M. hyorhinis in week one compared to week three (50%; p<0.05). The detection of M. hyosynoviae was minimal in piglets at both weeks of sampling (0% and 0.9%). Lameness was scored in pigs 5-22 weeks of age, with the highest score observed at week 5. The correlation between PCR detection and lameness scores revealed that the relative risk of developing lameness post-weaning was significantly associated with detection of M. hyorhinis in piglets at three weeks of age (r = 0.44; p<0.05). The detection pattern of M. hyorhinis and M. hyosynoviae in dams did not reflect the detection pattern in piglets. Results of this study suggest that positive detection of M. hyorhinis in piglets preweaning could act as a predictor for lameness development at later production stages.	[Roos, Luiza R.; Nair, Meera Surendran; Rendahl, Aaron K.; Pieters, Maria] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Pieters, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	piet0094@umn.edu		Rendahl, Aaron/0000-0001-5434-3592				BARDEN JA, 1971, ARTHRITIS RHEUM, V14, P193, DOI 10.1002/art.1780140202; Clavijo MJ, 2017, VET REC, V181, P68, DOI 10.1136/vr.104064; Clavijo MJ, 2014, J VET DIAGN INVEST, V26, P755, DOI 10.1177/1040638714555175; FRIIS NF, 1994, ACTA VET SCAND, V35, P93; Gois M, 2010, ZENTRALBLATT VETER B, V24, P89, DOI [10.1111/j.1439-0450.1977.tb00978.x, DOI 10.1111/J.1439-0450.1977.TB00978.X]; Gois M, 2010, ZENTRALBLATT VETER B, V21, P352, DOI [10.1111/j.1439-0450.1974.tb00510.x, DOI 10.1111/J.1439-0450.1974.TB00510.X]; Hagedorn-Olsen T, 1999, J VET MED A, V46, P555, DOI 10.1046/j.1439-0442.1999.00246.x; Hagedorn-Olsen T, 1999, APMIS, V107, P201, DOI 10.1111/j.1699-0463.1999.tb01545.x; Hagedorn-Olsen T, 1999, J VET MED A, V46, P317, DOI 10.1046/j.1439-0442.1999.00217.x; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Lauritsen KT, 2017, VET IMMUNOL IMMUNOP, V183, P22, DOI 10.1016/j.vetimm.2016.12.002; Lauritsen KT, 2008, VET MICROBIOL, V130, P385, DOI 10.1016/j.vetmic.2008.02.002; Luehrs A, 2017, VET MICROBIOL, V203, P1, DOI 10.1016/j.vetmic.2017.02.001; Neto J.C.G., 2012, THESIS; Neto JG, 2000, J SWINE HEALTH PROD, V20, P82; Neto JCG, 2015, J VET SCI, V16, P195, DOI 10.4142/jvs.2015.16.2.195; Nielsen EO, 2005, VET MICROBIOL, V111, P41, DOI 10.1016/j.vetmic.2005.08.009; Nielsen EO, 2001, J VET MED A, V48, P475, DOI 10.1046/j.1439-0442.2001.00378.x; Potgieter LND, 1972, AM J VET RES; ROBERTS ED, 1963, AM J VET RES, V24, P9; ROSS RF, 1970, J AM VET MED ASSOC, V157, P1515; ROSS RF, 1973, AM J VET RES, V34, P373; Schwartz J, 2014, AM ASS SWIN VET ANN, P115; Sibila M, 2004, VET REC, V155, P57, DOI 10.1136/vr.155.2.57; SWITZER WP, 1955, AM J VET RES, V16, P540; Thacker EL, 2004, J SWINE HEALTH PROD, V12, P252	26	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0209975	10.1371/journal.pone.0209975	http://dx.doi.org/10.1371/journal.pone.0209975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605453	Green Published, Green Submitted, gold			2022-12-26	WOS:000454759900024
J	Tan, SY; Arshad, H; Abdullah, A				Tan, Siok Yee; Arshad, Haslina; Abdullah, Azizi			Distinctive accuracy measurement of binary descriptors in mobile augmented reality	PLOS ONE			English	Article								Mobile Augmented Reality (MAR) requires a descriptor that is robust to changes in viewing conditions in real time application. Many different descriptors had been proposed in the literature for example floating-point descriptors (SIFT and SURF) and binary descriptors (BRIEF, ORB, BRISK and FREAK). According to literature, floating-point descriptors are not suitable for real-time application because its operating speed does not satisfy real-time constraints. Binary descriptors have been developed with compact sizes and lower computation requirements. However, it is unclear which binary descriptors are more appropriate for MAR. Hence, a distinctive and efficient accuracy measurement of four state-of-the-art binary descriptors, namely, BRIEF, ORB, BRISK and FREAK were performed using the Mikolajczyk dataset and ALOI dataset to identify the most appropriate descriptor for MAR in terms of computation time and robustness to brightness, scale and rotation changes. The obtained results showed that FREAK is the most appropriate descriptor for MAR application as it able to produce an application that are efficient (shortest computation time) and robust towards scale, rotation and brightness changes.	[Tan, Siok Yee; Arshad, Haslina; Abdullah, Azizi] Univ Kebangsaan Malaysia, Ctr Artificial Intelligence & Technol, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Tan, SY (corresponding author), Univ Kebangsaan Malaysia, Ctr Artificial Intelligence & Technol, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia.	esther@ukm.edu.my	Tan, Siok Yee/V-5845-2018; arshad, haslina/AAF-8737-2019	Tan, Siok Yee/0000-0003-3566-9938; 	Universiti Kebangsaan Malaysia [GGPM-2018-011 (Geran Galakan Penyelidik Muda-2018-011), TD-2016-003 (Top Down-2016-003)]	Universiti Kebangsaan Malaysia	This research paper was fully sponsored by Universiti Kebangsaan Malaysia with grant number GGPM-2018-011 (Geran Galakan Penyelidik Muda-2018-011) and TD-2016-003 (Top Down-2016-003). Grant number TD-2016-003 had provided the necessary equipment and accessories like high performance laptop and android smartphone which used for development, analysis and evaluation purpose. Furthermore, grant number GGPM-2018-011 had sponsored this research paper in term of the publication fees.	Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; [Anonymous], P BR MACH VIS C 2003, DOI [10.5244/C.17.79, DOI 10.5244/C.17.79]; Arshad H, 2017, INT J ADV SCI ENG IN, V7, P496; Azuma R, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.963459; Azuma RT, 1997, PRESENCE-VIRTUAL AUG, V6, P355, DOI 10.1162/pres.1997.6.4.355; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Bleser G., 2009, VISUAL INERTIAL SLAM; Calle-Bustos AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184645; Calonder M, 2010, LECT NOTES COMPUT SC, V6314, P778, DOI 10.1007/978-3-642-15561-1_56; Geusebroek JM, 2005, INT J COMPUT VISION, DOI [10.1007/s11263-005-3849-9, DOI 10.1007/S11263-005-3849-9]; Henrysson A, 2007, GRAPHITE 2007: 5TH INTERNATIONAL CONFERENCE ON COMPUTER GRAPHICS AND INTERACTIVE TECHNIQUES IN AUSTRALASIA AND SOUTHERN ASIA, PROCEEDINGS, P187; Hou YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159185; Isi k, 2014, INT J APPL MATH ELEC, V3, DOI [10.18100/ijamec.60004, DOI 10.18100/IJAMEC.60004]; Kanan C, 2010, LECT NOTES COMPUTER, DOI [10.1007/978-3-642-17289-2_20, DOI 10.1007/978-3-642-17289-2_20]; Ke Y., 2004, P 2004 IEEE COMP SOC, V2, pII, DOI [10.1109/CVPR.2004.1315206, DOI 10.1109/CVPR.2004.1315206]; Khvedchenia I., 2011, FEATURE DESCRIPTOR C, P1; Kolivand H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108334; Koyasu H., 2014, ADV VISUAL COMPUTING, VVolume 8888, P315, DOI [10.1007/978-3-319-14364-4_30, DOI 10.1007/978-3-319-14364-4_30]; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lowe G, 2004, INT J-TORONTO, V2, P91, DOI DOI 10.1023/B:VISI.0000029664.99615.94; Martin P, 2014, IEEE IMAGE PROC, P3352, DOI 10.1109/ICIP.2014.7025678; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Molla Eray, 2010, 2010 9th IEEE International Symposium on Mixed and Augmented Reality (ISMAR). Science & Technology Papers, P253, DOI 10.1109/ISMAR.2010.5643593; Naimark L, 2002, INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P27, DOI 10.1109/ISMAR.2002.1115065; Niu YT, 2015, ACSR ADV COMPUT, V35, P153; Nizam SSM, 2018, ADV MULTIMED, V2018, DOI 10.1155/2018/5320984; Obeidy Waqas Khalid, 2015, Advances in Visual Informatics. 4th International Visual Informatics Conference, IVIC 2015. Proceedings: LNCS 9429, P99, DOI 10.1007/978-3-319-25939-0_9; Obeidy WK, 2013, LECT NOTES COMPUT SC, V8237, P447, DOI 10.1007/978-3-319-02958-0_41; Obeidy WK, 2014, MARKERLESS HYBRID TR; Pu M, 2017, INT J ADV SCI ENG IN, V7, P153; Quack T, 2008, LECT NOTES COMPUT SC, V4952, P230; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Rusinol M, 2015, PROC INT CONF DOC, P596, DOI 10.1109/ICDAR.2015.7333831; Sadik M.J., 2017, J ENG APPL SCI, V12, P2098; Satoh K, 2001, IEEE AND ACM INTERNATIONAL SYMPOSIUM ON AUGMENTED REALITY, PROCEEDINGS, P67, DOI 10.1109/ISAR.2001.970516; Shang LW., 2016, J TELECOMMUN ELECT C, V8, P135; Tan SY, 2014, 3 NAT DOCT SEM ART I, P1; Tan SY, 2016, J THEOR APPL INF TEC, V93; Tilak, 2015, REAL TIME MOBILE AUG; Tournier T, 2012, P INT WORKSH CONT BA, P43; Uchimura H, 2012, FISCAL DECENTRALIZATION AND DEVELOPMENT: EXPERIENCES OF THREE DEVELOPING COUNTRIES IN SOUTHEAST ASIA, P1; Ufkes A, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTER AND ROBOT VISION (CRV), P226, DOI 10.1109/CRV.2013.51; van de Sande KEA, 2010, IEEE T PATTERN ANAL, V32, P1582, DOI 10.1109/TPAMI.2009.154; Van Wyk C, 2011, MARKERLESS AUGMENTED; Wagner D, 2006, THESIS, P2008, DOI [10.1109/ISMAR.2007.4538819, DOI 10.1109/ISMAR.2007.4538819]; Wagner D, 2008, INT SYM MIX AUGMENT, P121, DOI 10.1109/ISMAR.2008.4637337; Wagner D, 2008, INT SYM MIX AUGMENT, P125, DOI 10.1109/ISMAR.2008.4637338; Wendt FL, 2008, LECT NOTES COMPUT SC, V5099, P439, DOI 10.1007/978-3-540-69905-7_50; Yu F., 2010, REAL TIME AUGMENTED; Yunchao Z, 2014, HIGH TECHNOL LETT, V20, P301	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0207191	10.1371/journal.pone.0207191	http://dx.doi.org/10.1371/journal.pone.0207191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605474	Green Published, Green Submitted, gold			2022-12-26	WOS:000454759900006
J	Kuo, SM; Chen, YR; Yin, SY; Ba, QX; Tsai, YC; Kuo, WHJ; Lin, YR				Kuo, Shu-meng; Chen, Yu-ru; Yin, Song-yu; Ba, Qing-xiong; Tsai, Yuan-ching; Kuo, Warren H. J.; Lin, Yann-rong			Waxy allele diversification in foxtail millet (Setaria italica) landraces of Taiwan	PLOS ONE			English	Article							L. P. BEAUV.; LOW-AMYLOSE CONTENT; MOLECULAR CHARACTERIZATION; GENOME SEQUENCE; GENE; ENDOSPERM; WHEAT; IDENTIFICATION; MUTANTS; ORIGINS	Foxtail millet (Setaria italica (L.) P. Beauv.), the second most cultivated millet species, is well adapted to diverse environments and remains an important cereal food and forage crop in arid and semiarid regions worldwide. A symbolic crop for indigenous Austronesian peoples, foxtail millet has been cultivated in Taiwan for more than 5,000 years, and landraces reflect diversifying selection for various food applications. A total of 124 accessions collected within Taiwan were assessed for Wx genotypes. Four identified Wx alleles, I, III, IV, and IX were caused by insertion of various transposable elements (TEs) and resulted in endosperm with non-waxy, low amylose content (AC), and waxy, respectively. A total of 16.9%, 4.0%, 49.2%, and 29.8% of accessions were classified as type I, III, IV, and IX, respectively; approximately half of the accessions belonged to the waxy type, indicating that glutinous grains were favored for making traditional food and wine. The TE insertion affected splicing efficiency rather than accuracy, leading to significantly reduced expression of wx in types III, IV, and IX, although their transcripts were the same as wild-type, type I. Consequently, the granule-bound starch synthase I (GBSSI) contents of the three mutated genotypes were relatively low, leading to waxy or low AC endosperm, and the Wx genotypes could explain 78% of variance in AC. The geographic distribution of Wx genotypes are associated with culinary preferences and migration routes of Taiwanese indigenous peoples-in particular, the genotype of landraces collected from Orchid Island was distinct from those from Taiwan Island. This information on the major gene regulating starch biosynthesis in foxtail millet endosperm can be applied to breeding programs for grain quality, and contributes to knowledge of Austronesian cultures.	[Kuo, Shu-meng; Yin, Song-yu; Ba, Qing-xiong; Kuo, Warren H. J.; Lin, Yann-rong] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Chen, Yu-ru] Agr Res Inst Taiwan, Crop Sci Div, Taichung, Taiwan; [Tsai, Yuan-ching] Natl Chiayi Univ, Dept Agron, Chiayi, Taiwan	National Taiwan University; Agricultural Research Institute of Taiwan; National Chiayi University	Lin, YR (corresponding author), Natl Taiwan Univ, Dept Agron, Taipei, Taiwan.	ylin@ntu.edu.tw		Lin, Yann-rong/0000-0001-6833-8276	Ministry of Science and Technology of Taiwan [MOST 104-2313-B-002 -014 -MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by the Ministry of Science and Technology (MOST 104-2313-B-002 -014 -MY3) of Taiwan (https://www.most.gov.tw/) to YL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal M, 1996, VARIATION ELECTROPHO; Austin DF, 2006, ECON BOT, V60, P143, DOI 10.1663/0013-0001(2006)60[143:FMSPFI]2.0.CO;2; Ayala M, 2015, THEOR APPL GENET, V128, P2427, DOI 10.1007/s00122-015-2597-7; Baltensperger DD, 2002, TRENDS NEW CROPS NEW; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Blust Robert, 1999, 8 INT C AUSTR LING, P31; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Chang CS, 2015, P NATL ACAD SCI USA, V112, P13537, DOI 10.1073/pnas.1503205112; Chen H, 2014, CROP SCI, V54, P2152, DOI 10.2135/cropsci2013.08.0548; Diao X, 2016, GENETICS GENOMICS SE, P61; Domon E, 2002, GENES GENET SYST, V77, P351, DOI 10.1266/ggs.77.351; Doust AN, 2002, AM J BOT, V89, P1203, DOI 10.3732/ajb.89.8.1203; Fan LJ, 2008, MOL BREEDING, V22, P329, DOI 10.1007/s11032-008-9178-2; Fan XY, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0677-x; Fukunaga K, 2002, MOL GENET GENOMICS, V268, P214, DOI 10.1007/s00438-002-0728-8; Grimaud F, 2008, J EXP BOT, V59, P3395, DOI 10.1093/jxb/ern198; Hachiken T, 2013, GENET RESOUR CROP EV, V60, P1559, DOI 10.1007/s10722-012-9942-3; Hachiken T, 2012, MOL BREEDING, V30, P1747, DOI 10.1007/s11032-012-9758-z; He SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137088; Hirano R, 2011, GENOME, V54, P498, DOI [10.1139/G11-015, 10.1139/g11-015]; Hsieh XL, 1989, STUDIES WAXY GENE EX; Hunt HV, 2010, MOL BIOL EVOL, V27, P1478, DOI 10.1093/molbev/msq040; Isshiki M, 1998, PLANT J, V15, P133, DOI 10.1046/j.1365-313X.1998.00189.x; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Kawase M, 2005, MOL GENET GENOMICS, V274, P131, DOI 10.1007/s00438-005-0013-8; Kellogg EA, 2009, INT J PLANT SCI, V170, P117, DOI 10.1086/593043; KIDA T., 1941, Journal of the Taihoku Society of Agriculture and Forestry, V5, P150; LI HW, 1945, J AM SOC AGRON, V37, P32; Lin BN, 2017, PLANT BREEDING, V136, P206, DOI 10.1111/pbr.12449; Lin HengSheng, 2012, Australian Journal of Crop Science, V6, P342; Liu LL, 2009, PLANT MOL BIOL, V71, P609, DOI 10.1007/s11103-009-9544-4; Loo JH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-21; Lu YG, 2013, GENOME, V56, P283, DOI 10.1139/gen-2013-0047; Marillonnet S, 1997, PLANT CELL, V9, P967, DOI 10.1105/tpc.9.6.967; Mikami I, 1999, EUPHYTICA, V105, P91, DOI 10.1023/A:1003457209225; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakayama H, 1998, EUPHYTICA, V102, P289, DOI 10.1023/A:1018344819531; Pedersen JF, 2005, EUPHYTICA, V144, P151, DOI 10.1007/s10681-005-5298-5; Pedersen JF, 2004, CROP SCI, V44, P764; RAHMAN S, 1995, AUST J PLANT PHYSIOL, V22, P793, DOI 10.1071/PP9950793; Ross Malcolm, 2005, J AUSTRONESIAN STUDI, V1, P1; Saito M, 2004, THEOR APPL GENET, V108, P1205, DOI 10.1007/s00122-003-1549-9; Sakamoto S., 1978, B NAT MUSEUM ETHNOL, V3, P682; Saleh ASM, 2013, COMPR REV FOOD SCI F, V12, P281, DOI 10.1111/1541-4337.12012; Sanchez-Mazas A, 2005, PEOPLING E ASIA PUTT, P273; Sato H, 2002, BREEDING SCI, V52, P131, DOI 10.1270/jsbbs.52.131; Sattler SE, 2009, MOL BREEDING, V24, P349, DOI 10.1007/s11032-009-9296-5; Taitung Sustainable Development Society, 2018, SUST DEV GREEN EC TA; Tian MengLiang, 2008, Acta Agronomica Sinica, V34, P729, DOI 10.3724/SP.J.1006.2008.00729; Till-Bottraud I, 1992, THEOR APPL GENET, V83, P940, DOI 10.1007/BF00232954; Tsang CH, 2017, BOT STUD, V58, DOI 10.1186/s40529-016-0158-2; Van Eck J, 2015, METHODS MOL BIOL, V1223, P57, DOI 10.1007/978-1-4939-1695-5_5; Van K, 2008, MOL GENET GENOMICS, V279, P255, DOI 10.1007/s00438-007-0310-5; Vinoth A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00029; Vrinten P, 1999, MOL GEN GENET, V261, P463, DOI 10.1007/s004380050989; Wang RY, 2018, CROP J, V6, P377, DOI 10.1016/j.cj.2018.02.004; Wu XY, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0612-6; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang LL, 2017, THEOR APPL GENET, V130, P1321, DOI 10.1007/s00122-017-2878-4; Zhao Q, 2018, NAT GENET, V50, P279, DOI 10.1038/s41588-018-0041-z	60	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210025	10.1371/journal.pone.0210025	http://dx.doi.org/10.1371/journal.pone.0210025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596758	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200127
J	Ryoo, NK; Ahn, SJ; Park, KH; Ahn, J; Seo, J; Han, JW; Kim, KW; Woo, SJ				Ryoo, Na-Kyung; Ahn, Seong Joon; Park, Kyu Hyung; Ahn, Jeeyun; Seo, Jiyeong; Han, Ji Won; Kim, Ki Woong; Woo, Se Joon			Thickness of retina and choroid in the elderly population and its association with Complement Factor H polymorphism: KLoSHA Eye study	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; MACULAR-DEGENERATION; VASCULAR HYPERPERMEABILITY; AGE; CHORIOCAPILLARIS; PREVALENCE; ETHNICITY; MEMBRANE; OCT	Purpose To analyze the associations of retinal and choroidal thickness on enhanced-depth imaging optical coherence tomography (EDI-OCT) with clinical, ophthalmic and genetic factors in the normal elderly population (aged 65 years or older). Methods In this prospective, population-based cohort study, people aged 65 years or older were enrolled in the baseline study of the Korean Longitudinal Study on Health and Aging (KLoSHA) Eye Study. All participants underwent spectral domain-OCT scan using the EDI technique. A topographic map of the retina was obtained and subfoveal choroidal thickness (SFCT) was measured manually. Blood samples from all subjects were genotyped for major age-related macular degeneration (AMD)-associated single nucleotide polymorphisms (SNPs) the major AMD-associated SNPs; CFH Y402H rs1061170, CFH I62V rs800292, ARMS2 A69S rs10490924. A statistical analysis was conducted to compare the retinal thickness, choroidal thickness, and AMD risk genotypes. Results Among the three hundred eighty people enrolled, the mean age was 76.6 years (range 6599 years). Factors that showed correlation with either tomographic retinal parameters, retinal nerve fiber layer, or SFCT, were age and gender. Significant age-related decrease in thickness was observed in the RNFL, mean central thickness (MCT) and SFCT. Gender differences existed in central foveolar thickness (CFT) and MCT, where it was thicker in men. While chorioretinal parameters were not related with other genotypes, CFH rs1061170 risk genotype was significantly associated with thin SFCT. The group containing the AMD-risk allele (CT) had a 14.7% reduction in the SFCT compared to the non-risk TT group. Conclusions In addition to the well-known association with AMD, CFH rs1061170 is a significant genetic risk factor associated with choroidal thinning in normal eyes of the elderly population. Such findings may provide further insight into the pathogenesis of age-related macular degeneration as well as normal aging. In addition, our study provides the first normative data on retinal and choroidal thickness in population-based aged groups with a mean age over seventy-five.	[Ryoo, Na-Kyung; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea; [Ryoo, Na-Kyung] Vet Hlth Serv Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Ahn, Seong Joon] Hanyang Univ, Dept Ophthalmol, Seoul, South Korea; [Ahn, Jeeyun] Seoul Natl Univ, Boramae Med Ctr, Dept Ophthalmol, Seoul Metropolitan Govt, Seoul, South Korea; [Seo, Jiyeong] Gyeongsang Natl Univ Hosp, Changwon Hosp, Dept Psychiat, Chang Won, South Korea; [Han, Ji Won; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seongnam, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Neuropsychiat, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea	Seoul National University (SNU); Veterans Health Service Medical Center; Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	sejoon1@snu.ac.kr	Woo, Se Joon/I-7357-2013	Woo, Se Joon/0000-0003-3692-7169; Ahn, Jeeyun/0000-0001-9017-1652	Seoul National University Bundang Hospital Research Funds [11-2008-002, 03-2009-008, 11-2009-037, 11-2010-037, 18-2018-024]; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2009-0072603]; NRF [2016R1D1A1B03934724]; NRF Bio & Medical Technology Development Program - Korean government (MSIP) [2018M3A9B5021319]; NRF Bio & Medical Technology Development Program - Korean government (MSIT) [2018M3A9B5021319]; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI09C1379 [A092077], A111161]	Seoul National University Bundang Hospital Research Funds; National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); NRF; NRF Bio & Medical Technology Development Program - Korean government (MSIP); NRF Bio & Medical Technology Development Program - Korean government (MSIT); Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by Seoul National University Bundang Hospital Research Funds (grant nos. 11-2008-002, 03-2009-008, 11-2009-037, 11-2010-037, 18-2018-024 [PMC]), a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science, and Technology (2009-0072603), NRF grant 2016R1D1A1B03934724 and the NRF Bio & Medical Technology Development Program (grant no. 2018M3A9B5021319) funded by the Korean government (MSIP and MSIT), and grants from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant nos. HI09C1379 [A092077] and A111161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037638; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; DeAngelis MM, 2011, SEMIN OPHTHALMOL, V26, P77, DOI 10.3109/08820538.2011.577129; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Esmaeelpour M, 2014, INVEST OPHTH VIS SCI, V55, P5074, DOI 10.1167/iovs.14-14646; FEENEYBURNS L, 1990, AM J OPHTHALMOL, V109, P265, DOI 10.1016/S0002-9394(14)74549-0; Fein JG, 2014, OPHTHAL SURG LAS IM, V45, P32, DOI 10.3928/23258160-20131220-04; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Hosoda Y, 2018, P NATL ACAD SCI USA, V115, P6261, DOI 10.1073/pnas.1802212115; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Jylhava J, 2009, EXP GERONTOL, V44, P297, DOI 10.1016/j.exger.2008.10.006; Kanamori A, 2003, OPHTHALMOLOGICA, V217, P273, DOI 10.1159/000070634; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Kim Jeehyoung, 2016, Dent Hypotheses, V7, P73; Kim NR, 2011, INVEST OPHTH VIS SCI, V52, P3413, DOI 10.1167/iovs.10-6648; Lattanzio R, 2002, EUR J OPHTHALMOL, V12, P482, DOI 10.1177/112067210201200606; Lee BR, 2009, RETINA-J RET VIT DIS, V29, P1328, DOI 10.1097/IAE.0b013e3181ac7d30; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Mullins RF, 2014, AM J PATHOL, V184, P3142, DOI 10.1016/j.ajpath.2014.07.017; Oshitari T, 2007, CLIN OPHTHALMOL, V1, P133; Park JH, 2007, PSYCHIAT INVEST, V4, P80; Poinoosawmy D, 1997, BRIT J OPHTHALMOL, V81, P350, DOI 10.1136/bjo.81.5.350; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Restrepo NA, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14246; Roh Young-Rae, 2013, Korean J Ophthalmol, V27, P268, DOI 10.3341/kjo.2013.27.4.268; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Shin JW, 2012, OPHTHALMOLOGY, V119, P1017, DOI 10.1016/j.ophtha.2011.10.029; Sohn EH, 2014, INVEST OPHTH VIS SCI, V55, P1352, DOI 10.1167/iovs.13-13754; Toprak AB, 2000, BRIT J OPHTHALMOL, V84, P473, DOI 10.1136/bjo.84.5.473; Wakitani Y, 2003, RETINA-J RET VIT DIS, V23, P177, DOI 10.1097/00006982-200304000-00007; Wexler A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-13; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Woo SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132771; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yoneyama S, 2016, RETINA-J RET VIT DIS, V36, P1535, DOI 10.1097/IAE.0000000000000964	40	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209276	10.1371/journal.pone.0209276	http://dx.doi.org/10.1371/journal.pone.0209276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596689	Green Submitted, gold, Green Published			2022-12-26	WOS:000454627200039
J	Wang, HC; Lin, YT; Lin, TH; Chang, NJ; Lin, CC; Hsu, HC; Yeh, ML				Wang, Hsueh-Chun; Lin, Yi-Ting; Lin, Tzu-Hsiang; Chang, Nai-Jen; Lin, Chih-Chan; Hsu, Horng-Chaung; Yeh, Ming-Long			Intra-articular injection of N-acetylglucosamine and hyaluronic acid combined with PLGA scaffolds for osteochondral repair in rabbits	PLOS ONE			English	Article							BONE-MARROW; ANGIOGENIC OLIGOSACCHARIDES; CHONDROGENIC DIFFERENTIATION; GLUCOSAMINE SULFATE; KNEE OSTEOARTHRITIS; HYALINE CARTILAGE; CELLS; REGENERATION; PLACEBO; PROGRESSION	Repairing damaged articular cartilage is particularly challenging because of the limited ability of cartilage to perform self-repair. Intra-articular injections of N-acetylglucosamine (GlcNAc) comprise a method of repairing full-thickness articular cartilage defects in the rabbit knee joint model. To date, the effects of administration of GlcNAc and hyaluronic acid (HA) have been investigated only in the context of osteoarthritis treatment. Therefore, we evaluated the therapeutic effects of using cell-free porous poly lactic-co-glycolic acid (PLGA) graft implants and intra-articular injections of GlcNAc or HA in a rabbit model of osteochondral regeneration to investigate whether they have the potential for inducing osteochondral regeneration when used alone or simultaneously. Twenty-four rabbits were randomized into one of four groups: the scaffold-only group (PLGA), the scaffold with intraarticular injections of GlcNAc (PLGA+G) group, twice per week for four weeks; the scaffold with intra-articular injections of HA group (PLGA+HA) group, once per week for three weeks; and the scaffold with intra-articular injections of GlcNAc and HA (PLGA+G+HA) group, once per week for three weeks. Knees were evaluated at 4 and 12 weeks after surgery. At the end of testing, only the PLGA+G+HA group exhibited significant bone reconstruction, chondrocyte clustering, and good interactions with adjacent surfaces at 4 weeks. Additionally, the PLGA+G+HA group demonstrated essentially original hyaline cartilage structures that appeared to have sound chondrocyte orientation, considerable glycosaminoglycan levels, and reconstruction of the bone structure at 12 weeks. Moreover, the PLGA+G+HA group showed organized osteochondral integration and significantly higher bone volume per tissue volume and trabecular thickness. However, there were no significant differences between the PLGA+G and PLGA+HA groups except for gap formation on subchondral bone in the PLGA+G group. This study demonstrated that PLGA implantation combined with intra-articular injections of GlcNAc and HA allowed for cartilage and bone regeneration and significantly promoted osteochondral regeneration in rabbits without supplementation of exogenous growth factors. And the combination of this two supplements with PLGA scaffold could also prolong injection interval and better performance than either of them alone for the reconstruction of osteochondral tissue in the knee joints of rabbits.	[Wang, Hsueh-Chun; Lin, Yi-Ting; Lin, Tzu-Hsiang; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Chang, Nai-Jen] Kaohsiung Med Univ, Dept Sports Med, Kaohsiung, Taiwan; [Lin, Chih-Chan] Chi Mei Med Ctr, Dept Med Res, Lab Anim Ctr, Tainan, Taiwan; [Hsu, Horng-Chaung] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Chi Mei Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University	Yeh, ML (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Yeh, ML (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	mlyeh@mail.ncku.edu.tw	Chang, Nai-Jen/L-5777-2019	Chang, Nai-Jen/0000-0001-8408-8334	Ministry of Science and Technology, Taiwan [101-2221-E-006-062-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan (grant 101-2221-E-006-062-MY3).	Arkill KP, 2008, OSTEOARTHR CARTILAGE, V16, P708, DOI 10.1016/j.joca.2007.10.001; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; BROWN TJ, 1991, EXP PHYSIOL, V76, P125, DOI 10.1113/expphysiol.1991.sp003474; Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201; Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016; Chang NJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0100-y; Chang NJ, 2015, ACTA BIOMATER, V28, P128, DOI 10.1016/j.actbio.2015.09.026; Chang NJ, 2013, ANN BIOMED ENG, V41, P385, DOI 10.1007/s10439-012-0656-7; Chang NJ, 2012, BIOMATERIALS, V33, P3153, DOI 10.1016/j.biomaterials.2011.12.054; Chiang H, 2013, OSTEOARTHR CARTILAGE, V21, P589, DOI 10.1016/j.joca.2013.01.004; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; de Haart M, 1999, ACTA ORTHOP SCAND, V70, P55, DOI 10.3109/17453679909000959; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242; FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43; Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427; Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7; Hansen M K, 1975, Ugeskr Laeger, V137, P617; Henderson IJP, 2005, KNEE, V12, P435, DOI 10.1016/j.knee.2005.04.003; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Jiang YZ, 2010, TISSUE ENG PT A, V16, P1621, DOI [10.1089/ten.tea.2009.0681, 10.1089/ten.TEA.2009.0681]; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df; Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37; Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008; Mendelson A, 2011, FASEB J, V25, P3496, DOI 10.1096/fj.10-176305; Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137; Miskowiec Krzysztof, 2016, Przegl Lek, V73, P221; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; Nagaoka I, 2012, ADV FOOD NUTR RES, V65, P337, DOI 10.1016/B978-0-12-416003-3.00022-6; NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003; NAMIKI O, 1982, INT J CLIN PHARM TH, V20, P501; O'Driscoll SW, 2001, TISSUE ENG, V7, P313, DOI 10.1089/10763270152044170; Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034; Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883; Pavelka K, 2002, ARCH INTERN MED, V162, P2113, DOI 10.1001/archinte.162.18.2113; Reginster JY, 2001, LANCET, V357, P251, DOI 10.1016/S0140-6736(00)03610-2; SATO H, 1988, ARTHRITIS RHEUM, V31, P63, DOI 10.1002/art.1780310110; Sawitzke AD, 2010, ANN RHEUM DIS, V69, P1459, DOI 10.1136/ard.2009.120469; Schagemann JC, 2013, J BIOMED MATER RES A, V101, P1620, DOI 10.1002/jbm.a.34457; Schlichting K, 2008, AM J SPORT MED, V36, P2379, DOI 10.1177/0363546508322899; Shea KG JJJ, 2012, CLIN ORTHOP RELAT RE; Shikhman AR, 2005, ANN RHEUM DIS, V64, P89, DOI 10.1136/ard.2003.019406; Shikhman AR, 2001, J IMMUNOL, V166, P5155, DOI 10.4049/jimmunol.166.8.5155; Shim JH, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/014102; Slevin M, 2004, INT J CANCER, V109, P793, DOI 10.1002/ijc.20059; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487; Yang JR, 2018, ACTA BIOMATER, V74, P156, DOI 10.1016/j.actbio.2018.05.005; Yang KGA, 2006, TISSUE ENG, V12, P2435, DOI 10.1089/ten.2006.12.2435; Yao H, 2017, MAT SCI ENG C-MATER, V79, P661, DOI 10.1016/j.msec.2017.05.043	57	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209747	10.1371/journal.pone.0209747	http://dx.doi.org/10.1371/journal.pone.0209747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596714	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200076
J	Falcone, LM; Erdely, A; Salmen, R; Keane, M; Battelli, L; Kodali, V; Bowers, L; Stefaniak, AB; Kashon, ML; Antonini, JM; Zeidler-Erdely, PC				Falcone, Lauryn M.; Erdely, Aaron; Salmen, Rebecca; Keane, Michael; Battelli, Lori; Kodali, Vamsi; Bowers, Lauren; Stefaniak, Aleksandr B.; Kashon, Michael L.; Antonini, James M.; Zeidler-Erdely, Patti C.			Pulmonary toxicity and lung tumorigenic potential of surrogate metal oxides in gas metal arc welding-stainless steel fume: Iron as a primary mediator versus chromium and nickel	PLOS ONE			English	Article							INHALATION EXPOSURE; SODIUM DICHROMATE; RISK-ASSESSMENT; MILD-STEEL; IN-VITRO; CANCER; CARCINOGENICITY; WELDERS; MECHANISMS; RESPONSES	In 2017, the International Agency for Research on Cancer classified welding fumes as "carcinogenic to humans" (Group 1). Both mild steel (MS) welding, where fumes lack carcinogenic chromium and nickel, and stainless steel (SS) increase lung cancer risk in welders; therefore, further research to better understand the toxicity of the individual metals is needed. The objectives were to (1) compare the pulmonary toxicity of chromium (as Cr(III) oxide [Cr2O3] and Cr (VI) calcium chromate [CaCrO4]), nickel [II] oxide (NiO), iron [III] oxide (Fe2O3), and gas metal arc welding-SS (GMAW-SS) fume; and (2) determine if these metal oxides can promote lung tumors. Lung tumor susceptible A/J mice (male, 4-5 weeks old) were exposed by oropharyngeal aspiration to vehicle, GMAW-SS fume (1.7 mg), or a low or high dose of surrogate metal oxides based on the respective weight percent of each metal in the fume: Cr2O3 + CaCrO4 (366 + 5 mu g and 731 + 11 mu g), NiO (141 and 281 mu g), or Fe2O3 (1 and 2 mg). Bronchoalveolar lavage, histopathology, and lung/liver qPCR were done at 1, 7, 28, and 84 days post-aspiration. In a two-stage lung carcinogenesis model, mice were initiated with 3-methylcholanthrene (10 mu g/g; intraperitoneal; 1x) or corn oil then exposed to metal oxides or vehicle (1 x/week for 5 weeks) by oropharyngeal aspiration. Lung tumors were counted at 30 weeks post-initiation. Results indicate the inflammatory potential of the metal oxides was Fe2O3 > Cr2O3 + CaCrO4 > NiO. Overall, the pneumotoxic effects were negligible for NiO, acute but not persistent for Cr2O3 + CaCrO4, and persistent for the Fe2O3 exposures. Fe2O3, but not Cr2O3 + CaCrO4 or NiO significantly promoted lung tumors. These results provide experimental evidence that Fe2O3 is an important mediator of welding fume toxicity and support epidemiological findings and the IARC classification.	[Falcone, Lauryn M.; Erdely, Aaron; Salmen, Rebecca; Keane, Michael; Battelli, Lori; Kodali, Vamsi; Bowers, Lauren; Kashon, Michael L.; Antonini, James M.; Zeidler-Erdely, Patti C.] NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA; [Falcone, Lauryn M.; Erdely, Aaron; Zeidler-Erdely, Patti C.] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA; [Stefaniak, Aleksandr B.] NIOSH, Resp Hlth Div, Morgantown, WV USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Zeidler-Erdely, PC (corresponding author), NIOSH, Hlth Effects Lab Div, Morgantown, WV 26505 USA.; Zeidler-Erdely, PC (corresponding author), West Virginia Univ, Sch Med, Morgantown, WV 26506 USA.	paz9@cdc.gov	Kodali, Vamsi/D-2497-2009	Kodali, Vamsi/0000-0001-6177-0568				[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V49, P1; Antonini JM, 2007, TOXICOL APPL PHARM, V223, P234, DOI 10.1016/j.taap.2007.06.020; Antonini JM, 2006, J OCCUP ENVIRON HYG, V3, P194, DOI 10.1080/15459620600584352; Antonini JM, 2004, J TOXICOL ENV HEAL A, V67, P233, DOI 10.1080/15287390490266909; Antonini JM, 2003, CRIT REV TOXICOL, V33, P61, DOI 10.1080/713611032; Barkhordari A, 2014, IRAN J PUBLIC HEALTH, V43, P666; Bassim N., 2014, COMPREHENSIVE MAT PR, V8, P49; Cai Ying, 1999, Zhonghua Yufang Yixue Zazhi, V33, P75; COGGON D, 1994, LANCET, V344, P41, DOI 10.1016/S0140-6736(94)91056-1; Coggon D, 2016, THORAX, V71, P581, DOI 10.1136/thoraxjnl-2016-208464; Coggon D, 2015, THORAX, V70, P198, DOI 10.1136/thoraxjnl-2014-206129; COHEN MD, 1993, CRIT REV TOXICOL, V23, P255, DOI 10.3109/10408449309105012; COSTA M, 1991, ANNU REV PHARMACOL, V31, P321; Dally H, 1997, CARCINOGENESIS, V18, P1021, DOI 10.1093/carcin/18.5.1021; Falcone LM, 2018, TOXICOLOGY, V409, P24, DOI 10.1016/j.tox.2018.07.007; Falcone LM, 2017, ARCH TOXICOL, V91, P2953, DOI 10.1007/s00204-016-1909-2; GLASER U, 1986, TOXICOLOGY, V42, P219, DOI 10.1016/0300-483X(86)90011-9; Guha N, 2017, LANCET ONCOL, V18, P581, DOI 10.1016/S1470-2045(17)30255-3; Guyton KZ, 2018, CARCINOGENESIS, V39, P614, DOI 10.1093/carcin/bgy031; Hansen KS, 1996, AM J IND MED, V30, P373, DOI 10.1002/(SICI)1097-0274(199610)30:4<373::AID-AJIM1>3.0.CO;2-X; IARC, 2018, IARC MONOGRAPHS EVAL, V118, P36; IARC, 2012, IARC MONOGR, V100, P497; IARC, 2014, IARC MONOGRAPHS EVAL; IARC Working Group on the Evaluation of Carcinogenic Risk to Humans, 2009, ID RES NEEDS RES CAR, V42, P40; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P11; International Agency for Research on Cancer (IARC), 1987, IARC MON, V1-42, P216; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Keenan CM, 2015, TOXICOL PATHOL, V43, P730, DOI 10.1177/0192623314560031; Kendzia B, 2013, AM J EPIDEMIOL, V178, P1513, DOI 10.1093/aje/kwt201; Kimura S, 1979, WELD RES S, P195; Kodali V, 2013, ACS NANO, V7, P6997, DOI 10.1021/nn402145t; Kodali VK, 2017, NANOTOXICOLOGY, V11, P1040, DOI 10.1080/17435390.2017.1390177; Lauritsen JM, 1996, AM J IND MED, V30, P383, DOI 10.1002/(SICI)1097-0274(199610)30:4<383::AID-AJIM2>3.0.CO;2-X; LEVY LS, 1986, BRIT J IND MED, V43, P243; M'Bemba-Meka P, 2005, MUTAT RES-GEN TOX EN, V586, P124, DOI 10.1016/j.mrgentox.2005.06.001; Matrat M, 2016, OCCUP ENVIRON MED, V73, P254, DOI 10.1136/oemed-2015-102964; NETTESHEIM P, 1971, JNCI-J NATL CANCER I, V47, P1129; NTP (National Toxicology Program), 2016, REP CARC; Occupational Safety and Health Administration (OSHA) Department of Labor, 2006, Fed Regist, V71, P10099; Palmer KT, 2003, AM J EPIDEMIOL, V157, P227, DOI 10.1093/aje/kwf188; PEDERSEN B, 1987, ANN OCCUP HYG, V31, P325, DOI 10.1093/annhyg/31.3.325; POOLZOBEL BL, 1994, ENVIRON MOL MUTAGEN, V24, P23, DOI 10.1002/em.2850240105; Pouniotis DS, 2006, CLIN EXP IMMUNOL, V143, P363, DOI 10.1111/j.1365-2249.2006.02998.x; Proctor DM, 2014, TOXICOLOGY, V325, P160, DOI 10.1016/j.tox.2014.08.009; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; REHM S, 1989, TOXICOL PATHOL, V17, P737, DOI 10.1177/0192623389017004201; Renne R, 2009, TOXICOL PATHOL, V37, p5S, DOI 10.1177/0192623309353423; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHEN HM, 1994, ENVIRON HEALTH PERSP, V102, P275, DOI 10.1289/ehp.94102s1275; Siew SS, 2008, SCAND J WORK ENV HEA, V34, P444, DOI 10.5271/sjweh.1296; STEINHOFF D, 1986, EXP PATHOL-JENA, V30, P129, DOI 10.1016/S0232-1513(86)80085-8; Wild Pascal, 2009, V472, P139, DOI 10.1007/978-1-60327-492-0_6; Zeidler-Erdely PC, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-45; Zeidler-Erdely PC, 2012, J IMMUNOTOXICOL, V9, P411, DOI 10.3109/1547691X.2011.652783; Zeidler-Erdely PC, 2011, INHAL TOXICOL, V23, P112, DOI 10.3109/08958378.2010.548838; Zeidler-Erdely PC, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-12	57	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209413	10.1371/journal.pone.0209413	http://dx.doi.org/10.1371/journal.pone.0209413			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586399	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400063
J	Ghaffarzadegan, N; Xu, R				Ghaffarzadegan, Navid; Xu, Ran			Late retirement, early careers, and the aging of US science and engineering professors	PLOS ONE			English	Article							MANDATORY RETIREMENT; RESEARCH PRODUCTIVITY; AGE; IMPACT; TOO	Studies of rescuing early-career scientists often take narrow approaches and focus on PhD students or postdoc populations. In a multi-method systems approach, we examine the inter-relations between the two ends of the pipeline and ask: what are the effects of late retirement on aging and hiring in academia? With a simulation model, we postulate that the decline in the retirement rate in academia contributes to the aging pattern through two mechanisms: (a) direct effect: longer stay of established professors, and (b) indirect effect: a hiring decline in tenure-track positions. Late retirement explains more than half of the growth in average age and brings about 20% decline in hiring. We provide empirical evidence based on the natural experimental set-up of the removal of mandatory retirement in the 1990s.	[Ghaffarzadegan, Navid; Xu, Ran] Virginia Tech, Dept Ind & Syst Engn, Falls Church, VA 22043 USA	Virginia Polytechnic Institute & State University	Ghaffarzadegan, N (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Falls Church, VA 22043 USA.	navidg@vt.edu		Ghaffarzadegan, Navid/0000-0003-3632-8588	National Institute of General Medical Sciences; Office of Behavioral and Social Sciences Research of the National Institutes of Health [2U01GM094141-05]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Behavioral and Social Sciences Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by the National Institute of General Medical Sciences and the Office of Behavioral and Social Sciences Research of the National Institutes of Health (2U01GM094141-05 to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Andalib MA, 2016, SYSTEMS RES BEHAV SC, DOI [10.1002/sres.2405, DOI 10.1002/SRES.2405]; Ashenfelter O, 2002, AM ECON REV, V92, P957, DOI 10.1257/00028280260344542; Blau DM, 2017, P NATL ACAD SCI USA, V114, P3879, DOI 10.1073/pnas.1611748114; Burtless G, 2002, WORKING PAPERS EC, V17, P82; Clark RL, 2008, IND RELAT, V47, P153, DOI 10.1111/j.1468-232X.2008.00510.x; Clauset A, 2017, SCIENCE, V355, P477, DOI 10.1126/science.aal4217; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Feinsod RR, 2006, WORLDATWORK J, V15, P14; Ghaffarzadegan N, 2018, BIOSCIENCE, V68, P744, DOI 10.1093/biosci/biy092; Ghaffarzadegan N, 2018, SYST DYNAM REV, V34, P327, DOI 10.1002/sdr.1598; Ghaffarzadegan N, 2015, SYST RES BEHAV SCI, V32, P402, DOI 10.1002/sres.2324; Ginsberg B., 2011, WASHINGTON MONTHLY; Hammond PB, 1991, ENDING MANDATORY RET; Hur H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170887; June A. W., 2012, CHRONICLE HIGHER ED; Kahn S, 2017, NAT BIOTECHNOL, V35, P90, DOI 10.1038/nbt.3766; Larson RC, 2018, SCIENCE, V362, P610, DOI 10.1126/science.362.6414.610; Larson RC, 2014, SYST RES BEHAV SCI, V31, P745, DOI 10.1002/sres.2210; Larson Richard C, 2012, Serv Sci, V4, P69; LEVIN SG, 1989, RES HIGH EDUC, V30, P531, DOI 10.1007/BF00992202; National Academies of Sciences Engineering and Medicine, 2018, NEXT GEN BIOM BEH SC, DOI [10.17226/25008, DOI 10.17226/25008]; Neumark D, 2003, CONTEMP ECON POLICY, V21, P297, DOI 10.1093/cep/byg012; Paullin C., 2014, AGING WORKFORCE LEVE; Sauermann H, 2016, SCIENCE, V352, P663, DOI 10.1126/science.aaf2061; Sax LJ, 2002, RES HIGH EDUC, V43, P423, DOI 10.1023/A:1015575616285; Sterman J, 2018, SYST DYNAM REV, V34, P5, DOI 10.1002/sdr.1601; Stonebraker RJ, 2015, RES HIGH EDUC, V56, P793, DOI 10.1007/s11162-015-9374-y; Warman C, 2010, LABOUR ECON, V17, P1022, DOI 10.1016/j.labeco.2010.04.014; Weinberg SL, 2013, EDUC RESEARCHER, V42, P338, DOI 10.3102/0013189X13497993	31	4	5	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208411	10.1371/journal.pone.0208411	http://dx.doi.org/10.1371/journal.pone.0208411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586402	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400021
J	Rangel, LP; Ferretti, GDS; Costa, CL; Andrade, SMMV; Carvalho, RS; Costa, DCF; Silva, JL				Rangel, Luciana P.; Ferretti, Giulia D. S.; Costa, Caroline L.; Andrade, Sarah M. M. V.; Carvalho, Renato S.; Costa, Danielly C. F.; Silva, Jerson L.			p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; p53; anticancer drug; protein misfolding	PRION-LIKE AGGREGATION; TUMOR-SUPPRESSOR P53; BREAST-CANCER; SMALL MOLECULES; WILD-TYPE; GAIN; BINDING; P63; STABILITY; RESISTANCE	p53 mutants can form amyloid-like structures that accumulate in cells. p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) and its primary active metabolite, 2-methylene-3-quinuclidinone (MQ), can restore unfolded p53 mutants to a native conformation that induces apoptosis and activates several p53 target genes. However, whether PRIMA-1 can clear p53 aggregates is unclear. In this study, we investigated whether PRIMA-1 can restore aggregated mutant p53 to a native form. We observed that the p53 mutant protein is more sensitive to both PRIMA-1 and MQ aggregation inhibition than WT p53. The results of anti-amyloid oligomer antibody assays revealed that PRIMA-1 reverses mutant p53 aggregate accumulation in cancer cells. Size-exclusion chromatography of the lysates from mutant p53-containing breast cancer and ovarian cell lines confirmed that PRIMA-1 substantially decreases p53 aggregates. We also show that MDA-MB-231 cell lysates can seed aggregation of the central core domain of recombinant WT p53, corroborating the prion-like behavior of mutant p53. We also noted that this aggregation effect was inhibited by MQ and PRIMA-1. This study provides the first demonstration that PRIMA-1 can rescue amyloid-state p53 mutants, a strategy that could be further explored as a cancer treatment.	[Rangel, Luciana P.; Andrade, Sarah M. M. V.; Carvalho, Renato S.] Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, Brazil; [Rangel, Luciana P.; Ferretti, Giulia D. S.; Costa, Caroline L.; Costa, Danielly C. F.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941902 Rio De Janeiro, Brazil; [Ferretti, Giulia D. S.; Costa, Caroline L.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil; [Costa, Danielly C. F.] Univ Estado Rio de Janeiro, Dept Nutr Basica & Expt, Inst Nutr, BR-20550013 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Rangel, LP (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, Brazil.; Rangel, LP; Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941902 Rio De Janeiro, Brazil.; Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil.	lprangel@pharma.ufrj.br; jerson@bioqmed.ufrj.br	Silva, Jerson/J-8984-2014; Rangel, Luciana/E-7861-2018; SILVA, JERSON Lima/GRF-1442-2022; Carvalho, Renato/AAK-3890-2020	Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; /0000-0002-6154-0815; Diniz da Silva Ferretti, Giulia/0000-0002-1205-6090	Serrapilheira Institute [Serra-1708-15204]; Fundacao do Cancer; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [465395/2014-7, 402321/2016-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant [202955/2015]; Ministerio da Saude; Financiadora de Estudos e Projetos of Brazil	Serrapilheira Institute; Fundacao do Cancer; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant; Ministerio da Saude; Financiadora de Estudos e Projetos of Brazil	This work was supported by Serrapilheira Institute Grant Serra-1708-15204 (to L. P. R.), Fundacao do Cancer, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 465395/2014-7 and 402321/2016-2 (to J. L. S.), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant 202955/2015 (to J. L. S.), Ministerio da Saude, and Financiadora de Estudos e Projetos of Brazil. The authors declare that they have no conflicts of interest with the contents of this article.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Antony H, 2012, CANCER METAST REV, V31, P1, DOI 10.1007/s10555-011-9325-9; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Buhlmann S, 2008, BBA-REV CANCER, V1785, P207, DOI 10.1016/j.bbcan.2008.01.002; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2005, ONCOGENE, V24, P3484, DOI 10.1038/sj.onc.1208419; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Bykov VJN, 2002, CARCINOGENESIS, V23, P2011, DOI 10.1093/carcin/23.12.2011; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Bykov VJN, 2018, NAT REV CANCER, V18, P89, DOI 10.1038/nrc.2017.109; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Chemes LB, 2013, J BIOL CHEM, V288, P18923, DOI 10.1074/jbc.M113.467316; Chen ZL, 2017, BIOCHEM BIOPH RES CO, V489, P130, DOI 10.1016/j.bbrc.2017.05.111; Cino EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32535; Costa DCF, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023614; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Ghosh S, 2017, CELL DEATH DIFFER, V24, P1784, DOI 10.1038/cdd.2017.105; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Herzog G, 2015, BIOCHEMISTRY-US, V54, P3729, DOI 10.1021/bi501092p; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; JUVEN T, 1993, ONCOGENE, V8, P3411; Kaar JL, 2010, PROTEIN SCI, V19, P2267, DOI 10.1002/pro.507; Kehrloesser S, 2016, CELL DEATH DIFFER, V23, P1952, DOI 10.1038/cdd.2016.75; Kirilyuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048243; Lambert JMR, 2010, ONCOGENE, V29, P1329, DOI 10.1038/onc.2009.425; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lasagna-Reeves CA, 2013, BIOCHEM BIOPH RES CO, V430, P963, DOI 10.1016/j.bbrc.2012.11.130; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Liang YY, 2009, INT J ONCOL, V35, P1015, DOI 10.3892/ijo_00000416; Liu DS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14844; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizejewski GJ, 2017, BREAST CANCER-TARGET, V9, DOI 10.2147/BCTT.S131394; Mohell N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.143; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Peng X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.417; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Piantino CB, 2013, CLINICS, V68, P297, DOI 10.6061/clinics/2013(03)OA03; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Rieber M, 2012, BIOCHEM PHARMACOL, V84, P1563, DOI 10.1016/j.bcp.2012.09.003; Rokaeus N, 2007, ONCOGENE, V26, P982, DOI 10.1038/sj.onc.1209858; Rokaeus N, 2010, ONCOGENE, V29, P6442, DOI 10.1038/onc.2010.382; Russo D, 2010, BIOCHEM BIOPH RES CO, V402, P345, DOI 10.1016/j.bbrc.2010.10.031; Schilling T, 2010, BIOCHEM BIOPH RES CO, V394, P817, DOI 10.1016/j.bbrc.2010.03.082; Silva JL, 2018, ACCOUNTS CHEM RES, V51, P181, DOI 10.1021/acs.accounts.7b00473; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Synnott NC, 2017, INT J CANCER, V140, P234, DOI 10.1002/ijc.30425; Takagi K, 2013, CANCER SCI, V104, P1532, DOI 10.1111/cas.12239; Vieira TCRG, 2014, FASEB J, V28, P2667, DOI 10.1096/fj.13-246777; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang GZ, 2017, P NATL ACAD SCI USA, V114, pE2634, DOI 10.1073/pnas.1700308114; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; Wiech M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051426; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Wong RPC, 2007, MOL CANCER THER, V6, P1054, DOI 10.1158/1535-7163.MCT-06-0336; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Zhang Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0463-7; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	67	36	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3670	3682		10.1074/jbc.RA118.004671	http://dx.doi.org/10.1074/jbc.RA118.004671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602570	Green Published, hybrid			2022-12-26	WOS:000461853900029
J	Veronese, S; Rabitti, E; Costantini, M; Valle, A; Higginson, I				Veronese, Simone; Rabitti, Elisa; Costantini, Massimo; Valle, Alessandro; Higginson, Irene			Translation and cognitive testing of the Italian Integrated Palliative Outcome Scale (IPOS) among patients and healthcare professionals	PLOS ONE			English	Article								Background Outcome measurement is fundamental to assess needs and priority of care in palliative care settings. The Integrated Palliative care Outcome Scale (IPOS) was developed from earlier versions of this tool. Its use is encouraged to ameliorate the assessment of individual outcomes in palliative care settings. This study aimed to translate and culturally adapt IPOS into Italian, and explore its face and content validity. Methods After forward-backward translation, a qualitative study explored the views of and cognitive processes used by respondents. We conducted individual semi structured interviews with 21 patients admitted to two palliative care services, from hospitals, hospices and the community, and focus groups with 12 professionals working in multidisciplinary palliative care teams and used thematic analysis. The results were integrated in a final audit, including the project team and the original POS developers, to refine the final format of the tool. Results We conducted 21 face to face cognitive interviews with patients, and 2 focus groups with 14 professionals. Patients and professionals felt content and format of IPOS appropriate and feasible, and not burdensome. Some layout problems were raised leading to adaptation. Main issues regarded: clarifying the meaning of choices and some cultural interpretation of some questions and response options and interpretation of some instructions. We proposed using some new terms as more appropriate and comprehensive in our context, such as replacing the term "family" with "dear ones". The items that appeared unchanged from the previously validated Italian POS were left unmodified to maintain coherence. Conclusions The Italian IPOS, in its four versions directed to patients or staff and with a recall period of 3 or 7 days, has face and content validity for use in clinical settings and is ready for further psychometric and clinimetric validation.	[Veronese, Simone; Valle, Alessandro] Fdn FARO Onlus, Turin, Italy; [Rabitti, Elisa] Azienda USL Reggio Emilia IRCCS, Psychooncol Unit, Reggio Emilia, Italy; [Costantini, Massimo] Azienda USL Reggio Emilia IRCCS, Sci Directorate, Reggio Emilia, Italy; [Higginson, Irene] Kings Coll London, Cicely Saunders Inst Palliat Care Policy & Rehabi, London, England	University of London; King's College London	Veronese, S (corresponding author), Fdn FARO Onlus, Turin, Italy.	simone.veronese@fondazionefaro.it	costantini, massimo/AAK-5388-2021; Veronese, Simone/GYD-2978-2022; Higginson, Irene Julie/C-7309-2012	costantini, massimo/0000-0002-5293-7079; Veronese, Simone/0000-0002-9555-7252; Higginson, Irene Julie/0000-0002-3687-1313	Fondazione FARO, Torino; IRCSS Reggio Emilia, Italy	Fondazione FARO, Torino; IRCSS Reggio Emilia, Italy	The study was UNFUNDED, the only obtained funds are the publication costs covered by the two main involved institutions: Fondazione FARO, Torino and IRCSS Reggio Emilia, Italy.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Antunes B., 2012, PALLIATIVE CARE OUTC; Boland J, 2013, BMJ SUPPORT PALLIAT, V3, P2, DOI 10.1136/bmjspcare-2013-000446; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Costantini M, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0095-6; Gao W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165379; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; Higginson IJ, 1999, BRIT MED J, V318, P123, DOI 10.1136/bmj.318.7176.123; Kulis D, 2017, EORTC QUALITY LIFE G; Lee J, 2014, ASSESSMENT, V21, P227, DOI 10.1177/1073191112436671; Schildmann EK, 2016, PALLIATIVE MED, V30, P599, DOI 10.1177/0269216315608348; van Vliet LM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0449-6; World Health Organization (WHO), DEF PALL CAR	13	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208536	10.1371/journal.pone.0208536	http://dx.doi.org/10.1371/journal.pone.0208536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601810	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200014
J	Erritouni, YR; Reinke, BA; Calsbeek, R				Erritouni, Yasmeen R.; Reinke, Beth A.; Calsbeek, Ryan			A novel body coloration phenotype in Anolis sagrei: Implications for physiology, fitness, and predation	PLOS ONE			English	Article							SEXUAL SELECTION; MATE CHOICE; VITAMIN-E; CAROTENOID-PIGMENTS; ENDURANCE CAPACITY; AVIAN PREDATION; TISSUE-DAMAGE; FREE-RADICALS; LIZARD; EXERCISE	In animals, color signals that convey information about quality are often associated with costs linked to the expression of coloration and may therefore be honest signals of sender quality. Honest indicators are often seen in sexual signals that are used by males to advertise quality to females. Carotenoid and pterin pigments are responsible for yellow, orange, and red coloration in a variety of taxa, but can also serve important roles as antioxidants by reducing free radicals in the body. In this study, we test the effects of a novel full-bodied orange color phenotype of the brown anole, Anolis sagrei, on mate choice, physiology, and survival. We found no evidence that lizards expressing the orange phenotype were preferred by females. Additionally, they did not differ in immune function, running endurance, or maximum sprint speed from lizards that did not express the novel phenotype. Pigment extractions revealed that orange body coloration resulted from pterin pigments and not carotenoids. Visual models suggest that the orange phenotype is less conspicuous to bird predators than the brown phenotype and may provide an adaptive explanation for the persistence of this trait. Given its small, yet positive effect on fitness, we expect the orange color phenotype to increase in frequency in subsequent decades.	[Erritouni, Yasmeen R.; Reinke, Beth A.; Calsbeek, Ryan] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Erritouni, Yasmeen R.] Univ Bristol, Dept Earth Sci, Bristol, Avon, England; [Reinke, Beth A.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA	Dartmouth College; University of Bristol; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Erritouni, YR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.; Erritouni, YR (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	yasmeenerritouni@gmail.com			National Science Foundation Division of Environmental Biology [1655092]	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was awarded to RC by the National Science Foundation Division of Environmental Biology under the grant number 1655092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BURTON GW, 1989, J NUTR, V119, P109, DOI 10.1093/jn/119.1.109; Calsbeek R, 2008, J ANIM ECOL, V77, P103, DOI 10.1111/j.1365-2656.2007.01320.x; Cantwell LR, 2013, J HERPETOL, V47, P293, DOI 10.1670/11-184; Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S; Cook EG, 2013, NATURWISSENSCHAFTEN, V100, P993, DOI 10.1007/s00114-013-1095-5; Cuervo JJ, 2016, COMP BIOCHEM PHYS B, V193, P17, DOI 10.1016/j.cbpb.2015.11.011; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Driessens T, 2015, BEHAV ECOL SOCIOBIOL, V69, P1251, DOI 10.1007/s00265-015-1938-5; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Evans LT, 1938, J COMP PSYCHOL, V26, P475, DOI 10.1037/h0056331; Fleishman LJ, 2011, P ROY SOC B-BIOL SCI, V278, P2891, DOI 10.1098/rspb.2011.0118; Garland T, 1999, ANIM BEHAV, V58, P77, DOI 10.1006/anbe.1999.1132; GERSTER H, 1991, Z ERNAHRUNGSWISS, V30, P89, DOI 10.1007/BF01610064; GEY GO, 1970, J AMER MED ASSOC, V211, P105, DOI 10.1001/jama.211.1.105; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Greenberg B., 1944, PHYSIOL ZOOL, V17, P392; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Ji LL, 1997, AGE, V20, P91, DOI 10.1007/s11357-997-0009-x; Kang SW, 2012, J CLIN BIOCHEM NUTR, V50, P106, DOI 10.3164/jcbn.11-46; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Lozano GA, 2001, AM NAT, V158, P200, DOI 10.1086/321313; Macedonia JM, 2000, J HERPETOL, V34, P99, DOI 10.2307/1565245; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; McGraw KJ, 2005, ANIM BEHAV, V69, P757, DOI 10.1016/j.anbehav.2004.06.022; McGraw KJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P391, DOI 10.1007/s00265-004-0853-y; MCLAUGHLIN JF, 1989, ECOLOGY, V70, P617, DOI 10.2307/1940213; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Mougeot F, 2007, BEHAV ECOL SOCIOBIOL, V61, P741, DOI 10.1007/s00265-006-0304-z; Ng J, 2013, J HERED, V104, P862, DOI 10.1093/jhered/est060; Ng J, 2013, EVOLUTION, V67, P573, DOI 10.1111/j.1558-5646.2012.01795.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reinke BA, 2018, COMP BIOCHEM PHYS A, V218, P56, DOI 10.1016/j.cbpa.2018.01.014; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; SHEPHARD RJ, 1974, EUR J APPL PHYSIOL O, V33, P119, DOI 10.1007/BF00449513; Simons MJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043088; Skarstein F, 1996, OIKOS, V76, P359, DOI 10.2307/3546208; Steffen JE, 2007, COMP BIOCHEM PHYS B, V146, P42, DOI 10.1016/j.cbpb.2006.08.017; Steffen JE, 2009, COMP BIOCHEM PHYS B, V154, P334, DOI 10.1016/j.cbpb.2009.07.009; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Swierk L, 2012, BEHAV ECOL SOCIOBIOL, V66, P1033, DOI 10.1007/s00265-012-1351-2; TOKARZ RR, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P17, DOI 10.2307/1466994; Tokarz RR, 1998, HERPETOLOGICA, V54, P388; Trigo S, 2015, BEHAV ECOL SOCIOBIOL, V69, P481, DOI 10.1007/s00265-014-1860-2; VANDERBEEK EJ, 1990, J AM COLL NUTR, V9, P332; Venditti P, 1996, ARCH BIOCHEM BIOPHYS, V331, P63, DOI 10.1006/abbi.1996.0283; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Weiss SL, 2012, COMP BIOCHEM PHYS B, V161, P117, DOI 10.1016/j.cbpb.2011.10.004; WITT EH, 1992, J NUTR, V122, P766, DOI 10.1093/jn/122.suppl_3.766; WUNDERLE JM, 1981, HERPETOLOGICA, V37, P104; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	58	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209261	10.1371/journal.pone.0209261	http://dx.doi.org/10.1371/journal.pone.0209261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596690	Green Published, gold			2022-12-26	WOS:000454627200038
J	Mullhaupt, B; Bruggmann, P; Bihl, F; Blach, S; Lavanchy, D; Razavi, H; Scott, SR; Semela, D; Negro, F				Mullhaupt, Beat; Bruggmann, Philip; Bihl, Florian; Blach, Sarah; Lavanchy, Daniel; Razavi, Homie; Scott, Sarah Robbins; Semela, David; Negro, Francesco			Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?	PLOS ONE			English	Article							C VIRUS-INFECTION; EPIDEMIOLOGY; PREVALENCE	Catalyzed by the concerns over the growing public health and economic burden of Hepatitis C virus (HCV) in Switzerland, a diverse group of experts and patient representatives came together in 2014 to develop the Swiss Hepatitis Strategy, setting targets for the elimination of viral hepatitis in Switzerland by 2030. Previous studies have reported the estimated number of chronic HCV infections and forecasted burden of disease given different intervention strategies. However, given new prevalence data by the Swiss Federal Office of Public Health, which decreased total infections by about half, an updated analysis is warranted. We aimed to provide an updated viremic prevalence estimate for Switzerland and evaluate the impact on forecasted liver related morbidity and mortality of an 'inaction' scenario and intervention scenarios to achieve the Global Health Sector Strategy for Viral Hepatitis and Swiss Hepatitis Strategy goals by 2030. A Markov disease-progression model was used to calculate the present and future burden of HCV infection by disease stage according to these different strategies. In 2017, there were an estimated 36,800 (95% UI: 26,90039,200) viremic infections in Switzerland. Given the current standard of care, total viremic infections are expected to decline by 45%, while cases of decompensated cirrhosis, hepatocellular carcinoma, and liver-related deaths will decrease by 20%. If treatment and diagnosis efforts were to cease in 2018, late stage HCV-related morbidity and mortality would increase by 90-100% by 2030. Increasing treatment and diagnosis to achieve the Global Health Sector Strategy or Swiss Hepatitis Strategy goals by 2030, will reduce the number of chronic infections to less than 13,000 and 4,000, respectively. Although the HCV epidemic is declining in Switzerland, efforts to expand diagnosis and treatment are needed to achieve elimination by 2030.	[Mullhaupt, Beat] Univ Hosp Zurich, Swiss HPB Hepatopancreatobiliary Ctr, Zurich, Switzerland; [Mullhaupt, Beat] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Bruggmann, Philip] Arud Ctr Addict Med, Zurich, Switzerland; [Bihl, Florian] Osped Cantonale, Gastroenterol Dept, Bellinzona, Switzerland; [Blach, Sarah; Razavi, Homie; Scott, Sarah Robbins] CDA, Lafayette, CO USA; [Lavanchy, Daniel] Ruelle Chataigniers 1, Denges Vd, Switzerland; [Semela, David] Cantonal Hosp St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland; [Negro, Francesco] Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp, Div Clin Pathol, Geneva, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Geneva; University of Geneva	Mullhaupt, B (corresponding author), Univ Hosp Zurich, Swiss HPB Hepatopancreatobiliary Ctr, Zurich, Switzerland.; Mullhaupt, B (corresponding author), Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland.	beat.muellhaupt@usz.ch	Blach, Sarah/J-5833-2019; Mullhaupt, Beat/O-3744-2016	Blach, Sarah/0000-0002-9252-7576; Robbins, Sarah/0000-0002-0455-644X; Mullhaupt, Beat/0000-0002-9020-8192; Razavi, Homie/0000-0002-2658-6930	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This work was supported by Gilead Sciences. Gilead Sciences had no input on the content, the study design, data selection, decision to publish or preparation of the manuscript.	Andrea B, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14544; [Anonymous], 2015, SWISS HEPATITIS STRA; [Anonymous], 2016, SWISS STAT CANC INCI; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Assembly WHOS-NWH, 2016, GLOB HLTH SECT STRAT; Beguelin C, 2018, LIVER INT, V38, P424, DOI 10.1111/liv.13528; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Bruggmann P, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14221; Deltenre P, 2015, J HEPATOL, V62, P1225, DOI 10.1016/j.jhep.2015.02.044; Deuffic-Burban S, 2018, J HEPATOL, V69, P785, DOI 10.1016/j.jhep.2018.05.027; Estill J, 2018, IMPACT SCREENING TRE; Fretz R, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13793; Jacqueline AB, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14560; Kalichman SC, 2015, SUBST USE MISUSE, V50, P1536, DOI 10.3109/10826084.2015.1023451; Mullhaupt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125214; Omran H., 2018, DAILY NEWS EGYPT; Philip B, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14543; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Richard J-L, 2018, SWISS MED WEEKLY, P148; Sagmeister M, 2002, EUR J GASTROEN HEPAT, V14, P25, DOI 10.1097/00042737-200201000-00006; Strasser SI, 2017, AUST PRESCR, V40, P64, DOI 10.18773/austprescr.2017.017; Zahnd C, 2017, SITUATION ANAL HEPAT	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209374	10.1371/journal.pone.0209374	http://dx.doi.org/10.1371/journal.pone.0209374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596701	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000454627200042
J	Zhu, X; Zhang, LJ; Hu, YX; Zhang, JL				Zhu, Xia; Zhang, Lujun; Hu, Yangxi; Zhang, Jianliang			Identification of suitable reference genes for real-time qPCR in homocysteine-treated human umbilical vein endothelial cells	PLOS ONE			English	Article							BETA-ACTIN; EXPRESSION; SELECTION; PCR; NORMALIZATION; THIOLACTONE; MIR-145	The imbalance in homocysteine (Hcy) metabolism has been implicated in the pathogenesis of human diseases, including cardiovascular and neurodegenerative disorders. When attempting to identify gene expression profiles using quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR), the selection of suitable reference genes is important. Here, the expression levels of 10 commonly used reference genes were assessed for normalization of RT-qPCR in Hcy-treated human umbilical vein endothelial cells (HUVECs) and control cells. The suitability of eight selected candidate genes was comparatively analyzed across the tested samples and separately ranked by four programs, geNorm, NormFinder, BestKeeper, and the Delta Ct method. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was the most stable gene in the final ranking using the RankAggreg package. Surprisingly, the beta-actin (ACTB) levels decreased significantly in Hcy-treated HUVECs compared with control HUVECs (P<0.05), and further study indicated that Hcy suppressed the expression of ACTB by upregulating the miR-145-5p level in Hcy-treated HUVECs. Our data suggest that GAPDH can be used as a reliable reference gene, while ACTB cannot; normalization of gene expression in RT-qPCR experiments in Hcy-treated HUVECs. The data, which identifies a suitable reference gene in Hcy-treated HUVECs, will contribute to the design of an effective and accurate method for quantitation of gene expression.	[Zhu, Xia; Zhang, Lujun; Hu, Yangxi; Zhang, Jianliang] Naval Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China; [Zhu, Xia] Urumqi Friendship Hosp, Dept Cardiol, Urumqi, Peoples R China	Naval Medical University	Zhang, LJ; Zhang, JL (corresponding author), Naval Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China.	402732743@qq.com; cqmu6600267@126.com		Hu, Yang-Xi/0000-0003-2585-7636; Zhang, Lujun/0000-0002-9219-3908; Zhu, Xia/0000-0003-2272-8214; Zhang, Jian-Liang/0000-0002-3963-476X	Youth Start-up Fund of Shanghai Changhai Hospital [CH201805]	Youth Start-up Fund of Shanghai Changhai Hospital	This study was supported by the Youth Start-up Fund of Shanghai Changhai Hospital (Grant No. CH201805, URL: http://chhospital.com.cn) to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Chang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181862; Fu Y, 2018, BRIT J PHARMACOL, V175, P1173, DOI 10.1111/bph.13988; Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6; Guo X, 2016, SCI REP-UK, V6, DOI 10.1038/srep35302; Gurda D, 2015, AMINO ACIDS, V47, P1319, DOI 10.1007/s00726-015-1956-7; Hu HM, 2016, BIOMED PHARMACOTHER, V80, P63, DOI 10.1016/j.biopha.2016.02.022; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Kalaria RN, 2016, ACTA NEUROPATHOL, V131, P659, DOI 10.1007/s00401-016-1571-z; Kaur R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191558; Lan XT, 2019, J CELL MOL MED, V23, P2351, DOI 10.1111/jcmm.13497; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Li HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195096; Liu KJ, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0596-0; Lyu YP, 2017, J MICROBIOL METH, V141, P28, DOI 10.1016/j.mimet.2017.07.011; Ma N, 2013, CARCINOGENESIS, V34, P236, DOI 10.1093/carcin/bgs354; Ma N, 2012, J CELL BIOCHEM, V113, P1, DOI 10.1002/jcb.23341; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mishra PK, 2009, CELL BIOCHEM BIOPHYS, V55, P153, DOI 10.1007/s12013-009-9063-6; Momin M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06611-3; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; Perla-Kajan J, 2016, FASEB J, V30, P3810, DOI 10.1096/fj.201600539; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Sala F, 2014, THROMB HAEMOSTASIS, V112, P796, DOI 10.1160/TH13-11-0905; Santovito D, 2013, EXPERT OPIN THER TAR, V17, P217, DOI 10.1517/14728222.2013.745512; Shekh K, 2017, AQUAT TOXICOL, V190, P217, DOI 10.1016/j.aquatox.2017.07.009; Sikand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047510; Silveira TLR, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00075; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Starikova I, 2015, THROMB RES, V136, P566, DOI 10.1016/j.thromres.2015.07.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XY, 2017, J CANCER, V8, P2846, DOI 10.7150/jca.19897; You YC, 2018, GENOME, V61, P349, DOI 10.1139/gen-2017-0176; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Yuan JX, 2017, CELL PHYSIOL BIOCHEM, V42, P2207, DOI 10.1159/000479995; Zhang LJ, 2014, INT J MOL SCI, V15, P21825, DOI 10.3390/ijms151221825; Zhang ZM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5736506; Zhao Q, 2018, ONCOL LETT, V15, P6115, DOI 10.3892/ol.2018.8117	41	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210087	10.1371/journal.pone.0210087	http://dx.doi.org/10.1371/journal.pone.0210087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596787	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200137
J	Jaramillo, AM; Londono, LF; Orozco, JC; Patino, G; Belalcazar, J; Davrieux, F; Talsma, EF				Jaramillo, Angelica M.; Fernando Londono, Luis; Camilo Orozco, Juan; Patino, Gelver; Belalcazar, John; Davrieux, Fabrice; Talsma, Elise F.			A comparison study of five different methods to measure carotenoids in biofortified yellow cassava (Manihot esculenta)	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; VITAMIN-A; DRY-MATTER; RETENTION; ROOTS; SELECTION; ASSAY; MILK	The most commonly used method for measuring carotenoid concentration is high-performance liquid chromatography (HPLC). Nevertheless, easier, quicker, and less costly proxy methods exist. We aimed to determine the diagnostic performance of several proxy methods: the spectrophotometer, iCheck Carotene, and near-infrared spectroscopy using both a desktop (dNIRS) and a portable (pNIRS) device for the measurement of total carotenoid concentration (TCC) and all-trans-beta-carotene concentration (trans-BC) in 30 fresh cassava (Manihot esculenta Crantz) storage roots in comparison with HPLC. The spectrophotometer presented the highest predictability for TCC, followed by iCheck, dNIRS, and pNIRS. The dNIRS showed the highest predictability and agreement for trans-BC. The pNIRS showed the poorest repeatability and greatest underestimations compared with HPLC. The agreement between all methods was lower for higher carotenoid concentration, with the exception of the spectrophotometer. According to our results, and for screening purposes, the measurement of carotenoids in fresh cassava roots can be carried out by spectrophotometer, iCheck Carotene and NIRS methods depending on the availability of equipment.	[Jaramillo, Angelica M.; Fernando Londono, Luis; Camilo Orozco, Juan; Patino, Gelver; Talsma, Elise F.] Int Ctr Trop Agr CIAT, HarvestPlus, Cali, Valle Del Cauca, Colombia; [Belalcazar, John] Int Ctr Trop Agr CIAT, Cassava Program, Cali, Valle Del Cauca, Colombia; [Davrieux, Fabrice] Agr Res Dev CIRAD, UMR Qualisud, St Pierre, La Reunion, France; [Talsma, Elise F.] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Gelderland, Netherlands	Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT; CIRAD; Universite de Montpellier; Wageningen University & Research	Talsma, EF (corresponding author), Int Ctr Trop Agr CIAT, HarvestPlus, Cali, Valle Del Cauca, Colombia.; Talsma, EF (corresponding author), Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Gelderland, Netherlands.	elise.talsma@gmail.com		Jaramillo, Angelica M./0000-0002-7463-6816; Talsma, Elise/0000-0002-6034-4708; Belalcazar Martinez, John Eiver/0000-0002-4418-2526	HarvestPlus	HarvestPlus	This study was supported by HarvestPlus (http://www.harvestplus.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M. S., 2017, African Journal of Food, Agriculture, Nutrition and Development, V17, P11905, DOI 10.18697/ajfand.78.harvestplus05; AOAC International, 2012, APPENDIX K GUIDELINE; Baranski R, 2005, PLANTA, V222, P448, DOI 10.1007/s00425-005-1566-9; Belalcazar J, 2016, CROP SCI, V56, P2916, DOI 10.2135/cropsci2015.11.0701; Berardo N., 2004, Innovative Food Science & Emerging Technologies, V5, P393, DOI 10.1016/j.ifset.2004.03.001; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonierbale M, 2009, J FOOD COMPOS ANAL, V22, P509, DOI 10.1016/j.jfca.2008.08.009; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Butarelo SS, 2004, CIENCIA TECNOLOGIA A, P311, DOI [10.1590/S0101-20612004000300001, DOI 10.1590/S0101-20612004000300001]; Carvalho LMJ, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.15788; Ceballos H, 2013, CROP SCI, V53, P2342, DOI 10.2135/cropsci2013.02.0123; Ceballos H, 2012, FOOD RES INT, V45, P52, DOI 10.1016/j.foodres.2011.10.001; Chavez AL, 2007, J SCI FOOD AGR, V87, P388, DOI 10.1002/jsfa.2704; Chavez AL, 2005, EUPHYTICA, V143, P125, DOI 10.1007/s10681-005-3057-2; Davrieux F, 2016, J NEAR INFRARED SPEC, V24, P109, DOI 10.1255/jnirs.1213; De Moura FF, 2015, CRIT REV FOOD SCI, V55, P1246, DOI 10.1080/10408398.2012.724477; Engle-Stone R, 2014, EUR J CLIN NUTR, V68, P938, DOI 10.1038/ejcn.2014.63; HAMILTON PB, 1992, POULTRY SCI, V71, P718, DOI 10.3382/ps.0710718; Iglesias C, 1997, EUPHYTICA, V94, P367, DOI 10.1023/A:1002962108315; Ikeogu UN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188918; Islam KMS, 2015, FOOD CHEM, V172, P233, DOI 10.1016/j.foodchem.2014.09.045; Kimura M., 2004, HARVESTPLUS TECHNICA; Kulakow PA., 2015, EUR, V5, P1040, DOI [10.13140/2.1.4534.4007, DOI 10.13140/2.1.4534.4007]; Laillou A, 2014, FOOD NUTR BULL, V35, P449, DOI 10.1177/156482651403500407; Mellado-Ortega E, 2017, FOOD RES INT, V99, P877, DOI 10.1016/j.foodres.2016.05.012; MURPHY EW, 1975, J AGR FOOD CHEM, V23, P1153, DOI 10.1021/jf60202a021; Pedro AMK, 2005, ANAL CHEM, V77, P2505, DOI 10.1021/ac048651r; Raila J, 2012, VET CLIN PATH, V41, P119, DOI 10.1111/j.1939-165X.2012.00400.x; Rodriguez-Amaya D.B., 2001, GUIDE CAROTENOID ANA; Sanchez T, 2014, FOOD CHEM, V151, P444, DOI 10.1016/j.foodchem.2013.11.081; SHENK JS, 1991, CROP SCI, V31, P469, DOI 10.2135/cropsci1991.0011183X003100020049x; Talsma EF, 2016, AM J CLIN NUTR, V103, P258, DOI 10.3945/ajcn.114.100164; Thakkar SK, 2009, J AGR FOOD CHEM, V57, P1344, DOI 10.1021/jf803053d; Williams S., 1984, OFF METH AN AOAC	34	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209702	10.1371/journal.pone.0209702	http://dx.doi.org/10.1371/journal.pone.0209702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592746	Green Published, Green Submitted, gold			2022-12-26	WOS:000454621900039
J	Cai, Y; Jiao, T; Lei, ZM; Liu, L; Zhao, SG				Cai, Yuan; Jiao, Ting; Lei, Zhaomin; Liu, Li; Zhao, Shengguo			Maternal genetic and phylogenetic characteristics of domesticated cattle in northwestern China	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ORIGIN; EVOLUTION; FEATURES; INSIGHT; HISTORY; MTDNA	Northwestern China, an important part of the Silk Road, was the birthplace of the Zhouzu farming culture. The domestication of cattle as an important aspect of farming culture has had a long history in northwestern China. In this study, we assessed the maternal structure and phylogeny of cattle by analyzing the mitochondrial DNA hypervariable segment I (HVS-I) in 698 native cattle from eight areas of northwestern China. The phylogenetic analyses revealed two highly divergent mtDNA clades: clade T, which had four sub-clades (Ta-Td), and clade I. The cattle domesticated from Bos taurus showed a clear dominant distribution pattern in northwestern China. The nucleotide diversity of the Bos indicus clade was lower than that of clades from Bos taurus. In summary, our results suggest that the native cattle of northwestern China were domesticated from two different maternal ancestors, Bos taurus and Bos indicus, which migrated to the central plains of China from the north and south, respectively, with Bos taurus remaining at the edges of the region. The population expansion of the cattle domesticated from Bos taurus occurred in the Longdong region of Gansu Province, and these cattle formed four relatively independent evolutionary branches. Subsequent to this expansion event, Bos indicus migrated from southern to northern China.	[Cai, Yuan; Lei, Zhaomin; Liu, Li; Zhao, Shengguo] Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Gansu, Peoples R China; [Jiao, Ting] Gansu Agr Univ, Coll Grassland, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University	Zhao, SG (corresponding author), Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Gansu, Peoples R China.	zhaoshengguo0628@hotmail.com			College of Animal Science and Technology, Gansu Agricultural University	College of Animal Science and Technology, Gansu Agricultural University	The fund of College of Animal Science and Technology, Gansu Agricultural University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Cai Xin, 2007, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V23, P666; Chen H., 1993, Hereditas (Beijing), V15, P14; Chen NB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04737-0; Colli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2342-2; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Eltanany MA, 2016, J ADV RES, V7, P615, DOI 10.1016/j.jare.2016.06.005; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felius Marleen, 2014, Diversity-Basel, V6, P705, DOI 10.3390/d6040705; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Fu YX, 1997, GENETICS, V147, P915; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Jia SG, 2010, J GENET GENOMICS, V37, P173, DOI 10.1016/S1673-8527(09)60035-7; Jia Shangang, 2007, Journal of Genetics and Genomics, V34, P510, DOI 10.1016/S1673-8527(07)60056-3; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; [赖松家 Lai Songjia], 2005, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V36, P887; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Meydan H, 2016, ASIAN AUSTRAL J ANIM, V29, P1547, DOI 10.5713/ajas.15.1060; Niemi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123821; Orozco-terWengel P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00191; Sambrook J., 2001, MOL CLONING LAB MANU; Singh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077858; Storey AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039171; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Wu J. P., 2013, Revitalising Grasslands to Sustain our Communities: Proceedings, 22nd International Grassland Congress, 15-19 September, 2013, Sydney, Australia, P541; Zhang H., 2013, CHINA NAT COMMUN, DOI [10.1038/ncomms3755, DOI 10.1038/NCOMMS3755]; Zhang LZ, 2015, GENOME BIOL EVOL, V7, P2352, DOI 10.1093/gbe/evv151; Zhao Sheng-Guo, 2013, Chinese Journal of Zoology, V48, P109	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209645	10.1371/journal.pone.0209645	http://dx.doi.org/10.1371/journal.pone.0209645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589861	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200036
J	Zhang, JN; Simonti, CN; Capra, JA				Zhang, Joanna; Simonti, Corinne N.; Capra, John A.			Genome-wide maps of distal gene regulatory enhancers active in the human placenta	PLOS ONE			English	Article							PRETERM BIRTH; ELEMENTS; EVOLUTION; SUBJECT; AGE	Placental dysfunction is implicated in many pregnancy complications, including preeclampsia and preterm birth (PTB). While both these syndromes are influenced by environmental risk factors, they also have a substantial genetic component that is not well understood. Precisely controlled gene expression during development is crucial to proper placental function and often mediated through gene regulatory enhancers. However, we lack accurate maps of placental enhancer activity due to the challenges of assaying the placenta and the difficulty of comprehensively identifying enhancers. To address the gap in our knowledge of gene regulatory elements in the placenta, we used a two-step machine learning pipeline to synthesize existing functional genomics studies, transcription factor (TF) binding patterns, and evolutionary information to predict placental enhancers. The trained classifiers accurately distinguish enhancers from the genomic background and placental enhancers from enhancers active in other tissues. Genomic features collected from tissues and cell lines involved in pregnancy are the most predictive of placental regulatory activity. Applying the classifiers genome-wide enabled us to create a map of 33,010 predicted placental enhancers, including 4,562 high-confidence enhancer predictions. The genome-wide placental enhancers are significantly enriched nearby genes associated with placental development and birth disorders and for SNPs associated with gestational age. These genome-wide predicted placental enhancers provide candidate regions for further testing in vitro, will assist in guiding future studies of genetic associations with pregnancy phenotypes, and aid interpretation of potential mechanisms of action for variants found through genetic studies.	[Zhang, Joanna; Capra, John A.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Simonti, Corinne N.; Capra, John A.] Vanderbilt Univ, Vanderbilt Genet Inst, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capra, John A.] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Capra, JA (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Capra, JA (corresponding author), Vanderbilt Univ, Vanderbilt Genet Inst, 221 Kirkland Hall, Nashville, TN 37235 USA.; Capra, JA (corresponding author), Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA.	tony.capra@vanderbilt.edu			National Institutes of Health [R01GM115836, R35GM127087]; March of Dimes Ohio Collaborative; Burroughs Wellcome Fund; Vanderbilt Undergraduate Summer Research Program (VUSRP) Fellowship; Preterm Birth Initiative Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127087, R01GM115836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Ohio Collaborative; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Vanderbilt Undergraduate Summer Research Program (VUSRP) Fellowship; Preterm Birth Initiative Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (https://www.nih.gov) grants R01GM115836 and R35GM127087 to JAC, an Innovation Catalyst Award from the March of Dimes Ohio Collaborative (http://prematurityresearch.org/ohiocollaborative/) to JAC, and a Burroughs Wellcome Fund (https://www.bwfund.org) Preterm Birth Initiative Award to JAC. JZ was supported by a Vanderbilt Undergraduate Summer Research Program (VUSRP) Fellowship (https://www.vanderbilt.edu/immersion/vusrp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emera D, 2012, BRIEF FUNCT GENOMICS, V11, P267, DOI 10.1093/bfgp/els013; Erwin GD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003677; Faye-Petersen OM, 2008, J CLIN PATHOL, V61, P1261, DOI 10.1136/jcp.2008.055244; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim M, 2016, NUCLEIC ACIDS RES, V44, pD908, DOI 10.1093/nar/gkv1137; Kovo M, 2011, J PERINAT MED, V39, P423, DOI [10.1515/JPM.2011.038, 10.1515/jpm.2011.038]; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Monangi NK, 2015, SEMIN PERINATOL, V39, P574, DOI 10.1053/j.semperi.2015.09.005; Morgan TK., 2014, NEOREVIEWS, V15, P518, DOI [10.1542/neo.15-12-e518, DOI 10.1542/NE0.15-12-E518, DOI 10.1542/NEO.15-12-E518]; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratajczak CK, 2010, DIS MODEL MECH, V3, P407, DOI 10.1242/dmm.001701; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonazzi G, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.016; Simonti CN, 2017, MOL BIOL EVOL, V34, P2856, DOI 10.1093/molbev/msx219; Swaggart KA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023127; Tuteja G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003449; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Williams PJ, 2011, BEST PRACT RES CL OB, V25, P405, DOI 10.1016/j.bpobgyn.2011.02.007; Wu W, 2015, HUM GENET, V134, P803, DOI 10.1007/s00439-015-1558-1; Zhang G, 2017, NEW ENGL J MED, V377, P1156, DOI 10.1056/NEJMoa1612665; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	32	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209611	10.1371/journal.pone.0209611	http://dx.doi.org/10.1371/journal.pone.0209611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589856	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200032
J	Araniti, F; Costas-Gil, A; Cabeiras-Freijanes, L; Lupini, A; Sunseri, F; Reigosa, MJ; Abenavoli, MR; Sanchez-Moreiras, AM				Araniti, Fabrizio; Costas-Gil, Aitana; Cabeiras-Freijanes, Luz; Lupini, Antonio; Sunseri, Francesco; Reigosa, Manuel J.; Abenavoli, Maria Rosa; Sanchez-Moreiras, Adela M.			Rosmarinic acid induces programmed cell death in Arabidopsis seedlings through reactive oxygen species and mitochondrial dysfunction	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE DISMUTASES; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; PLANT; GROWTH; AUXIN; ASSAY; DERIVATIVES; SYSTEMS	Phytotoxic potential of rosmarinic acid (RA), a caffeic acid ester largely found in aromatic species, was evaluated on Arabidopsis through metabolomic and microscopic approaches. In-vitro bioassays pointed out that RA affected root growth and morphology, causing ROS burst, ROS scavengers activity inhibition and consequently, an alteration on cells organization and ultrastructure. In particular, RA-treatment (175 mu M) caused strong vacuolization, alteration of mitochondria structure and function and a consistent ROS-induced reduction of their transmembrane potential (Delta Psi(m)). These data suggested a cell energy deficit also confirmed by the metabolomic analysis, which highlighted a strong alteration of both TCA cycle and amino acids metabolism. Moreover, the increase in H2O2 and O-2(-) contents suggested that RA-treated meristems underwent oxidative stress, resulting in apoptotic bodies and necrotic cells. Taken together, these results suggest that RA inhibits two of the main ROS scavengers causing high ROS accumulation, responsible of the alterations on mitochondrial ultrastructure and activity through Delta Psi(m) dissipation, TCA-cycle alteration, cell starvation and consequently cell death on Arabidopsis seedlings. All these effects resulted in a strong inhibition on root growth and development, which convert RA in a promising molecule to be explored for further use in weed management.	[Araniti, Fabrizio; Lupini, Antonio; Sunseri, Francesco; Abenavoli, Maria Rosa] Univ Mediterranea Reggio Calabria, Dept AGRARIA, Reggio Di Calabria, Italy; [Costas-Gil, Aitana; Cabeiras-Freijanes, Luz; Reigosa, Manuel J.; Sanchez-Moreiras, Adela M.] Univ Vigo, Dept Plant Biol & Soil Sci, Campus Lagoas Marcosende, Vigo, Spain; [Cabeiras-Freijanes, Luz; Reigosa, Manuel J.; Sanchez-Moreiras, Adela M.] Univ Vigo, CITACA, Agrifood Res & Transfer Cluster, Campus Auga, Orense, Spain	Universita Mediterranea di Reggio Calabria; Universidade de Vigo; Universidade de Vigo	Araniti, F (corresponding author), Univ Mediterranea Reggio Calabria, Dept AGRARIA, Reggio Di Calabria, Italy.	fabrizio.araniti@unirc.it	Lupini, Antonio/D-9126-2012; Araniti, Fabrizio/F-9925-2016; Cabeiras-Freijanes, Luz/ABB-4378-2020; Sanchez-Moreiras, ADELA M/A-8222-2011; Sunseri, Francesco/O-8013-2015	Lupini, Antonio/0000-0003-0321-3151; Araniti, Fabrizio/0000-0002-4983-4116; Cabeiras-Freijanes, Luz/0000-0003-2961-5853; Sanchez-Moreiras, ADELA M/0000-0002-0771-9259; Abenavoli, Maria Rosa/0000-0001-5926-9985; Sunseri, Francesco/0000-0001-5201-5413	Italian Ministry of Education, University and Research (MIUR) [RBSI14L9CE]; Galician Government [GRC2015/012]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Galician Government	This work was supported by the Italian Ministry of Education, University and Research (MIUR), project SIR-2014 cod. RBSI14L9CE (MEDANAT) to FA, and by the project 'Agrobioloxia Ambiental: Calidade, Solos e Plantas' number GRC2015/012 from the Galician Government to AMSM.; This work was supported by the Italian Ministry of Education, University and Research (MIUR), project SIR-2014 cod. RBSI14L9CE (MEDANAT) and by the project 'Agrobioloxia Ambiental: Calidade, Solos e Plantas' number GRC2015/012 from the Galician Government.	Aebi H., 1983, CATALASE, P673; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Araniti F, 2017, PLANT BIOLOGY, V19, P79, DOI 10.1111/plb.12471; Araniti F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170161; Araniti F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160202; Araniti F, 2015, MOLECULES, V20, P17883, DOI 10.3390/molecules201017883; Araniti F, 2013, NAT PROD RES, V27, P2297, DOI 10.1080/14786419.2013.827193; Arpagaus S, 2002, J BIOL CHEM, V277, P1780, DOI 10.1074/jbc.M109416200; ASADA K, 1974, AGR BIOL CHEM TOKYO, V38, P471, DOI 10.1080/00021369.1974.10861178; Bais HP, 2002, PLANT PHYSIOL BIOCH, V40, P983, DOI 10.1016/S0981-9428(02)01460-2; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Bhadoria P. B. S., 2011, American Journal of Experimental Agriculture, V1, P7; Blum U., 2014, PLANT PLANT ALLELOPA, P185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Cheng F., 2015, FRONT PLANT SCI, V6; CIAMPOROVA M, 1993, ENVIRON EXP BOT, V33, P11, DOI 10.1016/0098-8472(93)90052-H; Ciniglia C, 2010, ALLELOPATHY J, V26, P301; Cole DJ, 2000, PESTIC OUTLOOK, V11, P223, DOI [DOI 10.1039/B009272J, 10.1039/B009272J]; Costa-Gil A., 2015, JAI, V1, P39; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Dat JF, 2003, PLANT J, V33, P621, DOI 10.1046/j.1365-313X.2003.01655.x; Dayan FE, 2012, PEST MANAG SCI, V68, P519, DOI 10.1002/ps.2332; Diaz-Tielas C, 2017, J PLANT PHYSIOL, V218, P56, DOI 10.1016/j.jplph.2017.07.014; Diaz-Tielas C, 2012, PLANT CELL ENVIRON, V35, P1500, DOI 10.1111/j.1365-3040.2012.02506.x; Elstner E.F., 1983, METHOD ENZYMAT AN, VIII, P293; Frenkel C., 1991, Trends in Food Science & Technology, V2, P39, DOI 10.1016/0924-2244(91)90613-N; Gelsomino A., 2015, JA, V1, P25; Gniazdowska A, 2005, ACTA PHYSIOL PLANT, V27, P395, DOI 10.1007/s11738-005-0017-3; Grana E, 2013, J CHEM ECOL, V39, P271, DOI 10.1007/s10886-013-0250-y; Grana E, 2017, J PLANT PHYSIOL, V218, P45, DOI 10.1016/j.jplph.2017.07.007; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jabs T, 1999, BIOCHEM PHARMACOL, V57, P231, DOI 10.1016/S0006-2952(98)00227-5; KALYANARAMAN B, 1985, J BIOL CHEM, V260, P4003; Krause M, 2004, MOL PLANT MICROBE IN, V17, P131, DOI 10.1094/MPMI.2004.17.2.131; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Liptakova L, 2012, PLANT CELL REP, V31, P2189, DOI 10.1007/s00299-012-1329-6; Ma X, 2017, ENZYME INHIBITORS AC; Marino D, 2007, PLANTA, V225, P413, DOI 10.1007/s00425-006-0354-5; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittova V, 2003, PLANT CELL ENVIRON, V26, P845, DOI 10.1046/j.1365-3040.2003.01016.x; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Ogus IH, FREE RADICALS OXIDAT; Pallett K., 2000, MODE ACTION ISOXAFLU, P215; Pallett KE, 1997, PROC BRIGHTON CROP, P575; Parsons HL, 1999, PLANT PHYSIOL, V121, P1309, DOI 10.1104/pp.121.4.1309; Pasternak T, 2005, J EXP BOT, V56, P1991, DOI 10.1093/jxb/eri196; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; Popov VN, 1997, FEBS LETT, V415, P87, DOI 10.1016/S0014-5793(97)01099-5; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Rubio MC, 2004, MOL PLANT MICROBE IN, V17, P1294, DOI 10.1094/MPMI.2004.17.12.1294; Scognamiglio M, 2012, BIOCHEM SYST ECOL, V43, P108, DOI 10.1016/j.bse.2012.02.025; Srivastava S, 2016, MYCORRHIZA, V26, P919, DOI 10.1007/s00572-016-0721-4; Suksungworn R, 2017, PAK J BOT, V49, P1173; Sulmon C, 2006, PLANT CELL REP, V25, P489, DOI 10.1007/s00299-005-0062-9; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Sweetlove LJ, PLANT MITOCHONDRIA F; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; VERNIQUET F, 1991, BIOCHEM J, V276, P643, DOI 10.1042/bj2760643; VLADIMIROV YA, 1980, ADV LIPID RES, V17, P173; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Yao N, 2004, PLANT J, V40, P596, DOI 10.1111/j.1365-313X.2004.02239.x; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Yao N, 2002, MOL PLANT MICROBE IN, V15, P1000, DOI 10.1094/MPMI.2002.15.10.1000	71	24	24	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208802	10.1371/journal.pone.0208802	http://dx.doi.org/10.1371/journal.pone.0208802			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586368	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400037
J	Turner, HN; Patel, AA; Cox, DN; Galko, MJ				Turner, Heather N.; Patel, Atit A.; Cox, Daniel N.; Galko, Michael J.			Injury-induced cold sensitization in Drosophila larvae involves behavioral shifts that require the TRP channel Brv1	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; NOCICEPTIVE NEURONS; NERVOUS-SYSTEM; NOXIOUS COLD; C.-ELEGANS; PAIN; NOMPC; TOUCH; THERMOSENSATION; DISCRIMINATION	Nociceptive sensitization involves an increase in responsiveness of pain sensing neurons to sensory stimuli, typically through the lowering of their nociceptive threshold. Nociceptive sensitization is common following tissue damage, inflammation, and disease and serves to protect the affected area while it heals. Organisms can become sensitized to a range of noxious and innocuous stimuli, including thermal stimuli. The basic mechanisms underlying sensitization to warm or painfully hot stimuli have begun to be elucidated, however, sensitization to cold is not well understood. Here, we develop a Drosophila assay to study cold sensitization after UV-induced epidermal damage in larvae. Larvae respond to acute cold stimuli with a set of unique behaviors that include a contraction of the head and tail (CT) or a raising of the head and tail into a U-Shape (US). Under baseline, non-injured conditions larvae primarily produce a CT response to an acute cold (10 degrees C) stimulus, however, we show that cold-evoked responses shift following tissue damage: CT responses decrease, US responses increase and some larvae exhibit a lateral body roll (BR) that is typically only observed in response to high temperature and noxious mechanical stimuli. At the cellular level, class III neurons are required for the decrease in CT, chordotonal neurons are required for the increase in US, and chordotonal and class IV neurons are required for the appearance of BR responses after UV. At the molecular level, we found that the transient receptor potential (TRP) channel brivido-1 (brv1) is required for these behavioral shifts. Our Drosophila model will allow us to precisely identify the genes and circuits involved in cold nociceptive sensitization.	[Turner, Heather N.; Galko, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Patel, Atit A.; Cox, Daniel N.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Turner, Heather N.] Univ Southern Calif, Neurobiol Sect, Los Angeles, CA USA	University of Texas System; UTMD Anderson Cancer Center; University System of Georgia; Georgia State University; University of Southern California	Galko, MJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Cox, DN (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.	dcox18@gsu.edu; mjgalko@mdanderson.org		Galko, Michael/0000-0002-3759-2017	National Institute of Neurological Disorders and Stroke [R01 NS086082]; NIH Predoctoral Kirschstein National Research Service Award Fellowship [NINDS F31 NS083306]; National Institute of General Medical Sciences [R35 GM126929]; Marilyn and Frederick R. Lummis, Jr. MD Fellowship; Georgia State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM126929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086082] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Predoctoral Kirschstein National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marilyn and Frederick R. Lummis, Jr. MD Fellowship; Georgia State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Institute of Neurological Disorders and Stroke (R01 NS086082 to DNC) and a NIH Predoctoral Kirschstein National Research Service Award Fellowship (NINDS F31 NS083306 to HNT). This work was also supported by the National Institute of General Medical Sciences (R35 GM126929 to MJG), the Marilyn and Frederick R. Lummis, Jr. MD Fellowship (HNT); and Georgia State University (the 2CI Neurogenomics Fellowship and Kenneth W. and Georgeanne F. Honeycutt Fellowship to AAP; and a GSU Brains and Behavior grant to DNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Babcock DT, 2011, CURR BIOL, V21, P1525, DOI 10.1016/j.cub.2011.08.020; Babcock DT, 2009, CURR BIOL, V19, P799, DOI 10.1016/j.cub.2009.03.062; Babcock DT, 2010, THESIS; Berglund B, 2002, PAIN, V96, P177, DOI 10.1016/S0304-3959(01)00443-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Crook RJ, 2014, CURR BIOL, V24, P1121, DOI 10.1016/j.cub.2014.03.043; Das R, 2017, GENETICS, V207, P1401, DOI 10.1534/genetics.117.300393; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Extra JM, 1998, SEMIN ONCOL, V25, P13; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Greenspan JD, 2004, PAIN, V109, P357, DOI [10.1016/j.pain.2004.02.002, 10.1016/S0304-3959(04)00068-5]; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hu C, 2017, NAT NEUROSCI, V20, P1085, DOI 10.1038/nn.4580; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Iftinca M, 2016, MOL PAIN, V12, DOI 10.1177/1744806916663945; Illich PA, 1997, J NEUROSCI, V17, P459, DOI 10.1523/JNEUROSCI.17-01-00459.1997; Im SH, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.034231; Im SH, 2015, ELIFE, V4, DOI 10.7554/eLife.10735; Iyer EPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072434; Jasmin L, 1998, PAIN, V75, P367, DOI 10.1016/S0304-3959(98)00017-7; Jo J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.474; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Khan N, 2014, INFLAMMOPHARMACOLOGY, V22, P1, DOI 10.1007/s10787-013-0195-3; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Klein M, 2015, P NATL ACAD SCI USA, V112, pE220, DOI 10.1073/pnas.1416212112; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010; Lippoldt EK, 2013, J NEUROSCI, V33, P12543, DOI 10.1523/JNEUROSCI.5765-12.2013; Moran MM, 2018, BRIT J PHARMACOL, V175, P2185, DOI 10.1111/bph.14044; Munns C, 2007, CELL CALCIUM, V41, P331, DOI 10.1016/j.ceca.2006.07.008; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni L, 2016, ELIFE, V5, DOI 10.7554/eLife.13254; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; Patel AA, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2388; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; PIZZIKETTI RJ, 1985, EUR J PHARMACOL, V119, P23, DOI 10.1016/0014-2999(85)90317-6; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Rose JK, 2001, LEARN MEMORY, V8, P63, DOI 10.1101/lm.37801; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sarria I, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-79; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Summers T, 2015, J EXP BIOL, V218, P3023, DOI 10.1242/jeb.120600; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsubouchi A, 2012, CURR BIOL, V22, P2124, DOI 10.1016/j.cub.2012.09.019; Turner HN, 2016, CURR BIOL, V26, P3116, DOI 10.1016/j.cub.2016.09.038; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; WANKLYN P, 1994, STROKE, V25, P1765, DOI 10.1161/01.STR.25.9.1765; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057; Zhou YT, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-39	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209577	10.1371/journal.pone.0209577	http://dx.doi.org/10.1371/journal.pone.0209577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586392	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400073
J	Guiguet, A; Hamatani, A; Amano, T; Takeda, S; Lopez-Vaamonde, C; Giron, D; Ohshima, I				Guiguet, Antoine; Hamatani, Akihisa; Amano, Taisuke; Takeda, Seiji; Lopez-Vaamonde, Carlos; Giron, David; Ohshima, Issei			Inside the horn of plenty: Leaf-mining micromoth manipulates its host plant to obtain unending food provisioning	PLOS ONE			English	Article							ADAPTIVE SIGNIFICANCE; ACROCERCOPS-TRANSECTA; EVOLUTION; QUALITY; CECIDOMYIIDAE; LEPIDOPTERA; DYNAMICS; INSECTS; DEFENSE; MINERS	Leaves represent the main resource for herbivorous insects and their performances are mainly a function of leaf nutritional quality. Two feeding strategies are known to optimize the exploitation of leaf resources: leaf-miners that selectively feed on tissues of high nutritional quality and gall-inducers that induce the development of a new tissue showing an enhanced nutritional value. Some leaf-miners are known to also manipulate their nutritional environment, but do not affect plant development. Cases of callus proliferation in leaf-mines have been reported, however, the direct role of the insect in the formation of additional plant cells and the nutritional function of this tissue have never been established. Using an experimental approach, we show that leaf-mining larvae of micromoth, Borboryctis euryae (Lepidoptera: Gracillariidae), that grow on Eurya japonica (Pentaphylacaceae), actively induce callus proliferation within their leaf-mine at the fourth instar. We experimentally demonstrated that, at this developmental stage, the larva feeds exclusively on this newly formed tissue and feeding of the tissue is essential for completing larval stage. Phenological census revealed considerable expansion and variation of fourth instar duration caused by the continuous production of callus. We propose here the "cornucopia" hypothesis which states that the newly produced callus induced by the leaf-mining larvae provides virtually unending nourishment, which in turn allows flexible larval development time. This represents the first example of a leaf-miner manipulating plant development to its benefit, like a gall-inducer. We propose to name this life style "mine-galler".	[Guiguet, Antoine; Lopez-Vaamonde, Carlos; Giron, David] Univ Tours, CNRS, Inst Rech Biol Insecte, UFR Sci & Tech,UMR 7261, Tours, France; [Guiguet, Antoine; Hamatani, Akihisa; Amano, Taisuke; Ohshima, Issei] Kyoto Prefectural Univ, Dept Life & Environm Sci, Kyoto, Japan; [Takeda, Seiji] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Cell & Genome Biol, Kyoto, Japan; [Takeda, Seiji] Kyoto Prefectural Agr Forestry & Fisheries Techno, Biotechnol Res Dept, Seika, Kyoto, Japan; [Lopez-Vaamonde, Carlos] INRA, Zool Forestiere, UR0633, Orleans, France; [Hamatani, Akihisa] Dept Agr & Fisheries, Shiga, Shiga, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; Kyoto Prefectural University; Kyoto Prefectural University; INRAE	Guiguet, A (corresponding author), Univ Tours, CNRS, Inst Rech Biol Insecte, UFR Sci & Tech,UMR 7261, Tours, France.; Guiguet, A (corresponding author), Kyoto Prefectural Univ, Dept Life & Environm Sci, Kyoto, Japan.	antoine.guiguet@etu.univ-tours.fr	Vaamonde, Carlos Lopez/A-5548-2009; Giron, David/B-9108-2013	Vaamonde, Carlos Lopez/0000-0003-2278-2368; Giron, David/0000-0001-8356-0983; Guiguet, Antoine/0000-0002-3101-825X; Takeda, Seiji/0000-0003-0183-7390	PRC project 1724 Origen - National Center for Scientific Research (CNRS); Bilateral Join Research Project - National Center for Scientific Research (CNRS); Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [17H06260]; strategic prioritized research in KPU; ENS Lyon; KPU	PRC project 1724 Origen - National Center for Scientific Research (CNRS); Bilateral Join Research Project - National Center for Scientific Research (CNRS); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); strategic prioritized research in KPU; ENS Lyon; KPU	This study was supported by the PRC project 1724 Origen (to D.G.) and Bilateral Join Research Project (to I.O.) funded by the National Center for Scientific Research (CNRS) and the Japan Society for the Promotion of Science (JSPS), JSPS KAKENHI Grant Number 17H06260 to I.O. and S.T., and the strategic prioritized research in KPU to I.O. and S.T. We would like to thank the ENS Lyon for the PhD scholarship and KPU for International Exchange Support Program to A.G.	Ashihara H, 2017, PROG CHEM ORG NAT PR, V105, P1, DOI 10.1007/978-3-319-49712-9_1; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Body M, 2015, ARTHROPOD-PLANT INTE, V9, P75, DOI 10.1007/s11829-014-9349-5; Body M, 2013, J CHEM ECOL, V39, P969, DOI 10.1007/s10886-013-0307-y; Chen KW, 2018, INSECT SCI, V25, P337, DOI 10.1111/1744-7917.12399; Connor EF, 1997, OIKOS, V79, P6, DOI 10.2307/3546085; Gertz O., 1918, BOTANISKA NOTISER 19, P121; Giron D, 2007, BIOL LETTERS, V3, P340, DOI 10.1098/rsbl.2007.0051; Giron David, 2017, Atti della Accademia Nazionale Italiana di Entomologia Rendiconti, V65, P191; Hering EM, 1951, BIOL LEAF MINERS; HESSE M, 1972, OSTERR BOT Z, V120, P213, DOI 10.1007/BF01373375; JEANNEAU Y, 1971, B SOC BOT FR, V118, P589, DOI 10.1080/00378941.1971.10838929; Meyer J., 1983, ANATOMIE DES GALLES; MORAN N, 1980, J THEOR BIOL, V86, P247, DOI 10.1016/0022-5193(80)90004-1; Murphy SM, 2018, INSECT SCI, V25, P352, DOI 10.1111/1744-7917.12459; New T.R., 1981, Cecidologia Internationale, V2, P109; Ohshima I, 2005, ENTOMOL SCI, V8, P227, DOI 10.1111/j.1479-8298.2005.00120.x; Ohshima I, 2015, J NAT HIST, V49, P815, DOI 10.1080/00222933.2014.953613; Perianez-Rodriguez J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00219; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; Redfern M, 2005, ECOL ENTOMOL, V30, P86, DOI 10.1111/j.0307-6946.2005.00658.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Scheirs J, 2002, ECOL ENTOMOL, V27, P84, DOI 10.1046/j.1365-2311.2002.0378a.x; Scheirs J, 2001, ECOL ENTOMOL, V26, P509, DOI 10.1046/j.1365-2311.2001.00356.x; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Tooker JF, 2014, J CHEM ECOL, V40, P742, DOI 10.1007/s10886-014-0457-6; Uesugi A, 2015, ECOL ENTOMOL, V40, P221, DOI 10.1111/een.12177; Uyi OO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190700; van Nieukerken EJ, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.628.9805; Yukawa J, 2016, ENTOMOL SCI, V19, P275, DOI 10.1111/ens.12183	32	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209485	10.1371/journal.pone.0209485	http://dx.doi.org/10.1371/journal.pone.0209485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576396	Green Submitted, Green Published, gold			2022-12-26	WOS:000454149400052
J	Schira, J; Heinen, A; Poschmann, G; Ziegler, B; Hartung, HP; Stuhler, K; Kury, P				Schira, Jessica; Heinen, Andre; Poschmann, Gereon; Ziegler, Brigida; Hartung, Hans-Peter; Stuehler, Kai; Kuery, Patrick			Secretome analysis of nerve repair mediating Schwann cells reveals Smad-dependent trophism	FASEB JOURNAL			English	Article						peripheral; dedifferentiation; glia; mass spectrometry; Fingolimod	GROWTH-FACTOR-BETA; N-TERMINAL KINASE; PERIPHERAL-NERVE; C-JUN; FUNCTIONAL RECOVERY; PROTEASE NEXIN-1; NEGATIVE REGULATOR; NEURITE OUTGROWTH; SIGNALING CASCADE; REGENERATION	Schwann cells promote nerve regeneration by adaptation of a regenerative phenotype referred to as repair mediating Schwann cell. Down-regulation of myelin proteins, myelin clearance, formation of Bungner's bands, and secretion of trophic factors characterize this cell type. We have previously shown that the sphingosine-1-phosphate receptor agonist Fingolimod/FTY720P promotes the generation of this particular Schwann cell phenotype by activation of dedifferentiation markers and concomitant release of trophic factors resulting in enhanced neurite growth of dorsal root ganglion neurons. Despite its biomedical relevance, a detailed characterization of the corresponding Schwann cell secretome is lacking, and the impact of FTY720P on enhancing neurite growth is not defined. Here, we applied a label-free quantitative mass spectrometry approach to characterize the secretomes derived from primary neonatal and adult rat Schwann cells in response to FTY720P. We identified a large proportion of secreted proteins with a high overlap between the neonatal and adult Schwann cells, which can be associated with biologic processes such as development, axon growth, and regeneration. Moreover, FTY720P-treated Schwann cells release proteins downstream of Smad signaling known to support neurite growth. Our results therefore uncover a network of trophic factors involved in glial-mediated repair of the peripheral nervous system.	[Schira, Jessica; Heinen, Andre; Ziegler, Brigida; Hartung, Hans-Peter; Kuery, Patrick] Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany; [Schira, Jessica; Poschmann, Gereon; Stuehler, Kai] Heinrich Heine Univ, Mol Prote Lab, Biomed Res Ctr, Dusseldorf, Germany; [Stuehler, Kai] Univ Hosp Dusseldorf, Inst Mol Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Schira, J (corresponding author), Heinrich Heine Univ, Neuroregenerat Lab, Dept Neurol, Moorenstr 5, D-40225 Dusseldorf, Germany.	J.Schira@uni-duesseldorf.de		Poschmann, Gereon/0000-0003-2448-0611; Kury, Patrick/0000-0002-2654-1126; Schira-Heinen, Jessica/0000-0002-2184-9746	Deutsche Forschungsgemeinschaft (DFG) [KU1934/2_1, KU1934/5_1, HE 6443/1-1]; Stifterverband/Novartisstiftung; Walter and Ilse Rose Foundation; James and Elisabeth Cloppenburg, Peek and Cloppenburg Dusseldorf Stiftung; Christiane and Claudia Hempel Foundation for Stem Cell Research; Forschungskommission of the Heinrich-Heine-University Dusseldorf	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Stifterverband/Novartisstiftung; Walter and Ilse Rose Foundation; James and Elisabeth Cloppenburg, Peek and Cloppenburg Dusseldorf Stiftung; Christiane and Claudia Hempel Foundation for Stem Cell Research; Forschungskommission of the Heinrich-Heine-University Dusseldorf	The authors thank Marion Gehrke (Molecular Proteomics Laboratory and Institute for Molecular Medicine) for sample preparation for LC-MS/MS analysis, and Anja Stefanski (Molecular Proteomics Laboratory and Institute for Molecular Medicine) for technical support of the LC-MS/MS analysis. Research on myelin repair and neuroregeneration in the laboratory of P.K. was supported by the Deutsche Forschungsgemeinschaft (DFG; Grants KU1934/2_1, KU1934/5_1; HE 6443/1-1) and by the Stifterverband/Novartisstiftung. The Multiple Sclerosis Center at the Department of Neurology was supported, in part, by the Walter and Ilse Rose Foundation and the James and Elisabeth Cloppenburg, Peek and Cloppenburg Dusseldorf Stiftung. J.S. was supported by the Christiane and Claudia Hempel Foundation for Stem Cell Research. Research in the laboratory of K. S. was supported by the Forschungskommission of the Heinrich-Heine-University Dusseldorf. P.K. performed consultancy work for Geneuro; H.-P.H. received compensation for consulting, speaking, and serving on steering committees from Bayer Healthcare, Biogen, Geneuro, MedImmune, Merck, Novartis, Opexa, Receptos Celgene, Roche, Sanofi Genzyme, and Teva with approval by the Rector of Heinrich-Heine-University; and all remaining authors declare no conflicts of interest.	ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Au E, 2007, J NEUROSCI, V27, P7208, DOI 10.1523/JNEUROSCI.0509-07.2007; Bampton ETW, 2005, EUR J NEUROSCI, V21, P2611, DOI 10.1111/j.1460-9568.2005.04128.x; Banyai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010758; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Bonner J, 2001, J NEUROSCI, V21, P9782, DOI 10.1523/JNEUROSCI.21-24-09782.2001; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chao T, 2013, ANN NEUROL, V73, P210, DOI 10.1002/ana.23781; Chen HL, 2012, INT J MOL SCI, V13, P9380, DOI 10.3390/ijms13079380; Cua RC, 2013, GLIA, V61, P972, DOI 10.1002/glia.22489; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; Elegheert J, 2017, NEURON, V96, P242, DOI 10.1016/j.neuron.2017.09.011; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Fukaya K, 2003, J NEUROPATH EXP NEUR, V62, P162, DOI 10.1093/jnen/62.2.162; GUENARD V, 1995, J NEUROSCI, V15, P419; Heinen A, 2008, P NATL ACAD SCI USA, V105, P8748, DOI 10.1073/pnas.0802659105; Heinen A, 2015, EXP NEUROL, V271, P25, DOI 10.1016/j.expneurol.2015.05.002; Hiraiwa M, 1997, P NATL ACAD SCI USA, V94, P4778, DOI 10.1073/pnas.94.9.4778; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jessen KR, 2015, DEV CELL, V34, P613, DOI 10.1016/j.devcel.2015.09.005; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Kury P, 1997, DEVELOPMENT, V124, P1251; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee JA, 2008, MECH DEVELOP, V125, P167, DOI 10.1016/j.mod.2007.09.009; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lino MM, 2007, J NEUROSCI, V27, P3677, DOI 10.1523/JNEUROSCI.0277-07.2007; Ma LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095098; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Malik AR, 2013, J BIOL CHEM, V288, P8544, DOI 10.1074/jbc.M112.411629; Marcos S, 2015, J NEUROSCI, V35, P4729, DOI 10.1523/JNEUROSCI.3304-13.2015; Meier C, 1999, J NEUROSCI, V19, P3847; MEIER R, 1989, NATURE, V342, P548, DOI 10.1038/342548a0; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; MULLIGAN LP, 1991, NEUROSCI LETT, V128, P42, DOI 10.1016/0304-3940(91)90756-J; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Panteri R, 2006, MOL CELL NEUROSCI, V32, P133, DOI 10.1016/j.mcn.2006.03.004; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Park JA, 2008, GLIA, V56, P247, DOI 10.1002/glia.20600; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Rayego-Mateos S, 2013, J MOL CELL BIOL, V5, P323, DOI 10.1093/jmcb/mjt030; Roet KCD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109401; ROGISTER B, 1993, J NEUROSCI RES, V34, P32, DOI 10.1002/jnr.490340105; Scarlato M, 2003, EXP NEUROL, V183, P489, DOI 10.1016/S0014-4886(03)00046-3; SCHERER SS, 1993, GLIA, V8, P265, DOI 10.1002/glia.440080407; Schira J, 2015, MOL CELL PROTEOMICS, V14, P2630, DOI 10.1074/mcp.M115.049312; SCHMIDT JT, 1991, J NEUROBIOL, V22, P40, DOI 10.1002/neu.480220105; Sharma S, 2011, J PHARMACOL PHARMACO, V2, P49, DOI 10.4103/0976-500X.77118; SHASHOUA VE, 1991, ANN NY ACAD SCI, V627, P94; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sulaiman OAR, 2002, GLIA, V37, P206, DOI 10.1002/glia.10022; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Szepanowski F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0612-9; TANAKA J, 1994, J NEUROSCI, V14, P1038, DOI 10.1523/JNEUROSCI.14-03-01038.1994; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Tzekova N, 2014, J CLIN IMMUNOL, V34, pS86, DOI 10.1007/s10875-014-0015-6; van Erp S, 2015, DEV CELL, V35, P537, DOI 10.1016/j.devcel.2015.11.008; Vincent AJ, 2008, DEV DYNAM, V237, P1449, DOI 10.1002/dvdy.21495; Wahab NA, 2005, J AM SOC NEPHROL, V16, P340, DOI 10.1681/ASN.2003100905; Xin CY, 2006, BRIT J PHARMACOL, V147, P164, DOI 10.1038/sj.bjp.0706452; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yanagisawa H, 2010, NEUROSCI RES, V66, P111, DOI 10.1016/j.neures.2009.10.002; Zainul Z, 2018, J NEUROSCI, V38, P4243, DOI 10.1523/JNEUROSCI.3119-17.2018; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Zheng M, 2000, J NEUROBIOL, V42, P212, DOI 10.1002/(SICI)1097-4695(20000205)42:2<212::AID-NEU5>3.3.CO;2-3; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	79	19	19	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4703	4715		10.1096/fj.201801799R	http://dx.doi.org/10.1096/fj.201801799R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592632	Bronze			2022-12-26	WOS:000462888500006
J	Hada, K; Hirota, K; Inanobe, A; Kako, K; Miyata, M; Araoi, S; Matsumoto, M; Ohta, R; Arisawa, M; Daitoku, H; Hanada, T; Fukamizu, A				Hada, Kazumasa; Hirota, Keiko; Inanobe, Ai; Kako, Koichiro; Miyata, Mai; Araoi, Sho; Matsumoto, Masaki; Ohta, Reiya; Arisawa, Mitsuhiro; Daitoku, Hiroaki; Hanada, Toshikatsu; Fukamizu, Akiyoshi			Tricarboxylic acid cycle activity suppresses acetylation of mitochondrial proteins during early embryonic development in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polyamine; Caenorhabditis elegans (C; elegans); tricarboxylic acid cycle (TCA cycle) (Krebs cycle); post-translational modification (PTM); acetyl coenzyme A (acetyl-CoA); citrate synthase; deacetylase; early embryogenesis; mitochondrial protein acetylation; sirtuin	PROGRESSION; SPERMIDINE; METABOLISM; INHIBITORS; AUTOPHAGY; DISEASES	The tricarboxylic acid (TCA) cycle (or citric acid cycle) is responsible for the complete oxidation of acetyl-CoA and formation of intermediates required for ATP production and other anabolic pathways, such as amino acid synthesis. Here, we uncovered an additional mechanism that may help explain the essential role of the TCA cycle in the early embryogenesis of Caenorhabditis elegans. We found that knockdown of citrate synthase (cts-1), the initial and rate-limiting enzyme of the TCA cycle, results in early embryonic arrest, but that this phenotype is not because of ATP and amino acid depletions. As a possible alternative mechanism explaining this developmental deficiency, we observed that cts-1 RNAi embryos had elevated levels of intracellular acetyl-CoA, the starting metabolite of the TCA cycle. Of note, we further discovered that these embryos exhibit hyperacetylation of mitochondrial proteins. We found that supplementation with acetylase-inhibiting polyamines, including spermidine and putrescine, counteracted the protein hyperacetylation and developmental arrest in the cts-1 RNAi embryos. Contrary to the hypothesis that spermidine acts as an acetyl sink for elevated acetyl-CoA, the levels of three forms of acetylspermidine, N-1-acetylspermidine, N-8-acetylspermidine, and N-1,N-8-diacetylspermidine, were not significantly increased in embryos treated with exogenous spermidine. Instead, we demonstrated that the mitochondrial deacetylase sirtuin 4 (encoded by the sir-2.2 gene) is required for spermidine's suppression of protein hyperacetylation and developmental arrest in the cts-1 RNAi embryos. Taken together, these results suggest the possibility that during early embryogenesis, acetyl-CoA consumption by the TCA cycle in C. elegans prevents protein hyperacetylation and thereby protects mitochondrial function.	[Hada, Kazumasa; Daitoku, Hiroaki; Fukamizu, Akiyoshi] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr Survival Dynam, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan; [Hada, Kazumasa; Hanada, Toshikatsu] Oita Univ, Fac Med, Dept Cell Biol, 1-1 Hasama Machi, Yufu, Oita 8795593, Japan; [Hirota, Keiko; Kako, Koichiro] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan; [Hirota, Keiko] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan; [Inanobe, Ai; Miyata, Mai; Araoi, Sho] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan; [Matsumoto, Masaki] Kyushu Univ, Med Inst Bioregulat, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Ohta, Reiya; Arisawa, Mitsuhiro] Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; Oita University; University of Tsukuba; University of Tsukuba; Tokyo Women's Medical University; University of Tsukuba; Kyushu University; Osaka University; University of Tsukuba	Fukamizu, A (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr Survival Dynam, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Arisawa, Mitsuhiro/D-9098-2012; Ohta, Reiya/J-8064-2016	Ohta, Reiya/0000-0003-4932-9440	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23116001]; Japan Society for the Promotion of Science [26450119, 17K07746, 26350957, 17K01942, 17K08193];  [17H01519]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by Grant-in-Aid Project 23116001 (Scientific Research on Innovative Areas) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to A. F.) and the Japan and Grants-in-Aid for Scientific Research (A) 17H01519 (to A. F.); Grants-in-Aid for Scientific Research (C) 26450119 and 17K07746 (to K. H.), 26350957 and 17K01942 (to K. K.), and 17K08193 (to H. D.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; KANE MT, 1977, J REPROD FERTIL, V49, P261, DOI 10.1530/jrf.0.0490261; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Rahman MM, 2014, P NATL ACAD SCI USA, V111, P2602, DOI 10.1073/pnas.1311635111; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; THOMSON JL, 1967, EXP CELL RES, V46, P252, DOI 10.1016/0014-4827(67)90063-8; Tsuchiya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097693; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wirth M, 2013, MITOCHONDRION, V13, P705, DOI 10.1016/j.mito.2013.02.002	21	8	8	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3091	3099		10.1074/jbc.RA118.004726	http://dx.doi.org/10.1074/jbc.RA118.004726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30606736	hybrid, Green Published			2022-12-26	WOS:000464980100010
J	Alshawi, A; Agius, L				Alshawi, Ahmed; Agius, Loranne			Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metformin; metabolic regulation; metabolic disease; gluconeogenesis; redox regulation; dimethylbiguanide; mitochondrial glycerophosphate dehydrogenase; phosphofructokinase-1	REDUCING-EQUIVALENT SHUTTLES; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; GLUCOSE-PRODUCTION; FATTY-ACID; MICE; DEHYDROGENASE; GLUCOKINASE; LIVER; PHOSPHORYLATION	The mechanisms by which metformin (dimethylbiguanide) inhibits hepatic gluconeogenesis at concentrations relevant for type 2 diabetes therapy remain debated. Two proposed mechanisms are 1) inhibition of mitochondrial Complex 1 with consequent compromised ATP and AMP homeostasis or 2) inhibition of mitochondrial glycerophosphate dehydrogenase (mGPDH) and thereby attenuated transfer of reducing equivalents from the cytoplasm to mitochondria, resulting in a raised lactate/pyruvate ratio and redox-dependent inhibition of gluconeogenesis from reduced but not oxidized substrates. Here, we show that metformin has a biphasic effect on the mitochondrial NADH/NAD redox state in mouse hepatocytes. A low cell dose of metformin (therapeutic equivalent: <2 nmol/mg) caused a more oxidized mitochondrial NADH/NAD state and an increase in lactate/pyruvate ratio, whereas a higher metformin dose (>= 5 nmol/mg) caused a more reduced mitochondrial NADH/NAD state similar to Complex 1 inhibition by rotenone. The low metformin dose inhibited gluconeogenesis from both oxidized (dihydroxyacetone) and reduced (xylitol) substrates by preferential partitioning of substrate toward glycolysis by a redox-independent mechanism that is best explained by allosteric regulation at phosphofructokinase-1 (PFK1) and/or fructose 1,6-bisphosphatase (FBP1) in association with a decrease in cell glycerol 3-phosphate, an inhibitor of PFK1, rather than by inhibition of transfer of reducing equivalents. We conclude that at a low pharmacological load, the metformin effects on the lactate/pyruvate ratio and glucose production are explained by attenuation of transmitochondrial electrogenic transport mechanisms with consequent compromised malate-aspartate shuttle and changes in allosteric effectors of PFK1 and FBP1.	[Alshawi, Ahmed; Agius, Loranne] Newcastle Univ, Inst Cellular Med, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Alshawi, Ahmed] Al Furat AL Awsat Tech Univ, Kufa Inst, Clin Pathol Dept, Kufa, Iraq	Newcastle University - UK; Al-Furat Al-Awsat Technical University	Agius, L (corresponding author), Newcastle Univ, Inst Cellular Med, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	loranne.agius@ncl.ac.uk	Alshawi, Ahmed/J-1256-2019	Alshawi, Ahmed/0000-0002-0328-3486; Agius, Loranne/0000-0002-6419-6503	Higher Committee for Education Development (HCED) Iraq; Diabetes UK [13/0004701]	Higher Committee for Education Development (HCED) Iraq; Diabetes UK(Diabetes UK)	Supported by Higher Committee for Education Development (HCED) Iraq Grant 2015-2019.; Supported by Diabetes UK Grant 13/0004701.	AGIUS L, 1986, DIABETES, V35, P1286, DOI 10.2337/diabetes.35.11.1286; Al-Oanzi ZH, 2017, DIABETES OBES METAB, V19, P1078, DOI 10.1111/dom.12910; Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z; Barbera A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5; Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013; BERRY MN, 1994, EUR J BIOCHEM, V225, P557, DOI 10.1111/j.1432-1033.1994.00557.x; BERRY MN, 1992, BIOCHIM BIOPHYS ACTA, V1136, P223, DOI 10.1016/0167-4889(92)90110-W; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CLAUS TH, 1982, J BIOL CHEM, V257, P7541; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dang Q, 2009, J MED CHEM, V52, P2880, DOI 10.1021/jm900078f; DAVIS EJ, 1980, J BIOL CHEM, V255, P2277; DAWSON AP, 1969, BIOCHEM J, V111, P27, DOI 10.1042/bj1110027; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulgencio JP, 2001, BIOCHEM PHARMACOL, V62, P439, DOI 10.1016/S0006-2952(01)00679-7; Gouaref I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172053; Harndahl L, 2006, FEBS J, V273, P336, DOI 10.1111/j.1742-4658.2005.05067.x; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; LANOUE KF, 1974, J BIOL CHEM, V249, P7514; Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Maldonado EN, 2016, J BIOL CHEM, V291, P19642, DOI 10.1074/jbc.M116.734814; MCCUNE SA, 1989, BIOCHEM J, V259, P925, DOI 10.1042/bj2590925; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; NOMURA T, 1983, BIOCHIM BIOPHYS ACTA, V754, P315; Orr AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089938; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pelantova H, 2016, MOL CELL ENDOCRINOL, V431, P88, DOI 10.1016/j.mce.2016.05.003; Qi HY, 2018, DIABETOLOGIA, V61, P445, DOI 10.1007/s00125-017-4445-6; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; SIBILLE B, 1995, EUR J BIOCHEM, V231, P498, DOI 10.1111/j.1432-1033.1995.tb20724.x; STAPPENBECK R, 1990, J AUTOM CHEM, V12, P213, DOI 10.1155/S1463924690000281; Taleux N, 2009, J BIOL CHEM, V284, P4308, DOI 10.1074/jbc.M806187200; VINCENT MF, 1989, FASEB J, V3, P1855, DOI 10.1096/fasebj.3.7.2523832; von Morze C, 2018, MAGN RESON MED, V79, P1862, DOI 10.1002/mrm.27054; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	56	37	37	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2839	2853		10.1074/jbc.RA118.006670	http://dx.doi.org/10.1074/jbc.RA118.006670			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591586	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000459601600022
J	Robinett, NG; Culbertson, EM; Peterson, RL; Sanchez, H; Andes, DR; Nett, JE; Culotta, VC				Robinett, Natalie G.; Culbertson, Edward M.; Peterson, Ryan L.; Sanchez, Hiram; Andes, David R.; Nett, Jeniel E.; Culotta, Valeria C.			Exploiting the vulnerable active site of a copper-only superoxide dismutase to disrupt fungal pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; yeast; superoxide dismutase (SOD); superoxide ion; fungi; Candida; Cu-only SOD; metalloenzyme; mycocide; virulence; fungi; virulence	CANDIDA-ALBICANS; ZINC PYRITHIONE; PLATE ASSAY; BINDING; INSIGHTS; MUTANTS; ATPASE; ERYTHROCUPREIN; PROLIFERATION; ALZHEIMERS	Copper-only superoxide dismutases (SODs) represent a new class of SOD enzymes that are exclusively extracellular and unique to fungi and oomycetes. These SODs are essential for virulence of fungal pathogens in pulmonary and disseminated infections, and we show here an additional role for copper-only SODs in promoting survival of fungal biofilms. The opportunistic fungal pathogen Candida albicans expresses three copper-only SODs, and deletion of one of them, SOD5, eradicated candidal biofilms on venous catheters in a rodent model. Fungal copper-only SODs harbor an irregular active site that, unlike their Cu,Zn-SOD counterparts, contains a copper co-factor unusually open to solvent and lacks zinc for stabilizing copper binding, making fungal copper-only SODs highly vulnerable to metal chelators. We found that unlike mammalian Cu,Zn-SOD1, C. albicans SOD5 indeed rapidly loses its copper to metal chelators such as EDTA, and binding constants for Cu(II) predict that copper-only SOD5 has a much lower affinity for copper than does Cu,Zn-SOD1. We screened compounds with a variety of indications and identified several metal-binding compounds, including the ionophore pyrithione zinc (PZ), that effectively inhibit C. albicans SOD5 but not mammalian Cu,Zn-SOD1. We observed that PZ both acts as an ionophore that promotes uptake of toxic metals and inhibits copper-only SODs. The pros and cons of a vulnerable active site for copper-only SODs and the possible exploitation of this vulnerability in antifungal drug design are discussed.	[Robinett, Natalie G.; Culbertson, Edward M.; Peterson, Ryan L.; Culotta, Valeria C.] Johns Hopkins Bloomberg Sch Publ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Sanchez, Hiram; Andes, David R.; Nett, Jeniel E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53726 USA; [Sanchez, Hiram; Andes, David R.; Nett, Jeniel E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53726 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Culotta, VC (corresponding author), Johns Hopkins Bloomberg Sch Publ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculott1@jhu.edu	Andes, David/ABE-8033-2020	Andes, David/0000-0002-7927-9950	National Institutes of Health [RO1GM50016, RO1 AI119949, R01 AI073289, F31 DK111114, F32 GM112320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073289, R01AI119949, K08AI108727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK111114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1GM50016 and RO1 AI119949 (to V. C. C.), R01 AI073289 (to D. R. A.), F31 DK111114 (to E. M. C.), and F32 GM112320 (to R. L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonyuk SV, 2009, J MOL BIOL, V388, P310, DOI 10.1016/j.jmb.2009.03.026; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BARNETT BL, 1977, INORG CHEM, V16, P1834, DOI 10.1021/ic50174a002; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Battistoni A, 1998, J BIOL CHEM, V273, P5655, DOI 10.1074/jbc.273.10.5655; Broxton CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005295; Bush AI, 2002, NEUROBIOL AGING, V23, P1031, DOI 10.1016/S0197-4580(02)00120-3; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; COCCO D, 1981, J BIOL CHEM, V256, P8983; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Crow JP, 1997, J NEUROCHEM, V69, P1936; Dalecki AG, 2017, ADV MICROB PHYSIOL, V70, P193, DOI 10.1016/bs.ampbs.2017.01.007; Ding XQ, 2011, J NUTR BIOCHEM, V22, P301, DOI 10.1016/j.jnutbio.2010.06.010; Diphoorn J., 2015, BMJ CLIN EVID, V05, P1713; Djoko KY, 2015, ANTIMICROB AGENTS CH, V59, P6444, DOI 10.1128/AAC.01289-15; Dong XW, 2016, CHEM SCI, V7, P6251, DOI 10.1039/c6sc01272h; Doose CA, 2004, J CHROMATOGR A, V1052, P103, DOI 10.1016/j.chroma.2004.08.028; Duggan S, 2015, VIRULENCE, V6, P316, DOI 10.4161/21505594.2014.988096; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; Fenlon LA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00437-17; Ferrada E, 2007, NEUROTOXICOLOGY, V28, P445, DOI 10.1016/j.neuro.2007.02.004; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; Fisher CL, 1997, PROTEINS, V29, P103, DOI 10.1002/(SICI)1097-0134(199709)29:1<103::AID-PROT8>3.0.CO;2-G; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gabbianelli R, 2004, BIOL CHEM, V385, P749, DOI 10.1515/BC.2004.091; Garcia-Santamarina S, 2015, J BIOL CHEM, V290, P18945, DOI 10.1074/jbc.R115.649129; Geddes-McAlister J, 2019, ANN NY ACAD SCI, V1435, P57, DOI 10.1111/nyas.13739; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; GORDGE MP, 1995, BRIT J PHARMACOL, V114, P1083, DOI 10.1111/j.1476-5381.1995.tb13317.x; Haas KL, 2009, CHEM REV, V109, P4921, DOI 10.1021/cr900134a; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Helsel ME, 2017, METALLOMICS, V9, P69, DOI [10.1039/C6MT00172F, 10.1039/c6mt00172f]; Hider RC, 2015, DALTON T, V44, P5197, DOI 10.1039/c5dt00063g; HIROSE J, 1982, ARCH BIOCHEM BIOPHYS, V218, P179, DOI 10.1016/0003-9861(82)90334-4; HJALMARSSON K, 1987, P NATL ACAD SCI USA, V84, P6340, DOI 10.1073/pnas.84.18.6340; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; Jimenez-Lopez C, 2013, EUKARYOT CELL, V12, P91, DOI 10.1128/EC.00290-12; Johnson CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005884; Juarez JC, 2006, CLIN CANCER RES, V12, P4974, DOI 10.1158/1078-0432.CCR-06-0171; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kiss T, 1998, J INCLUS PHENOM MOL, V32, P385, DOI 10.1023/A:1008046330815; Kodama H, 1997, LIFE SCI, V61, P899, DOI 10.1016/S0024-3205(97)00592-4; Kohn B, 2018, BIOPHYS J, V115, P1007, DOI 10.1016/j.bpj.2018.07.040; KOMSHIAN SV, 1989, REV INFECT DIS, V11, P379; Lee REB, 2005, J ANTIMICROB CHEMOTH, V55, P655, DOI 10.1093/jac/dki105; Li CH, 2010, J ALZHEIMERS DIS, V21, P1249, DOI 10.3233/JAD-2010-100024; Lind SE, 2009, TRANSL RES, V154, P153, DOI 10.1016/j.trsl.2009.06.002; Linder MC, 2016, METALLOMICS, V8, P887, DOI 10.1039/c6mt00103c; Mackie J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158683; MARKLUND SL, 1984, BIOCHEM J, V220, P269, DOI 10.1042/bj2200269; MARKS R, 1985, BRIT J DERMATOL, V112, P415, DOI 10.1111/j.1365-2133.1985.tb02314.x; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; MISRA HP, 1979, J BIOL CHEM, V254, P1623; Morgan MT, 2017, J BIOL CHEM, V292, P21558, DOI 10.1074/jbc.M117.817452; Nagai M, 2012, FREE RADICAL BIO MED, V52, P2142, DOI 10.1016/j.freeradbiomed.2012.03.017; Nett JE, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0008-2014; Nett JE, 2015, INFECT IMMUN, V83, P4630, DOI 10.1128/IAI.00931-15; Nett JE, 2011, J CLIN MICROBIOL, V49, P1426, DOI 10.1128/JCM.02273-10; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Park M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30588-2; Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032; Peskin AV, 2017, FREE RADICAL BIO MED, V103, P188, DOI 10.1016/j.freeradbiomed.2016.12.033; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Peterson RL, 2016, J BIOL CHEM, V291, P20911, DOI 10.1074/jbc.M116.748251; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Pushie MJ, 2014, J INORG BIOCHEM, V133, P50, DOI 10.1016/j.jinorgbio.2014.01.003; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Reeder NL, 2011, BRIT J DERMATOL, V165, P9, DOI 10.1111/j.1365-2133.2011.10571.x; Reeder NL, 2011, ANTIMICROB AGENTS CH, V55, P5753, DOI 10.1128/AAC.00724-11; Richet H, 2002, CLIN MICROBIOL INFEC, V8, P405, DOI 10.1046/j.1469-0691.2002.00446.x; Robinett NG, 2018, J BIOL CHEM, V293, P4636, DOI 10.1074/jbc.TM117.000182; Rossi DCP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006763; Sanders NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105817; Schatzman SS, 2018, ACS INFECT DIS, V4, P893, DOI 10.1021/acsinfecdis.8b00026; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Smirnova J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19873-2; Soma S, 2018, P NATL ACAD SCI USA, V115, P8161, DOI 10.1073/pnas.1806296115; Subissi A, 2010, DRUGS, V70, P2133, DOI 10.2165/11538110-000000000-00000; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Tamayo D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004481; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P4245, DOI 10.1073/pnas.76.9.4245; VEIEN NK, 1980, CLIN EXP DERMATOL, V5, P53, DOI 10.1111/j.1365-2230.1980.tb01665.x; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; You Z, 2018, J MYCOL MED, V28, P492, DOI 10.1016/j.mycmed.2018.03.007; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	95	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2700	2713		10.1074/jbc.RA118.007095	http://dx.doi.org/10.1074/jbc.RA118.007095			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593499	Green Published, hybrid			2022-12-26	WOS:000459601600012
J	Middleton, BA; Travis, SE; Kubatova, B; Johnson, D; Edwards, KR				Middleton, Beth A.; Travis, Steven E.; Kubatova, Barbora; Johnson, Darren; Edwards, Keith R.			Morphology and genetics of Lythrum salicaria from latitudinal gradients of the Northern Hemisphere grown in cold and hot common gardens	PLOS ONE			English	Article							PURPLE LOOSESTRIFE; PHENOTYPIC PLASTICITY; POPULATION-STRUCTURE; ADAPTIVE EVOLUTION; SPARTINA-ALTERNIFLORA; COMPETITIVE ABILITY; FLOWERING PHENOLOGY; INVASIVE PLANTS; RANGE EXPANSION; AFLP	The aim of this project was to compare the phenotypic responses of global populations of Lythrum salicaria in cold/dry and hot/humid environments to determine if phenotypic plasticity varied between the native and invasive ranges, and secondarily if this variation was linked to genetic diversity. Common garden studies were conducted in Trebon, Czech Republic, and Lafayette, Louisiana, USA (cold/dry vs. hot/humid garden, respectively), using populations from latitudinal gradients in Eurasia and North America. Lythrum salicaria seeds collected from the same maternal plants across these latitudinal gradients were germinated and grown in Trebon and Lafayette. Tissue masses (above-, below-ground, inflorescence and total) of these individuals were assessed at the end of each growing season (2006-2008). Worldwide field measurements of L. salicaria height were made by volunteers from 2004-2016. Biomass and height data were analyzed using the General Linear Model framework and multivariate techniques. Molecular markers (amplified fragment length polymorphisms) of individuals used in the common garden study were analyzed using traditional genetic diversity metrics and Bayesian clustering algorithms in STRUCTURE. Reaction norms were developed from differences in maternal plant responses in Trebon versus Lafayette. In the common garden studies, stem/leaf, root and total biomass generally were highest for individuals grown from seeds collected in the southern part of the range in the cold garden, particularly by the third year of the study. In contrast, inflorescence biomass in the cold garden was higher by the third year in individuals from mid-latitude populations. As measured by volunteers, plants were taller in Eurasia than in North America moving from north to south with the pattern switching southward of 40 degrees N latitude. Genetic diversity was similar between native and non-native invasive populations regardless of geographical origin of the seed and was not significantly different in the GLM Select model (p > 0.05). Reaction norm slopes showed that Eurasia had larger values than North America for reaction norms for above-ground and total biomass. Plants from the seeds of mother plants from Turkey had wide variation in total biomass when grown in Trebon versus Lafayette; this variation in response within certain populations may have contributed to the lack of populationlevel differences in plasticity. These results indicate no loss of genetic diversity for L. salicaria during its North American invasion, nor reduction in plastic tissue allocation responses to a varying environment, which may help explain some of its invasive qualities and which could be of adaptive value under changing future environments.	[Middleton, Beth A.] US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA 70506 USA; [Travis, Steven E.] Univ New England, Dept Biol, Biddeford, ME USA; [Kubatova, Barbora] ASCR, SoWa Natl Res Infrastruct, Biol Ctr, Ceske Budejovice, Czech Republic; [Johnson, Darren] Wetland & Aquat Res Ctr, Cherokee Nations Technol, Los Angeles, CA USA; [Edwards, Keith R.] Univ South Bohemia, Fac Sci, Ecosyst Biol, Ceske Budejovice, Czech Republic	United States Department of the Interior; United States Geological Survey; University of New England - Maine; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Middleton, BA (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA 70506 USA.	middletonb@usgs.gov	Edwards, Keith/D-7184-2016; Kubatova, Barbora/D-6249-2016; Middleton, Beth/D-1778-2014	Edwards, Keith/0000-0003-3018-0201; Kubatova, Barbora/0000-0001-9461-7578; Middleton, Beth/0000-0002-1220-2326	USGS; Ministry of Education, Youth and Sports of the Czech Republic [LM2015075]	USGS(United States Geological Survey); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by USGS Ecosystems and Invasive Species Programs, and Ministry of Education, Youth and Sports of the Czech Republic Grant No. LM2015075. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank K. Foster and E. Anemaet for assistance with the set-up and maintenance of our common gardens; K. Wessner for assistance with our molecular marker analysis; and N.A. Bingol, P. Casals, B. Grewell, and P. Strakova for assistance with procuring our seed samples. We thank J. Marburger and anonymous reviewers for comments on earlier versions of the manuscript. The Louisiana work was conducted under SOP #2004-290v1 with USDA permit #37-86751 under State of Louisiana Wildlife and Fisheries requirements using a confined garden, i.e., a greenhouse. Many thanks for volunteers who collected height data on L. salicaria including P. Adam, J. P. Anderson, N.A. Bingol, J. Carol, J. Carter, M. Chauhan, K. Clark, P. Cook, K.F. Cretini, D. Devlin, D. Hamilla, B. Handley, D. Holland, J. Kvet, H.L. Lindon, C. Maki, R. Maerklein, J. Marburger, E. Middleton, R. Runshek, R. Sengupta, W. Smith, D. Stevens, K. Theiss, P. Vavlova, K. Welton, T. Walte, G. Wang and T. Williard. This work was partially supported by the USGS Ecosystems and Invasive Species Programs and the Ministry of Education, Youth and Sports of the Czech Republic Grant No. LM2015075. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data are available at: Middleton, B.A., Travis, S.E., Kubatova, Barbora, and Edwards, K. R., 2018, Morphology and genetics of Lythrum salicaria from latitudinal gradients of the Northern Hemisphere grown in cold and hot common gardens: U.S. Geological Survey data release, https://doi.org/10.5066/F74M92P8.	ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Bastlova D, 2002, FLORA, V197, P332, DOI 10.1078/0367-2530-00049; Bastlova-Hanzelyova D, 2001, PLANT INVASIONS: SPECIES ECOLOGY AND ECOSYSTEM MANAGEMENT, P33; Benham J.J., 2001, GENOGRAPHER VERSION; Blossey B, 2001, BIODIVERS CONSERV, V10, P1787, DOI 10.1023/A:1012065703604; Blossey B., 1996, Proceedings of the 9th international symposium on biological control of weeds, Stellenbosch, South Africa, 19-26 January 1996., P3; Bossdorf O, 2004, ECOL LETT, V7, P346, DOI 10.1111/j.1461-0248.2004.00583.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Chun YJ, 2007, ECOLOGY, V88, P1499, DOI 10.1890/06-0856; Chun YJ, 2011, BIOL INVASIONS, V13, P819, DOI 10.1007/s10530-010-9871-z; Chun YJ, 2010, AQUAT BOT, V93, P221, DOI 10.1016/j.aquabot.2010.09.001; Chun YJ, 2009, MOL ECOL, V18, P3020, DOI 10.1111/j.1365-294X.2009.04254.x; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Colautti RI, 2011, EVOLUTION, V65, P2514, DOI 10.1111/j.1558-5646.2011.01313.x; Colautti RI, 2010, INT J PLANT SCI, V171, P960, DOI 10.1086/656444; Colautti RI, 2010, P ROY SOC B-BIOL SCI, V277, P1799, DOI 10.1098/rspb.2009.2231; Colautti RI, 2009, EVOL APPL, V2, P187, DOI 10.1111/j.1752-4571.2008.00053.x; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Delisle F, 2003, J BIOGEOGR, V30, P1033, DOI 10.1046/j.1365-2699.2003.00897.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felker-Quinn E, 2013, ECOL EVOL, V3, P739, DOI 10.1002/ece3.488; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Houghton-Thompson J, 2005, ANN BOT-LONDON, V96, P877, DOI 10.1093/aob/mci240; Hovick SM, 2011, J ECOL, V99, P225, DOI 10.1111/j.1365-2745.2010.01754.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kollmann J, 2004, DIVERS DISTRIB, V10, P377, DOI 10.1111/j.1366-9516.2004.00126.x; Le Roux J, 2009, ANN APPL BIOL, V154, P1, DOI 10.1111/j.1744-7348.2008.00280.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Ludeke M. K. B., 1994, CLIM RES, V4, P143, DOI DOI 10.3354/CR004143; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Lynch M., 1998, GENETICS ANAL QUANTI; Mal TK, 2005, AM J BOT, V92, P819, DOI 10.3732/ajb.92.5.819; MAL TK, 1992, CAN J PLANT SCI, V72, P1305, DOI 10.4141/cjps92-164; Mal TK, 1997, OIKOS, V79, P26, DOI 10.2307/3546086; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; McCune B., 2011, MULTIVARIATE ANAL EC; Middleton BA, 2004, GLOBAL ECOL BIOGEOGR, V13, P247, DOI 10.1111/j.1466-822X.2004.00088.x; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Pappert RA, 2000, AM J BOT, V87, P1240, DOI 10.2307/2656716; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Pursh F.T., 1813, FLORA AM SEPTENTRION, V1; Rodriguez-Ramilo ST, 2012, MOL ECOL RESOUR, V12, P873, DOI 10.1111/j.1755-0998.2012.03156.x; SAS Institute Inc, 2002, SAS GLMSELECT 9 3 RE; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schooler SS, 2009, B ENTOMOL RES, V99, P229, DOI 10.1017/S0007485308006251; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SHAMSI SRA, 1974, J ECOL, V62, P279, DOI 10.2307/2258893; Sokal RR, 1998, BIOMETRY; Stuckey RL., 1980, BARTONIA, V47, P3; Tavernia BG, 2012, AM MIDL NAT, V168, P352, DOI 10.1674/0003-0031-168.2.352; Thompson DW., 1987, SPREAD IMPACT CONTRO; Travis SE, 2005, J ECOL, V93, P417, DOI 10.1111/j.0022-0477.2005.00985.x; Travis SE, 2004, ECOL APPL, V14, P1189, DOI 10.1890/03-5135; Travis SE, 1996, MOL ECOL, V5, P735, DOI 10.1111/j.1365-294X.1996.tb00370.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	65	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0208300	10.1371/journal.pone.0208300	http://dx.doi.org/10.1371/journal.pone.0208300			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605466	gold, Green Submitted, Green Published			2022-12-26	WOS:000454759900011
J	Pirsean, C; Negut, C; Stefan-van Staden, RI; Dinu-Pirvu, CE; Armean, P; Udeanu, DI				Pirsean, Corina; Negut, Catalina; Stefan-van Staden, Raluca-Ioana; Dinu-Pirvu, Cristina Elena; Armean, Petru; Udeanu, Denisa Ioana			The salivary levels of leptin and interleukin-6 as potential inflammatory markers in children obesity	PLOS ONE			English	Article							RESISTANCE; EXPRESSION; PLASMA	Background Obesity among children is an alarming issue due to an increased incidence over the last years with devastating physiological and psychological consequences. Current available medical diagnostic tools use invasive methods to evaluate and monitor the lipid profile, glycaemia or liver status for determining the overweight/obesity complications. The standard methods proposed for the assay of IL6 and leptin from saliva cannot detect these two biomarkers in children saliva; the levels of IL6 and leptin in children's saliva are lower than the limit of determination of the standard methods. Therefore, we proposed a method based on utilization of stochastic sensors, able to simultaneously perform a qualitative and quantitative determination of these two biomarkers within minutes, in the range able to cover healthy and obese children. Methods Children from the urban area monitored for annual standard analyses and health status assessment at National Institute of Endocrinology C.I. Parhon within University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania were included in the study. In the same day, for all participants of the study, blood analyses were performed and saliva samples were collected for the determination of the IL-6 and leptin levels. Findings/Results The children diagnosed with overweight/obesity presented not significantly different blood lipid profile and glycaemia comparing to the control group. Only few cases of the children presented high levels of cholesterol, low level of HDL-cholesterol, a slightly increased level of triglycerides and transaminases. No correlation with the body mass index could be established with the blood analyses results. In case of the overweight/obese children, the salivary level of the proinflammatory citokynes IL-6 (41ng/mL +/- 21) and leptin (40.4ng/mL +/- 28.8), were significantly increased comparing to normal weight children (IL-6 8.1 +/- 4.6, leptin 9.58 +/- 3.1). Moreover, the saliva level of the IL-6 was positively correlated with the body mass index. Salivary leptin level was highly variable in case of obese children, 6 patients presenting similar levels with the control group. Conclusions Increased levels of salivary IL-6 and leptin sustain a systemic inflammation status despite normal range of standard blood analyses. The results were positively correlated in case of IL-6 with the body mass index the general accepted method used for the assessment of the obesity or overweight degree The determination of these markers in saliva samples by a stochastic method proved the utility within the medical examination for a better evaluation of the health status in obesity. The method has some advantages like: easy collection of the biological sample, fast determination of low concentrations and could be promising in case of no associated oral cavity infections or inflammations which could interfere the results.	[Pirsean, Corina; Armean, Petru] Univ Med & Pharm Carol Davila, Sch Midwifery & Nursing, Bucharest, Romania; [Negut, Catalina; Stefan-van Staden, Raluca-Ioana] Natl Inst Res Electrochem & Condensed Matter, Lab Electrochem, Bucharest, Romania; [Negut, Catalina; Stefan-van Staden, Raluca-Ioana] Natl Inst Res Electrochem & Condensed Matter, PATLAB Bucharest, Bucharest, Romania; [Dinu-Pirvu, Cristina Elena] Univ Med & Pharm Carol Davila, Dept Phys & Colloidal Chem, Fac Pharm, Bucharest, Romania; [Udeanu, Denisa Ioana] Univ Med & Pharm Carol Davila, Dept Clin Lab, Food Safety, Fac Pharm, Bucharest, Romania	Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy	Stefan-van Staden, RI (corresponding author), Natl Inst Res Electrochem & Condensed Matter, Lab Electrochem, Bucharest, Romania.; Stefan-van Staden, RI (corresponding author), Natl Inst Res Electrochem & Condensed Matter, PATLAB Bucharest, Bucharest, Romania.	ralucavanstaden@gmail.com	DINU-PIRVU, CRISTINA/AAM-4265-2020; Catalina, Negut/AAE-7031-2020; Dinu-Pirvu, Cristina-Elena/B-1076-2013; UDEANU, DENISA/AAO-1427-2020	Dinu-Pirvu, Cristina-Elena/0000-0003-1704-7887; UDEANU, DENISA/0000-0001-5266-2530; Stefan-van Staden, Raluca Ioana/0000-0001-8244-2483; Catalina, Negut/0000-0001-7307-0075	National Council for higher Education [CNFIS-FDI-2018-0507]	National Council for higher Education(Consiliul National al Cercetarii Stiintifice (CNCS))	This study was financially supported by National Council for higher Education, project CNFIS-FDI-2018-0507, MEDEX to CDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Ahmad R, 2018, J IMMUNOL, V200, P3599, DOI 10.4049/jimmunol.1701552; Akhter N, 2018, J DIABETES METAB DIS, V17, P77, DOI 10.1007/s40200-018-0341-y; Aydin S, 2005, PEPTIDES, V26, P647, DOI 10.1016/j.peptides.2004.11.008; Baffi Cynthia Wilson, 2015, Asthma Res Pract, V1, P1; Desai GS, 2014, WORLD J DIABETES, V5, P730, DOI 10.4239/wjd.v5.i6.730; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Engelmann G, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.14112; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Farr OM, 2015, CURR OPIN ENDOCRINOL, V22, P353, DOI 10.1097/MED.0000000000000184; Flak JN, 2016, MOL ENDOCRINOL, V30, P3, DOI 10.1210/me.2015-1232; Gonzalez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Gugoasa LA, 2016, MICROSYST TECHNOL, V22, P11, DOI 10.1007/s00542-015-2628-y; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Jayachandran T, 2017, ANGLE ORTHOD, V87, P739, DOI 10.2319/120216-869.1; Kochumon S, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3087; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Macedo IC, 2012, PEPTIDES, V38, P189, DOI 10.1016/j.peptides.2012.08.007; Naqvi S, 2017, CUREUS, V9, DOI 10.7759/cureus.1347; Negut CC, 2015, ELECTROCHEM COMMUN, V51, P98, DOI 10.1016/j.elecom.2014.12.010; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Sindhu S, 2018, CELL PHYSIOL BIOCHEM, V45, P572, DOI 10.1159/000487034; Tanase C, 2016, REV CHIM-BUCHAREST, V67, P282; Williamson S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/246178; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	31	26	27	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0210288	10.1371/journal.pone.0210288	http://dx.doi.org/10.1371/journal.pone.0210288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605486	gold, Green Submitted, Green Published			2022-12-26	WOS:000454759900032
J	Lorand, L; Iismaa, SE				Lorand, Laszlo; Iismaa, Siiri E.			Transglutaminase diseases: from biochemistry to the bedside	FASEB JOURNAL			English	Article						TGase; factor XIII; FXIII; protein 4; 2	FACTOR-XIII-A; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; MESENCHYMAL TRANSITION; TARGETED INACTIVATION; CELIAC-DISEASE; MICE LACKING; GENE; STABILIZATION; IDENTIFICATION	In humans, 9 members of the transglutaminase (TG) family have been identified, of which 8 [factor XIII (FXIII)A and TG1-TG7] catalyze post-translational protein-modifying reactions, and 1 does not (protein 4.2). The TG enzymatic activities considered in our discussion of human disease include deamidation of glutamine (Gln) residues, amine incorporation into Gln residues, and protein crosslinking. Except for TG7, which remains poorly studied, all individual TG members have been correlated with disparate human diseases that arise from either TG function or lack of function. Loss of TG function is associated with numerous orphan diseases that affect a relatively small number of individuals: loss of FXIIIa (transamidase-activated form) crosslinking leads to defects in blood coagulation in FXIII deficiency; loss of TG1 and TG5 cross linking leads to defects in epidermal cornification in lamellar ichthyosis and acral peeling skin syndrome, respectively; loss of TG3 crosslinking in hair-cuticle formation leads to uncombable hair syndrome; the predicted loss of TG6 crosslinking leads to spinocerebellar ataxia-35; and loss of the structural erythrocyte membrane protein, protein 4.2, leads to hereditary spherocytosis type 5. The enzymatic activity of TG2 is involved in the exacerbation of celiac disease and in at least 1 case of hemoglobinopathy, characterized by shortened erythrocyte lifespan. TGs are also autoantigens in a number of immune diseases, resulting in the production of autoantibodies against FXIIIa in acquired FXIII deficiency, TG2 in celiac disease, TG3 in dermatitis herpetiformis, TG4 in autoimmume polyglandular syndrome type 1, and TG6 in gluten axonal neuropathy and gluten ataxia. Much still remains to be learned and confirmed with respect to disease mechanisms, particularly with respect to TG-related immune diseases, in which development of isozyme-specific inhibitors may be useful for treatment.Lorand, L., Iismaa, S. E. Transglutaminase diseases: from biochemistry to the bedside.	[Lorand, Laszlo] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Iismaa, Siiri E.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Iismaa, Siiri E.] Univ New South Wales, St Vincents Clin Sch, Kensington, NSW, Australia	Northwestern University; Feinberg School of Medicine; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Iismaa, SE (corresponding author), Victor Chang Cardiac Res Inst, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	s.iismaa@victorchang.edu.au	Iismaa, Siiri/C-9300-2013	Iismaa, Siiri/0000-0003-2409-7356	National Health and Medical Research Council of Australia [573732, 1074386]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	H The authors thank Dr. Kurt J. Isselbacher and Dr. Alessio Fasano (both from Harvard Medical School and Massachussetts General Hospital, Boston, MA, USA) for the benefit of discussion about celiac disease. S.E.I. is grateful for support from the National Health and Medical Research Council of Australia (Grants 573732 and 1074386). The authors declare no conflicts of interest.	Ablin RJ, 2017, ANTICANCER RES, V37, P481, DOI 10.21873/anticanres.11340; Basmanav FBU, 2016, AM J HUM GENET, V99, P1292, DOI 10.1016/j.ajhg.2016.10.004; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; BOARD PG, 1993, BLOOD REV, V7, P229, DOI 10.1016/0268-960X(93)90010-2; Bognar P, 2014, J INVEST DERMATOL, V134, P105, DOI 10.1038/jid.2013.307; BOUHASSIRA EE, 1992, BLOOD, V79, P1846; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Cheng T, 2014, J MOL CELL BIOL, V6, P506, DOI 10.1093/jmcb/mju039; Cosgrove D, 2018, KIDNEY INT, V94, P303, DOI 10.1016/j.kint.2018.02.024; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Dean MD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003185; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dubbink HJ, 1998, GENOMICS, V51, P434, DOI 10.1006/geno.1998.5393; DUCKERT F, 1960, THROMB DIATH HAEMOST, V5, P179, DOI 10.1055/s-0038-1654918; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Hadjivassiliou M, 2008, ANN NEUROL, V64, P332, DOI 10.1002/ana.21450; HAYASHI S, 1974, BIOCHEM BIOPH RES CO, V57, P1038, DOI 10.1016/0006-291X(74)90801-8; Hitomi K., 2015, TRANSGLUTAMINASES MU, P63; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Iismaa S. E., 2015, TRANSGLUTAMINASES MU, P83; Iismaa S. E, 2016, ANN TRANSLATIONAL S1, V4, P35; Iismaa SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063346; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Ikenaga N, 2017, GUT, V66, P1697, DOI 10.1136/gutjnl-2016-312473; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; John S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034252; Johnson GVW, 2004, J NEUROSCI METH, V134, P151, DOI 10.1016/j.jneumeth.2003.11.006; Johnson TS, 1997, J CLIN INVEST, V99, P2950, DOI 10.1172/JCI119490; Keillor JW, 2016, EXPERT OPIN THER PAT, V26, P49, DOI 10.1517/13543776.2016.1115836; Kim DS, 2010, BIOCHEM BIOPH RES CO, V403, P479, DOI 10.1016/j.bbrc.2010.11.063; Koseki-Kuno S, 2003, BLOOD, V102, P4410, DOI 10.1182/blood-2003-05-1467; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Landegren N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9186; Lauer P, 2002, THROMB HAEMOSTASIS, V88, P967, DOI 10.1055/s-0037-1613342; Lionetti E, 2012, J PEDIATR-US, V161, P908, DOI 10.1016/j.jpeds.2012.05.008; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LOPACIUK S, 1978, J CLIN INVEST, V61, P1196, DOI 10.1172/JCI109035; LORAND L, 1955, P SOC EXP BIOL MED, V89, P45; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; Lorand L, 1996, P NATL ACAD SCI USA, V93, P14310, DOI 10.1073/pnas.93.25.14310; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 1999, BLOOD, V93, P909, DOI 10.1182/blood.V93.3.909.403k17_909_917; Lorand L, 2000, ARTERIOSCL THROM VAS, V20, P2, DOI 10.1161/01.ATV.20.1.2; LORAND L, 1972, BIOCHEMISTRY-US, V11, P434, DOI 10.1021/bi00753a021; Lorand L, 2002, NEUROCHEM INT, V40, P7, DOI 10.1016/S0197-0186(01)00056-0; Lorand L, 1980, Prog Hemost Thromb, V5, P245; LORAND L, 1950, NATURE, V166, P694, DOI 10.1038/166694a0; LORAND L, 1976, P NATL ACAD SCI USA, V73, P4479, DOI 10.1073/pnas.73.12.4479; LORAND L, 1981, P NATL ACAD SCI-BIOL, V78, P1356, DOI 10.1073/pnas.78.3.1356; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorand L, 1998, NAT GENET, V20, P231, DOI 10.1038/3033; Lorand L, 2007, FASEB J, V21, P1627, DOI 10.1096/fj.07-0602ufm; Lorand Laszlo, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P385; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Menalled LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099520; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Mousa A, 2017, CELL DEATH DIFFER, V24, P844, DOI 10.1038/cdd.2017.21; Muszbek L, 2018, J THROMB HAEMOST, V16, P822, DOI 10.1111/jth.13982; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nemes Zoltan, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P347; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Perelis M, 2015, SCIENCE, V350, DOI 10.1126/science.aac4250; Peters LL, 1999, J CLIN INVEST, V103, P1527, DOI 10.1172/JCI5766; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Pitolli C, 2017, AMINO ACIDS, V49, P635, DOI 10.1007/s00726-016-2356-3; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; SARKAR NK, 1957, BIOCHIM BIOPHYS ACTA, V25, P451, DOI 10.1016/0006-3002(57)90512-7; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Sharief LAT, 2013, HAEMOPHILIA, V19, pE349, DOI 10.1111/hae.12259; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; SIMON M, 1984, CELL, V36, P827, DOI 10.1016/0092-8674(84)90032-1; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; Tatsukawa H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25674-4; Tatsukawa H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45049; Thibaut S, 2005, J INVEST DERMATOL, V125, P581, DOI 10.1111/j.0022-202X.2005.23868.x; Van Strien ME, 2011, GLIA, V59, P1622, DOI 10.1002/glia.21204; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wang Z, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0573-2; WILLIAMSASHMAN HG, 1977, BIOCHEM BIOPH RES CO, V79, P1192, DOI 10.1016/0006-291X(77)91132-9; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710	90	17	18	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					3	12		10.1096/fj.201801544R	http://dx.doi.org/10.1096/fj.201801544R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30593123				2022-12-26	WOS:000457401500002
J	Abou Ali, E; Bordacahar, B; Mestas, JL; Batteux, F; Lafon, C; Camus, M; Prat, F				Abou Ali, Einas; Bordacahar, Benoit; Mestas, Jean-Louis; Batteux, Frederic; Lafon, Cyril; Camus, Marine; Prat, Frederic			Ultrasonic cavitation induces necrosis and impairs growth in three-dimensional models of pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							PERITONEAL CARCINOMATOSIS; COCULTURE MODEL; CANCER; CHEMOTHERAPY; GEMCITABINE; DOXORUBICIN; DELIVERY; THERAPY; CELLS	Introduction Pancreatic ductal adenocarcinoma (PDAC) is a rapidly increasing cause of mortality whose dismal prognosis is mainly due to overwhelming chemoresistance. New therapeutic approaches include physical agents such as ultrasonic cavitation, but clinical applications require further insights in the mechanisms of cytotoxicity. 3-D in vitro culture models such as spheroids exploit realistic spatial, biochemical and cellular heterogeneity that may bridge some of the experimental gap between conventional in vitro and in vivo experiments. Purpose To assess the feasibility and efficiency of inertial cavitation associated or not with chemotherapy, in a spheroid model of PDAC. Methods We used DT66066 cells, derived from a genetically-engineered murine PDAC, isolated from KPC-transgenic mice (LSL-Kras(G12D/+;) LSL-Trp53(R172H/+;) Pdx-1-Cre). Spheroids were obtained by either a standard centrifugation-based method, or by using a magnetic nano-shuttle method allowing the formation of spheroids within 24 hours and facilitating their handling. The spheroids were exposed to ultrasonic inertial cavitation in a specially designed setup. Eight or nine spheroids were analyzed for each of 4 conditions: control, gemcitabine alone, US cavitation alone, US cavitation + gemcitabine. Five US inertial cavitation indexes, corresponding to increased US intensities, were evaluated. The effectiveness of treatment was assessed after 24 hours with the following criteria: spheroid size (growth), ratio of phase S-entered cells (proliferation), proportion of cells in apoptosis or necrosis (mortality). These parameters were assessed by quantitative immunofluorescence techniques. Results The 3D culture model presented excellent reproducibility. Cavitation induced a significant decrease in the size of spheroids, an effect significantly correlated to an increasing cavitation index (p < 0.0001). The treatment induced cell death whose predominant mechanism was necrosis (p < 0.0001). There was a tendency to a synergistic effect of US cavitation and gemcitabine at 5 mu M concentration, however significant in only one of the cavitation indexes used (p = 0.013). Conclusion Ultrasonic inertial cavitation induced a significant reduction of tumor growth in a spheroid model of PDAC., with necrosis rather than apoptosis as a Cell dominant mechanism of cell death. More investigations are needed to understand the potential role of inertial cavitation in overcoming chemoresistance.	[Abou Ali, Einas; Bordacahar, Benoit; Camus, Marine; Prat, Frederic] Cochin Hosp, Gastroenterol & Endoscopy Dept, Paris, France; [Abou Ali, Einas; Bordacahar, Benoit; Batteux, Frederic; Camus, Marine; Prat, Frederic] Cochin Inst, Paris, France; [Mestas, Jean-Louis; Lafon, Cyril] INSERM, U1032, LabTau, Lyon, France; [Batteux, Frederic; Camus, Marine; Prat, Frederic] Paris Descartes Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prat, F (corresponding author), Cochin Hosp, Gastroenterol & Endoscopy Dept, Paris, France.; Prat, F (corresponding author), Cochin Inst, Paris, France.; Prat, F (corresponding author), Paris Descartes Univ, Paris, France.	frederic.prat@aphp.fr	Lafon, Cyril/W-8107-2019; Mestas, Jean-Louis/A-6358-2008; Lafon, Cyril/E-4152-2016	Lafon, Cyril/0000-0003-1550-970X; Mestas, Jean-Louis/0000-0002-4684-6082; Lafon, Cyril/0000-0003-1550-970X				[Anonymous], 2017, UNITED EUROPEAN G S1, V5; Bosetti C, 2012, MOL CARCINOGEN, V51, P3, DOI 10.1002/mc.20785; Brennen C E, 2015, INTERFACE FOCUS, V5; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Carpentier A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6086; Chettab K, 2017, MOL PHARMACEUT, V14, P441, DOI 10.1021/acs.molpharmaceut.6b00880; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Daquinag AC, 2013, TISSUE ENG PART C-ME, V19, P336, DOI [10.1089/ten.tec.2012.0198, 10.1089/ten.TEC.2012.0198]; Duco W, 2016, METHODS, V109, P141, DOI 10.1016/j.ymeth.2016.07.015; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; Ebbini ES, 2015, INT J HYPERTHER, V31, P77, DOI 10.3109/02656736.2014.995238; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Haisler WL, 2013, NAT PROTOC, V8, P1940, DOI 10.1038/nprot.2013.125; Hessmann E, 2017, GUT; Horodyckid C, 2017, J NEUROSURG, V126, P1351, DOI 10.3171/2016.3.JNS151635; Huang PT, 2015, ONCOTARGET, V6, P20241, DOI 10.18632/oncotarget.4048; Kotopoulis S, 2017, J CONTROL RELEASE, V245, P70, DOI 10.1016/j.jconrel.2016.11.019; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Lee JW, 2016, CURR PROTOC PHARM, V44, DOI [10.1089/ten.TEC.2012.0198, DOI 10.1089/TEN.TEC.2012.0198]; Li T, 2015, CANCER RES, V75, P3738, DOI 10.1158/0008-5472.CAN-15-0296; Liu Y, 2016, TUMOR BIOL, V37, P15283, DOI 10.1007/s13277-016-5321-6; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Nomikou N, 2010, CANCER LETT, V296, P133, DOI 10.1016/j.canlet.2010.06.002; PRAT F, 1991, CANCER RES, V51, P3024; PRAT F, 1993, BRIT J CANCER, V68, P13, DOI 10.1038/bjc.1993.279; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Tseng H, 2014, ACTA BIOMATER, V10, P173, DOI 10.1016/j.actbio.2013.09.003; Tseng H, 2013, TISSUE ENG PART C-ME, V19, P665, DOI [10.1089/ten.tec.2012.0157, 10.1089/ten.TEC.2012.0157]; Turrini O, 2009, EJSO-EUR J SURG ONC, V35, P1306, DOI 10.1016/j.ejso.2009.06.005; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Westphalen CB, 2012, CANCER J, V18, P502, DOI 10.1097/PPO.0b013e31827ab4c4	33	5	5	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209094	10.1371/journal.pone.0209094	http://dx.doi.org/10.1371/journal.pone.0209094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596678	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200029
J	Kooistra, RL; David, R; Ruiz, AC; Powers, SW; Haselton, KJ; Kiernan, K; Blagborough, AM; Solamen, L; Olsen, KW; Putonti, C; Kanzok, SM				Kooistra, Rachel L.; David, Robin; Ruiz, Ana C.; Powers, Sean W.; Haselton, Kyle J.; Kiernan, Kaitlyn; Blagborough, Andrew M.; Solamen, Ligin; Olsen, Kenneth W.; Putonti, Catherine; Kanzok, Stefan M.			Characterization of a protozoan Phosducin-like protein-3 (PhLP-3) reveals conserved redox activity	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSFECTION; PLASMODIUM-FALCIPARUM; THIOREDOXIN SYSTEM; TARGET PROTEINS; MALARIA; BERGHEI; GENE; EXPRESSION; REDUCTION; COMPLEX	We recently identified three novel thioredoxin-like genes in the genome of the protozoan parasite Plasmodium that belong to the Phosducin-like family of proteins (PhLP). PhLPs are small cytosolic proteins hypothesized to function in G-protein signaling and protein folding. Although PhLPs are highly conserved in eukaryotes from yeast to mammals, only a few representatives have been experimentally characterized to date. In addition, while PhLPs contain a thioredoxin domain, they lack a CXXC motif, a strong indicator for redox activity, and it is unclear whether members of the PhLP family are enzymatically active. Here, we describe PbPhLP-3 as the first phosducin-like protein of a protozoan organism, Plasmodium berghei. Initial transcription analysis revealed continuous low-level expression of pbphlp-3 throughout the complex Plasmodium life cycle. Attempts to knockout pbphlp-3 in P. berghei did not yield live parasites, suggesting an essential role for the gene in Plasmodium. We cloned, expressed and purified PbPhLP-3 and determined that the recombinant protein is redox active in vitro in a thioredoxin-coupled redox assay. It also has the capacity to reduce the organic compound tert-Butyl hydroperoxide (TBHP) in vitro, albeit at low efficiency. Sequence analysis, structural modeling, and site-directed mutagenesis revealed a conserved cysteine in the thioredoxin domain to be the redox active residue. Lastly, we provide evidence that recombinant human PhLP-3 exhibits redox activity similar to that of PbPhLP-3 and suggest that redox activity may be conserved in PhLP-3 homologs of other species. Our data provide new insight into the function of PhLP-3, which is hypothesized to act as co-chaperones in the folding and regulation of cytoskeletal proteins. We discuss the potential implications of PhLP-3 as a thioredoxin-target protein and possible links between the cellular redox network and the eukaryotic protein folding machinery.	[Kooistra, Rachel L.; David, Robin; Ruiz, Ana C.; Powers, Sean W.; Haselton, Kyle J.; Kiernan, Kaitlyn; Solamen, Ligin; Putonti, Catherine; Kanzok, Stefan M.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Blagborough, Andrew M.] Imperial Coll London, Dept Life Sci, South Kensington Campus, London, England; [Solamen, Ligin; Putonti, Catherine; Kanzok, Stefan M.] Loyola Univ, Bioinformat Program, Chicago, IL 60611 USA; [Olsen, Kenneth W.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA; [Putonti, Catherine] Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA	Loyola University Chicago; Imperial College London; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Kanzok, SM (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.; Kanzok, SM (corresponding author), Loyola Univ, Bioinformat Program, Chicago, IL 60611 USA.	skanzok@luc.edu			Loyola University of Chicago; Loyola University Chicago; MRC [MR/N00227X/1] Funding Source: UKRI	Loyola University of Chicago; Loyola University Chicago; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Loyola University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Loyola University Chicago for financial support, and Dali Liu from the Biochemistry Department for helpful discussion and manuscript review.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Belli G, 2002, J BIOL CHEM, V277, P37590, DOI 10.1074/jbc.M201688200; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Castellano MM, 2008, PLANT CELL, V20, P969, DOI 10.1105/tpc.107.057737; Djuika CF, 2013, BBA-GEN SUBJECTS, V1830, P4073, DOI 10.1016/j.bbagen.2013.04.020; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eldering M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2414-z; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Haque SJ, 2012, ANTIOXID REDOX SIGN, V17, P674, DOI 10.1089/ars.2011.4433; Haselton KJ, 2015, PARASITOL INT, V64, P282, DOI 10.1016/j.parint.2014.02.004; Hayes NVL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028271; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2011, TRENDS PARASITOL, V27, P31, DOI 10.1016/j.pt.2010.06.016; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Kawazu S, 2003, INT J PARASITOL, V33, P1455, DOI 10.1016/S0020-7519(03)00184-X; Kawazu SI, 2010, PARASITOL INT, V59, P298, DOI 10.1016/j.parint.2010.03.005; Komaki-Yasuda K, 2003, FEBS LETT, V547, P140, DOI 10.1016/S0014-5793(03)00694-X; Lacefield S, 2003, GENETICS, V165, P531; Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Lou XC, 2009, ACTA CRYSTALLOGR F, V65, P67, DOI 10.1107/S1744309108037342; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Mahajan B, 2006, INT J PARASITOL, V36, P1037, DOI 10.1016/j.ijpara.2006.04.012; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nickel C, 2006, ANTIOXID REDOX SIGN, V8, P1227, DOI 10.1089/ars.2006.8.1227; Ogawa S, 2004, GENES CELLS, V9, P83, DOI 10.1111/j.1356-9597.2004.00708.x; Olshina MA, 2016, FASEB J, V30, P405, DOI 10.1096/fj.15-276618; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Putonti C, 2013, INFECT GENET EVOL, V13, P49, DOI 10.1016/j.meegid.2012.08.023; Rahlfs S, 2001, EUR J BIOCHEM, V268, P1404, DOI 10.1046/j.1432-1327.2001.02005.x; Ruan ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097509; SANGER F, 1949, BIOCHEM J, V44, P126, DOI 10.1042/bj0440126; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Moretti AIS, 2017, ARCH BIOCHEM BIOPHYS, V617, P106, DOI 10.1016/j.abb.2016.11.007; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200; Srinivasan S, 2013, J BIOL CHEM, V288, P23171, DOI 10.1074/jbc.M113.473173; Stirling PC, 2006, J BIOL CHEM, V281, P7012, DOI 10.1074/jbc.M513235200; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Swearingen KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005791; Sztajer H, 2001, J BIOL CHEM, V276, P7397, DOI 10.1074/jbc.M008631200; Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200; Thompson J, 1999, MOL MICROBIOL, V31, P253, DOI 10.1046/j.1365-2958.1999.01167.x; Turturice BA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003136; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Yano K, 2005, PARASITOL INT, V54, P35, DOI 10.1016/j.parint.2004.08.005; Yano K, 2008, MOL BIOCHEM PARASIT, V159, P142, DOI 10.1016/j.molbiopara.2008.03.002	65	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209699	10.1371/journal.pone.0209699	http://dx.doi.org/10.1371/journal.pone.0209699			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596727	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200073
J	Takahashi, K; Morizane, Y; Hisatomi, T; Tachibana, T; Kimura, S; Hosokawa, MM; Shiode, Y; Hirano, M; Doi, S; Toshima, S; Araki, R; Matsumae, H; Kanzaki, Y; Hosogi, M; Yoshida, A; Sonoda, KH; Shiraga, F				Takahashi, Kosuke; Morizane, Yuki; Hisatomi, Toshio; Tachibana, Takashi; Kimura, Shuhei; Hosokawa, Mio Morizane; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Matsumae, Hiroshi; Kanzaki, Yuki; Hosogi, Mika; Yoshida, Atsushi; Sonoda, Koh-Hei; Shiraga, Fumio			The influence of subretinal injection pressure on the microstructure of the monkey retina	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GENE-THERAPY; SUBMACULAR HEMORRHAGE; MACULAR DEGENERATION; PHOTORECEPTOR APOPTOSIS; DETACHMENT; DISPLACEMENT; REATTACHMENT; VITRECTOMY; RECOVERY	Purpose To investigate the influence of subretinal injection pressure on the microstructure of the retina in a monkey model. Methods After vitrectomy, balanced salt solution was injected subretinally into one eye each of four cynomolgus monkeys while controlling the injection pressure. Initially, a pressure of 2 psi was used, and this was gradually increased to determine the minimum required pressure. Subsequent injections were performed at two pressures: minimum (n = 13) and high (n = 6). To compare the influence of these injection pressures on retinal structure, optical coherence tomography (OCT) was performed before surgery and every week afterwards. The monkeys were euthanized and their eyes were enucleated at 1 or 6 weeks after the injections. The eyes were processed for light microscopy and transmission electron microscopy (TEM) as well as for TdT-mediated dUTP nick end labeling. Results The minimum pressure required to perform subretinal injection was 6 psi. After injection at this pressure, both OCT and microscopy showed that the retinal structure was well-preserved throughout the experimental period at all injection sites. Conversely, after injection at high pressure (20 psi) OCT images at all injection sites showed disruption of the ellipsoid zone (EZ) after 1 week. Microscopy indicated damage to the photoreceptor outer segment (OS) and stratification of the retinal pigment epithelium (RPE). After 6 weeks, OCT demonstrated that the EZ had become continuous and TEM confirmed that the OS and RPE had recovered. Photoreceptor apoptosis was absent after subretinal injection at both pressures. Conclusions The retinal damage caused by subretinal injection increases depending on pressure, indicating that clinicians should perform subretinal injection at pressures as low as possible to ensure safety.	[Takahashi, Kosuke; Morizane, Yuki; Kimura, Shuhei; Hosokawa, Mio Morizane; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Araki, Ryoichi; Matsumae, Hiroshi; Kanzaki, Yuki; Hosogi, Mika; Shiraga, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan; [Hisatomi, Toshio; Tachibana, Takashi; Sonoda, Koh-Hei] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Fukuoka, Japan; [Yoshida, Atsushi] Santen Pharmaceut Co Ltd, Div Res & Dev, Nara, Japan	Okayama University; Kyushu University; Santen Pharmaceutical Co Ltd	Morizane, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan.	moriza-y@okayama-u.ac.jp	Kanzaki, Yuki/HGU-6189-2022	Hisatomi, Toshio/0000-0003-2552-9595				Arroyo JG, 2005, AM J OPHTHALMOL, V139, P605, DOI 10.1016/j.ajo.2004.11.046; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Besirli CG, 2010, INVEST OPHTH VIS SCI, V51, P2177, DOI 10.1167/iovs.09-4439; Campochiaro PA, 2017, HUM GENE THER, V28, P99, DOI 10.1089/hum.2016.117; Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004; dell'Omo R, 2015, INVEST OPHTH VIS SCI, V56, P1040, DOI 10.1167/iovs.14-15633; Doi S, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0090-3; Fischer MD, 2016, HUM GENE THER METHOD, V27, P150, DOI 10.1089/hgtb.2016.086; GUERIN CJ, 1993, INVEST OPHTH VIS SCI, V34, P175; GUERIN CJ, 1989, INVEST OPHTH VIS SCI, V30, P1708; Haupert CL, 2001, AM J OPHTHALMOL, V131, P208, DOI 10.1016/S0002-9394(00)00734-0; Hisatomi T, 2001, AM J PATHOL, V158, P1271, DOI 10.1016/S0002-9440(10)64078-3; Inoue M, 2015, GRAEF ARCH CLIN EXP, V253, P1663, DOI 10.1007/s00417-014-2861-6; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kimura S, 2017, JPN J OPHTHALMOL, V61, P472, DOI 10.1007/s10384-017-0530-0; Kimura S, 2015, AM J OPHTHALMOL, V159, P683, DOI 10.1016/j.ajo.2014.12.020; KITA M, 1990, INVEST OPHTH VIS SCI, V31, P624; Kobayashi M, 2016, INVEST OPHTH VIS SCI, V57, P889, DOI 10.1167/iovs.15-18403; Kogachi K, 2017, INVEST OPHTH VIS SCI, V58, P5270, DOI 10.1167/iovs.17-22737; Lewis GP, 2002, INVEST OPHTH VIS SCI, V43, P2412; Machemer R, 1998, AM J OPHTHALMOL, V125, P698, DOI 10.1016/S0002-9394(98)00020-8; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Menke MN, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14412; Morizane Y, 2002, AM J OPHTHALMOL, V133, P848, DOI 10.1016/S0002-9394(02)01413-7; Morizane Y, 2015, JPN J OPHTHALMOL, V59, P279, DOI 10.1007/s10384-015-0390-4; Nork TM, 2012, ARCH OPHTHALMOL-CHIC, V130, P65, DOI 10.1001/archophthalmol.2011.295; Ochakovski GA, 2017, INVEST OPHTH VIS SCI, V58, P4155, DOI 10.1167/iovs.17-22402; Ochakovski GA, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00174; Okanouchi T, 2016, RETINA-J RET VIT DIS, V36, P1035, DOI 10.1097/IAE.0000000000001029; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Song WK, 2015, STEM CELL REP, V4, P860, DOI 10.1016/j.stemcr.2015.04.005; Takagi H, 1999, OPHTHALMOLOGY, V106, P249, DOI 10.1016/S0161-6420(99)90054-4; Toshima S, 2019, RETINA-J RET VIT DIS, V39, P162, DOI 10.1097/IAE.0000000000001771; Xue K, 2017, EYE, V31, P1308, DOI 10.1038/eye.2017.158	36	14	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209996	10.1371/journal.pone.0209996	http://dx.doi.org/10.1371/journal.pone.0209996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596769	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200121
J	Yaya, S; Ghose, B				Yaya, Sanni; Ghose, Bishwajit			Prevalence of unmet need for contraception and its association with unwanted pregnancy among married women in Angola	PLOS ONE			English	Article							TRENDS; BIRTH; COST; SAFE; AGE	Background Unmet need for contraception and unwanted pregnancy are recognised as significant barriers to promoting women's reproductive health and well-being. Currently there is no research evidence on these two crucial indicators of reproductive care in Angola. Therefore, we conducted this study with the objectives of exploring the current prevalence of unmet need for contraception and unintended pregnancy as well as their relationship among married women in Angola. Methods This study was based on cross-sectional data from Angola Demographic and Health Survey (DHS) conducted in 2015-16. Participants were 7,808 married women aged 15-49 years. Unwanted pregnancy was measured in terms of the mistimed and unintended conception for the last-born child. Unmet need for contraception included those who reported unmet need for spacing and limiting. Data were analysed using bivariate and multivariable techniques. Results The combined prevalence of mistimed and unwanted pregnancy was 38.3% (95%CI = 35.9-40.7), and that of unmet need for contraception for spacing and limiting was 51.7% (49.9-53.5). Among the 18 regions, Luanda had the highest prevalence of unmet need for contraception and of unwanted pregnancy with the prevalence being higher than more than one-third of the women. Multivariable analysis significantly revealed a significantly positive association between unmet need and unwanted pregnancy. In all the models, the odds of unwanted pregnancy were found to be as high as four times among women with unmet need compared with those had no unmet need. Compared to women who had no unmet need, those who had unmet need had respectively four (OR = 4.380; 95%CI = 3.690-5.198) and seven (OR = 6.951; 95%CI = 4.642-10.410) times higher odds of experiencing unwanted pregnancy. Conclusion This study concludes that the prevalence of unmet need for contraception and unwanted pregnancy are high with significant disparities across the regions. Women in the capital city had the highest prevalence of both unmet need for contraception and unwanted pregnancy. Although the data were cross-sectional and do not indicate causal relationships, the findings showed a strong positive association between unmet need for contraception and unwanted pregnancy. However, it is recommended to conduct further studies to replicate the findings and to explore the influence behavioural and cultural practices on unwanted pregnancy.	[Yaya, Sanni] Univ Parakou, Fac Med, Parakou, Benin; [Ghose, Bishwajit] Univ Dhaka, Inst Nutr & Food Sci, Dhaka, Bangladesh	University of Dhaka	Ghose, B (corresponding author), Univ Dhaka, Inst Nutr & Food Sci, Dhaka, Bangladesh.	brammaputram@gmail.com	Yaya, Sanni/C-1079-2019; Ghose, Bishwajit/L-8479-2015	Yaya, Sanni/0000-0002-4876-6043; Ghose, Bishwajit/0000-0003-4461-3821				Adhikari R, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-17; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Alum AC, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0089-5; Bishwajit G, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1379-4; Black AY, 2015, J OBSTET GYNAECOL CA, V37, P1086, DOI 10.1016/S1701-2163(16)30074-3; Curtis S, 2011, INT PERSPECT SEX R H, V37, P58, DOI 10.1363/3705811; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Dastgiri Saeed, 2017, Mater Sociomed, V29, P58, DOI 10.5455/msm.2017.29.58-67; Exavery A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-63; Haider Sadia, 2013, Glob Adv Health Med, V2, P94, DOI 10.7453/gahmj.2013.056; Horvath S, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0832-4; Hurley KM, 2005, J AM DIET ASSOC, V105, P963, DOI 10.1016/j.jada.2005.03.007; Jackson E, 2011, THROMB RES, V127, pS35, DOI 10.1016/S0049-3848(11)70010-X; Joseph JG, 2009, AM J PUBLIC HEALTH, V99, P1053, DOI 10.2105/AJPH.2007.131425; Lothian JA, 2009, J PERINAT EDUC, V18, P48, DOI 10.1624/105812409X461225; Machiyama K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0268-z; Maier KM, 2002, CAN FAM PHYSICIAN, V48, P1199; Mccoy SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105320; Melese T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166287; Mezmur M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2298-9; Nieto-Andrade B, 2017, GLOB HEALTH-SCI PRAC, V5, P75, DOI 10.9745/GHSP-D-16-00304; Prusty RK, 2014, J HEALTH POPUL NUTR, V32, P342; ROTHBERG AD, 1991, AM J OBSTET GYNECOL, V165, P403, DOI 10.1016/0002-9378(91)90103-X; Salazar M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-26; Shah IH, 2012, REPROD HEALTH MATTER, V20, P169, DOI 10.1016/S0968-8080(12)39598-0; Skordis N, 2014, FERTILITY PREGNANCY; Srikanthan A, 2008, J OBSTET GYNAECOL CA, V30, P129, DOI 10.1016/S1701-2163(16)32736-0; Stephenson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103085; Trussell J, 2007, CONTRACEPTION, V75, P168, DOI 10.1016/j.contraception.2006.11.009; Umar Abubakar Sadiq, 2016, Int J MCH AIDS, V5, P61; WHO, UNM NEED FAM PLANN; Yotebieng M, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.235.5859	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209801	10.1371/journal.pone.0209801	http://dx.doi.org/10.1371/journal.pone.0209801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596733	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200089
J	Buisman, LL; Alsaaod, M; Bucher, E; Kofler, J; Steiner, A				Buisman, Lindsay L.; Alsaaod, Maher; Bucher, Esther; Kofler, Johann; Steiner, Adrian			Objective assessment of lameness in cattle after foot surgery	PLOS ONE			English	Article							DAIRY-COWS; INTERPHALANGEAL JOINT; SEPTIC ARTHRITIS; SURGICAL-MANAGEMENT; WEIGHT DISTRIBUTION; DIGIT AMPUTATION; SCORING SYSTEM; LOCOMOTION; LESIONS; GAIT	Assessment of lameness in cattle after foot surgery is important to monitor the recovery period, to improve the long-term success and the cows` welfare. This longitudinal multicenter retrospective study was carried out to evaluate the usefulness of automated tools of weight bearing and gait analysis following foot surgery to support the clinician to monitor lameness in cattle. For this purpose, the effect of involvement of different anatomical structures and the use of different surgery methods on gait parameters of post-operative recovery was assessed. The study consisted of 2 experiments and included cattle with unilateral foot pathologies located in the digital region which needed 1 (experiment 1; n = 30) or 2 (experiment 2; n = 4) surgical interventions. The surgical techniques were debridement, joint lavage, partial resection of bones, tendons or synovial structures, total resection of the sesamoid bone and digit amputation. Two accelerometers (400 Hz; kinematic outcome = stance phase duration; kinetic outcome = foot load and toe-off), a 4-scale weighing platform (difference of mean weight distribution across the limbs; Delta(weight)) and a subjective locomotion score were used to evaluate gait parameters every 3 to 4 days after surgery. A repeated measures ANOVA was used in experiment 1 and a receiver operator characteristic analysis was used to determine the optimal cutoff values in experiment 2. Results showed that the differences across limbs for the pedogram variables of stance phases and peaks of foot load and toe-off, Delta(weight) and the locomotion score were highest if joints or sesamoid bones were involved, suggesting that these cattle were more severely lame compared to cattle with more superficial foot pathologies. There was a significantly lower degree of lameness after surgical debridement and after digit amputation compared to partial and total resection of anatomical structures of the foot. The use of accelerometers and a 4-scale weighing platform represent promising objective tools for post-operative monitoring of lameness and can support the clinician in gait assessment to improve the long-term success of surgical interventions in the area of the foot.	[Buisman, Lindsay L.; Alsaaod, Maher; Bucher, Esther; Steiner, Adrian] Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland; [Buisman, Lindsay L.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Kofler, Johann] Univ Vet Med Vienna, Clin Ruminants, Vienna, Austria	University of Bern; Utrecht University; University of Veterinary Medicine Vienna	Alsaaod, M (corresponding author), Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland.	maher.alsaaod@vetsuisse.unibe.ch	Steiner, Adrian/AAD-6814-2022	Steiner, Adrian/0000-0003-2415-3768				Alsaaod M, 2017, J DAIRY SCI, V100, P4897, DOI 10.3168/jds.2016-12235; Alsaaod M, 2017, J DAIRY SCI, V100, P1417, DOI 10.3168/jds.2016-11678; Anderson DE, 2017, VET CLIN N AM-FOOD A, V33, P329, DOI 10.1016/j.cvfa.2017.02.011; Antalovsky A., 1965, VET MED PRAG, V7, P413; Barker ZE, 2010, J DAIRY SCI, V93, P932, DOI 10.3168/jds.2009-2309; BAXTER GM, 1991, COMP CONT EDUC PRACT, V13, P1022; Becker J, 2014, SCHWEIZ ARCH TIERH, V156, P71, DOI 10.1024/0036-7281/a000553; Beer G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155796; Bruijnis MRN, 2010, J DAIRY SCI, V93, P2419, DOI 10.3168/jds.2009-2721; Chapinal N, 2010, J DAIRY SCI, V93, P3039, DOI 10.3168/jds.2009-2987; Chapinal N, 2010, J DAIRY SCI, V93, P2007, DOI 10.3168/jds.2009-2803; Desrochers A, 2001, VET CLIN N AM-FOOD A, V17, P143, DOI 10.1016/S0749-0720(15)30059-1; Desrochers A, 1996, VET CLIN N AM-FOOD A, V12, P277, DOI 10.1016/S0749-0720(15)30448-5; Desrochers A, 2008, VET CLIN N AM-FOOD A, V24, P535, DOI 10.1016/j.cvfa.2008.07.005; Desrochers A, 2014, VET CLIN N AM-FOOD A, V30, P177, DOI 10.1016/j.cvfa.2013.11.006; DIRKSEN G, 2002, INNERE MED CHIRURG R, P978; Dirksen G., 2012, BOVINE INTERNAL DIS; Dirksen G, 2002, INNERE MED CHIRURG R, V4th, P912; Engel B, 2003, J AGR SCI-CAMBRIDGE, V140, P317, DOI 10.1017/S0021859603002983; Enting H, 1997, LIVEST PROD SCI, V49, P259, DOI 10.1016/S0301-6226(97)00051-1; Feist M, 2004, UNTERSUCHUNGEN ZUM S; Ferguson J., 1997, LAMENESS CATTLE, V3rd, P248; Flower FC, 2006, J DAIRY SCI, V89, P139, DOI 10.3168/jds.S0022-0302(06)72077-X; Heppelmann M, 2009, VET J, V182, P162, DOI 10.1016/j.tvjl.2008.06.009; Huxley JN, 2013, LIVEST SCI, V156, P64, DOI 10.1016/j.livsci.2013.06.012; Joeng S., 1993, THESIS; KOFLER J, 1989, WIEN TIERARZTL MONAT, V76, P224; Kofler J, 2017, REV ACAD CIENC ANIM, V15, P45, DOI [10.7213/academica.15.S02.2017.A06, DOI 10.7213/ACADEMICA.15.S02.2017.A06]; Kofler J, 2007, BERL MUNCH TIERARZTL, V120, P156, DOI 10.2376/0005-9366-120-156; Kofler J, 2017, VET CLIN N AM-FOOD A, V33, P301, DOI 10.1016/j.cvfa.2017.02.005; Kofler J, 2014, VET CLIN N AM-FOOD A, V30, P11, DOI 10.1016/j.cvfa.2013.11.003; Kofler J, 2011, BERL MUNCH TIERARZTL, V124, P272, DOI 10.2376/0005-9366-124-272; Leach KA, 2009, J DAIRY SCI, V92, P1567, DOI 10.3168/jds.2008-1648; Mulon PY, 2016, VET CLIN N AM-FOOD A, V32, P777, DOI 10.1016/j.cvfa.2016.05.014; Murray RD, 1996, VET REC, V138, P586, DOI 10.1136/vr.138.24.586; Nechanitzky K, 2016, J DAIRY SCI, V99, P2904, DOI 10.3168/jds.2015-10109; Neveux S, 2006, J DAIRY SCI, V89, P2503, DOI 10.3168/jds.S0022-0302(06)72325-6; Nuss K, 2004, PRAKT TIERARZT, V85, P586; NUSS K, 2004, ERKRANKUNGEN KLAUEN, P130; Nuss K, 2016, VET CLIN N AM-FOOD A, V32, P753, DOI [10.1016/j.cyfa.2016.05.011, 10.1016/j.cvfa.2016.05.011]; Pastell M, 2008, COMPUT ELECTRON AGR, V64, P34, DOI 10.1016/j.compag.2008.05.007; Pastell M, 2010, J DAIRY SCI, V93, P954, DOI 10.3168/jds.2009-2385; Pastell ME, 2007, J DAIRY SCI, V90, P2283, DOI 10.3168/jds.2006-267; Rizk A, 2012, VET J, V192, P193, DOI 10.1016/j.tvjl.2011.05.022; Rushen J, 2007, APPL ANIM BEHAV SCI, V106, P173, DOI 10.1016/j.applanim.2006.07.001; Schlageter-Tello A, 2015, J DAIRY SCI, V98, P8623, DOI 10.3168/jds.2014-9059; Schlageter-Tello A, 2014, PREV VET MED, V116, P12, DOI 10.1016/j.prevetmed.2014.06.006; Schlageter-Tello A, 2014, J DAIRY SCI, V97, P5533, DOI 10.3168/jds.2014-8129; Shearer JK, 2013, VET CLIN N AM-FOOD A, V29, P135, DOI 10.1016/j.cvfa.2012.11.012; Shearer JK, 2012, VET CLIN N AM-FOOD A, V28, P535, DOI 10.1016/j.cvfa.2012.07.003; Shearer JK, 2001, VET CLIN N AM-FOOD A, V17, P53, DOI 10.1016/S0749-0720(15)30054-2; Solano L, 2016, J DAIRY SCI, V99, P6828, DOI 10.3168/jds.2016-10941; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Starke A, 2008, CATTLE PRACT, V16, P36; Starke A, 2007, VET SURG, V36, P350, DOI 10.1111/j.1532-950X.2007.00257.x; STEINER A, 1990, SCHWEIZ ARCH TIERH, V132, P227; Tadich N, 2010, VET J, V184, P60, DOI 10.1016/j.tvjl.2009.01.005; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Van Nuffel A, 2015, ANIMALS-BASEL, V5, P838, DOI 10.3390/ani5030387; von Keyserlingk MAG, 2012, J DAIRY SCI, V95, P7399, DOI 10.3168/jds.2012-5807; Weaver AD, 2005, BOVINE SURGERY AND LAMENESS, 2ND EDITION, P198; Whay HR, 1998, VET J, V156, P23, DOI 10.1016/S1090-0233(98)80058-0	62	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209783	10.1371/journal.pone.0209783	http://dx.doi.org/10.1371/journal.pone.0209783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592750	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900042
J	Veroux, M; Gozzo, C; Corona, D; Murabito, P; Caltabiano, DC; Mammino, L; Giaquinta, A; Zerbo, D; Sinagra, N; Veroux, P; Palmucci, S				Veroux, Massimiliano; Gozzo, Cecilia; Corona, Daniela; Murabito, Paolo; Caltabiano, Daniele Carmelo; Mammino, Luca; Giaquinta, Alessia; Zerbo, Domenico; Sinagra, Nunziata; Veroux, Pierfrancesco; Palmucci, Stefano			Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease	PLOS ONE			English	Article							BILATERAL NATIVE NEPHRECTOMY; RENAL-TRANSPLANTATION; MAGNETIC-RESONANCE; PROGRESSION; BIOMARKER; ADPKD; MRI	Background The indication to bilateral nephrectomy in patients with autosomal dominant polycystic kidney scheduled for kidney transplantation is controversial. Indeed, the progressive enlargement of cysts may increase the risk of complications and the need for nephrectomy. However, very few studies investigated the change in kidney volume after kidney transplantation. Material and methods In this prospective cohort study, the change in native kidney volume in polycystic patients was evaluated with magnetic resonance imaging. Forty patients were included in the study. Kidney diameters and total kidney volume were evaluated with magnetic resonance imaging in patients who underwent simultaneous nephrectomy and kidney transplantation and in patients with kidney transplant alone, before transplantation and 1 year after transplantation. Results There was a significant reduction of kidney volume after transplantation, with a mean degree of kidney diameters reduction varying from 12.24% to 14.43%. Mean total kidney volume of the 55 kidney considered in the analysis significantly reduced from 1617.94 +/- 833.42 ml to 1381.42 +/- 1005.73 ml (P<0.05), with a mean rate of 16.44% of volume decrease. More than 80% of patients had a volume reduction in both groups. Conclusions Polycystic kidneys volume significantly reduces after kidney transplantation, and this would reduce the need for prophylactic bilateral nephrectomy in asymptomatic patients.	[Veroux, Massimiliano; Corona, Daniela; Giaquinta, Alessia; Zerbo, Domenico; Sinagra, Nunziata; Veroux, Pierfrancesco] Azienda Osped Policlin Catania, Vasc Surg & Organ Transplant Unit, Catania, Italy; [Gozzo, Cecilia] Univ Palermo, Dept Med Biopathol & Biotechnol, Palermo, Italy; [Murabito, Paolo] Azienda Osped Policlin Catania, Anaesthesiol & Intens Care Unit, Catania, Italy; [Caltabiano, Daniele Carmelo; Mammino, Luca; Palmucci, Stefano] Azienda Osped Policlin Catania, Radiol Unit, Catania, Italy	University of Palermo	Veroux, M (corresponding author), Azienda Osped Policlin Catania, Vasc Surg & Organ Transplant Unit, Catania, Italy.	veroux@unict.it	Veroux, Massimiliano/K-4821-2018; Palmucci, Stefano/ABD-1465-2020; veroux, pierfrancesco/K-5195-2018; Palmucci, Stefano/K-8056-2016	Veroux, Massimiliano/0000-0002-2780-6421; Palmucci, Stefano/0000-0002-7196-2974; Palmucci, Stefano/0000-0002-7196-2974; Gozzo, Cecilia/0000-0001-8997-6605; Murabito, Paolo/0000-0002-2662-1898				Ahmad SB, 2016, TRANSPLANTATION, V100, P407, DOI 10.1097/TP.0000000000000838; Alam A, 2015, AM J KIDNEY DIS, V66, P564, DOI 10.1053/j.ajkd.2015.01.030; [Anonymous], 2013, NEPHROL DIAL TRANSPL, V28, P1, DOI 10.1093/ndt/gft218; Bae KT, 2000, J COMPUT ASSIST TOMO, V24, P614, DOI 10.1097/00004728-200007000-00019; Bell PD, 2011, J AM SOC NEPHROL, V22, P839, DOI 10.1681/ASN.2010050526; Bennett WM, 2013, NEPHROL DIAL TRANSPL, V28, P245, DOI 10.1093/ndt/gfs176; Casteleijn NF, 2016, WORLD J UROL, V34, P907, DOI 10.1007/s00345-016-1799-1; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Cheong B, 2007, CLIN J AM SOC NEPHRO, V2, P38, DOI 10.2215/CJN.00930306; Connell L, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001711; Davis S, 2018, TRANSPL P, V50, P1243, DOI 10.1016/j.transproceed.2018.02.060; Dinckan A, 2013, ANN TRANSPL, V18, P697, DOI 10.12659/AOT.889377; Ekser B, 2010, NEW ENGL J MED, V363, P71, DOI 10.1056/NEJMicm0905399; Fuller TF, 2005, J UROLOGY, V174, P2284, DOI 10.1097/01.ju.0000181208.06507.aa; Ghavamian R, 2012, BJU INT, V110, pE1008, DOI 10.1111/j.1464-410X.2012.11386.x; Glassmann DT, 2000, J UROLOGY, V164, P661, DOI 10.1016/S0022-5347(05)67276-X; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Grodstein EI, 2017, TRANSPLANTATION, V101, P2774, DOI 10.1097/TP.0000000000001779; Guo PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129317; Jo WR, 2017, EUR J RADIOL, V95, P56, DOI 10.1016/j.ejrad.2017.07.023; Jung Y, 2016, NEPHROL DIAL TRANSPL, V31, P73, DOI 10.1093/ndt/gfv227; Kanaan N, 2014, NAT REV NEPHROL, V10, P455, DOI 10.1038/nrneph.2014.104; KEITH DS, 1994, J AM SOC NEPHROL, V4, P1661; Kirkman MA, 2011, BJU INT, V108, P590, DOI 10.1111/j.1464-410X.2010.09938.x; Kline TL, 2018, ABDOM RADIOL, V43, P629, DOI 10.1007/s00261-017-1236-y; Kramer A, 2009, J UROLOGY, V181, P724, DOI 10.1016/j.juro.2008.10.008; Lucas SM, 2010, J UROLOGY, V5, P2054, DOI DOI 10.1016/J.JUR0.2010.06.150; Lucas SM, 2010, J UROLOGY, V184, P2054, DOI 10.1016/j.juro.2010.06.150; Magistroni R, 2018, AM J NEPHROL, V48, P67, DOI 10.1159/000491022; Martin AD, 2012, BJU INT, V110, pE1003, DOI 10.1111/j.1464-410X.2012.11379.x; McEwan P, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-017-0804-2; Nunes P, 2007, TRANSPL P, V39, P2483, DOI 10.1016/j.transproceed.2007.07.035; Palmucci S, 2012, TRANSPL P, V44, P1884, DOI 10.1016/j.transproceed.2012.06.045; Palmucci S, 2015, EUR J RADIOL OPEN, V2, P71, DOI 10.1016/j.ejro.2015.05.001; Paul BM, 2014, WIRES DEV BIOL, V3, P465, DOI 10.1002/wdev.152; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Perrone RD, 2017, KIDNEY INT REP, V2, P442, DOI 10.1016/j.ekir.2017.01.003; Sharma K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178488; Tangri Navdeep, 2017, Can J Kidney Health Dis, V4, p2054358117693355, DOI 10.1177/2054358117693355; Tyson MD, 2013, J UROLOGY, V190, P2170, DOI 10.1016/j.juro.2013.05.057; van Gastel MDA, 2018, ABDOM RADIOL, V43, P1215, DOI 10.1007/s00261-017-1285-2; Veroux M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155481; Veroux M, 2016, TRANSPLANTATION, V100, pE3, DOI 10.1097/TP.0000000000000982; Xue C, 2018, KIDNEY INT, V93, P540, DOI 10.1016/j.kint.2017.10.027; Yamamoto T, 2012, TRANSPLANTATION, V93, P794, DOI 10.1097/TP.0b013e318246f910; Yu ASL, 2018, KIDNEY INT, V93, P691, DOI 10.1016/j.kint.2017.09.027	46	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209332	10.1371/journal.pone.0209332	http://dx.doi.org/10.1371/journal.pone.0209332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589879	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200018
J	Ayibieke, A; Sato, W; Mahazu, S; Prah, I; Addow-Thompson, J; Ohashi, M; Suzuki, T; Iwanaga, S; Ablordey, A; Saito, R				Ayibieke, Alafate; Sato, Wakana; Mahazu, Samiratu; Prah, Isaac; Addow-Thompson, John; Ohashi, Mitsuko; Suzuki, Toshihiko; Iwanaga, Shiroh; Ablordey, Anthony; Saito, Ryoichi			Molecular characterisation of the NDM-1-encoding plasmid p2189-NDM in an Escherichia coli ST410 clinical isolate from Ghana	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; GENETIC CONTEXTS; ENTEROBACTERIACEAE; RESISTANCE; IDENTIFICATION; BLA(NDM-1); EVOLUTION	Global dissemination of New Delhi metallo-beta-lactamase (NDM)-producing bacteria has become a major health threat. However, there are few reports regarding the identification and characterisation of NDM-producing bacteria from West Africa, including Ghana. An Escherichia coli strain with resistance to meropenem was isolated from the Tamale Teaching Hospital in Ghana. Its identification and determination of antibiotic susceptibility profile were carried out using commercial systems. The antibiotic resistance mechanism was analysed by phenotypic detection kits, PCR, and DNA sequencing. Conjugation experiments, S1 nuclease pulsed field gel electrophoresis, and Southern blotting were performed. Finally, the NDM-1-harbouring plasmid was characterised using next-generation sequencing and phylogenetic analysis. The meropenem-resistant Escherichia coli strain EC2189 harboured bla(NDM-1) and belonged to sequence type 410. bla(NDM-1) was located on the IncHI type transferrable plasmid p2189-NDM (248,807 bp long), which co-carried multiple resistance genes, such as bla(CTX-M-15), aadA1, aac(6')-Ib, sul3, dfrA12, and cmlA1. p2189-NDM phylogenetically differed from previously identified bla(NDM-1)-positive IncHI type plasmids. A truncated Tn125 containing bla(NDM-1) was bracketed by an ISSm-1-like insertion sequence upstream and by a site-specific integrase downstream. To the best of our knowledge, we have, for the first time identified and molecularly characterised an NDM-1-producing Enterobacteriaceae strain in Ghana with bla(NDM-1) that had a novel genetic structure. Our findings indicate a possibility of NDM-1 dissemination in Ghana and underscore the need for constant monitoring of carbapenemase-producing bacteria.	[Ayibieke, Alafate; Sato, Wakana; Saito, Ryoichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Microbiol, Tokyo, Japan; [Mahazu, Samiratu; Prah, Isaac; Addow-Thompson, John; Ablordey, Anthony] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Ohashi, Mitsuko; Iwanaga, Shiroh] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Environm Parasitol, Tokyo, Japan; [Suzuki, Toshihiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Bacterial Pathogenesis, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Ghana; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Saito, R (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Microbiol, Tokyo, Japan.	r-saito.mi@tmd.ac.jp	Saito, Ryoichi/W-5331-2019; Ablordey, Anthony/AAY-4016-2021	Saito, Ryoichi/0000-0003-3398-8572; Iwanaga, Shiroh/0000-0002-4394-7267; Ablordey, Anthony/0000-0002-4486-0286; Ayibieke, Alafate/0000-0003-4916-0200	Japan Agency for Medical Research and Development (AMED) [17fm0108010h0003]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Japan Agency for Medical Research and Development (AMED, URL: http://www.amed.go.jp/en/) under Grant Number 17fm0108010h0003 (MO, TS, SI, RS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Clinical and Laboratory Standards Institute, 2014, M100S24 PACLSI; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Doi Y, 2014, ANTIMICROB AGENTS CH, V58, P5947, DOI 10.1128/AAC.03180-14; Fiett J, 2014, ANTIMICROB AGENTS CH, V58, P1203, DOI 10.1128/AAC.01197-13; Gamal D, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.24; He SS, 2015, MBIO, V6, DOI 10.1128/mBio.00762-15; Johnning A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01355; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lampkowska J, 2008, INT J FOOD MICROBIOL, V127, P172, DOI 10.1016/j.ijfoodmicro.2008.06.017; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6065, DOI 10.1128/AAC.00117-12; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Qin SS, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.117; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Wachino J, 2011, ANTIMICROB AGENTS CH, V55, P5143, DOI 10.1128/AAC.05045-11; Wailan AM, 2016, ANTIMICROB AGENTS CH, V60, P136, DOI 10.1128/AAC.01243-15; Wailan AM, 2015, ANTIMICROB AGENTS CH, V59, P7405, DOI 10.1128/AAC.01319-15; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209623	10.1371/journal.pone.0209623	http://dx.doi.org/10.1371/journal.pone.0209623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576382	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400067
J	Wang, GQ; Yu, F; Lin, H; Murugesan, K; Huang, WH; Hoss, AG; Dhand, A; Lee, LY; Jian, ZG; Yin, CH; Montecalvo, M; Dimitrova, N; Fallon, JT				Wang, Guiqing; Yu, Fan; Lin, Henry; Murugesan, Karthikeyan; Huang, Weihua; Hoss, Andrew G.; Dhand, Abhay; Lee, Leslie Y.; Jian Zhuge; Yin, Changhong; Montecalvo, Marisa; Dimitrova, Nevenka; Fallon, John T.			Evolution and mutations predisposing to daptomycin resistance in vancomycin-resistant Enterococcus faecium ST736 strains	PLOS ONE			English	Article							HIGH-DOSE DAPTOMYCIN; BACTEREMIA; SUSCEPTIBILITY; DELETION; COUNTRIES; OUTCOMES; THERAPY; LIAFSR; SAFETY; VRE	We recently identified a novel vancomycin-resistant Enterococcus faecium (VREfm) clone ST736 with reduced daptomycin susceptibility. The objectives of this study were to assess the population dynamics of local VREfm strains and genetic alterations predisposing to daptomycin resistance in VREfm ST736 strains. Multilocus sequence typing and single nucleotide variant data were derived from whole-genome sequencing of 250 E. faecium isolates from 1994-1995 (n = 43), 2009-2012 (n = 115) and 2013 (n = 92). A remarkable change was noticed in the clonality and antimicrobial resistance profiles of E. faecium strains between 1994-1995 and 2013. VREfm sequence type 17 (ST17), the prototype strain of clade A1, was the dominant clone (76.7%) recognized in 1994-1995. By contrast, clone ST736 accounted for 46.7% of VREfm isolates, followed by ST18 (26.1%) and ST412 (20.7%) in 2013. Bayesian evolutionary analysis suggested that clone ST736 emerged between 1996 and 2009. Co-mutations (liaR.W73C and liaS.T120A) of the liaFSR system were identified in all ST736 isolates (n = 111, 100%) examined. Thirty-eight (34.2%) ST736 isolates exhibited daptomycin-resistant phenotype, of which 13 isolates had mutations in both the liaFSR and cardiolipin synthase (cls) genes and showed high level of resistance with a daptomycin MIC50 of 32 mu g/mL. The emergence of ST736 strains with mutations predisposing to daptomycin resistance and subsequent clonal spread among inpatients contributed to the observed high occurrence of daptomycin resistance in VREfm at our institution. The expanding geographic distribution of ST736 strains in other states and countries raises concerns about its global dissemination.	[Wang, Guiqing; Huang, Weihua; Yin, Changhong; Fallon, John T.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Wang, Guiqing; Jian Zhuge; Fallon, John T.] Westchester Med Ctr, Dept Pathol, Valhalla, NY 10595 USA; [Wang, Guiqing; Jian Zhuge; Fallon, John T.] Westchester Med Ctr, Clin Labs, Valhalla, NY 10595 USA; [Yu, Fan; Lin, Henry; Murugesan, Karthikeyan; Hoss, Andrew G.; Dimitrova, Nevenka] Philips Res North Amer, Cambridge, MA USA; [Dhand, Abhay; Montecalvo, Marisa] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Lee, Leslie Y.] Westchester Med Ctr, Dept Pharm, Valhalla, NY USA	New York Medical College; Westchester Medical Center; Westchester Medical Center; Philips; Philips Research; New York Medical College; Westchester Medical Center	Wang, GQ (corresponding author), New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA.; Wang, GQ (corresponding author), Westchester Med Ctr, Dept Pathol, Valhalla, NY 10595 USA.	guiqing_wang@nymc.edu		Huang, Weihua/0000-0003-1176-3719; Dhand, Abhay/0000-0003-3527-1938; Murugesan, Karthikeyan/0000-0002-2275-1126; Wang, Guiqing/0000-0001-6590-5394	Department of Pathology of New York Medical College; Philips Healthcare North America; Cubist Pharmaceuticals	Department of Pathology of New York Medical College; Philips Healthcare North America; Cubist Pharmaceuticals	This work was supported in part by research funds from the Department of Pathology of New York Medical College, Philips Healthcare North America and Cubist Pharmaceuticals. The funders did not have any role in the study design and data collection. Philips Healthcare North America provided support in the form of salaries for authors (FY, HL, KM, AGH, ND) who participated in part of data analysis, decision to publish and preparation of manuscript. The specific roles of these authors are articulated in the 'Author contributions' section.	Akpaka PE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185920; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Bashir A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170449; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472; Chacko KI, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02007-17, 10.1128/aac.02007-17]; Davlieva M, 2013, ANTIMICROB AGENTS CH, V57, P289, DOI 10.1128/AAC.01743-12; Diaz L, 2014, ANTIMICROB AGENTS CH, V58, P4527, DOI 10.1128/AAC.02686-14; Dudeck MA, 2015, AM J INFECT CONTROL, V43, P206, DOI 10.1016/j.ajic.2014.11.014; Freitas AR, 2016, J ANTIMICROB CHEMOTH, V71, P3351, DOI 10.1093/jac/dkw312; Galloway-Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030187; Galloway-Pena JR, 2009, J INFECT DIS, V200, P1566, DOI 10.1086/644790; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Haas JP, 2014, AM J INFECT CONTROL, V42, P586, DOI 10.1016/j.ajic.2013.12.013; Haddad LE, 2017, OPEN FORUM INFECT DI, V4, pS646; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Humphries RM, 2013, CLIN MICROBIOL REV, V26, P759, DOI 10.1128/CMR.00030-13; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kelesidis T, 2013, J ANTIMICROB CHEMOTH, V68, P1926, DOI 10.1093/jac/dkt117; Kullar R, 2013, J ANTIMICROB CHEMOTH, V68, P2921, DOI 10.1093/jac/dkt294; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Lellek H, 2015, INT J MED MICROBIOL, V305, P902, DOI 10.1016/j.ijmm.2015.09.005; Li DH, 2016, METHODS, V102, P3, DOI 10.1016/j.ymeth.2016.02.020; Long KS, 2012, ANTIMICROB AGENTS CH, V56, P603, DOI 10.1128/AAC.05702-11; Michael KE, 2016, ASSESSMENT ENV CONTA; Miller C, 2013, ANTIMICROB AGENTS CH, V57, P5373, DOI 10.1128/AAC.01473-13; Montecalvo MA, 1999, ANN INTERN MED, V131, P269, DOI 10.7326/0003-4819-131-4-199908170-00006; MONTECALVO MA, 1994, ANTIMICROB AGENTS CH, V38, P1363, DOI 10.1128/AAC.38.6.1363; Munita JM, 2014, CLIN INFECT DIS, V59, P1277, DOI 10.1093/cid/ciu642; Munita JM, 2013, ANTIMICROB AGENTS CH, V57, P2831, DOI 10.1128/AAC.00021-13; Munita JM, 2012, ANTIMICROB AGENTS CH, V56, P4354, DOI 10.1128/AAC.00509-12; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Panesso D, 2015, ANTIMICROB AGENTS CH, V59, P7327, DOI 10.1128/AAC.01073-15; Polidori M, 2011, J CHEMOTHERAPY, V23, P240, DOI 10.1179/joc.2011.23.4.240; Prematunge C, 2016, INFECT CONT HOSP EP, V37, P26, DOI 10.1017/ice.2015.228; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Raven KE, 2017, CLIN INFECT DIS, V64, P886, DOI 10.1093/cid/ciw872; Reyes J, 2015, J INFECT DIS, V211, P1317, DOI 10.1093/infdis/jiu602; Roach DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005413; Sader HS, 2013, DIAGN MICR INFEC DIS, V75, P417, DOI 10.1016/j.diagmicrobio.2013.01.001; Sader HS, 2009, DIAGN MICR INFEC DIS, V65, P158, DOI 10.1016/j.diagmicrobio.2009.06.016; Schutt AC, 2009, ANN PHARMACOTHER, V43, P2108, DOI 10.1345/aph.1M324; Shukla BS, 2016, CLIN INFECT DIS, V62, P1514, DOI 10.1093/cid/ciw173; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sinel C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11265-2; Sinel C, 2016, J ANTIMICROB CHEMOTH, V71, P2793, DOI 10.1093/jac/dkw229; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; The Canadian Nosocomial Infection Surveillance Program (CNISP), 2012, ANT RES ORG ARO SURV; Tran TT, 2015, ANN NY ACAD SCI, V1354, P32, DOI 10.1111/nyas.12948; Tran TT, 2012, ANTIMICROB AGENTS CH, V56, P3461, DOI 10.1128/AAC.00046-12; Wang GQ, 2014, ANTIMICROB AGENTS CH, V58, P4848, DOI 10.1128/AAC.02683-14; Werner G, 2016, MLST TYPING BLOODSTR; Williams R, 2012, TRANSL INTERPRET STU, V7, P19, DOI 10.1075/tis.7.1.02wil; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	57	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209785	10.1371/journal.pone.0209785	http://dx.doi.org/10.1371/journal.pone.0209785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576392	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400080
J	Puissant, MM; Muere, C; Levchenko, V; Manis, AD; Martino, P; Forster, HV; Palygin, O; Staruschenko, A; Hodges, MR				Puissant, Madeleine M.; Muere, Clarissa; Levchenko, Vladislav; Manis, Anna D.; Martino, Paul; Forster, Hubert V.; Palygin, Oleg; Staruschenko, Alexander; Hodges, Matthew R.			Genetic mutation of Kcnj16 identifies Kir5.1-containing channels as key regulators of acute and chronic pH homeostasis	FASEB JOURNAL			English	Article						pH regulation; control of breathing; ion channels	SENSORINEURAL DEAFNESS; SEROTONERGIC NEURONS; POTASSIUM CHANNELS; CAROTID-BODY; K+ CHANNEL; KIR5.1; SENSITIVITY; MODULATION; EXPRESSION; KIR4.1	Acute and chronic homeostatic pH regulation is critical for the maintenance of optimal cellular function. Renal mechanisms dominate global pH regulation over longer time frames, and rapid adjustments in ventilation compensate for acute pH and CO2 changes. Ventilatory CO2 and pH chemoreflexes are primarily determined by brain chemoreceptors with intrinsic pH sensitivity likely driven by K+ channels. Here, we studied acute and chronic pH regulation in Kcnj16 mutant Dahl salt-sensitive (SSKcnj16-/-) rats; Kcnj16 encodes the pH-sensitive inwardly rectifying K+ 5.1 (Kir5.1) channel. SSKcnj16-/- rats hyperventilated at rest, likely compensating for a chronic metabolic acidosis. Despite their resting hyperventilation, SSKcnj16-/- rats showed up to 45% reduction in the ventilatory response to graded hypercapnic acidosis vs. controls. SSKcnj16-/- rats chronically treated with bicarbonate or the carbonic anhydrase inhibitor hydrochlorothiazide had partial restoration of arterial pH, but there was a further reduction in the ventilatory response to hypercapnic acidosis. SSKcnj16-/- rats also had a nearly absent hypoxic ventilatory response, suggesting major contributions of Kir5.1 to O-2- and CO2-dependent chemoreflexes. Although previous studies demonstrated beneficial effects of a high-K+ diet (HKD) on cardiorenal phenotypes in SSKcnj16-/- rats, HKD failed to restore the observed ventilatory phenotypes. We conclude that Kir5.1 is a key regulator of renal H+ handling and essential for acute and chronic regulation of arterial pH as determinants of the ventilatory CO2 chemoreflex.	[Puissant, Madeleine M.; Muere, Clarissa; Levchenko, Vladislav; Manis, Anna D.; Martino, Paul; Forster, Hubert V.; Palygin, Oleg; Staruschenko, Alexander; Hodges, Matthew R.] Med Coll Wisconsin, Dept Physiol, BSB-504,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Palygin, Oleg; Hodges, Matthew R.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Martino, Paul] Carthage Coll, Dept Biol, Kenosha, WI USA	Medical College of Wisconsin; Medical College of Wisconsin	Hodges, MR (corresponding author), Med Coll Wisconsin, Dept Physiol, BSB-504,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mhodges@mcw.edu	Palygin, Oleg/AAT-3047-2020; Hodges, Matthew/GZB-0433-2022	Palygin, Oleg/0000-0002-3680-5527; Staruschenko, Alexander/0000-0002-5190-8356	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [HL007852, HL122358, HL135749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007852, R01HL122358, R35HL135749] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants HL007852 (to M.M.P. and A.D.M.), HL122358 (to M.R.H.), and HL135749 (to A.S.). The authors declare no conflicts of interest.	Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Brasko C, 2017, BRAIN STRUCT FUNCT, V222, P41, DOI 10.1007/s00429-016-1199-8; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; Cui N, 2001, J CELL PHYSIOL, V189, P229, DOI 10.1002/jcp.10021; D'Adamo MC, 2011, J BIOL CHEM, V286, P192, DOI 10.1074/jbc.M110.189290; FENCL V, 1966, AM J PHYSIOL, V210, P459, DOI 10.1152/ajplegacy.1966.210.3.459; Funk GD, 2018, J PHYSIOL-LONDON, V596, P2935, DOI 10.1113/JP275707; Gourine AV, 2017, J APPL PHYSIOL, V123, P1344, DOI 10.1152/japplphysiol.00194.2017; Haruna Y, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9483; Hodges MR, 2013, RESP PHYSIOL NEUROBI, V186, P221, DOI 10.1016/j.resp.2013.02.020; Hodges MR, 2002, J APPL PHYSIOL, V93, P974, DOI 10.1152/japplphysiol.00019.2002; HORNBEIN TF, 1963, J APPL PHYSIOL, V18, P580, DOI 10.1152/jappl.1963.18.3.580; Juang JMJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06733; Lachheb S, 2008, AM J PHYSIOL-RENAL, V294, pF1398, DOI 10.1152/ajprenal.00288.2007; Mouradian GC, 2012, J PHYSIOL-LONDON, V590, P3335, DOI 10.1113/jphysiol.2012.234658; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Nattie E, 2009, J APPL PHYSIOL, V106, P1464, DOI 10.1152/japplphysiol.00112.2008; Palygin O, 2017, ACTA PHYSIOL, V219, P260, DOI 10.1111/apha.12703; Palygin O, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92331; PAPPENHEIMER JR, 1965, AM J PHYSIOL, V208, P436, DOI 10.1152/ajplegacy.1965.208.3.436; Paulais M, 2011, P NATL ACAD SCI USA, V108, P10361, DOI 10.1073/pnas.1101400108; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Pessia M, 2001, J PHYSIOL-LONDON, V532, P359, DOI 10.1111/j.1469-7793.2001.0359f.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Pineda J, 1997, NEUROSCIENCE, V77, P723, DOI 10.1016/S0306-4522(96)00485-X; Puissant MM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00034; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Tanemoto M, 2002, NEURON, V34, P387, DOI 10.1016/S0896-6273(02)00675-X; Trapp S, 2011, EXP PHYSIOL, V96, P451, DOI 10.1113/expphysiol.2010.055848; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Yamamoto Y, 2008, HISTOL HISTOPATHOL, V23, P799, DOI 10.14670/HH-23.799	37	14	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5067	5075		10.1096/fj.201802257R	http://dx.doi.org/10.1096/fj.201802257R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30605394	Green Published			2022-12-26	WOS:000462888500035
J	Laschet, C; Dupuis, N; Hanson, J				Laschet, Celine; Dupuis, Nadine; Hanson, Julien			A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); G protein; high-throughput screening; drug screening; pharmacology; biased signaling; complementation assay; dopamine; functional selectivity; Nanoluciferase	COUPLED RECEPTOR ACTIVATION; RESONANCE ENERGY-TRANSFER; DRUG DISCOVERY; DOPAMINE-D-2 RECEPTOR; INTERNATIONAL UNION; PARKINSONS-DISEASE; AGONIST REGULATION; SELECTIVITY; REPORTER; ACCURATE	G protein-coupled receptors (GPCRs) are currently the target of more than 30% of the marketed medicines. However, there is an important medical need for ligands with improved pharmacological activities on validated drug targets. Moreover, most of these ligands remain poorly characterized, notably because of a lack of pharmacological tools. Thus, there is an important demand for innovative assays that can detect and drive the design of compounds with novel or improved pharmacological properties. In particular, a functional and screening-compatible GPCR-G protein interaction assay is still unavailable. Here, we report on a nanoluciferase-based complementation technique to detect ligands that promote a GPCR-G protein interaction. We demonstrate that our system can be used to profile compounds with regard to the G proteins they activate through a given GPCR. Furthermore, we established a proof of applicability of screening for distinct G proteins on dopamine receptor D-2 whose differential coupling to G(i/o) family members has been extensively studied. In a D-2-G(i1)versus D-2-G(o) screening, we retrieved five agonists that are currently being used in antiparkinsonian medications. We determined that in this assay, piribedil and pergolide are full agonists for the recruitment of G(i1) but are partial agonists for G(o), that the agonist activity of ropinirole is biased in favor of G(i1) recruitment, and that the agonist activity of apomorphine is biased for G(o). We propose that this newly developed assay could be used to develop molecules that selectively modulate a particular G protein pathway.	[Laschet, Celine; Dupuis, Nadine; Hanson, Julien] Univ Liege, GIGA Mol Biol Dis, Lab Mol Pharmacol, B-4000 Liege, Belgium; [Hanson, Julien] Univ Liege, Liege CHU, CIRM Drug Target & Lead Discovery, Lab Med Chem, B34 4, B-4000 Liege, Belgium	University of Liege; University of Liege	Hanson, J (corresponding author), Univ Liege, GIGA, Lab Mol Pharmacol, CHU, B34 4,11 Ave Hop, B-4000 Liege, Belgium.	j.hanson@uliege.be	Hanson, Julien/A-8242-2008	Hanson, Julien/0000-0001-7063-7590	Fonds pour la Recherche Scientifique (F.R.S.-FNRS) [F.4510.14]; Leon Fredericq Foundation; University of Liege (Fonds Speciaux)	Fonds pour la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq Foundation; University of Liege (Fonds Speciaux)(University of Liege)	This work was supported by the Fonds pour la Recherche Scientifique (F.R.S.-FNRS) Incentive Grant F.4510.14 for Scientific Research, University of Liege (Fonds Speciaux), and the Leon Fredericq Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Beaulieu JM, 2015, BRIT J PHARMACOL, V172, P1, DOI 10.1111/bph.12906; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Cordeaux Y, 2001, J BIOL CHEM, V276, P28667, DOI 10.1074/jbc.M008644200; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; DEKEYSER J, 1995, PROG NEURO-PSYCHOPH, V19, P1147, DOI 10.1016/0278-5846(95)00232-4; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Dupuis N, 2017, MOL PHARMACOL, V91, P595, DOI 10.1124/mol.116.107714; England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112; FREEDMAN SB, 1994, J PHARMACOL EXP THER, V268, P417; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gazi L, 2003, BRIT J PHARMACOL, V138, P775, DOI 10.1038/sj.bjp.0705116; Gilissen J, 2016, PHARMACOL THERAPEUT, V159, P56, DOI 10.1016/j.pharmthera.2016.01.008; Gilissen J, 2015, BIOCHEM PHARMACOL, V98, P381, DOI 10.1016/j.bcp.2015.09.010; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Hattori M, 2013, MOL BIOSYST, V9, P957, DOI 10.1039/c2mb25443c; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Laschet C, 2018, BIOCHEM PHARMACOL, V153, P62, DOI 10.1016/j.bcp.2018.02.016; Liu RF, 2016, BIOCHEM PHARMACOL, V114, P103, DOI 10.1016/j.bcp.2016.02.010; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Ma Q, 2017, EXPERT OPIN DRUG DIS, V12, P511, DOI 10.1080/17460441.2017.1303473; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Ngo T, 2016, BRIT J PHARMACOL, V173, P2934, DOI 10.1111/bph.13452; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oertel W, 2016, J NEUROCHEM, V139, P325, DOI 10.1111/jnc.13750; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Panula P, 2015, PHARMACOL REV, V67, P601, DOI 10.1124/pr.114.010249; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Szpakowska M, 2018, BRIT J PHARMACOL, V175, P1419, DOI 10.1111/bph.14132; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Williams C, 2004, NAT REV DRUG DISCOV, V3, P125, DOI 10.1038/nrd1306; Winpenny D, 2016, BRIT J PHARMACOL, V173, P1393, DOI 10.1111/bph.13441; Yano H, 2018, BIOTECHNIQUES, V65, P9, DOI 10.2144/btn-2018-0039; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	54	26	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4079	4090		10.1074/jbc.RA118.006231	http://dx.doi.org/10.1074/jbc.RA118.006231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30593506	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000461854400021
J	Shu, PC; Wu, C; Liu, W; Ruan, XB; Liu, C; Hou, L; Zeng, Y; Fu, HY; Wang, M; Chen, P; Zhang, XL; Yin, B; Yuan, JG; Qiang, BQ; Peng, XZ				Shu, Pengcheng; Wu, Chao; Liu, Wei; Ruan, Xiangbin; Liu, Chang; Hou, Lin; Zeng, Yi; Fu, Hongye; Wang, Ming; Chen, Pan; Zhang, Xiaoling; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong			The spatiotemporal expression pattern of microRNAs in the developing mouse nervous system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); neurodevelopment; central nervous system (CNS); brain; mouse; embryo; gene expression; expression pattern; in situ hybridization	INTERKINETIC NUCLEAR MIGRATION; SINGLE-CELL ANALYSIS; IN-SITU DETECTION; NONCODING RNAS; NEURONS; ATLAS; HETEROGENEITY; REGULATORS; DYNAMICS; CLUSTER	MicroRNAs (miRNAs) control various biological processes by inducing translational repression and transcript degradation of the target genes. In mammalian development, knowledge of the timing and expression pattern of each miRNA is important to determine and predict its function in vivo. So far, no systematic analyses of the spatiotemporal expression pattern of miRNAs during mammalian neurodevelopment have been performed. Here, we isolated total RNAs from the embryonic dorsal forebrain of mice at different developmental stages and subjected these RNAs to microarray analyses. We selected 279 miRNAs that exhibited high signal intensities or ascending or descending expression dynamics. To ascertain the expression patterns of these miRNAs, we used locked nucleic acid (LNA)-modified miRNA probes in in situ hybridization experiments. Multiple miRNAs exhibited spatially restricted/enriched expression in anatomically distinct regions or in specific neuron subtypes in the embryonic brain and spinal cord, such as in the ventricular area, the striatum (and other basal ganglia), hypothalamus, choroid plexus, and the peripheral nervous system. These findings provide new insights into the expression and function of miRNAs during the development of the nervous system and could be used as a resource to facilitate studies in neurodevelopment.	[Shu, Pengcheng; Wu, Chao; Liu, Wei; Ruan, Xiangbin; Liu, Chang; Hou, Lin; Zeng, Yi; Fu, Hongye; Wang, Ming; Chen, Pan; Zhang, Xiaoling; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Chinese Acad Med Sci, Dept Mol Biol, State Key Lab Med Mol Biol,Sch Basic Med,Peking U, Inst Basic Med Sci,Med Primates Res Ctr,Neurosci, Beijing 100005, Peoples R China; [Shu, Pengcheng; Wu, Chao; Liu, Wei; Ruan, Xiangbin; Liu, Chang; Hou, Lin; Zeng, Yi; Fu, Hongye; Wang, Ming; Chen, Pan; Zhang, Xiaoling; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Chinese Acad Med Sci, Dept Biochem, State Key Lab Med Mol Biol,Sch Basic Med,Peking U, Inst Basic Med Sci,Med Primates Res Ctr,Neurosci, Beijing 100005, Peoples R China; [Peng, Xiaozhong] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China; [Peng, Xiaozhong] Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Peng, XZ (corresponding author), Chinese Acad Med Sci, Dept Mol Biol & Biochem, Inst Basic Med Sci, 5 Dongdan San Tiao, Beijing 100005, Peoples R China.; Peng, XZ (corresponding author), Peking Union Med Coll, 5 Dongdan San Tiao, Beijing 100005, Peoples R China.	pengxiaozhong@pumc.edu.cn	Ruan, Xiangbin/A-7239-2013; Shu, Pengcheng/D-7023-2015	Ruan, Xiangbin/0000-0002-6895-2070; Shu, Pengcheng/0000-0002-3091-2559	National Key Research and Development Program of China [2016YFA0100702, 2016YFC0902502]; National Natural Science Foundation of China [31670789]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-2-001, 2016-I2M-1-004, 2017-I2M-1-004]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS)	This work was supported by National Key Research and Development Program of China Grants 2016YFA0100702 and 2016YFC0902502, National Natural Science Foundation of China Grant 31670789, and CAMS Innovation Fund for Medical Sciences (CIFMS) Grants 2016-I2M-2-001, 2016-I2M-1-004, and 2017-I2M-1-004. The authors declare that they have no conflicts of interest with the contents of this article.	Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Allaway KC, 2017, DEV BIOL, V421, P1, DOI 10.1016/j.ydbio.2016.11.007; Amin ND, 2015, SCIENCE, V350, P1525, DOI 10.1126/science.aad2509; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fan JG, 2017, P NATL ACAD SCI USA, V114, pE4271, DOI 10.1073/pnas.1619442114; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hu P, 2017, MOL CELL, V68, P1006, DOI 10.1016/j.molcel.2017.11.017; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lein E, 2017, SCIENCE, V358, P64, DOI 10.1126/science.aan6827; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Peng CG, 2017, SCIENCE, V356, P1168, DOI 10.1126/science.aam7671; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Rajman M, 2017, DEVELOPMENT, V144, P2310, DOI 10.1242/dev.144337; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Redshaw N, 2009, BRAIN RES, V1250, P20, DOI 10.1016/j.brainres.2008.11.020; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shu PC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08450-8; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sokol NS, 2012, CURR OPIN GENET DEV, V22, P368, DOI 10.1016/j.gde.2012.04.001; Son DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4000; Spear PC, 2012, DEV GROWTH DIFFER, V54, P306, DOI 10.1111/j.1440-169X.2012.01342.x; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Thiebes KP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8718; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Zhong Y, 2004, CEREB CORTEX, V14, P1144, DOI 10.1093/cercor/bhh074; Zhou JJ, 2017, BBA-GENE REGUL MECH, V1860, P1159, DOI 10.1016/j.bbagrm.2017.10.002; Zhuo S, 2016, DIABETES, V65, P3276, DOI 10.2337/db16-0166	56	13	15	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3444	3453		10.1074/jbc.RA118.004390	http://dx.doi.org/10.1074/jbc.RA118.004390			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30578296	Green Published, hybrid			2022-12-26	WOS:000461853900012
J	Dent, AT; Mourino, S; Huang, WL; Wilks, A				Dent, Alecia T.; Mourino, Susana; Huang, Weiliang; Wilks, Angela			Post-transcriptional regulation of the Pseudomonas aeruginosa heme assimilation system (Has) fine-tunes extracellular heme sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; bacterial signal transduction; bacterial transcription; sigma receptor; Pseudomonas aeruginosa (P. aeruginosa); extracytoplasmic function (ECF) function; heme assimilation system; post-transcriptional regulation	MEMBRANE RECEPTORS PHUR; OUTER-MEMBRANE; SERRATIA-MARCESCENS; HEMOPHORE HASAP; IRON TRANSPORT; SIGMA-FACTOR; GENE; ACQUISITION; EXPRESSION; IDENTIFICATION	Pseudomonas aeruginosa is an opportunistic pathogen that utilizes heme as a primary iron source within the host. Extracellular heme is sensed via a heme assimilation system (has) that encodes an extracytoplasmic function (ECF) sigma factor system. Herein, using has deletion mutants, quantitative PCR analyses, and immunoblotting, we show that the activation of the sigma factor HasI requires heme release from the hemophore HasAp to the outer-membrane receptor HasR. Using RT-PCR and 5 '-RACE, we observed that following transcriptional activation of the co-transcribed hasRAp, it is further processed into specific mRNAs varying in stability. We noted that the processing and variation in stability of the hasAp and hasR mRNAs in response to heme provide a mechanism for differential expression from co-transcribed genes. The multiple layers of post-transcriptional regulation of the ECF signaling cascade, including the previously reported post-transcriptional regulation of HasAp by the heme metabolites biliverdin IX beta and IX delta, allow fine-tuning of the cell-surface signaling system in response to extracellular heme levels. We hypothesize that the complex post-transcriptional regulation of the Has system provides P. aeruginosa an advantage in colonizing a variety of physiological niches in the host.	[Dent, Alecia T.; Mourino, Susana; Huang, Weiliang; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu		Dent, Alecia/0000-0002-6376-7482	National Institutes of Health [R01 AI102883, AI134886]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI134886, R01AI102883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 AI102883 and AI134886 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alontaga AY, 2009, BIOCHEMISTRY-US, V48, P96, DOI 10.1021/bi801860g; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Benevides-Matos N, 2010, MICROBIOL-SGM, V156, P1749, DOI 10.1099/mic.0.034405-0; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; Caillet-Saguy C, 2012, J BIOL CHEM, V287, P26932, DOI 10.1074/jbc.M112.366385; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Cwerman H, 2006, J BACTERIOL, V188, P3357, DOI 10.1128/JB.188.9.3357-3364.2006; DeLoughery A, 2018, P NATL ACAD SCI USA, V115, pE5585, DOI 10.1073/pnas.1803283115; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; GAMPER M, 1993, GENE, V129, P119, DOI 10.1016/0378-1119(93)90706-9; GAMPER M, 1992, J MOL BIOL, V226, P943, DOI 10.1016/0022-2836(92)91044-P; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; HEINRICHS DE, 1991, INFECT IMMUN, V59, P3680, DOI 10.1128/IAI.59.10.3680-3684.1991; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huang WL, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1112-5; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Kumar R, 2014, BIOCHEMISTRY-US, V53, P2112, DOI 10.1021/bi500030p; Leoni L, 2000, J BACTERIOL, V182, P1481, DOI 10.1128/JB.182.6.1481-1491.2000; Leoni L, 1996, J BACTERIOL, V178, P2299, DOI 10.1128/jb.178.8.2299-2313.1996; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Llamas MA, 2014, FEMS MICROBIOL REV, V38, P569, DOI 10.1111/1574-6976.12078; Marvig RL, 2014, MBIO, V5, DOI 10.1128/mBio.00966-14; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mourino S, 2016, J BIOL CHEM, V291, P20503, DOI 10.1074/jbc.M116.728527; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Payne SM, 2016, MICROBIOL MOL BIOL R, V80, P69, DOI 10.1128/MMBR.00046-15; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Redly GA, 2003, J BACTERIOL, V185, P1261, DOI 10.1128/JB.185.4.1261-1265.2003; Redly GA, 2005, J BACTERIOL, V187, P5648, DOI 10.1128/JB.187.16.5648-5657.2005; Reinhart AA, 2015, INFECT IMMUN, V83, P863, DOI 10.1128/IAI.02707-14; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Royt P W, 1990, Biol Met, V3, P28, DOI 10.1007/BF01141174; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sineva E, 2017, CURR OPIN MICROBIOL, V36, P128, DOI 10.1016/j.mib.2017.05.004; Smith AD, 2015, BIOCHEMISTRY-US, V54, P2601, DOI 10.1021/acs.biochem.5b00017; Smith AD, 2015, J BIOL CHEM, V290, P7756, DOI 10.1074/jbc.M114.633495; Vanderpool CK, 2003, J BACTERIOL, V185, P909, DOI 10.1128/JB.185.3.909-917.2003; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f	60	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2771	2785		10.1074/jbc.RA118.006185	http://dx.doi.org/10.1074/jbc.RA118.006185			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593511	hybrid, Green Published			2022-12-26	WOS:000459601600017
J	Li, F; Sabunciyan, S; Yolken, RH; Lee, D; Kim, S; Karlsson, H				Li, Fang; Sabunciyan, Sarven; Yolken, Robert H.; Lee, Doheon; Kim, Sanghyeon; Karlsson, Hakan			Transcription of human endogenous retroviruses in human brain by RNA-seq analysis	PLOS ONE			English	Article							HERV-W FAMILY; COMPREHENSIVE ANALYSIS; EXPRESSION; ENVELOPE; CELLS; GLYCOPROTEIN; INDIVIDUALS; PROTEINS; ELEMENTS; PLASMA	Background Human endogenous retroviruses (HERV) comprise 8% of the human genome and can be classified into at least 31 families. Increased levels of transcripts from the W and H families of HERV have been observed in association with human diseases, such as multiple sclerosis and schizophrenia. Although HERV transcripts have been detected in many tissues and cell-types based on microarray and PCR studies, the extent of HERV expression in different cell-types and diseases state has been less comprehensively studied. Results We examined overall transcription of HERV, and particularly of HERV-W and HERV-H elements in human postmortem brain samples obtained from individuals with psychiatric diagnoses (n = 111) and healthy controls (n = 51) by analyzing publicly available RNA sequencing datasets. Sequence reads were aligned to prototypical sequences representing HERV, downloaded from Repbase. We reported a consistent expression (0.1 similar to 0.2% of mappable reads) of different HERV families across three regions of human brains. Spearman correlations revealed highly correlated expression levels between three brain regionsacross 475 consensus sequences. By mapping sequences that aligned to the consensus sequences of HERV-W and HERV-H families to individual loci on chromosome 7, more than 60 loci from each family were identified, part of which are being transcribed. The ERVWE1, locus located at chr7q21.2, exhibited high levels of transcription across the three datasets. Notably, we demonstrated a trend of increased expression of overall HERV, as well as HERV-W family in samples from both schizophrenia and bipolar disorder patients. Conclusions The current analyses indicate that RNA sequencing is a useful approach for investigating global expression of repetitive elements, such as HERV, in the human genome. HERV-W/H with the tendency of transcription up-regulation in patients suggests potential implication of HERV-W/H in psychiatric diseases.	[Li, Fang] Hunan Normal Univ, Ctr Heart Dev, Key Lab MOE Dev Biol & Prot Chem, Coll Life Sci, Changsha, Hunan, Peoples R China; [Li, Fang; Karlsson, Hakan] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Sabunciyan, Sarven; Yolken, Robert H.] Johns Hopkins Univ, Sch Med, Dept Pediat, Stanley Div Dev Neurovirol, Baltimore, MD 21205 USA; [Lee, Doheon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Kim, Sanghyeon] Johns Hopkins Univ, Sch Med, Stanley Med Res Inst, Baltimore, MD USA	Hunan Normal University; Karolinska Institutet; Johns Hopkins University; Korea Advanced Institute of Science & Technology (KAIST); Johns Hopkins University	Li, F (corresponding author), Hunan Normal Univ, Ctr Heart Dev, Key Lab MOE Dev Biol & Prot Chem, Coll Life Sci, Changsha, Hunan, Peoples R China.; Li, F; Karlsson, H (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	li-evans@hotmail.com; hakan.karlsson.2@ki.se	Karlsson, Hakan/AAH-8798-2019; yolken, robert/AAW-2556-2021	Sabunciyan, Sarven/0000-0002-7231-0820; Karlsson, Hakan/0000-0001-5985-7330	Stanley Medical Research Institute, Bethesda, MD [NV-002]	Stanley Medical Research Institute, Bethesda, MD	This study was supported by the Stanley Medical Research Institute (No. NV-002), Bethesda, MD.	Agoni L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00180; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, AIDS RES HUM RETROV, V23, P1251, DOI 10.1089/aid.2006.0274; Antony JM, 2006, AIDS RES HUM RETROV, V22, P1253, DOI 10.1089/aid.2006.22.1253; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Bhardwaj N, 2015, VIRUSES-BASEL, V7, P939, DOI 10.3390/v7030939; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Buscher K, 2006, MELANOMA RES, V16, P223; Christensen T, 2000, ACTA NEUROL SCAND, V101, P229, DOI 10.1034/j.1600-0404.2000.101004229.x; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Darby MM, 2016, HUM MOL GENET, V25, P4962, DOI 10.1093/hmg/ddw321; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Forsman A, 2005, J VIROL METHODS, V129, P16, DOI 10.1016/j.jviromet.2005.04.016; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Goering W, 2015, PROSTATE, V75, P1958, DOI 10.1002/pros.23095; Gonzalez-Hernandez MJ, 2014, J VIROL, V88, P8924, DOI 10.1128/JVI.00556-14; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; Ishida Toshiaki, 2008, Cancer Immun, V8, P15; Karlsson H, 2004, MOL PSYCHIATR, V9, P12, DOI 10.1038/sj.mp.4001439; Karlsson H, 2001, P NATL ACAD SCI USA, V98, P4634, DOI 10.1073/pnas.061021998; Kim HS, 1999, J GEN VIROL, V80, P2613, DOI 10.1099/0022-1317-80-10-2613; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-22; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Montesion M, 2018, J VIROL, V92, DOI 10.1128/JVI.01258-17; Nellaker C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-532; Perot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040194; Perron H, 2008, BIOL PSYCHIAT, V64, P1019, DOI 10.1016/j.biopsych.2008.06.028; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Ruprecht K, 2008, J VIROL, V82, P10008, DOI 10.1128/JVI.01016-08; Schmitt K, 2013, J VIROL, V87, P13837, DOI 10.1128/JVI.02388-13; Schmitt K, 2013, GENOME BIOL EVOL, V5, P307, DOI 10.1093/gbe/evt010; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Tyekucheva S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-495; Voisset C, 2000, AIDS RES HUM RETROV, V16, P731, DOI 10.1089/088922200308738; Yao Y, 2008, GENES BRAIN BEHAV, V7, P103, DOI 10.1111/j.1601-183X.2007.00334.x	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0207353	10.1371/journal.pone.0207353	http://dx.doi.org/10.1371/journal.pone.0207353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605476	gold, Green Published, Green Submitted			2022-12-26	WOS:000454759900007
J	Baillot, N; Girousse, C; Allard, V; Piquet-Pissaloux, A; Gouis, J				Baillot, Nadege; Girousse, Christine; Allard, Vincent; Piquet-Pissaloux, Agnes; Le Gouis, Jacques			Different grain-filling rates explain grain-weight differences along the wheat ear	PLOS ONE			English	Article							DRY-MATTER; NITROGEN ACCUMULATION; YIELD COMPONENTS; ABSCISIC-ACID; CARPEL SIZE; DURATION; POSTANTHESIS; TEMPERATURE; POSITIONS; PATTERN	Thousand grain weight is one of the components determining wheat grain yield. It represents the average value of individual grain weights which depends on position within the ear and on positon within the spikelet. Our objective was to quantify the influences of individual floret anthesis date, of carpel weight at anthesis and of rate and duration of grain filling, on variation in individual final grain weight. Two bread wheat cultivars were grown in a greenhouse and their ears were sampled from anthesis through to harvest. Each ear was divided into three parts-basal, central and apical-where the two proximal grains were dissected from each of two spikelets. We analysed (i) the flowering time shift within the ear and within the spikelet; and (ii) the growth kinetics during grain filling in relation to position along the ear. For both cultivars, florets located in the central part of the ear were the first to reach anthesis followed by those in the apical part and then the basal part. Within a spikelet, the floret located nearest the rachis flowered first followed by the more distal ones. We found no significant systematic effect of flowering time-shift on final grain weight. Nevertheless, grains in the central part were heavier than the basal ones (9.75% smaller) and than the apical ones (18.25% smaller). These differences were explained mainly by differences in mean grain filling rates. Analysis of growth kinetics enabled an improved explanation of the variability of individual grain weight along the ear.	[Baillot, Nadege; Piquet-Pissaloux, Agnes] Vetagrosup, Campus Agron, Lempdes, France; [Baillot, Nadege; Girousse, Christine; Allard, Vincent; Piquet-Pissaloux, Agnes; Le Gouis, Jacques] UCA, INRA, GDEC, Clermont Ferrand, France	VetAgro Sup; INRAE	Gouis, J (corresponding author), UCA, INRA, GDEC, Clermont Ferrand, France.	Jacques.le-gouis@inra.fr	Allard, Vincent/B-8806-2009	Allard, Vincent/0000-0003-1949-9158; Le Gouis, Jacques/0000-0001-5726-4902	Auvergne regional council	Auvergne regional council(Region Auvergne-Rhone-Alpes)	This work was funded by the general directorate for education and research and the Auvergne regional council.	Ahmadi A, 1999, PLANT GROWTH REGUL, V28, P187, DOI 10.1023/A:1006223925694; BREMNER PM, 1972, AUST J BIOL SCI, V25, P657, DOI 10.1071/BI9720657; Calderini DF, 1999, J AGR SCI, V132, P453, DOI 10.1017/S0021859699006504; Calderini DF, 2000, AUST J PLANT PHYSIOL, V27, P183; Charmet G, 2005, THEOR APPL GENET, V111, P540, DOI 10.1007/s00122-005-2045-1; CROSS HZ, 1975, CROP SCI, V15, P532, DOI 10.2135/cropsci1975.0011183X001500040023x; DAYNARD TB, 1971, CROP SCI, V11, P45, DOI 10.2135/cropsci1971.0011183X001100010015x; DEVRIES AP, 1973, EUPHYTICA, V22, P445, DOI 10.1007/BF00036640; Evans L. T., 1970, AUSTR J BIOL SCI, V23, P753, DOI [10.1071/BI9700753, DOI 10.1071/BI9700753]; Feng F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00129; Ferrante A, 2015, FIELD CROP RES, V177, P109, DOI 10.1016/j.fcr.2015.03.009; FUSSELL LK, 1978, FIELD CROP RES, V1, P21, DOI 10.1016/0378-4290(78)90004-7; GEBEYEHOU G, 1982, CROP SCI, V22, P337, DOI 10.2135/cropsci1982.0011183X002200020033x; Gouache D, 2012, EUR J AGRON, V39, P62, DOI 10.1016/j.eja.2012.01.009; Hasan AK, 2011, FIELD CROP RES, V123, P241, DOI 10.1016/j.fcr.2011.05.019; HERZOG H, 1983, EUPHYTICA, V32, P511, DOI 10.1007/BF00021463; JONES DB, 1979, CROP SCI, V19, P641, DOI 10.2135/cropsci1979.0011183X001900050023x; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155351; Liu Y., 2013, PLOS ONE, V8; Marti J, 2014, FIELD CROP RES, V156, P258, DOI 10.1016/j.fcr.2013.10.008; MIRALLES DJ, 1995, FIELD CROP RES, V43, P55, DOI 10.1016/0378-4290(95)00041-N; Prasad PVV, 2014, FUNCT PLANT BIOL, V41, P1261, DOI 10.1071/FP14061; RAWSON HM, 1972, AUST J AGR RES, V23, P551, DOI 10.1071/AR9720551; RAWSON HM, 1970, AUST J BIOL SCI, V23, P753, DOI 10.1071/BI9700753; Robert N, 1999, AGRONOMIE, V19, P405, DOI 10.1051/agro:19990507; Sadras VO, 2012, FIELD CROP RES, V127, P215, DOI 10.1016/j.fcr.2011.11.014; Semenov MA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00066; Sharma D. L., 2009, CROP PASTURE SCI; Shewry PR, 2012, J CEREAL SCI, V56, P21, DOI 10.1016/j.jcs.2011.11.007; WHINGWIRI EE, 1981, ANN BOT-LONDON, V48, P189, DOI 10.1093/oxfordjournals.aob.a086113; Willenborg CJ, 2009, AGRON J, V101, P1311, DOI 10.2134/agronj2009.0137; Xie Q, 2015, J EXP BOT, V66, P6715, DOI 10.1093/jxb/erv378; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012	34	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209597	10.1371/journal.pone.0209597	http://dx.doi.org/10.1371/journal.pone.0209597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596702	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200061
J	Gul, MR; Griffen, BD				Gul, Mustafa R.; Griffen, Blaine D.			Impacts of human disturbance on ghost crab burrow morphology and distribution on sandy shores	PLOS ONE			English	Article							OFF-ROAD VEHICLES; OCYPODE-QUADRATA FABRICIUS; NATIONAL SEASHORE; RAPID ASSESSMENT; BEACHES; ARCHITECTURE; ORVS; CERATOPHTHALMA; ENVIRONMENTS; CONSERVATION	Ghost crabs have been widely used as a bio-indicator species of human impacts on sandy beaches to obtain reliable biological data for management and conservation purposes. Ghost crab population densities and individual sizes decline dramatically under human pressure. However, distribution within a beach and the factors that determine this distribution of ghost crabs is still an open question. These factors may provide valuable information for understanding human impacts on sandy beaches. Here we examine ghost crab burrows on 20 sandy beaches of South Carolina, USA under various levels of human impacts to understand the response in terms of spatial distribution of this species to human impacts. We also examine the burrow characteristics and environmental properties of the burrows to determine whether these factors alter burrow characteristics. We show that crabs on heavily impacted beaches altered their spatial distribution to mostly occupy the edges of impacted beaches. Further, this change in spatial distribution was influenced by the size distribution of the population on a beach (i.e. larger individuals occupy upper parts on the beaches). We also found that ghost crabs altered the morphology of their burrows on heavily impacted beaches. Ghost crabs create deeper, steeper and smaller burrows under human impacts. These patterns were also influenced by physical characteristics of the beach. Our results suggest that human impacts can directly influence the spatial distribution of ghost crab populations within a beach and therefore sampling at upper parts of the beaches overestimates the population density and individual sizes. Our results support the use of ghost crabs as indicator species in effective beach management, but suggest that assessments would benefit from examining the morphology and distribution of burrows as opposed to simply using burrow counts to assess the health of sandy shores.	[Gul, Mustafa R.] Univ South Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA; [Griffen, Blaine D.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	University of South Carolina System; University of South Carolina Columbia; Brigham Young University	Gul, MR (corresponding author), Univ South Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA.	mremzigul@gmail.com	, 叶叶叶/ABE-1619-2020; Griffen, Blaine/AAC-6384-2021	Gul, Mustafa/0000-0002-2864-273X	Ministry of National Education, Republic of Turkey	Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey)	This work was supported by the Ministry of National Education, Republic of Turkey (awarded to MRG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aheto DW, 2011, MOMONA ETHIOP J SCI, V3, P93, DOI 10.4314/mejs.v3i2.67715; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Barros F, 2001, BIOL CONSERV, V97, P399, DOI 10.1016/S0006-3207(00)00116-6; BLICKHAN R, 1987, J EXP BIOL, V130, P155; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; BURROWS M, 1973, J EXP BIOL, V58, P327; Cardoso RS, 2016, ECOL INDIC, V62, P154, DOI 10.1016/j.ecolind.2015.11.039; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; CHAKRABARTI A, 1981, J PALEONTOL, V55, P431; Chan BKK, 2006, HYDROBIOLOGIA, V560, P43, DOI 10.1007/s10750-005-1088-2; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; de Oliveira CAG, 2016, MAR BIODIVERS, V46, P809, DOI 10.1007/s12526-015-0436-3; de Souza GN, 2017, OCEAN COAST MANAGE, V140, P1, DOI 10.1016/j.ocecoaman.2017.02.007; Defeo O, 2002, MAR BIOL, V140, P1215, DOI 10.1007/s00227-002-0783-z; Defeo O, MAR ECOL PROG SER, V123, P72; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Dixon RW, 2015, PHYS GEOGR, V36, P188, DOI 10.1080/02723646.2015.1033182; Fisher JB, 1979, CRUSTACEANA S, V5, P31; Folk R. L, 1980, PETROLOGY SEDIMENTAR; Gonzalez SA, 2014, MAR POLLUT BULL, V83, P265, DOI 10.1016/j.marpolbul.2014.03.042; Gul MR, 2018, SOUTHEAST NAT, V17, P357, DOI 10.1656/058.017.0217; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hobbs CH, 2008, J COASTAL RES, V24, P1450, DOI 10.2112/07-0856.1; James RJ, 2000, OCEAN COAST MANAGE, V43, P495, DOI 10.1016/S0964-5691(00)00040-5; Jonah FE, 2015, OCEAN COAST MANAGE, V112, P18, DOI 10.1016/j.ocecoaman.2015.05.001; Kana T.W., 1988, BEACH EROSION S CARO; Lucrezi S, 2014, ENVIRON MANAGE, V53, P520, DOI 10.1007/s00267-013-0223-5; Lucrezi S, 2010, ENVIRON MANAGE, V45, P1352, DOI 10.1007/s00267-010-9491-5; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; Lucrezi S, 2009, ENVIRON MONIT ASSESS, V152, P413, DOI 10.1007/s10661-008-0326-2; McLachlan A, 2006, ECOLOGY SANDY SHORES; MILNE LJ, 1946, AM NAT, V80, P362, DOI 10.1086/281450; MuMIn K., 2017, MULTIMODEL INFERENCE; Neves FM, 2006, BIOL CONSERV, V133, P431, DOI 10.1016/j.biocon.2006.04.041; OJIMA DS, 1994, BIOSCIENCE, V44, P300, DOI 10.2307/1312379; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; Pombo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083792; Pombo M, 2017, MAR ECOL PROG SER, V565, P131, DOI 10.3354/meps11991; Rodrigues E, 2016, AFR J MAR SCI, V38, P181, DOI 10.2989/1814232X.2016.1176602; Sakai K, 2016, MEMOIRS QUEENSLAND M, V56, P665; Schlacher TA, 2010, VIE MILIEU, V60, P313; Schlacher TA, 2008, HYDROBIOLOGIA, V610, P345, DOI 10.1007/s10750-008-9426-9; Schlacher TA, 2007, MAR ECOL-EVOL PERSP, V28, P354, DOI 10.1111/j.1439-0485.2007.00156.x; Schlacher TA, 2016, J SEA RES, V112, P55, DOI 10.1016/j.seares.2016.04.001; Schlacher TA, 2016, ESTUAR COAST SHELF S, V169, P56, DOI 10.1016/j.ecss.2015.11.025; Sheppard N, 2009, J EXP MAR BIOL ECOL, V380, P113, DOI 10.1016/j.jembe.2009.09.009; Silva W.T.A.F., 2014, BIORXIV, DOI DOI 10.1101/006098; Silva WTAF, 2013, CENT EUR J BIOL, V8, P843, DOI 10.2478/s11535-013-0208-7; Solomon M, 2003, BIODIVERS CONSERV, V12, P2435, DOI 10.1023/A:1025805731366; STEINER AJ, 1981, BIOL CONSERV, V20, P111, DOI 10.1016/0006-3207(81)90022-7; Suciu MC, 2018, J CRUSTACEAN BIOL, V38, P420, DOI 10.1093/jcbiol/ruy027; Vachhrajani K., 2016, INT J MAR SCI, V6, P1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WOLCOTT TG, 1976, NATURE, V264, P756, DOI 10.1038/264756a0; WOLCOTT TG, 1978, J EXP MAR BIOL ECOL, V31, P67, DOI 10.1016/0022-0981(78)90137-5; WOLCOTT TG, 1984, BIOL CONSERV, V29, P217, DOI 10.1016/0006-3207(84)90100-9	57	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209977	10.1371/journal.pone.0209977	http://dx.doi.org/10.1371/journal.pone.0209977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596743	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200119
J	Newton, AC; Boscolo, D; Ferreira, PA; Lopes, LE; Evans, P				Newton, Adrian C.; Boscolo, Danilo; Ferreira, Patricia A.; Lopes, Luciano E.; Evans, Paul			Impacts of deforestation on plant-pollinator networks assessed using an agent based model	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; ATLANTIC FOREST; HABITAT LOSS; CROP YIELD; LANDSCAPE; SPECIALIZATION; BEHAVIOR; METRICS; BEES; ARCHITECTURE	Plant-pollinator networks have been widely used to understand the ecology of mutualistic interactions between plants and animals. While a number of general patterns have been identified, the mechanisms underlying the structure of plant-pollinator networks are poorly understood. Here we present an agent based model (ABM) that simulates the movement of bees over heterogeneous landscapes and captures pollination events, enabling the influence of landscape pattern on pollination networks to be explored. Using the model, we conducted a series of experiments using virtual landscapes representing a gradient of forest loss and fragmentation. The ABM was able to produce expected trends in network structure, from simulations of interactions between individual plants and pollinators. For example, results indicated an increase in the index of complementary specialization (H-2') and a decline in network connectance with increasing forest cover. Furthermore, network nestedness was not associated with the degree of forest cover, but was positively related to forest patch size, further supporting results obtained in the field. This illustrates the potential value of ABMs for exploring the structure and dynamics of plant-pollinator networks, and for understanding the mechanisms that underlie them. We attribute the results obtained primarily to a shift from specialist to generalist pollinators with increasing forest loss, a trend that has been observed in some field situations.	[Newton, Adrian C.; Evans, Paul] Bournemouth Univ, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England; [Boscolo, Danilo; Ferreira, Patricia A.] Univ Sao Paulo, Fac Philosophy Sci & Literature Ribeirao Preto, Biol Dept, Ribeirao Preto, Brazil; [Boscolo, Danilo; Ferreira, Patricia A.] Univ Sao Paulo, FFCLRP, Sao Paulo, Brazil; [Lopes, Luciano E.] Univ Fed Sao Carlos, Dept Ciencias Ambientais, Ctr Ciencias Biol & Saude, Sao Carlos, SP, Brazil	Bournemouth University; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Newton, AC (corresponding author), Bournemouth Univ, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England.	anewton@bournemouth.ac.uk	Boscolo, Danilo/I-8655-2019; Lopes, Luciano Elsinor/C-5186-2012	Boscolo, Danilo/0000-0002-0741-501X; Lopes, Luciano Elsinor/0000-0001-5869-8972	Newton Fund/Sao Paulo Research Foundation (FAPESP) award [2014/50971-5]; Newton Fund-FAPESP / CONFAP / UK Academies short-term mobility grant [2014/50971-5]	Newton Fund/Sao Paulo Research Foundation (FAPESP) award; Newton Fund-FAPESP / CONFAP / UK Academies short-term mobility grant	This work was supported by the Newton Fund/Sao Paulo Research Foundation (FAPESP) award to DB, http://www.newtonfund.ac.uk/, No 2014/50971-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Newton Fund-FAPESP / CONFAP / UK Academies short-term mobility grant to Danilo Boscolo, Fapesp no 2014/50971-5.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Cambui ECB, 2015, ECOL INFORM, V25, P57, DOI 10.1016/j.ecoinf.2014.12.001; Bartomeus I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069200; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Becher MA, 2016, ECOL MODEL, V340, P126, DOI 10.1016/j.ecolmodel.2016.09.013; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boscolo D, 2017, PERSPECT ECOL CONSER, V15, P18, DOI 10.1016/j.pecon.2017.03.002; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; de Vries H, 1998, BEHAV ECOL SOCIOBIOL, V44, P109, DOI 10.1007/s002650050522; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; Dyer AG, 2014, ECOL MODEL, V277, P119, DOI 10.1016/j.ecolmodel.2014.01.009; Estavillo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082369; Tapia-Armijos MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133701; Ferreira PA, 2018, FOREST FRAGMENTATION; Ferreira PA, 2015, LANDSCAPE ECOL, V30, P2067, DOI 10.1007/s10980-015-0231-3; Ferreira PA, 2013, ECOL INDIC, V31, P35, DOI 10.1016/j.ecolind.2012.07.025; Garibaldi LA, 2016, SCIENCE, V351, P388, DOI 10.1126/science.aac7287; Geslin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063421; Gonzalez A, 2011, AM J BOT, V98, P503, DOI 10.3732/ajb.1000424; Grass I, 2018, NAT ECOL EVOL, V2, P1408, DOI 10.1038/s41559-018-0631-2; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kaiser-Bunbury CN, 2017, NATURE, V542, P223, DOI 10.1038/nature21071; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Mandelik Y, 2012, ECOL APPL, V22, P1535, DOI 10.1890/11-1299.1; McGarigal K., 2012, TECH REP; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Moreira EF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123628; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Potts S. G., 2016, SUMMARY POLICYMAKERS, P36; Qu HC, 2013, SIMUL MODEL PRACT TH, V37, P107, DOI 10.1016/j.simpat.2013.06.003; Railsback S.F., 2011, AGENT BASED INDIVIDU; RCore Team, 2020, R LANG ENV STAT COMP; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rivera-Hutinel A, 2012, ECOLOGY, V93, P1593, DOI 10.1890/11-1803.1; Soares RGS, 2017, ECOL INDIC, V78, P361, DOI 10.1016/j.ecolind.2017.03.037; Spiesman BJ, 2013, ECOLOGY, V94, P2688, DOI 10.1890/13-0977.1; Traveset A, 2018, OIKOS, V127, P45, DOI 10.1111/oik.04154; Vanbergen AJ, 2017, FUNCT ECOL, V31, P1285, DOI 10.1111/1365-2435.12823; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Watts S, 2016, ANN BOT-LONDON, V118, P415, DOI 10.1093/aob/mcw114; Wilensky U., 1999, NETLOGO; Xiao Y, 2016, PLANT ECOL, V217, P857, DOI 10.1007/s11258-016-0608-7	61	7	8	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209406	10.1371/journal.pone.0209406	http://dx.doi.org/10.1371/journal.pone.0209406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596693	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000454627200043
J	Rizvi, ZA; Puri, N; Saxena, RK				Rizvi, Zaigham Abbas; Puri, Niti; Saxena, Rajiv K.			Evidence of CD1d pathway of lipid antigen presentation in mouse primary lung epithelial cells and its up-regulation upon Mycobacterium bovis BCG infection	PLOS ONE			English	Article							MHC CLASS-I; NKT CELLS; T-CELLS; MOLECULES; IDENTIFICATION; TUBERCULOSIS; RECOGNITION; STRATEGIES; INSIGHTS; SYSTEM	Presentation of a prototype lipid antigen alpha-Galactosylceramide (alpha GC) was examined on primary epithelial cells derived from mouse lungs and on bronchoalveolar lavage (BAL) cells that essentially comprise alveolar macrophages. Presence of CD1d molecules coupled to alpha GC was demonstrated on both types of cells pre-treated with alpha GC, suggesting that both cell types are equipped to present lipid antigens. Internalization of Mycobacterium bovis Bacillus Calmette-Guerin (BCG: a prototype pathogen), a pre-requisite to the processing and presentation of protein as well as lipid antigens, was clearly demonstrated in primary lung epithelial (PLE) cells as well as BAL cells. Both PLE and BAL cells expressed CD1d molecule and a significant up-regulation of its expression occurred upon infection of these cells with BCG. Besides CD1d, the expression of other important molecules that participate in lipid antigen presentation pathway (i.e. microsomal triglyceride transfer protein (MTTP), scavenger receptor B1 (SR-B1) and Saposin) was also significantly upregulated in PLE and BAL cells upon BCG infection. In situ up-regulation of CD1d expression on lung epithelial cells was also demonstrated in the lungs of mice exposed intra-tracheally to BCG. Taken together these results suggest that lung epithelial cells may have the ability to present lipid antigens and this pathway seems to get significantly upregulated in response to BCG infection.	[Rizvi, Zaigham Abbas; Puri, Niti] Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India; [Saxena, Rajiv K.] South Asian Univ, Fac Life Sci & Biotechnol, Delhi, India	Jawaharlal Nehru University, New Delhi; South Asian University (SAU)	Puri, N (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India.	purin@mail.jnu.ac.in		Rizvi, Zaigham Abbas/0000-0001-7850-5672	Department of Science and Technology, Government of India [SR/S0/HS/0261/2012]; Department of Science and Technology under Promotion of University Research and Scientific Excellence (DST-PURSE) [SR/PURSE/PHASE 2/11 (C)]; Indian Council of Medical Research, New Delhi	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Science and Technology under Promotion of University Research and Scientific Excellence (DST-PURSE); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was supported by a grant supported by Department of Science and Technology, Government of India, (SR/S0/HS/0261/2012). NP also received funding from an umbrella grant to the School of Life Sciences from the Department of Science and Technology under Promotion of University Research and Scientific Excellence (DST-PURSE No. SR/PURSE/PHASE 2/11 (C)). ZAR received Senior Research Fellowship from Indian Council of Medical Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant supported by Department of Science and Technology, Government of India, (SR/S0/HS/0261/2012). NP also received funding from an umbrella grant to the School of Life Sciences from the Department of Science and Technology under Promotion of University Research and Scientific Excellence (DST-PURSE No. SR/PURSE/PHASE 2/11 (C)). ZAR received Senior Research Fellowship from Indian Council of Medical Research, New Delhi. Analysis of IHC images was carried out by Dr. Ashok Mukopadhya at All India Institute of Medical Sciences (New Delhi).	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Behar SM, 1999, J EXP MED, V189, P1973, DOI 10.1084/jem.189.12.1973; BLUMBERG RS, 1995, IMMUNOL REV, V147, P5, DOI 10.1111/j.1600-065X.1995.tb00085.x; Bricard G, 2007, CELL MOL LIFE SCI, V64, P1824, DOI 10.1007/s00018-007-7007-0; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; Dutronc Y, 2002, TISSUE ANTIGENS, V60, P337, DOI 10.1034/j.1399-0039.2002.600501.x; Ehlers MRW, 1998, TRENDS MICROBIOL, V6, P328, DOI 10.1016/S0966-842X(98)01301-8; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Ghosh S, 2004, EXP MOL MED, V36, P387, DOI 10.1038/emm.2004.51; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Holtzman MJ, 2014, NAT REV IMMUNOL, V14, P686, DOI 10.1038/nri3739; Hong SM, 1999, IMMUNOL REV, V169, P31, DOI 10.1111/j.1600-065X.1999.tb01304.x; Kain L, 2014, IMMUNITY, V41, P543, DOI 10.1016/j.immuni.2014.08.017; Kinjo Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01266; Kumari A, 2016, CELL BIOL RES THERAP, V2016, DOI [10.4172/2324-9293.1000121, DOI 10.4172/2324-9293.1000121]; Kumari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031890; Kumari M, 2011, INFECT IMMUN, V79, P3159, DOI 10.1128/IAI.05406-11; Layre E, 2009, CHEM BIOL, V16, P82, DOI 10.1016/j.chembiol.2008.11.008; Leon L, 2012, P NATL ACAD SCI USA, V109, P4357, DOI 10.1073/pnas.1200764109; Matsuda JL, 2001, CURR OPIN IMMUNOL, V13, P19, DOI 10.1016/S0952-7915(00)00176-X; Messier EM, 2012, EXP LUNG RES, V38, P363, DOI 10.3109/01902148.2012.713077; Moody DB, 2017, CURR OPIN IMMUNOL, V46, P127, DOI 10.1016/j.coi.2017.07.013; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Rampuria P, 2018, IMMUNOLOGY, P55, DOI [10.1016/B978-0-12-809819-6.00005-8, DOI 10.1016/B978-0-12-809819-6.00005-8]; Rizvi ZA, 2015, TOXICOL IN VITRO, V29, P1275, DOI 10.1016/j.tiv.2014.10.022; Saxena RK, 2002, J BIOSCIENCES, V27, P143, DOI 10.1007/BF02703771; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Singh N, 1999, J IMMUNOL, V163, P2373; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Somnay-Wadgaonkar K, 1999, INT IMMUNOL, V11, P383, DOI 10.1093/intimm/11.3.383; Storni T, 2004, J IMMUNOL, V172, P6129, DOI 10.4049/jimmunol.172.10.6129; Sugita M, 2004, CURR OPIN IMMUNOL, V16, P90, DOI 10.1016/j.coi.2003.11.014; Yu KOA, 2007, J IMMUNOL METHODS, V323, P11, DOI 10.1016/j.jim.2007.03.006; Zeissig S, 2017, P NATL ACAD SCI USA, V114, P10449, DOI 10.1073/pnas.1701428114; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703; Zhang LJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01417	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210116	10.1371/journal.pone.0210116	http://dx.doi.org/10.1371/journal.pone.0210116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596774	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200140
J	Saad, MN; Mabrouk, MS; Eldeib, AM; Shaker, OG				Saad, Mohamed N.; Mabrouk, Mai S.; Eldeib, Ayman M.; Shaker, Olfat G.			Comparative study for haplotype block partitioning methods - Evidence from chromosome 6 of the North American Rheumatoid Arthritis Consortium (NARAC) dataset	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; SINGLE-NUCLEOTIDE POLYMORPHISMS; DYNAMIC-PROGRAMMING ALGORITHM; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SUSCEPTIBILITY VARIANTS; GENETIC RISK; DISEASE; LOCI; ALPHA	Haplotype-based methods compete with "one-SNP-at-a-time" approaches on being preferred for association studies. Chromosome 6 contains most of the known genetic biomarkers for rheumatoid arthritis (RA) disease. Therefore, chromosome 6 serves as a benchmark for the haplotype methods testing. The aim of this study is to test the North American Rheumatoid Arthritis Consortium (NARAC) dataset to find out if haplotype block methods or single-locus approaches alone can sufficiently provide the significant single nucleotide polymorphisms (SNPs) associated with RA. In addition, could we be satisfied with only one method of the haplotype block methods for partitioning chromosome 6 of the NARAC dataset? In the NARAC dataset, chromosome 6 comprises 35,574 SNPs for 2,062 individuals (868 cases, 1,194 controls). Individual SNP approach and three haplotype block methods were applied to the NARAC dataset to identify the RA biomarkers. We employed three haplotype partitioning methods which are confidence interval test (CIT), four gamete test (FGT), and solid spine of linkage disequilibrium (SSLD). P-values after stringent Bonferroni correction for multiple testing were measured to assess the strength of association between the genetic variants and RA susceptibility. Moreover, the block size (in base pairs (bp) and number of SNPs included), number of blocks, percentage of uncovered SNPs by the block method, percentage of significant blocks from the total number of blocks, number of significant haplotypes and SNPs were used to compare among the three haplotype block methods. Individual SNP, CIT, FGT, and SSLD methods detected 432, 1,086, 1,099, and 1,322 associated SNPs, respectively. Each method identified significant SNPs that were not detected by any other method (Individual SNP: 12, FGT: 37, CIT: 55, and SSLD: 189 SNPs). 916 SNPs were discovered by all the three haplotype block methods. 367 SNPs were discovered by the haplotype block methods and the individual SNP approach. The P-values of these 367 SNPs were lower than those of the SNPs uniquely detected by only one method. The 367 SNPs detected by all the methods represent promising candidates for RA susceptibility. They should be further investigated for the European population. A hybrid technique including the four methods should be applied to detect the significant SNPs associated with RA for chromosome 6 of the NARAC dataset. Moreover, SSLD method may be preferred for its favored benefits in case of selecting only one method.	[Saad, Mohamed N.] Menia Univ, Fac Engn, Dept Biomed Engn, Al Minya, Egypt; [Mabrouk, Mai S.] Misr Univ Sci & Technol, Fac Engn, Dept Biomed Engn, 6th October City, Egypt; [Eldeib, Ayman M.] Cairo Univ, Fac Engn, Syst & Biomed Engn Dept, Giza, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Med Biochem & Mol Biol Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Saad, MN (corresponding author), Menia Univ, Fac Engn, Dept Biomed Engn, Al Minya, Egypt.	m.n.saad@ieee.org	Shaker, Olfat G/S-2010-2017; Saad, Mohamed Nagy/AAF-7628-2019; O, Shaker/Y-6125-2019; Talaat, Randa/E-7144-2019	Saad, Mohamed Nagy/0000-0001-8229-0280; O, Shaker/0000-0002-3031-3599; Talaat, Randa/0000-0003-0619-1234	National Institutes of Health [N01-AR-2-2263, R01-AR-44422]; National Arthritis Foundation;  [R01 GM031575]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Arthritis Foundation; 	The authors would like to acknowledge the Genetic Analysis Workshop grant (R01 GM031575) for providing the NARAC dataset. This work is based on data that was gathered with the support of grants from the National Institutes of Health (N01-AR-2-2263, R01-AR-44422) and the National Arthritis Foundation.	Achour Y, 2017, J GENET, V96, P911, DOI 10.1007/s12041-017-0855-y; Alekseyenko AV, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-25; Amos CI, 2009, BMC P, V3, P1; Anderson EC, 2003, AM J HUM GENET, V73, P336, DOI 10.1086/377106; Andreasi RB, 2017, ANN RHEUM DIS, V76, P207, DOI 10.1136/annrheumdis-2017-eular.6252; [Anonymous], 2013, ARTHRITIS RHEUMATISM, V65, P1457; Arya Rector, 2009, BMC Proc, V3 Suppl 7, pS84; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bermejo Justo Lorenzo, 2009, BMC Proc, V3 Suppl 7, pS10; Black Mary Helen, 2009, BMC Proc, V3 Suppl 7, pS129; Brorsson CA, 2015, DIABETES; Caliz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072732; Chanda P, 2009, BMC P, V3, pS72; Chattopadhyay AS, 2014, GENE, V533, P304, DOI 10.1016/j.gene.2013.09.041; Chen Lianfu, 2009, BMC Proc, V3 Suppl 7, pS6; Chen W.-P., 2013, BIOMED RESEARCH INTE, V2013; Chiu Yen-Feng, 2009, BMC Proc, V3 Suppl 7, pS85; Cho Seoae, 2009, BMC Proc, V3 Suppl 7, pS25; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Das S, 2018, INT J IMMUNOGENET, V45, P1, DOI 10.1111/iji.12347; Delgado-Vega A, 2010, CURR OPIN IMMUNOL, V22, P698, DOI 10.1016/j.coi.2010.09.002; Deng F.-Y., 2013, J RHEUMATOLOGY; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Fang H, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0384-y; Fattal I, 2014, IMMUNOLOGY, V143, P374, DOI 10.1111/imm.12316; Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gall BJ, 2016, GENES IMMUN, V17, P139, DOI 10.1038/gene.2016.3; Gonzalez-Recio Oscar, 2009, BMC Proc, V3 Suppl 7, pS63; Goris A, 2015, BRAIN, V138, P632, DOI 10.1093/brain/awu405; Govind N, 2014, MOL MED, V20, P341, DOI 10.2119/molmed.2014.00097; Han TU, 2009, ARTHRITIS RHEUM-US, V60, P2577, DOI 10.1002/art.24759; Hinks A, 2018, ARTHRITIS RHEUMATOL, V70, P957, DOI 10.1002/art.40443; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jalil S. F., 2013, THE JOURNAL OF RHEUM; Jeffries Neal, 2009, BMC Proc, V3 Suppl 7, pS56; Jiang Renfang, 2009, BMC Proc, V3 Suppl 7, pS8; Jiang X, 2015, ARTHRITIS RHEUMATOL, V67, P352, DOI 10.1002/art.38927; Ju JH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005537; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Jung Jeesun, 2009, BMC Proc, V3 Suppl 7, pS76, DOI 10.1186/1753-6561-3-S7-S76; Katanforoush A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-269; Kim K, 2013, J INVEST DERMATOL, V133, pS17; Kim Sun Ah, 2016, Genomics & Informatics, V14, P196, DOI 10.5808/GI.2016.14.4.196; Kimmel G, 2005, J COMPUT BIOL, V12, P1243, DOI 10.1089/cmb.2005.12.1243; Kirsten H, 2015, HUM MOL GENET, V24, P4746, DOI 10.1093/hmg/ddv194; Kitajima H, 2012, GENES IMMUN, V13, P543, DOI 10.1038/gene.2012.35; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Koivisto M, 2003, Pac Symp Biocomput, P502; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Lemire Mathieu, 2009, BMC Proc, V3 Suppl 7, pS33; Li H., 2013, CLIN DEV IMMUNOL, V2013, P6; Liu CY, 2011, HUM GENET, V129, P473, DOI 10.1007/s00439-010-0943-z; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Herraez DL, 2013, ARTHRITIS RHEUM-US, V65, P1457, DOI 10.1002/art.37923; Lu Q, 2010, J BIOPHARM STAT, V20, P401, DOI 10.1080/10543400903572811; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Manning Alisa K, 2009, BMC Proc, V3 Suppl 7, pS81; Matzaraki V, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1207-1; Mitsunaga S, 2013, J HUM GENET, V58, P210, DOI 10.1038/jhg.2013.2; Mo XB, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00299; Nagai Y, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat073; Okada Y, 2009, ARTHRITIS RHEUM-US, V60, P3582, DOI 10.1002/art.24939; Orozco G, 2005, HUM IMMUNOL, V66, P1235, DOI 10.1016/j.humimm.2006.02.003; Orozco G, 2014, ARTHRITIS RHEUMATOL, V66, P24, DOI 10.1002/art.38196; Park Jungsun, 2009, BMC Proc, V3 Suppl 7, pS34; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pattaro C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-405; Peise E, 2015, PARALLEL COMPUT, V42, P75, DOI 10.1016/j.parco.2014.09.005; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Prasad P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031584; Pugach I, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r19; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rai E, 2011, SEMIN IMMUNOL, V23, P67, DOI 10.1016/j.smim.2011.01.015; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Rivera NV, 2016, AM J RESP CRIT CARE, V193, P1008, DOI 10.1164/rccm.201507-1372OC; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Saad M. N., 2014, 7 CAIR INT BIOM ENG; Saad MN, 2016, J ADV RES, V7, P1, DOI 10.1016/j.jare.2015.01.008; Saad MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131960; Saad MN, 2015, GENE, V568, P124, DOI 10.1016/j.gene.2015.05.037; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaub MA, 2009, BIOINFORMATICS, V25, pI21, DOI 10.1093/bioinformatics/btp226; Scott I. C., 2015, J RHEUMATOLOGY; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shim Heejung, 2009, BMC Proc, V3 Suppl 7, pS35; Simmons CR, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-33; SNIR O, 2014, ARTHRITIS RES THERAP, V16; Solus JF, 2015, CLIN RHEUMATOL, V34, P1375, DOI 10.1007/s10067-015-2881-6; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steer S, 2007, GENES IMMUN, V8, P57, DOI 10.1038/sj.gene.6364359; stunkar G., 2011, J INTEGRATIVE BIOINF, V8, P204; Su SC, 2005, BIOINFORMATICS, V21, P2001, DOI 10.1093/bioinformatics/bti261; Su SC, 2007, IEEE SIGNAL PROC MAG, V24, P75; Taliun D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-10; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; VIATTE S, 2012, ARTHRITIS RES THER, V14; Vignal C, 2009, ARTHRITIS RHEUM-US, V60, P53, DOI 10.1002/art.24138; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wallace AD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00298; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Wang Minghui, 2009, BMC Proc, V3 Suppl 7, pS69; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Wei W.-H., 2016, J RHEUMATOLOGY; Wei WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05447-1; Wolin A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00422; Wu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109330; Xie G, 2013, ANN RHEUM DIS, V72, P1249, DOI 10.1136/annrheumdis-2012-202076; Yarwood A, 2016, ANN RHEUM DIS, V75, P317, DOI 10.1136/annrheumdis-2014-207210; Yarwood A, 2015, ANN RHEUM DIS, V74, P170, DOI 10.1136/annrheumdis-2013-204133; Zahiri J, 2010, J THEOR BIOL, V267, P164, DOI 10.1016/j.jtbi.2010.08.019; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhang L, 2018, INT J COMPUT VISION, V126, P797, DOI 10.1007/s11263-018-1080-8; Zheng WY, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0715-1	126	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209603	10.1371/journal.pone.0209603	http://dx.doi.org/10.1371/journal.pone.0209603			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596705	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200065
J	Hadl, A; Rastgoo, A; Haghighipour, N; Bolhassani, A; Asgari, F; Soleymani, S				Hadl, Amin; Rastgoo, Abbas; Haghighipour, Nooshin; Bolhassani, Azam; Asgari, Fatemeh; Soleymani, Sepehr			Enhanced gene delivery in tumor cells using chemical carriers and mechanical loadings	PLOS ONE			English	Article							MICROFLUIDIC ELECTROPORATION; STEM-CELLS; MECHANOTRANSDUCTION; EXPRESSION; STRAIN; DIFFERENTIATION; PROLIFERATION; IMMUNOTHERAPY; STIMULATION; MORPHOLOGY	Intracellular delivery of DNA is considered a challenge in biological research and treatment of diseases. The previously reported transfection rate by commercially available transfection reagents in cancer cell lines, such as the mouse lung tumor cell line (TC-1), is very low. The purpose of this study is to introduce and optimize an efficient gene transfection method by mechanical approaches. The combinatory transfection effect of mechanical treatments and conventional chemical carriers is also investigated on a formerly reported hard-to-transfect cell line (TC-1). To study the effect of mechanical loadings on transfection rate, TC-1 tumor cells are subjected to uniaxial cyclic stretch, equiaxial cyclic stretch, and shear stress. The TurboFect transfection reagent is exerted for chemical transfection purposes. The pEGFP-N1 vector encoding the green fluorescent protein (GFP) expression is utilized to determine gene delivery into the cells. The results show a significant DNA delivery rate (by similar to 30%) in mechanically transfected cells compared to the samples that were transfected with chemical carriers. Moreover, the simultaneous treatment of TC-1 tumor cells with chemical carriers and mechanical loadings significantly increases the gene transfection rate up to similar to 63% after 24 h post-transfection. Our results suggest that the simultaneous use of mechanical loading and chemical reagent can be a promising approach in delivering cargoes into cells with low transfection potentials and lead to efficient cancer treatments.	[Hadl, Amin; Rastgoo, Abbas] Univ Tehran, Sch Mech Engn, Tehran, Iran; [Haghighipour, Nooshin; Asgari, Fatemeh] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran; [Bolhassani, Azam; Soleymani, Sepehr] Pasteur Inst Iran, Dept Hepatitis & AIDs, Tehran, Iran	University of Tehran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Haghighipour, N (corresponding author), Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.; Bolhassani, A (corresponding author), Pasteur Inst Iran, Dept Hepatitis & AIDs, Tehran, Iran.	haghighipour@pasteur.ac.ir; A_bolhasani@pasteur.ac.ir	Bolhassani, Azam/HDN-7200-2022; Hadi, Amin/G-2501-2019	Bolhassani, Azam/0000-0001-7363-7406; Hadi, Amin/0000-0003-0668-8398				Adamo A, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/3/035026; Akimov SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12749-x; Akimov SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12127-7; Amin S, 2014, CELL BIOL INT, V38, P219, DOI 10.1002/cbin.10194; Anisi F, 2014, J ARTIF ORGANS, V17, P329, DOI 10.1007/s10047-014-0790-0; Assanah F, 2018, J MATER SCI, V53, P5618, DOI 10.1007/s10853-017-1948-y; Bian ST, 2017, SCI REP-UK, V7, DOI 10.1038/srep42512; Chen J, 2017, STEM CELL TRANSL MED, V6, P982, DOI 10.5966/sctm.2016-0118; Chou Te-hui W., 2004, V245, P147; De Almeida CV, 2017, ONCOL REP, V38, P561, DOI 10.3892/or.2017.5692; Derfus AM, 2004, ADV MATER, V16, P961, DOI 10.1002/adma.200306111; Deshpande RS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40639; Donahue DA, 2017, J VIROLOGY; Dunn SL, 2016, PHYS THER, V96, P712, DOI 10.2522/ptj.20150073; Gao M, 2017, CHEM SOC REV, V46, P2237, DOI 10.1039/c6cs00908e; Geng T, 2013, LAB CHIP, V13, P3803, DOI 10.1039/c3lc50566a; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Hadi A, 2018, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aad369; Haghighipour N, 2010, ARTIF ORGANS, V34, P481, DOI 10.1111/j.1525-1594.2010.01003.x; Harris J, 2005, BBA-GEN SUBJECTS, V1724, P127, DOI 10.1016/j.bbagen.2005.03.013; Hatami J, 2013, EXP MECH, V53, P1291, DOI 10.1007/s11340-013-9744-3; Huang D, 2017, SENSOR ACTUAT B-CHEM, V250, P703, DOI 10.1016/j.snb.2017.04.085; Im DJ, 2017, BIOCHEM ENG J, V122, P133, DOI 10.1016/j.bej.2017.03.010; Ji HX, 1998, INT J CANCER, V78, P41, DOI 10.1002/(SICI)1097-0215(19980925)78:1<41::AID-IJC8>3.0.CO;2-X; Kaestner L, 2015, BIOORG MED CHEM LETT, V25, P1171, DOI 10.1016/j.bmcl.2015.01.018; Kamimura Kenya, 2011, Pharmaceut Med, V25, P293; Kubanek J, 2018, J NEUROSCI, P1458; Kyte JA, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232237; Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17817; Mascharak S, 2017, BIOMATERIALS, V115, P155, DOI 10.1016/j.biomaterials.2016.11.019; Norizadeh-Abbariki T, 2014, J BIOMATER TISS ENG, V4, P579, DOI 10.1166/jbt.2014.1205; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Pan HH, 2017, COLLOID SURFACE B, V152, P344, DOI 10.1016/j.colsurfb.2017.01.039; Paul NE, 2018, J TISSUE ENG REGEN M, V12, P276, DOI 10.1002/term.2411; Price JCFA, 2017, DEV VALIDATION HYDRO; Rashidi N, 2018, BIOMED ENG-BIOMED TE, V63, P317, DOI 10.1515/bmt-2016-0228; Riehl BD, 2012, TISSUE ENG PART B-RE, V18, P288, DOI [10.1089/ten.teb.2011.0465, 10.1089/ten.TEB.2011.0465]; Safshekan F, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500547; Samet M. M., 1999, MECH FORCES ENDOTHEL, P1; Sapir L, 2017, SEMINARS CELL DEV BI; Schroder C, 2016, J MECH MED BIOL, V16, DOI 10.1142/S0219519416500251; Shahbazi S, 2018, BIOTECHNOL LETT, V40, P923, DOI 10.1007/s10529-018-2551-2; Sharei A, 2013, P NATL ACAD SCI USA; Sharei A. R, 2013, CELL SQUEEZING VECTO; Shoajei S, 2014, CELL BIOL INT, V38, P577, DOI 10.1002/cbin.10237; Suswillo RFL, 2017, CELL BIOCHEM FUNCT, V35, P56, DOI 10.1002/cbf.3245; Tabatabaei FS, 2014, MOL CELL BIOMECH, V11, P209; Tian FM, 2018, J ORTHOP RES, V36, P576, DOI 10.1002/jor.23767; Tsau JS, 2018, J IMMUNOL; Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01157; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212; Xu T, 2013, SENSING TECHNOLOGIES, DOI [10.1038/s41598-017-12749-x, DOI 10.1038/S41598-017-12749-X]; Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138; Zhou ZZ, 2018, BIOCHEM BIOPH RES CO, V498, P667, DOI 10.1016/j.bbrc.2018.03.040	55	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209199	10.1371/journal.pone.0209199	http://dx.doi.org/10.1371/journal.pone.0209199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592721	gold, Green Published			2022-12-26	WOS:000454621900016
J	Suikkanen, J; Matinolli, HM; Eriksson, JG; Jarvenpaa, AL; Andersson, S; Kajantie, E; Hovi, P				Suikkanen, Julia; Matinolli, Hanna-Maria; Eriksson, Johan G.; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero; Hovi, Petteri			Early postnatal nutrition after preterm birth and cardiometabolic risk factors in young adulthood	PLOS ONE			English	Article							HUMAN-MILK PROTEIN; BORN PRETERM; INSULIN SENSITIVITY; BODY-COMPOSITION; BLOOD-PRESSURE; FOLLOW-UP; INFANTS; WEIGHT; SUPPLEMENTATION; RESISTANCE	Objectives Adults born preterm at very low birthweight (VLBW; <1500 g) have a non-optimal cardiometabolic risk factor profile. Since higher protein intake during the first weeks of life predicted a healthier body composition in adulthood in our previous studies, we hypothesized that it would also predict a favorable cardiometabolic profile. Study design The Helsinki Study of VLBW Adults includes 166 VLBW and preterm infants born between 1978 and 1985. We collected postnatal nutrition data among 125 unimpaired subjects, who attended two study visits at the mean ages of 22.5 and 25.1 years. We evaluated the effects of energy and macronutrient intakes during the first three 3-week periods of life on key cardiometabolic risk factors with multiple linear regression models. We also report results adjusted for prenatal, postnatal and adult characteristics. Results Macronutrient and energy intakes were not associated with blood pressure, heart rate, or lipid levels in adulthood. Intakes were neither associated with fasting glucose or most other markers of glucose metabolism. An exception was that the first-three-weeks-of-life intakes predicted higher fasting insulin levels: 1 g/kg/day higher protein intake by 37.6% (95% CI: 8.0%, 75.2%), and 10 kcal/kg/day higher energy intake by 8.6% (2.6%, 14.9%), when adjusted for sex and age. These early intakes similarly predicted the adult homeostasis model assessment index. Further adjustments strengthened these findings. Conclusions Among VLBW infants with relatively low early energy intake, early macronutrient and energy intakes were unrelated to blood pressure, lipid levels and intravenous glucose tolerance test results. Contrary to our hypothesis, a higher macronutrient intake during the first three weeks of life predicted higher fasting insulin concentration in young adulthood.	[Suikkanen, Julia; Matinolli, Hanna-Maria; Eriksson, Johan G.; Kajantie, Eero; Hovi, Petteri] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Suikkanen, Julia; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero; Hovi, Petteri] Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland; [Suikkanen, Julia; Eriksson, Johan G.; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero; Hovi, Petteri] Helsinki Univ Hosp, Helsinki, Finland; [Matinolli, Hanna-Maria] Univ Turku, Dept Nursing Sci, Turku, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Kajantie, Eero] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Helsinki; Folkhalsan Research Center; University of Oulu; University of Oulu; Norwegian University of Science & Technology (NTNU)	Suikkanen, J (corresponding author), Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland.; Suikkanen, J (corresponding author), Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Helsinki, Finland.; Suikkanen, J (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	julia.suikkanen@helsinki.fi; eero.kajantie@thl.fi	Matinolli, Hanna-Maria/P-9477-2019	Suikkanen, Julia/0000-0002-6494-7346; Matinolli, Hanna-Maria/0000-0001-8281-6801	Academy of Finland; Biomedicum Helsinki Foundation; Diabetes Research Foundation, Finland; Jenny and Antti Wihuri Foundation; Emil Aaltonen Foundation; Finnish Government Special Subsidiary for Health Sciences; Finnish Foundation for Cardiovascular Research; Finnish Foundation of Pediatric Research; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; University of Helsinki Research Foundation; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); Biomedicum Helsinki Foundation; Diabetes Research Foundation, Finland; Jenny and Antti Wihuri Foundation; Emil Aaltonen Foundation; Finnish Government Special Subsidiary for Health Sciences; Finnish Foundation for Cardiovascular Research; Finnish Foundation of Pediatric Research; Finnish Medical Society Duodecim; Finska Lakaresallskapet; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Foundation; Yrjo Jahnsson Foundation	This study was part of the Helsinki Study of Very Low Birth Weight Adults, which was funded by the Academy of Finland (www.aka.fi), Biomedicum Helsinki Foundation (www.biomedicum.fi), The Diabetes Research Foundation, Finland (www.diabetestutkimus.fi), Jenny and Antti Wihuri Foundation (https://wihurinrahasto.fi), Emil Aaltonen Foundation (https://emilaaltonen.fi/), the Finnish Government Special Subsidiary for Health Sciences (evo), Finnish Foundation for Cardiovascular Research (www.sydantutkimussaatio.fi), Finnish Foundation of Pediatric Research (www.lastentautientutkimussaatio.fi), the Finnish Medical Society Duodecim (www.duodecim.fi), Finska Lakaresallskapet (www.fls.fi), Jalmari and Rauha Ahokas Foundation (www.ahokkaansaatio.org), Juho Vainio Foundation (http://juhovainionsaatio.fi), Novo Nordisk Foundation (http://novonordiskfonden.dk/en), Signe and Ane Gyllenberg Foundation (http://gyllenbergs.fi/), Sigrid Juselius Foundation (http://sigridjuselius.fi), the University of Helsinki Research Foundation (www.helsinki.fi/en/university/university-of-helsinki-research-foundation), and Yrjo Jahnsson Foundation (www.yjs.fi).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Amesz EM, 2010, J PEDIATR GASTR NUTR, V50, P200, DOI 10.1097/MPG.0b013e3181a8150d; ANDERSON DM, 1983, AM J CLIN NUTR, V37, P810, DOI 10.1093/ajcn/37.5.810; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2016, HYPERTENSION, V68, P880, DOI 10.1161/HYPERTENSIONAHA.116.08167; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Kajantie E, 2015, J CLIN ENDOCR METAB, V100, P244, DOI 10.1210/jc.2014-3184; Lapillonne A, 2013, J PEDIATR-US, V162, pS7, DOI 10.1016/j.jpeds.2012.11.048; LUCAS A, 1994, BRIT MED J, V309, P304, DOI 10.1136/bmj.309.6950.304; Ludwig-Auser Heidi, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P161; Matinolli HM, 2015, J NUTR, V145, P2084, DOI 10.3945/jn.115.212415; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Pihkala J, 1989, Duodecim, V105, P1540; Pilgaard K, 2010, DIABETOLOGIA, V53, P2526, DOI 10.1007/s00125-010-1917-3; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Regan FM, 2006, PEDIATRICS, V118, P1943, DOI 10.1542/peds.2006-0733; Roggero P, 2008, J PEDIATR GASTR NUTR, V47, P375, DOI 10.1097/MPG.0b013e3181615cba; RONNHOLM KAR, 1984, PEDIATRICS, V74, P792; RONNHOLM KAR, 1982, J PEDIATR-US, V101, P243, DOI 10.1016/S0022-3476(82)80133-9; Saarenpaa HK, 2015, PEDIATRICS, V136, P642, DOI 10.1542/peds.2014-2651; Sammallahti S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185632; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Singhal A, 2004, LANCET, V363, P1571, DOI 10.1016/S0140-6736(04)16198-9; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Weber M, 2014, AM J CLIN NUTR, V99, P1041, DOI 10.3945/ajcn.113.064071	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209404	10.1371/journal.pone.0209404	http://dx.doi.org/10.1371/journal.pone.0209404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592733	Green Published, Green Submitted, gold			2022-12-26	WOS:000454621900024
J	Simoes, RV; Cabanas, ME; Loreiro, C; Illa, M; Crispi, F; Gratacos, E				Simoes, Rui V.; Cabanas, Miquel E.; Loreiro, Carla; Illa, Miriam; Crispi, Fatima; Gratacos, Eduard			Assessment of prenatal cerebral and cardiac metabolic changes in a rabbit model of fetal growth restriction based on C-13-labelled substrate infusions and ex vivo multinuclear HRMAS	PLOS ONE			English	Article							STRUCTURAL BRAIN NETWORKS; MRS ISOTOPOMER ANALYSIS; GLUTAMINE; GLYCEROPHOSPHOCHOLINE; COMPARTMENTATION; SPECTROSCOPY; PRESSURE; ACETATE; MUSCLE; FLUX	Background We have used a previously reported rabbit model of fetal growth restriction (FGR), reproducing perinatal neurodevelopmental and cardiovascular impairments, to investigate the main relative changes in cerebral and cardiac metabolism of term FGR fetuses during nutrient infusion. Methods FGR was induced in 9 pregnant New Zealand rabbits at 25 days of gestation: one horn used as FGR, by partial ligation of uteroplacental vessels, and the contralateral as control (appropriate for gestation age, AGA). At 30 days of gestation, fasted mothers under anesthesia were infused i.v. with 1-C-13-glucose (4 mothers), 2-C-13-acetate (3 mothers), or not infused (2 mothers). Fetal brain and heart samples were quickly harvested and frozen down. Brain cortex and heart apex regions from 30 fetuses were studied ex vivo by HRMAS at 4 degrees C, acquiring multinuclear 1D and 2D spectra. The data were processed, quantified by peak deconvolution or integration, and normalized to sample weight. Results Most of the total C-13-labeling reaching the fetal brains/hearts (80-90%) was incorporated to alanine and lactate (cytosol), and to the glutamine-glutamate pool (mitochondria). Acetate-derived lactate (Lac C2C3) had a slower turnover in FGR brains (similar to-20%). In FGR hearts, mitochondrial turnover of acetate-derived glutamine (Gln C4) was slower (-23%) and there was a stronger accumulation of phospholipid breakdown products (glycerophosphoethanolamine and glycerophosphocholine, +50%), resembling the profile of non-infused control hearts. Conclusions Our results indicate specific functional changes in cerebral and cardiac metabolism of FGR fetuses under nutrient infusion, suggesting glial impairment and restricted mitochondrial metabolism concomitant with slower cell membrane turnover in cardiomyocytes, respectively. These prenatal metabolic changes underlie neurodevelopmental and cardiovascular problems observed in this FGR model and in clinical patients, paving the way for future studies aimed at evaluating metabolic function postnatally and in response to stress and/or treatment.	[Simoes, Rui V.; Loreiro, Carla; Illa, Miriam; Crispi, Fatima; Gratacos, Eduard] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Fetal I D Fetal Med Res Ctr,ICGON,IDIBAPS,Hosp Cl, Barcelona, Spain; [Simoes, Rui V.; Loreiro, Carla; Illa, Miriam; Crispi, Fatima; Gratacos, Eduard] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, IDIBAPS, Hosp St Joan Deu,ICGON, Barcelona, Spain; [Cabanas, Miquel E.] UAB, Serv Resonancia Magnet Nucl, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona	Simoes, RV (corresponding author), Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Fetal I D Fetal Med Res Ctr,ICGON,IDIBAPS,Hosp Cl, Barcelona, Spain.; Simoes, RV (corresponding author), Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, IDIBAPS, Hosp St Joan Deu,ICGON, Barcelona, Spain.	portasferre@clinic.ub.es	Gratacos, Eduard/AAR-4939-2020; Egaña, Miquel Cabañas/A-1430-2011; Simoes, Rui Vasco/AAB-3303-2020	Gratacos, Eduard/0000-0002-7405-7224; Egaña, Miquel Cabañas/0000-0003-0104-0197; Simoes, Rui Vasco/0000-0001-7574-4723; Illa, Miriam/0000-0002-8366-830X	La Caixa Foundation; AGAUR [928]; Instituto de Salud Carlos III [PI14/00226, PI15/00130, INT16/00168]; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER) "Otra manera de hacer Europa", Spain	La Caixa Foundation(La Caixa Foundation); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER) "Otra manera de hacer Europa", Spain	This work was partially supported by grants from La Caixa Foundation (https://www.fundacionbancarialacaixa.org/), AGAUR (http://agaur.gencat.cat, 2014 SGR grant no 928) and Instituto de Salud Carlos III (http://www.isciii.es/, PI14/00226, PI15/00130 and INT16/00168) integrated in Plan Nacional de I+D+I and co-funded by ISCIII-Subdireccion General de Evaluacion and Fondo Europeo de Desarrollo Regional (FEDER) "Otra manera de hacer Europa", Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Batalle D, 2014, NEUROIMAGE, V100, P24, DOI 10.1016/j.neuroimage.2014.05.065; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; BLUSZTAJN JK, 1990, BRAIN RES, V536, P240, DOI 10.1016/0006-8993(90)90030-F; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; Cohen DM, 2003, AM J PHYSIOL-ENDOC M, V285, pE1312, DOI 10.1152/ajpendo.00539.2002; Crispi F, 2014, CIRC-CARDIOVASC IMAG, V7, P781, DOI 10.1161/CIRCIMAGING.113.001490; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.0.CO;2-E; Cruz-Lemini M, 2012, FETAL DIAGN THER, V32, P116, DOI 10.1159/000333001; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Egana-Ugrinovic G, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.008; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Fujimiya T, 1999, ALCOHOL CLIN EXP RES, V23, P1452, DOI 10.1111/j.1530-0277.1999.tb04666.x; Gonzalez-Tendero A, 2013, AM J PHYSIOL-HEART C, V305, pH1752, DOI 10.1152/ajpheart.00514.2013; Haber S, 2001, BRAIN RES, V896, P102, DOI 10.1016/S0006-8993(01)02065-0; He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429; Hirrlinger J, 2014, GLIA, V62, P1749, DOI 10.1002/glia.22737; Holloway CJ, 2011, PROG CARDIOVASC DIS, V54, P320, DOI 10.1016/j.pcad.2011.08.002; Iruretagoyena JI, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.023; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; KALKHOFF RK, 1982, AM J OBSTET GYNECOL, V142, P735; KAY HH, 1993, AM J OBSTET GYNECOL, V168, P246, DOI 10.1016/S0002-9378(12)90921-7; KRIVOKAPICH J, 1984, AM J PHYSIOL, V246, pH267, DOI 10.1152/ajpheart.1984.246.2.H267; LAPIDOT A, 1994, J BIOL CHEM, V269, P27198; Lapidot A, 2000, DEV NEUROSCI-BASEL, V22, P444, DOI 10.1159/000017474; Lauzier B, 2013, J MOL CELL CARDIOL, V55, P92, DOI 10.1016/j.yjmcc.2012.11.008; LEWANDOWSKI ED, 1992, CIRC RES, V70, P576, DOI 10.1161/01.RES.70.3.576; Milkevitch M, 2005, BBA-MOL CELL BIOL L, V1734, P1, DOI 10.1016/j.bbalip.2005.01.008; Nielsen TT, 2011, CARDIOVASC RES, V91, P382, DOI 10.1093/cvr/cvr051; NOYSZEWSKI EA, 1989, AM J OBSTET GYNECOL, V161, P282, DOI 10.1016/0002-9378(89)90499-7; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Rodriguez-Lopez M, 2017, ULTRASOUND OBST GYN, V50, P207, DOI 10.1002/uog.17365; Roth AD, 2016, ADV EXP MED BIOL, V949, P167, DOI 10.1007/978-3-319-40764-7_8; Sanz-Cortes M, 2015, FETAL DIAGN THER, V37, P108, DOI 10.1159/000365102; Schipke J, 2017, HISTOCHEM CELL BIOL, V148, P557, DOI 10.1007/s00418-017-1587-z; Simoes RV, 2010, NMR BIOMED, V23, P23, DOI 10.1002/nbm.1421; Simoes RV, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.089; Simoes RV, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.011; Simoes RV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131310; Somm E, 2014, PEDIATR RES, V75, P51, DOI 10.1038/pr.2013.199; Story L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.032; Szczepaniak L, 1996, MAGN RESON MED, V36, P451, DOI 10.1002/mrm.1910360318; Torre I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113067; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Vollenweider FX, 1997, EUR NEUROPSYCHOPHARM, V7, P25, DOI 10.1016/S0924-977X(96)00042-9; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; WALSH SL, 1994, NEUROPSYCHOPHARMACOL, V10, P157, DOI 10.1038/npp.1994.18; WEISS RG, 1992, CIRC RES, V70, P392, DOI 10.1161/01.RES.70.2.392; Zwingmann C, 2003, NMR BIOMED, V16, P370, DOI 10.1002/nbm.850	56	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208784	10.1371/journal.pone.0208784	http://dx.doi.org/10.1371/journal.pone.0208784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589837	Green Published, Green Submitted, gold			2022-12-26	WOS:000454418200009
J	Admassu-Yimer, B; Bonman, JM; Klos, KE				Admassu-Yimer, Belayneh; Bonman, J. Michael; Klos, Kathy Esvelt			Mapping of crown rust resistance gene Pc53 in oat (Avena sativa)	PLOS ONE			English	Article							F-SP AVENAE; VIRULENCE ASSOCIATIONS; PUCCINIA; RECOMBINATION; POPULATIONS; MARKERS; REGION	Crown rust disease caused by the fungus Puccinia coronata f. sp. avenae (Pca) is a major production constraint of oat in North America, Europe, and Australia. There are over 100 genes effective against one or more Pca races, but only a handful of seedling resistance (Pc) genes have been mapped to a known chromosomal location. The goal of the present study was to use linkage mapping to identify the genomic location of the Pc53 gene, and to produce a list of linked SNPs with potential as molecular markers for marker assisted breeding. The Pc53 gene was placed on the linkage group Mrg08 at 82.4 cM using F5-derived recombinant inbred lines (RILs) from a cross between the Pc53 carrier 6-112-1-15 (PI 311624) and the susceptible cultivar Otana. The map location was validated using RILs from a cross between 6-112-1-15 and the Pc50 differential line. Single nucleotide polymorphism marker GMI_ES02_c14533_567 was the closest to Pc53. A major seedling resistance gene 'PcKM' and QTL QcC.Core.08.1, QCr.Core.08.2, QCr.Core.08.3 and QCr.cdl9-12D were previously reported on Mrg08. QPc.Core.08.1 and PcKM were mapped to within 1 cM of Pc53; but previous virulence studies have indicated separate identities. The chromosomal location of Pc53 and SNPs linked with it will facilitate the utilization of Pc53 in oat breeding programs.	[Admassu-Yimer, Belayneh] ARS, Oak Ridge Inst Sci & Educ ORISE Res Participant, Small Grains & Potato Germplasm Res Unit, USDA, Aberdeen, ID 83210 USA; [Bonman, J. Michael; Klos, Kathy Esvelt] ARS, Small Grains & Potato Germplasm Res Unit, USDA, Aberdeen, ID USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Admassu-Yimer, B (corresponding author), ARS, Oak Ridge Inst Sci & Educ ORISE Res Participant, Small Grains & Potato Germplasm Res Unit, USDA, Aberdeen, ID 83210 USA.	belayneh.yimer@ars.usda.gov		Yimer, Belayneh Admassu/0000-0003-2797-3550	North American Millers' Association [58-2050-5-010]; ORAU under DOE [DE-SC0014664]	North American Millers' Association; ORAU under DOE	This research was supported in part by North American Millers' Association 58-2050-5-010 to KEK, and by an appointment of the first author to the Agricultural Research Service (ARS) Research Participation Program administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). ORISE is managed by ORAU under DOE contract number DE-SC0014664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu-Yimer B, 2018, PLANT DIS, V102, P2180, DOI 10.1094/PDIS-04-18-0566-RE; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; Babiker EM, 2015, PHYTOPATHOLOGY, V105, P239, DOI 10.1094/PHYTO-04-14-0114-R; Bush AL, 1998, MOL BREEDING, V4, P13, DOI 10.1023/A:1009652222382; Cabral AL, 2014, EUPHYTICA, V196, P385, DOI 10.1007/s10681-013-1041-9; Carson ML, 2008, PLANT DIS, V92, P379, DOI 10.1094/PDIS-92-3-0379; Carson ML, 2011, PLANT DIS, V95, P1528, DOI 10.1094/PDIS-09-10-0639; Chaffin AS, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.10.0102; Chen G, 2006, CAN J PLANT PATHOL, V28, P214, DOI 10.1080/07060660609507289; Chong J, 1996, CAN J PLANT PATHOL, V18, P286, DOI 10.1080/07060669609500626; Chong J, 2000, PLANT DIS, V84, P580, DOI 10.1094/PDIS.2000.84.5.580; Chong J, 2004, CAN J PLANT PATHOL, V26, P89; CHONG J, 1993, CAN J BOT, V71, P248, DOI 10.1139/b93-026; Gnanesh BN, 2015, THEOR APPL GENET, V128, P247, DOI 10.1007/s00122-014-2425-5; GREGORY JW, 1994, GENOME, V37, P92, DOI 10.1139/g94-011; Hoffman DL, 2006, CROP SCI, V46, P2630, DOI 10.2135/cropsci2006.01.0014; Klos KE, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.10.0107; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Leonard KJ, 2007, PLANT PATHOL, V56, P35, DOI 10.1111/j.1365-3059.2006.01490.x; Leonard KJ, 2005, PHYTOPATHOLOGY, V95, P53, DOI 10.1094/PHYTO-95-0053; MARTENS JW, 1980, CAN J GENET CYTOL, V22, P641, DOI 10.1139/g80-070; May WE, 2014, CAN J PLANT SCI, V94, P911, DOI [10.4141/CJPS2013-333, 10.4141/cjps2013-333]; McCallum BD, 2007, AUST J AGR RES, V58, P639, DOI 10.1071/AR06145; McCartney CA, 2011, THEOR APPL GENET, V122, P317, DOI 10.1007/s00122-010-1448-9; Oliver RE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058068, 10.1371/journal.pone.0062488]; Sebasta J, 2003, ARCH PHYTOPATHOL PLA, V36, P179; Simons MD, 1978, US DEP AGR HDB, V509; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Wight CP, 2004, MOL BREEDING, V14, P349, DOI 10.1007/s11032-004-0148-z; Wise RP, 1996, PHYTOPATHOLOGY, V86, P340, DOI 10.1094/Phyto-86-340	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209105	10.1371/journal.pone.0209105	http://dx.doi.org/10.1371/journal.pone.0209105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586454	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400052
J	Afandi, A; Murayama, E; Yin-Ling; Hieno, A; Suga, H; Kageyama, K				Afandi, Auliana; Murayama, Emi; Yin-Ling; Hieno, Ayaka; Suga, Haruhisa; Kageyama, Koji			Population structures of the water-borne plant pathogen Phytopythium helicoides reveal its possible origins and transmission modes in Japan	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; PYTHIUM-HELICOIDES; PHYTOPHTHORA-SOJAE; GENETIC DIVERSITY; ROOT-ROT; INFERENCE; SOFTWARE; LINKAGE; IDENTIFICATION; PROGRAM	The purpose of this study was to clarify the genetic diversity of Phytopythium helicoides and to understand the transmission mode of the pathogen in Japan. In total, 232 P. helicoides isolates were collected from various host plants and geographic origins, including farms and natural environments. We developed 6 novel microsatellite markers for use in the study and found 90 alleles among the 6 markers in the 232 isolates. The analysis of molecular variance suggested that P. helicoides has high variance within individuals and low fixation indices between populations. A phylogenetic analysis revealed that isolates collected from the same hosts and/or geographic origins were often grouped together. For example, several isolates from natural environments were grouped with isolates from nearby agricultural areas. On the other hand, 2 geographically distant populations collected from the same host plant had similar genotypes. Our results suggested that migration of the pathogen could be facilitated naturally via drainage systems or by human activity in the transport of agricultural materials.	[Afandi, Auliana] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Afandi, Auliana] Univ Gadjah Mada, Biotechnol Study Program, Grad Sch, Yogyakarta, Indonesia; [Murayama, Emi; Hieno, Ayaka; Kageyama, Koji] Gifu Univ, River Basin Res Ctr, Gifu, Japan; [Yin-Ling] Inner Mongolia Univ Nationalities, Tongliao, Peoples R China; [Suga, Haruhisa] Gifu Univ, Life Sci Res Ctr, Gifu, Japan	Gifu University; Gadjah Mada University; Gifu University; Inner Mongolia University for Nationalities; Gifu University	Afandi, A (corresponding author), Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan.; Afandi, A (corresponding author), Univ Gadjah Mada, Biotechnol Study Program, Grad Sch, Yogyakarta, Indonesia.	aulia@green.gifu-u.ac.jp	Hieno, Ayaka/W-7562-2018	Hieno, Ayaka/0000-0001-5019-2336; Afandi, Auliana/0000-0002-8995-2627				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Bala K, 2010, PERSOONIA, V24, P127, DOI DOI 10.3767/003158510X512748; Barres B, 2012, HEREDITY, V109, P269, DOI 10.1038/hdy.2012.37; Biasi A, 2016, PHYTOPATHOLOGY, V106, P1006, DOI 10.1094/PHYTO-11-15-0299-R; BRASIER CM, 1992, ANNU REV PHYTOPATHOL, V30, P153, DOI 10.1146/annurev.py.30.090192.001101; Chellemi DO, 2000, PLANT DIS, V84, P1271, DOI 10.1094/PDIS.2000.84.12.1271; Chen XR, 2016, EUR J PLANT PATHOL, V146, P715, DOI 10.1007/s10658-016-0952-4; Coats K, 2016, MICROSATELLITE ANAL, V1, P98371; de Cock AWAM, 2015, PERSOONIA, V34, P25, DOI 10.3767/003158515X685382; Dhingra O.D., 1985, BASIC PLANT PATHOLOG; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Engelbrecht J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17799-9; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Francis DM, 1997, PHYTOPATHOLOGY, V87, P454, DOI 10.1094/PHYTO.1997.87.4.454; Gagnon M-C, 2016, POPULATION BIOL DEV, DOI [10.1094/PHYTO-12-15-0317-R, DOI 10.1094/PHYTO-12-15-0317-R]; Grunwald NJ, POPULATION BIOL HIER, DOI [10.1094/PHYTO-96-1134, DOI 10.1094/PHYTO-96-1134]; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Han KS, 2010, PLANT PATHOLOGY J, V26, P429, DOI 10.5423/PPJ.2010.26.4.429; Harvey PR, 2000, PLANT PATHOL, V49, P619, DOI 10.1046/j.1365-3059.2000.00493.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ishiguro Y, 2014, J GEN PLANT PATHOL, V80, P423, DOI 10.1007/s10327-014-0520-8; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kageyama K, 2003, J PHYTOPATHOL, V151, P485, DOI 10.1046/j.1439-0434.2003.00757.x; Kageyama K, 2007, MYCOL RES, V111, P416, DOI 10.1016/j.mycres.2007.01.019; Kageyama Koji, 2002, Journal of General Plant Pathology, V68, P15, DOI 10.1007/PL00013047; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Li Y, 2013, PLANT PATHOL, V62, P932, DOI 10.1111/j.1365-3059.2012.02687.x; Naegele RP, 2016, POPULATION BIOL REGI, DOI [10.1094/PHYTO-02-15-0043-R, DOI 10.1094/PHYTO-02-15-0043-R]; Paradis E, 2004, ANAL PHYLOGENETICS E, DOI [10.1093/bioinformatics/btg412, DOI 10.1093/BIOINFORMATICS/BTG412]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schoebel CN, 2013, DEV NEW POLYMORPHIC, DOI [10.1094/PHYTO-01-13-0026-R, DOI 10.1094/PHYTO-01-13-0026-R]; Schoebel CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085368; Stewart S, 2011, BIOTECHNOL LETT, V33, P2217, DOI 10.1007/s10529-011-0682-9; Stroud JA, 2016, PLANT PATHOL, V65, P334, DOI 10.1111/ppa.12407; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Velez ML, 2014, PLANT PATHOL, V63, P212, DOI 10.1111/ppa.12067; Wang KX, 2015, PLANT DIS, V99, P725, DOI 10.1094/PDIS-08-14-0817-PDN; Watanabe Hideki, 2007, Journal of General Plant Pathology, V73, P81, DOI 10.1007/s10327-006-0338-0; WHISSON SC, 1994, CURR GENET, V27, P77, DOI 10.1007/BF00326582; Yin-Ling, 2009, FEMS MICROBIOL LETT, V293, P85, DOI 10.1111/j.1574-6968.2009.01518.x	48	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209667	10.1371/journal.pone.0209667	http://dx.doi.org/10.1371/journal.pone.0209667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586460	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400082
J	Onodera, H; Shingu, S; Ohnuma, M; Horie, T; Kihira, M; Kusano, H; Teramura, H; Shimada, H				Onodera, Hitomi; Shingu, Saeko; Ohnuma, Mariko; Horie, Takaaki; Kihira, Miho; Kusano, Hiroaki; Teramura, Hiroshi; Shimada, Hiroaki			Establishment of a conditional TALEN system using the translational enhancer dMac3 and an inducible promoter activated by glucocorticoid treatment to increase the frequency of targeted mutagenesis in plants	PLOS ONE			English	Article							GENOME; GENE; NUCLEASES; SITES; TOOLS	Transcription activator-like effector nuclease (TALEN) is an artificial nuclease that causes DNA cleavage at the target site and induces few off-target reactions because of its high sequence specificity. Powerful and variable tools using TALENs can be used in practical applications and may facilitate the molecular breeding of many plant species. We have developed a convenient construction system for a plant TALEN vector named the Emerald Gateway TALEN system. In this study, we added new properties to this system, which led to an increase in the efficiency of targeted mutagenesis. Rice dMac3 is a translational enhancer that highly increases the efficiency of translation of the downstream ORF. We inserted dMac3 into the 5' untranslated region of the TALEN gene. In the cultured rice cells to which the TALEN gene was introduced, the frequency of targeted mutagenesis was highly increased compared with those altered using the conventional system. Next, the promoter for the TALEN gene was replaced with iPromoter, and its expression was stringently controlled by a GVG transcription factor that was activated in the presence of glucocorticoid. This conditional expression system worked effectively and led to a higher frequency of targeted mutagenesis than that by the constitutive expression system, while no mutagenesis was detected without glucocorticoid treatment. These results suggest that our system can be applied to genome editing to create the desired mutation.	[Onodera, Hitomi; Shingu, Saeko; Ohnuma, Mariko; Horie, Takaaki; Kihira, Miho; Kusano, Hiroaki; Teramura, Hiroshi; Shimada, Hiroaki] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo, Japan; [Kihira, Miho] Nara Inst Sci & Technol, Div Biol Sci, Takayama, Ikoma, Japan; [Kusano, Hiroaki] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Uji, Kyoto, Japan	Tokyo University of Science; Nara Institute of Science & Technology; Kyoto University	Shimada, H (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo, Japan.	shimadah@rs.noda.tus.ac.jp		Shimada, Hiroaki/0000-0001-9304-3293	Cross-Ministerial Strategic Innovation Promotion Program (SIP)	Cross-Ministerial Strategic Innovation Promotion Program (SIP)	This work was partly supported by a grant from the Cross-Ministerial Strategic Innovation Promotion Program (SIP) to HS and by a grant within the scope of Bayer Crop Science's initiative "Grants4Traits-Novel solutions to increase crop productivity" to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aoki H, 2014, PLANT BIOTECHNOL-NAR, V31, P221, DOI 10.5511/plantbiotechnology.14.0512a; Aouida M, 2014, CURR GENET, V60, P61, DOI 10.1007/s00294-013-0412-z; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; CHU CC, 1975, SCI SINICA, V18, P659; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Gaj T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023754; Guha TK, 2017, COMPUT STRUCT BIOTEC, V15, P146, DOI 10.1016/j.csbj.2016.12.006; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kusano H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32049-2; Kusano H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30234; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lee J, 2016, PLANT BIOTECHNOL J, V14, P448, DOI 10.1111/pbi.12465; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Osakabe Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26685; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Puchta H, 2013, INT J DEV BIOL, V57, P629, DOI 10.1387/ijdb.130194hp; Schmitz J, 1996, NUCLEIC ACIDS RES, V24, P257, DOI 10.1093/nar/24.2.257; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	26	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208959	10.1371/journal.pone.0208959	http://dx.doi.org/10.1371/journal.pone.0208959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586438	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400047
J	Zhao, L; Lin, XM; Li, F; Li, KR; He, B; Zhang, LY; Pan, JJ; Wang, QR; Gao, JM; Johnson, N; Yuan, XF; Lv, JZ; Wu, SQ; Liu, YH				Zhao, Li; Lin, Xiang-Mei; Li, Fei; Li, Kai-Rui; He, Bo; Zhang, Lu-Yao; Pan, Jiao-Jiao; Wang, Qiang-Rong; Gao, Jia-Min; Johnson, Nicholas; Yuan, Xiang-Fen; Lv, Ji-Zhou; Wu, Shao-Qiang; Liu, Yong-Hong			A survey of argasid ticks and tick-associated pathogens in the Peripheral Oases around Tarim Basin and the first record of Argas japonicus in Xinjiang, China	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; RICKETTSIA; IDENTIFICATION; SPP.; GENE	Argasid ticks (Acari: Argasidae) carry and transmit a variety of pathogens of animals and humans, including viruses, bacteria and parasites. There are several studies reporting ixodid ticks (Acari: Ixodidae) and associated tick-borne pathogens in Xinjiang, China. However, little is known about the argasid ticks and argasid tick-associated pathogens in this area. In this study, a total of 3829 adult argasid ticks infesting livestock were collected at 12 sampling sites of 10 counties in the Peripheral Oases, which carry 90% of the livestock and humans population, around the Tarim Basin (southern Xinjiang) from 2013 to 2016. Tick specimens were identified to two species from different genera by morphology and sequences of mitochondrial 16S rRNA and 12S rRNA were derived to confirm the species designation. The results showed that the dominant argasid ticks infesting livestock in southern Xinjiang were Ornithodoros lahorensis (87.86%, 3364/3829). Ornithodoros lahorensis was distributed widely and were collected from 10 counties of southern Xinjiang. Argas japonicus was collected from Xinjiang for the first time. In addition, we screened these ticks for tick-associated pathogens and showed the presence of DNA sequences of Rickettsia spp. of Spotted fever group and Anaplasma spp. in the argasid ticks. This finding suggests the potential role for Argas japonicus as a vector of pathogens to livestock and humans.	[Zhao, Li; Li, Fei; Li, Kai-Rui; He, Bo; Zhang, Lu-Yao; Pan, Jiao-Jiao; Wang, Qiang-Rong; Gao, Jia-Min; Liu, Yong-Hong] Tarim Univ, Coll Anim Sci, Alar, Peoples R China; [Zhao, Li; Li, Fei; Li, Kai-Rui; He, Bo; Zhang, Lu-Yao; Pan, Jiao-Jiao; Wang, Qiang-Rong; Gao, Jia-Min; Liu, Yong-Hong] Key Lab Tarim Anim Husb Sci & Technol Xinjiang Pr, Alar, Peoples R China; [Lin, Xiang-Mei; Yuan, Xiang-Fen; Lv, Ji-Zhou; Wu, Shao-Qiang] Chinese Acad Inspect & Quarantine, Inst Anim Quarantine, Beijing, Peoples R China; [Li, Fei] Anim Loimia Controlling & Diagnost Ctr Aksu Reg, Aksu, Peoples R China; [Johnson, Nicholas] Anim & Plant Hlth Agcy, Woodham Lane, Surrey, England	Tarim University; Chinese Academy of Inspection & Quarantine; Animal & Plant Health Agency UK	Liu, YH (corresponding author), Tarim Univ, Coll Anim Sci, Alar, Peoples R China.; Liu, YH (corresponding author), Key Lab Tarim Anim Husb Sci & Technol Xinjiang Pr, Alar, Peoples R China.; Lv, JZ; Wu, SQ (corresponding author), Chinese Acad Inspect & Quarantine, Inst Anim Quarantine, Beijing, Peoples R China.	lvjz@caiq.gov.cn; sqwu@sina.com; lyhdky@126.com	刘, 永宏/AGU-9569-2022		National Natural Science Foundation of China [31460655, 31860698]; National key research and development program of China [2016YFD0501100]; open project of Key Laboratory of Tarim Animal Husbandry Science and Technology, Xinjiang Production AMP; Construction Corps [HS201501, HS201801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key research and development program of China; open project of Key Laboratory of Tarim Animal Husbandry Science and Technology, Xinjiang Production AMP; Construction Corps	This study was funded by National Natural Science Foundation of China (No. 31460655 to LZ and No. 31860698 to Y.H.L.), and the National key research and development program of China (No. 2016YFD0501100 to SOW), and the open project of Key Laboratory of Tarim Animal Husbandry Science and Technology, Xinjiang Production & Construction Corps (HS201501 to YHL, HS201801 to LJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1673-4; Anstead CA, 2013, APPL ENVIRON MICROB, V79, P7583, DOI 10.1128/AEM.02286-13; Burland T G, 2000, Methods Mol Biol, V132, P71; Chen M, 1998, ACTA VIROL, V42, P61; Chen YN, 2006, HYDROL PROCESS, V20, P2207, DOI 10.1002/hyp.6200; Chen Z, 2010, EXP APPL ACAROL, V51, P393, DOI 10.1007/s10493-010-9335-2; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; de Marco MDF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2178-5; Deng G.-F., 1978, EC INSECT FAUNA CHIN; Deng GF, 1991, EC INSECT FAUNA CHIN, V39; Dietrich M, 2011, VECTOR-BORNE ZOONOT, V11, P453, DOI 10.1089/vbz.2010.0009; FAN MY, 1987, J CLIN MICROBIOL, V25, P628, DOI 10.1128/JCM.25.4.628-632.1987; Feng Q, 1999, SCI CHINA SER D, V42, P101, DOI 10.1007/BF02878858; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Guo Y., 2013, THESIS; Hao XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep35418; Karim S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005681; Kawahara M, 2006, APPL ENVIRON MICROB, V72, P1102, DOI 10.1128/AEM.72.2.1102-1109.2006; Kumsa B, 2016, PARASITOL RES, V115, P4199, DOI 10.1007/s00436-016-5197-9; Lv JZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-93; Mediannikov O, 2014, MICROB PATHOGENESIS, V77, P142, DOI 10.1016/j.micpath.2014.09.008; Park HS, 2004, J CLIN MICROBIOL, V42, P1270, DOI 10.1128/JCM.42.3.1270-1273.2004; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2009, EMERG INFECT DIS, V15, P1105, DOI 10.3201/eid1507.081449; Takada N, 2001, APPL ENVIRON MICROB, V67, P5161, DOI 10.1128/AEM.67.11.5161-5165.2001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavassoli M, 2012, PARASITOL RES, V111, P1779, DOI 10.1007/s00436-012-3023-6; Tian ZC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-19; Wang YZ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1021-0; Wei QQ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1242-2; Wu X, 2013, PARASITE VECTOR; Wu ZT, 2010, CLIMATIC CHANGE, V99, P457, DOI 10.1007/s10584-009-9760-6; YAMAGUTI N, 1968, J MED ENTOMOL, V5, P453, DOI 10.1093/jmedent/5.4.453; Yang JF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0727-3; Yu X, 1997, TICKS FAUNA XINJIANG; Yu ZJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0628-x; Zhao SS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1614-2; Zhong, 1986, CHIN J PARASITOL PAR, V4, P77	39	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208615	10.1371/journal.pone.0208615	http://dx.doi.org/10.1371/journal.pone.0208615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586406	Green Submitted, gold, Green Published			2022-12-26	WOS:000454416400027
J	Cejas, RB; Lorenz, V; Garay, YC; Irazoqui, FJ				Cejas, Romina B.; Lorenz, Virginia; Garay, Yohana C.; Irazoqui, Fernando J.			Biosynthesis of O-N-acetylgalactosamine glycans in the human cell nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycoconjugate; glycoprotein biosynthesis; nucleus; enzyme catalysis; substrate specificity; glycosylation; epigenetics; biosynthesis; O-GalNAc glycans; polypeptide N-acetylgalactosaminyltransferase 3; post-translational modification; proteins	GLCNAC TRANSFERASE; DNA-DAMAGE; LAMIN B1; GLYCOSYLATION; GENOME; CANCER; ACETYLGLUCOSAMINE; PHOSPHORYLATION; GLYCOPROTEOME; GLCNACYLATION	Biological functions of nuclear proteins are regulated by post-translational modifications (PTMs) that modulate gene expression and cellular physiology. However, the role of O-linked glycosylation (O-GalNAc) as a PTM of nuclear proteins in the human cell has not been previously reported. Here, we examined in detail the initiation of O-GalNAc glycan biosynthesis, representing a novel PTM of nuclear proteins in the nucleus of human cells, with an emphasis on HeLa cells. Using soluble nuclear fractions from purified nuclei, enzymatic assays, fluorescence microscopy, affinity chromatography, MS, and FRET analyses, we identified all factors required for biosynthesis of O-GalNAc glycans in nuclei: the donor substrate (UDP-GalNAc), nuclear polypeptide GalNAc -transferase activity, and a GalNAc transferase (polypeptide GalNAc-T3). Moreover, we identified O-GalNAc glycosylated proteins in the nucleus and present solid evidence for O-GalNAc glycan synthesis in this organelle. The demonstration of O-GalNAc glycosylation of nuclear proteins in mammalian cells reported here has important implications for cell and chemical biology.	[Cejas, Romina B.; Garay, Yohana C.; Irazoqui, Fernando J.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET, Ciudad Univ,X5000HUA, Cordoba, Argentina; [Cejas, Romina B.; Garay, Yohana C.] Univ Nacl Cordoba, Dept Quim Biol Ranwel Caputto, Fac Ciencias Quim, Ciudad Univ,X5000HUA, Cordoba, Argentina; [Lorenz, Virginia] Univ Nacl Litoral, Inst Salud & Ambiente Litoral, ISAL, CONICET, S3000ZAA, Santa Fe, Argentina; [Lorenz, Virginia] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, S3000ZAA, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; National University of the Littoral	Irazoqui, FJ (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET, Ciudad Univ,X5000HUA, Cordoba, Argentina.	irazoqui@fcq.unc.edu.ar		Cejas, Romina/0000-0002-5484-4722	CONICET [PIP 11220150100226]; SeCyT, UNC Grant [05/C422]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SeCyT, UNC Grant	This work was supported by CONICET Grant PIP 11220150100226 and SeCyT, UNC Grant 05/C422 (to F.J.I.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Amendola M, 2014, CURR OPIN CELL BIOL, V28, P61, DOI 10.1016/j.ceb.2014.03.003; Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Camps J, 2015, NUCLEUS-PHILA, V6, P8, DOI 10.1080/19491034.2014.1003510; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Collas P, 2014, BIOESSAYS, V36, P75, DOI 10.1002/bies.201300138; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Gambetta MC, 2015, CHROMOSOMA, V124, P429, DOI 10.1007/s00412-015-0513-1; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart G. W., 2009, ESSENTIALS GLYCOBIOL, P263; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Irazoqui FJ, 2005, BIOCHEM BIOPH RES CO, V336, P14, DOI 10.1016/j.bbrc.2005.08.028; Irazoqui FJ, 1999, GLYCOBIOLOGY, V9, P59, DOI 10.1093/glycob/9.1.59; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Klymenko T, 2018, LEUKEMIA, V32, P364, DOI 10.1038/leu.2017.255; Kumar SR, 2005, CLIN CANCER RES, V11, P6868, DOI 10.1158/1078-0432.CCR-05-0146; Lloyd JT, 2018, J CELL PHYSIOL, V233, P1877, DOI 10.1002/jcp.26010; Lorenz V, 2016, J BIOL CHEM, V291, P25339, DOI 10.1074/jbc.M116.740795; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simon DN, 2013, MOL BIOL CELL, V24, P342, DOI 10.1091/mbc.E12-07-0527; Skalska L, 2017, NAT REV MOL CELL BIO, V18, P1, DOI 10.1038/nrm.2017.12; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Torvaldson E, 2015, NUCLEUS-PHILA, V6, P166, DOI 10.1080/19491034.2015.1017167; Trapannone R, 2016, BIOCHEM J, V473, P1693, DOI 10.1042/BCJ20160092; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varki A., 2009, ESSENTIALS GLYCOBIOL, P37; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Wollaston-Hayden Edith E, 2014, Front Endocrinol (Lausanne), V5, P223, DOI 10.3389/fendo.2014.00223; Xie W, 2016, CURR BIOL, V26, pR348, DOI 10.1016/j.cub.2016.01.055; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhu YP, 2016, J MOL CELL BIOL, V8, P2, DOI 10.1093/jmcb/mjv033	49	17	17	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					2997	3011		10.1074/jbc.RA118.005524	http://dx.doi.org/10.1074/jbc.RA118.005524			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30591584	Green Published, hybrid			2022-12-26	WOS:000464980100003
J	Ma, WZ; Chen, XJ; Cerne, R; Syed, SK; Ficorilli, JV; Cabrera, O; Obukhov, AG; Efanov, AM				Ma, Wenzhen; Chen, Xingjuan; Cerne, Rok; Syed, Samreen K.; Ficorilli, James V.; Cabrera, Over; Obukhov, Alexander G.; Efanov, Alexander M.			Catechol estrogens stimulate insulin secretion in pancreatic beta-cells via activation of the transient receptor potential A1 (TRPA1) channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen; ion channel; transient receptor potential channels (TRP channels); insulin secretion; pancreatic islet	CATION CHANNELS; 17-BETA-ESTRADIOL; ESTRADIOL; PROTEIN; METABOLITES; INHIBITION; APOPTOSIS; PITUITARY; RELEASE; BINDING	Estrogen hormones play an important role in controlling glucose homeostasis and pancreatic beta-cell function. Despite the significance of estrogen hormones for regulation of glucose metabolism, little is known about the roles of endogenous estrogen metabolites in modulating pancreatic beta-cell function. In this study, we evaluated the effects of major natural estrogen metabolites, catechol estrogens, on insulin secretion in pancreatic beta-cells. We show that catechol estrogens, hydroxylated at positions C2 and C4 of the steroid A ring, rapidly potentiated glucose-induced insulin secretion via a nongenomic mechanism. 2-Hydroxyestrone, the most abundant endogenous estrogen metabolite, was more efficacious in stimulating insulin secretion than any other tested catechol estrogens. In insulin-secreting cells, catechol estrogens produced rapid activation of calcium influx and elevation in cytosolic free calcium. Catechol estrogens also generated sustained elevations in cytosolic free calcium and evoked inward ion current in HEK293 cells expressing the transient receptor potential A1 (TRPA1) cation channel. Calcium influx and insulin secretion stimulated by estrogen metabolites were dependent on the TRPA1 activity and inhibited with the channel-specific pharmacological antagonists or the siRNA. Our results suggest the role of estrogen metabolism in a direct regulation of TRPA1 activity with potential implications for metabolic diseases.	[Ma, Wenzhen; Cerne, Rok; Syed, Samreen K.; Ficorilli, James V.; Cabrera, Over; Efanov, Alexander M.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Chen, Xingjuan; Obukhov, Alexander G.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis	Efanov, AM (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA.	efanov_alexander@lilly.com	chen, xingjuan/V-4064-2019; Efanov, Alexander/R-3630-2019; Obukhov, Alexander G./C-7246-2008	chen, xingjuan/0000-0002-7380-8399; Efanov, Alexander/0000-0002-8630-1503; Obukhov, Alexander G./0000-0002-3862-6004				Alonso-Magdalena P, 2013, DIABETES, V62, P2015, DOI 10.2337/db12-1562; Anand P, 2010, CHEM-BIOL INTERACT, V186, P72, DOI 10.1016/j.cbi.2010.03.044; BALL P, 1978, J CLIN ENDOCR METAB, V47, P732, DOI 10.1210/jcem-47-4-732; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Beckmann H, 2017, CELL CALCIUM, V66, P10, DOI 10.1016/j.ceca.2017.05.012; Cao DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038005; Castagnetta LAM, 2002, CLIN CANCER RES, V8, P3146; Chen J, 2011, PAIN, V152, P1165, DOI 10.1016/j.pain.2011.01.049; Chen XJ, 2017, J BIOL CHEM, V292, P898, DOI 10.1074/jbc.M116.755470; Chepurny OG, 2016, SCI REP-UK, V6, DOI 10.1038/srep28934; Colsoul B, 2011, REV PHYSIOL BIOCH P, V161, P87, DOI 10.1007/112_2011_2; COSTRINI NV, 1971, J CLIN INVEST, V50, P992, DOI 10.1172/JCI106593; De Cree C, 1997, J APPL PHYSIOL, V82, P364, DOI 10.1152/jappl.1997.82.1.364; DECUPIS A, 1995, BRIT J PHARMACOL, V116, P2391; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Emery EC, 2015, DIABETES, V64, P1202, DOI 10.2337/db14-0737; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; FISHMAN J, 1983, ANNU REV PHYSIOL, V45, P61, DOI 10.1146/annurev.ph.45.030183.000425; Fuhrman BJ, 2014, CANCER EPIDEM BIOMAR, V23, P2649, DOI 10.1158/1055-9965.EPI-14-0438; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Irnaten M, 2009, STEROIDS, V74, P642, DOI 10.1016/j.steroids.2009.02.002; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kilic G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087941; Kim MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071603; Kumar A, 2015, GEN COMP ENDOCR, V220, P23, DOI 10.1016/j.ygcen.2014.10.004; Kumar S, 2012, J CELL PHYSIOL, V227, P1408, DOI 10.1002/jcp.22855; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; LONGCOPE C, 1982, J CLIN ENDOCR METAB, V54, P374, DOI 10.1210/jcem-54-2-374; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Majeed Y, 2011, BRIT J PHARMACOL, V162, P1509, DOI 10.1111/j.1476-5381.2010.01136.x; Majeed Y, 2010, BRIT J PHARMACOL, V161, P430, DOI 10.1111/j.1476-5381.2010.00892.x; Majeed Y, 2012, CELL CALCIUM, V51, P1, DOI 10.1016/j.ceca.2011.09.005; Markides CSA, 2005, J ENDOCRINOL, V185, P235, DOI 10.1677/joe.1.06014; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Numazawa S, 2012, BIOL PHARM BULL, V35, P346, DOI 10.1248/bpb.35.346; Obukhov AG, 1998, NEUROSCIENCE, V85, P487, DOI 10.1016/S0306-4522(97)00616-7; Rogan EG, 2003, CARCINOGENESIS, V24, P697, DOI 10.1093/carcin/bgg004; SCHAEFFER JM, 1980, J BIOL CHEM, V255, P9838; Standop J, 2003, TOXICOL PATHOL, V31, P506, DOI 10.1080/01926230390226041; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Yuchi Y, 2015, DIABETES, V64, P3218, DOI 10.2337/db14-1798; Zhou ZQ, 2018, J BIOL CHEM, V293, P4735, DOI 10.1074/jbc.M117.805069; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	51	13	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2935	2946		10.1074/jbc.RA118.005504	http://dx.doi.org/10.1074/jbc.RA118.005504			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30587572	Green Published, hybrid			2022-12-26	WOS:000459601600030
J	Konerman, MA; Beste, LA; Van, T; Liu, B; Zhang, XF; Zhu, J; Saini, SD; Su, GL; Nallamothu, BK; Ioannou, GN; Waljee, AK				Konerman, Monica A.; Beste, Lauren A.; Van, Tony; Liu, Boang; Zhang, Xuefei; Zhu, Ji; Saini, Sameer D.; Su, Grace L.; Nallamothu, Brahmajee K.; Ioannou, George N.; Waljee, Akbar K.			Machine learning models to predict disease progression among veterans with hepatitis C virus	PLOS ONE			English	Article							REGULARIZATION PATHS	Background Machine learning (ML) algorithms provide effective ways to build prediction models using longitudinal information given their capacity to incorporate numerous predictor variables without compromising the accuracy of the risk prediction. Clinical risk prediction models in chronic hepatitis C virus (CHC) can be challenging due to non-linear nature of disease progression. We developed and compared two ML algorithms to predict cirrhosis development in a large CHC-infected cohort using longitudinal data. Methods and findings We used national Veterans Health Administration (VHA) data to identify CHC patients in care between 2000-2016. The primary outcome was cirrhosis development ascertained by two consecutive aspartate aminotransferase (AST)-to-platelet ratio indexes (APRIs) > 2 after time zero given the infrequency of liver biopsy in clinical practice and that APRI is a validated non-invasive biomarker of fibrosis in CHC. We excluded those with initial APRI > 2 or pre-existing diagnosis of cirrhosis, hepatocellular carcinoma or hepatic decompensation. Enrollment was defined as the date of the first APRI. Time zero was defined as 2 years after enrollment. Cross-sectional (CS) models used predictors at or closest before time zero as a comparison. Longitudinal models used CS predictors plus longitudinal summary variables (maximum, minimum, maximum of slope, minimum of slope and total variation) between enrollment and time zero. Covariates included demographics, labs, and body mass index. Model performance was evaluated using concordance and area under the receiver operating curve (AuROC). A total of 72,683 individuals with CHC were analyzed with the cohort having a mean age of 52.8, 96.8% male and 53% white. There are 11,616 individuals (16%) who met the primary outcome over a mean follow-up of 7 years. We found superior predictive performance for the longitudinal Cox model compared to the CS Cox model (concordance 0.764 vs 0.746), and for the longitudinal boosted-survival-tree model compared to the linear Cox model (concordance 0.774 vs 0.764). The accuracy of the longitudinal models at 1,3,5 years after time zero also showed superior performance compared to the CS model, based on AuROC. Conclusions Boosted-survival-tree based models using longitudinal information are statistically superior to cross-sectional or linear models for predicting development of cirrhosis in CHC, though all four models were highly accurate. Similar statistical methods could be applied to predict outcomes in other non-linear chronic disease states.	[Konerman, Monica A.; Saini, Sameer D.; Su, Grace L.; Waljee, Akbar K.] Michigan Med, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; [Beste, Lauren A.] Vet Affairs Puget Sound Healthcare Syst, Dept Med, Seattle, WA USA; [Beste, Lauren A.] Univ Washington, Seattle, WA 98195 USA; [Van, Tony; Saini, Sameer D.; Su, Grace L.; Waljee, Akbar K.] VA Ann Arbor Hlth Serv Res & Dev Ctr Clin Managem, Ann Arbor, MI 48105 USA; [Liu, Boang; Zhang, Xuefei; Zhu, Ji] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Michigan Med, Dept Internal Med, Div Cardiol, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.; Waljee, Akbar K.] Michigan Integrated Ctr Hlth Analyt & Med Predict, Ann Arbor, MI 48109 USA; [Ioannou, George N.] Univ Washington, Dept Med, Div Gastroenterol, Seattle, WA USA; [Ioannou, George N.] Vet Affairs Puget Sound Healthcare Syst, Dept Med, Div Gastroenterol, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Waljee, AK (corresponding author), Michigan Med, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.; Waljee, AK (corresponding author), VA Ann Arbor Hlth Serv Res & Dev Ctr Clin Managem, Ann Arbor, MI 48105 USA.; Waljee, AK (corresponding author), Michigan Integrated Ctr Hlth Analyt & Med Predict, Ann Arbor, MI 48109 USA.	awaljee@med.umich.edu	Waljee, Akbar K/G-2067-2010; Tincopa, Monica/AAK-7187-2021; Su, GL/N-9606-2019; zhu, ji/HDM-1538-2022	Waljee, Akbar K/0000-0003-1964-8790; Su, GL/0000-0002-8701-774X; 	United States (U.S.) Department of Veterans Affairs Health Services R&D (HSRD) Service [IIR 16-024]; Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP) in the Institute for Healthcare Policy and Innovation at the University of Michigan Medical School; Veterans Affairs [I01HX002220] Funding Source: NIH RePORTER	United States (U.S.) Department of Veterans Affairs Health Services R&D (HSRD) Service(US Department of Veterans Affairs); Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP) in the Institute for Healthcare Policy and Innovation at the University of Michigan Medical School; Veterans Affairs(US Department of Veterans Affairs)	Drs. Waljee, Beste, Ioannou Saini, Su are funded by IIR 16-024 from the United States (U.S.) Department of Veterans Affairs Health Services R&D (HSRD) Service. Drs. Waljee, Nallamothu and Zhu are supported by the Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP) in the Institute for Healthcare Policy and Innovation at the University of Michigan Medical School. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox D.R., 1992, BREAKTHROUGHS STAT, P527, DOI DOI 10.1007/978-1-4612-4380-9_37; Freeman AJ, 2003, J VIRAL HEPATITIS, V10, P285, DOI 10.1046/j.1365-2893.2003.00436.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Konerman MA, 2016, J VIRAL HEPATITIS; Konerman MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187344; Konerman MA, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.50; Konerman MA, 2015, HEPATOLOGY, V61, P1832, DOI 10.1002/hep.27750; Lee YH, 2016, ENDOCRINOL METAB, V31, P38, DOI 10.3803/EnM.2016.31.1.38; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Ridgeway G., 1999, COMPUT SCI STAT, P172; Simon N, 2011, J STAT SOFTW, V39, P1; Sood N, 2018, ANN INTERNAL MED; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Waljee AK, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.19; Zeremski M, 2016, J INFECT DIS, V214, P1164, DOI 10.1093/infdis/jiw332; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	20	32	32	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0208141	10.1371/journal.pone.0208141	http://dx.doi.org/10.1371/journal.pone.0208141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608929	Green Published, Green Submitted, gold			2022-12-26	WOS:000454952800008
J	Cho, JH; Rhee, EJ; Park, SE; Kwon, H; Jung, JH; Han, KD; Park, YG; Yoo, SJ; Kim, YH; Lee, WY; Kim, YH; Kwon, HS; Park, SE; Seo, MH; Son, JW; Yoo, SH; Lee, SS; Jung, CH; Han, K; Han, B				Cho, Jung-Hwan; Rhee, Eun-Jung; Park, Se Eun; Kwon, Hyemi; Jung, Jin-Hyung; Han, Kyung-Do; Park, Yong-Gyu; Yoo, Soon-Jib; Kim, Yang-Hyun; Lee, Won-Young; Kim, Yang-Hyun; Kwon, Hyuk-Sang; Park, Se Eun; Seo, Mi Hae; Son, Jang Won; Yoo, Seung-Hyun; Lee, Seong-Su; Jung, Chan-Hee; Han, Kyungdo; Han, Byungduck		Taskforce Team Obesity Fact Sheet	Maintenance of body weight is an important determinant for the risk of ischemic stroke: A nationwide population-based cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MASS INDEX; OVERWEIGHT; OBESITY; GUIDELINES; MORTALITY; HEALTH; ASSOCIATIONS; BENEFITS; OUTCOMES	Background Overweight is known as a risk factor for ischemic stroke. However, the effect of weight change on the development of ischemic stroke remains controversial. We investigated the relationship between weight change and the risk of ischemic stroke using a nationwide population-based cohort. Methods Our study enrolled 11,084,683 participants (Mean age 49.7 +/- 13.5 years, range 20-114 years) in the Korean National Health Screening Program from 2009 to 2012. Weight change was calculated using the difference between the baseline weight and the weight at health screening four years prior to the baseline. The occurrence of newly-diagnosed ischemic stroke was observed until the end of 2015. We categorized the study population according to weight change and performed multivariable analysis to compare the risk. Results Ischemic stroke was newly diagnosed in 113,591 subjects. The crude incidence rates of ischemic stroke per 1000 person-years according to the change in body weight were 3.059, 1.906, and 1.491 in the <-5%, +/- 5%, and >=+5% groups, respectively. After adjusting all variables, the hazard ratio (HR) of ischemic stroke was higher in subjects who underwent weight loss (HR 1.152) or weight gain (HR 1.087) than in those who maintained their weight. When analyzed by eight groups of 5% intervals, the risk showed a U-shaped curve with those who maintained their weight showing the lowest risk. Conclusions The risk of ischemic stroke was gradually increased in those who lost or gained more than 5% of their weight over four years, after adjusting for confounders. We should be aware of the increased risk of ischemic stroke in people who undergo weight change and should identify and manage the cause of weight change.	[Cho, Jung-Hwan; Rhee, Eun-Jung; Park, Se Eun; Kwon, Hyemi; Lee, Won-Young] Kangbuk Samsung Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea; [Jung, Jin-Hyung; Han, Kyung-Do; Park, Yong-Gyu] Catholic Univ, Dept Med Stat, Coll Med, Seoul, South Korea; [Yoo, Soon-Jib] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Bucheon St Marys Hosp,Coll Med, Bucheon, South Korea; [Kim, Yang-Hyun] Korea Univ, Dept Family Med, Korea Univ Hosp, Coll Med, Seoul, South Korea; [Kim, Yang-Hyun] Korea Univ, Seoul, South Korea; [Kwon, Hyuk-Sang; Son, Jang Won; Lee, Seong-Su; Han, Kyungdo] Catholic Univ Korea, Seoul, South Korea; [Park, Se Eun] Sungkyunkwan Univ, Seoul, South Korea; [Seo, Mi Hae; Jung, Chan-Hee] Soonchunhyang Univ, Asan, South Korea; [Yoo, Seung-Hyun] Natl Hlth Insurance Serv, Jeonju, South Korea; [Han, Byungduck] Sahmyook Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Catholic University of Korea; Sungkyunkwan University (SKKU); Soonchunhyang University; National Health Insurance Service	Lee, WY (corresponding author), Kangbuk Samsung Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea.; Kim, YH (corresponding author), Korea Univ, Dept Family Med, Korea Univ Hosp, Coll Med, Seoul, South Korea.	mrchir@naver.com; drlwy@hanmail.net	Jung, Chan-Hee/AAV-3164-2020; LEE, WON-YOUNG/C-7249-2018	Jung, Chan-Hee/0000-0001-8988-0187; Kim, Yang-Hyun/0000-0003-3548-8758; LEE, WON-YOUNG/0000-0002-1082-7592; YOO, SOON JIB/0000-0002-9932-4130	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC16C2285]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC16C2285) to SJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Korean National Health Insurance Corporation and all the participants of the study and health check-up. This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC16C2285).	Bangalore S, 2017, NEW ENGL J MED, V376, P1332, DOI 10.1056/NEJMoa1606148; Barker-Collo S, 2015, NEUROEPIDEMIOLOGY, V45, P203, DOI 10.1159/000441103; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Caterson ID, 2012, DIABETES OBES METAB, V14, P523, DOI 10.1111/j.1463-1326.2011.01554.x; de las Fuentes L, 2009, J AM COLL CARDIOL, V54, P2376, DOI 10.1016/j.jacc.2009.07.054; Espeland M, 2007, DIABETES CARE, V30, P1374; Galanis DJ, 1998, AM J EPIDEMIOL, V147, P379; HIGGINS M, 1993, ANN INTERN MED, V119, P758, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00025; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Kim KI, 2016, KOREAN CIRC J, V46, P275, DOI 10.4070/kcj.2016.46.3.275; Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405; Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; McAuley PA, 2012, MAYO CLIN PROC, V87, P443, DOI 10.1016/j.mayocp.2012.01.013; Mehta T, 2014, OBES REV, V15, P870, DOI 10.1111/obr.12222; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pack QR, 2014, MAYO CLIN PROC, V89, P1368, DOI 10.1016/j.mayocp.2014.04.033; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Saito I, 2011, INT J OBESITY, V35, P283, DOI 10.1038/ijo.2010.131; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Sorensen TIA, 2005, PLOS MED, V2, P510, DOI 10.1371/journal.pmed.0020171; Stevens J, 2013, AM J EPIDEMIOL, V178, P239, DOI 10.1093/aje/kws461; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Wannamethee SG, 2000, AM J EPIDEMIOL, V151, P667, DOI 10.1093/oxfordjournals.aje.a010261; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680; Yun S, 2017, NUTR RES PRACT, V11, P147, DOI 10.4162/nrp.2017.11.2.147; Zhang YL, 2016, MOL CLIN ONCOL, V5, P388, DOI 10.3892/mco.2016.923	32	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0210153	10.1371/journal.pone.0210153	http://dx.doi.org/10.1371/journal.pone.0210153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605484	Green Published, gold, Green Submitted			2022-12-26	WOS:000454759900029
J	Michelis, R; Tadmor, T; Barhoum, M; Shehadeh, M; Shvidel, L; Aviv, A; Stemer, G; Dally, N; Rahimi-Levene, N; Yuklea, M; Braester, A				Michelis, Regina; Tadmor, Tamar; Barhoum, Masad; Shehadeh, Mona; Shvidel, Lev; Aviv, Ariel; Stemer, Galia; Dally, Najib; Rahimi-Levene, Naomi; Yuklea, Mona; Braester, Andrei			A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; ACTIVATION; MECHANISMS; RITUXIMAB; SAMPLES; SYSTEM; C1; C4	Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the Western world. The therapeutic approach to CLL includes chemotherapeutic regimens and immunotherapy. Complement-mediated cytotoxicity, which is one of the mechanisms activated by the therapeutic monoclonal antibodies, depends on the availability and activity of the complement (C) system. The aim was to study the structure of circulating C components and evaluate the importance of C5 structural integrity for C activity in CLL patients. Blood samples were collected from 40 naive CLL patients and 15 normal controls (NC). The Western blot analysis showed abnormal C5 pattern in some CLL patients, while patterns of C3 and C4 were similar in all subjects. Levels of the C activation markers sC5b-9 and C5a were quantified before and after activation via the classical (CP) and alternative (AP) pathways. In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. The data indicate a link between CP activation and apparent C5 alterations in CLL. This provides a potential prognostic tool that may personalize therapy by identifying a sub-group of CLL patients who display an abnormal C5 pattern, high basal levels of sC5b-9 and C5a, and impaired CP activity, and are likely to be less responsive to immunotherapy due to compromised CP activity.	[Michelis, Regina] Galilee Med Ctr, Inst Med Res, Nahariyya, Israel; [Tadmor, Tamar] Bnai Zion Med Ctr, Div Hematol, Haifa, Israel; [Tadmor, Tamar] Technion, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Barhoum, Masad; Braester, Andrei] Galilee Med Ctr, Inst Hematol, Nahariyya, Israel; [Barhoum, Masad; Braester, Andrei] Bar Ilan Univ, Fac Med Galilee, Safed, Israel; [Shehadeh, Mona] Galilee Med Ctr, Biochem Lab, Nahariyya, Israel; [Shvidel, Lev] Kaplan Med Ctr, Inst Hematol, Rehovot, Israel; [Shvidel, Lev] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Aviv, Ariel; Stemer, Galia] Emek Med Ctr, Dept Hematol, Afula, Israel; [Dally, Najib] Ziv Med Ctr, Dept Hematol, Safed, Israel; [Rahimi-Levene, Naomi] Assaf Harofeh Med Ctr, Hematol Unit, Zerifin, Israel; [Rahimi-Levene, Naomi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Yuklea, Mona] Meir Med Ctr, Hematol Unit, Kefar Sava, Israel	Western Galilee Hospital; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Western Galilee Hospital; Bar Ilan University; Western Galilee Hospital; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Emek Medical Center; Ziv Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Michelis, R (corresponding author), Galilee Med Ctr, Inst Med Res, Nahariyya, Israel.	ReginaM@gmc.gov.il		Tadmor, Tamar/0000-0002-3435-8612; Michelis, Regina/0000-0002-3513-9016	Dangoor Foundation via the Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel [292956]; Health Corporation of Galilee Medical Center, Nahariya, Israel	Dangoor Foundation via the Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel; Health Corporation of Galilee Medical Center, Nahariya, Israel	This work was supported by the Dangoor Foundation via the Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel (Grant 292956); The Health Corporation of Galilee Medical Center, Nahariya, Israel.	Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; Basta M, 2008, MOL IMMUNOL, V45, P4073, DOI 10.1016/j.molimm.2008.07.012; Blom AM, 2014, CLIN EXP IMMUNOL, V178, P142, DOI 10.1111/cei.12388; Blom AM, 2015, MOL IMMUNOL, V66, P164, DOI 10.1016/j.molimm.2015.02.029; FUST G, 1987, IMMUNOL LETT, V14, P255, DOI 10.1016/0165-2478(87)90110-6; FUST G, 1985, CLIN EXP IMMUNOL, V60, P489; HIDVEGI T, 1989, IMMUNOL LETT, V22, P1, DOI 10.1016/0165-2478(89)90133-8; Klepfish A, 2007, LANCET ONCOL, V8, P361, DOI 10.1016/S1470-2045(07)70106-7; Klepfish A, 2009, ANN NY ACAD SCI, V1173, P865, DOI 10.1111/j.1749-6632.2009.04803.x; Marquart HV, 1995, CLIN EXP IMMUNOL, V102, P575; Middleton O, 2015, LEUKEMIA, V29, P107, DOI 10.1038/leu.2014.146; MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484; Mortensen S, 2016, J BIOL CHEM, V291, P16494, DOI 10.1074/jbc.M116.722017; Mortensen S, 2015, J IMMUNOL, V194, P5488, DOI 10.4049/jimmunol.1500087; Pfeifer PH, 1999, CLIN CHEM, V45, P1190; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Schlesinger M, 1996, LEUKEMIA, V10, P1509; Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101; Tedesco F, 2004, COMPLEMENT SYSTEM: NOVEL ROLES IN HEALTH AND DISEASE, P97, DOI 10.1007/1-4020-8056-5_6; VARGA L, 1995, CLIN EXP IMMUNOL, V99, P112; VOGT W, 1985, MOL IMMUNOL, V22, P101, DOI 10.1016/S0161-5890(85)80003-1; Walker J. M., PROTEIN PROTOCOLS HD, P721; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209024	10.1371/journal.pone.0209024	http://dx.doi.org/10.1371/journal.pone.0209024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601845	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200030
J	Alegre, F; Ormonde, AR; Snider, KM; Woolard, K; Yu, AM; Wittenburg, LA				Alegre, Fernando; Ormonde, Amanda R.; Snider, Kellie M.; Woolard, Kevin; Yu, Ai-Ming; Wittenburg, Luke A.			A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma	PLOS ONE			English	Article							RNA-DERIVED FRAGMENTS; COMPARATIVE ONCOLOGY; CANCER PROGRESSION; MIR-34A; EXPRESSION; CELLS; PROLIFERATION; INVASION; QUANTIFICATION; METASTASIS	Osteosarcoma (OSA) represents the most common primary bone tumor in humans and pet dogs. Little progress has been made with regard to viable treatment options in the past three decades and patients presenting with metastatic disease continue to have a poor prognosis. Recent mouse studies have suggested that microRNA-34a (miR-34a) may have anti-tumor activities in human OSA models. Due to the conservation of microRNA across species, we hypothesized that a bioengineered miR-34a prodrug (tRNA/miR-34a) would have similar effects in canine OSA, providing a valuable preclinical model for development of this therapeutic modality. Using a panel of canine OSA cell lines, we found that tRNA/miR-34a reduced viability, clonogenic growth, and migration and invasion while increasing tumor cell apoptosis. Furthermore, canine OSA cells successfully process the tRNA/miR-34a into mature miR-34a which reduces expression of target proteins such as platelet derived growth factor receptor alpha (PDGFR alpha), Notch1 and vascular endothelial growth factor (VEGF). Additionally, our subcutaneous OSA xenograft model demonstrated in vivo tumor growth delay, increased necrosis and apoptosis by tRNA/miR-34a, and decreased cellular proliferation ability. Taken together, these data support that this novel microRNA-based therapy may possess clinical utility in a spontaneously-occurring large animal model of OSA, which can then serve to inform the clinical development of this therapy for human OSA patients.	[Alegre, Fernando; Ormonde, Amanda R.; Snider, Kellie M.; Wittenburg, Luke A.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Woolard, Kevin] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Yu, Ai-Ming] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Alegre, F (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	falegreguerra@ucdavis.edu		Yu, Aiming/0000-0003-1441-4012; Alegre, Fernando/0000-0003-1732-6309	University of California, Davis Medical Center Interdepartmental/Center Collaborative Research Seed Grant; National Institute of General Medical Sciences [R01GM133888]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD026526] Funding Source: NIH RePORTER	University of California, Davis Medical Center Interdepartmental/Center Collaborative Research Seed Grant; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from University of California, Davis Medical Center Interdepartmental/Center Collaborative Research Seed Grant [L.A. Wittenburg] and The National Institute of General Medical Sciences [R01GM133888; A.M. Yu], National Institutes of Health.	Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Anderson P, 2014, FEBS LETT, V588, P4297, DOI 10.1016/j.febslet.2014.09.001; Angstadt AY, 2012, CANCER GENET-NY, V205, P572, DOI 10.1016/j.cancergen.2012.09.005; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Chandrasekaran KS, 2016, TUMOR BIOL, V37, P13155, DOI 10.1007/s13277-016-5261-1; Chen X, 2016, J CANCER, V7, P1057, DOI 10.7150/jca.15061; Cirera S, 2014, METHODS MOL BIOL, V1182, P73, DOI 10.1007/978-1-4939-1062-5_7; Fan Timothy M, 2015, Vet Sci, V2, P210, DOI 10.3390/vetsci2030210; Fenger JM, 2014, ILAR J, V55, P69, DOI 10.1093/ilar/ilu009; Fowles JS, 2017, VET COMP ONCOL, V15, P481, DOI 10.1111/vco.12192; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He CL, 2009, BIOCHEM BIOPH RES CO, V388, P35, DOI 10.1016/j.bbrc.2009.07.101; Ho PY, 2018, J PHARMACOL EXP THER, V365, P494, DOI 10.1124/jpet.118.247775; Ho PY, 2016, WIRES RNA, V7, P186, DOI 10.1002/wrna.1324; Huang BQ, 2017, CANCER RES, V77, P3194, DOI 10.1158/0008-5472.CAN-16-3146; Kim YH, 2017, ONCOTARGET, V8, P8726, DOI 10.18632/oncotarget.14429; Legare ME, 2011, J CANCER, V2, P262, DOI 10.7150/jca.2.262; Li C, 2016, NEOPLASMA, V63, P734, DOI 10.4149/neo_2016_510; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lopez CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190086; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; Marley K, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-15; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Navarro F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132767; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sahabi K, 2018, J VET SCI, V19, P162, DOI 10.4142/jvs.2018.19.2.162; Saito Y, 2015, J CLIN MED, V4, P1951, DOI 10.3390/jcm4111951; Salvatore V, 2017, ONCOTARGET, V8, P9608, DOI 10.18632/oncotarget.14155; Saraf AJ, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvarajah GT, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1281-3; Seo KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042960; Shahi MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131006; Shoeneman JK, 2012, CANCER RES, V72, P249, DOI 10.1158/0008-5472.CAN-11-2315; Slabakova E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.495; Sun CX, 2018, CANCER LETT, V414, P16, DOI 10.1016/j.canlet.2017.10.031; Suzuki HI, 2015, ONCOGENE, V34, P3085, DOI 10.1038/onc.2014.254; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Varshney Jyotika, 2016, Vet Sci, V3, DOI 10.3390/vetsci3010003; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vetter NS, 2017, MOL CANCER RES, V15, P953, DOI 10.1158/1541-7786.MCR-16-0372; Wang WP, 2015, J PHARMACOL EXP THER, V354, P131, DOI 10.1124/jpet.115.225631; Wang Y, 2015, AM J TRANSL RES, V7, P111; Wang Z, 2017, ONCOTARGET, V8, P111258, DOI 10.18632/oncotarget.22770; Wen J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705761; Wu XY, 2013, INT J MED SCI, V10, P676, DOI 10.7150/ijms.5528; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; York D, 2017, VET COMP ONCOL, V15, P1087, DOI 10.1111/vco.12250; Zhang R, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0331-y; ZHAO Y, 2016, SCI REP UK, V6; Zhao Y, 2015, BIOCHEM PHARMACOL, V98, P602, DOI 10.1016/j.bcp.2015.10.015; Zou YG, 2017, MOL MED REP, V15, P1631, DOI 10.3892/mmr.2017.6187	59	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209941	10.1371/journal.pone.0209941	http://dx.doi.org/10.1371/journal.pone.0209941			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596759	gold, Green Submitted, Green Published			2022-12-26	WOS:000454627200116
J	Massa, M; Planas, E; Ribera, C				Massa, Marc; Planas, Enric; Ribera, Carles			The Mediterranean as a melting pot: Phylogeography of Loxosceles rufescens (Sicariidae) in the Mediterranean Basin	PLOS ONE			English	Article							ARANEAE SICARIIDAE; RECLUSE SPIDER; PROGRAM	The species Loxosceles rufescens is native to the Mediterranean but considered cosmopolitan because it has been dispersed worldwide. A previous study revealed 11 evolutionary lineages across the Mediterranean, grouped into two main clades, without any clear phylogeographic pattern. The high genetic diversity within this species (p-distances of up to 7.8% in some Mediterranean lineages), together with the results obtained with different species delimitation methods (GMYC, TCS) could indicate the existence of cryptic species. Here we compare the mitochondrial and microsatellite diversity to elucidate if the lineages of L. rufescens in the Mediterranean should be considered different species (cryptic species) or populations of the same species. To do so, we analyzed the cox1 diversity of 196 individuals, of which, we genotyped 148, sampled from 19 localities across the Mediterranean. STRUCTURE analyses of microsatellite data identified two genetic clusters of L. rufescens. One cluster included individuals from Western Mediterranean localities (Iberian Peninsula, Morocco, Balearic Islands) and Israel, while the second one grouped individuals from Italian and Greek localities, including Sardinia, Sicily and Tunisia. These patterns suggest that geographic proximity is the more significant factor in the clustering with microsatellite data and shows the existence of gene flow between the nearest geographic areas, even if the individuals belong to different mitochondrial lineages or clades. The lack of correspondence between both genetic markers suggests that the evolutionary lineages found within L. rufescens should not be considered different species. We conclude that these phylogenetic linages and their distribution may be the result of the maternal evolutionary history of the species and human-mediated dispersion.	[Ribera, Carles] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain; Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat IRBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Ribera, C (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain.	cribera@ub.edu	; Ribera, Carles/H-5569-2015	Massa Gomez, Marc/0000-0003-2959-7288; Ribera, Carles/0000-0002-7316-1441	Ministerio de Ciencia y Tecnologia, Spain [CGL2008-03385, CGL2016-80651-P]; Generalitat de Catalunya [2017-SGR-83]; FPI grant from the Ministerio de Ciencia y Tecnologia, Spain [BES-2009-015871]	Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FPI grant from the Ministerio de Ciencia y Tecnologia, Spain	Funding for this research was provided by the projects CGL2008-03385 and CGL2016-80651-P from Ministerio de Ciencia y Tecnologia, Spain and 2017-SGR-83 from Generalitat de Catalunya (CR and EP). EP was supported by an FPI grant from the Ministerio de Ciencia y Tecnologia, Spain (BES-2009-015871).	Bidegaray-Batista L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-317; Binford GJ, 2008, MOL PHYLOGENET EVOL, V49, P538, DOI 10.1016/j.ympev.2008.08.003; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duncan RP, 2010, MOL PHYLOGENET EVOL, V55, P234, DOI 10.1016/j.ympev.2009.11.026; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Greene Albert, 2009, American Entomologist, V55, P158; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kobelt M, 2008, DIVERS DISTRIB, V14, P273, DOI 10.1111/j.1472-4642.2007.00426.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lotz LN, 2017, ZOOTAXA, V4341, P475, DOI [10.11646/Zootaxa.4341.4.2, 10.11646/zootaxa.4341.4.2]; Lotz LN, 2012, ZOOTAXA, P1; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nentwig W, 2017, TOXICON, V132, P19, DOI 10.1016/j.toxicon.2017.04.007; Planas E, 2015, ZOOL J LINN SOC-LOND, V174, P47, DOI 10.1111/zoj.12226; Planas E, 2014, J ARACHNOL, V42, P315, DOI 10.1636/B13-88.1; Planas E, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0195-y; Planas E, 2014, J BIOGEOGR, V41, P1255, DOI 10.1111/jbi.12321; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2014, R A LANGUAGE AND ENV; Ribera C, 2009, ZOOKEYS, P217, DOI 10.3897/zookeys.16.232; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stefani F, 2012, MOL PHYLOGENET EVOL, V65, P718, DOI 10.1016/j.ympev.2012.07.022; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Tahami MS, 2017, ZOOTAXA, V4318, P377, DOI 10.11646/zootaxa.4318.2.10; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vetter RS, 2008, J ARACHNOL, V36, P150, DOI 10.1636/RSt08-06.1; Vettera RS, 2003, TOXICON, V42, P413, DOI 10.1016/S0041-0101(03)00173-9	34	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210093	10.1371/journal.pone.0210093	http://dx.doi.org/10.1371/journal.pone.0210093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596790	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200138
J	Eaton, EF; Austin, EL; Dodson, CK; Heudebert, JP; Jackson, D; Muzny, CA				Eaton, Ellen F.; Austin, Erika L.; Dodson, Catherine K.; Heudebert, Jose P.; Jackson, D'Netria; Muzny, Christina A.			Do young black men who have sex with men in the deep south prefer traditional over alternative STI testing?	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTION; MYCOPLASMA-GENITALIUM; HIV; HEALTH; PERFORMANCE; CHLAMYDIA	Background High sexually transmitted infection (STI) rates in the South, especially among young black men who have sex with men (YB MSM), make STI testing imperative for public health. Purpose To identify STI testing preferences in this population to improve testing delivery and utilization. Methods YB MSM ages 16-35 in Birmingham, Alabama participated in focus groups (FG). A trained qualitative researcher coded transcripts after each FG and added questions to explore emerging themes. Results Between September 2017 and January 2018, 36 YB MSM participated in 5 focus groups. Median age was 25.5 (Interquartile range 22-30). Participants preferred STI testing at doctors' offices conducted by physicians but they also preferred having options related to testing locations, frequency, and timing to address diverse needs. Participants did not prefer testing by non-physician staff or home self-testing. Conclusion A variety of options, including varied locations, personnel, and methods (self-collected and provider collected) are needed to make patient-preferred STI testing a reality among YB MSM in the Deep South. Further, the desire to be tested by a trusted physician highlights the need for access to primary care providers. Results suggest that newer home-based tests and self-collected tests are less preferable to YB MSM in the South, which deserves further study as these tests are rapidly integrated into clinical care.	[Eaton, Ellen F.; Heudebert, Jose P.; Jackson, D'Netria; Muzny, Christina A.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Austin, Erika L.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL USA; [Dodson, Catherine K.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Eaton, EF (corresponding author), Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA.	eeaton@uab.edu	Muzny, Christina/R-9826-2019	Muzny, Christina/0000-0002-4005-3858; Eaton, Ellen/0000-0001-8539-4907	National Institute of Allergy and Infectious Diseases [K23AI106957]; Center for AIDS Research [P30AI027767-13]; Sexually Transmitted Infections Cooperative Research Centers [U19AI113212-01]; U.S. Department of Veterans Affairs [VA HSRD IIR 15-095]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI113212, P30AI027767, K23AI106957] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research; Sexually Transmitted Infections Cooperative Research Centers; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Christina A. Muzny, MD is currently supported by grant K23AI106957 from the National Institute of Allergy and Infectious Diseases. Ellen F. Eaton, MD, is supported by the Center for AIDS Research (P30AI027767-13), the Sexually Transmitted Infections Cooperative Research Centers (U19AI113212-01). MPH is supported in part by funding from the U.S. Department of Veterans Affairs (grant VA HSR&D IIR 15-095).	Ahmed-Little Y, 2016, J PUBLIC HEALTH-UK, V38, P585, DOI 10.1093/pubmed/fdv075; Austin EL, 2014, SEX HEALTH, V11, P24, DOI 10.1071/SH13145; Bernstein KT, 2016, SEX TRANSM DIS, V43, pS42, DOI 10.1097/OLQ.0000000000000343; CDC, HIV US GLANC; Centers for Disease Control and Prevention, LIF RISK HIV DIAGN 2; Centers for Disease Control and Prevention, REPORTED STDS IN THE; Centers for Disease Control and Prevention, STAT STDS; Datta J, 2018, SEX TRANSM INFECT, V94, P46, DOI 10.1136/sextrans-2016-052983; Dionne-Odom J, 2018, CLIN INFECT DIS, V66, P796, DOI 10.1093/cid/cix853; Dize L, 2016, DIAGN MICR INFEC DIS, V86, P131, DOI 10.1016/j.diagmicrobio.2016.07.018; Dorell CG, 2011, AIDS PATIENT CARE ST, V25, P657, DOI 10.1089/apc.2011.0203; Elliot E, 2016, SEX TRANSM INFECT, V92, P470, DOI 10.1136/sextrans-2015-052090; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gravett RM, 2018, IDWEEK; Habel MA, 2018, SEX TRANSM DIS, V45, P272, DOI 10.1097/OLQ.0000000000000733; Harris KM, 2006, ARCH PEDIAT ADOL MED, V160, P74, DOI 10.1001/archpedi.160.1.74; Heudebert JP, 2018, SEX TRANSM DIS PREV; Hubach RD, 2014, SEX TRANSM DIS, V41, P129, DOI 10.1097/OLQ.0000000000000082; Human Rights Watch, 2018, SO EXP HUM RIGHTS HI; Kerr JC, 2014, AIDS BEHAV, V18, P1063, DOI 10.1007/s10461-013-0687-6; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Kudroff K FM, 2017, AN PREP US SEX BEH N; Lichtenstein B, 2003, SOC SCI MED, V57, P2435, DOI 10.1016/j.socscimed.2003.08.002; McCormack S., 2016, ICAP GRAND ROUNDS CO; Paudyal P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124310; Reif S, 2017, J COMMUNITY HLTH; Sanchez T, 2010, AIDS BEHAV, V14, P351, DOI 10.1007/s10461-009-9610-6; Sexton ME, 2013, J FAM PRACTICE, V62, P70; Shafii T, 2014, J ADOLESCENT HEALTH, V54, pS10, DOI 10.1016/j.jadohealth.2013.10.036; Siedner M, 2004, SEX TRANSM DIS, V31, P557, DOI 10.1097/01.olq.0000137903.48413.5e; Vaughan AS, 2014, AIDS RES HUM RETROV, V30, P740, DOI [10.1089/aid.2014.0144, 10.1089/AID.2014.0144]	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209666	10.1371/journal.pone.0209666	http://dx.doi.org/10.1371/journal.pone.0209666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589854	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200043
J	Hino, T; Togao, O; Hiwatashi, A; Yamashita, K; Kikuchi, K; Momosaka, D; Honda, H				Hino, Takuya; Togao, Osamu; Hiwatashi, Akio; Yamashita, Koji; Kikuchi, Kazufumi; Momosaka, Daichi; Honda, Hiroshi			Clinical efficacy of simplified intravoxel incoherent motion imaging using three b-values for differentiating high- and low-grade gliomas	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; PERFUSION FRACTION; WEIGHTED MRI; TUMORS; LIVER; IVIM	In this study, we evaluated the efficacy of intravoxel incoherent motion (IVIM)-derived parameters calculated with three b-values in differentiating high-grade gliomas (HGGs) from low-grade gliomas (LGGs) by comparing those calculated with multiple b-values. Ten patients with LGG (ages 35.1 +/- 12.1 yrs; 4 males, 6 females) and 21 patients with HGG (ages 60.6 +/- 19.1 yrs; 10 males, 11 females) who underwent subsequent surgical resections were examined with both IVIM imaging and histopathological analysis. The IVIM diffusion-weighted imaging was conducted using a single-shot echo planar sequence with 13 b-factors (0, 10, 20, 30, 50, 80, 100, 200, 300, 400, 600, 800, and 1000 sec/mm(2)) at 3T. In the conventional IVIM analysis, the perfusion fraction (f) and true diffusion coefficient (D) were calculated by biexponential fitting model with 13 b-values. In the simplified method with the selected three b-values (0, 300, and 1000 sec/mm(2)), D simply corresponds to the slope of a straight line passing through two logarithmic signal intensities (SIs) at the b-values of 300 and 1000 s/mm(2), and f corresponds to the difference between the intercept of this line and SI at the b-value of 0 sec/mm(2). The maximum f (f-max) and minimum D (D-min) was measured in each tumor. The f-max values calculated with three b-values (12.8 +/- 5.9%) were significantly lower than those with 13 b-values (17.3 +/- 7.5%, p<0.0001), but a good correlation and agreement were observed between these sets of f-max values (r = 0.79, ICC = 0.87). In the IVIM imaging with both three and 13 b-values, the HGGs showed significantly higher f-max values compared to the LGGs (p<0.001, respectively). The D-min values calculated with three b-values (1.06 +/- 0.31 x10(-3) mm(2)/sec) was not different from those with 13 b-values (1.07 +/- 0.33 x10(-3) mm(2)/sec), and an excellent correlation and agreement were found between them (r = 0.99, ICC = 0.99). The simplified IVIM imaging using three b-values can efficiently differentiate HGGs and LGGs.	[Hino, Takuya; Togao, Osamu; Yamashita, Koji; Kikuchi, Kazufumi; Momosaka, Daichi; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Fukuoka, Japan; [Hiwatashi, Akio] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka, Fukuoka, Japan	Kyushu University; Kyushu University	Togao, O (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka, Fukuoka, Japan.	togao@radiol.med.kyushu-u.ac.jp	Togao, Osamu/AAE-4702-2022; Kikuchi, Kazufumi/AAP-4286-2021	Kikuchi, Kazufumi/0000-0003-1292-1846; Hino, Takuya/0000-0002-8225-0737; Togao, Osamu/0000-0002-5910-7852; Yamashita, Koji/0000-0002-7417-739X	JSPS KAKENHI [JP17K10410]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP17K10410. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; Bisdas S, 2013, NEURORADIOLOGY, V55, P1189, DOI 10.1007/s00234-013-1229-7; Bulakbasi N, 2004, J COMPUT ASSIST TOMO, V28, P735, DOI 10.1097/00004728-200411000-00003; Cao MQ, 2018, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00432; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Claus EB, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.10.FOCUS12367; Conklin J, 2016, AM J NEURORADIOL, V37, P2251, DOI 10.3174/ajnr.A4929; DAUMASDUPORT C, 1988, CANCER-AM CANCER SOC, V62, P2152, DOI 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T; Federau C, 2014, AM J NEURORADIOL, V35, P256, DOI 10.3174/ajnr.A3686; Federau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072856; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Han X, 2017, J MAGN RESON IMAGING, V45, P722, DOI 10.1002/jmri.25405; Higano S, 2006, RADIOLOGY, V241, P839, DOI 10.1148/radiol.2413051276; Jefferies SJ, 2013, CLIN ONCOL-UK, V25, P391, DOI 10.1016/j.clon.2013.03.005; Kiss R, 1997, AM J CLIN PATHOL, V107, P321, DOI 10.1093/ajcp/107.3.321; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Law M, 2004, AM J NEURORADIOL, V25, P746; Law M, 2003, AM J NEURORADIOL, V24, P1989; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lewin M, 2011, EUR RADIOL, V21, P281, DOI 10.1007/s00330-010-1914-4; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Meeus EM, 2018, MAGN RESON MATER PHY, V31, P269, DOI 10.1007/s10334-017-0656-6; Shen NX, 2016, J MAGN RESON IMAGING, V44, P620, DOI 10.1002/jmri.25191; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Suh CH, 2014, RADIOLOGY, V272, P504, DOI 10.1148/radiol.14131895; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Togao O, 2016, NEURO-ONCOLOGY, V18, P132, DOI 10.1093/neuonc/nov147; Yamada I, 1999, RADIOLOGY, V210, P617, DOI 10.1148/radiology.210.3.r99fe17617; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209796	10.1371/journal.pone.0209796	http://dx.doi.org/10.1371/journal.pone.0209796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589912	Green Submitted, Green Published, gold			2022-12-26	WOS:000454418200055
J	Cobbs, GA; Alexander, JE				Cobbs, Gary A.; Alexander, James E., Jr.			Assessment of oxygen consumption in response to progressive hypoxia	PLOS ONE			English	Article							AIC MODEL SELECTION; DECLINING OXYGEN; MULTIMODEL INFERENCE; BODY-SIZE; TENSION; ADAPTATIONS; REGRESSION; ECOLOGY	A new method is presented for describing the rate of oxygen consumption in response to progressive hypoxia. The method consists of screening candidate functions describing the relationship between Vo(2) (oxygen consumption rate) and Po-2 (ambient oxygen concentration) by testing each for fit to observed data for a single curve and the function that best fits is chosen using lowest AICc value as the criterion. Descriptive statistics are then extracted from the selected function that best describes the pattern present in the curve. Several new descriptive statistics for the pattern of response are proposed which are based on the null model of simple diffusion and no regulation. The method quantifies deviation from the null model at each point on the curve and measures both positive and negative deviation which occur when the curve changes more slowly or more rapidly than the null model predicts, respectively. The new descriptive statistics generalize the traditional one used in the past, the critical oxygen tension (P-c), and allow interpretation of a variety of shapes of curves which cannot be analyzed with conventional methods. Because the method is descriptive, it does not implicate any specific mechanisms in generating the response. The method is applied to data from 68 animals in 14 different species groups reported in the literature. The overall results suggest the existence of substantial diversity in response types among animals, which requires a more complex description than has traditionally been used.	[Cobbs, Gary A.; Alexander, James E., Jr.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA	University of Louisville	Cobbs, GA (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	gacobb01@louisville.edu		Cobbs, Gary/0000-0003-1375-7662				Alexander JE, 2004, COMP BIOCHEM PHYS A, V137, P425, DOI 10.1016/j.cbpb.2003.11.003; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; BAYNE B, 1973, COMP BIOCHEM PHYSIOL, V45, P793, DOI 10.1016/0300-9629(73)90082-0; BAYNE BL, 1976, OECOLOGIA, V22, P229, DOI 10.1007/BF00344794; Breitburg D, 2018, SCIENCE, V359, P46, DOI 10.1126/science.aam7240; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CRISP M, 1978, J MAR BIOL ASSOC UK, V58, P387, DOI 10.1017/S002531540002806X; HERREID CF, 1980, COMP BIOCHEM PHYS A, V67, P311, DOI 10.1016/S0300-9629(80)80002-8; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kristensen E., 1983, EFFECTS HYPOXIA MAR, V12, P289, DOI DOI 10.3354/MEPS012289; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; MANGUM C, 1973, AM ZOOL, V13, P529; Marsden ID, 2012, J MAR BIOL ASSOC UK, V92, P1603, DOI 10.1017/S0025315411001512; Marshall DJ, 2013, J EXP BIOL, V216, P2176, DOI 10.1242/jeb.085712; Mueller CA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P522, DOI 10.1086/661953; Pohle B, 2005, LIMNOLOGICA, V35, P78, DOI 10.1016/j.limno.2004.12.001; Prosser C.L., 1973, COMP ANIMAL PHYSL, VThird; Randall DJ, 2002, ECKERT ANIMAL PHYSL, V5; Tang PS, 1933, Q REV BIOL, V8, P260, DOI 10.1086/394439; TAYLOR AC, 1975, J EXP MAR BIOL ECOL, V19, P187, DOI 10.1016/0022-0981(75)90046-5; VANWINKLE W, 1975, J EXP MAR BIOL ECOL, V17, P103, DOI 10.1016/0022-0981(75)90025-8; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WIENS A. WAYNE, 1961, PHYSIOL ZOOL, V34, P39; Willmer P, 2005, ENV PHYSL ANIMALS; Wood CM, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163717; YEAGER DP, 1989, PHYSIOL ZOOL, V62, P888, DOI 10.1086/physzool.62.4.30157935; [No title captured]	30	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0208836	10.1371/journal.pone.0208836	http://dx.doi.org/10.1371/journal.pone.0208836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576395	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400020
J	Smith, CJ; Baer, RJ; Oltman, SP; Breheny, PJ; Bao, W; Robinson, JG; Dagle, JM; Liang, L; Feuer, SK; Chambers, CD; Jelliffe-Pawlowski, LL; Ryckman, KK				Smith, Caitlin J.; Baer, Rebecca J.; Oltman, Scott P.; Breheny, Patrick J.; Bao, Wei; Robinson, Jennifer G.; Dagle, John M.; Liang, Liang; Feuer, Sky K.; Chambers, Christina D.; Jelliffe-Pawlowski, Laura L.; Ryckman, Kelli K.			Maternal dyslipidemia and risk for preterm birth	PLOS ONE			English	Article							PREGNANCY OUTCOMES; LIPIDS	Maternal lipid profiles during pregnancy are associated with risk for preterm birth. This study investigates the association between maternal dyslipidemia and subsequent preterm birth among pregnant women in the state of California. Births were identified from California birth certificate and hospital discharge records from 2007-2012 (N = 2,865,987). Preterm birth was defined as <37 weeks completed gestation and dyslipidemia was defined by diagnostic codes. Subtypes of preterm birth were classified as preterm premature rupture of membranes (PPROM), spontaneous labor, and medically indicated, according to birth certificate data and diagnostic codes. The association between dyslipidemia and preterm birth was tested with logistic regression. Models were adjusted for maternal age at delivery, race/ethnicity, hypertension, pre-pregnancy body mass index, insurance type, and education. Maternal dyslipidemia was significantly associated with increased odds of preterm birth (adjusted OR: 1.49, 95% CI: 1.39, 1.59). This finding was consistent across all subtypes of preterm birth, including PPROM (adjusted OR: 1.54, 95% CI: 1.34, 1.76), spontaneous (adjusted OR: 1.51, 95% CI: 1.39, 1.65), and medically indicated (adjusted OR: 1.454, 95% CI: 1.282, 1.649). This study suggests that maternal dyslipidemia is associated with increased risk for all types of preterm birth.	[Smith, Caitlin J.; Bao, Wei; Robinson, Jennifer G.; Ryckman, Kelli K.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Baer, Rebecca J.; Chambers, Christina D.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Baer, Rebecca J.; Oltman, Scott P.; Jelliffe-Pawlowski, Laura L.] Univ Calif San Francisco, Calif Preterm Birth Initiat, San Francisco, CA 94143 USA; [Oltman, Scott P.; Jelliffe-Pawlowski, Laura L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Breheny, Patrick J.] Univ Iowa, Dept Biostat, Iowa City, IA USA; [Dagle, John M.; Ryckman, Kelli K.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Liang, Liang] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Feuer, Sky K.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of Iowa; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa; University of Iowa; Stanford University; University of California System; University of California San Francisco	Ryckman, KK (corresponding author), Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.; Ryckman, KK (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	kelli-ryckman@uiowa.edu	Bao, Wei/AAG-2431-2019; , Jennifer/AAD-8336-2019	Bao, Wei/0000-0002-7301-5786; Chambers, Christina D/0000-0003-4675-7722; Ryckman, Kelli/0000-0002-9496-4147	California Preterm Birth Initiative within the University of California, San Francisco [UCSF7027075]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR064194] Funding Source: NIH RePORTER	California Preterm Birth Initiative within the University of California, San Francisco; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the California Preterm Birth Initiative within the University of California, San Francisco (UCSF7027075). Members of the California Preterm Birth Initiative participated as authors on this manuscript and are specifically noted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by the California Preterm Birth Initiative within the University of California, San Francisco.	Alleman BW, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.03.005; [Anonymous], 2014, INT CLASS DIS 9 REV; [Anonymous], 2015, AD BMI CTR DIS CONTR; Baer RJ, 2018, EUR J OBSTET GYN R B, V231, P235, DOI 10.1016/j.ejogrb.2018.11.004; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bouhairie VE, 2015, CARDIOL CLIN, V33, P169, DOI 10.1016/j.ccl.2015.01.001; Bronstein JM, 2018, INT J HEALTH SERV, V48, P622, DOI 10.1177/0020731418786360; Chatzi L, 2009, AM J EPIDEMIOL, V170, P829, DOI 10.1093/aje/kwp211; Edison RJ, 2007, PEDIATRICS, V120, P723, DOI 10.1542/peds.2006-1939; Emet T, 2013, ARCH GYNECOL OBSTET, V288, P49, DOI 10.1007/s00404-013-2750-y; Ferre C, 2016, MMWR-MORBID MORTAL W, V65, P1181, DOI 10.15585/mmwr.mm6543a1; Ferrero DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162506; Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004; Hartling L, 2014, DIABETIC MED, V31, P319, DOI 10.1111/dme.12357; Jelliffe-Pawlowski LL, 2015, BJOG-INT J OBSTET GY, V122, P1484, DOI 10.1111/1471-0528.13495; Jelliffe-Pawlowski L. L., 2014, AM J OBSTET GYNECOL, V211, pe1, DOI DOI 10.1016/J.AJ0G.2014.02.019); Jiang SY, 2017, TAIWAN J OBSTET GYNE, V56, P9, DOI 10.1016/j.tjog.2016.07.012; Jin HF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111760; Jin WY, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0852-9; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Kramer MS, 2009, INT J EPIDEMIOL, V38, P715, DOI 10.1093/ije/dyp167; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Lei Q, 2016, DIABETES-METAB RES, V32, P835, DOI 10.1002/dmrr.2803; Maymunah AO, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.28; Mudd LM, 2012, ACTA OBSTET GYN SCAN, V91, P726, DOI 10.1111/j.1600-0412.2012.01391.x; Niromanesh S, 2012, NATL MED J INDIA, V25, P265; Oluwole Ayodeji A, 2014, Niger Med J, V55, P406, DOI 10.4103/0300-1652.140381; Papoutsidakis N, 2014, MED CHEM, V10, P643, DOI 10.2174/1573406410666140318101936; Stone NJ, 2013, REPORT AM COLL CARDI; Toleikyte I, 2011, CIRCULATION, V124, P1606, DOI 10.1161/CIRCULATIONAHA.110.990929; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Wild R, 2015, CARDIOL CLIN, V33, P209, DOI 10.1016/j.ccl.2015.01.002	32	19	22	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209579	10.1371/journal.pone.0209579	http://dx.doi.org/10.1371/journal.pone.0209579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576377	gold, Green Submitted, Green Published			2022-12-26	WOS:000454149400059
J	Hedges, CP; Bishop, DJ; Hickey, AJR				Hedges, Christopher P.; Bishop, David J.; Hickey, Anthony J. R.			Voluntary wheel running prevents the acidosis-induced decrease in skeletal muscle mitochondrial reactive oxygen species emission	FASEB JOURNAL			English	Article						pH; mitochondria function; oxidative phosphorylation; oxidative stress; ROS	SUPEROXIDE-PRODUCTION; FIBER COMPOSITION; ENZYME-ACTIVITY; H2O2 RELEASE; EXERCISE; ADAPTATIONS; PH; INTERVAL; RESPIRATION; CAPACITY	Decreases in pH (acidosis) in vitro can alter skeletal muscle mitochondrial function [respiration and reactive oxygen species (ROS) emission]. However, because skeletal muscles readily adapt to exercise, the effects of acidosis may be different on sedentary vs. trained muscle. The aim of this work was to compare the effects of pH on skeletal muscle mitochondrial function between sedentary vs. exercise-trained male Sprague-Dawley rats (n = 10 in each cohort). Rates of mitochondrial respiration and ROS emission were determined from the soleus muscle of both cohorts over a physiologic range of pH values (pH 6.2-7.1). Exercise-trained rats had 14% higher mean muscle buffering capacities; 46 and 40% greater enzyme activity of citrate synthase and lactate dehydrogenase, respectively; and greater activity of respiratory complexes I-IV. ADP-stimulated respiration with complex I and II substrates was similar to 25% greater in exercise-trained rats but was unaffected by pH in either cohort. In both cohorts, lowering pH decreased respiration only in complex I- and complex II-supported nonphosphorylating (leak) state. However, as pH decreased, ROS emissions in complex I- and complex II-supported leak state decreased only in sedentary rats; in exercise-trained rats, ROS emissions in this state remained constant. We hypothesize that this effect may result from modulation at complex III, which declined 47% per unit pH in sedentary rats, in comparison to 23% in exercise-trained rats. Taken together, these data suggest that pH regulates mitochondrial respiratory complexes and that exercise training can decrease the effects of pH on skeletal muscle mitochondrial function.	[Hedges, Christopher P.; Hickey, Anthony J. R.] Univ Auckland, Sch Biol Sci, Appl Surg & Metab Lab, Auckland, New Zealand; [Hedges, Christopher P.; Bishop, David J.] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Bishop, David J.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia	University of Auckland; Victoria University; Edith Cowan University	Hickey, AJR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	a.hickey@auckland.ac.nz	Bishop, David John/X-9826-2019	Bishop, David John/0000-0002-6956-9188; Hedges, Christopher/0000-0003-1104-0385	Faculty Research and Development Fund grant	Faculty Research and Development Fund grant	The authors thank Amorita Volschenk (University of Auckland) for expert technical assistance throughout the study, Dr. Cian McGinley (Sportscotland Institute of Sport, Stirling, United Kingdom) for advice on muscle buffer capacity experiments, and Dr. Kathy Ruggiero (University of Auckland) for guidance with statistical analyses. This project was funded by a Faculty Research and Development Fund grant (to A.J.R.H.). The authors declare no conflicts of interest.	Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505; Banh S, 2013, FEBS LETT, V587, P1799, DOI 10.1016/j.febslet.2013.04.035; Bishop DJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE225, DOI 10.1152/ajpendo.00738.2009; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135; Daussin FN, 2008, J APPL PHYSIOL, V104, P1436, DOI 10.1152/japplphysiol.01135.2007; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Foster C, 2015, J SPORT SCI MED, V14, P747; Gnaiger E, 1998, J EXP BIOL, V201, P1129; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Granata C, 2016, FASEB J, V30, P3413, DOI 10.1096/fj.201500100R; Grivennikova VG, 2013, BBA-BIOENERGETICS, V1827, P446, DOI 10.1016/j.bbabio.2013.01.002; Harkema SJ, 1997, AM J PHYSIOL-CELL PH, V272, pC491, DOI 10.1152/ajpcell.1997.272.2.C491; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; Jubrias SA, 2003, J PHYSIOL-LONDON, V553, P589, DOI 10.1113/jphysiol.2003.045872; Kemp G, 2005, AM J PHYSIOL-REG I, V289, pR895, DOI 10.1152/ajpregu.00641.2004; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; MANNION AF, 1993, J APPL PHYSIOL, V75, P1412, DOI 10.1152/jappl.1993.75.3.1412; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; SAHLIN K, 1978, ACTA PHYSIOL SCAND, V104, P370, DOI 10.1111/j.1748-1716.1978.tb06289.x; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Servais S, 2003, FREE RADICAL BIO MED, V35, P24, DOI 10.1016/S0891-5849(03)00177-1; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Thomas C, 2007, AM J PHYSIOL-ENDOC M, V293, pE916, DOI 10.1152/ajpendo.00164.2007; Tonkonogi M, 1999, AM J PHYSIOL-CELL PH, V277, pC288, DOI 10.1152/ajpcell.1999.277.2.C288; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494; Walsh B, 2002, J APPL PHYSIOL, V92, P2273, DOI 10.1152/japplphysiol.01132.2001; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Weston AR, 1996, ACTA PHYSIOL SCAND, V157, P211, DOI 10.1046/j.1365-201X.1996.488225000.x; Zoll J, 2003, J CELL PHYSIOL, V194, P186, DOI 10.1002/jcp.10224	37	2	2	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4996	5004		10.1096/fj.201801870R	http://dx.doi.org/10.1096/fj.201801870R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30596520	Bronze			2022-12-26	WOS:000462888500029
J	Wang, Y; La, M; Pham, T; Lovrecz, GO; Nie, GY				Wang, Yao; La, Mylinh; Tam Pham; Lovrecz, George O.; Nie, Guiying			High levels of HtrA4 detected in preeclamptic circulation may disrupt endothelial cell function by cleaving the main VEGFA receptor KDR	FASEB JOURNAL			English	Article						early onset preeclampsia; angiogenesis; endothelial dysfunction; HUVEC	GROWTH-FACTOR RECEPTOR-2; EARLY-ONSET PREECLAMPSIA; TYROSINE KINASE-1; GENE-EXPRESSION; PREGNANCY; RISK; DYSFUNCTION; MORTALITY; PROTEIN; FAMILY	Systemic endothelial dysfunction is a key characteristic of preeclampsia (PE), which is a serious disorder of human pregnancy. We have previously reported that high-temperature requirement factor (Htr)A4 is a placenta-specific protease that is secreted into the maternal circulation and significantly up-regulated in PE, especially early-onset PE. We have also demonstrated that high levels of HtrA4 detected in the early onset PE circulation induce endothelial dysfunction in HUVECs. In the current study, we investigated whether HtrA4 could cleave the main receptor of VEGFA, the kinase domain receptor (KDR), thereby inhibiting VEGFA signaling. We first demonstrated that HtrA4 cleaved recombinant KDR in vitro. We then confirmed that HtrA4 reduced the level of KDR in HUVECs and inhibited the VEGFA-induced phosphorylation of Akt kinase, which is essential for downstream signaling. Further functional studies demonstrated that HtrA4 prevented the VEGFA-induced tube formation in HUVECs and dose-dependently inhibited the VEGFA-induced angiogenesis in explants of mouse aortic rings. These data strongly suggest that high levels of HtrA4 in the maternal circulation could cleave the main receptor of VEGFA in endothelial cells to induce a wide-spread impairment of angiogenesis. Our studies therefore suggest that HtrA4 is a potential causal factor of early onset PE.	[Wang, Yao; Nie, Guiying] Hudson Inst Med Res, Ctr Reprod Hlth, Implantat & Placental Dev Lab, Clayton, Vic, Australia; [Wang, Yao; Nie, Guiying] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [Nie, Guiying] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [La, Mylinh; Tam Pham; Lovrecz, George O.] Commonwealth Sci & Ind Res Org CSIRO Mfg, Clayton, Vic, Australia	Hudson Institute of Medical Research; Monash University; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nie, GY (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	guiying.nie@hudson.org.au			National Health and Medical Research Council of Australia [1041835, 1108365]; Dora Lush (Biomedical) Research Scholarship; Victorian State Government Operational Infrastructure Scheme; National Collaborative Research Infrastructure Strategy	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush (Biomedical) Research Scholarship; Victorian State Government Operational Infrastructure Scheme; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	The authors thank Dr. Sonia Teoh for assistance with studies involving mice and Dr. Sophea Heng (both from Hudson Institute of Medical Research) for assistance with confocal imaging. This work was supported by National Health and Medical Research Council of Australia Fellowship 1041835 and Project Grant 1108365 (to G.N.), a Dora Lush (Biomedical) Research Scholarship (to Y.W.), the Victorian State Government Operational Infrastructure Scheme, and the National Collaborative Research Infrastructure Strategy. The authors declare no conflicts of interest.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Brew O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161504; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Cross Sarah N, 2012, Rev Obstet Gynecol, V5, P2; Dellinger MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028947; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Inagaki A, 2012, PLACENTA, V33, P919, DOI 10.1016/j.placenta.2012.08.003; Kaartokallio T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14107; Lapaire O, 2012, FETAL DIAGN THER, V31, P147, DOI 10.1159/000337325; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Liu CH, 2018, MOL MED REP, V18, P2937, DOI 10.3892/mmr.2018.9289; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mellembakken JR, 2002, HYPERTENSION, V39, P155, DOI 10.1161/hy0102.100778; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Palmer KR, 2015, HYPERTENSION, V66, P1251, DOI 10.1161/HYPERTENSIONAHA.115.05883; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Poston Lucilla, 2006, Pharmacol Rep, V58 Suppl, P69; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; RODGERS GM, 1988, AM J OBSTET GYNECOL, V159, P908, DOI 10.1016/S0002-9378(88)80169-8; Schipper EJI, 2005, J MATERN-FETAL NEO M, V18, P283, DOI 10.1080/14767050500246466; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Singh H, 2015, J CLIN ENDOCR METAB, V100, pE936, DOI 10.1210/jc.2014-3969; Singh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108235; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Vitoratos N, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/908649; Wang Y, 2018, SLAS DISCOV, V23, P1092, DOI 10.1177/1087057116682425; Wang Y, 2016, PLACENTA, V47, P46, DOI 10.1016/j.placenta.2016.09.003; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1	46	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					5058	5066		10.1096/fj.201802151RR	http://dx.doi.org/10.1096/fj.201802151RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601675				2022-12-26	WOS:000462888500034
J	Machovina, MM; Ellis, ES; Carney, TJ; Brushett, FR; DuBois, JL				Machovina, Melodie M.; Ellis, Emerald S.; Carney, Thomas J.; Brushett, Fikile R.; DuBois, Jennifer L.			How a cofactor-free protein environment lowers the barrier to O-2 reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); oxidase; electron transfer; antibiotics; radical; cofactor-independent; Marcus theory	INDEPENDENT MONOOXYGENASE SNOAB; ELECTRON-TRANSFER; OXYGEN ACTIVATION; REDOX POTENTIALS; OXIDATION; KINETICS; THERMODYNAMICS; CRYSTALLIZATION; BIOSYNTHESIS; PURIFICATION	Molecular oxygen (O-2)-utilizing enzymes are among the most important in biology. The abundance of O-2, its thermodynamic power, and the benign nature of its end products have raised interest in oxidases and oxygenases for biotechnological applications. Although most O-2-dependent enzymes have an absolute requirement for an O-2-activating cofactor, several classes of oxidases and oxygenases accelerate direct reactions between substrate and O-2 using only the protein environment. Nogalamycin monooxygenase (NMO) from Streptomyces nogalater is a cofactor-independent enzyme that catalyzes rate-limiting electron transfer between its substrate and O-2. Here, using enzyme-kinetic, cyclic voltammetry, and mutagenesis methods, we demonstrate that NMO initially activates the substrate, lowering its pK(a) by 1.0 unit (G* = 1.4 kcal mol(-1)). We found that the one-electron reduction potential, measured for the deprotonated substrate both inside and outside the protein environment, increases by 85 mV inside NMO, corresponding to a G(0) of 2.0 kcal mol(-1) (0.087 eV) and that the activation barrier, G(double dagger), is lowered by 4.8 kcal mol(-1) (0.21 eV). Applying the Marcus model, we observed that this suggests a sizable decrease of 28 kcal mol(-1) (1.4 eV) in the reorganization energy (), which constitutes the major portion of the protein environment's effect in lowering the reaction barrier. A similar role for the protein has been proposed in several cofactor-dependent systems and may reflect a broader trend in O-2-utilizing proteins. In summary, NMO's protein environment facilitates direct electron transfer, and NMO accelerates rate-limiting electron transfer by strongly lowering the reorganization energy.	[Machovina, Melodie M.; Ellis, Emerald S.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA; [Carney, Thomas J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Brushett, Fikile R.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Montana State University System; Montana State University Bozeman; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA.	jennifer.dubois1@montana.edu		Carney, Thomas/0000-0002-9250-1659	National Science Foundation [MCB1715176]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB1715176. The authors declare that they havenoconflicts of interest with the contents of this article.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Carney TJ, 2017, CHEM MATER, V29, P4801, DOI 10.1021/acs.chemmater.7b00616; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Elgrishi N, 2018, J CHEM EDUC, V95, P197, DOI 10.1021/acs.jchemed.7b00361; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gray HB, 2009, CHEM PHYS LETT, V483, P1, DOI 10.1016/j.cplett.2009.10.051; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hamdane D, 2008, PHOTOSYNTH RES, V98, P657, DOI 10.1007/s11120-008-9322-1; Kendrew SG, 2000, ACTA CRYSTALLOGR D, V56, P481, DOI 10.1107/S0907444900001189; Kendrew SG, 1997, J BACTERIOL, V179, P4305, DOI 10.1128/jb.179.13.4305-4310.1997; Khoshtariya DE, 2010, P NATL ACAD SCI USA, V107, P2757, DOI 10.1073/pnas.0910837107; Koskiniemi H, 2009, ACTA CRYSTALLOGR F, V65, P256, DOI 10.1107/S1744309109001389; Kulys J, 2000, J BIOL INORG CHEM, V5, P333, DOI 10.1007/PL00010662; Lee SY, 1999, BIOCHEMISTRY-US, V38, P4423, DOI 10.1021/bi982712w; Li C, 1999, J PHYS CHEM B, V103, P6653, DOI 10.1021/jp983819w; Machovina MM, 2016, J BIOL CHEM, V291, P17816, DOI 10.1074/jbc.M116.730051; Miller AF, 2004, CURR OPIN CHEM BIOL, V8, P162, DOI 10.1016/j.cbpa.2004.02.011; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; NOZAKI K, 1989, J ELECTROANAL CHEM, V270, P191, DOI 10.1016/0022-0728(89)85036-3; O'Reilly NJ, 2005, LANGMUIR, V21, P1009, DOI 10.1021/la048796t; Olshansky L, 2016, J AM CHEM SOC, V138, P1196, DOI 10.1021/jacs.5b09259; OTURAN MA, 1984, J ELECTROANAL CHEM, V161, P377, DOI 10.1016/S0022-0728(84)80194-1; Pavlishchuk VV, 2000, INORG CHIM ACTA, V298, P97, DOI 10.1016/S0020-1693(99)00407-7; Que L. Q., 2007, BIOL INORGANIC CHEM, P1; Roth HG, 2016, SYNLETT, V27, P714, DOI 10.1055/s-0035-1561297; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Silverstein TP, 2012, J CHEM EDUC, V89, P1159, DOI 10.1021/ed1007712; Sirajuddin S, 2015, BIOCHEMISTRY-US, V54, P2283, DOI 10.1021/acs.biochem.5b00198; TAUBE H, 1965, J GEN PHYSIOL, V49, P29, DOI 10.1085/jgp.49.1.29; Verdolino V, 2008, J PHYS CHEM B, V112, P16860, DOI 10.1021/jp8068877; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k	37	2	2	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3661	3669		10.1074/jbc.RA118.006144	http://dx.doi.org/10.1074/jbc.RA118.006144			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602564	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000461853900028
J	Bruns, I; Sauer, B; Burger, MC; Eriksson, J; Hofmann, U; Braun, Y; Harter, PN; Luger, AL; Ronellenfitsch, MW; Steinbach, JP; Rieger, J				Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Eriksson, Jule; Hofmann, Ute; Braun, Yannick; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.; Rieger, Johannes			Disruption of peroxisome proliferator-activated receptor coactivator (PGC)-1 reverts key features of the neoplastic phenotype of glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; hypoxia; reactive oxygen species (ROS); transcription coactivator; tumor metabolism; peroxisome proliferator-activated receptor coactivator 1-(PGC-1) (PPARGC1A)	MITOCHONDRIAL BIOGENESIS; GLUCOSE TRANSPORTERS; GAMMA COACTIVATOR-1; MAMMALIAN TARGET; PROTECTS GLIOMA; CANCER-CELLS; EXPRESSION; RESPIRATION; METABOLISM; VEGF	The peroxisome proliferator-activated receptor coactivator (PGC)-1 is a master regulator of mitochondrial biogenesis and controls metabolism by coordinating transcriptional events. Here, we interrogated whether PGC-1 is involved in tumor growth and the metabolic flexibility of glioblastoma cells. PGC-1 was expressed in a subset of established glioma cell lines and primary glioblastoma cell cultures. Furthermore, a higher PGC-1 expression was associated with an adverse outcome in the TCGA glioblastoma dataset. Suppression of PGC-1 expression by shRNA in the PGC-1-positive U343MG glioblastoma line suppressed mitochondrial gene expression, reduced mitochondrial membrane potential, and diminished oxygen as well as glucose consumption, and lactate production. Compatible with the known PGC-1 functions in reactive oxygen species (ROS) metabolism, glioblastoma cells deficient in PGC-1 displayed ROS accumulation, had reduced RNA levels of proteins involved in ROS detoxification, and were more susceptible to death induction by H2O2 compared with control cells. PGC-1sh cells also had impaired proliferation and migration rates in vitro and displayed less stem cell characteristics. Complementary effects were observed in PGC-1-low LNT-229 cells engineered to overexpress PGC-1. In an in vivo xenograft experiment, tumors formed by U343MG PGC-1sh glioblastoma cells grew much slower than control tumors and were less invasive. Interestingly, the PGC-1 knockdown conferred protection against hypoxia-induced cell death, probably as a result of less active anabolic pathways, and this effect was associated with reduced epidermal growth factor expression and mammalian target of rapamycin signaling. In summary, PGC-1 modifies the neoplastic phenotype of glioblastoma cells toward more aggressive behavior and therefore makes PGC-1 a potential target for anti-glioblastoma therapies.	[Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Eriksson, Jule; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.; Rieger, Johannes] Goethe Univ, Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, Schleusenweg 2-16, D-60528 Frankfurt, Germany; [Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, D-60590 Frankfurt, Germany; [Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.] Goethe Univ, Univ Hosp Frankfurt, Univ Canc Ctr UCT, D-60590 Frankfurt, Germany; [Eriksson, Jule] Univ Basel, Dept Neurol, CH-4031 Basel, Switzerland; [Hofmann, Ute] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Hofmann, Ute] Univ Tubingen, D-72074 Tubingen, Germany; [Braun, Yannick; Harter, Patrick N.] Goethe Univ, Univ Hosp Frankfurt, Edinger Inst, Inst Neurol, D-60528 Frankfurt, Germany; [Rieger, Johannes] Univ Hosp Tubingen, Hertie Inst Clin Brain Res, Interdisciplinary Div Neurooncol, D-72076 Tubingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ronellenfitsch, MW; Steinbach, JP (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	m.ronellenfitsch@gmx.net; joachim.steinbach@med.uni-frankfurt.de	Ronellenfitsch, Michael/AAW-8201-2020; Thiepold, Anna-Luisa/AAW-8310-2021	Ronellenfitsch, Michael/0000-0002-1402-6290; Rieger, Johannes/0000-0002-7918-1777; Harter, Patrick N./0000-0001-5530-6910	Deutsche Forschungsgemeinschaft (DFG) [RI2175/1-1]; Robert-Bosch Foundation, Stuttgart, Germany; University Cancer Center (UCT) Frankfurt; Frankfurt Research Funding within the framework of the "Sponsorship Model"; Else Kroner-Forschungskolleg (EKE) - Else Kroner-Fresenius Foundation; Medical Faculty, University Hospital Frankfurt Program "Nachwuchsforscher 2012"; Clinician Scientists Program	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert-Bosch Foundation, Stuttgart, Germany; University Cancer Center (UCT) Frankfurt; Frankfurt Research Funding within the framework of the "Sponsorship Model"; Else Kroner-Forschungskolleg (EKE) - Else Kroner-Fresenius Foundation; Medical Faculty, University Hospital Frankfurt Program "Nachwuchsforscher 2012"; Clinician Scientists Program	This work was supported in part by Grant RI2175/1-1 from the Deutsche Forschungsgemeinschaft (DFG) (to J.P.S. and J.R.). J.P.S. and J.R. have served as consultants for Roche Applied Science, the European distributor of bevacizumab.; Supported by the Robert-Bosch Foundation, Stuttgart, Germany.; Recipient of a fellowship from the University Cancer Center (UCT) Frankfurt.; Recipient of funding from Frankfurt Research Funding within the framework of the "Sponsorship Model" and a fellowship in the program "Clinician Scientist" by the Else Kroner-Forschungskolleg (EKE), which is supported by The Else Kroner-Fresenius Foundation.; Recipient of funding from the Medical Faculty, University Hospital Frankfurt Program "Nachwuchsforscher 2012" as well as "Clinician Scientists Program", and a fellowship from the University Cancer Center (UCT) Frankfurt.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; De Luca A, 2015, ONCOTARGET, V6, P14777, DOI 10.18632/oncotarget.4401; Di K, 2016, ONCOTARGET, V7, P77457, DOI 10.18632/oncotarget.12681; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Evans A, 2008, CANCER CHEMOTH PHARM, V61, P377, DOI 10.1007/s00280-007-0480-1; Fu XF, 2016, J ZHEJIANG UNIV-SC B, V17, P136, DOI 10.1631/jzus.B1500158; GRADY JE, 1960, CANCER RES, V20, P1114; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hartel I, 2016, INT J ONCOL, V49, P173, DOI 10.3892/ijo.2016.3498; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Keibler MA, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0156-6; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin H, 2017, NEURO-ONCOLOGY, V19, P43, DOI 10.1093/neuonc/now128; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu Y, 2009, BRAIN RES, V1304, P149, DOI 10.1016/j.brainres.2009.09.083; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Mao XG, 2016, ONCOTARGET, V7, P47808, DOI 10.18632/oncotarget.10029; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; Santos JM, 2014, MED HYPOTHESES, V82, P748, DOI 10.1016/j.mehy.2014.03.018; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinbach JP, 2004, CANCER RES, V64, P1575, DOI 10.1158/0008-5472.CAN-03-3775; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Teng CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026961; Thiepold AL, 2017, BRAIN, V140, P2623, DOI 10.1093/brain/awx196; Vannucci SJ, 1996, J CEREBR BLOOD F MET, V16, P77, DOI 10.1097/00004647-199601000-00009; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhu LY, 2010, CELL RES, V20, P676, DOI 10.1038/cr.2010.46	58	12	12	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3037	3050		10.1074/jbc.RA118.006993	http://dx.doi.org/10.1074/jbc.RA118.006993			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30578297	hybrid, Green Published			2022-12-26	WOS:000464980100006
J	Watson, A; Timperio, A; Brown, H; Hinkley, T; Hesketh, KD				Watson, Amanda; Timperio, Anna; Brown, Helen; Hinkley, Trina; Hesketh, Kylie D.			Associations between organised sport participation and classroom behaviour outcomes among primary school-aged children	PLOS ONE			English	Article							QUALITY-OF-LIFE; POPULATION HEALTH MEASURE; PHYSICAL-ACTIVITY; ACADEMIC-ACHIEVEMENT; DIFFICULTIES QUESTIONNAIRE; FEASIBILITY; RELIABILITY; STRENGTHS; EXERCISE; SKILLS	Introduction Physical activity is positively associated with children's classroom behaviour. However, less is known about how different types of physical activity contribute to these outcomes. This study examines associations between sport participation and classroom behaviour among primary school-aged children. Methods Parents of 568 children aged 9-11 years reported child sport participation and classroom behaviour outcomes (school functioning, inattention, classroom behaviour (fidgetiness), acting without thinking and poor concentration). Sport participation included: duration (hours/week) and type (individual; team; team and individual). Regression analyses assessed associations between sport participation and classroom behaviour outcomes. Analyses adjusted for maternal education, and objectively-measured overall physical activity, and accounted for clustering by recruitment centre. Sex differences in associations were explored as a secondary aim. Results In comparison to children who did not participate in sport, children who participated in sport displayed less inattention/hyperactivity (individual sport: B = -1.00; 95% CI:-1.90, -0.00; team sport:-0.88; 95% CI:-1.73, -0.03) and less acting without thinking (individual sport: OR = 0.35; 95% CI: 0.13,0.98), after adjusting for overall physical activity. There were no sex differences in associations. Conclusions Findings indicated sport participation, one form of physical activity, was associated with less inattention/hyperactivity and acting without thinking, over and above the influence of overall physical activity levels. Parents may consider sport as one way to contribute to their child's overall physical activity levels, although the impact of organised sport on classroom behaviour is modest at best.	[Watson, Amanda; Timperio, Anna; Brown, Helen; Hinkley, Trina; Hesketh, Kylie D.] Deakin Univ, Sch Exercise & Nutr Sci, IPAN, Geelong, Vic, Australia	Deakin University	Hesketh, KD (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, IPAN, Geelong, Vic, Australia.	kylie.hesketh@deakin.edu.au	Brown, Helen/AAY-4382-2020; Watson, Amanda/Y-6674-2019; Hesketh, Kylie/B-7031-2013; Timperio, Anna/A-3086-2013	Watson, Amanda/0000-0002-9058-3435; Hesketh, Kylie/0000-0002-2702-7110; Brown, Helen/0000-0002-5460-3654; Timperio, Anna/0000-0002-8773-5012; Hinkley, Trina/0000-0003-2742-8579	Australian Research Council [DP140100554]; Deakin University; National Heart Foundation of Australia Future Leader Fellowship [100046]; National Health and Medical Research Council Early Career Fellowship [APP1070571]; Australian Research Council Future Fellowship [FT130100637]; Honorary National Heart Foundation of Australia Future Leader Fellowship [100370]	Australian Research Council(Australian Research Council); Deakin University; National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia); National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); Honorary National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia)	The Healthy Active Preschool and Primary Years (HAPPY) study was funded by the Australian Research Council (DP140100554) to Kylie D Hesketh. Amanda Watson is a recipient of a Postgraduate Scholarship from Deakin University. Anna Timperio was supported by a National Heart Foundation of Australia Future Leader Fellowship (Award 100046). Trina Hinkley was supported by a National Health and Medical Research Council Early Career Fellowship (APP1070571). Kylie D Hesketh is supported by an Australian Research Council Future Fellowship (FT130100637) & Honorary National Heart Foundation of Australia Future Leader Fellowship (100370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Amanda Watson is a recipient of a Postgraduate Scholarship from Deakin University. Anna Timperio was supported by a National Heart Foundation of Australia Future Leader Fellowship (Award 100046). Trina Hinkley was supported by a National Health and Medical Research Council Early Career Fellowship (APP1070571). Kylie Hesketh is supported by an Australian Research Council Future Fellowship (FT130100637) & Honorary National Heart Foundation of Australia Future Leader Fellowship (100370).	Abbott G, 2016, J PHYS ACT HEALTH, V13, P269, DOI 10.1123/jpah.2015-0136; Active Healthy Kids Australia, 2016, PHYS LITERACY OUR KI; Alesi M, 2016, PERCEPT MOTOR SKILL, V122, P27, DOI 10.1177/0031512515627527; Australian Bureau of Statistics, 2017, AUSTR HLTH SURV PHYS; Australian Bureau of Statistics, 2012, CHILDR PART SPORT LE; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Chang YK, 2013, EXP BRAIN RES, V225, P187, DOI 10.1007/s00221-012-3360-9; Children and Adults with Attention-Deficit/ Hyperactivity Disorder (CHADD): The National resource on ADHD, BEN SPORTS ADHD CAN; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1223, DOI 10.1249/MSS.0000000000000966; Dyer AM, 2017, AM J HEALTH BEHAV, V41, P179, DOI [10.5993/ajhb.41.2.9, 10.5993/AJHB.41.2.9]; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Erwin H, 2012, J APPL SCH PSYCHOL, V28, P14, DOI 10.1080/15377903.2012.643755; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Haapala EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107031; Hinkley T, 2017, J PHYS ACT HEALTH, V14, P308, DOI 10.1123/jpah.2015-0700; Hirvonen R, 2010, J RES READ, P302; Howie EK, 2012, J SPORT HEALTH SCI, V1, P160, DOI 10.1016/j.jshs.2012.09.003; Kren F, 2012, GENDER DIFFERENCES P; Kumpulainen K, 1999, EUROPEAN CHILD AD S4, V8, P41; Lee JWI, 2016, BORD TRANSCULT STUD, P1; Lubans D, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1642; Maguire LK, 2016, EDUC PSYCHOL-UK, V36, P1408, DOI 10.1080/01443410.2015.1034090; Okely AD., 2012, SYSTEMATIC REV UPDAT; Pan CY, 2016, RES DEV DISABIL, V57, P1, DOI 10.1016/j.ridd.2016.06.009; Piche Genevieve, 2015, Am J Health Promot, V30, pe32, DOI 10.4278/ajhp.131021-QUAN-537; Riley N, 2015, J SCI MED SPORT, V18, P656, DOI 10.1016/j.jsams.2014.09.005; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Saevarsson ES, 2017, SCAND J PUBLIC HEALT, V45, P861, DOI 10.1177/1403494817705560; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2006, QUAL LIFE RES, V15, P203, DOI 10.1007/s11136-005-1388-z; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Vella SA, 2014, J PEDIATR-US, V164, P1469, DOI 10.1016/j.jpeds.2014.01.071; Watson A, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0569-9; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Williams J, 2005, JAMA-J AM MED ASSOC, V293, P70, DOI 10.1001/jama.293.1.70	41	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209354	10.1371/journal.pone.0209354	http://dx.doi.org/10.1371/journal.pone.0209354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG1BB	30601859	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000454683200058
J	Floyd, EL; Queimado, L; Wang, J; Regens, JL; Johnson, DL				Floyd, Evan L.; Queimado, Lurdes; Wang, Jun; Regens, James L.; Johnson, David L.			Electronic cigarette power affects count concentration and particle size distribution of vaping aerosol	PLOS ONE			English	Article							MULTIPLE-PATH MODEL; RESPIRATORY-TRACT; PUFF TOPOGRAPHY; DEPOSITION; MAINSTREAM; PARAMETERS; SMOKE	Introduction Electronic cigarettes (EC) have evolved rapidly toward higher powered devices that produce more vaping aerosol and a more satisfying vaping experience. This research characterized the particle size distribution and estimated the mass concentration of vaping aerosols produced at power outputs spanning the operating range typical of second generation variable voltage EC devices. Methods EC aerosol was characterized from a single coil atomizer powered by a variable voltage EC battery at the minimum and maximum dial settings (3.3, 11.2 Watts, W), and a lab controlled power supply (3-11.9 W). Aerosol particle size distribution was measured by a Scanning Mobility Particle Sizer and Aerodynamic Particle Sizer, spanning 16 nm to 19.8 mu m. A mouth puff was simulated using a 100 mL glass syringe. Results Consistent with prior studies, sub-micron EC aerosol size distributions were bimodal, with peaks at 40 and 200 nm, however a previously unreported third mode was observed at approximately 1000 nm. The similar to 1000 nm mode accounted for 7-20x the aerosol mass of the smaller modes. Increasing atomizer power decreased count concentration of particles <600 nm but increased particle count >600 nm. Particle mass distribution shifted toward micron sized particles with increasing power and increased the respirable fraction of aerosol, likely due to increased coagulation and condensation around nano-sized particles. Conclusions Vaping power greatly affects EC aerosol count and mass distribution. Mouth puffed EC aerosol spans a much wider particle size range than previously reported, although the major portion of the mass is still well within the alveolar size range the larger particles will deposit within the oro-pharyngeal cavity at 2-3x greater efficiency than in alveoli. These observations have major clinical implications, as aerosol particle size distribution determines deposition sites along the respiratory tract. The results of this experiment stress the need for further research to inform the design, regulation and use of e-cigarette products.	[Floyd, Evan L.; Wang, Jun; Johnson, David L.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Occupat & Environm Hlth, Oklahoma City, OK 73104 USA; [Floyd, Evan L.; Queimado, Lurdes; Johnson, David L.] Oklahoma Tobacco Res Ctr, Oklahoma City, OK 73104 USA; [Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Otorhinolaryngol, Oklahoma City, OK 73190 USA; [Regens, James L.] Univ Oklahoma, OU Ctr Intelligence & Natl Secur, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Floyd, EL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Occupat & Environm Hlth, Oklahoma City, OK 73104 USA.; Floyd, EL (corresponding author), Oklahoma Tobacco Res Ctr, Oklahoma City, OK 73104 USA.	evan-floyd@ouhsc.edu	Queimado, Lurdes/L-7465-2013; Queimado, Lurdes/AAY-2545-2021	Queimado, Lurdes/0000-0002-1106-4873; Queimado, Lurdes/0000-0002-1106-4873; Floyd, Evan/0000-0002-0402-0565	Oklahoma Tobacco Research Center (OTRC) - Oklahoma Tobacco Settlement Endowment Trust [C1081507]	Oklahoma Tobacco Research Center (OTRC) - Oklahoma Tobacco Settlement Endowment Trust	This research was supported by an Advanced Development Grant from the Oklahoma Tobacco Research Center (OTRC), C1081507, which is funded by the Oklahoma Tobacco Settlement Endowment Trust.	Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; Administration FaD, 2014, DEEM TOB PROD BE SUB; ANJILVEL S, 1995, FUND APPL TOXICOL, V28, P41, DOI 10.1006/faat.1995.1144; Asgharian B, 2001, AEROSOL SCI TECH, V34, P332, DOI 10.1080/02786820119122; Bradford JA, 1936, IND ENG CHEM, V28, P836, DOI 10.1021/ie50319a020; BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325; Brown CJ, 2014, TOB CONTROL, V23, P4, DOI 10.1136/tobaccocontrol-2013-051476; CORESTA, 2015, NO 81 ROUT AN MACH E; Dickens C, 2009, J PHYS CONF SER, V151, DOI 10.1088/1742-6596/151/1/012019; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Fuoco FC, 2014, ENVIRON POLLUT, V184, P523, DOI 10.1016/j.envpol.2013.10.010; Herrington JS, 2015, J CHROMATOGR A, V1418, P192, DOI 10.1016/j.chroma.2015.09.034; HEYDER J, 1986, J AEROSOL SCI, V17, P811, DOI 10.1016/0021-8502(86)90035-2; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; HINDS WC, 1978, AM IND HYG ASSOC J, V39, P48, DOI 10.1080/0002889778507712; Ingebrethsen BJ, 2012, INHAL TOXICOL, V24, P976, DOI 10.3109/08958378.2012.744781; Ingebrethsen BJ, 2011, AEROSOL SCI TECH, V45, P1422, DOI 10.1080/02786826.2011.596863; Ji EH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154447; Keith C. H., 1960, J COLL SCI IMP U TOK, V15, P340; Kosmider L, 2014, NICOTINE TOB RES; Laino T, 2012, J PHYS CHEM A, V116, P4602, DOI 10.1021/jp300997d; Laino T, 2011, J PHYS CHEM A, V115, P3592, DOI 10.1021/jp201078e; Londahl J, 2007, INHAL TOXICOL, V19, P109, DOI 10.1080/08958370601051677; Mikheev VB, 2016, NICOTINE TOB RES; NIST, NIST CHEM WEBBOOK, P69; Ogunwale MA, 2017, ACS OMEGA, V2, P1207, DOI 10.1021/acsomega.6b00489; Ohta K, 2011, BUNSEKI KAGAKU, V60, P791; Sahu SK, 2013, AEROSOL AIR QUAL RES, V13, P324, DOI 10.4209/aaqr.2012.02.0041; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; SmokTech, 2017, Q BOX KIT; STAHLHOFEN W, 1980, AM IND HYG ASSOC J, V41, P385, DOI 10.1080/15298668091424933; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Uchiyama S, 2012, ANAL SCI INT J JAPAN, V29, P1219; Wagener TL, 2016, TOBACCO CONTROL; Zhang YP, 2013, NICOTINE TOB RES, V15, P501, DOI 10.1093/ntr/nts165; Zhao TK, 2016, ATMOS ENVIRON, V134, P61, DOI 10.1016/j.atmosenv.2016.03.027	37	60	61	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210147	10.1371/journal.pone.0210147	http://dx.doi.org/10.1371/journal.pone.0210147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596800	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200147
J	Mitra, S; Dolvin, E; Krishnamurthy, K; Wewers, MD; Sarkar, A				Mitra, Srabani; Dolvin, Erin; Krishnamurthy, Karthikeyan; Wewers, Mark D.; Sarkar, Anasuya			Francisella induced microparticulate caspase-1/gasdermin-D activation is regulated by NLRP3 independent of Pyrin	PLOS ONE			English	Article							NOD-LIKE RECEPTORS; GASDERMIN-D; INFLAMMATORY CASPASES; NALP3 INFLAMMASOME; PYROPTOSIS; PROTEIN; GSDMD; PORE; TULARENSIS; MECHANISM	Although the study of pathogen sensing by host defense systems continues to uncover a role for inflammasome components specific to particular pathogens, gaps remain in our knowledge. After internalization, Francisella escapes from the phagosome in mononuclear cells and is thought to be detected by intracellular pathogen-response-receptors pyrin and Aim2 in human and murine models, respectively. However, it remains controversial as to the role of pyrin in detecting Francisella. Our current work aims to study the contribution of inflammasome sensor, Pyrin in regulating microparticulate caspase-1/GSDM-D activation by Francisella. Our findings suggest that NLRP3 is central to the activation/release of active caspase-1/GSDM-D encapsulated in microparticles (MP) by Francisella. We also provide evidence that this regulation is independent of pyrin, implicated in sensing cytosolic Francisella in NLRP3-/- conditions where endogenous Pyrin is present. Absence of NLRP3 completely abrogated Francisella mediated MP caspase-1/GSDM-D activation and release both before and after internalization of the pathogen. However, deletion of pyrin not only enhanced both LPS and Francisella mediated MP active caspase-1/GSDM-D release, but pyrin overexpression resulted in a reduction of inflammasome activation and release; suggesting an inhibitory role of pyrin in LPS and Francisella mediated MP responses. This NLRP3 dependence and inhibitory effect of pyrin correlated with cytokine release as well. These observations also correlated with MPs ability to induce cell death; as LPS and Francisella-induced MPs from pyrin-deficient cells were more potent than wild-type monocytes whereas, NLRP3-/- MPs failed to induce cell death. Taken together, we report that NLPR3 not only mediates Francisella induced cytokine responses, but is also critical for cytokine-independent microparticle-induced inflammasome activation and endothelial cell injury independent of pyrin.	[Mitra, Srabani; Dolvin, Erin; Krishnamurthy, Karthikeyan; Sarkar, Anasuya] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Wewers, Mark D.; Sarkar, Anasuya] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sarkar, A (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.; Sarkar, A (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	anasuya.sarkar@osumc.edu	Wewers, Mark/AAB-6202-2021	Dolvin, Erin/0000-0003-1989-991X	NIH [R01HL24325, R01GM108928]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01HL24325 to Sarkar and NIH R01GM108928 to Sarkar/Wewers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Atianand MK, 2011, J BIOL CHEM, V286, P39033, DOI 10.1074/jbc.M111.244079; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Exline MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090968; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gavrilin MA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00011; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Lagrange B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02682-y; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2015, CELL RES, V25, P1183, DOI 10.1038/cr.2015.124; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mitra S, 2018, AM J RESP CELL MOL, V59, P56, DOI 10.1165/rcmb.2017-0393OC; Mitra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145607; Motta V, 2015, PHYSIOL REV, V95, P149, DOI 10.1152/physrev.00009.2014; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shamaa OR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142203; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhu QF, 2018, CELL REP, V22, P3168, DOI 10.1016/j.celrep.2018.02.096	42	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209931	10.1371/journal.pone.0209931	http://dx.doi.org/10.1371/journal.pone.0209931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596757	gold, Green Submitted, Green Published			2022-12-26	WOS:000454627200111
J	Lee, WJ; Moon, J; Jeon, D; Kim, TJ; Yoo, JS; Park, DK; Lee, ST; Jung, KH; Park, KI; Jung, KY; Kim, M; Lee, SK; Chu, K				Lee, Woo-Jin; Moon, Jangsup; Jeon, Daejong; Kim, Tae-Joon; Yoo, Jung-Suk; Park, Dong-Kyu; Lee, Soon-Tae; Jung, Keun-Hwa; Park, Kyung-Il; Jung, Ki-Young; Kim, Manho; Lee, Sang Kun; Chu, Kon			Possible epigenetic regulatory effect of dysregulated circular RNAs in epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SPONTANEOUS RECURRENT SEIZURES; LONG NONCODING RNAS; CELL PROLIFERATION; STATUS EPILEPTICUS; EXPRESSION; EPILEPTOGENESIS; BRAIN; NEUROGENESIS; HIPPOCAMPUS	Circular RNAs (circRNAs) involve in the epigenetic regulation and its major mechanism is the sequestration of the target micro RNAs (miRNAs). We hypothesized that circRNAs might be related with the pathophysiology of chronic epilepsy and evaluated the altered circRNA expressions and their possible regulatory effects on their target miRNAs and mRNAs in a mouse epilepsy model. The circRNA expression profile in the hippocampus of the pilocarpine mice was analyzed and compared with control. The correlation between the expression of miRNA binding sites (miRNA response elements, MRE) in the dysregulated circRNAs and the expression of their target miRNAs was evaluated. As miRNAs also inhibit their target mRNAs, circRNA-miRNA-mRNA regulatory network, comprised of dysregulated RNAs that targets one another were searched. For the identified networks, bioinformatics analyses were performed. As the result, Forty-three circRNAs were dysregulated in the hippocampus (up-regulated, 26; down-regulated, 17). The change in the expression of MRE in those circRNAs negatively correlated with the change in the relevant target miRNA expression (r = -0.461, P< 0.001), supporting that circRNAs inhibit their target miRNA. 333 dysregulated circRNA-miRNA-mRNA networks were identified. Gene ontology and pathway analyses demonstrated that the up-regulated mRNAs in those networks were closely related to the major processes in epilepsy. Among them, STRING analysis identified 37 key mRNAs with abundant (>= 4) interactions with other dysregulated target mRNAs. The dysregulation of the circRNAs which had multiple interactions with key mRNAs were validated by PCR. We concluded that dysregulated circRNAs might have a pathophysiologic role in chronic epilepsy by regulating multiple disease relevant mRNAs via circRNA-miRNA-mRNA interactions.	[Lee, Woo-Jin; Moon, Jangsup; Jeon, Daejong; Kim, Tae-Joon; Yoo, Jung-Suk; Park, Dong-Kyu; Lee, Soon-Tae; Jung, Keun-Hwa; Park, Kyung-Il; Jung, Ki-Young; Kim, Manho; Lee, Sang Kun; Chu, Kon] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Neurotherapeut, Comprehens Epilepsy Ctr,Dept Neurol, Seoul, South Korea; [Lee, Woo-Jin; Moon, Jangsup; Kim, Tae-Joon; Lee, Soon-Tae; Jung, Keun-Hwa; Park, Kyung-Il; Jung, Ki-Young; Kim, Manho; Lee, Sang Kun; Chu, Kon] Seoul Natl Univ, Coll Med, Neurosci Res Inst SNUMRC, Program Neurosci, Seoul, South Korea; [Park, Kyung-Il] Seoul Natl Univ, Healthcare Syst Gangnam Ctr, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, SK; Chu, K (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Neurotherapeut, Comprehens Epilepsy Ctr,Dept Neurol, Seoul, South Korea.; Lee, SK; Chu, K (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst SNUMRC, Program Neurosci, Seoul, South Korea.	sangkun2923@gmail.com; stemcell.snu@gmail.com		Moon, Jangsup/0000-0003-1282-4528; Lee, Soon-Tae/0000-0003-4767-7564; Jung, Keun-Hwa/0000-0003-1433-8005; Park, Kyung-Il/0000-0001-8064-6749; Chu, Kon/0000-0001-5863-0302; Jeon, Daejong/0000-0002-6998-7603	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014R1A2A1A11052709]; Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea [HI14C2502]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea	KC was supported by the National Research Foundation of Korea (NRF) ((www.nrf.re.kr/eng/main) grant funded by the Korea government (MSIP) (No. 2014R1A2A1A11052709); and by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C2502) (www.mohw.go.kr/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A1A11052709). This study was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C2502).	Baccarini AB, 2016, MOL THER, V24, pS30, DOI 10.1016/S1525-0016(16)32879-9; Bachmayr-Heyda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08057; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Bielefeld P, BRAIN PLAST, P1; Busceti CL, 2007, EPILEPSIA, V48, P694, DOI 10.1111/j.1528-1167.2007.01055.x; Chen J, 2005, NEUROSCI LETT, V375, P192, DOI 10.1016/j.neulet.2004.11.008; Chen W, 2016, TRENDS NEUROSCI, V39, P597, DOI 10.1016/j.tins.2016.06.006; Chen YD, 2002, BIOINFORMATICS, V18, P1207, DOI 10.1093/bioinformatics/18.9.1207; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; Crespel A, 2005, NEUROBIOL DIS, V19, P436, DOI 10.1016/j.nbd.2005.01.020; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; Gualtieri F, 2012, NEUROSCIENCE, V218, P278, DOI 10.1016/j.neuroscience.2012.05.018; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hauser RM, 2017, NEUROSCIENTIST, V0; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Hinoi E, 2004, J PHARMACOL SCI, V94, P215, DOI 10.1254/jphs.94.215; Jang Y, 2018, SEIZURE-EUR J EPILEP, V58, P110, DOI 10.1016/j.seizure.2018.04.010; Jeon D, 2011, EPILEPSIA, V52, P1617, DOI 10.1111/j.1528-1167.2011.03182.x; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KH, 2011, EPILEPSIA, V52, P541, DOI 10.1111/j.1528-1167.2010.02916.x; Jung S, 2012, NEUROSCI LETT, V529, P133, DOI 10.1016/j.neulet.2012.08.087; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lee DY, 2015, BIOCHEM BIOPH RES CO, V462, P433, DOI 10.1016/j.bbrc.2015.04.149; Lee ST, 2017, MOL NEUROBIOL, V54, P3300, DOI 10.1007/s12035-016-9901-7; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lu D, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2015.00053, 10.3389/fgene.2016.00053]; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; Moon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085617; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Perosa SR, 2002, BRAIN RES BULL, V58, P509, DOI 10.1016/S0361-9230(02)00822-5; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2016, TRENDS GENET, V32, P309, DOI 10.1016/j.tig.2016.03.002; Sand M, 2016, J DERMATOL SCI, V83, P210, DOI 10.1016/j.jdermsci.2016.05.012; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Toninelli GF, 2003, NEUROREPORT, V14, P917, DOI 10.1097/01.wnr.0000069962.11849.e6; Yoshihara Y, 2003, NEUROSCIENCE, V117, P391, DOI 10.1016/S0306-4522(02)00876-X	54	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209829	10.1371/journal.pone.0209829	http://dx.doi.org/10.1371/journal.pone.0209829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592747	Green Published, gold			2022-12-26	WOS:000454621900046
J	Liu, CL; Li, X; Li, C; Zhang, ZY; Gao, XJ; Jia, ZL; Chen, HX; Jia, Q; Zhao, XJ; Liu, JX; Liu, BH; Xu, ZG; Tian, YP; He, KL				Liu, Chunlei; Li, Xin; Li, Chen; Zhang, Zeyu; Gao, XiaoJian; Jia, Zhilong; Chen, Haixu; Jia, Qian; Zhao, Xiaojing; Liu, Jixuan; Liu, Bohan; Xu, Zhenguo; Tian, Yaping; He, Kunlun			SLC3A2 is a novel endoplasmic reticulum stress-related signaling protein that regulates the unfolded protein response and apoptosis	PLOS ONE			English	Article							ER STRESS; CD98HC SLC3A2; MEDIATED APOPTOSIS; TUNICAMYCIN; EXPRESSION; INHIBITORS; GADD153; PATHWAY; GENE	Endoplasmic reticulum (ER) stress results from imbalances in unfolded/misfolded proteins, contributing to a wide variety of human diseases. To better understand the mechanisms involved in the cellular response to ER stress in cardiomyocytes, we previously conducted a genome-wide screening in an in vitro ER stress model of rat cardiomyocytes, which highlighted amino acid transporter heavy chain, member 2 (SLC3A2) as an important factor in ER stress. In the present study, we characterized the role of SLC3A2 during the unfolded protein response (UPR), as one of the primary pathways activated during ER stress. First, we confirmed the induction of Slc3a2 mRNA expression following treatment with various ER stress inducers in rat cardiomyocytes (H9C2) and neural cells (PC12). Knockdown of Slc3a2 expression with small interfering RNA (siRNA) revealed that the encoded protein functions upstream of three important UPR proteins: ATF4, ATF6, and XBP1. siRNA-mediated knockdown of both SLC3A2 and mammalian target of rapamycin 1 (mTOR1) revealed that mTOR1 acts as a mediator between SLC3A2 and the UPR. RNA sequencing was then performed to gain a more thorough understanding of the function of SLC3A2, which identified 23 highly differentially regulated genes between the control and knockdown cell lines, which were related to the UPR and amino acid transport. Notably, flow cytometry further showed that SLC3A2 inhibition also enhanced the apoptosis of rat cardiomyocytes. Taken together, these results highlight SLC3A2 as a complex, multifunctional signaling protein that acts upstream of well-known UPR proteins with anti-apoptotic properties, suggesting its potential as a therapeutic target for ER stress-related diseases.	[Liu, Chunlei; Li, Xin; Li, Chen; Zhang, Zeyu; Gao, XiaoJian; Jia, Zhilong; Chen, Haixu; Jia, Qian; Zhao, Xiaojing; Liu, Jixuan; Liu, Bohan; Xu, Zhenguo; Tian, Yaping; He, Kunlun] Gen Hosp Chinese Peoples Liberat, Dept Translat Med, Beijing, Peoples R China; [Liu, Chunlei; Li, Xin; Jia, Qian; Zhao, Xiaojing; Tian, Yaping; He, Kunlun] Beijing Key Lab Chron Heart Failure Precis Med, Beijing, Peoples R China		Tian, YP; He, KL (corresponding author), Gen Hosp Chinese Peoples Liberat, Dept Translat Med, Beijing, Peoples R China.; Tian, YP; He, KL (corresponding author), Beijing Key Lab Chron Heart Failure Precis Med, Beijing, Peoples R China.	tianyp@301hospital.com.cn; hekl301@aliyun.com	Liu, Bohan/GZL-4063-2022; 陈, 海旭/AAC-3673-2019	Liu, Bohan/0000-0002-4810-8374; 陈, 海旭/0000-0003-4359-960X; He, Kunlun/0000-0002-3335-5700	Chinese PLA General Hospital Medical Large Data Project [2016MBD-002]; Chinese PLA General Hospital Translational Medicine Project [2016-TM-013]; Major International Science and Technology Cooperation Projects [2013DFA31170]; National Key Technologies R&D Program for New Drug of China [2018ZX09J18109-004]	Chinese PLA General Hospital Medical Large Data Project; Chinese PLA General Hospital Translational Medicine Project; Major International Science and Technology Cooperation Projects; National Key Technologies R&D Program for New Drug of China	This study was supported by Chinese PLA General Hospital Medical Large Data Project (No. 2016MBD-002), Chinese PLA General Hospital Translational Medicine Project (No. 2016-TM-013), Major International Science and Technology Cooperation Projects (No. 2013DFA31170) and National Key Technologies R&D Program for New Drug of China (2018ZX09J18109-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablack JNG, 2015, J CELL SCI, V128, P4273, DOI 10.1242/jcs.178129; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chen YG, 2016, DEV COMP IMMUNOL, V57, P57, DOI 10.1016/j.dci.2015.12.005; Farber CR, 2013, G3-GENES GENOM GENET, V3, P119, DOI 10.1534/g3.112.004788; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Hang TTN, 2011, J CLIN INVEST, V121, P1733, DOI 10.1172/JCI44631; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kropski JA, 2018, J CLIN INVEST, V128, P64, DOI 10.1172/JCI93560; Lakshmanan AP, 2011, EUR J PHARM SCI, V44, P627, DOI 10.1016/j.ejps.2011.10.009; Liu CL, 2016, INT J MOL MED, V37, P407, DOI 10.3892/ijmm.2015.2442; Liu CL, 2016, MOL CELL BIOCHEM, V413, P57, DOI 10.1007/s11010-015-2639-0; Liu YT, 2012, BIOMETALS, V25, P837, DOI 10.1007/s10534-012-9544-8; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Milkereit R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8250; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Prager GW, 2009, EUR J CLIN INVEST, V39, P304, DOI 10.1111/j.1365-2362.2009.02096.x; Sasaya H, 2008, J BIOCHEM, V144, P251, DOI 10.1093/jb/mvn063; Shen MZ, 2015, MOL MED REP, V12, P5149, DOI 10.3892/mmr.2015.4040; Uosaki H, 2015, CELL REP, V13, P1705, DOI 10.1016/j.celrep.2015.10.032; Zou L, 2017, MOL MED REP, V16, P6934, DOI 10.3892/mmr.2017.7404	26	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0208993	10.1371/journal.pone.0208993	http://dx.doi.org/10.1371/journal.pone.0208993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592731	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900011
J	Sarazin, A; Dendooven, A; Delbeke, M; Gatault, S; Pagny, A; Standaert, A; Rousseaux, C; Desreumaux, P; Dubuquoy, L; Capron, M				Sarazin, Aurore; Dendooven, Arnaud; Delbeke, Marie; Gatault, Solene; Pagny, Aurelien; Standaert, Annie; Rousseaux, Christel; Desreumaux, Pierre; Dubuquoy, Laurent; Capron, Monique			Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; OXIDATIVE STRESS; ULCERATIVE-COLITIS; BOWEL-DISEASE; PROTEIN; MYELOPEROXIDASE; IMMUNOPATHOLOGY; THERAPY; VACCINE	Background P28GST, a 28Kd glutathione S-transferase enzymatic protein derived from a schistosome helminth prevents experimental colitis when administered subcutaneously in the presence of adjuvant by decreasing pro-inflammatory Th1/Th17 response. Given the antioxidant properties of P28GST, we evaluated its anti-inflammatory potential when administered locally after colitis induction in the absence of adjuvant. Methods Colitis was induced in BALB/c mice by rectal administration of TNBS, followed by two intraperitoneal injections of P28GST at day 1 and day 2. Mice were sacrificed 48h after TNBS administration and evaluated for macroscopic and histological scores, myeloperoxidase (MPO) quantification and cytokine messenger RNA expression in the colonic tissues. Results Both clinical and histological scores significantly decreased in mice treated with P28GST at 5 or 50 mu g/kg when compared to vehicle-treated mice. A significant reduction of MPO was detected in colonic tissues from P28GST-treated mice, similarly to mice treated with methylprednisolone as the reference treatment. Pro-inflammatory cytokines TNF, IL-1 beta, and IL-6, mRNA as well as serum levels were down-regulated in mice colonic tissues treated with P28GST at 5 or 50 mu g/kg. In addition, a significant decrease of mRNA expression levels of T-bet, and ROR-Y, respective markers of Th1 and Th17 cells was observed. Whereas no significant effect was detected on Gata3 mRNA, a marker of Th2 cells, the Arg/iNOS mRNA levels significantly increased in P28GST-treated mice, suggesting the induction of M2 macrophages. Conclusions These findings provide evidence that P28GST injected locally after colitis induction induces a potent decrease of colitis inflammation in mice, associated to downregulation of Th1/Th17 response, and induction of anti-inflammatory alternatively activated macrophages.	[Sarazin, Aurore; Dendooven, Arnaud; Delbeke, Marie; Gatault, Solene; Pagny, Aurelien; Standaert, Annie; Desreumaux, Pierre; Dubuquoy, Laurent; Capron, Monique] Univ Lille, CHU Lille, INSERM, U995,LIRIC, Lille, France; [Rousseaux, Christel] IBD Biotech, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Capron, M (corresponding author), Univ Lille, CHU Lille, INSERM, U995,LIRIC, Lille, France.	monique.capron@univ-lille.fr	Capron, monique/Z-2207-2019; Dubuquoy, laurent/J-4978-2015; Standaert, Annie/R-5826-2018; Dendooven, Arnaud/Z-2434-2019; Standaert, Annie/AAD-8209-2020; Gatault, Solene/M-4348-2018; Pagny, Aurélien/S-9890-2019; Dubuquoy, Laurent/N-1623-2019	Capron, monique/0000-0001-5625-5158; Dubuquoy, laurent/0000-0003-3596-5497; Standaert, Annie/0000-0002-7752-3964; Standaert, Annie/0000-0002-7752-3964; Gatault, Solene/0000-0002-8887-8517; Pagny, Aurélien/0000-0002-5585-8368; 	Institut National de la Sante et de la Recherche Medicale (Inserm); Lille University; French National Research Agency (ANR) via the grant ACROHNEM [ANR-11-RPIB-0021]; SATT-NORD (Societe d'Acceleration du Transfert de Technologies); DigestScience Foundation; FHU IMMINeNT; (French) National Agency of Research (ANR); ANR; SATT Nord	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Lille University; French National Research Agency (ANR) via the grant ACROHNEM; SATT-NORD (Societe d'Acceleration du Transfert de Technologies); DigestScience Foundation; FHU IMMINeNT; (French) National Agency of Research (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); SATT Nord	This study was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm) and Lille University, as main sponsors of the LIRIC (Lille Inflammation Research International Center). It was also supported by the French National Research Agency (ANR) via the grant ACROHNEM (ANR-11-RPIB-0021), as well as by SATT-NORD (Societe d'Acceleration du Transfert de Technologies). The funders had no role in study design, data collection and analysis or preparation of the manuscript. Additionally, we acknowledge the supports of the DigestScience Foundation and the FHU IMMINeNT. Digest Science Foundation is a non-profit Foundation recognized as a public interest organization, in order to favor exchanges in the field of Intestinal Bowel Diseases, in the interest of patients: there was no financial support nor material but fruitful exchanges with the research team. The participation as co-author of Dr Christel Rousseaux, member of Intestinal Biotech Development, a small private company, is linked to the funding of the present research project by the (French) National Agency of Research (ANR), in the context of a Call for proposals (ANR RPIB) specifically devoted to reinforce partnerships between Academic teams and Small and Medium Enterprises. The reference of this funding was clearly given in the "financial disclosure of our manuscript" (ANR-11-RPIB-0021). Both the Academic teams and the IBD Biotech Society received funds from ANR for this specific project. There was absolutely no financial support (salaries or materials) from IBD Biotech to the academic teams. FHU IMMINeNT means Hospital University Federative Project (FHU) of Lille devoted to Immune-mediated inflammatory diseases and targeted therapies. This academic organization will provide support for the publication fee of the present paper.; The authors thank the DigestScience Foundation, SATT Nord and FHU Imminent for support.	Ameho CK, 1997, GUT, V41, P487, DOI 10.1136/gut.41.4.487; BALLOUL JM, 1987, NATURE, V326, P149, DOI 10.1038/326149a0; Balmus IM, 2016, SAUDI J GASTROENTERO, V22, P3, DOI 10.4103/1319-3767.173753; Bjorndal B, 2013, DIGEST DIS SCI, V58, P97, DOI 10.1007/s10620-012-2321-2; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Boulanger D, 1999, VACCINE, V17, P319, DOI 10.1016/S0264-410X(98)00202-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY PP, 1982, BLOOD, V60, P618; Capron A, 2005, TRENDS PARASITOL, V21, P143, DOI 10.1016/j.pt.2005.01.003; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Driss V, 2016, MUCOSAL IMMUNOL, V9, P322, DOI 10.1038/mi.2015.62; Elliott DE, 2012, CURR OPIN GASTROEN, V28, P551, DOI 10.1097/MOG.0b013e3283572f73; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Filippi J, 2006, INFLAMM BOWEL DIS, V12, P185, DOI 10.1097/01.MIB.0000206541.15963.c3; Gisbert JP, 2015, ALIMENT PHARM THER, V41, P613, DOI 10.1111/apt.13083; Halliwell B, 1997, NUTR REV, V55, pS44, DOI 10.1111/j.1753-4887.1997.tb06100.x; Harusato A, 2013, INFLAMM BOWEL DIS, V19, P740, DOI 10.1097/MIB.0b013e3182802968; Hengstermann S, 2008, CLIN NUTR, V27, P571, DOI 10.1016/j.clnu.2008.01.007; Ishizaki S, 2012, LIFE SCI, V90, P657, DOI 10.1016/j.lfs.2012.03.018; Johnson KA, 2003, BIOCHEMISTRY-US, V42, P10084, DOI 10.1021/bi034449r; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Lebens M, 2003, VACCINE, V21, P514, DOI 10.1016/S0264-410X(02)00471-1; Marsal J, 2012, J INTERN MED, V272, P411, DOI 10.1111/j.1365-2796.2012.02588.x; Moatamedi Pour L, 2014, IRAN J PUBLIC HEALTH, V43, P994; Moldoveanu AC, 2015, ROM J INTERN MED, V53, P118, DOI 10.1515/rjim-2015-0016; Pereira C, 2015, INFLAMM BOWEL DIS, V21, P2403, DOI 10.1097/MIB.0000000000000506; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Riveau G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001704; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Sipahi AM, 2017, WORLD J GASTROENTERO, V23, P6009, DOI 10.3748/wjg.v23.i33.6009; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Thi THH, 2017, INT J PHARMACEUT, V533, P26, DOI 10.1016/j.ijpharm.2017.09.037; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Wammes LJ, 2014, LANCET INFECT DIS, V14, P1150, DOI 10.1016/S1473-3099(14)70771-6; Wasko-Czopnik D, 2012, ADV CLIN EXP MED, V21, P5; Zhu JF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-122	40	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209681	10.1371/journal.pone.0209681	http://dx.doi.org/10.1371/journal.pone.0209681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592734	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900036
J	Kalinga, AK; Ishengoma, DS; Kavishe, R; Temu, L; Mswanya, C; Mwanziva, C; Mgina, EJ; Chiduo, S; Mahikwano, L; Mgata, S; Anova, L; Amoo, G; Wurapa, E; Vesely, B; Kamau, E; Hickman, M; Waters, N; Kreishman-Deitrick, M; Paris, R; Ohrt, C				Kalinga, Akili K.; Ishengoma, Deus S.; Kavishe, Reginald; Temu, Lucky; Mswanya, Christopher; Mwanziva, Charles; Mgina, Erick J.; Chiduo, Sarah; Mahikwano, Lucas; Mgata, Saidi; Anova, Lalaine; Amoo, George; Wurapa, Eyako; Vesely, Brian; Kamau, Edwin; Hickman, Mark; Waters, Norman; Kreishman-Deitrick, Mara; Paris, Robert; Ohrt, Colin			The use of Fionet technology for external quality control of malaria rapid diagnostic tests and monitoring health workers' performance in rural military health facilities in Tanzania	PLOS ONE			English	Article							IMPLEMENTATION	Introduction Internal and external quality control (QC) of rapid diagnostic tests (RDTs) is important to increase reliability of RDTs currently used to diagnose malaria. However, cross-checking of used RDTs as part of quality assurance can rarely be done by off-site personnel because there is no guarantee of retaining visible test lines after manufacturers' recommended reading time. Therefore, this study examined the potential of using Fionet (TM) technology for remote RDT quality monitoring at seven clinics, identifying reasons for making RDT processing and interpretation errors, and taking corrective actions for improvement of diagnosis and consequently improved management of febrile patients Methods The study was conducted at seven military health facilities in Mainland Tanzania and utilized RDTs capable of detecting Plasmodium falciparum specific Histidine-rich protein 2 (Pf-HRP2) and the genus specific Plasmodium lactate dehydrogenase (pLDH) for other species of plasmodium (P. vivax, P. malariae or P. ovale; pan-pLDH). Patients' data and images of processed RDTs from seven clinics were uploaded on a Fionet web portal and reviewed regularly to monitor preparation procedures and visual interpretation of test results compared to automated analysis using the Deki reader of RDT. Problems detected were rapidly communicated to remote laboratory personnel at the clinic for corrective action and follow-up of patients who were falsely diagnosed as negative and missed treatment. Factors contributing to making errors in visual interpretation of RDT results were analyzed during visits to the health facilities. Results A total of 1,367 (1.6%) out of 83,294 RDT test images uploaded to the Fionet portal had discordant test results of which 822 (60.1%) and 545 (39.9%) were falsely reported as negative and positive, respectively. False negative and false positive test results were common for a single test line in 515 (62.7%) and 741 (54.2%) tests, respectively. Out of 1,367 RDT images assessed, 98 (7.2%) had quality problems related to preparation procedures of which 95 (96.9%) errors were due to putting too much blood on the sample well or insufficient buffer in the respective wells. The reasons for discrepant results included, false reporting of none existent lines in 526 (38.5%) tests, missing a faint positive line in 493 (36.1%), missing a strong positive line in 248(18.1%) and errors caused by poorly processed RDTs in 96 (7.2%) tests. Among the false negative tests (n = 822), 669 (48.9%) patients were eligible for follow-up and only 339 (48.5%) were reached and 291 (85.8%) received appropriate anti-malaria therapy. Conclusion Fionet technology enabled remote monitoring of RDT quality issues, identifying reasons contributing to laboratory personnel making errors and provided a rapid method to implement corrective actions at remote sites to improve malaria diagnosis and consequently improved health care management of febrile patients infected with malaria.	[Kalinga, Akili K.; Mgina, Erick J.] Tukuyu Ctr, Natl Inst Med Res, Tukuyu, Tanzania; [Kalinga, Akili K.; Kavishe, Reginald] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Ishengoma, Deus S.] Tanga Ctr, Natl Inst Med Res, Tanga, Tanzania; [Temu, Lucky; Chiduo, Sarah; Mahikwano, Lucas; Mgata, Saidi] Henry Jackson Fdn Med Res Int, Dar Es Salaam, Tanzania; [Mswanya, Christopher; Mwanziva, Charles] Tanzania Peoples Def Forces, Dar Es Salaam, Tanzania; [Anova, Lalaine; Wurapa, Eyako; Vesely, Brian; Kamau, Edwin; Hickman, Mark; Waters, Norman; Kreishman-Deitrick, Mara; Paris, Robert; Ohrt, Colin] Walter Reed Army Inst Res, Washington, DC USA; [Amoo, George] FORGYN Hlth Syst Consultants LLc, Washington, DC USA; [Ohrt, Colin] Consortium Hlth Act, Phnom Penh, Cambodia	National Institute of Medical Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Kalinga, AK (corresponding author), Tukuyu Ctr, Natl Inst Med Res, Tukuyu, Tanzania.; Kalinga, AK (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania.	kalingaaka@yahoo.com		KALINGA, AKILI/0000-0003-1884-3869; Hickman, Mark/0000-0001-8183-2076; Mgina, Erick Josephat/0000-0002-3940-9458	Walter Reed Army Institute of Research (WRAIR); government of Tanzania through Tanzania Commission for Science and Technology (COSTECH); Fio Corporation	Walter Reed Army Institute of Research (WRAIR); government of Tanzania through Tanzania Commission for Science and Technology (COSTECH); Fio Corporation	This study was supported through funding received from Walter Reed Army Institute of Research (WRAIR) for malaria surveillance and diagnostic quality improvement program in Tanzania. The material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the US Department of the Army or the Department of Defense. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. The corresponding Author [AK] who is a PhD student, received financial support from the government of Tanzania through Tanzania Commission for Science and Technology (COSTECH) and Fio Corporation for school fees and stipend at the college. One author [GA] was employed by a commercial company called FORGYN Health Systems Consultants LLc at the time of submission of this article. The company did not fund the project; it just provided support in the form.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Adah P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2356-8; Aidoo M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-239; Bell D, 2017, AM J TROP MED HYG, V96, P319, DOI 10.4269/ajtmh.16-0498; Berhane A, 2017, MALARIA J, P16; Boyce MR, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2358-6; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; Fancony C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-284; FIND, 2016, POS CONTR WELLS MAL; FIND, 2014, POS CONTR WELLS QUAL; Health(WHO), 2006, US RAP DIAGN TEST RD; Herrera S, 2014, MALARIA J, P13; KAHAMAMARO J, 2011, MALARIA J, V10, P14262; Kalinga AK, 2018, MALARIA J, P17; Kozycki CT, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1768-1; Laktabai J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191968; Maltha J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-20; Masanja IM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0597-3; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Ministry of Health, 2016, TANZ DEM HLTH SURV M; Mohammed A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-415; Mukadi P, 2015, MALARIA J, P14; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; NBS) National Bureau of Statistics D es S, 2017, TANZ MAL IND SURV TM, V2017; Nora Zwingerman, 2015, FIELD ASSESSMENT MAL, V2015; Ochodo E, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i107; Oyet C, 2017, MALAR J BIOMED CENTR, V16, P4, DOI [10.1186/s12936-016-1652-4, DOI 10.1186/S12936-016-1652-4]; QGIS Development Team, 2018, QGIS GEOGR INF SYST, DOI 10.1038/nrg1769; Seidahmed OE, END USER ERRORS APPL, DOI [10.1186/1475-2875-12-415, DOI 10.1186/1475-2875-12-415]; SHEKALAGHE S, 2013, MALARIA J, V12, P14262; Sousa-Figueiredo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033189; Tamiru A, 2015, MALARIA J, V14, P1, DOI [10.1186/1475-2875-14-1, DOI 10.1186/1475-2875-14-1]; Tanzania Commission for AIDS (ZAC), 2013, TANZ 2011 12 HIV AID; *WHO, 2011, LYMPH FIL TRANSM ASS, P1; WHO/ FIND/ CDC, 2016, MALARIA RAPID DIAGNO; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2009, PAR CONF RMAT MAL DI; World Health Organization, 2011, UN ACC MAL DIAGM TES; World Health Organization, 2015, GUID TREATM MAL, Vthird	41	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208583	10.1371/journal.pone.0208583	http://dx.doi.org/10.1371/journal.pone.0208583			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589853	gold, Green Published, Green Submitted			2022-12-26	WOS:000454418200008
J	Robbins, A; Loader, J; Timms, P; Hanger, J				Robbins, Amy; Loader, Joanne; Timms, Peter; Hanger, Jonathan			Optimising the short and long-term clinical outcomes for koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease	PLOS ONE			English	Article							ENROFLOXACIN; CHLORAMPHENICOL; FLORFENICOL; PCR	Koalas (Phascolarctos cinereus) have suffered severe declines in the northern extent of their range due to a variety of threats, including habitat destruction, trauma from cars and dogs, climate change and importantly, disease. The most significant pathogen in koalas is Chlamydia pecorum, which causes inflammation and fibrosis at mucosal sites, resulting in blindness, infertility and death in severe cases. Chlamydia treatment can be problematic in koalas as the response to treatment is often poor in chronic cases and antimicrobial choice is limited. Thus, chlamydial disease is a severely threatening process for koala conservation. We investigated the short and long-term clinical outcomes for 167 koalas with Chlamydia that underwent capture, telemetric monitoring and intensive veterinary management as part of a large-scale population management program in South East Queensland. Chlamydia treatments included the standard regimen of daily subcutaneous chloramphenicol injections (60mg/kg) for 14 to 28-days, and a variety of non-standard regimens such as topical antimicrobials only (for ocular disease), surgical treatment only (for bilateral reproductive tract disease), and other antimicrobials/treatment lengths. To assess these regimens we analysed clinical records, field monitoring data and swab samples collected from the urogenital tract and ocular conjunctiva. Overall, in contrast to other studies, treatment was generally successful with 86.3% of treated koalas released back into the wild. The success of treatment rose to 94.8% however, when the standard treatment regimen was employed. Further, 100% of koalas that were also treated with surgical ovariohysterectomy (n = 12) remained healthy for a median of 466 days of post-treatment monitoring, demonstrating the benefits of surgical treatment. Previous studies reported 45-day chloramphenicol regimens, but the shorter standard regimen still achieved microbiological cure and reduces the risk of negative sequelae associated with treatment and/or captivity and treatment costs. Despite these positive clinical outcomes, alternatives to chloramphenicol are warranted due to its decreasing availability.	[Robbins, Amy; Loader, Joanne; Hanger, Jonathan] Endeavour Vet Ecol Pty Ltd, Toorbul, Qld, Australia; [Robbins, Amy; Timms, Peter] Univ Sunshine Coast, Genecol Ctr, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld, Australia	University of the Sunshine Coast	Robbins, A (corresponding author), Endeavour Vet Ecol Pty Ltd, Toorbul, Qld, Australia.; Robbins, A (corresponding author), Univ Sunshine Coast, Genecol Ctr, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld, Australia.	amy@endeavourvet.com.au		Robbins, Amy/0000-0001-9231-0636; Timms, Peter/0000-0002-1682-0025	Queensland Government (Department of Transport and Main Roads); University of the Sunshine Coast; Koala Action Inc.; Endeavour Veterinary Ecology Pty Ltd; Australian Research Council	Queensland Government (Department of Transport and Main Roads); University of the Sunshine Coast; Koala Action Inc.; Endeavour Veterinary Ecology Pty Ltd; Australian Research Council(Australian Research Council)	The Queensland Government (Department of Transport and Main Roads), specifically the Moreton Bay Rail Project, financially supported Endeavour Veterinary Ecology Pty Ltd to undertake the koala management program. The University of the Sunshine Coast contributed to the financial support of this project with a Research Training Program Scholarship for AR, and Koala Action Inc. contributed to the financial support of this project by providing funds to The University of the Sunshine Coast for koala Chlamydia research. Finally, PT was a recipient of the Australian Research Council Linkage Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Endeavour Veterinary Ecology Pty Ltd also provided support in the form of research materials and salaries for authors AR, JL and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams-Hosking C, 2016, DIVERS DISTRIB, P1; Beyer HL, 2018, J APPL ECOL, V55, P1966, DOI 10.1111/1365-2664.13127; Black LA, 2015, AUST VET J, V93, P420, DOI 10.1111/avj.12364; Black LA, 2014, J VET PHARMACOL THER, V37, P301, DOI 10.1111/jvp.12091; Budd C, 2017, AUST VET J, V95, P343, DOI 10.1111/avj.12617; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Desclozeaux M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178786; Govendir M, 2012, J VET PHARMACOL THER, V35, P147, DOI 10.1111/j.1365-2885.2011.01307.x; Griffith J., 2010, THESIS; Griffith JE, 2012, AUST VET J, V90, P457, DOI 10.1111/j.1751-0813.2012.00963.x; Griffith JE, 2010, J VET PHARMACOL THER, V33, P595, DOI 10.1111/j.1365-2885.2010.01169.x; Hanger J., 2017, MORETON BAY RAIL KOA; Hanger J, 2013, VET J, V195, P391, DOI 10.1016/j.tvjl.2012.07.024; Higgins DP, 2005, CLIN DIAGN LAB IMMUN, V12, P632, DOI 10.1128/CDLI.12.5.632-639.2005; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Hulse LS, 2018, J VET DIAGN INVEST, V30, P523, DOI 10.1177/1040638718770490; Jackson M, 1999, VET MICROBIOL, V65, P225; Jelocnik M, 2017, PEERJ, V5, DOI 10.7717/peerj.3799; Kempster Roxanne C., 1996, Veterinary and Comparative Ophthalmology, V6, P14; Lawrence A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31466; Loader J, 2010, THESIS U QUEENSLAND; Markey B, 2007, VET MICROBIOL, V120, P334, DOI 10.1016/j.vetmic.2006.11.022; OSAWA R, 1993, AUST J ZOOL, V41, P599, DOI 10.1071/ZO9930599; OSAWA R, 1990, AUST VET J, V67, P305, DOI 10.1111/j.1751-0813.1990.tb07805.x; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Quigley BL, 2018, J VIROL, V92, DOI 10.1128/JVI.01871-17; Rhodes J. R., 2015, S E QUEENSL KOAL POP; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Waugh C, 2016, BIOLOGICALS, V44, P588, DOI 10.1016/j.biologicals.2016.09.006; Waugh C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146934; Waugh CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00137-4	31	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209679	10.1371/journal.pone.0209679	http://dx.doi.org/10.1371/journal.pone.0209679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589897	Green Published, gold, Green Submitted			2022-12-26	WOS:000454418200046
J	Toor, A; Culibrk, L; Singhera, GK; Moon, KM; Prudova, A; Foster, LJ; Moore, MM; Dorscheid, DR; Tebbutt, SJ				Toor, Amreen; Culibrk, Luka; Singhera, Gurpreet K.; Moon, Kyung-Mee; Prudova, Anna; Foster, Leonard J.; Moore, Margo M.; Dorscheid, Delbert R.; Tebbutt, Scott J.			Transcriptomic and proteomic host response to Aspergillus fumigatus conidia in an air-liquid interface model of human bronchial epithelium	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; GENE ONTOLOGY; IN-VITRO; CELLS; A549; INTERNALIZATION; IRON; CALRETICULIN; PATHOGENESIS; ENRICHMENT	Aspergillus fumigatus (A. fumigatus) is a wide-spread fungus that is a potent allergen in hypersensitive individuals but also an opportunistic pathogen in immunocompromised patients. It reproduces asexually by releasing airborne conidiospores (conidia). Upon inhalation, fungal conidia are capable of reaching the airway epithelial cells (AECs) in bronchial and alveolar tissues. Previous studies have predominantly used submerged monolayer cultures for studying this host-pathogen interaction; however, these cultures do not recapitulate the mucocililary differentiation phenotype of the in vivo epithelium in the respiratory tract. Thus, the aim of this study was to use well-differentiated primary human bronchial epithelial cells (HBECs) grown at the air-liquid interface (ALI) to determine their transcriptomic and proteomic responses following interaction with A. fumigatus conidia. We visualized conidial interaction with HBECs using confocal laser scanning microscopy (CLSM), and applied NanoString nCounter and shotgun proteomics to assess gene expression changes in the human cells upon interaction with A. fumigatus conidia. Western blot analysis was used to assess the expression of top three differentially expressed proteins, CALR, SET and NUCB2. CLSM showed that, unlike submerged monolayer cultures, well-differentiated ALI cultures of primary HBECs were estimated to internalize less than 1% of bound conidia. Nevertheless, transcriptomic and proteomic analyses revealed numerous differentially expressed host genes; these were enriched for pathways including apoptosis/autophagy, translation, unfolded protein response and cell cycle (up-regulated); complement and coagulation pathways, iron homeostasis, nonsense mediated decay and rRNA binding (down-regulated). CALR and SET were confirmed to be up-regulated in ALI cultures of primary HBECs upon exposure to A. fumigatus via western blot analysis. Therefore, using transcriptomics and proteomics approaches, ALI models recapitulating the bronchial epithelial barrier in the conductive zone of the respiratory tract can provide novel insights to the molecular response of bronchial epithelial cells upon exposure to A. fumigatus conidia.	[Toor, Amreen] Univ British Columbia, Expt Med, Vancouver, BC, Canada; [Toor, Amreen; Culibrk, Luka; Singhera, Gurpreet K.; Dorscheid, Delbert R.; Tebbutt, Scott J.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Moon, Kyung-Mee; Prudova, Anna; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Dorscheid, Delbert R.; Tebbutt, Scott J.] Univ British Columbia, Div Resp Med, Dept Med, Vancouver, BC, Canada; [Tebbutt, Scott J.] Prevent Organ Failure PROOF Ctr Excellence, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Simon Fraser University; University of British Columbia	Tebbutt, SJ (corresponding author), Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada.; Tebbutt, SJ (corresponding author), Univ British Columbia, Div Resp Med, Dept Med, Vancouver, BC, Canada.; Tebbutt, SJ (corresponding author), Prevent Organ Failure PROOF Ctr Excellence, Vancouver, BC, Canada.	scott.tebbutt@hli.ubc.ca		Foster, Leonard/0000-0001-8551-4817	National Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-05043]; BC Proteomics Network	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); BC Proteomics Network	This research was supported by funding from National Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2015-05043) and BC Proteomics Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT CD, 1990, CELL BIOL TOXICOL, V6, P379, DOI 10.1007/BF00120804; Aldajani WA, 2016, ONCOTARGET, V7, P57606, DOI 10.18632/oncotarget.11586; Antosiewicz J, 2007, FREE RADICAL BIO MED, V43, P265, DOI 10.1016/j.freeradbiomed.2007.04.023; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balloy V, 2008, J BIOL CHEM, V283, P30513, DOI 10.1074/jbc.M803149200; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Becker KL, 2015, CLIN EXP ALLERGY, V45, P423, DOI 10.1111/cea.12354; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Beisswenger C, 2012, EUR RESPIR J, V39, P411, DOI 10.1183/09031936.00096110; Bellanger AP, 2009, J MED MICROBIOL, V58, P174, DOI 10.1099/jmm.0.005488-0; Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; BeruBe K, 2010, TOXICOLOGY, V278, P311, DOI 10.1016/j.tox.2010.04.004; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bongomin F, 2017, J FUNGI, V3; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Botterel F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-97; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135720; Cozens D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19079-y; Croft CA, 2016, FRONT MICROBIOL, P7; Culibrk L, 2016, OMICS, V20, P127, DOI 10.1089/omi.2015.0185; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Espinosa V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00272; Fekkar A, 2012, J INFECT DIS, V205, P1163, DOI 10.1093/infdis/jis031; Feldmesser M, 2006, INFECT IMMUN, V74, P6514, DOI 10.1128/IAI.01551-06; Forbes B, 2003, INT J PHARM, V257, P161, DOI 10.1016/S0378-5173(03)00129-7; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gomez P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-358; GREENBERGER PA, 1988, J ALLERGY CLIN IMMUN, V81, P646, DOI 10.1016/0091-6749(88)91034-2; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; HINSON KFW, 1952, THORAX, V7, P317, DOI 10.1136/thx.7.4.317; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Jia XD, 2014, MICROBES INFECT, V16, P491, DOI 10.1016/j.micinf.2014.03.001; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kalnina Z, 2009, EUR J HISTOCHEM, V53, P7; Karp PH, 2002, METHOD MOL BIOL, P115, DOI [10.1385/1-59259-185-X:115, DOI 10.1385/1-59259-185-X:115]; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Khoufache K, 2010, MED MYCOL, V48, P1049, DOI 10.3109/13693786.2010.496119; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Knutsen AP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/843763; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Koltsova EK, 2010, IMMUNITY, V33, P7, DOI 10.1016/j.immuni.2010.07.012; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Latge JP, 2017, MED MYCOL, V55, P4, DOI 10.1093/mmy/myw076; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LAUFER P, 1984, J ALLERGY CLIN IMMUN, V73, P44, DOI 10.1016/0091-6749(84)90482-2; Lopez-Souza N, 2003, IN VITRO CELL DEV-AN, V39, P266; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; MULLINS J, 1976, CLIN ALLERGY, V6, P209, DOI 10.1111/j.1365-2222.1976.tb01899.x; Nickless A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0153-7; Oosthuizen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020527; Osherov N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00346; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Patchell BJ, 2007, AM J PHYSIOL-LUNG C, V293, pL354, DOI 10.1152/ajplung.00412.2006; Prokopec SD, 2013, RNA, V19, P51, DOI 10.1261/rna.034710.112; Radke L, 2014, MICROCHIM ACTA, V181, P1733, DOI 10.1007/s00604-014-1221-x; Rammaert B, 2015, AM J PATHOL, V185, P2421, DOI 10.1016/j.ajpath.2015.04.027; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sharon H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017509; Sheppard DC, 2011, CURR OPIN MICROBIOL, V14, P375, DOI 10.1016/j.mib.2011.07.006; SLAVIN RG, 1988, J ALLERGY CLIN IMMUN, V81, P718, DOI 10.1016/0091-6749(88)91044-5; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stewart CE, 2012, J ALLERGY; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; SUN L, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0021468; Sun WK, 2012, EUR J CLIN MICROBIOL, V31, P2755, DOI 10.1007/s10096-012-1624-8; Tam A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100633; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; Tomee JFC, 1997, J INFECT DIS, V176, P300, DOI 10.1086/517272; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Wong SSW, 2018, J FUNGI, V4, DOI 10.3390/jof4010003; Xu JY, 2015, J BANK REGUL, V16, P1, DOI 10.1057/jbr.2013.19; Xu XL, 2016, SCI CHINA LIFE SCI, V59, P656, DOI 10.1007/s11427-016-0018-0; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012; Zheng JF, 2017, INT J CLIN EXP MED, V10, P8854; Zuehlke AD, 2015, GENE, V570, P8, DOI 10.1016/j.gene.2015.06.018	95	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209652	10.1371/journal.pone.0209652	http://dx.doi.org/10.1371/journal.pone.0209652			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589860	Green Published, gold, Green Submitted			2022-12-26	WOS:000454418200038
J	Gabriel, M; Julien, C; Salin, PA; Jean-Christophe, C				Gabriel, Meyer; Julien, Carponcy; Salin, Paul A.; Jean-Christophe, Comte			Differential recordings of local field potential: A genuine tool to quantify functional connectivity	PLOS ONE			English	Article							SOURCE-DENSITY METHOD; FIRING RATES; HIPPOCAMPAL; SELECTIVITY; SIGNALS; ORIGIN	Local field potential (LFP) recording is a very useful electrophysiological method to study brain processes. However, this method is criticized for recording low frequency activity in a large area of extracellular space potentially contaminated by distal activity. Here, we theoretically and experimentally compare ground-referenced (RR) with differential recordings (DR). We analyze electrical activity in the rat cortex with these two methods. Compared with RR, DR reveals the importance of local phasic oscillatory activities and their coherence between cortical areas. Finally, we show that DR provides a more faithful assessment of functional connectivity caused by an increase in the signal to noise ratio, and of the delay in the propagation of information between two cortical structures.	[Gabriel, Meyer; Julien, Carponcy; Jean-Christophe, Comte] Univ Lyon 1, INSERM, Lyon Neurosci Res Ctr CRNL, Forgetting & Cort Dynam Team,CNRS, Lyon, France; [Salin, Paul A.; Jean-Christophe, Comte] Univ Lyon 1, INSERM, Lyon Neurosci Res Ctr CRNL, Biphoton Microscopy Team,CNRS, Lyon, France; [Jean-Christophe, Comte] Univ Lyon 1, INSERM, Lyon Neurosci Res Ctr CRNL, CNRS, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Jean-Christophe, C (corresponding author), Univ Lyon 1, INSERM, Lyon Neurosci Res Ctr CRNL, Forgetting & Cort Dynam Team,CNRS, Lyon, France.; Jean-Christophe, C (corresponding author), Univ Lyon 1, INSERM, Lyon Neurosci Res Ctr CRNL, Biphoton Microscopy Team,CNRS, Lyon, France.; Jean-Christophe, C (corresponding author), Univ Lyon 1, INSERM, Lyon Neurosci Res Ctr CRNL, CNRS, Lyon, France.	jean-christophe.comte@univ-lyon1.fr		COMTE, Jean-Christophe/0000-0002-9598-4641; Salin, Paul/0000-0001-5221-9109				[Anonymous], 2004, NAT NEUROSCI, V7, P446, DOI DOI 10.1038/NN1233; Bedard C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051911; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Bedard C, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041909; Berens P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.002.2008; Brette R, 2012, HDB NEURONAL ACTIVIT; Einevoll GT, 2007, J NEUROPHYSIOL, V97, P2174, DOI 10.1152/jn.00845.2006; Fernandez L, 2017, CEREB CORTEX, V27, P1; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gold C, 2007, J COMPUT NEUROSCI, V23, P39, DOI 10.1007/s10827-006-0018-2; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Herreras O, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00101; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Lalla L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0128-17.2017; Leski S, 2007, NEUROINFORMATICS, V5, P207, DOI 10.1007/s12021-007-9000-z; Leski S, 2011, NEUROINFORMATICS, V9, P401, DOI 10.1007/s12021-011-9111-4; Linden H, 2010, J COMPUT NEUROSCI, V29, P423, DOI 10.1007/s10827-010-0245-4; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Maingret N, 2016, NAT NEUROSCI, V19, P959, DOI 10.1038/nn.4304; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Nunez PL, 2006, ELECT FIELD BRAIN NE, DOI [10.1016/j.neuron.2005.12.019, DOI 10.1016/J.NEURON.2005.12.019]; Parabucki A, 2017, CELL REP, V21, P919, DOI 10.1016/j.celrep.2017.09.094; Pettersen KH, 2009, BMC NEUROSCI, V10, P224, DOI [10.1186/1471-2202-10-S1-P224, DOI 10.1186/1471-2202-10-S1-P224]; Pettersen KH, 2008, J COMPUT NEUROSCI, V24, P291, DOI 10.1007/s10827-007-0056-4; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; RECCE M K, 1989, Society for Neuroscience Abstracts, V15, P1250; Sander TH, 2010, IEEE ENG MED BIO, P1714, DOI 10.1109/IEMBS.2010.5626851; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sreenivasan V, 2016, NEURON, V92, P1368, DOI 10.1016/j.neuron.2016.12.001; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	39	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209001	10.1371/journal.pone.0209001	http://dx.doi.org/10.1371/journal.pone.0209001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586445	gold, Green Submitted, Green Published			2022-12-26	WOS:000454416400049
J	Ma, K; Feng, Y; Zong, ZY				Ma, Ke; Feng, Yu; Zong, Zhiyong			Fitness cost of a mcr-1-carrying IncHI2 plasmid	PLOS ONE			English	Article							CONJUGATIVE PLASMID; ESCHERICHIA-COLI; HOST-RANGE; EVOLUTION; RESISTANCE; ELEMENTS	IncHI2 is a common type of large mcr-1-carrying plasmids that have been found worldwide. Large plasmids could impose metabolic burden for host bacterial strains, we therefore examine the stability and fitness cost of a mcr-1-carrying 265.5-kb IncHI2 plasmid, pMCR1_1943, in Escherichia coli in nutrient-rich LB and nutrient-restricted M9 broth. Stability tests revealed that pMCR1_1943 was stably maintained with a stability frequency of 0.99 +/- 0.01 (mean +/- standard deviation) after 880 generations in LB and 0.97 +/- 0.00 after 220 generations in M9 broth. Relative fitness (expressed as w, defined as relative fitness of the plasmid-carrying strain compared to the plasmid-free progenitor strain) was examined using the 24-h head to head competitions. pMCR1_1943 initially imposed costs (w, 0.88 +/- 0.03 in LB, 0.87 +/- 0.01 in M9) but such costs were largely reduced after 14-day cultures (w, 0.97 +/- 0.03 in LB, 0.95 +/- 0.03 in M9). The stable maintenance and the largely compensated cost after passage may contribute to the wide spread of mcr-1-carrying IncHI2 plasmids. To investigate potential mechanisms for the reduced fitness cost, we performed whole genome sequencing and single nucleotide polymorphism calling for the competitor strains. We identified that molecular chaperone-encoding dnaK, cell division protein-encoding cpoB and repeat protein-encoding rhsC were associated with the cost reduction for pMCR1_1943, which may represent new mechanisms for host bacterial strains to compensate fitness costs imposed by large plasmids and warrant further studies.	[Ma, Ke; Feng, Yu; Zong, Zhiyong] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Sichuan, Peoples R China; [Ma, Ke; Feng, Yu; Zong, Zhiyong] State Key Lab Biotherapy, Div Infect Dis, Chengdu, Sichuan, Peoples R China; [Ma, Ke; Feng, Yu; Zong, Zhiyong] Sichuan Univ, West China Hosp, Ctr Pathogen Res, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Sichuan, Peoples R China.; Zong, ZY (corresponding author), State Key Lab Biotherapy, Div Infect Dis, Chengdu, Sichuan, Peoples R China.; Zong, ZY (corresponding author), Sichuan Univ, West China Hosp, Ctr Pathogen Res, Chengdu, Sichuan, Peoples R China.	zongzhiy@scu.edu.cn	Feng, Yu/L-7486-2018	Feng, Yu/0000-0002-5654-4256; ZONG, ZHIYONG/0000-0002-7675-260X	National Natural Science Foundation of China [81772233, 81661130159]; Newton Advanced Fellowship, Royal Society, UK [NA150363]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Newton Advanced Fellowship, Royal Society, UK	ZZ was supported by grants from the National Natural Science Foundation of China (project no. 81772233 and 81661130159) and the Newton Advanced Fellowship, Royal Society, UK (NA150363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China (project no. 81772233 and 81661130159) and the Newton Advanced Fellowship, Royal Society, UK (NA150363).	Baltrus DA, 2013, TRENDS ECOL EVOL, V28, P489, DOI 10.1016/j.tree.2013.04.002; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bottery MJ, 2017, NAT ECOL EVOL, V1, P1364, DOI 10.1038/s41559-017-0242-3; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Carroll AC, 2018, CAN J MICROBIOL, V64, P293, DOI 10.1139/cjm-2017-0609; Dahlberg C, 2003, GENETICS, V165, P1641; Dionisio F, 2005, BIOL LETT-UK, V1, P250, DOI 10.1098/rsbl.2004.0275; Funnell BE, 2004, PLASMID BIOLOGY, P81; Gama JA, 2018, PLASMID, V99, P82, DOI 10.1016/j.plasmid.2018.09.009; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Gray AN, 2015, ELIFE, V4, DOI 10.7554/eLife.07118; Harrison E, 2015, CURR BIOL, V25, P2034, DOI 10.1016/j.cub.2015.06.024; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Loftie-Eaton W, 2016, MOL BIOL EVOL, V33, P885, DOI 10.1093/molbev/msv339; Matamoros S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15539-7; Millan AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7845; MODI RI, 1991, EVOLUTION, V45, P656, DOI 10.1111/j.1558-5646.1991.tb04336.x; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Pacheco JO, 2017, MBIO, V8, DOI 10.1128/mBio.00500-17; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Porse A, 2016, MOL BIOL EVOL, V33, P2860, DOI 10.1093/molbev/msw163; San Millan AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6208; San Millan A, 2019, MICROBIAL TRANSMISSION, P65, DOI 10.1128/microbiolspec.MTBP-0016-2017; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sota M, 2010, ISME J, V4, P1568, DOI 10.1038/ismej.2010.72; Starikova I, 2013, J ANTIMICROB CHEMOTH, V68, P2755, DOI 10.1093/jac/dkt270; THISTED T, 1994, EMBO J, V13, P1960, DOI 10.1002/j.1460-2075.1994.tb06465.x; Vogwill T, 2015, EVOL APPL, V8, P284, DOI 10.1111/eva.12202; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Zhao FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02094; ZHAO S, 1993, J BACTERIOL, V175, P2799, DOI 10.1128/JB.175.10.2799-2808.1993	33	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209706	10.1371/journal.pone.0209706	http://dx.doi.org/10.1371/journal.pone.0209706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586457	gold, Green Published, Green Submitted			2022-12-26	WOS:000454416400087
J	Sibert, BS; Navine, AK; Pennington, J; Wang, XF; Ahlquist, P				Sibert, Bryan S.; Navine, Amanda K.; Pennington, Janice; Wang, Xiaofeng; Ahlquist, Paul			Cowpea chlorotic mottle bromovirus replication proteins support template-selective RNA replication in Saccharomyces cerevisiae	PLOS ONE			English	Article							BROME MOSAIC-VIRUS; ENDOPLASMIC-RETICULUM; HELICASE-LIKE; COMPARTMENT FORMATION; TOBACCO PROTOPLASTS; CRUCIAL ROLES; MODEL HOST; 1A; IDENTIFICATION; RECOMBINATION	Positive-strand RNA viruses generally assemble RNA replication complexes on rearranged host membranes. Alphaviruses, other members of the alpha-like virus superfamily, and many other positive-strand RNA viruses invaginate host membrane into vesicular RNA replication compartments, known as spherules, whose interior is connected to the cytoplasm. Brome mosaic virus (BMV) and its close relative, cowpea chlorotic mottle virus (CCMV), form spherules along the endoplasmic reticulum. BMV spherule formation and RNA replication can be fully reconstituted in S. cerevisiae, enabling many studies identifying host factors and viral interactions essential for these processes. To better define and understand the conserved, core pathways of bromovirus RNA replication, we tested the ability of CCMV to similarly support spherule formation and RNA replication in yeast. Paralleling BMV, we found that CCMV RNA replication protein 1a was the only viral factor necessary to induce spherule membrane rearrangements and to recruit the viral 2a polymerase (2a(pol)) to the endoplasmic reticulum. CCMV 1a and 2a(pol) also replicated CCMV and BMV genomic RNA2, demonstrating core functionality of CCMV 1a and 2a(pol) in yeast. However, while BMV and CCMV 1a/2a(pol) strongly replicate each others' genomic RNA3 in plants, neither supported detectable CCMV RNA3 replication in yeast. Moreover, in contrast to plant cells, in yeast CCMV 1a/2a(pol) supported only limited replication of BMV RNA3 (<5% of that by BMV 1a/2a(pol)). In keeping with this, we found that in yeast CCMV 1a was significantly impaired in recruiting BMV or CCMV RNA3 to the replication complex. Overall, we show that many 1a and 2a(pol) functions essential for replication complex assembly, and their ability to be reconstituted in yeast, are conserved between BMV and CCMV. However, restrictions of CCMV RNA replication in yeast reveal previously unknown 1a-linked, RNA-selective host contributions to the essential early process of recruiting viral RNA templates to the replication complex.	[Sibert, Bryan S.; Navine, Amanda K.; Pennington, Janice; Wang, Xiaofeng; Ahlquist, Paul] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Sibert, Bryan S.; Pennington, Janice; Ahlquist, Paul] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Navine, Amanda K.; Ahlquist, Paul] Univ Wisconsin, John W & Jeanne M Rowe Ctr Res Virol, Morgridge Inst Res, Madison, WI 53706 USA; [Wang, Xiaofeng] Virginia Tech Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; Virginia Polytechnic Institute & State University	Ahlquist, P (corresponding author), Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.; Ahlquist, P (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.; Ahlquist, P (corresponding author), Univ Wisconsin, John W & Jeanne M Rowe Ctr Res Virol, Morgridge Inst Res, Madison, WI 53706 USA.	ahlquist@wisc.edu		Sibert, Bryan/0000-0003-2650-2343; Navine, Amanda/0000-0003-4827-461X	NIH; John W. and Jeanne M. Rowe Virology Venture Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John W. and Jeanne M. Rowe Virology Venture Fund	P.A. is an investigator of the Howard Hughes Medical Institute and the Morgridge Institute for Research, and gratefully acknowledges support from these institutes, the NIH, and the John W. and Jeanne M. Rowe Virology Venture Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 1992, CURR OPIN GENET DEV, V2, P71, DOI 10.1016/S0959-437X(05)80325-9; Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; Ahola T, 1999, J VIROL, V73, P10061, DOI 10.1128/JVI.73.12.10061-10069.1999; Ahola T, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0050-0; ALLISON R, 1990, P NATL ACAD SCI USA, V87, P1820, DOI 10.1073/pnas.87.5.1820; ALLISON RF, 1988, J VIROL, V62, P3581, DOI 10.1128/JVI.62.10.3581-3588.1988; ALLISON RF, 1989, VIROLOGY, V172, P321, DOI 10.1016/0042-6822(89)90134-7; Alves-Rodrigues I, 2006, VIRUS RES, V120, P49, DOI 10.1016/j.virusres.2005.11.018; Bamunusinghe D, 2011, J VIROL, V85, P2953, DOI 10.1128/JVI.02020-10; BURGESS J, 1974, PLANTA, V117, P133, DOI 10.1007/BF00390795; Chen JB, 2000, J VIROL, V74, P4310, DOI 10.1128/JVI.74.9.4310-4318.2000; Chen JB, 2001, J VIROL, V75, P3207, DOI 10.1128/JVI.75.7.3207-3219.2001; CHOMCZYNSKI P, 1994, ANAL BIOCHEM, V221, P303, DOI 10.1006/abio.1994.1416; den Boon JA, 2001, J VIROL, V75, P12370, DOI 10.1128/JVI.75.24.12370-12381.2001; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Diaz A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004742; Diaz A, 2014, CURR OPIN VIROL, V9, P104, DOI 10.1016/j.coviro.2014.09.018; Diaz A, 2012, J VIROL, V86, P821, DOI 10.1128/JVI.05684-11; Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107; Diez J, 2000, P NATL ACAD SCI USA, V97, P3913, DOI 10.1073/pnas.080072997; DINANT S, 1993, J VIROL, V67, P7181, DOI 10.1128/JVI.67.12.7181-7189.1993; Fujisaki K, 2003, J GEN VIROL, V84, P1367, DOI 10.1099/vir.0.19020-0; Gancarz BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023988; Giddings TH, 2003, J MICROSC-OXFORD, V212, P53, DOI 10.1046/j.1365-2818.2003.01228.x; Hellstrom K, 2017, J VIROL, V91, DOI 10.1128/JVI.00787-17; Ishikawa M, 1997, J VIROL, V71, P7781, DOI 10.1128/JVI.71.10.7781-7790.1997; Janda M, 1998, P NATL ACAD SCI USA, V95, P2227, DOI 10.1073/pnas.95.5.2227; JANDA M, 1993, CELL, V72, P961, DOI 10.1016/0092-8674(93)90584-D; Kallio K, 2013, J VIROL, V87, P9125, DOI 10.1128/JVI.00660-13; Kao CC, 2000, MOL PLANT PATHOL, V1, P91, DOI 10.1046/j.1364-3703.2000.00017.x; KAO CC, 1992, J VIROL, V66, P7293, DOI 10.1128/JVI.66.12.7293-7302.1992; KIM KS, 1977, J GEN VIROL, V35, P535, DOI 10.1099/0022-1317-35-3-535; Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11; Kopek BG, 2010, J VIROL, V84, P12492, DOI 10.1128/JVI.01495-10; Krol MA, 1999, P NATL ACAD SCI USA, V96, P13650, DOI 10.1073/pnas.96.24.13650; Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Lee WM, 2003, J VIROL, V77, P12819, DOI 10.1128/JVI.77.23.12819-12828.2003; Lee WM, 2001, J VIROL, V75, P2097, DOI 10.1128/JVI.75.5.2097-2106.2001; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li JH, 2016, J CELL SCI, V129, P3597, DOI 10.1242/jcs.190082; Liu L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000351; Magliano D, 1998, VIROLOGY, V240, P57, DOI 10.1006/viro.1997.8906; Martelli GP, 1985, PLANT VIRUSES, V1, P163; MISE K, 1993, J VIROL, V67, P2815, DOI 10.1128/JVI.67.5.2815-2823.1993; MOTOYOSHI F, 1973, J GEN VIROL, V20, P177, DOI 10.1099/0022-1317-20-2-177; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; O'Reilly EK, 1998, J VIROL, V72, P7160; PACHA RF, 1991, J VIROL, V65, P3693, DOI 10.1128/JVI.65.7.3693-3703.1991; PACHA RF, 1992, VIROLOGY, V187, P298, DOI 10.1016/0042-6822(92)90318-J; Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32; Price BD, 2005, J VIROL, V79, P495, DOI 10.1128/JVI.79.1.495-502.2005; Price BD, 2002, J VIROL, V76, P1610, DOI 10.1128/JVI.76.4.1610-1616.2002; Rausalu K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37124; Restrepo-Hartwig M, 1999, J VIROL, V73, P10303, DOI 10.1128/JVI.73.12.10303-10309.1999; RestrepoHartwig MA, 1996, J VIROL, V70, P8908, DOI 10.1128/JVI.70.12.8908-8916.1996; Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Schwartz M, 2004, P NATL ACAD SCI USA, V101, P11263, DOI 10.1073/pnas.0404157101; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Sullivan ML, 1999, J VIROL, V73, P2622, DOI 10.1128/JVI.73.4.2622-2632.1999; Sztuba-Solinska J, 2011, ANNU REV PHYTOPATHOL, V49, P415, DOI 10.1146/annurev-phyto-072910-095351; TRAYNOR P, 1990, J VIROL, V64, P69, DOI 10.1128/JVI.64.1.69-77.1990; Wang XF, 2005, J VIROL, V79, P13747, DOI 10.1128/JVI.79.21.13747-13758.2005; Wang XF, 2011, J VIROL, V85, P5494, DOI 10.1128/JVI.02031-10	67	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208743	10.1371/journal.pone.0208743	http://dx.doi.org/10.1371/journal.pone.0208743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586378	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400032
J	Yoon, K; Jeong, C; Kim, SW; Cho, B; Kwak, J; Kim, SS; Song, SY; Choi, EK; Ahn, S; Lee, SW				Yoon, KyoungJun; Jeong, Chiyoung; Kim, Sung-woo; Cho, Byungchul; Kwak, Jungwon; Kim, Su Ssan; Song, Si Yeol; Choi, Eun Kyung; Ahn, SeungDo; Lee, Sang-Wook			Dosimetric evaluation of respiratory gated volumetric modulated arc therapy for lung stereotactic body radiation therapy using 3D printing technology	PLOS ONE			English	Article							DOSE CALCULATION; ACUROS XB; VERIFICATION; ALGORITHM; ACCURACY; PHANTOM	Purpose This study aimed to evaluate the dosimetric accuracy of respiratory gated volumetric modulated arc therapy (VMAT) for lung stereotactic body radiation therapy (SBRT) under simulation conditions similar to the actual clinical situation using patient-specific lung phantoms and realistic target movements. Methods Six heterogeneous lung phantoms were fabricated using a 3D-printer (3DISON, ROKIT, Seoul, Korea) to be dosimetrically equivalent to actual target regions of lung SBRT cases treated via gated VMAT. They were designed to move realistically via a motion device (QUASAR, Modus Medical Devices, Canada). Using the lung phantoms and a homogeneous phantom (model 500-3315, Modus Medical Devices), film dosimetry was performed with and without respiratory gating for VMAT delivery (TrueBeam STx; Varian Medical Systems, Palo Alto, CA, USA). The measured results were analyzed with the gamma passing rates (GPRs) of 2%/1 mm criteria, by comparing with the calculated dose via the AXB and AAA algorithms of the Eclipse Treatment Planning System (version 10.0.28; Varian Medical Systems). Results GPRs were greater than the acceptance criteria 80% for all film measurements with the stationary and homogeneous phantoms in conventional QAs. Regardless of the heterogeneity of phantoms, there were no significant differences (p > 0.05) in GPRs obtained with and without target motions; the statistical significance (p = 0.031) was presented between both algorithms under the utilization of heterogeneous phantoms. Conclusions Dosimetric verification with heterogeneous patient-specific lung phantoms could be successfully implemented as the evaluation method for gated VMAT delivery. In addition, it could be dosimetrically confirmed that the AXB algorithm improved the dose calculation accuracy under patient-specific simulations using 3D printed lung phantoms.	[Yoon, KyoungJun; Jeong, Chiyoung; Kim, Sung-woo; Cho, Byungchul; Kwak, Jungwon; Kim, Su Ssan; Song, Si Yeol; Choi, Eun Kyung; Ahn, SeungDo; Lee, Sang-Wook] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kwak, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	jwkwak0301@gmail.com			Basic Science Research Program of Science and Technology [2014R1A1A2058154, 2016R1C1B2014792]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013M2A2A7043506, 2015M2A2A6A02045253]	Basic Science Research Program of Science and Technology; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program of Science and Technology (2014R1A1A2058154 and 2016R1C1B2014792) and by the Radiation Technology R&D program (2013M2A2A7043506 and 2015M2A2A6A02045253) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning.	Bush K, 2011, MED PHYS, V38, P2208, DOI 10.1118/1.3567146; Cardenas Alex, 2004, J Appl Clin Med Phys, V5, P55, DOI 10.1120/jacmp.2021.25276; Chow JCL, 2005, MED PHYS, V32, P759, DOI 10.1118/1.1861413; Court LE, 2010, MED PHYS, V37, P5850, DOI 10.1118/1.3496356; Ehler ED, 2014, PHYS MED BIOL, V59, P5763, DOI 10.1088/0031-9155/59/19/5763; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fogliata A, 2012, INT J RADIAT ONCOL, V83, P1587, DOI 10.1016/j.ijrobp.2011.10.078; Han T, 2013, MED PHYS, V40, DOI 10.1118/1.4802216; Huang BT, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0357-0; Jung J, 2015, INT J RADIAT ONCOL, V92, P745, DOI 10.1016/j.ijrobp.2015.02.055; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Kim JI, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-167; Kincaid RE, 2013, MED PHYS, V40, DOI 10.1118/1.4795336; Knoos T, 2006, PHYS MED BIOL, V51, P5785, DOI 10.1088/0031-9155/51/22/005; Kroon PS, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-149; 윤경준, 2014, [PROGRESS in MEDICAL PHYSICS, 의학물리], V25, P100, DOI 10.14316/pmp.2014.25.2.100; Li RJ, 2012, MED PHYS, V39, P2686, DOI 10.1118/1.4704729; Li XA, 2007, MED PHYS, V34, P867, DOI 10.1118/1.2514027; Nicolini G, 2010, PHYS MED BIOL, V55, pN347, DOI 10.1088/0031-9155/55/12/N01; Qian JG, 2011, PHYS MED BIOL, V56, P4827, DOI 10.1088/0031-9155/56/15/013; Su S., 2014, J APPL CLIN MED PHYS, V15, P4831, DOI [DOI 10.1120/JACMP.V15I4.4831, 10.1120/jacmp.v15i4.4831]; Swamy ST, 2016, INT J RADIAT RES, V14, P81; Viel F, 2013, DEV QA PROCEDURE GAT; Viel F, 2015, J APPL CLIN MED PHYS, V16, P78, DOI 10.1120/jacmp.v16i4.5350; Wen C-D, 2012, ESTABLISHING QA METH; Zhu XF, 2015, MED PHYS, V42, P6269, DOI 10.1118/1.4932223	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208685	10.1371/journal.pone.0208685	http://dx.doi.org/10.1371/journal.pone.0208685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586367	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400030
J	Ning, Y; Wu, GJ; Ma, H; Guo, JL; Zhang, MY; Li, W; Wang, YF; Duoerji, SL				Ning, Yu; Wu, Gao-Jie; Ma, Hua; Guo, Ju-Lan; Zhang, Man-Yin; Li, Wei; Wang, Yi-Fei; Duoerji, Suo-Lang			Contrasting fine-scale genetic structure of two sympatric clonal plants in an alpine swampy meadow featured by tussocks	PLOS ONE			English	Article							INTEGRATION AFFECTS GROWTH; EVOLUTIONARY CONSEQUENCES; COMPETITIVE ABILITY; BIOMASS ALLOCATION; KOBRESIA-PYGMAEA; DIVERSITY; REPRODUCTION; POPULATIONS; INCREASE; PLATEAU	Tussocks are unique vegetation structures in wetlands. Many tussock species mainly reproduce by clonal growth, resulting in genetically identical offspring distributed in various spatial patterns. These fine-scale patterns could influence mating patterns and thus the long-term evolution of wetland plants. Here, we contribute the first genetic and clonal structures of two key species in alpine wetlands on the Qinghai-Tibet Plateau, Kobresia tibetica and Blysmus sinocompressus, using > 5000 SNPs identified by 2b-RAD sequencing. The tussock-building species, K. tibetica, has a phalanx (clumping) growth form, but different genets could cooccur within the tussocks, indicating that it is not proper to treat a tussock as one genetic individual. Phalanx growth does not necessarily lead to increased inbreeding in K. tibetica. B. sinocompressus has a guerilla (spreading) growth form, with the largest detected clone size being 18.32 m, but genets at the local scale tend to be inbred offspring. Our results highlight that the combination of clone expansion and seedling recruitment facilitates the contemporary advantage of B. sinocompressus, but its evolutionary potential is limited by the input genetic load of the original genets. The tussocks of K. tibetica are more diverse and a valuable genetic legacy of former well-developed wet meadows, and they are worthy of conservation attention.	[Ning, Yu; Wu, Gao-Jie; Ma, Hua; Guo, Ju-Lan; Zhang, Man-Yin; Li, Wei; Wang, Yi-Fei] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Ma, Hua; Guo, Ju-Lan; Wang, Yi-Fei] Zoige Alpine Wetland Ecosyst Res Stn, Zoige, Sichuan, Peoples R China; [Zhang, Man-Yin; Li, Wei] Chinese Acad Forestry, Key Lab Wetland Serv & Restorat, Beijing, Peoples R China; [Duoerji, Suo-Lang] Adm Zoige Wetland Natl Nat Preserve, Zoige, Sichuan, Peoples R China	Chinese Academy of Forestry; Institute of Wetland Research, CAF; Chinese Academy of Forestry	Wang, YF (corresponding author), Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China.; Wang, YF (corresponding author), Zoige Alpine Wetland Ecosyst Res Stn, Zoige, Sichuan, Peoples R China.	Wangyf_wetland@126.com	马, 骅/AFH-8663-2022; Zhang, Manyin/AAK-5171-2020	NING, Yu/0000-0002-8269-7248; wang, yi fei/0000-0003-2839-0488	National Nonprofit Institute Research Grant from CAFINT [CAFINT2015C11]; Fundamental Research Funds for the Central Nonprofit Research Institution of CAF [CAFYBB2017QA040]; National Nonprofit Institute Research Grant [CAFINT2015C11]	National Nonprofit Institute Research Grant from CAFINT; Fundamental Research Funds for the Central Nonprofit Research Institution of CAF; National Nonprofit Institute Research Grant	This work was supported by the National Nonprofit Institute Research Grant from CAFINT (No. CAFINT2015C11) and the Fundamental Research Funds for the Central Nonprofit Research Institution of CAF(No. CAFYBB2017QA040) to YN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We give special thanks to Alde Zu of Ba Xi County for his kind assistance and participation. We are also grateful to Si YANG and Zhao-Rui LIANG for providing the field photos. This study was financially supported by the National Nonprofit Institute Research Grant (CAFINT2015C11) and the Fundamental Research Funds for the Central Nonprofit Research Institution of CAF (CAFYBB2017QA040). In addition, we would like to thank two anonymous reviewers for their help in improving this manuscript.	Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Barrett SCH, 2015, P NATL ACAD SCI USA, V112, P8859, DOI 10.1073/pnas.1501712112; Bartha S, 2003, APPL VEG SCI, V6, P205, DOI 10.1111/j.1654-109X.2003.tb00581.x; Binks R M, 2015, HEREDITY, V115, P1, DOI [10.1038/hdy.2015.12, DOI 10.1038/HDY.2015.12]; Bjornstad O. N, NCF SPATIAL NONPARAM; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Charpentier A, 2002, EVOLUTIONARY ECOLOGY, V15, P521, DOI DOI 10.1023/A:1016057503722; [褚希彤 Chu Xitong], 2013, [草业科学, Pratacultural Science], V30, P1025; Crain CM, 2005, ECOLOGY, V86, P2695, DOI 10.1890/04-1517; Crawford KM, 2012, J ECOL, V100, P1512, DOI 10.1111/j.1365-2745.2012.02016.x; CRUDEN RW, 1988, BOT GAZ, V149, P1, DOI 10.1086/337684; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; Eckert CG, 2016, AQUAT BOT, V135, P46, DOI 10.1016/j.aquabot.2016.03.006; Forge T.A., 2007, NEMATODES, P415; Friedman J, 2009, ANN BOT-LONDON, V103, P1515, DOI 10.1093/aob/mcp035; Fu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079960; Gao YH, 2018, ECOL ENG, V116, P31, DOI 10.1016/j.ecoleng.2018.02.016; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Grootjans A, 2017, J COAST CONSERV, V21, P631, DOI 10.1007/s11852-016-0448-6; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Herben T, 2004, EVOL ECOL, V18, P493, DOI 10.1007/s10682-004-5141-9; Hu YP, 2016, AQUAT BOT, V134, P54, DOI 10.1016/j.aquabot.2016.06.011; Kamvar ZN, 2015, PHYTOPATHOLOGY, V105, P982, DOI 10.1094/PHYTO-12-14-0350-FI; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Klimesova J, 2012, POL POLAR RES, V33, P421, DOI 10.2478/v10183-012-0019-y; [李春秀 LI Chun-xiu], 2009, [草业科学, Pratacultural Science], V26, P77; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang SY, 2010, FLORA CHINA, V23, P251; Ma QF, 2017, WETLANDS, V37, P461, DOI 10.1007/s13157-017-0882-8; Miehe G, 2011, J ARID ENVIRON, V75, P711, DOI 10.1016/j.jaridenv.2011.03.001; Ning Y, 2014, POL J ECOL, V62, P77, DOI 10.3161/104.062.0108; Oesterheld M, 2004, OIKOS, V107, P576, DOI 10.1111/j.0030-1299.2004.13442.x; Oksanen J, 2013, LC RODRIGUEZ, V48, P103; Paradis E, 2012, BIOINFORMATICS, V26, P419; R Core TeamR, LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SALZMAN AG, 1985, SCIENCE, V228, P603, DOI 10.1126/science.3983647; Seeber E, 2016, J PLANT ECOL, V9, P87, DOI 10.1093/jpe/rtv035; Seeber E, 2014, BOT J LINN SOC, V176, P22, DOI 10.1111/boj.12189; THOMSON JD, 1981, EVOLUTION, V35, P1094, DOI 10.1111/j.1558-5646.1981.tb04979.x; TSUYUZAKI S, 1992, CAN J BOT, V70, P2310, DOI 10.1139/b92-287; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; Van Drunen WE, 2015, P NATL ACAD SCI USA, V112, P8929, DOI 10.1073/pnas.1501720112; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Wang S, 2016, NAT PROTOC, V11, P2189, DOI 10.1038/nprot.2016.133; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Wu Jian-guo, 2012, Yingyong Shengtai Xuebao, V23, P1003; Wu Liang, 2017, Journal of Resources and Ecology, V8, P20, DOI 10.5814/j.issn.1674-764x.2017.01.004; Yu FH, 2006, INT J PLANT SCI, V167, P513, DOI 10.1086/500474; Yu FH, 2010, BASIC APPL ECOL, V11, P743, DOI 10.1016/j.baae.2010.09.005; Yue DongXia, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P248; Zhang SR, 2010, FLORA CHINA, V23, P269; Zhao NN, 2017, WATER-SUI, V9, DOI 10.3390/w9120971; Zhao QF, 2006, HEREDITAS, V143, P33, DOI 10.1111/j.2006.0018-0661.01924.x	55	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209572	10.1371/journal.pone.0209572	http://dx.doi.org/10.1371/journal.pone.0209572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576376	gold, Green Published, Green Submitted			2022-12-26	WOS:000454149400058
J	Apasu, JE; Schuette, D; LaRanger, R; Steinle, JA; Nguyen, LD; Grosshans, HK; Zhang, ML; Cai, WL; Yan, Q; Robert, ME; Mak, M; Ehrlich, BE				Apasu, Jonathan E.; Schuette, Daniel; LaRanger, Ryan; Steinle, Julia A.; Nguyen, Lien D.; Grosshans, Henrike K.; Zhang, Meiling; Cai, Wesley L.; Yan, Qin; Robert, Marie E.; Mak, Michael; Ehrlich, Barbara E.			Neuronal calcium sensor 1 (NCS1) promotes motility and metastatic spread of breast cancer cells in vitro and in vivo	FASEB JOURNAL			English	Article						cell migration; xenograft model; calcium binding protein; metastasis; Ca2+ signaling	LIM KINASES; GENE; OSCILLATIONS; MECHANISMS; MIGRATION; ENHANCEMENT; EXOCYTOSIS; PROTEIN-1; RECEPTOR; TUMOR	Increased levels of the calcium-binding protein neuronal calcium sensor 1 (NCS1) predict an unfavorable patient outcome in several aggressive cancers, including breast and liver tumors. Previous studies suggest that NCS1 overexpression facilitates metastatic spread of these cancers. To investigate this hypothesis, we explored the effects of NCS1 overexpression on cell proliferation, survival, and migration patterns in vitro in 2- and 3-dimensional (2/3-D). Furthermore, we translated our results into an in vivo mouse xenograft model. Cell-based proliferation assays were used to demonstrate the effects of overexpression of NCS1 on growth rates. In vitro colony formation and wound healing experiments were performed and 3-D migration dynamics were studied using collagen gels. Nude mice were injected with breast cancer cells to monitor NCS1-dependent metastasis formation over time. We observed that increased NCS1 levels do not change cellular growth rates, but do significantly increase 2- and 3-D migration dynamics in vitro. Likewise, NCS1-overexpressing cells have an increased capacity to form distant metastases and demonstrate better survival and less necrosis in vivo. We found that NCS1 preferentially localizes to the leading edge of cells and overexpression increases the motility of cancer cells. Furthermore, this phenotype is correlated with an increased number of metastases in a xenograft model. These results lay the foundation for exploring the relevance of an NCS1-mediated pathway as a metastatic biomarker and as a target for pharmacologic interventions.	[Apasu, Jonathan E.; Schuette, Daniel; Steinle, Julia A.; Nguyen, Lien D.; Grosshans, Henrike K.; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, 333 Cedar St,Room B-147,POB 208026, New Haven, CT 06520 USA; [LaRanger, Ryan; Mak, Michael] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Zhang, Meiling; Cai, Wesley L.; Yan, Qin; Robert, Marie E.] Yale Univ, Dept Pathol, New Haven, CT USA; [Apasu, Jonathan E.] Univ Bonn, Bonn, Germany; [Steinle, Julia A.] Univ Munster, Munster, Germany	Yale University; Yale University; Yale University; University of Bonn; University of Munster	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St,Room B-147,POB 208026, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021; Yan, Qin/E-8893-2012	/0000-0001-9657-9704; Yan, Qin/0000-0003-4077-453X; Nguyen, Lien/0000-0001-8096-1570; Schuette, Daniel/0000-0002-4746-537X	German Academic Scholarship Foundation; Yale University; NSF Graduate Research Fellowship [DGE-1122492]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [5P01DK057751]; NIH National Institute of Biomedical Imaging and Bioengineering [1R21EB026630]; U.S. Department of Defense [W81XWH-15-1-0117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751] Funding Source: NIH RePORTER	German Academic Scholarship Foundation; Yale University; NSF Graduate Research Fellowship(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Sabine Lang (Yale University) for technical and administrative support. The authors acknowledge helpful discussions with Allison Brill, Dr. David Calderwood, and Dr. Tamar Taddei (Yale University). J.E.A., D.S., J.A.S., and H.K.G. received a scholarship from the German Academic Scholarship Foundation. M.Z. received a Brown Coxe Postdoctoral Fellowship from Yale University. W.L.C. received NSF Graduate Research Fellowship DGE-1122492. This work was supported, in part, by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant 5P01DK057751 (to B.E.E. and M.E.R.), NIH National Institute of Biomedical Imaging and Bioengineering (Grant 1R21EB026630 to M.M.), and U.S. Department of Defense Grant W81XWH-15-1-0117 (to Q.Y.). B.E.E. is a founder of Osmol Therapeutics, a company that is targeting NCS1 for therapeutic purposes. Primary data are maintained in the Ehrlich Laboratory at Yale University. Reagents not commercially available are available from the Ehrlich Laboratory. The authors declare no conflicts of interest.	Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Ando Hideaki, 2018, Advances in Biological Regulation, V68, P64, DOI 10.1016/j.jbior.2017.12.001; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Blasiole B, 2005, J NEUROBIOL, V64, P285, DOI 10.1002/neu.20138; Boeckel GR, 2018, BBA-MOL CELL RES, V1865, P1660, DOI 10.1016/j.bbamcr.2018.05.005; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; D'Onofrio S, 2015, J NEUROPHYSIOL, V113, P709, DOI 10.1152/jn.00828.2014; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Florea AM, 2009, NEUROTOXICOLOGY, V30, P803, DOI 10.1016/j.neuro.2009.04.014; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li R, 2013, CLIN EXP METASTAS, V30, P483, DOI 10.1007/s10585-012-9553-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Moore LM, 2017, MOL CANCER RES, V15, P942, DOI 10.1158/1541-7786.MCR-16-0408; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Prunier C, 2017, ONCOTARGET, V8, P41749, DOI 10.18632/oncotarget.16978; Rajebhosale M, 2003, J BIOL CHEM, V278, P6075, DOI 10.1074/jbc.M204702200; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Schuette D, 2018, CANCER EPIDEM BIOMAR, V27, P1091, DOI 10.1158/1055-9965.EPI-18-0167; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Stewart TA, 2015, BBA-BIOMEMBRANES, V1848, P2502, DOI 10.1016/j.bbamem.2014.08.016; Stuelten CH, 2018, NAT REV CANCER, V18, P296, DOI 10.1038/nrc.2018.15; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Taketo MM, 2011, CANCER PREV RES, V4, P324, DOI 10.1158/1940-6207.CAPR-11-0046; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Xiao MB, 2018, ONCOL LETT, V15, P175, DOI 10.3892/ol.2017.7295; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	55	6	6	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4802	4813		10.1096/fj.201802004R	http://dx.doi.org/10.1096/fj.201802004R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592625	Green Published, Bronze			2022-12-26	WOS:000462888500014
J	Young, J; Duong, F				Young, John; Duong, Franck			Investigating the stability of the SecA-SecYEG complex during protein translocation across the bacterial membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein translocation; membrane transport; protein-protein interaction; protein dynamic; lipid-protein interaction; ATPase; Sec translocon	BINDING; CHANNEL; NUCLEOTIDE; MOVEMENT; ACTIVATE; DOMAIN; LIPIDS; SITE	During posttranslational translocation in Escherichia coli, polypeptide substrates are driven across the membrane through the SecYEG protein-conducting channel using the ATPase SecA, which binds to SecYEG and couples nucleotide hydrolysis to polypeptide movement. Recent studies suggest that SecA is a highly dynamic enzyme, able to repeatedly bind and dissociate from SecYEG during substrate translocation, but other studies indicate that these dynamics, here referred to as SecA processivity, are not a requirement for transport. We employ a SecA mutant (PrlD23) that associates more tightly to membranes than WT SecA, in addition to a SecA-SecYEG cross-linked complex, to demonstrate that SecA-SecYEG binding and dissociation events are important for efficient transport of the periplasmic protein proPhoA. Strikingly however, we find that transport of the precursor of the outer membrane protein proOmpA does not depend on SecA processivity. By exchanging signal sequence and protein domains of similar size between PhoA and OmpA, we find that SecA processivity is not influenced by the sequence of the protein substrate. In contrast, using an extended proOmpA variant and a truncated derivative of proPhoA, we show that SecA processivity is affected by substrate length. These findings underscore the importance of the dynamic nature of SecA-SecYEG interactions as a function of the preprotein substrate, features that have not yet been reported using other biophysical or in vivo methods.	[Young, John; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Young, John/0000-0003-3541-509X	Canadian Institutes of Health Research Grant [MOP 201309]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP 201309. The authors declare that they have no conflicts of interest with the contents of this article.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Allen WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15598; Bariya P, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00493-18; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Carlson ML, 2018, ELIFE, V7, DOI 10.7554/eLife.34085; Chatzi KE, 2017, J CELL BIOL, V216, P1357, DOI 10.1083/jcb.201609022; Chatzi KE, 2014, BBA-MOL CELL RES, V1843, P1466, DOI 10.1016/j.bbamcr.2014.02.014; Collinson I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0025; Crane Jennine M, 2017, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0002-2017; Cranford-Smith T, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny093; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; Dalal K, 2009, J BIOL CHEM, V284, P7897, DOI 10.1074/jbc.M808305200; Ding HY, 2003, BIOCHEMISTRY-US, V42, P13468, DOI 10.1021/bi035099b; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Fessl T, 2018, ELIFE, V7, DOI 10.7554/eLife.35112; Gold VAM, 2013, BIOCHEM J, V449, P695, DOI 10.1042/BJ20121314; Gouridis G, 2013, MOL CELL, V52, P655, DOI 10.1016/j.molcel.2013.10.036; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Koch S, 2016, J BIOL CHEM, V291, P22534, DOI 10.1074/jbc.M116.743831; Mao CF, 2013, P NATL ACAD SCI USA, V110, P11815, DOI 10.1073/pnas.1303289110; Morita K, 2012, J BIOL CHEM, V287, P455, DOI 10.1074/jbc.M111.301754; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Schmidt M, 2000, J BIOL CHEM, V275, P15440, DOI 10.1074/jbc.M000605200; Sugano Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183434; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Tsirigotaki A, 2018, STRUCTURE, V26, P695, DOI 10.1016/j.str.2018.03.006; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191	33	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3577	3587		10.1074/jbc.RA118.006447	http://dx.doi.org/10.1074/jbc.RA118.006447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602566	Green Published, hybrid			2022-12-26	WOS:000461853900022
J	Yang, AL; Fan, HT; Zhao, YA; Chen, XN; Zhu, ZX; Zha, XJ; Zhao, YF; Chai, XY; Li, J; Tu, PF; Hu, ZD				Yang, Ailin; Fan, Haitao; Zhao, Yanan; Chen, Xiaonan; Zhu, Zhixiang; Zha, Xiaojun; Zhao, Yunfang; Chai, Xingyun; Li, Jun; Tu, Pengfei; Hu, Zhongdong			An immune-stimulating proteoglycan from the medicinal mushroom Huaier up-regulates NF-kappa B and MAPK signaling via Toll-like receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; proteoglycan; Toll-like receptor 4 (TLR4); NF-kappaB; mitogen-activated protein kinase (MAPK); immunotherapy; cytokine response; Huaier; immunomodulation; TPG-1; trametes; anti-tumor; TPG-1	HEPATOCELLULAR-CARCINOMA GROWTH; 4-DEPENDENT ACTIVATION; NITRIC-OXIDE; LAMIN B1; POLYSACCHARIDE; MACROPHAGE; PATHWAYS; PROTEIN; INNATE; TNF	Trametes robiniophila Murr. (Huaier) is a mushroom with a long history of use as a medicinal ingredient in China and exhibits good clinical efficacy in cancer management. However, the antitumor components of Huaier and the underlying molecular mechanisms remain poorly understood. Here, we isolated a proteoglycan with a molecular mass of similar to 5.59 x 10(4) Da from Huaier aqueous extract. We named this proteoglycan TPG-1, and using FTIR and additional biochemical analyses, we determined that its total carbohydrate and protein compositions are 43.9 and 41.2%, respectively. Using biochemical assays and immunoblotting, we found that exposing murine RAW264.7 macrophages to TPG-1 promotes the production of nitric oxide (NO), tumor necrosis factor alpha (TNF alpha), and interleukin-6 (IL-6) through Toll-like receptor 4 (TLR4)-dependent activation of NF-kappa B and mitogen-activated protein kinase (MAPK) signaling. Of note, the TPG-1 treatment significantly inhibited the tumorigenesis of human hepatoma HepG2 cells likely at least in part by increasing serum levels of TNF alpha and promoting leukocyte infiltration into tumors in nude mice. TPG-1 also exhibited good antitumor activity in hepatoma H22-bearing mice and had no obvious adverse effects in these mice. We conclude that TPG-1 exerts antitumor activity partially through an immune-potentiating effect due to activation of the TLR4-NF-kappa B/MAPK signaling cassette. Therefore, TPG-1 may be a promising candidate drug for cancer immunotherapy. This study has identified the TPG-1 proteoglycan as an antitumor agent and provided insights into TPG-1's molecular mechanism, suggesting a potential utility for applying this agent in cancer therapy.	[Yang, Ailin; Zhao, Yanan; Chen, Xiaonan; Zhu, Zhixiang; Zhao, Yunfang; Chai, Xingyun; Li, Jun; Tu, Pengfei; Hu, Zhongdong] Beijing Univ Chinese Med, Sch Chinese Mat Med, Modern Res Ctr Tradit Chinese Med, 11 North Third Ring Rd, Beijing 100029, Peoples R China; [Fan, Haitao] Beijing Polytech, Coll Bioengn, Beijing 100029, Peoples R China; [Zha, Xiaojun] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China	Beijing University of Chinese Medicine; Beijing Polytechnic; Anhui Medical University	Tu, PF; Hu, ZD (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Modern Res Ctr Tradit Chinese Med, 11 North Third Ring Rd, Beijing 100029, Peoples R China.	pengfeitu@163.com; zdhu@bucm.edu.cn	Li, Jun/M-9884-2016	Li, Jun/0000-0001-8243-5267	National Natural Science Foundation of China [81403147]; Fundamental Research Funds for the Central Universities [2015-JYB-XYQ-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grant 81403147 and Fundamental Research Funds for the Central Universities Grant 2015-JYB-XYQ-004. The authors declare that they have no conflicts of interest with the contents of this article.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bukata SV, 2004, J ORTHOP RES, V22, P6, DOI 10.1016/S0736-0266(03)00153-0; Chang HH, 2009, J AGR FOOD CHEM, V57, P6129, DOI 10.1021/jf9011399; Chen Q, 2018, GUT, V67, P2006, DOI 10.1136/gutjnl-2018-315983; Chen XM, 2014, CARBOHYD POLYM, V105, P113, DOI 10.1016/j.carbpol.2014.01.056; Eggermont AMM, 2003, LANCET ONCOL, V4, P429, DOI 10.1016/S1470-2045(03)01141-0; Fisher M, 2002, ANTICANCER RES, V22, P1737; Guzman G, 2005, MODERN PATHOL, V18, P1498, DOI 10.1038/modpathol.3800458; Hu ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31298; Hu ZD, 2015, J BIOL CHEM, V290, P25756, DOI 10.1074/jbc.M115.665208; Jin FQ, 2017, HUM MOL GENET, V26, P407, DOI 10.1093/hmg/ddw397; Karnjanapratum S, 2011, INT J BIOL MACROMOL, V48, P311, DOI 10.1016/j.ijbiomac.2010.12.002; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KROSL G, 1994, CANCER LETT, V84, P43, DOI 10.1016/0304-3835(94)90356-5; Lee KY, 2006, J ETHNOPHARMACOL, V103, P372, DOI 10.1016/j.jep.2005.08.037; Li C, 2015, TUMOR BIOL, V36, P1739, DOI 10.1007/s13277-014-2775-2; Li C, 2015, INT J BIOL MACROMOL, V75, P115, DOI 10.1016/j.ijbiomac.2015.01.016; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Long TT, 2018, INT J BIOL MACROMOL, V111, P813, DOI 10.1016/j.ijbiomac.2018.01.070; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Medeiros R, 2010, BEHAV BRAIN RES, V209, P165, DOI 10.1016/j.bbr.2010.01.040; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakao S, 2002, MOL CELL BIOCHEM, V238, P11, DOI 10.1023/A:1019927616000; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Song XJ, 2015, ONCOL REP, V34, P12, DOI 10.3892/or.2015.3950; STAUB A. M., 1965, METHOD CARBOHYD CHEM, V5, P5; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Sun Y, 2013, CARBOHYD POLYM, V92, P577, DOI 10.1016/j.carbpol.2012.09.006; Tan BKH, 2004, CURR MED CHEM, V11, P1423, DOI 10.2174/0929867043365161; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wei W, 2016, J ETHNOPHARMACOL, V179, P243, DOI 10.1016/j.jep.2015.12.060; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Yang AL, 2018, ONCOL REP, V39, P3055, DOI 10.3892/or.2018.6358; Yoon YD, 2003, INT IMMUNOPHARMACOL, V3, P1873, DOI 10.1016/j.intimp.2003.09.005; Yu Q, 2014, FOOD CHEM TOXICOL, V66, P14, DOI 10.1016/j.fct.2014.01.018; Zhang CX, 2011, FOOD CHEM TOXICOL, V49, P2961, DOI 10.1016/j.fct.2011.07.044; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zheng JS, 2014, INT J BIOL MACROMOL, V64, P106, DOI 10.1016/j.ijbiomac.2013.11.034; Zhou LJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44822; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026	54	23	28	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2628	2641		10.1074/jbc.RA118.005477	http://dx.doi.org/10.1074/jbc.RA118.005477			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30602571	Green Published, hybrid			2022-12-26	WOS:000459601600006
J	Li, YL; Appius, A; Pattipaka, T; Feyereislova, A; Cassidy, A; Ganti, AK				Li, Yulin; Appius, Anita; Pattipaka, Thirupathi; Feyereislova, Andrea; Cassidy, Adrian; Ganti, Apar Kishor			Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA	PLOS ONE			English	Article							OPEN-LABEL; 1ST-LINE TREATMENT; PHASE-III; CHEMOTHERAPY; MULTICENTER; ADENOCARCINOMA; GEFITINIB; ERLOTINIB; AFATINIB; GEMCITABINE	Background Randomized phase III trials have established the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as first-line treatment for EGFR mutation-positive advanced non-small-cell lung cancer (EGFR Mut+ NSCLC). This retrospective cohort study examined the management patterns and outcomes of patients with EGFR Mut+ NSCLC in a real-world setting. Materials and methods Data were extracted from the US Flatiron Electronic Health Record-derived database. Adult patients with stage IIIB/IV EGFR Mut+ NSCLC (exon 19 deletion or exon 21 L858R mutation) who had received first-line systemic therapy between 2011 and 2016 were included. Demographic and clinical characteristics were analyzed. Outcomes evaluated were time to next treatment (a surrogate for progression-free survival) and overall survival. Results Of the 22,258 patients with advanced NSCLC in the database, 961 met the inclusion criteria. Median age was 69.0 years (range: 61-78) and the majority were female (68.0%), with stage IV (93.9%), non-squamous cell carcinoma (97.4%). EGFR tyrosine kinase inhibitors were the most widely prescribed first-line therapy (72.8%). The likelihood of receiving an EGFR tyrosine kinase inhibitor or chemotherapy was unaffected by the type of medical insurance patients had. Patients treated with an EGFR tyrosine kinase inhibitor had significantly longer time to next treatment than those given other first-line systemic therapies (p < 0.0001). There were no significant differences in overall survival according to treatment type. Conclusion Results from this large US cohort study reflect those obtained in randomized trials of patients with advanced EGFR Mut+ NSCLC and demonstrate their transferability into a real-world setting.	[Li, Yulin] F Hoffmann La Roche Ltd, Pharma Dev, Beijing, Peoples R China; [Appius, Anita; Pattipaka, Thirupathi; Feyereislova, Andrea; Cassidy, Adrian] F Hoffmann La Roche Ltd, Pharma Dev, Basel, Switzerland; [Ganti, Apar Kishor] Univ Nebraska Med Ctr, Div Oncol Hematol, Nebraska Med Ctr, VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA	Roche Holding; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Li, YL (corresponding author), F Hoffmann La Roche Ltd, Pharma Dev, Beijing, Peoples R China.	yulin.li@roche.com	Ganti, Apar Kishor/D-5498-2015	Ganti, Apar Kishor/0000-0003-3724-2671	F. Hoffmann-La Roche Ltd; Roche; F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Roche(Roche Holding); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	The sponsor, F. Hoffmann-La Roche Ltd, designed the protocol and statistical analysis plan for this retrospective cohort study, based on which the data were extracted from the Flatiron database and analyzed. Roche also supported the preparation of the manuscript (no grant number is applicable). The authors contributed with data interpretation and analyses as well as with the decision to publish the results and review of the manuscript.; Third-party medical writing assistance, under the direction of the authors, was provided by Fiona Fernando, PhD, of Gardiner-Caldwell Communications, and was funded by F. Hoffmann-La Roche Ltd.	Abernethy AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178420; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Batson S, 2017, ONCOTARGETS THER, V10, P2473, DOI 10.2147/OTT.S134382; Curtis MD, 2018, HEALTH SERV RES, V53, P4460, DOI 10.1111/1475-6773.12872; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Howlader N, 2013, SEER CANCER STATISTI; Isobe H, 2017, LUNG CANCER-TARGETS, V8, P191, DOI 10.2147/LCTT.S140491; Jadhav S, USING REAL WORLD DAT; Juan O, 2017, THER ADV MED ONCOL, V9, P201, DOI 10.1177/1758834016687262; Lee DH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202865; Lim C, 2015, ANN ONCOL, V26, P1415, DOI 10.1093/annonc/mdv208; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mckay C, 2016, CLIN LUNG CANCER, V17, P449, DOI 10.1016/j.cllc.2016.03.008; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Schneeweiss S, 2016, CLIN PHARMACOL THER, V100, P633, DOI 10.1002/cpt.512; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Wu YL, 2015, ANN ONCOL, V26, P1883, DOI 10.1093/annonc/mdv270; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	28	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209709	10.1371/journal.pone.0209709	http://dx.doi.org/10.1371/journal.pone.0209709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608948	gold, Green Published, Green Submitted			2022-12-26	WOS:000454952800023
J	Luttrell, LM; Dar, MS; Gesty-Palmer, D; El-Shewy, HM; Robinson, KM; Haycraft, CJ; Barth, JL				Luttrell, Louis M.; Dar, Moahad S.; Gesty-Palmer, Diane; El-Shewy, Hesham M.; Robinson, Katherine M.; Haycraft, Courtney J.; Barth, Jeremy L.			Transcriptomic characterization of signaling pathways associated with osteoblastic differentiation of MC-3T3E1 cells	PLOS ONE			English	Article							GENE-EXPRESSION; TGF-BETA; OSTEOGENIC DIFFERENTIATION; COLLAGEN-SYNTHESIS; CDNA MICROARRAY; BONE-FORMATION; STEM-CELLS; IN-VITRO; IDENTIFICATION; MODULATION	Bone remodeling involves the coordinated actions of osteoclasts, which resorb the calcified bony matrix, and osteoblasts, which refill erosion pits created by osteoclasts to restore skeletal integrity and adapt to changes in mechanical load. Osteoblasts are derived from pluripotent mesenchymal stem cell precursors, which undergo differentiation under the influence of a host of local and environmental cues. To characterize the autocrine/paracrine signaling networks associated with osteoblast maturation and function, we performed gene network analysis using complementary "agnostic" DNA microarray and "targeted" NanoString nCounter datasets derived from murine MC3T3-E1 cells induced to undergo synchronized osteoblastic differentiation in vitro. Pairwise datasets representing changes in gene expression associated with growth arrest (day 2 to 5 in culture), differentiation (day 5 to 10 in culture), and osteoblast maturation (day 10 to 28 in culture) were analyzed using Ingenuity Systems Pathways Analysis to generate predictions about signaling pathway activity based on the temporal sequence of changes in target gene expression. Our data indicate that some pathways involved in osteoblast differentiation, e.g. Wnt/beta-catenin signaling, are most active early in the process, while others, e.g. TGF beta/BMP, cytokine/JAK-STAT and TNF alpha/RANKL signaling, increase in activity as differentiation progresses. Collectively, these pathways contribute to the sequential expression of genes involved in the synthesis and mineralization of extracellular matrix. These results provide insight into the temporal coordination and complex interplay between signaling networks controlling gene expression during osteoblast differentiation. A more complete understanding of these processes may aid the discovery of novel methods to promote osteoblast development for the treatment of conditions characterized by low bone mineral density.	[Luttrell, Louis M.; El-Shewy, Hesham M.; Robinson, Katherine M.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Luttrell, Louis M.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Dar, Moahad S.; Gesty-Palmer, Diane] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Haycraft, Courtney J.] Mississippi Coll, Dept Biol, Clinton, MS USA; [Barth, Jeremy L.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Duke University; Medical University of South Carolina	Luttrell, LM (corresponding author), Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA.; Luttrell, LM (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Luttrell, LM (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA.	luttrell@musc.edu		Barth, Jeremy/0000-0001-6113-8140; Luttrell, Louis/0000-0003-2805-6949	NIH/NIGMS [R01 GM095497, R35 GM126955, P30 GM103342, P20 GM103499]; United States Department of Veterans Affairs [I01 BX003188]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342, R35GM126955, P20GM103499, R01GM095497] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003188] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Supported by NIH/NIGMS grants R01 GM095497 (LML), R35 GM126955 (LML), P30 GM103342 (JLB), P20 GM103499 (JLB), and the United States Department of Veterans Affairs grant I01 BX003188 (LML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Bernardini C, 2010, GENE EXPRESSION, V15, P27, DOI 10.3727/105221610X12819686555097; Bourne S, 2004, TISSUE ENG, V10, P796, DOI 10.1089/1076327041348293; CENTRELLA M, 1988, ENDOCRINOLOGY, V123, P1442, DOI 10.1210/endo-123-3-1442; Choi HD, 2011, J PERIODONTAL IMPLAN, V41, P30, DOI 10.5051/jpis.2011.41.1.30; Dean AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S5; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Granchi D, 2010, TISSUE ENG PART C-ME, V16, P511, DOI [10.1089/ten.tec.2009.0405, 10.1089/ten.TEC.2009.0405]; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hatch NE, 2009, J BONE MINER RES, V24, P652, DOI 10.1359/JBMR.081213; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jones SJ, 1997, BONE, V21, P393, DOI 10.1016/S8756-3282(97)00174-9; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kawane T, 2014, J BONE MINER RES, V29, P1960, DOI 10.1002/jbmr.2240; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Komori T, 2017, ADV EXP MED BIOL, V962, P83, DOI 10.1007/978-981-10-3233-2_6; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Maudsley S, 2011, METHODS MOL BIOL, V756, P99, DOI 10.1007/978-1-61779-160-4_5; MUNDY GR, 1990, ANN NY ACAD SCI, V593, P91, DOI 10.1111/j.1749-6632.1990.tb16102.x; NODA M, 1989, CONNECT TISSUE RES, V21, P401, DOI 10.3109/03008208909049997; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Piek E, 2010, BONE, V46, P613, DOI 10.1016/j.bone.2009.10.024; Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; QUARLES LD, 1992, J BONE MINER RES, V7, P683; QUARLES LD, 1991, ENDOCRINOLOGY, V128, P3144, DOI 10.1210/endo-128-6-3144; Raisz LG, 1999, CLIN CHEM, V45, P1353; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; SMITH DD, 1987, ENDOCRINOLOGY, V120, P2494, DOI 10.1210/endo-120-6-2494; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; van den Bosch MH, 2016, RHEUMATOLOGY, V55, P1536, DOI 10.1093/rheumatology/kev402; van den Bosch MH, 2014, CELL SIGNAL, V26, P951, DOI 10.1016/j.cellsig.2014.01.021; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang LM, 2005, AM J PHYSIOL-ENDOC M, V288, pE826, DOI 10.1152/ajpendo.00422.2004; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	47	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0204197	10.1371/journal.pone.0204197	http://dx.doi.org/10.1371/journal.pone.0204197			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608923	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800003
J	Maerle, AV; Simonova, MA; Pivovarov, VD; Voronina, DV; Drobyazina, PE; Trofimov, DY; Alekseev, LP; Zavriev, SK; Ryazantsev, DY				Maerle, Artem V.; Simonova, Maria A.; Pivovarov, Victor D.; Voronina, Daria V.; Drobyazina, Polina E.; Trofimov, Dmitriy Yu.; Alekseev, Leonid P.; Zavriev, Sergei K.; Ryazantsev, Dmitriy Yu.			Development of the covalent antibody-DNA conjugates technology for detection of IgE and IgM antibodies by immuno-PCR	PLOS ONE			English	Article							PROTEIN-DETECTION; CYCLOADDITION; REAGENTS; ESTERS	Immuno-PCR (iPCR) is one of the methods used for the detection of a wide range of analytes and features the high sensitivity of the polymerase chain reaction (PCR) method. iPCR uses antibodies coupled to DNA, followed by the amplification of the attached DNA using RT-PCR. Two major types of antibody-DNA conjugates are currently used, which are obtained as a result of non-covalent (biotin-streptavidin) or covalent interactions. Using a strain-promoted azide-alkyne cycloaddition (SPAAC), we synthesized covalent DNA-antibody conjugates, optimized the reaction conditions, and developed an efficient protocol for the purification of conjugates, with which all unreacted antibodies and oligonucleotides are separated. Covalent DNA-antibody conjugates were tested with iPCR assays that were previously developed for the detection of IgE and IgM antibodies with the use of the supramolecular complex of 5'- and 3'-biotinylated DNA and streptavidin. The results show that the modification of antibodies with amino groups did not allow us to obtain monolabeled antibodies or antibodies with a strictly defined number of DNA-labels. The degree of labeling determined by the dyes introduced through the azido group reflects the actual labeling degree statistically. If the average labeling degree for azido groups is 1.1, the conjugates contain 25% mono-labeled antibodies, 50% double-labeled antibodies, and 25% unlabeled ones. The specificity of the monoclonal antibody to human IgE (BE5) changed after conjugation with the oligonucleotide. The sensitivity of iPCR in the detection of IgM antibodies produced against the Le C disaccharide using a covalent conjugate was similar to that of a supramolecular complex of 5'- and 3'-biotinylated DNA and streptavidin, but the new procedure is two steps shorter.	[Maerle, Artem V.] OOO DNA Technol TS, Moscow, Russia; [Simonova, Maria A.; Pivovarov, Victor D.; Voronina, Daria V.; Drobyazina, Polina E.; Zavriev, Sergei K.; Ryazantsev, Dmitriy Yu.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Trofimov, Dmitriy Yu.] Minist Healthcare Russian Federat, Natl Med Res Ctr Obstet Gynecol & Perinatol, Fed State Budget Inst, Moscow, Russia; [Alekseev, Leonid P.] Fed Biomed Agcy Russia, NRC Inst Immunol, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; NRC Institute of Immunology FMBA of Russia	Maerle, AV (corresponding author), OOO DNA Technol TS, Moscow, Russia.	maerle@yandex.ru	Maerle, Artem/ABB-8115-2021; Voronina, Daria/AAI-4570-2020; Voronina, Daria/HHM-9938-2022; Simonova, Maria A/E-6081-2014; Trofimov, Dmitry Y./P-7223-2015	Voronina, Daria/0000-0001-6629-744X; Trofimov, Dmitry Y./0000-0002-1569-8486; Simonova, Maria/0000-0002-6920-5384; Simonova, Maria/0000-0001-5186-7876	Russian Science Foundation [16-14-00136]	Russian Science Foundation(Russian Science Foundation (RSF))	MAS, VDP, DVV, PED, SKZ, DYuR were supported by the Russian Science Foundation (project no. 16-14-00136). OOO DNA-Technology TS provided support in the form of salary for author AVM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Debets MF, 2010, CHEM COMMUN, V46, P97, DOI 10.1039/b917797c; Debets MF, 2011, ACCOUNTS CHEM RES, V44, P805, DOI 10.1021/ar200059z; Fernandes D, 2005, EUR BIOPHARM REV, P106; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gee KR, 1999, TETRAHEDRON LETT, V40, P1471, DOI 10.1016/S0040-4039(98)02695-1; Gong HB, 2016, BIOCONJUGATE CHEM, V27, P217, DOI 10.1021/acs.bioconjchem.5b00613; HENDRICKSON ER, 1995, NUCLEIC ACIDS RES, V23, P522, DOI 10.1093/nar/23.3.522; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Jang S, 2012, BIOCONJUGATE CHEM, V23, P2256, DOI 10.1021/bc300364z; Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q; Kozlov IA, 2004, BIOPOLYMERS, V73, P621, DOI 10.1002/bip.20009; Li XR, 2014, ANGEW CHEM INT EDIT, V53, P7179, DOI 10.1002/anie.201402606; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Maerle AV, 2017, GLYCOCONJ J, V34; Malou N, 2011, TRENDS MICROBIOL, V19, P295, DOI 10.1016/j.tim.2011.03.004; Manova RK, 2012, LANGMUIR, V28, P8651, DOI 10.1021/la300921e; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Niemeyer CM, 1999, NUCLEIC ACIDS RES, V27, P4553, DOI 10.1093/nar/27.23.4553; Reddington SC, 2015, CURR OPIN CHEM BIOL, V29, P94, DOI 10.1016/j.cbpa.2015.10.002; Ren KW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04360; Ryazantsev D. Yu., 2012, GLOBAL J ANAL CHEM, V3, pe17; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197; Simonova MA, 2018, BIOANALYSIS, V10, P757, DOI 10.4155/bio-2017-0194; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Svirshchevskaya E, 2016, CLIN IMMUNOL, V170, P31, DOI 10.1016/j.clim.2016.07.022; van Buggenum JAGL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22675; Wals K, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00015	29	17	17	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209860	10.1371/journal.pone.0209860	http://dx.doi.org/10.1371/journal.pone.0209860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608947	gold, Green Published, Green Submitted			2022-12-26	WOS:000454952800028
J	Smyrnakis, M; Bauso, D; Hamidou, T				Smyrnakis, Michalis; Bauso, Dario; Hamidou, Tembine			An evolutionary game perspective on quantised consensus in opinion dynamics	PLOS ONE			English	Article							AVERAGE CONSENSUS; GOSSIP ALGORITHMS; SOCIAL-INFLUENCE; NETWORKS; MODEL	Quantised consensus has been used in the context of opinion dynamics. In this context agents interact with their neighbours and they change their opinion according to their interests and the opinions of their neighbours. We consider various quantised consensus models, where agents have different levels of susceptibility to the inputs received from their neighbours. The provided models share similarities with collective decision making models inspired by honeybees and evolutionary games. As first contribution, we develop an evolutionary game-theoretic model that accommodates the different consensus dynamics in a unified framework. As second contribution, we study equilibrium points and extend such study to the symmetric case where the transition probabilities of the evolutionary game dynamics are symmetric. Symmetry is associated with the case of equally favourable options. As third contribution, we study stability of the equilibrium points for the different cases. We corroborate the theoretical results with some simulations to study the outcomes of the various models.	[Smyrnakis, Michalis; Hamidou, Tembine] New York Univ Abu Dhabi, Learning & Game Theory Lab, Abu Dhabi, U Arab Emirates; [Bauso, Dario] Univ Groningen, Fac Sci & Engn, ENTEG, Jan C Willems Ctr Syst & Control, Groningen, Netherlands; [Bauso, Dario] Univ Palermo, DIID, Palermo, Italy	University of Groningen; University of Palermo	Smyrnakis, M (corresponding author), New York Univ Abu Dhabi, Learning & Game Theory Lab, Abu Dhabi, U Arab Emirates.	m.smyrnakis@nyu.edu	tembine, hamidou/H-3589-2013	tembine, hamidou/0000-0002-1604-8223; Smyrnakis, Michalis/0000-0003-1416-3727	U.S. Air Force Office of Scientific Research [FA9550-17-1-0259]	U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by U.S. Air Force Office of Scientific Research under grant number FA9550-17-1-0259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2013, MATH OPER RES, V38, P1, DOI 10.1287/moor.1120.0570; Acemoglu D, 2011, DYN GAMES APPL, V1, P3, DOI 10.1007/s13235-010-0004-1; Aeyels D, 2008, PHYSICA D, V237, P2517, DOI 10.1016/j.physd.2008.02.024; Allahverdyan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099557; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Aysal TC, 2008, IEEE T SIGNAL PROCES, V56, P4905, DOI 10.1109/TSP.2008.927071; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Blondel VD, 2010, SIAM J CONTROL OPTIM, V48, P5214, DOI 10.1137/090766188; Boyd S, 2005, IEEE INFOCOM SER, P1653; Boyd S, 2006, IEEE T INFORM THEORY, V52, P2508, DOI 10.1109/TIT.2006.874516; Carli Ruggero, 2007, Proceedings of the European Control Conference 2007 (ECC), P1852; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Como G, 2011, ANN APPL PROBAB, V21, P1537, DOI 10.1214/10-AAP739; de Arruda GF, 2016, NON TRADITIONAL REF; Dimakis AG, 2010, P IEEE, V98, P1847, DOI 10.1109/JPROC.2010.2052531; Dong YC, 2018, INFORM FUSION, V43, P57, DOI 10.1016/j.inffus.2017.11.009; Freris NM, 2012, IEEE DECIS CONTR P, P1411, DOI 10.1109/CDC.2012.6427110; FRIEDKIN NE, 1990, J MATH SOCIOL, V15, P193, DOI 10.1080/0022250X.1990.9990069; Gargiulo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048916; Gordon MB, 2009, MATH MOD METH APPL S, V19, P1441, DOI 10.1142/S0218202509003887; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Hofbauer J, 2011, P S APPL MATH; Hovareshti P, 2008, IEEE DECIS CONTR P, P375, DOI 10.1109/CDC.2008.4738890; Kashyap A, 2007, AUTOMATICA, V43, P1192, DOI 10.1016/j.automatica.2007.01.002; Krause U, 2000, COMMUNICATIONS IN DIFFERENCE EQUATIONS, P227; Nedic A, 2017, SIAM J OPTIMIZ, V27, P2597, DOI 10.1137/16M1084316; Nedic A, 2008, IEEE DECIS CONTR P, P4825, DOI 10.1109/CDC.2008.4738891; Nedic A, 2009, IEEE T AUTOMAT CONTR, V54, P2506, DOI 10.1109/TAC.2009.2031203; Nedic A, 2009, IEEE T AUTOMAT CONTR, V54, P48, DOI 10.1109/TAC.2008.2009515; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Olfati-Saber R, 2005, P AMER CONTR CONF, P2371, DOI 10.1109/ACC.2005.1470321; Ozturk MK, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500100; Pluchino A, 2006, EUR PHYS J B, V50, P169, DOI 10.1140/epjb/e2006-00131-0; Quattrociocchi W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04938; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Saber RF, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P4126; Shutters Shade T., 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P93, DOI 10.1007/978-3-642-37210-0_11; Shutters ST, 2008, P 2 INT C COMP CULT, P71; Sirbu A, 2017, UNDERST COMPLEX SYST, P363, DOI 10.1007/978-3-319-25658-0_17; Stella L, 2017, P 20 IFAC WORLD C TO; SZNITMAN AS, 1991, LECT NOTES MATH, V1464, P165; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Xiao L, 2005, IPSN 2005 4 INT S IN; Zouzias A, 2015, 2015 EUROPEAN CONTROL CONFERENCE (ECC), P1920, DOI 10.1109/ECC.2015.7330819	45	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0209212	10.1371/journal.pone.0209212	http://dx.doi.org/10.1371/journal.pone.0209212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608933	Green Published, gold, Green Submitted			2022-12-26	WOS:000454952800017
J	Seewald, S; Obermaier, M; Lefering, R; Bohn, A; Georgieff, M; Muth, CM; Grasner, JT; Masterson, S; Scholz, J; Wnent, J				Seewald, Stephan; Obermaier, Manuel; Lefering, Rolf; Bohn, Andreas; Georgieff, Michael; Muth, Claus-Martin; Graesner, Jan-Thorsten; Masterson, Siobhan; Scholz, Jens; Wnent, Jan			Application of mechanical cardiopulmonary resuscitation devices and their value in out-of-hospital cardiac arrest: A retrospective analysis of the German Resuscitation Registry	PLOS ONE			English	Article							MANUAL CHEST COMPRESSION; DEFIBRILLATION; INTERRUPTIONS; SURVIVAL; QUALITY; SCORE; CPR	Background Cardiac arrest is an event with a limited prognosis which has not substantially changed since the first description of cardiopulmonary resuscitation (CPR) in 1960. A promising new treatment approach may be mechanical CPR devices (mechanical CPR). Methods In a retrospective analysis of the German Resuscitation Registry between 2007-2014, we examined the outcome after using mechanical CPR on return of spontaneous circulation (ROSC) in adults with out-of-hospital cardiac arrest (OHCA). We compared mechanical CPR to manual CPR. According to preclinical risk factors, we calculated the predicted ROSC-after-cardiac-arrest (RACA) score for each group and compared it to the rate of ROSC observed. Using multivariate analysis, we adjusted the influence of the devices' application on ROSC for epidemiological factors and therapeutic measures. Results We included 19,609 patients in the study. ROSC was achieved in 51.5% of the mechanical CPR group (95%-CI 48.2-54.8%, ROSC expected 42.5%) and in 41.2% in the manual CPR group (95%-CI 40.4-41.9%, ROSC expected 39.2%). After multivariate adjustment, mechanical CPR was found to be an independent predictor of ROSC (OR 1.77; 95%-CI 1.48-2.12). Duration of CPR is a key determinant for achieving ROSC. Conclusions Mechanical CPR was associated with an increased rate of ROSC and when adjusted for risk factors appeared advantageous over manual CPR. Mechanical CPR devices may increase survival and should be considered in particular circumstances according to a physicians' decision, especially during prolonged resuscitation.	[Seewald, Stephan; Graesner, Jan-Thorsten; Wnent, Jan] Schleswig Holstein Univ Hosp, Inst Emergency Med, Campus Kiel, Kiel, Germany; [Seewald, Stephan; Graesner, Jan-Thorsten; Wnent, Jan] Schleswig Holstein Univ Hosp, Dept Anaesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany; [Obermaier, Manuel] Heidelberg Univ Hosp, Dept Anaesthesiol, Heidelberg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med, Fac Med, Cologne, Germany; [Bohn, Andreas] City Muenster, Fire Dept, Munster, Germany; [Georgieff, Michael] Ulm Univ Hosp, Dept Anaesthesiol, Ulm, Germany; [Muth, Claus-Martin] Ulm Univ Hosp, Sect Emergency Med, Dept Anaesthesiol, Ulm, Germany; [Masterson, Siobhan] Natl Univ Ireland Galway, Discipline Gen Practice, Galway, Ireland; [Scholz, Jens] Schleswig Holstein Univ Hosp, Kiel, Germany	Ruprecht Karls University Heidelberg; University of Cologne; Witten Herdecke University; Ulm University; Ulm University; Ollscoil na Gaillimhe-University of Galway; University of Kiel; Schleswig Holstein University Hospital	Wnent, J (corresponding author), Schleswig Holstein Univ Hosp, Inst Emergency Med, Campus Kiel, Kiel, Germany.; Wnent, J (corresponding author), Schleswig Holstein Univ Hosp, Dept Anaesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	wnent@reanimationsregister.de	Obermaier, Manuel/AAH-2210-2021; Masterson, Siobhan/AFM-8837-2022; Grasner, Jan-Thorsten/G-1934-2014	Obermaier, Manuel/0000-0003-0881-4757; Masterson, Siobhan/0000-0002-3003-4792; Grasner, Jan-Thorsten/0000-0001-8143-0376				Brooks SC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007260.pub3; Buckler DG, 2016, CIRCULATION, V134, P2131, DOI 10.1161/CIRCULATIONAHA.116.026053; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Crile G, 1906, J EXP MED, V8, P713, DOI 10.1084/jem.8.6.713; Eftestol T, 2002, CIRCULATION, V105, P2270, DOI 10.1161/01.CIR.0000016362.42586.FE; Grasner JT, 2011, EUR HEART J, V32, P1649, DOI 10.1093/eurheartj/ehr107; Grasner JT, 2009, RESUSCITATION, V80, P199, DOI 10.1016/j.resuscitation.2008.10.008; Hallstrom A, 2006, JAMA-J AM MED ASSOC, V295, P2620, DOI 10.1001/jama.295.22.2620; Lukas RP, 2012, RESUSCITATION, V83, P1212, DOI 10.1016/j.resuscitation.2012.03.027; Ochoa FJ, 1998, RESUSCITATION, V37, P149, DOI 10.1016/S0300-9572(98)00057-4; Ock SM, 2011, EUR J EMERG MED, V18, P251, DOI 10.1097/MEJ.0b013e328345340f; Paradis NA, 2010, AM J EMERG MED, V28, P391, DOI 10.1016/j.ajem.2010.02.002; Perkins GD, 2015, RESUSCITATION, V96, P328, DOI 10.1016/j.resuscitation.2014.11.002; Perkins GD, 2015, LANCET, V385, P947, DOI 10.1016/S0140-6736(14)61886-9; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Valenzuela TD, 2005, CIRCULATION, V112, P1259, DOI 10.1161/CIRCULATIONAHA.105.537282; Westfall M, 2013, CRIT CARE MED, V41, P1782, DOI 10.1097/CCM.0b013e31828a24e3; Wik L, 2014, RESUSCITATION, V85, P741, DOI 10.1016/j.resuscitation.2014.03.005; Yost D, 2012, RESUSCITATION, V83, P961, DOI 10.1016/j.resuscitation.2012.01.019; Youngquist ST, 2016, RESUSCITATION, V106, P102, DOI 10.1016/j.resuscitation.2016.06.039	21	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208113	10.1371/journal.pone.0208113	http://dx.doi.org/10.1371/journal.pone.0208113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601816	Green Submitted, gold, Green Published			2022-12-26	WOS:000454683200008
J	Kugler, P; Erhardt, AH; Bulelzai, MAK				Kuegler, Philipp; Erhardt, Andre H.; Bulelzai, M. A. K.			Early afterdepolarizations in cardiac action potentials as mixed mode oscillations due to a folded node singularity	PLOS ONE			English	Article							MYOCYTES; BIFURCATION; DYNAMICS; CANARDS	Early afterdepolarizations (EADs) are pathological voltage oscillations during the repolarization phase of cardiac action potentials. They are considered as potential precursors to cardiac arrhythmias and have recently gained much attention in the context of preclinical drug safety testing under the Comprehensive in vitro Proarrhythmia Assay (CiPA) paradigm. From the viewpoint of multiple time scales theory, the onset of EADs has previously been studied by means of mathematical action potential models with one slow ion channel gating variable. In this article, we for the first time associate EADs with mixed mode oscillations in dynamical systems with two slow gating variables and present a folded node singularity of the slow flow as a novel mechanism for EADs genesis. We derive regions of the pharmacology parameter space in which EADs occur using both the folded node analysis and a full system bifurcation analysis, and we suggest the normal distance to the boundary of the EADs region as a mechanism-based risk metric to computationally estimate a drug's proarrhythmic liability.	[Kuegler, Philipp] Univ Hohenheim, Inst Appl Math & Stat, Stuttgart, Germany; [Erhardt, Andre H.] Univ Oslo, Dept Math, Oslo, Norway; [Bulelzai, M. A. K.] Quaid E Awam Univ Engn Sci & Technol, Dept Basic Sci & Related Studies, Nawabshah, Pakistan	University Hohenheim; University of Oslo	Kugler, P (corresponding author), Univ Hohenheim, Inst Appl Math & Stat, Stuttgart, Germany.	philipp.kuegler@uni-hohenheim.de	Erhardt, André H./D-1034-2018; Kugler, Philipp/B-4444-2015	Erhardt, André H./0000-0003-4389-8554; Kugler, Philipp/0000-0002-1041-9265				[Anonymous], 2017, MATLAB RELEASE 2017B; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Bertram R, 2015, MATHEMATICAL ANALYSI; Brons M, 2006, FIELDS I COMMUN, V49, P39; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Colatsky T, 2016, J PHARMACOL TOX MET, V81, P15, DOI 10.1016/j.vascn.2016.06.002; Desroches M, 2008, SIAM J APPL DYN SYST, V7, P1131, DOI 10.1137/070708810; Desroches M, 2012, SIAM REV, V54, P211, DOI 10.1137/100791233; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Doedel E. J ., 2007, AUTO 07P CONTINUATIO; Dutta S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00616; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton F.H., 2008, SCHOLARPEDIA, V3, P1868, DOI [10.4249/scholarpedia.1868, DOI 10.4249/SCHOLARPEDIA.1868]; Fermini B, 2016, J BIOMOL SCREEN, V21, P1, DOI 10.1177/1087057115594589; Gray RA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005087; Kugler P, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0422-4; Kugler P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151178; Kuehn C, 2015, MULTIPLE TIME SCALE, P1; Kurata Y, 2017, AM J PHYSIOL-HEART C, V312, pH106, DOI 10.1152/ajpheart.00115.2016; McMillan B, 2017, TOXICOL RES-UK, V6, P912, DOI 10.1039/c7tx00141j; Mitchell CC, 2003, B MATH BIOL, V65, P767, DOI 10.1016/S0092-8240(03)00041-7; NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317, DOI 10.1113/jphysiol.1962.sp006849; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Paci M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00709; Passini E, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00668; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Roberts A, 2016, J ATMOS SCI, V73, P1755, DOI 10.1175/JAS-D-15-0191.1; Roberts A, 2015, PHYSICA D, V292, P70, DOI 10.1016/j.physd.2014.11.003; Sager PT, 2014, AM HEART J, V167, P292, DOI 10.1016/j.ahj.2013.11.004; Sato D, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00388; Sato D, 2010, BIOPHYS J, V99, P765, DOI 10.1016/j.bpj.2010.05.019; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Szmolyan P, 2001, J DIFFER EQUATIONS, V177, P419, DOI 10.1006/jdeq.2001.4001; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Vandersickel N, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00404; Vo T, 2012, DISCRETE CONT DYN-A, V32, P2879, DOI 10.3934/dcds.2012.32.2879; Vo T, 2010, J COMPUT NEUROSCI, V28, P443, DOI 10.1007/s10827-010-0226-7; Wechselberger M, 2005, SIAM J APPL DYN SYST, V4, P101, DOI 10.1137/030601995; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; Xie YF, 2014, BIOPHYS J, V106, P1391, DOI 10.1016/j.bpj.2013.12.050; Yan GX, 2001, CIRCULATION, V103, P2851; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zimik S, 2015, PLOS ONE, V10	45	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209498	10.1371/journal.pone.0209498	http://dx.doi.org/10.1371/journal.pone.0209498			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596698	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200052
J	Li, XJ; Wang, Q; Li, M; Wang, S; Zhang, CQ; Xie, KQ				Li, Xianjie; Wang, Qiong; Li, Ming; Wang, Shuo; Zhang, Cuiqin; Xie, Keqin			Hair pyrrole adducts serve as biomarkers for peripheral nerve impairment induced by 2,5-hexanedione and n-hexane in rats	PLOS ONE			English	Article							CROSS-LINKING; NEUROFILAMENT; NEUROPATHY; EXPOSURE; BINDING; URINE	Pyrrole adducts are specific reaction products of 2,5-hexadione (2,5-HD) in vivo and are considered highly relevant to the pathogenesis of peripheral nerve impairments after exposure to n-hexane, though the exact mechanism remains unclear. In this study, 40 male Wistar rats were randomly divided into three experimental groups and one control group, in which all rat's hair were shaved completely at the beginning. The rats in three experimental groups were treated with 2,5-HD by gavage at dosages of 100, 200 and 300 mg/kg per day respectively, six times per week for 8 weeks. Abnormality of gait and changes in the rota-rod latency were surveilled. Pyrrole adducts in hair, urine and serum of all rats were measured at the endpoint. Results showed that the increased pyrrole adducts in hair, urine and serum accumulated in dose-response relationship. Spearman's correlation analysis between pyrrole adducts and gait scores showed that hair pyrrole adducts were highly relevant to the gait scores. Moreover, we treated rats with n-hexane and succeed to verify the results aforesaid. Further, multiply linear regression analysis showed that hair pyrrole adducts have higher partial correlation coefficients than these in serum and urine in both 2,5-HD and n-hexane treated models. Our findings draw the conclusion that the hair pyrrole adducts might serve as a promising biomarker of n-hexane induced peripheral neuropathy.	[Li, Xianjie; Wang, Qiong; Li, Ming; Zhang, Cuiqin; Xie, Keqin] Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan, Shandong, Peoples R China; [Wang, Shuo] Liaocheng Univ, Sch Pharmaceut, Liaocheng, Shandong, Peoples R China	Shandong University; Liaocheng University	Xie, KQ (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan, Shandong, Peoples R China.	keqinx@sdu.edu.cn	Wang, Shuo/AAY-6797-2021		National Natural Science Foundation of China [81373044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from National Natural Science Foundation of China (Grant No: 81373044), awarded to Dr. Keqin Xie.	ABOUDONIA MB, 1982, TOXICOL APPL PHARM, V62, P369, DOI 10.1016/0041-008X(82)90139-9; CAVENDER FL, 1984, FUND APPL TOXICOL, V4, P191, DOI 10.1016/0272-0590(84)90119-2; Chiu FC, 2000, TOXICOL APPL PHARM, V165, P141, DOI 10.1006/taap.2000.8938; Crosbie SJ, 1997, HUM EXP TOXICOL, V16, P131, DOI 10.1177/096032719701600301; DECAPRIO AP, 1982, TOXICOL APPL PHARM, V65, P440, DOI 10.1016/0041-008X(82)90389-1; DeCaprio AP, 1997, TOXICOL APPL PHARM, V145, P211, DOI 10.1006/taap.1997.8181; Decaprio AP, 1987, HEXANE NEUROPATHY ST; Torres ME, 2014, TOXICOL LETT, V224, P54, DOI 10.1016/j.toxlet.2013.10.011; GENTER MB, 1987, TOXICOL APPL PHARM, V87, P351, DOI 10.1016/0041-008X(87)90296-1; GRAHAM DG, 1985, NEUROTOXICOLOGY, V6, P55; GRAHAM DG, 1995, CRIT REV TOXICOL, V25, P91, DOI 10.3109/10408449509021609; JOHNSON DJ, 1995, J TOXICOL ENV HEALTH, V45, P313, DOI 10.1080/15287399509531998; KESSLER W, 1990, ARCH TOXICOL, V64, P242, DOI 10.1007/BF02010731; Lack L, 2008, TOXICOL MECH METHOD, V12, P277; Lehning EJ, 2000, TOXICOL APPL PHARM, V165, P127, DOI 10.1006/taap.2000.8937; Li X J, 2018, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V36, P382, DOI 10.3760/cma.j.issn.1001-9391.2018.05.020; LoPachin RM, 2005, TOXICOL SCI, V86, P214, DOI 10.1093/toxsci/kfi197; LoPachin RM, 2005, NEUROTOXICOLOGY, V26, P229, DOI 10.1016/j.neuro.2004.09.007; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Neghab M, 2012, J OCCUP HEALTH, V54, P376, DOI 10.1539/joh.12-0029-FS; Passarin MG, 1996, NEUROPATH APPL NEURO, V22, P60; Puri V, 2015, ANN INDIAN ACAD NEUR, V18, P464, DOI 10.4103/0972-2327.160088; Song FY, 2012, FOOD CHEM TOXICOL, V50, P4277, DOI 10.1016/j.fct.2012.08.049; SPENCER PS, 1980, CRC CR REV TOXICOL, V7, P279, DOI 10.3109/10408448009037489; Wang C, 2014, CELL BIOCHEM BIOPHYS, V70, P579, DOI 10.1007/s12013-014-9959-7; Wang S, 2016, TOXICOLOGY RES, V6; Wang SO, 2017, CHEM-BIOL INTERACT, V265, P1, DOI 10.1016/j.cbi.2017.01.013; Yin HY, 2014, INT ARCH OCC ENV HEA, V87, P655, DOI 10.1007/s00420-013-0907-4; Yin HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086108; Yin HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076011; ZHU MS, 1994, CHEM RES TOXICOL, V7, P551, DOI 10.1021/tx00040a011	31	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209939	10.1371/journal.pone.0209939	http://dx.doi.org/10.1371/journal.pone.0209939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596762	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200115
J	Makumbi, F; Byabagambi, J; Muwanika, R; Kigozi, G; Gray, R; Galukande, M; Bagaya, B; Ssebagala, D; Karamagi, E; Rahimzai, M; Kaggwa, M; Watya, S; Mbonye, AK; Aceng, JR; Musinguzi, J; Kiggundu, V; Njeuhmeli, E; Nanteza, B				Makumbi, Fredrick; Byabagambi, John; Muwanika, Richard; Kigozi, Godfrey; Gray, Ronald; Galukande, Moses; Bagaya, Bernard; Ssebagala, Darix; Karamagi, Esther; Rahimzai, Mirwais; Kaggwa, Mugagga; Watya, Stephen; Mbonye, Anthony K.; Aceng, Jane Ruth; Musinguzi, Joshua; Kiggundu, Valerian; Njeuhmeli, Emmanuel; Nanteza, Barbara			Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda	PLOS ONE			English	Article							HIV PREVENTION; DIPHTHERIA; CHILDREN; RAKAI	Introduction Tetanus infection associated with men who had male circumcision has been reported in East Africa, suggesting a need for tetanus toxoid-containing vaccines (TTCV). Objective To determine the prevalence of tetanus toxoid antibodies following vaccination among men seeking circumcision. Methods We enrolled 620 consenting men who completed a questionnaire and received TTCV at enrollment (day 0) prior to circumcision on day 28. Blood samples were obtained at day 0 from all enrollees and on days 14, 28 and 42 from a random sample of 237 participants. Tetanus toxoid (TT) IgG antibody levels were assayed using EUROIMMUN. Analyses included prevalence of TT antibodies at enrollment and used a mixed effects model to determine the immunological response. Results Mean age was 21.4 years, 65.2% had knowledge of tetanus, 56.6% knew how tetanus was contracted, 22.8% reported ever receipt of TTCV, and 16.8% had current/recently healed wounds. Insufficient tetanus immunity was 57.1% at enrollment, 7.2% at day 14, 3.8% at day 28, and 0% at day 42. Antibody concentration was 0.44IU/ml (CI 0.35-0.53) on day 0, 3.86IU/ml (CI 3.60-4.11) on day 14, 4.05IU/ml (CI 3.81-4.29) on day 28, and 4.48IU/ml (CI 4.28-4.68) on day 42. TT antibodies increased by 0.24IU/ml (CI 0.23, 0.26) between days 0 and 14 and by 0.023IU/ml (CI 0.015, 0.031) between days 14 and 42 days. Immunological response was poorer in HIV-infected clients and men aged 35+ years. Conclusion Insufficient immunity was common prior to TTCV, and a protective immunological response was achieved by day 14. Circumcision may safely be provided 14 days after vaccination in HIV-uninfected men aged less than 35 years.	[Makumbi, Fredrick] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Makumbi, Fredrick; Muwanika, Richard; Kigozi, Godfrey; Ssebagala, Darix] Rakai Hlth Sci Program, Kalisizo, Uganda; [Byabagambi, John; Karamagi, Esther; Rahimzai, Mirwais] Univ Res Co LLC URC, USAID Applying Sci Strengthen & Improve Syst ASSI, Kampala, Uganda; [Gray, Ronald] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Galukande, Moses] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Bagaya, Bernard] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda; [Kaggwa, Mugagga] WHO, Uganda Country Off, Kampala, Uganda; [Watya, Stephen] UroCare Hosp, Kampala, Uganda; [Mbonye, Anthony K.; Aceng, Jane Ruth; Musinguzi, Joshua; Nanteza, Barbara] Minist Hlth, Kampala, Uganda; [Kiggundu, Valerian; Njeuhmeli, Emmanuel] USAID, Off HIV AIDS, Global Hlth Bur, Washington, DC USA	Makerere University; Rakai Health Sciences Program; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Makerere University; World Health Organization; United States Agency for International Development (USAID)	Makumbi, F (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda.; Makumbi, F (corresponding author), Rakai Hlth Sci Program, Kalisizo, Uganda.	fmakumbi@musph.ac.ug	Byabagambi, John/GVU-6682-2022; Byabagambi, MD, MPH, MMS, FISQua, John/GWC-7323-2022	Byabagambi, John/0000-0002-1456-3387; MAKUMBI, FREDRICK/0000-0002-6460-7325	Fogarty International Center; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID); WHO-Uganda; USAID ASSIST Project	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); WHO-Uganda; USAID ASSIST Project(United States Agency for International Development (USAID))	Fogarty International Center, through student training program, supported laboratory processing, testing and storage and laboratory data management. Also RHSP provided compensation to clients as to the site staff collecting questionnaire data and processing laboratory samples. With funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID), the USAID ASSIST Project provided logistical support for the data collection, data management, supplies and site visits, while WHO-Uganda provided support to the Safe Monitoring Team (SMT).	Alsina L, 2013, VACCINE, V31, P2417, DOI 10.1016/j.vaccine.2013.03.035; [Anonymous], 2015, WHO INF CONS TET VOL; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Ching N, 2007, EUR J PEDIATR, V166, P51, DOI 10.1007/s00431-006-0184-2; Choi JH, 2010, J KOREAN MED SCI, V25, P1727, DOI 10.3346/jkms.2010.25.12.1727; Galukande M., 2009, E CENT AFR J SURG, V14; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kankaka EN, 2017, BJU INT, V119, P164, DOI 10.1111/bju.13589; Kigozi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100008; Lunner-Kolstrup C, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00137; Ministry of Health (MoH), 2014, MIN HLTH SAF MAL CIR; MOH, 2010, NAT GUID MAN COMM CO; Nanteza B, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2309-z; Oshinaike OO, 2012, TROP DOCT, V42, P208, DOI 10.1258/td.2012.120250; Rosenblatt HM, 2005, J ALLERGY CLIN IMMUN, V116, P698, DOI 10.1016/j.jaci.2005.05.016; Shohat T, 2000, J AM GERIATR SOC, V48, P949, DOI 10.1111/j.1532-5415.2000.tb06893.x; Soumare M, 2008, SENEGAL B SOC PATHOL, V101, P54; Tumwesigye NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148511; Uganda Ministry of Health, 2016, UG POP BAS HIV IMP A; Wafula ST, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.77.8916; World Health Organization, 2010, WHO CURR REC TREATM	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209167	10.1371/journal.pone.0209167	http://dx.doi.org/10.1371/journal.pone.0209167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596676	Green Submitted, gold, Green Published			2022-12-26	WOS:000454627200031
J	Matanza, XM; Osorio, CR				Matanza, Xose M.; Osorio, Carlos R.			Transcriptome changes in response to temperature in the fish pathogen Photobacterium damselae subsp. damselae: Clues to understand the emergence of disease outbreaks at increased seawater temperatures	PLOS ONE			English	Article							VIBRIO-DAMSELA; GENE-EXPRESSION; STRESS-RESPONSE; BACTERIAL VIRULENCE; READ ALIGNMENT; VI SECRETION; SEA BASS; IRON; ACID; PARAHAEMOLYTICUS	The marine bacterium Photobacterium damselae subsp. damselae (Pdd) is a generalist and facultative pathogen that causes disease in a wide range of marine animals including fish species of importance in aquaculture. Disease outbreaks in fish farms have been correlated with an increased water temperature during summer months. In this study, we have used RNA sequencing to analyze the transcriptome of Pdd RM-71 cultured at two different temperatures, which simulated temperature conditions experienced during free swimming lifestyle at mid latitudes in winter months (15 degrees C) and during outbreaks in aquaculture in warm summer months (25 degrees C). The enhanced bacterial growth of Pdd observed at 25 degrees C in comparison to 15 degrees C suggests that an elevated seawater temperature contributes to the build-up of a sufficient bacterial population to cause disease. In comparison to growth at 15 degrees C, growth at 25 degrees C resulted in the upregulation of genes involved in DNA synthesis, nutrient uptake, chemotaxis, flagellar motility, secretion systems and antimicrobial resistance. Plasmid-encoded virulence factors, which include a putative adhesin/invasin OmpU, a transferrin receptor and a serum resistance protein, were also upregulated. Transcription factor RpoS, genes involved in cold shock response, modulation of cell envelope and amino acid metabolism, as well as genes of yet unknown function were downregulated at 25 degrees C. Notably, the gene encoding damselysin cytotoxin (Dly) was among the most highly transcribed genes at the two assayed temperatures, at levels comparable to the most highly expressed housekeeping genes. This study contributes to our understanding of the regulatory networks and biology of a generalist marine bacterial pathogen, and provides evidence that temperature regulates multiple physiological and virulence-related functions in Pdd.	[Matanza, Xose M.; Osorio, Carlos R.] Univ Santiago de Compostela, Inst Acuicultura, Dept Microbiol & Parasitol, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Osorio, CR (corresponding author), Univ Santiago de Compostela, Inst Acuicultura, Dept Microbiol & Parasitol, Santiago De Compostela, Spain.	cr.osorio@usc.es	Osorio, Carlos R./M-4399-2015	Osorio, Carlos R./0000-0002-3099-4064; Matanza Fente, Xose Manuel/0000-0002-3559-7439	State Agency for Research (AEI) of Spain [AGL2016-79738-R]; Xunta de Galicia (Spain) [GRC-2014/007]; FEDER Programme from the European Union; Xunta de Galicia, Spain	State Agency for Research (AEI) of Spain; Xunta de Galicia (Spain)(Xunta de Galicia); FEDER Programme from the European Union; Xunta de Galicia, Spain(Xunta de Galicia)	This work has been supported by grant AGL2016-79738-R (AEI/FEDER, EU) from the State Agency for Research (AEI) of Spain, and co-funded by the FEDER Programme from the European Union, to CRO. The support of Xunta de Galicia (Spain) with grant GRC-2014/007 to CRO and XMM is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders websites: http://www.ciencia.gob.es/, http://www.edu.xunta.gal/portal/.; XM thanks Xunta de Galicia, Spain, for a predoctoral fellowship. We would like to thank Genevieve Garriss at Karolinska Institutet, Sweden, for critical reading of the manuscript and for useful comments.	Amaro C, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.VE-0005-2014; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ayala JC, 2015, MOL MICROBIOL, V97, P630, DOI 10.1111/mmi.13058; Baker-Austin C, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0005-8; Baker-Austin C, 2017, TRENDS MICROBIOL, V25, P76, DOI 10.1016/j.tim.2016.09.008; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P7, DOI 10.1111/j.1758-2229.2009.00096.x; Balado M, 2017, FRONT CELL INFECT MI, V7, P1, DOI 10.3389/fcimb.2017.00361; BEALL B, 1994, J BACTERIOL, V176, P2003, DOI 10.1128/jb.176.7.2003-2012.1994; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Bremer H, 1996, ESCHERICHIA COLI SAL; Brot N, 2000, BIOPOLYMERS, V55, P288, DOI 10.1002/1097-0282(2000)55:4<288::AID-BIP1002>3.0.CO;2-M; Chang SC, 2018, MICROBIOL-SGM, V164, P221, DOI 10.1099/mic.0.000591; Chen YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13450-9; DeLoney-Marino CR, 2003, APPL ENVIRON MICROB, V69, P7527, DOI 10.1128/AEM.69.12.7527-7530.2003; Dryselius R, 2007, RES MICROBIOL, V158, P479, DOI 10.1016/j.resmic.2007.04.007; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Eissa IAM, 2018, MICROB PATHOGENESIS, V114, P315, DOI 10.1016/j.micpath.2017.12.006; Essam HM, 2016, MICROB PATHOGENESIS, V99, P41, DOI 10.1016/j.micpath.2016.08.003; Fadel, 2017, J PHARM CHEM BIOL SC, V5, P354; Fernandez NL, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00005-18; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fouz B, 1998, FEMS MICROBIOL LETT, V168, P181, DOI 10.1111/j.1574-6968.1998.tb13271.x; FOUZ B, 1994, FEMS MICROBIOL LETT, V121, P181, DOI 10.1111/j.1574-6968.1994.tb07097.x; Fouz B, 2000, J APPL MICROBIOL, V88, P531, DOI 10.1046/j.1365-2672.2000.00992.x; FOUZ B, 1992, DIS AQUAT ORGAN, V12, P155, DOI 10.3354/dao012155; Fouz B, 1997, J APPL MICROBIOL, V82, P157, DOI 10.1111/j.1365-2672.1997.tb03568.x; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Guijarro JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00700; Gumpenberger T, 2016, MOL MICROBIOL, V99, P470, DOI 10.1111/mmi.13143; Haghjoo E, 2007, MOL MICROBIOL, V64, P1549, DOI 10.1111/j.1365-2958.2007.05754.x; Hinchliffe P, 2013, ANNU REV MICROBIOL, V67, P221, DOI 10.1146/annurev-micro-092412-155718; Hundenborn J, 2013, CASE REP MED, V2013, DOI 10.1155/2013/610632; Institute Broad, PIC TOOLS; Johansson J, 2003, TRENDS MICROBIOL, V11, P280, DOI 10.1016/S0966-842X(03)00118-5; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; KREGER AS, 1987, INFECT IMMUN, V55, P3209, DOI 10.1128/IAI.55.12.3209-3212.1987; KREGER AS, 1984, INFECT IMMUN, V44, P326, DOI 10.1128/IAI.44.2.326-331.1984; Labella A, 2011, RECENT ADV FISH FARM, P136; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeRoux F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00830; LEW DP, 1980, CLIN EXP IMMUNOL, V42, P506; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WJ, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.511; Liu XR, 2017, HYDROL PROCESS, V31, P446, DOI 10.1002/hyp.11042; LOVE M, 1981, SCIENCE, V214, P1139, DOI 10.1126/science.214.4525.1139; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Y, 2017, J MICROBIOL, V55, P44, DOI 10.1007/s12275-017-6370-2; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Martin-Platero AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02571-4; Martinez-Urtaza J, 2018, EMERG INFECT DIS, V24, P852, DOI 10.3201/eid2405.171700; Mendez J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01098; Merrell DS, 2000, J BACTERIOL, V182, P5342, DOI 10.1128/JB.182.19.5342-5350.2000; Morris CR, 2013, INFECT IMMUN, V81, P3068, DOI 10.1128/IAI.00537-13; Nyholm SV, 2009, ENVIRON MICROBIOL, V11, P483, DOI 10.1111/j.1462-2920.2008.01788.x; Okada K, 2005, J BACTERIOL, V187, P752, DOI 10.1128/JB.187.2.752-757.2005; Osorio CR, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00002-18; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pajuelo D, 2015, ENVIRON MICROBIOL, V17, P2076, DOI 10.1111/1462-2920.12782; Pedersen K, 2009, J FISH DIS, V32, P465, DOI 10.1111/j.1365-2761.2009.01041.x; Pedersen K, 1997, APPL ENVIRON MICROB, V63, P3711, DOI 10.1128/AEM.63.9.3711-3715.1997; Pensinger DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006001; Puentes B, 2017, VET MICROBIOL, V201, P257, DOI 10.1016/j.vetmic.2017.01.040; Pursley BR, 2018, J BACTERIOL, V200, DOI [10.1128/JB.00578-17, 10.1128/jb.00578-17]; Rio SJ, 2005, ARCH MICROBIOL, V183, P347, DOI 10.1007/s00203-005-0779-4; Rivas AJ, 2015, INFECT IMMUN, V83, P4335, DOI 10.1128/IAI.00277-15; Rivas AJ, 2015, INFECT IMMUN, V83, P1246, DOI 10.1128/IAI.02608-14; Rivas AJ, 2013, INFECT IMMUN, V81, P3287, DOI 10.1128/IAI.00155-13; Rivas AJ, 2011, INFECT IMMUN, V79, P4617, DOI 10.1128/IAI.05436-11; Roig FJ, 2009, MICROBIOL-SGM, V155, P489, DOI 10.1099/mic.0.023424-0; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Sharma SRK, 2017, J FISH DIS, V40, P953, DOI 10.1111/jfd.12557; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Steinmann R, 2013, FUTURE MICROBIOL, V8, P85, DOI [10.2217/FMB.12.129, 10.2217/fmb.12.129]; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; Tao Z, 2018, AQUACULTURE, V492, P201, DOI 10.1016/j.aquaculture.2018.04.013; Terceti MS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02155; Terceti MS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00582; Terceti MS, 2016, APPL ENVIRON MICROB, V82, P3736, DOI 10.1128/AEM.00781-16; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; TIBBLES BJ, 1994, MICROBIAL ECOL, V27, P65, DOI 10.1007/BF00170115; Townsley L, 2016, APPL ENVIRON MICROB, V82, P4441, DOI 10.1128/AEM.00807-16; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uzun E, 2015, AQUACULTURE, V437, P30, DOI 10.1016/j.aquaculture.2014.11.017; Vences A, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00401-17, 10.1128/aem.00401-17]; Vera P., 1991, Bulletin of the European Association of Fish Pathologists, V11, P112; von Hoven G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02996; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wurm P, 2017, INT J MED MICROBIOL, V307, P154, DOI 10.1016/j.ijmm.2017.01.006; Yang L, 2009, FEMS MICROBIOL LETT, V291, P50, DOI 10.1111/j.1574-6968.2008.01434.x; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI [10.1139/O09-182, 10.1139/o09-182]	97	20	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210118	10.1371/journal.pone.0210118	http://dx.doi.org/10.1371/journal.pone.0210118			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596794	Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200142
J	McHale, P; Hungerford, D; Taylor-Robinson, D; Lawrence, T; Astles, T; Morton, B				McHale, Philip; Hungerford, Daniel; Taylor-Robinson, David; Lawrence, Thomas; Astles, Timothy; Morton, Ben			Socioeconomic status and 30-day mortality after minor and major trauma: A retrospective analysis of the Trauma Audit and Research Network (TARN) dataset for England	PLOS ONE			English	Article							INJURY MORTALITY; SECONDARY CARE; TIME TRENDS; INEQUALITIES; DEPRIVATION; ASSOCIATION; DISEASE; IMPACT; AREAS; RISK	Introduction Socioeconomic status (SES) is associated with rate and severity of trauma. However, it is unclear whether there is an independent association between SES and mortality after injury. Our aim was to assess the relationship between SES and mortality from trauma. Materials and methods We conducted a secondary analysis of the Trauma Audit and Research Network dataset. Participants were patients admitted to NHS hospitals for trauma between January 2015 and December 2015, and resident in England. Analyses used multivariate logistic regression with thirty-day mortality as the main outcome. Co-variates include SES derived from area-level deprivation, age, injury severity and comorbidity. All analyses were stratified into minor and major trauma. Results There were 48,652 admissions (68% for minor injury, ISS<15) included, and 3,792 deaths. Thirty-day mortality was 10% for patients over 85 with minor trauma, which was higher than major trauma for all age groups under 65. Deprivation was not significantly associated with major trauma mortality. For minor trauma, patients older than 40 had significantly higher aORs than the 0-15 age group. Both the most and second most deprived had significantly higher aORs (1.35 and 1.28 respectively). Conclusions This study provides evidence of an independent relationship between SES and mortality after minor trauma, but not for major trauma. Our results identify that, for less severe trauma, older patients and patients with low SES with have an increased risk of 30-day mortality. Policy makers and service providers should consider extending the provision of 'major trauma' healthcare delivery to this at-risk population.	[McHale, Philip; Taylor-Robinson, David] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Hungerford, Daniel] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Hungerford, Daniel] Publ Hlth England, Natl Infect Serv, Field Epidemiol Serv, Liverpool, Merseyside, England; [Lawrence, Thomas] Univ Manchester, Salford Royal Hosp, Manchester Med Acad Hlth Sci Ctr, Trauma Audit & Res Network,Inst Populat Hlth, Salford, Lancs, England; [Astles, Timothy; Morton, Ben] Aintree Univ Hosp NHS Fdn Trust, Crit Care Dept, Liverpool, Merseyside, England; [Morton, Ben] Univ Liverpool Liverpool Sch Trop Med, Clin Sci, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Public Health England; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Aintree University Hospitals NHS Foundation Trust; Liverpool School of Tropical Medicine	McHale, P (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.	p.mchale@liverpool.ac.uk	Hungerford, Daniel/AAA-8805-2019	Hungerford, Daniel/0000-0002-9770-0163; Morton, Ben/0000-0002-6164-2854; Taylor-Robinson, David/0000-0002-5828-7724; McHale, Philip/0000-0002-8560-2291	National Institute of Health Research [16/136/35]; MRC [MR/P008577/1]; Republic of Ireland	National Institute of Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Republic of Ireland	Dr Morton thanks the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM -"IMPALA" for helping to make this work possible (URL: www.nihr.ac.uk).In relation to IMPALA (grant number 16/136/35) specifically: IMPALA was commissioned by the National Institute of Health Research using Official Development Assistance (ODA) funding. David Taylor-Robinson is funded by the MRC (URL: https://mrc.ukri.org/) on a Clinician Scientist Fellowship (MR/P008577/1). TARN is funded by subscription from its member hospitals in England, Wales, Republic of Ireland, Denmark and Switzerland (URL: www.tarn.ac.uk).The funders had no role in study design, data collection and analysis, or decision to publish, or preparation of the manuscript.	Ali MT, 2013, SURGERY, V154, P461, DOI 10.1016/j.surg.2013.05.036; Bouamra O, 2015, EMERG MED J, V32, P933, DOI 10.1136/emermed-2015-205176; Corfield A, 2015, ANN EMERG MED, V66; Corfield AR, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0275-7; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Gill B, 2015, ENGLISH INDICES DEPR; Gotsens M, 2013, HEALTH PLACE, V24, P165, DOI 10.1016/j.healthplace.2013.09.003; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hungerford D, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0989-z; Kellezi B, 2016, J PUBLIC HEALTH-UK, V38, pE464, DOI 10.1093/pubmed/fdv173; Krieger N, 2002, AM J PUBLIC HEALTH, V92, P1100, DOI 10.2105/AJPH.92.7.1100; Laflamme L, 2009, SOC SCI MED, V68, P1826, DOI 10.1016/j.socscimed.2009.02.050; Laursen B, 2008, EUR J PUBLIC HEALTH, V18, P366, DOI 10.1093/eurpub/ckn034; Lawson F, 2015, INJURY PREV, V21, P260, DOI 10.1136/injuryprev-2014-041437; Lee J, 2014, J EPIDEMIOL COMMUN H, V68, P457, DOI 10.1136/jech-2013-203082; Mackenbach JP, 2017, HEALTH AFFAIR, V36, P1110, DOI 10.1377/hlthaff.2016.1674; Mikhail JN, 2016, J TRAUMA NURS, V23, P347, DOI 10.1097/JTN.0000000000000246; Moran CG, 2018, ECLINICALMEDICINE, V2-3, P13, DOI 10.1016/j.eclinm.2018.07.001; Mulvaney C, 2009, J PUBLIC HEALTH-UK, V31, P154, DOI 10.1093/pubmed/fdn103; National Audit Office, 2010, MAJ TRAUM CAR ENGL, P2009; NHS Choices, 2017, MAJ TRAUM SERV EM UR; NICE, 2016, MAJ TRAUM SERV DEL; Nyberg C, 2012, GLOB PUBLIC HEALTH, V7, P1170, DOI 10.1080/17441692.2012.736172; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Pearce A, 2012, J EPIDEMIOL COMMUN H, V66, P181, DOI 10.1136/jech.2011.139626; Socialist Health Association, 2010, REV LIT DOES INV CAR; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Trauma Audit Research Network, TARN PROB SURV MOD; UK Data Service Census Support, 2015, GEOCONVERT FREQ ASK	29	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210226	10.1371/journal.pone.0210226	http://dx.doi.org/10.1371/journal.pone.0210226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HG0IO	30596799	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000454627200153
J	Shu, H; Lindh, CH; Wikstrom, S; Bornehag, CG				Shu, Huan; Lindh, Christian H.; Wikstrom, Sverre; Bornehag, Carl-Gustaf			Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study	PLOS ONE			English	Article							PERFLUORINATED ALKYL ACIDS; POLYFLUOROALKYL CHEMICALS; PRENATAL EXPOSURE; DIETARY-INTAKE; BLOOD-SERUM; SWEDEN; HEALTH; FOOD; SEAFOOD; COHORT	Background Perfluoroalkyl substances (PFAS) are used in numerous consumer products. They are persistent, bioaccumulating, and suspected to be endocrine disrupting chemicals (EDCs). A growing body of research has reported the association between PFAS exposure and adverse health effects. Concerns have been raised with special focus in childhood development. Methods Perfluoroheptanoic acid (PFHpA), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), perfluorododecanoic acid (PFDoDA), perfluorohexane sulfonate (PFHxS) and perfluorooctane sulfonate (PFOS) were analyzed by LC/MS/MS in serum from 1,616 pregnant women in the Swedish SELMA study. The serum samples were collected in the first trimester (median week 10). Least square geometric means (LSGM) of PFAS were estimated for each year period for, adjusted for potential determinants including parity, fish intake in the family, and mother's age. Results Six PFAS (PFNA, PFDA, PFUnDA, PFHxS, PFOA, and PFOS) were detected above levels of detection (LOD) in more than 99% of the SELMA women, while PFHpA, and PFDoDA were detected above LOD in 73.4% and 46.7% respectively. Parity, maternal age, maternal smoking, and fish intake during pregnancy were found to be significantly associated (p<0.05) with serum PFAS levels in the pregnant women. Finally, serum concentration of six PFAS (PFNA, PFDA, PFHxS, PFHpA, PFOA and PFOS) were significantly decreasing (range 14-31%) during the period of 30 months from 2007-2010. Conclusions Our analysis shows that six out of eight PFAS could be identified in serum of more than 99% of SELMA subjects with a significant slightly decreasing trend for five of these compounds. Furthermore, parity, higher fish intake and mothers age are determinants for serum levels of PFAS in pregnant women.	[Shu, Huan] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Shu, Huan; Bornehag, Carl-Gustaf] Karlstad Univ, Dept Hlth Sci, Karlstad, Sweden; [Lindh, Christian H.] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Wikstrom, Sverre] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Bornehag, Carl-Gustaf] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA	Stockholm University; Karlstad University; Lund University; Orebro University; Icahn School of Medicine at Mount Sinai	Bornehag, CG (corresponding author), Karlstad Univ, Dept Hlth Sci, Karlstad, Sweden.; Bornehag, CG (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.	caguborn@kau.se	shu, huan/AAK-9665-2021	Lindh, Christian/0000-0001-7435-9890; Bornehag, Carl-Gustaf/0000-0003-0417-1686	European Union's Horizon 2020 research and innovation programme [634880]; Swedish Environmental Protection Agency	European Union's Horizon 2020 research and innovation programme; Swedish Environmental Protection Agency	This study was supported by the European Union's Horizon 2020 research and innovation programme under grant agreement no 634880, Swedish Environmental Protection Agency.	Begley TH, 2005, FOOD ADDIT CONTAM A, V22, P1023, DOI 10.1080/02652030500183474; Berger U, 2009, CHEMOSPHERE, V76, P799, DOI 10.1016/j.chemosphere.2009.04.044; Bjerregaard-Olesen C, 2016, INT J HYG ENVIR HEAL, V219, P867, DOI 10.1016/j.ijheh.2016.07.008; Bjerregaard-Olesen C, 2016, ENVIRON INT, V91, P14, DOI 10.1016/j.envint.2016.02.010; Bornehag CG, 2012, PAEDIATR PERINAT EP, V26, P456, DOI 10.1111/j.1365-3016.2012.01314.x; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Cho CR, 2015, SCI TOTAL ENVIRON, V512, P397, DOI 10.1016/j.scitotenv.2015.01.070; Clarke DB, 2010, FOOD ADDIT CONTAM A, V27, P530, DOI 10.1080/19440040903476590; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P1910, DOI 10.1001/jama.2012.3633; Granum B, 2013, J IMMUNOTOXICOL, V10, P373, DOI 10.3109/1547691X.2012.755580; Haug LS, 2010, ENVIRON INT, V36, P772, DOI 10.1016/j.envint.2010.05.016; Heo JJ, 2014, J HAZARD MATER, V279, P402, DOI 10.1016/j.jhazmat.2014.07.004; Hoffman K, 2010, ENVIRON HEALTH PERSP, V118, P1762, DOI 10.1289/ehp.1001898; Johnson PI, 2014, ENVIRON HEALTH PERSP, V122, P1028, DOI 10.1289/ehp.1307893; Karrman A, 2007, ENVIRON HEALTH PERSP, V115, P226, DOI 10.1289/ehp.9491; Karrman A, 2006, ENVIRON SCI TECHNOL, V40, P3742, DOI 10.1021/es060301u; KEMI SCA, 2015, OCCURRENCE AND USE O; Kristensen SL, 2013, HUM REPROD, V28, P3337, DOI 10.1093/humrep/det382; Kvist L, 2012, REPROD TOXICOL, V34, P644, DOI 10.1016/j.reprotox.2012.09.007; Lin CY, 2011, ENVIRON SCI TECHNOL, V45, P10691, DOI 10.1021/es201964x; Lindh CH, 2012, CHEMOSPHERE, V88, P1269, DOI 10.1016/j.chemosphere.2012.03.049; Long MH, 2015, SCI TOTAL ENVIRON, V529, P198, DOI 10.1016/j.scitotenv.2015.05.022; Mitro Susanna D, 2015, Curr Environ Health Rep, V2, P367, DOI 10.1007/s40572-015-0064-x; Ng CA, 2014, ENVIRON SCI TECHNOL, V48, P4637, DOI 10.1021/es404008g; Noorlander CW, 2011, J AGR FOOD CHEM, V59, P7496, DOI 10.1021/jf104943p; Ode A, 2013, ENVIRON SCI POLLUT R, V20, P7970, DOI 10.1007/s11356-013-1573-5; Schuetze A, 2010, CHEMOSPHERE, V78, P647, DOI 10.1016/j.chemosphere.2009.12.015; Velez MP, 2015, HUM REPROD, V30, P701, DOI 10.1093/humrep/deu350; Wang IJ, 2011, ENVIRON RES, V111, P785, DOI 10.1016/j.envres.2011.04.006; Wang ZY, 2013, ENVIRON INT, V60, P242, DOI 10.1016/j.envint.2013.08.021; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681	33	35	35	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209255	10.1371/journal.pone.0209255	http://dx.doi.org/10.1371/journal.pone.0209255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596681	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200036
J	Abramenkovs, A; Stenerlow, B				Abramenkovs, Andris; Stenerlow, Bo			Removal of heat-sensitive clustered damaged DNA sites is independent of double-strand break repair	PLOS ONE			English	Article							LABILE SITES; INHIBITOR NVP-BEZ235; MAMMALIAN-CELLS; PATHWAY CHOICE; PKCS; ATM	DNA double-strand breaks (DSBs) are the most deleterious lesions that can arise in cells after ionizing radiation or radiometric drug treatment. In addition to prompt DSBs, DSBs may also be produced during repair, evolving from a clustered DNA damaged site, which is composed of two or more distinct lesions that are located within two helical turns. A specific type of cluster damage is the heat-sensitive clustered site (HSCS), which transforms into DSBs upon treatment at elevated temperatures. The actual lesions or mechanisms that mediate the HSCS transformation into DSBs are unknown. However, there are two possibilities; either these lesions are transformed into DSBs due to DNA lesion instability, e.g., transfer of HSCS into single-strand breaks (SSBs), or they are formed due to local DNA structure instability, e.g., DNA melting, where two SSBs on opposite strands meet and transform into a DSB. The importance of these processes in living cells is not understood, but they significantly affect estimates of DSB repair capacity. In this study, we show that HSCS removal in human cells is not affected by defects in DSB repair or inhibition of DSB repair. Under conditions where rejoining of prompt DSBs was almost completely inhibited, heat-sensitive DSBs were successfully rejoined, without resulting in increased DSB levels, indicating that HSCS do not transfer into DSB in cells under physiological conditions. Furthermore, analysis by atomic force microscopy suggests that prolonged heating of chromosomal DNA can induce structural changes that facilitate transformation of HSCS into DSB. In conclusion, the HSCS do not generate additional DSBs at physiological temperatures in human cells, and the repair of HSCS is independent of DSB repair.	[Abramenkovs, Andris; Stenerlow, Bo] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University	Abramenkovs, A (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Andris.Abramenkovs@igp.uu.se		Abramenkovs, Andris/0000-0001-5185-0898	Swedish Cancer Society [CAN2014/661, CAN2016/649]; Swedish Radiation Safety Authority [SSM2017-2374, SSM2018-2181]	Swedish Cancer Society(Swedish Cancer Society); Swedish Radiation Safety Authority	This research was supported by grants from the Swedish Cancer Society, CAN2014/661 and CAN2016/649 (https://www.cancerfonden.se/) and the Swedish Radiation Safety Authority, SSM2017-2374 and SSM2018-2181 (https://www.stralsakerhetsmyndigheten.se/) to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrabi S, HOMOLOGOUS RECOMBINA; Aparicio T, 2014, DNA REPAIR, V19, P169, DOI 10.1016/j.dnarep.2014.03.014; Baird BJ, 2011, MUTAT RES-FUND MOL M, V711, P142, DOI 10.1016/j.mrfmmm.2010.12.006; Bee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069061; Biehs R, 2017, MOL CELL, V65, P671, DOI 10.1016/j.molcel.2016.12.016; Datta K, 2005, P NATL ACAD SCI USA, V102, P10569, DOI 10.1073/pnas.0503975102; Datta K, 2007, RADIAT RES, V167, P152, DOI 10.1667/RR0629.1; Datta K, 2006, RADIAT RES, V166, P767, DOI 10.1667/RR0628.1; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Gulston M, 2004, NUCLEIC ACIDS RES, V32, P1602, DOI 10.1093/nar/gkh306; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; JONES GDD, 1994, RADIAT RES, V138, P291, DOI 10.2307/3578601; Karlsson KH, 2008, RADIAT RES, V169, P506, DOI 10.1667/RR1076.1; Kuger S, 2013, TRANSL ONCOL, V6, P169, DOI 10.1593/tlo.12364; Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512; Nikitaki Z, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00035; Rube CE, 2011, DNA REPAIR, V10, P427, DOI 10.1016/j.dnarep.2011.01.012; Rydberg B, 2000, RADIAT RES, V153, P805, DOI 10.1667/0033-7587(2000)153[0805:RIHLST]2.0.CO;2; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Shubsda MF, 1997, J BIOCHEM BIOPH METH, V34, P73, DOI 10.1016/S0165-022X(96)01204-3; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Singh SK, 2011, NUCLEIC ACIDS RES, V39, P8416, DOI 10.1093/nar/gkr463; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; VANTOUW JH, 1985, INT J RADIAT BIOL, V48, P567, DOI 10.1080/09553008514551621; Vispe S, 2000, J BIOL CHEM, V275, P27386; von Sonntag C, 1991, Basic Life Sci, V58, P287; von Sonntag C, 2006, FREE RADICAL INDUCED, DOI [10.1007/3-540-30592-0, DOI 10.1007/3-540-30592-0]; WARD JF, 1991, RADIAT RES, V127, P90, DOI 10.2307/3578093; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Yan LF, 2002, JPN J APPL PHYS 1, V41, P7556, DOI 10.1143/JJAP.41.7556	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209594	10.1371/journal.pone.0209594	http://dx.doi.org/10.1371/journal.pone.0209594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592737	gold, Green Published, Green Submitted			2022-12-26	WOS:000454621900032
J	Galaska, R; Kulawiak-Galaska, D; Chmara, M; Chlebus, K; Studniarek, M; Fijalkowski, M; Wasag, B; Rynkiewicz, A; Gruchala, M				Galaska, Rafal; Kulawiak-Galaska, Dorota; Chmara, Magdalena; Chlebus, Krzysztof; Studniarek, Michal; Fijalkowski, Marcin; Wasag, Bartosz; Rynkiewicz, Andrzej; Gruchala, Marcin			Aortic valve calcium score in hypercholesterolemic patients with and without low-density lipoprotein receptor gene mutation	PLOS ONE			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA; POTENTIAL ROLE; CALCIFICATION; PROGRESSION; STENOSIS; ATHEROSCLEROSIS; ROSUVASTATIN; ASSOCIATION; TRIAL	The aim of this study was a comparison of aortic valve calcium score (AVCS) between patients with hypercholesterolemia and genetic diagnosis of familial hypercholesterolemia with low-density lipoprotein receptor gene mutation (LDLR-M group), versus patients with hypercholesterolemia without LDLR gene mutation (LDLR-WT group). A total of 72 LDLR-M patients and 50 LDLR-WT patients were enrolled in the study and underwent CT as a part of an assessment of coronary calcium scoring. AVCS was determined and compared between the two patient groups. AVCS was significantly higher in the LDLR-M group in comparison to the LDLR-WT group (13.8 +/- 37.9 vs. 0.94 +/- 3.1, p = 0.03). The Yates' chi-squared test for independence revealed that LDLR mutation and AVCS were significantly dependable (Chi boolean AND 2 = 6.106, p = 0.013). The LDLR mutation was a strong predictor of a high AVCS (OR 7.83, 95% CI 2.08-29.50, p = 0.002) on multivariate regression analysis. Among the traditional risk factors, age (odds ratio 1.12, 95% CI 1.05-1.18, p<0.001) and SBP (OR 1.04, 95% CI 1.00-1.07, p = 0.045) were also significant for high result of AVCS. An assessment of computed tomography calcium scores showed that LDLR-M patients have increased AVCS in comparison to those with LDLR-WT. In addition, LDLR mutation can be considered as an independent risk factor of having high AVSC even after adjustment for risk factors including cholesterol levels. This may result from the associated process connected with the regulatory role of LDLR in evolution of aortic valve calcifications.	[Galaska, Rafal; Chlebus, Krzysztof; Fijalkowski, Marcin; Gruchala, Marcin] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland; [Kulawiak-Galaska, Dorota; Studniarek, Michal] Med Univ Gdansk, Dept Radiol, Gdansk, Poland; [Chmara, Magdalena; Wasag, Bartosz] Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland; [Rynkiewicz, Andrzej] Univ Warmia & Mazury, Dept Cardiol & Cardiosurg, Olsztyn, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Warmia & Mazury	Galaska, R (corresponding author), Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland.	rga@gumed.edu.pl	Chlebus, Krzysztof/AAH-6957-2019; Rynkiewicz, Andrzej/AAW-8733-2021; Wasag, Bartosz/Q-9630-2018; Kulawiak Galaska, Dorota/V-2483-2018	Chlebus, Krzysztof/0000-0001-6546-0858; Wasag, Bartosz/0000-0002-3634-7562; Fijalkowski, Marcin/0000-0002-2913-5457; Rynkiewicz, Andrzej/0000-0002-5284-9511; Kulawiak Galaska, Dorota/0000-0002-4256-5312; Chmara, Magdalena/0000-0003-1430-8367; Galaska, Rafal/0000-0001-9487-2966; Studniarek, Michal/0000-0002-9200-1320	"National Center Diagnosis and Treatment of Familial Hypercholesterolemia" grant [POIG.01.01.02-22-079/09]	"National Center Diagnosis and Treatment of Familial Hypercholesterolemia" grant	This study was supported by the "National Center Diagnosis and Treatment of Familial Hypercholesterolemia" grant (grant no. POIG.01.01.02-22-079/09; to Medical University of Gdansk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrasadi K, 2009, AM HEART J, V157, P170, DOI 10.1016/j.ahj.2008.08.021; Awan Z, 2008, ARTERIOSCL THROM VAS, V28, P777, DOI 10.1161/ATVBAHA.107.160408; Awan Z, 2011, ATHEROSCLEROSIS, V219, P455, DOI 10.1016/j.atherosclerosis.2011.08.035; Bostrom KI, 2011, CIRC RES, V109, P564, DOI 10.1161/CIRCRESAHA.110.234278; Budoff MJ, 2006, ACAD RADIOL, V13, P166, DOI 10.1016/j.acra.2005.09.090; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Chmara M, 2010, J APPL GENET, V51, P95, DOI 10.1007/BF03195716; Chui MCK, 2001, CLIN CARDIOL, V24, P52, DOI 10.1002/clc.4960240109; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Fantus D, 2013, ATHEROSCLEROSIS, V226, P9, DOI 10.1016/j.atherosclerosis.2012.08.026; Galaska R, 2016, J ATHEROSCLER THROMB, V23, P588, DOI 10.5551/jat.31161; Johnson ML, 2007, REV ENDOCR METAB DIS, V7; Messika-Zeitoun D, 2007, ARTERIOSCL THROM VAS, V27, P642, DOI 10.1161/01.ATV.0000255952.47980.c2; Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Pohle K, 2001, CIRCULATION, V104, P1927, DOI 10.1161/hc4101.097527; Rajamannan NM, 2005, CIRCULATION, V112, pI229, DOI 10.1161/01.CIRCULATIONAHA.104.524306; Rallidis L, 1998, HEART, V80, P583, DOI 10.1136/hrt.80.6.583; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Teo KK, 2011, CAN J CARDIOL, V27, P800, DOI 10.1016/j.cjca.2011.03.012; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Yutzey KE, 2014, ARTERIOSCL THROM VAS, V34, P2387, DOI 10.1161/ATVBAHA.114.302523	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209229	10.1371/journal.pone.0209229	http://dx.doi.org/10.1371/journal.pone.0209229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592719	Green Published, Green Submitted, gold			2022-12-26	WOS:000454621900017
J	Castello, MJ; Medina-Puche, L; Lamilla, J; Tornero, P				Jose Castello, Maria; Medina-Puche, Laura; Lamilla, Julian; Tornero, Pablo			NPR1 paralogs of Arabidopsis and their role in salicylic acid perception	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; DISEASE RESISTANCE; TRANSCRIPTION FACTORS; CONTROLS LEAF; GENE; ACTIVATION; EXPRESSION; INTERACTS; PROTEIN; OVEREXPRESSION	Salicylic acid (SA) is responsible for certain plant defence responses and NON EXPRESSER OF PATHOGENESIS RELATED 1 (NPR1) is the master regulator of SA perception. In Arabidopsis thaliana there are five paralogs of NPR1. In this work we tested the role of these paralogs in SA perception by generating combinations of mutants and transgenics. NPR2 was the only paralog able to partially complement an npr1 mutant. The null npr2 reduces SA perception in combination with npr1 or other paralogs. NPR2 and NPR1 interacted in all the conditions tested, and NPR2 also interacted with other SA-related proteins as NPR1 does. The remaining paralogs behaved differently in SA perception, depending on the genetic background, and the expression of some of the genes induced by SA in an npr1 background was affected by the presence of the paralogs. NPR2 fits all the requirements of an SA receptor while the remaining paralogs also work as SA receptors with a strong hierarchy. According to the data presented here, the closer the gene is to NPR1, the more relevant its role in SA perception.	[Jose Castello, Maria; Medina-Puche, Laura; Lamilla, Julian; Tornero, Pablo] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Medina-Puche, Laura] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Lamilla, Julian] Univ Mil Nueva Granada, Fac Ciencias Basicas & Aplicadas, Lab Biotecnol Vegetal, Costado Oriental, Colombia	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Tornero, P (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain.	ptornero@ibmcp.upv.es	Lamilla, Julian/AAJ-5090-2021; Medina-Puche, Laura/L-2388-2013; Medina-Puche, Laura/AAF-4474-2020	Medina-Puche, Laura/0000-0001-8362-8087; Medina-Puche, Laura/0000-0001-8362-8087; Tornero, Pablo/0000-0001-9755-7726; Lamilla, Julian/0000-0001-5395-6055	Spanish Ministry of Economy and Competitiveness [BIO2013-45444-P]; Valencia Regional Government [ACOMP/2013/052]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Valencia Regional Government	This work was supported by the Spanish Ministry of Economy and Competitiveness (www.idi.mineco.gob.es/portal/site/MICINN, Grant BIO2013-45444-P to PT) and the Valencia Regional Government (www.ceice.gva.es/web/ciencia, Grant ACOMP/2013/052 to PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai W, 2011, PLANT BIOTECHNOL J, V9, P205, DOI 10.1111/j.1467-7652.2010.00544.x; Belda-Palazon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046907; Blanco F, 2005, PLANT MOL BIOL, V59, P927, DOI 10.1007/s11103-005-2227-x; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Breen S, 2017, TRENDS PLANT SCI, V22, P871, DOI 10.1016/j.tplants.2017.06.013; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Canet JV, 2010, PLANT BIOTECHNOL J, V8, P126, DOI 10.1111/j.1467-7652.2009.00468.x; Canet JV, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-199; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Caufield JH, 2012, METHODS, V58, P317, DOI 10.1016/j.ymeth.2012.12.001; Ciannamea S, 2006, J EXP BOT, V57, P3419, DOI 10.1093/jxb/erl144; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Leon IP, 2002, PLANT J, V29, P61, DOI 10.1046/j.1365-313x.2002.01195.x; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Ding YL, 2018, CELL, V173, P1454, DOI 10.1016/j.cell.2018.03.044; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Glazebrook J, 1996, GENETICS, V143, P973; Goossens J, 2016, PLANT MOL BIOL, V91, P673, DOI 10.1007/s11103-016-0480-9; Ha CM, 2003, DEVELOPMENT, V130, P161, DOI 10.1242/dev.00196; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; Hepworth SR, 2005, PLANT CELL, V17, P1434, DOI 10.1105/tpc.104.030536; Hong ZL, 2001, PLANT CELL, V13, P769, DOI 10.1105/tpc.13.4.769; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; KAUFFMANN S, 1990, PLANT MOL BIOL, V14, P381, DOI 10.1007/BF00028774; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Maier F, 2011, MOL PLANT PATHOL, V12, P73, DOI 10.1111/j.1364-3703.2010.00653.x; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Manohar M, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00777; Medina-Puche L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181820; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Seyfferth C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00697; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Tian MY, 2012, PLANT J, V72, P1027, DOI 10.1111/tpj.12016; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Uquillas C, 2004, MOL PLANT MICROBE IN, V17, P34, DOI 10.1094/MPMI.2004.17.1.34; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Canet JV, 2012, PLANT CELL, V24, P4220, DOI 10.1105/tpc.112.103028; Canet JV, 2010, PLANT CELL ENVIRON, V33, P1911, DOI 10.1111/j.1365-3040.2010.02194.x; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Weigel RR, 2005, PLANT CELL, V17, P1279, DOI 10.1105/tpc.104.027441; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu YuanQi, 2012, Agricultural Biotechnology, V1, P1; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191	56	31	34	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209835	10.1371/journal.pone.0209835	http://dx.doi.org/10.1371/journal.pone.0209835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592744	gold, Green Submitted, Green Published			2022-12-26	WOS:000454621900048
J	Khan, MA; Aldebasi, YH; Alsuhaibani, SA; AlSahli, MA; Alzohairy, MA; Khan, A; Younus, H				Khan, Masood A.; Aldebasi, Yousef H.; Alsuhaibani, Sultan A.; AlSahli, Mohammed A.; Alzohairy, Mohammad A.; Khan, Arif; Younus, Hina			Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice	PLOS ONE			English	Article							NIGELLA-SATIVA; DRUG-RESISTANCE; STREPTOZOTOCIN; MELLITUS; INDUCTION	The present study was aimed to develop a liposomal formulation of thymoquinone (Lip-TQ) to treat Candida albicans infection in diabetic mice. Streptozotocin (STZ) was injected to induce hyperglycemia and on day 3 post STZ administration, mice were intravenously infected with C. albicans. Various doses (2, 5 and 10 mg/kg) of Free or Lip-TQ were administered in C. albicans infected diabetic mice. The effect of Lip-TQ was also determined on the organ indices, liver and kidney function parameters. Lip-TQ at a dose of 10 mg/kg significantly reduced the level of the blood glucose and alleviated the systemic C. albicans infection in diabetic mice. C. albicans infected diabetic mice treated with Lip-TQ at a dose of 10 mg/kg showed the survival rate of 70% as compared to that of 20% in the group treated with free TQ. The treatment with Lip-TQ resulted in the recovery of the organ indices, liver inflammation, kidney functioning and pancreas regeneration in diabetic mice. Moreover, TQ formulations also showed the direct therapeutic effect against candidiasis in the untreated or metformin-treated diabetic mice. Therefore, the findings of the present study support the use of Lip-TQ in the treatment of candidiasis in the diabetic patients.	[Khan, Masood A.; Aldebasi, Yousef H.; Alsuhaibani, Sultan A.; AlSahli, Mohammed A.; Alzohairy, Mohammad A.; Khan, Arif] Qassim Univ, Coll Appl Med Sci, Buraydah, Saudi Arabia; [Younus, Hina] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Qassim University; Aligarh Muslim University	Khan, MA (corresponding author), Qassim Univ, Coll Appl Med Sci, Buraydah, Saudi Arabia.	a_khan@qu.edu.sa	Younus, Hina/AAF-3337-2019; Khan, Masood A./G-9693-2011; Aldebasi, Yousef/AAZ-1871-2020	Khan, Masood A./0000-0003-4031-4189; Alzohairy, Mohammad/0000-0002-2779-8193; Alsahli, Mohammed A. A./0000-0001-9357-2216	Deanship of Scientific Research, Qassim University [3059]	Deanship of Scientific Research, Qassim University	This research was supported by the Deanship of Scientific Research, Qassim University, Grant No. #3059. This grant was awarded to Dr. Masood A. Khan.	Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Al Mahmud H, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1786-0; Al-Ali Amein, 2008, J Ayub Med Coll Abbottabad, V20, P25; Almshawit H, 2017, MICROBIOL RES, V195, P81, DOI 10.1016/j.micres.2016.11.008; Belazi M, 2005, MYCOSES, V48, P192, DOI 10.1111/j.1439-0507.2005.01124.x; Bissong Mea, 2015, Odontostomatol Trop, V38, P49; Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Dorcely Brenda, 2017, Diabetes Metab Syndr Obes, V10, P345, DOI 10.2147/DMSO.S100074; El-Mahmoudy A, 2005, INT IMMUNOPHARMACOL, V5, P195, DOI 10.1016/j.intimp.2004.09.001; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Giri S, 2012, INDIAN J MED MICROBI, V30, P270, DOI 10.4103/0255-0857.99484; Goswami D, 2006, J INFECTION, V52, P111, DOI 10.1016/j.jinf.2005.03.005; Jiang C, 2013, J ANTIMICROB CHEMOTH, V68, P778, DOI 10.1093/jac/dks481; Kanter M, 2004, ANAT REC PART A, V279A, P685, DOI 10.1002/ar.a.20056; Kanter M, 2009, J MOL HISTOL, V40, P107, DOI 10.1007/s10735-009-9220-7; Khan MA, 2006, J ANTIMICROB CHEMOTH, V58, P125, DOI 10.1093/jac/dkl177; Khan MA, 2018, J DRUG TARGET, V26, P709, DOI 10.1080/1061186X.2018.1424857; Khan MA, 2014, INT J BIOL MACROMOL, V65, P16, DOI 10.1016/j.ijbiomac.2014.01.001; Laskar AA, 2016, BIOCHIMIE, V127, P205, DOI 10.1016/j.biochi.2016.05.020; Lee MK, 2004, J ANTIMICROB CHEMOTH, V53, P217, DOI 10.1093/jac/dkh040; Meghana K, 2007, EUR J PHARMACOL, V577, P183, DOI 10.1016/j.ejphar.2007.09.002; Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X; Nair HB, 2010, BIOCHEM PHARMACOL, V80, P1833, DOI 10.1016/j.bcp.2010.07.021; Nq AW, 2003, J PHARM PHARM SCI, V6, P67; Odeh F, 2012, DRUG DELIV, V19, P371, DOI 10.3109/10717544.2012.727500; Poradzka A, 2013, ACTA POL PHARM, V70, P587; Rahmani AH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761608; Rajput S, 2015, MOL PHARMACEUT, V12, P4214, DOI 10.1021/acs.molpharmaceut.5b00692; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Randhawa MA, 2017, J INTERCULT ETHNOPHA, V6, P97, DOI 10.5455/jice.20161018021238; Richard C., 2017, BMJ Open Diabetes Research and Care, V5, pe000379, DOI 10.1136/bmjdrc-2016-000379; Sangi SMA, 2015, PHARMACOGN MAG, V11, pS251, DOI 10.4103/0973-1296.166017; Shokri H, 2016, AVICENNA J PHYTOMEDI, V6, P21; Singh N, 2001, CLIN INFECT DIS, V33, P1692, DOI 10.1086/323895; Sun NX, 2005, MEDIAT INFLAMM, P202, DOI 10.1155/MI.2005.202; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Zhang C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11457-w; Zhang XC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010057	39	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208951	10.1371/journal.pone.0208951	http://dx.doi.org/10.1371/journal.pone.0208951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589842	Green Published, gold, Green Submitted			2022-12-26	WOS:000454418200012
J	Marahatta, SB; Amatya, R; Adhikari, S; Giri, D; Lama, S; Kaehler, N; Rijal, KR; Marahatta, S; Adhikari, B				Marahatta, Sujan Babu; Amatya, Rakchya; Adhikari, Srijana; Giri, Deena; Lama, Sarina; Kaehler, Nils; Rijal, Komal Raj; Marahatta, Suchana; Adhikari, Bipin			Perceived stigma of leprosy among community members and health care providers in Lalitpur district of Nepal: A qualitative study	PLOS ONE			English	Article							ELIMINATION; DISEASE	Background Leprosy remains a major stigmatizing condition. Stigma is a dynamic process resulting from the interaction between physical attributes caused by leprosy and the existing stereotypes in a community. Leprosy has pervasive impacts on all areas of life including psychosocial burden to an individual, social interaction, marriage, and employment. These impacts vary and are largely dependent on a particular culture and community. The main objective of this study was to explore the perceived stigma of leprosy amongst community members and health care providers in Lalitpur district of Nepal. Methods A total of six focused group discussions (FGDs) with 43 participants from a community living close to Anandaban Leprosy Hospital and ten semi structured interviews (SSIs) with health care providers were conducted between October and December 2016. An interview guide was used for the FGDs and SSIs. All qualitative data were transcribed and translated into English and were thematically analyzed using Atlas.ti software. Results Visible deformities due to leprosy was one of the major contributing factors for stigma. Stigma was further exacerbated by an attitude to conceal the disease due to perceived fear of potential discrimination. While over the years, stigma was felt to be decreasing, various aspects of life were still affected by leprosy stigma including marriage, employment and social interaction. This was largely attributed to leprosy and its consequences, specifically the disability and deformity caused by leprosy. Conclusion Leprosy was still perceived to be feared and concealed because of potential discrimination, even within the community that was close to a long established leprosy hospital. Various aspects such as marriage, employment and social interaction were still affected by the stigma which was strongly associated with visible deformities. In addition to ongoing rehabilitation and stigma reduction programs, integrating strategies such as community engagement wherein community and leprosy affected person jointly take a role in stigma reduction programs can be helpful.	[Marahatta, Sujan Babu; Amatya, Rakchya; Adhikari, Srijana; Giri, Deena; Lama, Sarina] Manmohan Mem Inst Hlth Sci, Kathmandu, Nepal; [Kaehler, Nils; Adhikari, Bipin] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand; [Rijal, Komal Raj] Tribhuvan Univ, Cent Dept Microbiol, Kathmandu, Nepal; [Marahatta, Suchana] BP Koirala Inst Hlth Sci, Dharan, Nepal	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Tribhuvan University; B.P. Koirala Institute of Health Sciences	Adhikari, B (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand.	biopion@gmail.com	Marahatta, Suchana/ABE-1460-2020; Rijal, Komal Raj/AAG-2828-2019; Adhikari, Bipin/X-3110-2019	Rijal, Komal Raj/0000-0001-6281-8236; Adhikari, Bipin/0000-0001-8981-3910; Giri, Deena/0000-0002-6176-1706; Marahatta, Suchana/0000-0002-3542-0350	SEARO-WHO/TDR [2017/717053-0]	SEARO-WHO/TDR	This study was funded by grants from the SEARO-WHO/TDR, grant number: 2017/717053-0.	Adhikari B, 2013, J Nepal Health Res Counc, V11, P264; Adhikari B, 2013, J MANMOHAN MEMORIAL, V1, P3; Adhikari B, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2158-4; Adhikari B, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2070-y; Adhikari B, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1366136; Adhikari B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1593-y; Adhikari B, 2013, J HEALTH RES, V27, P295; Adhikari B, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00121; Adhikari B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002940; Alberts CJ, 2011, B WORLD HEALTH ORGAN, V89, P487, DOI 10.2471/BLT.10.085662; [Anonymous], 2015, Wkly Epidemiol Rec, V91, P405; Blok DJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1143-4; Brouwers C, 2011, QUALITY LIFE PERCEIV, V22; Calcraft J. H., 2006, ASIA PACIFIC DIABILI, V17; Chaptini C, 2015, LEPROSY REV, V86, P307; CTSA, 2011, NIH PUBLICATION; de Stigter DH, 2000, LEPROSY REV, V71, P492; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Glasser B.G., 1967, DISCOVERY GROUNDED T; Heijnders ML, 2004, INT J LEPROSY, V72, P437, DOI 10.1489/1544-581X(2004)72&lt;437:TDOSIL&gt;2.0.CO;2; Hofstraat K, 2016, INT HEALTH, V8, pi53, DOI 10.1093/inthealth/ihv071; JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4; Jha RK, 2014, DOWRY DEATHS RISE NE; John A S, 2005, Indian J Lepr, V77, P247; Kaehler N, 2013, J HEALTH RES, V27, P359; Kaehler N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129086; Kajeechiwa Ladda, 2017, Wellcome Open Res, V2, P59, DOI 10.12688/wellcomeopenres.12051.1; Lusli M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005088; Lusli M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261329; Marahatta S B, 2015, J Nepal Health Res Counc, V13, P95; Muthuvel T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005192; Pell C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1854-4; Peters RMH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004003; Peto TJ, 2018, AM J TROP MED HYG, V98, P100, DOI 10.4269/ajtmh.17-0428; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Sermrittirong S, 2015, LEPROSY REV, V86, P54; Sermrittirong S, 2014, LEPROSY REV, V85, P36; Try L, 2006, ASIA PAC DISABIL REH, V17, P55; van Brakel WH, 2003, INT J LEPROSY, V71, P190, DOI 10.1489/1544-581X(2003)71&lt;190:MLSPRO&gt;2.0.CO;2; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; van Brakel WH, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18394; van Haaren MAC, 2017, CHRONIC ILLN, V13, P117, DOI 10.1177/1742395316657398; Van't Noordende AT, 2016, J TROP MED-US, V2016, DOI 10.1155/2016/4230235; Varkevisser CM, 2009, LEPROSY REV, V80, P65; WEISS MG, 1992, BRIT J PSYCHIAT, V160, P819, DOI 10.1192/bjp.160.6.819; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237	47	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0209676	10.1371/journal.pone.0209676	http://dx.doi.org/10.1371/journal.pone.0209676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589875	Green Submitted, gold, Green Published			2022-12-26	WOS:000454418200045
J	Gonzalez-Serna, D; Carmona, EG; Ortego-Centeno, N; Simeon, CP; Solans, R; Hernandez-Rodriguez, J; Tolosa, C; Castaneda, S; Narvaez, J; Martinez-Valle, F; Witte, T; Neumann, T; Holle, J; Beretta, L; Boiardi, L; Emmi, G; Cimmino, MA; Vaglio, A; Herrick, AL; Denton, CP; Salvarani, C; Cid, MC; Morgan, AW; Fonseca, C; Gonzalez-Gay, MA; Martin, J; Marquez, A				Gonzalez-Serna, David; Carmona, Elio G.; Ortego-Centeno, Norberto; Simeon, Carmen P.; Solans, Roser; Hernandez-Rodriguez, Jose; Tolosa, Carlos; Castaneda, Santos; Narvaez, Javier; Martinez-Valle, Ferran; Witte, Torsten; Neumann, Thomas; Holle, Julia; Beretta, Lorenzo; Boiardi, Luigi; Emmi, Giacomo; Cimmino, Marco A.; Vaglio, Augusto; Herrick, Ariane L.; Denton, Christopher P.; Salvarani, Carlo; Cid, Maria C.; Morgan, Ann W.; Fonseca, Carmen; Gonzalez-Gay, Miguel A.; Martin, Javier; Marquez, Ana		European GCA Consortium; European Scleroderma Grp	A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility	PLOS ONE			English	Article							BAFF; HOMEOSTASIS	Background The TNFSF13B (TNF superfamily member 13b) gene encodes BAFF, a cytokine with a crucial role in the differentiation and activation of B cells. An insertion-deletion variant (GCTGT -> A) of this gene, leading to increased levels of BAFF, has been recently implicated in the genetic predisposition to several autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Based on the elevated levels of this cytokine found in patients with giant cell arteritis (GCA) and systemic sclerosis (SSc), we aimed to assess whether this functional variant also represents a novel genetic risk factor for these two disorders. Methods A total of 1,728 biopsy-proven GCA patients from 4 European cohorts, 4,584 SSc patients from 3 European cohorts and 5,160 ethnically-matched healthy controls were included in the study. The single nucleotide polymorphism (SNP) rs374039502, which colocalizes with the genetic variant previously implicated in autoimmunity, was genotyped using a custom TaqMan assay. First, association analysis was conducted in each independent cohort using chi(2) test in Plink (v1.9). Subsequently, different case/control sets were meta-analyzed by the inverse variance method. Results No statistically significant differences were found when allele distributions were compared between cases and controls for any of the analyzed cohorts. Similarly, combined analysis of the different sets evidenced a lack of association of the rs374039502 variant with GCA (P = 0.421; OR (95% CI) = 0.92 (0.75-1.13)) and SSc (P = 0.500; OR (95% CI) = 1.05 (0.91-1.22)). The stratified analysis considering the main clinical subphenotypes of these diseases yielded similar negative results. Conclusion Our data suggest that the TNFSF13B functional variant does not contribute to the genetic network underlying GCA and SSc.	[Gonzalez-Serna, David; Carmona, Elio G.; Martin, Javier; Marquez, Ana] PTS Granada, Inst Parasitol & Biomed Lopez Neyra, CSIC, Granada, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, System Autoimmune Dis Unit, Granada, Spain; [Simeon, Carmen P.; Solans, Roser; Martinez-Valle, Ferran] Autonomous Univ Barcelona, Autoimmune System Dis Unit, Dept Internal Med, Hosp Vall dHebron, Barcelona, Spain; [Hernandez-Rodriguez, Jose; Cid, Maria C.] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAP, Hosp Clin, Vasculitis Res Unit,Dept Autoimmune Dis, Barcelona, Spain; [Tolosa, Carlos] Hosp Parc Tauli, Dept Internal Med, Sabadell, Spain; [Castaneda, Santos] IIS Princesa, Hosp Princesa, Dept Rheumatol, Madrid, Spain; [Narvaez, Javier] Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain; [Witte, Torsten] Hannover Med Sch, Hannover, Germany; [Neumann, Thomas] Univ Hosp Jena, Klin Innere Med 3, Jena, Germany; [Holle, Julia] Klinikum Bad Bramstedt, Vasculitis Clin, Bad Bramstedt, Germany; [Holle, Julia] Univ Hosp Schleswig Holstein, Bad Bramstedt, Germany; [Beretta, Lorenzo] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Referral Ctr System Autoimmune Dis, Milan, Italy; [Boiardi, Luigi] Ist Ricovero & Cura Carattere Sci, Rheumatol Unit, Dept Internal Med, Azienda Osped Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; [Emmi, Giacomo] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Cimmino, Marco A.] Univ Genoa, Dept Internal Med, Res Lab, Genoa, Italy; [Cimmino, Marco A.] Univ Genoa, Dept Internal Med, Acad Div Clin Rheumatol, Genoa, Italy; [Vaglio, Augusto] Univ Firenze, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy; [Vaglio, Augusto] Meyer Childrens Univ Hosp, Nephrol & Dialysis Unit, Florence, Italy; [Herrick, Ariane L.] Univ Manchester, Ctr Musculoskeletal Res, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Herrick, Ariane L.] Univ Manchester, NIHR Manchester Musculoskeletal Biomed Res Unit, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Denton, Christopher P.; Fonseca, Carmen] Royal Free & Univ Coll Med Sch, Ctr Rheumatol, London, England; [Salvarani, Carlo] Azienda USL IRCCS Reggio Emilia, Reggio Emilia, Italy; [Salvarani, Carlo] Univ Modena & Reggio Emilia, Reggio Emilia, Italy; [Morgan, Ann W.] Univ Leeds, Sch Med, Leeds, W Yorkshire, England; [Morgan, Ann W.] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Gonzalez-Gay, Miguel A.] Univ Cantabria, Hosp Univ Marque Valdecilla, Dept Rheumatol, IDIVAL, Santander, Spain; [Marquez, Ana] Hosp Clin San Cecilio, Inst Invest Biosanitaria Granada Ibs GRANADA, System Autoimmune Dis Unit, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario San Cecilio; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hannover Medical School; Friedrich Schiller University of Jena; University of Kiel; Schleswig Holstein University Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Arcispedale S. Maria Nuova; University of Florence; University of Genoa; University of Genoa; University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Salford Royal NHS Foundation Trust; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester; University of London; University College London; Universita di Modena e Reggio Emilia; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada	Marquez, A (corresponding author), PTS Granada, Inst Parasitol & Biomed Lopez Neyra, CSIC, Granada, Spain.; Marquez, A (corresponding author), Hosp Clin San Cecilio, Inst Invest Biosanitaria Granada Ibs GRANADA, System Autoimmune Dis Unit, Granada, Spain.	anamaort@ipb.csic.es	Beretta, Lorenzo/AAB-8605-2019; Cid, Maria C./J-4553-2016; Salvarani, Carlo/K-2431-2018; Narvaez, Javier/AAD-7456-2020; Witte, Torsten/B-5783-2016; Martín, María/HDL-9512-2022; Vaglio, Augusto/AHE-8117-2022; Emmi, Giacomo/J-6913-2016; Narvaez, Javier/AAD-7434-2020; Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; Hernandez-Rodriguez, Jose/L-2073-2017; Ortego-Centeno, Norberto/C-4793-2019	Beretta, Lorenzo/0000-0002-6529-6258; Cid, Maria C./0000-0002-4730-0938; Narvaez, Javier/0000-0002-1614-8064; Vaglio, Augusto/0000-0002-3814-9172; Martin, Javier/0000-0002-2202-0622; Carmona, Elio/0000-0003-1315-5469; Morgan, Ann/0000-0003-1109-624X; Emmi, Giacomo/0000-0001-9575-8321; Guillen-Del-Castillo, Alfredo/0000-0003-0626-507X; Simeon-Aznar, Carmen Pilar/0000-0003-3390-9029; Hernandez-Rodriguez, Jose/0000-0002-2357-2015; Ortego-Centeno, Norberto/0000-0003-2325-0937; Marquez, Ana/0000-0001-9913-7688	Consejeria de Innovacion, Ciencia y Tecnologia, Junta de Andalucia (Spain) [P12-BIO-1395]; Cooperative Research Thematic Network (RETICS) programme [RD16/0012/0013]; Instituto de Salud Carlos III (ISCIII, Spanish Ministry of Economy, Industry and Competitiveness); ISCIII (Spanish Ministry of Economy, Industry and Competitiveness) [CP17/00008]; MRC [MR/N011775/1] Funding Source: UKRI	Consejeria de Innovacion, Ciencia y Tecnologia, Junta de Andalucia (Spain)(Junta de Andalucia); Cooperative Research Thematic Network (RETICS) programme; Instituto de Salud Carlos III (ISCIII, Spanish Ministry of Economy, Industry and Competitiveness); ISCIII (Spanish Ministry of Economy, Industry and Competitiveness); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the following grants: P12-BIO-1395 from Consejeria de Innovacion, Ciencia y Tecnologia, Junta de Andalucia (Spain) (JM), and the Cooperative Research Thematic Network (RETICS) programme (RD16/0012/0013) (RIER) (JM), from Instituto de Salud Carlos III (ISCIII, Spanish Ministry of Economy, Industry and Competitiveness). AM is recipient of a Miguel Servet fellowship (CP17/00008) from ISCIII (Spanish Ministry of Economy, Industry and Competitiveness) (AM).	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bossini-Castillo L, 2015, J AUTOIMMUN, V64, P53, DOI 10.1016/j.jaut.2015.07.005; Brkic Z, 2016, ANN RHEUM DIS, V75, P1567, DOI 10.1136/annrheumdis-2015-207392; Carmona FD, 2016, EXPERT REV CLIN IMMU, V12, P57, DOI 10.1586/1744666X.2016.1089173; Forestier A, 2018, AUTOIMMUN REV, V17, P244, DOI 10.1016/j.autrev.2017.10.015; Francois A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4352; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1065; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Matsushita T, 2006, ARTHRITIS RHEUM-US, V54, P192, DOI 10.1002/art.21526; Richard-Miceli C, 2012, GENOME MED, V4, DOI 10.1186/gm305; Steri M, 2017, NEW ENGL J MED, V376, P1615, DOI 10.1056/NEJMoa1610528; van der Geest KSM, 2015, RHEUMATOLOGY, V54, P1397, DOI 10.1093/rheumatology/keu526; van der Geest KSM, 2014, ARTHRITIS RHEUMATOL, V66, P1927, DOI 10.1002/art.38625	13	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209343	10.1371/journal.pone.0209343	http://dx.doi.org/10.1371/journal.pone.0209343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586461	Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400059
J	Law, E; Levesque, JV; Lambert, S; Girgis, A				Law, Eleanor; Levesque, Janelle V.; Lambert, Sylvie; Girgis, Afaf			The "sphere of care": A qualitative study of colorectal cancer patient and caregiver experiences of support within the cancer treatment setting	PLOS ONE			English	Article							PERCEIVED SOCIAL SUPPORT; STAGE BREAST-CANCER; OF-LIFE; HEALTH-CARE; DEPRESSIVE SYMPTOMS; SCREENING-PROGRAM; FINANCIAL BURDEN; CONTROLLED-TRIAL; PEER-SUPPORT; 1ST YEAR	Introduction Colorectal cancer is associated with considerable physical and psychosocial burden. Whilst social support is known to facilitate psychological adjustment to cancer, patients' and caregivers' experiences of social support within a treatment setting and their perceptions of the role of the treating team in providing this support is unknown. Specifically, there is a gap in the research that explores in detail who people affected by colorectal cancer consider to be supportive, and the function, timing and nature of this support, whilst receiving treatment. This study explored both patients' and caregivers' a) experiences of social support and how this relates to their experience of treatment; and b) what facilitates support in the treatment setting. Methods Individual interviews (N = 20) were conducted with patients diagnosed with colorectal cancer and caregivers of such patients. Audiotaped interviews were transcribed verbatim and analysed using the framework method. Results Three major themes emerged from the data: a) treating team as a source of support, highlighting the importance of connection with the treating team; b) changes in existing social supports, encompassing issues regarding distance in interpersonal relationships as a consequence of cancer; and c) differing dimensions of support, exploring the significance of shared experience, practical, financial, and emotional support. Conclusions Patients and caregivers perceived the treating team as a major source of support. Support from the treating team was particularly important in the context of the changes that occur as a result of a diagnosis of colorectal cancer and the effects of subsequent treatment. Incidental support from others encountered in the treatment setting was also experienced and was equally important to both patients and caregivers. This has implications for the way health care professionals respond to both patients and caregivers in the treatment setting in terms of communication, interventions and environment.	[Law, Eleanor] ACT Hlth, Canberra, ACT, Australia; [Law, Eleanor; Levesque, Janelle V.; Girgis, Afaf] Ingham Inst Appl Med Res, Ctr Oncol Educ & Res Translat CONCERT, Liverpool, Australia; [Law, Eleanor; Levesque, Janelle V.; Girgis, Afaf] Univ New South Wales, UNSW Med, South Western Sydney Clin Sch, Liverpool, Australia; [Lambert, Sylvie] McGill Univ, Ingram Sch Nursing, Montreal, PQ, Canada	Ingham Institute for Applied Medical Research; University of New South Wales Sydney; McGill University	Law, E (corresponding author), ACT Hlth, Canberra, ACT, Australia.; Law, E (corresponding author), Ingham Inst Appl Med Res, Ctr Oncol Educ & Res Translat CONCERT, Liverpool, Australia.; Law, E (corresponding author), Univ New South Wales, UNSW Med, South Western Sydney Clin Sch, Liverpool, Australia.	elly.law@act.gov.au	Lambert, Sylvie/AAB-2890-2019	Lambert, Sylvie/0000-0002-9202-9251	Centre for Oncology And Research Translation (CONCERT); Cancer Institute NSW; University of New South Wales; Western Sydney University; University of Wollongong; Illawara Shoalhaven Local Health District; Ingham Institute	Centre for Oncology And Research Translation (CONCERT); Cancer Institute NSW; University of New South Wales; Western Sydney University; University of Wollongong; Illawara Shoalhaven Local Health District; Ingham Institute(Ingham Institute for Applied Medical Research)	Acknowledgment is extended to the Centre for Oncology And Research Translation (CONCERT) for funding of Eleanor Law's postgraduate research scholarship. CONCERT is funded by the Cancer Institute NSW, with contributions from University of New South Wales, Western Sydney University, University of Wollongong, Illawara Shoalhaven Local Health District and Ingham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora NK, 2007, PSYCHO-ONCOL, V16, P474, DOI 10.1002/pon.1084; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Boutin-Foster Carla, 2005, Health Qual Life Outcomes, V3, P52, DOI 10.1186/1477-7525-3-52; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bryman A., 2016, SOCIAL RES METHODS; Carlson LE, 2013, J CLIN ONCOL, V31, P3119, DOI 10.1200/JCO.2012.47.5210; Ceilleachair AO, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-62; Chambers SK, 2012, QUAL LIFE RES, V21, P1551, DOI 10.1007/s11136-011-0067-5; Chen H, 2016, INT J CLIN EXP MED, V9, P18479; Cotrim H, 2008, EUR J ONCOL NURS, V12, P217, DOI 10.1016/j.ejon.2007.11.005; DAKOF GA, 1990, J PERS SOC PSYCHOL, V58, P80, DOI 10.1037/0022-3514.58.1.80; Drageset S, 2016, SCAND J CARING SCI, V30, P340, DOI 10.1111/scs.12250; DUNKELSCHETTER C, 1984, J SOC ISSUES, V40, P77, DOI 10.1111/j.1540-4560.1984.tb01108.x; Fenn KM, 2014, J ONCOL PRACT, V10, P332, DOI 10.1200/JOP.2013.001322; Fong AJ, 2017, PSYCHO-ONCOLOGY, V26, P664, DOI 10.1002/pon.4064; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Girgis A, 2017, CANC FORUM, V41; Girgis A, 2013, J ONCOL PRACT, V9, P197, DOI 10.1200/JOP.2012.000690; Girgis A, 2009, CANCER FORUM, V33, P167; Given Barbara A, 2012, Semin Oncol Nurs, V28, P205, DOI 10.1016/j.soncn.2012.09.002; Gropper S, 2016, SUPPORT CARE CANCER, V24, P2351, DOI 10.1007/s00520-015-3042-9; Haviland J, 2017, PSYCHO-ONCOLOGY, V26, P2276, DOI 10.1002/pon.4556; Helgeson VS, 2000, HEALTH PSYCHOL, V19, P107, DOI 10.1037/0278-6133.19.2.107; Hoey LM, 2008, PATIENT EDUC COUNS, V70, P315, DOI 10.1016/j.pec.2007.11.016; Hoon LS, 2013, EUR J ONCOL NURS, V17, P883, DOI 10.1016/j.ejon.2013.05.001; Hoybye MT, 2014, MED ANTHROPOL Q, V28, P305, DOI 10.1111/maq.12063; Jones RM, 2010, AM J PREV MED, V38, P508, DOI 10.1016/j.amepre.2010.01.021; Kim Y, 2013, PSYCHO-ONCOLOGY, V22, P362, DOI 10.1002/pon.2100; Kvrgic Z, 2018, ARTHRIT CARE RES, V70, P1439, DOI 10.1002/acr.23501; Lazarus R.S., 1984, EMOTION ADAPTATION; Lee MK, 2011, SUPPORT CARE CANCER, V19, P1379, DOI 10.1007/s00520-010-0960-4; Leung J, 2014, PSYCHO-ONCOLOGY, V23, P1014, DOI 10.1002/pon.3523; Lincoln KD, 2000, SOC SERV REV, V74, P231, DOI 10.1086/514478; Lund L, 2015, SUPPORT CARE CANCER, V23, P1719, DOI 10.1007/s00520-014-2529-0; MacPhail C, 2016, QUAL RES, V16, P198, DOI 10.1177/1468794115577012; Mager WM, 2002, PSYCHO-ONCOLOGY, V11, P35, DOI 10.1002/pon.563; Maguire R, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12527; Manne SL, 2005, HEALTH PSYCHOL, V24, P635, DOI 10.1037/0278-6133.24.6.635; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Mertens DM., 2014, RES EVALUATION ED PS, DOI DOI 10.1007/s10803-010-1068-x; Mols F, 2018, CANCER-AM CANCER SOC, V124, P2621, DOI 10.1002/cncr.31369; Monti DA, 2006, PSYCHO-ONCOL, V15, P363, DOI 10.1002/pon.988; Mosher CE, 2015, PSYCHO-ONCOLOGY, DOI [10.1002/pon, DOI 10.1002/PON]; NEULING SJ, 1988, SOC SCI MED, V27, P385, DOI 10.1016/0277-9536(88)90273-0; Orford NR, 2017, BMJ SUPPORTIVE AMP; Palmer CK, 2014, BRIT J CANCER, V110, P1705, DOI 10.1038/bjc.2014.125; Parkinson S, 2016, QUAL RES PSYCHOL, V13, P109, DOI 10.1080/14780887.2015.1119228; Penedo F. J., 2011, J SUPPORTIVE ONCOLOG, V10, P119, DOI DOI 10.1016/J.SUP0NC.2011.09.002; Phelan SM, 2013, PSYCHO-ONCOLOGY, V22, P65, DOI 10.1002/pon.2048; Pistrang N, 2013, PSYCHO-ONCOLOGY, V22, P886, DOI 10.1002/pon.3080; Razafsha M, 2012, METHODS MOL BIOL, V829; Regan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133837; Riege AM, 2003, INT J-TORONTO, V6, P75, DOI [10.1108/13522750310470055, DOI 10.1108/13522750310470055]; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rocque R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139577; Salonen P, 2014, EUR J CANCER CARE, V23, P274, DOI 10.1111/ecc.12153; SANDELOWSKI M, 1994, RES NURS HEALTH, V17, P479, DOI 10.1002/nur.4770170611; Shen MJ, 2018, J RACIAL ETHN HEALTH, V5, P117, DOI 10.1007/s40615-017-0350-4; Shieh SC, 2012, J NURS SCHOLARSHIP, V44, P223, DOI 10.1111/j.1547-5069.2012.01453.x; Siedlecki KL, 2014, SOC INDIC RES, V117, P561, DOI 10.1007/s11205-013-0361-4; Smith Joanna, 2011, Nurse Res, V18, P52; Song LX, 2011, QUAL LIFE RES, V20, P371, DOI 10.1007/s11136-010-9753-y; Thompson T, 2013, HEALTH PSYCHOL, V32, P886, DOI 10.1037/a0031894; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trevino KM, 2014, CANCER-AM CANCER SOC, V120, P2272, DOI 10.1002/cncr.28740; Uchino BN, 2012, SOC SCI MED, V74, P949, DOI 10.1016/j.socscimed.2011.11.023; von Wagner C, 2009, BRIT J CANCER, V101, pS60, DOI 10.1038/sj.bjc.6605392; Yilmaz SD, 2015, CANCER NURS, V38, pE57, DOI 10.1097/NCC.0000000000000186; Yoo GJ, 2010, SUPPORT CARE CANCER, V18, P1521, DOI 10.1007/s00520-009-0774-4; Zafar SY, 2015, J ONCOL PRACT, V11, P145, DOI 10.1200/JOP.2014.001542	71	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209436	10.1371/journal.pone.0209436	http://dx.doi.org/10.1371/journal.pone.0209436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF7JV	30586391	gold, Green Submitted, Green Published			2022-12-26	WOS:000454416400065
J	Jagadeesh, AT; Puttur, A; Mondal, S; Ibrahim, S; Udupi, A; Prasanna, LC; Kamath, A				Jagadeesh, Akshay Thimmappaiah; Puttur, Anushree; Mondal, Soumayan; Ibrahim, Sufyan; Udupi, Anurupa; Prasanna, Lokadolalu Chandracharya; Kamath, Asha			Devising focused strategies to improve organ donor registrations: A cross-sectional study among professional drivers in coastal South India	PLOS ONE			English	Article							HEALTH-CARE; DONATION; ATTITUDE; KNOWLEDGE	Background In India, annually, 500,000 people die due to non-availability of organs. Given the large proportion of brain death amongst road accident victims, any improvement in organ donation practices amongst this cohort could potentially address this deficit. In this study, we identify the potential areas for intervention to improve organ donation amongst professional drivers, a population more likely to suffer from road accidents. Methods 300 participants were surveyed using a structured, orally-administered questionnaire to assess knowledge, attitudes and practices regarding organ donation. Multivariate analysis was performed to identify key variables affecting intent to practice. Results Nearly half our participants had unsatisfactory knowledge and attitude scores. Knowledge and attitude was positively correlated, r(s) (298) = .247, p < .001, with better scores associated with a higher likelihood of intent to practice organ donation [AOR: 2.23 (1.26-3.94), p = .006; AOR: 12.164 (6.85-21.59), p < .001 respectively]. Lack of family support and fear of donated organs going into medical research were the key barriers for the same [AOR: 0.43 (0.19-0.97), p = .04; AOR: 0.27 (0.09-0.85), p = .02 respectively]. Conclusion Targeted health-education, behaviour change communication, and legal interventions, in conjunction, are key to improving organ donor registrations.	[Jagadeesh, Akshay Thimmappaiah; Puttur, Anushree; Mondal, Soumayan; Ibrahim, Sufyan; Udupi, Anurupa] Manipal Acad Higher Educ, Kasturba Med Coll, Manipal, Karnataka, India; [Prasanna, Lokadolalu Chandracharya] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Anat, Manipal, Karnataka, India; [Kamath, Asha] Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Dept Stat, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE)	Prasanna, LC (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Dept Anat, Manipal, Karnataka, India.	prasanna.lc@manipal.edu	Ibrahim, Sufyan/AAJ-6015-2021	Ibrahim, Sufyan/0000-0001-9127-2738; LC, Prasanna/0000-0002-0737-9573; Puttur, Anushree/0000-0002-7471-8838; Mondal, Soumayan/0000-0002-8074-2527; Thimmappaiah Jagadeesh, Akshay/0000-0001-9482-7890	Kasturba Medical College Short-term-studentship (KMC-STS) 2017 grant	Kasturba Medical College Short-term-studentship (KMC-STS) 2017 grant	This work was supported by the Kasturba Medical College Short-term-studentship (KMC-STS) 2017 grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Kasturba Medical College Short-term-studentship (KMC-STS) 2017 grant. The authors would like acknowledge Dr. Kumar MR Bhat, Professor & Chairperson Anatomy, RAK Medical and Health Sciences University, UAE, for his help in designing the study, and Ms. Sannutha Shetty, B.A. LL.B. (Hons) Student, National Law University, Delhi, for the legal consultancy provided.	Abraham Georgi, 2016, World J Transplant, V6, P331, DOI 10.5500/wjt.v6.i2.331; Abukhaizaran N, 2018, LANCET; Ahuja A., 2017, NDTV; Annadurai K, 2013, PROG HLTH SCI, V3, P59; [Anonymous], 2016, TIMES INDIA; [Anonymous], 2017, NEWS LETT TRANSPLANT, V22, P1; Asefa NG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118675; Balwani MR, 2015, RENAL FAILURE, V37, P582, DOI 10.3109/0886022X.2015.1007820; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Browne T, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0326-3; Chakradhar K, 2016, INT J TRANSPLANT MED, V7, P28; Dar R., 2014, EUR C OPT COMM ECOC, P1; Directorate of Census Operations Karnataka, 2011, DISTR CENS HDB UD; Geroge S., 2001, NATL LAW SCH INDIA R, V13, P240; Ghods AJ, 2015, EXP CLIN TRANSPLANT, V13, P13, DOI 10.6002/ect.mesot2014.L17; HART LG, 1987, J CHRON DIS, V40, pS117, DOI 10.1016/S0021-9681(87)80041-3; Jagadeesh AT, KNOWLEDGE ATTITUDE P; Kamalakannan SK, 2015, SHORT COMMUNICATION, V18, P16; Kanchan T, 2012, J FORENSIC LEG MED, V19, P448, DOI 10.1016/j.jflm.2012.02.031; Lam LT, 2004, ACCIDENT ANAL PREV, V36, P905, DOI 10.1016/j.aap.2003.10.001; Marvan ML, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13112; Manojan KK, 2014, AMJI, P225; Mithra P, 2013, INDIAN J PALLIAT CAR, V19, P83, DOI 10.4103/0973-1075.116701; Navin S, 2014, DECEASED ORGAN DONAT, P1; Nie JB, 2018, DEV WORLD BIOETH, V18, P26, DOI 10.1111/dewb.12170; Oliver M, 2011, NEPHROL DIAL TRANSPL, V26, P437, DOI 10.1093/ndt/gfq628; Patthi B, 2015, J INDIAN ASS PUBLIC, V13, P58, DOI [10.4103/2319-5932.153588, DOI 10.4103/2319-5932.153588]; Reddy AVR, 2003, TRANSPL P, V35, P18, DOI 10.1016/S0041-1345(02)03792-2; Russell E, 2012, J COMMUN HEALTH, V37, P40, DOI 10.1007/s10900-011-9413-3; Sachdeva S, 2017, INDIAN J TRANSPLANT, V11, P127; Sanner M. A., 2006, MORTALITY, V11, P133; Shaw David, 2017, J Intensive Care Soc, V18, P96, DOI 10.1177/1751143717694916; Shroff S, 2009, INDIAN J UROL, V25, P348, DOI 10.4103/0970-1591.56203; Siebelink MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178128; Siminoff LA, 2010, J TRAUMA, V69, P956, DOI 10.1097/TA.0b013e3181d8924b; Spencer M., 2012, END LIFE J, V2, P1, DOI [10.1136/eoljnl-02-02.5, DOI 10.1136/EOLJNL-02-02.5]; Transport Research Wing Ministry of Road Transport and Highways G of I, 2017, ROAD ACC IND 2016; Uplap PA, 2017, EXPLORING SCOPE IMPR, V4, P229, DOI [10.18203/2394-6040.ijcmph20164744.35, DOI 10.18203/2394-6040.IJCMPH20164744.35]; Vijayalakshmi P, 2016, NATL MED J INDIA, V29, P257; Zhao Y., 2015, PERIOD POLYTECH, V43, P189, DOI [10.3311/PPtr.7742, DOI 10.3311/PPTR.7742]	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209686	10.1371/journal.pone.0209686	http://dx.doi.org/10.1371/journal.pone.0209686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576381	Green Published, Green Submitted, gold			2022-12-26	WOS:000454149400070
J	Yeatman, S; Chamberlin, S; Dovel, K				Yeatman, Sara; Chamberlin, Stephanie; Dovel, Kathryn			Women's (health) work: A population-based, cross-sectional study of gender differences in time spent seeking health care in Malawi	PLOS ONE			English	Article							HOUSEHOLD COSTS; SOUTH-AFRICA; SERVICES; MEN; MONEY	Background There has been a notable expansion in routine health care in sub-Saharan Africa. While heath care is nominally free in many contexts, the time required to access services reflects an opportunity cost that may be substantial and highly gendered, reflecting the gendered nature of health care guidelines and patterns of use. The time costs of health care use, however, have rarely been systematically assessed at the population-level. Methods Data come from the 2015 wave of a population-based cohort study of young adults in southern Malawi during which 1,453 women and 407 men between the ages of 21 and 31 were interviewed. We calculated the time spent seeking health care over a two-month period, dis-aggregating findings by men, recently-pregnant women, mothers with children under two years old, and "other women". We then extrapolated the time required for specific services to estimate the time that would be needed for each subpopulation to meet government recommendations for routine health services over the course of a year. Results Approximately 60% of women and 22% of men attended at least one health care visit during the preceding two months. Women spent six times as long seeking care as did men (t = -4.414, p<0.001), with an average 6.4 hours seeking care over a two-month period compared to 1 hour for men. In order to meet government recommendations for routine health services, HIV-negative women would need to spend between 19 and 63 hours annually seeking health care compared to only three hours for men. An additional 40 hours would be required of HIV-positive individuals initiating antiretroviral care. Conclusions Women in Malawi spend a considerable amount of time seeking routine health care services, while men spend almost none. The substantial time women spend seeking health care exacerbates their time poverty and constrains opportunities for other meaningful activities. At the same time, few health care guidelines pertain to men who thus have little interaction with the health care system. Additional public health strategies such as integration of services for those services frequently used by women and specific guidelines and outreach for men are urgently needed.	[Yeatman, Sara; Chamberlin, Stephanie] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Dovel, Kathryn] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Dovel, Kathryn] Partners Hope, Lilongwe, Malawi	University of Colorado System; University of Colorado Denver; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yeatman, S (corresponding author), Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA.	sara.yeatman@ucdenver.edu		Yeatman, Sara/0000-0002-5991-6473	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD058366, R01-HD077873]; population center at the University of Colorado (CUPC) [P2CHD066613]; U.S. Agency for International Development (USAID) [AID-OAA-A-15-00070]; President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-15-00070]; National Institute of Mental Health (NIMH) [T32MH080634-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD066613, R01HD077873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); population center at the University of Colorado (CUPC); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research uses data from Tsogolo la Thanzi, a research project designed by Jenny Trinitapoli and Sara Yeatman and funded by grants R01-HD058366 and R01-HD077873 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The research was also supported by the population center at the University of Colorado (CUPC; P2CHD066613). KD's time is partially supported by the U.S. Agency for International Development (USAID) and the President's Emergency Plan for AIDS Relief (PEPFAR) under Cooperative Agreement AID-OAA-A-15-00070 and the National Institute of Mental Health (NIMH) through T32MH080634-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSMITH B, 1992, HEALTH POLICY PLANN, V7, P329, DOI 10.1093/heapol/7.4.329; Angotti N, 2011, HEALTH POLICY PLANN, V26, P307, DOI 10.1093/heapol/czq066; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], 2013, STAT GRAPH MAN REF M; Auyero J, 2011, LAT AM RES REV, V46, P5, DOI 10.1353/lar.2011.0014; Baker P, 2014, B WORLD HEALTH ORGAN, V92, P618, DOI 10.2471/BLT.13.132795; Bardasi E, 2010, FEM ECON, V16, P45, DOI 10.1080/13545701.2010.508574; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Blackden CM, 2006, GENDER TIME USE POVE, Vxiii; Bourdieu P., 2000, PASCALIAN MEDITATION; Cappiccie A, 2017, SOCIAL SCI, V6, P145; Carmona A., 2013, MALAWI PRIVATE HLTH; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Celletti F, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21185; Cooper D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1577-9; Cornell M, 2013, S AFR J HIV MED, V14, P12, DOI 10.7196/SAJHIVMED.894; Cornell M, 2015, TROP MED INT HEALTH, V20, P1634, DOI 10.1111/tmi.12593; Cueto M, 2004, AM J PUBLIC HEALTH, V94, P1864, DOI 10.2105/AJPH.94.11.1864; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Elborgh-Woytek K., 2013, IMF STAFF DISCUSSION; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Floro MS, 2011, FEM ECON, V17, P33, DOI 10.1080/13545701.2011.614954; Folbre N, 2014, J AFR ECON, V23, pI128, DOI 10.1093/jae/ejt026; Folbre Nancy., 2006, J HUMAN DEV, V7, P183, DOI DOI 10.1080/14649880600768512; Goudge J, 2009, TROP MED INT HEALTH, V14, P458, DOI 10.1111/j.1365-3156.2009.02256.x; Greene ME, 2000, POPUL DEV REV, V26, P81, DOI 10.1111/j.1728-4457.2000.00081.x; Grollman C, 2017, LANCET GLOB HEALTH, V5, pE104, DOI 10.1016/S2214-109X(16)30304-7; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harrison A, 2014, AIDS BEHAV, V18, P595, DOI 10.1007/s10461-013-0515-z; Hawkes S, 2017, LANCET GLOB HEALTH, V5, pE871, DOI 10.1016/S2214-109X(17)30266-8; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; Hirway I., 2010, UNPAID WORK EC GENDE, P22; ICF NSONMa, 2017, MAL DEM HLTH SURV 20 MAL DEM HLTH SURV 20; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Kowalewski Marga, 2002, Afr J Reprod Health, V6, P65, DOI 10.2307/3583147; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Levin A, 2003, INT J HEALTH PLAN M, V18, P3, DOI 10.1002/hpm.690; Lush L, 1999, B WORLD HEALTH ORGAN, V77, P771; Malawi Ministry of Health, 2009, NAT SEX REPR HLTH RI; Malawi Ministry of Health, 2015, MAL STAND TREATM GUI; Manafa O, 2009, HUMAN RESOURCES HLTH, V7, P1; Messac L., 2018, J IMPERIAL COMMONWEA, P1; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Ministry of Health M, 2017, MAL POP BAS HIV IMP; Mody A, 2018, CLIN INFECT DIS, V66, P237, DOI 10.1093/cid/cix756; (MOH) MMoH, 2011, MAL HLTH SECT STRAT; (MOH) MMoH, 2016, HIV TEST SERV GUID; [(MOH) MMoH AIDS DoHa], 2016, MAL GUID CLIN MAN HI; Pinto AD., 2013, J INT AIDS SOC, V16, P1; Poulin M, 2016, WORLD DEV, V85, P16, DOI 10.1016/j.worlddev.2016.04.008; Sande L, 2018, AIDS CARE, V30, P27, DOI 10.1080/09540121.2018.1479032; Schouten EJ, 2013, LANCET, V381, P1272, DOI 10.1016/S0140-6736(13)60832-6; Smith J, 2006, WHAT DO WE KNOW MENS; UNICEF Malawi, 2017, HLTH BUDG BRIEF MAL; World Health Organization, 2016, 69 WORLD HLTH ASSEMB	58	30	30	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209586	10.1371/journal.pone.0209586	http://dx.doi.org/10.1371/journal.pone.0209586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HF3QK	30576388	Green Submitted, gold, Green Published			2022-12-26	WOS:000454149400061
J	Shiina, N				Shiina, Nobuyuki			Liquid- and solid-like RNA granules form through specific scaffold proteins and combine into biphasic granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA binding protein; scaffold protein; molecular dynamics; fluorescence recovery after photobleaching (FRAP); cell permeabilization; core-shell; liquid; liquid-liquid phase separation (LLPS); RNA granule; solid	STRESS GRANULES; DENDRITIC LOCALIZATION; PHASE-SEPARATION; BINDING PROTEIN; MESSENGER-RNA; TRANSLATION; LINK	RNA granules consist of membrane-less RNA-protein assemblies and contain dynamic liquid-like shells and stable solid-like cores, which are thought to function in numerous processes in mRNA sorting and translational regulation. However, how these distinct substructures are formed, whether they are assembled by different scaffolds, and whether different RNA granule scaffolds induce these different substructures remains unknown. Here, using fluorescence microscopy-based morphological and molecular-dynamics analyses, we demonstrate that RNA granule scaffold proteins (scaffolds) can be largely classified into two groups, liquid and solid types, which induce the formation of liquid-like and solid-like granules, respectively, when expressed separately in cultured cells. We found that when co-expressed, the liquid-type and solid-type scaffolds combine and form liquid- and solid-like substructures in the same granules, respectively. The combination of the different types of scaffolds reduced the immobile fractions of the solid-type scaffolds and their dose-dependent ability to decrease nascent polypeptides in granules, but had little effect on the dynamics of the liquid-type scaffolds or their dose-dependent ability to increase nascent polypeptides in granules. These results suggest that solid- and liquid-type scaffolds form different substructures in RNA granules and differentially affect each other. Our findings provide detailed insight into the assembly mechanism and distinct dynamics and functions of core and shell substructures in RNA granules.	[Shiina, Nobuyuki] Natl Inst Basic Biol, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki] Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Shiina, N (corresponding author), Natl Inst Basic Biol, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan.	nshiina@nibb.ac.jp		Shiina, Nobuyuki/0000-0002-1854-4239	Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Orion Project of Okazaki Institute for Integrative Bioscience	Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Orion Project of Okazaki Institute for Integrative Bioscience	This work was supported by the Takeda Science Foundation, the Astellas Foundation for Research on Metabolic Disorders, and the Orion Project of Okazaki Institute for Integrative Bioscience to N. S. The author declares that he has no conflicts of interest with the contents of this article.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Ganassi M, 2016, MOL CELL, V63, P796, DOI 10.1016/j.molcel.2016.07.021; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mateju D, 2017, EMBO J, V36, P1669, DOI 10.15252/embj.201695957; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Moon BU, 2016, LAB CHIP, V16, P2601, DOI 10.1039/c6lc00576d; Nakayama K, 2017, ELIFE, V6, DOI 10.7554/eLife.29677; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 2014, J BIOL CHEM, V289, P21163, DOI 10.1074/jbc.M114.556365; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Souquere S, 2009, J CELL SCI, V122, P3619, DOI 10.1242/jcs.054437; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wu YH, 2016, ACTA CRYSTALLOGR D, V72, P718, DOI 10.1107/S2059798316004903	37	27	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3532	3548		10.1074/jbc.RA118.005423	http://dx.doi.org/10.1074/jbc.RA118.005423			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30606735	Green Published, hybrid			2022-12-26	WOS:000461853900019
J	Sikimic, J; McMillen, TS; Bleile, C; Dastvan, F; Quast, U; Krippeit-Drews, P; Drews, G; Bryan, J				Sikimic, Jelena; McMillen, Timothy S.; Bleile, Cita; Dastvan, Frank; Quast, Ulrich; Krippeit-Drews, Peter; Drews, Gisela; Bryan, Joseph			ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K-ATP channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-binding cassette transporter subfamily C member 8 (ABCC8); ABC transporter; allosteric regulation; diabetes; ion channel; ATP-sensitive potassium channel; glibenclamide; hyperinsulinism; KCNJ11 (Kir6; 2); neonatal diabetes; K-ATP channel; SUR1; congenital hyperinsulinism; metabolic sensor	SENSITIVE POTASSIUM CHANNELS; BETA-CELL; TOLBUTAMIDE-SENSITIVITY; INSULIN SECRETAGOGUES; GLIBENCLAMIDE BINDING; NUCLEOTIDE REGULATION; STIMULATORY ACTION; ABC TRANSPORTERS; N-TERMINUS; MUTATIONS	Neuroendocrine-type ATP-sensitive K+ (K-ATP) channels are metabolite sensors coupling membrane potential with metabolism, thereby linking insulin secretion to plasma glucose levels. They are octameric complexes, (SUR1/Kir6.2)(4), comprising sulfonylurea receptor 1 (SUR1 or ABCC8) and a K+-selective inward rectifier (Kir6.2 or KCNJ11). Interactions between nucleotide-, agonist-, and antagonist-binding sites affect channel activity allosterically. Although it is hypothesized that opening these channels requires SUR1-mediated MgATP hydrolysis, we show here that ATP binding to SUR1, without hydrolysis, opens channels when nucleotide antagonism on Kir6.2 is minimized and SUR1 mutants with increased ATP affinities are used. We found that ATP binding is sufficient to switch SUR1 alone between inward- or outward-facing conformations with low or high dissociation constant, K-D, values for the conformation-sensitive channel antagonist [H-3]glibenclamide ([H-3]GBM), indicating that ATP can act as a pure agonist. Assembly with Kir6.2 reduced SUR1's K-D for [H-3]GBM. This reduction required the Kir N terminus (KNtp), consistent with KNtp occupying a transport cavity, thus positioning it to link ATP-induced SUR1 conformational changes to channel gating. Moreover, ATP/GBM site coupling was constrained in WT SUR1/WT Kir6.2 channels; ATP-bound channels had a lower K-D for [H-3]GBM than ATP-bound SUR1. This constraint was largely eliminated by the Q1179R neonatal diabetes-associated mutation in helix 15, suggesting that a swapped helix pair, 15 and 16, is part of a structural pathway connecting the ATP/GBM sites. Our results suggest that ATP binding to SUR1 biases K-ATP channels toward open states, consistent with SUR1 variants with lower K-D values causing neonatal diabetes, whereas increased K-D values cause congenital hyperinsulinism.	[Sikimic, Jelena; Bleile, Cita; Krippeit-Drews, Peter; Drews, Gisela] Univ Tubingen, Dept Pharmacol, Inst Pharm, D-72076 Tubingen, Germany; [McMillen, Timothy S.; Dastvan, Frank; Bryan, Joseph] Pacific Northwest Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA; [Quast, Ulrich] Eberhard Karls Univ Hosp & Clin, Dept Expt & Clin Pharmacol & Toxicol, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Pacific Northwest Diabetes Research Institute (PNDRI); Eberhard Karls University of Tubingen	Bryan, J (corresponding author), Pacific Northwest Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA.	jbryan1941@outlook.com	RAHI, DEEPALI/GMW-8189-2022	RAHI, DEEPALI/0000-0002-4818-5572; McMillen, Timothy/0000-0001-5261-3229	National Institutes of Health [DK098647]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK098647 (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Akers D. L., 2001, MATH J, V8, P27; ALPER JS, 1993, TALANTA, V40, P355, DOI 10.1016/0039-9140(93)80246-N; ASHCROFT FM, 1989, DIABETOLOGIA, V32, P591; ASHCROFT FM, 1987, FEBS LETT, V215, P9, DOI 10.1016/0014-5793(87)80103-5; Babenko ADP, 2005, J MOL CELL CARDIOL, V39, P79, DOI 10.1016/j.yjmcc.2004.12.004; Babenko AP, 2008, J BIOL CHEM, V283, P8778, DOI 10.1074/jbc.C700243200; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 1999, J BIOL CHEM, V274, P11587, DOI 10.1074/jbc.274.17.11587; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Baukrowitz T, 2000, BIOCHEM PHARMACOL, V60, P735, DOI 10.1016/S0006-2952(00)00267-7; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bowman P, 2012, DIABETOLOGIA, V55, P123, DOI 10.1007/s00125-011-2319-x; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Choi KH, 2008, J PHYS CHEM B, V112, P10314, DOI 10.1021/jp712088v; Christesen H. B. T., 2005, HORM RES, V64, P135; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Dabrowski M, 2001, DIABETOLOGIA, V44, P747, DOI 10.1007/s001250051684; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; Dickinson KEJ, 1997, MOL PHARMACOL, V52, P473, DOI 10.1124/mol.52.3.473; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; DUNNE MJ, 1987, J MEMBRANE BIOL, V99, P215, DOI 10.1007/BF01995702; Emdin CA, 2017, DIABETES, V66, P2310, DOI 10.2337/db17-0149; Fatehi M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150143; Fatehi M, 2012, DIABETES, V61, P241, DOI 10.2337/db11-0371; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Hambrock A, 1998, BRIT J PHARMACOL, V125, P577, DOI 10.1038/sj.bjp.0702109; Hansen AMK, 2005, BRIT J PHARMACOL, V144, P551, DOI 10.1038/sj.bjp.0706082; Hattersley AT, 2017, DIABETOLOGIA, V60, P769, DOI 10.1007/s00125-017-4226-2; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; HOPKINS WF, 1992, J MEMBRANE BIOL, V129, P287; Hu SL, 2000, J PHARMACOL EXP THER, V293, P444; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Kuhner P, 2012, N-S ARCH PHARMACOL, V385, P299, DOI 10.1007/s00210-011-0709-8; LEBRUN P, 1989, J PHARMACOL EXP THER, V250, P1011; Lee KPK, 2017, ELIFE, V6, DOI 10.7554/eLife.32481; Lemelman MB, 2018, CLIN PERINATOL, V45, P41, DOI 10.1016/j.clp.2017.10.006; Li LH, 2000, BIOPHYS J, V79, P841, DOI 10.1016/S0006-3495(00)76340-5; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lin YF, 2008, NEUROSCIENCE, V152, P371, DOI 10.1016/j.neuroscience.2008.01.003; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Masia R, 2007, DIABETES, V56, P328, DOI 10.2337/db06-1275; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; NIKI I, 1991, BIOCHIM BIOPHYS ACTA, V1133, P95, DOI 10.1016/0167-4889(91)90246-T; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Ortiz D, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00048; Ortiz D, 2013, J BIOL CHEM, V288, P18894, DOI 10.1074/jbc.M113.476887; Ortiz D, 2012, J BIOL CHEM, V287, P17985, DOI 10.1074/jbc.M112.349019; PANTEN U, 1990, N-S ARCH PHARMACOL, V342, P566; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Proks P, 2014, J GEN PHYSIOL, V144, P469, DOI 10.1085/jgp.201411222; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; SCHMIDANTOMARCHI H, 1987, J BIOL CHEM, V262, P15840; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; SCHWANSTECHER M, 1994, J BIOL CHEM, V269, P17768; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; SCHWANSTECHER M, 1992, BRIT J PHARMACOL, V105, P531, DOI 10.1111/j.1476-5381.1992.tb09014.x; SCHWANSTECHER M, 1991, N-S ARCH PHARMACOL, V343, P83; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SIEGEL S, 1956, NONPARAMETRIC STAT, P75; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stephan D, 2006, DIABETOLOGIA, V49, P2039, DOI 10.1007/s00125-006-0307-3; STURGESS NC, 1988, BRIT J PHARMACOL, V95, P83, DOI 10.1111/j.1476-5381.1988.tb16551.x; STURGESS NC, 1985, LANCET, V2, P474; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Wu JX, 2018, PROTEIN CELL, V9, P553, DOI 10.1007/s13238-018-0530-y; Zingman LV, 2007, J APPL PHYSIOL, V103, P1888, DOI 10.1152/japplphysiol.00747.2007; Zingman LV, 2002, J BIOL CHEM, V277, P14206, DOI 10.1074/jbc.M109452200; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7; ZUNKLER BJ, 1988, N-S ARCH PHARMACOL, V337, P225	102	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3707	3719		10.1074/jbc.RA118.005236	http://dx.doi.org/10.1074/jbc.RA118.005236			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30587573	Green Published, hybrid			2022-12-26	WOS:000461853900032
J	Manta, B; Moller, MN; Bonilla, M; Deambrosi, M; Grunberg, K; Bellanda, M; Comini, MA; Ferrer-Sueta, G				Manta, Bruno; Moller, Matias N.; Bonilla, Mariana; Deambrosi, Matias; Grunberg, Karin; Bellanda, Massimo; Comini, Marcelo A.; Ferrer-Sueta, Gerardo			Kinetic studies reveal a key role of a redox-active glutaredoxin in the evolution of the thiol-redox metabolism of trypanosomatid parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						trypanosome; glutathionylation; oxidation-reduction (redox); enzyme catalysis; disulfide; thiol; fluorescence; trypanothione	PROTEIN DISULFIDE-ISOMERASE; NMR SOLUTION STRUCTURE; IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; MIXED DISULFIDE; AFRICAN TRYPANOSOMES; DITHIOL GLUTAREDOXINS; GLUTATHIONE-REDUCTASE; CATALYTIC-PROPERTIES; ENZYMATIC MECHANISM	Trypanosomes are flagellated protozoan parasites (kinetoplastids) that have a unique redox metabolism based on the small dithiol trypanothione (T(SH)(2)). Although GSH may still play a biological role in trypanosomatid parasites beyond being a building block of T(SH)(2), most of its functions are replaced by T(SH)(2) in these organisms. Consequently, trypanosomes have several enzymes adapted to using T(SH)(2) instead of GSH, including the glutaredoxins (Grxs). However, the mechanistic basis of Grx specificity for T(SH)(2) is unknown. Here, we combined fast-kinetic and biophysical approaches, including NMR, MS, and fluorescent tagging, to study the redox function of Grx1, the only cytosolic redox-active Grx in trypanosomes. We observed that Grx1 reduces GSH-containing disulfides (including oxidized trypanothione) in very fast reactions (k > 5 x 10(5) m(-1) s(-1)). We also noted that disulfides without a GSH are much slower oxidants, suggesting a strongly selective binding of the GSH molecule. Not surprisingly, oxidized Grx1 was also reduced very fast by T(SH)(2) (4.8 x 10(6) m(-1) s(-1)); however, GSH-mediated reduction was extremely slow (39 m(-1) s(-1)). This kinetic selectivity in the reduction step of the catalytic cycle suggests that Grx1 uses preferentially a dithiol mechanism, forming a disulfide on the active site during the oxidative half of the catalytic cycle and then being rapidly reduced by T(SH)(2) in the reductive half. Thus, the reduction of glutathionylated substrates avoids GSSG accumulation in an organism lacking GSH reductase. These findings suggest that Grx1 has played an important adaptive role during the rewiring of the thiol-redox metabolism of kinetoplastids.	[Manta, Bruno; Bonilla, Mariana; Deambrosi, Matias; Grunberg, Karin; Comini, Marcelo A.] Inst Pasteur Montevideo, Grp Biol Redox Tripanosomas, Montevideo 11400, Uruguay; [Manta, Bruno; Moller, Matias N.; Bonilla, Mariana; Grunberg, Karin; Ferrer-Sueta, Gerardo] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Fisicoquim Biol, Montevideo 11400, Uruguay; [Bonilla, Mariana; Deambrosi, Matias] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Enzimol, Montevideo 11400, Uruguay; [Moller, Matias N.; Ferrer-Sueta, Gerardo] Univ Republica, Ctr Free Radical & Biomed Res, Montevideo, Uruguay; [Bellanda, Massimo] Univ Padua, Dipartimento Sci Chim, I-35131 Padua, Italy; [Manta, Bruno] New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Padua; New England Biolabs	Ferrer-Sueta, G (corresponding author), Fac Ciencias, Lab Fisicoquim Biol, Igua 4225, Montevideo 11400, Uruguay.	gferrer@fcien.edu.uy	Ferrer-Sueta, Gerardo/C-3316-2011	Ferrer-Sueta, Gerardo/0000-0002-8663-8480; Bonilla, Mariana/0000-0002-9206-345X; Deambrosi, Matias/0000-0001-9111-5898; Moller, Matias N./0000-0002-3486-8217; BELLANDA, MASSIMO/0000-0002-8187-0264; Comini, Marcelo/0000-0001-5000-1333	Comision Sectorial de Investigacion Cientifica Universidad de la Republica [C601-348]; International Centre for Genetic Engineering and Biotechnology [CRP/URU14-01]; PRAT Universita degli Studi di Padova [COF 03/11, CPDA137397/13]; European Comission [261863]; Fondo para la Convergencia Estructural del Mercosur	Comision Sectorial de Investigacion Cientifica Universidad de la Republica; International Centre for Genetic Engineering and Biotechnology; PRAT Universita degli Studi di Padova; European Comission(European CommissionEuropean Commission Joint Research Centre); Fondo para la Convergencia Estructural del Mercosur	This work was supported by Grant C601-348 from Comision Sectorial de Investigacion Cientifica Universidad de la Republica (to B. M. and G. F. S.), CRP/URU14-01 International Centre for Genetic Engineering and Biotechnology and Fondo para la Convergencia Estructural del Mercosur, COF 03/11 (to M. A. C.), and CPDA137397/13 from PRAT Universita degli Studi di Padova, and European Comission Project number 261863 Bio-NMR (to M. Bellanda). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; Arias DG, 2013, FREE RADICAL BIO MED, V63, P65, DOI 10.1016/j.freeradbiomed.2013.04.036; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Attarian R, 2009, FEBS LETT, V583, P3215, DOI 10.1016/j.febslet.2009.09.007; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Begas P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14835; Berndt C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00168; Bjornberg O, 2006, BIOCHEMISTRY-US, V45, P2362, DOI 10.1021/bi0522495; Bjornberg O, 1991, Protein Expr Purif, V2, P287, DOI 10.1016/1046-5928(91)90085-W; Bocedi A, 2018, FEBS J, V285, P3225, DOI 10.1111/febs.14609; Bonilla M, 2011, J BIOL CHEM, V286, P4959, DOI 10.1074/jbc.M110.170761; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Chandrangsu P, 2018, ANTIOXID REDOX SIGN, V28, P445, DOI 10.1089/ars.2017.7057; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2013, ANTIOXID REDOX SIGN, V19, P708, DOI 10.1089/ars.2012.4932; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00518; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Ebersoll S, 2018, REDOX BIOL, V15, P532, DOI 10.1016/j.redox.2018.01.011; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; ERIKSSON SA, 1970, FEBS LETT, V7, P26, DOI 10.1016/0014-5793(70)80608-1; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020; Fueller F, 2012, J BIOL CHEM, V287, P8792, DOI 10.1074/jbc.M111.338285; Fyfe PK, 2012, P NATL ACAD SCI USA, V109, P11693, DOI 10.1073/pnas.1202593109; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; GAN ZR, 1987, J BIOL CHEM, V262, P6704; Gao XH, 2010, FEBS LETT, V584, P2242, DOI 10.1016/j.febslet.2010.04.034; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gonzalez-Chavez Z, 2015, BBA-GEN SUBJECTS, V1850, P263, DOI 10.1016/j.bbagen.2014.10.029; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; HENDERSON GB, 1991, P NATL ACAD SCI USA, V88, P8769, DOI 10.1073/pnas.88.19.8769; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; Iversen R, 2010, BIOCHEMISTRY-US, V49, P810, DOI 10.1021/bi9015956; Jao SC, 2006, BIOCHEMISTRY-US, V45, P4785, DOI 10.1021/bi0516327; JENSEN EV, 1959, SCIENCE, V130, P1319, DOI 10.1126/science.130.3385.1319; Jensen KS, 2011, J AM CHEM SOC, V133, P3034, DOI 10.1021/ja1096539; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lundstrom-Ljung J, 1999, FEBS LETT, V443, P85, DOI 10.1016/S0014-5793(98)01698-6; Manta B, 2018, ANTIOXID REDOX SIGN, V28, P463, DOI 10.1089/ars.2017.7133; Manta B, 2013, ANTIOXID REDOX SIGN, V19, P665, DOI 10.1089/ars.2012.4859; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; MIEYAL JJ, 1991, BIOCHEMISTRY-US, V30, P8883, DOI 10.1021/bi00100a023; MOUTIEZ M, 1995, BIOCHEM J, V310, P433, DOI 10.1042/bj3100433; MOUTIEZ M, 1994, CHEM PHARM BULL, V42, P2641; Musunda B, 2015, MOL BIOCHEM PARASIT, V204, P93, DOI 10.1016/j.molbiopara.2016.02.001; NAGAI S, 1968, J BIOL CHEM, V243, P1942; Noguera ME, 2017, SCI REP-UK, V7, DOI 10.1038/srep42343; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Nordstrand K, 1999, FEBS LETT, V449, P196, DOI 10.1016/S0014-5793(99)00401-9; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Portillo-Ledesma S, 2014, BIOCHEMISTRY-US, V53, P6113, DOI 10.1021/bi500389m; RABENSTEIN DL, 1995, BBA-PROTEIN STRUCT M, V1249, P29, DOI 10.1016/0167-4838(95)00067-5; RACKER E, 1955, J BIOL CHEM, V217, P867; Reckenfelderbaumer N, 2002, J BIOL CHEM, V277, P17548, DOI 10.1074/jbc.M112115200; Reyes AM, 2018, ANTIOXID REDOX SIGN, V28, P487, DOI 10.1089/ars.2017.7074; Sagemark J, 2007, PROTEINS, V68, P879, DOI 10.1002/prot.21416; Sardi F, 2013, ANAL BIOCHEM, V435, P74, DOI 10.1016/j.ab.2012.12.017; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Stefani M, 2016, BIOMOL NMR ASSIGN, V10, P85, DOI 10.1007/s12104-015-9643-x; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; TSANG MLS, 1981, J BACTERIOL, V146, P1059, DOI 10.1128/JB.146.3.1059-1066.1981; Ulrich K, 2017, ANTIOXID REDOX SIGN, V27, P517, DOI 10.1089/ars.2016.6947; Van Laer K, 2014, PROTEIN SCI, V23, P238, DOI 10.1002/pro.2397; WILSON JM, 1977, J AM CHEM SOC, V99, P7922, DOI 10.1021/ja00466a027; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zaffagnini M, 2012, ANTIOXID REDOX SIGN, V16, P17, DOI 10.1089/ars.2011.3933; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	84	8	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3235	3248		10.1074/jbc.RA118.006366	http://dx.doi.org/10.1074/jbc.RA118.006366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593501	Green Published, hybrid			2022-12-26	WOS:000464980100021
J	Feng, W; Nakabayashi, N; Narita, K; Inomata, E; Aoki, MN; Agatsuma, Y				Feng, Wenping; Nakabayashi, Nobuyasu; Narita, Kazumi; Inomata, Eri; Aoki, Masakazu N.; Agatsuma, Yukio			Reproduction and population structure of the sea urchin Heliocidaris crassispina in its newly extended range: The Oga Peninsula in the Sea of Japan, northeastern Japan	PLOS ONE			English	Article							HEMICENTROTUS-PULCHERRIMUS; CENTROSTEPHANUS-RODGERSII; ANTHOCIDARIS-CRASSISPINA; STRONGYLOCENTROTUS-DROEBACHIENSIS; GONADAL MATURATION; CLIMATE-CHANGE; KELP BEDS; GROWTH; CYCLE; TEMPERATURE	Ocean warming has facilitated the range expansion of commercially important sea urchin species to higher latitudes. Heliocidaris crassispina was recorded to extend northward to Toga Bay along the Oga Peninsula, Japan following an increase in seawater temperatures, and replacement of local sea urchin species Mesocentrotus nudus. In order to identify evidence of adaptation occurring in response to a range extension of H. crassispina to the newly extended environments, we randomly collected 106 H. crassispina in August 2014 in Toga Bay, determined the growth and age composition and examined gonad traits (size, color and development). To confirm the gonad development, 30 H. crassispina with > 30 mm diameter were collected in July, August and September 2017. We found slower growth in the extended range than the central range. More delayed gonad development of males than those of females and a large variety of developmental stages in the acini of testis indicated that the spawning of both sexes of the sea urchins were asynchronous. In terms of gonad color, L* (lightness) values increased with increasing GI, while b* (yellowness) values decreased with increasing age. The population consisted of seven year-classes from 2006 to 2012, suggesting persistent juvenile recruitment. Long-term water temperature data indicated that the range extension of H. crassispina was due to ocean warming, in particular during the summer spawning season.	[Feng, Wenping; Narita, Kazumi; Inomata, Eri; Aoki, Masakazu N.; Agatsuma, Yukio] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi, Japan; [Nakabayashi, Nobuyasu] Akita Prefectural Inst Fisheries, Oga, Akita, Japan	Tohoku University	Agatsuma, Y (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi, Japan.	yukio.agatsuma.c7@tohoku.ac.jp		Feng, Wenping/0000-0003-1768-8721; Aoki, Masakazu/0000-0003-1951-8400				Agatsuma Y, 2004, J MAR BIOL ASSOC UK, V84, P401, DOI 10.1017/S0025315404009348h; Agatsuma Y, 2005, MAR ECOL-EVOL PERSP, V26, P100, DOI 10.1111/j.1439-0485.2005.00046.x; Agatsuma Y, 2007, J SHELLFISH RES, V26, P629, DOI 10.2983/0730-8000(2007)26[629:NEOGRO]2.0.CO;2; Agatsuma Y, 2013, DEV AQUAC FISH SCI, V38, P461, DOI 10.1016/B978-0-12-396491-5.00030-7; Allee W., 1949, PRINCIPLES ANIMAL EC; Allison E. H., 2005, EFFECTS CLIMATE CHAN, P174; Andrew N.L., 2001, Developments in Aquaculture and Fisheries Science, V32, P149; Azad AK, 2011, AQUACULTURE, V317, P187, DOI 10.1016/j.aquaculture.2011.03.019; Balch T, 2001, ECHINOD ST, V6, P1; BYRNE M, 1990, MAR BIOL, V104, P275, DOI 10.1007/BF01313269; CHIU ST, 1990, B MAR SCI, V47, P94; COCHRAN RC, 1975, BIOL BULL, V148, P393, DOI 10.2307/1540516; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; FIELDS PA, 1993, TRENDS ECOL EVOL, V8, P361, DOI 10.1016/0169-5347(93)90220-J; Fisher R.A., 1930, GENETICAL THEORY SEX; FUJISAWA H, 1989, BIOL BULL, V176, P96, DOI 10.2307/1541576; Guillou M, 1998, AQUACULT INT, V6, P147, DOI 10.1023/A:1009290307840; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HART MW, 1988, MAR BIOL, V99, P167, DOI 10.1007/BF00391978; Hayashi Ikuo, 2000, Bulletin of the Japan Sea National Fisheries Research Institute, V50, P43; Hill NA, 2003, MAR FRESHWATER RES, V54, P691, DOI 10.1071/MF03052; HIMMELMAN JH, 1971, MAR BIOL, V9, P315, DOI 10.1007/BF00372825; Horii T, 1997, NIPPON SUISAN GAKK, V63, P17; Imai T, 1980, RES REP KANAGAWA PRE, V1, P35; Ito Y, 2014, AKITA SAKIGAKE  0814; JENSEN M, 1969, SARSIA, P41; Johnson CR, 2005, 2001044 FRDC U TASM; Kawamura K., 1973, Scientific Rep Hokkaido Fish Exp Stn, VNo. 16, P1; KING CK, 1994, MAR BIOL, V120, P95; Kiyomoto Setuo, 2011, Japanese Journal of Benthology, V66, P48; LAEGDSGAARD P, 1991, MAR BIOL, V110, P359, DOI 10.1007/BF01344355; LARSON RJ, 1980, ECOL MONOGR, V50, P221, DOI 10.2307/1942480; Lawrence J.M., 1982, P331; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Ling SD, 2009, MAR ECOL PROG SER, V374, P113, DOI 10.3354/meps07729; Ling SD, 2008, GLOBAL CHANGE BIOL, V14, P907, DOI 10.1111/j.1365-2486.2008.01543.x; Machiguchi Yuji, 1993, Bulletin of the Hokkaido National Fisheries Research Institute, V57, P81; Meidel SK, 1998, MAR BIOL, V131, P461, DOI 10.1007/s002270050338; Minor MA, 1997, MAR BIOL, V129, P159, DOI 10.1007/s002270050156; Mizuno M, 2015, ASAHI SHIMBUN N 0414; Oshima Y., 1957, SUISANZOSHOKU JPN J, V5, P26; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pecorino D, 2013, MAR BIOL RES, V9, P157, DOI 10.1080/17451000.2012.708046; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Robinson A, 2002, Patent No. [US6338349B1, 6338349]; SAKAIRI K, 1989, ZOOL SCI, V6, P721; Shigei M., 1995, GUIDE SEASHORE ANIMA, VII, P538; Spirlet C., 1998, P835; Stanwell-Smith D, 1998, BIOL BULL-US, V194, P44, DOI 10.2307/1542512; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Tsuji S, 1989, B KYOTO I OCEANIC FI, V12, P15; Tsuji S., 1994, B KYOTO I OCEAN FISH, V17, P51; YAMAMOTO M, 1988, ZOOL SCI, V5, P979; Yamasaki Makoto, 1993, Bulletin of the Seikai National Fisheries Research Institute, V71, P33; Yatsuya K, 2004, FISHERIES SCI, V70, P233, DOI 10.1111/j.1444-2906.2003.00796.x	59	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209858	10.1371/journal.pone.0209858	http://dx.doi.org/10.1371/journal.pone.0209858			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601863	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200061
J	Martin, FN; Zhang, YH; Cooke, DEL; Coffey, MD; Grunwald, NJ; Fry, WE				Martin, Frank N.; Zhang, Yonghong; Cooke, David E. L.; Coffey, Mike D.; Grunwald, Niklaus J.; Fry, William E.			Insights into evolving global populations of Phytophthora infestans via new complementary mtDNA haplotype markers and nuclear SSRs	PLOS ONE			English	Article							IRISH POTATO FAMINE; MITOCHONDRIAL GENOME SEQUENCES; FRAGMENT-LENGTH-POLYMORPHISMS; LATE BLIGHT; GENOTYPIC DIVERSITY; CLONAL LINEAGES; SEXUAL REPRODUCTION; DNA; PATHOGEN; TOMATO	In many parts of the world the damaging potato late blight pathogen, Phytophthora infestans, is spread as a succession of clonal lineages. The discrimination of genetic diversity within such evolving populations provides insights into the processes generating novel lineages and the pathways and drivers of pathogen evolution and dissemination at local and global scales. This knowledge, in turn, helps optimise management practices. Here we combine two key methods for dissecting mitochondrial and nuclear diversity and resolve intra and inter-lineage diversity of over 100 P. infestans isolates representative of key clonal lineages found globally. A novel set of PCR primers that amplify five target regions are provided for mitochondrial DNA sequence analysis. These five loci increased the number of mtDNA haplotypes resolved from four with the PCR RFLP method to 37 (17, 6, 8 and 4 for Ia, Ib, IIa, and IIb haplotypes, respectively, plus 2 Herb-1 haplotypes). As with the PCR RFLP method, two main lineages, I and II were defined. Group I contained 25 mtDNA haplotypes that grouped broadly according to the Ia and Ib types and resolved several sub-clades amongst the global sample. Group II comprised two distinct clusters with four haplotypes corresponding to the RFLP type IIb and eight haplotypes resolved within type IIa. The 12-plex SSR assay revealed 90 multilocus genotypes providing accurate discrimination of dominant clonal lineages and other genetically diverse isolates. Some association of genetic diversity and geographic region of contemporary isolates was observed; US and Mexican isolates formed a loose grouping, distinct from isolates from Europe, South America and other regions. Diversity within clonal lineages was observed that varied according to the age of the clone. In combination, these fine-scale nuclear and maternally inherited mitochondrial markers enabled a greater level of discrimination among isolates than previously available and provided complementary perspectives on evolutionary questions relating to the diversity, phylogeography and the origins and spread of clonal lineages of P. infestans.	[Martin, Frank N.] USDA ARS, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA; [Zhang, Yonghong; Coffey, Mike D.] Univ Calif Riverside, Plant Pathol & Microbiol Dept, Riverside, CA 92521 USA; [Cooke, David E. L.] James Hutton Inst, Dundee, Scotland; [Grunwald, Niklaus J.] USDA ARS, Hort Crops Res Lab, Corvallis, OR USA; [Fry, William E.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Sch Integrat Plant Sci, Ithaca, NY USA	United States Department of Agriculture (USDA); University of California System; University of California Riverside; James Hutton Institute; United States Department of Agriculture (USDA); Cornell University	Martin, FN (corresponding author), USDA ARS, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA.; Cooke, DEL (corresponding author), James Hutton Inst, Dundee, Scotland.	Frank.martin@ars.usda.gov; David.Cooke@hutton.ac.uk	Grunwald, Niklaus` J/K-6041-2013; Cooke, David/D-1933-2012	Grunwald, Niklaus` J/0000-0003-1656-7602; Cooke, David/0000-0002-9154-7954; Martin, Frank/0000-0002-8050-1248	Rural & Environment Science & Analytical Services Division of the Scottish Government; USDA ARS [2072-22000-041-00-D]; USDA National Institute of Food and Agriculture [2011-68004-30154, 2010-511001-21649]	Rural & Environment Science & Analytical Services Division of the Scottish Government; USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	DC acknowledges funding from the Rural & Environment Science & Analytical Services Division of the Scottish Government. NJG was supported by funds from USDA ARS Project 2072-22000-041-00-D and USDA National Institute of Food and Agriculture Grant 2011-68004-30154 and 2010-511001-21649.	Andree K, 2010, MOL ECOL RESOUR, V10, P1098, DOI 10.1111/j.1755-0998.2010.02898.x; Avila-Adame C, 2006, CURR GENET, V49, P39, DOI 10.1007/s00294-005-0016-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Birch PRJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00954; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Blair JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037003; BOURKE PMA, 1964, NATURE, V203, P805, DOI 10.1038/203805a0; Brurberg MB, 2011, FUNGAL BIOL-UK, V115, P335, DOI 10.1016/j.funbio.2011.01.003; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; CARTER DA, 1990, MYCOL RES, V94, P1123, DOI 10.1016/S0953-7562(09)81344-0; Catal M, 2010, CYTOM PART A, V77A, P769, DOI 10.1002/cyto.a.20888; Chmielarz M, 2014, PLANT PATHOL, V63, P203, DOI 10.1111/ppa.12076; Chowdappa P, 2015, PLANT PATHOL, V64, P191, DOI 10.1111/ppa.12228; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Cooke DEL, 2004, PLANT PATHOL, V53, P692, DOI 10.1111/j.1365-3059.2004.01104.x; Danies G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116354; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Flier WG, 2001, PLANT PATHOL, V50, P292, DOI 10.1046/j.1365-3059.2001.00574.x; Forbes GA, 1998, PLANT DIS, V82, P811, DOI 10.1094/PDIS.1998.82.7.811; FORSTER H, 1990, EXP MYCOL, V14, P351, DOI 10.1016/0147-5975(90)90058-2; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Fry WE, 2009, OOMYCETE GENETICS GE, P139; Gavino PD, 2002, MYCOLOGIA, V94, P781, DOI 10.2307/3761693; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; GOODWIN SB, 1992, CURR GENET, V22, P107, DOI 10.1007/BF00351469; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Goss EM, 2014, P NATL ACAD SCI USA, V111, P8791, DOI 10.1073/pnas.1401884111; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; Grunwald NJ, 2011, PLANT DIS, V95, P337, DOI 10.1094/PDIS-08-10-0609; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hamed BH, 2013, PLANT PATHOL, V62, P708, DOI 10.1111/j.1365-3059.2012.02655.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kildea S, 2013, EUR J PLANT PATHOL, V135, P237, DOI 10.1007/s10658-012-0098-y; Knapova G, 2002, PLANT PATHOL, V51, P641, DOI 10.1046/j.1365-3059.2002.00750.x; Knaus BJ, 2016, PHYTOPATHOLOGY, V106, P1393, DOI 10.1094/PHYTO-10-15-0279-R; KOH YJ, 1994, PHYTOPATHOLOGY, V84, P922, DOI 10.1094/Phyto-84-922; Lassiter ES, 2015, CURR GENET, V61, P567, DOI 10.1007/s00294-015-0480-3; Lees AK, 2006, PLANT PATHOL, V55, P311, DOI 10.1111/j.1365-3059.2006.01359.x; Li Y, 2013, PLANT PATHOL, V62, P932, DOI 10.1111/j.1365-3059.2012.02687.x; Li Y, 2012, G3-GENES GENOM GENET, V2, P1529, DOI 10.1534/g3.112.004150; Li Y, 2017, MOL PLANT MICROBE IN, V30, P45, DOI [10.1094/mpmi-08-16-0156-r, 10.1094/MPMI-08-16-0156-R]; Li Y, 2013, J MICROBIOL METH, V92, P316, DOI 10.1016/j.mimet.2012.11.021; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludwig JA, 1988, STAT ECOLOGY; Martin MD, 2016, MOL BIOL EVOL, V33, P478, DOI 10.1093/molbev/msv241; Martin MD, 2014, MOL BIOL EVOL, V31, P1414, DOI 10.1093/molbev/msu086; Martin MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3172; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; NEI M, 1978, GENETICS, V89, P583; Oliva RF, 2010, PLANT PATHOL, V59, P613, DOI 10.1111/j.1365-3059.2010.02287.x; Oliva RF, 2002, PLANT PATHOL, V51, P710, DOI 10.1046/j.1365-3059.2002.00784.x; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Saville AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168381; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shimelash D, 2016, CURR GENET, V62, P657, DOI 10.1007/s00294-016-0572-8; Sjoholm L, 2013, FUNGAL BIOL-UK, V117, P722, DOI 10.1016/j.funbio.2013.08.002; STODDART JA, 1988, GENETICS, V118, P705; Tabima JF, 2016, PEERJ, V4, DOI 10.7717/peerj.2279; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang JN, 2017, MOL ECOL, V26, P1091, DOI 10.1111/mec.14000; Wattier RAM, 2003, MOL ECOL NOTES, V3, P136, DOI 10.1046/j.1471-8286.2003.00378.x; WHITTAKER SL, 1994, MYCOL RES, V98, P569, DOI 10.1016/S0953-7562(09)80481-4; Yang ZH, 2013, J MICROBIOL METH, V95, P117, DOI 10.1016/j.mimet.2013.08.001; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x; Zadoks JC, 2008, POTATO RES, V51, P5, DOI 10.1007/s11540-008-9091-4	78	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208606	10.1371/journal.pone.0208606	http://dx.doi.org/10.1371/journal.pone.0208606			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601865	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200015
J	Norona, LM; Nguyen, DG; Gerber, DA; Presnell, SC; Mosedale, M; Watkins, PB				Norona, Leah M.; Nguyen, Deborah G.; Gerber, David A.; Presnell, Sharon C.; Mosedale, Merrie; Watkins, Paul B.			Bioprinted liver provides early insight into the role of Kupffer cells in TGF-beta 1 and methotrexate-induced fibrogenesis	PLOS ONE			English	Article							INJURY	Hepatic fibrosis develops from a series of complex interactions among resident and recruited cells making it a challenge to replicate using standard in vitro approaches. While studies have demonstrated the importance of macrophages in fibrogenesis, the role of Kupffer cells (KCs) in modulating the initial response remains elusive. Previous work demonstrated utility of 3D bio-printed liver to recapitulate basic fibrogenic features following treatment with fibrosis-associated agents. In the present study, culture conditions were modified to recapitulate a gradual accumulation of collagen within the tissues over an extended exposure timeframe. Under these conditions, KCs were added to the model to examine their impact on the injury/fibrogenic response following cytokine and drug stimuli. A 28-day exposure to 10 ng/mL TGF-beta 1 and 0.209 mu M methotrexate (MTX) resulted in sustained LDH release which was attenuated when KCs were incorporated in the model. Assessment of miR-122 confirmed early hepatocyte injury in response to TGF-beta 1 that appeared delayed in the presence of KCs, whereas MTX-induced increases in miR-122 were observed when KCs were incorporated in the model. Although the collagen responses were mild under the conditions tested to mimic early fibrotic injury, a global reduction in cytokines was observed in the KC-modified tissue model following treatment. Furthermore, gene expression profiling suggests KCs have a significant impact on baseline tissue function over time and an important modulatory role dependent on the context of injury. Although the number of differentially expressed genes across treatments was comparable, pathway enrichment suggests distinct, KC-and time-dependent changes in the transcriptome for each agent. As such, the incorporation of KCs and impact on baseline tissue homeostasis may be important in recapitulating temporal dynamics of the fibrogenic response to different agents.	[Norona, Leah M.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27515 USA; [Norona, Leah M.; Mosedale, Merrie; Watkins, Paul B.] UNC Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA; [Norona, Leah M.; Mosedale, Merrie; Watkins, Paul B.] Univ North Carolina Chapel Hill, Inst Drug Safety Sci, Res Triangle Pk, NC USA; [Nguyen, Deborah G.; Presnell, Sharon C.] Organovo Inc, Res & Dev, San Diego, CA USA; [Gerber, David A.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Presnell, Sharon C.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Norona, Leah M.] Genentech Inc, Safety Assessment, Investigat Toxicol, San Francisco, CA 94080 USA	University of North Carolina; University of North Carolina Chapel Hill; The Hamner Institutes for Health Sciences; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roche Holding; Genentech	Norona, LM (corresponding author), Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27515 USA.; Norona, LM (corresponding author), UNC Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA.; Norona, LM (corresponding author), Univ North Carolina Chapel Hill, Inst Drug Safety Sci, Res Triangle Pk, NC USA.; Norona, LM (corresponding author), Genentech Inc, Safety Assessment, Investigat Toxicol, San Francisco, CA 94080 USA.	noronal@gene.com		Norona, Leah M./0000-0002-3372-2793	National Institutes of Health (NIH), Initiative for Maximizing Student Diversity (IMSD) at University of North Carolina at Chapel Hill [R25 GM055336]; National Institute of Environmental Health Sciences (NIEHS) Toxicology Training Grant [T32 ES007126]; Organovo, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055336] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Initiative for Maximizing Student Diversity (IMSD) at University of North Carolina at Chapel Hill; National Institute of Environmental Health Sciences (NIEHS) Toxicology Training Grant; Organovo, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH), Initiative for Maximizing Student Diversity (IMSD) at University of North Carolina at Chapel Hill [R25 GM055336 to L.M.N.], the National Institute of Environmental Health Sciences (NIEHS) Toxicology Training Grant [T32 ES007126 to L.M.N.], and Organovo, Inc. The content is the authors' own and does not reflect the views of the NIH. The research described in this article has been reviewed by Organovo, Inc., San Diego, and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the Company, nor does the mention of trade names of commercial products constitute endorsement or recommendation for use. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fogel-Petrovic M, 2007, INT IMMUNOPHARMACOL, V7, P1924, DOI 10.1016/j.intimp.2007.07.003; Horvat T, 2017, ARCH TOXICOL, V91, P1523, DOI 10.1007/s00204-016-1814-8; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kia R, 2015, TOXICOL SCI, V144, P173, DOI 10.1093/toxsci/kfu269; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Krenkel O, 2017, NAT REV IMMUNOL; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Landesmann B, 2016, ADVERSE OUTCOME PATH; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Miousse IR, 2017, FOOD CHEM TOXICOL, V109, P194, DOI 10.1016/j.fct.2017.08.025; Nguyen DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158674; Norona LM, 2016, TOXICOL SCI, V154, P354, DOI 10.1093/toxsci/kfw169; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sziksz E, 2015, MEDIAT INFLAMM, V2015, P15; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025	22	33	37	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208958	10.1371/journal.pone.0208958	http://dx.doi.org/10.1371/journal.pone.0208958			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601836	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200028
J	Schmid, F; Malinovska, A; Weigel, K; Bosia, T; Nickel, CH; Bingisser, R				Schmid, Fabrizia; Malinovska, Alexandra; Weigel, Karin; Bosia, Tito; Nickel, Christian H.; Bingisser, Roland			Construct validity of acute morbidity as a novel outcome for emergency patients	PLOS ONE			English	Article							VALIDATION; ADMISSION; SEVERITY; TOOLS; DEATH; CARE	Objectives Validation of acute morbidity as a novel outcome in emergency medicine. Methods Construct validity of acute morbidity was established by comparison to other outcomes using linear and logistic regression models. Results Data of 4608 patients were analysed. 1869 patients (40.6%) fulfilled the criteria for acute morbidity. Using multivariate analyses, acute morbidity was associated with outcomes such as hospitalisation (OR: 11, 95%-CI 9-13), mortality (OR 15, 95%-CI 6-49), and ICU admission (OR: 46, 95%-CI 25-96). Reliability of the construct "acute morbidity" was estimated using Cohens Kappa, which was 0.96 for intra-rater and 0.94 for inter-rater reliability. Conclusion Reliability of the framework for acute morbidity was high. Construct validity was shown by associations with hospitalisation, mortality, and ICU admission.	[Schmid, Fabrizia; Bosia, Tito; Nickel, Christian H.; Bingisser, Roland] Univ Hosp Basel, Emergency Dept, Basel, Switzerland; [Malinovska, Alexandra] Univ Hosp Basel, Dept Internal Med, Basel, Switzerland; [Weigel, Karin] Joint Practice Boettcher & Hoeller, Laufenburg, Germany	University of Basel; University of Basel	Schmid, F; Bingisser, R (corresponding author), Univ Hosp Basel, Emergency Dept, Basel, Switzerland.	fabrizia.schmid@usb.ch; roland.bingisser@usb.ch		Malinovska, Alexandra/0000-0003-4768-5556				Anneveld M, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-21; Bardelli P, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13760; Becker JB, 2015, REV ESC ENFERM USP, V49, P779, DOI 10.1590/S0080-623420150000500011; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chotirmall SH, 2014, INTERN MED J, V44, P546, DOI 10.1111/imj.12440; Conway R, 2015, EUR J INTERN MED, V26, P12, DOI 10.1016/j.ejim.2014.12.013; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; George F, 2015, HLTH SCI J; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Gilboy N, 2012, IMPLEMENTATION HDB; Graham CA, 2015, CHANGING FACE EMERGE; Grossmann FF, 2011, ANN EMERG MED, V57, P257, DOI 10.1016/j.annemergmed.2010.07.021; Hung KKC, 2017, EUR J EMERG MED, V24, P1, DOI 10.1097/MEJ.0000000000000443; Hunter AEL, 2016, J GEN INTERN MED, V31, P37, DOI 10.1007/s11606-015-3438-8; Ibrahim I, 2013, SINGAP MED J, V54, P634; Kellett J, 2016, EUR J INTERN MED, V32, pE11, DOI 10.1016/j.ejim.2016.03.014; Kong GL, 2015, INJURY, V46, P1784, DOI 10.1016/j.injury.2015.06.002; LaMantia MA, 2010, ACAD EMERG MED, V17, P252, DOI 10.1111/j.1553-2712.2009.00675.x; Mehra T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140874; Misch F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098097; MUSHLIN AI, 1976, AM J PUBLIC HEALTH, V66, P170, DOI 10.2105/AJPH.66.2.170; Nemec M, 2010, ACAD EMERG MED, V17, P284, DOI 10.1111/j.1553-2712.2009.00658.x; O'Sullivan E, 2012, Acute Med, V11, P59; Rohacek M, 2015, INT J CLIN PRACT, V69, P710, DOI 10.1111/ijcp.12606; Schull MJ, 2007, ANN EMERG MED, V49, P257, DOI 10.1016/j.annemergmed.2006.06.027; Wiswell J, 2013, AM J EMERG MED, V31, P1448, DOI 10.1016/j.ajem.2013.07.018; Worster A, 2005, ANN EMERG MED, V45, P448, DOI 10.1016/j.annemergmed.2004.11.021	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0207906	10.1371/journal.pone.0207906	http://dx.doi.org/10.1371/journal.pone.0207906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601812	Green Published, gold, Green Submitted			2022-12-26	WOS:000454683200005
J	Zelis, N; Mauritz, AN; Kuijpers, LIJ; Buijs, J; de Leeuw, PW; Stassen, PM				Zelis, Noortje; Mauritz, Arisja N.; Kuijpers, Lonne I. J.; Buijs, Jacqueline; de Leeuw, Peter W.; Stassen, Patricia M.			Short-term mortality in older medical emergency patients can be predicted using clinical intuition: A prospective study	PLOS ONE			English	Article							SELF-RATED HEALTH; MORBIDITY; ILLNESS; ADULTS	Background Older emergency department (ED) patients are at risk for adverse outcomes, however, it is hard to predict these. We aimed to assess the discriminatory value of clinical intuition, operationalized as disease perception, self-rated health and first clinical impression, including the 30-day surprise question (SQ: "Would I be surprised if this patient died in the next 30 days" of patients, nurses and physicians. Endpoints used to evaluate the discriminatory value of clinical intuition were short-term (30-day) mortality and other adverse outcomes (intensive/medium care admission, prolonged length of hospital stay, loss of independent living or 30-day readmission). Methods In this prospective, multicentre cohort study, older medical patients (>= 65 years), nurses and physicians filled in scores regarding severity of illness and their concerns (i.e. disease perception and clinical impression scores) immediately after arrival of the patient in the ED. In addition, patients filled in a self-rated health score and nurses and physicians answered the SQ. Area under the curves (AUCs) of receiver operating characteristics (ROCs) were calculated. Results The median age of the 602 included patients was 79 years and 86.7% were community dwelling. Within 30 days, 66 (11.0%) patients died and 263 (43.7%) patients met the composite endpoint. The severity of concern score of both nurses and physicians yielded the highest AUCs for 30-day mortality (for both 0.75; 95% CI 0.68-0.81). AUCs for the severity of illness score and SQ of nurses and physicians ranged from 0.71 to 0.74 while those for the disease perception and self-rated health of patients ranged from 0.64 to 0.69. The discriminatory value of the scores for the composite endpoint was lower (AUCs ranging from 0.60 to 0.67). We used scores that have not been previously validated which could influence their generalisability. Conclusion Clinical intuition,-disease perception, self-rated health and first clinical impression-documented at an early stage after arrival in the ED, is a useful clinical tool to predict mortality and other adverse outcomes in older ED patients. Highest discriminatory values were found for the nurses' and physicians' severity of concern score. Intuition may be helpful for the implementation of personalised medical care in the future.	[Zelis, Noortje; Kuijpers, Lonne I. J.; Buijs, Jacqueline; de Leeuw, Peter W.] Zuyderland Med Ctr, Dept Internal Med & Gastroenterol, Heerlen, Netherlands; [Zelis, Noortje; de Leeuw, Peter W.] Maastricht Univ, Maastricht Univ Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Mauritz, Arisja N.; de Leeuw, Peter W.; Stassen, Patricia M.] Maastricht Univ, Maastricht Univ Med Ctr, Sect Acute Med, Dept Internal Med,Div Gen Internal Med, Maastricht, Netherlands; [Stassen, Patricia M.] Maastricht Univ, Maastricht Univ Med Ctr, Sch CAPHRI, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Zelis, N (corresponding author), Zuyderland Med Ctr, Dept Internal Med & Gastroenterol, Heerlen, Netherlands.; Zelis, N (corresponding author), Maastricht Univ, Maastricht Univ Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	n.zelis@zuyderland.nl		Zelis, Noortje/0000-0003-0015-5240	Zuyderland MC	Zuyderland MC	Noortje Zelis was funded by Zuyderland MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Bamia C, 2017, MATURITAS, V103, P37, DOI 10.1016/j.maturitas.2017.06.023; Beglinger B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000374; Brabrand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101739; Buurman BM, 2008, J GEN INTERN MED, V23, P1883, DOI 10.1007/s11606-008-0741-7; Carpenter CR, 2015, ACAD EMERG MED, V22, P1, DOI 10.1111/acem.12569; CHARLSON ME, 1986, J CHRON DIS, V39, P439, DOI 10.1016/0021-9681(86)90111-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Downar J, 2017, CAN MED ASSOC J, V189, pE484, DOI 10.1503/cmaj.160775; Godard-Sebillotte C, 2016, QUAL LIFE RES, V25, P2335, DOI 10.1007/s11136-016-1252-3; Grossmann FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106203; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Hamano J, 2015, ONCOLOGIST, V20, P839, DOI 10.1634/theoncologist.2015-0015; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Rohacek M, 2015, INT J CLIN PRACT, V69, P710, DOI 10.1111/ijcp.12606; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Simundic Ana-Maria, 2009, EJIFCC, V19, P203; Sinuff T, 2006, CRIT CARE MED, V34, P878, DOI 10.1097/01.CCM.0000201881.58644.41; van der Vegt AE, 2012, EUR J EMERG MED, V19, P373, DOI 10.1097/MEJ.0b013e32834def59; White N, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0907-4; *WHO, 2004, ICD 10 INT STAT CLAS, V2; Wong DD, 2007, EMERG MED AUSTRALAS, V19, P196, DOI 10.1111/j.1742-6723.2007.00924.x	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208741	10.1371/journal.pone.0208741	http://dx.doi.org/10.1371/journal.pone.0208741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601815	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200021
J	De La Fuente, G; Chiantore, M; Gaino, F; Asnaghi, V				De La Fuente, Gina; Chiantore, Mariachiara; Gaino, Federico; Asnaghi, Valentina			Ecological status improvement over a decade along the Ligurian coast according to a macroalgae based index (CARLIT)	PLOS ONE			English	Article							ROCKY-SHORE COMMUNITIES; NUTRIENT ENRICHMENT; QUALITY; SEA; CLASSIFICATION; AREA; VARIABILITY; ROBUSTNESS; ECOSYSTEMS; INDICATORS	According to the Water Framework Directive, within 2015 European Union countries must reach and maintain the "good" Ecological Status (ES), quantified through indices based on key biological elements as indicators. Along the Ligurian shallow rocky coasts (NW Italy), a macroalgae based index (CARtography of LITtoral and upper-sublittoral benthic communities, CARLIT), calibrated according to national characteristics and management needs, has been applied by the Regional Environmental Agency over the last ten years. In 2015, at least a "good" ES was achieved in all Ligurian water bodies except one, located in the Eastern Ligurian coastline, characterized by the lack of the most sensitive species, Cystoseira amentacea var. stricta. A general ES improvement has been observed along the Ligurian coastline, also in comparison with other quality indices (macroinvertebrates and fecal bacteria), and in particular in the Genoa water body, as proved by a relevant increase of C. amentacea abundance, probably as a consequence of enhancement in wastewater treatments. In the present study, the reliability of the observed improvement of the ES over a decade has been assessed, teasing apart intra-seasonal and operator-related variability. These results support the reliability of monitoring procedures carried out though the CARLIT Index and highlight the need and the effectiveness of reduction measures for anthropogenic impacts in order to achieve the ES required by European directives.	[De La Fuente, Gina; Chiantore, Mariachiara; Asnaghi, Valentina] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita DISTAV, Genoa, Italy; [Chiantore, Mariachiara; Asnaghi, Valentina] CoNISMa, Rome, Italy; [Gaino, Federico] ARPAL, Genoa, Italy	University of Genoa; CoNISMa	De La Fuente, G (corresponding author), Univ Genoa, Dipartimento Sci Terra Ambiente & Vita DISTAV, Genoa, Italy.	gina.delafuente@edu.unige.it	Asnaghi, Valentina/AFT-8900-2022; Chiantore, Mariachiara/C-7070-2017	Chiantore, Mariachiara/0000-0002-5862-1470; De La Fuente, Gina/0000-0003-1222-9091; Asnaghi, Valentina/0000-0003-1659-2613	LIFE Programme [LIFE16 NAT/IT/000816]; University of Genoa; Ligurian Environmental Agency (ARPAL)	LIFE Programme; University of Genoa; Ligurian Environmental Agency (ARPAL)	The present work is a contribution to the project ROC-POP LIFE, Promoting biodiversity enhancement by Restoration Of Cystoseira POPulations (LIFE16 NAT/IT/000816), funded by LIFE Programme. This work was supported by the University of Genoa and the Ligurian Environmental Agency (ARPAL).; This work was supported by the University of Genoa and the Ligurian Environmental Agency (ARPAL). Authors thank all colleagues and students who helped in the field and during sample processing. Authors thank also IRETI S.p.A. for the precious information provided about intervention on sewage treatment. The present work is a contribution to the project ROC-POP LIFE, Promoting biodiversity enhancement by Restoration Of Cystoseira POPulations (LIFE16 NAT/IT/000816), funded by LIFE Programme.	Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; Akcali I, 2011, MAR POLLUT BULL, V62, P637, DOI 10.1016/j.marpolbul.2010.12.021; [Anonymous], [No title captured]; Arevalo R, 2007, MAR POLLUT BULL, V55, P104, DOI 10.1016/j.marpolbul.2006.08.023; Asnaghi V, 2009, MAR ECOL-EVOL PERSP, V30, P505, DOI 10.1111/j.1439-0485.2009.00346.x; Badreddine A, 2018, ECOL INDIC, V85, P37, DOI 10.1016/j.ecolind.2017.10.006; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Bennett S, 2011, MAR POLLUT BULL, V62, P1616, DOI 10.1016/j.marpolbul.2011.06.016; Bermejo R, 2013, MAR POLLUT BULL, V72, P107, DOI 10.1016/j.marpolbul.2013.04.011; Blanfune A, 2017, ECOL INDIC, V72, P249, DOI 10.1016/j.ecolind.2016.07.049; Blanfune A, 2016, MAR POLLUT BULL, V109, P409, DOI 10.1016/j.marpolbul.2016.05.041; Blanfune A, 2011, EUR J PHYCOL, V46, P173; Buia M.C., 2007, P 3 MED S MAR VEG MA, P253; Bulleri F, 2002, J EXP MAR BIOL ECOL, V267, P89, DOI 10.1016/S0022-0981(01)00361-6; Cavallo M, 2016, MAR POLLUT BULL, V102, P122, DOI 10.1016/j.marpolbul.2015.11.047; Chakraborty S, 2014, ECOTOX ENVIRON SAFE, V100, P61, DOI 10.1016/j.ecoenv.2013.12.003; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Clarke RT, 2006, HYDROBIOLOGIA, V566, P477, DOI 10.1007/s10750-006-0076-5; Diez I, 1999, MAR POLLUT BULL, V38, P463, DOI 10.1016/S0025-326X(98)90161-8; Diez I, 2009, EUR J PHYCOL, V44, P1, DOI 10.1080/09670260802158642; FERRIGNO F, 2014, BIOL MAR MEDITERR, V21, P257; Flo E, 2011, WG365INF7 UNEPDEPI M, P37; Gasparini GP, 2009, J MARINE SYST, V78, pS48, DOI 10.1016/j.jmarsys.2009.01.010; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Johnson LE, 1998, OECOLOGIA, V117, P517, DOI 10.1007/s004420050688; Juanes JA, 2008, ECOL INDIC, V8, P351, DOI 10.1016/j.ecolind.2007.04.005; Krause-Jensen D, 2007, MAR POLLUT BULL, V55, P114, DOI 10.1016/j.marpolbul.2006.08.019; Lasinio GJ, 2017, ECOL INDIC, V73, P293, DOI 10.1016/j.ecolind.2016.09.038; Lin DT, 2008, MAR POLLUT BULL, V56, P245, DOI 10.1016/j.marpolbul.2007.09.031; LITTLER MM, 1975, MAR BIOL, V30, P277, DOI 10.1007/BF00390633; Mangialajo L., 2008, QUADERNO METODOLOGIC, V105; Mangialajo L, 2007, MAR POLLUT BULL, V55, P30, DOI 10.1016/j.marpolbul.2006.08.022; Mangialajo L, 2012, J EXP MAR BIOL ECOL, V412, P72, DOI 10.1016/j.jembe.2011.10.031; Mascaro O, 2013, HYDROBIOLOGIA, V704, P279, DOI 10.1007/s10750-012-1426-0; Nikolic V, 2013, ECOL INDIC, V34, P87, DOI 10.1016/j.ecolind.2013.04.021; Omrane A., 2010, RAC SPA PUBL, P204; Orfanidis S., 2001, MEDITERRANEAN MARINE, V2, P45, DOI [DOI 10.12681/MMS.266, 10.12681/mms.266]; Panayotidis P, 1999, ESTUAR COAST SHELF S, V48, P205, DOI 10.1006/ecss.1998.0411; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; Rende F, 2011, 21 C SOC IT EC OCT 3; Salas F, 2006, OCEAN COAST MANAGE, V49, P308, DOI 10.1016/j.ocecoaman.2006.03.001; Sfriso A, 2011, ECOL INDIC, V11, P772, DOI 10.1016/j.ecolind.2010.10.002; Susini M-L., 2006, THESIS	44	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0206826	10.1371/journal.pone.0206826	http://dx.doi.org/10.1371/journal.pone.0206826			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596657	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200009
J	Hellequin, E; Monard, C; Quaiser, A; Henriot, M; Klarzynski, O; Binet, F				Hellequin, Eve; Monard, Cecile; Quaiser, Achim; Henriot, Morgane; Klarzynski, Olivier; Binet, Francoise			Specific recruitment of soil bacteria and fungi decomposers following a biostimulant application increased crop residues mineralization	PLOS ONE			English	Article							MICROBIAL BIOMASS; AGRICULTURAL BIOSTIMULANTS; COMMUNITY STRUCTURE; ORGANIC-MATTER; CARBON; PH; DIVERSITY; GROWTH; IDENTIFICATION; DYNAMICS	Agriculture is undergoing important changes in order to meet sustainable soil management with respect to biodiversity (namely agroecology). Within this context, alternative solutions to mineral fertilizers such as agricultural biostimulants are thus promoted and being developed. The mechanisms by which some soil biostimulants sustain soil biological functioning and indirectly increase crop yields are still unknown. Our goal in the present study was to demonstrate if and to what extent the application of a soil biostimulant affects the soil heterotrophic microbial communities that are involved in organic matter decomposition and carbon mineralization. We hypothesized that the addition of a biostimulant results in changes in the composition and in the biomass of soil microbial communities. This in turn increases the mineralization of the organic matter derived from crop residues. We performed soil microcosm experiments with the addition of crop residues and a biostimulant, and we monitored the organic carbon (orgC) mineralization and the microbial biomass, along with the microbial community composition by sequencing 16S rRNA gene and ITS amplicons. The addition of a soil biostimulant caused a pH neutralizing effect and simultaneous enhancement of the orgC mineralization of crop residues (+ 400 mu g orgC g(-1) dry soil) and microbial biomass (+ 60 mu g orgC g(-1) dry soil) that were linked to changes in the soil microbial communities. Our findings suggest that the soil carbon mineralization enhancement in the presence of the biostimulant was supported by the specific recruitment of soil bacteria and fungi. Whereas archaea remained stable, several operational taxonomic units (OTUs) of indigenous soil bacteria and fungi were enriched and affiliated with known microbial decomposers such as Cytophagaceae, Phaselicystis sp., Verrucomicrobia, Pseudomonas sp., Ramicandelaber sp., and Mortierella sp., resulting in lower soil microbial richness and diversity.	[Hellequin, Eve; Monard, Cecile; Quaiser, Achim; Binet, Francoise] Univ Rennes, CNRS, ECOBIO Ecosyst Biodiversite Evolut, UMR 6553, Rennes, France; [Hellequin, Eve; Henriot, Morgane; Klarzynski, Olivier] BIO3G Co, Merdrignac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Hellequin, E; Binet, F (corresponding author), Univ Rennes, CNRS, ECOBIO Ecosyst Biodiversite Evolut, UMR 6553, Rennes, France.; Hellequin, E (corresponding author), BIO3G Co, Merdrignac, France.	eve.hellequin@univ-rennes1.fr; francoise.binet@univ-rennes1.fr		Hellequin, Eve/0000-0001-9629-2316	Agence nationale de reglementation des telecommunications (ANRT) [2016/0091]; CBB Capbiotek program of the Brittany region; "Association Nationale de la Recherche et de la Technologies" (ANRT) [2016 / 0091]	Agence nationale de reglementation des telecommunications (ANRT)(French National Research Agency (ANR)); CBB Capbiotek program of the Brittany region; "Association Nationale de la Recherche et de la Technologies" (ANRT)(French National Research Agency (ANR))	This research was supported by: the "Agence nationale de reglementation des telecommunications (ANRT) through an industrial CIFRE convention between the BIO3G Company and the University of Rennes (Number of convention No 2016/0091, http://www.anrt.asso.fr/fr/cifre-7843, E. Hellequin) and by the CBB Capbiotek program of the Brittany region (http://www.cbb-developpement.com/) F. Binet, C. Monard, O. Klarzynski. The Bio3G SAS provided support in the form of salary for Eve Hellequin. Morgane Henriot and Olivier Klarzynski did the study design and the soil samples collection. Eve Hellequin, Cecile Monard and Francoise Binet took part in the analyses, the data collection and exploitation and the paper writing.r This research was supported by the "Association Nationale de la Recherche et de la Technologies" (ANRT) through an industrial CIFRE convention between the BIO3G Company and the University of Rennes1 (Number of convention No 2016 / 0091, http:// www.anrt.asso.fr/fr/cifre-7843, E. Hellequin) to F. Binet and O. Klarzynski and by the CBB Capbiotek program of the Brittany region (http://www.cbb-developpement.com/) to C. Monard. The authors thank the manager of the Jailliere site, willing to provide the BIO3G company with the field access and soil collection. Special thanks to Kevin Potard and Nathan Vannier for statistical advice, Sophie Michon-Coudouel and Marine Biget from the GEH Platform for assisting with the DNA extraction and library construction and Nathalie Le Bris for the microbial carbon biomass measurements. The authors are also grateful to the editor and anonymous reviewers for improving the manuscript and to Sara Mullin for her support in the English editing.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2013, 16S METAGENMOIC SEQU; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Billard V, 2014, J PLANT GROWTH REGUL, V33, P305, DOI 10.1007/s00344-013-9372-2; BINGEMAN C. W., 1953, Proceedings. Soil Science Society of America, V17, P34; Blagodatskaya E, 2011, SOIL BIOL BIOCHEM, V43, P778, DOI 10.1016/j.soilbio.2010.12.011; Bowles TM, 2014, SOIL BIOL BIOCHEM, V68, P252, DOI 10.1016/j.soilbio.2013.10.004; Calvo P, 2014, PLANT SOIL, V383, P3, DOI [10.1007/s11104-014-2131-8, 10.1109/BigData.2014.7004461]; Carter MR, 2008, CANADIAN SOCIETY OF; Chen HH, 2015, MICROB ECOL, V69, P180, DOI 10.1007/s00248-014-0488-0; Chen SK, 2003, SOIL BIOL BIOCHEM, V35, P9, DOI 10.1016/S0038-0717(02)00209-2; Chen SK, 2002, APPL SOIL ECOL, V19, P249, DOI 10.1016/S0929-1393(02)00002-1; Coppens F, 2007, SOIL BIOL BIOCHEM, V39, P2339, DOI 10.1016/j.soilbio.2007.04.005; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Farrell M, 2014, SOIL BIOL BIOCHEM, V77, P261, DOI 10.1016/j.soilbio.2014.07.003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Garcia, 2014, PROKARYOTES, P239, DOI DOI 10.1007/978-3-642-39044-9_307; Garcia-Martinez AM, 2010, PROCESS BIOCHEM, V45, P1127, DOI 10.1016/j.procbio.2010.04.005; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gweon HS, 2015, METHODS ECOL EVOL, V6, P973, DOI 10.1111/2041-210X.12399; Hanson CA, 2008, ECOSYSTEMS, V11, P1157, DOI 10.1007/s10021-008-9186-4; Helgason BL, 2014, SOIL BIOL BIOCHEM, V68, P231, DOI 10.1016/j.soilbio.2013.10.002; Hoyle FC, 2008, BIOL FERT SOILS, V44, P571, DOI 10.1007/s00374-007-0237-3; Hu HW, 2013, J SOIL SEDIMENT, V13, P1439, DOI 10.1007/s11368-013-0726-y; Ishii T., 2000, P 9 INT SOC CITR CUL, P1030; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Khan W, 2009, J PLANT GROWTH REGUL, V28, P386, DOI 10.1007/s00344-009-9103-x; Kjoller AH, 2002, BOOK SOIL P, P267; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kocira S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00388; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Liu SW, 2016, GCB BIOENERGY, V8, P392, DOI 10.1111/gcbb.12265; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Maini P., 2006, FERTILITAS AGRORUM, V1, P29; Garcia-Martinez AM, 2010, J AGR FOOD CHEM, V58, P9697, DOI 10.1021/jf101289n; McBride M.J., 2014, PROKARYOTES OTHER MA, P577, DOI DOI 10.1007/978-3-642-38954-2_382; Miltner A, 2004, ORG GEOCHEM, V35, P1015, DOI 10.1016/j.orggeochem.2004.05.001; Monard C, 2008, APPL ENVIRON MICROB, V74, P5589, DOI 10.1128/AEM.00333-08; Moorhead DL, 2000, APPL SOIL ECOL, V14, P71, DOI 10.1016/S0929-1393(99)00043-8; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Niemenmaa O, 2008, BIODEGRADATION, V19, P555, DOI 10.1007/s10532-007-9161-3; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; Ogawa Y, 2001, RAMICANDELABER NEW G, P193; Padmanabhan P, 2003, APPL ENVIRON MICROB, V69, P1614, DOI 10.1128/AEM.69.3.1614-1622.2003; Parrado J, 2008, BIORESOURCE TECHNOL, V99, P2312, DOI 10.1016/j.biortech.2007.05.029; Pascault N, 2013, ECOSYSTEMS, V16, P810, DOI 10.1007/s10021-013-9650-7; Quaiser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102561; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Redin M, 2014, SOIL BIOL BIOCHEM, V78, P65, DOI 10.1016/j.soilbio.2014.07.014; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Shahbaz M, 2017, BIOL FERT SOILS, V53, P287, DOI 10.1007/s00374-016-1174-9; Sharp RG, 2013, AGRONOMY-BASEL, V3, P757, DOI 10.3390/agronomy3040757; Siwik-Ziomek A, 2018, ACTA AGR SCAND B-S P, V68, P50, DOI 10.1080/09064710.2017.1358762; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Szczepanek M, 2017, ACTA AGR SCAND B-S P, V67, P334, DOI 10.1080/09064710.2017.1278783; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tejada M, 2011, APPL SOIL ECOL, V49, P11, DOI 10.1016/j.apsoil.2011.07.009; van Leeuwen JP, 2017, EUR J SOIL BIOL, V79, P14, DOI 10.1016/j.ejsobi.2017.02.001; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang XQ, 2015, APPL ENVIRON MICROB, V81, P4607, DOI 10.1128/AEM.00055-15; WARCUP J. H., 1951, TRANS BRIT MYCOL SOC, V34, P376; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wezel A, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P27, DOI 10.1007/978-94-007-0394-0_3; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yamanaka T, 2003, MYCOLOGIA, V95, P584, DOI 10.2307/3761934; Yelle DJ, 2008, ENVIRON MICROBIOL, V10, P1844, DOI 10.1111/j.1462-2920.2008.01605.x; Yokoya NS, 2010, J PHYCOL, V46, P1198, DOI 10.1111/j.1529-8817.2010.00898.x; Zhang HS, 2011, BIOL FERT SOILS, V47, P543, DOI 10.1007/s00374-011-0563-3; Zhang YT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01325	82	14	14	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209089	10.1371/journal.pone.0209089	http://dx.doi.org/10.1371/journal.pone.0209089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596675	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200028
J	Salguero-Jimenez, A; Grego-Bessa, J; D'Amato, G; Jimenez-Borreguero, LJ; de la Pompa, JL				Salguero-Jimenez, Alejandro; Grego-Bessa, Joaquim; D'Amato, Gaetano; Jimenez-Borreguero, Luis J.; de la Pompa, Jose Luis			Myocardial Notch1-Rbpj deletion does not affect NOTCH signaling, heart development or function	PLOS ONE			English	Article							CARDIAC DEVELOPMENT; ENDOCARDIAL CUSHION; MAMMALIAN HEART; PATHWAY; PROTEIN; REVEALS; BINDING; MICE; CARDIOMYOCYTES; MORPHOGENESIS	During vertebrate cardiac development NOTCH signaling activity in the endocardium is essential for the crosstalk between endocardium and myocardium that initiates ventricular trabeculation and valve primordium formation. This crosstalk leads later to the maturation and compaction of the ventricular chambers and the morphogenesis of the cardiac valves, and its alteration may lead to disease. Although endocardial NOTCH signaling has been shown to be crucial for heart development, its physiological role in the myocardium has not been clearly established. Here we have used mouse genetics to evaluate the role of NOTCH in myocardial development. We have inactivated the unique and ubiquitous NOTCH effector RBPJ in early cardiomyocytes progenitors, and examined its consequences in cardiac development and function. Our results show that mice with Tnnt2-Cre-mediated myocardial-specific deletion of Rbpj develop to term, with homozygous mutant animals showing normal expression of cardiac development markers, and normal adult heart function. Similar observations have been obtained after Notch1 deletion with Tnnt2-Cre. We have also deleted Rbpj in both myocardial and endocardial progenitor cells, using the Nkx2.5-Cre driver, resulting in ventricular septal defect (VSD), double outlet right ventricle (DORV), and bicuspid aortic valve (BAV), due to NOTCH signaling abrogation in the endocardium of cardiac valves. Our data demonstrate that NOTCH-RBPJ inactivation in the myocardium does not affect heart development or adult cardiac function.	[Salguero-Jimenez, Alejandro; Grego-Bessa, Joaquim; D'Amato, Gaetano; de la Pompa, Jose Luis] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Intercellular Signaling Cardiovasc Dev & Dis Lab, Madrid, Spain; [Salguero-Jimenez, Alejandro; Grego-Bessa, Joaquim; D'Amato, Gaetano; de la Pompa, Jose Luis] CIBER CV, Madrid, Spain; [D'Amato, Gaetano] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Jimenez-Borreguero, Luis J.] Hosp La Princesa, Inst Invest Sanitaria, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Stanford University	de la Pompa, JL (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Intercellular Signaling Cardiovasc Dev & Dis Lab, Madrid, Spain.; de la Pompa, JL (corresponding author), CIBER CV, Madrid, Spain.	jlpompa@cnic.es	De La Pompa, José Luis/F-9719-2014; D'Amato, Gaetano/Q-3141-2019; Grego-Bessa, Joaquim/F-4398-2010; D'Amato, Gaetano/S-1847-2019; Jimenez-Borreguero, Luis Jesus/L-8107-2014	De La Pompa, José Luis/0000-0001-6761-7265; D'Amato, Gaetano/0000-0003-2640-5826; Grego-Bessa, Joaquim/0000-0002-0938-2346; Salguero-Jimenez, Alejandro/0000-0001-6816-8983; Jimenez-Borreguero, Luis Jesus/0000-0001-5870-237X	Spanish Ministry of Science, Innovation and Universities (MCIU) [SAF2016-78370-R, CB16/11/00399, RD16/0011/0021]; Fundacion BBVA [BIO14_298]; Fundacion La Marato [20153431]; Ministerio de Educacion, Cultura y Deporte of Spain; Programa de Atraccion de Talento of the Comunidad de Madrid [2016T1/BMD1540]; FEDER funds; MEIC; Pro-CNIC Foundation	Spanish Ministry of Science, Innovation and Universities (MCIU); Fundacion BBVA(BBVA Foundation); Fundacion La Marato; Ministerio de Educacion, Cultura y Deporte of Spain; Programa de Atraccion de Talento of the Comunidad de Madrid; FEDER funds(European Commission); MEIC; Pro-CNIC Foundation	This study was funded by grants SAF2016-78370-R, CB16/11/00399 (CIBER CV) and RD16/0011/0021 (TERCEL) from the the Spanish Ministry of Science, Innovation and Universities (MCIU) and grants from the Fundacion BBVA (Ref.: BIO14_298) and Fundacion La Marato (Ref.: 20153431) to JLDLP. AS-J holds a FPU fellowship from the Ministerio de Educacion, Cultura y Deporte of Spain. JG-B is funded by the Programa de Atraccion de Talento of the Comunidad de Madrid (2016T1/BMD1540). The cost of this publication was supported in part with FEDER funds. The CNIC (https://www.cnic.es/en) is supported by the MEIC and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Benedito R, 2013, EXP CELL RES, V319, P1281, DOI 10.1016/j.yexcr.2013.01.010; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; D'Amato G, 2016, FEBS J, V283, P4223, DOI 10.1111/febs.13773; D'Amato G, 2016, NAT CELL BIOL, V18, P7, DOI 10.1038/ncb3280; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; del Monte-Nieto G, 2018, NATURE, V557, P439, DOI 10.1038/s41586-018-0110-6; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Diaz-Trelles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12088; Eley L, 2018, ELIFE, V7, DOI 10.7554/eLife.34110; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Galderisi Maurizio, 2005, Cardiovasc Ultrasound, V3, P9; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Grego-Bessa J, 2004, CELL CYCLE, V3, P718; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; He LJ, 2014, J CELL MOL MED, V18, P2152, DOI 10.1111/jcmm.12415; High Frances, 2007, Novartis Found Symp, V283, P152; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Jain R, 2011, J CLIN INVEST, V121, P422, DOI 10.1172/JCI44244; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Kratsios P, 2010, CIRC RES, V106, P559, DOI 10.1161/CIRCRESAHA.109.203034; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Loomes KM, 2002, AM J MED GENET, V112, P181, DOI 10.1002/ajmg.10592; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Luxan G, 2016, CIRC RES, V118, pE1, DOI 10.1161/CIRCRESAHA.115.305350; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; MacGrogan D, 2016, CIRC RES, V118, P1480, DOI 10.1161/CIRCRESAHA.115.308077; MacGrogan D, 2011, BIRTH DEFECTS RES A, V91, P449, DOI 10.1002/bdra.20815; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nowotschin S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-15; OKA C, 1995, DEVELOPMENT, V121, P3291; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rentschler S, 2012, CIRCULATION, V126, P1058, DOI 10.1161/CIRCULATIONAHA.112.103390; Rones MS, 2000, DEVELOPMENT, V127, P3865; Saga Y, 1999, DEVELOPMENT, V126, P3437; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Stanley EG, 2002, INT J DEV BIOL, V46, P431; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tomanek RJ, 2002, DEV DYNAM, V225, P233, DOI 10.1002/dvdy.10158; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; VanDusen NJ, 2014, CELL REP, V9, P2071, DOI 10.1016/j.celrep.2014.11.021; VanKempen MJA, 1996, CARDIOVASC RES, V32, P886; Wang YD, 2017, EUR HEART J, V38, P675, DOI 10.1093/eurheartj/ehv520; Wang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060244; Weber D, 2014, CURR TOP DEV BIOL, V110, P285, DOI 10.1016/B978-0-12-405943-6.00008-7; Yang JW, 2012, CARDIOVASC RES, V96, P276, DOI 10.1093/cvr/cvs250; Zhao C, 2014, DEVELOPMENT, V141, P281, DOI 10.1242/dev.093690	64	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0203100	10.1371/journal.pone.0203100	http://dx.doi.org/10.1371/journal.pone.0203100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596653	Green Published, Green Submitted, gold			2022-12-26	WOS:000454627200003
J	Shahriari, N; Georgiadis, JR; Oudkerk, M; Misra, S				Shahriari, Navid; Georgiadis, Janniko R.; Oudkerk, Matthijs; Misra, Sarthak			Hybrid control algorithm for flexible needle steering: Demonstration in phantom and human cadaver	PLOS ONE			English	Article							LUNG-BIOPSY; PNEUMOTHORAX; SYSTEM; ROBOT; RISK	Needles are commonly used in the clinic for percutaneous procedures. The outcome of such procedures heavily depends on accurate placement of the needle. There are two main challenges to achieve high accuracy: First, aligning the needle with the targeted lesion, and second, compensating for the deflection of the needle in the tissue. In order to address these challenges, scientists have developed several robotic setups for needle steering. However, the subject is still under research and reliable implementations which can be used in clinical practice are not yet available. In this paper, we have taken some steps in order to bring needle steering closer to practice. A new hybrid control algorithm is developed, which enables us to control a flexible needle by combing base-manipulation and beveled-tip steering methods. A pre-operative path planner is developed which considers the clinical requirements. The proposed method is tested in the lung of a fresh-frozen human cadaver. The work-flow of the experiments are similar to the current clinical practice. Three experimental cases are used to evaluate the proposed steering algorithm. Experimental Case I shows that using the proposed steering algorithm controllability of the needle is increased. In Case II and Case III, the needle is steered in a gelatin phantom and a human cadaver, respectively. The targeting accuracy of 1.35 +/- 0.49mm in gelatin phantom and 1.97 +/- 0.89mm in cadave is achieved. A feasibility study is performed, in which a fine needle aspiration (FNA) needle is steered in the lungs of a human cadaver under computed tomography guidance. The targeting error for the feasibility study is 2.89 +/- 0.22mm. The results suggest that such a robotic system can be beneficial for clinical use and the patient receives less x-ray radiation.	[Shahriari, Navid; Oudkerk, Matthijs; Misra, Sarthak] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Shahriari, Navid; Misra, Sarthak] Univ Twente, Dept Biomech Engn, Surg Robot Lab, Enschede, Netherlands; [Georgiadis, Janniko R.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Misra, Sarthak] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Groningen, Netherlands	University of Groningen; University of Twente; University of Groningen; University of Groningen	Shahriari, N (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands.; Shahriari, N (corresponding author), Univ Twente, Dept Biomech Engn, Surg Robot Lab, Enschede, Netherlands.	n.shahriari@utwente.nl		Oudkerk, Matthijs/0000-0003-2800-4110	Samenwerkingsverband Noord-Nederland (SNN) Program (Project RICIBION-Robotic Interventions using CT-Images for Biopsies of Lung Nodules); European Research Council (ERC), The European Unions Horizon 2020 Research and Innovation program (Project ROBOTAR: Robot-Assisted Flexible Needle Steering for Targeted Delivery of Magnetic Agents) [638428]; University Medical Center Groningen (UMCG); European Research Council (ERC) under the European Unions Horizon 2020 Research and Innovation programme [638428]	Samenwerkingsverband Noord-Nederland (SNN) Program (Project RICIBION-Robotic Interventions using CT-Images for Biopsies of Lung Nodules); European Research Council (ERC), The European Unions Horizon 2020 Research and Innovation program (Project ROBOTAR: Robot-Assisted Flexible Needle Steering for Targeted Delivery of Magnetic Agents); University Medical Center Groningen (UMCG); European Research Council (ERC) under the European Unions Horizon 2020 Research and Innovation programme(European Research Council (ERC))	Samenwerkingsverband Noord-Nederland (SNN) Program (Project RICIBIONRobotic Interventions using CT-Images for Biopsies of Lung Nodules) to MO, European Research Council (ERC), The European Unions Horizon 2020 Research and Innovation program (Project ROBOTAR: Robot-Assisted Flexible Needle Steering for Targeted Delivery of Magnetic Agents) 638428 to SM, and University Medical Center Groningen (UMCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Wout J. Heerink, Klaas van Linschoten and Steve Oosterhoff for their assistance. This study was supported by funds from the Samenwerkingsverband Noord-Nederland (SNN) Program (Project RICIBION-Robotic Interventions using CT-Images for Biopsies of Lung Nodules), European Research Council (ERC) under the European Unions Horizon 2020 Research and Innovation programme (Grant Agreement #638428-project ROBOTAR: Robot-Assisted Flexible Needle Steering for Targeted Delivery of Magnetic Agents), and University Medical Center Groningen (UMCG).	Abayazid M, 2015, MED ENG PHYS, V37, P145, DOI 10.1016/j.medengphy.2014.10.005; Alterovitz R, 2008, INT J ROBOT RES, V27, P1361, DOI 10.1177/0278364908097661; Bernardes MC, 2011, IEEE INT C INT ROBOT, P2545, DOI [10.1109/IROS.2011.6094594, 10.1109/IROS.2011.6048259]; Cham MD, 2008, SEMIN RESP CRIT CARE, V29, P335, DOI 10.1055/s-2008-1081278; DiMaio SP, 2005, IEEE T BIO-MED ENG, V52, P965, DOI 10.1109/TBME.2005.846734; Gefen Amit, 2007, Technol Health Care, V15, P259; Glozman D, 2007, IEEE T ROBOT, V23, P459, DOI 10.1109/TRO.2007.898972; Heerink WJ, 2017, EUR RADIOL, V27, P138, DOI 10.1007/s00330-016-4357-8; Kauczor HU, 2015, EUR RADIOL, V25, P2519, DOI 10.1007/s00330-015-3697-0; Khan MF, 2008, EUR RADIOL, V18, P1356, DOI 10.1007/s00330-008-0893-1; Ko SY, 2013, IEEE T BIO-MED ENG, V60, P910, DOI 10.1109/TBME.2012.2227741; Kratchman LB, 2011, P INT SOC OPT PHOT S, V7964; Minhas DS, 2007, P ANN INT IEEE EMBS, P2756, DOI 10.1109/IEMBS.2007.4352899; Misra S, 2010, INT J ROBOT RES, V29, P1640, DOI 10.1177/0278364910369714; Neubach Z, 2010, IEEE T BIO-MED ENG, V57, P799, DOI 10.1109/TBME.2009.2030169; Okazawa S, 2005, IEEE-ASME T MECH, V10, P285, DOI 10.1109/TMECH.2005.848300; Patil S, 2010, P IEEE RAS-EMBS INT, P893, DOI 10.1109/BIOROB.2010.5625965; Shahriari N, 2017, MED ENG PHYS, V45, P71, DOI 10.1016/j.medengphy.2017.04.009; Shahriari N, 2016, IEEE INT CONF ROBOT, P4443, DOI 10.1109/ICRA.2016.7487644; Shahriari N, 2015, INT J COMPUT ASS RAD, V10, P1845, DOI 10.1007/s11548-015-1176-3; Simone C, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P2085, DOI 10.1109/ROBOT.2002.1014848; Stewart BW, 2014, ANN INTERN MED, V160, P330, DOI [10.7326/M13-2771, DOI 10.7326/M13-2771]; Webster RJ, 2006, INT J ROBOT RES, V25, P509, DOI 10.1177/0278364906065388; Yao X, 2012, CURR ONCOL, V19, pE16, DOI 10.3747/co.19.871; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748	25	4	4	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0210052	10.1371/journal.pone.0210052	http://dx.doi.org/10.1371/journal.pone.0210052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596801	Green Published, gold			2022-12-26	WOS:000454627200133
J	Yang, HC; Jung, EK; Yoon, SH; Cho, HH				Yang, Hyung Chae; Jung, Eun Kyung; Yoon, Sung Ho; Cho, Hyong-Ho			The efficacy of drug induced sleep endoscopy using multimodality monitoring system	PLOS ONE			English	Article							APNEA; MANAGEMENT; SELECTION; PROPOFOL; CPAP	Introduction To overcome the limited readability of the conventional drug induced sleep endoscopy (DISE) system which only records flexible endoscopy images, we devised the Multimodality DISE System (MDS). MDS encompasses the monitoring systems for oxygen saturation, electrocardiogram, blood pressure, snoring intensity, and patient's position. It enabled to record comprehensive situation of patients who underwent DISE. In this study, we compared the efficacy of MDS with that of the conventional DISE system. Methods and materials Ten patients underwent DISE at a tertiary hospital. DISE evaluated the airway of each patient in four positions; supine, supine with jaw thrust, right lateral decubitus, and left lateral decubitus. In addition, every examination was recorded by using both single monitoring system and MDS system. Five otolaryngologists interpreted the recorded examinations without knowledge of patient information (10 conventional DISE and 10 MDS). The visual analogue scale (VAS) scores for readability, reading times, ease of patient explanation and the ease of decision making were analyzed. Results Mean VAS scores for readability of conventional DISE and MDS were 4.41+2.56 and 8.42+2.07 (p<0.001). Mean reading times for conventional DISE and MDS were 238.80+61.26 sec and 81.00+44.99 sec, respectively (p<0.001). MDS showed superiority in patient communication (p<0.001). MDS was helpful in decision making regarding patients with obstructive sleep apnea (p<0.001). Conclusions MDS enhanced the readability of previously recorded DISE and enabled easier doctor-patient communication. In addition, MDS is more effective in decision making regarding patients with OSA. MDS has laid the groundwork for separating the DISE prescriber from the DISE performer.	[Cho, Hyong-Ho] Chonnam Natl Univ, Med Sch, Dept Otolaryngol Head & Neck Surg, Gwangju, South Korea; Chonnam Natl Univ Hosp, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital	Cho, HH (corresponding author), Chonnam Natl Univ, Med Sch, Dept Otolaryngol Head & Neck Surg, Gwangju, South Korea.	victocho@hanmail.net	Yang, Hyung Chae/V-8794-2019	Yang, Hyung Chae/0000-0002-9187-1367	Bio & Medical Technology Development Program of the NRF - Korean government [NRF-2017M3A9E8023021]; Chonnam National University Hospital Biomedical Research Institute [CRI18095-1]	Bio & Medical Technology Development Program of the NRF - Korean government; Chonnam National University Hospital Biomedical Research Institute	The Bio & Medical Technology Development Program of the NRF funded by the Korean government NRF-2017M3A9E8023021 to Dr. Hyung Chae Yang and Chonnam National University Hospital Biomedical Research Institute CRI18095-1 to Professor Hyong-Ho Cho supported this work.	Capasso R, 2016, OTOLARYNG HEAD NECK, V154, P765, DOI 10.1177/0194599815625972; CROFT CB, 1991, CLIN OTOLARYNGOL, V16, P504, DOI 10.1111/j.1365-2273.1991.tb01050.x; De Corso E, 2015, ACTA OTORHINOLARYNGO, V35, P426, DOI 10.14639/0392-100X-959; De Corso E, 2013, ACTA OTORHINOLARYNGO, V33, P405; De Vito A, 2014, SLEEP BREATH, V18, P453, DOI 10.1007/s11325-014-0989-6; Galluzzi F, 2015, SLEEP MED, V16, P331, DOI 10.1016/j.sleep.2014.10.017; Gazzaz MJ, 2017, J OTOLARYNGOL-HEAD N, V46, DOI 10.1186/s40463-017-0190-6; Gillespie MB, 2013, LARYNGOSCOPE, V123, P277, DOI 10.1002/lary.23506; Jung SH, 2017, EUR ARCH OTO-RHINO-L, V274, P247, DOI 10.1007/s00405-016-4233-9; Rabelo FAW, 2010, OTOLARYNG HEAD NECK, V142, P218, DOI 10.1016/j.otohns.2009.11.002; Shteamer JW, 2017, LARYNGOSCOPE, V127, P273, DOI 10.1002/lary.26132; Vanderveken OM, 2013, SLEEP BREATH, V17, P13, DOI 10.1007/s11325-012-0671-9; Vroegop AVMT, 2013, SLEEP, V36, P947, DOI 10.5665/sleep.2732	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209775	10.1371/journal.pone.0209775	http://dx.doi.org/10.1371/journal.pone.0209775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596740	gold, Green Published, Green Submitted			2022-12-26	WOS:000454627200083
J	Cela, M; Paulus, C; Santos, MAS; Moura, GR; Frugier, M; Rudinger-Thirion, J				Cela, Marta; Paulus, Caroline; Santos, Manuel A. S.; Moura, Gabriela R.; Frugier, Magali; Rudinger-Thirion, Joelle			Plasmodium apicoplast tyrosyl-tRNA synthetase recognizes an unusual, simplified identity set in cognate tRNA(Tyr)	PLOS ONE			English	Article							SELECTIVE-INHIBITION; PROTEIN-SYNTHESIS; ACCEPTOR STEM; GENETIC-CODE; AMINOACYLATION; SEQUENCE; EVOLUTION; REVEALS	The life cycle of Plasmodium falciparum, the agent responsible for malaria, depends on both cytosolic and apicoplast translation fidelity. Apicoplast aminoacyl-tRNA synthetases (aaRS) are bacterial-like enzymes devoted to organellar tRNA aminoacylation. They are all encoded by the nuclear genome and are translocated into the apicoplast only after cytosolic biosynthesis. Apicoplast aaRSs contain numerous idiosyncratic sequence insertions: An understanding of the roles of these insertions has remained elusive and they hinder efforts to heterologously overexpress these proteins. Moreover, the A/T rich content of the Plasmo-dium genome leads to A/U rich apicoplast tRNA substrates that display structural plasticity. Here, we focus on the P. falciparum apicoplast tyrosyl-tRNA synthetase (Pf-apiTyrRS) and its cognate tRNA(Tyr) substrate (Pf-apitRNA(Tyr)). Cloning and expression strategies used to obtain an active and functional recombinant Pf-apiTyrRS are reported. Functional analyses established that only three weak identity elements in the apitRNA(Tyr) promote specific recognition by the cognate Pf-apiTyrRS and that positive identity elements usually found in the tRNA(Tyr) acceptor stem are excluded from this set. This finding brings to light an unusual behavior for a tRNA(Tyr) aminoacylation system and suggests that Pf-apiTyrRS uses primarily negative recognition elements to direct tyrosylation specificity.	[Cela, Marta; Paulus, Caroline; Frugier, Magali; Rudinger-Thirion, Joelle] CNRS, Inst Biol Mol & Cellulaire, UPR Architecture & React ARN 9002, Strasbourg, France; [Santos, Manuel A. S.; Moura, Gabriela R.] Univ Aveiro, Dept Med Sci, Aveiro, Portugal; [Santos, Manuel A. S.; Moura, Gabriela R.] Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade de Aveiro; Universidade de Aveiro	Frugier, M (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR Architecture & React ARN 9002, Strasbourg, France.	m.frugier@ibmc-cnrs.unistra.fr	Moura, Gabriela/GPF-9079-2022	Moura, Gabriela/0000-0003-2243-6123; Santos, Manuel/0000-0002-0437-1146; Cela, Marta/0000-0002-8287-6879	CNRS; University of Strasbourg; Fondation pour la Recherche Medicale [FDT201704337050]; Universite de Strasbourg; Fondation pour la Recherche Medicale (FRM) [FDT201704337050];  [LABEX: ANR-10-LABX-0036_NETRNA]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Universite de Strasbourg; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); 	This work was supported by CNRS (http://www.cnrs.fr/) to JRT, MF; the University of Strasbourg (https://www.unistra.fr/) to CP and the LABEX: ANR-10-LABX-0036_NETRNA (www.agence-nationale-recherche.fr) and Fondation pour la Recherche Medicale [grant numbers FDT201704337050](www.frm.org) to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Tamara Hendrickson and Richard Giege for critical reading of the manuscript and Anne Theobald-Dietrich for technical assistance. This work was supported by the CNRS, the Universite de Strasbourg and the Fondation pour la Recherche Medicale (FRM) [grant numbers FDT201704337050]. This work has been published under the framework of the LABEX: ANR-10-LABX-0036_NETRNA.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; BEDOUELLE H, 1990, BIOCHIMIE, V72, P589, DOI 10.1016/0300-9084(90)90122-W; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bonnefond L, 2005, BIOCHIMIE, V87, P873, DOI 10.1016/j.biochi.2005.03.008; Bonnefond L, 2005, RNA, V11, P558, DOI 10.1261/rna.7246805; Bonnefond L, 2008, RNA, V14, P641, DOI 10.1261/rna.938108; Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; Campanacci V, 2004, J MOL BIOL, V337, P273, DOI 10.1016/j.jmb.2004.01.027; CELIS JE, 1973, NATURE-NEW BIOL, V244, P261, DOI 10.1038/newbio244261a0; Chaudhry SR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18695-y; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fechter P, 2000, BIOCHEMISTRY-US, V39, P1725, DOI 10.1021/bi992276t; Fechter P, 2001, EUR J BIOCHEM, V268, P761, DOI 10.1046/j.1432-1327.2001.01931.x; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Frugier M, 2010, FEBS LETT, V584, P448, DOI 10.1016/j.febslet.2009.11.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Giege R, 2016, ECOSAL PLUS, V7; Giege R, 2014, TRANSFER RNA RECOGNI, DOI [10.1371/journal.pone.0026817, DOI 10.1371/JOURNAL.PONE.0026817]; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GROSJEAN H, 1982, GENE, V18, P199, DOI 10.1016/0378-1119(82)90157-3; HIMENO H, 1990, NUCLEIC ACIDS RES, V18, P6815, DOI 10.1093/nar/18.23.6815; Hoen R, 2013, CHEMBIOCHEM, V14, P499, DOI 10.1002/cbic.201200620; HOU YM, 1989, BIOCHEMISTRY-US, V28, P4942, DOI 10.1021/bi00438a005; Hu SL, 2013, J BIOL CHEM, V288, P30855, DOI 10.1074/jbc.M113.467977; Huot JL, 2014, BIOCHIMIE, V100, P95, DOI 10.1016/j.biochi.2014.01.004; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jackson KE, 2012, INT J PARASITOL, V42, P177, DOI 10.1016/j.ijpara.2011.11.008; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Khan S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1247-0; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; LEE CP, 1993, P NATL ACAD SCI USA, V90, P7149, DOI 10.1073/pnas.90.15.7149; Mailu BM, 2013, J BIOL CHEM, V288, P32539, DOI 10.1074/jbc.M113.507467; Messmer M, 2009, BIOCHIMIE, V91, P596, DOI 10.1016/j.biochi.2009.02.005; Moura GR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026817; OpenWetWare contributors, 2014, ESCH COL COD US; Pasaje CFA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27531; Pham JS, 2014, BIOCHEM J, V458, P513, DOI 10.1042/BJ20131451; Pinheiro M, 2006, METHOD INFORM MED, V45, P163, DOI 10.1055/s-0038-1634061; Putz J, 2010, FEBS LETT, V584, P350, DOI 10.1016/j.febslet.2009.11.050; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Saint-Leger A, 2016, BIOENGINEERED, V7, P60, DOI 10.1080/21655979.2016.1149270; Sharma A, 2015, BIOCHEM J, V465, P459, DOI 10.1042/BJ20140998; SHERMAN JM, 1992, J MOL BIOL, V228, P1055, DOI 10.1016/0022-2836(92)90314-A; Sohm B, 2003, J MOL BIOL, V328, P995, DOI 10.1016/S0022-2836(03)00373-5; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Vinayak M, 2010, BIOSCIENCE REP, V30, P135, DOI 10.1042/BSR20090057; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wolf YI, 1999, GENOME RES, V9, P689; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	58	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209805	10.1371/journal.pone.0209805	http://dx.doi.org/10.1371/journal.pone.0209805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592748	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900045
J	Wang, LY; Xu, Y; Li, Y; Zhao, YD				Wang, Liying; Xu, Yan; Li, Yu; Zhao, Yuanding			Voxel segmentation-based 3D building detection algorithm for airborne LIDAR data	PLOS ONE			English	Article							EXTRACTION; RECONSTRUCTION; PATTERNS	Among traditional Light Detection And Ranging (LIDAR) data representations such as raster grid, triangulated irregular network, point clouds and octree, the explicit 3D nature of voxel-based representation makes it a promising alternative. Despite the benefit of voxel-based representation, voxel-based algorithms have rarely been used for building detection. In this paper, a voxel segmentation-based 3D building detection algorithm is developed for separating building and nonbuilding voxels. The proposed algorithm first voxelizes the LIDAR point cloud into a grayscale voxel structure in which the grayscale of the voxel corresponds to the quantized mean intensity of the LIDAR points within the voxel. The voxelized dataset is segmented into multiple 3D-connected regions depending on the connectivity and grayscale similarity among voxels. The 3D-connected regions corresponding to the building roof and facade are detected sequentially according to characteristics such as their area, density, elevation difference and location. The obtained results for the detected buildings are evaluated by the LIDAR data provided by working group III/4 of ISPRS, which demonstrate a high rate of success. Average completeness, correctness, quality, and kappa coefficient indexes values of 90.0%, 96.0%, 88.1% and 88.7%, respectively, are obtained for buildings.	[Wang, Liying; Xu, Yan; Li, Yu; Zhao, Yuanding] Liaoning Tech Univ, Sch Geomat, Fuxing, Liaoning, Peoples R China; [Xu, Yan] Beijing Brisight Technol Co, Beijing, Peoples R China	Liaoning Technical University	Wang, LY (corresponding author), Liaoning Tech Univ, Sch Geomat, Fuxing, Liaoning, Peoples R China.	wangliyinglntu@163.com	Li, Yu/ABF-6732-2020		Natural Science Foundation of Liaoning Province of China [20170540419]	Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province)	This work was supported by the Natural Science Foundation of Liaoning Province of China, grant No. 20170540419. URL: http://kjjh.lninfo.gov.cn/.Outside the submitted work, author Yan Xu is employed by Beijing Brisight Technology Company. The specific roles of these authors are articulated in the ` author contributions' section.	Vo AV, 2015, ISPRS J PHOTOGRAMM, V104, P88, DOI 10.1016/j.isprsjprs.2015.01.011; Bellakaout A, 2016, INT ARCH PHOTOGRAMM, V41, P173, DOI 10.5194/isprsarchives-XLI-B3-173-2016; Cao RJ, 2017, INT J REMOTE SENS, V38, P3684, DOI 10.1080/01431161.2017.1302112; Carlberg M, 2009, IEEE INT C IM PROC, DOI [10.1109/ICIP.2009.5413385, DOI 10.1109/ICIP.2009.5413385]; Chasmer L, 2004, INT ARCH PHOTOGRAMME, V36, P66; Cheng L, 2013, OPT COMMUN, V286, P244, DOI 10.1016/j.optcom.2012.08.028; Cramer M, 2010, PHOTOGRAMM FERNERKUN, P73, DOI 10.1127/1432-8364/2010/0041; Filin S, 2006, ISPRS J PHOTOGRAMM, V60, P71, DOI 10.1016/j.isprsjprs.2005.10.005; Filin S., 2002, INT ARCH PHOTOGRAMM, V34, P119; Gilani S A N, 2016, P IEEE INT C IM PROC; Hagstrom S.T., 2014, THESIS; He MZ, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030189; Hofmann A., 2004, INT ARCH PHOTOGRAMME, V35, P302; Jjumba A, 2016, J GEOGR SYST, V18, P183, DOI 10.1007/s10109-016-0231-0; Kim C, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16020140; Kim E, 2016, FORESTS, V7, DOI 10.3390/f7110259; Kong DM, 2014, IEEE T INSTRUM MEAS, V63, P1200, DOI 10.1109/TIM.2013.2292310; Maas H. G., 1999, INT ARCH PHOTOGRAMME, V32, P1; Meng XL, 2009, PHOTOGRAMM ENG REM S, V75, P437, DOI 10.14358/PERS.75.4.437; Mongus D, 2013, ISPRS ANN PHOTO REM, VII-3/W1, P21, DOI 10.5194/isprsannals-II-3-W1-21-2013; Morgan M, 2002, P ACSM ASPRS ANN C 2; Moussa A, 2012, INT ARCH PHOTOGRAMM, V39-B3, P309; Orthuber E, 2015, ISPRS ANN PHOTO REM, V2-3, P157, DOI 10.5194/isprsannals-II-3-W4-157-2015; Petras V., 2017, OPEN GEOSPATIAL DATA, V1, P9; Reinhard K, 2004, DIGITAL GEOMETRY GEO; Rutzinger M, 2009, IEEE J-STARS, V2, P11, DOI 10.1109/JSTARS.2009.2012488; Sithole G., 2003, P 2 GRSS ISPRS JOINT; Song JW, 2015, OPTIK, V126, P513, DOI 10.1016/j.ijleo.2015.01.011; Sun SH, 2013, IEEE J-STARS, V6, P1440, DOI 10.1109/JSTARS.2013.2251457; Truong-Hong L., 2014, COMPUT AIDED DESIGN, V53, P46, DOI DOI 10.1016/J.CAD.2014.03.001; Vetter M, 2011, INT ARCH PHOTOGRAMM, V38-5, P265; Vosselman G., 2004, INT ARCH PHOTOGRAMM, V46, P33; Wang L, 2008, P SPIE DEF SEC S 200; [王丽英 Wang Liying], 2017, [中国图象图形学报, Journal of Image and Graphics], V22, P1436; Wang LY, 2017, PHOTOGRAMM ENG REM S, V83, P95, DOI 10.14358/PERS.83.2.95; Wang M., 2004, INT ARCH PHOTOGRAMM, V2, P1; Wang RS, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.016022; Weishampel JF, 2000, INT J REMOTE SENS, V21, P409, DOI 10.1080/014311600210939; Yan J, 2014, IEEE T GEOSCI REMOTE, V53, P3; Yastikli N, 2016, INT ARCH PHOTOGRAMM, V41, P441, DOI 10.5194/isprsarchives-XLI-B3-441-2016; Zhang J.X., 2012, ISPRS ANN PHOTOGRAMM, P135, DOI [DOI 10.5194/isprsannals-I-3-135-2012, 10.5194/isprsannals-I-3-135-2012, DOI 10.5194/ISPRSANNALS-I-3-135-2012]; Zhang K, 2006, IEEE T GEOSCI REMOTE, V44, P2523, DOI 10.1109/TGRS.2006.874137; Zhang ZX, 2016, IEEE T GEOSCI REMOTE, V54, P3309, DOI 10.1109/TGRS.2016.2514508; [赵泉华 Zhao Quanhua], 2017, [通信学报, Journal on Communications], V38, P34; Zhao QH, 2014, J INDIAN SOC REMOTE, V42, P529, DOI 10.1007/s12524-013-0358-0; Zhou QY, 2013, GRAPH MODELS, V75, P118, DOI 10.1016/j.gmod.2012.09.001	46	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0208996	10.1371/journal.pone.0208996	http://dx.doi.org/10.1371/journal.pone.0208996			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592729	Green Published, gold, Green Submitted			2022-12-26	WOS:000454621900012
J	Werther, T; Aichhorn, L; Baumgartner, S; Berger, A; Klebermass-Schrehof, K; Salzer-Muhar, U				Werther, Tobias; Aichhorn, Lukas; Baumgartner, Sigrid; Berger, Angelika; Klebermass-Schrehof, Katrin; Salzer-Muhar, Ulrike			Discrepancy between invasive and non-invasive blood pressure readings in extremely preterm infants in the first four weeks of life	PLOS ONE			English	Article							BIRTH-WEIGHT; COMPLICATIONS; MANAGEMENT; ACCURACY; NEONATE	Background The agreement between invasive and non-invasive blood pressure (BP) readings in the first days of life of preterm infants is contentiously debated. Objective To compare mean, systolic and diastolic invasive (IBP) and non-invasive BP (NBP) readings obtained during routine care in the first four weeks of life of extremely preterm infants. Methods We extracted pairs of IBP and NBP readings obtained from preterm infants born below 28 weeks of gestation from the local database. After exclusion of erroneous measurements, we investigated the repeated measures correlation and analyzed the agreement (bias) and precision adjusted for multiple measurements per individual. Results Among 335 pairs of IBP and NBP readings obtained from 128 patients, we found correlation coefficients >0.65 for mean, systolic and diastolic BP values. The bias for mean BP readings was -0.4 mmHg (SD 6.1), for systolic BP readings 6.2 mmHg (SD 8.1), and for diastolic BP readings -4.3 mmHg (SD 6.5). Overestimation of systolic IBP and underestimation of diastolic IBP by the non-invasive measurement were found both in the group with gestational age from 23 to 25.9 weeks and in the group with gestational age from 26 to 27.9 weeks. Systolic NBP readings tended to exceed invasive readings in the range <50 mmHg (bias 9.9 mmHg) whereas diastolic NBP readings were lower than invasive values particularly in the range > 30 mmHg (bias -5.5 mmHg). Conclusion The disagreement between invasive and non-invasive BP readings in infants extends to the first four weeks of life. Biases differ for mean, systolic and diastolic BP values. Our observation implies that they may depend on the range of the blood pressure. Awareness of these biases and preemptive concomitant use of IBP and NPB readings may contribute to reducing over- or under-treatment.	[Werther, Tobias; Aichhorn, Lukas; Baumgartner, Sigrid; Berger, Angelika; Klebermass-Schrehof, Katrin] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Neonatol Pediat Intens Care & Neuropediat, Vienna, Austria; [Salzer-Muhar, Ulrike] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Pediat Cardiol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Werther, T (corresponding author), Med Univ Vienna, Dept Pediat & Adolescent Med, Div Neonatol Pediat Intens Care & Neuropediat, Vienna, Austria.	tobias.werther@meduniwien.ac.at	Klebermass-Schrehof, Katrin/B-4599-2018; Werther, Tobias/A-6608-2018	Klebermass-Schrehof, Katrin/0000-0001-5387-6602; Werther, Tobias/0000-0003-2442-8557; Berger, Angelika/0000-0001-8775-2405				BUTT WW, 1984, J PEDIATR-US, V105, P630, DOI 10.1016/S0022-3476(84)80437-0; CUNNINGHAM S, 1994, EARLY HUM DEV, V36, P27, DOI 10.1016/0378-3782(94)90030-2; Dannevig I, 2005, ACTA PAEDIATR, V94, P191, DOI 10.1080/08035250410023629; Deindl P, 2018, ACTA PAEDIATR, V107, P240, DOI 10.1111/apa.14100; Dempsey EM, 2014, NEONATOLOGY, V105, P275, DOI 10.1159/000357553; EI-Khuffash A, 2017, CLIN PERINATOL, V44, P377, DOI 10.1016/j.clp.2017.02.001; Giesinger RE, 2017, PEDIATR RES, V82, P901, DOI 10.1038/pr.2017.200; Hermansen MC, 2005, CLIN PERINATOL, V32, P141, DOI 10.1016/j.clp.2004.11.005; Jilek Jiri, 2005, Biomedical Instrumentation & Technology, V39, P237; Joffe R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1354-x; Konig K, 2012, INTENS CARE MED, V38, P670, DOI 10.1007/s00134-012-2499-y; Lalan S, 2014, J AM SOC HYPERTENS, V8, P36, DOI 10.1016/j.jash.2013.10.003; Lehman LWH, 2013, CRIT CARE MED, V41, P34, DOI 10.1097/CCM.0b013e318265ea46; Meidert AS, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00231; Meyer S, 2010, J PAEDIATR CHILD H, V46, P249, DOI 10.1111/j.1440-1754.2009.01679.x; O'Shea J, 2009, AM J PERINAT, V26, P113, DOI 10.1055/s-0028-1091391; Pereira SS, 2019, ARCH DIS CHILD-FETAL, V104, pF298, DOI 10.1136/archdischild-2017-314159; Saherwala AA, 2018, NEUROCRIT CARE, V28, P265, DOI 10.1007/s12028-018-0521-0; Sheshadri Veena, 2017, Anesth Essays Res, V11, P169, DOI 10.4103/0259-1162.181430; Singh Y, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00002; SONESSON SE, 1987, ACTA PAEDIATR SCAND, V76, P338, DOI 10.1111/j.1651-2227.1987.tb10471.x; Takci S, 2012, ACTA PAEDIATR, V101, P132, DOI 10.1111/j.1651-2227.2011.02458.x; Wax DB, 2011, ANESTHESIOLOGY, V115, P973, DOI 10.1097/ALN.0b013e3182330286; WEINDLING AM, 1989, ARCH DIS CHILD-FETAL, V64, P444, DOI 10.1136/adc.64.4_Spec_No.444; Zou GY, 2013, STAT METHODS MED RES, V22, P630, DOI 10.1177/0962280211402548	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209831	10.1371/journal.pone.0209831	http://dx.doi.org/10.1371/journal.pone.0209831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592742	Green Published, Green Submitted, gold			2022-12-26	WOS:000454621900047
J	Danza, F; Ravasi, D; Storelli, N; Roman, S; Ludin, S; Bueche, M; Tonolla, M				Danza, Francesco; Ravasi, Damiana; Storelli, Nicola; Roman, Samuele; Ludin, Samuel; Bueche, Matthieu; Tonolla, Mauro			Bacterial diversity in the water column of meromictic Lake Cadagno and evidence for seasonal dynamics	PLOS ONE			English	Article							PHOTOTROPHIC SULFUR BACTERIA; IN-SITU ANALYSIS; MICROBIAL DIVERSITY; COMMUNITY STRUCTURE; CHEMOCLINE; VERRUCOMICROBIA; POPULATION	The meromictic Lake Cadagno is characterized by a compact chemocline with high concentrations of anoxygenic phototrophic purple and green sulfur bacteria. However, a complete picture of the bacterial diversity, and in particular of effects of seasonality and compartmentalization is missing. To characterize bacterial communities and elucidate relationships between them and their surrounding environment high-throughput 16S rRNA gene pyrosequencing was conducted. Proteobacteria, Chlorobi, Verrucomicrobia, and Actinobacteria were the dominant groups in Lake Cadagno water column. Moreover, bacterial interaction within the chemocline and between oxic and anoxic lake compartments were investigated through fluorescence in situ hybridization (FISH) and flow cytometry (FCM). The different populations of purple sulfur bacteria (PSB) and green sulfur bacteria (GSB) in the chemocline indicate seasonal dynamics of phototrophic sulfur bacteria composition. Interestingly, an exceptional bloom of a cyanobacteria population in the oxic-anoxic transition zone affected the common spatial distribution of phototrophic sulfur bacteria with consequence on chemocline location and water column stability. Our study suggests that both bacterial interactions between different lake compartments and within the chemocline can be a dynamic process influencing the stratification structure of Lake Cadagno water column.	[Danza, Francesco; Ravasi, Damiana; Storelli, Nicola; Roman, Samuele; Ludin, Samuel; Tonolla, Mauro] Univ Appl Sci & Arts Southern Switzerland SUPSI, Lab Appl Microbiol LMA, Dept Environm Construct & Design DACD, Bellinzona, Switzerland; [Danza, Francesco; Ludin, Samuel; Tonolla, Mauro] Univ Geneva, Dept Bot & Plant Biol, Microbiol Unit, Geneva, Switzerland; [Roman, Samuele; Tonolla, Mauro] Alpine Biol Ctr Fdn, Bellinzona, Switzerland; [Ludin, Samuel] Spiez Lab, Div Biol, Fed Off Civil Protect, Spiez, Switzerland; [Bueche, Matthieu] Univ Neuchatel, Inst Chem, Neuchatel, Switzerland; [Bueche, Matthieu] Bueche Lab, Le Paquier, Switzerland	University of Geneva; University of Neuchatel	Tonolla, M (corresponding author), Univ Appl Sci & Arts Southern Switzerland SUPSI, Lab Appl Microbiol LMA, Dept Environm Construct & Design DACD, Bellinzona, Switzerland.; Tonolla, M (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Microbiol Unit, Geneva, Switzerland.; Tonolla, M (corresponding author), Alpine Biol Ctr Fdn, Bellinzona, Switzerland.	mauro.tonolla@supsi.ch	Storelli, Nicola/AAP-5061-2021	Storelli, Nicola/0000-0002-1318-115X; Ludin, Samuel/0000-0002-2803-2536; Tonolla, Mauro/0000-0002-8861-7763	Scuola Universitaria Professionale della Svizzera Italiana	Scuola Universitaria Professionale della Svizzera Italiana	This work was supported by Scuola Universitaria Professionale della Svizzera Italiana. Bueche mu lab provided support in the form of salaries for author MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andrei AS, 2015, ISME J, V9, P2642, DOI 10.1038/ismej.2015.60; Baatar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150847; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bosshard PP, 2000, FEMS MICROBIOL ECOL, V31, P173, DOI 10.1111/j.1574-6941.2000.tb00682.x; Cabello-Yeves PJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02131; Camacho A, 2001, AQUAT SCI, V63, P91, DOI 10.1007/PL00001346; Camacho A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00323; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charvet S, 2012, FRONT MICROBIOL, V3, P1; Christoffersen K, 2006, HYDROBIOLOGIA, V560, P259, DOI 10.1007/s10750-005-1221-2; Danza F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189510; Decristophoris PMA, 2009, J LIMNOL, V68, P16, DOI 10.4081/jlimnol.2009.16; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finlay BJ, 1997, OIKOS, V80, P209, DOI 10.2307/3546587; FISCHER K, 1995, CAN J MICROBIOL, V41, P666, DOI 10.1139/m95-092; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Gregersen LH, 2009, FEMS MICROBIOL ECOL, V70, P30, DOI 10.1111/j.1574-6941.2009.00737.x; Gulati R.D., 2017, ECOLOGICAL STUDIES 2; Habicht KS, 2011, ENVIRON MICROBIOL, V13, P203, DOI 10.1111/j.1462-2920.2010.02321.x; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Islam T, 2008, P NATL ACAD SCI USA, V105, P300, DOI 10.1073/pnas.0704162105; Kembel S. W., 2012, PLOS COMPUT BIOL, V8, P16, DOI DOI 10.1371/J0URNAL.PCBI.1002743; Klepac-Ceraj V, 2012, GEOBIOLOGY, V10, P223, DOI 10.1111/j.1472-4669.2012.00317.x; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Lindstrom ES, 2004, J PLANKTON RES, V26, P241, DOI 10.1093/plankt/fbh010; Lliros M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13803; Lurling M, 2013, FRESHWATER BIOL, V58, P552, DOI 10.1111/j.1365-2427.2012.02866.x; MalinskyRushansky NZ, 1997, J PLANKTON RES, V19, P979, DOI 10.1093/plankt/19.8.979; Maniatis T., 1982, MOL CLONING; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Milucka J, 2015, ISME J, V9, P1991, DOI 10.1038/ismej.2015.12; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Noguerola I, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv086; Oliverio AM, 2014, GENOME BIOL EVOL, V6, P482, DOI 10.1093/gbe/evu024; Oswald K, 2017, ISME J, V11, P2124, DOI 10.1038/ismej.2017.77; OVERMANN J, 1991, LIMNOL OCEANOGR, V36, P846, DOI 10.4319/lo.1991.36.5.0846; OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150; Overmann J., 2013, PROKARYOTES, P203, DOI DOI 10.1007/978-3-642-30123-0_51; Ozen A, 2018, HYDROBIOLOGIA, V806, P13, DOI 10.1007/s10750-017-3329-6; Ozen A, 2013, FRESHWATER BIOL, V58, P483, DOI 10.1111/j.1365-2427.2012.02824.x; Peduzzi R, 1998, DOC I ITAL IDROBIOL, V63, P1; Peduzzi S, 2003, FEMS MICROBIOL ECOL, V45, P29, DOI 10.1016/S0168-6496(03)00107-7; Peduzzi S, 2012, SYST APPL MICROBIOL, V35, P139, DOI 10.1016/j.syapm.2012.01.001; PFENNIG N, 1962, ARCH MIKROBIOL, V42, P90, DOI 10.1007/BF00425194; Posth NR, 2017, GEOBIOLOGY, V15, P798, DOI 10.1111/gbi.12254; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; Sommer T., 2017, GEOPHYS RES LETT; STORELLI N, 2014, EUPA OPEN PROTEOM, V2, P17, DOI DOI 10.1016/J.EUPR0T.2013.11.010; Storelli N, 2013, FEMS MICROBIOL ECOL, V84, P421, DOI 10.1111/1574-6941.12074; Tonolla M, 1999, APPL ENVIRON MICROB, V65, P1325; Tonolla M, 2005, APPL ENVIRON MICROB, V71, P3544, DOI 10.1128/AEM.71.7.3544-3550.2005; Tonolla M, 2003, FEMS MICROBIOL ECOL, V43, P89, DOI 10.1111/j.1574-6941.2003.tb01048.x; Tonolla M, 2000, APPL ENVIRON MICROB, V66, P820, DOI 10.1128/AEM.66.2.820-824.2000; Tonolla M, 2006, MILIEUX EXTREMES CON, P21; Tonolla M, 2017, ECOL STUD-ANAL SYNTH, V228, P155, DOI 10.1007/978-3-319-49143-1_7; van Gemerden H, 1974, MICROB ECOL, V1, P104, DOI 10.1007/BF02512382; Visscher P.T., 2003, BIOGEOCHEMISTRY, V8, P317, DOI DOI 10.1016/B0-08-043751-6/08132-9; Zarda B, 1997, ARCH MICROBIOL, V168, P185, DOI 10.1007/s002030050486; Zwart G, 2003, APPL ENVIRON MICROB, V69, P5875, DOI 10.1128/AEM.69.10.5875-5883.2003	59	10	10	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209743	10.1371/journal.pone.0209743	http://dx.doi.org/10.1371/journal.pone.0209743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586464	Green Published, Green Submitted, gold			2022-12-26	WOS:000454416400090
J	Raphael, DM; Roos, L; Myovela, V; Mchomvu, E; Namamba, J; Kilindimo, S; Gingo, W; Hatz, C; Paris, DH; Weisser, M; Kobza, R; Rohacek, M				Raphael, Dominick M.; Roos, Laurine; Myovela, Victor; Mchomvu, Elisante; Namamba, Jabir; Kilindimo, Said; Gingo, Winfrid; Hatz, Christoph; Paris, Daniel H.; Weisser, Maja; Kobza, Richard; Rohacek, Martin			Heart diseases and echocardiography in rural Tanzania: Occurrence, characteristics, and etiologies of underappreciated cardiac pathologies	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; AMERICAN SOCIETY; EUROPEAN ASSOCIATION; CLINICAL CHARACTERISTICS; ATRIAL-FIBRILLATION; FAILURE; HYPERTENSION; RECOMMENDATIONS; MANAGEMENT; DIAGNOSIS	Background Little is known about heart diseases and their treatment in rural sub-Saharan Africa. This study aimed to describe the occurrence, characteristics, and etiologies of heart diseases, and the medication taken before and prescribed after echocardiography in a rural referral Hospital in Tanzania. Methods This prospective descriptive cohort study included all adults and children referred for echocardiography. Clinical and echocardiographic data were collated for analysis. Results From December 2015 to October 2017, a total of 1'243 echocardiograms were performed. A total of 815 adults and 59 children. 15 years had abnormal echocardiographic findings; in adults 537/815 (66%) had hypertension, with 230/537(43%) on antihypertensive drugs, and 506/815 (62%) were not on regular cardiac medication; 346/815 (42%) had severe eccentric or concentric left ventricular hypertrophy, and 182/815 (22%) had severe systolic heart failure. Only 44% demonstrated normal left ventricular systolic function. The most frequent heart diseases were hypertensive heart disease (41%), valvular heart disease (18%), coronary heart disease (18%), peripartum cardiomyopathy (7%), and other non-hypertensive dilated cardiomyopathies (6%) in adults, and congenital heart disease (34%) in children. Following echocardiography, 802/815 (98%) adults and 40/59 (68%) children had an indication for cardiac medication, 70/815 (9%) and 2/59 (3%) for oral anticoagulation, and 35/815 (4%) and 23/59 (39%) for cardiac surgery, respectively. Conclusion Hypertension is the leading etiology of heart diseases in rural Tanzania. Most patients present with advanced stages of heart disease, and the majority are not treated before echocardiography. There is an urgent need for increased awareness, expertise and infrastructure to detect and treat hypertension and heart failure in rural Africa.	[Raphael, Dominick M.; Myovela, Victor; Mchomvu, Elisante; Namamba, Jabir; Gingo, Winfrid; Rohacek, Martin] St Francis Referral Hosp, Ifakara, Tanzania; [Roos, Laurine; Hatz, Christoph; Paris, Daniel H.; Weisser, Maja; Rohacek, Martin] Univ Basel, Basel, Switzerland; [Kilindimo, Said] Muhimbili Univ Hlth & Allied Sci, Emergency Dept, Dar Es Salaam, Tanzania; [Hatz, Christoph; Paris, Daniel H.; Weisser, Maja; Rohacek, Martin] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Weisser, Maja; Rohacek, Martin] Ifakara Hlth Inst, Ifakara, Tanzania; [Weisser, Maja] Univ Hosp Basel, Div Infect Dis, Basel, Switzerland; [Kobza, Richard] Luzerner Kantonsspital, Div Cardiol, Luzern, Switzerland	University of Basel; Muhimbili University of Health & Allied Sciences; University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute; University of Basel; Lucerne Cantonal Hospital	Rohacek, M (corresponding author), St Francis Referral Hosp, Ifakara, Tanzania.; Rohacek, M (corresponding author), Univ Basel, Basel, Switzerland.; Rohacek, M (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Rohacek, M (corresponding author), Ifakara Hlth Inst, Ifakara, Tanzania.	mrohacek@ihi.or.tz	Paris, Daniel/GLN-7566-2022; Kobza, Richard/AAE-5714-2022; Kobza, Richard/AAP-9149-2020; Paris, Daniel/AFV-4762-2022	Kobza, Richard/0000-0003-3988-7262; Weisser, Maja/0000-0002-0134-1929; Roos, Laurine/0000-0002-8591-0673; Raphael, Dominick Mkombozi/0000-0002-0502-4058; PARIS, Daniel/0000-0003-4743-5987	Symphasis Foundation, Zurich, Switzerland; Hella Langer Foundation, Grafelfing, Germany; Ernst Gohner Foundation, Zug, Switzerland	Symphasis Foundation, Zurich, Switzerland; Hella Langer Foundation, Grafelfing, Germany; Ernst Gohner Foundation, Zug, Switzerland	We received support from the following foundations: Symphasis Foundation, Zurich, Switzerland, Hella Langer Foundation, Grafelfing, Germany, and Ernst Gohner Foundation, Zug, Switzerland to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe TB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0418-9; Agbor VN, 2018, INT J CARDIOL, V257, P207, DOI 10.1016/j.ijcard.2017.12.048; Anakwue R, 2017, ANN AFR MED, V16, P164, DOI 10.4103/aam.aam_35_17; [Anonymous], 2016, DEATHS CAUS AG SEX C; Antignac M, 2018, HYPERTENSION, V71, P577, DOI 10.1161/HYPERTENSIONAHA.117.10512; Argent AC, 2017, CARDIOL YOUNG, V27, pS22, DOI 10.1017/S104795111700258X; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; BERTRANOU EG, 1978, AM J CARDIOL, V42, P458, DOI 10.1016/0002-9149(78)90941-4; Bonsu KO, 2017, INT J CARDIOL, V238, P128, DOI 10.1016/j.ijcard.2017.03.014; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Callender T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001699; Cantinotti M, 2014, J AM SOC ECHOCARDIOG, V27, P1279, DOI 10.1016/j.echo.2014.08.005; DANNENBERG AL, 1988, AM J PUBLIC HEALTH, V78, P676, DOI 10.2105/AJPH.78.6.676; Dokainish H, 2017, LANCET GLOB HEALTH, V5, pE665, DOI [10.1016/s2214-109x(17)30196-1, 10.1016/S2214-109X(17)30196-1]; Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Garfinkle MA, 2017, J AM SOC HYPERTENS, V11, P385, DOI 10.1016/j.jash.2017.04.006; Grimaldi A, 2016, CIRCULATION, V133, P2503, DOI 10.1161/CIRCULATIONAHA.115.021178; Haghikia A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0366-9; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Henaine R, 2012, ARCH CARDIOVASC DIS, V105, P517, DOI 10.1016/j.acvd.2012.02.013; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Khoury PR, 2009, J AM SOC ECHOCARDIOG, V22, P709, DOI 10.1016/j.echo.2009.03.003; Kwan GF, 2013, JACC-HEART FAIL, V1, P230, DOI 10.1016/j.jchf.2013.03.006; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Magana-Serrano JA, 2011, AM J CARDIOL, V108, P1289, DOI 10.1016/j.amjcard.2011.06.044; Mazurek M, 2017, THROMB HAEMOSTASIS, V117, P2376, DOI 10.1160/TH17-08-0555; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Minette MS, 2006, CIRCULATION, V114, P2190, DOI 10.1161/CIRCULATIONAHA.106.618124; Ministry of Health and Welfare United Republic of Tanzania, 2014, TANZANIA NATIONAL NU; Ministry of Health United Republic of Tanzania, 2017, TANZ HIV IMP SURV 20; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Ntep-Gweth M, 2010, EUROPACE, V12, P482, DOI 10.1093/europace/euq006; Onen CL, 2013, CARDIOVASC J AFR, V24, P34, DOI 10.5830/CVJA-2012-071; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Ramaiya A, 2014, SPOTLIGHT; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Swanepoel B, 2016, J AM SOC HYPERTENS, V10, P829, DOI 10.1016/j.jash.2016.08.007; Tantchou Tchoumi Jacques Cabral, 2011, Pan Afr Med J, V8, P11; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; Villafane J, 2013, J AM COLL CARDIOL, V62, P2155, DOI 10.1016/j.jacc.2013.07.100; Yako YY, 2018, J CLIN HYPERTENS, V20, P485, DOI 10.1111/jch.13225; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yankah C, 2014, THORAC CARDIOV SURG, V62, P393, DOI 10.1055/s-0034-1383723; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	52	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0208931	10.1371/journal.pone.0208931	http://dx.doi.org/10.1371/journal.pone.0208931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586432	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000454416400046
J	Erdenechuluun, J; Lin, YH; Ganbat, K; Bataakhuu, D; Makhbal, Z; Tsai, CY; Lin, YH; Chan, YH; Hsu, CJ; Hsu, WC; Chen, PL; Wu, CC				Erdenechuluun, Jargalkhuu; Lin, Yin-Hung; Ganbat, Khongorzul; Bataakhuu, Delgermaa; Makhbal, Zaya; Tsai, Cheng-Yu; Lin, Yi-Hsin; Chan, Yen-Hui; Hsu, Chuan-Jen; Hsu, Wei-Chung; Chen, Pei-Lung; Wu, Chen-Chi			Unique spectra of deafness-associated mutations in Mongolians provide insights into the genetic relationships among Eurasian populations	PLOS ONE			English	Article							ENLARGED VESTIBULAR AQUEDUCT; NON-SYNDROMIC DEAFNESS; SENSORINEURAL HEARING-LOSS; GJB2 MUTATIONS; PENDRED-SYNDROME; CONNEXIN-26 MUTATIONS; PRELINGUAL DEAFNESS; MOLECULAR ANALYSIS; SLC26A4 MUTATIONS; FOUNDER	Genetic factors are an important cause of idiopathic sensorineural hearing impairment (SNHI). From the epidemiological perspective, mutations of three deafness genes: GJB2, SLC26A4, and MT-RNR1, are much more prevalent than those of other genes worldwide. However, mutation spectra of common deafness genes differ remarkably across different populations. Here, we performed comprehensive genetic examination and haplotype analyses in 188 unrelated Mongolian families with idiopathic SNHI, and compared their mutation spectra and haplotypes to those of other European and Asian cohorts. We confirmed genetic diagnoses in 18 (9.6%) of the 188 families, including 13 with bi-allelic GJB2 mutations, three with bi-allelic SLC26A4 mutations, and two with homoplasmic MT-RNR1 m. 1555A>G mutation. Moreover, mono-allelic mutations were identified in 17 families (9.0%), including 14 with mono-allelic GJB2 mutations and three with mono-allelic SLC26A4 mutations. Interestingly, three GJB2 mutations prevalent in other populations, including c.35delG in Caucasians, c.235delC in East Asians, and c.-23+1G>A in Southwest and South Asians, were simultaneously detected in Mongolian patients. Haplotype analyses further confirmed founder effects for each of the three mutations, indicating that each mutation derived from its ancestral origin independently. By demonstrating the unique spectra of deafness-associated mutations, our findings may have important clinical and scientific implications for refining the molecular diagnostics of SNHI in Mongolian patients, and for elucidating the genetic relationships among Eurasian populations.	[Erdenechuluun, Jargalkhuu] Mongolian Natl Univ Med Sci, Dept Otolaryngol, Ulaanbaatar, Mongolia; [Erdenechuluun, Jargalkhuu; Ganbat, Khongorzul] EMJJ Otolaryngol Hosp, Ulaanbaatar, Mongolia; [Lin, Yin-Hung; Tsai, Cheng-Yu; Lin, Yi-Hsin; Chan, Yen-Hui; Hsu, Chuan-Jen; Hsu, Wei-Chung; Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lin, Yin-Hung; Tsai, Cheng-Yu; Chen, Pei-Lung] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan; [Ganbat, Khongorzul; Bataakhuu, Delgermaa; Makhbal, Zaya] Natl Ctr Maternal & Child Hlth, Dept Otolaryngol, Ulaanbaatar, Mongolia; [Chen, Pei-Lung; Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan	Mongolian National University of Medical Sciences; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.; Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan.	chenchiwu@ntuh.gov.tw	; Chen, Pei-Lung/A-3520-2010	WU, CHEN-CHI/0000-0002-5047-2204; Tsai, Cheng-Yu/0000-0001-6150-4577; Chen, Pei-Lung/0000-0002-5640-3074	Taiwanese-Mongolian Joint Research Project (Ministry of Science and Technology of Taiwan) [MOST 105-2923-B-002-006, MOST 107-2314-B-002-137-MY3]	Taiwanese-Mongolian Joint Research Project (Ministry of Science and Technology of Taiwan)	This study was supported by the Taiwanese-Mongolian Joint Research Project (Grant No.: MOST 105-2923-B-002-006 and MOST 107-2314-B-002-137-MY3, the Ministry of Science and Technology of Taiwan, https://www.most.gov.tw/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Taiwanese-Mongolian Joint Research Project (Grant No.: MOST 105-2923-B-002-006 and MOST 107-2314-B-002-137-MY3, the Ministry of Science and Technology of Taiwan). We would like to thank National Center for High-performance Computing (NCHC) of National Applied Research Laboratories (NARLabs) of Taiwan for providing computational resources and storage resources. We also wish to thank all subjects and their family members for participating in the present study.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Azaiez H, 2004, HUM MUTAT, V24, P305, DOI 10.1002/humu.20084; Azaiez H, 2007, HUM GENET, V122, P451, DOI 10.1007/s00439-007-0415-2; Bai HH, 2014, GENOME BIOL EVOL, V6, P3122, DOI 10.1093/gbe/evu242; Bajaj Y, 2008, CLIN OTOLARYNGOL, V33, P313, DOI 10.1111/j.1749-4486.2008.01754.x; Barashkov NA, 2011, J HUM GENET, V56, P631, DOI 10.1038/jhg.2011.72; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Choi BY, 2009, J MED GENET, V46, P856, DOI 10.1136/jmg.2009.067892; Coyle B, 1998, HUM MOL GENET, V7, P1105, DOI 10.1093/hmg/7.7.1105; Dai P, 2008, GENET MED, V10, P586, DOI [10.1097/GIM.0b013e31817d2ef1, 10.1097GIM.0b013e31817d2ef1]; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dai P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-74; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Dzhemileva LU, 2011, ACTA NATURAE, V3, P52, DOI 10.32607/20758251-2011-3-3-52-63; Dzhemileva LU, 2010, J HUM GENET, V55, P749, DOI 10.1038/jhg.2010.101; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Feder KP, 2017, EAR HEARING, V38, P7, DOI 10.1097/AUD.0000000000000345; Frei K, 2002, EUR J HUM GENET, V10, P427, DOI 10.1038/sj.ejhg.5200826; Gasmelseed Nagla M A, 2004, Hum Mutat, V23, P206, DOI 10.1002/humu.9216; Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173; Guo YF, 2008, ACTA OTO-LARYNGOL, V128, P297, DOI 10.1080/00016480701767382; Gurtler N, 2005, LARYNGOSCOPE, V115, P640, DOI 10.1097/01.mlg.0000161355.28073.f5; Gurtler N, 2003, EAR HEARING, V24, P440, DOI 10.1097/01.AUD.0000090440.84513.B3; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hutchin T, 2005, CLIN GENET, V68, P506, DOI 10.1111/j.1399-0004.2005.00539.x; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Kim S., 2016, J OPEN INNOV TECHNOL, V2, P1, DOI DOI 10.1186/s40852-016-0032-1; Kolman CJ, 1996, GENETICS, V142, P1321; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lin PH, 2017, JAMA OTOLARYNGOL, V143, P912, DOI 10.1001/jamaoto.2017.0945; Lin YH, 2018, J MOL DIAGN; Lin YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08236-y; Liu YZ, 2016, GENET MOL BIOL, V39, P567, DOI [10.1590/1678-4685-GMB-2015-0218, 10.1590/1678-4685-gmb-2015-0218]; Lu CY, 2018, J PEDIATR-US, V199, P144, DOI 10.1016/j.jpeds.2018.02.064; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mahdieh N, 2004, CLIN GENET, V65, P506, DOI 10.1111/j.1399-0004.2004.00262.x; Matos TD, 2007, J MED GENET, V44, P721, DOI 10.1136/jmg.2007.050682; McClay JE, 2002, ARCH OTOLARYNGOL, V128, P664, DOI 10.1001/archotol.128.6.664; Merriwether DA, 1996, AM J HUM GENET, V59, P204; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nance WE, 2000, LANCET, V356, P500, DOI 10.1016/S0140-6736(00)02565-4; O'Sullivan ME, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00325; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Padma G, 2009, J GENET, V88, P267, DOI 10.1007/s12041-009-0039-5; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Sennaroglu L, 2002, LARYNGOSCOPE, V112, P2230, DOI 10.1097/00005537-200212000-00019; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Sirmaci A, 2006, J GENET, V85, P213, DOI 10.1007/BF02935334; Snoeckx RL, 2005, AM J MED GENET A, V135A, P126, DOI 10.1002/ajmg.a.30726; Stinckens C, 2004, ANN OTO RHINOL LARYN, V113, P587, DOI 10.1177/000348940411300714; Tekin M, 2010, ANN HUM GENET, V74, P155, DOI 10.1111/j.1469-1809.2010.00564.x; Trotta L, 2011, INT J AUDIOL, V50, P133, DOI 10.3109/14992027.2010.537377; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Wake M, 2006, PEDIATRICS, V118, P1842, DOI 10.1542/peds.2005-3168; Wu CC, 2005, LARYNGOSCOPE, V115, P1060, DOI 10.1097/01.MLG.0000163339.61909.D0; Wu CC, 2005, LARYNGOSCOPE, V115, P132, DOI 10.1097/01.mlg.0000150691.85387.3f; Wu CC, 2008, AUDIOL NEURO-OTOL, V13, P172, DOI 10.1159/000112425; Wu CC, 2017, GENET MED, V19, P6, DOI 10.1038/gim.2016.66; Wu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057369; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P57, DOI 10.1159/000231567; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yan D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169219; Yang XL, 2013, ACTA OTO-LARYNGOL, V133, P930, DOI 10.3109/00016489.2013.795288; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	72	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2018	13	12							e0209797	10.1371/journal.pone.0209797	http://dx.doi.org/10.1371/journal.pone.0209797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF3QK	30576380	Green Published, gold, Green Submitted			2022-12-26	WOS:000454149400081
J	Bernardini, A; Lorenzo, M; Nardini, M; Mantovani, R; Gnesutta, N				Bernardini, Andrea; Lorenzo, Mariangela; Nardini, Marco; Mantovani, Roberto; Gnesutta, Nerina			The phosphorylatable Ser320 of NF-YA is involved in DNA binding of the NF-Y trimer	FASEB JOURNAL			English	Article						transcription factor; DNA-protein interactions; post-translational modification; cyclin-dependent kinase; histone-fold domain	TRANSCRIPTION FACTOR; UP-REGULATION; CDK2-DEPENDENT PHOSPHORYLATION; FACTOR CBF; CCAAT BOX; B-SUBUNIT; ACTIVATION; GENE; EXPRESSION; SPECIFICITY	Nuclear factor Y (NF-Y) is a transcription factor trimer binding to the functionally important CCAAT box, present in promoters of growth-promoting and cell cycle-regulated genes. The regulatory nuclear factor YA (NF-YA) subunit confers sequence-specificity to the histone-like nuclear factor YB/YC dimer. NF-YA harbors 2 serines-Ser320 and Ser326-shown to be phosphorylated by cyclin-dependent kinase 2. High-throughput proteomics data indicate that they are phosphorylated in vivo. Specifically, Ser320 makes structural contacts with the DNA phosphate backbone; Ser320-P is the major NF-YA phosphorylation isoform following overexpression in HeLa cells, increasing upon mitotic arrest. EMSA with recombinant Ala and Glu mutants confirm a role of Ser320, but not Ser326, in stabilization of DNA binding. Transactivation assays of the CCAAT-dependent MDR1 and RHOB promoters show loss in transcription function for Ser320Glu and Ser320Ala NF-YA mutants. Phylogenetic analysis of NF-YA proteins indicates that Ser320 is indeed evolutionarily conserved. We conclude that phosphorylation of this residue belongs to the core mechanisms of DNA-binding control, possibly driven by the necessity to unfasten binding of or to evict NF-Y from CCAAT sites under specific conditions of growth regulation.	[Bernardini, Andrea; Lorenzo, Mariangela; Nardini, Marco; Mantovani, Roberto; Gnesutta, Nerina] Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy	University of Milan	Mantovani, R; Gnesutta, N (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	mantor@unimi.it; nerina.gnesutta@unimi.it	Gnesutta, Nerina/I-5432-2015; Bernardini, Andrea/ABC-5669-2021	Gnesutta, Nerina/0000-0002-2465-8881; Bernardini, Andrea/0000-0001-5082-5295	Italian Association for Cancer Research [IG 2014/IG-15267, IG 2016/IG-19050, IG 2013/IG-14130]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	The authors thank D. Kardassis [University of Crete/Institute of Molecular Biology and Biotechnology (Forth), Heraklion, Greece] and Dr. K. Scotto (Cancer Institute of New Jersey-Rutgers, New Brunswick, NJ, USA) for gifts of the RHOB and MDR1 promoters constructs. This work was supported by Italian Association for Cancer Research Investgator Grants IG 2014/IG-15267 (to M.N.), IG 2016/IG-19050, and IG 2013/IG-14130 (to R.M.). The authors declare no conflicts of interest.	Ahn J, 2011, BIOCHEM BIOPH RES CO, V409, P211, DOI 10.1016/j.bbrc.2011.04.121; Arampatzi P, 2013, NUCLEIC ACIDS RES, V41, P2202, DOI 10.1093/nar/gks1365; Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; Bi WM, 1997, J BIOL CHEM, V272, P26562, DOI 10.1074/jbc.272.42.26562; Bisikirska B, 2016, CANCER RES, V76, P664, DOI 10.1158/0008-5472.CAN-15-0828; Ceribelli M, 2009, J BIOL CHEM, V284, P34189, DOI 10.1074/jbc.M109.008417; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Cicchillitti L, 2017, ONCOTARGET, V8, P7935, DOI 10.18632/oncotarget.13854; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; Cui H, 2016, NEUROSCI LETT, V631, P40, DOI 10.1016/j.neulet.2016.08.003; Dardaei L, 2015, ONCOTARGET, V6, P25175, DOI 10.18632/oncotarget.4488; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Garipov A, 2013, MOL CANCER RES, V11, P360, DOI 10.1158/1541-7786.MCR-12-0661; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Guo J, 2016, MOL MED REP, V14, P5007, DOI 10.3892/mmr.2016.5897; Gurtner A, 2017, BBA-GENE REGUL MECH, V1860, P604, DOI 10.1016/j.bbagrm.2016.12.005; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu Z, 2000, J BIOL CHEM, V275, P2979, DOI 10.1074/jbc.275.4.2979; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; LI XY, 1992, J BIOL CHEM, V267, P8984; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; MAITY SN, 1992, J BIOL CHEM, V267, P8286; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nardone V, 2017, BBA-GENE REGUL MECH, V1860, P571, DOI 10.1016/j.bbagrm.2016.09.006; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Raccaud M, 2018, FEBS LETT, V592, P878, DOI 10.1002/1873-3468.12828; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Sekiya T, 2017, FEBS OPEN BIO, V7, P397, DOI 10.1002/2211-5463.12189; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Sinha S, 1996, MOL CELL BIOL, V16, P328; Suske G, 2017, BBA-GENE REGUL MECH, V1860, P590, DOI 10.1016/j.bbagrm.2016.08.011; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Tong YA, 2015, CANCER CELL, V27, P712, DOI 10.1016/j.ccell.2015.04.005; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; Xu ZH, 2016, ONCOL REP, V35, P3630, DOI 10.3892/or.2016.4761; Yoshioka Y, 2008, GENES CELLS, V13, P117, DOI 10.1111/j.1365-2443.2007.01155.x; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Yun Un-Jung, 2006, Cancer Res Treat, V38, P224, DOI 10.4143/crt.2006.38.4.224; Zambelli F, 2017, BBA-GENE REGUL MECH, V1860, P581, DOI 10.1016/j.bbagrm.2016.10.007	57	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4790	4801		10.1096/fj.201801989R	http://dx.doi.org/10.1096/fj.201801989R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30589568				2022-12-26	WOS:000462888500013
J	Huang, XR; Wu, CX; Park, YS; Long, XW; Hoang, QYQ; Liao, JL				Huang, Xiaorong; Wu, Chunxiang; Park, Yangshin; Long, Xuwei; Hoang, Quyen Q.; Liao, Jingling			The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2	FASEB JOURNAL			English	Article						disease-associated mutation; monomer-dimer; GTPase activity	GTPASE ACTIVITY; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; KINASE-ACTIVITY; PROTEIN; BINDING; LOCALIZATION; NUCLEOTIDES; INSIGHTS; REVEALS; MUTANT	Parkinson disease-associated mutations within the GTPase domain Ras of complex proteins (ROC) of leucine rich repeat kinase 2 (LRRK2) result in an abnormal over-activation of its kinase domain. However, the mechanisms involved remain unclear. Recent study has shown that LRRK2 G-domain cycles between monomeric and dimeric conformations upon binding to GTP or guanosine diphosphate, and that the Parkinson's disease (PD)-associated R1441C/G/H mutations impair the G-domain monomer-dimer dynamics and trap the G-domain in a constitutive monomeric conformation. That led us to question whether other disease-associated mutations in G-domain would also affect its conformation. Here, we report that another PD-associated N1437H mutation also impairs its monomer-dimer conformational dynamics and GTPase activity. In contrast with mutations at R1441, ROCN1437H was found to be locked in a stable dimeric conformation in solution and its GTPase activity was similar to 4-fold lower than that of the wild-type. Furthermore, the N1437H mutation reduced the GTP binding affinity by similar to 2.5-fold when compared with other pathogenic G-domain mutations. Moreover, ROCN1437H was found to have a slower GTP dissociation rate, indicating that N1437H might interrupt the nucleotide exchange cycle. Taken together, our data support that conformational dynamics is important for LRRK2 GTPase activity and that the N1437H mutation impairs GTPase activity by locking the ROC domain in a persistently dimeric state.	[Huang, Xiaorong; Long, Xuwei; Liao, Jingling] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China; [Wu, Chunxiang; Park, Yangshin; Hoang, Quyen Q.; Liao, Jingling] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Park, Yangshin; Hoang, Quyen Q.] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA; [Liao, Jingling] Wuhan Univ Sci & Technol, Sch Med, Dept Publ Hlth, Wuhan, Hubei, Peoples R China	Nanjing University of Science & Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Wuhan University of Science & Technology	Liao, JL (corresponding author), Nanjing Univ Sci & Technol, Xiaolingwei 200, Nanjing 210094, Jiangsu, Peoples R China.	jingliao@iu.edu	Long, Xuwei/GLU-2908-2022; Huang, Xiaorong/GVU-4903-2022		National Nature Science Foundation of China [31500596]; Fundamental Research Funds for the Central Universities [30916011309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111639, R01GM115844] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the experimental equipment support provided by the State Key Laboratory of Natural Medicines, China Pharmaceutic University (Nanjing, China). This work was supported by grants from the National Nature Science Foundation of China (31500596), and by the Fundamental Research Funds for the Central Universities (30916011309). The authors declare no conflicts of interest.	Aasly JO, 2010, MOVEMENT DISORD, V25, P2156, DOI 10.1002/mds.23265; Nguyen APT, 2017, ADV NEUROBIOL, V14, P71, DOI 10.1007/978-3-319-49969-7_4; Atashrazm F, 2016, CLIN PHARMACOL-ADV A, V8, P177, DOI 10.2147/CPAA.S102191; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Biosa A, 2013, HUM MOL GENET, V22, P1140, DOI 10.1093/hmg/dds522; Ramirez MB, 2017, HUM MOL GENET, V26, P2747, DOI 10.1093/hmg/ddx161; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Civiero L, 2017, ADV NEUROBIOL, V14, P107, DOI 10.1007/978-3-319-49969-7_6; Cookson MR, 2017, ADV NEUROBIOL, V14, P227, DOI 10.1007/978-3-319-49969-7_12; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deyaert E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01103-4; Esteves AR, 2014, EXP NEUROL, V261, P206, DOI 10.1016/j.expneurol.2014.05.025; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guaitoli G, 2016, P NATL ACAD SCI USA, V113, pE4357, DOI 10.1073/pnas.1523708113; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li YC, 2009, BBA-MOL BASIS DIS, V1792, P1194, DOI 10.1016/j.bbadis.2009.09.010; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu ZY, 2015, FASEB J, V29, DOI 10.1096/fj.15-277095; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Nixon-Abell J, 2016, BIOCHEM SOC T, V44, P1625, DOI 10.1042/BST20160240; Petsko GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-108; Puschmann A, 2012, PARKINSONISM RELAT D, V18, P332, DOI 10.1016/j.parkreldis.2011.11.019; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Wider C, 2010, NEURODEGENER DIS, V7, P175, DOI 10.1159/000289232; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zhao J, 2015, BIOCHEM J, V469, P107, DOI 10.1042/BJ20141305	35	12	13	3	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4814	4823		10.1096/fj.201802031R	http://dx.doi.org/10.1096/fj.201802031R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592623	Bronze, Green Published			2022-12-26	WOS:000462888500015
J	Papatheodorou, P; Song, S; Lopez-Urena, D; Witte, A; Marques, F; Ost, GS; Schorch, B; Chaves-Olarte, E; Aktories, K				Papatheodorou, Panagiotis; Song, Shuo; Lopez-Urena, Diana; Witte, Alexander; Marques, Felicia; Ost, Gerhard Stefan; Schorch, Bjoern; Chaves-Olarte, Esteban; Aktories, Klaus			Cytotoxicity of Clostridium difficile toxins A and B requires an active and functional SREBP-2 pathway	FASEB JOURNAL			English	Article						bacterial toxins; toxin uptake; toxin pore; toxin inhibitor; cholesterol	RECEPTOR; CELLS; IDENTIFICATION; PROTEINS; MODE; RISK	Clostridium difficile is associated with antibiotic-associated diarrhea and pseudomembranous colitis in humans. Its 2 major toxins, toxins A and B, enter host cells and inactivate GTPases of the Ras homologue/rat sarcoma family by glucosylation. Pore formation of the toxins in the endosomal membrane enables the translocation of their glucosyltransferase domain into the cytosol, and membrane cholesterol is crucial for this process. Here, we asked whether the activity of the sterol regulatory element-binding protein 2 (SREBP-2) pathway, which regulates the cholesterol content in membranes, affects the susceptibility of target cells toward toxins A and B. We show that the SREBP-2 pathway is crucial for the intoxication process of toxins A and B by using pharmacological inhibitors (PF-429242, 25-hydroxycholesterol) and cells that are specifically deficient in SREBP-2 pathway signaling. SREBP-2 pathway inhibition disturbed the cholesterol-dependent pore formation of toxin B in cellular membranes. Preincubation with the cholesterol-lowering drug simvastatin protected cells from toxin B intoxication. Inhibition of the SREBP-2 pathway was without effect when the enzyme portion of toxin B was introduced into target cells via the cell delivery property of anthrax protective antigen. Taken together, these findings allowed us to identify the SREBP-2 pathway as a suitable target for the development of antitoxin therapeutics against C. difficile toxins A and B.	[Papatheodorou, Panagiotis; Song, Shuo; Witte, Alexander; Marques, Felicia; Ost, Gerhard Stefan; Schorch, Bjoern; Aktories, Klaus] Albert Ludwigs Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Fak Med, Freiburg, Germany; [Lopez-Urena, Diana; Chaves-Olarte, Esteban] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Papatheodorou, Panagiotis] Univ Klinikum Ulm, Ulm, Germany; [Song, Shuo] Southern Univ Sci & Technol, Shenzhen, Peoples R China; [Witte, Alexander] Univ Klinikum Tubingen, Tubingen, Germany	University of Freiburg; Universidad Costa Rica; Ulm University; Southern University of Science & Technology; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Papatheodorou, P (corresponding author), Univ Klinikum Ulm, Inst Pharmakol & Toxikol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	panagiotis.papatheodorou@uni-ulm.de	Aktories, Klaus/CAJ-5682-2022; song, shuo/AAO-4335-2020; Schorch, Björn/T-2522-2019	Aktories, Klaus/0000-0002-5397-0436; song, shuo/0000-0001-6224-2302; Lopez-Urena, Diana/0000-0002-2117-921X; Schorch, Bjorn/0000-0001-8311-0210; Papatheodorou, Panagiotis/0000-0003-3571-695X	Deutsche Forschungsgemeinschaft [AK6/16-4]; Centre for Biological Signaling Studies; University of Costa Rica [B7158, B8117]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Biological Signaling Studies; University of Costa Rica	The authors thank Ferdy van Diemen and Thijn Brummelkamp (Netherlands Cancer Institute, Amsterdam, The Netherlands) for the haploid genetic screen, Otilia Wunderlich (Universitat Freiburg) and Marlen Cordero (University of Costa Rica) for excellent technical assistance and the Joseph L. Goldstein (The University of Texas at Austin, Austin, TX, USA) and John Collier (Harvard Medical School, Boston, MA, USA) laboratories for sharing material. This work was supported by Grant AK6/16-4 from the Deutsche Forschungsgemeinschaft (to K.A. and P.P.), the Centre for Biological Signaling Studies (to K.A.), and the Vice-Presidency for Research, University of Costa Rica (Projects B7158 and B8117). The authors declare no conflicts of interest.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; Gerhard R, 2017, CURR TOP MICROBIOL, V406, P79, DOI 10.1007/82_2016_17; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Motzkus-Feagans CA, 2012, GUT, V61, P1538, DOI 10.1136/gutjnl-2011-301378; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Nseir W, 2013, J ANTIMICROB CHEMOTH, V68, P1889, DOI 10.1093/jac/dkt101; Papatheodorou P, 2018, ADV EXP MED BIOL, V1050, P77, DOI 10.1007/978-3-319-72799-8_6; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Saliba W, 2014, CLIN MICROBIOL INFEC, V20, P1061, DOI 10.1111/1469-0691.12672; Schorch B, 2014, P NATL ACAD SCI USA, V111, P6431, DOI 10.1073/pnas.1323790111; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169	28	7	7	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4883	4892		10.1096/fj.201801440R	http://dx.doi.org/10.1096/fj.201801440R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30592645	Bronze			2022-12-26	WOS:000462888500020
J	Zhou, YL; Lv, MX; Li, T; Zhang, TG; Duncan, R; Wang, LY; Lu, XL				Zhou, Yilu; Lv, Mengxi; Li, Tong; Zhang, Tiange; Duncan, Randall; Wang, Liyun; Lu, X. Lucas			Spontaneous calcium signaling of cartilage cells: from spatiotemporal features to biophysical modeling	FASEB JOURNAL			English	Article						autocatalytic; threshold regulating; articular; chondrocytes; fingerprint	INTRACELLULAR CALCIUM; ARTICULAR CHONDROCYTES; INDUCED MECHANOTRANSDUCTION; EXTRACELLULAR ATP; GENE-EXPRESSION; OSCILLATIONS; RELEASE; WAVES; FLOW; CHANNELS	Intracellular calcium ([Ca2+](i)) oscillation is a fundamental signaling response of cartilage cells under mechanical loading or osmotic stress. Chondrocytes are usually considered as nonexcitable cells with no spontaneous [Ca2+](i) signaling. This study proved that chondrocytes can exhibit robust spontaneous [Ca2+](i) signaling without explicit external stimuli. The intensity of [Ca2+](i) peaks from individual chondrocytes maintain a consistent spatiotemporal pattern, acting as a unique fingerprint for each cell. Statistical analysis revealed lognormal distributions of the temporal parameters of [Ca2+](i) peaks, as well as strong linear correlations between their means and sds. Based on these statistical findings, we hypothesized that the spontaneous [Ca2+](i) peaks may result from an autocatalytic process and that [Ca2+](i) oscillation is controlled by a threshold-regulating mechanism. To test these 2 mechanisms, we established a multistage biophysical model by assuming the spontaneous [Ca2+](i) signaling of chondrocytes as a combination of deterministic and stochastic processes. The theoretical model successfully explained the lognormal distribution of the temporal parameters and the fingerprint feature of [Ca2+](i) peaks. In addition, by using antagonists for 10 pathways, we revealed that the initiation of spontaneous [Ca2+](i) peaks in chondrocytes requires the presence of extracellular Ca2+, and that the PLC-inositol 1,4,5-trisphosphate pathway, which controls the release of calcium from the endoplasmic reticulum, can affect the initiation of spontaneous [Ca2+](i) peaks in chondrocytes. The purinoceptors and transient receptor potential vanilloid 4 channels on the plasma membrane also play key roles in the spontaneous [Ca2+](i) signaling of chondrocytes. In contrast, blocking the T-type or L-type voltage-gated calcium channel promoted the spontaneous calcium signaling. This study represents a systematic effort to understand the features and initiation mechanisms of spontaneous [Ca2+](i) signaling in chondrocytes, which are critical for chondrocyte mechanobiology.	[Zhou, Yilu; Li, Tong; Zhang, Tiange; Wang, Liyun; Lu, X. Lucas] Univ Delaware, Dept Mech Engn, 130 Acad St,SPL126, Newark, DE 19716 USA; [Li, Tong] Univ Delaware, Dept Biol Sci, Newark, DC USA; [Lv, Mengxi] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DC USA; [Duncan, Randall] Dalian Univ Technol, Dept Engn Mech, Dalian, Peoples R China	University of Delaware; University of Delaware; University of Delaware; Dalian University of Technology	Lu, XL (corresponding author), Univ Delaware, Dept Mech Engn, 130 Acad St,SPL126, Newark, DE 19716 USA.	xlu@udel.edu	Li, Tong/AAS-7522-2020; Duncan, Randall/AAK-3888-2020; lu, xl/HDO-8340-2022; Lv, Mengxi/HGA-8647-2022	Li, Tong/0000-0003-3567-5908; Duncan, Randall/0000-0001-5733-6603	U.S. Department of Defense [W81XWH-13-1-0148]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR054385]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054385] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Jie Ma (Department of Biomedical Engineering, University of Delaware) for help in analyzing calcium peak traces. This work was supported by the U.S. Department of Defense (Grant W81XWH-13-1-0148 to X.L.L.) and the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR054385 to L.W.). The authors declare no conflicts of interest.	Adachi T, 2009, J BIOMECH, V42, P1989, DOI 10.1016/j.jbiomech.2009.04.034; Armbruster D., 2005, NETWORKS INTERACTING, V3; Berridge MJ, 2012, BIOCHEM SOC T, V40, P297, DOI 10.1042/BST20110766; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Bian L, 2008, J BIOMECH, V41, P1153, DOI 10.1016/j.jbiomech.2008.01.026; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Browning JA, 2004, BIORHEOLOGY, V41, P299; Bugrim AE, 1999, CELL CALCIUM, V25, P219, DOI 10.1054/ceca.1999.0027; Chao PHG, 2006, AM J PHYSIOL-CELL PH, V291, pC718, DOI 10.1152/ajpcell.00127.2005; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P167; D'Andrea P, 1998, BIOCHEM J, V329, P681, DOI 10.1042/bj3290681; Daluz H.M, 2019, FUNDAMENTALS FINGERP, Vsecond, P1; Deepak V, 2017, FASEB J, V31, P3027, DOI 10.1096/fj.201601280R; Degala S, 2011, ARCH BIOCHEM BIOPHYS, V505, P112, DOI 10.1016/j.abb.2010.08.003; Del Negro CA, 2011, J NEUROSCI, V31, P1017, DOI 10.1523/JNEUROSCI.4731-10.2011; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; Duncan RL, 1998, SEMIN NEPHROL, V18, P178; Dupont G, 2014, WIRES SYST BIOL MED, V6, P227, DOI 10.1002/wsbm.1261; Duszynski J, 2006, BBA-BIOENERGETICS, V1757, P380, DOI 10.1016/j.bbabio.2006.04.017; Evans JD., 1996, STRAIGHTFORWARD STAT; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Fodor J, 2013, CELL CALCIUM, V54, P1, DOI 10.1016/j.ceca.2013.03.003; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; FURUYA K, 1993, PFLUG ARCH EUR J PHY, V422, P295, DOI 10.1007/BF00374284; Garcia M, 2010, J ORTHOP RES, V28, P510, DOI 10.1002/jor.21025; Godin LM, 2007, BIOMECH MODEL MECHAN, V6, P391, DOI 10.1007/s10237-006-0059-5; Gong XY, 2019, J CELL PHYSIOL, V234, P9711, DOI 10.1002/jcp.27657; Grandolfo M, 1998, J BONE MINER RES, V13, P443, DOI 10.1359/jbmr.1998.13.3.443; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Guilak F, 1999, J ORTHOPAED RES, V17, P421, DOI 10.1002/jor.1100170319; Guilak F, 2010, ANN NY ACAD SCI, V1192, P404, DOI 10.1111/j.1749-6632.2010.05389.x; Guzman-Aranguez A, 2008, EUR J PHARMACOL, V584, P72, DOI 10.1016/j.ejphar.2008.02.002; Hattori S, 2007, BIOCHEM BIOPH RES CO, V358, P99, DOI 10.1016/j.bbrc.2007.04.142; Hayes JA, 2012, P NATL ACAD SCI USA, V109, P8286, DOI 10.1073/pnas.1200912109; He Z, 2016, OSTEOARTHR CARTILAGE, V24, P892, DOI 10.1016/j.joca.2015.11.015; HENTSCHEL HGE, 1983, PHYS REV A, V28, P417, DOI 10.1103/PhysRevA.28.417; Hernjak N, 2005, BIOPHYS J, V89, P3790, DOI 10.1529/biophysj.105.065771; HOEFFDING W, 1948, DUKE MATH J, V15, P773, DOI 10.1215/S0012-7094-48-01568-3; Hung CT, 1997, AM J PHYSIOL-CELL PH, V272, pC1611, DOI 10.1152/ajpcell.1997.272.5.C1611; Huo B, 2010, CELL CALCIUM, V47, P234, DOI 10.1016/j.ceca.2009.12.005; Huo B, 2010, PHILOS T R SOC A, V368, P617, DOI 10.1098/rsta.2009.0221; Huo B, 2008, CELL MOL BIOENG, V1, P58, DOI 10.1007/s12195-008-0011-0; Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578; Jung HJ, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.5; Jung HJ, 2015, BONE, V76, P88, DOI 10.1016/j.bone.2015.03.014; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Knight MM, 2009, J ANAT, V214, P275, DOI 10.1111/j.1469-7580.2008.01021.x; Kono T, 2006, CELL BIOCHEM FUNCT, V24, P103, DOI 10.1002/cbf.1304; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Kwon J, 2017, EXP NEUROBIOL, V26, P42, DOI 10.5607/en.2017.26.1.42; Lee JI, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-19; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Lewis KJ, 2017, P NATL ACAD SCI USA, V114, P11775, DOI 10.1073/pnas.1707863114; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Lopez L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00350; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Lv MX, 2018, J ORTHOP RES, V36, P730, DOI 10.1002/jor.23768; Machaca K, 2011, CELL CALCIUM, V49, P323, DOI 10.1016/j.ceca.2011.05.004; Mancilla EE, 2007, J CELL BIOCHEM, V101, P389, DOI 10.1002/jcb.21183; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Matta C, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0521-4; Matta C, 2015, PFLUG ARCH EUR J PHY, V467, P429, DOI 10.1007/s00424-014-1529-8; Matta Csaba, 2013, Front Biosci (Schol Ed), V5, P305; Meister S, 2010, NEOPLASIA, V12, P550, DOI 10.1593/neo.10228; Millward-Sadler SJ, 2004, BIORHEOLOGY, V41, P567; Nguyen V, 2005, B MATH BIOL, V67, P393, DOI 10.1016/j.bulm.2004.08.010; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Onimaru H, 2012, J PHYSIOL SCI, V62, P71, DOI 10.1007/s12576-011-0179-2; Parker I, 1996, CELL CALCIUM, V20, P105, DOI 10.1016/S0143-4160(96)90100-1; Parvizi J, 2002, J ORTHOPAED RES, V20, P51, DOI 10.1016/S0736-0266(01)00069-9; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Pingguan-Murphy B, 2006, J CELL PHYSIOL, V209, P389, DOI 10.1002/jcp.20747; Qusous A, 2012, GEN PHYSIOL BIOPHYS, V31, P299, DOI 10.4149/gpb_2012_035; Ralevic V, 1998, PHARMACOL REV, V50, P413; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roberts SR, 2001, J APPL PHYSIOL, V90, P1385, DOI 10.1152/jappl.2001.90.4.1385; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Rudiger S, 2014, PHYS REP, V534, P39, DOI 10.1016/j.physrep.2013.09.002; Sauer H, 2000, AM J PHYSIOL-CELL PH, V279, pC295, DOI 10.1152/ajpcell.2000.279.2.C295; SERVINVENCES M, 2017, G R, V6, DOI DOI 10.7554/ELIFE.21074; Shuai J W, 2002, Phys Rev Lett, V88, P068102; Srinivasan PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127290; Steward AJ, 2016, TISSUE ENG PT A, V22, P831, DOI [10.1089/ten.tea.2015.0047, 10.1089/ten.TEA.2015.0047]; Sun XH, 2012, BONE, V51, P860, DOI 10.1016/j.bone.2012.08.116; Sun XH, 2012, BONE, V50, P581, DOI 10.1016/j.bone.2011.12.015; TANG YH, 1994, BIOPHYS J, V67, P2223, DOI 10.1016/S0006-3495(94)80707-6; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Voets T, 2009, EMBO J, V28, P4, DOI 10.1038/emboj.2008.261; Wagenmakers EJ, 2005, J MATH PSYCHOL, V49, P195, DOI 10.1016/j.jmp.2005.02.003; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001; Yellowley CE, 1999, J CELL PHYSIOL, V180, P402, DOI 10.1002/(SICI)1097-4652(199909)180:3<402::AID-JCP11>3.0.CO;2-4; Zhou YL, 2016, ANN BIOMED ENG, V44, P1138, DOI 10.1007/s10439-015-1406-4; Zhou YL, 2015, J BIOMECH, V48, P990, DOI 10.1016/j.jbiomech.2015.02.005	102	13	13	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2019	33	4					4675	4687		10.1096/fj.201801460R	http://dx.doi.org/10.1096/fj.201801460R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HR1JP	30601690	Green Published, Bronze			2022-12-26	WOS:000462888500004
J	Dhingra, N; Wei, L; Zhao, XL				Dhingra, Nalini; Wei, Lei; Zhao, Xiaolan			Replication protein A (RPA) sumoylation positively influences the DNA damage checkpoint response in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; small ubiquitin-like modifier (SUMO); checkpoint control; Saccharomyces cerevisiae; DNA damage checkpoint; DNA damage induced sumoylation; RPA; sumoylation, Sgs1, checkpoint kinase activation	SUMO-MEDIATED REGULATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; REPAIR; RECOMBINATION; COMPLEX; SRS2; MEC1/ATR; RECOVERY; LIGASE	The DNA damage response relies on protein modifications to elicit physiological changes required for coping with genotoxic conditions. Besides canonical DNA damage checkpoint-mediated phosphorylation, DNA damage-induced sumoylation has recently been shown to promote genotoxin survival. Cross-talk between these two pathways exists in both yeast and human cells. In particular, sumoylation is required for optimal checkpoint function, but the underlying mechanisms are not well-understood. To address this question, we examined the sumoylation of the first responder to DNA lesions, the ssDNA-binding protein complex replication protein A (RPA) in budding yeast (Saccharomyces cerevisiae). We delineated the sumoylation sites of the RPA large subunit, Rfa1 on the basis of previous and new mapping data. Findings using a sumoylation-defective Rfa1 mutant suggested that Rfa1 sumoylation acts in parallel with the 9-1-1 checkpoint complex to enhance the DNA damage checkpoint response. Mechanistically, sumoylated Rfa1 fostered an interaction with a checkpoint adaptor protein, Sgs1, and contributed to checkpoint kinase activation. Our results suggest that SUMO-based modulation of a DNA damage sensor positively influences the checkpoint response.	[Dhingra, Nalini; Wei, Lei; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Wei, Lei] Princeton Univ, Mol Biol Dept, Princeton, NJ 08544 USA	Memorial Sloan Kettering Cancer Center; Princeton University	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA.	zhaox1@mskcc.org		Zhao, Xiaolan/0000-0002-8302-6905; Dhingra, Nalini/0000-0003-0949-883X	NIGMS, National Institutes of Health [GM080670]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080670] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM080670 (to X. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almedawar S, 2012, CURR BIOL, V22, P1576, DOI 10.1016/j.cub.2012.06.046; Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Bonner JN, 2016, CELL REP, V16, P368, DOI 10.1016/j.celrep.2016.06.015; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chung I, 2015, GENE DEV, V29, P1593, DOI 10.1101/gad.265058.115; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Cussiol JR, 2017, CHROMOSOMA, V126, P45, DOI 10.1007/s00412-016-0600-y; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hegnauer AM, 2012, EMBO J, V31, P3768, DOI 10.1038/emboj.2012.195; James P, 1996, GENETICS, V144, P1425; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Klein H, 2001, GENETICS, V157, P557; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Marini V, 2010, DNA REPAIR, V9, P268, DOI 10.1016/j.dnarep.2010.01.007; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Sarangi P, 2015, TRENDS BIOCHEM SCI, V40, P233, DOI 10.1016/j.tibs.2015.02.006; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Ulrich Hehe D., 2009, V497, P81, DOI 10.1007/978-1-59745-566-4_6; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wei L, 2016, NAT STRUCT MOL BIOL, V23, P209, DOI 10.1038/nsmb.3173; Wu CS, 2014, GENE DEV, V28, P1472, DOI 10.1101/gad.238535.114; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yeung M, 2011, DNA REPAIR, V10, P1213, DOI 10.1016/j.dnarep.2011.09.005; Zhao XL, 2018, MOL CELL, V71, P409, DOI 10.1016/j.molcel.2018.07.027; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zou L, 2013, GENE DEV, V27, P227, DOI 10.1101/gad.213306.113	45	13	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2690	2699		10.1074/jbc.RA118.006006	http://dx.doi.org/10.1074/jbc.RA118.006006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591583	Green Published, hybrid			2022-12-26	WOS:000459601600011
J	Yang, CZ; Zang, WC; Ji, YP; Li, TT; Yang, YF; Zheng, XF				Yang, Chuanzhen; Zang, Weicheng; Ji, Yapeng; Li, Tingting; Yang, Yongfeng; Zheng, Xiaofeng			Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly(ADP-ribose) polymerase-dependent manner and regulates the DNA damage response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; ubiquitylation (ubiquitination); DNA repair; cell signaling; E3 ubiquitin ligase; histone; histone H2A; MDC1; PARP; Ribosomal Protein L6	P53; 53BP1; NUCLEOLUS; PATHWAY; ATM; ACTIVATION; COMPLEX; RNF168; REPAIR; RNF8	Ribosomal proteins are the building blocks of ribosome biogenesis. Beyond their known participation in ribosome assembly, the ribosome-independent functions of ribosomal proteins are largely unknown. Here, using immunoprecipitation, subcellular fractionation, His-ubiquitin pulldown, and immunofluorescence microscopy assays, along with siRNA-based knockdown approaches, we demonstrate that ribosomal protein L6 (RPL6) directly interacts with histone H2A and is involved in the DNA damage response (DDR). We found that in response to DNA damage, RPL6 is recruited to DNA damage sites in a poly(ADP-ribose) polymerase (PARP)-dependent manner, promoting its interaction with H2A. We also observed that RPL6 depletion attenuates the interaction between mediator of DNA damage checkpoint 1 (MDC1) and H2A histone family member X, phosphorylated (gamma H2AX), impairs the accumulation of MDC1 at DNA damage sites, and reduces both the recruitment of ring finger protein 168 (RNF168) and H2A Lys-15 ubiquitination (H2AK15ub). These RPL6 depletion-induced events subsequently inhibited the recruitment of the following downstream repair proteins: tumor protein P53-binding protein 1 (TP53BP1) and BRCA1, DNA repair-associated (BRCA1). Moreover, the RPL6 knockdown resulted in defects in the DNA damage-induced G(2)-M checkpoint, DNA damage repair, and cell survival. In conclusion, our study identifies RPL6 as a critical regulatory factor involved in the DDR. These findings expand our knowledge of the extraribosomal functions of ribosomal proteins in cell physiology and deepen our understanding of the molecular mechanisms underlying DDR regulation.	[Yang, Chuanzhen; Zang, Weicheng; Ji, Yapeng; Li, Tingting; Yang, Yongfeng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Yang, Chuanzhen; Zang, Weicheng; Ji, Yapeng; Li, Tingting; Yang, Yongfeng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China	Peking University; Peking University	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn		Ji, Yapeng/0000-0003-2343-4365	National Science Foundation of China [81730080, 31670786, 31470754]; National Key Research and Development Program of China [2016YFC1302401]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Science Foundation of China Grants 81730080, 31670786, and 31470754 and the National Key Research and Development Program of China Grant 2016YFC1302401. The authors declare that they have no conflicts of interest with the contents of this article.	Bai DM, 2014, NUCLEIC ACIDS RES, V42, P1799, DOI 10.1093/nar/gkt971; Bailly A, 2016, ONCOGENE, V35, P415, DOI 10.1038/onc.2015.104; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cui D, 2014, ONCOGENE, V33, P2225, DOI 10.1038/onc.2013.170; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; de Marval PLM, 2011, ONCOTARGET, V2, P234; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kim H, 2014, NATURE, V506, P334, DOI 10.1038/nature13039; Lee JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01051-z; Li TT, 2014, J CELL SCI, V127, P2238, DOI 10.1242/jcs.138891; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Naganuma T, 2010, J BIOL CHEM, V285, P4747, DOI 10.1074/jbc.M109.068098; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Nowsheen S, 2018, NAT CELL BIOL, V20, P455, DOI 10.1038/s41556-018-0071-x; Pan WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021625; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Stepinski D, 2016, HISTOCHEM CELL BIOL, V146, P119, DOI 10.1007/s00418-016-1443-6; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yang CZ, 2018, CANCER RES, V78, P1069, DOI 10.1158/0008-5472.CAN-17-2143; Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	48	23	24	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2827	2838		10.1074/jbc.RA118.007009	http://dx.doi.org/10.1074/jbc.RA118.007009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30598506	hybrid, Green Published			2022-12-26	WOS:000459601600021
J	Chan, S; Brophy, M; Nishimura, N; Schaffer, CB				Chan, Sandy; Brophy, Morgan; Nishimura, Nozomi; Schaffer, Chris B.			Aspirin treatment does not increase microhemorrhage size in young or aged mice	PLOS ONE			English	Article							INTRACEREBRAL HEMORRHAGE; CEREBRAL MICROBLEEDS; HEMOSTASIS CHANGES; HEMATOMA VOLUME; PRETREATMENT	Microhemorrhages are common in the aging brain and are thought to contribute to cognitive decline and the development of neurodegenerative diseases, such as Alzheimer's disease. Chronic aspirin therapy is widespread in older individuals and decreases the risk of coronary artery occlusions and stroke. There remains a concern that such aspirin usage may prolong bleeding after a vessel rupture in the brain, leading to larger bleeds that cause more damage to the surrounding tissue. Here, we aimed to understand the influence of aspirin usage on the size of cortical microhemorrhages and explored the impact of age. We used femtosecond laser ablation to rupture arterioles in the cortex of both young (2-5 months old) and aged (18-29 months old) mice dosed on aspirin in their drinking water and measured the extent of penetration of both red blood cells and blood plasma into the surrounding tissue. We found no difference in microhemorrhage size for both young and aged mice dosed on aspirin, as compared to controls (hematoma diameter = 104 +/- 39 (97 +/- 38) mu m in controls and 109 +/- 25 (101 +/- 28) mu m in aspirin-treated young (aged) mice; mean +/- SD). In contrast, young mice treated with intravenous heparin had an increased hematoma diameter of 136 +/- 44 mu m. These data suggest that aspirin does not increase the size of microhemorrhages, supporting the safety of aspirin usage.	[Chan, Sandy; Brophy, Morgan; Nishimura, Nozomi; Schaffer, Chris B.] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA	Cornell University	Schaffer, CB (corresponding author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.	cs385@cornell.edu	Schaffer, Chris B./A-7409-2008	Schaffer, Chris B./0000-0002-7800-9596	NIH [NS080098]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant NS080098 (CBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cianchetti FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065663; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; De Reuck J, 2011, J NEUROL SCI, V300, P63, DOI 10.1016/j.jns.2010.09.031; Falcone GJ, 2014, STROKE, V45, P3151, DOI 10.1161/STROKEAHA.114.005787; Favaloro EJ, 2014, SEMIN THROMB HEMOST, V40, P621, DOI 10.1055/s-0034-1384631; Foerch C, 2006, STROKE, V37, P2165, DOI 10.1161/01.STR.0000231842.32153.74; Foerch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054203; Franchini M, 2006, CRIT REV ONCOL HEMAT, V60, P144, DOI 10.1016/j.critrevonc.2006.06.004; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Lauer A, 2013, LANCET NEUROL, V12, P394, DOI 10.1016/S1474-4422(13)70049-8; Lauer A, 2011, CIRCULATION, V124, P1654, DOI 10.1161/CIRCULATIONAHA.111.035972; Lauer A, 2011, J CEREBR BLOOD F MET, V31, P1736, DOI 10.1038/jcbfm.2011.22; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; ROEHM E, 1995, AM J CARDIOL, V76, P637, DOI 10.1016/S0002-9149(99)80177-5; Rosidi NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026612; Salman RA, 2014, STROKE, V45, P3149, DOI 10.1161/STROKEAHA.114.005786; Saloheimo P, 2006, STROKE, V37, P129, DOI 10.1161/01.STR.0000196991.03618.31; Selim MH, 2014, STROKE, V45, P3153, DOI 10.1161/STROKEAHA.114.006620; Sepulveda C, 2015, MECH AGEING DEV, V150, P46, DOI 10.1016/j.mad.2015.08.006; Vernooij MW, 2009, ARCH NEUROL-CHICAGO, V66, P714, DOI 10.1001/archneurol.2009.42; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005; Wong KS, 2000, NEUROLOGY, V54, P2298, DOI 10.1212/WNL.54.12.2298	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2019	14	1							e0204295	10.1371/journal.pone.0204295	http://dx.doi.org/10.1371/journal.pone.0204295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG4NS	30608925	gold, Green Published, Green Submitted			2022-12-26	WOS:000454952800004
J	Malau-Aduli, AEO; Nguyen, DV; Le, HV; Nguyen, QV; Otto, JR; Malau-Aduli, BS; Nichols, PD				Malau-Aduli, Aduli E. O.; Nguyen, Don V.; Le, Hung V.; Nguyen, Quang V.; Otto, John R.; Malau-Aduli, Bunmi S.; Nichols, Peter D.			Correlations between growth and wool quality traits of genetically divergent Australian lambs in response to canola or flaxseed oil supplementation	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; CARCASS CHARACTERISTICS; MEAT QUALITY; PERFORMANCE; FIBER; LIPIDS; MERINO; FISH; REPRODUCTION; LIVEWEIGHT	The correlations between growth and wool traits in response to canola and flaxseed oil supplementation were evaluated in Australian prime lambs. Sixty dual-purpose prime lambs including purebred Merino and crossbred lambs were allocated to one of five treatments of lucerne hay basal diet supplemented with isocaloric and isonitrogenous wheat-based pellets. Treatments were: no oil inclusion (Control); 2.5% canola oil; 5% canola oil; 2.5% flaxseed oil and 5% flax-seed oil, with lamb groups balanced by breed and gender. Each lamb was daily supplemented with 1kg of pellets and had free access to lucerne hay and water throughout the 7-week feeding trial, after a 3-week adaptation. Individual animal basal and supplementary pellet feed intakes were recorded daily, while body conformation traits, body condition scores and liveweights were measured on days 0, 21, 35 and 49. The lambs were dye-banded on the mid-side and shorn before commencing the feeding trial and mid-side wool samples were collected from the same dye-banded area of each lamb at the end of the experiment. Correlations between wool quality traits and lamb performance were non-significant (P>0.05). Oil supplementation had no detrimental effect on lamb growth and wool quality traits (P>0.05). Gender significantly affected wither height gain and fibre diameter. There were significant interactions between oil supplementation and lamb breed on chest girth. The correlations between clean fleece yield (CFY) and other wool quality traits were moderate ranging from 0.29 to 0.55. Moderate to high correlations between fibre diameter (FD) and other wool quality traits were detected (0.46-0.99) with the strongest relationship between FD and wool spinning fineness (SF). The relationship between CFY and wool comfort factor (CF) were positive, while negative relationships between CFY and the others were observed. A combination of 5% oil supplementation and genetics is an effective and strategic management tool for enhancing feed efficiency and growth performance without negative effects on wool quality in dual-purpose lamb production. This is a good outcome for dual-purpose sheep farmers. It essentially means the absorbed nutrients in supplemented lambs yielded good growth performance without any detrimental impact on wool quality; a win-win case of nutrient partitioning into the synthesis of muscle and wool without compromising either traits.	[Malau-Aduli, Aduli E. O.; Nguyen, Don V.; Le, Hung V.; Nguyen, Quang V.; Otto, John R.; Nichols, Peter D.] James Cook Univ, Anim Genet & Nutr, Vet Sci Discipline, Coll Publ Hlth Med & Vet Sci,Div Trop Hlth & Med, Townsville, Qld, Australia; [Nguyen, Don V.; Le, Hung V.] Natl Inst Anim Sci, Hanoi, Vietnam; [Nguyen, Quang V.] Thai Nguyen Univ, Coll Econ & Tech, Thai Nguyen, Vietnam; [Malau-Aduli, Bunmi S.] James Cook Univ, Coll Med & Dent, Div Trop Hlth & Med, Townsville, Qld, Australia; [Nichols, Peter D.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia	James Cook University; Thai Nguyen University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Malau-Aduli, AEO (corresponding author), James Cook Univ, Anim Genet & Nutr, Vet Sci Discipline, Coll Publ Hlth Med & Vet Sci,Div Trop Hlth & Med, Townsville, Qld, Australia.	aduli.malauaduli@jcu.edu.au	Malau-Aduli, Aduli Enoch Othniel/C-2419-2014; Nguyen, Don/L-9859-2019; Malau-Aduli, Bunmi/J-9388-2014	Malau-Aduli, Aduli Enoch Othniel/0000-0002-3660-7862; Nguyen, Don/0000-0002-4273-0672; Malau-Aduli, Bunmi/0000-0001-6054-8498; Nguyen, Vu Quang/0000-0003-4271-9710	John Allwright Fellowship of the Australian Centre for International Agricultural Research	John Allwright Fellowship of the Australian Centre for International Agricultural Research	The John Allwright Fellowship of the Australian Centre for International Agricultural Research funded DVN with a PhD scholarship that enabled the execution of this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NR, 2003, AUST J AGR RES, V54, P1, DOI 10.1071/AR02059; Annett RW, 2011, ANIMAL, V5, P1023, DOI 10.1017/S1751731110002703; [Anonymous], 2014, STAT AN SYST VERS 9; Asadollahi S, 2017, SMALL RUMINANT RES, V153, P95, DOI 10.1016/j.smallrumres.2017.05.012; Bessa RJB, 2005, LIVEST PROD SCI, V96, P185, DOI 10.1016/j.livprodsci.2005.01.017; Bessa RJB, 2015, EUR J LIPID SCI TECH, V117, P1325, DOI 10.1002/ejlt.201400468; BUTLER KL, 1992, AUST J AGR RES, V43, P1441, DOI 10.1071/AR9921441; Cake MA, 2007, AUST J EXP AGR, V47, P1128, DOI 10.1071/EA07058; Ekiz B, 2009, MEAT SCI, V82, P64, DOI 10.1016/j.meatsci.2008.12.001; Ekmekcioglu C, 2018, CRIT REV FOOD SCI, V58, P247, DOI 10.1080/10408398.2016.1158148; Ferreira EM, 2014, ANIM FEED SCI TECH, V187, P9, DOI 10.1016/j.anifeedsci.2013.09.016; Flakemore AR, 2017, MEAT SCI, V123, P79, DOI 10.1016/j.meatsci.2016.09.006; Francisco A, 2016, ANIMAL, V10, P2061, DOI 10.1017/S1751731116001129; Francisco A, 2015, MEAT SCI, V100, P275, DOI 10.1016/j.meatsci.2014.10.014; Garnsworthy PC, 2004, ANIM SCI, V79, P327, DOI 10.1017/S1357729800090184; Gillingham LG, 2011, BRIT J NUTR, V105, P417, DOI 10.1017/S0007114510003697; Hegarty RS, 2006, AUST J AGR RES, V57, P593, DOI 10.1071/AR04275; Holman B. W. B., 2014, Journal of Agricultural Science (Toronto), V6, P120; Holman BWB, 2014, SMALL RUMINANT RES, V120, P6, DOI 10.1016/j.smallrumres.2014.04.014; Holman B. W. B., 2012, Annual Review & Research in Biology, V2, P1; Holman B. W. B., 2012, American Journal of Experimental Agriculture, V2, P160; Holman BWB, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3174; IKWUEGBU OA, 1982, BRIT J NUTR, V48, P365, DOI 10.1079/BJN19820120; Jaworska D, 2016, MEAT SCI, V119, P185, DOI 10.1016/j.meatsci.2016.05.003; Kitessa SM, 2014, NUTRIENTS, V6, P2035, DOI 10.3390/nu6052035; LANG LANDS J. P., 1968, AUST J EXP AGR ANIM HUSB, V8, P265, DOI 10.1071/EA9680265; Lenihan-Geels G, 2013, NUTRIENTS, V5, P1301, DOI 10.3390/nu5041301; Lewis RM, 2006, AUST J AGR RES, V57, P707, DOI 10.1071/AR05196; Malau-Aduli A. E. O., 2012, American Journal of Experimental Agriculture, V2, P31; Malau-Aduli AEO, 2010, J DAIRY SCI, V93, P860; Malau-Aduli AEO, 2014, 10 WORLD C GEN APPL; Malau-Aduli AEO, 2012, WORLD ACAD SCI ENG T, V67, P792; Manso T, 2009, MEAT SCI, V83, P511, DOI 10.1016/j.meatsci.2009.06.035; McGregor BA, 2014, J TEXT I, V105, P597, DOI 10.1080/00405000.2013.828448; Meale SJ, 2015, J ANIM SCI, V93, P3110, DOI 10.2527/jas.2014-8437; Mertens DR, 2002, J AOAC INT, V85, P1217; Mitchell AD, 2007, J NUTR, V137, P711, DOI 10.1093/jn/137.3.711; Nguyen D.V., 2017, INT MED REV, V3, P1, DOI DOI 10.18103/IMR.V3I3.295; Nguyen DV, 2018, ANIM PROD SCI, V58, P2100, DOI 10.1071/AN16812; Nguyen DV, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080893; Nichols PD, 2010, NUTRIENTS, V2, P572, DOI 10.3390/nu2060572; PITCHFORD WS, 1992, AUST J AGR RES, V43, P1417, DOI 10.1071/AR9921417; Plowman JE, 2003, J CHROMATOGR B, V787, P63, DOI 10.1016/S1570-0232(02)00211-8; Radunz AE, 2009, J ANIM SCI, V87, P4082, DOI 10.2527/jas.2009-2059; Rodriguez AB, 2011, LIVEST SCI, V138, P13, DOI 10.1016/j.livsci.2010.11.020; Safari E, 2005, LIVEST PROD SCI, V92, P271, DOI 10.1016/j.livprodsci.2004.09.003; Scales GH, 2000, NEW ZEAL J AGR RES, V43, P93, DOI 10.1080/00288233.2000.9513412; Scollan ND, 2014, MEAT SCI, V97, P384, DOI 10.1016/j.meatsci.2014.02.015; Urrutia O, 2015, LIVEST SCI, V178, P345, DOI 10.1016/j.livsci.2015.05.006; Urrutia O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156765; Van Beem D, 2008, AUST J EXP AGR, V48, P879, DOI 10.1071/EA08063; Warn LK., 2006, INT J SHEEP WOOL SCI, V54, P40; Wolk A, 2017, J INTERN MED, V281, P106, DOI 10.1111/joim.12543; Woods VB, 2009, LIVEST SCI, V126, P1, DOI 10.1016/j.livsci.2009.07.002	54	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2019	14	1							e0208229	10.1371/journal.pone.0208229	http://dx.doi.org/10.1371/journal.pone.0208229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1ZC	30605467	Green Accepted, Green Published, gold			2022-12-26	WOS:000454759900010
J	Tverin, M; Esparza-Salas, R; Stromberg, A; Tang, P; Kokkonen, I; Herrero, A; Kauhala, K; Karlsson, O; Tiilikainen, R; Vetemaa, M; Sinisalo, T; Kakela, R; Lundstrom, K				Tverin, Malin; Esparza-Salas, Rodrigo; Stromberg, Annika; Tang, Patrik; Kokkonen, Iiris; Herrero, Annika; Kauhala, Kaarina; Karlsson, Olle; Tiilikainen, Raisa; Vetemaa, Markus; Sinisalo, Tuula; Kakela, Reijo; Lundstrom, Karl			Complementary methods assessing short and long-term prey of a marine top predator - Application to the grey seal-fishery conflict in the Baltic Sea	PLOS ONE			English	Article							ECOLOGICAL REGIME SHIFTS; STABLE-ISOTOPE ANALYSIS; FATTY-ACID-COMPOSITION; PHOCA-HISPIDA-BOTNICA; FOOD-WEB; HALICHOERUS-GRYPUS; CARBON ISOTOPES; DIET COMPOSITION; RINGED SEALS; BLUBBER	The growing grey seal (Halichoerus grypus) population in the Baltic Sea has created conflicts with local fisheries, comparable to similar emerging problems worldwide. Adequate information on the foraging habits is a requirement for responsible management of the seal population. We investigated the applicability of available dietary assessment methods by comparing morphological analysis and DNA metabarcoding of gut contents (short-term diet; n = 129/125 seals, respectively), and tissue chemical markers i.e. fatty acid (FA) profiles of blubber and stable isotopes (SIs) of liver and muscle (mid- or long-term diet; n = 108 seals for the FA and SI markers). The methods provided complementary information. Short-term methods indicated prey species and revealed dietary differences between age groups and areas but for limited time period. In the central Baltic, herring was the main prey, while in the Gulf of Finland percid and cyprinid species together comprised the largest part of the diet. Perch was also an important prey in the western Baltic Proper. The DNA analysis provided firm identification of many prey species, which were neglected or identified only at species group level by morphological analysis. Liver SIs distinguished spatial foraging patterns and identified potentially migrated individuals, whereas blubber FAs distinguished individuals frequently utilizing certain types of prey. Tissue chemical markers of adult males suggested specialized feeding to certain areas and prey, which suggest that these individuals are especially prone to cause economic losses for fisheries. We recommend combined analyses of gut contents and tissue chemical markers as dietary monitoring methodology of aquatic top predators to support an optimal ecosystem-based management.	[Tverin, Malin; Tang, Patrik; Kokkonen, Iiris; Kakela, Reijo] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Programme, Helsinki, Finland; [Esparza-Salas, Rodrigo] Univ Oulu, Dept Biol, Oulu, Finland; [Stromberg, Annika; Karlsson, Olle] Swedish Museum Nat Hist, Dept Environm Res & Monitoring, Stockholm, Sweden; [Herrero, Annika] Luke, Nat Resources Inst, Helsinki, Finland; [Kauhala, Kaarina] Luke, Nat Resources Inst, Turku, Finland; [Tiilikainen, Raisa] Metsahallitus Pk & Wildlife, Savonlinna, Finland; [Vetemaa, Markus] Univ Tartu, Estonian Marine Inst, Tartu, Estonia; [Sinisalo, Tuula] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Lundstrom, Karl] Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden; [Esparza-Salas, Rodrigo] Swedish Museum Nat Hist, Dept Bioinformat & Genet, Stockholm, Sweden; [Tang, Patrik] Univ Bergen, Dept Biol Sci, Bergen, Norway	University of Helsinki; University of Oulu; Swedish Museum of Natural History; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of Tartu; Estonian Marine Institute; University of Jyvaskyla; Swedish University of Agricultural Sciences; Swedish Museum of Natural History; University of Bergen	Lundstrom, K (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden.	karl.lundstrom@slu.se	Esparza-Salas, Rodrigo/O-4954-2018	Esparza Salas, Rodrigo/0000-0002-7568-2515; Lundstrom, Karl/0000-0002-3758-0665	EU; Finnish Cultural Foundation [00150994]; Otto A. Malms donationsfond [7-5077-44]; Oskar Oflunds stiftelse [2-3496-18]	EU(European Commission); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Otto A. Malms donationsfond; Oskar Oflunds stiftelse	The collection and analysis of seal and fish samples was supported by the EU funded Ecoseal project in 2012-13. Additional funding was obtained from Finnish Cultural Foundation (00150994), Otto A. Malms donationsfond (7-5077-44) and Oskar Oflunds stiftelse (2-3496-18).	Ahlgren G, 2005, CAN J FISH AQUAT SCI, V62, P2240, DOI 10.1139/F05-140; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; [Anonymous], SUOMEN RIISTA; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Blankenberg D, 2001, CURRENT PROTOCOLS MO; Bond AL, 2012, WATERBIRDS, V35, P324, DOI 10.1675/063.035.0213; Bowen WD, 2013, MAMMAL REV, V43, P207, DOI 10.1111/j.1365-2907.2012.00217.x; Bradshaw CJA, 2003, P ROY SOC B-BIOL SCI, V270, P1283, DOI 10.1098/rspb.2003.2371; Budge SM, 2004, PHYSIOL BIOCHEM ZOOL, V77, P682, DOI 10.1086/420945; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Butler JRA, 2011, MAR POLICY, V35, P317, DOI 10.1016/j.marpol.2010.10.011; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHRISTIE OHJ, 1979, ANAL LETT PT A, V12, P979; Connolly RM, 2004, OECOLOGIA, V138, P161, DOI 10.1007/s00442-003-1415-0; Cooper MH, 2005, J COMP PHYSIOL B, V175, P133, DOI 10.1007/s00360-004-0469-6; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DUNN WJ, 1980, BIOORG CHEM, V9, P505, DOI 10.1016/0045-2068(80)90010-3; Elliott KH, 2016, J EXP MAR BIOL ECOL, V474, P54, DOI 10.1016/j.jembe.2015.09.017; Engelhard GH, 2014, ICES J MAR SCI, V71, P90, DOI 10.1093/icesjms/fst087; Focken U, 1998, OECOLOGIA, V115, P337, DOI 10.1007/s004420050525; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Fry B., 2006, STABLE ISOTOPE ECOLO; Graham IM, 2011, ANIM CONSERV, V14, P587, DOI 10.1111/j.1469-1795.2011.00469.x; Grahl-Nielsen O, 2011, MAR ECOL PROG SER, V426, P263, DOI 10.3354/meps09011; Hammill MO, 2014, ICES J MAR SCI, V71, P1332, DOI 10.1093/icesjms/fsu123; Hammond PS, 2006, MF0319 DEP ENV FOOD; Harding Karin C., 2007, NAMMCO Scientific Publications, V6, P33; Harding KC, 1999, AMBIO, V28, P619; Harkonen T.J., 1986, GUIDE OTOLITHS BONY, P256; HEWER H. R., 1964, PROC ZOOL SOC LONDON, V142, P593; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; IRVING LAURENCE, 1957, CANADIAN JOUR ZOOL, V35, P497, DOI 10.1139/z57-041; Iverson SJ, 2007, MAR ECOL PROG SER, V352, P235, DOI 10.3354/meps07073; JOBLING M, 1986, SARSIA, V71, P265, DOI 10.1080/00364827.1986.10419696; Kakela R, 2005, MAR ECOL PROG SER, V293, P191, DOI 10.3354/meps293191; Kakela R, 2009, FUNCT ECOL, V23, P141, DOI 10.1111/j.1365-2435.2008.01475.x; KAKELA R, 1993, COMP BIOCHEM PHYS B, V105, P553, DOI 10.1016/0305-0491(93)90088-M; Kauhala K, 2015, ANN ZOOL FENN, V52, P103, DOI 10.5735/086.052.0209; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Konigson S, 2013, FISH RES, V148, P117, DOI 10.1016/j.fishres.2013.07.014; Kurle CM, 2002, MAR ECOL PROG SER, V236, P289, DOI 10.3354/meps236289; Lind Y, 2012, MAR ECOL PROG SER, V461, P283, DOI 10.3354/meps09769; Lundstrom K., 2007, NAMMCO Scientific Publications, V6, P177; Lundstrom K, 2010, ICES J MAR SCI, V67, P1230, DOI 10.1093/icesjms/fsq022; Meheust E, 2015, MAR BIOL RES, V11, P385, DOI 10.1080/17451000.2014.943240; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Nordstrom CA, 2008, MAR ECOL PROG SER, V360, P245, DOI 10.3354/meps07378; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Oksanen SM, 2014, MAR ECOL PROG SER, V507, P297, DOI 10.3354/meps10846; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sinisalo T, 2008, MAR MAMMAL SCI, V24, P159, DOI 10.1111/j.1748-7692.2007.00170.x; Soderberg S., 1975, P S SEAL BALT JUN 4, P66; Strandberg U, 2008, PHYSIOL BIOCHEM ZOOL, V81, P473, DOI 10.1086/589108; Strandberg U, 2011, J EXP MAR BIOL ECOL, V407, P256, DOI 10.1016/j.jembe.2011.06.021; Suuronen P, 2012, FISH RES, V125, P283, DOI 10.1016/j.fishres.2012.03.007; Taipale SJ, 2016, ENVIRON INT, V96, P156, DOI 10.1016/j.envint.2016.08.018; Thomas AC, 2014, MOL ECOL, V23, P3706, DOI 10.1111/mec.12523; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tomczak MT, 2012, ECOL MODEL, V230, P123, DOI 10.1016/j.ecolmodel.2011.12.014; TORMOSOV DD, 1978, FINN GAME RES, V37, P14; Vanhatalo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113836; Vuorinen I, 1998, ICES J MAR SCI, V55, P767, DOI 10.1006/jmsc.1998.0398; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Winter, 2001, WORLD BIODIVERSITY D; Wold S., 1977, CHEMOMETRICS THEORY, P243, DOI DOI 10.1021/BK-1977-0052.CH012	74	22	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0208694	10.1371/journal.pone.0208694	http://dx.doi.org/10.1371/journal.pone.0208694			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601857	Green Published, Green Submitted, gold			2022-12-26	WOS:000454683200018
J	Zebertavage, L; Bambina, S; Shugart, J; Alice, A; Zens, KD; Lauer, P; Hanson, B; Gough, MJ; Crittenden, MR; Bahjat, KS				Zebertavage, Lauren; Bambina, Shelly; Shugart, Jessica; Alice, Alejandro; Zens, Kyra D.; Lauer, Peter; Hanson, Bill; Gough, Michael J.; Crittenden, Marka R.; Bahjat, Keith S.			A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+T cells and anti-tumor immunity	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PEPTIDE VACCINATION; RESPONSES; EXPRESSION; HEAD; CONTRIBUTES; ACTIVATION; RESISTANCE; INVASION; POTENCY	Dysregulated signaling via the epidermal growth factor receptor (EGFR)-family is believed to contribute to the progression of a diverse array of cancers. The most common variant of EGFR is EGFRvIII, which results from a consistent and tumor-specific in-frame deletion of exons 2-7 of the EGFR gene. This deletion generates a novel glycine at the junction and leads to constitutive ligand-independent activity. This junction forms a novel shared tumor neo-antigen with demonstrated immunogenicity in both mice and humans. A 21-amino acid peptide spanning the junctional region was selected, and then one or five copies of this 21-AA neo-peptide were incorporated into live-attenuated Listeria monocytogenes-based vaccine vector. These vaccine candidates demonstrated efficient secretion of the recombinant protein and potent induction of EGFRvIII-specific CD8+ T cells, which prevented growth of an EGFRvIII-expressing squamous cell carcinoma. These data demonstrate the potency of a novel cancer-specific vaccine candidate that can elicit EGFRvIII-specific cellular immunity, for the purpose of targeting EGFRvIII positive cancers that are resistant to conventional therapies.	[Zebertavage, Lauren; Bambina, Shelly; Shugart, Jessica; Alice, Alejandro; Zens, Kyra D.; Gough, Michael J.; Crittenden, Marka R.; Bahjat, Keith S.] Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Zebertavage, Lauren] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Lauer, Peter; Hanson, Bill] Aduro Biotech, Berkeley, CA USA; [Crittenden, Marka R.] Oregon Clin, Portland, OR USA	Providence Portland Medical Center; Oregon Health & Science University	Gough, MJ (corresponding author), Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA.	michael.gough@providence.org	Gough, Michael/AAY-3419-2020	Gough, Michael/0000-0002-5575-0074; Zens, Kyra/0000-0001-7979-076X	Susan G. Komen(R) [CCR12226309]; NIH [R01CA182311, R21AI126151]; Kuni Foundation; Providence Portland Medical Foundation; Aduro Biotech; NIH Tetramer Core Facility [HHSN272201300006C]; NATIONAL CANCER INSTITUTE [R01CA182311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126151] Funding Source: NIH RePORTER	Susan G. Komen(R); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kuni Foundation; Providence Portland Medical Foundation; Aduro Biotech; NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from Susan G. Komen (R) CCR12226309 (KSB), NIH R01CA182311 (MJG and MRC) and R21AI126151 (MJG and MRC), the Kuni Foundation (MRC), and the Providence Portland Medical Foundation (KSB). Additional funding was provided by Aduro Biotech in the form of salaries to authors PL and BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from Susan G. Komen CCR12226309 (KSB), NIH R01CA182311 (MJG and MRC) and R21AI126151 (MRC and MJG), the Kuni Foundation (MRC), and the Providence Portland Medical Foundation (KSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of K<SUP>k</SUP> -EEKKGNYV tetramers.	Ashley DM, 1997, J NEUROIMMUNOL, V78, P34, DOI 10.1016/S0165-5728(97)00080-5; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Gan HK, 2013, FEBS J, V280, P5350, DOI 10.1111/febs.12393; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Heimberger AB, 2003, CLIN CANCER RES, V9, P4247; Heimberger AB, 2002, NEUROSURGERY, V50, P158, DOI 10.1097/00006123-200201000-00024; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jungbluth AA, 2003, P NATL ACAD SCI USA, V100, P639, DOI 10.1073/pnas.232686499; Khurana D, 2001, HEAD NECK-J SCI SPEC, V23, P899, DOI 10.1002/hed.1130; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; Learn CA, 2004, CLIN CANCER RES, V10, P3216, DOI 10.1158/1078-0432.CCR-03-0521; Leong ML, 2009, INFECT IMMUN, V77, P3958, DOI 10.1128/IAI.01274-08; Li L, 2009, NEURO-ONCOLOGY, V11, P9, DOI 10.1215/15228517-2008-081; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Nagane M, 2001, J NEUROSURG, V95, P472, DOI 10.3171/jns.2001.95.3.0472; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Purev E, 2004, J IMMUNOL, V173, P6472, DOI 10.4049/jimmunol.173.10.6472; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; Shinojima N, 2003, CANCER RES, V63, P6962; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Weller M, 2017, LANCET ONCOL, V18, P1373, DOI 10.1016/S1470-2045(17)30517-X; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0209153	10.1371/journal.pone.0209153	http://dx.doi.org/10.1371/journal.pone.0209153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	30601871	Green Submitted, Green Published, gold			2022-12-26	WOS:000454683200040
J	Carroll, JA; Race, B; Williams, K; Chesebro, B				Carroll, James A.; Race, Brent; Williams, Katie; Chesebro, Bruce			Toll-like receptor 2 confers partial neuroprotection during prion disease	PLOS ONE			English	Article							INNATE IMMUNITY; C5A ANAPHYLATOXINS; MURINE MODELS; MOUSE MODEL; COMPLEMENT; MICROGLIA; EXPRESSION; BRAIN; COMPONENT; SYSTEM	Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. To identify additional components of innate immunity that might impact prion disease within the central nervous system (CNS), we screened RNA from brains of pre-clinical and clinical 22L-infected mice for alterations in genes associated with innate immunity. Transcription of several genes encoding damage-associated molecular pattern (DAMP) proteins and receptors were increased in the brains of prion-infected mice. To investigate the role of some of these proteins in prion disease of the CNS, we infected mice deficient in DAMP receptor genes Tlr2, C3ar1, and C5ar1 with 22L scrapie. Elimination of TLR2 accelerated disease by a median of 10 days, while lack of C3aR1 or C5aR1 had no effect on disease tempo. Histopathologically, all knockout mouse strains tested were similar to infected control mice in gliosis, vacuolation, and PrPSc deposition. Analysis of proinflammatory markers in the brains of infected knockout mice indicated only a few alterations in gene expression suggesting that C5aR1 and TLR2 signaling did not act synergistically in the brains of prion-infected mice. These results indicate that signaling through TLR2 confers partial neuroprotection during prion infection.	[Carroll, James A.; Race, Brent; Williams, Katie; Chesebro, Bruce] NIAID, Lab Persistent Viral Dis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Carroll, JA (corresponding author), NIAID, Lab Persistent Viral Dis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	carrollja2@niaid.nih.gov		Carroll, James/0000-0003-4329-1488	NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000937] Funding Source: NIH RePORTER	NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JAC, BR, KW, and BC were supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jeffrey Severson for assistance with animal husbandry; Nancy Kurtz and Lori Lubke for assistance with immunohistochemical procedures; and Drs. Karin Peterson, Sonja Best, and Suzette Priola for critical reading of the manuscript. This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases.	Ager RR, 2010, J NEUROCHEM, V113, P389, DOI 10.1111/j.1471-4159.2010.06595.x; Aguzzi A, 2017, J CLIN INVEST, V127, P3230, DOI 10.1172/JCI90605; Aguzzi A, 2012, NAT NEUROSCI, V15, P936, DOI 10.1038/nn.3120; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Amor S, 2014, IMMUNOLOGY, V141, P287, DOI 10.1111/imm.12134; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Bradford BM, 2012, VIRUSES-BASEL, V4, P3389, DOI 10.3390/v4123389; Carroll JA, 2018, J VIROL, P487, DOI [10.1038/86562, DOI 10.1038/86562]; Carroll JA, 2017, J GEN VIROL, V98, P2190, DOI 10.1099/jgv.0.000876; Carroll JA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005551; Carroll JA, 2015, J VIROL, V89, P2388, DOI 10.1128/JVI.02952-14; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CAVAILLON JM, 1990, EUR J IMMUNOL, V20, P253, DOI 10.1002/eji.1830200204; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dzamko N, 2017, ACTA NEUROPATHOL, V133, P303, DOI 10.1007/s00401-016-1648-8; Falsig J, 2008, J NEUROSCI RES, V86, P1434, DOI 10.1002/jnr.21590; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Flierl MA, 2006, J INVEST SURG, V19, P255, DOI 10.1080/08941930600778263; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Guo RF, 2003, FASEB J, V17, P1889, DOI 10.1096/fj.03-0009fje; Hajishengallis G, 2016, IMMUNOL REV, V274, P233, DOI 10.1111/imr.12467; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Hernandez MX, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0210-z; Hong S, 2016, DEV CELL, V38, P126, DOI 10.1016/j.devcel.2016.07.006; Hovland A, 2015, ATHEROSCLEROSIS, V241, P480, DOI 10.1016/j.atherosclerosis.2015.05.038; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Ishibashi D, 2012, J VIROL, V86, P4947, DOI 10.1128/JVI.06326-11; Jauneau AC, 2003, FEBS LETT, V537, P17, DOI 10.1016/S0014-5793(03)00060-7; Kane SJ, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00493-17; Kang SG, 2016, GLIA, V64, P937, DOI 10.1002/glia.22973; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; KIM C, 2013, NAT COMMUN, V4; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kofler J, 2011, TOXICOL PATHOL, V39, P103, DOI 10.1177/0192623310387619; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Mabbott NA, 2004, IMMUNOBIOLOGY, V209, P545, DOI 10.1016/j.imbio.2004.06.003; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; MARCEAU F, 1984, J PHARMACOL EXP THER, V230, P749; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Meade-White K, 2007, J VIROL, V81, P4533, DOI 10.1128/JVI.02762-06; Michel B, 2013, INT IMMUNOL, V25, P697, DOI 10.1093/intimm/dxt034; Michel B, 2012, J IMMUNOL, V189, P4520, DOI 10.4049/jimmunol.1201579; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; Moody LR, 2009, PRION, V3, P99, DOI 10.4161/pri.3.2.9059; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Nau R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00138; Nuvolone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117208; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Prinz M, 2003, EMBO REP, V4, P195, DOI 10.1038/sj.embor.embor731; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Sakai K, 2013, J VIROL, V87, P13433, DOI 10.1128/JVI.02072-13; SCHUMACHER WA, 1991, AGENTS ACTIONS, V34, P345, DOI 10.1007/BF01988727; Seow V, 2013, J IMMUNOL, V191, P4308, DOI 10.4049/jimmunol.1301355; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Shastri A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/342931; SHIN HS, 1968, SCIENCE, V162, P361, DOI 10.1126/science.162.3851.361; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tal Y, 2003, J NEUROSCI RES, V71, P286, DOI 10.1002/jnr.10474; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Tribouillard-Tanvier D, 2012, J VIROL, V86, P10377, DOI 10.1128/JVI.01340-12; Tribouillard-Tanvier D, 2009, J VIROL, V83, P11244, DOI 10.1128/JVI.01413-09; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vincenti JE, 2016, J VIROL, V90, P3003, DOI 10.1128/JVI.02613-15; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Woodruff TM, 2010, NEUROMOL MED, V12, P179, DOI 10.1007/s12017-009-8085-y; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	83	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0208559	10.1371/journal.pone.0208559	http://dx.doi.org/10.1371/journal.pone.0208559			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596651	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200016
J	Zhang, JY; Yu, YC; Yeh, JT; Hwang, TC				Zhang, Jingyao; Yu, Ying-Chun; Yeh, Jiunn-Tyng; Hwang, Tzyh-Chang			Functional characterization reveals that zebrafish CFTR prefers to occupy closed channel conformations	PLOS ONE			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; NUCLEOTIDE-BINDING; CHLORIDE CHANNEL; ABC-TRANSPORTERS; ANION CONDUCTION; GATING BEHAVIOR; FLICKERY BLOCK; ATP; MURINE; PHOSPHORYLATION	Cystic fibrosis transmembrane conductance regulator (CFTR), the culprit behind the genetic disease cystic fibrosis (CF), is a phosphorylation-activated, but ATP-gated anion channel. Studies of human CFTR over the past two decades have provided an in-depth understanding of how CFTR works as an ion channel despite its structural resemblance to ABC transporters. Recently-solved cryo-EM structures of unphosphorylated human and zebrafish CFTR (hCFTR and zCFTR), as well as phosphorylated ATP-bound zebrafish and human CFTR offer an unprecedented opportunity to understand CFTR's function at a molecular level. Interestingly, despite millions of years of phylogenetic distance between human and zebrafish, the structures of zCFTR and hCFTR exhibit remarkable similarities. In the current study, we characterized biophysical and pharmacological properties of zCFTR with the patch-clamp technique, and showed surprisingly very different functional properties between these two orthologs. First, while hCFTR has a single-channel conductance of 8.4 pS with a linear I-V curve, zCFTR shows an inwardly-rectified I-V relationship with a single-channel conductance of similar to 3.5 pS. Second, single-channel gating behaviors of phosphorylated zCFTR are very different from those of hCFTR, featuring a very low open probability P-o (0.03 +/- 0.02, vs. similar to 0.50 for hCFTR) with exceedingly long closed events and brief openings. In addition, unlike hCFTR where each open burst is clearly defined with rare short-lived flickery closures, the open bursts of zCFTR are not easily resolved. Third, although abolishing ATP hydrolysis by replacing the catalytic glutamate with glutamine (i.e., E1372Q) drastically prolongs the open bursts defined by the macroscopic relaxation analysis in zCFTR, the Po within a "locked-open" burst of E1372Q-zCFTR is only similar to 0.35 (vs. P-o > 0.94 in E1371Q-hCFTR). Collectively, our data not only provide a reasonable explanation for the unexpected closed-state structure of phosphorylated E1372Q-zCFTR with a canonical ATP-bound dimer of the nucleotide binding domains (NBDs), but also implicate significant structural and functional differences between these two evolutionarily distant orthologs.	[Zhang, Jingyao] Univ Missouri, Dept Bioengn, Columbia, MO USA; [Zhang, Jingyao; Yu, Ying-Chun; Yeh, Jiunn-Tyng; Hwang, Tzyh-Chang] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Hwang, Tzyh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Hwang, TC (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.; Hwang, TC (corresponding author), Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA.	hwangt@health.missouri.edu	Yeh, Jiunn-Tyng/AAQ-6883-2021	Yeh, Jiunn-Tyng/0000-0003-2595-1892	National Institutes of Health [NIHR01DK55835]; Cystic Fibrosis Foundation [Hwang15G0]; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program in Taiwan [102-Y-A-001]; Cystic Fibrosis Foundation Therapeutics (Bethesda, MD, USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program in Taiwan; Cystic Fibrosis Foundation Therapeutics (Bethesda, MD, USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the National Institutes of Health (www.nih.gov, NIHR01DK55835) and the Cystic Fibrosis Foundation (www.cff.org, research grant Hwang15G0) to Tzyh-Chang Hwang. Jiunn-Tyng Yeh is a recipient of a scholarship from the Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program in Taiwan (nymu-e.ym.edu.tw, no. 102-Y-A-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Michel Bagnat (Duke University, Durham, NC) and Dr. Jun Chen (Rockefeller University, New York City, NY) for their generosity in providing us the cDNA constructs for native and codon-optimized zCFTR. We thank Cindy Chu and Shenghui Hu for their technical assistance. We also thank Dr. Robert Bridges (Rosalind Franklin University, Chicago, IL) who directs the Chemical Compound Distribution Program sponsored by Cystic Fibrosis Foundation Therapeutics (Bethesda, MD, USA) for providing GlyH-101 and CFTRinh-172.	Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bartoszewski R, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0025-x; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bose SJ, 2015, BIOCHEM SOC T, V43, P975, DOI 10.1042/BST20150129; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chin S, 2017, CELL MOL LIFE SCI, V74, P57, DOI 10.1007/s00018-016-2388-6; Corradi V, 2018, BIOPHYS J, V114, P1751, DOI 10.1016/j.bpj.2018.03.003; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui GY, 2016, AM J PHYSIOL-LUNG C, V311, pL192, DOI 10.1152/ajplung.00056.2016; Cui GY, 2015, AM J PHYSIOL-LUNG C, V309, pL687, DOI 10.1152/ajplung.00181.2015; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; El Hiani Y, 2016, CELL MOL LIFE SCI, V73, P1917, DOI 10.1007/s00018-015-2113-x; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hadida S, 2014, J MED CHEM, V57, P9776, DOI 10.1021/jm5012808; Hwang TC, 2018, J GEN PHYSIOL, V150, P539, DOI 10.1085/jgp.201711946; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Jih KY, 2017, CURR OPIN PHARMACOL, V34, P98, DOI 10.1016/j.coph.2017.09.015; Jih KY, 2012, PHYSIOLOGY, V27, P351, DOI 10.1152/physiol.00026.2012; Jih KY, 2012, J GEN PHYSIOL, V140, P347, DOI 10.1085/jgp.201210834; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; Lansdell KA, 1998, J PHYSIOL-LONDON, V508, P379, DOI 10.1111/j.1469-7793.1998.379bq.x; Lansdell KA, 1998, J PHYSIOL-LONDON, V512, P751, DOI 10.1111/j.1469-7793.1998.751bd.x; Linsdell P, 1996, AM J PHYSIOL-CELL PH, V271, pC628, DOI 10.1152/ajpcell.1996.271.2.C628; Linsdell P, 2018, CHANNELS, V12, P284, DOI 10.1080/19336950.2018.1502585; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu XM, 2007, AM J RESP CELL MOL, V36, P313, DOI 10.1165/rcmb.2006-0286OC; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Moran O, 2017, CELL MOL LIFE SCI, V74, P85, DOI 10.1007/s00018-016-2390-z; Navis A, 2013, DEVELOPMENT, V140, P1703, DOI 10.1242/dev.091819; Norimatsu Y, 2012, MOL PHARMACOL, V82, P1042, DOI 10.1124/mol.112.080267; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; RIORDAN JR, 1989, SCIENCE, V245, P1066; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Sohma Y, 2015, HDB ION CHANNELS, P627; Stahl M, 2012, AM J PHYSIOL-CELL PH, V302, pC67, DOI 10.1152/ajpcell.00225.2011; Szellas T, 2003, FEBS LETT, V535, P141, DOI 10.1016/S0014-5793(02)03892-9; Szollosi D, 2018, BBA-BIOMEMBRANES, V1860, P818, DOI 10.1016/j.bbamem.2017.10.028; Tabcharani JA, 1997, J GEN PHYSIOL, V110, P341, DOI 10.1085/jgp.110.4.341; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Tsai MF, 2009, J GEN PHYSIOL, V133, P405, DOI 10.1085/jgp.200810186; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Yeh HI, 2015, J GEN PHYSIOL, V145, P47, DOI 10.1085/jgp.201411272; YORIFUJI T, 1991, GENOMICS, V10, P547, DOI 10.1016/0888-7543(91)90434-G; Yu YC, 2016, J PHYSIOL-LONDON, V594, P3227, DOI 10.1113/JP271723; Zhang JY, 2017, J GEN PHYSIOL, V149, P355, DOI 10.1085/jgp.201611664; Zhang JY, 2015, BIOCHEMISTRY-US, V54, P3839, DOI 10.1021/acs.biochem.5b00427; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhou Z, 2001, J PHYSIOL-LONDON, V532, P435, DOI 10.1111/j.1469-7793.2001.0435f.x; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	71	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2018	13	12							e0209862	10.1371/journal.pone.0209862	http://dx.doi.org/10.1371/journal.pone.0209862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0IO	30596737	Green Submitted, Green Published, gold			2022-12-26	WOS:000454627200098
J	da Silva, KE; Maciel, WG; Croda, J; Cayo, R; Ramos, AC; de Sales, RO; Kurihara, MNL; Vasconcelos, NG; Gales, AC; Simionatto, S				da Silva, Kesia Esther; Maciel, Wirlaine Glauce; Croda, Julio; Cayo, Rodrigo; Ramos, Ana Carolina; de Sales, Romario Oliveira; Lucas Kurihara, Mariana Neri; Vasconcelos, Nathalie Gaebler; Gales, Ana Cristina; Simionatto, Simone			A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit	PLOS ONE			English	Article							SPM-1-PRODUCING PSEUDOMONAS-AERUGINOSA; DESORPTION IONIZATION-TIME; BLOOD-STREAM INFECTIONS; HIGH-RISK CLONES; CARBAPENEM RESISTANCE; MASS-SPECTROMETRY; EMERGENCE; SPREAD; IMPACT; COLONIZATION	The global spread of carbapenem-resistant Acinetobacter baumannii (A. baumannii) strains has restricted the therapeutic options available to treat infections due to this pathogen. Understanding the prevalence of such infections and the underlying genetic mechanisms of resistance may help in the implementation of adequate measures to control and prevent acquisition of nosocomial infections, especially in an intensive care unit setting. This study describes the molecular characteristics and risk factors associated with OXA-23-producing A. baumannii infections. A case-control study was undertaken from September/2013 to April/2015. Acquisition of OXA-23-producing A. baumannii was found to be associated with the use of nasogastric tubes, haemodialysis, and the use of cephalosporins. These isolates were only susceptible to amikacin, gentamicin, tigecycline, and colistin, and contained the ISAba1 insertion sequence upstream of bla(OXA-23) and bla(OXA-51) genes. Twenty-six OXA-23-producing A. baumannii strains belonged to the ST79 (CC79) clonal group, and patients infected or colonised by these isolates had a higher mortality rate (34.6%). In conclusion, this study showed a dissemination of OXA-23-producing A. baumannii strains that was associated with several healthcare-related risk factors and high mortality rates among intensive care unit patients.	[da Silva, Kesia Esther; Maciel, Wirlaine Glauce; Croda, Julio; de Sales, Romario Oliveira; Lucas Kurihara, Mariana Neri; Vasconcelos, Nathalie Gaebler; Simionatto, Simone] UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil; [Croda, Julio] Fundacao Osvaldo Cruz FIOCRUZ, Campo Grande, MS, Brazil; [Croda, Julio] UFGD, Fac Med, Dourados, MS, Brazil; [Cayo, Rodrigo; Ramos, Ana Carolina; Gales, Ana Cristina] Univ Fed Sao Paulo UNIFESP, Lab Alerta, Disciplina Infectol, Dept Med,EPM, Sao Paulo, SP, Brazil	Universidade Federal da Grande Dourados; Fundacao Oswaldo Cruz; Universidade Federal da Grande Dourados; Universidade Federal de Sao Paulo (UNIFESP)	Simionatto, S (corresponding author), UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.	simonesimionatto@ufgd.edu.br	Simionatto, Simone/AAG-7509-2020; Croda, Julio/I-5172-2013; Gales, Ana Cristina/C-8280-2013	Simionatto, Simone/0000-0003-2367-0915; Croda, Julio/0000-0002-6665-6825; Gales, Ana Cristina/0000-0003-0913-768X; Cayo, Rodrigo/0000-0002-0709-6282; Oliveira de Sales, Romario/0000-0002-4668-6752	National Council for Science and Technological Development (CNPq) [480949/2013-1]; Support Foundation for the Development of Education, Science and Technology of Mato Grosso do Sul state of (FUNDECT) [0212/12, 0077/12, 0068/13, 44/2014, 092/2015]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88887.103413/2015-01, PNPD 20131991]; CNPq [307816/2009-5]	National Council for Science and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Support Foundation for the Development of Education, Science and Technology of Mato Grosso do Sul state of (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was partially supported by the National Council for Science and Technological Development (CNPq grants 480949/2013-1), the Support Foundation for the Development of Education, Science and Technology of Mato Grosso do Sul state of (FUNDECT grants 0212/12, 0077/12, 0068/13, 44/2014, and 092/2015) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, 88887.103413/2015-01). W. G. M., K. E. S., A. C. R., and R. C. (PNPD 20131991) received scholarship grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). A. C. G. is a researcher from the CNPq (Process number: 307816/2009-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoba EE, 2018, MICROB DRUG RESIST; Arantes A, 2003, REV SAUDE PUBL, V37, P768, DOI 10.1590/S0034-89102003000600012; Castilho SRA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176790; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Cardoso JP, 2016, DIAGN MICR INFEC DIS, V85, P90, DOI 10.1016/j.diagmicrobio.2016.01.018; Carvalhaes CG, 2013, J CLIN MICROBIOL, V51, P287, DOI 10.1128/JCM.02365-12; Chan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085973; Cheng VCC, 2016, INFECT CONT HOSP EP, V37, P983, DOI 10.1017/ice.2016.84; Chopra T, 2014, ANTIMICROB AGENTS CH, V58, P4630, DOI 10.1128/AAC.02441-14; Chusri S, 2015, J INFECT CHEMOTHER, V21, P90, DOI 10.1016/j.jiac.2014.10.002; Fehlberg LCC, 2014, ANTIMICROB AGENTS CH, V58, P1831, DOI 10.1128/AAC.01260-13; Fehlberg LCC, 2013, DIAGN MICR INFEC DIS, V77, P126, DOI 10.1016/j.diagmicrobio.2013.06.011; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eijkelkamp BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1020; Ellis D, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0083-2; European Committee on Antimicrobial Susceptibility Testing, 2018, BREAKP TABL INT MICS; Chagas TPG, 2014, DIAGN MICR INFEC DIS, V79, P468, DOI 10.1016/j.diagmicrobio.2014.03.006; Henig O, 2015, EUR J CLIN MICROBIOL, V34, P2063, DOI 10.1007/s10096-015-2452-4; Rodriguez CH, 2018, REV ARGENT MICROBIOL, V50, P327, DOI 10.1016/j.ram.2017.10.006; Institute C Standards L, 2017, M100 CLSI S; Kumar A, 2014, J INFECT DEV COUNTR, V8, P1049, DOI 10.3855/jidc.4248; Levy-Blitchteini S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0127-9; Maamar E, 2018, INT J ANTIMICROB AGE; Maciel WG, 2018, J HOSP INFECT, V98, P300, DOI 10.1016/j.jhin.2017.10.015; Moghnieh R, 2016, J HOSP INFECT, V92, P47, DOI 10.1016/j.jhin.2015.10.007; Nasrolahei M, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0038-0; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Pagano M, 2017, INFECT CONT HOSP EP, V38, P252, DOI 10.1017/ice.2016.287; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pillonetto M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3287-2; Rocha IV, 2018, BRAZ J INFECT DIS; Royer S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198643; Ryoo NH, 2010, KOREAN J CLIN MICROB, V13, P169; Sennati S, 2016, J GLOB ANTIMICROB RE, V4, P70, DOI 10.1016/j.jgar.2015.10.007; Sydnor ERM, 2011, CLIN MICROBIOL REV, V24, P141, DOI 10.1128/CMR.00027-10; Turano H, 2016, DIAGN MICR INFEC DIS, V86, P80, DOI 10.1016/j.diagmicrobio.2016.06.005; Turkoglu M, 2011, J CRIT CARE, V26, P460, DOI 10.1016/j.jcrc.2011.04.007; Vasconcelos ATR, 2015, DIAGN MICR INFEC DIS, V83, P382, DOI 10.1016/j.diagmicrobio.2015.08.006; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Young HL, 2018, INFECT CONT HOSP EP, V39, P1273, DOI 10.1017/ice.2018.202; Zarrilli R, 2012, J HOSP INFECT, V82, P260, DOI 10.1016/j.jhin.2012.08.018	42	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2018	13	12							e0209367	10.1371/journal.pone.0209367	http://dx.doi.org/10.1371/journal.pone.0209367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0GV	30592758	Green Submitted, Green Published, gold			2022-12-26	WOS:000454621900022
J	Huang, CW; Hwang, IH; Lee, YS; Hwang, SJ; Ko, SG; Chen, FP; Jang, BH				Huang, Ching-Wen; Hwang, I-Hsuan; Lee, Ye-seul; Hwang, Shinn-Jang; Ko, Seong-Gyu; Chen, Fang-Pey; Jang, Bo-Hyoung			Utilization patterns of traditional medicine in Taiwan and South Korea by using national health insurance data in 2011	PLOS ONE			English	Article								Background The growing popularity of traditional medicine (TM) is reflected in the increasing trend for its use worldwide. Many people are turning to use TM as a complementary or integrative treatment. The aim of this study is to present the first nationwide report describing the use of TM in two countries (South Korea and Taiwan). Materials and methods To present the TM utilization patterns between South Korea and Taiwan, we analyzed data from the National Health Insurance cohorts in each country, each of which has approximately one million inhabitants. Results In total, 261,478 (25.5%) of 1,025,340 people in South Korea and 260,529 (26.8%) of 970,866 people in Taiwan used TM services at least once under the National Health Insurance in 2011. Using multivariable logistic regression, TM users in South Korea were significantly more likely to be female, 61-80 years of age and individuals with a high income, and those in Taiwan were significantly more likely to be female, 21-40 years of age and individuals with a middle income. The two countries showed similar utilization patterns in visit seasons. People visited TM clinics more frequently than TM hospitals in both countries. The most common TM treatment in South Korea was acupuncture, whereas in Taiwan, various powdered Chinese herbal preparations were the most commonly used treatment. The most common diseases for people seeking TM services were musculoskeletal system and connective tissue diseases in South Korea and Symptoms, signs, and ill-defined conditions in Taiwan. Conclusion According to the National Health Insurance database, about one fourth of the NHI beneficiaries of South Korea and Taiwan had TM use in 2011. Different TM utilization patterns existed between South Korea and Taiwan, which might be due to the differences in insurance coverage between the two countries.	[Huang, Ching-Wen; Ko, Seong-Gyu; Jang, Bo-Hyoung] Kyung Hee Univ, Dept Prevent Med, Coll Korean Med, Seoul, South Korea; [Huang, Ching-Wen; Ko, Seong-Gyu] Kyung Hee Univ, Grad Sch, Dept Sci Korean Med, 26 Kyungheedae Ro, Seoul, South Korea; [Hwang, I-Hsuan] Cheng Hsin Gen Hosp, Ctr Qual Control, Taipei, Taiwan; [Lee, Ye-seul] Gachon Univ, Coll Korean Med, Dept Anat & Acupoint, Seongnam, South Korea; [Hwang, Shinn-Jang] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hwang, Shinn-Jang] Natl Yang Ming Univ, Sch Med, Dept Family Med, Taipei, Taiwan; [Chen, Fang-Pey] Taipei Vet Gen Hosp, Ctr Tradit Med, Taipei, Taiwan; [Chen, Fang-Pey] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei, Taiwan	Kyung Hee University; Kyung Hee University; Cheng Hsin General Hospital; Gachon University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Jang, BH (corresponding author), Kyung Hee Univ, Dept Prevent Med, Coll Korean Med, Seoul, South Korea.; Chen, FP (corresponding author), Taipei Vet Gen Hosp, Ctr Tradit Med, Taipei, Taiwan.; Chen, FP (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei, Taiwan.	fpchen@vghtpe.gov.tw; bhjang@khu.ac.kr	Jang, Bo-Hyoung/ABF-2923-2020	Lee, Ye-Seul/0000-0001-6127-5401; Jang, Bo-Hyoung/0000-0002-2141-3483	Basic Science Research Program through the National Research Foundation of Korea [NRF-2018R1D1A1A02077145]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea. (No. NRF-2018R1D1A1A02077145).	Association of Korean Oriental Medicine Institute of Oriental Medicine Pusan National University School of Korean Medicine, 2012, YB TRAD KOR MED 2011; Chen FP, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-26; Hamsten A., 2014, CAN MED ASSOC J, V186, P9; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Huang TP, 2014, COMPLEMENT THER MED, V22, P500, DOI 10.1016/j.ctim.2014.04.002; Ishikawa H., 2014, JAP MED ASS J, V54, P192; Lai JN, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/891893; Leung SW, 2016, EVIDENCE BASED RES M; Lim B, 2013, INTEGR MED RES, V2, P81, DOI 10.1016/j.imr.2013.06.004; Ministry of Health and Welfare, 2011, STAT ANN REP MED CAR; Ministry of Health and Welfare, NHI W MED INP US TRA; Ministry of Health and Welfare, 2016, HEALTH AND NATIONAL; Ministry of Health and Welfare, 2016, 3 FOST DEV PLAN KOR; Park HL, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/429103, DOI 10.1155/2012/429103]; Snadal Jon, 2014, Japan Med Assoc J, V57, P68; World Health Organization, 2016, ICD 11 BETA DRAFT JO; Yang PR, 2015, J ETHNOPHARMACOL, V169, P328, DOI 10.1016/j.jep.2015.04.046; Yang SH, 2001, INT IMMUNOPHARMACOL, V1, P1173, DOI 10.1016/S1567-5769(01)00051-0	18	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2018	13	12							e0208569	10.1371/journal.pone.0208569	http://dx.doi.org/10.1371/journal.pone.0208569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7KM	30589852	Green Submitted, gold, Green Published			2022-12-26	WOS:000454418200007
J	Park, IK; Park, J; Kim, TH; Lee, J; Han, K; Oh, C; Park, CH				Park, In Kyung; Park, Jeffrey; Kim, Tae Hoon; Lee, Joohee; Han, Kyunghwa; Oh, Chisuk; Park, Chul Hwan			Non-inferior low-dose coronary computed tomography angiography image quality with knowledge-based iterative model reconstruction for overweight patients	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; CT ANGIOGRAPHY; RADIATION-EXPOSURE; CARDIAC-CT; MULTICENTER; ACQUISITION; PROTOCOLS	We investigated the feasibility of low-dose coronary computed tomography angiography (CCTA), using a prospective electrocardiogram (ECG)-triggered axial scan protocol, knowledge-based iterative model reconstruction (IMR), and fixed tube current, in overweight subjects. Forty non-overweight (group A; body-mass index [BMI] < 25 kg/m(2)) and 40 overweight individuals (group B; BMI = 25-30 kg/m(2)), who underwent CCTA for coronary artery disease screening, were retrospectively and consecutively enrolled. A 64-slice CT scanner was used at 100-kVp tube voltage and 150-mA tube current, and images were reconstructed using IMR techniques. Image noise, attenuation at the aorta, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) at the proximal right and left main coronary arteries (pRCA and LMCA) were calculated. CCTA images were qualitatively evaluated using a four-point scale (1, poor; 4, excellent) and analyzed using a non-inferiority test with a pre-defined non-inferiority margin of -0.2. The mean CCTA radiation dose (Group A: 1.33 +/- 0.02 mSv; Group B: 1.35 +/- 0.10 mSv; p = 0.151) and mean aortic root CT attenuation values (Group A: 447.9 +/- 81.6 HU; Group B: 439.5 +/- 63.6 HU; p = 0.571) did not differ significantly between the two groups. The mean noise in groups A and B was 26.0 +/- 4.8 HU and 29.2 +/- 4.4 HU, respectively (p = 0.005). The noise reduction ratio in the groups, compared to filtered back projection, was 65.0% and 68.1%, respectively. The mean grade of image quality did not differ significantly (3.75 +/- 0.04 vs. 3.71 +/- 0.04, p = 0.478). Group B CCTA image quality was non-inferior (mean difference = -0.043, 95% CI = -0.162-0.077) to that of Group A. We concluded that low-dose CCTA with prospective ECG-triggering and IMR might be applied to overweight subjects, as well as to normal-weight subjects, by using a fixed tube current without an increase in tube current based on the patient's body size.	[Park, In Kyung; Kim, Tae Hoon; Lee, Joohee; Oh, Chisuk; Park, Chul Hwan] Yonsei Univ, Coll Med, Dept Radiol, Gangnam Severance Hosp, Seoul, South Korea; [Park, In Kyung; Kim, Tae Hoon; Lee, Joohee; Oh, Chisuk; Park, Chul Hwan] Yonsei Univ, Res Inst Radiol Sci, Gangnam Severance Hosp, Coll Med, Seoul, South Korea; [Park, Jeffrey] Univ Calif Berkeley, Coll Letters & Sci, Berkeley, CA 94720 USA; [Han, Kyunghwa] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea; [Han, Kyunghwa] Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California Berkeley; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, CH (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Gangnam Severance Hosp, Seoul, South Korea.; Park, CH (corresponding author), Yonsei Univ, Res Inst Radiol Sci, Gangnam Severance Hosp, Coll Med, Seoul, South Korea.	park_chulhwan@yuhs.ac	Nam, Jae Do/F-2201-2013	/0000-0003-3598-2529; Park, Chul Hwan/0000-0002-0004-9475; Han, Kyunghwa/0000-0002-5687-7237				Abbara S, 2016, J CARDIOVASC COMPUT, V10, P435, DOI 10.1016/j.jcct.2016.10.002; Bischoff B, 2009, JACC-CARDIOVASC IMAG, V2, P940, DOI 10.1016/j.jcmg.2009.02.015; Bogaard K, 2015, INT J CARDIOVAS IMAG, V31, P125, DOI 10.1007/s10554-014-0515-8; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Den Harder AM, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150068; Deseive S, 2015, JACC-CARDIOVASC IMAG, V8, P888, DOI 10.1016/j.jcmg.2015.02.024; Deseive S, 2015, J CARDIOVASC COMPUT, V9, P278, DOI 10.1016/j.jcct.2015.03.001; Fuchs TA, 2014, EUR HEART J, V35, P1131, DOI 10.1093/eurheartj/ehu053; Halpern EJ, 2014, ACAD RADIOL, V21, P805, DOI 10.1016/j.acra.2014.02.017; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Hausleiter J, 2012, JACC-CARDIOVASC IMAG, V5, P484, DOI 10.1016/j.jcmg.2011.12.017; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Hong YJ, 2011, INT J CARDIOVAS IMAG, V27, P425, DOI 10.1007/s10554-010-9674-4; Lee J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163410; Leschka S, 2008, EUR RADIOL, V18, P1809, DOI 10.1007/s00330-008-0966-1; Menke J, 2005, RADIOLOGY, V236, P565, DOI 10.1148/radiol.2362041327; Oda S, 2014, EUR J RADIOL, V83, P1408, DOI 10.1016/j.ejrad.2014.04.027; Oda S, 2014, ACAD RADIOL, V21, P104, DOI 10.1016/j.acra.2013.10.002; Park CH, 2015, INT J CARDIOVAS IMAG, V31, P197, DOI 10.1007/s10554-015-0795-7; Scheffel H, 2012, EUR J RADIOL, V81, pE363, DOI 10.1016/j.ejrad.2011.11.051; Schoenhagen P, 2012, CURR CARDIOL REP, V14, DOI 10.1007/s11886-011-0225-y; Tang K, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/130169; Trattner S, 2014, J AM COLL RADIOL, V11, P271, DOI 10.1016/j.jacr.2013.10.016; Wang D, 2012, INT J CARDIOVAS IMAG, V28, P415, DOI 10.1007/s10554-011-9822-5; Yuki H, 2014, J CARDIOVASC COMPUT, V8, P115, DOI 10.1016/j.jcct.2013.12.010	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2018	13	12							e0209243	10.1371/journal.pone.0209243	http://dx.doi.org/10.1371/journal.pone.0209243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF7JV	30586449	Green Submitted, Green Published, gold			2022-12-26	WOS:000454416400056
